data_1prs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1prs _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.812 0.339 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -179.53 131.4 0.1 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.166 -1.013 . . . . 0.0 110.699 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.7 pt -73.44 153.22 7.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.453 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.0 m -130.44 116.43 18.23 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.886 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 m -96.67 172.08 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.515 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.971 ' CE2' ' NE2' ' A' ' 16' ' ' GLN . 16.1 m-85 -130.72 134.85 47.26 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.878 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -59.28 5.5 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.214 -0.995 . . . . 0.0 112.777 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.552 ' N ' HD21 ' A' ' 9' ' ' ASN . 1.9 m120 -89.03 167.04 13.48 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.478 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.584 ' CG ' ' H ' ' A' ' 11' ' ' ASP . 16.4 tt0 -77.16 -178.23 4.94 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.918 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.584 ' H ' ' CG ' ' A' ' 10' ' ' GLU . 4.7 t0 60.77 43.64 11.95 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.61 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.414 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 35.8 t80 49.3 15.47 0.12 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.497 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.503 ' CG ' ' N ' ' A' ' 14' ' ' GLY . 8.1 tt0 -103.02 168.93 8.87 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.833 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.549 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 89.53 124.49 2.56 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.816 -1.183 . . . . 0.0 111.143 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 14' ' ' GLY . 7.2 mmmm -29.95 137.76 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 123.921 0.424 . . . . 0.0 111.643 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.971 ' NE2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -103.51 170.92 7.66 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.678 -0.809 . . . . 0.0 112.087 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.6 t -142.03 134.41 27.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.804 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -92.98 117.16 29.75 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.578 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.1 mt -113.03 132.99 22.12 Favored Pre-proline 0 N--CA 1.492 1.625 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.075 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.11 160.64 43.72 Favored 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 120.94 1.093 . . . . 0.0 111.208 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.85 -159.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 121.615 1.543 . . . . 0.0 111.017 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.437 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 84.32 176.36 51.06 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.318 -1.42 . . . . 0.0 111.001 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.628 ' CA ' HH21 ' A' ' 83' ' ' ARG . 1.4 p30 -103.3 135.92 44.04 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.543 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.413 ' OH ' ' CD1' ' A' ' 82' ' ' ILE . 51.6 p90 -158.31 -174.61 4.89 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.119 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.642 ' CG2' ' N ' ' A' ' 26' ' ' ARG . 5.4 t -161.03 -150.02 0.19 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.396 -1.321 . . . . 0.0 112.297 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.642 ' N ' ' CG2' ' A' ' 25' ' ' THR . 11.9 ttt-85 -56.79 -31.04 64.27 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.253 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.509 ' H ' HG21 ' A' ' 25' ' ' THR . . . -60.99 -63.35 1.33 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.569 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -57.48 -44.28 84.78 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.485 -1.286 . . . . 0.0 109.822 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.6 mt -58.78 -37.6 76.66 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.71 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.35 -33.71 44.19 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 118.537 -1.265 . . . . 0.0 107.762 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.44 -40.84 89.71 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.375 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.3 mt -72.81 -80.84 0.06 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.79 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.58 -29.18 0.29 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.841 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.8 tt -82.64 151.13 4.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.724 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 4.3 pt-20 -179.93 146.25 0.24 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.552 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 4.0 t30 74.61 -143.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.065 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.523 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.3 m-80 -58.79 82.08 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.612 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 36' ' ' ASN . 43.4 p -149.33 -46.36 0.14 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.226 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mt -68.45 71.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.623 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 38' ' ' THR . 33.5 t -75.31 -72.1 0.32 Allowed 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.403 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -95.64 167.43 11.3 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.965 -1.094 . . . . 0.0 109.626 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.32 154.37 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 118.786 -1.166 . . . . 0.0 112.394 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -145.1 104.01 3.92 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.75 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.6 t -126.5 111.26 23.14 Favored Pre-proline 0 N--CA 1.496 1.842 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.63 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.37 168.21 18.48 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 121.081 1.187 . . . . 0.0 110.808 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 48' ' ' VAL . 1.4 Cg_endo -62.93 -170.22 0.1 OUTLIER 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 121.843 1.695 . . . . 0.0 110.971 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.85 -12.04 31.46 Favored Glycine 0 N--CA 1.48 1.614 0 C-N-CA 118.829 -1.653 . . . . 0.0 109.627 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.426 ' H ' ' C ' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -155.87 149.47 11.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.448 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.417 ' N ' HG21 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -121.09 127.2 51.41 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.616 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.61 157.02 17.47 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.359 -0.936 . . . . 0.0 113.096 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 60.3 mt -136.11 115.41 16.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.453 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.71 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 2.1 mp -89.97 161.22 16.0 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.857 -1.137 . . . . 0.0 112.763 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.506 ' OH ' ' NE2' ' A' ' 62' ' ' GLN . 5.5 m-85 -140.58 109.95 6.25 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.782 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.651 HE21 ' ND2' ' A' ' 55' ' ' ASN . 11.7 tt0 -43.52 -87.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.035 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.651 ' ND2' HE21 ' A' ' 54' ' ' GLN . 3.3 m120 -59.92 145.45 45.85 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.093 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.19 -174.92 0.06 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.518 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.84 26.7 58.25 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.178 -1.487 . . . . 0.0 110.025 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 55.31 65.03 1.59 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.51 175.35 10.63 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.439 -0.905 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.25 168.0 32.07 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.257 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -49.3 129.17 18.09 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.348 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.506 ' NE2' ' OH ' ' A' ' 53' ' ' TYR . 1.4 pt20 -101.0 179.04 4.5 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.119 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.467 HG23 ' H ' ' A' ' 64' ' ' GLU . 4.7 mt -144.04 169.01 10.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.404 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.467 ' H ' HG23 ' A' ' 63' ' ' ILE . 38.7 tt0 -145.09 128.62 17.04 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.955 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.7 m -149.31 167.14 3.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.902 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 t -146.64 -2.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.527 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.42 -154.11 0.61 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.882 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.05 155.18 16.86 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.566 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.42 87.06 2.35 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.225 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -51.9 -43.15 63.23 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.346 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 72' ' ' LEU . 5.5 mm-40 -123.88 81.19 1.88 Allowed 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.586 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 71' ' ' GLU . 1.2 tp -28.96 -81.22 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.702 0.626 . . . . 0.0 112.545 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.31 -165.92 36.63 Favored Glycine 0 N--CA 1.497 2.701 0 C-N-CA 118.901 -1.618 . . . . 0.0 111.09 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.493 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.8 Cg_endo -67.37 -44.21 5.02 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 122.148 1.899 . . . . 0.0 112.055 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.43 ' H ' HD22 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -69.74 10.45 0.38 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.059 -1.056 . . . . 0.0 111.289 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.493 ' H ' ' C ' ' A' ' 74' ' ' PRO . 20.4 t-20 -70.13 1.45 4.7 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.61 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -74.7 -5.2 41.85 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.712 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -167.3 124.42 1.2 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.295 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.4 t -145.97 140.24 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.67 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 m -159.7 -31.92 0.06 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.092 -1.043 . . . . 0.0 112.292 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.46 ' OG ' ' OG1' ' A' ' 25' ' ' THR . 3.0 m -103.86 142.93 33.54 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.439 -0.905 . . . . 0.0 111.339 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.413 ' CD1' ' OH ' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -149.15 162.2 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.73 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.784 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -146.06 116.38 7.49 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.396 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.784 ' H ' HH22 ' A' ' 83' ' ' ARG . 10.2 t -119.3 137.77 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 120.056 -0.657 . . . . 0.0 111.636 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.588 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 4.5 mt -139.13 126.67 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.51 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.5 p -40.54 154.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.585 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.93 146.79 19.65 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.65 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -51.18 159.35 2.82 Favored 'Trans proline' 0 C--N 1.325 -0.7 0 C-N-CA 121.805 1.67 . . . . 0.0 112.164 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.8 m -69.67 134.68 29.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.326 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -140.25 124.58 10.85 Favored Pre-proline 0 N--CA 1.489 1.488 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.113 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -59.79 -164.11 0.03 OUTLIER 'Trans proline' 0 C--O 1.21 -0.912 0 C-N-CA 120.758 0.972 . . . . 0.0 110.516 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.451 ' CA ' HD13 ' A' ' 136' ' ' LEU . 20.8 ptt-85 -177.48 -160.29 0.05 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.913 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.81 154.25 48.45 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.92 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -123.94 122.26 37.49 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.812 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 24.8 m-85 -108.71 151.41 26.22 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.041 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.4 ' CD2' ' HA ' ' A' ' 101' ' ' PHE . 31.3 m-85 -118.53 159.06 24.22 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.927 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.434 ' HB2' ' N ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -78.68 -83.29 0.09 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 118.162 -1.415 . . . . 0.0 111.781 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.677 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 4.6 mmmm -56.07 157.87 4.33 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.6 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 29.2 tt0 -79.62 86.62 5.23 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.524 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.98 HE21 ' C ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 162.77 48.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.625 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 24.7 p90 39.96 41.06 0.82 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.102 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.55 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 43.1 m-20 -142.75 -174.46 4.17 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.635 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.484 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 75.89 161.77 11.18 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 118.92 -1.609 . . . . 0.0 109.498 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 103' ' ' GLY . 7.3 mtpm? -27.58 122.82 0.1 Allowed 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 121.244 0.545 . . . . 0.0 112.09 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.09 137.21 40.66 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.572 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.73 151.57 24.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.021 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -143.66 151.15 39.74 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.098 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.8 mt -139.25 143.81 37.88 Favored Pre-proline 0 N--CA 1.497 1.876 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.617 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -71.23 170.17 18.9 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 121.724 1.616 . . . . 0.0 111.052 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.42 ' HA ' ' CG2' ' A' ' 172' ' ' ILE . 3.7 Cg_exo -60.44 141.55 95.83 Favored 'Trans proline' 0 C--N 1.321 -0.921 0 C-N-CA 121.728 1.619 . . . . 0.0 110.972 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.649 ' C ' ' NE2' ' A' ' 112' ' ' GLN . . . 150.2 -153.78 25.27 Favored Glycine 0 N--CA 1.497 2.759 0 C-N-CA 118.675 -1.726 . . . . 0.0 111.49 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.649 ' NE2' ' C ' ' A' ' 111' ' ' GLY . 11.7 mp0 -131.36 148.16 52.64 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.614 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.631 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 3.3 m-85 -139.63 157.15 46.27 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.606 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.4 p -119.0 -175.46 2.91 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -77.88 47.78 0.66 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.216 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.41 -56.47 0.09 Allowed 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.329 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.468 ' HG2' ' N ' ' A' ' 118' ' ' LEU . 1.7 tt0 -76.77 -58.0 3.53 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.543 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -36.99 -69.5 0.11 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.74 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 120' ' ' ARG . 0.6 OUTLIER -49.57 -63.12 1.2 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.166 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.459 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 0.1 OUTLIER -75.86 24.18 0.13 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.284 -0.966 . . . . 0.0 112.575 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.461 ' O ' ' CG ' ' A' ' 121' ' ' TYR . 33.7 t80 -131.81 -9.16 3.53 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.368 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.28 -46.94 0.02 OUTLIER Glycine 0 C--N 1.29 -1.998 0 C-N-CA 118.87 -1.633 . . . . 0.0 110.526 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.492 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -141.18 -98.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.281 -0.967 . . . . 0.0 110.66 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.492 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 7.4 t0 -168.37 -166.2 0.67 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.729 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.45 ' ND2' ' OE1' ' A' ' 119' ' ' GLU . 10.0 m120 -59.75 -6.79 1.32 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.134 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.503 ' CG ' ' H ' ' A' ' 127' ' ' THR . 44.5 t30 -172.09 -134.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.189 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.503 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 0.5 OUTLIER 36.56 69.07 0.22 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.203 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.5 ' O ' ' CB ' ' A' ' 129' ' ' SER . 8.0 mm -102.25 -86.68 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.388 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 84.83 -166.54 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' SER . 10.9 m -17.98 120.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.7 -1.591 . . . . 0.0 114.703 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.45 HG12 ' CD2' ' A' ' 95' ' ' PHE . 3.5 t -121.76 149.83 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.544 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -143.82 95.69 5.71 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 119.536 -0.865 . . . . 0.0 110.863 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -53.78 112.46 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.16 1.24 . . . . 0.0 111.099 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -79.46 -17.27 54.59 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.84 -32.68 0.02 OUTLIER Glycine 0 N--CA 1.488 2.158 0 C-N-CA 118.752 -1.689 . . . . 0.0 111.93 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.451 HD13 ' CA ' ' A' ' 92' ' ' ARG . 0.4 OUTLIER -121.26 156.38 32.61 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.155 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.29 153.43 39.37 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 118.863 -1.135 . . . . 0.0 110.077 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.9 140.21 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.859 -0.736 . . . . 0.0 112.046 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.93 127.19 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.231 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 mp -105.79 148.95 26.92 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 119.396 -0.922 . . . . 0.0 113.211 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.545 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 2.4 m-85 -121.34 146.34 46.95 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.754 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -107.86 43.08 1.24 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.302 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -169.91 156.28 6.11 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.856 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 146' ' ' PHE . 32.0 t70 -57.75 175.83 0.17 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.298 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.642 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 8.0 p-10 34.59 32.44 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.964 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.642 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.3 p90 40.72 64.8 0.89 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.198 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.505 ' CB ' ' ND2' ' A' ' 145' ' ' ASN . 25.6 t -144.19 97.05 2.98 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.865 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.96 -156.79 28.03 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -60.21 157.62 13.01 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.963 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.5 p -150.14 170.94 17.73 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.984 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.435 ' C ' ' CD2' ' A' ' 151' ' ' LEU . 1.2 tt -142.44 91.33 7.69 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.035 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.32 107.37 1.57 Allowed 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.945 1.764 . . . . 0.0 113.598 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.6 t -84.12 89.15 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.089 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.594 ' C ' HD21 ' A' ' 154' ' ' ASN . 0.4 OUTLIER -80.73 11.58 3.76 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.4 p -170.04 -171.81 1.22 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.62 -1.632 . . . . 0.0 113.136 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -58.1 148.37 26.76 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.028 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.635 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -166.53 74.85 1.15 Allowed Pre-proline 0 C--N 1.304 -1.378 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.954 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.78 21.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.734 1.623 . . . . 0.0 111.999 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.635 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.4 OUTLIER -169.42 112.68 0.51 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.795 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.0 tp -146.64 17.95 1.3 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.195 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 C-N-CA 119.241 -1.457 . . . . 0.0 110.299 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.826 0.346 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 13.1 m -76.14 98.28 4.34 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.955 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 9.1 m -82.82 -40.1 20.82 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.72 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.49 159.83 41.7 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.619 -1.233 . . . . 0.0 111.139 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.413 HG12 ' CD1' ' A' ' 118' ' ' LEU . 15.5 pt -140.64 163.02 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.22 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -145.07 102.39 3.75 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.025 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.42 ' CG2' ' HA ' ' A' ' 110' ' ' PRO . 4.9 mt -81.63 100.66 5.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.439 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.896 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.843 0.354 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 2.0 p-10 -172.66 105.66 0.16 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.111 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.6 pt -72.09 156.75 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.622 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -139.75 126.91 21.13 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.818 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -107.28 179.0 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 119.848 -0.741 . . . . 0.0 112.412 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.769 ' CZ ' ' CE1' ' A' ' 12' ' ' PHE . 32.5 m-85 -132.47 144.7 50.64 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.112 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.94 -46.97 27.07 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.497 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 2.4 m-80 -89.33 162.63 15.72 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.296 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.504 ' C ' ' CG ' ' A' ' 11' ' ' ASP . 12.8 mt-10 -72.94 158.48 35.39 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.245 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.1 OUTLIER 76.02 44.73 0.13 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.612 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.769 ' CE1' ' CZ ' ' A' ' 7' ' ' PHE . 70.2 t80 52.78 10.88 0.17 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.631 -0.828 . . . . 0.0 112.079 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.457 ' HG3' ' H ' ' A' ' 14' ' ' GLY . 1.6 tp60 -99.72 171.41 7.91 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.581 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.497 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 86.42 135.71 4.16 Favored Glycine 0 N--CA 1.502 3.072 0 C-N-CA 119.904 -1.141 . . . . 0.0 111.267 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 14' ' ' GLY . 15.9 mtpp -31.46 141.47 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.913 0.419 . . . . 0.0 111.727 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.588 ' NE2' ' CZ ' ' A' ' 7' ' ' PHE . 2.3 pt20 -110.14 172.52 6.81 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.873 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.3 t -146.79 133.91 14.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.414 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -89.93 139.94 30.11 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.312 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.0 mt -135.69 133.02 19.85 Favored Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 120.026 -0.669 . . . . 0.0 110.714 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -69.69 155.16 66.88 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 121.081 1.187 . . . . 0.0 110.999 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.66 -166.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.497 1.464 . . . . 0.0 110.803 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.39 -161.03 26.08 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.951 -1.595 . . . . 0.0 110.671 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -128.04 127.42 43.13 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.997 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -144.46 -171.58 3.62 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.92 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.0 p -142.62 -170.54 3.23 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.262 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -59.41 -22.07 60.89 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.883 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.96 -58.86 6.65 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.882 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.474 ' NE2' ' CD2' ' A' ' 32' ' ' LEU . 29.2 tp60 -54.92 -44.54 74.31 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.029 -1.069 . . . . 0.0 109.398 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 31.4 mt -57.08 -42.34 80.51 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.294 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.3 -30.54 18.46 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.825 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.75 -34.76 64.88 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.941 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.474 ' CD2' ' NE2' ' A' ' 28' ' ' GLN . 11.7 mt -78.88 -72.97 0.36 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.579 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.56 -40.91 0.21 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.47 ' CG1' ' H ' ' A' ' 35' ' ' GLU . 10.2 tt -68.89 178.48 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.49 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.634 ' CG ' ' N ' ' A' ' 36' ' ' ASN . 5.5 tt0 178.53 167.32 0.85 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.057 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.634 ' N ' ' CG ' ' A' ' 35' ' ' GLU . 24.4 p30 -36.33 152.75 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.533 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.809 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.0 OUTLIER 78.07 32.76 0.36 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.484 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 39' ' ' ILE . 72.0 p -147.19 -121.61 0.06 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.767 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.438 ' C ' ' O ' ' A' ' 38' ' ' THR . 4.5 mt 32.58 62.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.402 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.646 ' OG ' ' N ' ' A' ' 41' ' ' SER . 22.7 p -64.69 -62.3 1.66 Allowed 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.733 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.646 ' N ' ' OG ' ' A' ' 40' ' ' SER . 0.7 OUTLIER -106.73 171.45 7.35 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.262 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.468 HG13 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -145.48 140.55 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.096 -1.041 . . . . 0.0 111.643 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -129.14 102.19 6.36 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.917 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.5 t -126.62 109.39 22.95 Favored Pre-proline 0 N--CA 1.49 1.537 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.618 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -67.6 169.76 15.2 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 121.049 1.166 . . . . 0.0 110.633 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 48' ' ' VAL . 1.8 Cg_endo -62.21 -170.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.844 1.696 . . . . 0.0 111.185 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.2 -11.8 7.94 Favored Glycine 0 N--CA 1.483 1.827 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.698 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.433 ' H ' ' C ' ' A' ' 46' ' ' PRO . 35.3 m -150.18 134.95 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 118.944 -1.102 . . . . 0.0 111.799 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -104.35 132.03 51.05 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.247 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.8 154.86 23.36 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.479 -0.889 . . . . 0.0 112.844 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.414 HD11 ' NH2' ' A' ' 83' ' ' ARG . 12.0 mt -146.32 112.01 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.103 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 mp -89.56 152.09 21.6 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.704 -1.198 . . . . 0.0 112.477 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.497 ' CD2' ' C ' ' A' ' 58' ' ' PHE . 53.5 m-85 -129.48 110.9 12.25 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.315 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.619 HE21 ' H ' ' A' ' 61' ' ' ASP . 3.2 tt0 -48.61 -55.45 11.19 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.631 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -85.67 147.67 26.26 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.032 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -56.38 178.1 0.06 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.776 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.34 27.22 60.29 Favored Glycine 0 N--CA 1.488 2.105 0 C-N-CA 119.346 -1.407 . . . . 0.0 110.173 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.497 ' C ' ' CD2' ' A' ' 53' ' ' TYR . 12.4 m-85 56.29 67.44 1.0 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.876 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.23 -170.43 3.65 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.97 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.09 -177.23 39.36 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.425 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.619 ' H ' HE21 ' A' ' 54' ' ' GLN . 38.1 t0 -45.19 107.64 0.1 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.355 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -91.05 151.35 21.06 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.642 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.582 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 8.5 mm -131.31 170.3 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.36 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.582 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 27.8 mt-10 -146.48 132.61 19.34 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.694 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.6 m -150.45 147.91 15.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 118.964 -1.094 . . . . 0.0 111.698 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 t -130.61 0.93 2.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.67 ' N ' ' HH ' ' A' ' 121' ' ' TYR . . . -134.41 -151.19 0.42 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.684 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -97.25 119.12 35.18 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.105 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.468 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -89.58 101.7 14.38 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.178 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -55.13 -35.98 65.26 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.346 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 72' ' ' LEU . 8.6 tp10 -140.16 96.51 3.06 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.611 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 71' ' ' GLU . 1.5 tp -37.97 -84.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.099 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.402 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 178.91 -168.64 39.64 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.095 -1.526 . . . . 0.0 110.719 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.21 -6.3 15.87 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.097 1.865 . . . . 0.0 111.859 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.503 ' H ' HD21 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -92.11 13.98 17.34 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.022 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -72.55 -5.16 35.15 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.518 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -89.21 -6.84 56.57 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.107 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -166.1 104.88 0.66 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 118.714 -1.194 . . . . 0.0 111.711 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.648 ' H ' ' H ' ' A' ' 37' ' ' ASN . 11.6 t -113.5 -167.81 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.415 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.646 ' H ' ' CG1' ' A' ' 79' ' ' VAL . 0.3 OUTLIER 159.48 -59.33 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.449 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.6 m -108.5 145.83 34.12 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.307 -0.957 . . . . 0.0 113.317 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.21 154.26 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.915 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.737 ' NH1' ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.61 128.5 25.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.333 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.737 ' CA ' ' NH1' ' A' ' 83' ' ' ARG . 6.5 t -138.1 132.94 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.329 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.416 HD13 ' HE ' ' A' ' 83' ' ' ARG . 68.1 mt -129.31 128.69 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.806 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 m -42.3 153.49 0.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.213 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.56 148.62 31.56 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.753 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.48 127.76 27.57 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.229 1.286 . . . . 0.0 110.946 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 p -59.43 136.38 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.478 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -139.71 152.76 69.14 Favored Pre-proline 0 N--CA 1.486 1.355 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.695 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.15 -156.88 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.818 0 C-N-CA 121.064 1.176 . . . . 0.0 110.941 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.467 ' N ' HD13 ' A' ' 136' ' ' LEU . 8.5 ptt180 175.71 -162.05 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.266 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.03 158.57 43.97 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.013 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.91 147.5 35.71 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.935 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.448 ' CE1' HD13 ' A' ' 108' ' ' LEU . 29.9 m-85 -130.48 100.89 5.5 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.403 ' CG ' ' HB3' ' A' ' 105' ' ' GLU . 33.7 m-85 -74.93 177.06 6.57 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.581 -0.847 . . . . 0.0 113.111 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -110.54 159.73 17.27 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.635 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt 59.3 153.98 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.048 0.927 . . . . 0.0 113.182 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.555 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 30.7 tp10 -71.99 105.99 4.1 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.459 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 1.282 ' NE2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 103.83 46.2 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.01 0 O-C-N 124.981 1.426 . . . . 0.0 109.076 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.631 ' CE1' ' CD ' ' A' ' 100' ' ' GLN . 27.0 p90 31.56 58.56 0.3 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.669 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 102' ' ' ASP . 0.4 OUTLIER -94.54 19.85 9.24 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.939 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -159.64 159.02 30.21 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -48.59 171.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.64 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -129.72 169.69 14.78 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.053 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.35 151.81 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.764 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 23.3 p-10 -98.43 152.78 19.14 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.965 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.448 HD13 ' CE1' ' A' ' 95' ' ' PHE . 54.0 mt -146.09 113.27 4.51 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.268 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.83 164.43 27.03 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 121.421 1.414 . . . . 0.0 112.061 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.97 146.39 57.87 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 122.268 1.979 . . . . 0.0 111.787 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.11 -156.33 25.52 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.699 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.638 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 18.0 tt0 -135.75 156.99 47.95 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.648 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.638 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 12.0 m-85 -141.07 156.41 46.0 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.428 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.401 ' C ' ' H ' ' A' ' 116' ' ' ALA . 1.4 p -108.89 -179.2 3.79 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.712 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.413 ' NE2' ' HB3' ' A' ' 168' ' ' SER . 39.2 tt0 -75.9 44.1 0.29 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.19 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 114' ' ' THR . . . -154.22 -58.94 0.12 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.976 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 121' ' ' TYR . 31.2 tp10 -71.59 -51.44 23.3 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.413 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.576 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 1.4 tt -36.88 -73.37 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.142 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.498 ' HG3' ' H ' ' A' ' 120' ' ' ARG . 5.4 pt-20 -49.78 -55.54 13.7 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.696 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.498 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -76.66 16.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.752 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.67 ' HH ' ' N ' ' A' ' 67' ' ' ALA . 28.2 t80 -123.64 -12.75 7.62 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.488 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -145.26 -42.65 0.05 OUTLIER Glycine 0 N--CA 1.496 2.636 0 C-N-CA 118.84 -1.648 . . . . 0.0 110.963 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.493 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -142.57 -97.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.606 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.589 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 23.8 t70 -167.4 -170.01 1.36 Allowed 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.745 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.589 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 27.8 t-20 -62.1 -105.63 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.63 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.456 ' N ' ' OD1' ' A' ' 125' ' ' ASN . 1.8 p-10 -67.11 107.9 2.46 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.396 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 128' ' ' ILE . 3.1 t -172.9 -165.75 0.32 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.358 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.563 ' N ' ' OG1' ' A' ' 127' ' ' THR . 1.4 mt 66.52 140.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.806 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 160' ' ' LEU . 4.8 m -154.67 -5.51 0.15 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.333 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.5 m -150.94 127.98 11.11 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.176 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -120.26 148.0 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.475 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.93 78.59 19.52 Favored Pre-proline 0 N--CA 1.483 1.198 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.402 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -61.19 97.64 0.13 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.264 1.31 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -91.51 33.23 1.01 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.413 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.72 -58.85 0.04 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 118.691 -1.718 . . . . 0.0 111.356 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 92' ' ' ARG . 0.8 OUTLIER -120.32 178.05 4.8 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.028 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.62 138.33 31.65 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.701 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.9 141.13 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.73 -0.788 . . . . 0.0 112.152 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.412 HG11 ' CE1' ' A' ' 141' ' ' PHE . 57.7 t -125.54 130.96 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.495 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.0 mp -105.47 137.05 43.92 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.646 -0.822 . . . . 0.0 113.085 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.521 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 2.3 m-85 -120.95 128.03 52.36 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.207 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -79.86 -30.64 40.32 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.141 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.417 ' HB3' ' HG ' ' A' ' 147' ' ' SER . 4.8 m-20 -83.08 177.77 8.44 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.785 -1.166 . . . . 0.0 111.86 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 146' ' ' PHE . 21.7 t0 -61.73 -105.99 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.875 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.642 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 2.2 m120 -58.54 75.56 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.457 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.642 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.5 p90 32.76 70.39 0.1 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.143 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.417 ' HG ' ' HB3' ' A' ' 143' ' ' ASN . 0.8 OUTLIER -136.18 -161.65 1.18 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.325 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 50.58 -148.66 7.14 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.745 -1.217 . . . . 0.0 111.127 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -78.18 162.39 26.64 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.124 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.0 p -150.66 165.39 33.55 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tt -133.19 90.91 29.33 Favored Pre-proline 0 N--CA 1.484 1.238 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.08 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -64.41 105.52 0.62 Allowed 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 121.589 1.526 . . . . 0.0 112.748 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.45 84.44 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.551 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -77.05 12.83 1.25 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.624 -0.83 . . . . 0.0 112.407 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -170.69 -167.49 0.59 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 118.214 -1.395 . . . . 0.0 112.361 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.55 152.05 19.13 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.576 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.585 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -169.13 65.47 0.58 Allowed Pre-proline 0 C--N 1.308 -1.225 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.269 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.468 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.0 OUTLIER -65.76 23.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 122.171 1.914 . . . . 0.0 112.046 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.585 ' H ' ' C ' ' A' ' 157' ' ' ALA . 3.0 t -166.5 138.7 3.68 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.782 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 129' ' ' SER . 0.3 OUTLIER -160.11 -78.22 0.06 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.221 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.479 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.77 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.427 HD22 ' ND2' ' A' ' 125' ' ' ASN . 2.6 t-20 . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.659 0.266 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 85.2 m -42.27 104.43 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.32 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.413 ' HB3' ' NE2' ' A' ' 115' ' ' GLN . 0.2 OUTLIER -87.89 -61.3 1.75 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.017 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.4 p -123.61 158.99 30.23 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.947 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.426 HG12 ' CD1' ' A' ' 118' ' ' LEU . 13.1 pt -142.0 162.21 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.176 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.441 ' CZ ' ' OG ' ' A' ' 173' ' ' SER . 2.6 ttt-85 -142.44 102.7 4.13 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.015 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 7.9 mt -84.01 93.81 3.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.757 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.441 ' OG ' ' CZ ' ' A' ' 171' ' ' ARG . 4.4 m . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 116.363 -1.78 . . . . 0.0 110.813 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.421 ' CB ' ' CG1' ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.952 0.406 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -178.22 115.93 0.08 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.545 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.405 ' O ' ' CG1' ' A' ' 4' ' ' ILE . 2.9 pt -61.98 129.12 24.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.707 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -107.67 122.33 46.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.49 150.65 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.726 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.611 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 12.5 m-85 -103.92 156.13 18.09 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.654 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.9 -35.8 23.82 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.247 -0.981 . . . . 0.0 113.048 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.489 ' C ' ' OG ' ' A' ' 40' ' ' SER . 14.1 m120 -104.49 170.89 7.63 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.259 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.466 ' HG3' ' H ' ' A' ' 11' ' ' ASP . 4.2 tp10 -76.52 -176.34 3.69 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.471 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' A' ' 13' ' ' GLN . 1.1 m-20 51.79 42.48 29.98 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.073 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.611 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 21.4 t80 54.1 6.57 0.1 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.652 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.498 ' H ' ' C ' ' A' ' 11' ' ' ASP . 7.3 tt0 -87.13 170.99 11.03 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.503 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 89.19 120.35 1.84 Allowed Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.587 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 14' ' ' GLY . 6.9 mtpm? -28.85 137.54 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 O-C-N 123.95 0.441 . . . . 0.0 111.731 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -105.43 133.07 50.79 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 p -108.1 153.41 9.6 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.039 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.811 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.07 140.2 34.64 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.543 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 mt -132.05 126.84 20.81 Favored Pre-proline 0 N--CA 1.493 1.688 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.205 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.54 151.3 83.21 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 121.026 1.151 . . . . 0.0 111.579 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.33 -164.6 0.06 OUTLIER 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 121.609 1.539 . . . . 0.0 111.484 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.57 179.93 46.29 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.454 -1.355 . . . . 0.0 111.066 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.796 ' CB ' ' HE ' ' A' ' 83' ' ' ARG . 1.7 m120 -90.4 121.95 32.83 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.914 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.8 ' H ' ' NH2' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -144.33 154.99 43.6 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.315 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.0 p -144.4 -150.76 0.33 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.858 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 30' ' ' ALA . 10.0 mtm180 -55.89 -37.16 68.47 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.18 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.401 ' O ' ' CB ' ' A' ' 30' ' ' ALA . . . -53.44 -59.11 5.0 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.269 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.09 -47.32 75.1 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 118.695 -1.202 . . . . 0.0 109.411 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 32' ' ' LEU . 21.5 mt -61.09 -28.58 69.19 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.442 -1.303 . . . . 0.0 109.023 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 26' ' ' ARG . . . -54.34 -33.43 58.96 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.2 -29.94 60.48 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.587 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 29' ' ' LEU . 14.7 mt -85.75 -91.72 0.09 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.338 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.45 13.45 0.26 Allowed Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.225 -1.464 . . . . 0.0 111.54 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.558 ' CG1' ' N ' ' A' ' 35' ' ' GLU . 1.0 OUTLIER -95.08 -38.81 9.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.635 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.558 ' N ' ' CG1' ' A' ' 34' ' ' ILE . 3.7 pt-20 -12.9 132.21 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.803 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.677 ' C ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER 84.77 135.06 0.05 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 114.359 -1.291 . . . . 0.0 113.737 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 40.27 39.23 0.64 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.72 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.791 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 52.5 p -106.38 -141.3 0.37 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.929 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' A' ' 38' ' ' THR . 1.4 mm 30.86 41.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.958 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.489 ' OG ' ' C ' ' A' ' 9' ' ' ASN . 2.1 t -48.77 -38.98 23.41 Favored 'General case' 0 C--N 1.282 -2.342 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.064 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.67 176.56 8.59 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.493 HG13 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -150.63 146.63 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 117.76 -1.576 . . . . 0.0 113.075 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.406 ' HG3' ' HZ1' ' A' ' 43' ' ' LYS . 1.4 tmtp? -136.09 102.1 4.92 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.359 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.6 t -122.71 104.33 36.6 Favored Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.381 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -69.48 171.01 14.92 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.077 1.185 . . . . 0.0 109.991 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.0 -173.19 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.494 1.463 . . . . 0.0 110.907 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.77 -21.72 7.38 Favored Glycine 0 N--CA 1.484 1.849 0 C-N-CA 119.109 -1.52 . . . . 0.0 110.551 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.421 ' CG1' ' CB ' ' A' ' 2' ' ' ALA . 25.1 m -148.97 141.98 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 118.921 -1.112 . . . . 0.0 112.176 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -110.18 139.2 45.58 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.739 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.21 155.03 42.46 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 118.964 -1.094 . . . . 0.0 113.2 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.34 120.84 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.199 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.707 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 2.2 mp -94.62 155.66 16.78 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 118.744 -1.182 . . . . 0.0 112.942 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 62' ' ' GLN . 40.5 m-85 -140.7 117.5 11.03 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.723 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.488 ' HG3' ' N ' ' A' ' 55' ' ' ASN . 6.4 pt20 -57.58 -41.94 82.12 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.363 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.488 ' N ' ' HG3' ' A' ' 54' ' ' GLN . 19.7 t30 -93.26 142.99 26.7 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.24 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 0.3 OUTLIER -54.49 171.09 0.13 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.487 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.663 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 58.82 34.83 79.59 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.162 -1.494 . . . . 0.0 109.43 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.711 ' H ' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER 44.26 74.16 0.13 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.316 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.22 168.18 22.35 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.082 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.24 -166.69 48.37 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.525 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.42 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 3.7 m-20 -50.92 117.09 2.29 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.448 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.449 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 3.9 pt20 -99.82 151.45 21.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.887 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.483 HG21 ' H ' ' A' ' 64' ' ' GLU . 1.8 mt -127.79 166.0 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.922 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.558 ' OE1' ' N ' ' A' ' 64' ' ' GLU . 46.0 mp0 -142.77 130.52 21.51 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.24 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.2 m -150.45 164.8 2.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.936 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.619 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 2.0 t -149.94 -1.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.158 -1.383 . . . . 0.0 107.881 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.72 -153.36 0.56 Allowed 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.624 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.52 ' O ' ' ND2' ' A' ' 68' ' ' ASN . 1.2 p-10 -98.32 114.03 26.19 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.53 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.493 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -89.72 98.9 12.03 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.425 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -54.78 -73.96 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.726 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 73' ' ' GLY . 24.6 mm-40 -80.9 -0.16 37.9 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.797 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.2 tp 60.09 -79.88 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.219 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 171.08 -179.06 43.17 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.129 -1.51 . . . . 0.0 110.804 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.573 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.2 Cg_endo -65.1 -40.14 21.23 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.433 2.089 . . . . 0.0 112.421 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.688 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 2.1 pt? -71.3 27.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.16 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.698 ' H ' HD21 ' A' ' 76' ' ' ASN . 0.7 OUTLIER -76.98 6.97 5.38 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.573 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -88.52 -9.41 52.47 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.967 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -157.85 130.69 7.42 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.136 -1.026 . . . . 0.0 111.219 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.791 ' CG2' ' H ' ' A' ' 38' ' ' THR . 15.3 m -140.09 164.93 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.533 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 174.64 -56.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.872 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.711 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 22.3 m -96.67 141.08 30.35 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.347 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.646 ' C ' ' NH1' ' A' ' 83' ' ' ARG . 18.3 mt -150.57 128.25 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.974 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.8 ' NH2' ' H ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -103.94 125.93 50.7 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.808 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -133.27 133.72 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.978 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.87 139.87 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.635 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.2 p -45.94 149.82 0.62 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.234 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -153.29 142.89 14.99 Favored Pre-proline 0 N--CA 1.484 1.264 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.866 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -52.29 148.5 25.2 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 121.432 1.421 . . . . 0.0 111.811 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.2 m -76.23 145.38 10.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.993 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -146.13 136.51 12.15 Favored Pre-proline 0 C--N 1.304 -1.388 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.963 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -60.33 -156.67 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.869 0 C-N-CA 121.178 1.252 . . . . 0.0 110.687 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.559 ' N ' ' CD ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -175.55 -164.53 0.14 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.354 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.37 165.47 25.4 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.027 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.616 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -128.66 151.46 49.48 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.777 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 1.2 m-85 -142.43 139.92 31.79 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.534 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.515 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 27.7 m-85 -95.09 179.74 5.1 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 118.414 -1.314 . . . . 0.0 112.492 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.65 -74.75 0.61 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.023 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.472 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 25.9 tttm -63.29 160.6 15.48 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.858 0.837 . . . . 0.0 112.499 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.587 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -71.7 103.45 3.07 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.477 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.832 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.8 OUTLIER 113.1 55.48 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.496 0 O-C-N 125.245 1.591 . . . . 0.0 111.056 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.561 ' CD2' ' O ' ' A' ' 101' ' ' PHE . 17.9 p90 28.52 41.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.492 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.566 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 6.4 p-10 -115.26 24.15 11.88 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.66 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.472 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -139.42 150.45 21.34 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.475 ' CB ' ' HZ1' ' A' ' 104' ' ' LYS . 0.8 OUTLIER -33.34 142.21 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.598 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.404 ' O ' ' CD ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -105.66 162.95 13.06 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.635 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.536 ' CG1' ' N ' ' A' ' 107' ' ' ASP . 1.4 t -132.62 167.57 26.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.476 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.536 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 2.6 p30 -150.18 149.0 29.61 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.099 -1.44 . . . . 0.0 112.438 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.2 mt -137.22 143.2 40.73 Favored Pre-proline 0 N--CA 1.499 1.98 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.446 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.81 166.43 27.69 Favored 'Trans proline' 0 C--O 1.212 -0.782 0 C-N-CA 121.789 1.66 . . . . 0.0 112.346 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.89 145.98 95.01 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 122.296 1.997 . . . . 0.0 111.233 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.17 -143.27 12.63 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.279 -1.438 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.597 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 10.5 tt0 -146.46 154.27 41.39 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.165 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.597 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 8.4 m-85 -138.64 152.89 48.49 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.102 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.6 p -88.43 -166.84 1.7 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.669 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.446 ' HB2' ' HG ' ' A' ' 168' ' ' SER . 4.4 tt0 -96.57 51.17 1.16 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.389 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.58 -68.81 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.35 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 121' ' ' TYR . 8.6 pt-20 -68.54 -41.68 79.52 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.891 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.583 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -37.49 -75.07 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.633 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.633 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -51.68 -52.2 49.97 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.574 -0.851 . . . . 0.0 110.855 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -74.57 16.33 0.28 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.961 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.619 ' HH ' ' H ' ' A' ' 66' ' ' VAL . 17.8 t80 -124.52 -13.8 6.99 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.517 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -138.13 -52.94 0.05 OUTLIER Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.506 -1.33 . . . . 0.0 110.603 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.558 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -138.4 -101.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.407 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.558 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 32.0 t70 -164.41 176.79 8.73 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.162 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.541 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 45.7 t30 -59.83 137.61 58.01 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.843 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.554 ' OD1' ' N ' ' A' ' 127' ' ' THR . 7.4 p30 43.59 -151.07 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.914 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.554 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 13.7 t 48.35 20.09 0.26 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.59 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.487 ' O ' ' CB ' ' A' ' 129' ' ' SER . 7.4 mm -50.57 -84.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.927 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 1.2 p 80.51 120.01 0.05 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.44 114.16 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.022 -1.445 . . . . 0.0 114.197 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.482 HG12 ' CD2' ' A' ' 95' ' ' PHE . 3.6 t -121.47 134.55 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.571 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.4 ttmm -131.32 99.37 17.57 Favored Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.664 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.85 107.43 1.87 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.018 1.145 . . . . 0.0 110.47 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -86.29 11.14 12.82 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.843 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.5 -45.73 0.04 OUTLIER Glycine 0 N--CA 1.494 2.564 0 C-N-CA 118.097 -2.001 . . . . 0.0 111.762 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.23 163.17 18.17 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.154 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 173' ' ' SER . . . -80.44 159.94 25.47 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.79 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 20.8 t -122.41 141.68 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.921 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.86 130.86 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.71 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.22 139.33 40.04 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.319 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 3.0 m-85 -121.44 129.23 52.87 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.987 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.423 ' H ' ' HD2' ' A' ' 142' ' ' LYS . 0.1 OUTLIER -77.07 -48.44 17.81 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.484 -0.887 . . . . 0.0 112.228 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.454 ' N ' HD21 ' A' ' 143' ' ' ASN . 1.8 m-80 -74.32 135.78 42.56 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.069 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 143' ' ' ASN . 6.4 m-20 -9.16 -110.42 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.589 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 16.7 m-80 -68.45 86.69 0.3 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 146' ' ' PHE . 1.1 p90 30.32 72.55 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.889 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.7 m -142.67 -160.64 1.12 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.091 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 44.25 -158.01 0.16 Allowed Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.81 -1.186 . . . . 0.0 111.106 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -62.08 163.71 7.65 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.932 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.5 p -150.34 162.9 39.63 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.409 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.7 88.58 53.98 Favored Pre-proline 0 N--CA 1.485 1.296 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.041 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HB2' ' ND2' ' A' ' 154' ' ' ASN . 2.9 Cg_endo -66.08 105.3 0.81 Allowed 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.433 1.422 . . . . 0.0 111.965 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.43 69.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.238 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.679 ' H ' HD21 ' A' ' 154' ' ' ASN . 0.6 OUTLIER -81.06 37.28 0.43 Allowed 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.127 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.627 ' HG ' ' H ' ' A' ' 156' ' ' ASP . 13.7 t -170.9 -175.15 1.7 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.061 -1.055 . . . . 0.0 111.161 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.627 ' H ' ' HG ' ' A' ' 155' ' ' SER . 16.3 m-20 -76.78 142.12 40.49 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.559 -0.857 . . . . 0.0 111.141 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.586 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -154.96 74.33 5.62 Favored Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.458 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.23 23.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 122.065 1.843 . . . . 0.0 112.317 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.586 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -171.43 115.71 0.4 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.701 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.74 4.47 5.48 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.719 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.831 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.3 p30 . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.086 0.469 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.4 m -75.97 104.77 6.66 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.835 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.446 ' HG ' ' HB2' ' A' ' 115' ' ' GLN . 1.3 t -82.17 -68.0 0.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.732 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.531 ' CB ' ' H ' ' A' ' 146' ' ' PHE . 28.6 m -114.03 163.73 14.76 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.926 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 22.0 pt -141.02 161.29 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.089 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -141.8 98.7 3.39 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.542 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.6 mt -77.71 99.49 2.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.037 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 137' ' ' ALA . 39.7 m . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.814 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.876 0.369 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -173.93 123.46 0.33 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.464 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.9 pt -76.05 148.54 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.379 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.5 m -122.89 109.82 14.64 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.243 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 m -100.75 150.93 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.924 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.791 ' CZ ' ' CE1' ' A' ' 12' ' ' PHE . 25.9 m-85 -109.51 163.64 13.25 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.636 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.29 -3.21 47.84 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.051 -1.06 . . . . 0.0 113.681 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.677 HD21 HE22 ' A' ' 13' ' ' GLN . 83.4 m-20 -136.0 164.32 28.26 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.945 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -70.63 176.68 3.97 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.69 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.572 ' C ' ' H ' ' A' ' 13' ' ' GLN . 5.9 m-20 57.44 46.55 17.91 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.344 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.791 ' CE1' ' CZ ' ' A' ' 7' ' ' PHE . 85.4 t80 49.91 7.24 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.341 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.68 ' CD ' ' H ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -92.06 174.27 7.41 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.434 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.68 ' H ' ' CD ' ' A' ' 13' ' ' GLN . . . 93.84 127.33 4.69 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.053 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' GLY . 13.7 mptt -31.38 141.49 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.056 0.455 . . . . 0.0 111.914 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.17 162.71 13.91 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.834 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -148.09 125.22 2.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.964 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -93.15 128.49 39.1 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.971 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.4 mt -122.28 129.82 24.94 Favored Pre-proline 0 N--CA 1.491 1.615 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.728 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -67.96 162.44 39.83 Favored 'Trans proline' 0 C--N 1.325 -0.684 0 C-N-CA 120.806 1.004 . . . . 0.0 111.141 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.04 -161.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 121.667 1.578 . . . . 0.0 110.864 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.4 -179.46 49.32 Favored Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.295 -1.431 . . . . 0.0 111.082 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.665 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.6 OUTLIER -106.21 135.47 47.63 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.204 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -152.23 167.75 27.57 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.104 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.6 p -142.05 -161.44 1.23 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.108 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -56.71 -29.2 62.22 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.054 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.18 -67.68 0.43 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.125 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -57.56 -41.46 81.1 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.428 -1.309 . . . . 0.0 110.003 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 32' ' ' LEU . 28.6 mt -61.04 -39.76 91.01 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.892 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.95 -32.61 33.93 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 118.035 -1.466 . . . . 0.0 107.807 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.39 -36.66 79.46 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.318 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 29' ' ' LEU . 14.3 mt -74.75 -80.01 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.872 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.46 -22.67 0.09 OUTLIER Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.854 -1.641 . . . . 0.0 111.222 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.442 ' C ' ' CG ' ' A' ' 35' ' ' GLU . 6.5 pt -85.39 158.08 3.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.263 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER 170.27 137.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.708 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 8.1 t-20 74.97 -147.3 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.557 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.654 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.0 OUTLIER -58.68 96.7 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.651 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 39' ' ' ILE . 60.6 p -152.1 -142.57 0.12 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.106 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.457 HD11 ' N ' ' A' ' 39' ' ' ILE . 2.2 mm 36.82 44.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.323 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.51 ' OG ' ' C ' ' A' ' 9' ' ' ASN . 12.7 t -49.08 -43.01 40.72 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.502 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.2 171.74 13.82 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.469 HG13 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -152.1 141.85 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 118.093 -1.443 . . . . 0.0 112.954 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -134.05 103.77 5.94 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.943 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.3 t -120.48 108.31 37.8 Favored Pre-proline 0 N--CA 1.494 1.743 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.231 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -67.21 168.73 16.85 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.11 1.206 . . . . 0.0 110.746 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -59.35 -170.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.929 1.753 . . . . 0.0 111.179 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.18 -11.7 11.45 Favored Glycine 0 N--CA 1.483 1.81 0 C-N-CA 119.278 -1.439 . . . . 0.0 110.961 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.49 141.7 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.114 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.7 tttt -116.01 126.58 54.01 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.2 165.32 13.06 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.109 -1.036 . . . . 0.0 113.307 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.2 mt -142.44 120.65 8.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 114.211 -1.359 . . . . 0.0 108.524 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.484 ' CD2' ' H ' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -92.19 148.38 22.2 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.104 -1.038 . . . . 0.0 112.074 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.484 ' H ' ' CD2' ' A' ' 52' ' ' LEU . 17.6 m-85 -132.83 114.71 14.4 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.183 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -53.16 -84.29 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.787 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -59.48 149.37 29.83 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.1 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -57.22 -173.01 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.637 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.1 32.43 35.42 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.19 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 49.53 45.13 24.27 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.732 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.54 -169.45 1.67 Allowed 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.011 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 68.0 166.38 3.54 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.892 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 60' ' ' GLY . 26.6 t70 -42.78 130.37 4.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.535 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.606 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 5.9 pm0 -99.86 166.06 11.26 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.052 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 64' ' ' GLU . 5.5 mm -135.13 169.5 21.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.534 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.467 ' N ' HG23 ' A' ' 63' ' ' ILE . 36.7 mt-10 -146.34 132.45 19.33 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.003 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 m -149.32 151.59 12.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.358 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.3 t -140.2 -0.26 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.461 ' CB ' ' OH ' ' A' ' 121' ' ' TYR . . . -130.8 -147.61 0.33 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.669 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.5 119.1 38.0 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.671 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.469 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -89.36 104.41 16.96 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.861 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -64.32 -77.68 0.05 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.003 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 73' ' ' GLY . 6.5 mm-40 -83.41 1.31 42.11 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.5 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.413 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 3.0 tp 56.63 -89.22 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.55 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.413 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 177.82 -166.48 36.76 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.155 -1.498 . . . . 0.0 110.621 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.581 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.9 Cg_endo -66.45 -40.96 12.9 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 122.135 1.89 . . . . 0.0 112.163 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.664 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 1.9 pt? -68.13 26.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.465 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.581 ' H ' ' C ' ' A' ' 74' ' ' PRO . 34.0 t-20 -68.55 -34.89 76.62 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.574 -0.85 . . . . 0.0 111.277 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -87.98 29.78 0.9 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.098 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -171.88 112.92 0.32 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.335 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.5 t -147.38 155.38 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.902 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.2 t -171.62 -34.85 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 118.744 -1.182 . . . . 0.0 112.265 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.1 m -116.66 137.91 51.84 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.956 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.3 mt -148.6 155.18 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.511 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.834 HH12 ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -149.71 133.49 16.88 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.889 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.834 ' N ' HH12 ' A' ' 83' ' ' ARG . 13.9 t -140.68 148.25 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.911 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.68 ' N ' ' CD1' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -142.41 136.46 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.846 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.53 ' H ' ' HG ' ' A' ' 86' ' ' SER . 5.6 m -39.91 152.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.166 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -153.24 141.36 13.85 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.224 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -49.25 151.08 6.82 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.451 1.434 . . . . 0.0 111.706 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.6 m -71.51 147.22 11.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.903 -0.719 . . . . 0.0 112.309 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -145.87 129.73 8.55 Favored Pre-proline 0 C--N 1.301 -1.523 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.922 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -58.17 -159.4 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.874 0 C-N-CA 120.987 1.125 . . . . 0.0 110.801 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.481 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.58 -161.82 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.162 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.27 164.72 27.43 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.841 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 39.7 ttm-85 -121.99 126.17 47.94 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.714 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 11.4 m-85 -116.8 125.31 51.41 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.797 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -84.65 168.07 15.63 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.191 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.438 ' HB3' ' H ' ' A' ' 98' ' ' LYS . 1.2 t80 -80.35 -92.11 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 118.502 -1.279 . . . . 0.0 112.939 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.438 ' H ' ' HB3' ' A' ' 97' ' ' TYR . 18.8 mmmt -68.22 156.05 38.41 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.932 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 1.091 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 3.5 tm-20 -66.57 85.01 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.127 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 1.091 ' NE2' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 173.86 30.05 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.202 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.61 ' O ' ' CD1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER 47.81 11.51 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.797 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.597 ' H ' ' C ' ' A' ' 100' ' ' GLN . 34.7 t70 -104.4 -177.47 3.37 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.316 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.489 ' H ' ' CG ' ' A' ' 102' ' ' ASP . . . 72.41 128.81 0.1 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.068 -1.539 . . . . 0.0 109.998 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 103' ' ' GLY . 48.1 mttt -30.06 136.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 123.99 0.465 . . . . 0.0 111.438 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.96 170.39 8.76 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.502 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.461 HG11 ' N ' ' A' ' 107' ' ' ASP . 29.9 t -137.36 155.31 31.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.69 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.461 ' N ' HG11 ' A' ' 106' ' ' VAL . 3.0 p30 -129.24 147.01 51.04 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.654 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.1 mt -136.42 139.31 29.25 Favored Pre-proline 0 N--CA 1.501 2.106 0 C-N-CA 119.724 -0.791 . . . . 0.0 110.811 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -71.04 167.75 25.2 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 121.662 1.575 . . . . 0.0 112.193 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.32 150.83 85.71 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 122.101 1.868 . . . . 0.0 111.573 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.18 -168.81 23.6 Favored Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.03 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.594 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 2.2 mp0 -113.74 159.1 20.11 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.6 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 40.7 m-85 -144.84 149.89 36.16 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.755 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.4 p -89.64 -153.06 0.26 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.123 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.432 ' H ' ' HG3' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -110.95 31.81 5.75 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.67 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -134.93 -64.31 0.66 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.953 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.6 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 17.2 pt-20 -66.21 -49.37 67.5 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.066 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.6 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -37.12 -67.15 0.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.293 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.653 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 20.6 mp0 -48.2 -66.74 0.35 Allowed 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.14 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -72.44 12.32 0.48 Allowed 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.06 -1.056 . . . . 0.0 113.301 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 117' ' ' GLU . 12.8 t80 -101.97 -21.86 14.41 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.007 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -165.36 -12.97 0.03 OUTLIER Glycine 0 N--CA 1.486 2.014 0 C-N-CA 118.237 -1.935 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.8 mt -145.69 -125.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.876 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -156.98 -160.38 0.96 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.457 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -59.55 -53.62 56.0 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.809 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -155.62 123.68 5.77 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.601 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.401 ' H ' ' H ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 177.71 0.81 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.042 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 130' ' ' SER . 70.5 mt -56.43 -72.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.285 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m 55.7 -85.1 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.776 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 128' ' ' ILE . 15.1 m -72.62 115.74 12.26 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.488 -0.885 . . . . 0.0 112.391 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.4 t -122.7 161.78 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.779 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -165.08 80.51 1.24 Allowed Pre-proline 0 C--N 1.296 -1.726 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.293 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -60.59 102.9 0.2 Allowed 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 121.568 1.512 . . . . 0.0 110.242 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.82 19.71 3.38 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.467 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.12 -50.93 0.03 OUTLIER Glycine 0 N--CA 1.491 2.352 0 C-N-CA 117.91 -2.09 . . . . 0.0 112.191 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.86 179.85 3.96 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.454 -0.899 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -92.1 152.33 19.98 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.776 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 68.2 t -124.11 138.86 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.127 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.3 t -131.71 128.42 60.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.417 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 8.3 mp -103.99 141.77 35.6 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.365 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.415 ' HB2' ' HG ' ' A' ' 169' ' ' SER . 19.2 m-85 -114.16 126.98 55.68 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.515 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -59.21 -78.62 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.437 ' N ' HD21 ' A' ' 143' ' ' ASN . 1.2 m-80 -73.71 155.54 38.85 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.816 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 146' ' ' PHE . 5.3 p-10 -62.49 -162.18 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.567 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.497 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 43.7 t30 42.5 24.15 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.675 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.497 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.4 OUTLIER 57.17 54.82 6.45 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.703 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.707 ' HG ' ' H ' ' A' ' 148' ' ' GLY . 7.8 t -130.73 -171.68 2.62 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.305 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.707 ' H ' ' HG ' ' A' ' 147' ' ' SER . . . 64.11 -177.9 8.27 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.024 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 150' ' ' THR . 25.5 t0 -59.68 177.23 0.22 Allowed 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.262 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.478 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 19.5 p -146.56 178.59 8.17 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.193 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.0 tp -153.07 86.61 4.09 Favored Pre-proline 0 C--N 1.306 -1.303 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.778 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.46 108.07 1.13 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.871 1.714 . . . . 0.0 113.131 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.7 t -82.72 93.59 2.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.788 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.641 ' N ' HD21 ' A' ' 154' ' ' ASN . 1.3 m120 -58.8 -29.35 66.77 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 48.0 p -170.38 -146.36 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 117.986 -1.486 . . . . 0.0 112.854 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 1.1 m-20 -48.98 153.24 0.91 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.99 -1.004 . . . . 0.0 112.491 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.489 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -179.89 65.24 0.14 Allowed Pre-proline 0 N--CA 1.486 1.37 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.206 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 159' ' ' THR . 6.4 Cg_endo -69.03 66.29 1.34 Allowed 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 122.27 1.98 . . . . 0.0 111.959 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.497 ' CB ' ' O ' ' A' ' 158' ' ' PRO . 0.1 OUTLIER 161.11 -68.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.56 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.48 ' H ' ' CG2' ' A' ' 159' ' ' THR . 0.9 OUTLIER 57.04 -81.41 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.829 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 159' ' ' THR . . . . . . . . 0 N--CA 1.489 2.207 0 C-N-CA 118.495 -1.812 . . . . 0.0 109.683 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.9 p30 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.024 0.44 . . . . 0.0 111.562 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.0 m -70.44 104.91 2.87 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.836 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.2 m -80.98 -66.25 0.91 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.216 -0.993 . . . . 0.0 111.599 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.438 ' H ' ' HG ' ' A' ' 169' ' ' SER . 2.8 p -118.7 159.89 22.83 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.978 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 23.2 pt -135.53 179.8 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.246 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -159.5 100.99 1.51 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.821 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.8 mt -82.06 96.88 3.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.78 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 116.302 -1.808 . . . . 0.0 111.095 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 179.62 118.21 0.05 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.995 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.3 pt -79.27 164.8 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.388 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.5 m -138.93 123.02 17.96 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.729 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -104.62 168.12 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.285 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.403 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 68.9 m-85 -128.94 144.6 51.23 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.71 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -52.86 19.83 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.783 -0.767 . . . . 0.0 113.041 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.478 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 24.8 m120 -95.27 170.42 9.4 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.409 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.707 ' CG ' ' H ' ' A' ' 11' ' ' ASP . 16.6 tt0 -64.26 -178.7 0.38 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.778 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.707 ' H ' ' CG ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER 41.51 62.17 1.61 Allowed 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.325 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.655 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 44.9 p90 36.71 27.14 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.229 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ASP . 2.0 tp-100 -101.46 162.46 12.88 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.729 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.478 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 89.37 137.32 6.3 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.472 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -30.04 137.52 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.057 0.456 . . . . 0.0 111.889 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.412 ' HB2' HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -103.32 162.97 12.56 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.034 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -144.23 130.26 15.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.297 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.58 133.6 34.53 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.749 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 mt -126.13 123.73 24.44 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.578 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.94 162.22 29.92 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 120.975 1.117 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.27 -170.08 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 121.705 1.604 . . . . 0.0 110.967 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.3 -179.08 38.99 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.095 -1.526 . . . . 0.0 110.958 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.764 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.2 OUTLIER -109.36 129.94 55.51 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.715 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -143.23 175.19 10.07 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.433 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.0 p -140.35 -160.0 1.02 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.475 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -61.15 -20.56 62.84 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.7 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.91 -62.35 1.7 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.157 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.64 -43.1 75.91 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.661 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.4 mt -59.45 -41.2 89.11 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.424 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.65 -31.01 23.86 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 118.805 -1.158 . . . . 0.0 108.662 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.55 -38.16 71.02 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.0 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.5 mt -73.13 -74.39 0.17 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.688 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.46 -34.87 0.47 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.057 -1.544 . . . . 0.0 110.841 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.92 140.43 16.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.615 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 2.8 pt-20 178.54 131.72 0.07 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.78 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 1.5 t-20 78.22 127.49 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.511 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 51.55 7.85 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.705 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.466 ' N ' HG23 ' A' ' 79' ' ' VAL . 67.2 p -91.48 -135.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.664 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' A' ' 38' ' ' THR . 2.2 mt 35.74 39.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.604 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.52 -57.51 6.92 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.762 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.403 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -116.66 168.96 9.73 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.266 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.482 HG11 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -149.73 148.96 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 118.529 -1.269 . . . . 0.0 112.396 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -137.87 96.02 3.15 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.157 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.6 t -111.21 110.66 56.13 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.386 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -69.07 171.21 14.11 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.114 1.209 . . . . 0.0 110.411 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.45 -173.94 0.19 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.663 1.575 . . . . 0.0 111.082 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.04 -17.86 6.84 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.328 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.81 138.85 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.312 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -105.9 119.7 39.86 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -97.38 155.65 16.81 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.194 -1.002 . . . . 0.0 112.884 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.1 mt -141.76 117.21 5.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.921 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.725 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 2.0 mp -89.47 157.71 18.0 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.349 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.423 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 43.3 m-85 -138.47 107.36 5.97 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.553 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -40.93 -76.92 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.95 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.458 ' C ' ' OG ' ' A' ' 80' ' ' SER . 12.6 m120 -68.45 153.33 43.97 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.311 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -59.99 -174.95 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.653 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 49.21 40.49 29.43 Favored Glycine 0 N--CA 1.484 1.891 0 C-N-CA 119.114 -1.517 . . . . 0.0 109.656 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.653 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.5 OUTLIER 41.5 69.19 0.37 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.452 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.69 -162.39 1.42 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.993 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.48 -176.59 0.63 Allowed Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.23 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -46.2 160.85 0.06 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.879 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -146.99 161.17 41.33 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.864 -1.135 . . . . 0.0 111.67 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 64' ' ' GLU . 38.4 mt -133.03 172.97 15.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.112 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.454 ' N ' HG23 ' A' ' 63' ' ' ILE . 3.3 tm-20 -144.81 130.44 18.99 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.154 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.4 ' N ' ' OE2' ' A' ' 64' ' ' GLU . 21.1 m -145.19 154.54 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 118.615 -1.234 . . . . 0.0 112.108 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.438 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 2.1 t -136.91 -1.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.491 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.38 -124.12 0.23 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.062 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.631 ' ND2' ' OD1' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -121.82 121.26 36.79 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.95 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.482 ' H ' HG11 ' A' ' 42' ' ' VAL . . . -88.47 109.05 19.72 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.673 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 30.4 tp10 -61.9 -87.69 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.307 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 18.4 mt-10 -78.81 1.01 24.75 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.428 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 2.2 tp 74.73 -82.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.835 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 169.82 -169.19 41.94 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.225 -1.464 . . . . 0.0 110.696 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.503 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.3 Cg_endo -65.91 -46.54 4.7 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.307 2.005 . . . . 0.0 112.384 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.472 ' H ' HD21 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -73.62 34.9 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.291 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.503 ' H ' ' C ' ' A' ' 74' ' ' PRO . 29.0 p-10 -75.34 -24.05 57.3 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.745 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -80.12 4.48 17.18 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.985 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -151.93 114.12 4.5 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.533 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.466 HG23 ' N ' ' A' ' 38' ' ' THR . 24.2 m -133.9 158.29 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.963 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.607 ' HG ' ' H ' ' A' ' 81' ' ' SER . 96.4 p -164.44 -69.43 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 118.391 -1.324 . . . . 0.0 112.453 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.607 ' H ' ' HG ' ' A' ' 80' ' ' SER . 73.7 m -107.42 160.89 15.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.49 -0.884 . . . . 0.0 112.485 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.7 mt -149.87 159.7 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.635 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.79 HH22 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.7 130.72 15.32 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 118.929 -1.108 . . . . 0.0 111.415 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.79 ' CA ' HH22 ' A' ' 83' ' ' ARG . 4.2 t -132.2 141.65 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.847 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.463 HG12 ' NH2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -136.17 140.32 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.047 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 90.2 p -43.27 151.05 0.17 Allowed 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.599 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.85 144.14 13.75 Favored Pre-proline 0 C--N 1.307 -1.273 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.638 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -50.05 146.27 17.63 Favored 'Trans proline' 0 C--O 1.213 -0.763 0 C-N-CA 121.256 1.304 . . . . 0.0 111.345 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.95 145.94 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.053 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -145.28 153.66 52.7 Favored Pre-proline 0 N--CA 1.486 1.349 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.469 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -60.52 -152.07 0.01 OUTLIER 'Trans proline' 0 C--O 1.211 -0.868 0 C-N-CA 121.061 1.174 . . . . 0.0 110.501 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.426 ' HB2' ' H ' ' A' ' 93' ' ' ALA . 15.4 ptt180 179.76 -163.39 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.826 -1.15 . . . . 0.0 110.86 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.426 ' H ' ' HB2' ' A' ' 92' ' ' ARG . . . -133.76 169.92 16.33 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.201 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.473 ' HE ' ' HG3' ' A' ' 105' ' ' GLU . 66.7 ttt180 -137.91 110.02 7.29 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.969 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 19.3 m-85 -93.91 168.52 10.92 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.419 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.47 ' CD1' ' HB3' ' A' ' 105' ' ' GLU . 49.2 m-85 -137.87 177.08 8.15 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 119.033 -1.067 . . . . 0.0 112.075 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.524 ' CE2' ' CG2' ' A' ' 127' ' ' THR . 3.2 m-85 -115.63 133.21 56.26 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.4 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 19.4 tttp 78.59 137.72 0.07 Allowed 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.035 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.588 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 0.7 OUTLIER -68.2 104.84 1.92 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.219 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.614 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 1.7 tp-100 126.28 39.44 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.263 0 O-C-N 125.565 1.791 . . . . 0.0 109.721 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.614 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 25.7 p90 29.67 49.51 0.06 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.8 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -103.65 -17.67 15.04 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.076 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -102.41 164.07 16.67 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.594 -1.288 . . . . 0.0 110.976 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.46 ' CG ' ' N ' ' A' ' 105' ' ' GLU . 16.9 ttmt -40.7 160.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.823 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 105' ' ' GLU . 1.3 pm0 -127.14 158.97 35.64 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.613 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.4 156.43 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.741 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.631 ' OD1' ' ND2' ' A' ' 68' ' ' ASN . 4.8 p-10 -125.91 148.47 49.2 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.578 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.451 HD11 ' CE1' ' A' ' 95' ' ' PHE . 41.2 mt -139.19 124.69 11.95 Favored Pre-proline 0 N--CA 1.487 1.421 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.342 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.439 ' CB ' ' HD2' ' A' ' 110' ' ' PRO . 1.9 Cg_endo -64.39 171.59 7.78 Favored 'Trans proline' 0 C--O 1.213 -0.77 0 C-N-CA 121.476 1.451 . . . . 0.0 111.356 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.439 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 1.9 Cg_endo -60.78 146.41 97.42 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.875 1.717 . . . . 0.0 111.568 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.19 -154.92 25.74 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.674 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.591 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 28.5 mt-30 -133.24 161.29 34.85 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.842 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.591 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 24.0 m-85 -144.54 150.64 37.87 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.372 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 1.3 p -91.78 -142.17 0.19 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.697 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.597 ' N ' ' OG1' ' A' ' 114' ' ' THR . 13.7 mt-30 -90.31 -86.46 0.2 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.31 -28.2 62.86 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -70.09 -61.06 1.93 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.307 -1.357 . . . . 0.0 108.454 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.586 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 2.2 tt -43.35 -64.04 0.71 Allowed 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.557 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.415 ' CD ' ' O ' ' A' ' 115' ' ' GLN . 1.1 mp0 -42.86 -68.3 0.21 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.36 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.554 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 10.6 mpt_? -68.43 0.33 4.09 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.624 -0.83 . . . . 0.0 113.199 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.438 ' HH ' ' H ' ' A' ' 66' ' ' VAL . 22.3 t80 -89.03 -24.87 22.24 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 118.464 -1.295 . . . . 0.0 110.554 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -153.75 -20.75 0.05 OUTLIER Glycine 0 N--CA 1.485 1.951 0 C-N-CA 118.429 -1.844 . . . . 0.0 111.688 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.424 ' HB ' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -145.32 -115.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.329 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.424 ' H ' ' HB ' ' A' ' 123' ' ' ILE . 4.2 m-20 -167.57 -164.89 0.61 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -58.13 -76.09 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.163 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 127' ' ' THR . 3.7 t-20 -74.68 -138.11 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.123 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.524 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 0.5 OUTLIER 68.78 -138.45 0.09 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.785 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 mm 73.55 -49.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.477 0 O-C-N 124.168 0.918 . . . . 0.0 110.435 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 130' ' ' SER . 47.0 p 39.35 -135.32 0.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.937 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.542 ' N ' ' OG ' ' A' ' 129' ' ' SER . 24.1 m -63.37 143.9 57.42 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.381 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.03 151.46 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.489 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -150.31 81.67 6.62 Favored Pre-proline 0 C--N 1.304 -1.391 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.489 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -61.08 92.4 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.316 1.344 . . . . 0.0 110.043 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -73.64 26.18 0.07 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.118 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 176.71 -51.75 0.11 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 117.53 -2.272 . . . . 0.0 112.735 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.63 173.76 6.17 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.598 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -91.76 141.94 28.13 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.581 -0.848 . . . . 0.0 108.974 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 153' ' ' VAL . 66.9 t -109.89 139.99 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.547 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.03 127.17 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.701 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 mp -101.52 138.88 37.93 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.552 -0.859 . . . . 0.0 112.39 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.431 ' CG ' ' HA ' ' A' ' 146' ' ' PHE . 22.3 m-85 -114.07 118.56 34.42 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.082 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -48.19 -77.49 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.625 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.427 ' HB3' ' H ' ' A' ' 144' ' ' ASP . 3.3 m-20 -74.59 -156.49 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.341 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 146' ' ' PHE . 6.8 p-10 -62.07 -154.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.722 ' H ' HD21 ' A' ' 145' ' ' ASN . 1.9 m-80 -33.62 88.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.159 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.529 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 3.3 p90 36.31 66.07 0.41 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.663 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 92.5 p -61.0 -108.05 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.738 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.52 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . -115.4 -63.23 0.38 Allowed Glycine 0 N--CA 1.502 3.043 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.974 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.404 ' C ' ' CG2' ' A' ' 150' ' ' THR . 24.3 t70 -74.13 144.47 44.87 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.58 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.404 ' CG2' ' C ' ' A' ' 149' ' ' ASP . 6.7 p -151.67 173.74 14.32 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.491 -0.883 . . . . 0.0 111.187 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.406 ' C ' ' CD2' ' A' ' 151' ' ' LEU . 3.0 tt -144.25 87.51 7.78 Favored Pre-proline 0 C--N 1.31 -1.145 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.153 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.14 103.99 0.56 Allowed 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.671 1.581 . . . . 0.0 112.651 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 138' ' ' VAL . 2.8 t -77.75 93.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.154 -1.019 . . . . 0.0 109.912 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -43.78 -42.85 5.79 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.888 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.1 t -171.2 -130.09 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 118.456 -1.298 . . . . 0.0 112.229 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -46.44 141.89 3.36 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.681 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.558 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.85 64.13 1.06 Allowed Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.195 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.6 Cg_endo -63.08 21.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.279 1.986 . . . . 0.0 113.269 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.558 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.3 t -172.37 106.4 0.18 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.806 -1.157 . . . . 0.0 110.911 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.453 HD11 ' N ' ' A' ' 161' ' ' GLY . 3.0 tm? -103.6 -78.63 0.55 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.288 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.453 ' N ' HD11 ' A' ' 160' ' ' LEU . . . . . . . . 0 N--CA 1.494 2.539 0 C-N-CA 119.859 -1.163 . . . . 0.0 111.656 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.578 0.228 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.8 m 44.72 83.08 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.391 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.36 -52.22 8.37 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.846 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.458 ' HG ' ' H ' ' A' ' 146' ' ' PHE . 3.2 p -123.66 163.77 20.41 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.68 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 36.2 pt -143.34 178.22 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.522 ' NH1' ' OE1' ' A' ' 112' ' ' GLN . 35.5 ttt85 -156.8 109.23 2.51 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.64 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.2 mt -85.95 95.8 4.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.149 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 C--N 1.303 -1.415 0 CA-C-O 116.379 -1.772 . . . . 0.0 110.825 -179.92 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.985 0.421 . . . . 0.0 111.506 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.713 ' N ' ' ND2' ' A' ' 3' ' ' ASN . 0.1 OUTLIER 179.49 122.3 0.06 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.517 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 4' ' ' ILE . 1.7 pt -77.44 126.91 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.985 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.9 m -105.51 108.21 19.61 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.11 165.23 2.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.028 -1.069 . . . . 0.0 112.717 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.428 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 50.1 m-85 -123.37 145.15 48.99 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.837 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.443 ' HB2' ' N ' ' A' ' 15' ' ' LYS . 2.0 m-85 -83.91 8.45 15.0 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 13' ' ' GLN . 0.4 OUTLIER -150.19 171.08 17.49 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 118.132 -1.427 . . . . 0.0 111.979 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.497 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 11.6 mm-40 -78.36 146.88 34.39 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.348 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.587 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 2.1 t70 76.87 60.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.42 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.587 ' CG ' ' O ' ' A' ' 11' ' ' ASP . 54.7 p90 42.78 15.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.774 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 11' ' ' ASP . 14.2 mt-30 -101.42 154.5 18.75 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.193 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 1.144 ' O ' ' NE2' ' A' ' 16' ' ' GLN . . . 116.63 139.34 6.48 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 1.279 ' C ' ' NE2' ' A' ' 16' ' ' GLN . 9.3 mtpm? -36.41 147.38 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.491 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 1.437 HE21 ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -99.88 142.25 31.61 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.584 -0.847 . . . . 0.0 112.25 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 t -144.48 123.72 6.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.523 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -95.47 119.39 33.89 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.414 -0.914 . . . . 0.0 112.106 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.1 125.7 30.1 Favored Pre-proline 0 N--CA 1.494 1.762 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.471 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -65.44 162.39 33.97 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 120.993 1.128 . . . . 0.0 111.724 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.31 -178.83 0.51 Allowed 'Trans proline' 0 C--N 1.322 -0.838 0 C-N-CA 121.768 1.645 . . . . 0.0 110.966 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.679 ' C ' HD21 ' A' ' 23' ' ' ASN . . . 108.4 -170.9 15.3 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.381 -1.39 . . . . 0.0 110.662 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.679 HD21 ' C ' ' A' ' 22' ' ' GLY . 0.6 OUTLIER -117.21 124.69 49.72 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.96 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 3.2 p90 -144.3 169.43 17.91 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.786 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.7 p -140.75 -142.04 0.14 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.992 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.444 ' NH2' ' ND2' ' A' ' 36' ' ' ASN . 15.7 tpp180 -69.32 -38.5 78.25 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.031 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.7 -58.59 6.94 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.14 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -56.89 -51.18 70.1 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.484 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 28.4 mt -58.26 -28.8 65.27 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.446 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 26' ' ' ARG . . . -56.26 -32.09 64.18 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.42 -36.04 63.41 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.72 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.3 mt -77.01 -83.65 0.07 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.89 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.39 -16.91 0.77 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.033 -1.556 . . . . 0.0 111.225 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.36 138.98 18.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.073 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.505 ' C ' ' CG ' ' A' ' 36' ' ' ASN . 1.8 pt-20 172.42 150.31 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.403 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.53 ' O ' ' N ' ' A' ' 38' ' ' THR . 0.5 OUTLIER 75.86 123.81 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 43.39 12.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.358 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 36' ' ' ASN . 64.3 p -88.86 -151.38 0.21 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.447 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 38' ' ' THR . 2.3 mt 42.49 60.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.736 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.8 t -80.14 -33.15 38.74 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.418 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -143.14 153.72 43.16 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.247 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.457 HG21 ' H ' ' A' ' 69' ' ' ALA . 25.4 m -143.38 170.44 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 118.128 -1.429 . . . . 0.0 113.578 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -143.48 95.67 2.79 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.862 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.99 108.48 46.27 Favored Pre-proline 0 N--CA 1.493 1.716 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.73 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.411 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.6 Cg_endo -68.52 170.29 15.35 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 120.975 1.117 . . . . 0.0 110.321 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.411 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 2.5 Cg_endo -60.28 -170.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.877 1.718 . . . . 0.0 111.407 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.3 -12.34 10.11 Favored Glycine 0 N--CA 1.485 1.945 0 C-N-CA 119.407 -1.377 . . . . 0.0 111.13 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 m -148.77 139.55 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.142 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -115.38 120.23 38.89 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.03 155.25 19.58 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.287 -0.965 . . . . 0.0 112.808 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.4 mt -142.22 118.28 6.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.094 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.442 HD11 ' H ' ' A' ' 52' ' ' LEU . 3.6 mp -88.8 159.37 17.78 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.008 -1.077 . . . . 0.0 112.504 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.409 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 72.1 m-85 -141.59 118.89 11.43 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.836 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -49.9 -82.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.461 ' ND2' ' H ' ' A' ' 56' ' ' ASP . 2.7 t-20 -58.59 155.06 13.06 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.386 -0.925 . . . . 0.0 111.799 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.461 ' H ' ' ND2' ' A' ' 55' ' ' ASN . 21.1 p-10 -59.89 -177.9 0.07 Allowed 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.705 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.581 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 50.45 38.71 35.23 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 39.17 71.12 0.18 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.521 0.677 . . . . 0.0 111.058 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.3 172.52 12.81 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.969 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.34 -174.64 55.0 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.445 -1.36 . . . . 0.0 109.981 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -44.87 158.1 0.06 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.895 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.502 ' NE2' ' C ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -149.84 168.41 23.81 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.812 -1.155 . . . . 0.0 111.499 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.523 ' CG2' ' H ' ' A' ' 64' ' ' GLU . 73.0 mt -134.85 174.11 13.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.723 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.523 ' H ' ' CG2' ' A' ' 63' ' ' ILE . 24.8 mt-10 -144.74 133.92 22.86 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.568 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.4 m -150.55 152.89 11.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 118.628 -1.229 . . . . 0.0 112.224 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.54 -10.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.412 ' HB2' ' H ' ' A' ' 68' ' ' ASN . . . -119.92 -156.93 0.69 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.56 -1.655 . . . . 0.0 109.673 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.434 ' ND2' ' C ' ' A' ' 68' ' ' ASN . 0.5 OUTLIER -93.23 127.85 38.98 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.077 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.457 ' H ' HG21 ' A' ' 42' ' ' VAL . . . -90.43 119.52 30.78 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.781 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -79.9 -58.74 3.02 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.445 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -106.52 19.47 20.44 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.612 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.0 tp 53.01 -98.4 0.07 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.466 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.82 -158.99 31.47 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.093 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.546 ' O ' ' N ' ' A' ' 76' ' ' ASN . 1.5 Cg_endo -66.02 -157.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.451 1.434 . . . . 0.0 110.545 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 74' ' ' PRO . 1.4 pt? 31.69 32.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 123.8 0.687 . . . . 0.0 111.79 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.546 ' N ' ' O ' ' A' ' 74' ' ' PRO . 8.5 t-20 -80.22 -12.03 59.67 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.795 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -72.72 -12.84 61.18 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.085 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -160.29 134.67 7.43 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 118.889 -1.124 . . . . 0.0 111.69 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.39 153.18 14.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.845 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 81' ' ' SER . 86.9 p -164.89 -57.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.351 -1.34 . . . . 0.0 112.772 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.473 ' N ' ' OG ' ' A' ' 80' ' ' SER . 32.9 t -89.9 146.42 24.43 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.613 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.454 HD11 ' HH ' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -146.77 134.01 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 118.74 -1.184 . . . . 0.0 111.153 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.623 ' HA ' ' NE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -108.74 141.15 41.16 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.304 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.537 ' HB ' ' H ' ' A' ' 22' ' ' GLY . 9.4 t -144.33 123.55 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.226 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.5 mt -129.07 125.67 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.303 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.8 m -43.73 132.71 4.95 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.686 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.65 139.38 34.64 Favored Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.499 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -52.76 143.55 47.16 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.127 1.218 . . . . 0.0 110.741 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.0 t -59.98 122.24 9.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.229 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -102.89 135.32 19.45 Favored Pre-proline 0 C--N 1.306 -1.326 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.987 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -52.53 -33.0 55.9 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 120.85 1.033 . . . . 0.0 110.283 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.9 mtt-85 50.68 -164.43 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.662 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.514 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.66 177.2 8.66 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.185 -1.37 . . . . 0.0 108.437 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -150.36 132.19 15.08 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 118.21 -1.396 . . . . 0.0 112.088 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.476 ' CE2' HG11 ' A' ' 131' ' ' VAL . 21.9 m-85 -118.68 147.65 43.58 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.757 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -121.15 159.29 26.13 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.185 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' A' ' 97' ' ' TYR . 8.0 m-30 -95.15 164.14 12.99 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.603 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 tttt 67.7 135.6 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.691 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.595 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 8.6 tp10 -63.69 100.94 0.31 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.273 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 1.124 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 119.73 38.17 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.882 0 O-C-N 125.426 1.704 . . . . 0.0 108.47 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.771 ' CD1' ' NE2' ' A' ' 100' ' ' GLN . 22.5 p90 33.78 44.09 0.08 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.76 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -103.64 32.33 3.93 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.581 -0.847 . . . . 0.0 111.453 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -153.66 170.11 32.38 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.167 -1.492 . . . . 0.0 110.751 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.1 OUTLIER -35.03 151.13 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.428 ' CD ' ' C ' ' A' ' 105' ' ' GLU . 1.4 pp20? -121.92 168.31 12.04 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.847 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.88 139.41 19.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.283 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 6.3 p30 -108.98 151.44 26.31 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.748 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 72.3 mt -139.64 140.27 24.56 Favored Pre-proline 0 N--CA 1.497 1.877 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.804 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -76.03 164.13 31.97 Favored 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 121.944 1.763 . . . . 0.0 111.254 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.41 142.01 76.88 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.555 1.503 . . . . 0.0 110.581 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 144.05 -158.63 27.48 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 118.916 -1.612 . . . . 0.0 111.466 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.58 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 24.4 tt0 -125.28 154.97 40.9 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.88 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.58 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 25.3 m-85 -143.53 152.71 41.79 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.738 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.7 p -106.44 178.43 4.56 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.867 0.841 . . . . 0.0 112.97 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.644 ' NE2' ' CD ' ' A' ' 119' ' ' GLU . 24.1 tp60 -59.39 -20.85 58.12 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.558 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.44 -60.71 1.85 Allowed 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.901 -1.12 . . . . 0.0 114.01 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -67.4 -56.83 8.07 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.219 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.607 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -34.11 -74.02 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 O-C-N 123.801 0.688 . . . . 0.0 111.817 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.644 ' CD ' ' NE2' ' A' ' 115' ' ' GLN . 69.5 mt-10 -51.19 -56.36 13.24 Favored 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.739 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.413 ' HD3' ' H ' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -75.06 14.65 0.5 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.474 -1.291 . . . . 0.0 111.647 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 117' ' ' GLU . 18.4 t80 -119.39 -16.44 8.96 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.856 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -139.49 -48.08 0.06 OUTLIER Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.676 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.433 ' CD1' ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -137.85 -108.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.969 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.586 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 18.3 t70 -161.75 -146.8 0.13 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.402 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.586 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 4.4 m-20 -60.67 -52.72 63.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.338 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.689 HD21 HD21 ' A' ' 166' ' ' ASN . 29.4 t-20 -158.04 134.71 9.72 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.426 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.5 t -178.61 -10.1 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.507 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 9.4 mt -70.42 141.39 17.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.528 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.403 ' O ' ' OG ' ' A' ' 130' ' ' SER . 8.3 t -157.33 12.55 0.23 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.026 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 129' ' ' SER . 14.3 m -170.7 117.12 0.49 Allowed 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.579 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.476 HG11 ' CE2' ' A' ' 95' ' ' PHE . 3.6 t -110.51 156.28 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.995 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.469 ' NZ ' ' HG3' ' A' ' 158' ' ' PRO . 1.6 tppt? -155.02 87.25 3.32 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.292 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.02 101.4 0.18 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.309 1.34 . . . . 0.0 111.678 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.514 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 38.2 tt0 -54.17 -12.21 0.6 Allowed 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.986 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -178.83 -36.6 0.06 OUTLIER Glycine 0 N--CA 1.497 2.76 0 C-N-CA 118.412 -1.852 . . . . 0.0 112.245 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mt -92.1 -174.97 3.93 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.998 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.45 137.04 48.68 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.459 ' CG1' ' CD1' ' A' ' 140' ' ' LEU . 7.2 t -103.1 140.49 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.413 -0.915 . . . . 0.0 112.866 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.43 HG13 ' CE1' ' A' ' 141' ' ' PHE . 96.4 t -131.2 120.15 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.453 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.49 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 10.1 mp -98.59 143.75 28.64 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.327 -0.949 . . . . 0.0 113.307 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.43 ' CE1' HG13 ' A' ' 139' ' ' VAL . 27.8 m-85 -120.27 130.89 54.68 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.111 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -67.21 -69.67 0.3 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.142 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -70.16 164.19 24.72 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.558 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 146' ' ' PHE . 3.6 m-20 -63.58 -160.05 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.606 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.654 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 2.5 p30 32.76 34.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 123.733 0.646 . . . . 0.0 111.57 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.654 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 42.82 61.24 2.17 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 44.5 t -136.26 -178.55 5.21 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.006 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.491 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 75.67 -163.13 53.47 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.354 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.76 164.12 3.94 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.144 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.2 p -148.2 170.16 18.48 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.944 -1.103 . . . . 0.0 111.668 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.1 tp -141.89 84.98 11.48 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.151 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -62.45 102.66 0.29 Allowed 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.076 1.85 . . . . 0.0 113.59 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 138' ' ' VAL . 6.8 t -89.19 80.36 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.346 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -76.88 14.09 0.91 Allowed 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.592 -0.843 . . . . 0.0 113.015 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.711 ' HG ' ' H ' ' A' ' 156' ' ' ASP . 19.8 t -169.97 -169.67 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 117.785 -1.566 . . . . 0.0 112.959 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.711 ' H ' ' HG ' ' A' ' 155' ' ' SER . 64.3 m-20 -57.03 152.26 13.48 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.519 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.54 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -172.88 62.62 0.29 Allowed Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.072 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.54 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 5.8 Cg_endo -70.05 34.38 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 122.336 2.024 . . . . 0.0 112.2 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.451 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.6 OUTLIER -176.33 76.57 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.407 -1.317 . . . . 0.0 112.389 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.466 ' N ' HD21 ' A' ' 160' ' ' LEU . 2.8 mm? -81.2 -87.51 0.08 Allowed 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.63 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.106 0 C-N-CA 119.585 -1.293 . . . . 0.0 111.857 179.786 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.689 HD21 HD21 ' A' ' 126' ' ' ASN . 15.1 m120 . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.861 0.363 . . . . 0.0 111.88 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.7 m -59.82 112.81 1.98 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.424 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.6 t -97.24 -63.13 1.16 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.549 -0.861 . . . . 0.0 112.043 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.5 ' HG ' ' H ' ' A' ' 146' ' ' PHE . 0.9 OUTLIER -116.06 162.39 17.47 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.04 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 25.6 pt -147.78 179.49 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.307 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -161.32 114.62 1.93 Allowed 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.302 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 42.9 mt -90.57 98.97 8.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.349 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--N 1.304 -1.405 0 CA-C-O 116.298 -1.81 . . . . 0.0 110.988 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.435 ' CB ' HG13 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.784 0.326 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 2' ' ' ALA . 21.9 m-80 -169.29 110.97 0.48 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.707 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.4 pt -70.68 140.87 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.102 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -115.35 120.31 39.18 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.715 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -104.3 155.79 5.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.923 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.448 ' N ' ' CG2' ' A' ' 6' ' ' VAL . 38.8 m-85 -115.64 139.98 49.61 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.191 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -62.92 1.36 Allowed 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.385 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.493 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 3.2 m120 -89.5 168.36 12.25 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.52 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.35 -162.56 0.06 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.414 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.622 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 1.3 m-20 47.43 45.91 17.19 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.254 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.622 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 51.3 p90 38.63 24.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.951 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ASP . 3.8 pt20 -113.04 163.58 14.52 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.493 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 103.9 134.35 8.17 Favored Glycine 0 N--CA 1.501 2.996 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.457 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -28.99 132.88 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.02 0.438 . . . . 0.0 111.741 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.665 ' NE2' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -97.63 164.81 12.26 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.727 -0.789 . . . . 0.0 112.423 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 t -149.7 123.63 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.658 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.76 120.84 32.85 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.612 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mt -108.8 140.96 22.36 Favored Pre-proline 0 N--CA 1.489 1.513 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.081 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -72.2 165.72 31.8 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 120.909 1.072 . . . . 0.0 111.277 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.77 -158.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 121.905 1.736 . . . . 0.0 111.089 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.71 168.3 24.56 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 119.272 -1.442 . . . . 0.0 111.551 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.533 ' ND2' ' H ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -95.87 140.45 30.62 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.065 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.481 ' O ' ' CE1' ' A' ' 58' ' ' PHE . 36.7 p90 -155.68 176.2 12.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.673 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.647 ' HG1' ' H ' ' A' ' 26' ' ' ARG . 6.3 t -138.09 -157.32 0.76 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.009 -1.077 . . . . 0.0 112.443 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.647 ' H ' ' HG1' ' A' ' 25' ' ' THR . 13.1 ptm180 -63.69 -25.82 68.38 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.358 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.609 ' H ' ' CG2' ' A' ' 25' ' ' THR . . . -58.56 -55.96 28.27 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.652 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.29 -45.1 88.6 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.637 -1.225 . . . . 0.0 109.555 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 30.2 mt -59.97 -34.09 72.82 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.518 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.74 -32.02 59.27 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.46 -40.55 70.24 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.675 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 mt -70.35 -81.04 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.967 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 160.09 -26.43 0.32 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 118.952 -1.594 . . . . 0.0 111.049 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.457 HG12 ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -85.73 152.22 3.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.574 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.466 ' H ' HG22 ' A' ' 38' ' ' THR . 3.4 pt-20 -178.51 154.31 0.78 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.357 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 38' ' ' THR . 1.3 m120 64.68 -149.93 0.27 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.549 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -56.21 81.43 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.724 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 36' ' ' ASN . 39.6 p -143.75 -33.56 0.42 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.664 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.9 mt -78.87 51.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 119.181 -1.008 . . . . 0.0 109.452 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 38' ' ' THR . 24.8 t -51.38 -46.98 62.99 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.573 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.21 167.29 15.06 Favored 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.79 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -155.45 149.69 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 118.197 -1.401 . . . . 0.0 113.05 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -133.59 126.92 31.98 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.492 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.2 t -144.0 113.62 5.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 C-N-CA 119.173 -1.011 . . . . 0.0 112.149 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.37 167.6 21.86 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 121.283 1.322 . . . . 0.0 111.082 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.67 -169.22 0.1 OUTLIER 'Trans proline' 0 C--N 1.32 -0.937 0 C-N-CA 121.97 1.78 . . . . 0.0 111.504 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.66 -15.26 7.95 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.808 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.435 HG13 ' CB ' ' A' ' 2' ' ' ALA . 24.1 m -150.91 139.58 14.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.873 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -109.25 129.24 55.51 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.095 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.76 152.55 24.21 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.409 -0.916 . . . . 0.0 112.661 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.587 ' CD1' HH21 ' A' ' 83' ' ' ARG . 71.1 mt -139.57 121.3 16.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.992 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.69 162.01 13.35 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 119.384 -0.926 . . . . 0.0 112.341 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 62' ' ' GLN . 11.6 m-85 -140.76 115.28 9.45 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.668 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -46.54 -78.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.871 -0.731 . . . . 0.0 112.044 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -59.77 156.41 14.09 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.112 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -64.59 -173.69 0.11 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.726 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.86 36.31 33.23 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.355 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.481 ' CE1' ' O ' ' A' ' 24' ' ' TYR . 12.0 m-85 49.71 59.16 4.71 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.728 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.36 -176.88 4.54 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 76.51 170.22 31.04 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 60' ' ' GLY . 17.7 m-20 -42.41 125.85 3.31 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.147 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.411 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.4 pt20 -95.01 163.83 13.15 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.75 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.635 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 4.6 mm -134.93 168.77 22.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.009 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.635 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 30.8 tt0 -150.48 132.26 15.02 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.253 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.0 m -148.34 151.46 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.301 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.467 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 3.3 t -137.0 -7.73 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.768 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -122.99 -139.27 0.31 Allowed 'General case' 0 C--O 1.206 -1.237 0 CA-C-N 114.042 -1.436 . . . . 0.0 109.281 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -114.2 116.74 29.54 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.646 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.64 112.39 23.61 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.8 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -67.03 -85.79 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.451 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 7.8 mm-40 -72.56 -1.99 18.12 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.738 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.494 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 3.8 tp 75.99 -84.57 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.87 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.449 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 176.03 -161.67 30.29 Favored Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.151 -1.5 . . . . 0.0 110.753 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.583 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.6 Cg_endo -68.87 -55.41 0.21 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.121 1.881 . . . . 0.0 112.335 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.542 ' C ' ' H ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER -69.77 27.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.599 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.583 ' H ' ' C ' ' A' ' 74' ' ' PRO . 3.2 p30 -70.91 10.76 0.48 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.118 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.542 ' H ' ' C ' ' A' ' 75' ' ' LEU . 23.3 t-20 -89.47 -9.98 48.07 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.096 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -166.49 132.68 2.41 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.726 -1.19 . . . . 0.0 111.697 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t -147.95 142.47 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.057 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 m -154.63 -48.27 0.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.238 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.6 t -90.01 136.28 33.14 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.062 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 10.6 mt -151.76 149.94 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.434 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.587 HH21 ' CD1' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -151.32 153.33 34.6 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.844 -1.142 . . . . 0.0 111.213 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.478 ' C ' HH12 ' A' ' 83' ' ' ARG . 3.3 t -142.7 147.19 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.394 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.485 HG12 ' NH1' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -138.77 132.25 39.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.389 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 85' ' ' ILE . 78.7 p -36.78 147.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.89 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -151.44 140.62 13.81 Favored Pre-proline 0 N--CA 1.487 1.385 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.27 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -50.89 133.55 40.16 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 121.256 1.304 . . . . 0.0 111.372 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.525 ' CG2' ' N ' ' A' ' 90' ' ' GLN . 2.5 p -65.93 160.96 3.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.912 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.525 ' N ' ' CG2' ' A' ' 89' ' ' VAL . 62.4 mt-30 -143.51 151.31 53.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.157 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.448 ' C ' ' CG ' ' A' ' 92' ' ' ARG . 1.8 Cg_endo -64.93 -40.58 20.45 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 121.587 1.525 . . . . 0.0 112.164 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.448 ' CG ' ' C ' ' A' ' 91' ' ' PRO . 3.0 mtm-85 57.98 -164.92 0.17 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.737 0.78 . . . . 0.0 112.431 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.477 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -138.89 173.31 11.7 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.812 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -150.85 123.03 8.29 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.291 -1.364 . . . . 0.0 112.339 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.478 ' O ' ' CB ' ' A' ' 105' ' ' GLU . 8.2 m-30 -95.92 166.39 11.81 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.275 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -135.47 154.65 51.35 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -95.57 146.53 24.39 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.424 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.9 tttt 66.97 126.06 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.564 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 28.6 tt0 -64.27 90.81 0.07 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.702 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.674 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 169.71 21.78 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.734 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.674 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 28.5 p90 38.81 42.22 0.6 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.142 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -118.26 -57.86 2.04 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.533 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -44.52 159.58 0.13 Allowed Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.613 -1.28 . . . . 0.0 110.705 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -47.58 168.82 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.251 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -134.57 167.46 20.76 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.39 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.7 t -143.26 137.46 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.94 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -110.74 160.79 16.4 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 119.325 -0.95 . . . . 0.0 113.23 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.9 mt -145.94 139.01 14.24 Favored Pre-proline 0 N--CA 1.49 1.551 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.03 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -69.55 166.05 28.66 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 121.505 1.47 . . . . 0.0 111.156 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.99 144.68 99.63 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.734 1.622 . . . . 0.0 111.35 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 139.78 178.91 17.21 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 119.188 -1.482 . . . . 0.0 111.423 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.454 ' OE1' ' N ' ' A' ' 113' ' ' TYR . 14.4 tm0? -106.68 157.76 17.47 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.471 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.454 ' N ' ' OE1' ' A' ' 112' ' ' GLN . 67.8 m-85 -145.86 149.97 35.26 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.069 -1.053 . . . . 0.0 111.298 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.0 p -88.08 -157.27 0.4 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.347 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.39 52.22 0.72 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.019 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.18 -69.84 0.12 Allowed 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -70.54 -42.15 71.56 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.499 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.583 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 2.4 tt -40.53 -73.55 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.254 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.657 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.7 OUTLIER -52.59 -49.87 64.16 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.955 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -70.99 -0.33 9.1 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.851 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.533 ' N ' ' O ' ' A' ' 117' ' ' GLU . 24.5 t80 -100.82 -22.81 14.73 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.497 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -131.12 -47.75 0.12 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.208 -1.473 . . . . 0.0 110.811 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.555 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -142.94 -107.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.113 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.555 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 7.0 m-20 -149.26 -178.67 6.53 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.998 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.07 10.61 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.473 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 124' ' ' ASP . 0.4 OUTLIER -163.72 -139.23 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.511 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 126' ' ' ASN . 0.0 OUTLIER 33.78 87.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.275 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.9 mm -127.23 -41.98 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.071 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.7 m 46.1 -138.31 0.57 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.36 -0.836 . . . . 0.0 113.129 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.5 m -56.98 140.33 49.24 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.576 -1.193 . . . . 0.0 113.005 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 t -122.28 150.45 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.647 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -145.52 98.6 4.55 Favored Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.907 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -66.49 105.42 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.177 1.252 . . . . 0.0 110.969 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.477 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 28.0 mm-40 -57.97 -11.15 2.18 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.588 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 172.4 -30.31 0.11 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 118.226 -1.94 . . . . 0.0 112.352 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.3 mt -98.18 169.45 9.58 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.246 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -88.39 130.17 35.23 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.0 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.7 t -99.85 137.92 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.21 -0.996 . . . . 0.0 112.094 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.442 HG13 ' CE1' ' A' ' 141' ' ' PHE . 86.6 t -136.44 121.73 27.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.149 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.0 mp -103.56 148.0 26.51 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.952 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.519 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 15.9 m-85 -120.79 130.54 54.03 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.134 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -66.32 -72.23 0.17 Allowed 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.476 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -75.17 164.74 26.17 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.59 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.634 ' CG ' ' H ' ' A' ' 145' ' ' ASN . 28.7 t0 -62.68 -161.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.831 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.641 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 2.5 m120 41.16 26.33 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.192 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.641 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 3.1 p90 41.01 58.11 2.6 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.489 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.8 t -136.78 -172.05 3.08 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.237 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.9 -165.54 50.64 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.129 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -59.33 148.86 30.72 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.996 -1.081 . . . . 0.0 110.178 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.2 p -138.82 177.15 8.1 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.534 -0.867 . . . . 0.0 111.468 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.417 ' C ' ' CD1' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -142.64 84.81 10.68 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.608 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.28 104.4 0.88 Allowed 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 121.8 1.667 . . . . 0.0 112.736 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 26.0 t -85.17 86.53 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.403 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -58.02 -21.32 44.56 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.938 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 59.4 p -169.79 -149.32 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 117.841 -1.544 . . . . 0.0 113.046 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -49.51 142.49 7.92 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.769 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.568 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -161.7 64.44 1.78 Allowed Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.666 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.1 Cg_endo -62.08 19.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 122.199 1.933 . . . . 0.0 113.066 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.568 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.5 t -172.92 83.22 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 118.27 -1.372 . . . . 0.0 112.128 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.99 -67.45 0.85 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.739 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 C-N-CA 119.849 -1.167 . . . . 0.0 111.464 179.906 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.429 ' C ' ' HG1' ' A' ' 167' ' ' THR . 4.6 t-20 . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 121.083 0.468 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.429 ' HG1' ' C ' ' A' ' 166' ' ' ASN . 44.9 m -147.98 98.67 2.97 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.271 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.3 m -89.67 -38.86 13.59 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.657 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.1 p -146.31 152.4 39.09 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.754 -1.179 . . . . 0.0 110.103 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 23.0 pt -134.07 175.96 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.331 -0.947 . . . . 0.0 111.015 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -153.48 108.76 3.2 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.438 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 11.1 mt -91.89 93.3 4.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.295 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 116.334 -1.793 . . . . 0.0 110.909 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.512 ' C ' ' ND2' ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.516 0.198 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.512 ' ND2' ' C ' ' A' ' 2' ' ' ALA . 11.2 m-80 -159.67 128.75 5.19 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.842 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.481 ' CG1' ' O ' ' A' ' 4' ' ' ILE . 1.2 pt -73.28 124.93 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.127 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -97.86 106.24 18.51 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.256 -0.978 . . . . 0.0 108.511 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -90.47 166.38 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 119.195 -1.002 . . . . 0.0 113.257 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.678 ' CZ ' ' CE1' ' A' ' 12' ' ' PHE . 37.6 m-85 -122.7 134.44 54.46 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.358 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.69 -60.23 4.12 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.584 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 3.0 m120 -89.72 174.28 7.81 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.129 -1.028 . . . . 0.0 112.15 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 7.4 tp10 -81.96 165.25 20.89 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.779 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 10' ' ' GLU . 1.6 t70 76.17 42.01 0.2 Allowed 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.027 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.678 ' CE1' ' CZ ' ' A' ' 7' ' ' PHE . 78.1 t80 51.69 11.17 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.423 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -107.32 162.1 14.21 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.318 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.584 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 106.15 133.89 7.61 Favored Glycine 0 N--CA 1.503 3.142 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.853 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 14' ' ' GLY . 33.4 mttp -29.86 138.88 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.17 158.43 15.45 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.446 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 t -147.84 125.73 3.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.596 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -92.09 120.67 32.92 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.161 -1.016 . . . . 0.0 111.694 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 mt -114.3 133.17 22.47 Favored Pre-proline 0 N--CA 1.498 1.959 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.265 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -69.53 167.89 22.84 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 120.848 1.032 . . . . 0.0 111.155 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -67.2 -162.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.893 1.729 . . . . 0.0 110.767 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.18 172.8 48.93 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.138 -1.506 . . . . 0.0 111.079 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.534 ' HB3' ' NE ' ' A' ' 83' ' ' ARG . 2.7 p30 -106.26 139.9 40.05 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.859 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 4.0 p90 -155.75 -174.62 5.04 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.425 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.5 p -144.4 -156.29 0.68 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.036 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -65.67 -22.03 66.6 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.77 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.0 -60.67 2.96 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.501 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -54.86 -45.65 74.59 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.498 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.0 mt -56.89 -43.05 80.93 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.579 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.76 -34.25 18.67 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 118.878 -1.129 . . . . 0.0 108.826 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.55 -42.29 87.36 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.421 -0.911 . . . . 0.0 109.793 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.6 mt -71.71 -71.92 0.25 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.715 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.41 -37.76 0.68 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.329 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 tt -79.3 146.35 8.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.367 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -179.89 161.63 0.98 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.53 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 38' ' ' THR . 7.9 m120 60.1 -128.43 1.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.094 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.638 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -51.98 90.67 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.874 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.647 ' OG1' ' N ' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -178.91 -165.99 0.09 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.383 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.647 ' N ' ' OG1' ' A' ' 38' ' ' THR . 5.2 mt 46.77 37.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-O 122.208 1.004 . . . . 0.0 108.829 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.442 ' OG ' ' CD ' ' A' ' 10' ' ' GLU . 30.9 t -70.02 -31.99 69.92 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.394 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.423 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -134.81 154.97 51.4 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -147.45 168.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 117.894 -1.523 . . . . 0.0 113.785 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -141.93 91.06 2.32 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.27 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.4 t -107.91 108.94 61.95 Favored Pre-proline 0 N--CA 1.487 1.38 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.034 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.405 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 2.4 Cg_endo -67.21 172.01 10.66 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.146 1.231 . . . . 0.0 109.587 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HB3' ' HE ' ' A' ' 92' ' ' ARG . 2.1 Cg_endo -60.81 -168.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.329 1.353 . . . . 0.0 110.712 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.05 -19.0 10.84 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.12 -1.514 . . . . 0.0 111.871 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.454 ' N ' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -155.49 155.53 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 118.118 -1.433 . . . . 0.0 113.054 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.45 ' N ' HG21 ' A' ' 48' ' ' VAL . 24.4 ttpt -123.61 129.74 51.61 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.257 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.96 134.11 52.85 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.385 -0.926 . . . . 0.0 113.175 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.3 mt -115.51 117.67 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.154 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.665 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -96.35 163.06 13.23 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.215 -0.994 . . . . 0.0 113.337 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -139.92 111.61 7.33 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.052 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -82.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.309 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -59.99 137.56 58.05 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.546 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.638 ' CG ' ' H ' ' A' ' 57' ' ' GLY . 26.2 t70 -58.94 -168.77 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.384 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.638 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 56.97 27.59 57.08 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 118.885 -1.626 . . . . 0.0 109.758 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 53.9 61.76 2.93 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.114 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.96 -166.64 2.59 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.703 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.71 167.06 6.84 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.295 -1.431 . . . . 0.0 109.974 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -45.31 124.3 4.67 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.464 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -94.61 159.18 15.2 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.906 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.581 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 7.5 mm -136.27 171.12 17.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.688 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.581 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 2.3 pt-20 -150.57 132.28 14.94 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.346 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.2 m -150.19 161.88 4.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.426 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.478 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 3.0 t -145.57 -8.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.021 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -119.15 -149.01 0.43 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.105 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -90.36 141.55 28.62 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.908 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.62 94.47 5.05 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.843 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.64 -53.62 55.29 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.157 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.477 ' O ' ' C ' ' A' ' 72' ' ' LEU . 10.0 tp10 -128.85 66.64 1.42 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.18 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 71' ' ' GLU . 11.5 tp -21.14 -90.91 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.282 0.989 . . . . 0.0 113.071 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.53 ' O ' ' ND2' ' A' ' 76' ' ' ASN . . . -170.66 -159.64 17.15 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 118.917 -1.611 . . . . 0.0 110.783 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.443 ' C ' HD21 ' A' ' 76' ' ' ASN . 2.6 Cg_endo -65.08 -34.48 46.46 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 121.911 1.741 . . . . 0.0 111.488 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.567 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -77.85 15.57 0.84 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.89 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.779 ' H ' HD21 ' A' ' 76' ' ' ASN . 0.3 OUTLIER -62.54 -61.18 2.61 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.854 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.625 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 1.9 t30 -78.68 33.94 0.21 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.86 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.45 ' H ' ' C ' ' A' ' 76' ' ' ASN . 3.1 t-20 -171.42 71.66 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.241 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -94.59 -177.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.307 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.673 ' HG ' ' N ' ' A' ' 81' ' ' SER . 1.5 t 174.82 -71.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.769 -1.172 . . . . 0.0 112.312 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.673 ' N ' ' HG ' ' A' ' 80' ' ' SER . 3.0 m -99.97 145.64 27.62 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.495 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -149.65 160.88 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.812 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.784 HH22 ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -144.03 110.1 5.38 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.732 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.784 ' N ' HH22 ' A' ' 83' ' ' ARG . 11.2 t -116.91 140.34 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.884 -0.727 . . . . 0.0 111.584 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.605 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 3.7 mt -144.97 135.11 19.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.413 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.2 m -41.88 157.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.488 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.454 HG11 ' N ' ' A' ' 48' ' ' VAL . 0.6 OUTLIER -154.61 139.86 12.13 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.318 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.506 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 8.0 Cg_exo -50.12 129.31 24.82 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 121.313 1.342 . . . . 0.0 111.071 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 90' ' ' GLN . 2.7 p -66.48 156.34 6.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.039 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -144.42 154.51 56.88 Favored Pre-proline 0 N--CA 1.487 1.388 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.872 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.11 -35.7 91.6 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 121.466 1.444 . . . . 0.0 111.142 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.477 ' HE ' ' HB3' ' A' ' 46' ' ' PRO . 86.5 mtt-85 54.72 -157.97 0.2 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.918 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.95 172.22 12.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.527 ' NE ' ' CD ' ' A' ' 105' ' ' GLU . 11.7 ttt180 -148.31 122.34 9.45 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.126 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 26.3 m-85 -105.05 165.54 11.01 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.503 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.541 ' CE2' ' O ' ' A' ' 101' ' ' PHE . 0.5 OUTLIER -125.69 172.76 9.52 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.513 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.447 ' CD1' ' O ' ' A' ' 104' ' ' LYS . 2.1 m-85 -92.32 -97.02 0.13 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.939 -1.104 . . . . 0.0 112.654 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -45.37 164.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.576 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -87.51 67.78 9.45 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.49 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.682 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -175.34 33.58 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.804 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.541 ' O ' ' CE2' ' A' ' 96' ' ' PHE . 29.1 t80 55.22 20.55 3.49 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.345 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -119.78 161.07 21.4 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.644 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 94.33 137.08 8.54 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.043 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.447 ' O ' ' CD1' ' A' ' 97' ' ' TYR . 52.7 mttm -28.0 138.93 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.527 ' CD ' ' NE ' ' A' ' 94' ' ' ARG . 11.6 pt-20 -99.48 175.94 5.67 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.26 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.4 t -150.7 120.11 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.153 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 26.7 p-10 -96.62 155.75 16.64 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.597 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 69.5 mt -142.75 149.4 49.93 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.147 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -77.27 165.03 28.37 Favored 'Trans proline' 0 C--O 1.213 -0.77 0 C-N-CA 121.84 1.693 . . . . 0.0 111.595 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -68.82 153.99 71.92 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 121.686 1.591 . . . . 0.0 110.843 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.45 -161.58 20.76 Favored Glycine 0 N--CA 1.509 3.521 0 C-N-CA 119.194 -1.479 . . . . 0.0 111.835 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.457 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 2.9 mp0 -116.13 161.67 18.57 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.261 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -145.49 146.41 31.45 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.008 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.9 p -74.9 -159.1 0.09 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.437 ' NE2' ' HB3' ' A' ' 144' ' ' ASP . 1.2 pt20 -108.0 40.05 1.82 Allowed 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.22 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.478 ' C ' ' N ' ' A' ' 118' ' ' LEU . . . -157.55 -87.5 0.04 OUTLIER 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 118.684 -1.206 . . . . 0.0 110.88 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 116' ' ' ALA . 11.3 pt-20 -45.53 -25.49 0.45 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.036 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.583 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 5.6 tt -57.86 -66.53 0.46 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.113 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.468 ' N ' HD21 ' A' ' 118' ' ' LEU . 8.1 mm-40 -49.2 -49.95 40.45 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.406 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.47 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 4.0 mmm-85 -67.17 -12.44 60.04 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 118.718 -1.193 . . . . 0.0 112.016 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.478 ' HH ' ' H ' ' A' ' 66' ' ' VAL . 13.8 t80 -91.97 -24.95 19.08 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.154 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -115.93 -67.43 0.41 Allowed Glycine 0 N--CA 1.483 1.791 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.478 HD11 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -138.64 -103.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.186 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.609 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 15.2 t70 -154.01 -165.48 2.12 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.314 -0.955 . . . . 0.0 111.198 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.609 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 1.0 OUTLIER -58.71 -100.08 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.34 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.647 HD21 ' N ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -80.41 127.68 32.69 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.582 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.647 ' N ' HD21 ' A' ' 126' ' ' ASN . 0.0 OUTLIER 175.48 -106.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.523 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.623 ' N ' ' OG1' ' A' ' 127' ' ' THR . 6.2 mm 48.62 -97.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.005 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER 78.1 -42.77 0.36 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.2 m -143.56 126.34 16.13 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.682 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.59 158.84 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-O 121.975 0.893 . . . . 0.0 113.015 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.14 99.32 4.28 Favored Pre-proline 0 C--N 1.3 -1.544 0 CA-C-N 113.865 -1.516 . . . . 0.0 107.86 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.67 ' C ' ' H ' ' A' ' 135' ' ' GLY . 2.8 Cg_exo -52.66 -15.79 4.75 Favored 'Trans proline' 0 C--O 1.209 -0.955 0 C-N-CA 121.181 1.254 . . . . 0.0 112.491 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 53.17 -6.19 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.764 -0.774 . . . . 0.0 112.498 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.67 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . 160.45 -47.36 0.4 Allowed Glycine 0 N--CA 1.483 1.802 0 C-N-CA 118.766 -1.683 . . . . 0.0 111.242 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.1 mt -84.49 -164.31 0.94 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 117.95 -1.5 . . . . 0.0 110.787 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -119.17 131.11 55.82 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.0 t -101.76 143.12 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.796 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.438 HG13 ' CE1' ' A' ' 141' ' ' PHE . 57.6 t -137.32 117.76 16.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.315 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.454 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 10.9 mp -97.71 142.85 29.0 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.483 -0.887 . . . . 0.0 112.37 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.528 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 34.6 m-85 -120.51 133.46 55.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.432 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -74.3 -61.1 1.98 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.488 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -71.46 -175.99 1.43 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.089 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 146' ' ' PHE . 1.8 m-20 -77.18 -165.06 0.52 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.691 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.668 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 16.4 t30 27.95 39.51 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 123.931 0.769 . . . . 0.0 112.138 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.668 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.6 p90 41.65 60.44 2.16 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.197 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.84 -168.11 1.98 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.233 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 63.51 -162.45 33.45 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.607 -1.282 . . . . 0.0 110.145 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -59.58 156.05 14.23 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.189 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.3 p -144.72 160.75 40.7 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.679 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.8 tp -126.39 82.83 65.45 Favored Pre-proline 0 N--CA 1.486 1.325 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.125 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.68 106.56 0.63 Allowed 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 121.884 1.722 . . . . 0.0 113.162 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 43.6 t -87.94 82.45 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 119.455 -0.898 . . . . 0.0 108.949 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.613 ' H ' HD21 ' A' ' 154' ' ' ASN . 0.8 OUTLIER -62.59 -9.6 9.4 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.6 p -169.4 -167.9 0.75 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 117.456 -1.698 . . . . 0.0 113.475 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -42.29 150.83 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.53 -1.213 . . . . 0.0 112.812 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.593 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -171.94 66.83 0.41 Allowed Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.65 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.5 Cg_endo -65.6 23.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.173 1.916 . . . . 0.0 112.02 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.593 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.3 t -175.42 57.23 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.042 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 129' ' ' SER . 18.8 tp -63.63 -11.18 23.17 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.895 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 160' ' ' LEU . . . . . . . . 0 N--CA 1.496 2.682 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.46 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.822 0.344 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 51.7 m -58.8 111.39 1.26 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.003 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 74.7 m -90.13 -69.28 0.73 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.618 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.413 ' HG ' ' H ' ' A' ' 146' ' ' PHE . 3.0 p -116.0 158.09 23.61 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.593 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 1.4 pt -141.1 -178.59 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.856 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -160.59 114.9 2.15 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.677 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 14.0 mt -90.34 95.51 5.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.08 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 116.291 -1.814 . . . . 0.0 110.835 179.98 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.903 0.383 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -116.1 115.86 26.84 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.391 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.3 pt -74.56 143.86 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.859 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.3 m -128.41 135.5 49.6 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.678 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 m -120.79 158.64 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.015 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 14.0 m-85 -114.03 157.83 22.0 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.133 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -89.06 9.9 23.65 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.518 ' C ' ' OG ' ' A' ' 40' ' ' SER . 20.1 m120 -151.32 173.29 14.67 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.732 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -78.41 169.93 17.46 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.83 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' GLN . 6.7 t70 65.46 38.08 5.81 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.602 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.539 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 9.0 t80 62.81 -4.67 0.23 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.483 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' ASP . 32.6 mt-30 -87.69 166.75 14.43 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.129 -1.028 . . . . 0.0 110.906 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 113.95 137.66 6.68 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -29.35 138.28 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.578 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.493 ' O ' ' HG3' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -103.17 123.7 47.2 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -179.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.401 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 9.9 p -126.45 138.5 54.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.861 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -100.92 146.6 27.15 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.856 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 mt -137.94 141.46 32.63 Favored Pre-proline 0 N--CA 1.485 1.306 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.676 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -71.86 166.87 28.23 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.794 0.996 . . . . 0.0 111.711 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -67.12 -172.92 0.37 Allowed 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 121.998 1.799 . . . . 0.0 110.934 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.423 ' H ' ' HB ' ' A' ' 84' ' ' VAL . . . 98.44 -156.08 20.27 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.634 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.472 ' N ' HD21 ' A' ' 23' ' ' ASN . 0.3 OUTLIER -146.48 150.5 35.72 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.835 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -164.15 -164.2 0.84 Allowed 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.417 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.687 ' HG1' ' H ' ' A' ' 27' ' ' ALA . 40.6 p -139.7 175.48 9.53 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.612 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.4 ptt85 -58.1 -13.52 4.98 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.275 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.687 ' H ' ' HG1' ' A' ' 25' ' ' THR . . . -67.59 -59.3 3.46 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.478 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -52.69 -43.06 65.34 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 118.506 -1.278 . . . . 0.0 108.201 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 32' ' ' LEU . 29.7 mt -58.77 -43.74 90.44 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.039 -1.064 . . . . 0.0 109.011 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -47.65 -30.39 3.7 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.618 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.61 -36.86 51.31 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.864 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 29' ' ' LEU . 12.7 mt -76.43 -67.37 0.7 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.614 -0.835 . . . . 0.0 110.627 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.6 -7.0 0.13 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.699 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.501 HG21 ' H ' ' A' ' 35' ' ' GLU . 1.3 mt -98.61 -167.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.165 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.501 ' H ' HG21 ' A' ' 34' ' ' ILE . 3.0 pt-20 175.05 -168.23 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.88 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.755 HD21 ' ND2' ' A' ' 78' ' ' ASN . 24.4 p-10 -77.06 -178.71 5.13 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.506 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.9 t30 71.05 -15.36 0.41 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.642 ' O ' ' N ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -86.84 -77.78 0.31 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.058 -1.457 . . . . 0.0 110.938 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.62 ' N ' ' OG1' ' A' ' 38' ' ' THR . 4.3 mt -13.96 75.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 124.924 1.39 . . . . 0.0 112.074 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.642 ' N ' ' O ' ' A' ' 38' ' ' THR . 43.0 t -81.89 -36.14 28.46 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.49 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.513 ' HG ' ' H ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -135.2 172.02 13.61 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.49 HG13 ' H ' ' A' ' 69' ' ' ALA . 1.1 t -149.97 144.8 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 118.029 -1.468 . . . . 0.0 112.516 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -132.73 101.51 5.31 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.841 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.5 t -125.04 110.1 27.28 Favored Pre-proline 0 N--CA 1.491 1.617 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.267 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -69.19 166.78 25.72 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.129 1.219 . . . . 0.0 110.802 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 48' ' ' VAL . 1.8 Cg_endo -61.29 -168.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 121.754 1.636 . . . . 0.0 110.948 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.43 ' C ' ' CG1' ' A' ' 48' ' ' VAL . . . 76.21 -8.25 25.65 Favored Glycine 0 C--O 1.207 -1.578 0 C-N-CA 118.902 -1.618 . . . . 0.0 109.743 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -151.24 134.41 7.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.143 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -107.37 121.16 44.03 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.91 159.38 20.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.01 -1.076 . . . . 0.0 113.095 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.481 HG13 HH22 ' A' ' 83' ' ' ARG . 35.0 mt -142.92 124.21 11.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.603 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.461 HD11 ' H ' ' A' ' 52' ' ' LEU . 5.2 mp -89.26 160.35 16.96 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.714 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -138.89 115.98 10.98 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.505 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -56.86 -80.26 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.771 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.449 ' ND2' ' H ' ' A' ' 56' ' ' ASP . 2.8 t-20 -59.47 148.17 33.91 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.175 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.506 ' OD1' ' CB ' ' A' ' 80' ' ' SER . 1.0 OUTLIER -60.26 172.44 0.83 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.725 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.05 31.69 80.16 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.11 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 50.56 47.32 24.38 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.779 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.24 -161.58 1.01 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.835 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.38 -178.87 2.01 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.317 -1.421 . . . . 0.0 109.889 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -48.24 163.62 0.06 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.217 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.589 HE21 ' C ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -148.12 141.07 24.81 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.544 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.502 HG21 ' H ' ' A' ' 64' ' ' GLU . 3.0 mt -107.5 168.65 3.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.679 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.502 ' H ' HG21 ' A' ' 63' ' ' ILE . 48.9 tt0 -137.1 132.92 34.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.8 m -148.65 159.92 6.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 118.371 -1.332 . . . . 0.0 112.495 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 t -150.18 -1.48 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.483 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.492 ' H ' ' HH ' ' A' ' 121' ' ' TYR . . . -132.57 -150.13 0.4 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.649 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.406 HD22 ' CG ' ' A' ' 107' ' ' ASP . 1.5 p30 -101.05 113.63 26.81 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.634 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.49 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -89.53 97.72 11.36 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.906 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -62.87 -74.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.397 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -67.51 -8.95 37.8 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.446 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.424 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 5.3 tp 66.78 -80.2 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.592 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.424 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 143.49 -158.51 27.32 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.438 -1.363 . . . . 0.0 110.138 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 76' ' ' ASN . 2.2 Cg_endo -64.56 -159.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.649 1.566 . . . . 0.0 110.814 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 74' ' ' PRO . 1.1 pt? 32.83 32.06 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.722 0.639 . . . . 0.0 111.945 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 74' ' ' PRO . 49.6 t30 -84.98 -15.47 44.14 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.098 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -86.98 0.43 55.16 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.273 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.755 ' ND2' HD21 ' A' ' 36' ' ' ASN . 1.1 t-20 -172.02 122.34 0.48 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 118.51 -1.276 . . . . 0.0 112.162 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.567 ' N ' HD21 ' A' ' 78' ' ' ASN . 1.9 t -122.8 -148.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.443 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER 154.33 -59.57 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.416 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.1 m -111.98 156.07 22.72 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.511 -0.876 . . . . 0.0 113.137 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.22 163.78 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.933 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.733 ' NH1' ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -143.12 133.47 24.69 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.651 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.733 ' CA ' ' NH1' ' A' ' 83' ' ' ARG . 22.1 t -139.98 128.57 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.936 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.424 HG13 HH11 ' A' ' 83' ' ' ARG . 55.3 mt -130.69 124.44 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.415 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.4 p -45.25 148.02 0.68 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.558 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.07 152.05 39.07 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.275 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -55.45 155.57 20.36 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.14 1.227 . . . . 0.0 110.859 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.3 t -59.71 144.39 12.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.732 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -144.74 119.06 5.73 Favored Pre-proline 0 N--CA 1.487 1.415 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.461 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -61.65 -157.53 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.832 0 C-N-CA 121.07 1.18 . . . . 0.0 111.184 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.444 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER 178.98 -162.14 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.274 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.419 ' N ' ' HD3' ' A' ' 92' ' ' ARG . . . -138.39 173.31 11.73 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.094 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -119.95 149.98 41.25 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.158 -1.017 . . . . 0.0 112.513 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -141.46 115.44 9.22 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.608 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.423 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 55.5 m-85 -79.42 176.93 9.24 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.81 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.16 -46.9 3.5 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.409 -0.917 . . . . 0.0 112.15 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.49 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 14.8 ttmt -92.26 154.73 18.43 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.864 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.597 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -71.13 102.72 2.56 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.11 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.609 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 123.96 47.13 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.113 0 O-C-N 125.356 1.66 . . . . 0.0 109.072 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.609 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 21.9 p90 30.15 59.44 0.2 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.65 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.457 ' HB2' ' NE2' ' A' ' 100' ' ' GLN . 18.7 t70 -130.64 -12.54 3.84 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.252 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.49 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -93.66 157.23 22.89 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.459 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.1 OUTLIER -29.59 139.11 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.19 0.519 . . . . 0.0 112.258 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.445 ' H ' ' HD3' ' A' ' 104' ' ' LYS . 0.4 OUTLIER -93.85 105.42 17.44 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.229 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.7 t -92.64 137.9 21.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.051 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.406 ' CG ' HD22 ' A' ' 68' ' ' ASN . 1.9 p30 -121.53 155.07 35.76 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.95 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.7 mt -144.3 132.51 10.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.026 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -66.5 166.63 21.18 Favored 'Trans proline' 0 C--O 1.214 -0.725 0 C-N-CA 121.643 1.562 . . . . 0.0 111.69 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.55 149.24 68.16 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.81 1.673 . . . . 0.0 111.565 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.55 -176.3 20.45 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 119.415 -1.374 . . . . 0.0 110.932 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.407 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 40.8 tt0 -110.89 154.57 23.86 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.482 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 61.7 m-85 -146.22 155.46 42.7 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.436 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 3.1 p -92.49 -142.44 0.2 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.34 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.52 ' N ' ' OG1' ' A' ' 114' ' ' THR . 36.4 tt0 -111.97 -20.97 11.79 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.658 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.78 -57.59 3.72 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.381 -0.928 . . . . 0.0 112.644 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.596 ' CG ' ' H ' ' A' ' 118' ' ' LEU . 4.6 pt-20 -71.36 -55.93 7.0 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.837 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.596 ' H ' ' CG ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -32.34 -67.42 0.11 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.976 0.798 . . . . 0.0 111.273 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 121' ' ' TYR . 75.6 mt-10 -55.5 -61.55 2.27 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.726 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.476 ' NH1' ' OD1' ' A' ' 124' ' ' ASP . 1.7 mpt_? -73.86 19.88 0.11 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.199 -1.0 . . . . 0.0 112.344 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.492 ' HH ' ' H ' ' A' ' 67' ' ' ALA . 17.9 t80 -124.45 -15.59 6.6 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.858 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.22 -38.45 0.04 OUTLIER Glycine 0 C--N 1.295 -1.735 0 C-N-CA 118.771 -1.681 . . . . 0.0 110.822 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.433 HD11 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -141.75 -113.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.316 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.637 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 28.8 t70 -156.5 -176.86 6.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.396 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.637 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 46.9 t30 -79.22 148.82 32.09 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.845 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.521 HD21 ' CB ' ' A' ' 166' ' ' ASN . 32.5 m120 44.9 45.64 8.63 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.412 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.4 m -163.42 107.25 1.02 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.872 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.1 mm -138.95 -45.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.606 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.587 ' OG ' ' N ' ' A' ' 130' ' ' SER . 1.2 p 66.02 -152.45 0.24 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.587 ' N ' ' OG ' ' A' ' 129' ' ' SER . 26.8 m -49.79 129.86 20.5 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.404 -1.271 . . . . 0.0 113.066 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.4 151.17 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.928 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -160.58 112.69 1.35 Allowed Pre-proline 0 C--N 1.292 -1.896 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.598 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.26 170.79 3.7 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 120.605 0.87 . . . . 0.0 111.777 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -156.26 5.74 0.18 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.776 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.57 -50.92 0.04 OUTLIER Glycine 0 N--CA 1.481 1.677 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.405 HD13 ' CA ' ' A' ' 92' ' ' ARG . 0.4 OUTLIER -122.37 162.94 20.66 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.732 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.66 154.8 24.71 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.329 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.6 143.72 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.265 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.3 t -129.76 125.37 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.464 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.529 ' CD2' ' HG1' ' A' ' 167' ' ' THR . 8.6 mp -99.4 145.28 27.56 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.829 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.559 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 3.3 m-85 -120.78 143.23 48.93 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.3 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -73.85 -76.17 0.14 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.553 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -74.82 157.12 35.68 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.645 ' CG ' ' H ' ' A' ' 145' ' ' ASN . 26.4 t70 -57.92 -174.4 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.47 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.645 ' H ' ' CG ' ' A' ' 144' ' ' ASP . 0.4 OUTLIER 40.34 27.18 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.094 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.643 ' CZ ' ' ND2' ' A' ' 145' ' ' ASN . 1.9 p90 41.69 62.0 1.7 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.286 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.9 t -131.95 71.46 1.47 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.306 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 173.14 -163.12 34.65 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.277 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.52 162.76 4.66 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 118.914 -1.114 . . . . 0.0 109.788 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.7 p -149.35 164.2 35.56 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.732 -1.187 . . . . 0.0 111.612 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.5 mt -131.64 87.32 46.26 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.714 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -61.44 107.87 0.54 Allowed 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.487 1.458 . . . . 0.0 111.859 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 155' ' ' SER . 2.2 t -91.84 65.64 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.887 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -79.07 33.49 0.22 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.219 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 153' ' ' VAL . 16.8 t -167.09 -156.87 0.23 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.195 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -90.61 153.22 20.48 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.768 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.432 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -163.2 71.39 1.94 Allowed Pre-proline 0 N--CA 1.486 1.334 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.533 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.468 ' C ' ' OG ' ' A' ' 130' ' ' SER . 1.2 Cg_endo -67.73 35.77 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.535 2.157 . . . . 0.0 113.372 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.49 ' O ' ' CB ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -167.38 -83.34 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.336 -1.345 . . . . 0.0 111.852 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.49 ' CB ' ' O ' ' A' ' 159' ' ' THR . 2.3 tp 73.68 -69.65 0.18 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.424 -0.911 . . . . 0.0 110.544 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.431 0 C-N-CA 119.367 -1.397 . . . . 0.0 110.736 179.999 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.521 ' CB ' HD21 ' A' ' 126' ' ' ASN . 2.7 p-10 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.712 0.291 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.529 ' HG1' ' CD2' ' A' ' 140' ' ' LEU . 1.2 m -103.4 112.04 24.74 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.303 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 83.7 p -96.67 -35.35 11.06 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.75 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.67 154.44 50.92 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.898 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 16.8 pt -135.76 162.97 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.486 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.481 ' NH2' ' HG ' ' A' ' 173' ' ' SER . 41.2 ttp85 -146.32 100.99 3.44 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.846 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.6 mt -81.73 99.54 4.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.055 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.481 ' HG ' ' NH2' ' A' ' 171' ' ' ARG . 50.5 m . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 116.448 -1.739 . . . . 0.0 111.02 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.573 ' C ' HD21 ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 121.009 0.433 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.573 HD21 ' C ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER -175.89 122.66 0.19 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.192 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -84.29 153.68 3.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.136 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.4 m -128.09 118.78 24.07 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.092 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 16' ' ' GLN . 3.7 m -98.25 170.12 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.335 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 1.305 ' CE2' ' NE2' ' A' ' 16' ' ' GLN . 24.8 m-85 -129.49 149.46 51.26 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.56 ' CD2' ' NZ ' ' A' ' 15' ' ' LYS . 2.7 m-85 -77.28 -57.78 3.64 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.978 -1.089 . . . . 0.0 113.233 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.48 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 19.0 m120 -87.58 162.28 17.26 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.721 -1.191 . . . . 0.0 111.923 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.54 -179.04 0.99 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.326 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.647 ' C ' ' CG ' ' A' ' 12' ' ' PHE . 6.0 t70 51.52 52.63 14.3 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 118.313 -1.355 . . . . 0.0 110.52 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.647 ' CG ' ' C ' ' A' ' 11' ' ' ASP . 1.2 p90 41.65 20.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 11' ' ' ASP . 22.2 mt-30 -93.77 173.88 7.45 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.85 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.48 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 79.01 128.09 0.55 Allowed Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.188 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.56 ' NZ ' ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -40.99 156.34 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.935 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 1.305 ' NE2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -112.16 177.03 4.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 t -141.65 137.9 31.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 114.332 -1.304 . . . . 0.0 109.379 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 18' ' ' ASP . 8.5 p-10 -95.47 114.51 26.29 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.663 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.0 mt -107.88 133.05 20.62 Favored Pre-proline 0 N--CA 1.492 1.657 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.043 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -71.41 156.57 58.28 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 120.837 1.025 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.53 -167.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 121.506 1.471 . . . . 0.0 110.67 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.447 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 100.14 -174.22 26.11 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.942 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.686 ' CA ' HH11 ' A' ' 83' ' ' ARG . 0.6 OUTLIER -109.69 122.88 48.48 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.926 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 7.7 p90 -147.86 173.9 12.38 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 118.746 -1.182 . . . . 0.0 111.005 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.7 p -147.79 -154.83 0.58 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.051 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -62.43 -28.28 69.69 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.802 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.39 -63.43 1.24 Allowed 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.71 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -55.48 -49.59 72.13 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.603 -1.239 . . . . 0.0 109.481 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 32' ' ' LEU . 26.9 mt -51.84 -41.27 61.68 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.57 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.53 -35.84 21.55 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 118.558 -1.257 . . . . 0.0 108.006 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.04 -40.31 94.61 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.554 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 29' ' ' LEU . 17.0 mt -72.86 -74.12 0.18 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.601 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.12 -26.27 1.0 Allowed Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.995 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.0 142.41 13.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.194 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 9.1 pt-20 -177.86 155.0 0.96 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.642 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 2.1 t-20 90.18 -149.62 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 O-C-N 124.265 0.978 . . . . 0.0 112.408 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.54 ' H ' HD21 ' A' ' 37' ' ' ASN . 0.4 OUTLIER -70.14 32.48 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.045 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 40' ' ' SER . 1.0 OUTLIER -88.13 -40.99 13.32 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.62 -1.232 . . . . 0.0 110.336 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.7 mt -64.88 74.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.38 -0.928 . . . . 0.0 108.976 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 38' ' ' THR . 28.0 t -76.33 -72.97 0.3 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.704 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -99.15 168.04 10.31 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.888 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.483 HG13 ' H ' ' A' ' 69' ' ' ALA . 1.1 t -151.32 148.31 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 117.988 -1.485 . . . . 0.0 113.087 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -133.72 108.69 8.67 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.852 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.2 t -128.46 111.42 19.38 Favored Pre-proline 0 N--CA 1.5 2.05 0 C-N-CA 119.809 -0.756 . . . . 0.0 112.311 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.59 170.07 14.53 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.099 1.2 . . . . 0.0 110.851 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.16 -167.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.919 1.746 . . . . 0.0 110.978 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.21 -11.34 23.7 Favored Glycine 0 N--CA 1.484 1.851 0 C-N-CA 119.104 -1.522 . . . . 0.0 110.982 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.401 ' HA ' ' H ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -154.76 148.66 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 118.725 -1.19 . . . . 0.0 112.074 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -115.14 142.3 46.84 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.974 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.84 143.03 46.8 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.026 -1.07 . . . . 0.0 112.274 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.45 HG23 ' CE2' ' A' ' 53' ' ' TYR . 78.2 mt -121.04 121.75 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.284 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.99 147.21 23.13 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.306 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.45 ' CE2' HG23 ' A' ' 51' ' ' ILE . 53.3 m-85 -134.45 132.61 39.51 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.142 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -58.94 -84.44 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.052 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -65.17 163.65 14.69 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.65 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -63.09 -177.94 0.2 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.586 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.614 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 53.96 33.1 50.0 Favored Glycine 0 N--CA 1.487 2.059 0 C-N-CA 118.957 -1.592 . . . . 0.0 109.158 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.614 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 41.99 69.78 0.33 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.576 0.703 . . . . 0.0 110.751 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.91 174.21 10.79 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.07 -177.21 54.36 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.483 -1.342 . . . . 0.0 110.088 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.14 118.14 1.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.18 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.401 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 3.2 pt20 -101.27 172.39 7.02 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.738 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.48 HG21 ' H ' ' A' ' 64' ' ' GLU . 4.8 mt -144.47 163.84 13.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.553 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.48 ' H ' HG21 ' A' ' 63' ' ' ILE . 26.9 mt-10 -138.98 126.2 21.39 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.769 -0.773 . . . . 0.0 109.498 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.3 m -149.03 158.96 6.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 118.781 -1.168 . . . . 0.0 112.727 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.9 t -149.78 -1.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -125.42 -135.97 0.27 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.722 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -105.93 112.0 24.88 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.24 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.483 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -89.54 80.33 6.71 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.768 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -52.33 -81.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.048 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -69.12 -10.44 57.67 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.603 -0.839 . . . . 0.0 112.008 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.516 ' CD2' HD22 ' A' ' 76' ' ' ASN . 2.5 tp 63.23 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.434 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 175.15 -175.25 47.11 Favored Glycine 0 N--CA 1.501 2.998 0 C-N-CA 119.183 -1.484 . . . . 0.0 110.999 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.576 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.2 Cg_endo -66.72 -39.92 14.21 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 122.375 2.05 . . . . 0.0 112.188 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.739 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 1.7 pt? -71.11 30.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.144 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.576 ' H ' ' C ' ' A' ' 74' ' ' PRO . 0.6 OUTLIER -72.67 -9.6 58.81 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.639 -0.825 . . . . 0.0 110.605 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -87.57 13.16 10.78 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.126 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.644 ' N ' ' ND2' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -177.91 116.79 0.09 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 118.691 -1.204 . . . . 0.0 111.699 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.6 m -157.07 145.85 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.944 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.6 p -164.34 -36.86 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 118.562 -1.255 . . . . 0.0 113.131 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.415 ' C ' ' CG1' ' A' ' 82' ' ' ILE . 4.1 m -94.61 142.99 26.81 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 118.773 -1.171 . . . . 0.0 111.577 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.415 ' CG1' ' C ' ' A' ' 81' ' ' SER . 2.1 mt -148.58 143.21 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 118.821 -1.152 . . . . 0.0 111.426 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.792 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -121.31 116.01 24.04 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.783 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.792 ' H ' HH12 ' A' ' 83' ' ' ARG . 3.9 t -123.69 136.36 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.943 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.514 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 3.8 mt -139.1 126.74 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.196 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.6 p -48.98 133.02 18.59 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.433 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.401 ' H ' ' HA ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -122.9 149.92 57.7 Favored Pre-proline 0 N--CA 1.49 1.566 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.599 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -51.43 127.31 21.94 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 121.386 1.391 . . . . 0.0 111.216 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.3 p -58.51 136.87 21.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.881 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -145.91 151.46 45.56 Favored Pre-proline 0 N--CA 1.487 1.389 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.961 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.414 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 2.3 Cg_endo -58.89 -164.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 121.277 1.318 . . . . 0.0 111.111 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.467 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -175.79 -161.75 0.09 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.759 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -141.71 162.96 34.2 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.084 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.1 ttm-85 -135.82 107.48 6.99 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.05 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 18.5 m-85 -87.0 169.15 12.68 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.597 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 105' ' ' GLU . 26.8 m-85 -137.09 167.64 21.15 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.581 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.512 ' HH ' HG22 ' A' ' 127' ' ' THR . 3.4 m-85 -103.24 168.83 8.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.659 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.405 ' CB ' ' OD1' ' A' ' 102' ' ' ASP . 52.5 mttp 57.14 164.69 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.841 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 24.2 tt0 -90.85 75.78 6.41 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.737 ' HG2' ' CG ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 153.78 43.46 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 O-C-N 124.358 1.036 . . . . 0.0 109.376 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 100' ' ' GLN . 19.1 p90 33.47 32.67 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.284 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.737 ' CG ' ' HG2' ' A' ' 100' ' ' GLN . 22.7 p-10 -107.32 36.2 2.79 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.154 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -145.66 158.37 27.65 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.277 -1.439 . . . . 0.0 110.467 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.482 ' H ' ' HE3' ' A' ' 104' ' ' LYS . 1.2 mtmt -31.72 144.84 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.169 0.509 . . . . 0.0 112.318 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.458 ' HB3' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -105.86 149.49 26.48 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.175 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 45.4 t -143.91 150.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.761 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -136.8 156.53 48.37 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.241 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.8 mt -137.01 163.12 51.66 Favored Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.938 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.453 ' HD3' ' HH ' ' A' ' 121' ' ' TYR . 18.6 Cg_endo -88.78 166.92 5.96 Favored 'Trans proline' 0 C--O 1.212 -0.78 0 C-N-CA 121.871 1.714 . . . . 0.0 112.74 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -63.58 140.56 75.89 Favored 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 121.745 1.63 . . . . 0.0 110.89 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.75 -154.96 25.59 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.19 -1.481 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.595 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 37.3 tt0 -125.35 156.77 38.21 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.367 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 48.5 m-85 -144.07 149.55 36.78 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.792 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.3 p -96.81 -159.49 0.74 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.717 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.629 ' H ' ' CD ' ' A' ' 115' ' ' GLN . 2.5 pm0 -105.51 56.29 0.68 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.213 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.74 -64.34 0.11 Allowed 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.741 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.608 ' CG ' ' H ' ' A' ' 118' ' ' LEU . 9.0 pt-20 -69.77 -52.19 27.44 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.608 ' H ' ' CG ' ' A' ' 117' ' ' GLU . 1.9 tt -33.67 -60.23 0.37 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.167 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 121' ' ' TYR . 36.4 mt-10 -54.36 -69.42 0.13 Allowed 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.293 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.434 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 3.4 mpt_? -74.79 23.23 0.1 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.293 -0.963 . . . . 0.0 112.376 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 117' ' ' GLU . 13.0 t80 -114.13 -22.29 10.08 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.856 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.74 -21.55 0.02 OUTLIER Glycine 0 N--CA 1.488 2.117 0 C-N-CA 118.429 -1.844 . . . . 0.0 110.625 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.412 ' CG2' ' CG2' ' A' ' 127' ' ' THR . 9.1 mt -139.79 -120.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.746 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 124' ' ' ASP . 11.7 p30 -159.08 -154.98 0.44 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.767 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -76.22 -35.23 59.13 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.803 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.424 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 25.5 t30 -162.11 118.01 1.99 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.798 -1.161 . . . . 0.0 112.154 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.512 HG22 ' HH ' ' A' ' 97' ' ' TYR . 6.1 t -179.2 -14.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.895 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.484 HG21 ' H ' ' A' ' 129' ' ' SER . 2.1 mt -50.84 166.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.173 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.484 ' H ' HG21 ' A' ' 128' ' ' ILE . 43.8 p -175.4 -115.11 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.536 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.1 m -54.39 131.27 41.84 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.854 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.13 155.83 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.47 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.11 83.83 4.57 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.835 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.58 107.46 1.44 Allowed 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.317 1.345 . . . . 0.0 110.638 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -88.86 24.34 2.08 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.973 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -173.01 -56.01 0.05 OUTLIER Glycine 0 N--CA 1.494 2.542 0 C-N-CA 118.208 -1.949 . . . . 0.0 112.095 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.445 HD13 ' N ' ' A' ' 92' ' ' ARG . 0.9 OUTLIER -116.79 172.74 7.05 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.567 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -89.37 142.58 27.53 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.497 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.2 t -102.13 145.41 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.94 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.99 124.65 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.681 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.4 HD13 ' N ' ' A' ' 140' ' ' LEU . 4.5 mp -107.74 146.07 32.64 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.239 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 20.2 m-85 -120.02 137.51 54.05 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.591 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -71.03 -67.82 0.48 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.951 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -65.57 165.34 12.46 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.98 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 146' ' ' PHE . 3.0 m-20 -63.61 -162.51 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.735 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.665 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 35.1 m120 27.48 39.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 123.859 0.724 . . . . 0.0 112.101 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.665 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.2 OUTLIER 43.97 61.26 2.39 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.456 -0.897 . . . . 0.0 109.881 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -132.42 173.29 11.45 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.27 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.05 -166.3 53.86 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.347 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -59.41 172.97 0.57 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.026 -1.069 . . . . 0.0 109.944 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 43.1 p -151.67 177.33 10.47 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.972 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.63 79.72 33.98 Favored Pre-proline 0 N--CA 1.485 1.3 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.764 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.6 105.21 0.73 Allowed 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 122.025 1.817 . . . . 0.0 113.247 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 39.8 t -90.68 74.52 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.946 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 154' ' ' ASN . 1.8 m-20 -79.19 26.64 0.26 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.14 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 25.4 t -169.99 -174.06 1.7 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.626 -1.23 . . . . 0.0 111.839 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.433 ' N ' ' OG ' ' A' ' 155' ' ' SER . 1.8 m-20 -73.78 154.44 39.55 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.907 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.601 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -166.68 72.4 1.11 Allowed Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.239 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.32 20.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.968 1.779 . . . . 0.0 111.85 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.601 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.2 t -169.38 71.08 0.07 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.863 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.437 ' HB3' ' H ' ' A' ' 161' ' ' GLY . 0.2 OUTLIER -75.58 -83.76 0.06 Allowed 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.479 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.437 ' H ' ' HB3' ' A' ' 160' ' ' LEU . . . . . . . . 0 N--CA 1.493 2.453 0 C-N-CA 118.902 -1.618 . . . . 0.0 110.083 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.425 ' N ' ' OD1' ' A' ' 166' ' ' ASN . 29.3 p-10 . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 121.075 0.464 . . . . 0.0 111.994 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.18 120.81 14.36 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.865 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.735 ' HG ' ' N ' ' A' ' 169' ' ' SER . 54.4 p -92.78 -42.38 9.6 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.284 -0.967 . . . . 0.0 110.533 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.735 ' N ' ' HG ' ' A' ' 168' ' ' SER . 0.3 OUTLIER -136.72 164.09 29.08 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.788 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 30.0 pt -143.61 165.91 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -148.43 109.73 4.37 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.875 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.9 mt -89.12 99.47 9.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 119.271 -0.971 . . . . 0.0 109.946 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.305 -1.346 0 CA-C-O 116.352 -1.785 . . . . 0.0 111.12 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.58 0.228 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -175.87 119.75 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.673 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.482 ' CG1' ' O ' ' A' ' 4' ' ' ILE . 1.0 OUTLIER -77.57 122.42 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.821 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -95.93 106.53 18.69 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.131 -1.028 . . . . 0.0 108.602 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 m -88.43 170.06 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 118.974 -1.09 . . . . 0.0 112.344 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 1.216 ' CE2' ' HG2' ' A' ' 16' ' ' GLN . 40.3 m-85 -134.35 144.5 48.29 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.75 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -65.61 -62.18 1.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.975 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.474 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 29.8 m120 -90.52 160.57 15.91 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.754 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -58.88 -171.6 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.64 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.638 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 11.5 m-20 44.95 51.54 8.61 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.842 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.638 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 49.5 p90 39.48 24.38 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 11' ' ' ASP . 32.9 mm-40 -98.69 173.74 6.75 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.565 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.474 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 81.58 135.68 1.95 Allowed Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.389 -1.386 . . . . 0.0 110.352 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 14' ' ' GLY . 30.0 mmtm -29.82 136.83 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.957 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 1.216 ' HG2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -97.53 160.8 14.1 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.339 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -146.22 129.05 9.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.131 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -91.14 124.59 35.48 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.863 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.9 mt -119.46 125.85 27.3 Favored Pre-proline 0 N--CA 1.497 1.898 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.892 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.4 158.83 47.04 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 120.98 1.12 . . . . 0.0 111.485 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.14 -166.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.911 1.741 . . . . 0.0 111.154 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.95 -171.28 29.88 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.222 -1.466 . . . . 0.0 110.481 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.638 ' N ' ' ND2' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -117.83 131.57 56.54 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.087 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.56 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 1.1 p90 -149.47 -174.88 4.8 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.937 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.447 HG22 ' CZ ' ' A' ' 58' ' ' PHE . 4.1 p -155.7 -162.14 1.27 Allowed 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.908 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.471 ' CD ' ' C ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -54.08 -20.65 6.86 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.493 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.427 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . -67.58 -66.58 0.54 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.441 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.59 HE21 ' CA ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -54.58 -44.83 73.34 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.796 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.6 mt -57.64 -42.74 84.04 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.005 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.03 -32.0 32.35 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 118.409 -1.317 . . . . 0.0 108.817 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.38 -39.31 85.61 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.638 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 mt -75.76 -71.87 0.35 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.326 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.62 -36.72 0.73 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.376 -1.393 . . . . 0.0 110.609 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 tt -81.99 143.15 12.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.849 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -179.96 134.98 0.11 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.563 -1.255 . . . . 0.0 112.495 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.617 ' C ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER 74.76 128.94 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.075 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.507 ' H ' ' H ' ' A' ' 79' ' ' VAL . 2.6 t30 45.36 8.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.178 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.553 ' HG1' ' N ' ' A' ' 39' ' ' ILE . 66.3 p -89.3 -33.33 16.97 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.527 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.553 ' N ' ' HG1' ' A' ' 38' ' ' THR . 4.8 mm -75.71 66.4 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.743 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.533 ' HG ' HD22 ' A' ' 76' ' ' ASN . 42.0 t -73.37 -55.3 6.57 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.153 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.9 160.06 29.72 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.147 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.448 HG21 ' H ' ' A' ' 69' ' ' ALA . 18.6 m -149.73 168.01 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 118.356 -1.338 . . . . 0.0 113.409 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -142.62 98.37 3.28 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.87 -1.514 . . . . 0.0 108.099 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.0 t -116.17 113.28 41.51 Favored Pre-proline 0 N--CA 1.496 1.852 0 C-N-CA 119.873 -0.731 . . . . 0.0 112.81 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -69.3 171.7 13.5 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.041 1.161 . . . . 0.0 110.009 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.481 ' HG3' ' HE ' ' A' ' 92' ' ' ARG . 1.0 OUTLIER -64.88 -167.78 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.617 1.545 . . . . 0.0 111.158 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.59 -8.36 7.46 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.373 -1.394 . . . . 0.0 110.781 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.427 ' H ' ' C ' ' A' ' 46' ' ' PRO . 33.2 m -148.59 143.34 18.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.576 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -118.23 126.42 52.13 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.234 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.54 144.53 36.08 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.377 -0.929 . . . . 0.0 112.765 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 27.8 mt -133.11 112.39 17.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.097 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.442 HD11 ' H ' ' A' ' 52' ' ' LEU . 1.6 mp -89.72 160.45 16.57 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.68 -1.208 . . . . 0.0 112.773 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -138.54 108.55 6.36 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.107 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -49.38 -78.59 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.259 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.467 HD21 ' HA3' ' A' ' 60' ' ' GLY . 2.6 m-80 -59.76 141.44 55.23 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.965 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -55.64 177.81 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.852 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.46 29.48 69.42 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.334 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.447 ' CZ ' HG22 ' A' ' 25' ' ' THR . 21.4 m-85 54.88 67.6 0.99 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.787 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.59 -162.65 1.6 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.958 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.467 ' HA3' HD21 ' A' ' 55' ' ' ASN . . . 64.42 176.09 4.59 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.363 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 60' ' ' GLY . 63.0 m-20 -42.68 112.92 0.4 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.613 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.663 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -93.0 155.68 17.37 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.401 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 7.3 mm -134.71 169.42 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.747 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.569 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 41.0 tt0 -150.8 130.71 13.33 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.718 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.6 m -149.95 159.94 4.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 118.942 -1.103 . . . . 0.0 111.808 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.93 -11.98 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.908 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -116.69 -149.42 0.44 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.892 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -94.04 128.51 40.44 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.508 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.448 ' H ' HG21 ' A' ' 42' ' ' VAL . . . -92.48 95.69 9.79 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.423 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 7.0 tp10 -56.9 -78.16 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.538 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.453 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 7.3 tp10 -91.42 5.05 50.9 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.309 -0.957 . . . . 0.0 110.748 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.7 tp 53.2 -99.85 0.09 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.023 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.72 -169.95 34.39 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 118.897 -1.62 . . . . 0.0 111.166 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.663 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.2 Cg_endo -68.58 -37.44 12.7 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.574 2.183 . . . . 0.0 112.929 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 75' ' ' LEU . 2.6 pt? -57.01 8.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.102 -1.039 . . . . 0.0 111.586 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.663 ' H ' ' C ' ' A' ' 74' ' ' PRO . 22.7 t-20 -59.52 -9.89 2.92 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.329 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.535 ' ND2' ' N ' ' A' ' 77' ' ' ASN . 1.3 m120 -67.25 -24.26 65.79 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.014 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -168.53 133.87 1.73 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.064 -1.055 . . . . 0.0 111.482 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.507 ' H ' ' H ' ' A' ' 37' ' ' ASN . 2.3 t -146.75 125.97 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.237 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.3 t -146.29 -42.8 0.2 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.925 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 m -90.93 135.21 33.89 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.057 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.02 159.51 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.196 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.763 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -143.91 106.21 4.39 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.749 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.763 ' CA ' HH12 ' A' ' 83' ' ' ARG . 11.3 t -123.33 131.63 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.545 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.483 HG12 ' NH1' ' A' ' 83' ' ' ARG . 1.5 pt -136.23 140.47 43.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.527 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.466 ' HG ' ' N ' ' A' ' 87' ' ' VAL . 16.1 t -44.43 156.39 0.08 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.758 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.466 ' N ' ' HG ' ' A' ' 86' ' ' SER . 0.3 OUTLIER -150.37 140.43 13.92 Favored Pre-proline 0 C--N 1.307 -1.248 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.505 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -50.67 136.79 42.1 Favored 'Trans proline' 0 C--O 1.21 -0.892 0 C-N-CA 121.006 1.138 . . . . 0.0 111.464 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.4 t -50.15 141.27 3.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.933 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -119.51 131.62 24.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.505 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.88 -24.5 72.7 Favored 'Trans proline' 0 C--O 1.21 -0.876 0 C-N-CA 120.762 0.975 . . . . 0.0 110.592 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.481 ' HE ' ' HG3' ' A' ' 46' ' ' PRO . 7.2 ptt85 36.36 -157.79 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.222 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.72 173.27 11.69 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.886 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.424 ' CD ' ' OE1' ' A' ' 105' ' ' GLU . 30.1 ttp180 -145.0 109.83 5.05 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 118.484 -1.286 . . . . 0.0 112.574 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 17.3 m-85 -95.95 149.1 21.93 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.204 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.468 ' CD1' ' HB3' ' A' ' 105' ' ' GLU . 72.1 m-85 -115.16 -162.52 0.83 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 119.344 -0.943 . . . . 0.0 111.0 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -135.04 168.01 19.91 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.29 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt 58.05 157.94 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 122.064 0.935 . . . . 0.0 112.823 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.55 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 32.0 tt0 -67.46 106.32 2.09 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.404 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.561 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 1.0 OUTLIER 97.92 59.51 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.976 0 O-C-N 124.721 1.263 . . . . 0.0 111.341 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.561 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 35.2 p90 31.51 38.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.48 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 100' ' ' GLN . 93.6 m-20 -100.62 49.7 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.851 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -169.47 157.52 29.33 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.773 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -40.73 158.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.704 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.468 ' HB3' ' CD1' ' A' ' 96' ' ' PHE . 5.9 pt-20 -123.45 165.44 17.06 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.663 0.744 . . . . 0.0 112.855 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.7 t -146.18 119.53 2.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.805 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.59 164.04 14.92 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.999 -1.08 . . . . 0.0 111.996 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 79.3 mt -145.35 137.88 13.6 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.695 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -69.58 161.28 46.52 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 121.646 1.564 . . . . 0.0 111.787 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.84 149.04 91.71 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.812 1.675 . . . . 0.0 111.243 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.53 -164.36 25.14 Favored Glycine 0 N--CA 1.502 3.077 0 C-N-CA 119.288 -1.434 . . . . 0.0 111.368 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.594 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 24.2 mt-30 -119.06 156.49 29.6 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.205 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 29.0 m-85 -144.93 150.54 37.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.884 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.6 p -90.31 -162.62 0.91 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.548 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -102.83 46.78 0.91 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -150.59 -62.98 0.2 Allowed 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.636 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 121' ' ' TYR . 5.8 pt-20 -71.57 -42.75 67.41 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.399 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.589 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -40.19 -70.04 0.11 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.04 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 121' ' ' TYR . 52.4 mt-10 -53.06 -59.49 4.47 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.845 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.457 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -68.34 14.59 0.07 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.389 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 119' ' ' GLU . 9.4 t80 -117.59 -26.83 6.48 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.27 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -129.35 -43.21 0.21 Allowed Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.521 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.474 HD11 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -146.29 -114.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.038 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -146.19 -160.82 1.2 Allowed 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.237 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -59.69 -99.91 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.64 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.672 ' CG ' ' H ' ' A' ' 127' ' ' THR . 19.5 p-10 -57.54 -111.31 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.672 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 1.6 t 43.75 -120.13 0.67 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.894 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.595 ' N ' ' OG1' ' A' ' 127' ' ' THR . 8.4 mm 54.79 -96.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.714 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.4 OUTLIER 76.12 -138.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.297 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.561 ' HG ' ' H ' ' A' ' 101' ' ' PHE . 3.9 m -42.27 129.51 3.8 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.044 -0.663 . . . . 0.0 111.819 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' A' ' 95' ' ' PHE . 2.9 t -121.13 150.96 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.393 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.78 83.41 8.12 Favored Pre-proline 0 C--N 1.302 -1.49 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.475 ' C ' ' H ' ' A' ' 135' ' ' GLY . 4.3 Cg_exo -61.05 98.65 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.536 1.491 . . . . 0.0 110.433 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -55.27 -2.76 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.656 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . 175.21 -36.97 0.1 Allowed Glycine 0 N--CA 1.492 2.388 0 C-N-CA 117.87 -2.11 . . . . 0.0 112.588 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.465 HD13 ' N ' ' A' ' 92' ' ' ARG . 3.8 mt -90.24 171.53 9.42 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.414 -1.314 . . . . 0.0 111.894 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -94.91 127.25 40.8 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 153' ' ' VAL . 3.4 t -98.32 139.22 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.988 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 98.9 t -133.34 125.35 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.314 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.474 ' CD2' ' HG1' ' A' ' 167' ' ' THR . 10.5 mp -103.62 140.29 37.75 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.428 -0.909 . . . . 0.0 113.052 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -117.35 131.75 56.72 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.055 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -80.97 -44.12 18.65 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.419 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.434 ' HB3' ' CB ' ' A' ' 147' ' ' SER . 13.7 t30 -71.95 -171.68 0.74 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.698 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.34 -128.52 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.603 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 146' ' ' PHE . 45.7 t30 -53.57 93.26 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.439 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 145' ' ' ASN . 3.8 m-85 37.39 67.38 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.314 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.434 ' CB ' ' HB3' ' A' ' 143' ' ' ASN . 0.4 OUTLIER -140.83 165.79 26.55 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.116 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 75.79 -163.73 53.6 Favored Glycine 0 N--CA 1.503 3.1 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.998 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.01 171.82 10.18 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.725 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 p -148.18 164.13 34.88 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.697 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 mt -124.67 82.94 59.14 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.344 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -63.05 100.75 0.26 Allowed 'Trans proline' 0 C--N 1.318 -1.054 0 C-N-CA 121.649 1.566 . . . . 0.0 112.652 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 138' ' ' VAL . 10.3 t -80.81 90.01 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.366 -0.933 . . . . 0.0 109.66 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -49.87 -31.64 12.55 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.998 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.754 ' HG ' ' H ' ' A' ' 156' ' ' ASP . 13.3 t -170.39 -136.15 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.341 -1.344 . . . . 0.0 112.351 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.754 ' H ' ' HG ' ' A' ' 155' ' ' SER . 11.6 m-20 -50.55 141.62 12.11 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.18 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.574 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.44 63.43 1.07 Allowed Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.699 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.5 Cg_endo -63.22 21.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.214 1.943 . . . . 0.0 112.777 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.574 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -168.96 118.88 0.71 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.274 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.62 -40.64 0.14 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.407 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.602 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 166' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.126 0.488 . . . . 0.0 111.451 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.474 ' HG1' ' CD2' ' A' ' 140' ' ' LEU . 1.1 m -90.58 123.12 33.97 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.579 -0.849 . . . . 0.0 110.508 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.4 m -90.33 -79.55 0.34 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.141 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 7.0 m -105.29 159.87 15.55 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.433 HG12 ' CD1' ' A' ' 118' ' ' LEU . 32.8 pt -141.92 174.36 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.25 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -158.82 109.84 2.09 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.506 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 56.5 mt -88.08 92.27 3.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 118.832 -1.147 . . . . 0.0 109.414 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.939 -179.904 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.873 0.368 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 2.7 p30 -173.24 107.45 0.15 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.191 -1.003 . . . . 0.0 111.159 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 pt -76.36 175.13 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.932 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 m -148.06 153.1 38.47 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.364 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 m -138.02 160.04 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.235 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.488 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 22.2 m-85 -119.42 145.91 45.83 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.904 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.85 -66.52 0.6 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.516 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 13.4 m120 -76.1 179.82 5.43 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.311 -0.956 . . . . 0.0 112.364 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -73.93 176.81 6.08 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.226 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.654 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 16.8 t70 48.56 56.01 8.18 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.491 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.654 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 39.2 p90 38.23 27.42 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.451 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 11' ' ' ASP . 6.3 tp-100 -98.89 163.06 12.76 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.35 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.516 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 93.13 134.35 6.91 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.378 -1.391 . . . . 0.0 109.634 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 14' ' ' GLY . 38.7 mttp -29.45 140.82 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.47 164.55 12.23 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.322 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.3 t -145.58 129.94 11.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.664 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -92.94 137.09 32.67 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.231 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 mt -129.05 136.79 29.73 Favored Pre-proline 0 N--CA 1.49 1.558 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.33 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -72.44 156.72 54.1 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 121.087 1.191 . . . . 0.0 111.422 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.73 -161.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.463 1.442 . . . . 0.0 109.726 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.558 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 91.18 -162.47 28.46 Favored Glycine 0 N--CA 1.485 1.923 0 C-N-CA 118.528 -1.796 . . . . 0.0 110.991 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.682 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -123.03 133.18 54.35 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.238 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -155.7 174.51 15.19 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.522 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.0 p -138.25 -156.64 0.7 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.071 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.452 ' N ' ' CD ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -66.79 -16.68 64.43 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.599 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.449 ' H ' ' HD3' ' A' ' 26' ' ' ARG . . . -65.13 -59.88 3.62 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.637 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -56.41 -43.78 79.68 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 118.754 -1.178 . . . . 0.0 109.261 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 28.4 mt -59.21 -40.03 84.51 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.814 -1.155 . . . . 0.0 109.127 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.7 -32.73 14.08 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 118.735 -1.186 . . . . 0.0 108.077 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.87 -42.07 73.97 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.699 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 mt -70.58 -74.86 0.13 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.82 -29.67 0.74 Allowed Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.092 -1.527 . . . . 0.0 110.846 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.08 139.99 16.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.882 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.494 ' C ' ' CG ' ' A' ' 36' ' ' ASN . 2.2 pt-20 179.94 166.1 1.22 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.481 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.648 ' C ' ' H ' ' A' ' 38' ' ' THR . 0.6 OUTLIER 79.97 -143.54 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.545 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.706 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.0 OUTLIER -56.38 10.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.623 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.648 ' H ' ' C ' ' A' ' 36' ' ' ASN . 67.4 p -76.17 -142.4 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.618 -1.233 . . . . 0.0 111.023 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 38' ' ' THR . 9.1 mt 39.69 60.71 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.02 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.2 t -65.54 -50.39 65.4 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.12 172.26 8.38 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.355 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.62 154.48 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 118.529 -1.268 . . . . 0.0 112.607 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -138.66 125.28 20.76 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.457 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.9 t -140.0 114.43 7.74 Favored Pre-proline 0 N--CA 1.494 1.725 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.918 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -69.32 169.48 18.25 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 121.116 1.21 . . . . 0.0 111.231 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.63 -174.97 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 122.102 1.868 . . . . 0.0 111.387 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.86 -16.77 7.86 Favored Glycine 0 N--CA 1.482 1.766 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.985 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.4 m -149.25 146.4 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.779 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -119.55 139.35 52.28 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.55 159.43 20.41 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.199 -1.001 . . . . 0.0 112.937 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 70.5 mt -141.29 117.96 7.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.447 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.479 HD11 ' H ' ' A' ' 52' ' ' LEU . 4.2 mp -92.32 163.12 14.0 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.824 -1.15 . . . . 0.0 113.222 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.57 ' CZ ' ' NE2' ' A' ' 62' ' ' GLN . 30.7 m-85 -141.61 115.29 9.06 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.678 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -81.1 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.899 -0.72 . . . . 0.0 112.157 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -59.26 141.07 55.28 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.319 -0.953 . . . . 0.0 111.382 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.07 172.79 0.26 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.464 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.47 27.27 73.88 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.291 -1.433 . . . . 0.0 110.149 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 54.58 63.32 2.19 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.969 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.38 -161.6 1.34 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.01 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.0 170.02 1.21 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.462 -1.352 . . . . 0.0 110.106 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -44.74 121.44 2.71 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.343 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.57 ' NE2' ' CZ ' ' A' ' 53' ' ' TYR . 5.0 mt-30 -94.86 173.21 7.71 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.068 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.43 HG21 ' H ' ' A' ' 64' ' ' GLU . 2.9 mt -143.73 166.04 13.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.683 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.43 ' H ' HG21 ' A' ' 63' ' ' ILE . 4.6 tm-20 -146.93 131.18 17.45 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.299 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.6 m -150.17 160.31 4.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.806 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.43 -15.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.543 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.497 ' H ' ' HH ' ' A' ' 121' ' ' TYR . . . -111.1 -138.55 0.38 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.003 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -111.07 124.81 52.91 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.001 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.75 120.25 29.98 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.236 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.55 -85.18 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.108 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 6.5 mt-10 -85.51 3.56 39.84 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.69 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.454 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 1.6 tp 72.34 -89.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.584 -0.847 . . . . 0.0 111.74 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -179.13 -178.88 48.57 Favored Glycine 0 N--CA 1.499 2.876 0 C-N-CA 118.861 -1.638 . . . . 0.0 111.369 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -70.2 14.8 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.627 2.218 . . . . 0.0 112.99 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.474 ' H ' HD22 ' A' ' 75' ' ' LEU . 1.4 pt? -132.49 38.95 3.41 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.269 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -83.46 -2.04 54.98 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.655 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -73.14 -7.99 53.79 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.805 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -164.07 117.74 1.45 Allowed 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.122 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.27 127.32 11.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.232 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.1 t -155.45 -35.32 0.09 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 118.857 -1.137 . . . . 0.0 112.362 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.2 m -93.69 136.49 33.91 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.943 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -144.84 155.99 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 118.839 -1.144 . . . . 0.0 112.282 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.785 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.87 120.74 15.43 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.358 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.785 ' H ' HH12 ' A' ' 83' ' ' ARG . 18.4 t -129.92 136.8 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.939 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.591 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 2.6 mt -143.87 132.77 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.027 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.5 m -38.18 150.81 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.928 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -148.03 139.89 14.14 Favored Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.328 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -47.78 153.61 2.34 Favored 'Trans proline' 0 C--O 1.212 -0.821 0 C-N-CA 121.401 1.401 . . . . 0.0 111.512 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.34 141.25 15.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 119.756 -0.778 . . . . 0.0 112.312 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -145.97 136.41 12.16 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.582 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.83 -155.39 0.01 OUTLIER 'Trans proline' 0 C--O 1.21 -0.904 0 C-N-CA 121.421 1.414 . . . . 0.0 111.274 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.443 ' HB2' ' H ' ' A' ' 93' ' ' ALA . 5.2 ptt180 -178.76 -160.86 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 118.375 -1.33 . . . . 0.0 111.929 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.443 ' H ' ' HB2' ' A' ' 92' ' ' ARG . . . -143.0 168.7 19.09 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.385 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -125.15 156.52 38.25 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.635 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.457 ' CD2' HG12 ' A' ' 131' ' ' VAL . 73.7 m-85 -145.88 103.88 3.8 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.672 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -89.97 172.25 8.99 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.059 -1.057 . . . . 0.0 112.124 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.603 ' CE2' ' OG1' ' A' ' 127' ' ' THR . 0.3 OUTLIER -110.45 159.23 17.68 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.915 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 42.2 tttt 68.35 151.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.84 0.829 . . . . 0.0 112.359 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.562 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 26.8 tt0 -67.9 106.22 2.23 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.754 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.584 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 105.0 48.45 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.108 0 O-C-N 125.054 1.471 . . . . 0.0 110.637 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.584 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 33.9 p90 30.73 39.1 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.156 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 100' ' ' GLN . 24.9 t70 -99.41 26.75 5.76 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.465 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -146.94 179.99 23.46 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.141 -1.504 . . . . 0.0 111.28 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -29.72 145.12 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -119.08 137.65 53.42 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.322 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.466 ' CG1' ' N ' ' A' ' 107' ' ' ASP . 2.4 t -139.86 158.58 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.979 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.466 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 7.2 p-10 -144.86 156.35 43.96 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.646 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.461 HD21 ' CE2' ' A' ' 121' ' ' TYR . 32.2 mt -141.08 147.9 49.52 Favored Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.527 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -71.31 165.23 33.09 Favored 'Trans proline' 0 C--O 1.212 -0.819 0 C-N-CA 121.797 1.665 . . . . 0.0 111.08 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.54 149.42 82.18 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.646 1.564 . . . . 0.0 111.518 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.41 -151.38 22.6 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 119.069 -1.539 . . . . 0.0 111.436 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.678 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 41.5 tt0 -136.14 155.69 49.8 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.21 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.678 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 18.9 m-85 -145.6 155.32 42.96 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.51 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.9 p -96.45 -156.82 0.55 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.327 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.678 ' H ' ' CD ' ' A' ' 115' ' ' GLN . 3.8 pm0 -103.75 29.4 5.81 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.231 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.24 -65.48 0.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.769 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.55 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 9.6 pt-20 -70.33 -48.77 54.99 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.975 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.58 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 1.9 tt -35.12 -73.25 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.502 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -50.54 -54.22 24.14 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.555 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -76.28 17.66 0.35 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.638 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.511 ' N ' ' O ' ' A' ' 117' ' ' GLU . 18.1 t80 -123.7 -12.62 7.6 Favored 'General case' 0 N--CA 1.502 2.175 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.625 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -142.47 -48.49 0.04 OUTLIER Glycine 0 N--CA 1.485 1.953 0 C-N-CA 119.223 -1.465 . . . . 0.0 110.173 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.614 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -145.13 -99.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.835 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.614 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 17.9 t70 -165.76 -164.88 0.76 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.15 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.57 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 1.4 t-20 -64.53 -122.07 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.874 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.501 ' H ' ' CG ' ' A' ' 125' ' ' ASN . 3.6 m-20 -70.4 112.42 6.68 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.538 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.603 ' OG1' ' CE2' ' A' ' 97' ' ' TYR . 1.8 t -179.87 -5.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.744 -0.783 . . . . 0.0 110.798 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.2 mt -91.25 151.95 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.617 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.466 ' HB3' ' H ' ' A' ' 161' ' ' GLY . 19.3 m -153.42 -66.12 0.15 Allowed 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.373 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.497 ' H ' ' HG ' ' A' ' 130' ' ' SER . 0.0 OUTLIER -82.24 112.37 19.18 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.037 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.457 HG12 ' CD2' ' A' ' 95' ' ' PHE . 2.0 t -120.5 163.3 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.189 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.0 tttp -154.34 125.64 3.62 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.647 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 6.2 Cg_endo -65.33 -50.04 2.22 Favored 'Trans proline' 0 C--O 1.203 -1.262 0 C-N-CA 121.034 1.156 . . . . 0.0 111.081 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.479 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 72.23 -37.72 0.4 Allowed 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.38 -0.928 . . . . 0.0 112.621 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . -150.35 -48.88 0.02 OUTLIER Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.236 -1.459 . . . . 0.0 111.113 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.419 HD13 ' CA ' ' A' ' 92' ' ' ARG . 0.7 OUTLIER -109.56 153.4 24.19 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.008 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.06 153.75 41.54 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.118 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.64 143.82 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 119.663 -0.815 . . . . 0.0 112.321 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.48 HG13 ' CE1' ' A' ' 141' ' ' PHE . 93.3 t -135.94 123.07 33.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.984 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.3 mp -103.23 142.75 33.64 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.812 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.528 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 14.0 m-85 -120.61 136.52 54.79 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.082 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -75.05 -62.62 1.49 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.565 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.438 ' ND2' ' HA3' ' A' ' 148' ' ' GLY . 2.6 m-80 -61.01 159.99 10.65 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.271 -0.972 . . . . 0.0 112.362 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -27.35 -108.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.519 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 9.0 m120 -74.7 89.82 2.28 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.219 -0.901 . . . . 0.0 113.273 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.626 ' CG ' ' NE2' ' A' ' 112' ' ' GLN . 1.5 p90 33.04 73.11 0.07 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.131 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.3 t -145.83 -170.76 3.55 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.158 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.438 ' HA3' ' ND2' ' A' ' 143' ' ' ASN . . . 51.26 -157.97 2.54 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.124 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.99 174.1 0.54 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.654 -0.819 . . . . 0.0 110.833 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 55.3 p -155.05 174.5 15.09 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.914 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.7 tp -138.32 79.54 30.46 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.026 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -59.66 110.26 0.71 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.817 1.678 . . . . 0.0 112.945 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' A' ' 155' ' ' SER . 20.5 t -93.24 70.77 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.356 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -65.06 8.2 0.14 Allowed 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.219 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.595 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 9.3 t -170.94 177.68 3.67 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.282 -1.367 . . . . 0.0 112.211 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.595 ' N ' ' OG ' ' A' ' 155' ' ' SER . 3.2 m-20 -51.0 151.59 2.53 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.431 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.516 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -164.32 61.71 0.92 Allowed Pre-proline 0 C--N 1.309 -1.165 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.407 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.2 Cg_endo -63.72 22.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.534 2.156 . . . . 0.0 113.314 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.511 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -175.96 95.49 0.06 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 117.759 -1.576 . . . . 0.0 112.504 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 44.7 mt -112.56 -61.54 1.71 Allowed 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.65 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 129' ' ' SER . . . . . . . . 0 N--CA 1.499 2.89 0 C-N-CA 119.553 -1.308 . . . . 0.0 111.156 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.6 p30 . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 120.575 0.226 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 47.3 m 42.76 73.88 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.419 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.3 m -78.29 -23.55 47.14 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.204 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.592 ' CB ' ' H ' ' A' ' 146' ' ' PHE . 0.2 OUTLIER -149.25 162.07 40.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.34 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 29.1 pt -143.46 161.33 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 119.159 -1.017 . . . . 0.0 111.029 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -143.42 104.01 4.18 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.452 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.8 mt -82.63 95.12 3.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.179 -1.009 . . . . 0.0 110.154 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.3 m . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.845 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.873 0.368 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -175.15 118.96 0.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.526 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.5 pt -69.14 154.7 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.233 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -126.56 135.44 51.27 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.81 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -121.89 138.73 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.971 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.52 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 29.6 m-85 -96.48 146.7 24.56 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.798 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.04 -56.78 17.02 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.25 -0.98 . . . . 0.0 112.21 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.547 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 12.2 m-20 -96.85 170.94 8.83 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.507 ' HG2' ' N ' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -76.6 -165.92 0.59 Allowed 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.976 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.507 ' N ' ' HG2' ' A' ' 10' ' ' GLU . 66.4 m-20 52.67 35.4 18.21 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.523 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.52 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 18.2 t80 56.68 7.11 0.35 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.436 -0.905 . . . . 0.0 112.16 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.446 ' HG3' ' H ' ' A' ' 14' ' ' GLY . 5.3 tp-100 -96.31 160.21 14.54 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.551 -0.859 . . . . 0.0 111.678 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.547 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 102.38 131.23 7.27 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.738 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 14' ' ' GLY . 25.2 mtmm -31.79 141.11 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.927 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.56 ' NE2' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -99.44 161.19 13.76 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.119 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.1 t -145.47 134.48 17.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.206 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.16 134.09 39.66 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.141 -1.024 . . . . 0.0 112.116 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.6 mt -122.1 127.57 25.88 Favored Pre-proline 0 N--CA 1.489 1.479 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.524 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.5 163.6 31.92 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 120.928 1.086 . . . . 0.0 111.268 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.39 -169.28 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.65 1.567 . . . . 0.0 111.019 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.459 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 87.96 -176.91 46.05 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.744 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.605 ' ND2' ' H ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -112.18 142.29 44.83 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.884 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.602 ' CE2' ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -156.03 -174.77 5.1 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.314 179.777 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 24' ' ' TYR . 4.7 p -156.35 -157.17 0.69 Allowed 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.921 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.9 ttt85 -52.29 -33.54 42.65 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.289 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.79 -63.59 1.21 Allowed 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.863 -1.135 . . . . 0.0 110.524 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.404 ' NE2' ' HB2' ' A' ' 31' ' ' ALA . 1.8 tm0? -57.23 -32.95 67.05 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.779 -1.169 . . . . 0.0 109.882 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.602 ' CD2' ' CE2' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -60.56 -47.27 86.92 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.011 -1.076 . . . . 0.0 109.433 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.41 -32.99 28.33 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.163 -1.015 . . . . 0.0 108.92 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.404 ' HB2' ' NE2' ' A' ' 28' ' ' GLN . . . -64.08 -42.79 96.83 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.848 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 mt -71.9 -80.31 0.06 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.941 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.77 -29.79 0.16 Allowed Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.465 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -82.2 169.75 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.894 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.64 ' H ' ' CG2' ' A' ' 38' ' ' THR . 4.7 pt-20 178.68 111.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.289 -0.965 . . . . 0.0 111.904 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 38' ' ' THR . 1.0 OUTLIER 61.66 140.57 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.527 ' H ' ' H ' ' A' ' 79' ' ' VAL . 9.6 t30 47.01 4.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.658 -1.156 . . . . 0.0 113.695 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.64 ' CG2' ' H ' ' A' ' 35' ' ' GLU . 76.2 p -82.34 -29.87 30.74 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 117.992 -1.483 . . . . 0.0 111.424 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -78.24 53.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.328 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 10' ' ' GLU . 30.4 t -50.98 -53.93 28.85 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.761 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.0 169.65 10.27 Favored 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.307 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.464 HG11 ' H ' ' A' ' 69' ' ' ALA . 1.1 t -153.3 151.43 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 117.856 -1.538 . . . . 0.0 113.139 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -138.64 102.69 4.66 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.194 -1.367 . . . . 0.0 108.805 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 73.9 t -117.94 107.8 43.5 Favored Pre-proline 0 N--CA 1.496 1.865 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.228 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.25 168.2 19.98 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 121.31 1.34 . . . . 0.0 110.939 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.11 -173.19 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.753 1.635 . . . . 0.0 111.177 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.63 -14.77 11.46 Favored Glycine 0 N--CA 1.481 1.699 0 C-N-CA 119.125 -1.512 . . . . 0.0 110.691 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.3 m -151.59 134.28 6.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 C-N-CA 118.851 -1.14 . . . . 0.0 112.086 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -105.83 143.52 33.85 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.32 150.75 49.44 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.024 -1.07 . . . . 0.0 112.928 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.9 mt -135.04 117.75 22.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.737 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.442 HD11 ' H ' ' A' ' 52' ' ' LEU . 3.6 mp -96.61 160.83 14.18 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 118.927 -1.109 . . . . 0.0 113.8 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -135.3 116.38 14.3 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.675 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -47.59 -88.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.081 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -61.69 147.26 46.58 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.54 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -55.54 174.51 0.1 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.389 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.16 30.59 75.87 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.127 -1.511 . . . . 0.0 110.03 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.641 ' H ' ' HG ' ' A' ' 81' ' ' SER . 2.2 m-85 48.42 40.46 14.83 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.767 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.37 -176.97 3.02 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.821 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.69 164.27 5.27 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.064 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -45.55 131.87 8.47 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.545 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -99.24 172.31 7.44 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.865 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.463 HG21 ' H ' ' A' ' 64' ' ' GLU . 3.9 mt -135.28 165.29 31.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.763 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.463 ' H ' HG21 ' A' ' 63' ' ' ILE . 28.2 mt-10 -143.92 129.89 19.49 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.4 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.1 m -150.03 159.61 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 118.489 -1.284 . . . . 0.0 112.524 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 t -146.23 2.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.238 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -131.51 -144.6 0.25 Allowed 'General case' 0 C--O 1.207 -1.132 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.086 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.481 ' ND2' ' C ' ' A' ' 68' ' ' ASN . 0.5 OUTLIER -103.37 119.55 39.09 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.849 -0.741 . . . . 0.0 111.578 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.464 ' H ' HG11 ' A' ' 42' ' ' VAL . . . -97.45 97.86 9.45 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.17 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -58.72 -87.61 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.48 -0.888 . . . . 0.0 112.096 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 43.7 mm-40 -68.02 -5.83 19.39 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.41 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.466 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 2.8 tp 70.83 -77.88 0.05 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.049 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.43 -175.21 43.75 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.51 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.432 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.7 Cg_endo -65.35 -38.43 26.48 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.193 1.929 . . . . 0.0 111.865 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.484 ' H ' HD22 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -78.96 30.67 0.2 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.395 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.775 ' H ' HD21 ' A' ' 76' ' ' ASN . 0.0 OUTLIER -77.14 10.26 2.52 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.561 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 75' ' ' LEU . 11.6 t30 -87.83 -2.17 58.44 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.83 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -170.7 122.23 0.6 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.024 -1.07 . . . . 0.0 111.546 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.527 ' H ' ' H ' ' A' ' 37' ' ' ASN . 2.4 t -147.92 121.93 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.494 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.1 t -150.58 -34.1 0.16 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.908 -1.117 . . . . 0.0 112.517 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.641 ' HG ' ' H ' ' A' ' 58' ' ' PHE . 3.8 m -93.19 136.31 33.58 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.818 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 83' ' ' ARG . 21.3 mt -148.08 160.95 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.287 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.815 HH22 ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -142.78 108.1 5.01 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.824 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.815 ' N ' HH22 ' A' ' 83' ' ' ARG . 10.5 t -114.59 142.39 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.823 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.465 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 7.2 mt -142.48 132.43 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.745 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 m -40.38 153.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.663 -0.698 . . . . 0.0 112.319 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -150.77 149.1 24.78 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.968 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.33 177.55 0.15 Allowed 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 121.546 1.497 . . . . 0.0 112.099 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.6 m -88.29 136.12 24.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.316 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -146.17 123.68 6.1 Favored Pre-proline 0 C--N 1.308 -1.2 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.844 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -57.06 178.84 0.13 Allowed 'Trans proline' 0 C--O 1.205 -1.146 0 C-N-CA 121.088 1.192 . . . . 0.0 110.978 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.5 ' HD3' ' N ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -151.42 -160.12 1.12 Allowed 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.566 0.698 . . . . 0.0 110.23 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.98 167.03 23.06 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -132.35 116.07 16.4 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.674 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -99.09 130.27 45.41 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 105' ' ' GLU . 24.8 m-85 -102.47 165.39 11.13 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.639 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -103.31 162.67 12.81 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.41 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.455 ' CB ' ' CB ' ' A' ' 102' ' ' ASP . 22.3 mmtp 58.14 157.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 122.24 1.019 . . . . 0.0 112.858 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.552 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 36.4 tt0 -72.92 107.58 5.38 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.3 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 92.26 56.52 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.603 0 O-C-N 124.524 1.14 . . . . 0.0 111.256 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.588 ' O ' ' CG ' ' A' ' 101' ' ' PHE . 1.3 t80 37.98 64.1 0.73 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.486 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.455 ' CB ' ' CB ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -111.77 17.03 20.21 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.193 179.838 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -160.01 155.4 26.53 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.485 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -44.77 162.11 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.135 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.456 ' CD ' ' C ' ' A' ' 105' ' ' GLU . 2.2 pp20? -120.12 179.46 4.27 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.532 0.682 . . . . 0.0 112.551 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -140.01 177.0 4.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.799 -1.092 . . . . 0.0 108.963 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.469 ' N ' HG12 ' A' ' 106' ' ' VAL . 19.5 p-10 -142.55 150.91 41.02 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.653 -1.219 . . . . 0.0 112.006 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.3 mt -141.98 148.46 48.86 Favored Pre-proline 0 N--CA 1.5 2.064 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.732 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -77.28 163.01 30.7 Favored 'Trans proline' 0 C--O 1.211 -0.83 0 C-N-CA 122.096 1.864 . . . . 0.0 111.963 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.38 158.54 35.37 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 122.415 2.077 . . . . 0.0 111.484 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.91 -170.5 14.96 Favored Glycine 0 N--CA 1.501 2.985 0 C-N-CA 119.465 -1.35 . . . . 0.0 111.43 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.594 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 18.8 tt0 -111.2 155.43 22.94 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.611 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 26.0 m-85 -142.35 151.87 42.34 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.83 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.4 p -87.24 -164.77 1.14 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.686 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 56.54 0.68 Allowed 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.179 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.441 ' N ' ' OE1' ' A' ' 119' ' ' GLU . . . -155.18 -71.57 0.12 Allowed 'General case' 0 C--N 1.294 -1.804 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.234 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.1 pt-20 -67.04 -44.73 79.47 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.488 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.588 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 1.2 tt -39.56 -69.83 0.12 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.5 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.67 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 25.4 mp0 -48.11 -59.41 3.41 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.913 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.416 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 1.5 mpt_? -70.95 0.79 6.61 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.96 -1.096 . . . . 0.0 112.814 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 117' ' ' GLU . 13.8 t80 -97.9 -17.58 19.17 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.072 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.55 -41.05 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 C-N-CA 118.55 -1.786 . . . . 0.0 111.665 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.46 HD11 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -134.73 -117.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.461 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.581 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 15.7 t70 -148.92 -163.72 1.85 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.599 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.581 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -106.07 31.45 5.09 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.028 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.577 ' C ' HD21 ' A' ' 126' ' ' ASN . 0.4 OUTLIER -176.27 17.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.756 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 128' ' ' ILE . 8.5 t -114.67 -132.11 0.33 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.386 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.506 ' H ' HG22 ' A' ' 127' ' ' THR . 3.4 mt 62.84 158.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.097 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.723 ' HG ' ' H ' ' A' ' 130' ' ' SER . 8.2 p -165.85 -97.29 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.846 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.723 ' H ' ' HG ' ' A' ' 129' ' ' SER . 0.2 OUTLIER -70.65 136.88 49.42 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.889 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.59 157.25 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -150.8 96.48 3.34 Favored Pre-proline 0 C--N 1.304 -1.398 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.893 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.431 ' C ' ' H ' ' A' ' 135' ' ' GLY . 10.2 Cg_exo -53.26 93.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.238 1.292 . . . . 0.0 110.79 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.467 ' CG ' ' NH2' ' A' ' 92' ' ' ARG . 1.4 tp-100 -71.85 7.69 1.47 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.1 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . 171.52 -40.56 0.18 Allowed Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.92 -1.61 . . . . 0.0 111.02 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.67 151.02 40.92 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.314 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.0 156.36 39.73 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.657 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.29 136.49 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.818 -0.753 . . . . 0.0 112.249 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.447 HG11 ' CE1' ' A' ' 141' ' ' PHE . 74.3 t -125.14 128.77 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.826 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 10.8 mp -102.72 142.01 34.58 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.372 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.543 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 4.0 m-85 -120.6 134.23 55.3 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.397 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -70.28 -71.58 0.24 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.914 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.41 ' CG ' ' H ' ' A' ' 144' ' ' ASP . 47.1 t30 -72.81 -176.32 1.98 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.889 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.625 ' C ' ' ND2' ' A' ' 145' ' ' ASN . 1.5 m-20 -77.12 -164.25 0.44 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.665 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 1.1 p30 36.65 29.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.518 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.665 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 2.5 p90 39.58 61.64 1.35 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.779 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.5 t -146.66 137.67 24.13 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.2 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.42 -139.55 14.23 Favored Glycine 0 N--CA 1.503 3.125 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.56 141.65 44.77 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.099 -1.041 . . . . 0.0 109.863 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 34.3 p -147.82 162.28 39.57 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.911 -1.116 . . . . 0.0 111.869 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.8 tp -130.12 89.34 45.53 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.922 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.06 108.87 1.59 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 121.849 1.699 . . . . 0.0 113.006 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.58 80.56 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.412 -0.915 . . . . 0.0 108.925 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.478 ' C ' ' OG ' ' A' ' 155' ' ' SER . 50.9 t30 -65.35 -9.91 28.66 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.478 ' OG ' ' C ' ' A' ' 154' ' ' ASN . 1.2 m -161.03 -155.44 0.41 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 117.594 -1.643 . . . . 0.0 113.232 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.51 142.48 44.16 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.824 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.577 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -162.05 61.82 1.3 Allowed Pre-proline 0 C--N 1.308 -1.21 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.449 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.2 Cg_endo -64.71 21.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.291 1.994 . . . . 0.0 112.316 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.577 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -170.45 113.17 0.44 Allowed 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.677 -1.209 . . . . 0.0 111.331 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 mt -143.1 -56.78 0.42 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.406 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 C-N-CA 119.333 -1.413 . . . . 0.0 110.612 179.96 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.942 0.401 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.2 m -57.55 99.17 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.593 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 73.7 m -84.29 -56.29 3.72 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.517 ' HG ' ' H ' ' A' ' 146' ' ' PHE . 0.3 OUTLIER -122.68 158.39 30.18 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.176 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 35.1 pt -136.01 165.37 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.49 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -146.73 100.58 3.35 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.401 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.3 mt -78.97 105.13 7.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.256 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 51.6 m . . . . . 0 C--N 1.306 -1.324 0 CA-C-O 116.399 -1.762 . . . . 0.0 110.963 -179.937 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.42 ' C ' ' CG ' ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 121.068 0.461 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.42 ' CG ' ' C ' ' A' ' 2' ' ' ALA . 9.0 m-80 -158.97 122.33 3.78 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.854 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.417 ' O ' ' CG1' ' A' ' 4' ' ' ILE . 2.2 pt -75.49 133.86 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.852 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 m -110.89 114.69 28.21 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.353 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.32 164.6 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.304 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.905 ' CE2' ' OE1' ' A' ' 16' ' ' GLN . 39.6 m-85 -123.85 148.85 46.42 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.998 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.432 ' HB2' ' N ' ' A' ' 15' ' ' LYS . 3.2 m-85 -79.04 0.41 27.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.54 HD21 ' CA ' ' A' ' 14' ' ' GLY . 22.8 m-80 -151.3 172.82 15.28 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.026 -1.47 . . . . 0.0 112.114 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.56 -174.82 1.81 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.519 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 13' ' ' GLN . 15.3 t70 52.67 31.08 9.67 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.159 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.526 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 1.5 t80 68.45 -8.73 0.58 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.136 -1.026 . . . . 0.0 111.349 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -78.25 167.93 20.62 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.287 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 1.134 ' O ' ' NE2' ' A' ' 16' ' ' GLN . . . 109.3 134.82 7.12 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 1.176 ' C ' HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -35.25 144.57 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.688 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 1.429 HE21 ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -98.6 148.05 24.19 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.258 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.3 t -147.45 123.37 2.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.676 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -94.78 115.82 27.98 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.803 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt -105.98 132.49 20.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.598 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -68.53 164.69 31.89 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 120.874 1.049 . . . . 0.0 111.439 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.68 -161.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 121.774 1.649 . . . . 0.0 111.057 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.682 ' C ' HD21 ' A' ' 23' ' ' ASN . . . 83.68 -177.64 52.43 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.109 -1.52 . . . . 0.0 111.354 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.723 ' N ' HD21 ' A' ' 23' ' ' ASN . 0.3 OUTLIER -105.92 137.08 44.42 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.786 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.492 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 4.0 p90 -158.55 160.2 36.37 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.294 -0.963 . . . . 0.0 109.689 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.445 ' CG2' ' CE2' ' A' ' 58' ' ' PHE . 68.9 p -122.83 -162.02 0.99 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.1 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -66.3 -16.99 64.48 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.876 -1.13 . . . . 0.0 110.776 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.39 -58.42 6.52 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 118.816 -1.154 . . . . 0.0 109.211 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.452 HE21 ' HA ' ' A' ' 28' ' ' GLN . 0.3 OUTLIER -55.57 -44.89 77.27 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 118.686 -1.206 . . . . 0.0 108.918 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 32' ' ' LEU . 39.4 mt -57.33 -41.27 79.64 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.966 -1.094 . . . . 0.0 109.425 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.49 -33.14 13.68 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.86 -1.136 . . . . 0.0 108.263 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.95 -37.91 72.83 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.489 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 29' ' ' LEU . 20.2 mt -72.6 -73.2 0.21 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.646 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.81 -27.2 0.65 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.285 -1.436 . . . . 0.0 110.596 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 tt -75.63 145.82 10.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.173 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.53 ' H ' HG22 ' A' ' 38' ' ' THR . 5.6 pt-20 -174.38 146.68 1.09 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.657 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.514 ' CG ' ' C ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER 74.56 -140.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.402 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.637 ' H ' HD21 ' A' ' 37' ' ' ASN . 2.4 m-80 -40.3 -87.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.282 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.704 ' O ' ' N ' ' A' ' 40' ' ' SER . 20.3 p 37.5 -96.26 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.761 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.666 ' H ' ' HG1' ' A' ' 38' ' ' THR . 5.6 mt -38.0 79.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 124.412 1.07 . . . . 0.0 111.442 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.704 ' N ' ' O ' ' A' ' 38' ' ' THR . 28.5 t -96.07 -39.05 9.93 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.447 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.99 167.55 16.52 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.503 HG13 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -153.08 151.14 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 117.849 -1.54 . . . . 0.0 113.012 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -135.46 99.96 4.37 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.837 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.55 108.38 39.6 Favored Pre-proline 0 N--CA 1.494 1.753 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.577 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.94 167.66 20.94 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.092 1.195 . . . . 0.0 110.692 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.65 -171.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.748 1.632 . . . . 0.0 111.108 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.73 -14.51 9.77 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 119.317 -1.421 . . . . 0.0 110.93 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 m -147.32 140.46 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.339 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.1 tttt -114.81 125.79 54.09 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.808 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -117.37 139.7 50.53 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.184 -1.007 . . . . 0.0 113.061 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.413 HD11 HH21 ' A' ' 83' ' ' ARG . 44.3 mt -116.26 119.3 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.631 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.456 HD22 ' H ' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -94.58 146.9 23.8 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.26 -0.976 . . . . 0.0 112.239 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.456 ' H ' HD22 ' A' ' 52' ' ' LEU . 43.9 m-85 -127.01 112.58 15.4 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.267 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.523 ' CD ' ' N ' ' A' ' 55' ' ' ASN . 1.5 tm0? -49.87 -76.27 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.345 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.523 ' N ' ' CD ' ' A' ' 54' ' ' GLN . 62.3 t30 -59.97 155.9 15.73 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.047 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -68.68 -179.69 1.48 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.467 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.36 36.77 78.0 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.195 -1.478 . . . . 0.0 110.191 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 25' ' ' THR . 35.6 m-85 49.13 63.78 2.0 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.794 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.55 -166.23 2.43 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.318 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 68.91 173.09 8.32 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.383 -1.389 . . . . 0.0 109.868 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 9.7 m-20 -42.19 119.44 1.37 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.397 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.664 ' NE2' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -90.04 164.51 14.48 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.349 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 8.8 mm -137.91 166.67 23.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.382 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.461 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 19.2 mp0 -148.26 126.08 11.91 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.619 -0.832 . . . . 0.0 109.64 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.1 159.97 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 118.859 -1.136 . . . . 0.0 112.557 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.2 t -149.36 -7.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 114.195 -1.366 . . . . 0.0 107.495 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.404 ' HB2' ' H ' ' A' ' 68' ' ' ASN . . . -124.8 -155.88 0.69 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.966 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.404 ' H ' ' HB2' ' A' ' 67' ' ' ALA . 11.2 m-20 -93.32 117.76 30.47 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.626 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.503 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -89.26 111.76 22.65 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.91 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -73.21 -77.9 0.1 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.418 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 73' ' ' GLY . 24.4 tp10 -79.24 -2.92 43.39 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.103 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.428 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 6.7 tp 54.95 -87.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.392 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 176.11 -170.15 42.95 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 118.967 -1.587 . . . . 0.0 110.924 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.564 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.0 Cg_endo -65.45 -36.22 35.59 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.159 1.906 . . . . 0.0 111.941 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.6 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 2.4 pt? -70.9 19.51 0.05 Allowed 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.981 -1.088 . . . . 0.0 111.274 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.564 ' H ' ' C ' ' A' ' 74' ' ' PRO . 34.9 p-10 -77.33 -18.16 57.68 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.519 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -86.65 2.04 49.82 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.429 -0.909 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -175.87 115.65 0.13 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.326 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -123.05 -174.72 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.156 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.466 ' N ' HG12 ' A' ' 79' ' ' VAL . 39.1 t -172.01 -64.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.296 -1.362 . . . . 0.0 113.541 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.5 m -111.7 150.95 29.47 Favored 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.444 ' HB ' ' CZ ' ' A' ' 24' ' ' TYR . 3.0 mp -146.61 161.49 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.445 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.682 ' NH1' ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -150.85 145.58 25.77 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.993 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.682 ' N ' ' NH1' ' A' ' 83' ' ' ARG . 5.8 t -148.09 146.92 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.695 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.589 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -143.54 134.27 22.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.657 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 85' ' ' ILE . 17.4 m -38.33 148.38 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.336 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.01 141.03 13.98 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.507 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -53.42 143.16 55.86 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.078 1.186 . . . . 0.0 110.954 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.556 ' CG2' ' N ' ' A' ' 90' ' ' GLN . 2.4 p -79.73 164.27 3.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.537 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.556 ' N ' ' CG2' ' A' ' 89' ' ' VAL . 11.5 mm100 -142.39 151.74 58.73 Favored Pre-proline 0 N--CA 1.487 1.4 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.154 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.6 -39.18 90.29 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.599 1.533 . . . . 0.0 111.87 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.656 ' NH1' HE22 ' A' ' 134' ' ' GLN . 15.6 mtm180 58.02 -168.47 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.434 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.475 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.33 178.65 7.43 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.603 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -148.57 130.36 15.13 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.411 -1.316 . . . . 0.0 112.024 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 20.1 m-85 -103.44 172.07 7.01 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.777 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -139.09 168.66 19.33 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.836 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -114.61 170.45 8.3 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.672 -0.811 . . . . 0.0 112.351 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.503 ' HA ' ' HZ1' ' A' ' 98' ' ' LYS . 0.5 OUTLIER 54.67 168.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.233 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.532 ' OE1' ' HG3' ' A' ' 100' ' ' GLN . 1.2 tm-20 -62.5 103.16 0.38 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.585 -1.189 . . . . 0.0 112.5 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 102' ' ' ASP . 2.7 mt-30 68.55 100.95 0.05 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.48 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.478 ' C ' ' O ' ' A' ' 100' ' ' GLN . 19.3 p90 20.94 44.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 124.364 1.04 . . . . 0.0 112.773 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 100' ' ' GLN . 0.7 OUTLIER -102.26 15.64 28.54 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.98 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -154.61 159.79 29.17 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 118.967 -1.587 . . . . 0.0 111.135 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -41.26 157.39 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.832 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.533 ' N ' ' CD ' ' A' ' 105' ' ' GLU . 1.2 pm0 -122.05 163.71 18.94 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.67 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.595 ' CG1' ' N ' ' A' ' 107' ' ' ASP . 37.4 t -138.11 170.99 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.33 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.595 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 2.5 p30 -133.44 156.35 47.87 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.034 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.5 mt -145.15 139.35 14.99 Favored Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.26 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -70.18 163.66 37.79 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 121.597 1.532 . . . . 0.0 111.305 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.47 145.99 95.57 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.418 1.412 . . . . 0.0 110.937 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.32 -153.22 24.29 Favored Glycine 0 N--CA 1.499 2.878 0 C-N-CA 119.064 -1.541 . . . . 0.0 111.328 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.609 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 8.3 tt0 -128.94 158.42 38.87 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.755 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.609 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 41.8 m-85 -145.93 151.99 38.72 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.267 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.6 p -103.83 178.56 4.52 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.243 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.08 44.63 0.49 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.174 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -142.45 -61.95 0.44 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 121' ' ' TYR . 4.5 mt-10 -74.11 -54.55 7.57 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.485 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.538 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -29.74 -66.5 0.09 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.635 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.635 ' CD ' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER -59.04 -60.84 3.23 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.747 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.635 HH11 ' CD ' ' A' ' 119' ' ' GLU . 7.9 mpt_? -75.81 26.17 0.11 Allowed 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.952 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 117' ' ' GLU . 35.3 t80 -127.79 -18.48 4.27 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.603 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -155.68 -26.8 0.03 OUTLIER Glycine 0 N--CA 1.484 1.86 0 C-N-CA 118.267 -1.92 . . . . 0.0 111.104 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.1 pt -150.2 -112.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.039 -1.064 . . . . 0.0 110.785 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.424 ' C ' ' HB3' ' A' ' 119' ' ' GLU . 0.9 OUTLIER -165.75 -165.91 0.88 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.284 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.49 ' C ' ' ND2' ' A' ' 125' ' ' ASN . 0.7 OUTLIER -65.21 -105.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -179.683 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.47 ' N ' ' CG ' ' A' ' 125' ' ' ASN . 1.7 m120 -67.23 32.32 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.46 ' H ' ' C ' ' A' ' 125' ' ' ASN . 0.6 OUTLIER -87.17 -103.7 0.07 Allowed 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.726 -1.19 . . . . 0.0 109.819 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.546 ' O ' ' CB ' ' A' ' 129' ' ' SER . 0.3 OUTLIER 41.66 -162.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.22 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.618 ' OG ' ' N ' ' A' ' 130' ' ' SER . 1.6 t 151.17 -96.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.061 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.618 ' N ' ' OG ' ' A' ' 129' ' ' SER . 3.5 m -90.24 143.63 26.59 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.047 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.11 151.82 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.575 0.702 . . . . 0.0 111.675 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -148.87 107.09 3.45 Favored Pre-proline 0 C--N 1.301 -1.515 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.617 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 135' ' ' GLY . 10.5 Cg_endo -71.88 90.48 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.348 1.366 . . . . 0.0 110.68 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.656 HE22 ' NH1' ' A' ' 92' ' ' ARG . 10.0 tt0 -49.64 -11.57 0.06 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.391 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . -179.07 -37.46 0.07 OUTLIER Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.305 -1.902 . . . . 0.0 111.783 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.475 HD13 ' H ' ' A' ' 92' ' ' ARG . 0.5 OUTLIER -107.04 163.83 12.66 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.359 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.76 148.22 31.55 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.993 -1.083 . . . . 0.0 109.811 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.1 t -112.6 150.34 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.786 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.457 HG11 ' CE1' ' A' ' 141' ' ' PHE . 60.6 t -136.22 128.53 45.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.572 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.5 mp -106.13 139.86 39.99 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.905 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.567 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 4.7 m-85 -120.23 133.78 55.4 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.52 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -72.94 -71.52 0.3 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.403 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -62.87 161.68 12.36 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.959 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 20.7 p-10 -62.5 -162.89 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.586 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.651 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 1.7 p-10 31.62 35.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.712 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.651 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 42.12 62.4 1.65 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.084 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.536 ' CB ' ' ND2' ' A' ' 145' ' ' ASN . 48.4 t -139.3 175.87 9.19 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.421 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 80.91 -160.33 42.78 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.039 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -60.54 160.57 8.79 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.263 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.8 p -150.59 162.51 40.5 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.902 -1.119 . . . . 0.0 111.574 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.6 tp -129.33 86.14 57.27 Favored Pre-proline 0 N--CA 1.484 1.261 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.497 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -63.29 107.8 0.73 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.828 1.686 . . . . 0.0 112.522 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 47.5 t -84.78 85.56 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.389 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.557 ' H ' ' ND2' ' A' ' 154' ' ' ASN . 0.8 OUTLIER -55.87 -26.56 47.6 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.498 ' OG ' ' C ' ' A' ' 154' ' ' ASN . 0.7 OUTLIER -162.68 -146.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 117.941 -1.503 . . . . 0.0 113.107 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.45 144.76 20.06 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.017 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.537 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -165.58 66.06 1.08 Allowed Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.572 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.1 Cg_endo -66.71 27.95 0.11 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.26 1.973 . . . . 0.0 112.274 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.537 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.1 t -169.83 136.06 1.51 Allowed 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.846 -1.142 . . . . 0.0 111.461 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 tt -151.55 -76.01 0.14 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.351 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 C-N-CA 119.16 -1.495 . . . . 0.0 110.665 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.0 m120 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.885 0.374 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.1 m -88.49 147.17 24.79 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.795 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 92.3 p -135.67 -38.63 0.73 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.434 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.54 158.13 44.85 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.533 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 24.6 pt -145.54 157.19 12.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 118.589 -1.244 . . . . 0.0 111.904 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -137.92 110.26 7.41 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.527 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -87.83 94.74 4.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.25 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.959 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.902 0.382 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -176.78 112.79 0.1 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.322 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.44 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.3 pp -78.34 160.33 4.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.306 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 m -138.46 126.38 22.51 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.296 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.44 168.7 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.372 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 14.1 m-85 -134.8 138.73 44.52 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.343 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.9 -55.02 29.8 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.397 -0.921 . . . . 0.0 113.066 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.547 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 55.6 m-20 -92.37 167.06 12.24 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.375 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.577 ' N ' ' HG ' ' A' ' 40' ' ' SER . 7.4 tm-20 -79.98 160.66 25.83 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.199 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 10' ' ' GLU . 0.9 OUTLIER 81.41 38.97 0.06 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.546 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.456 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 5.0 t80 59.74 2.99 0.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.984 -1.086 . . . . 0.0 112.533 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -102.84 164.88 11.37 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.673 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.547 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 97.48 132.94 7.66 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.587 ' CB ' ' HZ1' ' A' ' 15' ' ' LYS . 8.2 mtpm? -29.27 135.98 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.755 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.94 171.72 7.42 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.301 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.0 t -144.37 145.96 20.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.511 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -91.85 128.08 37.55 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.74 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.494 HD13 ' CE2' ' A' ' 24' ' ' TYR . 2.3 mm? -118.14 107.2 44.0 Favored Pre-proline 0 N--CA 1.49 1.541 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.26 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -64.87 166.75 17.41 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 120.911 1.074 . . . . 0.0 111.265 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.28 176.25 1.65 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.732 1.621 . . . . 0.0 111.294 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.508 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 102.28 -167.92 18.41 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.391 -1.385 . . . . 0.0 110.788 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.781 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -110.98 141.93 43.78 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.022 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.644 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -156.67 152.84 27.61 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.243 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.4 p -132.02 -158.48 0.89 Allowed 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.079 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -58.74 -28.8 66.21 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.588 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.01 -54.74 33.59 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.034 -1.067 . . . . 0.0 110.895 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -52.79 -48.82 66.6 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.039 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.519 HD23 ' CE1' ' A' ' 24' ' ' TYR . 5.0 mt -59.48 -39.02 82.39 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.66 -1.216 . . . . 0.0 109.338 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.13 -29.06 4.83 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 118.564 -1.254 . . . . 0.0 108.397 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.14 -31.62 27.11 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.454 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 29' ' ' LEU . 10.2 mt -80.39 -86.4 0.08 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.333 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.74 -27.0 0.07 OUTLIER Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.226 -1.464 . . . . 0.0 110.787 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.47 -175.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 118.941 -1.103 . . . . 0.0 109.964 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.457 ' H ' HG22 ' A' ' 38' ' ' THR . 1.3 pt-20 177.48 113.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.708 -1.197 . . . . 0.0 112.604 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 42.31 -106.7 0.08 Allowed 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.558 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -50.46 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.947 -0.701 . . . . 0.0 112.391 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.667 ' C ' ' H ' ' A' ' 40' ' ' SER . 0.1 OUTLIER 170.44 -18.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.802 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.413 ' O ' ' C ' ' A' ' 40' ' ' SER . 7.8 mm -75.59 32.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.105 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.667 ' H ' ' C ' ' A' ' 38' ' ' THR . 29.6 t -37.62 -63.99 0.42 Allowed 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.326 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -116.03 165.09 13.52 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.447 HG11 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -148.2 156.67 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 118.342 -1.343 . . . . 0.0 113.44 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -137.82 110.92 7.8 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.523 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.44 HG23 ' CG2' ' A' ' 4' ' ' ILE . 88.4 t -133.95 106.25 11.53 Favored Pre-proline 0 N--CA 1.497 1.913 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.94 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.411 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 Cg_endo -70.16 171.5 14.79 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 121.647 1.564 . . . . 0.0 111.728 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.411 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.7 Cg_endo -62.78 -169.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 122.145 1.897 . . . . 0.0 111.204 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.87 -14.44 19.62 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 119.269 -1.444 . . . . 0.0 110.449 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.46 ' N ' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -152.93 157.14 4.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 118.836 -1.145 . . . . 0.0 111.697 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.454 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 31.7 ttpt -123.56 120.41 32.77 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.34 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.75 154.99 18.63 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.025 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 60.6 mt -138.91 119.79 15.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.338 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.449 HD11 ' H ' ' A' ' 52' ' ' LEU . 3.7 mp -94.79 155.37 16.84 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 118.683 -1.207 . . . . 0.0 112.352 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -133.55 114.97 14.17 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.053 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.451 ' CD ' ' N ' ' A' ' 55' ' ' ASN . 1.4 tm0? -53.64 -69.12 0.13 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.39 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.458 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 63.8 t30 -69.37 137.68 53.03 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.028 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -53.06 166.69 0.21 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.538 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.54 28.98 64.47 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.394 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 55.92 49.1 16.57 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.972 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.18 -171.16 2.62 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.795 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.458 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 74.16 171.75 25.69 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.355 -1.402 . . . . 0.0 109.743 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 60' ' ' GLY . 1.7 m-20 -42.57 116.14 0.81 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.491 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -89.75 155.02 19.47 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.361 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.477 HG21 ' H ' ' A' ' 64' ' ' GLU . 5.2 mt -130.18 167.08 26.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.761 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.477 ' H ' HG21 ' A' ' 63' ' ' ILE . 66.6 mt-10 -145.26 130.74 18.76 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.38 -0.928 . . . . 0.0 109.727 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.9 m -147.34 156.86 10.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 118.797 -1.161 . . . . 0.0 112.241 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.0 t -144.5 -2.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.137 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -125.32 -159.69 0.91 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.301 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.517 HD22 ' CG1' ' A' ' 106' ' ' VAL . 10.7 p-10 -94.28 118.59 31.82 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.476 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.447 ' H ' HG11 ' A' ' 42' ' ' VAL . . . -89.58 96.39 10.68 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.897 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -53.21 -70.99 0.08 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.821 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -90.55 3.21 54.65 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.239 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.404 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 14.7 tp 59.62 -90.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.634 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.404 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -177.2 -170.49 39.67 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.541 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.651 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.7 Cg_endo -67.16 -56.64 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.351 2.034 . . . . 0.0 112.266 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.661 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 2.1 pt? -64.75 19.52 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.321 -0.951 . . . . 0.0 111.409 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.651 ' H ' ' C ' ' A' ' 74' ' ' PRO . 45.3 p-10 -74.42 -17.12 60.84 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.387 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -77.88 4.93 10.71 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.577 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.536 HD21 ' N ' ' A' ' 79' ' ' VAL . 0.5 OUTLIER -167.9 115.01 0.72 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.172 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.727 ' CG1' ' H ' ' A' ' 80' ' ' SER . 26.3 t -132.32 -171.49 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.046 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.727 ' H ' ' CG1' ' A' ' 79' ' ' VAL . 21.0 p -176.31 -51.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.648 -1.221 . . . . 0.0 112.672 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.657 ' H ' ' HG ' ' A' ' 80' ' ' SER . 0.9 OUTLIER -124.96 162.2 25.0 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 119.148 -1.021 . . . . 0.0 112.854 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 10.2 mt -148.83 155.5 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.735 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.581 ' NH2' ' CG1' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -132.14 114.28 14.32 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.664 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.554 ' N ' ' NH2' ' A' ' 83' ' ' ARG . 37.1 t -121.38 136.56 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.756 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.581 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 4.0 mt -145.15 126.67 8.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.093 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 p -39.88 141.85 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.034 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 48' ' ' VAL . 1.3 p -134.09 138.58 30.87 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.339 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -47.21 136.66 18.68 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 121.207 1.271 . . . . 0.0 111.325 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.3 t -53.41 140.48 9.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.579 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -144.85 130.98 9.73 Favored Pre-proline 0 N--CA 1.487 1.387 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.906 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.45 -163.3 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.921 0 C-N-CA 121.039 1.159 . . . . 0.0 111.359 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.47 ' N ' HD13 ' A' ' 136' ' ' LEU . 9.6 ptt-85 -179.67 -158.17 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.939 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.532 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -137.4 166.97 22.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.65 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -120.81 140.78 51.25 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.456 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.417 ' CD2' HG11 ' A' ' 131' ' ' VAL . 80.5 m-85 -131.34 118.19 19.96 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.393 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -83.45 173.15 11.74 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.56 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.77 -70.34 0.72 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.991 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -62.36 163.98 7.82 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.901 -0.719 . . . . 0.0 112.249 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -89.89 63.62 6.08 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.808 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 101' ' ' PHE . 4.5 tt0 -176.0 50.1 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.713 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 100' ' ' GLN . 18.6 p90 41.44 44.2 2.4 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.111 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.449 ' CG ' ' N ' ' A' ' 103' ' ' GLY . 32.3 t70 -143.5 172.85 12.23 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.2 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 91.26 141.19 9.43 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.158 -1.496 . . . . 0.0 109.76 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 103' ' ' GLY . 47.0 mttp -28.66 130.3 0.06 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 123.971 0.454 . . . . 0.0 111.899 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -98.98 120.68 39.83 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.608 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.517 ' CG1' HD22 ' A' ' 68' ' ' ASN . 43.7 t -103.74 131.07 53.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.731 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -103.81 148.92 25.54 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.07 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.1 mt -138.11 123.15 12.22 Favored Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.154 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.424 ' CB ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -64.74 168.07 14.17 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.492 1.461 . . . . 0.0 111.797 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.424 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 6.1 Cg_exo -55.12 157.33 13.95 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 122.222 1.948 . . . . 0.0 111.973 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.38 178.89 15.73 Favored Glycine 0 N--CA 1.499 2.869 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.936 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.613 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 46.9 tt0 -109.31 157.1 19.2 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.125 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.613 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 33.2 m-85 -144.78 153.94 42.18 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.031 -1.067 . . . . 0.0 111.248 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.5 p -98.48 -161.43 0.87 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.008 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -101.34 54.38 0.83 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.958 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.33 -62.27 0.07 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.12 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.599 ' CG ' ' H ' ' A' ' 118' ' ' LEU . 6.4 pt-20 -69.18 -51.08 41.61 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.599 ' H ' ' CG ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -37.77 -69.51 0.12 Allowed 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.231 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -46.95 -66.5 0.4 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.66 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.446 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -70.33 4.77 2.06 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' A' ' 117' ' ' GLU . 17.0 t80 -98.61 -18.1 18.29 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 118.868 -1.133 . . . . 0.0 111.379 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.453 ' C ' ' CG1' ' A' ' 123' ' ' ILE . . . -165.79 -11.89 0.03 OUTLIER Glycine 0 C--N 1.289 -2.07 0 C-N-CA 118.152 -1.975 . . . . 0.0 111.043 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.453 ' CG1' ' C ' ' A' ' 122' ' ' GLY . 2.2 mt -148.89 -125.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 118.676 -1.21 . . . . 0.0 111.597 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.598 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 20.0 t70 -155.06 -162.58 1.39 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.832 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.598 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 12.4 p30 -71.44 -36.23 71.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.033 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -158.2 100.12 1.67 Allowed 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.955 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.4 t -177.22 25.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.309 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.8 mt -80.74 -60.35 2.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.409 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.7 m 59.32 -125.38 1.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 m -54.73 126.65 24.88 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.417 HG11 ' CD2' ' A' ' 95' ' ' PHE . 2.2 t -122.49 157.69 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.12 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -153.44 93.14 3.12 Favored Pre-proline 0 C--N 1.293 -1.862 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.178 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -53.73 124.21 15.27 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 121.125 1.217 . . . . 0.0 111.003 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.532 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 40.6 tp60 -89.22 -21.64 23.15 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.212 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -161.05 -29.55 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 C-N-CA 118.325 -1.893 . . . . 0.0 112.338 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 92' ' ' ARG . 0.5 OUTLIER -120.92 159.79 24.83 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.165 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.25 147.67 32.47 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.964 -1.094 . . . . 0.0 110.254 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 65.9 t -115.95 149.22 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.463 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.467 HG11 ' CE1' ' A' ' 141' ' ' PHE . 61.8 t -133.85 128.99 54.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.781 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.2 mp -102.72 138.2 39.93 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.963 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.836 ' CD2' ' CD1' ' A' ' 146' ' ' PHE . 8.6 m-85 -120.32 128.94 53.73 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.842 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.56 ' O ' ' CB ' ' A' ' 143' ' ' ASN . 53.9 mttm -85.33 102.12 13.12 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.049 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 142' ' ' LYS . 11.2 t-20 103.0 170.16 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.917 0 O-C-N 125.195 1.559 . . . . 0.0 111.292 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 146' ' ' PHE . 24.6 t70 -45.79 170.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.121 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.819 ' H ' HD21 ' A' ' 145' ' ' ASN . 1.2 m-80 -3.21 66.33 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 CA-C-N 113.921 -1.49 . . . . 0.0 113.986 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.836 ' CD1' ' CD2' ' A' ' 141' ' ' PHE . 0.9 OUTLIER 50.3 63.21 2.3 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.899 -1.121 . . . . 0.0 111.323 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.3 t -114.57 45.64 1.52 Allowed 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.557 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.24 -169.28 42.1 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.71 177.67 0.4 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.524 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.2 p -150.2 175.33 11.87 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.448 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -147.77 90.88 5.05 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.51 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.35 109.02 1.48 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.705 1.603 . . . . 0.0 112.272 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 49.5 t -80.98 90.84 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.004 -1.079 . . . . 0.0 109.92 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.565 ' N ' HD21 ' A' ' 154' ' ' ASN . 1.8 m120 -65.01 -20.45 66.5 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.569 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 11.0 t -168.33 -146.55 0.06 Allowed 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.063 -1.455 . . . . 0.0 112.634 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.4 m-20 -50.81 150.35 2.96 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.981 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.545 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -168.87 66.34 0.64 Allowed Pre-proline 0 C--N 1.31 -1.152 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.04 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.3 Cg_endo -62.46 23.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.323 2.015 . . . . 0.0 113.692 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER 176.86 91.23 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.45 -1.3 . . . . 0.0 111.394 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 tp -94.52 -23.26 17.76 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.247 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.264 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.421 ' O ' ' N ' ' A' ' 168' ' ' SER . 23.8 t-20 . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.424 0.154 . . . . 0.0 110.767 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 166' ' ' ASN . 9.1 m -40.0 99.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.601 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.476 ' HB2' ' H ' ' A' ' 143' ' ' ASN . 3.3 m -88.58 -55.86 3.54 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.407 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.489 ' HG ' ' H ' ' A' ' 146' ' ' PHE . 2.2 p -121.48 156.57 32.48 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.747 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 26.8 pt -139.37 165.14 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.49 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -146.45 106.07 3.95 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.332 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.81 95.46 4.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.401 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 116.458 -1.734 . . . . 0.0 111.076 -179.939 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -170.47 108.62 0.34 Allowed 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.228 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.414 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.6 pp -77.44 128.69 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.855 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.08 152.54 20.49 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.169 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 m -140.19 169.11 16.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.625 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 18.7 m-85 -128.93 153.71 47.26 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.93 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -78.17 -59.48 2.76 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.503 -0.879 . . . . 0.0 113.326 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.574 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 12.5 m120 -81.36 -178.02 6.75 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.811 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.579 ' CG ' ' H ' ' A' ' 11' ' ' ASP . 20.9 tt0 -74.03 179.32 4.44 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.829 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.615 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 1.5 p-10 40.53 67.16 0.53 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.339 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.615 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 43.7 p90 35.47 27.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.114 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' ASP . 7.2 tt0 -102.65 159.7 15.23 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.987 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.574 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 95.49 140.75 11.15 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.327 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 14' ' ' GLY . 5.5 mtpp -28.75 135.61 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.78 157.78 16.46 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.407 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.4 t -149.15 133.59 9.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.769 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -98.92 113.36 25.47 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.601 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 mt -102.01 136.87 19.4 Favored Pre-proline 0 N--CA 1.488 1.467 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.94 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -70.0 162.58 41.67 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 120.978 1.119 . . . . 0.0 111.137 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -66.33 -175.74 0.57 Allowed 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 121.694 1.596 . . . . 0.0 110.541 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.488 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 104.4 -166.54 15.24 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.242 -1.456 . . . . 0.0 111.263 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.592 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.4 OUTLIER -123.43 137.32 54.83 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.222 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 4.9 p90 -157.84 -179.93 8.61 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.445 -1.302 . . . . 0.0 111.676 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.444 ' HB ' ' H ' ' A' ' 26' ' ' ARG . 1.8 p -147.06 -157.55 0.82 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.461 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.444 ' H ' ' HB ' ' A' ' 25' ' ' THR . 34.7 ttt180 -61.27 -19.14 61.38 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.491 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.66 -66.59 0.53 Allowed 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.567 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -56.31 -43.12 78.62 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.782 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 30.9 mt -59.93 -40.49 89.08 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.154 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.02 -29.02 41.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 118.435 -1.306 . . . . 0.0 108.153 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.1 -35.47 64.18 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.696 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.27 -78.4 0.13 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.786 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.85 -25.25 0.56 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.153 -1.498 . . . . 0.0 110.688 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.458 ' C ' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -92.82 137.18 22.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.028 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.458 ' CG ' ' C ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER 168.61 158.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.198 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.696 HD21 ' ND2' ' A' ' 37' ' ' ASN . 6.0 t30 66.84 116.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.696 ' ND2' HD21 ' A' ' 36' ' ' ASN . 0.1 OUTLIER 56.42 3.99 0.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.098 -0.955 . . . . 0.0 113.045 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.469 ' O ' ' C ' ' A' ' 39' ' ' ILE . 39.9 p -82.98 -135.28 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.491 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 38' ' ' THR . 2.5 mt 25.37 52.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 123.902 0.751 . . . . 0.0 112.68 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.5 t -70.15 -41.51 73.74 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.214 -0.995 . . . . 0.0 110.118 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.4 166.25 15.02 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.312 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.515 HG13 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -145.3 149.68 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 118.533 -1.267 . . . . 0.0 112.666 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -140.05 87.25 2.14 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.609 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.414 HG23 ' CG2' ' A' ' 4' ' ' ILE . 78.0 t -109.44 115.48 56.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -69.7 168.5 21.3 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.207 1.271 . . . . 0.0 110.773 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.47 -177.09 0.36 Allowed 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 121.843 1.695 . . . . 0.0 111.126 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.07 -11.62 11.24 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.283 -1.437 . . . . 0.0 110.952 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.1 m -148.41 145.34 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.537 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.459 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 44.2 tttt -124.12 158.28 32.67 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.578 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.459 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -148.96 140.69 23.57 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.299 -1.361 . . . . 0.0 112.962 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.7 mt -119.06 124.19 72.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.591 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.491 HD11 ' H ' ' A' ' 52' ' ' LEU . 3.8 mp -93.9 165.91 12.43 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 118.641 -1.223 . . . . 0.0 112.341 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -141.22 108.95 5.64 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.956 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -47.28 -84.54 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.928 -0.709 . . . . 0.0 112.03 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.406 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 94.5 m-20 -59.34 142.55 51.84 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.476 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 11.9 p-10 -56.18 174.53 0.13 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.598 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.98 36.87 93.59 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.141 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 47.03 43.94 14.43 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.673 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.53 -165.5 1.25 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.901 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 65.01 165.19 1.08 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.364 -1.398 . . . . 0.0 109.855 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.49 130.1 19.79 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.586 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.462 ' C ' ' CD ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -101.07 161.87 13.29 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.106 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.566 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 7.7 mm -128.06 171.86 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.714 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.566 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 55.5 mt-10 -144.7 131.21 19.86 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.581 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.1 m -150.52 158.32 5.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.805 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 t -144.28 -4.31 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.56 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.517 ' CB ' ' HH ' ' A' ' 121' ' ' TYR . . . -128.72 -153.63 0.58 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.778 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.434 ' ND2' ' N ' ' A' ' 68' ' ' ASN . 3.2 m120 -92.32 125.74 37.11 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.353 -0.939 . . . . 0.0 109.754 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.515 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -97.3 133.95 41.23 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.356 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -74.55 -77.95 0.11 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.49 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -99.32 3.92 46.26 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.692 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.419 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 0.6 OUTLIER 63.95 -82.79 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.513 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.522 ' O ' ' ND2' ' A' ' 76' ' ' ASN . . . -172.67 -178.96 43.13 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.567 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.16 -18.05 56.05 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.149 1.899 . . . . 0.0 111.939 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.424 ' H ' HD21 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -85.08 41.47 0.88 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.06 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 73' ' ' GLY . 84.9 m-20 -79.89 -13.98 58.98 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.694 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -88.62 3.41 50.65 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.513 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -169.78 126.95 0.88 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 118.381 -1.328 . . . . 0.0 112.534 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.407 ' C ' ' OG ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -154.4 138.36 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.442 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.407 ' OG ' ' C ' ' A' ' 79' ' ' VAL . 1.7 m -157.76 -43.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.241 -1.383 . . . . 0.0 112.826 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.3 m -94.39 140.45 29.79 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.944 -1.103 . . . . 0.0 111.056 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -147.58 161.01 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 118.814 -1.155 . . . . 0.0 112.224 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.826 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -137.21 116.72 12.85 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.851 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.826 ' H ' HH12 ' A' ' 83' ' ' ARG . 12.8 t -120.37 127.68 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.873 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.493 HG13 ' NH2' ' A' ' 83' ' ' ARG . 27.8 mt -141.07 129.04 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.849 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 74.1 m -41.06 154.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.854 -0.739 . . . . 0.0 111.427 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.33 147.13 21.02 Favored Pre-proline 0 N--CA 1.487 1.419 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.203 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -54.12 145.32 54.34 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 121.27 1.313 . . . . 0.0 111.483 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.75 142.9 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.699 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -145.6 147.97 35.07 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.171 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.51 -166.62 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.911 0 C-N-CA 121.111 1.207 . . . . 0.0 110.394 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.452 ' CA ' HD13 ' A' ' 136' ' ' LEU . 12.6 ptt-85 -173.98 -162.44 0.14 Allowed 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.743 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.33 159.07 42.97 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.529 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -120.55 135.15 55.17 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.133 -1.027 . . . . 0.0 112.332 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -114.33 105.02 12.65 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.943 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.471 ' CZ ' ' CG ' ' A' ' 105' ' ' GLU . 26.2 m-85 -91.48 152.9 20.16 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.502 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 1.6 m-85 -97.05 157.93 15.68 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.739 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp 63.61 132.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.637 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.433 ' N ' ' HG ' ' A' ' 129' ' ' SER . 2.7 pt-20 -77.43 77.82 3.95 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.926 -1.109 . . . . 0.0 110.87 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 1.049 HE21 ' CA ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -172.58 16.19 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.096 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 42.9 t80 48.98 46.38 22.4 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.731 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 103' ' ' GLY . 38.7 t70 -116.85 -79.79 0.59 Allowed 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.768 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 102' ' ' ASP . . . -34.06 136.42 0.24 Allowed Glycine 0 N--CA 1.502 3.057 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.288 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -42.37 163.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.287 0.565 . . . . 0.0 112.336 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.471 ' CG ' ' CZ ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -115.72 165.07 13.46 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.501 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.2 t -130.35 132.03 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 23.2 p-10 -96.47 150.14 20.94 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.264 -0.974 . . . . 0.0 113.2 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.4 mt -143.81 127.97 9.28 Favored Pre-proline 0 N--CA 1.482 1.14 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.864 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -67.88 167.45 21.38 Favored 'Trans proline' 0 C--O 1.212 -0.825 0 C-N-CA 121.399 1.399 . . . . 0.0 111.727 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.57 151.03 78.54 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 122.055 1.837 . . . . 0.0 111.734 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.48 -173.72 21.02 Favored Glycine 0 N--CA 1.498 2.792 0 C-N-CA 119.448 -1.358 . . . . 0.0 111.16 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.592 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 39.9 tt0 -112.92 154.04 27.01 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.4 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.592 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 14.4 m-85 -139.48 151.57 46.29 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.105 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.8 p -92.71 -158.36 0.59 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.648 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -108.75 55.56 0.63 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.574 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.39 -68.8 0.13 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.989 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.553 ' O ' ' N ' ' A' ' 121' ' ' TYR . 8.0 pt-20 -70.39 -46.4 64.1 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.053 -1.059 . . . . 0.0 108.938 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.562 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -36.15 -71.55 0.07 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.858 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.569 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 22.9 mp0 -51.83 -56.43 14.01 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.99 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -73.74 14.48 0.37 Allowed 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.907 -1.117 . . . . 0.0 111.696 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 117' ' ' GLU . 16.1 t80 -122.46 -12.87 8.12 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.537 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -140.83 -51.48 0.05 OUTLIER Glycine 0 N--CA 1.485 1.955 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.189 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.471 HD11 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -137.48 -111.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.281 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -151.99 -151.96 0.41 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.062 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.15 10.1 13.14 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.451 -0.899 . . . . 0.0 111.205 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -157.78 -123.72 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.407 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.543 ' HG1' ' N ' ' A' ' 128' ' ' ILE . 7.3 p 51.11 -152.56 0.19 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.543 ' N ' ' HG1' ' A' ' 127' ' ' THR . 14.7 mt 65.62 159.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.977 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.433 ' HG ' ' N ' ' A' ' 99' ' ' GLU . 23.1 t -175.14 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.469 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.6 m -76.92 140.39 40.49 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.817 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.6 158.23 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 C-N-CA 119.924 -0.711 . . . . 0.0 111.16 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -156.29 85.5 3.13 Favored Pre-proline 0 C--N 1.306 -1.311 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.63 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.81 102.68 0.53 Allowed 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.093 1.195 . . . . 0.0 109.856 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.15 18.72 2.96 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.716 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -174.39 -47.63 0.05 OUTLIER Glycine 0 N--CA 1.489 2.197 0 C-N-CA 117.737 -2.173 . . . . 0.0 112.637 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.452 HD13 ' CA ' ' A' ' 92' ' ' ARG . 0.4 OUTLIER -121.33 169.62 10.42 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.245 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.8 151.79 24.1 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.078 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.6 t -121.88 144.09 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.231 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.415 HG11 ' CZ ' ' A' ' 141' ' ' PHE . 91.1 t -135.03 128.27 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.561 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 10.4 mp -106.4 140.44 39.32 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.674 -0.81 . . . . 0.0 112.744 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.472 ' CG ' ' HA ' ' A' ' 146' ' ' PHE . 62.9 m-85 -120.48 125.24 47.38 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.445 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -60.63 -65.1 0.74 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.172 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -70.33 -172.21 0.56 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.243 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.564 ' O ' ' N ' ' A' ' 146' ' ' PHE . 0.7 OUTLIER -66.32 -149.3 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.93 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.591 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 4.7 p-10 -15.68 75.76 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 O-C-N 124.386 1.054 . . . . 0.0 113.7 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.591 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.3 p90 37.07 64.95 0.54 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.229 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.456 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 28.6 t -128.49 173.7 10.01 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.949 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.456 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 64.17 -168.13 25.65 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.556 -1.306 . . . . 0.0 110.717 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -61.18 167.95 2.82 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.461 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.4 p -146.28 168.84 20.09 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.43 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.3 tt -138.24 84.59 19.89 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.471 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.59 107.93 1.13 Allowed 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 122.109 1.873 . . . . 0.0 113.094 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 40.2 t -83.9 89.96 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.308 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.442 ' H ' ' ND2' ' A' ' 154' ' ' ASN . 4.3 m-80 -64.45 -17.25 63.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 51.4 p -170.25 -141.28 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 117.735 -1.586 . . . . 0.0 112.929 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.438 ' N ' ' OG ' ' A' ' 155' ' ' SER . 20.7 m-20 -65.1 151.45 46.02 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.758 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.582 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -168.62 61.7 0.49 Allowed Pre-proline 0 C--N 1.305 -1.364 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.206 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.5 Cg_endo -62.13 17.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 122.173 1.916 . . . . 0.0 112.792 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.582 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -170.46 79.2 0.09 Allowed 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.612 -1.235 . . . . 0.0 111.384 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 tt -91.77 -75.65 0.47 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.342 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.418 0 C-N-CA 118.992 -1.575 . . . . 0.0 110.806 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 18.8 m120 . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 121.216 0.531 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.2 m -47.23 99.25 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.902 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.1 m -86.99 -53.69 4.74 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.616 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.62 160.42 21.84 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.201 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.424 HG12 ' CD1' ' A' ' 118' ' ' LEU . 22.2 pt -145.33 162.75 12.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.907 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -145.35 104.7 3.95 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.247 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.0 mt -85.27 95.61 4.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.407 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 116.371 -1.776 . . . . 0.0 110.955 -179.982 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.971 0.415 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -177.72 118.25 0.1 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.305 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 pt -77.33 154.53 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.294 -0.962 . . . . 0.0 111.059 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -133.67 127.12 32.26 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.671 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 m -107.11 173.43 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.37 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.689 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 53.8 m-85 -131.46 145.83 51.96 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.439 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.32 -37.09 77.59 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.501 ' C ' ' OG ' ' A' ' 40' ' ' SER . 25.3 m120 -117.25 165.62 13.23 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 119.101 -1.039 . . . . 0.0 111.814 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.504 ' N ' ' OG ' ' A' ' 40' ' ' SER . 46.8 mm-40 -69.18 173.5 5.57 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.253 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 13' ' ' GLN . 4.6 t0 62.38 31.39 17.29 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.692 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.689 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 5.3 t80 68.13 -9.71 0.47 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.304 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 11' ' ' ASP . 10.2 tt0 -71.88 167.68 19.52 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.861 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.472 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 90.71 129.67 4.29 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.803 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 1.1 mppt? -39.34 149.72 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.729 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.81 165.1 12.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.653 -0.819 . . . . 0.0 112.714 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 t -144.57 144.51 22.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.194 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -104.33 139.14 39.74 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.899 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 mt -132.06 141.71 42.44 Favored Pre-proline 0 N--CA 1.494 1.773 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.774 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -71.62 162.4 42.29 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 121.186 1.257 . . . . 0.0 111.893 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -68.51 -157.68 0.04 OUTLIER 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 121.94 1.76 . . . . 0.0 111.356 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.55 -159.93 50.01 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.854 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.69 ' ND2' ' H ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -90.95 149.86 21.71 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.292 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.602 ' OH ' ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -166.42 146.41 6.01 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.7 p -148.52 -146.59 0.2 Allowed 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 118.66 -1.216 . . . . 0.0 112.803 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -37.0 86.21 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.553 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.15 -57.34 13.03 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.75 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -58.41 -50.77 72.51 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.728 -1.189 . . . . 0.0 109.333 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.602 ' CD2' ' OH ' ' A' ' 24' ' ' TYR . 15.4 mt -51.07 -39.22 55.53 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.759 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.43 -37.16 47.21 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.357 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.92 -35.45 78.48 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.75 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 32' ' ' LEU . 6.9 mt -77.03 -83.59 0.07 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.825 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.416 ' H ' ' HB2' ' A' ' 32' ' ' LEU . . . 164.14 -27.47 0.21 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 118.811 -1.662 . . . . 0.0 111.452 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.3 pt -89.4 167.18 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.196 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 1.9 pt-20 173.32 152.65 0.09 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.102 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.691 HD21 ' H ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER 70.94 -155.48 0.11 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.715 179.812 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.691 ' H ' HD21 ' A' ' 36' ' ' ASN . 20.5 t30 -48.8 93.73 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.156 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' SER . 35.4 p -148.5 -50.1 0.16 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.626 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.2 mt -60.67 75.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.315 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' THR . 32.1 t -75.18 -52.59 10.57 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.74 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.501 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -120.48 174.06 6.78 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.489 HG11 ' H ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -152.94 150.27 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 117.963 -1.495 . . . . 0.0 112.803 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -137.41 110.55 7.8 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.533 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.2 t -133.65 116.14 13.73 Favored Pre-proline 0 N--CA 1.495 1.807 0 C-N-CA 119.666 -0.813 . . . . 0.0 112.087 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.43 167.57 22.04 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 120.941 1.094 . . . . 0.0 110.809 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 48' ' ' VAL . 1.2 Cg_endo -64.92 -171.08 0.16 Allowed 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.744 1.63 . . . . 0.0 111.1 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.46 -10.31 12.2 Favored Glycine 0 N--CA 1.481 1.652 0 C-N-CA 119.273 -1.441 . . . . 0.0 110.907 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.404 ' H ' ' C ' ' A' ' 46' ' ' PRO . 30.5 m -151.9 131.77 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.236 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -104.28 124.68 49.6 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.339 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.47 134.11 50.98 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.481 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.3 mt -112.59 123.08 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.116 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.476 HD22 ' H ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -89.91 152.87 21.02 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.286 -0.966 . . . . 0.0 112.443 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.476 ' H ' HD22 ' A' ' 52' ' ' LEU . 13.8 m-85 -140.07 125.08 18.53 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.22 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -53.33 -88.46 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.327 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -64.44 154.3 36.15 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.748 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -61.3 172.56 1.07 Allowed 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.362 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.66 17.99 76.95 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.12 -1.514 . . . . 0.0 109.924 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 59.24 54.05 5.03 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.971 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.52 -173.71 2.94 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.8 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.7 -175.78 33.49 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.482 -1.342 . . . . 0.0 109.955 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -50.65 166.88 0.07 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.69 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.62 161.92 36.74 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.366 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.579 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 10.0 mm -138.78 172.76 13.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.571 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.579 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 20.4 mt-10 -148.15 130.88 15.99 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.839 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.5 m -145.7 161.75 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 118.768 -1.173 . . . . 0.0 112.552 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.35 -14.7 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.006 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.04 -148.76 0.41 Allowed 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.404 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.707 HD21 ' H ' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -99.82 136.12 40.22 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.022 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.489 ' H ' HG11 ' A' ' 42' ' ' VAL . . . -106.06 128.0 53.56 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.928 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -80.6 -74.79 0.3 Allowed 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 73' ' ' GLY . 20.2 mm-40 -89.95 3.32 53.47 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.975 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.427 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 1.7 tp 55.7 -83.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.715 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 176.02 -169.7 42.41 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.316 -1.421 . . . . 0.0 110.679 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.558 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.2 Cg_endo -65.05 -39.22 24.9 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 122.295 1.997 . . . . 0.0 112.17 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.71 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 1.9 pt? -71.94 31.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.942 -1.103 . . . . 0.0 111.202 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.558 ' H ' ' C ' ' A' ' 74' ' ' PRO . 16.2 p-10 -80.77 -17.92 49.35 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.739 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -88.6 14.02 10.88 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.688 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.675 ' N ' ' ND2' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -167.6 115.01 0.75 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.722 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.8 m -155.47 153.63 7.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.514 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.1 t -172.55 -33.59 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 118.683 -1.207 . . . . 0.0 112.35 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.8 140.98 40.07 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.894 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.9 mt -150.52 149.79 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.381 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.687 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -141.32 126.41 18.39 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.248 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.687 ' CA ' HH12 ' A' ' 83' ' ' ARG . 3.5 t -117.7 135.92 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.1 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.55 ' CG1' ' CZ ' ' A' ' 83' ' ' ARG . 13.7 mt -119.34 121.92 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.654 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.4 p -46.16 129.99 10.17 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.708 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.26 151.31 69.42 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.7 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -55.87 139.03 83.66 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 121.234 1.29 . . . . 0.0 110.731 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.32 133.78 31.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.34 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -143.63 150.99 52.62 Favored Pre-proline 0 N--CA 1.487 1.402 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.9 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 2.5 Cg_endo -59.29 -160.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.241 1.294 . . . . 0.0 111.611 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.475 ' N ' HD13 ' A' ' 136' ' ' LEU . 14.5 ptt180 -174.93 -158.75 0.08 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.849 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.23 165.04 28.99 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.622 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -128.98 152.24 48.82 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.87 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.485 ' CE1' HG21 ' A' ' 131' ' ' VAL . 98.0 m-85 -142.61 133.89 26.17 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.748 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.445 ' CD2' ' C ' ' A' ' 101' ' ' PHE . 18.6 m-85 -94.55 -177.12 4.12 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.14 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.8 -52.1 2.87 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.031 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.529 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 15.5 mmtp -93.18 163.9 13.45 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.541 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -82.9 78.47 9.49 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.379 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.65 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.3 OUTLIER 178.85 26.79 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.349 -1.296 . . . . 0.0 107.973 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.65 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 33.9 p90 37.78 49.1 1.06 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.237 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -138.44 -28.91 0.82 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.828 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.529 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -58.89 153.77 29.32 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.303 -1.427 . . . . 0.0 110.46 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 103' ' ' GLY . 42.8 tttm -31.03 140.03 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.903 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -96.47 147.7 23.56 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.585 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 95.0 t -142.85 117.88 4.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -104.14 162.27 13.32 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.095 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -141.11 150.93 60.54 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.195 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -78.08 163.51 28.03 Favored 'Trans proline' 0 C--O 1.212 -0.796 0 C-N-CA 121.652 1.568 . . . . 0.0 111.957 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.21 139.94 74.95 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.593 1.529 . . . . 0.0 110.696 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.51 -159.75 27.57 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 118.884 -1.626 . . . . 0.0 111.574 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.55 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 34.7 tt0 -118.03 156.16 29.06 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.149 -0.525 . . . . 0.0 110.828 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 49.6 m-85 -145.55 149.22 34.18 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.157 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.458 ' C ' ' H ' ' A' ' 116' ' ' ALA . 3.3 p -101.92 175.8 5.42 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.335 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -72.28 17.32 0.11 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.864 -0.734 . . . . 0.0 112.387 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.458 ' H ' ' C ' ' A' ' 114' ' ' THR . . . -111.21 -65.75 1.14 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.564 -0.854 . . . . 0.0 111.716 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.585 ' CG ' ' H ' ' A' ' 118' ' ' LEU . 6.0 pt-20 -70.55 -53.98 13.94 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.822 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.585 ' H ' ' CG ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -30.61 -72.43 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 123.925 0.765 . . . . 0.0 111.188 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -53.04 -57.14 11.39 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.268 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.451 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 8.0 mpt_? -78.37 26.69 0.21 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.553 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 117' ' ' GLU . 27.9 t80 -135.18 -8.28 2.29 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.315 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.68 -44.59 0.02 OUTLIER Glycine 0 N--CA 1.481 1.642 0 C-N-CA 119.019 -1.562 . . . . 0.0 110.323 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.464 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -143.75 -102.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.822 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.464 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 2.0 p-10 -172.63 179.97 2.3 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.493 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -63.91 123.03 17.91 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.113 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.619 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 0.7 OUTLIER 56.28 106.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.968 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 128' ' ' ILE . 0.1 OUTLIER 172.49 -92.77 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.565 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.598 ' N ' ' OG1' ' A' ' 127' ' ' THR . 6.5 mm 45.81 -110.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.191 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 1.1 t 86.93 120.99 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 123.816 0.697 . . . . 0.0 111.924 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.603 ' H ' ' H ' ' A' ' 160' ' ' LEU . 2.7 m 58.97 114.72 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.136 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.485 HG21 ' CE1' ' A' ' 95' ' ' PHE . 4.0 p -113.13 160.13 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.605 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -160.96 89.68 1.62 Allowed Pre-proline 0 C--N 1.291 -1.967 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.183 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -69.32 121.32 8.11 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.035 1.157 . . . . 0.0 110.704 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -91.05 11.19 23.83 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.592 -0.843 . . . . 0.0 112.19 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -175.7 -49.67 0.06 OUTLIER Glycine 0 N--CA 1.491 2.339 0 C-N-CA 118.262 -1.923 . . . . 0.0 112.137 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 92' ' ' ARG . 0.6 OUTLIER -107.8 171.41 7.41 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.143 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -93.16 145.0 24.74 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.681 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 153' ' ' VAL . 31.6 t -101.42 147.52 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.157 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.25 116.71 13.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.821 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.7 137.47 43.51 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.78 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.413 ' CD2' ' HB3' ' A' ' 146' ' ' PHE . 10.9 m-85 -108.34 145.31 34.65 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.82 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -75.6 -61.73 1.82 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.913 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -82.19 149.49 27.88 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.858 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 145' ' ' ASN . 29.4 t70 -54.04 175.38 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.989 -1.085 . . . . 0.0 110.739 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.645 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 3.3 t-20 36.09 35.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.254 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.645 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 43.11 65.86 0.89 Allowed 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.103 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.2 t -120.59 34.76 5.1 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.543 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.0 -160.29 12.24 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.167 -1.492 . . . . 0.0 110.415 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -59.33 171.93 0.71 Allowed 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.093 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.5 p -149.82 160.16 43.79 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.562 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.21 84.58 62.82 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.066 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.53 102.61 0.61 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.71 1.607 . . . . 0.0 112.405 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 138' ' ' VAL . 81.3 t -83.74 87.66 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.649 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -83.75 22.27 1.14 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.801 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 42.3 p -170.39 -156.12 0.13 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.596 -1.241 . . . . 0.0 112.033 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -90.56 150.99 21.52 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.621 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -159.42 84.99 2.25 Favored Pre-proline 0 C--N 1.308 -1.207 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.103 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.527 ' C ' ' OG ' ' A' ' 130' ' ' SER . 1.7 Cg_endo -67.93 37.92 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.045 1.83 . . . . 0.0 112.421 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.5 OUTLIER -178.55 65.83 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.704 0.764 . . . . 0.0 109.244 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.603 ' H ' ' H ' ' A' ' 130' ' ' SER . 3.4 tm? -80.98 -35.38 32.14 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.188 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.466 ' N ' ' HA ' ' A' ' 129' ' ' SER . . . . . . . . 0 N--CA 1.496 2.65 0 C-N-CA 119.743 -1.218 . . . . 0.0 111.563 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.494 ' ND2' ' ND2' ' A' ' 126' ' ' ASN . 27.7 t-20 . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.854 0.359 . . . . 0.0 110.545 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.3 m -92.64 113.5 25.8 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.376 -0.929 . . . . 0.0 111.18 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 41.6 t -99.73 -56.15 2.46 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.163 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.497 ' HG ' ' H ' ' A' ' 146' ' ' PHE . 1.9 p -123.24 159.42 28.76 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.465 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 30.9 pt -141.54 174.25 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.541 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -156.29 113.3 3.16 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.364 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 7.0 mt -89.28 103.14 13.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.004 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.1 m . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 116.289 -1.815 . . . . 0.0 110.801 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.446 ' C ' ' ND2' ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 121.054 0.454 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.446 ' ND2' ' C ' ' A' ' 2' ' ' ALA . 0.6 OUTLIER 179.9 129.57 0.09 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.38 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.0 pt -82.5 153.19 3.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.814 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.3 m -121.7 126.04 48.03 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.127 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.24 150.26 5.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.389 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 1.1 ' CD2' ' NE2' ' A' ' 16' ' ' GLN . 47.6 m-85 -116.97 148.19 41.63 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.325 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.0 2.5 42.8 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.504 ' C ' ' OG ' ' A' ' 40' ' ' SER . 66.0 m-20 -154.17 167.94 28.2 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 117.779 -1.568 . . . . 0.0 112.449 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 9.4 tp10 -74.07 158.38 34.37 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.973 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.584 ' C ' ' H ' ' A' ' 13' ' ' GLN . 2.8 t0 72.21 41.04 0.65 Allowed 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.903 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.1 t80 63.3 -8.06 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.335 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.584 ' H ' ' C ' ' A' ' 11' ' ' ASP . 8.9 tt0 -74.44 175.01 8.13 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.526 -0.87 . . . . 0.0 111.169 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.489 ' HA3' ' N ' ' A' ' 9' ' ' ASN . . . 95.96 130.61 6.39 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.672 -1.252 . . . . 0.0 110.866 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 14' ' ' GLY . 48.1 mttp -38.99 152.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.919 -0.713 . . . . 0.0 111.311 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 1.1 ' NE2' ' CD2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -99.4 154.6 18.08 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.498 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.595 ' CG1' ' N ' ' A' ' 18' ' ' ASP . 2.6 t -147.1 166.47 6.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.424 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.595 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 12.3 m-20 -131.09 131.95 44.54 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.199 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.7 mt -130.29 121.79 19.7 Favored Pre-proline 0 N--CA 1.489 1.482 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.608 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -64.81 164.82 22.99 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 120.988 1.125 . . . . 0.0 111.946 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.65 -157.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.732 1.621 . . . . 0.0 110.668 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.88 -178.44 53.18 Favored Glycine 0 N--CA 1.48 1.587 0 C-N-CA 118.911 -1.614 . . . . 0.0 110.571 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.822 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -107.44 128.83 54.83 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.83 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 1.3 p90 -153.58 146.89 24.78 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.331 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 26' ' ' ARG . 7.8 p -120.48 -155.09 0.61 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.088 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.433 ' H ' ' HB ' ' A' ' 25' ' ' THR . 6.3 ppt_? -56.92 -28.11 61.69 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.718 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.04 -57.17 12.79 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.663 -1.215 . . . . 0.0 110.177 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -58.3 -48.54 80.18 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.731 -1.188 . . . . 0.0 109.648 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 29' ' ' LEU . 4.8 mt -59.97 -29.47 68.46 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.515 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 26' ' ' ARG . . . -56.03 -30.2 61.55 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.03 -34.57 57.31 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.421 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.4 mt -83.16 -68.93 0.67 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.73 34.22 2.47 Favored Glycine 0 N--CA 1.504 3.187 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.463 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.515 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -121.13 8.58 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.669 0.747 . . . . 0.0 110.498 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.1 179.66 6.7 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.966 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.521 ' ND2' ' OD1' ' A' ' 37' ' ' ASN . 0.1 OUTLIER 68.93 99.59 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.16 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.521 ' OD1' ' ND2' ' A' ' 36' ' ' ASN . 1.0 OUTLIER 33.81 78.16 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.104 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 40' ' ' SER . 60.5 p -140.39 -39.76 0.43 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.317 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 mt -67.27 72.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.487 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.504 ' OG ' ' C ' ' A' ' 9' ' ' ASN . 31.1 t -69.64 -46.24 66.64 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.694 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.465 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -127.57 164.1 22.72 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.156 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.441 HG11 ' N ' ' A' ' 43' ' ' LYS . 1.2 t -149.89 154.31 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 118.151 -1.42 . . . . 0.0 113.124 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.441 ' N ' HG11 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -140.23 121.61 15.02 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.183 -1.371 . . . . 0.0 108.777 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.4 t -139.12 114.76 8.42 Favored Pre-proline 0 N--CA 1.499 1.976 0 C-N-CA 119.308 -0.957 . . . . 0.0 112.095 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -69.76 169.5 18.77 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.849 1.032 . . . . 0.0 110.701 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 48' ' ' VAL . 1.6 Cg_endo -63.72 -170.32 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.703 1.602 . . . . 0.0 110.872 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.19 -15.03 12.39 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 119.088 -1.53 . . . . 0.0 110.589 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.4 ' H ' ' C ' ' A' ' 46' ' ' PRO . 21.6 m -150.77 135.43 9.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 118.774 -1.17 . . . . 0.0 112.172 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -105.96 127.85 53.42 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.35 153.94 24.22 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.918 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 99.1 mt -137.3 116.95 15.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.479 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 mp -93.78 162.96 13.71 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.01 -1.076 . . . . 0.0 113.177 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -142.47 131.5 23.12 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.216 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -54.16 -84.41 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.764 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.443 ' N ' HD21 ' A' ' 55' ' ' ASN . 1.3 m-80 -75.69 166.6 23.31 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.17 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.32 -173.82 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.729 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 47.71 34.03 9.97 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.138 -1.506 . . . . 0.0 109.948 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.773 ' H ' ' HG ' ' A' ' 81' ' ' SER . 7.9 m-85 45.83 43.29 9.83 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.358 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.38 -172.34 2.32 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.721 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.08 178.96 1.2 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.538 -1.315 . . . . 0.0 109.818 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -54.1 177.53 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 118.831 -1.148 . . . . 0.0 110.195 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -147.45 161.34 41.25 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.806 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.477 HG21 ' H ' ' A' ' 64' ' ' GLU . 4.1 mt -125.85 164.39 25.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.21 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.477 ' H ' HG21 ' A' ' 63' ' ' ILE . 67.0 mt-10 -139.38 131.8 28.53 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -149.15 155.87 8.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.325 -1.35 . . . . 0.0 112.564 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.556 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 2.3 t -137.96 0.2 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.034 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.466 ' H ' ' HH ' ' A' ' 121' ' ' TYR . . . -132.96 -135.91 0.18 Allowed 'General case' 0 C--O 1.208 -1.109 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.441 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.437 ' ND2' ' OD1' ' A' ' 107' ' ' ASP . 2.2 m-20 -111.89 124.44 52.37 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.329 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.11 94.32 6.45 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.639 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -58.64 -68.59 0.25 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.741 -0.784 . . . . 0.0 112.522 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.18 -12.82 59.98 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.369 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 tp 67.06 -79.33 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.738 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.62 176.07 36.74 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.238 -1.458 . . . . 0.0 110.77 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.623 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.0 OUTLIER -65.71 -35.12 38.35 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.249 1.966 . . . . 0.0 112.184 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.5 ' H ' HD22 ' A' ' 75' ' ' LEU . 1.5 pt? -67.99 23.92 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.35 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.623 ' H ' ' C ' ' A' ' 74' ' ' PRO . 7.2 p30 -75.19 -1.08 21.64 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.668 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -73.04 -8.55 56.26 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.14 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -168.5 127.03 1.12 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.159 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.38 137.58 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.273 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 87.8 p -162.3 -30.67 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.656 -1.218 . . . . 0.0 112.697 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.773 ' HG ' ' H ' ' A' ' 58' ' ' PHE . 1.2 m -98.83 139.99 33.68 Favored 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.058 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.409 ' CG1' ' C ' ' A' ' 81' ' ' SER . 0.6 OUTLIER -150.64 156.12 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 118.571 -1.252 . . . . 0.0 111.575 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.765 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -150.21 130.09 13.36 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.444 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.765 ' CA ' HH12 ' A' ' 83' ' ' ARG . 10.0 t -128.77 143.19 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.614 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.441 ' CG1' ' CZ ' ' A' ' 83' ' ' ARG . 7.8 mt -132.51 126.42 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.975 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.7 p -40.8 149.9 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.053 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.61 151.33 32.86 Favored Pre-proline 0 N--CA 1.483 1.203 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.539 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -53.93 153.39 20.38 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 C-N-CA 121.287 1.325 . . . . 0.0 111.091 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.2 m -77.73 139.36 18.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.612 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -146.46 130.1 8.36 Favored Pre-proline 0 C--N 1.297 -1.674 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.142 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.67 -151.75 0.01 OUTLIER 'Trans proline' 0 C--O 1.207 -1.028 0 C-N-CA 121.465 1.444 . . . . 0.0 111.364 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.6 ptt-85 -178.03 -163.94 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.856 -1.138 . . . . 0.0 112.223 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.57 172.12 13.36 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.012 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.559 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 8.4 tpp180 -126.39 157.9 37.32 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.306 -0.957 . . . . 0.0 111.486 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.559 ' CD1' ' C ' ' A' ' 94' ' ' ARG . 26.3 m-85 -148.26 113.59 5.58 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.312 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.411 ' CD2' ' HB3' ' A' ' 105' ' ' GLU . 14.7 m-85 -89.53 161.77 16.03 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.093 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.655 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 0.6 OUTLIER -98.62 167.05 11.04 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.987 -1.085 . . . . 0.0 112.099 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt 59.69 147.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.072 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 30.5 tt0 -65.61 109.68 2.47 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.251 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.665 ' NE2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 100.53 49.79 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.814 0 O-C-N 124.92 1.388 . . . . 0.0 110.181 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.589 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 26.0 p90 29.66 53.21 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.053 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -98.95 30.37 3.41 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.936 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -162.57 151.77 21.76 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.457 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.565 ' O ' ' CE2' ' A' ' 97' ' ' TYR . 88.6 mttt -38.0 155.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.118 0.485 . . . . 0.0 112.1 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.411 ' HB3' ' CD2' ' A' ' 96' ' ' PHE . 10.8 pt-20 -111.23 167.09 10.55 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.194 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.66 178.55 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.224 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.437 ' OD1' ' ND2' ' A' ' 68' ' ' ASN . 14.3 p-10 -150.34 145.95 26.44 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.351 -1.339 . . . . 0.0 112.295 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.6 mt -139.17 133.06 16.0 Favored Pre-proline 0 N--CA 1.496 1.873 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.199 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.88 169.34 14.96 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 121.517 1.478 . . . . 0.0 111.677 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -57.91 149.29 71.03 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 122.094 1.863 . . . . 0.0 111.643 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.22 -155.29 25.52 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.649 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.569 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 37.9 mt-30 -131.12 155.97 46.04 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.809 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.569 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 40.1 m-85 -141.67 155.0 45.71 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.663 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.9 p -102.68 176.46 5.16 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.769 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -83.12 56.8 3.64 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.425 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -153.5 -74.34 0.13 Allowed 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 121' ' ' TYR . 7.3 pt-20 -68.02 -44.6 76.16 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.02 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.584 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -33.94 -72.17 0.05 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.29 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.612 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -53.92 -50.3 66.71 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.436 -1.306 . . . . 0.0 110.08 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -80.65 24.38 0.48 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 118.784 -1.166 . . . . 0.0 111.017 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.556 ' HH ' ' H ' ' A' ' 66' ' ' VAL . 25.3 t80 -129.28 -12.78 4.5 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.027 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -143.8 -45.33 0.05 OUTLIER Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.297 -1.43 . . . . 0.0 110.39 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.527 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -143.8 -104.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.847 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.527 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 7.4 m-20 -160.62 179.01 8.93 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.044 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -74.8 131.49 40.83 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.691 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 m120 50.18 89.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.449 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.5 t -175.38 -2.66 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.195 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.6 mt -95.83 144.01 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.671 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 67.5 m -155.22 -49.34 0.08 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.316 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.8 m -87.99 98.41 11.5 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.99 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' A' ' 95' ' ' PHE . 3.2 t -104.9 159.69 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.842 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -157.24 85.73 2.81 Favored Pre-proline 0 C--N 1.295 -1.777 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.187 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.67 96.98 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 121.413 1.408 . . . . 0.0 110.576 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -87.39 25.81 1.35 Allowed 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.422 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -161.59 -62.71 0.02 OUTLIER Glycine 0 N--CA 1.487 2.072 0 C-N-CA 118.553 -1.784 . . . . 0.0 111.452 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.2 mp -121.53 -169.02 1.79 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.826 -0.749 . . . . 0.0 111.749 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 173' ' ' SER . . . -86.79 158.48 19.37 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.6 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.7 t -126.67 137.94 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.624 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.3 t -133.32 124.89 49.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.961 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.503 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 9.2 mp -101.27 140.08 36.05 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.529 -0.868 . . . . 0.0 112.285 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.41 ' CZ ' ' CB ' ' A' ' 171' ' ' ARG . 19.0 m-85 -107.98 132.79 53.15 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.47 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -79.1 -31.09 44.15 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.3 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.494 ' CG ' ' H ' ' A' ' 144' ' ' ASP . 33.2 t30 -78.12 179.09 7.06 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.589 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.494 ' H ' ' CG ' ' A' ' 143' ' ' ASN . 2.9 m-20 -69.45 -85.21 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.62 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.606 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 16.0 p-10 -76.16 75.69 2.99 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.637 -0.825 . . . . 0.0 112.097 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.606 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 0.9 OUTLIER 37.62 71.62 0.14 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.898 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.448 ' HB3' ' ND2' ' A' ' 143' ' ' ASN . 0.3 OUTLIER -147.98 -173.2 4.24 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.163 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 62.37 -168.69 15.97 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.669 -1.253 . . . . 0.0 111.081 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 149' ' ' ASP . 0.8 OUTLIER -61.19 176.48 0.44 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.721 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.1 p -151.01 163.26 39.17 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.776 -1.17 . . . . 0.0 112.211 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.5 tp -123.55 83.42 53.3 Favored Pre-proline 0 N--CA 1.488 1.434 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.115 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.42 108.45 0.7 Allowed 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 122.148 1.899 . . . . 0.0 113.368 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 24.9 t -86.15 89.38 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.347 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -54.95 -24.81 25.62 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.7 p -170.69 -143.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 117.793 -1.563 . . . . 0.0 113.097 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -57.1 145.06 32.21 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.543 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.502 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -174.6 65.93 0.28 Allowed Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.876 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 3.3 Cg_endo -69.28 38.95 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 122.532 2.155 . . . . 0.0 112.583 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . 0.1 OUTLIER -166.67 -82.32 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.339 -1.344 . . . . 0.0 111.911 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.509 ' N ' ' OG1' ' A' ' 159' ' ' THR . 79.0 mt 54.17 -84.35 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.572 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 159' ' ' THR . . . . . . . . 0 N--CA 1.496 2.65 0 C-N-CA 118.979 -1.582 . . . . 0.0 110.253 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 19.9 m120 . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.768 0.318 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 48.8 m -102.93 137.97 40.43 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.156 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.99 -60.84 1.13 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.856 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.01 167.01 12.17 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 24.7 pt -147.35 171.37 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 117.999 -1.481 . . . . 0.0 112.501 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.41 ' CB ' ' CZ ' ' A' ' 141' ' ' PHE . 23.7 ttm180 -152.29 106.0 3.1 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.262 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 11.4 mt -81.28 107.82 13.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 119.046 -1.061 . . . . 0.0 109.95 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 137' ' ' ALA . 36.1 m . . . . . 0 C--N 1.303 -1.419 0 CA-C-O 116.347 -1.787 . . . . 0.0 110.981 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 121.157 0.503 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 0.6 OUTLIER 179.43 121.56 0.05 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.706 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pp -82.65 125.23 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 118.549 -1.261 . . . . 0.0 111.288 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.1 m -105.85 157.65 17.32 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.471 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.3 164.6 17.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.288 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 5.4 m-85 -126.39 147.47 49.76 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.94 -68.76 0.38 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.303 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.473 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 34.9 m120 -73.04 170.15 15.48 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.629 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.472 ' CG ' ' N ' ' A' ' 11' ' ' ASP . 32.3 tt0 -73.55 171.06 13.9 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.08 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.63 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 3.4 t70 59.19 55.26 4.42 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.622 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.63 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 23.9 p90 38.72 26.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.102 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 11' ' ' ASP . 9.4 tp-100 -103.93 162.2 13.33 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.655 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.473 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 89.63 134.88 5.54 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.64 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 14' ' ' GLY . 16.0 mtpp -30.44 136.93 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.56 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -110.93 169.54 8.7 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.779 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.3 t -141.19 133.21 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.425 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.17 111.61 23.77 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.728 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mt -105.86 128.72 25.87 Favored Pre-proline 0 N--CA 1.491 1.619 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.772 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -67.57 165.93 25.67 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 120.657 0.905 . . . . 0.0 110.456 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.82 -164.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 121.623 1.549 . . . . 0.0 111.391 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.648 ' C ' HD21 ' A' ' 23' ' ' ASN . . . 97.17 174.44 34.48 Favored Glycine 0 N--CA 1.498 2.813 0 C-N-CA 119.396 -1.383 . . . . 0.0 111.28 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.873 ' N ' HD21 ' A' ' 23' ' ' ASN . 0.2 OUTLIER -103.38 135.18 45.48 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.617 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.541 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 2.5 p90 -155.12 176.22 12.82 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 118.482 -1.287 . . . . 0.0 111.701 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.0 p -141.06 -156.46 0.68 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.121 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.521 ' CD ' ' H ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -69.03 -22.68 64.03 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.957 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.473 ' H ' ' HD3' ' A' ' 26' ' ' ARG . . . -64.55 -59.81 3.86 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.652 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -58.73 -45.77 88.87 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.204 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.4 mt -57.47 -37.77 73.43 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.902 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.28 -34.22 56.4 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 118.474 -1.291 . . . . 0.0 108.469 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.9 -31.24 66.2 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.947 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.9 mt -81.15 -76.76 0.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.763 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.77 -29.94 0.44 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.522 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.7 mm -71.5 133.56 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.578 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -171.93 147.62 2.19 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.868 -1.133 . . . . 0.0 111.885 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.583 ' N ' ' ND2' ' A' ' 36' ' ' ASN . 0.4 OUTLIER 68.47 -146.81 0.12 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.546 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.519 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -72.96 88.22 1.36 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.628 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.511 ' HG1' ' N ' ' A' ' 39' ' ' ILE . 77.2 p -142.77 -31.54 0.51 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.718 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.511 ' N ' ' HG1' ' A' ' 38' ' ' THR . 5.8 mt -77.25 62.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.072 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 38.7 t -64.61 -70.02 0.25 Allowed 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.547 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.458 ' HG ' ' HA ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -93.57 171.16 9.07 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.553 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.485 HG11 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -153.75 157.12 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 118.412 -1.315 . . . . 0.0 112.107 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -149.08 100.65 3.08 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.5 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.5 t -123.83 101.76 35.78 Favored Pre-proline 0 N--CA 1.496 1.84 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.407 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.44 171.8 11.22 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 120.943 1.096 . . . . 0.0 109.847 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.63 -169.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.567 1.511 . . . . 0.0 111.033 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.84 -18.24 9.6 Favored Glycine 0 N--CA 1.483 1.785 0 C-N-CA 119.18 -1.486 . . . . 0.0 110.679 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.9 m -147.79 139.98 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.292 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -110.13 119.24 38.66 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.644 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.85 157.57 17.37 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.29 -0.964 . . . . 0.0 113.158 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.49 HG23 ' CE2' ' A' ' 53' ' ' TYR . 44.2 mt -143.0 114.62 2.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.365 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.708 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 2.7 mp -92.24 158.1 16.32 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.935 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.49 ' CE2' HG23 ' A' ' 51' ' ' ILE . 41.5 m-85 -140.03 108.48 5.86 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.488 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.403 ' HB3' ' H ' ' A' ' 55' ' ' ASN . 3.8 tt0 -45.84 -83.4 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.023 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.403 ' H ' ' HB3' ' A' ' 54' ' ' GLN . 83.0 m-20 -59.17 152.34 20.72 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.763 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -58.98 -171.18 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.945 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 49.9 37.84 29.56 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.231 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.431 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . 8.6 m-85 45.33 48.63 10.43 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.607 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.96 -164.09 1.16 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.159 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 64.84 168.93 1.91 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.265 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 60' ' ' GLY . 10.0 t70 -39.05 118.11 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.684 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 62' ' ' GLN . 4.7 pp0? -97.74 151.57 20.02 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.743 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.625 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 4.5 mm -130.59 168.98 22.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.423 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.625 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -147.39 133.71 19.56 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.127 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -145.07 162.19 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 118.79 -1.164 . . . . 0.0 112.56 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 t -149.36 -5.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.535 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.431 ' HB2' ' H ' ' A' ' 68' ' ' ASN . . . -129.62 -159.51 0.97 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.209 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.431 ' H ' ' HB2' ' A' ' 67' ' ' ALA . 4.5 t30 -91.15 136.91 32.77 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.714 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.485 ' H ' HG11 ' A' ' 42' ' ' VAL . . . -113.92 105.03 12.76 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.424 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -54.29 -77.88 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.753 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -91.73 5.59 49.19 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.803 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.1 tp 54.04 -99.35 0.09 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.588 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.61 -176.55 36.45 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 118.964 -1.588 . . . . 0.0 111.03 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.681 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.0 OUTLIER -66.37 -37.34 23.96 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.483 2.122 . . . . 0.0 112.357 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.49 HD22 ' N ' ' A' ' 75' ' ' LEU . 2.7 pt? -57.53 8.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.502 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.681 ' H ' ' C ' ' A' ' 74' ' ' PRO . 10.5 p-10 -69.47 1.19 4.2 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.652 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.578 ' N ' HD21 ' A' ' 77' ' ' ASN . 1.8 m120 -82.82 -15.41 51.75 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.364 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -164.69 126.52 2.2 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.104 -1.039 . . . . 0.0 111.169 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.38 151.15 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.432 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.3 t -166.0 -51.14 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.728 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 m -94.14 135.55 35.39 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.977 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.485 ' HB ' ' CZ ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -150.25 157.19 6.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.371 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.654 ' HE ' ' CD1' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -150.59 153.08 35.07 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.386 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.645 ' C ' HH21 ' A' ' 83' ' ' ARG . 13.9 t -150.27 140.29 16.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.497 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.654 ' CD1' ' HE ' ' A' ' 83' ' ' ARG . 42.4 mt -134.52 129.57 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.7 m -40.82 139.71 0.81 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.052 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.57 141.78 19.65 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.635 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.75 143.77 68.6 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 121.065 1.176 . . . . 0.0 111.156 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.0 t -64.2 145.06 14.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.123 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -122.7 139.14 30.56 Favored Pre-proline 0 N--CA 1.489 1.491 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.132 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.75 -23.48 50.06 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 121.143 1.229 . . . . 0.0 111.309 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 35.3 -151.85 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.667 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.449 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -147.72 173.06 13.13 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.046 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -147.03 113.0 5.78 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.168 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 5.7 m-85 -97.29 162.63 13.25 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.555 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -123.0 156.72 34.23 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.618 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 104' ' ' LYS . 1.4 m-85 -75.46 -91.37 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.134 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 1.234 ' HB3' ' OE1' ' A' ' 100' ' ' GLN . 51.2 mttp -47.74 162.63 0.07 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.125 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -90.6 67.57 6.46 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.66 -0.816 . . . . 0.0 112.35 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 1.234 ' OE1' ' HB3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER 178.85 51.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.667 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.9 t80 47.99 35.06 4.6 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.951 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.773 ' OD1' ' HG2' ' A' ' 100' ' ' GLN . 18.3 p-10 -142.1 171.07 14.56 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.616 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 85.38 139.94 5.09 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.019 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.477 ' HZ1' ' HB2' ' A' ' 104' ' ' LYS . 1.0 OUTLIER -29.58 132.91 0.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 123.895 0.409 . . . . 0.0 112.07 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.499 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 1.7 pm0 -104.7 163.22 12.65 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.302 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.1 t -140.97 128.8 22.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.109 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.47 155.22 17.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.788 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.2 mt -143.93 138.5 15.14 Favored Pre-proline 0 N--CA 1.481 1.087 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.847 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -73.08 167.33 27.62 Favored 'Trans proline' 0 C--O 1.212 -0.789 0 C-N-CA 121.636 1.557 . . . . 0.0 111.718 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.36 141.74 76.03 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.93 1.754 . . . . 0.0 110.965 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 144.69 -155.63 26.48 Favored Glycine 0 N--CA 1.498 2.817 0 C-N-CA 118.862 -1.637 . . . . 0.0 111.328 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.444 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 6.0 tt0 -125.65 152.42 45.24 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.934 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.444 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 28.8 m-85 -145.53 147.32 32.0 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.278 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.663 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 1.4 p -95.31 -136.46 0.22 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.08 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.663 ' N ' ' OG1' ' A' ' 114' ' ' THR . 5.4 tt0 -113.98 -25.38 8.59 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.063 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.45 -64.06 1.26 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.966 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.3 pt-20 -70.94 -50.34 35.68 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.587 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.584 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 2.4 tt -39.28 -71.05 0.09 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.459 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.569 ' OE1' ' NH1' ' A' ' 120' ' ' ARG . 75.9 mt-10 -48.89 -56.12 9.74 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.639 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.569 ' NH1' ' OE1' ' A' ' 119' ' ' GLU . 4.1 mpt_? -71.76 0.31 9.24 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.893 -1.123 . . . . 0.0 112.361 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 117' ' ' GLU . 24.7 t80 -105.08 -12.23 16.23 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.487 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -146.21 -46.51 0.03 OUTLIER Glycine 0 N--CA 1.486 1.993 0 C-N-CA 118.915 -1.612 . . . . 0.0 111.288 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -136.78 -112.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.183 -1.007 . . . . 0.0 111.724 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -156.26 -155.53 0.55 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.338 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -80.61 3.67 21.13 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.975 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.556 ' ND2' HD21 ' A' ' 166' ' ' ASN . 8.6 m120 -157.15 -152.04 0.34 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.582 -1.247 . . . . 0.0 112.147 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 39.32 96.78 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.103 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 13.5 mt -155.1 -75.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.507 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.3 p 41.54 -98.16 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.7 m -44.55 116.68 1.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.89 146.35 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.7 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -144.09 82.58 10.8 Favored Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.413 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -63.07 108.61 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.262 1.308 . . . . 0.0 111.053 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.449 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 6.9 mm100 -62.56 -2.3 1.05 Allowed 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.911 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 175.32 -41.21 0.11 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 118.249 -1.929 . . . . 0.0 112.476 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.6 mt -88.13 176.33 7.32 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.512 -1.275 . . . . 0.0 111.299 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.1 129.66 54.14 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.308 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.7 t -98.24 149.44 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.323 -0.951 . . . . 0.0 112.404 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.1 t -133.04 113.96 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.448 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 mp -91.01 139.26 30.93 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.818 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.462 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 3.7 m-85 -118.64 131.8 56.17 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.461 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -61.18 -80.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.911 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.451 ' N ' HD21 ' A' ' 143' ' ' ASN . 1.8 m-80 -66.25 164.03 16.68 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.272 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 146' ' ' PHE . 4.7 p30 -61.92 -161.17 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.537 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.638 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 6.6 t-20 37.19 29.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.12 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.638 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.1 p90 42.15 62.19 1.73 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.162 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.94 174.07 11.01 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.017 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.99 -162.13 49.82 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.488 -1.339 . . . . 0.0 110.529 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -59.96 160.54 7.72 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.41 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 71.5 p -149.13 166.04 29.99 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.56 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.46 ' C ' ' CD2' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -133.2 86.53 41.56 Favored Pre-proline 0 N--CA 1.483 1.223 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.901 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -63.24 104.77 0.43 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 C-N-CA 121.54 1.493 . . . . 0.0 112.328 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.81 81.99 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.637 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -78.85 19.77 0.5 Allowed 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.338 -0.847 . . . . 0.0 112.06 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.5 t -169.97 -151.67 0.09 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.54 -1.264 . . . . 0.0 111.89 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -87.54 157.49 19.15 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.927 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.472 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -167.52 69.06 0.91 Allowed Pre-proline 0 C--N 1.304 -1.377 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.802 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.3 Cg_endo -68.14 34.35 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.622 2.214 . . . . 0.0 112.933 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.465 HG21 ' H ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -169.87 -68.29 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.716 -1.193 . . . . 0.0 111.665 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.465 ' H ' HG21 ' A' ' 159' ' ' THR . 1.9 mt 51.69 -93.55 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.605 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 159' ' ' THR . . . . . . . . 0 N--CA 1.493 2.438 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.595 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.556 HD21 ' ND2' ' A' ' 126' ' ' ASN . 7.8 t-20 . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.953 0.406 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -39.32 136.54 0.88 Allowed 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.29 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.8 m -107.53 -36.08 6.56 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.827 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 10.8 p -153.84 155.57 36.02 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.7 -1.2 . . . . 0.0 111.022 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.9 172.97 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.494 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -142.04 113.26 7.59 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.58 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 3.4 mt -80.52 91.89 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 118.437 -1.305 . . . . 0.0 109.548 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.6 t . . . . . 0 C--N 1.305 -1.33 0 CA-C-O 116.331 -1.795 . . . . 0.0 110.894 -179.969 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.934 0.397 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -176.68 127.55 0.18 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.782 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.2 pt -68.06 168.69 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.441 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.419 HG22 HE21 ' A' ' 16' ' ' GLN . 1.2 m -149.3 124.76 10.3 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.292 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 m -101.67 137.01 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.718 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.534 ' CE2' ' O ' ' A' ' 12' ' ' PHE . 5.2 m-85 -92.35 148.34 22.2 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.124 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.437 ' HB2' ' N ' ' A' ' 15' ' ' LYS . 1.8 m-85 -81.52 0.71 36.79 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.505 ' C ' ' OG ' ' A' ' 40' ' ' SER . 31.6 m120 -152.38 164.3 37.76 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.063 -1.455 . . . . 0.0 112.009 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.498 ' N ' ' OG ' ' A' ' 40' ' ' SER . 3.0 tp10 -71.63 163.64 27.38 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.462 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.477 ' CG ' ' C ' ' A' ' 10' ' ' GLU . 0.3 OUTLIER 71.87 40.92 0.71 Allowed 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.576 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.534 ' O ' ' CE2' ' A' ' 7' ' ' PHE . 55.8 t80 53.48 10.63 0.22 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.138 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.578 HE21 ' H ' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -96.97 171.89 8.21 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.81 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.578 ' H ' HE21 ' A' ' 13' ' ' GLN . . . 96.08 139.32 10.33 Favored Glycine 0 N--CA 1.495 2.625 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.633 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.437 ' N ' ' HB2' ' A' ' 8' ' ' TYR . 12.5 mtmm -37.11 147.84 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.215 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.419 HE21 HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -118.54 118.86 32.84 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.182 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.405 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 14.4 p -104.82 130.71 55.4 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.028 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.182 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -90.25 143.26 26.93 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.326 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt -138.61 134.74 17.46 Favored Pre-proline 0 N--CA 1.493 1.693 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.146 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.83 165.89 22.08 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.048 1.165 . . . . 0.0 111.264 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.17 -173.73 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 C-N-CA 121.87 1.713 . . . . 0.0 111.163 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.12 -167.26 16.85 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.239 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.674 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -134.81 136.65 42.69 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.203 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.433 ' HH ' HD11 ' A' ' 82' ' ' ILE . 3.6 p90 -152.13 -172.48 4.24 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.04 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 p -142.65 -162.77 1.48 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.658 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.434 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 11.0 ttt180 -60.44 -11.99 8.32 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.725 -1.19 . . . . 0.0 110.116 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.01 -66.48 0.59 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.415 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -59.49 -42.63 92.57 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.363 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.8 mt -64.37 -36.74 85.12 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.32 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 26' ' ' ARG . . . -55.78 -28.88 58.32 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 117.923 -1.511 . . . . 0.0 107.767 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.78 -35.53 70.07 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.819 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.6 mt -81.98 -75.45 0.3 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.487 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.51 16.93 0.06 OUTLIER Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.489 -1.338 . . . . 0.0 110.791 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.7 mm -102.34 127.67 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.047 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 4.7 pt-20 -178.19 158.54 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.277 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 0.5 OUTLIER 81.24 -144.62 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.404 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.634 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 0.5 OUTLIER -94.95 18.44 11.97 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.126 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.683 ' C ' ' H ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -66.32 -20.73 66.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.195 -1.402 . . . . 0.0 110.361 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.499 ' CG2' ' O ' ' A' ' 39' ' ' ILE . 78.8 mt -76.18 33.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.692 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.683 ' H ' ' C ' ' A' ' 38' ' ' THR . 11.0 t -35.45 -55.85 0.65 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.222 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.451 ' HG ' ' H ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -122.74 174.68 6.97 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.418 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.01 161.01 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 118.165 -1.414 . . . . 0.0 112.438 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -141.6 123.31 15.18 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.163 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.4 t -144.65 102.75 4.58 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.05 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -68.31 171.26 13.1 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 121.032 1.154 . . . . 0.0 110.356 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 48' ' ' VAL . 2.1 Cg_endo -61.59 -173.35 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.549 1.499 . . . . 0.0 110.815 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.9 -13.69 8.48 Favored Glycine 0 N--CA 1.483 1.788 0 C-N-CA 119.195 -1.479 . . . . 0.0 110.474 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.429 ' H ' ' C ' ' A' ' 46' ' ' PRO . 2.6 m -151.72 129.42 2.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 118.919 -1.112 . . . . 0.0 112.105 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -98.74 149.54 22.74 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.17 149.62 51.04 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.365 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.59 ' CD1' HH22 ' A' ' 83' ' ' ARG . 1.9 mp -137.66 116.2 14.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.383 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.484 HD11 ' H ' ' A' ' 52' ' ' LEU . 4.3 mp -88.2 156.94 18.96 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.669 -1.212 . . . . 0.0 111.655 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -133.47 110.66 10.12 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.122 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.434 ' HB3' ' H ' ' A' ' 55' ' ' ASN . 3.7 tt0 -49.42 -79.38 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.48 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.434 ' H ' ' HB3' ' A' ' 54' ' ' GLN . 11.6 m120 -62.4 153.88 29.94 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.987 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 21.7 p-10 -64.66 178.46 0.77 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.756 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.0 32.23 66.35 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.248 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.59 ' H ' ' HG ' ' A' ' 81' ' ' SER . 39.9 m-85 52.73 68.08 0.89 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.748 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.41 -170.92 3.62 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.121 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.38 175.01 6.17 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.287 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -44.27 111.66 0.32 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.623 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.563 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -95.62 128.32 42.39 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.146 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.5 mt -96.8 163.78 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.553 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -136.99 130.52 31.59 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.706 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.0 m -150.3 163.72 3.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 118.813 -1.155 . . . . 0.0 112.178 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 t -147.42 -3.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.389 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.22 -146.13 0.32 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.273 -1.331 . . . . 0.0 109.122 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -96.94 124.39 40.9 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.546 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.16 108.73 19.77 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.054 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -65.05 -85.58 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.709 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 73' ' ' GLY . 9.8 mm-40 -80.35 5.86 13.7 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.354 -0.939 . . . . 0.0 111.539 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 tp 60.49 -79.63 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.045 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 170.56 174.72 38.77 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.397 -1.383 . . . . 0.0 110.477 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.26 -27.72 64.03 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.086 1.857 . . . . 0.0 111.982 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.511 ' C ' ' H ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER -83.4 18.81 1.69 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.549 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -68.89 7.59 0.66 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.511 ' H ' ' C ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -83.86 -10.48 57.99 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.519 -0.872 . . . . 0.0 111.269 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -165.75 122.94 1.44 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.381 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 t -149.49 142.79 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.657 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.7 m -158.35 -35.36 0.07 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.196 -1.001 . . . . 0.0 111.855 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.59 ' HG ' ' H ' ' A' ' 58' ' ' PHE . 14.5 m -94.58 143.14 26.67 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.164 -1.014 . . . . 0.0 111.468 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.433 HD11 ' HH ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -148.98 143.74 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.234 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.748 ' NH1' ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -125.0 135.07 52.44 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.81 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.748 ' CA ' ' NH1' ' A' ' 83' ' ' ARG . 13.2 t -141.22 142.92 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.391 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 68.6 mt -140.32 138.62 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.593 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.0 m -55.24 146.23 19.53 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.191 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.1 t -140.91 149.33 55.79 Favored Pre-proline 0 N--CA 1.483 1.225 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.626 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -56.79 157.76 18.75 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.491 1.461 . . . . 0.0 111.58 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.4 m -71.52 136.7 25.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.333 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -145.71 130.89 9.16 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.438 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -60.81 -154.34 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.877 0 C-N-CA 121.276 1.317 . . . . 0.0 111.09 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.464 ' N ' HD13 ' A' ' 136' ' ' LEU . 16.7 ptt180 178.28 -161.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.017 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.435 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.71 173.25 11.71 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.36 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.422 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 10.7 mtm180 -134.79 148.47 50.21 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.002 -1.079 . . . . 0.0 112.148 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 10.9 m-85 -133.79 133.34 41.56 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.764 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.496 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 27.2 m-85 -94.62 179.09 5.38 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.342 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.36 -64.7 1.02 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.431 -0.907 . . . . 0.0 112.973 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.492 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 46.4 tttm -81.02 158.19 25.21 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.94 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.575 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 42.2 mt-10 -64.65 108.31 1.66 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.567 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 1.141 ' NE2' ' HD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 106.04 57.14 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.208 0 O-C-N 125.109 1.505 . . . . 0.0 110.327 179.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 1.141 ' HD1' ' NE2' ' A' ' 100' ' ' GLN . 13.9 p90 26.41 40.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.672 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 100' ' ' GLN . 65.4 m-20 -100.72 -9.42 21.82 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.014 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.492 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -105.92 150.73 16.97 Favored Glycine 0 N--CA 1.499 2.9 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.395 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 103' ' ' GLY . 94.8 mttt -35.04 145.53 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.498 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.33 160.81 14.1 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.961 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.513 ' CG1' ' N ' ' A' ' 107' ' ' ASP . 1.5 t -143.6 165.38 14.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.232 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.513 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 5.7 p-10 -145.37 153.78 41.59 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 118.571 -1.252 . . . . 0.0 112.311 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.415 HD21 ' CE2' ' A' ' 121' ' ' TYR . 60.6 mt -139.39 146.38 48.23 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.371 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -73.15 165.75 31.84 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 121.676 1.584 . . . . 0.0 112.645 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.12 146.87 95.21 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 122.394 2.063 . . . . 0.0 111.491 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.11 -166.21 23.78 Favored Glycine 0 N--CA 1.501 2.973 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.154 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.587 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 55.3 mt-30 -113.37 159.22 19.66 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.737 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.587 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 44.9 m-85 -144.97 148.53 33.89 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.072 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.3 p -87.91 -165.68 1.38 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.879 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.91 57.0 0.73 Allowed 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.901 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.08 -68.16 0.13 Allowed 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.426 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 121' ' ' TYR . 9.7 pt-20 -69.8 -42.61 73.51 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.431 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.575 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -37.16 -74.49 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.529 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.628 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -52.08 -51.57 56.84 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.727 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 2.4 mpt_? -76.88 18.66 0.34 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.754 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 117' ' ' GLU . 16.7 t80 -127.71 -10.11 5.57 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.23 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -141.69 -49.77 0.05 OUTLIER Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.114 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.624 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -146.1 -102.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.627 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.624 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 20.1 m-20 -161.02 162.56 31.8 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.629 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.432 ' N ' ' HB3' ' A' ' 119' ' ' GLU . 17.3 p30 -60.47 -22.83 63.94 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.507 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.607 ' ND2' ' H ' ' A' ' 127' ' ' THR . 9.8 t30 -97.63 -175.3 3.15 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.184 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.607 ' H ' ' ND2' ' A' ' 126' ' ' ASN . 10.1 t 55.04 -152.39 0.35 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.091 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.459 ' N ' HG21 ' A' ' 127' ' ' THR . 2.6 mt 76.43 127.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.295 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.436 ' HB3' ' CA ' ' A' ' 161' ' ' GLY . 47.6 m -160.58 -54.77 0.05 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.895 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.661 ' CB ' ' H ' ' A' ' 101' ' ' PHE . 1.7 m -84.08 117.18 23.27 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.789 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 t -119.46 143.58 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.885 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -139.7 106.6 6.98 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.257 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.55 122.37 9.35 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.103 1.202 . . . . 0.0 111.07 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.435 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 1.0 OUTLIER -90.15 -2.13 58.03 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.964 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -175.92 -36.24 0.05 OUTLIER Glycine 0 N--CA 1.493 2.448 0 C-N-CA 118.469 -1.824 . . . . 0.0 111.805 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.464 HD13 ' N ' ' A' ' 92' ' ' ARG . 0.5 OUTLIER -120.3 164.34 16.45 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.852 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 173' ' ' SER . . . -78.03 155.78 30.48 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.374 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.5 t -119.43 140.12 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.427 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 92.2 t -130.98 124.52 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.845 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.2 mp -103.01 141.23 36.15 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.43 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.419 ' CB ' ' HA ' ' A' ' 146' ' ' PHE . 48.3 m-85 -120.13 125.78 49.09 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.14 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -65.78 -64.69 0.8 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.947 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.54 165.63 23.5 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.4 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 146' ' ' PHE . 31.4 m-20 -63.18 -158.72 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.723 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.655 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 4.0 m120 42.89 22.89 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.753 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.655 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.9 p90 40.6 59.17 2.2 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.114 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 t -143.25 -150.8 0.33 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.334 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 54.4 -153.79 9.55 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.42 -1.371 . . . . 0.0 109.974 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.51 143.13 50.96 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.068 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.426 ' HG1' ' HD3' ' A' ' 152' ' ' PRO . 3.2 p -143.99 167.67 21.8 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.47 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.3 mt -138.03 83.41 23.05 Favored Pre-proline 0 N--CA 1.485 1.31 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.922 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.426 ' HD3' ' HG1' ' A' ' 150' ' ' THR . 3.1 Cg_exo -64.88 104.41 0.56 Allowed 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 121.615 1.543 . . . . 0.0 111.933 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.402 ' C ' ' H ' ' A' ' 155' ' ' SER . 2.6 t -86.0 81.83 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.959 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -71.84 12.55 0.38 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.326 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 13.4 t -169.83 -151.71 0.09 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.378 -1.329 . . . . 0.0 111.618 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.3 m-20 -85.22 155.02 21.59 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.628 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.506 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -171.9 62.64 0.34 Allowed Pre-proline 0 C--N 1.302 -1.469 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.404 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 10.2 Cg_endo -69.87 69.8 1.68 Allowed 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.954 1.769 . . . . 0.0 111.197 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.617 ' HG1' ' H ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER 173.97 -94.45 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.379 -0.928 . . . . 0.0 111.064 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.617 ' H ' ' HG1' ' A' ' 159' ' ' THR . 49.7 mt 53.26 -90.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.842 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 159' ' ' THR . . . . . . . . 0 N--CA 1.494 2.507 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.764 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.4 m120 . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.86 0.362 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -55.74 122.28 11.07 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.222 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 73.0 m -91.23 -72.1 0.6 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.242 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.618 ' HG ' ' H ' ' A' ' 146' ' ' PHE . 0.1 OUTLIER -115.61 160.72 19.64 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.244 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.403 HG12 ' CD1' ' A' ' 118' ' ' LEU . 29.2 pt -142.37 169.87 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 119.506 -0.877 . . . . 0.0 110.633 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -154.1 107.0 2.86 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.052 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.5 mt -82.99 99.34 5.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.716 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 137' ' ' ALA . 11.0 t . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 116.328 -1.796 . . . . 0.0 110.966 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.426 ' CB ' HG13 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 121.065 0.459 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -179.97 115.33 0.05 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.18 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.4 pt -70.1 162.46 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.82 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -143.88 119.03 10.1 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.544 -0.863 . . . . 0.0 110.705 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 m -101.8 162.58 3.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.069 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.515 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 31.3 m-85 -120.62 152.7 37.81 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.934 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.98 -47.94 60.24 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.568 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 9.6 m120 -101.17 177.42 4.94 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.969 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 11' ' ' ASP . 5.5 tp10 -82.19 177.06 9.0 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.861 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.478 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 4.1 t70 61.58 36.26 16.9 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.15 -1.02 . . . . 0.0 110.756 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.515 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 1.3 t80 60.95 2.34 0.54 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.701 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.448 ' H ' ' C ' ' A' ' 11' ' ' ASP . 59.1 mt-30 -88.24 167.98 13.11 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.724 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.568 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 93.74 133.98 6.99 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 119.974 -1.107 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 14' ' ' GLY . 25.4 mtmm -30.15 139.47 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.095 0.474 . . . . 0.0 112.193 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.408 ' HB2' HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -96.38 162.07 13.65 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.935 -179.819 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 t -147.82 122.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.629 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 1.6 m-20 -90.25 138.78 31.25 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.798 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 mt -132.24 133.26 23.59 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.639 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -68.65 164.56 32.63 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 120.962 1.108 . . . . 0.0 111.494 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.02 -167.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.756 1.637 . . . . 0.0 110.533 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.474 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 89.56 178.8 45.19 Favored Glycine 0 N--CA 1.486 1.989 0 C-N-CA 118.79 -1.671 . . . . 0.0 110.88 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.898 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -110.52 141.84 43.13 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.359 -0.537 . . . . 0.0 112.2 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -155.77 178.87 9.77 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.879 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.414 ' HG1' ' H ' ' A' ' 27' ' ' ALA . 72.6 p -142.47 -168.65 2.79 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.616 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -57.97 -24.31 57.52 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.381 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.414 ' H ' ' HG1' ' A' ' 25' ' ' THR . . . -64.87 -63.4 1.12 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.003 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -56.73 -39.61 74.25 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.437 -1.305 . . . . 0.0 109.326 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 32' ' ' LEU . 46.1 mt -62.04 -40.1 94.6 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.324 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -48.76 -33.78 10.98 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 118.864 -1.135 . . . . 0.0 107.972 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.53 -38.68 71.05 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.575 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' LEU . 15.2 mt -71.89 -80.93 0.06 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.927 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.14 -21.87 0.1 OUTLIER Glycine 0 N--CA 1.491 2.324 0 C-N-CA 118.802 -1.666 . . . . 0.0 111.422 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -81.27 155.21 4.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.984 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 5.0 pt-20 174.32 117.88 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.468 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.641 ' CG ' ' N ' ' A' ' 37' ' ' ASN . 1.5 p-10 92.43 -150.67 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.966 0 O-C-N 124.299 0.999 . . . . 0.0 113.032 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.706 ' H ' HD21 ' A' ' 37' ' ' ASN . 1.9 m-80 -51.49 4.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.496 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.588 ' H ' ' C ' ' A' ' 36' ' ' ASN . 43.4 p -56.78 -54.26 48.36 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 117.801 -1.559 . . . . 0.0 110.944 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.505 ' N ' ' OG1' ' A' ' 38' ' ' THR . 3.6 mt -58.75 77.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.112 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 38' ' ' THR . 35.6 t -81.38 -58.53 3.0 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.101 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.76 169.49 8.79 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.489 HG11 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -149.68 148.79 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 118.137 -1.425 . . . . 0.0 112.919 -179.907 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -137.01 114.65 11.15 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.616 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.3 t -133.93 110.09 11.96 Favored Pre-proline 0 N--CA 1.498 1.955 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.063 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.405 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.0 OUTLIER -68.46 171.47 12.93 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.219 1.28 . . . . 0.0 111.223 179.879 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.405 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.5 Cg_endo -63.71 -171.92 0.15 Allowed 'Trans proline' 0 C--N 1.317 -1.079 0 C-N-CA 121.922 1.748 . . . . 0.0 111.131 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.38 -17.13 6.7 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.882 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.426 HG13 ' CB ' ' A' ' 2' ' ' ALA . 26.6 m -150.58 143.63 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.232 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -108.78 138.42 45.14 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.972 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -117.49 140.24 49.87 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.369 -0.932 . . . . 0.0 112.436 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -129.09 118.99 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.33 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.407 ' H ' HD11 ' A' ' 52' ' ' LEU . 3.8 mp -94.58 163.79 13.24 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.975 -1.09 . . . . 0.0 112.81 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -143.61 121.01 11.65 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.069 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -54.96 -85.87 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.665 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -59.88 154.07 19.45 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.28 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -62.45 -176.67 0.11 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.525 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.22 21.32 59.43 Favored Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.052 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 57.07 48.64 15.15 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.798 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -128.71 -177.83 4.35 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.591 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.41 171.68 36.44 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.076 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.5 m-20 -46.99 123.69 5.54 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.021 -1.071 . . . . 0.0 110.407 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.644 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -102.85 176.06 5.28 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.854 -0.739 . . . . 0.0 111.112 179.951 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.453 ' CG1' HD12 ' A' ' 75' ' ' LEU . 6.1 mt -143.65 164.31 15.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.625 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.567 ' CD ' ' N ' ' A' ' 64' ' ' GLU . 3.0 mp0 -142.94 132.16 23.26 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.191 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.3 m -149.95 162.95 3.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.645 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.669 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 2.9 t -145.46 -1.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.664 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -124.47 -125.07 0.25 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.877 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.539 ' C ' HD21 ' A' ' 68' ' ' ASN . 0.2 OUTLIER -121.64 115.83 23.47 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.201 179.915 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.489 ' H ' HG11 ' A' ' 42' ' ' VAL . . . -90.1 83.47 6.06 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.575 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -54.33 -51.16 65.59 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.444 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 72' ' ' LEU . 8.5 tp10 -111.93 81.46 1.46 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.87 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 71' ' ' GLU . 4.5 tp -31.17 -87.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.233 -0.894 . . . . 0.0 113.167 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.5 -168.17 38.56 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.007 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.664 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.1 Cg_endo -69.37 -50.38 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.402 2.068 . . . . 0.0 112.611 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.552 ' C ' ' H ' ' A' ' 77' ' ' ASN . 2.3 pt? -57.97 10.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.873 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.664 ' H ' ' C ' ' A' ' 74' ' ' PRO . 30.2 p30 -62.56 -0.58 0.63 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.861 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.552 ' H ' ' C ' ' A' ' 75' ' ' LEU . 55.0 t30 -71.22 -10.53 59.91 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.394 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -172.94 124.85 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.302 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.85 141.67 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.031 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.0 m -160.17 -41.77 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.748 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 m -94.6 139.03 31.73 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.244 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -146.25 162.59 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 118.919 -1.112 . . . . 0.0 111.728 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.827 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.24 114.42 5.85 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.116 -179.881 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.827 ' H ' HH22 ' A' ' 83' ' ' ARG . 10.9 t -110.11 130.31 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.613 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.446 HG13 ' NH1' ' A' ' 83' ' ' ARG . 4.9 mt -132.43 127.4 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.088 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.8 m -39.98 153.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.904 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -158.11 141.86 11.25 Favored Pre-proline 0 N--CA 1.488 1.437 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.98 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -50.46 153.79 7.04 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.346 1.364 . . . . 0.0 111.64 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 90' ' ' GLN . 3.1 p -90.51 158.59 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.96 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.521 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 52.5 mt-30 -142.25 150.46 55.31 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.432 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.528 ' C ' ' HE ' ' A' ' 92' ' ' ARG . 3.3 Cg_exo -59.71 -36.76 90.86 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.496 1.464 . . . . 0.0 111.299 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.528 ' HE ' ' C ' ' A' ' 91' ' ' PRO . 2.5 mtm180 57.21 -165.72 0.15 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.048 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.521 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -140.07 179.77 6.43 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.967 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -140.42 149.84 43.11 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.711 -1.195 . . . . 0.0 111.966 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -134.64 131.34 37.65 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.011 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.564 ' CZ ' ' CD ' ' A' ' 105' ' ' GLU . 5.4 m-85 -92.58 173.34 7.83 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.027 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.44 -68.89 0.75 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 118.893 -1.123 . . . . 0.0 112.117 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -75.46 166.7 23.19 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.319 -0.953 . . . . 0.0 111.844 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.71 ' C ' ' HG2' ' A' ' 100' ' ' GLN . 5.2 pt-20 -89.68 52.75 2.39 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.674 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.71 ' HG2' ' C ' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -159.32 33.24 0.2 Allowed 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.903 -179.995 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.7 t80 58.4 38.11 25.76 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.447 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -137.97 173.81 11.23 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 81.78 134.02 1.72 Allowed Glycine 0 N--CA 1.487 2.033 0 C-N-CA 119.38 -1.391 . . . . 0.0 109.893 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 103' ' ' GLY . 13.6 ptpt -32.69 148.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.066 0.509 . . . . 0.0 112.008 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.564 ' CD ' ' CZ ' ' A' ' 96' ' ' PHE . 20.9 mt-10 -108.52 167.54 9.97 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.737 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.6 t -137.19 130.0 43.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.768 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -102.1 155.87 17.92 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.338 -0.945 . . . . 0.0 113.103 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.1 mt -145.45 125.36 7.05 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.266 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.18 166.38 16.98 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 121.108 1.205 . . . . 0.0 111.756 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.97 150.24 84.96 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 121.78 1.653 . . . . 0.0 111.07 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 139.32 -140.62 11.03 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.188 -1.482 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.528 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 19.2 tt0 -147.55 159.46 43.72 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.791 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 53.5 m-85 -141.71 155.41 45.65 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.842 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.414 ' C ' ' H ' ' A' ' 116' ' ' ALA . 5.2 p -100.61 175.42 5.67 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.66 -0.816 . . . . 0.0 112.29 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.71 41.01 0.15 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.667 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.415 ' N ' ' OE2' ' A' ' 119' ' ' GLU . . . -154.32 -52.93 0.1 Allowed 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.273 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 118' ' ' LEU . 5.1 tp10 -71.83 -52.11 19.1 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.043 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.571 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -36.17 -72.09 0.06 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.435 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.616 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 1.2 pm0 -52.99 -54.93 27.82 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.728 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.437 ' H ' ' HG2' ' A' ' 119' ' ' GLU . 3.4 mpt_? -74.31 15.56 0.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.173 -1.011 . . . . 0.0 112.516 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.669 ' HH ' ' H ' ' A' ' 66' ' ' VAL . 41.0 t80 -121.1 -17.85 7.64 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.536 -0.865 . . . . 0.0 111.476 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -142.94 -40.61 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 C-N-CA 118.632 -1.747 . . . . 0.0 111.44 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.453 ' CD1' ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -139.01 -105.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.54 -179.867 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.571 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 19.1 t70 -162.61 -172.96 3.32 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.609 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.571 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 15.9 t-20 -59.09 -2.32 0.25 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.218 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 127' ' ' THR . 28.2 p30 -172.25 -134.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.754 -1.178 . . . . 0.0 111.948 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.55 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 9.1 t 41.0 33.98 0.25 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.877 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.484 ' C ' ' OG ' ' A' ' 129' ' ' SER . 3.0 mt -88.06 -75.75 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.122 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.484 ' OG ' ' C ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 77.22 -142.39 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 179.784 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.6 m -37.09 128.42 0.92 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.277 -1.329 . . . . 0.0 113.646 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.8 t -122.18 147.43 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.156 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -145.72 98.99 4.45 Favored Pre-proline 0 C--N 1.3 -1.549 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.125 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.02 110.13 1.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.044 1.163 . . . . 0.0 111.519 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.521 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 61.1 tp60 -57.95 -21.32 43.57 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.423 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.57 -36.32 0.03 OUTLIER Glycine 0 N--CA 1.495 2.602 0 C-N-CA 118.516 -1.802 . . . . 0.0 112.103 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.8 mt -92.11 -171.46 2.84 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.704 -1.198 . . . . 0.0 110.968 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.1 146.31 35.65 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.1 t -111.86 141.76 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 119.409 -0.916 . . . . 0.0 112.86 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.431 HG11 ' CE1' ' A' ' 141' ' ' PHE . 91.1 t -133.14 123.57 47.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.1 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.44 ' N ' HD13 ' A' ' 140' ' ' LEU . 5.2 mp -105.23 144.6 31.79 Favored 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 118.838 -1.145 . . . . 0.0 113.598 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.431 ' CE1' HG11 ' A' ' 139' ' ' VAL . 14.9 m-85 -120.14 132.51 55.43 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.047 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -73.91 -55.26 6.4 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.57 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.415 ' HB3' ' H ' ' A' ' 144' ' ' ASP . 9.4 m120 -74.58 -158.52 0.07 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.872 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.557 ' CG ' ' H ' ' A' ' 145' ' ' ASN . 17.8 t70 -64.49 -147.03 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.2 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.559 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 6.0 m-80 -51.59 88.57 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.559 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 8.1 p90 38.44 68.34 0.34 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.946 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 81.1 p -132.95 43.37 2.97 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.971 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -178.8 -155.53 14.88 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -65.73 152.88 43.26 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.234 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 22.5 p -149.83 163.1 38.91 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.806 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.25 97.91 14.46 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.275 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -70.55 109.93 2.59 Favored 'Trans proline' 0 C--N 1.325 -0.664 0 C-N-CA 121.536 1.491 . . . . 0.0 112.087 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.526 ' C ' ' H ' ' A' ' 155' ' ' SER . 3.3 t -89.02 74.73 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.504 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.73 31.07 0.08 Allowed 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.055 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 153' ' ' VAL . 10.5 t -170.31 -153.42 0.1 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.595 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -90.47 164.04 14.41 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.739 -0.785 . . . . 0.0 111.481 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.555 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -167.65 73.13 0.95 Allowed Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.784 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.8 23.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.07 1.846 . . . . 0.0 112.891 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.555 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -178.48 79.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.731 179.89 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 17.2 tp -70.71 -45.18 65.4 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.193 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.031 0 C-N-CA 119.151 -1.5 . . . . 0.0 109.64 -179.949 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.942 0.401 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.21 126.21 42.26 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.422 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.0 m -99.09 -73.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.635 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.509 ' HG ' ' H ' ' A' ' 146' ' ' PHE . 4.0 p -112.01 158.69 19.24 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.203 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.425 HG12 ' CD1' ' A' ' 118' ' ' LEU . 16.3 pt -139.81 170.56 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.748 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -147.95 109.0 4.25 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.97 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.2 mt -88.88 94.73 4.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.957 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 116.356 -1.783 . . . . 0.0 111.069 -179.966 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.914 0.387 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -178.57 127.39 0.11 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.61 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.24 147.65 6.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.331 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 1.154 HG22 ' NE2' ' A' ' 16' ' ' GLN . 22.6 m -128.64 139.15 52.4 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.515 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.13 173.69 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.821 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.448 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 52.7 m-85 -132.63 154.74 49.78 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.385 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -79.4 -19.17 50.72 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.023 1.119 . . . . 0.0 114.023 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.493 ' C ' ' OG ' ' A' ' 40' ' ' SER . 5.7 m120 -136.26 170.89 15.3 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.587 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.36 175.64 4.55 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.22 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 13' ' ' GLN . 6.9 t0 52.63 49.12 21.06 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.122 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.504 ' CE2' ' HG2' ' A' ' 70' ' ' GLU . 16.4 m-85 53.52 -4.25 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.745 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.585 ' H ' ' C ' ' A' ' 11' ' ' ASP . 29.4 mt-30 -75.58 169.05 18.86 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.613 -1.235 . . . . 0.0 111.24 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.6 134.13 5.73 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.495 -1.336 . . . . 0.0 110.498 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.604 ' CB ' ' NZ ' ' A' ' 15' ' ' LYS . 7.1 mtmp? -43.59 157.01 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.027 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 1.154 ' NE2' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -122.38 167.76 12.9 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.447 -0.901 . . . . 0.0 112.821 -179.79 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -145.06 130.35 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.675 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.37 118.09 30.88 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.38 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mt -112.67 139.78 23.15 Favored Pre-proline 0 N--CA 1.49 1.562 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.218 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -70.42 164.43 35.21 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 120.892 1.061 . . . . 0.0 111.075 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -163.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.037 0 C-N-CA 121.715 1.61 . . . . 0.0 110.723 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.24 176.12 50.59 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.779 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.738 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.4 OUTLIER -108.57 145.11 35.33 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.655 -179.885 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.6 p90 -159.03 -173.54 4.29 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.152 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 p -146.53 -162.46 1.53 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.067 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -62.67 -17.82 61.25 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.577 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.06 -62.86 1.26 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.258 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -56.06 -42.41 76.59 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.114 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 32' ' ' LEU . 68.9 mt -60.26 -39.86 88.27 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.454 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.56 -33.0 13.79 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 118.586 -1.246 . . . . 0.0 107.887 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.72 -39.43 80.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.151 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 29' ' ' LEU . 17.7 mt -74.88 -75.59 0.16 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.771 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.53 -24.87 0.66 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 118.801 -1.666 . . . . 0.0 111.471 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.459 HG12 ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -85.04 149.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.405 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.499 ' H ' HG22 ' A' ' 38' ' ' THR . 6.0 pt-20 176.95 151.87 0.18 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.473 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.496 ' CG ' ' C ' ' A' ' 35' ' ' GLU . 0.6 OUTLIER 80.37 -144.5 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 179.754 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -67.5 29.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.249 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.558 ' O ' ' N ' ' A' ' 40' ' ' SER . 80.6 p -87.01 -43.87 12.01 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.44 -1.304 . . . . 0.0 110.626 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.2 mt -60.05 78.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.779 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.558 ' N ' ' O ' ' A' ' 38' ' ' THR . 19.0 t -77.5 -69.65 0.52 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.967 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.448 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -104.49 170.2 8.03 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.486 179.862 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.462 HG13 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -147.49 146.92 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 118.498 -1.281 . . . . 0.0 112.895 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -132.62 117.69 18.24 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.168 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.637 ' H ' HD21 ' A' ' 68' ' ' ASN . 72.3 t -140.5 109.14 6.71 Favored Pre-proline 0 N--CA 1.495 1.801 0 C-N-CA 119.318 -0.953 . . . . 0.0 112.083 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.41 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.0 OUTLIER -69.67 170.94 15.3 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.404 1.403 . . . . 0.0 111.711 179.977 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.8 Cg_endo -62.69 -176.84 0.27 Allowed 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 122.263 1.975 . . . . 0.0 111.214 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.93 -12.25 18.2 Favored Glycine 0 N--CA 1.482 1.729 0 C-N-CA 119.189 -1.481 . . . . 0.0 110.563 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.409 ' H ' ' C ' ' A' ' 46' ' ' PRO . 18.1 m -149.27 131.72 6.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.799 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -105.85 136.78 44.87 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.125 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -117.87 151.98 36.3 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.351 -0.94 . . . . 0.0 112.627 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.1 mt -138.49 119.38 16.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 114.57 -1.196 . . . . 0.0 108.523 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.717 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 2.7 mp -91.97 161.85 14.63 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.535 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -142.75 108.95 5.24 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.785 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -48.17 -85.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.38 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.496 HD21 ' H ' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -59.47 150.2 27.41 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.421 -0.911 . . . . 0.0 111.225 -179.97 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.496 ' H ' HD21 ' A' ' 55' ' ' ASN . 20.6 p-10 -62.1 178.78 0.34 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.465 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.4 24.8 71.0 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.113 -1.518 . . . . 0.0 110.106 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 54.65 63.89 2.0 Allowed 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.72 -161.19 1.27 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.015 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.58 169.46 1.4 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.087 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -43.68 119.1 1.57 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.476 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -97.86 172.18 7.82 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.279 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.483 HG21 ' H ' ' A' ' 64' ' ' GLU . 3.4 mt -142.31 164.31 17.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.601 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.483 ' H ' HG21 ' A' ' 63' ' ' ILE . 14.3 mt-10 -141.86 130.7 22.97 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.796 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -147.66 159.18 8.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 118.758 -1.177 . . . . 0.0 112.43 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.31 -5.05 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.179 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -124.64 -147.58 0.37 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.534 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.637 HD21 ' H ' ' A' ' 44' ' ' VAL . 8.4 m120 -101.63 113.6 26.89 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.02 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.462 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -92.01 100.6 13.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.139 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.504 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 17.5 mt-10 -66.58 -86.34 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.773 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.437 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 28.3 tp10 -57.9 -16.11 10.9 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.533 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 4.6 tp 73.39 -83.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.528 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.405 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 172.58 -169.76 42.87 Favored Glycine 0 N--CA 1.5 2.901 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.583 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.8 Cg_endo -66.41 -47.78 2.88 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.385 2.056 . . . . 0.0 112.308 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.68 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 2.1 pt? -71.54 29.45 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.951 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.583 ' H ' ' C ' ' A' ' 74' ' ' PRO . 0.5 OUTLIER -82.64 55.63 3.05 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.902 179.951 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -145.92 1.48 0.88 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -171.76 115.55 0.37 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.249 -0.981 . . . . 0.0 111.012 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.2 t -139.14 156.12 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.463 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.5 t -166.41 -41.14 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 118.952 -1.099 . . . . 0.0 112.152 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 m -99.77 144.29 29.0 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.304 -0.959 . . . . 0.0 111.349 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -149.23 163.47 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.779 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.826 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -146.89 113.99 6.2 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.834 -179.972 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.826 ' H ' HH22 ' A' ' 83' ' ' ARG . 45.0 t -121.33 138.46 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.701 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.66 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 2.3 mt -143.43 132.43 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.269 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.6 m -40.17 153.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.917 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -149.24 149.88 30.43 Favored Pre-proline 0 N--CA 1.482 1.155 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.805 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.18 153.12 28.03 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 121.251 1.3 . . . . 0.0 111.354 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.14 134.73 27.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.776 -0.77 . . . . 0.0 111.236 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -145.25 126.12 7.47 Favored Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.366 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.62 -177.35 0.08 OUTLIER 'Trans proline' 0 C--O 1.212 -0.812 0 C-N-CA 120.851 1.034 . . . . 0.0 111.119 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.75 -160.33 0.69 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.713 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.49 161.23 27.58 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.157 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -119.42 147.94 43.8 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.981 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -134.75 136.63 42.78 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.564 -1.198 . . . . 0.0 107.889 179.813 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.498 ' CE2' ' OE2' ' A' ' 105' ' ' GLU . 18.3 m-85 -100.89 164.67 11.72 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 118.991 -1.084 . . . . 0.0 112.463 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.62 -56.88 3.59 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.421 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -93.34 167.0 12.02 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.043 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -87.98 68.33 9.19 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.563 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.656 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -175.59 49.56 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.555 -179.946 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.656 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 26.2 p90 39.58 40.31 0.61 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.644 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 20.9 p-10 -142.63 174.76 10.35 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.259 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 85.71 141.24 5.83 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.163 -1.494 . . . . 0.0 110.002 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 103' ' ' GLY . 11.9 tptt -28.49 123.15 0.12 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 124.016 0.48 . . . . 0.0 111.76 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.498 ' OE2' ' CE2' ' A' ' 96' ' ' PHE . 43.8 mt-10 -94.41 115.18 27.33 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.11 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.6 t -96.17 143.76 11.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.592 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -123.92 156.58 36.07 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.88 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.2 mt -143.4 137.96 15.08 Favored Pre-proline 0 N--CA 1.488 1.469 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.896 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -67.77 165.56 27.32 Favored 'Trans proline' 0 C--O 1.213 -0.762 0 C-N-CA 121.732 1.621 . . . . 0.0 112.018 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.69 153.11 51.57 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 C-N-CA 122.171 1.914 . . . . 0.0 111.599 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.97 -159.3 21.14 Favored Glycine 0 N--CA 1.503 3.107 0 C-N-CA 119.35 -1.405 . . . . 0.0 111.42 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.538 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 24.8 mt-30 -123.65 157.18 34.41 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.196 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 27.8 m-85 -138.43 143.92 39.91 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.156 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.2 p -91.37 176.25 6.63 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.838 -0.745 . . . . 0.0 112.604 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.408 ' C ' ' OE2' ' A' ' 119' ' ' GLU . 39.0 tt0 -77.72 46.01 0.53 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.543 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -146.76 -64.17 0.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.073 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.6 pt-20 -71.16 -49.1 47.42 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.927 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.553 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -31.9 -70.33 0.07 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.424 -179.999 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -58.18 -55.98 28.0 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.63 179.956 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.499 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.8 OUTLIER -75.1 21.27 0.12 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.526 -0.869 . . . . 0.0 111.806 -179.876 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' A' ' 117' ' ' GLU . 30.0 t80 -128.75 -15.95 4.3 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.206 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -143.87 -39.36 0.06 OUTLIER Glycine 0 N--CA 1.491 2.331 0 C-N-CA 118.742 -1.694 . . . . 0.0 111.09 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.576 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -144.57 -104.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.5 -179.968 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.576 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 0.3 OUTLIER -162.51 -169.81 2.23 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.013 179.931 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -88.8 36.37 0.8 Allowed 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.008 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.53 ' O ' ' N ' ' A' ' 128' ' ' ILE . 63.2 t30 -172.33 -74.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.418 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -40.62 85.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' A' ' 126' ' ' ASN . 42.3 mt -158.43 143.33 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.657 179.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.9 m -159.51 -119.84 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.267 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.3 m -38.5 128.11 1.45 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.014 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -122.22 154.48 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.714 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -147.59 100.68 3.76 Favored Pre-proline 0 C--N 1.302 -1.467 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.369 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -54.4 94.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 120.976 1.118 . . . . 0.0 110.461 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -57.65 -15.87 8.93 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.307 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.34 -25.6 0.05 OUTLIER Glycine 0 N--CA 1.488 2.131 0 C-N-CA 118.747 -1.692 . . . . 0.0 111.461 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 mt -120.87 148.28 44.26 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.539 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -66.38 161.96 21.42 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.496 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 40.4 t -131.39 147.83 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.482 -0.887 . . . . 0.0 112.259 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.494 HG11 ' CE1' ' A' ' 141' ' ' PHE . 76.2 t -138.82 124.02 22.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.442 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.9 mp -104.34 142.17 35.03 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 119.642 -0.823 . . . . 0.0 112.755 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.494 ' CE1' HG11 ' A' ' 139' ' ' VAL . 18.6 m-85 -120.68 135.06 55.23 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.621 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -72.63 -47.2 49.62 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.527 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.585 ' CG ' ' H ' ' A' ' 144' ' ' ASP . 5.1 t-20 -83.22 -157.33 0.23 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.703 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.585 ' H ' ' CG ' ' A' ' 143' ' ' ASN . 1.0 OUTLIER -69.25 -140.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.927 -179.924 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.604 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 6.0 m120 -52.67 86.09 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.053 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.604 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 6.2 p90 38.73 68.96 0.3 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.953 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 p -136.24 60.05 1.69 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.733 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 160.04 -151.68 22.38 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.134 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -59.41 156.81 12.22 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.336 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.5 p -149.01 170.14 19.03 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.754 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tt -144.24 83.04 10.32 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.449 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.85 105.92 0.71 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 121.999 1.799 . . . . 0.0 113.207 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 38.5 t -82.32 89.97 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.136 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.59 ' N ' HD21 ' A' ' 154' ' ' ASN . 0.0 OUTLIER -68.66 -7.48 33.6 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -179.831 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.53 ' N ' HD21 ' A' ' 154' ' ' ASN . 21.0 t -169.62 -135.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 117.666 -1.614 . . . . 0.0 113.293 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.462 ' N ' ' OG ' ' A' ' 155' ' ' SER . 23.7 m-20 -77.18 152.72 34.68 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.987 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.595 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -167.86 67.14 0.79 Allowed Pre-proline 0 C--N 1.307 -1.247 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.035 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.453 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.4 Cg_endo -62.72 20.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.231 1.954 . . . . 0.0 112.847 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.595 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -175.32 83.62 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.755 -1.178 . . . . 0.0 110.953 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 30.2 tp -98.78 -47.66 5.23 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.297 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.875 0 C-N-CA 119.212 -1.471 . . . . 0.0 110.043 -179.942 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.1 p30 . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.61 0.243 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.5 m -103.26 150.82 23.36 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.745 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.9 p -124.44 -68.04 0.88 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.157 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 77.3 p -116.33 153.19 32.43 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.611 -0.835 . . . . 0.0 108.819 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 19.2 pt -137.04 175.52 9.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.717 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -155.65 103.97 2.32 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.227 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.3 mt -78.23 103.38 5.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.791 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.0 t . . . . . 0 C--N 1.305 -1.349 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.777 -179.898 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.524 ' C ' HD21 ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.878 0.371 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.524 HD21 ' C ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER -175.04 118.32 0.18 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.365 -179.97 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.5 pt -69.27 145.8 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.684 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -121.56 112.87 19.01 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.003 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 m -91.12 175.47 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.238 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.511 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 23.9 m-85 -132.24 151.18 51.94 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.449 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.17 -6.77 59.27 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 118.824 -1.15 . . . . 0.0 113.289 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.52 ' C ' ' OG ' ' A' ' 40' ' ' SER . 34.1 m120 -147.13 161.85 40.04 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.646 -1.222 . . . . 0.0 111.536 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.449 ' N ' ' OG ' ' A' ' 40' ' ' SER . 26.2 mt-10 -70.85 179.02 2.84 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.394 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 13' ' ' GLN . 13.9 t70 59.37 39.33 22.32 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.402 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.6 t80 57.48 5.45 0.3 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.272 -0.971 . . . . 0.0 111.792 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.444 ' HG2' ' H ' ' A' ' 14' ' ' GLY . 6.7 tt0 -92.45 176.66 6.39 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.291 -0.963 . . . . 0.0 111.217 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.444 ' H ' ' HG2' ' A' ' 13' ' ' GLN . . . 88.47 131.43 3.84 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.993 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -42.78 157.64 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.572 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.23 166.96 13.24 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.461 -0.895 . . . . 0.0 112.545 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -143.86 135.41 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.929 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -94.1 113.28 25.21 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.419 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.8 mt -107.35 137.68 19.69 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.572 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -71.15 155.76 60.64 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 121.072 1.181 . . . . 0.0 110.972 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.44 -161.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 121.576 1.517 . . . . 0.0 110.533 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.54 178.45 49.43 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 119.175 -1.488 . . . . 0.0 111.038 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.758 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.5 OUTLIER -103.11 134.3 46.77 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.671 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 7.4 p90 -153.71 174.77 14.08 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.143 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.492 HG21 ' HG ' ' A' ' 81' ' ' SER . 26.5 p -145.67 -154.21 0.53 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.98 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.446 HH11 ' HB1' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -62.72 -30.92 71.77 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.973 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.98 -61.77 2.36 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -56.47 -47.4 79.28 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.502 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.2 mt -54.98 -39.48 69.03 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.528 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.446 ' HB1' HH11 ' A' ' 26' ' ' ARG . . . -51.68 -34.2 37.34 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 118.948 -1.101 . . . . 0.0 108.359 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.77 -39.49 87.87 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.696 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.3 mt -74.8 -75.07 0.17 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.617 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.59 -34.91 0.54 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.094 -1.526 . . . . 0.0 110.909 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.5 tt -79.89 150.76 4.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.735 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 179.92 150.74 0.38 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.605 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.69 -146.8 0.14 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.913 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -55.33 92.62 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.998 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 40' ' ' SER . 73.1 p -153.18 -46.97 0.1 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.106 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.3 mt -61.86 75.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 C-N-CA 119.661 -0.815 . . . . 0.0 109.764 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 38' ' ' THR . 8.6 t -74.21 -59.74 2.59 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.429 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.511 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -116.81 177.29 4.76 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.709 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.485 HG13 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -156.43 152.64 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 117.549 -1.66 . . . . 0.0 113.486 -179.896 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -140.17 106.97 5.38 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.595 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -126.08 108.21 24.71 Favored Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.598 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.411 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -69.81 171.04 15.25 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.042 1.162 . . . . 0.0 110.549 179.86 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.411 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.9 Cg_endo -62.39 -170.87 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.841 1.694 . . . . 0.0 110.91 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.9 -14.61 12.97 Favored Glycine 0 N--CA 1.478 1.468 0 C-N-CA 119.024 -1.56 . . . . 0.0 111.005 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.66 131.72 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 118.716 -1.194 . . . . 0.0 112.588 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -101.73 130.8 48.21 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.35 158.09 20.22 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.025 -1.07 . . . . 0.0 113.519 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.6 mt -144.71 116.24 2.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.242 179.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.7 mp -94.42 159.46 15.1 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.167 -1.013 . . . . 0.0 113.368 -179.685 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.419 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 83.2 m-85 -139.33 114.77 9.82 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.111 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -44.61 -87.05 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.459 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -59.45 151.02 24.98 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.338 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -58.99 -178.99 0.06 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.169 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.666 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 55.61 37.31 67.31 Favored Glycine 0 N--CA 1.484 1.853 0 C-N-CA 118.906 -1.616 . . . . 0.0 109.437 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.688 ' H ' ' CB ' ' A' ' 81' ' ' SER . 0.3 OUTLIER 41.1 69.08 0.37 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.838 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.02 174.39 10.63 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.767 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.71 173.61 40.64 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.236 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -48.46 122.28 5.29 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 118.999 -1.081 . . . . 0.0 110.352 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -99.05 173.32 6.88 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.93 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.478 HG23 ' H ' ' A' ' 64' ' ' GLU . 7.3 mt -138.66 169.93 17.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.711 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.478 ' H ' HG23 ' A' ' 63' ' ' ILE . 22.0 mt-10 -147.21 130.88 16.9 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.394 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.64 164.74 2.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.441 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.67 -9.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.658 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -118.01 -153.21 0.52 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.837 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -95.48 120.7 36.18 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.637 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.485 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -89.73 108.37 19.65 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.174 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 8.2 tp10 -73.62 -76.78 0.12 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.95 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.472 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 23.1 tp10 -76.86 2.02 15.8 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.038 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.1 tp 51.83 -97.55 0.06 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.111 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.5 -173.83 40.77 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 118.937 -1.601 . . . . 0.0 110.979 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.656 ' C ' ' H ' ' A' ' 76' ' ' ASN . 3.8 Cg_endo -71.86 -53.8 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.649 2.233 . . . . 0.0 112.306 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.479 ' H ' HD21 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -60.82 14.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.775 -179.853 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.656 ' H ' ' C ' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -67.51 0.81 2.74 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.453 179.943 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.433 ' H ' ' C ' ' A' ' 75' ' ' LEU . 25.8 t-20 -80.82 -8.77 59.79 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.091 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -164.75 122.54 1.66 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.596 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 t -148.33 137.47 15.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.72 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.5 p -145.11 -47.4 0.23 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.65 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.688 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 7.4 m -93.61 142.76 26.98 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.334 -179.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -147.98 160.38 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.01 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.774 ' NH2' ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.92 137.4 21.09 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.151 180.0 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.774 ' N ' ' NH2' ' A' ' 83' ' ' ARG . 5.4 t -140.74 143.87 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.7 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.478 HG12 ' NH2' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -135.71 135.13 51.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.125 -179.928 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.1 t -42.87 154.41 0.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.108 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.7 143.72 13.59 Favored Pre-proline 0 C--N 1.307 -1.27 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.118 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.54 130.12 28.83 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.091 1.194 . . . . 0.0 110.73 179.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.406 ' H ' HG11 ' A' ' 89' ' ' VAL . 2.3 p -59.48 140.24 17.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -117.33 152.44 49.25 Favored Pre-proline 0 N--CA 1.49 1.57 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.25 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.33 -34.27 97.74 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.287 1.324 . . . . 0.0 111.207 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 52.15 -161.96 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.359 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.53 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.1 175.86 9.42 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.867 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.487 ' NH2' HE22 ' A' ' 134' ' ' GLN . 28.3 ttm180 -143.68 120.15 11.01 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.45 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.405 ' CD1' HG12 ' A' ' 131' ' ' VAL . 6.7 m-30 -95.77 164.54 12.71 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.028 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.638 ' CD1' ' CE1' ' A' ' 101' ' ' PHE . 2.8 m-85 -143.41 149.06 37.12 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.468 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -93.68 160.43 14.77 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.597 -179.895 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.423 ' C ' ' OG ' ' A' ' 129' ' ' SER . 10.3 tttm 67.19 136.52 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.004 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.532 ' N ' ' OG ' ' A' ' 129' ' ' SER . 5.1 pt-20 -77.27 70.99 3.73 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.626 -1.23 . . . . 0.0 111.003 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.642 ' NE2' ' OD2' ' A' ' 102' ' ' ASP . 6.3 tt0 -173.67 19.02 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.515 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.638 ' CE1' ' CD1' ' A' ' 96' ' ' PHE . 33.8 t80 49.34 40.35 18.27 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.424 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.642 ' OD2' ' NE2' ' A' ' 100' ' ' GLN . 90.3 m-20 -104.09 -87.22 0.44 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.556 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 102' ' ' ASP . . . -30.68 145.88 0.01 OUTLIER Glycine 0 N--CA 1.507 3.402 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.917 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -34.72 155.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 114.587 -0.807 . . . . 0.0 112.998 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.473 ' HB3' ' CE1' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -116.4 164.74 14.1 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.411 -179.849 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.65 141.16 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -102.53 157.69 16.75 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.965 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.8 mt -144.27 140.01 16.37 Favored Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.964 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -72.86 164.39 35.71 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 121.756 1.637 . . . . 0.0 111.825 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.5 143.79 70.52 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.603 1.535 . . . . 0.0 110.72 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.9 -160.78 27.52 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 118.795 -1.669 . . . . 0.0 111.573 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.561 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 29.3 tt0 -117.63 158.13 25.19 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.216 -0.492 . . . . 0.0 111.038 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.561 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 56.0 m-85 -145.52 151.47 38.22 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.765 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.4 p -103.02 -168.24 1.49 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.322 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.47 ' CG ' ' OG ' ' A' ' 168' ' ' SER . 6.6 tt0 -92.23 49.64 1.54 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.146 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -151.19 -63.51 0.19 Allowed 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.744 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -70.2 -54.07 14.39 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.326 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.558 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -30.82 -69.34 0.07 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.012 -179.99 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.641 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 21.2 mp0 -54.92 -59.29 4.94 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.173 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.42 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 12.3 mpt_? -74.73 19.54 0.14 Allowed 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.71 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.543 ' N ' ' O ' ' A' ' 117' ' ' GLU . 16.1 t80 -121.22 -15.4 8.17 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.881 -0.727 . . . . 0.0 110.773 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.07 -37.19 0.05 OUTLIER Glycine 0 N--CA 1.483 1.817 0 C-N-CA 118.928 -1.606 . . . . 0.0 110.337 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.455 HD11 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -146.01 -112.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.527 -179.843 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.433 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 9.1 t70 -151.98 -147.3 0.22 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.275 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.716 HD21 ' N ' ' A' ' 126' ' ' ASN . 0.2 OUTLIER -73.81 -108.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.52 179.935 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.716 ' N ' HD21 ' A' ' 125' ' ' ASN . 23.7 t-20 -80.2 55.17 2.13 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.074 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 127' ' ' THR . 18.7 m -100.58 4.58 43.53 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.482 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.428 ' H ' HG12 ' A' ' 128' ' ' ILE . 2.3 mm -76.73 161.81 4.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.665 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 99' ' ' GLU . 2.4 t -161.91 -47.98 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.1 m -137.34 134.98 36.63 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.149 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.405 HG12 ' CD1' ' A' ' 95' ' ' PHE . 3.0 t -120.7 145.31 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.572 0.701 . . . . 0.0 111.855 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -146.18 93.56 5.06 Favored Pre-proline 0 C--N 1.296 -1.753 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.986 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -59.15 105.71 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.164 1.243 . . . . 0.0 111.877 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.53 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 8.2 tt0 -56.52 -9.52 0.75 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.568 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.44 -41.93 0.08 OUTLIER Glycine 0 N--CA 1.494 2.536 0 C-N-CA 118.49 -1.814 . . . . 0.0 111.933 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.9 mt -88.05 -167.12 1.78 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.105 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -115.79 142.64 46.5 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 153' ' ' VAL . 53.6 t -107.75 144.91 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.696 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.467 HG13 ' CE1' ' A' ' 141' ' ' PHE . 88.1 t -132.62 120.61 42.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.033 179.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.8 mp -97.84 139.33 33.85 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.343 -179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.467 ' CE1' HG13 ' A' ' 139' ' ' VAL . 29.4 m-85 -115.48 129.23 56.48 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.689 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -61.44 -75.02 0.07 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.653 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -76.22 167.98 20.88 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.259 -0.977 . . . . 0.0 110.513 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 146' ' ' PHE . 1.4 p30 -63.48 -158.43 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.59 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.643 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 0.4 OUTLIER 39.33 26.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.248 179.953 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.643 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 41.87 57.89 3.02 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.343 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.0 t -136.45 -172.93 3.27 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.028 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.48 -161.94 53.49 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.169 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -59.77 156.31 14.27 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.104 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.5 p -148.16 170.39 17.95 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.476 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.7 mt -137.93 82.56 25.32 Favored Pre-proline 0 C--N 1.303 -1.419 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.463 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -62.13 103.93 0.32 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.848 1.699 . . . . 0.0 112.231 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 138' ' ' VAL . 3.1 t -89.34 74.1 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.883 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -79.22 36.29 0.29 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.001 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 153' ' ' VAL . 13.6 t -170.97 -155.85 0.11 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.328 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.2 155.89 19.91 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.136 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.599 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.97 69.51 1.38 Allowed Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.526 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.4 Cg_endo -66.44 23.84 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.075 1.85 . . . . 0.0 111.313 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.599 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.3 t -168.76 134.34 1.7 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.412 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 129' ' ' SER . 0.2 OUTLIER -141.74 -55.57 0.46 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.949 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.939 0 C-N-CA 119.106 -1.521 . . . . 0.0 110.154 -179.988 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.45 125.61 51.22 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.838 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.47 ' OG ' ' CG ' ' A' ' 115' ' ' GLN . 36.8 t -91.15 -62.03 1.53 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.223 -0.991 . . . . 0.0 112.09 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.42 ' HG ' ' H ' ' A' ' 146' ' ' PHE . 0.5 OUTLIER -116.49 161.0 19.78 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.819 -179.936 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.401 HG12 ' CD1' ' A' ' 118' ' ' LEU . 45.7 pt -143.16 174.64 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.729 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.5 ttt85 -160.66 114.25 2.08 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.492 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 11.7 mt -86.87 101.41 11.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.466 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.5 t . . . . . 0 C--N 1.306 -1.307 0 CA-C-O 116.284 -1.817 . . . . 0.0 110.874 179.949 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.423 ' C ' ' ND2' ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.812 0.339 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.423 ' ND2' ' C ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER 179.83 125.89 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.683 179.969 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 pt -82.04 128.02 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.06 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -105.69 112.25 25.25 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.2 m -90.11 169.5 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 119.591 -0.844 . . . . 0.0 113.206 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -129.14 141.61 51.13 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.407 -1.27 . . . . 0.0 108.196 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.17 -21.72 58.55 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -179.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -123.95 169.73 11.32 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.028 -1.069 . . . . 0.0 112.477 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.437 ' HG2' ' H ' ' A' ' 11' ' ' ASP . 25.4 tt0 -67.21 173.77 3.64 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.888 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.558 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 14.5 m-20 52.01 58.2 5.69 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.774 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 7.3 p90 33.59 28.69 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.506 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 11' ' ' ASP . 8.7 tp-100 -106.55 168.44 9.17 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.92 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.537 ' H ' ' CD ' ' A' ' 13' ' ' GLN . . . 93.94 136.81 8.26 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.995 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -30.54 140.82 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 O-C-N 123.922 0.425 . . . . 0.0 111.712 -179.931 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 1.203 ' OE1' ' CD ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -100.52 151.71 21.26 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.498 -0.881 . . . . 0.0 113.17 -179.802 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -135.9 142.99 37.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.822 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -107.79 133.71 51.79 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.659 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 mt -129.3 126.81 23.08 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.982 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -67.91 163.59 35.0 Favored 'Trans proline' 0 C--N 1.327 -0.599 0 C-N-CA 120.629 0.886 . . . . 0.0 110.961 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.05 -162.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.493 1.462 . . . . 0.0 111.06 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.23 172.94 37.11 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.073 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.556 ' ND2' ' H ' ' A' ' 23' ' ' ASN . 0.9 OUTLIER -106.12 133.9 50.09 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.564 -179.947 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -155.24 177.12 11.71 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.394 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 p -137.88 -159.78 0.99 Allowed 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.85 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.86 -20.78 66.07 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.614 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.97 -58.9 5.78 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.216 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -56.67 -45.2 81.84 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.007 -1.077 . . . . 0.0 109.738 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 13.7 mt -58.73 -39.09 79.88 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.567 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.15 -32.66 48.8 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.853 -1.139 . . . . 0.0 108.589 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.1 -42.31 76.3 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.095 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.3 mt -69.93 -71.39 0.24 Allowed 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.666 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.64 -34.67 0.81 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.117 -1.516 . . . . 0.0 110.923 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.5 tt -83.32 141.62 14.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.27 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 175.82 154.96 0.19 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.031 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.1 t30 60.76 104.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.643 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.5 t30 51.23 69.99 0.59 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.586 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.539 ' C ' ' H ' ' A' ' 40' ' ' SER . 77.9 p -146.57 -32.23 0.33 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.339 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 40' ' ' SER . 8.9 mt -78.09 42.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.516 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 38' ' ' THR . 32.6 t -38.78 -53.73 1.65 Allowed 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.026 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.59 163.98 29.88 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.211 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.1 m -143.89 171.66 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 118.502 -1.279 . . . . 0.0 113.444 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -142.23 95.06 2.74 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.559 -1.655 . . . . 0.0 107.461 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 51.8 t -115.63 110.25 44.82 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -70.28 169.64 19.1 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.065 1.177 . . . . 0.0 110.311 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.85 -170.28 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.715 1.61 . . . . 0.0 111.207 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.86 -15.34 15.6 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.392 -1.385 . . . . 0.0 111.016 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.518 ' HA ' ' H ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -152.97 148.48 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.414 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -123.8 128.67 49.87 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.137 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.77 165.06 11.84 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.83 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.488 HG23 ' CE2' ' A' ' 53' ' ' TYR . 66.7 mt -138.73 125.09 24.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.661 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.17 122.65 42.66 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.647 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.488 ' CE2' HG23 ' A' ' 51' ' ' ILE . 32.9 m-85 -109.78 119.55 39.72 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.318 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -54.76 -77.01 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.144 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -62.28 156.16 22.94 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.0 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 19.2 p-10 -68.1 174.53 3.78 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.623 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.422 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 62.13 31.31 78.43 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.236 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.422 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.2 OUTLIER 54.2 67.18 1.05 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.619 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.42 -170.53 3.47 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.332 -0.947 . . . . 0.0 111.195 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 67.43 174.52 7.28 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.377 -1.392 . . . . 0.0 109.858 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 60' ' ' GLY . 13.4 m-20 -42.98 118.67 1.32 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.136 -1.026 . . . . 0.0 110.33 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.36 160.8 15.3 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.259 -0.977 . . . . 0.0 111.33 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 7.2 mm -137.53 168.63 20.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.353 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.517 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 20.2 mp0 -147.96 134.19 19.45 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.306 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.7 m -149.76 147.5 16.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 118.676 -1.21 . . . . 0.0 112.252 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.0 t -140.77 -0.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.6 ' H ' ' HH ' ' A' ' 121' ' ' TYR . . . -126.49 -153.85 0.59 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.686 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -93.49 144.05 25.72 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.437 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.17 108.98 18.83 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.732 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -78.29 -63.34 1.42 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.401 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -100.45 4.43 43.73 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.259 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 tp 46.18 -98.93 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.097 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -168.95 -177.24 39.63 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 118.778 -1.677 . . . . 0.0 110.842 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.632 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.0 OUTLIER -67.16 -46.02 3.4 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.169 1.913 . . . . 0.0 112.055 -179.983 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.58 ' C ' ' H ' ' A' ' 77' ' ' ASN . 2.4 pt? -56.72 3.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.403 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.632 ' H ' ' C ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -65.04 5.79 0.31 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.403 179.945 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.619 ' N ' HD21 ' A' ' 76' ' ' ASN . 26.3 t30 -86.92 -11.01 51.93 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.725 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -166.15 98.94 0.63 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.665 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -97.09 171.0 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.582 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.1 t -171.31 -69.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 118.348 -1.341 . . . . 0.0 112.901 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.402 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 4.4 m -96.99 148.64 22.77 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.72 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.68 153.05 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.311 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.79 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -145.91 140.42 26.96 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.753 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.79 ' CA ' HH12 ' A' ' 83' ' ' ARG . 10.1 t -138.82 140.45 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.99 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.549 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 2.8 mt -136.99 125.61 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.57 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -50.12 126.85 15.52 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.579 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.518 ' H ' ' HA ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -114.97 145.32 33.79 Favored Pre-proline 0 N--CA 1.49 1.545 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.302 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -52.61 120.29 7.26 Favored 'Trans proline' 0 C--N 1.326 -0.618 0 C-N-CA 121.356 1.37 . . . . 0.0 111.354 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.47 130.59 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.841 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -139.35 150.21 63.28 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.394 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.434 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 1.7 Cg_endo -59.13 -166.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.106 1.204 . . . . 0.0 111.102 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.457 ' N ' HD13 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -172.89 -157.56 0.1 Allowed 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.049 -179.9 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.68 162.08 36.24 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.156 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -129.99 117.43 20.05 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.043 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 10.5 m-85 -102.85 131.11 49.97 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.116 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -99.42 159.99 14.61 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.848 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.478 ' CE1' HG23 ' A' ' 127' ' ' THR . 1.0 OUTLIER -97.43 158.68 15.35 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.629 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt 62.47 138.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.815 0.816 . . . . 0.0 111.514 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.588 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 10.6 tp10 -71.12 102.44 2.49 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.605 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.838 ' NE2' ' HB2' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 129.67 39.25 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.467 0 O-C-N 125.286 1.616 . . . . 0.0 109.654 179.766 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.65 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 28.5 p90 33.96 48.33 0.23 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.124 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.838 ' HB2' ' NE2' ' A' ' 100' ' ' GLN . 53.5 t0 -124.36 57.58 1.23 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.472 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -177.01 156.42 20.39 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.902 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.45 ' H ' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -28.81 139.9 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.827 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -94.67 154.5 17.3 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.902 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.553 ' CG1' ' N ' ' A' ' 107' ' ' ASP . 2.5 t -140.31 165.67 20.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.888 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.553 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 17.7 p-10 -149.24 159.37 44.32 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.759 -1.176 . . . . 0.0 111.651 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.4 mt -142.07 149.08 51.07 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 119.639 -0.825 . . . . 0.0 111.23 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.41 165.93 24.79 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.044 1.829 . . . . 0.0 111.661 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.36 142.9 67.96 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.566 1.511 . . . . 0.0 110.687 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.422 ' C ' ' NE2' ' A' ' 112' ' ' GLN . . . 144.75 -158.72 27.66 Favored Glycine 0 N--CA 1.502 3.063 0 C-N-CA 118.787 -1.673 . . . . 0.0 111.711 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.541 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 11.2 mp0 -116.77 153.4 32.49 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.759 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 50.8 m-85 -145.84 146.68 31.22 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.633 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.9 p -89.47 -147.93 0.18 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.435 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.69 ' H ' ' CD ' ' A' ' 115' ' ' GLN . 0.3 OUTLIER -116.06 27.35 9.32 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.783 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.422 ' HB3' HE21 ' A' ' 115' ' ' GLN . . . -129.54 -64.56 0.88 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.762 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.495 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 8.1 pt-20 -68.67 -42.64 77.61 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.42 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.569 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -38.04 -72.65 0.06 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.77 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -52.55 -54.41 33.16 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.168 -179.969 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -72.93 16.66 0.14 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.432 -179.791 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.6 ' HH ' ' H ' ' A' ' 67' ' ' ALA . 13.9 t80 -124.49 -17.9 5.88 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.912 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -133.91 -49.75 0.08 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.114 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.581 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -144.99 -99.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.628 -179.934 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.581 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 13.3 t70 -168.73 177.69 4.99 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.172 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.608 HD21 ' N ' ' A' ' 126' ' ' ASN . 0.5 OUTLIER -59.15 135.14 57.54 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.701 -179.84 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.608 ' N ' HD21 ' A' ' 125' ' ' ASN . 5.7 p-10 35.85 81.28 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.812 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.478 HG23 ' CE1' ' A' ' 97' ' ' TYR . 97.9 m -161.56 -11.0 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.394 -0.923 . . . . 0.0 111.012 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.452 HD11 ' N ' ' A' ' 128' ' ' ILE . 1.5 mp -53.84 -56.32 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.256 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.9 m 55.35 -113.63 0.8 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.682 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.413 ' H ' ' HG ' ' A' ' 130' ' ' SER . 4.2 m -63.06 122.42 16.03 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.93 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.76 159.76 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.427 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -153.15 85.46 4.24 Favored Pre-proline 0 C--N 1.301 -1.518 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -62.42 97.06 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.416 1.41 . . . . 0.0 110.723 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -81.83 22.4 0.76 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.35 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.8 -54.44 0.04 OUTLIER Glycine 0 N--CA 1.498 2.778 0 C-N-CA 118.042 -2.027 . . . . 0.0 112.38 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 92' ' ' ARG . 1.3 mp -115.87 -172.07 2.09 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.002 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.75 143.11 31.31 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.652 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.6 t -110.0 139.09 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.765 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.97 138.02 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.036 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 9.3 mp -112.26 134.5 53.76 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.926 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.58 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 7.2 m-85 -115.0 131.92 56.77 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.78 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -64.21 -79.16 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.028 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -60.35 160.66 8.3 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.357 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 146' ' ' PHE . 10.0 m-20 -63.9 -156.19 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.554 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.686 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 6.3 t-20 41.13 24.44 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.017 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.686 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.1 OUTLIER 44.08 59.82 3.03 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.822 -179.946 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.6 t -141.83 -174.49 4.09 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.358 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.91 -163.22 54.2 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.591 -1.29 . . . . 0.0 110.025 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -59.81 160.47 7.52 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.952 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.0 p -150.34 174.73 12.54 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.809 -179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.5 tp -141.78 89.45 9.04 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.53 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.21 106.27 0.8 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 121.699 1.599 . . . . 0.0 113.23 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.98 92.42 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.537 179.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -55.79 -34.57 65.41 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.8 t -164.15 -149.82 0.14 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 117.907 -1.517 . . . . 0.0 112.665 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -43.72 146.51 0.54 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.31 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.582 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -172.45 69.15 0.41 Allowed Pre-proline 0 C--N 1.307 -1.244 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.343 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.2 Cg_endo -64.9 23.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.197 1.931 . . . . 0.0 112.481 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.582 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -177.72 102.3 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.139 179.967 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 3.7 mm? -99.37 -56.42 2.41 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.705 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 C-N-CA 119.375 -1.393 . . . . 0.0 110.53 -179.996 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.834 0.35 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.5 m -86.31 107.84 18.15 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.826 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 27.5 m -95.33 -53.16 3.87 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.172 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.54 160.91 21.51 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.032 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.41 HG12 ' CD1' ' A' ' 118' ' ' LEU . 31.4 pt -138.96 166.51 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -148.75 103.36 3.37 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.591 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.0 mt -81.17 97.55 3.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 118.978 -1.089 . . . . 0.0 109.347 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 C--N 1.305 -1.343 0 CA-C-O 116.324 -1.798 . . . . 0.0 111.026 -179.993 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.42 ' C ' ' ND2' ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 121.014 0.435 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.42 ' ND2' ' C ' ' A' ' 2' ' ' ALA . 31.3 m-80 -159.28 125.62 4.48 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.156 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.0 pt -72.01 155.17 7.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.513 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.407 HG21 ' N ' ' A' ' 6' ' ' VAL . 2.0 m -134.0 156.5 48.08 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.067 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.407 ' N ' HG21 ' A' ' 5' ' ' THR . 2.2 m -147.26 171.41 3.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 119.086 -1.045 . . . . 0.0 111.062 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -131.97 156.15 46.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.744 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -72.17 -51.6 20.52 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -179.525 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.646 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 73.2 m-80 -87.22 179.23 6.67 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.842 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -80.31 166.05 21.71 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.189 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.5 ' C ' ' H ' ' A' ' 13' ' ' GLN . 3.7 t0 66.15 45.35 2.36 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.782 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER 56.71 0.7 0.07 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.128 -1.029 . . . . 0.0 112.075 179.893 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.5 ' H ' ' C ' ' A' ' 11' ' ' ASP . 6.9 tt0 -87.97 162.96 16.57 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.199 -1.0 . . . . 0.0 112.287 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.646 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 98.06 147.67 22.62 Favored Glycine 0 N--CA 1.503 3.107 0 C-N-CA 120.259 -0.972 . . . . 0.0 110.926 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 14' ' ' GLY . 3.7 mptp? -29.26 139.0 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 O-C-N 123.956 0.445 . . . . 0.0 112.137 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 1.011 ' NE2' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -103.92 160.19 15.02 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.459 -179.775 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.613 ' CG1' ' N ' ' A' ' 18' ' ' ASP . 6.9 t -147.53 165.69 5.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.62 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.613 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 14.9 t70 -135.49 124.6 24.41 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.268 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mt -122.85 129.92 24.82 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.017 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -67.35 165.31 27.38 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.123 1.216 . . . . 0.0 111.317 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.99 -165.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 121.542 1.494 . . . . 0.0 110.289 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.53 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 94.95 -175.22 33.57 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 118.836 -1.649 . . . . 0.0 111.176 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.769 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.2 OUTLIER -113.2 134.02 54.78 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.153 -179.795 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.418 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 3.4 p90 -154.54 175.89 13.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.673 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 p -146.82 -155.43 0.62 Allowed 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.984 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -60.33 -20.92 61.22 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.692 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.96 -63.11 1.16 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.474 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -56.02 -46.73 78.71 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.486 -1.286 . . . . 0.0 109.805 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.9 mt -59.4 -38.95 81.89 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.539 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.57 -26.92 56.57 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 118.328 -1.349 . . . . 0.0 108.419 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.41 -37.95 60.16 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.739 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 mt -73.34 -74.97 0.16 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.525 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.29 -32.82 0.65 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.248 -1.454 . . . . 0.0 110.692 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.436 HG12 ' HG1' ' A' ' 38' ' ' THR . 7.8 tt -85.26 139.42 17.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 3.4 pt-20 174.24 142.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.195 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.596 ' ND2' ' ND2' ' A' ' 78' ' ' ASN . 1.7 t-20 75.57 116.31 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 47.14 9.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.735 179.74 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 40' ' ' SER . 71.4 p -83.35 -57.67 3.16 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 117.941 -1.503 . . . . 0.0 111.206 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.417 ' N ' ' OG1' ' A' ' 38' ' ' THR . 30.2 mt -57.92 78.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.23 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 38' ' ' THR . 13.7 t -77.79 -48.3 16.89 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.562 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.7 t -126.87 132.02 51.04 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.487 HG11 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -105.54 158.8 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 C-N-CA 119.492 -0.883 . . . . 0.0 113.052 -179.742 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.733 ' HZ1' HD22 ' A' ' 68' ' ' ASN . 33.4 tttp -143.38 98.43 3.25 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.788 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.1 t -121.78 109.37 34.19 Favored Pre-proline 0 N--CA 1.496 1.842 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.318 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -69.07 168.43 20.69 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 120.989 1.126 . . . . 0.0 110.898 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 48' ' ' VAL . 2.2 Cg_endo -61.42 -175.7 0.15 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 121.818 1.678 . . . . 0.0 111.097 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.69 -14.54 17.98 Favored Glycine 0 N--CA 1.481 1.688 0 C-N-CA 119.178 -1.487 . . . . 0.0 110.295 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 46' ' ' PRO . 15.5 m -149.28 135.42 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.685 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.414 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 37.4 tttm -110.32 156.2 21.06 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.249 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -149.7 158.62 44.34 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 118.139 -1.424 . . . . 0.0 112.916 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 78.4 mt -133.19 123.05 46.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 114.317 -1.311 . . . . 0.0 108.846 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.466 HD13 ' H ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -100.37 138.97 36.71 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.725 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.435 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 49.2 m-85 -113.73 114.05 25.82 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.712 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -46.72 -83.1 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.721 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -59.23 141.96 53.01 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.272 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -53.65 178.0 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.271 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.671 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 59.08 37.74 92.07 Favored Glycine 0 N--CA 1.487 2.049 0 C-N-CA 118.95 -1.595 . . . . 0.0 109.69 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.671 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.3 OUTLIER 41.08 70.52 0.25 Allowed 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.987 -179.943 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.05 -162.67 1.61 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.11 -178.03 5.14 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.325 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -49.46 123.79 8.23 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.45 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -95.54 158.3 15.51 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.101 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.525 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 7.7 mm -133.42 168.38 24.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.766 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.525 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 20.2 mt-10 -146.4 135.02 22.17 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.986 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.5 m -150.09 161.12 4.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.687 -1.205 . . . . 0.0 112.103 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 t -147.55 -3.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 114.402 -1.272 . . . . 0.0 107.799 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -131.31 -152.13 0.49 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.024 -1.443 . . . . 0.0 109.188 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.733 HD22 ' HZ1' ' A' ' 43' ' ' LYS . 3.2 m-20 -90.94 121.0 32.4 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.544 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.487 ' H ' HG11 ' A' ' 42' ' ' VAL . . . -89.01 81.22 6.87 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.51 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -45.56 -69.48 0.13 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.594 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.67 -3.47 56.27 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.606 -0.837 . . . . 0.0 111.868 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.43 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 2.7 tp 60.74 -93.61 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.164 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.43 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -177.76 -174.61 44.25 Favored Glycine 0 N--CA 1.491 2.367 0 C-N-CA 118.915 -1.612 . . . . 0.0 110.628 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.603 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.9 Cg_endo -65.27 -29.81 54.73 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.18 1.92 . . . . 0.0 112.092 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.544 ' C ' ' H ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER -65.41 13.25 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.219 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.603 ' H ' ' C ' ' A' ' 74' ' ' PRO . 3.6 t-20 -60.25 -2.12 0.42 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.071 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.544 ' H ' ' C ' ' A' ' 75' ' ' LEU . 9.6 t-20 -77.35 -24.17 50.76 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.852 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.64 HD21 ' N ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -171.45 133.3 0.81 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.303 -179.99 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.64 ' N ' HD21 ' A' ' 78' ' ' ASN . 5.9 t -127.86 157.47 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.332 179.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.6 m -165.68 -61.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 117.915 -1.514 . . . . 0.0 114.136 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.528 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 11.7 m -93.92 148.24 22.34 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.027 -1.069 . . . . 0.0 112.88 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -148.57 158.64 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.858 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.739 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -139.29 120.18 14.42 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.519 -179.887 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.739 ' H ' HH12 ' A' ' 83' ' ' ARG . 3.1 t -119.4 133.79 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.706 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.512 ' CD1' HH21 ' A' ' 83' ' ' ARG . 3.2 mp -135.88 121.32 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.886 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.6 m -40.63 151.82 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.623 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -147.76 149.33 33.18 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.681 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -52.81 160.53 3.91 Favored 'Trans proline' 0 C--N 1.326 -0.643 0 C-N-CA 121.296 1.331 . . . . 0.0 111.672 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.0 137.81 21.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.701 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -146.11 131.67 9.3 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.657 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -59.84 -156.42 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.85 0 C-N-CA 121.245 1.297 . . . . 0.0 110.715 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.457 ' HE ' ' HB2' ' A' ' 107' ' ' ASP . 5.7 ptm180 -174.36 -157.96 0.08 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.044 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.499 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.5 168.06 20.74 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.854 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.45 ' HE ' ' CB ' ' A' ' 105' ' ' GLU . 38.5 ttt180 -129.13 128.6 43.79 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.954 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.404 ' CD2' HG11 ' A' ' 131' ' ' VAL . 71.8 m-85 -120.44 134.12 55.32 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.2 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.544 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 66.9 m-85 -89.43 175.21 7.4 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.969 -1.092 . . . . 0.0 111.237 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.72 -28.87 51.0 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 118.772 -1.171 . . . . 0.0 113.032 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -156.79 -178.82 7.64 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 117.363 -1.735 . . . . 0.0 113.585 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.613 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -62.61 108.1 1.08 Allowed 'General case' 0 C--O 1.202 -1.425 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.857 -179.83 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 1.321 ' NE2' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 121.97 41.33 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.434 0 O-C-N 125.081 1.488 . . . . 0.0 109.881 179.802 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 1.321 ' CD1' ' NE2' ' A' ' 100' ' ' GLN . 37.2 p90 30.32 34.51 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.878 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 100' ' ' GLN . 21.3 t70 -106.54 169.61 8.42 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.338 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 77.2 136.68 0.82 Allowed Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.203 -1.475 . . . . 0.0 109.727 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.47 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.7 OUTLIER -29.1 136.94 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.236 0.541 . . . . 0.0 112.097 -179.778 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 1.4 pm0 -93.31 164.28 13.28 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.619 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 107' ' ' ASP . 3.9 t -140.04 167.83 18.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.691 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.557 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 2.8 p30 -148.16 159.28 44.11 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.346 -1.342 . . . . 0.0 111.81 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.8 mt -141.49 149.55 54.66 Favored Pre-proline 0 N--CA 1.495 1.776 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -76.99 166.34 26.93 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 121.763 1.642 . . . . 0.0 111.422 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.33 140.8 78.83 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 121.7 1.6 . . . . 0.0 110.928 179.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 145.52 -164.08 28.12 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 118.927 -1.606 . . . . 0.0 111.36 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.586 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 33.4 tt0 -115.99 157.25 24.88 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.211 -0.494 . . . . 0.0 110.783 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.586 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 53.8 m-85 -146.08 153.85 41.18 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.9 p -98.71 -159.62 0.75 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.412 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.504 ' HB2' ' HG ' ' A' ' 168' ' ' SER . 0.1 OUTLIER -106.91 54.3 0.68 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.211 -179.925 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.55 -67.43 0.13 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.346 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 121' ' ' TYR . 4.8 pt-20 -67.33 -50.05 61.6 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.359 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.514 ' H ' ' CG ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -36.23 -57.41 0.72 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.859 179.784 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -53.15 -66.52 0.37 Allowed 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.171 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.457 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 14.8 mmm-85 -73.66 7.23 2.56 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.641 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.547 ' N ' ' O ' ' A' ' 117' ' ' GLU . 15.0 t80 -99.95 -17.65 17.46 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.203 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -163.62 -28.32 0.02 OUTLIER Glycine 0 N--CA 1.484 1.841 0 C-N-CA 117.771 -2.156 . . . . 0.0 112.107 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.409 ' CD1' ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -135.83 -101.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.362 -179.848 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.627 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 25.2 t70 -173.28 -163.97 0.21 Allowed 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.663 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.627 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 1.5 t30 -72.17 -22.36 61.31 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.125 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -170.21 89.95 0.17 Allowed 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.8 t -168.05 14.05 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.968 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 129' ' ' SER . 4.6 mt -68.98 -70.66 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.508 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 69.9 -135.01 0.06 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.819 -0.752 . . . . 0.0 112.338 179.881 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.64 ' HG ' ' H ' ' A' ' 100' ' ' GLN . 16.2 m -45.29 128.36 7.65 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.7 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.404 HG11 ' CD2' ' A' ' 95' ' ' PHE . 5.5 t -121.67 160.35 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.183 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.553 ' CB ' ' HZ1' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -154.91 89.55 3.12 Favored Pre-proline 0 C--N 1.29 -1.981 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.784 179.913 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.22 121.54 10.09 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.091 1.194 . . . . 0.0 110.608 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.499 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 29.0 tt0 -90.96 -8.67 48.6 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.183 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.8 -32.68 0.02 OUTLIER Glycine 0 N--CA 1.494 2.502 0 C-N-CA 118.026 -2.035 . . . . 0.0 112.476 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.28 156.93 28.0 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.904 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.98 145.36 42.6 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.007 -1.077 . . . . 0.0 109.214 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.4 t -112.42 148.61 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.021 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.429 HG13 ' CZ ' ' A' ' 141' ' ' PHE . 59.2 t -137.36 118.53 17.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.02 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.2 mp -98.94 142.42 30.46 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.883 -179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.473 ' CB ' ' HA ' ' A' ' 146' ' ' PHE . 63.9 m-85 -120.02 134.46 55.24 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.402 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -65.88 -68.53 0.36 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.08 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -78.34 169.3 18.48 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.392 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 146' ' ' PHE . 11.1 p-10 -64.34 -160.99 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.014 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.645 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 5.8 m120 42.66 21.03 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.938 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.645 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.4 OUTLIER 40.77 58.65 2.38 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.677 -179.91 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.6 t -148.09 149.32 31.83 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.335 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 108.43 -146.67 16.5 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -65.36 105.02 1.05 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.171 -1.011 . . . . 0.0 110.204 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.0 p -103.18 168.93 8.86 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.781 -0.767 . . . . 0.0 111.826 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 tt -139.37 81.14 21.09 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.139 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.24 108.37 0.58 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.961 1.774 . . . . 0.0 112.968 -179.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.7 87.25 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.294 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -58.33 -21.97 51.53 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.886 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 12.9 t -168.9 -141.59 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 117.979 -1.489 . . . . 0.0 112.895 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.8 OUTLIER -57.66 141.19 49.18 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.159 -179.811 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.533 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -162.24 61.12 1.17 Allowed Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.294 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.5 Cg_endo -65.31 19.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 122.222 1.948 . . . . 0.0 112.856 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.509 ' H ' ' C ' ' A' ' 157' ' ' ALA . 4.7 t -169.12 101.92 0.37 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.385 -1.326 . . . . 0.0 111.867 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.5 mt -128.03 -48.9 1.34 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.646 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.316 179.901 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.981 0.419 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 m -82.39 114.96 21.19 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.446 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.504 ' HG ' ' HB2' ' A' ' 115' ' ' GLN . 36.1 t -86.86 -47.51 8.97 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.104 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.401 ' H ' ' HG ' ' A' ' 169' ' ' SER . 0.9 OUTLIER -134.19 165.96 23.89 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.152 179.982 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 38.1 pt -145.93 167.07 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 118.652 -1.219 . . . . 0.0 111.463 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -149.42 109.74 4.18 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.02 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mt -88.18 96.81 6.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.095 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 116.304 -1.808 . . . . 0.0 110.931 -179.973 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 120.882 0.372 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.8 120.76 0.06 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.496 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.6 pt -67.72 146.73 12.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 118.723 -1.191 . . . . 0.0 110.263 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.9 m -123.96 117.57 25.09 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.186 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.492 ' O ' ' CB ' ' A' ' 16' ' ' GLN . 1.2 m -92.1 174.18 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.434 -0.906 . . . . 0.0 111.167 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 61.1 m-85 -135.98 146.67 47.48 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.231 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -75.02 -28.1 60.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.63 -0.828 . . . . 0.0 112.764 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.499 ' C ' ' OG ' ' A' ' 40' ' ' SER . 33.6 m120 -126.76 163.0 24.5 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.451 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.592 ' N ' ' OG ' ' A' ' 40' ' ' SER . 18.9 mm-40 -63.56 -163.57 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.928 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.662 ' C ' ' H ' ' A' ' 13' ' ' GLN . 8.7 m-20 40.5 39.59 0.75 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.852 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER 56.22 -5.86 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.327 179.991 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.662 ' H ' ' C ' ' A' ' 11' ' ' ASP . 21.9 mt-30 -73.84 174.33 8.63 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.296 -0.961 . . . . 0.0 110.745 179.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 86.21 129.87 2.54 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.339 -1.41 . . . . 0.0 111.027 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.418 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -37.79 147.93 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.964 179.907 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.893 HE21 ' C ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -119.91 162.1 19.73 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.724 -0.79 . . . . 0.0 112.286 -179.868 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.07 139.35 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.882 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -94.41 134.47 36.89 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.421 -179.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.9 mt -129.86 126.47 22.53 Favored Pre-proline 0 N--CA 1.496 1.851 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.202 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.21 164.37 28.22 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 121.053 1.169 . . . . 0.0 111.157 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.24 -172.25 0.14 Allowed 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 121.648 1.565 . . . . 0.0 111.14 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.479 ' N ' ' HB ' ' A' ' 84' ' ' VAL . . . 103.65 -166.38 15.88 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.356 179.987 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.467 ' N ' HD21 ' A' ' 23' ' ' ASN . 0.4 OUTLIER -130.93 132.41 45.07 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.069 -179.978 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -148.12 -177.05 5.53 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.037 -179.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.577 ' CG2' ' CE2' ' A' ' 58' ' ' PHE . 20.3 p -141.26 -159.28 0.94 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.87 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -63.78 -24.23 67.68 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.061 -1.055 . . . . 0.0 110.361 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.03 -61.84 2.29 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.555 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -55.59 -44.14 76.66 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.543 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 23.1 mt -61.95 -32.84 73.31 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.789 -1.164 . . . . 0.0 109.633 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.8 -31.7 62.88 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 118.601 -1.24 . . . . 0.0 108.231 179.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.28 -37.28 69.06 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.38 179.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 mt -74.98 -77.07 0.13 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.471 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.09 -28.17 0.72 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.296 -1.43 . . . . 0.0 111.058 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.579 ' C ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -87.69 133.3 30.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.748 -179.988 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.567 ' C ' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 169.72 174.51 0.05 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.492 -179.905 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 1.5 t-20 70.91 -28.84 0.18 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.117 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.567 ' H ' ' C ' ' A' ' 35' ' ' GLU . 16.1 m120 -160.17 -108.61 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.767 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.63 ' OG1' ' N ' ' A' ' 39' ' ' ILE . 2.6 p 42.71 -134.98 0.4 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.572 179.943 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.63 ' N ' ' OG1' ' A' ' 38' ' ' THR . 1.9 mt 30.26 49.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.291 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.592 ' OG ' ' N ' ' A' ' 10' ' ' GLU . 44.1 t -61.11 -44.3 97.56 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.598 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.451 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -129.82 170.22 14.16 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.116 179.774 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.454 HG13 ' H ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -148.94 146.73 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 118.596 -1.242 . . . . 0.0 112.255 -179.838 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -136.67 102.59 4.96 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.897 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.4 t -120.98 106.16 39.37 Favored Pre-proline 0 N--CA 1.497 1.898 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.876 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -67.59 169.28 16.16 Favored 'Trans proline' 0 C--N 1.326 -0.633 0 C-N-CA 121.091 1.194 . . . . 0.0 110.458 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 48' ' ' VAL . 1.6 Cg_endo -61.03 -173.7 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.766 1.644 . . . . 0.0 110.683 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.25 -20.62 10.01 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 118.878 -1.629 . . . . 0.0 109.944 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.409 ' H ' ' C ' ' A' ' 46' ' ' PRO . 24.2 m -149.22 145.15 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.892 -179.963 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.4 tttt -120.97 152.46 38.51 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.604 179.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.92 147.81 30.12 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.896 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 84.9 mt -122.88 120.46 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.021 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.5 mt -89.07 154.46 20.17 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.752 -179.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -130.51 111.77 12.58 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.887 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.28 -79.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.032 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -59.16 139.06 57.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.089 -179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.99 170.65 0.17 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.917 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.24 33.16 86.49 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.425 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CE2' ' CG2' ' A' ' 25' ' ' THR . 19.4 m-85 53.74 65.11 1.61 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.931 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.65 -162.63 1.53 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.689 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 56.04 178.72 0.35 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.274 -1.441 . . . . 0.0 110.002 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -44.77 153.19 0.18 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.897 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -130.17 151.96 50.13 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.014 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.597 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 51.1 mt -123.65 173.16 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.876 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.597 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -150.09 130.3 13.64 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.03 179.988 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.3 m -148.36 156.59 8.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 118.806 -1.158 . . . . 0.0 112.565 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.507 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 3.8 t -140.49 -5.7 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.524 ' H ' ' HH ' ' A' ' 121' ' ' TYR . . . -128.7 -148.33 0.37 Allowed 'General case' 0 C--O 1.209 -1.07 0 CA-C-N 113.822 -1.536 . . . . 0.0 109.228 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.508 HD22 HG11 ' A' ' 106' ' ' VAL . 14.2 p-10 -99.57 120.44 39.66 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.038 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.454 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -90.84 96.44 10.64 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.218 179.865 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -56.01 -86.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.973 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 13.8 mm-40 -67.61 -11.46 58.18 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.915 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.487 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 4.0 tp 75.54 -84.57 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.724 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.12 -169.48 42.51 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.202 -1.475 . . . . 0.0 110.629 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.529 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.0 Cg_endo -66.02 -50.45 1.59 Allowed 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.208 1.938 . . . . 0.0 112.299 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.673 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 1.9 pt? -72.53 33.45 0.06 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.026 -1.069 . . . . 0.0 111.503 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 74' ' ' PRO . 1.8 t30 -76.63 -6.01 50.23 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.388 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.511 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 20.7 m120 -95.49 6.46 48.91 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.028 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -158.45 119.51 3.41 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.204 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 t -150.17 154.34 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 119.254 -0.979 . . . . 0.0 110.668 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.8 p -174.04 -41.92 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 118.981 -1.088 . . . . 0.0 111.549 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.3 t -99.0 141.49 31.69 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.556 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.4 mt -148.6 158.0 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.004 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.762 ' NH1' ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -135.61 135.15 40.01 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.3 -179.876 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.762 ' CA ' ' NH1' ' A' ' 83' ' ' ARG . 11.2 t -139.96 135.8 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.956 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.4 HG13 ' NH1' ' A' ' 83' ' ' ARG . 42.9 mt -140.08 129.48 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.665 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 53.1 m -43.1 151.94 0.13 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.487 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.1 t -151.44 150.22 26.26 Favored Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.647 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.55 166.24 6.6 Favored 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.166 1.244 . . . . 0.0 111.263 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.0 p -102.23 145.75 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.845 -179.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -130.53 150.63 76.85 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.458 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.34 -22.18 70.05 Favored 'Trans proline' 0 C--O 1.209 -0.928 0 C-N-CA 121.347 1.365 . . . . 0.0 111.302 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.669 HH11 ' CB ' ' A' ' 107' ' ' ASP . 31.4 ptt180 38.29 -158.77 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.995 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.478 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.46 176.66 9.01 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.848 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -150.29 121.65 7.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.912 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 18.2 m-85 -96.58 170.09 9.45 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.952 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.87 155.92 47.0 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.709 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -88.34 154.84 20.07 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.86 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt 60.08 158.59 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.438 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -90.44 69.82 6.93 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.03 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 1.434 ' NE2' ' CE1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -174.26 34.88 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.417 179.999 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 1.434 ' CE1' ' NE2' ' A' ' 100' ' ' GLN . 42.1 p90 39.82 27.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.188 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 100' ' ' GLN . 32.0 t70 -127.53 117.55 22.29 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.947 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 137.57 140.98 4.14 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.991 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.0 OUTLIER -32.73 124.44 0.35 Allowed 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.273 179.987 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -100.75 158.79 15.7 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.771 -179.875 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.591 ' CG1' ' N ' ' A' ' 107' ' ' ASP . 18.1 t -118.99 168.32 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.497 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.669 ' CB ' HH11 ' A' ' 92' ' ' ARG . 5.8 p-10 -145.24 143.68 30.38 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.13 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.2 mt -140.45 137.34 17.54 Favored Pre-proline 0 N--CA 1.499 1.994 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.944 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.419 ' CB ' ' HD2' ' A' ' 110' ' ' PRO . 2.4 Cg_endo -65.68 169.82 12.29 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 C-N-CA 121.522 1.481 . . . . 0.0 111.902 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 1.8 Cg_endo -61.12 142.8 98.05 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.106 1.871 . . . . 0.0 111.468 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.02 -146.6 16.88 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.013 -1.565 . . . . 0.0 111.163 179.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.649 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 64.6 mt-30 -137.95 156.36 47.94 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.649 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 10.0 m-85 -145.0 142.97 30.25 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.91 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.702 ' HG1' ' H ' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -94.24 174.03 7.35 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.378 -179.789 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -61.26 -24.05 66.11 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.941 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.702 ' H ' ' HG1' ' A' ' 114' ' ' THR . . . -90.3 -45.68 8.89 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.209 -0.996 . . . . 0.0 112.026 -179.852 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.463 ' O ' ' C ' ' A' ' 118' ' ' LEU . 8.6 tp10 -73.55 -65.21 0.85 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.707 -179.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.563 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -33.9 -68.62 0.11 Allowed 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.015 0.822 . . . . 0.0 110.547 179.961 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.507 ' N ' ' CD ' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -44.7 -68.37 0.2 Allowed 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.798 -179.95 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.425 ' HD3' ' H ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -75.07 20.89 0.13 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.159 -1.016 . . . . 0.0 113.249 -179.426 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.524 ' HH ' ' H ' ' A' ' 67' ' ' ALA . 15.8 t80 -114.01 -21.0 10.79 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.952 179.848 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.422 ' C ' ' CG1' ' A' ' 123' ' ' ILE . . . -166.46 -6.01 0.03 OUTLIER Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.318 -1.896 . . . . 0.0 110.764 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.475 ' C ' ' CG ' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -149.93 -134.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.605 -179.959 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.475 ' CG ' ' C ' ' A' ' 123' ' ' ILE . 0.7 OUTLIER -159.64 -173.36 4.09 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.615 179.909 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -58.49 109.51 0.8 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.442 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 128' ' ' ILE . 5.1 t-20 63.2 -125.64 0.58 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.905 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.0 t 39.78 24.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.868 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.69 ' C ' ' HG ' ' A' ' 129' ' ' SER . 3.5 mt -82.21 -71.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.611 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.69 ' HG ' ' C ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 69.91 -147.57 0.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.88 179.819 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 129' ' ' SER . 5.6 m -27.73 127.36 0.07 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.622 -179.862 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.3 t -121.87 136.89 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.843 179.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.28 86.69 29.88 Favored Pre-proline 0 C--N 1.302 -1.483 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.307 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.499 ' C ' ' H ' ' A' ' 135' ' ' GLY . 5.6 Cg_exo -59.0 101.49 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 121.105 1.204 . . . . 0.0 111.093 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.478 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 30.6 tp60 -56.63 -0.16 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.208 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . 172.3 -42.98 0.17 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 118.048 -2.025 . . . . 0.0 112.532 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.0 mt -92.2 -173.79 3.54 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.771 -1.171 . . . . 0.0 111.38 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.6 126.8 54.84 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 9.3 t -95.1 145.08 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.191 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.47 HG13 ' CZ ' ' A' ' 141' ' ' PHE . 96.2 t -129.77 110.29 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.13 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.9 mp -89.29 138.26 31.59 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.376 -0.93 . . . . 0.0 113.03 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.481 ' CE2' ' HB3' ' A' ' 146' ' ' PHE . 53.1 m-85 -120.8 136.23 54.95 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.7 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -73.97 0.12 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.278 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -64.42 -174.96 0.14 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.201 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 146' ' ' PHE . 2.0 m-20 -84.77 -168.28 2.14 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.769 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.677 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 44.1 m-80 35.9 31.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.021 179.882 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.677 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.0 OUTLIER 58.47 52.93 6.61 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.46 179.981 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 10.3 t -119.59 171.7 8.19 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.333 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.498 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 73.91 -165.63 54.77 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.214 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.411 ' C ' ' CG2' ' A' ' 150' ' ' THR . 1.0 OUTLIER -59.8 170.54 1.11 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.395 179.947 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.411 ' CG2' ' C ' ' A' ' 149' ' ' ASP . 2.2 p -150.19 158.08 43.78 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.593 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 tt -132.24 83.59 54.91 Favored Pre-proline 0 N--CA 1.483 1.214 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.346 179.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -63.18 104.42 0.41 Allowed 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 121.717 1.611 . . . . 0.0 112.761 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.33 78.77 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.986 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 154' ' ' ASN . 1.8 p-10 -83.64 27.98 0.59 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.394 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.427 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 19.0 t -170.28 -164.15 0.38 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.972 -1.091 . . . . 0.0 111.199 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.427 ' N ' ' OG ' ' A' ' 155' ' ' SER . 1.3 m-20 -79.94 154.89 27.99 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.15 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.584 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -165.1 69.98 1.37 Allowed Pre-proline 0 C--N 1.304 -1.391 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.904 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.8 Cg_endo -64.18 23.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.062 1.841 . . . . 0.0 112.579 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.584 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.3 OUTLIER -170.34 143.82 2.41 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.753 179.98 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.9 tp -163.92 -48.15 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.836 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.541 179.961 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.818 0.342 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 168' ' ' SER . 1.2 m -61.63 155.01 23.49 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.583 ' OG ' ' N ' ' A' ' 169' ' ' SER . 24.8 p -136.38 -53.73 0.73 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.164 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.583 ' N ' ' OG ' ' A' ' 168' ' ' SER . 20.7 p -127.58 149.98 49.92 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.213 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.452 HG12 ' N ' ' A' ' 171' ' ' ARG . 0.2 OUTLIER -140.72 -172.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.658 179.95 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.452 ' N ' HG12 ' A' ' 170' ' ' ILE . 43.7 ttt85 -155.05 106.7 2.65 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.062 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -75.38 94.16 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.008 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.305 -1.345 0 CA-C-O 116.326 -1.797 . . . . 0.0 110.754 -179.974 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.928 0.394 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.478 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 4.8 p30 -177.99 130.82 0.14 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.493 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.6 pt -78.49 160.01 4.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.3 m -134.99 119.41 17.93 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.476 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -103.36 172.03 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.975 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -133.4 148.81 51.83 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.726 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -37.07 84.59 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.5 -0.88 . . . . 0.0 112.991 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.454 ' C ' ' OG ' ' A' ' 40' ' ' SER . 2.3 m-20 -121.48 173.73 7.21 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.979 -179.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.446 ' N ' ' OG ' ' A' ' 40' ' ' SER . 15.6 pt-20 -70.35 -173.87 0.76 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.742 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.557 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 4.8 t70 49.64 48.0 22.05 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.655 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.557 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 54.4 p90 40.65 20.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.424 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 11' ' ' ASP . 3.7 tt0 -97.76 166.14 11.62 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.582 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 92.54 141.56 10.53 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.363 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' GLY . 1.1 tptp -33.97 144.66 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.769 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.03 156.42 20.54 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.556 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.2 t -145.04 127.2 9.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.264 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -93.07 125.89 37.89 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.059 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.4 mt -119.21 125.09 27.8 Favored Pre-proline 0 N--CA 1.491 1.58 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.455 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.73 167.24 19.82 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 120.932 1.088 . . . . 0.0 111.098 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.8 170.4 10.14 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 121.636 1.558 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' H ' ' HB ' ' A' ' 84' ' ' VAL . . . 116.65 170.91 15.71 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 119.728 -1.225 . . . . 0.0 111.054 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.82 ' CB ' ' HE ' ' A' ' 83' ' ' ARG . 1.1 p30 -97.78 128.87 44.72 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.846 ' N ' HH21 ' A' ' 83' ' ' ARG . 27.6 p90 -153.04 178.98 9.11 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.096 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.441 ' HB ' ' H ' ' A' ' 26' ' ' ARG . 1.5 p -151.1 -159.37 1.02 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.101 -179.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.441 ' H ' ' HB ' ' A' ' 25' ' ' THR . 72.0 ttt180 -57.99 -21.73 46.08 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.675 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.19 -69.48 0.29 Allowed 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.828 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -56.83 -45.31 82.43 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.461 -1.296 . . . . 0.0 109.696 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.0 mt -55.92 -41.62 74.84 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.615 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.47 -31.68 56.24 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 118.128 -1.429 . . . . 0.0 108.49 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.27 -30.74 65.12 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.611 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 mt -79.54 -77.8 0.17 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.718 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.97 -28.21 0.08 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.127 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 mm -75.54 152.84 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 119.544 -0.863 . . . . 0.0 110.241 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 4.4 pt-20 -178.93 116.69 0.07 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 118.761 -1.175 . . . . 0.0 112.196 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.781 HD21 HD21 ' A' ' 37' ' ' ASN . 3.0 t30 68.2 -145.94 0.12 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.76 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.781 HD21 HD21 ' A' ' 36' ' ' ASN . 0.7 OUTLIER -49.22 95.55 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.394 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.584 ' O ' ' N ' ' A' ' 40' ' ' SER . 2.2 p -157.78 -61.55 0.09 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.653 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.5 mt -56.72 79.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.979 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 38' ' ' THR . 43.6 t -81.47 -52.62 7.06 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.661 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.61 168.56 9.9 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.58 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -151.33 159.86 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 118.305 -1.358 . . . . 0.0 112.919 -179.89 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.42 ' N ' HG12 ' A' ' 42' ' ' VAL . 43.2 tttm -150.46 113.16 4.74 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.387 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.1 t -134.03 111.88 12.2 Favored Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 119.525 -0.87 . . . . 0.0 112.619 -179.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -69.57 169.97 17.44 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 121.145 1.23 . . . . 0.0 110.696 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.96 -175.12 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 121.989 1.793 . . . . 0.0 111.464 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.86 -14.27 10.93 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.569 -1.301 . . . . 0.0 110.622 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.2 m -147.46 139.46 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.156 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.466 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -116.76 155.37 29.03 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.639 179.999 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.466 ' N ' ' HG2' ' A' ' 49' ' ' LYS . . . -144.88 154.8 43.01 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.652 -1.219 . . . . 0.0 112.413 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.1 mp -132.39 121.35 45.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.84 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 mp -93.95 154.72 17.53 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 118.936 -1.106 . . . . 0.0 112.536 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.417 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 54.0 m-85 -140.24 116.65 10.69 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -46.61 -88.87 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.904 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -59.59 144.0 48.83 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.178 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -54.21 175.64 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.631 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.435 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 63.96 32.62 84.78 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 119.22 -1.467 . . . . 0.0 109.959 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.672 ' H ' ' HG ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 48.64 35.95 6.96 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.678 -179.938 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.78 -163.29 0.97 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.423 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 56.06 -174.0 1.34 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.027 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 62' ' ' GLN . 18.1 t70 -54.47 174.42 0.06 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.697 -1.201 . . . . 0.0 109.949 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.436 ' N ' ' OD1' ' A' ' 61' ' ' ASP . 20.6 pt20 -147.96 161.86 40.49 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.052 -1.059 . . . . 0.0 111.282 -179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.443 HG21 ' H ' ' A' ' 64' ' ' GLU . 3.9 mt -137.05 160.87 36.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.905 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 64' ' ' GLU . 2.6 mp0 -135.53 127.55 29.68 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.281 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.9 m -144.83 162.94 13.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 118.737 -1.185 . . . . 0.0 112.787 -179.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -150.04 -7.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.011 -1.449 . . . . 0.0 107.642 179.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.42 ' HB2' ' H ' ' A' ' 68' ' ' ASN . . . -121.29 -146.35 0.37 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.944 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.42 ' H ' ' HB2' ' A' ' 67' ' ' ALA . 36.2 t-20 -101.03 134.55 43.86 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.109 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.407 ' H ' HG11 ' A' ' 42' ' ' VAL . . . -114.89 101.82 9.4 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.046 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -65.27 -77.68 0.06 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.792 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -74.56 -9.77 58.9 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.529 -179.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.3 tp 64.98 -79.8 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.065 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.0 -177.0 44.95 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.111 -1.519 . . . . 0.0 110.626 -179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.58 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.0 Cg_endo -64.08 -42.44 18.62 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.247 1.965 . . . . 0.0 111.884 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.689 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 2.0 pt? -70.99 21.51 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.181 -1.007 . . . . 0.0 111.113 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.588 HD21 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -75.79 5.02 6.86 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.652 179.953 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.588 ' N ' HD21 ' A' ' 76' ' ' ASN . 29.9 m-80 -88.85 -2.29 58.52 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.031 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.412 ' C ' ' ND2' ' A' ' 78' ' ' ASN . 0.5 OUTLIER -169.29 128.67 1.03 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.035 -179.998 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.2 t -149.17 143.24 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.35 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.0 m -155.78 -40.93 0.08 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.22 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.672 ' HG ' ' H ' ' A' ' 58' ' ' PHE . 3.4 m -96.16 136.31 36.8 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.132 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.494 ' O ' ' CZ ' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -150.73 134.1 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 118.79 -1.164 . . . . 0.0 112.185 -179.94 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.846 HH21 ' N ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -110.02 120.08 41.32 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.025 179.877 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.469 ' HB ' ' H ' ' A' ' 22' ' ' GLY . 6.7 t -122.17 130.65 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.514 179.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mm -141.01 130.22 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.665 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 p -48.65 142.1 6.44 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.084 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.47 142.43 42.77 Favored Pre-proline 0 N--CA 1.492 1.638 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.513 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -53.62 129.81 35.76 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.133 1.222 . . . . 0.0 110.977 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 p -53.21 134.03 15.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.98 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -140.76 148.45 52.8 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.207 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.92 -167.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.104 1.203 . . . . 0.0 110.876 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.49 ' N ' HD13 ' A' ' 136' ' ' LEU . 24.8 ptt180 -172.88 -155.45 0.08 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.754 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.485 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.15 161.19 38.88 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.232 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -136.2 115.67 12.76 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.149 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 20.0 m-85 -100.29 150.54 22.45 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.897 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.448 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 39.4 m-85 -105.18 170.62 7.77 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.654 -0.819 . . . . 0.0 111.064 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.3 -57.55 2.57 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.919 -1.113 . . . . 0.0 111.988 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -83.06 154.2 24.52 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.377 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.604 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 30.3 tt0 -68.55 104.58 1.98 Allowed 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.03 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.604 ' CB ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 119.18 68.55 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.441 0 O-C-N 125.323 1.64 . . . . 0.0 110.918 179.755 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.562 ' CE1' ' HG2' ' A' ' 100' ' ' GLN . 33.2 p90 29.63 55.61 0.14 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.318 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.523 ' CG ' ' N ' ' A' ' 103' ' ' GLY . 4.5 t70 -144.57 170.52 15.91 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.706 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.523 ' N ' ' CG ' ' A' ' 102' ' ' ASP . . . 78.93 145.15 2.94 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 118.886 -1.626 . . . . 0.0 109.881 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 103' ' ' GLY . 5.0 tmtt? -28.76 131.24 0.06 Allowed 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 121.195 0.522 . . . . 0.0 112.106 -179.816 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -95.7 157.34 15.94 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.311 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.7 t -142.65 150.68 18.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.533 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 22.3 p-10 -130.9 159.28 37.86 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.806 -179.873 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.445 HD21 ' CE2' ' A' ' 121' ' ' TYR . 86.2 mt -141.77 151.18 59.22 Favored Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.144 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -78.96 167.37 22.14 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.976 1.784 . . . . 0.0 111.05 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.18 142.97 69.44 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 C-N-CA 121.4 1.4 . . . . 0.0 110.757 179.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.39 -157.23 26.06 Favored Glycine 0 N--CA 1.504 3.202 0 C-N-CA 119.021 -1.561 . . . . 0.0 111.572 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.504 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 11.2 mt-30 -116.12 158.79 22.67 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.141 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.504 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 79.2 m-85 -145.82 143.23 29.52 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.629 179.839 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.1 p -95.91 164.71 12.61 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.807 -179.718 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -58.97 -8.07 1.28 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.719 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.94 -48.68 3.56 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.347 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 118' ' ' LEU . 4.5 tp10 -70.34 -50.27 40.8 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.834 -179.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.565 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -40.62 -72.83 0.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.368 -179.916 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -55.95 10.03 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.041 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.443 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.5 OUTLIER -73.81 15.11 0.31 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.54 -179.716 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.445 ' CE2' HD21 ' A' ' 108' ' ' LEU . 16.8 t80 -126.77 -10.36 6.11 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.355 179.822 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -140.78 -48.49 0.05 OUTLIER Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.208 -1.472 . . . . 0.0 110.218 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.597 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -144.58 -97.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.664 -179.937 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.597 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 3.0 t70 -171.78 175.72 3.86 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -66.28 134.88 53.56 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.31 -179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.656 HD21 ' H ' ' A' ' 166' ' ' ASN . 4.0 t-20 52.24 94.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.602 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.7 t -174.01 -12.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.457 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 mm -73.53 163.27 4.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.17 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.9 t -169.83 -48.24 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.45 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.421 ' CB ' ' H ' ' A' ' 101' ' ' PHE . 49.7 m -122.93 127.61 49.15 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.044 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.54 159.63 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.569 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.448 ' HZ3' ' HG3' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -149.58 79.31 8.05 Favored Pre-proline 0 C--N 1.296 -1.731 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.746 179.921 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -53.21 96.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.215 1.277 . . . . 0.0 110.703 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.485 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 58.2 tp60 -45.91 -23.74 0.32 Allowed 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.54 -1.209 . . . . 0.0 113.064 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.91 -31.88 0.02 OUTLIER Glycine 0 N--CA 1.494 2.515 0 C-N-CA 117.738 -2.172 . . . . 0.0 112.942 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.49 HD13 ' N ' ' A' ' 92' ' ' ARG . 1.0 OUTLIER -98.66 179.4 4.69 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.659 -1.216 . . . . 0.0 111.161 -179.895 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -94.93 144.26 25.82 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.042 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 153' ' ' VAL . 7.5 t -115.54 147.97 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.849 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.469 HG13 ' CE1' ' A' ' 141' ' ' PHE . 98.3 t -136.53 129.3 45.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.897 179.842 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.8 mp -105.64 138.7 41.4 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.369 -0.932 . . . . 0.0 113.174 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.469 ' CE1' HG13 ' A' ' 139' ' ' VAL . 18.0 m-85 -117.39 121.59 41.49 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.778 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -63.44 -68.29 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.165 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -73.2 165.55 24.84 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.376 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 146' ' ' PHE . 16.7 m-20 -64.37 -157.82 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.796 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.643 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 10.9 p-10 32.0 35.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.216 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.643 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 2.0 p90 41.04 61.61 1.69 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.787 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 35.9 t -143.59 -176.22 4.87 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.121 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.531 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 75.87 -163.43 53.4 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.064 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 149' ' ' ASP . 1.4 m-20 -60.08 144.88 48.52 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.314 179.878 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.4 p -141.29 175.42 9.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.159 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.8 tp -152.78 95.05 3.08 Favored Pre-proline 0 C--N 1.305 -1.364 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.044 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.87 107.48 1.11 Allowed 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 121.385 1.39 . . . . 0.0 112.075 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 138' ' ' VAL . 47.0 t -79.08 91.28 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.145 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -44.33 -49.2 9.6 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.565 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.5 m -160.15 -133.9 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 118.728 -1.189 . . . . 0.0 111.923 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -48.05 137.61 10.17 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.119 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.36 63.96 1.13 Allowed Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.238 179.814 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.9 Cg_endo -67.08 24.83 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.126 1.884 . . . . 0.0 111.837 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.549 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.6 t -175.1 132.82 0.31 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.785 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.6 tp -165.23 -59.23 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.34 -179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.139 0 C-N-CA 119.164 -1.493 . . . . 0.0 110.317 -179.979 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.656 ' H ' HD21 ' A' ' 126' ' ' ASN . 31.5 t30 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -70.32 119.22 14.17 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.743 -1.183 . . . . 0.0 109.269 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 72.4 m -89.08 -80.02 0.31 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.96 -179.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.466 ' HG ' ' HA ' ' A' ' 146' ' ' PHE . 1.9 p -108.87 160.75 15.74 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.225 -179.803 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 27.8 pt -139.67 173.18 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.729 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -152.47 110.16 3.61 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.2 mt -87.47 93.29 4.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.236 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 69.4 m . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 116.363 -1.78 . . . . 0.0 110.963 -179.971 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 121.04 0.447 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -159.98 123.99 3.72 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.429 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.3 pt -76.72 149.24 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.594 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.4 m -136.98 118.28 14.6 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.733 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.6 m -109.63 160.59 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.672 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.407 ' CE2' ' CD2' ' A' ' 12' ' ' PHE . 56.0 m-85 -115.98 162.06 17.94 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.304 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -87.44 3.8 45.74 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.456 ' N ' ' HB3' ' A' ' 40' ' ' SER . 15.2 m120 -147.27 168.25 22.22 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.502 -1.279 . . . . 0.0 111.809 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.74 177.14 1.72 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.224 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.614 ' C ' ' H ' ' A' ' 13' ' ' GLN . 6.6 t70 56.2 39.56 30.25 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.893 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.574 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER 56.17 -3.43 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.137 179.957 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.614 ' H ' ' C ' ' A' ' 11' ' ' ASP . 7.4 tt0 -80.73 172.66 13.47 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.269 -0.973 . . . . 0.0 111.241 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.583 ' N ' ' CG ' ' A' ' 13' ' ' GLN . . . 100.55 141.93 12.51 Favored Glycine 0 N--CA 1.5 2.94 0 C-N-CA 119.877 -1.154 . . . . 0.0 110.548 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -33.41 140.56 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 120.191 -0.603 . . . . 0.0 111.432 179.96 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.5 157.9 15.93 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.392 -179.788 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.5 t -148.75 118.5 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.731 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -92.54 132.75 36.57 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.734 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -132.46 137.46 29.96 Favored Pre-proline 0 N--CA 1.49 1.56 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.909 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -72.1 166.27 30.15 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 120.843 1.029 . . . . 0.0 110.789 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.23 -163.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 121.628 1.552 . . . . 0.0 110.63 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.71 176.19 39.87 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.129 -1.51 . . . . 0.0 111.366 179.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.572 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.9 OUTLIER -107.75 132.66 53.13 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.496 -179.921 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -154.7 -177.96 6.86 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.502 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.533 ' OG1' ' N ' ' A' ' 26' ' ' ARG . 8.3 t -151.95 -161.23 1.27 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.337 -179.721 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.533 ' N ' ' OG1' ' A' ' 25' ' ' THR . 0.1 OUTLIER -54.96 -15.5 2.06 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.065 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.446 ' H ' HG22 ' A' ' 25' ' ' THR . . . -69.23 -64.59 0.84 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.563 179.849 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -57.83 -42.12 83.68 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 117.964 -1.495 . . . . 0.0 109.567 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.6 mt -63.68 -37.57 87.83 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.301 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.26 -27.29 54.68 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 118.112 -1.435 . . . . 0.0 107.785 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.84 -36.21 64.88 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.95 179.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.6 mt -75.97 -70.51 0.43 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.512 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.21 -24.9 0.6 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.055 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.6 tt -80.44 156.61 4.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.546 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -147.82 -179.62 7.03 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.068 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 5.1 p30 -47.95 169.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.795 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.669 ' H ' ' H ' ' A' ' 79' ' ' VAL . 8.8 t30 78.25 -23.85 0.23 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.939 179.867 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 36' ' ' ASN . 80.6 p -85.66 -139.66 0.08 Allowed 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.861 -1.135 . . . . 0.0 110.789 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.405 HD11 ' CG1' ' A' ' 79' ' ' VAL . 43.5 mt 41.81 62.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.93 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.456 ' HB3' ' N ' ' A' ' 9' ' ' ASN . 32.4 t -62.32 -44.43 96.52 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.868 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -129.09 176.95 7.49 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.11 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.41 HG11 ' H ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -144.29 146.74 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 119.025 -1.07 . . . . 0.0 112.197 -179.966 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -132.79 118.65 19.28 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.753 179.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.7 t -146.55 107.82 4.1 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.049 -1.06 . . . . 0.0 112.293 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.414 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 2.0 Cg_endo -66.79 170.89 11.84 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 121.245 1.296 . . . . 0.0 110.719 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 2.9 Cg_endo -59.54 -167.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.851 1.7 . . . . 0.0 110.922 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.93 -9.71 23.14 Favored Glycine 0 N--CA 1.48 1.609 0 C-N-CA 118.905 -1.617 . . . . 0.0 110.915 179.798 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.459 ' N ' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -155.72 151.87 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 118.279 -1.368 . . . . 0.0 112.407 179.972 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.424 ' N ' HG21 ' A' ' 48' ' ' VAL . 18.9 ttmt -117.92 125.28 50.17 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.883 179.794 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.53 158.26 17.72 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.807 -179.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 51.9 mt -145.43 123.25 4.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.482 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.723 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 2.4 mp -95.37 165.79 12.2 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.712 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -142.33 105.14 4.54 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.882 179.853 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -43.57 -84.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.775 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -58.9 133.57 56.15 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.502 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -54.47 171.82 0.11 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.423 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.25 29.93 71.83 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.205 -1.474 . . . . 0.0 110.06 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 53.66 63.22 2.28 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.031 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.13 -177.77 6.01 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.21 168.16 13.37 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.439 -1.363 . . . . 0.0 110.22 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -47.26 144.27 2.88 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.94 -1.104 . . . . 0.0 110.145 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -121.48 163.26 19.1 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.175 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.54 ' CG2' ' H ' ' A' ' 64' ' ' GLU . 9.6 mm -125.26 174.46 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.5 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.54 ' H ' ' CG2' ' A' ' 63' ' ' ILE . 20.1 mt-10 -146.44 130.6 17.43 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.751 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.4 m -149.18 163.24 4.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.816 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 t -146.76 -8.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.74 -147.2 0.39 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.103 179.768 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.421 HD22 HG11 ' A' ' 106' ' ' VAL . 4.4 p-10 -103.03 113.39 26.83 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.943 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.41 ' H ' HG11 ' A' ' 42' ' ' VAL . . . -89.52 94.68 9.96 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.125 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -54.29 -63.08 1.27 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.141 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 73' ' ' GLY . 6.5 tp10 -103.96 99.48 9.24 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.906 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 tp -52.34 -5.86 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.979 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 71' ' ' GLU . . . 78.34 -149.09 33.39 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 118.94 -1.6 . . . . 0.0 110.464 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 76' ' ' ASN . 3.4 Cg_exo -63.53 -151.68 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 121.505 1.47 . . . . 0.0 111.658 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 74' ' ' PRO . 0.9 OUTLIER 30.34 35.04 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 123.964 0.79 . . . . 0.0 112.06 -179.942 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 74' ' ' PRO . 13.5 t-20 -89.31 -3.93 58.31 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.286 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -93.03 3.92 54.9 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.964 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -162.53 109.67 1.28 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.743 -1.183 . . . . 0.0 111.444 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.669 ' H ' ' H ' ' A' ' 37' ' ' ASN . 7.1 t -147.96 92.82 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.149 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.8 t -121.07 -33.24 3.76 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.547 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.446 ' HG ' ' HG1' ' A' ' 25' ' ' THR . 10.0 m -92.31 136.29 33.32 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.739 -1.185 . . . . 0.0 110.9 -179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -150.98 158.8 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 118.262 -1.375 . . . . 0.0 111.656 -179.857 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.776 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.45 140.11 23.65 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.637 -179.922 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.776 ' CA ' HH12 ' A' ' 83' ' ' ARG . 16.1 t -144.99 146.38 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.684 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.552 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 1.5 mt -144.58 135.47 20.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.492 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.4 m -44.74 161.5 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.899 -0.721 . . . . 0.0 111.544 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.459 HG11 ' N ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -162.01 140.58 7.03 Favored Pre-proline 0 N--CA 1.483 1.18 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.209 -179.986 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -47.38 139.53 16.71 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.116 1.211 . . . . 0.0 110.775 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.515 ' CG2' ' N ' ' A' ' 90' ' ' GLN . 3.8 p -74.99 160.79 5.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.661 -0.816 . . . . 0.0 112.353 -179.839 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.515 ' N ' ' CG2' ' A' ' 89' ' ' VAL . 23.1 mp0 -141.06 154.87 68.6 Favored Pre-proline 0 N--CA 1.49 1.534 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.405 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.3 -45.37 9.75 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 121.47 1.447 . . . . 0.0 111.739 179.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.491 ' H ' HD13 ' A' ' 136' ' ' LEU . 9.9 mtm180 64.7 -160.73 0.29 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.265 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.495 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.96 172.77 12.25 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.65 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -142.49 121.38 12.77 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.544 -1.262 . . . . 0.0 112.547 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -103.57 162.77 12.77 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -124.59 163.73 21.32 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.528 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.57 -77.41 0.22 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.149 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.483 ' C ' ' OG ' ' A' ' 129' ' ' SER . 34.3 mmtt -66.09 154.41 39.67 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.737 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.604 ' C ' ' HG2' ' A' ' 100' ' ' GLN . 29.0 tt0 -81.71 86.69 6.38 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.118 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.604 ' HG2' ' C ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 163.56 35.68 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.297 -179.946 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.7 t80 56.13 42.38 28.33 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 119.634 -0.827 . . . . 0.0 110.488 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.451 ' CG ' ' H ' ' A' ' 103' ' ' GLY . 25.1 t0 -143.14 178.36 7.76 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.565 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 81.58 139.24 2.73 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.157 -1.496 . . . . 0.0 109.724 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 103' ' ' GLY . 1.1 mppt? -28.63 132.91 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.729 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -97.8 159.33 14.99 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.106 -179.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.421 HG11 HD22 ' A' ' 68' ' ' ASN . 53.4 t -144.3 116.05 2.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.115 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -104.72 154.73 19.62 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.413 -179.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.9 mt -139.64 138.13 19.67 Favored Pre-proline 0 N--CA 1.492 1.675 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.436 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.72 168.77 12.66 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 121.237 1.291 . . . . 0.0 110.998 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.08 150.31 87.04 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.655 1.57 . . . . 0.0 111.06 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.04 -155.04 24.24 Favored Glycine 0 N--CA 1.498 2.817 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.969 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.601 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 35.7 tt0 -133.48 158.35 43.31 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.699 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.601 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 30.2 m-85 -142.51 155.1 45.0 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.185 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.2 p -102.91 -175.38 2.79 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.017 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.446 ' N ' ' OE1' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -88.1 53.89 2.9 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.686 179.977 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -152.12 -65.88 0.17 Allowed 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.593 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -72.61 -50.18 27.08 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.343 -0.943 . . . . 0.0 109.467 179.963 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.564 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -33.81 -71.73 0.06 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.897 179.962 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.535 ' OE2' ' CZ ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -52.27 -57.63 9.14 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.103 179.923 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.535 ' CZ ' ' OE2' ' A' ' 119' ' ' GLU . 3.3 mpt_? -76.36 23.07 0.15 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.92 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.564 ' N ' ' O ' ' A' ' 117' ' ' GLU . 24.7 t80 -127.11 -17.06 4.9 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.659 179.993 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.403 ' CA ' HG12 ' A' ' 106' ' ' VAL . . . -148.06 -42.6 0.03 OUTLIER Glycine 0 N--CA 1.482 1.705 0 C-N-CA 118.74 -1.695 . . . . 0.0 111.118 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.42 HD11 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -135.8 -105.7 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.225 -179.93 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.532 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 18.6 t70 -171.72 -168.45 0.59 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.77 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.532 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -86.03 35.14 0.63 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.45 -179.9 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -166.48 -155.0 0.19 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.532 -1.267 . . . . 0.0 112.133 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.571 ' OG1' ' N ' ' A' ' 128' ' ' ILE . 2.6 t 40.31 -125.96 0.44 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.267 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.571 ' N ' ' OG1' ' A' ' 127' ' ' THR . 98.2 mt 60.67 118.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 CA-C-O 121.041 0.448 . . . . 0.0 111.209 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.483 ' OG ' ' C ' ' A' ' 98' ' ' LYS . 59.2 p -160.99 140.85 10.84 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.419 -0.913 . . . . 0.0 111.124 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.41 ' HA ' ' H ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER 67.92 113.16 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.965 -179.884 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.0 t -120.27 149.85 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.732 -179.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.547 ' NZ ' ' OD2' ' A' ' 156' ' ' ASP . 13.1 tptp -142.4 93.66 7.03 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.793 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 135' ' ' GLY . 4.1 Cg_exo -59.37 99.75 0.12 Allowed 'Trans proline' 0 C--N 1.32 -0.942 0 C-N-CA 120.959 1.106 . . . . 0.0 111.474 -179.799 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.495 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 5.6 tt0 -47.43 -14.23 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.074 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 133' ' ' PRO . . . 175.56 -34.02 0.09 OUTLIER Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.467 -1.825 . . . . 0.0 111.936 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.491 HD13 ' H ' ' A' ' 92' ' ' ARG . 2.2 mt -93.13 -173.82 3.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.664 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.22 144.15 36.06 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.746 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.5 t -112.8 143.56 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.962 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.48 HG13 ' CE1' ' A' ' 141' ' ' PHE . 91.3 t -135.39 122.3 34.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.91 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.408 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 10.1 mp -99.75 144.79 28.41 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.761 -179.802 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.492 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 21.9 m-85 -120.47 129.47 53.87 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.101 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -73.72 -63.15 1.27 Allowed 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.144 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -71.32 170.95 12.05 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.608 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 146' ' ' PHE . 47.7 m-20 -67.73 -161.41 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.254 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.641 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 7.6 p-10 28.96 38.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.371 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.641 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 41.69 61.51 1.85 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.982 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.501 ' CB ' HD22 ' A' ' 145' ' ' ASN . 0.5 OUTLIER -139.52 -167.7 2.32 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.353 -179.865 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 65.02 -160.4 42.44 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.706 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.55 158.72 9.37 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.301 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.4 p -148.55 170.69 17.51 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.979 -1.088 . . . . 0.0 111.818 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 23.4 tp -138.9 85.0 16.79 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.315 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -61.74 105.77 0.39 Allowed 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.922 1.748 . . . . 0.0 113.049 -179.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.501 ' C ' ' H ' ' A' ' 155' ' ' SER . 2.0 t -95.09 57.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.758 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -70.54 32.85 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.819 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 153' ' ' VAL . 21.0 p -170.65 -169.06 0.75 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.705 -1.198 . . . . 0.0 111.605 180.0 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.547 ' OD2' ' NZ ' ' A' ' 132' ' ' LYS . 1.3 m-20 -75.86 153.23 36.93 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.556 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.58 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -168.65 72.17 0.79 Allowed Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.935 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.93 24.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.057 1.838 . . . . 0.0 112.385 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.58 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.9 OUTLIER -170.61 68.23 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.633 179.925 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.41 ' H ' ' HA ' ' A' ' 130' ' ' SER . 5.8 tp -80.76 -64.19 1.24 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.876 -179.95 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.905 0 C-N-CA 119.136 -1.507 . . . . 0.0 109.863 -179.983 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.1 m120 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 121.082 0.467 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.7 124.31 20.96 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.949 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.423 ' OG ' ' N ' ' A' ' 169' ' ' SER . 57.3 p -86.18 -68.58 0.73 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.697 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.423 ' N ' ' OG ' ' A' ' 168' ' ' SER . 2.0 p -119.44 161.93 19.7 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.416 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 29.0 pt -141.01 171.59 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.199 -1.001 . . . . 0.0 111.649 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -153.21 110.92 3.56 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.76 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -89.17 92.92 4.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.107 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 116.313 -1.803 . . . . 0.0 111.088 -179.904 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.792 0.33 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.629 ' N ' ' ND2' ' A' ' 3' ' ' ASN . 0.1 OUTLIER 179.77 130.8 0.09 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.489 -179.906 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 pt -82.53 128.75 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.585 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.7 m -100.22 113.32 25.91 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.561 -0.856 . . . . 0.0 108.74 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.83 160.06 2.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.196 -1.002 . . . . 0.0 113.436 -179.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' A' ' 12' ' ' PHE . 87.9 m-85 -118.46 144.86 45.69 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.754 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -58.05 3.59 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.578 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 87.8 m-20 -85.52 -176.41 6.07 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.614 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -75.99 176.73 7.64 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.343 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.582 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 1.5 m-20 48.68 56.61 7.37 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.695 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 55.8 p90 40.19 20.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.23 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 11' ' ' ASP . 2.5 tp-100 -98.31 164.37 12.33 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.874 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.578 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 94.18 148.27 23.61 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.802 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.49 ' HE3' ' H ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -29.09 137.74 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.882 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.63 152.26 22.67 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.424 -179.889 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.1 t -149.42 138.79 15.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.884 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 1.1 m-20 -99.78 134.86 42.07 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.245 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 mt -123.89 122.57 26.3 Favored Pre-proline 0 N--CA 1.496 1.851 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.263 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.33 161.76 39.24 Favored 'Trans proline' 0 C--O 1.217 -0.533 0 C-N-CA 121.022 1.148 . . . . 0.0 111.247 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.54 -166.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.889 0 C-N-CA 121.602 1.534 . . . . 0.0 110.738 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.465 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 92.77 -163.59 27.18 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.989 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.733 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -117.96 133.22 56.13 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.432 -179.947 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.448 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 6.1 p90 -154.78 177.65 11.02 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.404 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.3 p -149.51 -150.12 0.33 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.415 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.442 ' HG3' ' HG ' ' A' ' 80' ' ' SER . 17.5 mtm-85 -62.82 -36.66 83.91 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.301 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.79 -61.51 2.38 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.44 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -56.02 -47.67 77.37 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.325 -1.35 . . . . 0.0 109.367 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.1 mt -57.87 -33.49 68.74 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.39 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.0 -33.02 55.99 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.4 -36.09 73.85 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.18 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.9 mt -78.48 -75.26 0.23 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.727 179.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 163.7 -29.47 0.24 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 118.898 -1.62 . . . . 0.0 111.244 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.484 HG13 ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -73.99 166.12 2.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.761 179.971 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.553 ' H ' ' CG2' ' A' ' 38' ' ' THR . 0.2 OUTLIER 174.66 103.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.403 179.946 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.548 ' ND2' ' ND2' ' A' ' 78' ' ' ASN . 2.1 t-20 69.23 140.61 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.7 p30 37.39 21.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.39 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.553 ' CG2' ' H ' ' A' ' 35' ' ' GLU . 40.9 p -93.95 -48.06 6.43 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.542 -1.263 . . . . 0.0 110.963 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 mt -62.6 74.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.148 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' THR . 26.8 t -72.06 -49.82 33.44 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.122 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.34 163.98 28.79 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.246 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.493 HG21 ' H ' ' A' ' 69' ' ' ALA . 25.1 m -148.94 167.82 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 C-N-CA 118.194 -1.402 . . . . 0.0 113.295 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -139.76 97.96 3.37 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 113.671 -1.604 . . . . 0.0 107.981 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 44.5 t -116.46 109.54 43.83 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.797 -179.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.83 169.11 16.9 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 121.227 1.284 . . . . 0.0 110.507 179.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.02 -172.44 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.708 1.605 . . . . 0.0 110.368 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.36 -15.37 35.02 Favored Glycine 0 C--N 1.3 -1.428 0 C-N-CA 118.654 -1.736 . . . . 0.0 110.486 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.449 HG21 ' N ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -148.53 151.76 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.951 179.938 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.449 ' N ' HG21 ' A' ' 48' ' ' VAL . 17.7 ttpp -127.17 126.23 42.5 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.869 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.16 160.34 17.02 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.873 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 62.4 mt -139.92 121.48 15.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.726 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.733 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 1.8 mp -90.17 159.8 16.57 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.927 -1.109 . . . . 0.0 112.584 -179.697 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -144.73 106.33 4.26 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.863 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -44.47 -81.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.298 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -58.87 138.2 57.43 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.544 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -54.92 173.39 0.09 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.439 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.31 27.69 72.72 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.184 -1.484 . . . . 0.0 110.156 -179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 55.13 67.91 0.94 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.8 -165.52 2.28 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.235 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.72 -170.01 14.35 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.021 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -51.34 167.89 0.08 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.818 -1.153 . . . . 0.0 109.805 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -147.03 162.71 38.24 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.477 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.485 ' CG2' ' H ' ' A' ' 64' ' ' GLU . 32.1 mt -142.23 173.61 7.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.944 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.536 ' OE2' ' N ' ' A' ' 65' ' ' VAL . 2.0 tm-20 -146.44 129.71 16.66 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.778 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.536 ' N ' ' OE2' ' A' ' 64' ' ' GLU . 32.2 m -145.64 158.02 12.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 118.629 -1.229 . . . . 0.0 112.465 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.572 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 3.8 t -146.61 -7.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-N 114.312 -1.313 . . . . 0.0 107.783 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.486 ' H ' ' HH ' ' A' ' 121' ' ' TYR . . . -117.13 -151.15 0.47 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.557 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -97.09 122.81 40.51 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.455 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.493 ' H ' HG21 ' A' ' 42' ' ' VAL . . . -89.81 113.46 25.03 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.1 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.465 ' C ' ' CD ' ' A' ' 70' ' ' GLU . 4.1 tp10 -72.33 -70.84 0.32 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.582 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.452 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 12.1 tt0 -96.69 -0.2 48.72 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.223 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.435 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 2.5 tp 69.74 -88.26 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.042 -0.663 . . . . 0.0 112.17 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.435 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 179.33 -162.08 28.61 Favored Glycine 0 N--CA 1.499 2.885 0 C-N-CA 118.99 -1.576 . . . . 0.0 111.086 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.2 Cg_endo -66.88 -49.84 1.34 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.168 1.912 . . . . 0.0 112.159 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.648 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 1.7 pt? -74.65 33.52 0.09 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.419 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 74' ' ' PRO . 21.8 p30 -70.28 -23.89 62.95 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.276 -0.97 . . . . 0.0 110.548 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.492 ' C ' HD21 ' A' ' 77' ' ' ASN . 0.1 OUTLIER -80.84 14.43 2.19 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.902 -179.99 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.548 ' ND2' ' ND2' ' A' ' 36' ' ' ASN . 0.5 OUTLIER -168.51 108.48 0.51 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.364 -179.975 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.528 ' N ' HD21 ' A' ' 78' ' ' ASN . 16.5 t -146.44 106.07 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.132 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.442 ' HG ' ' HG3' ' A' ' 26' ' ' ARG . 2.7 t -124.73 -44.66 1.94 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.679 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.4 m -94.5 138.86 31.9 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.597 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -146.94 152.03 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 119.069 -1.053 . . . . 0.0 111.873 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.799 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -130.09 123.24 29.97 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.272 -179.908 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.799 ' H ' HH12 ' A' ' 83' ' ' ARG . 13.3 t -136.01 137.75 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.59 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.54 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 1.4 mt -145.52 142.96 22.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.784 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.4 p -43.99 160.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.809 -0.756 . . . . 0.0 111.746 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -159.09 148.74 14.89 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.128 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -57.64 157.71 22.35 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.045 1.163 . . . . 0.0 110.067 179.735 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 90' ' ' GLN . 86.8 t -78.85 159.73 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.722 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.457 ' N ' ' CG1' ' A' ' 89' ' ' VAL . 30.0 mt-30 -143.41 145.63 32.71 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.607 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -65.3 -48.94 2.92 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 121.377 1.385 . . . . 0.0 111.854 179.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.501 ' H ' HD13 ' A' ' 136' ' ' LEU . 0.0 OUTLIER 64.81 -156.02 0.29 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.939 179.984 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.496 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -141.73 178.13 7.69 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.717 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -142.08 113.31 7.6 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.931 -1.107 . . . . 0.0 111.412 -179.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.449 ' CD2' HG11 ' A' ' 131' ' ' VAL . 96.8 m-85 -106.53 146.63 30.38 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.471 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -95.69 171.87 8.4 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.386 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.48 -66.86 0.87 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.889 -179.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -86.47 147.28 26.05 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.488 -0.885 . . . . 0.0 112.442 -179.778 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.585 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 5.8 tm-20 -71.51 101.43 2.45 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.262 -179.907 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.963 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 135.7 53.09 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.059 0 O-C-N 125.099 1.499 . . . . 0.0 109.94 179.891 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.504 ' O ' ' CG ' ' A' ' 101' ' ' PHE . 58.8 t80 43.12 52.54 5.43 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.689 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 103' ' ' GLY . 3.2 t70 -145.38 158.35 43.85 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.062 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.524 ' N ' ' OD1' ' A' ' 102' ' ' ASP . . . 85.16 133.29 2.85 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.87 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 103' ' ' GLY . 8.6 mtpm? -35.17 146.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.178 0.513 . . . . 0.0 111.813 -179.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -90.96 164.28 14.05 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.215 -179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.0 t -145.79 112.49 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.941 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -89.99 159.64 16.78 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.264 -0.975 . . . . 0.0 112.576 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.9 mt -143.93 131.39 10.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.986 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -66.82 168.66 16.38 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 121.36 1.374 . . . . 0.0 111.441 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.2 145.19 88.58 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 121.557 1.505 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.4 -171.87 24.1 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.137 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.596 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 16.7 tm0? -109.18 159.89 16.55 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.596 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 52.9 m-85 -146.18 148.66 32.77 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.441 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.6 p -102.25 170.99 7.74 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.423 -179.849 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -60.29 -8.92 2.88 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.604 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.38 -52.17 3.07 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 119.314 -0.954 . . . . 0.0 113.437 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 121' ' ' TYR . 23.9 mt-10 -72.79 -53.07 12.53 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.3 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.569 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -36.61 -67.48 0.17 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.807 0.813 . . . . 0.0 110.593 179.906 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -52.35 -60.86 2.72 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.13 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.417 ' HD3' ' N ' ' A' ' 120' ' ' ARG . 4.9 mpt_? -72.13 4.89 3.13 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.792 -179.634 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.572 ' HH ' ' H ' ' A' ' 66' ' ' VAL . 14.3 t80 -105.34 -16.28 14.8 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.973 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -151.36 -36.36 0.03 OUTLIER Glycine 0 N--CA 1.487 2.063 0 C-N-CA 117.684 -2.198 . . . . 0.0 112.141 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.99 -102.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.979 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 176.42 -173.91 0.1 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.975 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.505 ' C ' ' CG ' ' A' ' 126' ' ' ASN . 59.1 t30 -58.55 125.87 25.22 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.594 -1.243 . . . . 0.0 110.281 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.505 ' CG ' ' C ' ' A' ' 125' ' ' ASN . 0.4 OUTLIER 74.34 -139.02 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.967 -179.893 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.721 ' HG1' ' N ' ' A' ' 128' ' ' ILE . 1.4 p 59.28 -137.95 0.76 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.586 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.721 ' N ' ' HG1' ' A' ' 127' ' ' THR . 39.4 mt 59.37 -74.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.763 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 130' ' ' SER . 60.3 p 47.71 -123.41 1.55 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.239 -0.585 . . . . 0.0 112.335 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.552 ' N ' ' OG ' ' A' ' 129' ' ' SER . 0.8 OUTLIER -41.88 126.68 3.19 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.004 -179.847 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.449 HG11 ' CD2' ' A' ' 95' ' ' PHE . 6.8 t -122.42 156.71 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.262 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -150.39 84.46 5.65 Favored Pre-proline 0 C--N 1.296 -1.749 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.998 179.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.47 103.8 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.985 1.79 . . . . 0.0 111.706 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.496 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 52.1 tp60 -49.25 -30.6 7.41 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.215 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -169.91 -26.31 0.02 OUTLIER Glycine 0 N--CA 1.494 2.503 0 C-N-CA 118.407 -1.854 . . . . 0.0 112.322 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.501 HD13 ' H ' ' A' ' 92' ' ' ARG . 1.4 mt -96.57 165.02 12.36 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.492 -1.283 . . . . 0.0 110.425 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.86 143.72 26.44 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.464 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.3 t -110.05 148.49 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.654 -0.819 . . . . 0.0 112.616 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 46.8 t -137.37 125.54 32.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.926 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.465 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 8.8 mp -102.32 144.84 30.31 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.707 -179.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -117.75 131.38 56.61 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.544 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.72 ' HZ3' ' ND2' ' A' ' 143' ' ' ASN . 26.3 ttpp -67.85 -79.24 0.05 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.554 -179.739 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.72 ' ND2' ' HZ3' ' A' ' 142' ' ' LYS . 0.8 OUTLIER -51.92 166.03 0.17 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.19 -179.884 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -46.82 -100.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.893 -1.048 . . . . 0.0 113.264 -179.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.606 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 5.8 m120 -73.18 75.65 1.28 Allowed 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.578 -179.854 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.606 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.2 p90 34.22 72.47 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.358 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.0 m -141.5 64.67 1.4 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.719 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 171.77 -148.59 11.06 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.294 -1.432 . . . . 0.0 110.35 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -75.53 168.49 19.91 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.293 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.3 p -146.98 155.39 42.22 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.616 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 35.4 tp -123.79 90.93 50.21 Favored Pre-proline 0 N--CA 1.488 1.468 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.59 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.11 108.02 0.89 Allowed 'Trans proline' 0 C--N 1.321 -0.875 0 C-N-CA 121.738 1.625 . . . . 0.0 112.855 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 45.5 t -84.88 88.16 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.452 179.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.494 ' C ' ' OG ' ' A' ' 155' ' ' SER . 18.8 p-10 -52.28 -33.82 43.77 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.792 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.494 ' OG ' ' C ' ' A' ' 154' ' ' ASN . 0.8 OUTLIER -163.82 -130.93 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 117.867 -1.533 . . . . 0.0 113.232 -179.699 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -59.73 153.4 20.45 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.299 -179.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.607 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -176.06 69.91 0.25 Allowed Pre-proline 0 N--CA 1.48 1.061 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.657 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.76 20.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.039 1.826 . . . . 0.0 112.184 -179.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.607 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -176.38 117.42 0.13 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.285 179.935 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.1 tp -148.96 -63.97 0.23 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.214 -179.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.998 0 C-N-CA 119.2 -1.476 . . . . 0.0 109.606 -179.861 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.764 0.316 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 m -68.48 105.93 2.37 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.754 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 28.6 m -87.74 -64.26 1.18 Allowed 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.218 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.543 ' HG ' ' H ' ' A' ' 146' ' ' PHE . 1.9 p -115.63 163.62 15.53 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.011 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.417 HG12 ' CD1' ' A' ' 118' ' ' LEU . 30.1 pt -142.74 177.19 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.934 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -156.56 111.08 2.78 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.325 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.3 mt -90.19 98.03 7.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.314 -0.955 . . . . 0.0 110.385 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 C--N 1.306 -1.31 0 CA-C-O 116.393 -1.765 . . . . 0.0 110.957 -179.99 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.497 ' O ' ' ND2' ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.992 0.425 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 2' ' ' ALA . 45.6 m-80 -163.34 117.69 1.63 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.348 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.8 pt -70.31 149.79 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.532 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.2 m -128.86 116.04 18.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.581 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 m -93.6 171.04 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 C-N-CA 119.526 -0.869 . . . . 0.0 110.78 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.788 ' CE2' ' NE2' ' A' ' 16' ' ' GLN . 31.5 m-85 -133.83 154.21 51.18 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.73 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -83.77 -45.08 13.73 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.278 -0.969 . . . . 0.0 113.152 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.492 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 7.5 m120 -97.66 -175.69 3.26 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.54 -179.864 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.86 -178.14 7.0 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.54 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.614 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 0.9 OUTLIER 47.43 57.29 5.99 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.623 -179.946 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.614 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 48.3 p90 39.14 25.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.66 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 11' ' ' ASP . 7.6 tt0 -104.18 170.01 8.16 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.247 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.492 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 88.36 136.21 5.36 Favored Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.633 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 14' ' ' GLY . 25.8 mmtm -32.01 139.5 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.439 180.0 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.788 ' NE2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -115.27 170.07 8.66 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.805 -179.883 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 76.7 t -141.63 133.93 28.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.334 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -93.91 119.26 32.59 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.192 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.9 mt -116.6 138.25 24.34 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.376 179.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -72.11 164.94 34.11 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 120.973 1.116 . . . . 0.0 111.027 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.19 -162.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 121.691 1.594 . . . . 0.0 110.761 179.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.525 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 88.54 -178.95 46.02 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.098 -1.525 . . . . 0.0 111.164 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.598 ' N ' HH21 ' A' ' 83' ' ' ARG . 0.7 OUTLIER -109.99 137.47 47.71 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.818 -179.995 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 4.8 p90 -156.12 178.05 10.73 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.36 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.457 HG21 ' HG ' ' A' ' 81' ' ' SER . 1.3 p -151.25 -153.09 0.47 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.801 -179.801 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.424 ' H ' ' HB ' ' A' ' 25' ' ' THR . 35.0 ptt85 -58.61 -20.86 51.03 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.931 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.67 -64.11 0.92 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.244 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -58.38 -45.36 88.44 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.244 -1.383 . . . . 0.0 109.695 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.8 mt -61.93 -35.25 77.84 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.576 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.5 -25.41 64.43 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 118.098 -1.441 . . . . 0.0 107.879 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.85 -36.35 56.87 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.69 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.5 mt -76.23 -76.72 0.15 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.741 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.42 -26.94 0.87 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.684 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.598 ' C ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -88.14 139.01 18.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.842 180.0 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 2.9 pt-20 174.02 168.73 0.21 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.515 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.601 ' C ' ' H ' ' A' ' 38' ' ' THR . 1.7 t-20 80.91 -145.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 120.147 -0.621 . . . . 0.0 112.654 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -53.24 6.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.988 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.601 ' H ' ' C ' ' A' ' 36' ' ' ASN . 71.4 p -72.6 -149.05 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.358 -1.337 . . . . 0.0 110.75 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 38' ' ' THR . 2.8 mt 42.12 58.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.899 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t -72.92 -50.04 25.94 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.917 -179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.41 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -119.27 176.62 5.24 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.763 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.453 HG11 ' H ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -154.43 148.22 13.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 C-N-CA 117.856 -1.538 . . . . 0.0 112.813 -179.95 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -136.6 109.88 7.85 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.513 -1.222 . . . . 0.0 108.607 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.2 t -132.54 110.86 13.66 Favored Pre-proline 0 N--CA 1.495 1.803 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.322 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.13 167.96 20.43 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.007 1.138 . . . . 0.0 110.726 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.465 ' CG ' HH21 ' A' ' 92' ' ' ARG . 1.6 Cg_endo -62.18 -168.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.781 1.654 . . . . 0.0 111.326 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.89 -17.47 9.13 Favored Glycine 0 N--CA 1.482 1.73 0 C-N-CA 119.365 -1.397 . . . . 0.0 110.854 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.45 HG13 ' CB ' ' A' ' 2' ' ' ALA . 27.3 m -148.59 140.35 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.825 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -104.82 127.14 52.52 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.49 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.57 149.19 28.32 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.539 -0.864 . . . . 0.0 112.283 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.8 mt -139.87 114.58 7.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.569 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.471 HD11 ' H ' ' A' ' 52' ' ' LEU . 3.6 mp -94.11 164.95 12.86 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.942 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -140.46 116.37 10.37 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.006 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -49.22 -84.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.363 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -59.01 141.26 54.42 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.521 -179.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -60.92 -169.87 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.318 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.81 31.97 32.34 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.137 -1.506 . . . . 0.0 110.005 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.436 ' H ' ' HG ' ' A' ' 81' ' ' SER . 25.3 m-85 51.29 65.59 1.44 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.087 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.06 -174.14 4.19 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.171 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.67 177.9 15.39 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.037 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -50.89 170.72 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.212 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -143.58 133.03 23.41 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.058 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.5 mm -98.91 167.64 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.097 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -145.29 129.16 17.35 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.163 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -149.24 164.52 4.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 118.598 -1.241 . . . . 0.0 112.609 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.33 -11.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 114.372 -1.285 . . . . 0.0 107.69 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.405 ' HB2' ' H ' ' A' ' 68' ' ' ASN . . . -119.69 -152.19 0.5 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.144 179.884 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.604 HD22 ' H ' ' A' ' 107' ' ' ASP . 1.3 p30 -101.51 122.57 44.05 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.886 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.453 ' H ' HG11 ' A' ' 42' ' ' VAL . . . -89.53 121.85 32.13 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.723 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -74.33 -83.67 0.05 Allowed 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.328 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -77.32 -0.25 24.84 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.962 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.465 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 5.8 tp 59.24 -97.47 0.07 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.717 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.465 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -173.43 -174.83 40.73 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 118.893 -1.622 . . . . 0.0 111.117 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.616 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.4 Cg_endo -66.9 -34.04 31.25 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.688 2.259 . . . . 0.0 112.587 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.613 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 2.0 pt? -67.91 24.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.457 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.616 ' H ' ' C ' ' A' ' 74' ' ' PRO . 4.3 t30 -74.73 -6.35 48.35 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.201 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' ND2' ' A' ' 78' ' ' ASN . 4.6 t-20 -74.54 -25.11 59.11 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.992 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 31.9 m120 -158.14 132.03 7.9 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.384 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t -147.81 138.52 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.843 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.9 m -162.53 -34.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.44 -1.304 . . . . 0.0 112.831 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.457 ' HG ' HG21 ' A' ' 25' ' ' THR . 3.5 m -95.7 138.81 32.83 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.023 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -150.02 159.86 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 118.581 -1.248 . . . . 0.0 112.497 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.819 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -149.94 116.84 5.92 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.417 -179.977 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.819 ' H ' HH22 ' A' ' 83' ' ' ARG . 14.1 t -120.63 139.54 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.438 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.603 ' CD1' ' NH1' ' A' ' 83' ' ' ARG . 1.4 mp -138.72 129.25 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.562 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 p -40.5 152.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.989 -0.685 . . . . 0.0 111.609 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.47 141.25 13.26 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.266 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -52.37 132.55 45.05 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.168 1.246 . . . . 0.0 111.28 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.528 ' CG2' ' N ' ' A' ' 90' ' ' GLN . 4.0 p -59.13 163.96 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.639 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.528 ' N ' ' CG2' ' A' ' 89' ' ' VAL . 82.5 mm-40 -145.21 148.08 36.63 Favored Pre-proline 0 N--CA 1.487 1.387 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.045 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.64 -20.12 67.63 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 121.503 1.469 . . . . 0.0 111.846 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.465 HH21 ' CG ' ' A' ' 46' ' ' PRO . 20.3 ptt180 38.07 -158.31 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -147.87 172.76 13.65 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.61 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -141.21 115.48 9.37 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.865 -1.134 . . . . 0.0 112.087 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CD2' HG12 ' A' ' 131' ' ' VAL . 66.7 m-85 -99.97 159.17 15.29 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.634 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.442 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 26.0 m-85 -109.83 179.66 4.06 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.267 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.29 -66.97 0.91 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.438 -0.905 . . . . 0.0 112.755 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.513 ' CG ' ' N ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -87.49 163.05 16.91 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.918 0.866 . . . . 0.0 113.083 -179.735 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 13.6 tp10 -62.25 108.86 1.16 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.703 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 96.66 61.54 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.934 0 O-C-N 124.725 1.265 . . . . 0.0 111.113 179.895 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' A' ' 101' ' ' PHE . 9.1 p90 29.4 33.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.422 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 100' ' ' GLN . 23.8 t70 -96.93 32.85 2.01 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.754 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -161.2 144.48 9.88 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 103' ' ' GLY . 15.7 tptm -34.5 144.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.929 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.468 ' OE1' ' C ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -99.14 164.99 11.93 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.712 -0.795 . . . . 0.0 112.806 -179.803 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.422 HG12 ' CA ' ' A' ' 122' ' ' GLY . 7.0 t -140.28 118.57 10.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.495 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.604 ' H ' HD22 ' A' ' 68' ' ' ASN . 2.2 p-10 -93.83 163.08 13.66 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.535 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.2 mt -144.08 144.44 26.27 Favored Pre-proline 0 N--CA 1.486 1.339 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.632 179.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.21 163.48 32.6 Favored 'Trans proline' 0 C--O 1.213 -0.771 0 C-N-CA 121.708 1.605 . . . . 0.0 111.095 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.68 142.73 95.24 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 121.452 1.435 . . . . 0.0 110.892 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.87 -157.13 26.97 Favored Glycine 0 N--CA 1.501 3.026 0 C-N-CA 118.758 -1.687 . . . . 0.0 111.522 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.66 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 46.1 tt0 -128.26 157.27 41.37 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.518 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.66 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 13.4 m-85 -142.43 155.99 45.15 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.799 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.4 p -99.61 176.47 5.47 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -179.674 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.531 ' NE2' ' OD2' ' A' ' 144' ' ' ASP . 20.9 pt20 -73.42 37.63 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.866 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.32 -56.3 0.08 Allowed 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.615 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.11 -42.61 75.86 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.163 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.617 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -45.25 -74.1 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.159 179.912 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.601 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.1 OUTLIER -50.69 -55.45 16.48 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.011 -1.076 . . . . 0.0 112.796 -179.63 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -10.59 6.45 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.319 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -100.04 -8.08 24.25 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.471 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.422 ' CA ' HG12 ' A' ' 106' ' ' VAL . . . -152.0 -62.08 0.01 OUTLIER Glycine 0 N--CA 1.484 1.887 0 C-N-CA 118.498 -1.81 . . . . 0.0 111.989 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.754 ' N ' ' CD1' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -140.63 127.82 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.968 -179.746 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.582 ' C ' ' H ' ' A' ' 126' ' ' ASN . 36.9 t70 -39.48 161.41 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.84 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -58.29 13.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.105 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.582 ' H ' ' C ' ' A' ' 124' ' ' ASP . 1.6 p-10 -167.7 77.99 0.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.552 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 126' ' ' ASN . 1.1 p -163.66 -15.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.37 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -64.68 160.4 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.143 -179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.4 t -170.38 -87.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.55 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 m -81.93 138.02 35.07 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.487 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.479 HG12 ' CD2' ' A' ' 95' ' ' PHE . 2.1 t -121.14 156.84 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.509 0.671 . . . . 0.0 111.703 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -154.02 79.06 5.23 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.963 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.78 102.42 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.533 1.489 . . . . 0.0 110.834 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.446 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 3.5 mm-40 -51.55 -12.92 0.19 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.089 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 178.76 -34.86 0.08 OUTLIER Glycine 0 N--CA 1.49 2.278 0 C-N-CA 117.93 -2.081 . . . . 0.0 112.579 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 mt -87.35 171.87 10.27 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.185 -1.406 . . . . 0.0 111.824 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -95.16 123.21 38.53 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.41 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 153' ' ' VAL . 8.8 t -94.44 133.05 36.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.627 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.0 t -124.2 132.13 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.48 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.9 mp -107.31 134.13 50.83 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.435 -179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.431 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 25.8 m-85 -110.59 122.06 46.83 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.105 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -55.4 -84.19 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.988 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.408 HD22 ' HB3' ' A' ' 147' ' ' SER . 26.2 p-10 -71.91 173.58 8.13 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.193 179.98 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.531 ' OD2' ' NE2' ' A' ' 115' ' ' GLN . 2.3 m-20 -65.29 -153.35 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.175 -179.893 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.635 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 71.7 m-20 41.91 22.61 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.288 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.635 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.5 p90 40.08 57.12 2.44 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.154 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.408 ' HB3' HD22 ' A' ' 143' ' ' ASN . 8.4 t -138.66 -151.05 0.36 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.605 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 54.88 -166.02 2.87 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.377 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.5 157.14 11.87 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.88 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 p -148.12 174.68 11.71 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.568 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.3 mt -138.32 85.09 18.76 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.444 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -64.1 97.53 0.24 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 121.766 1.644 . . . . 0.0 112.387 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 138' ' ' VAL . 2.1 t -77.78 92.99 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.857 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -62.41 -21.49 65.42 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.808 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 52.3 p -169.84 -150.19 0.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 117.852 -1.539 . . . . 0.0 112.862 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -43.78 150.26 0.26 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.779 -179.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.575 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -171.8 65.07 0.39 Allowed Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.902 179.841 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.3 Cg_endo -61.95 19.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.267 1.978 . . . . 0.0 113.14 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.575 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER 178.67 111.76 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.053 179.873 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 13.5 mt -141.35 -42.97 0.37 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.467 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.026 0 C-N-CA 119.318 -1.42 . . . . 0.0 110.16 -179.994 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.961 0.41 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.37 131.12 45.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.504 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 169' ' ' SER . 97.0 p -93.69 -67.31 0.86 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.945 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.52 ' N ' ' OG ' ' A' ' 168' ' ' SER . 1.8 p -113.99 162.55 16.28 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.982 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.426 HG12 ' CD1' ' A' ' 118' ' ' LEU . 23.9 pt -143.01 175.73 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 118.735 -1.186 . . . . 0.0 112.037 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -154.51 109.18 3.04 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.477 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.4 mt -89.6 92.8 4.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.574 179.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 116.325 -1.798 . . . . 0.0 110.944 179.996 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ptm . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.922 0.391 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.64 163.24 16.68 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.662 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -179.53 131.4 0.1 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.166 -1.013 . . . . 0.0 110.699 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.7 pt -73.44 153.22 7.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.453 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.0 m -130.44 116.43 18.23 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.886 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 m -96.67 172.08 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.515 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.971 ' CE2' ' NE2' ' A' ' 16' ' ' GLN . 16.1 m-85 -130.72 134.85 47.26 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.878 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -59.28 5.5 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.214 -0.995 . . . . 0.0 112.777 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.552 ' N ' HD21 ' A' ' 9' ' ' ASN . 1.9 m120 -89.03 167.04 13.48 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.478 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.584 ' CG ' ' H ' ' A' ' 11' ' ' ASP . 16.4 tt0 -77.16 -178.23 4.94 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.918 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.584 ' H ' ' CG ' ' A' ' 10' ' ' GLU . 4.7 t0 60.77 43.64 11.95 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.61 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.414 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 35.8 t80 49.3 15.47 0.12 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.497 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.503 ' CG ' ' N ' ' A' ' 14' ' ' GLY . 8.1 tt0 -103.02 168.93 8.87 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.833 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.549 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 89.53 124.49 2.56 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.816 -1.183 . . . . 0.0 111.143 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 14' ' ' GLY . 7.2 mmmm -29.95 137.76 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 123.921 0.424 . . . . 0.0 111.643 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.971 ' NE2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -103.51 170.92 7.66 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.678 -0.809 . . . . 0.0 112.087 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.6 t -142.03 134.41 27.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.804 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -92.98 117.16 29.75 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.578 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.1 mt -113.03 132.99 22.12 Favored Pre-proline 0 N--CA 1.492 1.625 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.075 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.11 160.64 43.72 Favored 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 120.94 1.093 . . . . 0.0 111.208 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.85 -159.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 121.615 1.543 . . . . 0.0 111.017 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.437 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 84.32 176.36 51.06 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.318 -1.42 . . . . 0.0 111.001 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.628 ' CA ' HH21 ' A' ' 83' ' ' ARG . 1.4 p30 -103.3 135.92 44.04 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.543 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.413 ' OH ' ' CD1' ' A' ' 82' ' ' ILE . 51.6 p90 -158.31 -174.61 4.89 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.119 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.642 ' CG2' ' N ' ' A' ' 26' ' ' ARG . 5.4 t -161.03 -150.02 0.19 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.396 -1.321 . . . . 0.0 112.297 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.642 ' N ' ' CG2' ' A' ' 25' ' ' THR . 11.9 ttt-85 -56.79 -31.04 64.27 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.253 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.509 ' H ' HG21 ' A' ' 25' ' ' THR . . . -60.99 -63.35 1.33 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.569 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -57.48 -44.28 84.78 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.485 -1.286 . . . . 0.0 109.822 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.6 mt -58.78 -37.6 76.66 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.71 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.35 -33.71 44.19 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 118.537 -1.265 . . . . 0.0 107.762 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.44 -40.84 89.71 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.375 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.3 mt -72.81 -80.84 0.06 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.79 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.58 -29.18 0.29 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.841 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.8 tt -82.64 151.13 4.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.724 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 4.3 pt-20 -179.93 146.25 0.24 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.552 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 4.0 t30 74.61 -143.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.065 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.523 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.3 m-80 -58.79 82.08 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.612 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 36' ' ' ASN . 43.4 p -149.33 -46.36 0.14 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.226 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mt -68.45 71.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.623 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 38' ' ' THR . 33.5 t -75.31 -72.1 0.32 Allowed 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.403 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -95.64 167.43 11.3 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.965 -1.094 . . . . 0.0 109.626 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.32 154.37 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 118.786 -1.166 . . . . 0.0 112.394 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -145.1 104.01 3.92 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.75 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.6 t -126.5 111.26 23.14 Favored Pre-proline 0 N--CA 1.496 1.842 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.63 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.37 168.21 18.48 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 121.081 1.187 . . . . 0.0 110.808 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 48' ' ' VAL . 1.4 Cg_endo -62.93 -170.22 0.1 OUTLIER 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 121.843 1.695 . . . . 0.0 110.971 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.85 -12.04 31.46 Favored Glycine 0 N--CA 1.48 1.614 0 C-N-CA 118.829 -1.653 . . . . 0.0 109.627 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.426 ' H ' ' C ' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -155.87 149.47 11.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.448 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.417 ' N ' HG21 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -121.09 127.2 51.41 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.616 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.61 157.02 17.47 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.359 -0.936 . . . . 0.0 113.096 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 60.3 mt -136.11 115.41 16.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.453 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.71 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 2.1 mp -89.97 161.22 16.0 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.857 -1.137 . . . . 0.0 112.763 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.506 ' OH ' ' NE2' ' A' ' 62' ' ' GLN . 5.5 m-85 -140.58 109.95 6.25 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.782 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.651 HE21 ' ND2' ' A' ' 55' ' ' ASN . 11.7 tt0 -43.52 -87.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.035 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.651 ' ND2' HE21 ' A' ' 54' ' ' GLN . 3.3 m120 -59.92 145.45 45.85 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.093 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.19 -174.92 0.06 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.518 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.84 26.7 58.25 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.178 -1.487 . . . . 0.0 110.025 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 55.31 65.03 1.59 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.51 175.35 10.63 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.439 -0.905 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.25 168.0 32.07 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.257 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -49.3 129.17 18.09 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.348 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.506 ' NE2' ' OH ' ' A' ' 53' ' ' TYR . 1.4 pt20 -101.0 179.04 4.5 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.119 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.467 HG23 ' H ' ' A' ' 64' ' ' GLU . 4.7 mt -144.04 169.01 10.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.404 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.467 ' H ' HG23 ' A' ' 63' ' ' ILE . 38.7 tt0 -145.09 128.62 17.04 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.955 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.7 m -149.31 167.14 3.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.902 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 t -146.64 -2.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.527 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.42 -154.11 0.61 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.882 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.05 155.18 16.86 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.566 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.42 87.06 2.35 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.225 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -51.9 -43.15 63.23 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.346 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 72' ' ' LEU . 5.5 mm-40 -123.88 81.19 1.88 Allowed 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.586 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 71' ' ' GLU . 1.2 tp -28.96 -81.22 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.702 0.626 . . . . 0.0 112.545 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.31 -165.92 36.63 Favored Glycine 0 N--CA 1.497 2.701 0 C-N-CA 118.901 -1.618 . . . . 0.0 111.09 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.493 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.8 Cg_endo -67.37 -44.21 5.02 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 122.148 1.899 . . . . 0.0 112.055 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.43 ' H ' HD22 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -69.74 10.45 0.38 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.059 -1.056 . . . . 0.0 111.289 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.493 ' H ' ' C ' ' A' ' 74' ' ' PRO . 20.4 t-20 -70.13 1.45 4.7 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.61 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -74.7 -5.2 41.85 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.712 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -167.3 124.42 1.2 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.295 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.4 t -145.97 140.24 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.67 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 m -159.7 -31.92 0.06 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.092 -1.043 . . . . 0.0 112.292 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.46 ' OG ' ' OG1' ' A' ' 25' ' ' THR . 3.0 m -103.86 142.93 33.54 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.439 -0.905 . . . . 0.0 111.339 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.413 ' CD1' ' OH ' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -149.15 162.2 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.73 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.784 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -146.06 116.38 7.49 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.396 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.784 ' H ' HH22 ' A' ' 83' ' ' ARG . 10.2 t -119.3 137.77 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 120.056 -0.657 . . . . 0.0 111.636 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.588 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 4.5 mt -139.13 126.67 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.51 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.5 p -40.54 154.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.585 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.93 146.79 19.65 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.65 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -51.18 159.35 2.82 Favored 'Trans proline' 0 C--N 1.325 -0.7 0 C-N-CA 121.805 1.67 . . . . 0.0 112.164 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.8 m -69.67 134.68 29.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.326 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -140.25 124.58 10.85 Favored Pre-proline 0 N--CA 1.489 1.488 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.113 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -59.79 -164.11 0.03 OUTLIER 'Trans proline' 0 C--O 1.21 -0.912 0 C-N-CA 120.758 0.972 . . . . 0.0 110.516 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.451 ' CA ' HD13 ' A' ' 136' ' ' LEU . 20.8 ptt-85 -177.48 -160.29 0.05 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.913 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.81 154.25 48.45 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.92 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -123.94 122.26 37.49 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.812 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 24.8 m-85 -108.71 151.41 26.22 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.041 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.4 ' CD2' ' HA ' ' A' ' 101' ' ' PHE . 31.3 m-85 -118.53 159.06 24.22 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.927 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.434 ' HB2' ' N ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -78.68 -83.29 0.09 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 118.162 -1.415 . . . . 0.0 111.781 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.677 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 4.6 mmmm -56.07 157.87 4.33 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.6 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 29.2 tt0 -79.62 86.62 5.23 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.524 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.98 HE21 ' C ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 162.77 48.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.625 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 24.7 p90 39.96 41.06 0.82 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.102 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.55 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 43.1 m-20 -142.75 -174.46 4.17 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.635 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.484 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 75.89 161.77 11.18 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 118.92 -1.609 . . . . 0.0 109.498 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 103' ' ' GLY . 7.3 mtpm? -27.58 122.82 0.1 Allowed 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 121.244 0.545 . . . . 0.0 112.09 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.09 137.21 40.66 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.572 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.73 151.57 24.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.021 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -143.66 151.15 39.74 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.098 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.8 mt -139.25 143.81 37.88 Favored Pre-proline 0 N--CA 1.497 1.876 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.617 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -71.23 170.17 18.9 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 121.724 1.616 . . . . 0.0 111.052 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.42 ' HA ' ' CG2' ' A' ' 172' ' ' ILE . 3.7 Cg_exo -60.44 141.55 95.83 Favored 'Trans proline' 0 C--N 1.321 -0.921 0 C-N-CA 121.728 1.619 . . . . 0.0 110.972 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.649 ' C ' ' NE2' ' A' ' 112' ' ' GLN . . . 150.2 -153.78 25.27 Favored Glycine 0 N--CA 1.497 2.759 0 C-N-CA 118.675 -1.726 . . . . 0.0 111.49 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.649 ' NE2' ' C ' ' A' ' 111' ' ' GLY . 11.7 mp0 -131.36 148.16 52.64 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.614 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.631 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 3.3 m-85 -139.63 157.15 46.27 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.606 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.4 p -119.0 -175.46 2.91 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -77.88 47.78 0.66 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.216 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.41 -56.47 0.09 Allowed 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.329 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.468 ' HG2' ' N ' ' A' ' 118' ' ' LEU . 1.7 tt0 -76.77 -58.0 3.53 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.543 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -36.99 -69.5 0.11 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.74 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 120' ' ' ARG . 0.6 OUTLIER -49.57 -63.12 1.2 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.166 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.459 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 0.1 OUTLIER -75.86 24.18 0.13 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.284 -0.966 . . . . 0.0 112.575 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.461 ' O ' ' CG ' ' A' ' 121' ' ' TYR . 33.7 t80 -131.81 -9.16 3.53 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.368 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.28 -46.94 0.02 OUTLIER Glycine 0 C--N 1.29 -1.998 0 C-N-CA 118.87 -1.633 . . . . 0.0 110.526 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.492 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -141.18 -98.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.281 -0.967 . . . . 0.0 110.66 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.492 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 7.4 t0 -168.37 -166.2 0.67 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.729 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.45 ' ND2' ' OE1' ' A' ' 119' ' ' GLU . 10.0 m120 -59.75 -6.79 1.32 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.134 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.503 ' CG ' ' H ' ' A' ' 127' ' ' THR . 44.5 t30 -172.09 -134.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.189 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.503 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 0.5 OUTLIER 36.56 69.07 0.22 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.203 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.5 ' O ' ' CB ' ' A' ' 129' ' ' SER . 8.0 mm -102.25 -86.68 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.388 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 84.83 -166.54 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' SER . 10.9 m -17.98 120.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.7 -1.591 . . . . 0.0 114.703 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.45 HG12 ' CD2' ' A' ' 95' ' ' PHE . 3.5 t -121.76 149.83 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.544 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -143.82 95.69 5.71 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 119.536 -0.865 . . . . 0.0 110.863 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -53.78 112.46 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.16 1.24 . . . . 0.0 111.099 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -79.46 -17.27 54.59 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.84 -32.68 0.02 OUTLIER Glycine 0 N--CA 1.488 2.158 0 C-N-CA 118.752 -1.689 . . . . 0.0 111.93 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.451 HD13 ' CA ' ' A' ' 92' ' ' ARG . 0.4 OUTLIER -121.26 156.38 32.61 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.155 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.29 153.43 39.37 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 118.863 -1.135 . . . . 0.0 110.077 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.9 140.21 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.859 -0.736 . . . . 0.0 112.046 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.93 127.19 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.231 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 mp -105.79 148.95 26.92 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 119.396 -0.922 . . . . 0.0 113.211 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.545 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 2.4 m-85 -121.34 146.34 46.95 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.754 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -107.86 43.08 1.24 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.302 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -169.91 156.28 6.11 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.856 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 146' ' ' PHE . 32.0 t70 -57.75 175.83 0.17 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.298 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.642 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 8.0 p-10 34.59 32.44 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.964 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.642 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.3 p90 40.72 64.8 0.89 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.198 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.505 ' CB ' ' ND2' ' A' ' 145' ' ' ASN . 25.6 t -144.19 97.05 2.98 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.865 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.96 -156.79 28.03 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -60.21 157.62 13.01 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.963 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.5 p -150.14 170.94 17.73 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.984 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.435 ' C ' ' CD2' ' A' ' 151' ' ' LEU . 1.2 tt -142.44 91.33 7.69 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.035 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.32 107.37 1.57 Allowed 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.945 1.764 . . . . 0.0 113.598 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.6 t -84.12 89.15 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.089 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.594 ' C ' HD21 ' A' ' 154' ' ' ASN . 0.4 OUTLIER -80.73 11.58 3.76 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.4 p -170.04 -171.81 1.22 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.62 -1.632 . . . . 0.0 113.136 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -58.1 148.37 26.76 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.028 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.635 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -166.53 74.85 1.15 Allowed Pre-proline 0 C--N 1.304 -1.378 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.954 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.78 21.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.734 1.623 . . . . 0.0 111.999 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.635 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.4 OUTLIER -169.42 112.68 0.51 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.795 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.0 tp -146.64 17.95 1.3 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.195 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -82.43 48.17 3.9 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.241 -1.457 . . . . 0.0 110.299 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.98 32.68 0.1 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 119.256 -0.977 . . . . 0.0 111.117 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 11.7 tpt -156.77 -51.27 0.08 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.606 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.444 ' N ' ' OD1' ' A' ' 164' ' ' ASN . 23.5 p-10 -65.66 96.26 0.26 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.502 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -83.67 115.83 22.35 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.216 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.7 m120 49.43 89.13 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.509 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 13.1 m -76.14 98.28 4.34 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.955 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 9.1 m -82.82 -40.1 20.82 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.72 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.49 159.83 41.7 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.619 -1.233 . . . . 0.0 111.139 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.413 HG12 ' CD1' ' A' ' 118' ' ' LEU . 15.5 pt -140.64 163.02 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.22 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -145.07 102.39 3.75 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.025 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.42 ' CG2' ' HA ' ' A' ' 110' ' ' PRO . 4.9 mt -81.63 100.66 5.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.439 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.896 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.939 0.399 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.85 -155.06 0.14 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.879 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 2.0 p-10 -172.66 105.66 0.16 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.111 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.6 pt -72.09 156.75 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.622 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -139.75 126.91 21.13 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.818 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -107.28 179.0 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 119.848 -0.741 . . . . 0.0 112.412 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.769 ' CZ ' ' CE1' ' A' ' 12' ' ' PHE . 32.5 m-85 -132.47 144.7 50.64 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.112 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.94 -46.97 27.07 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.497 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 2.4 m-80 -89.33 162.63 15.72 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.296 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.504 ' C ' ' CG ' ' A' ' 11' ' ' ASP . 12.8 mt-10 -72.94 158.48 35.39 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.245 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.1 OUTLIER 76.02 44.73 0.13 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.612 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.769 ' CE1' ' CZ ' ' A' ' 7' ' ' PHE . 70.2 t80 52.78 10.88 0.17 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.631 -0.828 . . . . 0.0 112.079 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.457 ' HG3' ' H ' ' A' ' 14' ' ' GLY . 1.6 tp60 -99.72 171.41 7.91 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.581 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.497 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 86.42 135.71 4.16 Favored Glycine 0 N--CA 1.502 3.072 0 C-N-CA 119.904 -1.141 . . . . 0.0 111.267 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 14' ' ' GLY . 15.9 mtpp -31.46 141.47 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.913 0.419 . . . . 0.0 111.727 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.588 ' NE2' ' CZ ' ' A' ' 7' ' ' PHE . 2.3 pt20 -110.14 172.52 6.81 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.873 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.3 t -146.79 133.91 14.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.414 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -89.93 139.94 30.11 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.312 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.0 mt -135.69 133.02 19.85 Favored Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 120.026 -0.669 . . . . 0.0 110.714 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -69.69 155.16 66.88 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 121.081 1.187 . . . . 0.0 110.999 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.66 -166.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.497 1.464 . . . . 0.0 110.803 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.39 -161.03 26.08 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.951 -1.595 . . . . 0.0 110.671 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -128.04 127.42 43.13 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.997 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -144.46 -171.58 3.62 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.92 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.0 p -142.62 -170.54 3.23 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.262 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -59.41 -22.07 60.89 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.883 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.96 -58.86 6.65 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.882 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.474 ' NE2' ' CD2' ' A' ' 32' ' ' LEU . 29.2 tp60 -54.92 -44.54 74.31 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.029 -1.069 . . . . 0.0 109.398 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 31.4 mt -57.08 -42.34 80.51 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.294 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.3 -30.54 18.46 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.825 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.75 -34.76 64.88 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.941 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.474 ' CD2' ' NE2' ' A' ' 28' ' ' GLN . 11.7 mt -78.88 -72.97 0.36 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.579 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.56 -40.91 0.21 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.47 ' CG1' ' H ' ' A' ' 35' ' ' GLU . 10.2 tt -68.89 178.48 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.49 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.634 ' CG ' ' N ' ' A' ' 36' ' ' ASN . 5.5 tt0 178.53 167.32 0.85 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.057 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.634 ' N ' ' CG ' ' A' ' 35' ' ' GLU . 24.4 p30 -36.33 152.75 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.533 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.809 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.0 OUTLIER 78.07 32.76 0.36 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.484 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 39' ' ' ILE . 72.0 p -147.19 -121.61 0.06 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.767 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.438 ' C ' ' O ' ' A' ' 38' ' ' THR . 4.5 mt 32.58 62.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.402 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.646 ' OG ' ' N ' ' A' ' 41' ' ' SER . 22.7 p -64.69 -62.3 1.66 Allowed 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.733 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.646 ' N ' ' OG ' ' A' ' 40' ' ' SER . 0.7 OUTLIER -106.73 171.45 7.35 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.262 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.468 HG13 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -145.48 140.55 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.096 -1.041 . . . . 0.0 111.643 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -129.14 102.19 6.36 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.917 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.5 t -126.62 109.39 22.95 Favored Pre-proline 0 N--CA 1.49 1.537 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.618 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -67.6 169.76 15.2 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 121.049 1.166 . . . . 0.0 110.633 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 48' ' ' VAL . 1.8 Cg_endo -62.21 -170.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.844 1.696 . . . . 0.0 111.185 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.2 -11.8 7.94 Favored Glycine 0 N--CA 1.483 1.827 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.698 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.433 ' H ' ' C ' ' A' ' 46' ' ' PRO . 35.3 m -150.18 134.95 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 118.944 -1.102 . . . . 0.0 111.799 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -104.35 132.03 51.05 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.247 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.8 154.86 23.36 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.479 -0.889 . . . . 0.0 112.844 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.414 HD11 ' NH2' ' A' ' 83' ' ' ARG . 12.0 mt -146.32 112.01 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.103 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 mp -89.56 152.09 21.6 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.704 -1.198 . . . . 0.0 112.477 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.497 ' CD2' ' C ' ' A' ' 58' ' ' PHE . 53.5 m-85 -129.48 110.9 12.25 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.315 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.619 HE21 ' H ' ' A' ' 61' ' ' ASP . 3.2 tt0 -48.61 -55.45 11.19 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.631 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -85.67 147.67 26.26 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.032 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -56.38 178.1 0.06 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.776 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.34 27.22 60.29 Favored Glycine 0 N--CA 1.488 2.105 0 C-N-CA 119.346 -1.407 . . . . 0.0 110.173 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.497 ' C ' ' CD2' ' A' ' 53' ' ' TYR . 12.4 m-85 56.29 67.44 1.0 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.876 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.23 -170.43 3.65 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.97 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.09 -177.23 39.36 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.425 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.619 ' H ' HE21 ' A' ' 54' ' ' GLN . 38.1 t0 -45.19 107.64 0.1 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.355 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -91.05 151.35 21.06 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.642 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.582 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 8.5 mm -131.31 170.3 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.36 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.582 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 27.8 mt-10 -146.48 132.61 19.34 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.694 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.6 m -150.45 147.91 15.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 118.964 -1.094 . . . . 0.0 111.698 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 t -130.61 0.93 2.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.67 ' N ' ' HH ' ' A' ' 121' ' ' TYR . . . -134.41 -151.19 0.42 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.684 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -97.25 119.12 35.18 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.105 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.468 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -89.58 101.7 14.38 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.178 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -55.13 -35.98 65.26 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.346 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 72' ' ' LEU . 8.6 tp10 -140.16 96.51 3.06 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.611 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 71' ' ' GLU . 1.5 tp -37.97 -84.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.099 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.402 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 178.91 -168.64 39.64 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.095 -1.526 . . . . 0.0 110.719 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.21 -6.3 15.87 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.097 1.865 . . . . 0.0 111.859 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.503 ' H ' HD21 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -92.11 13.98 17.34 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.022 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -72.55 -5.16 35.15 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.518 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -89.21 -6.84 56.57 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.107 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -166.1 104.88 0.66 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 118.714 -1.194 . . . . 0.0 111.711 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.648 ' H ' ' H ' ' A' ' 37' ' ' ASN . 11.6 t -113.5 -167.81 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.415 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.646 ' H ' ' CG1' ' A' ' 79' ' ' VAL . 0.3 OUTLIER 159.48 -59.33 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.449 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.6 m -108.5 145.83 34.12 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.307 -0.957 . . . . 0.0 113.317 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.21 154.26 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.915 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.737 ' NH1' ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.61 128.5 25.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.333 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.737 ' CA ' ' NH1' ' A' ' 83' ' ' ARG . 6.5 t -138.1 132.94 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.329 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.416 HD13 ' HE ' ' A' ' 83' ' ' ARG . 68.1 mt -129.31 128.69 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.806 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 m -42.3 153.49 0.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.213 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.56 148.62 31.56 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.753 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.48 127.76 27.57 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.229 1.286 . . . . 0.0 110.946 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 p -59.43 136.38 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.478 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -139.71 152.76 69.14 Favored Pre-proline 0 N--CA 1.486 1.355 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.695 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.15 -156.88 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.818 0 C-N-CA 121.064 1.176 . . . . 0.0 110.941 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.467 ' N ' HD13 ' A' ' 136' ' ' LEU . 8.5 ptt180 175.71 -162.05 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.266 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.03 158.57 43.97 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.013 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.91 147.5 35.71 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.935 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.448 ' CE1' HD13 ' A' ' 108' ' ' LEU . 29.9 m-85 -130.48 100.89 5.5 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.403 ' CG ' ' HB3' ' A' ' 105' ' ' GLU . 33.7 m-85 -74.93 177.06 6.57 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.581 -0.847 . . . . 0.0 113.111 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -110.54 159.73 17.27 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.635 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt 59.3 153.98 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.048 0.927 . . . . 0.0 113.182 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.555 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 30.7 tp10 -71.99 105.99 4.1 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.459 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 1.282 ' NE2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 103.83 46.2 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.01 0 O-C-N 124.981 1.426 . . . . 0.0 109.076 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.631 ' CE1' ' CD ' ' A' ' 100' ' ' GLN . 27.0 p90 31.56 58.56 0.3 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.669 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 102' ' ' ASP . 0.4 OUTLIER -94.54 19.85 9.24 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.939 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -159.64 159.02 30.21 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -48.59 171.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.64 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -129.72 169.69 14.78 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.053 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.35 151.81 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.764 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 23.3 p-10 -98.43 152.78 19.14 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.965 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.448 HD13 ' CE1' ' A' ' 95' ' ' PHE . 54.0 mt -146.09 113.27 4.51 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.268 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.83 164.43 27.03 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 121.421 1.414 . . . . 0.0 112.061 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.97 146.39 57.87 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 122.268 1.979 . . . . 0.0 111.787 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.11 -156.33 25.52 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.699 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.638 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 18.0 tt0 -135.75 156.99 47.95 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.648 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.638 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 12.0 m-85 -141.07 156.41 46.0 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.428 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.401 ' C ' ' H ' ' A' ' 116' ' ' ALA . 1.4 p -108.89 -179.2 3.79 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.712 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.413 ' NE2' ' HB3' ' A' ' 168' ' ' SER . 39.2 tt0 -75.9 44.1 0.29 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.19 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 114' ' ' THR . . . -154.22 -58.94 0.12 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.976 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 121' ' ' TYR . 31.2 tp10 -71.59 -51.44 23.3 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.413 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.576 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 1.4 tt -36.88 -73.37 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.142 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.498 ' HG3' ' H ' ' A' ' 120' ' ' ARG . 5.4 pt-20 -49.78 -55.54 13.7 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.696 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.498 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -76.66 16.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.752 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.67 ' HH ' ' N ' ' A' ' 67' ' ' ALA . 28.2 t80 -123.64 -12.75 7.62 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.488 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -145.26 -42.65 0.05 OUTLIER Glycine 0 N--CA 1.496 2.636 0 C-N-CA 118.84 -1.648 . . . . 0.0 110.963 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.493 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -142.57 -97.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.606 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.589 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 23.8 t70 -167.4 -170.01 1.36 Allowed 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.745 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.589 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 27.8 t-20 -62.1 -105.63 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.63 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.456 ' N ' ' OD1' ' A' ' 125' ' ' ASN . 1.8 p-10 -67.11 107.9 2.46 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.396 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 128' ' ' ILE . 3.1 t -172.9 -165.75 0.32 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.358 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.563 ' N ' ' OG1' ' A' ' 127' ' ' THR . 1.4 mt 66.52 140.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.806 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 160' ' ' LEU . 4.8 m -154.67 -5.51 0.15 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.333 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.5 m -150.94 127.98 11.11 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.176 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -120.26 148.0 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.475 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.93 78.59 19.52 Favored Pre-proline 0 N--CA 1.483 1.198 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.402 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -61.19 97.64 0.13 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.264 1.31 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -91.51 33.23 1.01 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.413 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.72 -58.85 0.04 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 118.691 -1.718 . . . . 0.0 111.356 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 92' ' ' ARG . 0.8 OUTLIER -120.32 178.05 4.8 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.028 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.62 138.33 31.65 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.701 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.9 141.13 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.73 -0.788 . . . . 0.0 112.152 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.412 HG11 ' CE1' ' A' ' 141' ' ' PHE . 57.7 t -125.54 130.96 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.495 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.0 mp -105.47 137.05 43.92 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.646 -0.822 . . . . 0.0 113.085 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.521 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 2.3 m-85 -120.95 128.03 52.36 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.207 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -79.86 -30.64 40.32 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.141 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.417 ' HB3' ' HG ' ' A' ' 147' ' ' SER . 4.8 m-20 -83.08 177.77 8.44 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.785 -1.166 . . . . 0.0 111.86 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 146' ' ' PHE . 21.7 t0 -61.73 -105.99 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.875 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.642 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 2.2 m120 -58.54 75.56 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.457 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.642 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.5 p90 32.76 70.39 0.1 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.143 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.417 ' HG ' ' HB3' ' A' ' 143' ' ' ASN . 0.8 OUTLIER -136.18 -161.65 1.18 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.325 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 50.58 -148.66 7.14 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.745 -1.217 . . . . 0.0 111.127 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -78.18 162.39 26.64 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.124 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.0 p -150.66 165.39 33.55 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tt -133.19 90.91 29.33 Favored Pre-proline 0 N--CA 1.484 1.238 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.08 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -64.41 105.52 0.62 Allowed 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 121.589 1.526 . . . . 0.0 112.748 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.45 84.44 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.551 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -77.05 12.83 1.25 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.624 -0.83 . . . . 0.0 112.407 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -170.69 -167.49 0.59 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 118.214 -1.395 . . . . 0.0 112.361 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.55 152.05 19.13 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.576 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.585 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -169.13 65.47 0.58 Allowed Pre-proline 0 C--N 1.308 -1.225 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.269 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.468 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.0 OUTLIER -65.76 23.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 122.171 1.914 . . . . 0.0 112.046 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.585 ' H ' ' C ' ' A' ' 157' ' ' ALA . 3.0 t -166.5 138.7 3.68 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.782 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 129' ' ' SER . 0.3 OUTLIER -160.11 -78.22 0.06 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.221 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 163' ' ' MET . . . 42.97 -92.46 0.01 OUTLIER Glycine 0 N--CA 1.493 2.479 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.77 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -37.54 -25.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.291 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 161' ' ' GLY . 0.8 OUTLIER -75.61 -58.91 3.0 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.63 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.79 HD22 ' N ' ' A' ' 167' ' ' THR . 8.0 t30 -90.46 173.56 8.02 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.022 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.538 ' N ' ' ND2' ' A' ' 164' ' ' ASN . 2.7 t-20 -156.12 -12.1 0.1 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.271 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.442 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 2.6 t-20 -169.69 58.19 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.473 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.79 ' N ' HD22 ' A' ' 164' ' ' ASN . 85.2 m -42.27 104.43 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.32 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.413 ' HB3' ' NE2' ' A' ' 115' ' ' GLN . 0.2 OUTLIER -87.89 -61.3 1.75 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.017 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.4 p -123.61 158.99 30.23 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.947 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.426 HG12 ' CD1' ' A' ' 118' ' ' LEU . 13.1 pt -142.0 162.21 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.176 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.441 ' CZ ' ' OG ' ' A' ' 173' ' ' SER . 2.6 ttt-85 -142.44 102.7 4.13 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.015 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 7.9 mt -84.01 93.81 3.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.757 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.441 ' OG ' ' CZ ' ' A' ' 171' ' ' ARG . 4.4 m . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 116.363 -1.78 . . . . 0.0 110.813 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptp . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.421 ' CB ' ' CG1' ' A' ' 48' ' ' VAL . . . -150.11 156.64 42.01 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.187 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -178.22 115.93 0.08 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.545 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.405 ' O ' ' CG1' ' A' ' 4' ' ' ILE . 2.9 pt -61.98 129.12 24.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.707 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -107.67 122.33 46.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.49 150.65 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.726 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.611 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 12.5 m-85 -103.92 156.13 18.09 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.654 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.9 -35.8 23.82 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.247 -0.981 . . . . 0.0 113.048 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.489 ' C ' ' OG ' ' A' ' 40' ' ' SER . 14.1 m120 -104.49 170.89 7.63 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.259 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.466 ' HG3' ' H ' ' A' ' 11' ' ' ASP . 4.2 tp10 -76.52 -176.34 3.69 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.471 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' A' ' 13' ' ' GLN . 1.1 m-20 51.79 42.48 29.98 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.073 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.611 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 21.4 t80 54.1 6.57 0.1 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.652 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.498 ' H ' ' C ' ' A' ' 11' ' ' ASP . 7.3 tt0 -87.13 170.99 11.03 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.503 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 89.19 120.35 1.84 Allowed Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.587 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 14' ' ' GLY . 6.9 mtpm? -28.85 137.54 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 O-C-N 123.95 0.441 . . . . 0.0 111.731 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -105.43 133.07 50.79 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 p -108.1 153.41 9.6 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.039 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.811 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.07 140.2 34.64 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.543 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 mt -132.05 126.84 20.81 Favored Pre-proline 0 N--CA 1.493 1.688 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.205 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.54 151.3 83.21 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 121.026 1.151 . . . . 0.0 111.579 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.33 -164.6 0.06 OUTLIER 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 121.609 1.539 . . . . 0.0 111.484 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.57 179.93 46.29 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.454 -1.355 . . . . 0.0 111.066 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.796 ' CB ' ' HE ' ' A' ' 83' ' ' ARG . 1.7 m120 -90.4 121.95 32.83 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.914 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.8 ' H ' ' NH2' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -144.33 154.99 43.6 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.315 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.0 p -144.4 -150.76 0.33 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.858 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 30' ' ' ALA . 10.0 mtm180 -55.89 -37.16 68.47 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.18 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.401 ' O ' ' CB ' ' A' ' 30' ' ' ALA . . . -53.44 -59.11 5.0 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.269 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.09 -47.32 75.1 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 118.695 -1.202 . . . . 0.0 109.411 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 32' ' ' LEU . 21.5 mt -61.09 -28.58 69.19 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.442 -1.303 . . . . 0.0 109.023 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 26' ' ' ARG . . . -54.34 -33.43 58.96 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.2 -29.94 60.48 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.587 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 29' ' ' LEU . 14.7 mt -85.75 -91.72 0.09 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.338 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.45 13.45 0.26 Allowed Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.225 -1.464 . . . . 0.0 111.54 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.558 ' CG1' ' N ' ' A' ' 35' ' ' GLU . 1.0 OUTLIER -95.08 -38.81 9.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.635 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.558 ' N ' ' CG1' ' A' ' 34' ' ' ILE . 3.7 pt-20 -12.9 132.21 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.803 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.677 ' C ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER 84.77 135.06 0.05 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 114.359 -1.291 . . . . 0.0 113.737 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 40.27 39.23 0.64 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.72 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.791 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 52.5 p -106.38 -141.3 0.37 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.929 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' A' ' 38' ' ' THR . 1.4 mm 30.86 41.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.958 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.489 ' OG ' ' C ' ' A' ' 9' ' ' ASN . 2.1 t -48.77 -38.98 23.41 Favored 'General case' 0 C--N 1.282 -2.342 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.064 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.67 176.56 8.59 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.493 HG13 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -150.63 146.63 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 117.76 -1.576 . . . . 0.0 113.075 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.406 ' HG3' ' HZ1' ' A' ' 43' ' ' LYS . 1.4 tmtp? -136.09 102.1 4.92 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.359 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.6 t -122.71 104.33 36.6 Favored Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.381 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -69.48 171.01 14.92 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.077 1.185 . . . . 0.0 109.991 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.0 -173.19 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.494 1.463 . . . . 0.0 110.907 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.77 -21.72 7.38 Favored Glycine 0 N--CA 1.484 1.849 0 C-N-CA 119.109 -1.52 . . . . 0.0 110.551 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.421 ' CG1' ' CB ' ' A' ' 2' ' ' ALA . 25.1 m -148.97 141.98 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 118.921 -1.112 . . . . 0.0 112.176 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -110.18 139.2 45.58 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.739 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.21 155.03 42.46 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 118.964 -1.094 . . . . 0.0 113.2 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.34 120.84 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.199 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.707 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 2.2 mp -94.62 155.66 16.78 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 118.744 -1.182 . . . . 0.0 112.942 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 62' ' ' GLN . 40.5 m-85 -140.7 117.5 11.03 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.723 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.488 ' HG3' ' N ' ' A' ' 55' ' ' ASN . 6.4 pt20 -57.58 -41.94 82.12 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.363 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.488 ' N ' ' HG3' ' A' ' 54' ' ' GLN . 19.7 t30 -93.26 142.99 26.7 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.24 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 0.3 OUTLIER -54.49 171.09 0.13 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.487 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.663 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 58.82 34.83 79.59 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.162 -1.494 . . . . 0.0 109.43 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.711 ' H ' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER 44.26 74.16 0.13 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.316 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.22 168.18 22.35 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.082 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.24 -166.69 48.37 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.525 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.42 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 3.7 m-20 -50.92 117.09 2.29 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.448 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.449 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 3.9 pt20 -99.82 151.45 21.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.887 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.483 HG21 ' H ' ' A' ' 64' ' ' GLU . 1.8 mt -127.79 166.0 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.922 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.558 ' OE1' ' N ' ' A' ' 64' ' ' GLU . 46.0 mp0 -142.77 130.52 21.51 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.24 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.2 m -150.45 164.8 2.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.936 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.619 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 2.0 t -149.94 -1.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.158 -1.383 . . . . 0.0 107.881 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.72 -153.36 0.56 Allowed 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.624 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.52 ' O ' ' ND2' ' A' ' 68' ' ' ASN . 1.2 p-10 -98.32 114.03 26.19 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.53 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.493 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -89.72 98.9 12.03 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.425 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -54.78 -73.96 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.726 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 73' ' ' GLY . 24.6 mm-40 -80.9 -0.16 37.9 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.797 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.2 tp 60.09 -79.88 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.219 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 171.08 -179.06 43.17 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.129 -1.51 . . . . 0.0 110.804 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.573 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.2 Cg_endo -65.1 -40.14 21.23 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.433 2.089 . . . . 0.0 112.421 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.688 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 2.1 pt? -71.3 27.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.16 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.698 ' H ' HD21 ' A' ' 76' ' ' ASN . 0.7 OUTLIER -76.98 6.97 5.38 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.573 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -88.52 -9.41 52.47 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.967 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -157.85 130.69 7.42 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.136 -1.026 . . . . 0.0 111.219 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.791 ' CG2' ' H ' ' A' ' 38' ' ' THR . 15.3 m -140.09 164.93 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.533 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 174.64 -56.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.872 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.711 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 22.3 m -96.67 141.08 30.35 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.347 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.646 ' C ' ' NH1' ' A' ' 83' ' ' ARG . 18.3 mt -150.57 128.25 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.974 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.8 ' NH2' ' H ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -103.94 125.93 50.7 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.808 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -133.27 133.72 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.978 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.87 139.87 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.635 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.2 p -45.94 149.82 0.62 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.234 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -153.29 142.89 14.99 Favored Pre-proline 0 N--CA 1.484 1.264 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.866 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -52.29 148.5 25.2 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 121.432 1.421 . . . . 0.0 111.811 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.2 m -76.23 145.38 10.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.993 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -146.13 136.51 12.15 Favored Pre-proline 0 C--N 1.304 -1.388 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.963 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -60.33 -156.67 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.869 0 C-N-CA 121.178 1.252 . . . . 0.0 110.687 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.559 ' N ' ' CD ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -175.55 -164.53 0.14 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.354 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.37 165.47 25.4 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.027 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.616 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -128.66 151.46 49.48 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.777 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 1.2 m-85 -142.43 139.92 31.79 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.534 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.515 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 27.7 m-85 -95.09 179.74 5.1 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 118.414 -1.314 . . . . 0.0 112.492 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.65 -74.75 0.61 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.023 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.472 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 25.9 tttm -63.29 160.6 15.48 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.858 0.837 . . . . 0.0 112.499 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.587 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -71.7 103.45 3.07 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.477 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.832 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.8 OUTLIER 113.1 55.48 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.496 0 O-C-N 125.245 1.591 . . . . 0.0 111.056 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.561 ' CD2' ' O ' ' A' ' 101' ' ' PHE . 17.9 p90 28.52 41.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.492 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.566 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 6.4 p-10 -115.26 24.15 11.88 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.66 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.472 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -139.42 150.45 21.34 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.475 ' CB ' ' HZ1' ' A' ' 104' ' ' LYS . 0.8 OUTLIER -33.34 142.21 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.598 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.404 ' O ' ' CD ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -105.66 162.95 13.06 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.635 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.536 ' CG1' ' N ' ' A' ' 107' ' ' ASP . 1.4 t -132.62 167.57 26.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.476 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.536 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 2.6 p30 -150.18 149.0 29.61 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.099 -1.44 . . . . 0.0 112.438 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.2 mt -137.22 143.2 40.73 Favored Pre-proline 0 N--CA 1.499 1.98 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.446 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.81 166.43 27.69 Favored 'Trans proline' 0 C--O 1.212 -0.782 0 C-N-CA 121.789 1.66 . . . . 0.0 112.346 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.89 145.98 95.01 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 122.296 1.997 . . . . 0.0 111.233 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.17 -143.27 12.63 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.279 -1.438 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.597 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 10.5 tt0 -146.46 154.27 41.39 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.165 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.597 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 8.4 m-85 -138.64 152.89 48.49 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.102 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.6 p -88.43 -166.84 1.7 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.669 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.446 ' HB2' ' HG ' ' A' ' 168' ' ' SER . 4.4 tt0 -96.57 51.17 1.16 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.389 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.58 -68.81 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.35 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 121' ' ' TYR . 8.6 pt-20 -68.54 -41.68 79.52 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.891 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.583 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -37.49 -75.07 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.633 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.633 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -51.68 -52.2 49.97 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.574 -0.851 . . . . 0.0 110.855 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -74.57 16.33 0.28 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.961 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.619 ' HH ' ' H ' ' A' ' 66' ' ' VAL . 17.8 t80 -124.52 -13.8 6.99 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.517 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -138.13 -52.94 0.05 OUTLIER Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.506 -1.33 . . . . 0.0 110.603 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.558 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -138.4 -101.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.407 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.558 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 32.0 t70 -164.41 176.79 8.73 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.162 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.541 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 45.7 t30 -59.83 137.61 58.01 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.843 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.554 ' OD1' ' N ' ' A' ' 127' ' ' THR . 7.4 p30 43.59 -151.07 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.914 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.554 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 13.7 t 48.35 20.09 0.26 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.59 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.487 ' O ' ' CB ' ' A' ' 129' ' ' SER . 7.4 mm -50.57 -84.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.927 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 1.2 p 80.51 120.01 0.05 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.44 114.16 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.022 -1.445 . . . . 0.0 114.197 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.482 HG12 ' CD2' ' A' ' 95' ' ' PHE . 3.6 t -121.47 134.55 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.571 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.4 ttmm -131.32 99.37 17.57 Favored Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.664 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.85 107.43 1.87 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.018 1.145 . . . . 0.0 110.47 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -86.29 11.14 12.82 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.843 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.5 -45.73 0.04 OUTLIER Glycine 0 N--CA 1.494 2.564 0 C-N-CA 118.097 -2.001 . . . . 0.0 111.762 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.23 163.17 18.17 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.154 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 173' ' ' SER . . . -80.44 159.94 25.47 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.79 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 20.8 t -122.41 141.68 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.921 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.86 130.86 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.71 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.22 139.33 40.04 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.319 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 3.0 m-85 -121.44 129.23 52.87 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.987 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.423 ' H ' ' HD2' ' A' ' 142' ' ' LYS . 0.1 OUTLIER -77.07 -48.44 17.81 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.484 -0.887 . . . . 0.0 112.228 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.454 ' N ' HD21 ' A' ' 143' ' ' ASN . 1.8 m-80 -74.32 135.78 42.56 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.069 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 143' ' ' ASN . 6.4 m-20 -9.16 -110.42 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.589 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 16.7 m-80 -68.45 86.69 0.3 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 146' ' ' PHE . 1.1 p90 30.32 72.55 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.889 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.7 m -142.67 -160.64 1.12 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.091 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 44.25 -158.01 0.16 Allowed Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.81 -1.186 . . . . 0.0 111.106 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -62.08 163.71 7.65 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.932 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.5 p -150.34 162.9 39.63 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.409 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.7 88.58 53.98 Favored Pre-proline 0 N--CA 1.485 1.296 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.041 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HB2' ' ND2' ' A' ' 154' ' ' ASN . 2.9 Cg_endo -66.08 105.3 0.81 Allowed 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.433 1.422 . . . . 0.0 111.965 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.43 69.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.238 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.679 ' H ' HD21 ' A' ' 154' ' ' ASN . 0.6 OUTLIER -81.06 37.28 0.43 Allowed 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.127 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.627 ' HG ' ' H ' ' A' ' 156' ' ' ASP . 13.7 t -170.9 -175.15 1.7 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.061 -1.055 . . . . 0.0 111.161 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.627 ' H ' ' HG ' ' A' ' 155' ' ' SER . 16.3 m-20 -76.78 142.12 40.49 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.559 -0.857 . . . . 0.0 111.141 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.586 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -154.96 74.33 5.62 Favored Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.458 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.23 23.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 122.065 1.843 . . . . 0.0 112.317 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.586 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -171.43 115.71 0.4 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.701 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.424 ' C ' ' H ' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -128.74 4.47 5.48 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.719 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -76.03 41.61 1.53 Allowed Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.831 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.52 ' O ' ' SD ' ' A' ' 163' ' ' MET . . . -134.06 24.7 3.9 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.197 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.52 ' SD ' ' O ' ' A' ' 162' ' ' ALA . 63.0 mmm -142.93 59.66 1.42 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.468 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.442 ' C ' ' O ' ' A' ' 163' ' ' MET . 0.6 OUTLIER -29.19 90.02 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.352 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 163' ' ' MET . 8.2 t-20 -160.55 151.8 19.2 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.808 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -96.25 121.05 37.62 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.907 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.4 m -75.97 104.77 6.66 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.835 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.446 ' HG ' ' HB2' ' A' ' 115' ' ' GLN . 1.3 t -82.17 -68.0 0.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.732 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.531 ' CB ' ' H ' ' A' ' 146' ' ' PHE . 28.6 m -114.03 163.73 14.76 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.926 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 22.0 pt -141.02 161.29 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.089 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -141.8 98.7 3.39 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.542 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.6 mt -77.71 99.49 2.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.037 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 137' ' ' ALA . 39.7 m . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.814 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttt . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.91 0.386 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.2 167.72 21.34 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.895 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -173.93 123.46 0.33 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.464 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.9 pt -76.05 148.54 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.379 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.5 m -122.89 109.82 14.64 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.243 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 m -100.75 150.93 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.924 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.791 ' CZ ' ' CE1' ' A' ' 12' ' ' PHE . 25.9 m-85 -109.51 163.64 13.25 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.636 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.29 -3.21 47.84 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.051 -1.06 . . . . 0.0 113.681 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.677 HD21 HE22 ' A' ' 13' ' ' GLN . 83.4 m-20 -136.0 164.32 28.26 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.945 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -70.63 176.68 3.97 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.69 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.572 ' C ' ' H ' ' A' ' 13' ' ' GLN . 5.9 m-20 57.44 46.55 17.91 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.344 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.791 ' CE1' ' CZ ' ' A' ' 7' ' ' PHE . 85.4 t80 49.91 7.24 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.341 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.68 ' CD ' ' H ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -92.06 174.27 7.41 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.434 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.68 ' H ' ' CD ' ' A' ' 13' ' ' GLN . . . 93.84 127.33 4.69 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.053 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' GLY . 13.7 mptt -31.38 141.49 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.056 0.455 . . . . 0.0 111.914 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.17 162.71 13.91 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.834 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -148.09 125.22 2.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.964 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -93.15 128.49 39.1 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.971 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.4 mt -122.28 129.82 24.94 Favored Pre-proline 0 N--CA 1.491 1.615 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.728 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -67.96 162.44 39.83 Favored 'Trans proline' 0 C--N 1.325 -0.684 0 C-N-CA 120.806 1.004 . . . . 0.0 111.141 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.04 -161.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 121.667 1.578 . . . . 0.0 110.864 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.4 -179.46 49.32 Favored Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.295 -1.431 . . . . 0.0 111.082 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.665 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.6 OUTLIER -106.21 135.47 47.63 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.204 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -152.23 167.75 27.57 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.104 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.6 p -142.05 -161.44 1.23 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.108 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -56.71 -29.2 62.22 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.054 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.18 -67.68 0.43 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.125 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -57.56 -41.46 81.1 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.428 -1.309 . . . . 0.0 110.003 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 32' ' ' LEU . 28.6 mt -61.04 -39.76 91.01 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.892 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.95 -32.61 33.93 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 118.035 -1.466 . . . . 0.0 107.807 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.39 -36.66 79.46 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.318 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 29' ' ' LEU . 14.3 mt -74.75 -80.01 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.872 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.46 -22.67 0.09 OUTLIER Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.854 -1.641 . . . . 0.0 111.222 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.442 ' C ' ' CG ' ' A' ' 35' ' ' GLU . 6.5 pt -85.39 158.08 3.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.263 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER 170.27 137.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.708 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 8.1 t-20 74.97 -147.3 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.557 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.654 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.0 OUTLIER -58.68 96.7 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.651 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 39' ' ' ILE . 60.6 p -152.1 -142.57 0.12 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.106 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.457 HD11 ' N ' ' A' ' 39' ' ' ILE . 2.2 mm 36.82 44.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.323 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.51 ' OG ' ' C ' ' A' ' 9' ' ' ASN . 12.7 t -49.08 -43.01 40.72 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.502 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.2 171.74 13.82 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.469 HG13 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -152.1 141.85 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 118.093 -1.443 . . . . 0.0 112.954 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -134.05 103.77 5.94 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.943 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.3 t -120.48 108.31 37.8 Favored Pre-proline 0 N--CA 1.494 1.743 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.231 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -67.21 168.73 16.85 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.11 1.206 . . . . 0.0 110.746 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -59.35 -170.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.929 1.753 . . . . 0.0 111.179 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.18 -11.7 11.45 Favored Glycine 0 N--CA 1.483 1.81 0 C-N-CA 119.278 -1.439 . . . . 0.0 110.961 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.49 141.7 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.114 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.7 tttt -116.01 126.58 54.01 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.2 165.32 13.06 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.109 -1.036 . . . . 0.0 113.307 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.2 mt -142.44 120.65 8.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 114.211 -1.359 . . . . 0.0 108.524 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.484 ' CD2' ' H ' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -92.19 148.38 22.2 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.104 -1.038 . . . . 0.0 112.074 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.484 ' H ' ' CD2' ' A' ' 52' ' ' LEU . 17.6 m-85 -132.83 114.71 14.4 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.183 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -53.16 -84.29 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.787 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -59.48 149.37 29.83 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.1 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -57.22 -173.01 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.637 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.1 32.43 35.42 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.19 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 49.53 45.13 24.27 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.732 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.54 -169.45 1.67 Allowed 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.011 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 68.0 166.38 3.54 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.892 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 60' ' ' GLY . 26.6 t70 -42.78 130.37 4.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.535 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.606 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 5.9 pm0 -99.86 166.06 11.26 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.052 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 64' ' ' GLU . 5.5 mm -135.13 169.5 21.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.534 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.467 ' N ' HG23 ' A' ' 63' ' ' ILE . 36.7 mt-10 -146.34 132.45 19.33 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.003 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 m -149.32 151.59 12.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.358 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.3 t -140.2 -0.26 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.461 ' CB ' ' OH ' ' A' ' 121' ' ' TYR . . . -130.8 -147.61 0.33 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.669 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.5 119.1 38.0 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.671 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.469 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -89.36 104.41 16.96 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.861 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -64.32 -77.68 0.05 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.003 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 73' ' ' GLY . 6.5 mm-40 -83.41 1.31 42.11 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.5 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.413 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 3.0 tp 56.63 -89.22 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.55 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.413 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 177.82 -166.48 36.76 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.155 -1.498 . . . . 0.0 110.621 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.581 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.9 Cg_endo -66.45 -40.96 12.9 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 122.135 1.89 . . . . 0.0 112.163 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.664 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 1.9 pt? -68.13 26.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.465 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.581 ' H ' ' C ' ' A' ' 74' ' ' PRO . 34.0 t-20 -68.55 -34.89 76.62 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.574 -0.85 . . . . 0.0 111.277 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -87.98 29.78 0.9 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.098 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -171.88 112.92 0.32 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.335 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.5 t -147.38 155.38 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.902 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.2 t -171.62 -34.85 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 118.744 -1.182 . . . . 0.0 112.265 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.1 m -116.66 137.91 51.84 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.956 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.3 mt -148.6 155.18 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.511 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.834 HH12 ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -149.71 133.49 16.88 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.889 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.834 ' N ' HH12 ' A' ' 83' ' ' ARG . 13.9 t -140.68 148.25 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.911 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.68 ' N ' ' CD1' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -142.41 136.46 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.846 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.53 ' H ' ' HG ' ' A' ' 86' ' ' SER . 5.6 m -39.91 152.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.166 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -153.24 141.36 13.85 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.224 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -49.25 151.08 6.82 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.451 1.434 . . . . 0.0 111.706 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 17.6 m -71.51 147.22 11.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.903 -0.719 . . . . 0.0 112.309 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -145.87 129.73 8.55 Favored Pre-proline 0 C--N 1.301 -1.523 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.922 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -58.17 -159.4 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.874 0 C-N-CA 120.987 1.125 . . . . 0.0 110.801 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.481 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.58 -161.82 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.162 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.27 164.72 27.43 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.841 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 39.7 ttm-85 -121.99 126.17 47.94 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.714 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 11.4 m-85 -116.8 125.31 51.41 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.797 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -84.65 168.07 15.63 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.191 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.438 ' HB3' ' H ' ' A' ' 98' ' ' LYS . 1.2 t80 -80.35 -92.11 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 118.502 -1.279 . . . . 0.0 112.939 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.438 ' H ' ' HB3' ' A' ' 97' ' ' TYR . 18.8 mmmt -68.22 156.05 38.41 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.932 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 1.091 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 3.5 tm-20 -66.57 85.01 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.127 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 1.091 ' NE2' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 173.86 30.05 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.202 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.61 ' O ' ' CD1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER 47.81 11.51 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.797 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.597 ' H ' ' C ' ' A' ' 100' ' ' GLN . 34.7 t70 -104.4 -177.47 3.37 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.316 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.489 ' H ' ' CG ' ' A' ' 102' ' ' ASP . . . 72.41 128.81 0.1 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.068 -1.539 . . . . 0.0 109.998 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 103' ' ' GLY . 48.1 mttt -30.06 136.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 123.99 0.465 . . . . 0.0 111.438 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.96 170.39 8.76 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.502 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.461 HG11 ' N ' ' A' ' 107' ' ' ASP . 29.9 t -137.36 155.31 31.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.69 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.461 ' N ' HG11 ' A' ' 106' ' ' VAL . 3.0 p30 -129.24 147.01 51.04 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.654 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.1 mt -136.42 139.31 29.25 Favored Pre-proline 0 N--CA 1.501 2.106 0 C-N-CA 119.724 -0.791 . . . . 0.0 110.811 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -71.04 167.75 25.2 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 121.662 1.575 . . . . 0.0 112.193 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.32 150.83 85.71 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 122.101 1.868 . . . . 0.0 111.573 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.18 -168.81 23.6 Favored Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.03 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.594 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 2.2 mp0 -113.74 159.1 20.11 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.6 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 40.7 m-85 -144.84 149.89 36.16 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.755 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.4 p -89.64 -153.06 0.26 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.123 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.432 ' H ' ' HG3' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -110.95 31.81 5.75 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.67 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -134.93 -64.31 0.66 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.953 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.6 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 17.2 pt-20 -66.21 -49.37 67.5 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.066 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.6 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -37.12 -67.15 0.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.293 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.653 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 20.6 mp0 -48.2 -66.74 0.35 Allowed 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.14 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -72.44 12.32 0.48 Allowed 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.06 -1.056 . . . . 0.0 113.301 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 117' ' ' GLU . 12.8 t80 -101.97 -21.86 14.41 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.007 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -165.36 -12.97 0.03 OUTLIER Glycine 0 N--CA 1.486 2.014 0 C-N-CA 118.237 -1.935 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.8 mt -145.69 -125.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.876 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -156.98 -160.38 0.96 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.457 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -59.55 -53.62 56.0 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.809 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -155.62 123.68 5.77 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.601 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.401 ' H ' ' H ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 177.71 0.81 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.042 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 130' ' ' SER . 70.5 mt -56.43 -72.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.285 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m 55.7 -85.1 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.776 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 128' ' ' ILE . 15.1 m -72.62 115.74 12.26 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.488 -0.885 . . . . 0.0 112.391 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.4 t -122.7 161.78 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.779 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -165.08 80.51 1.24 Allowed Pre-proline 0 C--N 1.296 -1.726 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.293 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -60.59 102.9 0.2 Allowed 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 121.568 1.512 . . . . 0.0 110.242 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.82 19.71 3.38 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.467 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.12 -50.93 0.03 OUTLIER Glycine 0 N--CA 1.491 2.352 0 C-N-CA 117.91 -2.09 . . . . 0.0 112.191 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.86 179.85 3.96 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.454 -0.899 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -92.1 152.33 19.98 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.776 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 68.2 t -124.11 138.86 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.127 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.3 t -131.71 128.42 60.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.417 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 8.3 mp -103.99 141.77 35.6 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.365 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.415 ' HB2' ' HG ' ' A' ' 169' ' ' SER . 19.2 m-85 -114.16 126.98 55.68 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.515 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -59.21 -78.62 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.437 ' N ' HD21 ' A' ' 143' ' ' ASN . 1.2 m-80 -73.71 155.54 38.85 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.816 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 146' ' ' PHE . 5.3 p-10 -62.49 -162.18 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.567 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.497 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 43.7 t30 42.5 24.15 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.675 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.497 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.4 OUTLIER 57.17 54.82 6.45 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.703 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.707 ' HG ' ' H ' ' A' ' 148' ' ' GLY . 7.8 t -130.73 -171.68 2.62 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.305 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.707 ' H ' ' HG ' ' A' ' 147' ' ' SER . . . 64.11 -177.9 8.27 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.024 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 150' ' ' THR . 25.5 t0 -59.68 177.23 0.22 Allowed 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.262 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.478 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 19.5 p -146.56 178.59 8.17 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.193 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.0 tp -153.07 86.61 4.09 Favored Pre-proline 0 C--N 1.306 -1.303 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.778 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.46 108.07 1.13 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.871 1.714 . . . . 0.0 113.131 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.7 t -82.72 93.59 2.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.788 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.641 ' N ' HD21 ' A' ' 154' ' ' ASN . 1.3 m120 -58.8 -29.35 66.77 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 48.0 p -170.38 -146.36 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 117.986 -1.486 . . . . 0.0 112.854 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 1.1 m-20 -48.98 153.24 0.91 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.99 -1.004 . . . . 0.0 112.491 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.489 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -179.89 65.24 0.14 Allowed Pre-proline 0 N--CA 1.486 1.37 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.206 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 159' ' ' THR . 6.4 Cg_endo -69.03 66.29 1.34 Allowed 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 122.27 1.98 . . . . 0.0 111.959 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.497 ' CB ' ' O ' ' A' ' 158' ' ' PRO . 0.1 OUTLIER 161.11 -68.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.56 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.48 ' H ' ' CG2' ' A' ' 159' ' ' THR . 0.9 OUTLIER 57.04 -81.41 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.829 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 159' ' ' THR . . . 47.49 -150.67 2.41 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 118.495 -1.812 . . . . 0.0 109.683 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 44.37 40.93 4.11 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.489 ' C ' ' SD ' ' A' ' 163' ' ' MET . 0.0 OUTLIER -172.92 66.68 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.746 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -60.63 -111.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.75 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 54.49 -123.45 2.08 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.305 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -173.96 121.31 0.3 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.562 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.0 m -70.44 104.91 2.87 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.836 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.2 m -80.98 -66.25 0.91 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.216 -0.993 . . . . 0.0 111.599 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.438 ' H ' ' HG ' ' A' ' 169' ' ' SER . 2.8 p -118.7 159.89 22.83 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.978 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 23.2 pt -135.53 179.8 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.246 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -159.5 100.99 1.51 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.821 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.8 mt -82.06 96.88 3.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.78 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 116.302 -1.808 . . . . 0.0 111.095 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . 0.614 'CA ' ' OE2' ' A' ' 99' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.475 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.19 170.21 16.75 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 179.62 118.21 0.05 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.995 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.3 pt -79.27 164.8 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.388 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.5 m -138.93 123.02 17.96 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.729 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -104.62 168.12 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.285 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.403 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 68.9 m-85 -128.94 144.6 51.23 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.71 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -52.86 19.83 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.783 -0.767 . . . . 0.0 113.041 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.478 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 24.8 m120 -95.27 170.42 9.4 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.409 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.707 ' CG ' ' H ' ' A' ' 11' ' ' ASP . 16.6 tt0 -64.26 -178.7 0.38 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.778 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.707 ' H ' ' CG ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER 41.51 62.17 1.61 Allowed 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.325 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.655 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 44.9 p90 36.71 27.14 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.229 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ASP . 2.0 tp-100 -101.46 162.46 12.88 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.729 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.478 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 89.37 137.32 6.3 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.472 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -30.04 137.52 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.057 0.456 . . . . 0.0 111.889 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.412 ' HB2' HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -103.32 162.97 12.56 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.034 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -144.23 130.26 15.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.297 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.58 133.6 34.53 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.749 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 mt -126.13 123.73 24.44 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.578 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.94 162.22 29.92 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 120.975 1.117 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.27 -170.08 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 121.705 1.604 . . . . 0.0 110.967 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.3 -179.08 38.99 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.095 -1.526 . . . . 0.0 110.958 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.764 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.2 OUTLIER -109.36 129.94 55.51 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.715 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -143.23 175.19 10.07 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.433 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.0 p -140.35 -160.0 1.02 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.475 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -61.15 -20.56 62.84 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.7 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.91 -62.35 1.7 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.157 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.64 -43.1 75.91 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.661 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.4 mt -59.45 -41.2 89.11 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.424 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.65 -31.01 23.86 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 118.805 -1.158 . . . . 0.0 108.662 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.55 -38.16 71.02 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.0 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.5 mt -73.13 -74.39 0.17 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.688 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.46 -34.87 0.47 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.057 -1.544 . . . . 0.0 110.841 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.92 140.43 16.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.615 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 2.8 pt-20 178.54 131.72 0.07 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.78 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 1.5 t-20 78.22 127.49 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.511 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 51.55 7.85 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.705 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.466 ' N ' HG23 ' A' ' 79' ' ' VAL . 67.2 p -91.48 -135.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.664 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' A' ' 38' ' ' THR . 2.2 mt 35.74 39.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.604 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.52 -57.51 6.92 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.762 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.403 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -116.66 168.96 9.73 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.266 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.482 HG11 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -149.73 148.96 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 118.529 -1.269 . . . . 0.0 112.396 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -137.87 96.02 3.15 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.157 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.6 t -111.21 110.66 56.13 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.386 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -69.07 171.21 14.11 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.114 1.209 . . . . 0.0 110.411 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.45 -173.94 0.19 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.663 1.575 . . . . 0.0 111.082 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.04 -17.86 6.84 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.328 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.81 138.85 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.312 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -105.9 119.7 39.86 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -97.38 155.65 16.81 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.194 -1.002 . . . . 0.0 112.884 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.1 mt -141.76 117.21 5.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.921 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.725 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 2.0 mp -89.47 157.71 18.0 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.349 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.423 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 43.3 m-85 -138.47 107.36 5.97 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.553 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -40.93 -76.92 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.95 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.458 ' C ' ' OG ' ' A' ' 80' ' ' SER . 12.6 m120 -68.45 153.33 43.97 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.311 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -59.99 -174.95 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.653 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 49.21 40.49 29.43 Favored Glycine 0 N--CA 1.484 1.891 0 C-N-CA 119.114 -1.517 . . . . 0.0 109.656 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.653 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.5 OUTLIER 41.5 69.19 0.37 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.452 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.69 -162.39 1.42 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.993 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.48 -176.59 0.63 Allowed Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.23 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -46.2 160.85 0.06 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.879 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -146.99 161.17 41.33 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.864 -1.135 . . . . 0.0 111.67 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 64' ' ' GLU . 38.4 mt -133.03 172.97 15.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.112 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.454 ' N ' HG23 ' A' ' 63' ' ' ILE . 3.3 tm-20 -144.81 130.44 18.99 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.154 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.4 ' N ' ' OE2' ' A' ' 64' ' ' GLU . 21.1 m -145.19 154.54 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 118.615 -1.234 . . . . 0.0 112.108 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.438 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 2.1 t -136.91 -1.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.491 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.38 -124.12 0.23 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.062 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.631 ' ND2' ' OD1' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -121.82 121.26 36.79 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.95 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.482 ' H ' HG11 ' A' ' 42' ' ' VAL . . . -88.47 109.05 19.72 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.673 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 30.4 tp10 -61.9 -87.69 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.307 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 18.4 mt-10 -78.81 1.01 24.75 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.428 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 2.2 tp 74.73 -82.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.835 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 169.82 -169.19 41.94 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.225 -1.464 . . . . 0.0 110.696 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.503 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.3 Cg_endo -65.91 -46.54 4.7 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.307 2.005 . . . . 0.0 112.384 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.472 ' H ' HD21 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -73.62 34.9 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.291 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.503 ' H ' ' C ' ' A' ' 74' ' ' PRO . 29.0 p-10 -75.34 -24.05 57.3 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.745 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -80.12 4.48 17.18 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.985 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -151.93 114.12 4.5 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.533 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.466 HG23 ' N ' ' A' ' 38' ' ' THR . 24.2 m -133.9 158.29 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.963 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.607 ' HG ' ' H ' ' A' ' 81' ' ' SER . 96.4 p -164.44 -69.43 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 118.391 -1.324 . . . . 0.0 112.453 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.607 ' H ' ' HG ' ' A' ' 80' ' ' SER . 73.7 m -107.42 160.89 15.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.49 -0.884 . . . . 0.0 112.485 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.7 mt -149.87 159.7 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.635 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.79 HH22 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.7 130.72 15.32 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 118.929 -1.108 . . . . 0.0 111.415 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.79 ' CA ' HH22 ' A' ' 83' ' ' ARG . 4.2 t -132.2 141.65 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.847 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.463 HG12 ' NH2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -136.17 140.32 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.047 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 90.2 p -43.27 151.05 0.17 Allowed 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.599 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.85 144.14 13.75 Favored Pre-proline 0 C--N 1.307 -1.273 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.638 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -50.05 146.27 17.63 Favored 'Trans proline' 0 C--O 1.213 -0.763 0 C-N-CA 121.256 1.304 . . . . 0.0 111.345 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.95 145.94 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.053 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -145.28 153.66 52.7 Favored Pre-proline 0 N--CA 1.486 1.349 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.469 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -60.52 -152.07 0.01 OUTLIER 'Trans proline' 0 C--O 1.211 -0.868 0 C-N-CA 121.061 1.174 . . . . 0.0 110.501 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.426 ' HB2' ' H ' ' A' ' 93' ' ' ALA . 15.4 ptt180 179.76 -163.39 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.826 -1.15 . . . . 0.0 110.86 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.426 ' H ' ' HB2' ' A' ' 92' ' ' ARG . . . -133.76 169.92 16.33 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.201 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.473 ' HE ' ' HG3' ' A' ' 105' ' ' GLU . 66.7 ttt180 -137.91 110.02 7.29 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.969 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 19.3 m-85 -93.91 168.52 10.92 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.419 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.47 ' CD1' ' HB3' ' A' ' 105' ' ' GLU . 49.2 m-85 -137.87 177.08 8.15 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 119.033 -1.067 . . . . 0.0 112.075 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.524 ' CE2' ' CG2' ' A' ' 127' ' ' THR . 3.2 m-85 -115.63 133.21 56.26 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.4 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 19.4 tttp 78.59 137.72 0.07 Allowed 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.035 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.588 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 0.7 OUTLIER -68.2 104.84 1.92 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.219 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.614 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 1.7 tp-100 126.28 39.44 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.263 0 O-C-N 125.565 1.791 . . . . 0.0 109.721 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.614 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 25.7 p90 29.67 49.51 0.06 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.8 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -103.65 -17.67 15.04 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.076 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -102.41 164.07 16.67 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.594 -1.288 . . . . 0.0 110.976 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.46 ' CG ' ' N ' ' A' ' 105' ' ' GLU . 16.9 ttmt -40.7 160.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.823 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 105' ' ' GLU . 1.3 pm0 -127.14 158.97 35.64 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.613 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.4 156.43 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.741 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.631 ' OD1' ' ND2' ' A' ' 68' ' ' ASN . 4.8 p-10 -125.91 148.47 49.2 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.578 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.451 HD11 ' CE1' ' A' ' 95' ' ' PHE . 41.2 mt -139.19 124.69 11.95 Favored Pre-proline 0 N--CA 1.487 1.421 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.342 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.439 ' CB ' ' HD2' ' A' ' 110' ' ' PRO . 1.9 Cg_endo -64.39 171.59 7.78 Favored 'Trans proline' 0 C--O 1.213 -0.77 0 C-N-CA 121.476 1.451 . . . . 0.0 111.356 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.439 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 1.9 Cg_endo -60.78 146.41 97.42 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.875 1.717 . . . . 0.0 111.568 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.19 -154.92 25.74 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.674 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.591 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 28.5 mt-30 -133.24 161.29 34.85 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.842 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.591 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 24.0 m-85 -144.54 150.64 37.87 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.372 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 1.3 p -91.78 -142.17 0.19 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.697 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.597 ' N ' ' OG1' ' A' ' 114' ' ' THR . 13.7 mt-30 -90.31 -86.46 0.2 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.31 -28.2 62.86 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -70.09 -61.06 1.93 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.307 -1.357 . . . . 0.0 108.454 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.586 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 2.2 tt -43.35 -64.04 0.71 Allowed 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.557 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.415 ' CD ' ' O ' ' A' ' 115' ' ' GLN . 1.1 mp0 -42.86 -68.3 0.21 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.36 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.554 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 10.6 mpt_? -68.43 0.33 4.09 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.624 -0.83 . . . . 0.0 113.199 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.438 ' HH ' ' H ' ' A' ' 66' ' ' VAL . 22.3 t80 -89.03 -24.87 22.24 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 118.464 -1.295 . . . . 0.0 110.554 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -153.75 -20.75 0.05 OUTLIER Glycine 0 N--CA 1.485 1.951 0 C-N-CA 118.429 -1.844 . . . . 0.0 111.688 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.424 ' HB ' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -145.32 -115.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.329 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.424 ' H ' ' HB ' ' A' ' 123' ' ' ILE . 4.2 m-20 -167.57 -164.89 0.61 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -58.13 -76.09 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.163 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.456 ' ND2' ' ND2' ' A' ' 164' ' ' ASN . 3.7 t-20 -74.68 -138.11 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.123 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.524 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 0.5 OUTLIER 68.78 -138.45 0.09 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.785 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 mm 73.55 -49.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.477 0 O-C-N 124.168 0.918 . . . . 0.0 110.435 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 130' ' ' SER . 47.0 p 39.35 -135.32 0.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.937 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.542 ' N ' ' OG ' ' A' ' 129' ' ' SER . 24.1 m -63.37 143.9 57.42 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.381 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.03 151.46 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.489 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -150.31 81.67 6.62 Favored Pre-proline 0 C--N 1.304 -1.391 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.489 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -61.08 92.4 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.316 1.344 . . . . 0.0 110.043 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -73.64 26.18 0.07 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.118 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 176.71 -51.75 0.11 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 117.53 -2.272 . . . . 0.0 112.735 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.63 173.76 6.17 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.598 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -91.76 141.94 28.13 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.581 -0.848 . . . . 0.0 108.974 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 153' ' ' VAL . 66.9 t -109.89 139.99 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.547 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.03 127.17 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.701 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 mp -101.52 138.88 37.93 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.552 -0.859 . . . . 0.0 112.39 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.431 ' CG ' ' HA ' ' A' ' 146' ' ' PHE . 22.3 m-85 -114.07 118.56 34.42 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.082 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -48.19 -77.49 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.625 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.427 ' HB3' ' H ' ' A' ' 144' ' ' ASP . 3.3 m-20 -74.59 -156.49 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.341 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 146' ' ' PHE . 6.8 p-10 -62.07 -154.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.722 ' H ' HD21 ' A' ' 145' ' ' ASN . 1.9 m-80 -33.62 88.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.159 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.529 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 3.3 p90 36.31 66.07 0.41 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.663 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 92.5 p -61.0 -108.05 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.738 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.52 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . -115.4 -63.23 0.38 Allowed Glycine 0 N--CA 1.502 3.043 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.974 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.404 ' C ' ' CG2' ' A' ' 150' ' ' THR . 24.3 t70 -74.13 144.47 44.87 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.58 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.404 ' CG2' ' C ' ' A' ' 149' ' ' ASP . 6.7 p -151.67 173.74 14.32 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.491 -0.883 . . . . 0.0 111.187 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.406 ' C ' ' CD2' ' A' ' 151' ' ' LEU . 3.0 tt -144.25 87.51 7.78 Favored Pre-proline 0 C--N 1.31 -1.145 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.153 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.14 103.99 0.56 Allowed 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.671 1.581 . . . . 0.0 112.651 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 138' ' ' VAL . 2.8 t -77.75 93.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.154 -1.019 . . . . 0.0 109.912 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -43.78 -42.85 5.79 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.888 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.1 t -171.2 -130.09 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 118.456 -1.298 . . . . 0.0 112.229 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -46.44 141.89 3.36 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.681 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.558 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.85 64.13 1.06 Allowed Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.195 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.6 Cg_endo -63.08 21.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.279 1.986 . . . . 0.0 113.269 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.558 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.3 t -172.37 106.4 0.18 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.806 -1.157 . . . . 0.0 110.911 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.453 HD11 ' N ' ' A' ' 161' ' ' GLY . 3.0 tm? -103.6 -78.63 0.55 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.288 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 164' ' ' ASN . . . 61.44 -127.98 42.9 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.859 -1.163 . . . . 0.0 111.656 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.685 ' C ' ' H ' ' A' ' 164' ' ' ASN . . . -14.24 -57.08 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 163' ' ' MET . 3.4 mmt -64.49 17.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.078 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.685 ' H ' ' C ' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -64.73 -54.08 37.07 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.629 -0.829 . . . . 0.0 110.635 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 11.5 m120 47.19 -88.8 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.86 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 164' ' ' ASN . 21.1 t-20 -159.11 -33.77 0.06 Allowed 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.195 -1.002 . . . . 0.0 111.425 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.8 m 44.72 83.08 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.391 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.36 -52.22 8.37 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.846 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.458 ' HG ' ' H ' ' A' ' 146' ' ' PHE . 3.2 p -123.66 163.77 20.41 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.68 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 36.2 pt -143.34 178.22 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.522 ' NH1' ' OE1' ' A' ' 112' ' ' GLN . 35.5 ttt85 -156.8 109.23 2.51 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.64 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.2 mt -85.95 95.8 4.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.149 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 C--N 1.303 -1.415 0 CA-C-O 116.379 -1.772 . . . . 0.0 110.825 -179.92 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mtt . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 121.055 0.455 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.2 165.56 13.88 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.506 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.713 ' N ' ' ND2' ' A' ' 3' ' ' ASN . 0.1 OUTLIER 179.49 122.3 0.06 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.517 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 4' ' ' ILE . 1.7 pt -77.44 126.91 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.985 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.9 m -105.51 108.21 19.61 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.11 165.23 2.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.028 -1.069 . . . . 0.0 112.717 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.428 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 50.1 m-85 -123.37 145.15 48.99 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.837 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.443 ' HB2' ' N ' ' A' ' 15' ' ' LYS . 2.0 m-85 -83.91 8.45 15.0 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 13' ' ' GLN . 0.4 OUTLIER -150.19 171.08 17.49 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 118.132 -1.427 . . . . 0.0 111.979 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.497 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 11.6 mm-40 -78.36 146.88 34.39 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.348 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.587 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 2.1 t70 76.87 60.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.42 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.587 ' CG ' ' O ' ' A' ' 11' ' ' ASP . 54.7 p90 42.78 15.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.774 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 11' ' ' ASP . 14.2 mt-30 -101.42 154.5 18.75 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.193 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 1.144 ' O ' ' NE2' ' A' ' 16' ' ' GLN . . . 116.63 139.34 6.48 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 1.279 ' C ' ' NE2' ' A' ' 16' ' ' GLN . 9.3 mtpm? -36.41 147.38 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.491 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 1.437 HE21 ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -99.88 142.25 31.61 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.584 -0.847 . . . . 0.0 112.25 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 t -144.48 123.72 6.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.523 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -95.47 119.39 33.89 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.414 -0.914 . . . . 0.0 112.106 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.1 125.7 30.1 Favored Pre-proline 0 N--CA 1.494 1.762 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.471 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -65.44 162.39 33.97 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 120.993 1.128 . . . . 0.0 111.724 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.31 -178.83 0.51 Allowed 'Trans proline' 0 C--N 1.322 -0.838 0 C-N-CA 121.768 1.645 . . . . 0.0 110.966 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.679 ' C ' HD21 ' A' ' 23' ' ' ASN . . . 108.4 -170.9 15.3 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.381 -1.39 . . . . 0.0 110.662 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.679 HD21 ' C ' ' A' ' 22' ' ' GLY . 0.6 OUTLIER -117.21 124.69 49.72 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.96 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 3.2 p90 -144.3 169.43 17.91 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.786 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.7 p -140.75 -142.04 0.14 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.992 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.444 ' NH2' ' ND2' ' A' ' 36' ' ' ASN . 15.7 tpp180 -69.32 -38.5 78.25 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.031 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.7 -58.59 6.94 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.14 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -56.89 -51.18 70.1 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.484 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 28.4 mt -58.26 -28.8 65.27 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.446 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 26' ' ' ARG . . . -56.26 -32.09 64.18 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.42 -36.04 63.41 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.72 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.3 mt -77.01 -83.65 0.07 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.89 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.39 -16.91 0.77 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.033 -1.556 . . . . 0.0 111.225 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.36 138.98 18.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.073 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' C ' ' CG ' ' A' ' 36' ' ' ASN . 1.8 pt-20 172.42 150.31 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.403 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.53 ' O ' ' N ' ' A' ' 38' ' ' THR . 0.5 OUTLIER 75.86 123.81 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 43.39 12.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.358 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 36' ' ' ASN . 64.3 p -88.86 -151.38 0.21 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.447 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 38' ' ' THR . 2.3 mt 42.49 60.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.736 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.8 t -80.14 -33.15 38.74 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.418 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -143.14 153.72 43.16 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.247 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.457 HG21 ' H ' ' A' ' 69' ' ' ALA . 25.4 m -143.38 170.44 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 118.128 -1.429 . . . . 0.0 113.578 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -143.48 95.67 2.79 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.862 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.99 108.48 46.27 Favored Pre-proline 0 N--CA 1.493 1.716 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.73 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.411 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.6 Cg_endo -68.52 170.29 15.35 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 120.975 1.117 . . . . 0.0 110.321 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.411 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 2.5 Cg_endo -60.28 -170.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.877 1.718 . . . . 0.0 111.407 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.3 -12.34 10.11 Favored Glycine 0 N--CA 1.485 1.945 0 C-N-CA 119.407 -1.377 . . . . 0.0 111.13 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 m -148.77 139.55 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.142 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -115.38 120.23 38.89 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.03 155.25 19.58 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.287 -0.965 . . . . 0.0 112.808 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.4 mt -142.22 118.28 6.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.094 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.442 HD11 ' H ' ' A' ' 52' ' ' LEU . 3.6 mp -88.8 159.37 17.78 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.008 -1.077 . . . . 0.0 112.504 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.409 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 72.1 m-85 -141.59 118.89 11.43 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.836 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -49.9 -82.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.461 ' ND2' ' H ' ' A' ' 56' ' ' ASP . 2.7 t-20 -58.59 155.06 13.06 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.386 -0.925 . . . . 0.0 111.799 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.461 ' H ' ' ND2' ' A' ' 55' ' ' ASN . 21.1 p-10 -59.89 -177.9 0.07 Allowed 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.705 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.581 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 50.45 38.71 35.23 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 39.17 71.12 0.18 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.521 0.677 . . . . 0.0 111.058 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.3 172.52 12.81 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.969 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.34 -174.64 55.0 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.445 -1.36 . . . . 0.0 109.981 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -44.87 158.1 0.06 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.895 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.502 ' NE2' ' C ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -149.84 168.41 23.81 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.812 -1.155 . . . . 0.0 111.499 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.523 ' CG2' ' H ' ' A' ' 64' ' ' GLU . 73.0 mt -134.85 174.11 13.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.723 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.523 ' H ' ' CG2' ' A' ' 63' ' ' ILE . 24.8 mt-10 -144.74 133.92 22.86 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.568 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.4 m -150.55 152.89 11.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 118.628 -1.229 . . . . 0.0 112.224 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.54 -10.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.412 ' HB2' ' H ' ' A' ' 68' ' ' ASN . . . -119.92 -156.93 0.69 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.56 -1.655 . . . . 0.0 109.673 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.434 ' ND2' ' C ' ' A' ' 68' ' ' ASN . 0.5 OUTLIER -93.23 127.85 38.98 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.077 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.457 ' H ' HG21 ' A' ' 42' ' ' VAL . . . -90.43 119.52 30.78 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.781 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -79.9 -58.74 3.02 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.445 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -106.52 19.47 20.44 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.612 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.0 tp 53.01 -98.4 0.07 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.466 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.82 -158.99 31.47 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.093 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.546 ' O ' ' N ' ' A' ' 76' ' ' ASN . 1.5 Cg_endo -66.02 -157.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.451 1.434 . . . . 0.0 110.545 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 74' ' ' PRO . 1.4 pt? 31.69 32.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 123.8 0.687 . . . . 0.0 111.79 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.546 ' N ' ' O ' ' A' ' 74' ' ' PRO . 8.5 t-20 -80.22 -12.03 59.67 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.795 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -72.72 -12.84 61.18 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.085 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -160.29 134.67 7.43 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 118.889 -1.124 . . . . 0.0 111.69 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.39 153.18 14.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.845 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 81' ' ' SER . 86.9 p -164.89 -57.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.351 -1.34 . . . . 0.0 112.772 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.473 ' N ' ' OG ' ' A' ' 80' ' ' SER . 32.9 t -89.9 146.42 24.43 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.613 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.454 HD11 ' HH ' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -146.77 134.01 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 118.74 -1.184 . . . . 0.0 111.153 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.623 ' HA ' ' NE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -108.74 141.15 41.16 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.304 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.537 ' HB ' ' H ' ' A' ' 22' ' ' GLY . 9.4 t -144.33 123.55 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.226 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.5 mt -129.07 125.67 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.303 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.8 m -43.73 132.71 4.95 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.686 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.65 139.38 34.64 Favored Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.499 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -52.76 143.55 47.16 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.127 1.218 . . . . 0.0 110.741 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.0 t -59.98 122.24 9.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.229 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -102.89 135.32 19.45 Favored Pre-proline 0 C--N 1.306 -1.326 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.987 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -52.53 -33.0 55.9 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 120.85 1.033 . . . . 0.0 110.283 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.9 mtt-85 50.68 -164.43 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.662 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.514 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.66 177.2 8.66 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.185 -1.37 . . . . 0.0 108.437 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -150.36 132.19 15.08 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 118.21 -1.396 . . . . 0.0 112.088 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.476 ' CE2' HG11 ' A' ' 131' ' ' VAL . 21.9 m-85 -118.68 147.65 43.58 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.757 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -121.15 159.29 26.13 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.185 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' A' ' 97' ' ' TYR . 8.0 m-30 -95.15 164.14 12.99 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.603 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 tttt 67.7 135.6 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.691 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.595 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 8.6 tp10 -63.69 100.94 0.31 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.273 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 1.124 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 119.73 38.17 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.882 0 O-C-N 125.426 1.704 . . . . 0.0 108.47 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.771 ' CD1' ' NE2' ' A' ' 100' ' ' GLN . 22.5 p90 33.78 44.09 0.08 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.76 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -103.64 32.33 3.93 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.581 -0.847 . . . . 0.0 111.453 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -153.66 170.11 32.38 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.167 -1.492 . . . . 0.0 110.751 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.1 OUTLIER -35.03 151.13 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.428 ' CD ' ' C ' ' A' ' 105' ' ' GLU . 1.4 pp20? -121.92 168.31 12.04 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.847 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.88 139.41 19.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.283 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 6.3 p30 -108.98 151.44 26.31 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.748 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 72.3 mt -139.64 140.27 24.56 Favored Pre-proline 0 N--CA 1.497 1.877 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.804 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -76.03 164.13 31.97 Favored 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 121.944 1.763 . . . . 0.0 111.254 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.41 142.01 76.88 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.555 1.503 . . . . 0.0 110.581 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 144.05 -158.63 27.48 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 118.916 -1.612 . . . . 0.0 111.466 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.58 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 24.4 tt0 -125.28 154.97 40.9 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.88 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.58 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 25.3 m-85 -143.53 152.71 41.79 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.738 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.7 p -106.44 178.43 4.56 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.867 0.841 . . . . 0.0 112.97 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.644 ' NE2' ' CD ' ' A' ' 119' ' ' GLU . 24.1 tp60 -59.39 -20.85 58.12 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.558 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.44 -60.71 1.85 Allowed 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.901 -1.12 . . . . 0.0 114.01 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -67.4 -56.83 8.07 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.219 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.607 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -34.11 -74.02 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 O-C-N 123.801 0.688 . . . . 0.0 111.817 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.644 ' CD ' ' NE2' ' A' ' 115' ' ' GLN . 69.5 mt-10 -51.19 -56.36 13.24 Favored 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.739 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.413 ' HD3' ' H ' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -75.06 14.65 0.5 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.474 -1.291 . . . . 0.0 111.647 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 117' ' ' GLU . 18.4 t80 -119.39 -16.44 8.96 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.856 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -139.49 -48.08 0.06 OUTLIER Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.676 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.433 ' CD1' ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -137.85 -108.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.969 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.586 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 18.3 t70 -161.75 -146.8 0.13 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.402 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.586 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 4.4 m-20 -60.67 -52.72 63.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.338 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.689 HD21 HD21 ' A' ' 166' ' ' ASN . 29.4 t-20 -158.04 134.71 9.72 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.426 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.5 t -178.61 -10.1 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.507 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 9.4 mt -70.42 141.39 17.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.528 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.403 ' O ' ' OG ' ' A' ' 130' ' ' SER . 8.3 t -157.33 12.55 0.23 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.026 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 129' ' ' SER . 14.3 m -170.7 117.12 0.49 Allowed 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.579 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.476 HG11 ' CE2' ' A' ' 95' ' ' PHE . 3.6 t -110.51 156.28 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.995 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.469 ' NZ ' ' HG3' ' A' ' 158' ' ' PRO . 1.6 tppt? -155.02 87.25 3.32 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.292 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.02 101.4 0.18 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.309 1.34 . . . . 0.0 111.678 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.514 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 38.2 tt0 -54.17 -12.21 0.6 Allowed 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.986 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -178.83 -36.6 0.06 OUTLIER Glycine 0 N--CA 1.497 2.76 0 C-N-CA 118.412 -1.852 . . . . 0.0 112.245 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mt -92.1 -174.97 3.93 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.998 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.45 137.04 48.68 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.459 ' CG1' ' CD1' ' A' ' 140' ' ' LEU . 7.2 t -103.1 140.49 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.413 -0.915 . . . . 0.0 112.866 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.43 HG13 ' CE1' ' A' ' 141' ' ' PHE . 96.4 t -131.2 120.15 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.453 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.49 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 10.1 mp -98.59 143.75 28.64 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.327 -0.949 . . . . 0.0 113.307 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.43 ' CE1' HG13 ' A' ' 139' ' ' VAL . 27.8 m-85 -120.27 130.89 54.68 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.111 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -67.21 -69.67 0.3 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.142 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -70.16 164.19 24.72 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.558 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 146' ' ' PHE . 3.6 m-20 -63.58 -160.05 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.606 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.654 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 2.5 p30 32.76 34.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 123.733 0.646 . . . . 0.0 111.57 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.654 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 42.82 61.24 2.17 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 44.5 t -136.26 -178.55 5.21 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.006 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.491 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 75.67 -163.13 53.47 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.354 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.76 164.12 3.94 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.144 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.2 p -148.2 170.16 18.48 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.944 -1.103 . . . . 0.0 111.668 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.1 tp -141.89 84.98 11.48 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.151 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -62.45 102.66 0.29 Allowed 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.076 1.85 . . . . 0.0 113.59 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 138' ' ' VAL . 6.8 t -89.19 80.36 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.346 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -76.88 14.09 0.91 Allowed 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.592 -0.843 . . . . 0.0 113.015 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.711 ' HG ' ' H ' ' A' ' 156' ' ' ASP . 19.8 t -169.97 -169.67 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 117.785 -1.566 . . . . 0.0 112.959 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.711 ' H ' ' HG ' ' A' ' 155' ' ' SER . 64.3 m-20 -57.03 152.26 13.48 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.519 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.54 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -172.88 62.62 0.29 Allowed Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.072 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.54 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 5.8 Cg_endo -70.05 34.38 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 122.336 2.024 . . . . 0.0 112.2 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.451 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.6 OUTLIER -176.33 76.57 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.407 -1.317 . . . . 0.0 112.389 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.466 ' N ' HD21 ' A' ' 160' ' ' LEU . 2.8 mm? -81.2 -87.51 0.08 Allowed 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.63 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.655 ' C ' ' H ' ' A' ' 163' ' ' MET . . . 65.56 -70.59 0.11 Allowed Glycine 0 N--CA 1.503 3.106 0 C-N-CA 119.585 -1.293 . . . . 0.0 111.857 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -52.49 4.73 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.465 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.655 ' H ' ' C ' ' A' ' 161' ' ' GLY . 14.6 mmt -115.38 40.38 2.72 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.082 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.574 ' ND2' ' H ' ' A' ' 164' ' ' ASN . 2.7 m-80 -41.84 -18.78 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.64 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 163' ' ' MET . 17.0 m120 -40.88 120.98 1.41 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.451 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.689 HD21 HD21 ' A' ' 126' ' ' ASN . 15.1 m120 -56.82 95.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.88 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.7 m -59.82 112.81 1.98 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.424 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.6 t -97.24 -63.13 1.16 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.549 -0.861 . . . . 0.0 112.043 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.5 ' HG ' ' H ' ' A' ' 146' ' ' PHE . 0.9 OUTLIER -116.06 162.39 17.47 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.04 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 25.6 pt -147.78 179.49 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.307 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -161.32 114.62 1.93 Allowed 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.302 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 42.9 mt -90.57 98.97 8.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.349 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--N 1.304 -1.405 0 CA-C-O 116.298 -1.81 . . . . 0.0 110.988 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 tmm? . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.435 ' CB ' HG13 ' A' ' 48' ' ' VAL . . . -72.22 167.16 20.94 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.657 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 2' ' ' ALA . 21.9 m-80 -169.29 110.97 0.48 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.707 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.4 pt -70.68 140.87 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.102 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -115.35 120.31 39.18 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.715 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -104.3 155.79 5.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.923 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.448 ' N ' ' CG2' ' A' ' 6' ' ' VAL . 38.8 m-85 -115.64 139.98 49.61 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.191 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -62.92 1.36 Allowed 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.385 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.493 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 3.2 m120 -89.5 168.36 12.25 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.52 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.35 -162.56 0.06 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.414 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.622 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 1.3 m-20 47.43 45.91 17.19 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.254 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.622 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 51.3 p90 38.63 24.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.951 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ASP . 3.8 pt20 -113.04 163.58 14.52 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.493 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 103.9 134.35 8.17 Favored Glycine 0 N--CA 1.501 2.996 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.457 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -28.99 132.88 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.02 0.438 . . . . 0.0 111.741 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.665 ' NE2' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -97.63 164.81 12.26 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.727 -0.789 . . . . 0.0 112.423 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 t -149.7 123.63 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.658 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.76 120.84 32.85 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.612 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mt -108.8 140.96 22.36 Favored Pre-proline 0 N--CA 1.489 1.513 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.081 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -72.2 165.72 31.8 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 120.909 1.072 . . . . 0.0 111.277 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.77 -158.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 121.905 1.736 . . . . 0.0 111.089 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.71 168.3 24.56 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 119.272 -1.442 . . . . 0.0 111.551 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.533 ' ND2' ' H ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -95.87 140.45 30.62 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.065 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.481 ' O ' ' CE1' ' A' ' 58' ' ' PHE . 36.7 p90 -155.68 176.2 12.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.673 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.647 ' HG1' ' H ' ' A' ' 26' ' ' ARG . 6.3 t -138.09 -157.32 0.76 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.009 -1.077 . . . . 0.0 112.443 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.647 ' H ' ' HG1' ' A' ' 25' ' ' THR . 13.1 ptm180 -63.69 -25.82 68.38 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.358 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.609 ' H ' ' CG2' ' A' ' 25' ' ' THR . . . -58.56 -55.96 28.27 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.652 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.29 -45.1 88.6 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.637 -1.225 . . . . 0.0 109.555 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 30.2 mt -59.97 -34.09 72.82 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.518 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.74 -32.02 59.27 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.46 -40.55 70.24 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.675 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 mt -70.35 -81.04 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.967 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 160.09 -26.43 0.32 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 118.952 -1.594 . . . . 0.0 111.049 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.457 HG12 ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -85.73 152.22 3.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.574 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.466 ' H ' HG22 ' A' ' 38' ' ' THR . 3.4 pt-20 -178.51 154.31 0.78 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.357 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 38' ' ' THR . 1.3 m120 64.68 -149.93 0.27 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.549 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -56.21 81.43 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.724 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 36' ' ' ASN . 39.6 p -143.75 -33.56 0.42 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.664 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.9 mt -78.87 51.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 119.181 -1.008 . . . . 0.0 109.452 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 38' ' ' THR . 24.8 t -51.38 -46.98 62.99 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.573 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.21 167.29 15.06 Favored 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.79 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -155.45 149.69 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 118.197 -1.401 . . . . 0.0 113.05 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -133.59 126.92 31.98 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.492 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.2 t -144.0 113.62 5.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 C-N-CA 119.173 -1.011 . . . . 0.0 112.149 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.37 167.6 21.86 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 121.283 1.322 . . . . 0.0 111.082 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.67 -169.22 0.1 OUTLIER 'Trans proline' 0 C--N 1.32 -0.937 0 C-N-CA 121.97 1.78 . . . . 0.0 111.504 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.66 -15.26 7.95 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.808 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.435 HG13 ' CB ' ' A' ' 2' ' ' ALA . 24.1 m -150.91 139.58 14.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.873 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -109.25 129.24 55.51 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.095 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.76 152.55 24.21 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.409 -0.916 . . . . 0.0 112.661 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.587 ' CD1' HH21 ' A' ' 83' ' ' ARG . 71.1 mt -139.57 121.3 16.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.992 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.69 162.01 13.35 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 119.384 -0.926 . . . . 0.0 112.341 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 62' ' ' GLN . 11.6 m-85 -140.76 115.28 9.45 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.668 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -46.54 -78.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.871 -0.731 . . . . 0.0 112.044 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -59.77 156.41 14.09 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.112 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -64.59 -173.69 0.11 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.726 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.86 36.31 33.23 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.355 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.481 ' CE1' ' O ' ' A' ' 24' ' ' TYR . 12.0 m-85 49.71 59.16 4.71 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.728 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.36 -176.88 4.54 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 76.51 170.22 31.04 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 60' ' ' GLY . 17.7 m-20 -42.41 125.85 3.31 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.147 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.411 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.4 pt20 -95.01 163.83 13.15 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.75 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.635 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 4.6 mm -134.93 168.77 22.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.009 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.635 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 30.8 tt0 -150.48 132.26 15.02 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.253 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.0 m -148.34 151.46 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.301 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.467 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 3.3 t -137.0 -7.73 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.768 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -122.99 -139.27 0.31 Allowed 'General case' 0 C--O 1.206 -1.237 0 CA-C-N 114.042 -1.436 . . . . 0.0 109.281 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -114.2 116.74 29.54 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.646 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.64 112.39 23.61 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.8 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -67.03 -85.79 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.451 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 7.8 mm-40 -72.56 -1.99 18.12 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.738 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.494 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 3.8 tp 75.99 -84.57 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.87 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.449 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 176.03 -161.67 30.29 Favored Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.151 -1.5 . . . . 0.0 110.753 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.583 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.6 Cg_endo -68.87 -55.41 0.21 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.121 1.881 . . . . 0.0 112.335 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.542 ' C ' ' H ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER -69.77 27.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.599 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.583 ' H ' ' C ' ' A' ' 74' ' ' PRO . 3.2 p30 -70.91 10.76 0.48 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.118 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.542 ' H ' ' C ' ' A' ' 75' ' ' LEU . 23.3 t-20 -89.47 -9.98 48.07 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.096 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -166.49 132.68 2.41 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.726 -1.19 . . . . 0.0 111.697 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t -147.95 142.47 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.057 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 m -154.63 -48.27 0.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.238 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.6 t -90.01 136.28 33.14 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.062 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 10.6 mt -151.76 149.94 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.434 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.587 HH21 ' CD1' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -151.32 153.33 34.6 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.844 -1.142 . . . . 0.0 111.213 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.478 ' C ' HH12 ' A' ' 83' ' ' ARG . 3.3 t -142.7 147.19 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.394 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.485 HG12 ' NH1' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -138.77 132.25 39.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.389 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 85' ' ' ILE . 78.7 p -36.78 147.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.89 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -151.44 140.62 13.81 Favored Pre-proline 0 N--CA 1.487 1.385 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.27 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -50.89 133.55 40.16 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 121.256 1.304 . . . . 0.0 111.372 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.525 ' CG2' ' N ' ' A' ' 90' ' ' GLN . 2.5 p -65.93 160.96 3.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.912 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.525 ' N ' ' CG2' ' A' ' 89' ' ' VAL . 62.4 mt-30 -143.51 151.31 53.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.157 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.448 ' C ' ' CG ' ' A' ' 92' ' ' ARG . 1.8 Cg_endo -64.93 -40.58 20.45 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 121.587 1.525 . . . . 0.0 112.164 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.448 ' CG ' ' C ' ' A' ' 91' ' ' PRO . 3.0 mtm-85 57.98 -164.92 0.17 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.737 0.78 . . . . 0.0 112.431 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.477 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -138.89 173.31 11.7 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.812 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -150.85 123.03 8.29 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.291 -1.364 . . . . 0.0 112.339 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.478 ' O ' ' CB ' ' A' ' 105' ' ' GLU . 8.2 m-30 -95.92 166.39 11.81 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.275 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -135.47 154.65 51.35 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -95.57 146.53 24.39 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.424 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.9 tttt 66.97 126.06 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.564 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 28.6 tt0 -64.27 90.81 0.07 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.702 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.674 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 169.71 21.78 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.734 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.674 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 28.5 p90 38.81 42.22 0.6 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.142 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -118.26 -57.86 2.04 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.533 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -44.52 159.58 0.13 Allowed Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.613 -1.28 . . . . 0.0 110.705 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -47.58 168.82 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.251 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -134.57 167.46 20.76 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.39 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.7 t -143.26 137.46 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.94 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -110.74 160.79 16.4 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 119.325 -0.95 . . . . 0.0 113.23 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.9 mt -145.94 139.01 14.24 Favored Pre-proline 0 N--CA 1.49 1.551 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.03 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -69.55 166.05 28.66 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 121.505 1.47 . . . . 0.0 111.156 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.99 144.68 99.63 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.734 1.622 . . . . 0.0 111.35 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 139.78 178.91 17.21 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 119.188 -1.482 . . . . 0.0 111.423 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.454 ' OE1' ' N ' ' A' ' 113' ' ' TYR . 14.4 tm0? -106.68 157.76 17.47 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.471 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.454 ' N ' ' OE1' ' A' ' 112' ' ' GLN . 67.8 m-85 -145.86 149.97 35.26 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.069 -1.053 . . . . 0.0 111.298 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.0 p -88.08 -157.27 0.4 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.347 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.39 52.22 0.72 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.019 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.18 -69.84 0.12 Allowed 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -70.54 -42.15 71.56 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.499 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.583 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 2.4 tt -40.53 -73.55 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.254 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.657 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.7 OUTLIER -52.59 -49.87 64.16 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.955 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -70.99 -0.33 9.1 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.851 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.533 ' N ' ' O ' ' A' ' 117' ' ' GLU . 24.5 t80 -100.82 -22.81 14.73 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.497 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -131.12 -47.75 0.12 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.208 -1.473 . . . . 0.0 110.811 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.555 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -142.94 -107.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.113 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.555 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 7.0 m-20 -149.26 -178.67 6.53 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.998 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.07 10.61 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.473 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 124' ' ' ASP . 0.4 OUTLIER -163.72 -139.23 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.511 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 126' ' ' ASN . 0.0 OUTLIER 33.78 87.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.275 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.9 mm -127.23 -41.98 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.071 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.7 m 46.1 -138.31 0.57 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.36 -0.836 . . . . 0.0 113.129 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.5 m -56.98 140.33 49.24 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.576 -1.193 . . . . 0.0 113.005 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 t -122.28 150.45 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.647 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -145.52 98.6 4.55 Favored Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.907 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -66.49 105.42 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.177 1.252 . . . . 0.0 110.969 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.477 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 28.0 mm-40 -57.97 -11.15 2.18 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.588 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 172.4 -30.31 0.11 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 118.226 -1.94 . . . . 0.0 112.352 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.3 mt -98.18 169.45 9.58 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.246 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -88.39 130.17 35.23 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.0 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.7 t -99.85 137.92 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.21 -0.996 . . . . 0.0 112.094 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.442 HG13 ' CE1' ' A' ' 141' ' ' PHE . 86.6 t -136.44 121.73 27.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.149 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.0 mp -103.56 148.0 26.51 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.952 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.519 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 15.9 m-85 -120.79 130.54 54.03 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.134 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -66.32 -72.23 0.17 Allowed 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.476 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -75.17 164.74 26.17 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.59 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.634 ' CG ' ' H ' ' A' ' 145' ' ' ASN . 28.7 t0 -62.68 -161.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.831 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.641 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 2.5 m120 41.16 26.33 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.192 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.641 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 3.1 p90 41.01 58.11 2.6 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.489 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.8 t -136.78 -172.05 3.08 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.237 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.9 -165.54 50.64 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.129 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -59.33 148.86 30.72 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.996 -1.081 . . . . 0.0 110.178 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.2 p -138.82 177.15 8.1 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.534 -0.867 . . . . 0.0 111.468 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.417 ' C ' ' CD1' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -142.64 84.81 10.68 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.608 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.28 104.4 0.88 Allowed 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 121.8 1.667 . . . . 0.0 112.736 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 26.0 t -85.17 86.53 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.403 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -58.02 -21.32 44.56 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.938 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 59.4 p -169.79 -149.32 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 117.841 -1.544 . . . . 0.0 113.046 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -49.51 142.49 7.92 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.769 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.568 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -161.7 64.44 1.78 Allowed Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.666 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.1 Cg_endo -62.08 19.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 122.199 1.933 . . . . 0.0 113.066 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.568 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.5 t -172.92 83.22 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 118.27 -1.372 . . . . 0.0 112.128 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.99 -67.45 0.85 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.739 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 163' ' ' MET . . . 43.2 -131.13 5.68 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.849 -1.167 . . . . 0.0 111.464 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -32.88 85.62 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.558 ' N ' ' O ' ' A' ' 161' ' ' GLY . 9.2 tpp -177.42 -73.8 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.61 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.603 ' C ' ' H ' ' A' ' 166' ' ' ASN . 3.3 t-20 -92.22 70.49 5.27 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.58 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -60.42 4.12 0.06 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.071 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.603 ' H ' ' C ' ' A' ' 164' ' ' ASN . 4.6 t-20 -162.09 154.02 18.95 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.242 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.429 ' HG1' ' C ' ' A' ' 166' ' ' ASN . 44.9 m -147.98 98.67 2.97 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.271 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.3 m -89.67 -38.86 13.59 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.657 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.1 p -146.31 152.4 39.09 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.754 -1.179 . . . . 0.0 110.103 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 23.0 pt -134.07 175.96 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.331 -0.947 . . . . 0.0 111.015 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -153.48 108.76 3.2 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.438 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 11.1 mt -91.89 93.3 4.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.295 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 116.334 -1.793 . . . . 0.0 110.909 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 mtt . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.904 0.383 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.512 ' C ' ' ND2' ' A' ' 3' ' ' ASN . . . -73.02 173.52 9.2 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.717 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.512 ' ND2' ' C ' ' A' ' 2' ' ' ALA . 11.2 m-80 -159.67 128.75 5.19 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.842 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.481 ' CG1' ' O ' ' A' ' 4' ' ' ILE . 1.2 pt -73.28 124.93 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.127 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -97.86 106.24 18.51 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.256 -0.978 . . . . 0.0 108.511 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -90.47 166.38 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 119.195 -1.002 . . . . 0.0 113.257 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.678 ' CZ ' ' CE1' ' A' ' 12' ' ' PHE . 37.6 m-85 -122.7 134.44 54.46 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.358 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.69 -60.23 4.12 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.584 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 3.0 m120 -89.72 174.28 7.81 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.129 -1.028 . . . . 0.0 112.15 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 7.4 tp10 -81.96 165.25 20.89 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.779 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 10' ' ' GLU . 1.6 t70 76.17 42.01 0.2 Allowed 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.027 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.678 ' CE1' ' CZ ' ' A' ' 7' ' ' PHE . 78.1 t80 51.69 11.17 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.423 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -107.32 162.1 14.21 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.318 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.584 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 106.15 133.89 7.61 Favored Glycine 0 N--CA 1.503 3.142 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.853 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 14' ' ' GLY . 33.4 mttp -29.86 138.88 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.17 158.43 15.45 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.446 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 t -147.84 125.73 3.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.596 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -92.09 120.67 32.92 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.161 -1.016 . . . . 0.0 111.694 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 mt -114.3 133.17 22.47 Favored Pre-proline 0 N--CA 1.498 1.959 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.265 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -69.53 167.89 22.84 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 120.848 1.032 . . . . 0.0 111.155 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -67.2 -162.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.893 1.729 . . . . 0.0 110.767 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.18 172.8 48.93 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.138 -1.506 . . . . 0.0 111.079 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.534 ' HB3' ' NE ' ' A' ' 83' ' ' ARG . 2.7 p30 -106.26 139.9 40.05 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.859 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 4.0 p90 -155.75 -174.62 5.04 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.425 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.5 p -144.4 -156.29 0.68 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.036 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -65.67 -22.03 66.6 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.77 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.0 -60.67 2.96 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.501 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -54.86 -45.65 74.59 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.498 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.0 mt -56.89 -43.05 80.93 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.579 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.76 -34.25 18.67 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 118.878 -1.129 . . . . 0.0 108.826 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.55 -42.29 87.36 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.421 -0.911 . . . . 0.0 109.793 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.6 mt -71.71 -71.92 0.25 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.715 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.41 -37.76 0.68 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.329 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 tt -79.3 146.35 8.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.367 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -179.89 161.63 0.98 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.53 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 38' ' ' THR . 7.9 m120 60.1 -128.43 1.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.094 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.638 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -51.98 90.67 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.874 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.647 ' OG1' ' N ' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -178.91 -165.99 0.09 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.383 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.647 ' N ' ' OG1' ' A' ' 38' ' ' THR . 5.2 mt 46.77 37.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-O 122.208 1.004 . . . . 0.0 108.829 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.442 ' OG ' ' CD ' ' A' ' 10' ' ' GLU . 30.9 t -70.02 -31.99 69.92 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.394 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.423 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -134.81 154.97 51.4 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -147.45 168.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 117.894 -1.523 . . . . 0.0 113.785 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -141.93 91.06 2.32 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.27 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.4 t -107.91 108.94 61.95 Favored Pre-proline 0 N--CA 1.487 1.38 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.034 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.405 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 2.4 Cg_endo -67.21 172.01 10.66 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.146 1.231 . . . . 0.0 109.587 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HB3' ' HE ' ' A' ' 92' ' ' ARG . 2.1 Cg_endo -60.81 -168.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.329 1.353 . . . . 0.0 110.712 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.05 -19.0 10.84 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.12 -1.514 . . . . 0.0 111.871 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.454 ' N ' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -155.49 155.53 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 118.118 -1.433 . . . . 0.0 113.054 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.45 ' N ' HG21 ' A' ' 48' ' ' VAL . 24.4 ttpt -123.61 129.74 51.61 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.257 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.96 134.11 52.85 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.385 -0.926 . . . . 0.0 113.175 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.3 mt -115.51 117.67 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.154 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.665 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -96.35 163.06 13.23 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.215 -0.994 . . . . 0.0 113.337 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -139.92 111.61 7.33 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.052 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -82.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.309 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -59.99 137.56 58.05 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.546 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.638 ' CG ' ' H ' ' A' ' 57' ' ' GLY . 26.2 t70 -58.94 -168.77 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.384 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.638 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 56.97 27.59 57.08 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 118.885 -1.626 . . . . 0.0 109.758 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 53.9 61.76 2.93 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.114 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.96 -166.64 2.59 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.703 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.71 167.06 6.84 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.295 -1.431 . . . . 0.0 109.974 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -45.31 124.3 4.67 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.464 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -94.61 159.18 15.2 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.906 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.581 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 7.5 mm -136.27 171.12 17.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.688 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.581 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 2.3 pt-20 -150.57 132.28 14.94 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.346 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.2 m -150.19 161.88 4.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.426 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.478 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 3.0 t -145.57 -8.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.021 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -119.15 -149.01 0.43 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.105 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -90.36 141.55 28.62 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.908 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.62 94.47 5.05 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.843 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.64 -53.62 55.29 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.157 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.477 ' O ' ' C ' ' A' ' 72' ' ' LEU . 10.0 tp10 -128.85 66.64 1.42 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.18 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 71' ' ' GLU . 11.5 tp -21.14 -90.91 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.282 0.989 . . . . 0.0 113.071 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.53 ' O ' ' ND2' ' A' ' 76' ' ' ASN . . . -170.66 -159.64 17.15 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 118.917 -1.611 . . . . 0.0 110.783 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.443 ' C ' HD21 ' A' ' 76' ' ' ASN . 2.6 Cg_endo -65.08 -34.48 46.46 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 121.911 1.741 . . . . 0.0 111.488 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.567 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -77.85 15.57 0.84 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.89 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.779 ' H ' HD21 ' A' ' 76' ' ' ASN . 0.3 OUTLIER -62.54 -61.18 2.61 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.854 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.625 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 1.9 t30 -78.68 33.94 0.21 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.86 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.45 ' H ' ' C ' ' A' ' 76' ' ' ASN . 3.1 t-20 -171.42 71.66 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.241 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -94.59 -177.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.307 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.673 ' HG ' ' N ' ' A' ' 81' ' ' SER . 1.5 t 174.82 -71.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.769 -1.172 . . . . 0.0 112.312 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.673 ' N ' ' HG ' ' A' ' 80' ' ' SER . 3.0 m -99.97 145.64 27.62 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.495 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -149.65 160.88 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.812 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.784 HH22 ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -144.03 110.1 5.38 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.732 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.784 ' N ' HH22 ' A' ' 83' ' ' ARG . 11.2 t -116.91 140.34 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.884 -0.727 . . . . 0.0 111.584 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.605 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 3.7 mt -144.97 135.11 19.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.413 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.2 m -41.88 157.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.488 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.454 HG11 ' N ' ' A' ' 48' ' ' VAL . 0.6 OUTLIER -154.61 139.86 12.13 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.318 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.506 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 8.0 Cg_exo -50.12 129.31 24.82 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 121.313 1.342 . . . . 0.0 111.071 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 90' ' ' GLN . 2.7 p -66.48 156.34 6.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.039 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -144.42 154.51 56.88 Favored Pre-proline 0 N--CA 1.487 1.388 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.872 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.11 -35.7 91.6 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 121.466 1.444 . . . . 0.0 111.142 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.477 ' HE ' ' HB3' ' A' ' 46' ' ' PRO . 86.5 mtt-85 54.72 -157.97 0.2 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.918 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.95 172.22 12.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.527 ' NE ' ' CD ' ' A' ' 105' ' ' GLU . 11.7 ttt180 -148.31 122.34 9.45 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.126 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 26.3 m-85 -105.05 165.54 11.01 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.503 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.541 ' CE2' ' O ' ' A' ' 101' ' ' PHE . 0.5 OUTLIER -125.69 172.76 9.52 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.513 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.447 ' CD1' ' O ' ' A' ' 104' ' ' LYS . 2.1 m-85 -92.32 -97.02 0.13 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.939 -1.104 . . . . 0.0 112.654 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -45.37 164.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.576 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -87.51 67.78 9.45 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.49 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.682 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -175.34 33.58 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.804 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.541 ' O ' ' CE2' ' A' ' 96' ' ' PHE . 29.1 t80 55.22 20.55 3.49 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.345 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -119.78 161.07 21.4 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.644 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 94.33 137.08 8.54 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.043 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.447 ' O ' ' CD1' ' A' ' 97' ' ' TYR . 52.7 mttm -28.0 138.93 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.527 ' CD ' ' NE ' ' A' ' 94' ' ' ARG . 11.6 pt-20 -99.48 175.94 5.67 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.26 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.4 t -150.7 120.11 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.153 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 26.7 p-10 -96.62 155.75 16.64 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.597 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 69.5 mt -142.75 149.4 49.93 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.147 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -77.27 165.03 28.37 Favored 'Trans proline' 0 C--O 1.213 -0.77 0 C-N-CA 121.84 1.693 . . . . 0.0 111.595 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -68.82 153.99 71.92 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 121.686 1.591 . . . . 0.0 110.843 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.45 -161.58 20.76 Favored Glycine 0 N--CA 1.509 3.521 0 C-N-CA 119.194 -1.479 . . . . 0.0 111.835 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.457 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 2.9 mp0 -116.13 161.67 18.57 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.261 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -145.49 146.41 31.45 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.008 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.9 p -74.9 -159.1 0.09 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.437 ' NE2' ' HB3' ' A' ' 144' ' ' ASP . 1.2 pt20 -108.0 40.05 1.82 Allowed 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.22 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.478 ' C ' ' N ' ' A' ' 118' ' ' LEU . . . -157.55 -87.5 0.04 OUTLIER 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 118.684 -1.206 . . . . 0.0 110.88 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 116' ' ' ALA . 11.3 pt-20 -45.53 -25.49 0.45 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.036 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.583 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 5.6 tt -57.86 -66.53 0.46 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.113 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.468 ' N ' HD21 ' A' ' 118' ' ' LEU . 8.1 mm-40 -49.2 -49.95 40.45 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.406 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.47 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 4.0 mmm-85 -67.17 -12.44 60.04 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 118.718 -1.193 . . . . 0.0 112.016 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.478 ' HH ' ' H ' ' A' ' 66' ' ' VAL . 13.8 t80 -91.97 -24.95 19.08 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.154 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -115.93 -67.43 0.41 Allowed Glycine 0 N--CA 1.483 1.791 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.478 HD11 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -138.64 -103.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.186 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.609 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 15.2 t70 -154.01 -165.48 2.12 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.314 -0.955 . . . . 0.0 111.198 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.609 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 1.0 OUTLIER -58.71 -100.08 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.34 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.647 HD21 ' N ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -80.41 127.68 32.69 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.582 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.647 ' N ' HD21 ' A' ' 126' ' ' ASN . 0.0 OUTLIER 175.48 -106.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.523 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.623 ' N ' ' OG1' ' A' ' 127' ' ' THR . 6.2 mm 48.62 -97.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.005 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER 78.1 -42.77 0.36 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.2 m -143.56 126.34 16.13 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.682 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.59 158.84 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-O 121.975 0.893 . . . . 0.0 113.015 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.14 99.32 4.28 Favored Pre-proline 0 C--N 1.3 -1.544 0 CA-C-N 113.865 -1.516 . . . . 0.0 107.86 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.67 ' C ' ' H ' ' A' ' 135' ' ' GLY . 2.8 Cg_exo -52.66 -15.79 4.75 Favored 'Trans proline' 0 C--O 1.209 -0.955 0 C-N-CA 121.181 1.254 . . . . 0.0 112.491 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 53.17 -6.19 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.764 -0.774 . . . . 0.0 112.498 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.67 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . 160.45 -47.36 0.4 Allowed Glycine 0 N--CA 1.483 1.802 0 C-N-CA 118.766 -1.683 . . . . 0.0 111.242 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.1 mt -84.49 -164.31 0.94 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 117.95 -1.5 . . . . 0.0 110.787 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -119.17 131.11 55.82 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.0 t -101.76 143.12 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.796 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.438 HG13 ' CE1' ' A' ' 141' ' ' PHE . 57.6 t -137.32 117.76 16.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.315 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.454 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 10.9 mp -97.71 142.85 29.0 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.483 -0.887 . . . . 0.0 112.37 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.528 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 34.6 m-85 -120.51 133.46 55.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.432 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -74.3 -61.1 1.98 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.488 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -71.46 -175.99 1.43 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.089 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 146' ' ' PHE . 1.8 m-20 -77.18 -165.06 0.52 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.691 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.668 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 16.4 t30 27.95 39.51 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 123.931 0.769 . . . . 0.0 112.138 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.668 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.6 p90 41.65 60.44 2.16 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.197 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.84 -168.11 1.98 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.233 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 63.51 -162.45 33.45 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.607 -1.282 . . . . 0.0 110.145 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -59.58 156.05 14.23 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.189 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.3 p -144.72 160.75 40.7 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.679 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.8 tp -126.39 82.83 65.45 Favored Pre-proline 0 N--CA 1.486 1.325 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.125 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.68 106.56 0.63 Allowed 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 121.884 1.722 . . . . 0.0 113.162 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 43.6 t -87.94 82.45 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 119.455 -0.898 . . . . 0.0 108.949 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.613 ' H ' HD21 ' A' ' 154' ' ' ASN . 0.8 OUTLIER -62.59 -9.6 9.4 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.6 p -169.4 -167.9 0.75 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 117.456 -1.698 . . . . 0.0 113.475 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -42.29 150.83 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.53 -1.213 . . . . 0.0 112.812 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.593 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -171.94 66.83 0.41 Allowed Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.65 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.5 Cg_endo -65.6 23.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.173 1.916 . . . . 0.0 112.02 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.593 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.3 t -175.42 57.23 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.042 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 129' ' ' SER . 18.8 tp -63.63 -11.18 23.17 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.895 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 160' ' ' LEU . . . -40.04 97.19 0.01 OUTLIER Glycine 0 N--CA 1.496 2.682 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.46 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -177.27 -6.91 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.771 -0.771 . . . . 0.0 110.362 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -157.74 38.69 0.27 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.272 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.712 ' ND2' ' H ' ' A' ' 165' ' ' ASN . 3.4 p-10 -43.83 -73.55 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.735 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.712 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 1.0 OUTLIER 51.34 -95.48 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.359 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 164' ' ' ASN . 1.2 t-20 -172.36 86.03 0.07 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 119.043 -1.063 . . . . 0.0 111.556 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 51.7 m -58.8 111.39 1.26 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.003 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 74.7 m -90.13 -69.28 0.73 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.618 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.413 ' HG ' ' H ' ' A' ' 146' ' ' PHE . 3.0 p -116.0 158.09 23.61 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.593 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 1.4 pt -141.1 -178.59 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.856 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -160.59 114.9 2.15 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.677 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 14.0 mt -90.34 95.51 5.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.08 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 116.291 -1.814 . . . . 0.0 110.835 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.49 57.23 0.33 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.941 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -116.1 115.86 26.84 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.391 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.3 pt -74.56 143.86 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.859 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.3 m -128.41 135.5 49.6 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.678 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 m -120.79 158.64 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.015 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 14.0 m-85 -114.03 157.83 22.0 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.133 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -89.06 9.9 23.65 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.518 ' C ' ' OG ' ' A' ' 40' ' ' SER . 20.1 m120 -151.32 173.29 14.67 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.732 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -78.41 169.93 17.46 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.83 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' GLN . 6.7 t70 65.46 38.08 5.81 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.602 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.539 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 9.0 t80 62.81 -4.67 0.23 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.483 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' ASP . 32.6 mt-30 -87.69 166.75 14.43 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.129 -1.028 . . . . 0.0 110.906 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 113.95 137.66 6.68 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -29.35 138.28 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.578 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.493 ' O ' ' HG3' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -103.17 123.7 47.2 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -179.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.401 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 9.9 p -126.45 138.5 54.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.861 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -100.92 146.6 27.15 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.856 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 mt -137.94 141.46 32.63 Favored Pre-proline 0 N--CA 1.485 1.306 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.676 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -71.86 166.87 28.23 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.794 0.996 . . . . 0.0 111.711 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -67.12 -172.92 0.37 Allowed 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 121.998 1.799 . . . . 0.0 110.934 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.423 ' H ' ' HB ' ' A' ' 84' ' ' VAL . . . 98.44 -156.08 20.27 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.634 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.472 ' N ' HD21 ' A' ' 23' ' ' ASN . 0.3 OUTLIER -146.48 150.5 35.72 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.835 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -164.15 -164.2 0.84 Allowed 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.417 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.687 ' HG1' ' H ' ' A' ' 27' ' ' ALA . 40.6 p -139.7 175.48 9.53 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.612 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.4 ptt85 -58.1 -13.52 4.98 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.275 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.687 ' H ' ' HG1' ' A' ' 25' ' ' THR . . . -67.59 -59.3 3.46 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.478 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -52.69 -43.06 65.34 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 118.506 -1.278 . . . . 0.0 108.201 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 32' ' ' LEU . 29.7 mt -58.77 -43.74 90.44 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.039 -1.064 . . . . 0.0 109.011 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -47.65 -30.39 3.7 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.618 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.61 -36.86 51.31 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.864 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 29' ' ' LEU . 12.7 mt -76.43 -67.37 0.7 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.614 -0.835 . . . . 0.0 110.627 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.6 -7.0 0.13 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.699 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.501 HG21 ' H ' ' A' ' 35' ' ' GLU . 1.3 mt -98.61 -167.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.165 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.501 ' H ' HG21 ' A' ' 34' ' ' ILE . 3.0 pt-20 175.05 -168.23 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.88 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.755 HD21 ' ND2' ' A' ' 78' ' ' ASN . 24.4 p-10 -77.06 -178.71 5.13 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.506 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.9 t30 71.05 -15.36 0.41 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.642 ' O ' ' N ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -86.84 -77.78 0.31 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.058 -1.457 . . . . 0.0 110.938 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.62 ' N ' ' OG1' ' A' ' 38' ' ' THR . 4.3 mt -13.96 75.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 124.924 1.39 . . . . 0.0 112.074 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.642 ' N ' ' O ' ' A' ' 38' ' ' THR . 43.0 t -81.89 -36.14 28.46 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.49 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.513 ' HG ' ' H ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -135.2 172.02 13.61 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.49 HG13 ' H ' ' A' ' 69' ' ' ALA . 1.1 t -149.97 144.8 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 118.029 -1.468 . . . . 0.0 112.516 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -132.73 101.51 5.31 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.841 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.5 t -125.04 110.1 27.28 Favored Pre-proline 0 N--CA 1.491 1.617 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.267 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -69.19 166.78 25.72 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.129 1.219 . . . . 0.0 110.802 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 48' ' ' VAL . 1.8 Cg_endo -61.29 -168.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 121.754 1.636 . . . . 0.0 110.948 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.43 ' C ' ' CG1' ' A' ' 48' ' ' VAL . . . 76.21 -8.25 25.65 Favored Glycine 0 C--O 1.207 -1.578 0 C-N-CA 118.902 -1.618 . . . . 0.0 109.743 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -151.24 134.41 7.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.143 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -107.37 121.16 44.03 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.91 159.38 20.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.01 -1.076 . . . . 0.0 113.095 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.481 HG13 HH22 ' A' ' 83' ' ' ARG . 35.0 mt -142.92 124.21 11.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.603 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.461 HD11 ' H ' ' A' ' 52' ' ' LEU . 5.2 mp -89.26 160.35 16.96 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.714 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -138.89 115.98 10.98 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.505 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -56.86 -80.26 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.771 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.449 ' ND2' ' H ' ' A' ' 56' ' ' ASP . 2.8 t-20 -59.47 148.17 33.91 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.175 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.506 ' OD1' ' CB ' ' A' ' 80' ' ' SER . 1.0 OUTLIER -60.26 172.44 0.83 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.725 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.05 31.69 80.16 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.11 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 50.56 47.32 24.38 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.779 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.24 -161.58 1.01 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.835 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.38 -178.87 2.01 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.317 -1.421 . . . . 0.0 109.889 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -48.24 163.62 0.06 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.217 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.589 HE21 ' C ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -148.12 141.07 24.81 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.544 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.502 HG21 ' H ' ' A' ' 64' ' ' GLU . 3.0 mt -107.5 168.65 3.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.679 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.502 ' H ' HG21 ' A' ' 63' ' ' ILE . 48.9 tt0 -137.1 132.92 34.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.8 m -148.65 159.92 6.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 118.371 -1.332 . . . . 0.0 112.495 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 t -150.18 -1.48 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.483 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.492 ' H ' ' HH ' ' A' ' 121' ' ' TYR . . . -132.57 -150.13 0.4 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.649 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.406 HD22 ' CG ' ' A' ' 107' ' ' ASP . 1.5 p30 -101.05 113.63 26.81 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.634 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.49 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -89.53 97.72 11.36 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.906 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -62.87 -74.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.397 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -67.51 -8.95 37.8 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.446 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.424 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 5.3 tp 66.78 -80.2 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.592 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.424 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 143.49 -158.51 27.32 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.438 -1.363 . . . . 0.0 110.138 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 76' ' ' ASN . 2.2 Cg_endo -64.56 -159.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.649 1.566 . . . . 0.0 110.814 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 74' ' ' PRO . 1.1 pt? 32.83 32.06 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.722 0.639 . . . . 0.0 111.945 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 74' ' ' PRO . 49.6 t30 -84.98 -15.47 44.14 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.098 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -86.98 0.43 55.16 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.273 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.755 ' ND2' HD21 ' A' ' 36' ' ' ASN . 1.1 t-20 -172.02 122.34 0.48 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 118.51 -1.276 . . . . 0.0 112.162 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.567 ' N ' HD21 ' A' ' 78' ' ' ASN . 1.9 t -122.8 -148.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.443 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER 154.33 -59.57 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.416 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.1 m -111.98 156.07 22.72 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.511 -0.876 . . . . 0.0 113.137 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.22 163.78 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.933 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.733 ' NH1' ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -143.12 133.47 24.69 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.651 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.733 ' CA ' ' NH1' ' A' ' 83' ' ' ARG . 22.1 t -139.98 128.57 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.936 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.424 HG13 HH11 ' A' ' 83' ' ' ARG . 55.3 mt -130.69 124.44 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.415 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.4 p -45.25 148.02 0.68 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.558 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.07 152.05 39.07 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.275 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -55.45 155.57 20.36 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.14 1.227 . . . . 0.0 110.859 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.3 t -59.71 144.39 12.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.732 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -144.74 119.06 5.73 Favored Pre-proline 0 N--CA 1.487 1.415 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.461 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -61.65 -157.53 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.832 0 C-N-CA 121.07 1.18 . . . . 0.0 111.184 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.444 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER 178.98 -162.14 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.274 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.419 ' N ' ' HD3' ' A' ' 92' ' ' ARG . . . -138.39 173.31 11.73 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.094 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -119.95 149.98 41.25 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.158 -1.017 . . . . 0.0 112.513 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -141.46 115.44 9.22 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.608 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.423 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 55.5 m-85 -79.42 176.93 9.24 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.81 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.16 -46.9 3.5 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.409 -0.917 . . . . 0.0 112.15 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.49 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 14.8 ttmt -92.26 154.73 18.43 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.864 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.597 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -71.13 102.72 2.56 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.11 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.609 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 123.96 47.13 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.113 0 O-C-N 125.356 1.66 . . . . 0.0 109.072 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.609 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 21.9 p90 30.15 59.44 0.2 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.65 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.457 ' HB2' ' NE2' ' A' ' 100' ' ' GLN . 18.7 t70 -130.64 -12.54 3.84 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.252 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.49 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -93.66 157.23 22.89 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.459 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.1 OUTLIER -29.59 139.11 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.19 0.519 . . . . 0.0 112.258 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.445 ' H ' ' HD3' ' A' ' 104' ' ' LYS . 0.4 OUTLIER -93.85 105.42 17.44 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.229 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.7 t -92.64 137.9 21.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.051 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.406 ' CG ' HD22 ' A' ' 68' ' ' ASN . 1.9 p30 -121.53 155.07 35.76 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.95 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.7 mt -144.3 132.51 10.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.026 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -66.5 166.63 21.18 Favored 'Trans proline' 0 C--O 1.214 -0.725 0 C-N-CA 121.643 1.562 . . . . 0.0 111.69 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.55 149.24 68.16 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.81 1.673 . . . . 0.0 111.565 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.55 -176.3 20.45 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 119.415 -1.374 . . . . 0.0 110.932 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.407 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 40.8 tt0 -110.89 154.57 23.86 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.482 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 61.7 m-85 -146.22 155.46 42.7 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.436 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 3.1 p -92.49 -142.44 0.2 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.34 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.52 ' N ' ' OG1' ' A' ' 114' ' ' THR . 36.4 tt0 -111.97 -20.97 11.79 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.658 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.78 -57.59 3.72 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.381 -0.928 . . . . 0.0 112.644 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.596 ' CG ' ' H ' ' A' ' 118' ' ' LEU . 4.6 pt-20 -71.36 -55.93 7.0 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.837 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.596 ' H ' ' CG ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -32.34 -67.42 0.11 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.976 0.798 . . . . 0.0 111.273 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 121' ' ' TYR . 75.6 mt-10 -55.5 -61.55 2.27 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.726 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.476 ' NH1' ' OD1' ' A' ' 124' ' ' ASP . 1.7 mpt_? -73.86 19.88 0.11 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.199 -1.0 . . . . 0.0 112.344 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.492 ' HH ' ' H ' ' A' ' 67' ' ' ALA . 17.9 t80 -124.45 -15.59 6.6 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.858 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.22 -38.45 0.04 OUTLIER Glycine 0 C--N 1.295 -1.735 0 C-N-CA 118.771 -1.681 . . . . 0.0 110.822 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.433 HD11 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -141.75 -113.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.316 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.637 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 28.8 t70 -156.5 -176.86 6.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.396 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.637 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 46.9 t30 -79.22 148.82 32.09 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.845 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.521 HD21 ' CB ' ' A' ' 166' ' ' ASN . 32.5 m120 44.9 45.64 8.63 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.412 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.4 m -163.42 107.25 1.02 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.872 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.1 mm -138.95 -45.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.606 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.587 ' OG ' ' N ' ' A' ' 130' ' ' SER . 1.2 p 66.02 -152.45 0.24 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.587 ' N ' ' OG ' ' A' ' 129' ' ' SER . 26.8 m -49.79 129.86 20.5 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.404 -1.271 . . . . 0.0 113.066 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.4 151.17 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.928 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -160.58 112.69 1.35 Allowed Pre-proline 0 C--N 1.292 -1.896 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.598 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.26 170.79 3.7 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 120.605 0.87 . . . . 0.0 111.777 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -156.26 5.74 0.18 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.776 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.57 -50.92 0.04 OUTLIER Glycine 0 N--CA 1.481 1.677 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.405 HD13 ' CA ' ' A' ' 92' ' ' ARG . 0.4 OUTLIER -122.37 162.94 20.66 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.732 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.66 154.8 24.71 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.329 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.6 143.72 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.265 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.3 t -129.76 125.37 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.464 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.529 ' CD2' ' HG1' ' A' ' 167' ' ' THR . 8.6 mp -99.4 145.28 27.56 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.829 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.559 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 3.3 m-85 -120.78 143.23 48.93 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.3 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -73.85 -76.17 0.14 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.553 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -74.82 157.12 35.68 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.645 ' CG ' ' H ' ' A' ' 145' ' ' ASN . 26.4 t70 -57.92 -174.4 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.47 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.645 ' H ' ' CG ' ' A' ' 144' ' ' ASP . 0.4 OUTLIER 40.34 27.18 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.094 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.643 ' CZ ' ' ND2' ' A' ' 145' ' ' ASN . 1.9 p90 41.69 62.0 1.7 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.286 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.9 t -131.95 71.46 1.47 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.306 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 173.14 -163.12 34.65 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.277 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.52 162.76 4.66 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 118.914 -1.114 . . . . 0.0 109.788 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.7 p -149.35 164.2 35.56 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.732 -1.187 . . . . 0.0 111.612 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.5 mt -131.64 87.32 46.26 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.714 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -61.44 107.87 0.54 Allowed 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.487 1.458 . . . . 0.0 111.859 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 155' ' ' SER . 2.2 t -91.84 65.64 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.887 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -79.07 33.49 0.22 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.219 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 153' ' ' VAL . 16.8 t -167.09 -156.87 0.23 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.195 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -90.61 153.22 20.48 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.768 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.432 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -163.2 71.39 1.94 Allowed Pre-proline 0 N--CA 1.486 1.334 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.533 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.468 ' C ' ' OG ' ' A' ' 130' ' ' SER . 1.2 Cg_endo -67.73 35.77 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.535 2.157 . . . . 0.0 113.372 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.49 ' O ' ' CB ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -167.38 -83.34 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.336 -1.345 . . . . 0.0 111.852 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.49 ' CB ' ' O ' ' A' ' 159' ' ' THR . 2.3 tp 73.68 -69.65 0.18 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.424 -0.911 . . . . 0.0 110.544 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 54.97 55.55 27.44 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.367 -1.397 . . . . 0.0 110.736 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 50.7 89.78 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.889 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 2.3 mmt -74.54 -63.02 1.33 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.665 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -90.33 -59.61 2.14 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.678 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -155.31 -79.18 0.09 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.701 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.521 ' CB ' HD21 ' A' ' 126' ' ' ASN . 2.7 p-10 -157.82 163.69 37.75 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.916 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.529 ' HG1' ' CD2' ' A' ' 140' ' ' LEU . 1.2 m -103.4 112.04 24.74 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.303 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 83.7 p -96.67 -35.35 11.06 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.75 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.67 154.44 50.92 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.898 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 16.8 pt -135.76 162.97 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.486 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.481 ' NH2' ' HG ' ' A' ' 173' ' ' SER . 41.2 ttp85 -146.32 100.99 3.44 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.846 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.6 mt -81.73 99.54 4.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.055 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.481 ' HG ' ' NH2' ' A' ' 171' ' ' ARG . 50.5 m . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 116.448 -1.739 . . . . 0.0 111.02 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 mtt . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.855 0.359 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.573 ' C ' HD21 ' A' ' 3' ' ' ASN . . . -161.22 115.88 2.06 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.991 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.573 HD21 ' C ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER -175.89 122.66 0.19 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.192 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -84.29 153.68 3.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.136 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.4 m -128.09 118.78 24.07 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.092 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 16' ' ' GLN . 3.7 m -98.25 170.12 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.335 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 1.305 ' CE2' ' NE2' ' A' ' 16' ' ' GLN . 24.8 m-85 -129.49 149.46 51.26 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.56 ' CD2' ' NZ ' ' A' ' 15' ' ' LYS . 2.7 m-85 -77.28 -57.78 3.64 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.978 -1.089 . . . . 0.0 113.233 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.48 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 19.0 m120 -87.58 162.28 17.26 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.721 -1.191 . . . . 0.0 111.923 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.54 -179.04 0.99 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.326 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.647 ' C ' ' CG ' ' A' ' 12' ' ' PHE . 6.0 t70 51.52 52.63 14.3 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 118.313 -1.355 . . . . 0.0 110.52 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.647 ' CG ' ' C ' ' A' ' 11' ' ' ASP . 1.2 p90 41.65 20.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 11' ' ' ASP . 22.2 mt-30 -93.77 173.88 7.45 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.85 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.48 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 79.01 128.09 0.55 Allowed Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.188 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.56 ' NZ ' ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -40.99 156.34 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.935 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 1.305 ' NE2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -112.16 177.03 4.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 t -141.65 137.9 31.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 114.332 -1.304 . . . . 0.0 109.379 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 18' ' ' ASP . 8.5 p-10 -95.47 114.51 26.29 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.663 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.0 mt -107.88 133.05 20.62 Favored Pre-proline 0 N--CA 1.492 1.657 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.043 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -71.41 156.57 58.28 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 120.837 1.025 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.53 -167.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 121.506 1.471 . . . . 0.0 110.67 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.447 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 100.14 -174.22 26.11 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.942 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.686 ' CA ' HH11 ' A' ' 83' ' ' ARG . 0.6 OUTLIER -109.69 122.88 48.48 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.926 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 7.7 p90 -147.86 173.9 12.38 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 118.746 -1.182 . . . . 0.0 111.005 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.7 p -147.79 -154.83 0.58 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.051 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -62.43 -28.28 69.69 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.802 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.39 -63.43 1.24 Allowed 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.71 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -55.48 -49.59 72.13 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.603 -1.239 . . . . 0.0 109.481 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 32' ' ' LEU . 26.9 mt -51.84 -41.27 61.68 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.57 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.53 -35.84 21.55 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 118.558 -1.257 . . . . 0.0 108.006 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.04 -40.31 94.61 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.554 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 29' ' ' LEU . 17.0 mt -72.86 -74.12 0.18 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.601 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.12 -26.27 1.0 Allowed Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.995 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.0 142.41 13.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.194 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 9.1 pt-20 -177.86 155.0 0.96 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.642 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 2.1 t-20 90.18 -149.62 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 O-C-N 124.265 0.978 . . . . 0.0 112.408 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.54 ' H ' HD21 ' A' ' 37' ' ' ASN . 0.4 OUTLIER -70.14 32.48 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.045 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 40' ' ' SER . 1.0 OUTLIER -88.13 -40.99 13.32 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.62 -1.232 . . . . 0.0 110.336 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.7 mt -64.88 74.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.38 -0.928 . . . . 0.0 108.976 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 38' ' ' THR . 28.0 t -76.33 -72.97 0.3 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.704 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -99.15 168.04 10.31 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.888 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.483 HG13 ' H ' ' A' ' 69' ' ' ALA . 1.1 t -151.32 148.31 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 117.988 -1.485 . . . . 0.0 113.087 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -133.72 108.69 8.67 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.852 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 65.2 t -128.46 111.42 19.38 Favored Pre-proline 0 N--CA 1.5 2.05 0 C-N-CA 119.809 -0.756 . . . . 0.0 112.311 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.59 170.07 14.53 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.099 1.2 . . . . 0.0 110.851 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.16 -167.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.919 1.746 . . . . 0.0 110.978 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.21 -11.34 23.7 Favored Glycine 0 N--CA 1.484 1.851 0 C-N-CA 119.104 -1.522 . . . . 0.0 110.982 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.401 ' HA ' ' H ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -154.76 148.66 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 118.725 -1.19 . . . . 0.0 112.074 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -115.14 142.3 46.84 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.974 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.84 143.03 46.8 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.026 -1.07 . . . . 0.0 112.274 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.45 HG23 ' CE2' ' A' ' 53' ' ' TYR . 78.2 mt -121.04 121.75 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.284 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.99 147.21 23.13 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.306 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.45 ' CE2' HG23 ' A' ' 51' ' ' ILE . 53.3 m-85 -134.45 132.61 39.51 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.142 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -58.94 -84.44 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.052 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -65.17 163.65 14.69 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.65 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -63.09 -177.94 0.2 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.586 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.614 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 53.96 33.1 50.0 Favored Glycine 0 N--CA 1.487 2.059 0 C-N-CA 118.957 -1.592 . . . . 0.0 109.158 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.614 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 41.99 69.78 0.33 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.576 0.703 . . . . 0.0 110.751 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.91 174.21 10.79 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.07 -177.21 54.36 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.483 -1.342 . . . . 0.0 110.088 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.14 118.14 1.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.18 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.401 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 3.2 pt20 -101.27 172.39 7.02 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.738 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.48 HG21 ' H ' ' A' ' 64' ' ' GLU . 4.8 mt -144.47 163.84 13.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.553 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.48 ' H ' HG21 ' A' ' 63' ' ' ILE . 26.9 mt-10 -138.98 126.2 21.39 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.769 -0.773 . . . . 0.0 109.498 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.3 m -149.03 158.96 6.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 118.781 -1.168 . . . . 0.0 112.727 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.9 t -149.78 -1.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -125.42 -135.97 0.27 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.722 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -105.93 112.0 24.88 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.24 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.483 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -89.54 80.33 6.71 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.768 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -52.33 -81.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.048 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -69.12 -10.44 57.67 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.603 -0.839 . . . . 0.0 112.008 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.516 ' CD2' HD22 ' A' ' 76' ' ' ASN . 2.5 tp 63.23 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.434 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 175.15 -175.25 47.11 Favored Glycine 0 N--CA 1.501 2.998 0 C-N-CA 119.183 -1.484 . . . . 0.0 110.999 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.576 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.2 Cg_endo -66.72 -39.92 14.21 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 122.375 2.05 . . . . 0.0 112.188 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.739 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 1.7 pt? -71.11 30.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.144 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.576 ' H ' ' C ' ' A' ' 74' ' ' PRO . 0.6 OUTLIER -72.67 -9.6 58.81 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.639 -0.825 . . . . 0.0 110.605 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -87.57 13.16 10.78 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.126 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.644 ' N ' ' ND2' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -177.91 116.79 0.09 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 118.691 -1.204 . . . . 0.0 111.699 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.6 m -157.07 145.85 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.944 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.6 p -164.34 -36.86 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 118.562 -1.255 . . . . 0.0 113.131 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.415 ' C ' ' CG1' ' A' ' 82' ' ' ILE . 4.1 m -94.61 142.99 26.81 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 118.773 -1.171 . . . . 0.0 111.577 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.415 ' CG1' ' C ' ' A' ' 81' ' ' SER . 2.1 mt -148.58 143.21 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 118.821 -1.152 . . . . 0.0 111.426 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.792 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -121.31 116.01 24.04 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.783 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.792 ' H ' HH12 ' A' ' 83' ' ' ARG . 3.9 t -123.69 136.36 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.943 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.514 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 3.8 mt -139.1 126.74 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.196 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.6 p -48.98 133.02 18.59 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.433 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.401 ' H ' ' HA ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -122.9 149.92 57.7 Favored Pre-proline 0 N--CA 1.49 1.566 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.599 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -51.43 127.31 21.94 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 121.386 1.391 . . . . 0.0 111.216 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.3 p -58.51 136.87 21.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.881 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -145.91 151.46 45.56 Favored Pre-proline 0 N--CA 1.487 1.389 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.961 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.414 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 2.3 Cg_endo -58.89 -164.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 121.277 1.318 . . . . 0.0 111.111 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.467 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -175.79 -161.75 0.09 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.759 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -141.71 162.96 34.2 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.084 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.1 ttm-85 -135.82 107.48 6.99 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.05 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 18.5 m-85 -87.0 169.15 12.68 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.597 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 105' ' ' GLU . 26.8 m-85 -137.09 167.64 21.15 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.581 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.512 ' HH ' HG22 ' A' ' 127' ' ' THR . 3.4 m-85 -103.24 168.83 8.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.659 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.405 ' CB ' ' OD1' ' A' ' 102' ' ' ASP . 52.5 mttp 57.14 164.69 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.841 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 24.2 tt0 -90.85 75.78 6.41 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.737 ' HG2' ' CG ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 153.78 43.46 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 O-C-N 124.358 1.036 . . . . 0.0 109.376 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 100' ' ' GLN . 19.1 p90 33.47 32.67 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.284 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.737 ' CG ' ' HG2' ' A' ' 100' ' ' GLN . 22.7 p-10 -107.32 36.2 2.79 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.154 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -145.66 158.37 27.65 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.277 -1.439 . . . . 0.0 110.467 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.482 ' H ' ' HE3' ' A' ' 104' ' ' LYS . 1.2 mtmt -31.72 144.84 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.169 0.509 . . . . 0.0 112.318 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.458 ' HB3' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -105.86 149.49 26.48 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.175 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 45.4 t -143.91 150.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.761 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -136.8 156.53 48.37 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.241 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.8 mt -137.01 163.12 51.66 Favored Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.938 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.453 ' HD3' ' HH ' ' A' ' 121' ' ' TYR . 18.6 Cg_endo -88.78 166.92 5.96 Favored 'Trans proline' 0 C--O 1.212 -0.78 0 C-N-CA 121.871 1.714 . . . . 0.0 112.74 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -63.58 140.56 75.89 Favored 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 121.745 1.63 . . . . 0.0 110.89 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.75 -154.96 25.59 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.19 -1.481 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.595 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 37.3 tt0 -125.35 156.77 38.21 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.367 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 48.5 m-85 -144.07 149.55 36.78 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.792 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.3 p -96.81 -159.49 0.74 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.717 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.629 ' H ' ' CD ' ' A' ' 115' ' ' GLN . 2.5 pm0 -105.51 56.29 0.68 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.213 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.74 -64.34 0.11 Allowed 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.741 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.608 ' CG ' ' H ' ' A' ' 118' ' ' LEU . 9.0 pt-20 -69.77 -52.19 27.44 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.608 ' H ' ' CG ' ' A' ' 117' ' ' GLU . 1.9 tt -33.67 -60.23 0.37 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.167 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 121' ' ' TYR . 36.4 mt-10 -54.36 -69.42 0.13 Allowed 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.293 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.434 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 3.4 mpt_? -74.79 23.23 0.1 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.293 -0.963 . . . . 0.0 112.376 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 117' ' ' GLU . 13.0 t80 -114.13 -22.29 10.08 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.856 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.74 -21.55 0.02 OUTLIER Glycine 0 N--CA 1.488 2.117 0 C-N-CA 118.429 -1.844 . . . . 0.0 110.625 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.412 ' CG2' ' CG2' ' A' ' 127' ' ' THR . 9.1 mt -139.79 -120.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.746 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 124' ' ' ASP . 11.7 p30 -159.08 -154.98 0.44 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.767 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -76.22 -35.23 59.13 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.803 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.424 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 25.5 t30 -162.11 118.01 1.99 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.798 -1.161 . . . . 0.0 112.154 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.512 HG22 ' HH ' ' A' ' 97' ' ' TYR . 6.1 t -179.2 -14.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.895 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.484 HG21 ' H ' ' A' ' 129' ' ' SER . 2.1 mt -50.84 166.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.173 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.484 ' H ' HG21 ' A' ' 128' ' ' ILE . 43.8 p -175.4 -115.11 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.536 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.1 m -54.39 131.27 41.84 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.854 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.13 155.83 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.47 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.11 83.83 4.57 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.835 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.58 107.46 1.44 Allowed 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.317 1.345 . . . . 0.0 110.638 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -88.86 24.34 2.08 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.973 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -173.01 -56.01 0.05 OUTLIER Glycine 0 N--CA 1.494 2.542 0 C-N-CA 118.208 -1.949 . . . . 0.0 112.095 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.445 HD13 ' N ' ' A' ' 92' ' ' ARG . 0.9 OUTLIER -116.79 172.74 7.05 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.567 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -89.37 142.58 27.53 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.497 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.2 t -102.13 145.41 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.94 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.99 124.65 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.681 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.4 HD13 ' N ' ' A' ' 140' ' ' LEU . 4.5 mp -107.74 146.07 32.64 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.239 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 20.2 m-85 -120.02 137.51 54.05 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.591 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -71.03 -67.82 0.48 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.951 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -65.57 165.34 12.46 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.98 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 146' ' ' PHE . 3.0 m-20 -63.61 -162.51 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.735 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.665 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 35.1 m120 27.48 39.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 123.859 0.724 . . . . 0.0 112.101 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.665 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.2 OUTLIER 43.97 61.26 2.39 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.456 -0.897 . . . . 0.0 109.881 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -132.42 173.29 11.45 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.27 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.05 -166.3 53.86 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.347 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -59.41 172.97 0.57 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.026 -1.069 . . . . 0.0 109.944 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 43.1 p -151.67 177.33 10.47 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.972 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.63 79.72 33.98 Favored Pre-proline 0 N--CA 1.485 1.3 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.764 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.6 105.21 0.73 Allowed 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 122.025 1.817 . . . . 0.0 113.247 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 39.8 t -90.68 74.52 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.946 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 154' ' ' ASN . 1.8 m-20 -79.19 26.64 0.26 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.14 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 25.4 t -169.99 -174.06 1.7 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.626 -1.23 . . . . 0.0 111.839 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.433 ' N ' ' OG ' ' A' ' 155' ' ' SER . 1.8 m-20 -73.78 154.44 39.55 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.907 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.601 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -166.68 72.4 1.11 Allowed Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.239 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.32 20.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.968 1.779 . . . . 0.0 111.85 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.601 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.2 t -169.38 71.08 0.07 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.863 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.437 ' HB3' ' H ' ' A' ' 161' ' ' GLY . 0.2 OUTLIER -75.58 -83.76 0.06 Allowed 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.479 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.437 ' H ' ' HB3' ' A' ' 160' ' ' LEU . . . 56.46 176.06 0.27 Allowed Glycine 0 N--CA 1.493 2.453 0 C-N-CA 118.902 -1.618 . . . . 0.0 110.083 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 55.33 98.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.917 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 4.1 ptm -176.33 73.46 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.475 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -44.0 161.51 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.709 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 59.4 89.47 0.06 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.006 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.425 ' N ' ' OD1' ' A' ' 166' ' ' ASN . 29.3 p-10 -38.98 151.4 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.994 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.18 120.81 14.36 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.865 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.735 ' HG ' ' N ' ' A' ' 169' ' ' SER . 54.4 p -92.78 -42.38 9.6 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.284 -0.967 . . . . 0.0 110.533 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.735 ' N ' ' HG ' ' A' ' 168' ' ' SER . 0.3 OUTLIER -136.72 164.09 29.08 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.788 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 30.0 pt -143.61 165.91 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -148.43 109.73 4.37 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.875 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.9 mt -89.12 99.47 9.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 119.271 -0.971 . . . . 0.0 109.946 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.305 -1.346 0 CA-C-O 116.352 -1.785 . . . . 0.0 111.12 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.2 mmm . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.937 0.399 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.43 -148.05 0.16 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.588 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -175.87 119.75 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.673 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.482 ' CG1' ' O ' ' A' ' 4' ' ' ILE . 1.0 OUTLIER -77.57 122.42 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.821 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -95.93 106.53 18.69 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.131 -1.028 . . . . 0.0 108.602 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 m -88.43 170.06 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 118.974 -1.09 . . . . 0.0 112.344 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 1.216 ' CE2' ' HG2' ' A' ' 16' ' ' GLN . 40.3 m-85 -134.35 144.5 48.29 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.75 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -65.61 -62.18 1.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.975 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.474 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 29.8 m120 -90.52 160.57 15.91 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.754 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -58.88 -171.6 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.64 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.638 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 11.5 m-20 44.95 51.54 8.61 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.842 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.638 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 49.5 p90 39.48 24.38 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 11' ' ' ASP . 32.9 mm-40 -98.69 173.74 6.75 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.565 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.474 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 81.58 135.68 1.95 Allowed Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.389 -1.386 . . . . 0.0 110.352 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 14' ' ' GLY . 30.0 mmtm -29.82 136.83 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.957 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 1.216 ' HG2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -97.53 160.8 14.1 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.339 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -146.22 129.05 9.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.131 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -91.14 124.59 35.48 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.863 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.9 mt -119.46 125.85 27.3 Favored Pre-proline 0 N--CA 1.497 1.898 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.892 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.4 158.83 47.04 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 120.98 1.12 . . . . 0.0 111.485 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.14 -166.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.911 1.741 . . . . 0.0 111.154 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.95 -171.28 29.88 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.222 -1.466 . . . . 0.0 110.481 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.638 ' N ' ' ND2' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -117.83 131.57 56.54 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.087 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.56 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 1.1 p90 -149.47 -174.88 4.8 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.937 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.447 HG22 ' CZ ' ' A' ' 58' ' ' PHE . 4.1 p -155.7 -162.14 1.27 Allowed 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.908 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.471 ' CD ' ' C ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -54.08 -20.65 6.86 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.493 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.427 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . -67.58 -66.58 0.54 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.441 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.59 HE21 ' CA ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -54.58 -44.83 73.34 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.796 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.6 mt -57.64 -42.74 84.04 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.005 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.03 -32.0 32.35 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 118.409 -1.317 . . . . 0.0 108.817 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.38 -39.31 85.61 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.638 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 mt -75.76 -71.87 0.35 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.326 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.62 -36.72 0.73 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.376 -1.393 . . . . 0.0 110.609 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 tt -81.99 143.15 12.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.849 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -179.96 134.98 0.11 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.563 -1.255 . . . . 0.0 112.495 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.617 ' C ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER 74.76 128.94 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.075 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.507 ' H ' ' H ' ' A' ' 79' ' ' VAL . 2.6 t30 45.36 8.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.178 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.553 ' HG1' ' N ' ' A' ' 39' ' ' ILE . 66.3 p -89.3 -33.33 16.97 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.527 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.553 ' N ' ' HG1' ' A' ' 38' ' ' THR . 4.8 mm -75.71 66.4 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.743 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.533 ' HG ' HD22 ' A' ' 76' ' ' ASN . 42.0 t -73.37 -55.3 6.57 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.153 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.9 160.06 29.72 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.147 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.448 HG21 ' H ' ' A' ' 69' ' ' ALA . 18.6 m -149.73 168.01 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 118.356 -1.338 . . . . 0.0 113.409 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -142.62 98.37 3.28 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.87 -1.514 . . . . 0.0 108.099 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.0 t -116.17 113.28 41.51 Favored Pre-proline 0 N--CA 1.496 1.852 0 C-N-CA 119.873 -0.731 . . . . 0.0 112.81 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -69.3 171.7 13.5 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.041 1.161 . . . . 0.0 110.009 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.481 ' HG3' ' HE ' ' A' ' 92' ' ' ARG . 1.0 OUTLIER -64.88 -167.78 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.617 1.545 . . . . 0.0 111.158 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.59 -8.36 7.46 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.373 -1.394 . . . . 0.0 110.781 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.427 ' H ' ' C ' ' A' ' 46' ' ' PRO . 33.2 m -148.59 143.34 18.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.576 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -118.23 126.42 52.13 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.234 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.54 144.53 36.08 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.377 -0.929 . . . . 0.0 112.765 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 27.8 mt -133.11 112.39 17.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.097 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.442 HD11 ' H ' ' A' ' 52' ' ' LEU . 1.6 mp -89.72 160.45 16.57 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.68 -1.208 . . . . 0.0 112.773 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -138.54 108.55 6.36 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.107 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -49.38 -78.59 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.259 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.467 HD21 ' HA3' ' A' ' 60' ' ' GLY . 2.6 m-80 -59.76 141.44 55.23 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.965 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -55.64 177.81 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.852 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.46 29.48 69.42 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.334 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.447 ' CZ ' HG22 ' A' ' 25' ' ' THR . 21.4 m-85 54.88 67.6 0.99 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.787 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.59 -162.65 1.6 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.958 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.467 ' HA3' HD21 ' A' ' 55' ' ' ASN . . . 64.42 176.09 4.59 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.363 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 60' ' ' GLY . 63.0 m-20 -42.68 112.92 0.4 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.613 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.663 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -93.0 155.68 17.37 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.401 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 7.3 mm -134.71 169.42 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.747 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.569 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 41.0 tt0 -150.8 130.71 13.33 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.718 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.6 m -149.95 159.94 4.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 118.942 -1.103 . . . . 0.0 111.808 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.93 -11.98 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.908 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -116.69 -149.42 0.44 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.892 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -94.04 128.51 40.44 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.508 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.448 ' H ' HG21 ' A' ' 42' ' ' VAL . . . -92.48 95.69 9.79 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.423 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 7.0 tp10 -56.9 -78.16 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.538 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.453 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 7.3 tp10 -91.42 5.05 50.9 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.309 -0.957 . . . . 0.0 110.748 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.7 tp 53.2 -99.85 0.09 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.023 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.72 -169.95 34.39 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 118.897 -1.62 . . . . 0.0 111.166 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.663 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.2 Cg_endo -68.58 -37.44 12.7 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.574 2.183 . . . . 0.0 112.929 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 75' ' ' LEU . 2.6 pt? -57.01 8.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.102 -1.039 . . . . 0.0 111.586 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.663 ' H ' ' C ' ' A' ' 74' ' ' PRO . 22.7 t-20 -59.52 -9.89 2.92 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.329 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.535 ' ND2' ' N ' ' A' ' 77' ' ' ASN . 1.3 m120 -67.25 -24.26 65.79 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.014 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -168.53 133.87 1.73 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.064 -1.055 . . . . 0.0 111.482 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.507 ' H ' ' H ' ' A' ' 37' ' ' ASN . 2.3 t -146.75 125.97 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.237 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.3 t -146.29 -42.8 0.2 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.925 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 m -90.93 135.21 33.89 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.057 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.02 159.51 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.196 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.763 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -143.91 106.21 4.39 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.749 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.763 ' CA ' HH12 ' A' ' 83' ' ' ARG . 11.3 t -123.33 131.63 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.545 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.483 HG12 ' NH1' ' A' ' 83' ' ' ARG . 1.5 pt -136.23 140.47 43.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.527 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.466 ' HG ' ' N ' ' A' ' 87' ' ' VAL . 16.1 t -44.43 156.39 0.08 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.758 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.466 ' N ' ' HG ' ' A' ' 86' ' ' SER . 0.3 OUTLIER -150.37 140.43 13.92 Favored Pre-proline 0 C--N 1.307 -1.248 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.505 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -50.67 136.79 42.1 Favored 'Trans proline' 0 C--O 1.21 -0.892 0 C-N-CA 121.006 1.138 . . . . 0.0 111.464 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.4 t -50.15 141.27 3.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.933 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -119.51 131.62 24.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.505 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.88 -24.5 72.7 Favored 'Trans proline' 0 C--O 1.21 -0.876 0 C-N-CA 120.762 0.975 . . . . 0.0 110.592 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.481 ' HE ' ' HG3' ' A' ' 46' ' ' PRO . 7.2 ptt85 36.36 -157.79 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.222 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.72 173.27 11.69 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.886 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.424 ' CD ' ' OE1' ' A' ' 105' ' ' GLU . 30.1 ttp180 -145.0 109.83 5.05 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 118.484 -1.286 . . . . 0.0 112.574 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 17.3 m-85 -95.95 149.1 21.93 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.204 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.468 ' CD1' ' HB3' ' A' ' 105' ' ' GLU . 72.1 m-85 -115.16 -162.52 0.83 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 119.344 -0.943 . . . . 0.0 111.0 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -135.04 168.01 19.91 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.29 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt 58.05 157.94 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 122.064 0.935 . . . . 0.0 112.823 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.55 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 32.0 tt0 -67.46 106.32 2.09 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.404 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.561 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 1.0 OUTLIER 97.92 59.51 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.976 0 O-C-N 124.721 1.263 . . . . 0.0 111.341 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.561 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 35.2 p90 31.51 38.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.48 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 100' ' ' GLN . 93.6 m-20 -100.62 49.7 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.851 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -169.47 157.52 29.33 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.773 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -40.73 158.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.704 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.468 ' HB3' ' CD1' ' A' ' 96' ' ' PHE . 5.9 pt-20 -123.45 165.44 17.06 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.663 0.744 . . . . 0.0 112.855 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.7 t -146.18 119.53 2.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.805 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.59 164.04 14.92 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.999 -1.08 . . . . 0.0 111.996 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 79.3 mt -145.35 137.88 13.6 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.695 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -69.58 161.28 46.52 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 121.646 1.564 . . . . 0.0 111.787 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.84 149.04 91.71 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.812 1.675 . . . . 0.0 111.243 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.53 -164.36 25.14 Favored Glycine 0 N--CA 1.502 3.077 0 C-N-CA 119.288 -1.434 . . . . 0.0 111.368 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.594 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 24.2 mt-30 -119.06 156.49 29.6 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.205 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 29.0 m-85 -144.93 150.54 37.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.884 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.6 p -90.31 -162.62 0.91 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.548 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -102.83 46.78 0.91 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -150.59 -62.98 0.2 Allowed 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.636 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 121' ' ' TYR . 5.8 pt-20 -71.57 -42.75 67.41 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.399 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.589 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -40.19 -70.04 0.11 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.04 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 121' ' ' TYR . 52.4 mt-10 -53.06 -59.49 4.47 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.845 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.457 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -68.34 14.59 0.07 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.389 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 119' ' ' GLU . 9.4 t80 -117.59 -26.83 6.48 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.27 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -129.35 -43.21 0.21 Allowed Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.521 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.474 HD11 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -146.29 -114.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.038 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -146.19 -160.82 1.2 Allowed 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.237 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -59.69 -99.91 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.64 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.672 ' CG ' ' H ' ' A' ' 127' ' ' THR . 19.5 p-10 -57.54 -111.31 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.672 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 1.6 t 43.75 -120.13 0.67 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.894 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.595 ' N ' ' OG1' ' A' ' 127' ' ' THR . 8.4 mm 54.79 -96.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.714 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.4 OUTLIER 76.12 -138.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.297 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.561 ' HG ' ' H ' ' A' ' 101' ' ' PHE . 3.9 m -42.27 129.51 3.8 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.044 -0.663 . . . . 0.0 111.819 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' A' ' 95' ' ' PHE . 2.9 t -121.13 150.96 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.393 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.78 83.41 8.12 Favored Pre-proline 0 C--N 1.302 -1.49 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.475 ' C ' ' H ' ' A' ' 135' ' ' GLY . 4.3 Cg_exo -61.05 98.65 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.536 1.491 . . . . 0.0 110.433 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -55.27 -2.76 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.656 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . 175.21 -36.97 0.1 Allowed Glycine 0 N--CA 1.492 2.388 0 C-N-CA 117.87 -2.11 . . . . 0.0 112.588 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.465 HD13 ' N ' ' A' ' 92' ' ' ARG . 3.8 mt -90.24 171.53 9.42 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.414 -1.314 . . . . 0.0 111.894 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -94.91 127.25 40.8 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 153' ' ' VAL . 3.4 t -98.32 139.22 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.988 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 98.9 t -133.34 125.35 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.314 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.474 ' CD2' ' HG1' ' A' ' 167' ' ' THR . 10.5 mp -103.62 140.29 37.75 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.428 -0.909 . . . . 0.0 113.052 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -117.35 131.75 56.72 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.055 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.807 ' HZ3' ' ND2' ' A' ' 164' ' ' ASN . 43.8 mttm -80.97 -44.12 18.65 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.419 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.434 ' HB3' ' CB ' ' A' ' 147' ' ' SER . 13.7 t30 -71.95 -171.68 0.74 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.698 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.34 -128.52 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.603 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 146' ' ' PHE . 45.7 t30 -53.57 93.26 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.439 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 145' ' ' ASN . 3.8 m-85 37.39 67.38 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.314 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.434 ' CB ' ' HB3' ' A' ' 143' ' ' ASN . 0.4 OUTLIER -140.83 165.79 26.55 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.116 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 75.79 -163.73 53.6 Favored Glycine 0 N--CA 1.503 3.1 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.998 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.01 171.82 10.18 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.725 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 p -148.18 164.13 34.88 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.697 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 mt -124.67 82.94 59.14 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.344 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -63.05 100.75 0.26 Allowed 'Trans proline' 0 C--N 1.318 -1.054 0 C-N-CA 121.649 1.566 . . . . 0.0 112.652 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 138' ' ' VAL . 10.3 t -80.81 90.01 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.366 -0.933 . . . . 0.0 109.66 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -49.87 -31.64 12.55 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.998 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.754 ' HG ' ' H ' ' A' ' 156' ' ' ASP . 13.3 t -170.39 -136.15 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.341 -1.344 . . . . 0.0 112.351 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.754 ' H ' ' HG ' ' A' ' 155' ' ' SER . 11.6 m-20 -50.55 141.62 12.11 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.18 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.574 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.44 63.43 1.07 Allowed Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.699 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.5 Cg_endo -63.22 21.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.214 1.943 . . . . 0.0 112.777 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.574 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -168.96 118.88 0.71 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.274 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.62 -40.64 0.14 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.407 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 50.58 -171.57 0.16 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.602 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.09 109.21 1.23 Allowed 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.39 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 6.1 tpt -91.22 -75.42 0.47 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.412 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.807 ' ND2' ' HZ3' ' A' ' 142' ' ' LYS . 3.5 m-80 -91.31 -78.57 0.39 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.726 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 164' ' ' ASN . 10.0 m-80 -168.8 81.59 0.14 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.807 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 166' ' ' ASN . 0.6 OUTLIER 63.37 141.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.451 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.474 ' HG1' ' CD2' ' A' ' 140' ' ' LEU . 1.1 m -90.58 123.12 33.97 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.579 -0.849 . . . . 0.0 110.508 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.4 m -90.33 -79.55 0.34 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.141 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 7.0 m -105.29 159.87 15.55 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.433 HG12 ' CD1' ' A' ' 118' ' ' LEU . 32.8 pt -141.92 174.36 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.25 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -158.82 109.84 2.09 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.506 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 56.5 mt -88.08 92.27 3.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 118.832 -1.147 . . . . 0.0 109.414 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.939 -179.904 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.0 -141.39 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.73 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 2.7 p30 -173.24 107.45 0.15 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.191 -1.003 . . . . 0.0 111.159 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 pt -76.36 175.13 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.932 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 m -148.06 153.1 38.47 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.364 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 m -138.02 160.04 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.235 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.488 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 22.2 m-85 -119.42 145.91 45.83 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.904 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.85 -66.52 0.6 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.516 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 13.4 m120 -76.1 179.82 5.43 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.311 -0.956 . . . . 0.0 112.364 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -73.93 176.81 6.08 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.226 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.654 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 16.8 t70 48.56 56.01 8.18 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.491 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.654 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 39.2 p90 38.23 27.42 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.451 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 11' ' ' ASP . 6.3 tp-100 -98.89 163.06 12.76 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.35 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.516 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 93.13 134.35 6.91 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.378 -1.391 . . . . 0.0 109.634 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 14' ' ' GLY . 38.7 mttp -29.45 140.82 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.47 164.55 12.23 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.322 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.3 t -145.58 129.94 11.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.664 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -92.94 137.09 32.67 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.231 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 mt -129.05 136.79 29.73 Favored Pre-proline 0 N--CA 1.49 1.558 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.33 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -72.44 156.72 54.1 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 121.087 1.191 . . . . 0.0 111.422 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.73 -161.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.463 1.442 . . . . 0.0 109.726 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.558 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 91.18 -162.47 28.46 Favored Glycine 0 N--CA 1.485 1.923 0 C-N-CA 118.528 -1.796 . . . . 0.0 110.991 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.682 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -123.03 133.18 54.35 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.238 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -155.7 174.51 15.19 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.522 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.0 p -138.25 -156.64 0.7 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.071 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.452 ' N ' ' CD ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -66.79 -16.68 64.43 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.599 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.449 ' H ' ' HD3' ' A' ' 26' ' ' ARG . . . -65.13 -59.88 3.62 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.637 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -56.41 -43.78 79.68 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 118.754 -1.178 . . . . 0.0 109.261 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 28.4 mt -59.21 -40.03 84.51 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.814 -1.155 . . . . 0.0 109.127 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.7 -32.73 14.08 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 118.735 -1.186 . . . . 0.0 108.077 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.87 -42.07 73.97 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.699 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 mt -70.58 -74.86 0.13 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.82 -29.67 0.74 Allowed Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.092 -1.527 . . . . 0.0 110.846 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.08 139.99 16.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.882 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.494 ' C ' ' CG ' ' A' ' 36' ' ' ASN . 2.2 pt-20 179.94 166.1 1.22 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.481 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.648 ' C ' ' H ' ' A' ' 38' ' ' THR . 0.6 OUTLIER 79.97 -143.54 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.545 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.706 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.0 OUTLIER -56.38 10.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.623 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.648 ' H ' ' C ' ' A' ' 36' ' ' ASN . 67.4 p -76.17 -142.4 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.618 -1.233 . . . . 0.0 111.023 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 38' ' ' THR . 9.1 mt 39.69 60.71 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.02 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.2 t -65.54 -50.39 65.4 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.12 172.26 8.38 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.355 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.62 154.48 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 118.529 -1.268 . . . . 0.0 112.607 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -138.66 125.28 20.76 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.457 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.9 t -140.0 114.43 7.74 Favored Pre-proline 0 N--CA 1.494 1.725 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.918 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -69.32 169.48 18.25 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 121.116 1.21 . . . . 0.0 111.231 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.63 -174.97 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 122.102 1.868 . . . . 0.0 111.387 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.86 -16.77 7.86 Favored Glycine 0 N--CA 1.482 1.766 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.985 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.4 m -149.25 146.4 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.779 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -119.55 139.35 52.28 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.55 159.43 20.41 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.199 -1.001 . . . . 0.0 112.937 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 70.5 mt -141.29 117.96 7.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.447 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.479 HD11 ' H ' ' A' ' 52' ' ' LEU . 4.2 mp -92.32 163.12 14.0 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.824 -1.15 . . . . 0.0 113.222 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.57 ' CZ ' ' NE2' ' A' ' 62' ' ' GLN . 30.7 m-85 -141.61 115.29 9.06 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.678 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -81.1 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.899 -0.72 . . . . 0.0 112.157 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -59.26 141.07 55.28 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.319 -0.953 . . . . 0.0 111.382 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.07 172.79 0.26 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.464 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.47 27.27 73.88 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.291 -1.433 . . . . 0.0 110.149 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 54.58 63.32 2.19 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.969 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.38 -161.6 1.34 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.01 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.0 170.02 1.21 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.462 -1.352 . . . . 0.0 110.106 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -44.74 121.44 2.71 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.343 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.57 ' NE2' ' CZ ' ' A' ' 53' ' ' TYR . 5.0 mt-30 -94.86 173.21 7.71 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.068 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.43 HG21 ' H ' ' A' ' 64' ' ' GLU . 2.9 mt -143.73 166.04 13.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.683 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.43 ' H ' HG21 ' A' ' 63' ' ' ILE . 4.6 tm-20 -146.93 131.18 17.45 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.299 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.6 m -150.17 160.31 4.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.806 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.43 -15.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.543 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.497 ' H ' ' HH ' ' A' ' 121' ' ' TYR . . . -111.1 -138.55 0.38 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.003 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -111.07 124.81 52.91 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.001 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.75 120.25 29.98 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.236 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.55 -85.18 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.108 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 6.5 mt-10 -85.51 3.56 39.84 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.69 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.454 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 1.6 tp 72.34 -89.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.584 -0.847 . . . . 0.0 111.74 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -179.13 -178.88 48.57 Favored Glycine 0 N--CA 1.499 2.876 0 C-N-CA 118.861 -1.638 . . . . 0.0 111.369 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -70.2 14.8 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.627 2.218 . . . . 0.0 112.99 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.474 ' H ' HD22 ' A' ' 75' ' ' LEU . 1.4 pt? -132.49 38.95 3.41 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.269 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -83.46 -2.04 54.98 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.655 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -73.14 -7.99 53.79 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.805 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -164.07 117.74 1.45 Allowed 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.122 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.27 127.32 11.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.232 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.1 t -155.45 -35.32 0.09 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 118.857 -1.137 . . . . 0.0 112.362 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.2 m -93.69 136.49 33.91 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.943 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -144.84 155.99 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 118.839 -1.144 . . . . 0.0 112.282 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.785 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.87 120.74 15.43 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.358 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.785 ' H ' HH12 ' A' ' 83' ' ' ARG . 18.4 t -129.92 136.8 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.939 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.591 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 2.6 mt -143.87 132.77 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.027 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.5 m -38.18 150.81 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.928 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -148.03 139.89 14.14 Favored Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.328 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -47.78 153.61 2.34 Favored 'Trans proline' 0 C--O 1.212 -0.821 0 C-N-CA 121.401 1.401 . . . . 0.0 111.512 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.34 141.25 15.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 119.756 -0.778 . . . . 0.0 112.312 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -145.97 136.41 12.16 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.582 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.83 -155.39 0.01 OUTLIER 'Trans proline' 0 C--O 1.21 -0.904 0 C-N-CA 121.421 1.414 . . . . 0.0 111.274 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.443 ' HB2' ' H ' ' A' ' 93' ' ' ALA . 5.2 ptt180 -178.76 -160.86 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 118.375 -1.33 . . . . 0.0 111.929 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.443 ' H ' ' HB2' ' A' ' 92' ' ' ARG . . . -143.0 168.7 19.09 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.385 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -125.15 156.52 38.25 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.635 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.457 ' CD2' HG12 ' A' ' 131' ' ' VAL . 73.7 m-85 -145.88 103.88 3.8 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.672 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -89.97 172.25 8.99 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.059 -1.057 . . . . 0.0 112.124 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.603 ' CE2' ' OG1' ' A' ' 127' ' ' THR . 0.3 OUTLIER -110.45 159.23 17.68 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.915 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 42.2 tttt 68.35 151.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.84 0.829 . . . . 0.0 112.359 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.562 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 26.8 tt0 -67.9 106.22 2.23 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.754 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.584 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 105.0 48.45 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.108 0 O-C-N 125.054 1.471 . . . . 0.0 110.637 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.584 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 33.9 p90 30.73 39.1 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.156 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 100' ' ' GLN . 24.9 t70 -99.41 26.75 5.76 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.465 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -146.94 179.99 23.46 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.141 -1.504 . . . . 0.0 111.28 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -29.72 145.12 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -119.08 137.65 53.42 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.322 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.466 ' CG1' ' N ' ' A' ' 107' ' ' ASP . 2.4 t -139.86 158.58 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.979 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.466 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 7.2 p-10 -144.86 156.35 43.96 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.646 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.461 HD21 ' CE2' ' A' ' 121' ' ' TYR . 32.2 mt -141.08 147.9 49.52 Favored Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.527 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -71.31 165.23 33.09 Favored 'Trans proline' 0 C--O 1.212 -0.819 0 C-N-CA 121.797 1.665 . . . . 0.0 111.08 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.54 149.42 82.18 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.646 1.564 . . . . 0.0 111.518 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.41 -151.38 22.6 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 119.069 -1.539 . . . . 0.0 111.436 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.678 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 41.5 tt0 -136.14 155.69 49.8 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.21 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.678 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 18.9 m-85 -145.6 155.32 42.96 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.51 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.9 p -96.45 -156.82 0.55 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.327 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.678 ' H ' ' CD ' ' A' ' 115' ' ' GLN . 3.8 pm0 -103.75 29.4 5.81 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.231 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.24 -65.48 0.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.769 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.55 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 9.6 pt-20 -70.33 -48.77 54.99 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.975 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.58 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 1.9 tt -35.12 -73.25 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.502 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -50.54 -54.22 24.14 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.555 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -76.28 17.66 0.35 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.638 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.511 ' N ' ' O ' ' A' ' 117' ' ' GLU . 18.1 t80 -123.7 -12.62 7.6 Favored 'General case' 0 N--CA 1.502 2.175 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.625 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -142.47 -48.49 0.04 OUTLIER Glycine 0 N--CA 1.485 1.953 0 C-N-CA 119.223 -1.465 . . . . 0.0 110.173 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.614 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -145.13 -99.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.835 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.614 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 17.9 t70 -165.76 -164.88 0.76 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.15 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.57 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 1.4 t-20 -64.53 -122.07 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.874 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.501 ' H ' ' CG ' ' A' ' 125' ' ' ASN . 3.6 m-20 -70.4 112.42 6.68 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.538 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.603 ' OG1' ' CE2' ' A' ' 97' ' ' TYR . 1.8 t -179.87 -5.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.744 -0.783 . . . . 0.0 110.798 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.2 mt -91.25 151.95 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.617 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.466 ' HB3' ' H ' ' A' ' 161' ' ' GLY . 19.3 m -153.42 -66.12 0.15 Allowed 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.373 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.497 ' H ' ' HG ' ' A' ' 130' ' ' SER . 0.0 OUTLIER -82.24 112.37 19.18 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.037 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.457 HG12 ' CD2' ' A' ' 95' ' ' PHE . 2.0 t -120.5 163.3 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.189 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.0 tttp -154.34 125.64 3.62 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.647 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 6.2 Cg_endo -65.33 -50.04 2.22 Favored 'Trans proline' 0 C--O 1.203 -1.262 0 C-N-CA 121.034 1.156 . . . . 0.0 111.081 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.479 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 72.23 -37.72 0.4 Allowed 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.38 -0.928 . . . . 0.0 112.621 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . -150.35 -48.88 0.02 OUTLIER Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.236 -1.459 . . . . 0.0 111.113 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.419 HD13 ' CA ' ' A' ' 92' ' ' ARG . 0.7 OUTLIER -109.56 153.4 24.19 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.008 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.06 153.75 41.54 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.118 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.64 143.82 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 119.663 -0.815 . . . . 0.0 112.321 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.48 HG13 ' CE1' ' A' ' 141' ' ' PHE . 93.3 t -135.94 123.07 33.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.984 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.3 mp -103.23 142.75 33.64 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.812 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.528 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 14.0 m-85 -120.61 136.52 54.79 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.082 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -75.05 -62.62 1.49 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.565 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.438 ' ND2' ' HA3' ' A' ' 148' ' ' GLY . 2.6 m-80 -61.01 159.99 10.65 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.271 -0.972 . . . . 0.0 112.362 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -27.35 -108.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.519 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 9.0 m120 -74.7 89.82 2.28 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.219 -0.901 . . . . 0.0 113.273 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.626 ' CG ' ' NE2' ' A' ' 112' ' ' GLN . 1.5 p90 33.04 73.11 0.07 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.131 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.3 t -145.83 -170.76 3.55 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.158 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.438 ' HA3' ' ND2' ' A' ' 143' ' ' ASN . . . 51.26 -157.97 2.54 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.124 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.99 174.1 0.54 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.654 -0.819 . . . . 0.0 110.833 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 55.3 p -155.05 174.5 15.09 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.914 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.7 tp -138.32 79.54 30.46 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.026 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -59.66 110.26 0.71 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.817 1.678 . . . . 0.0 112.945 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' A' ' 155' ' ' SER . 20.5 t -93.24 70.77 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.356 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -65.06 8.2 0.14 Allowed 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.219 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.595 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 9.3 t -170.94 177.68 3.67 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.282 -1.367 . . . . 0.0 112.211 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.595 ' N ' ' OG ' ' A' ' 155' ' ' SER . 3.2 m-20 -51.0 151.59 2.53 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.431 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.516 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -164.32 61.71 0.92 Allowed Pre-proline 0 C--N 1.309 -1.165 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.407 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.2 Cg_endo -63.72 22.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.534 2.156 . . . . 0.0 113.314 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.511 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -175.96 95.49 0.06 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 117.759 -1.576 . . . . 0.0 112.504 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.578 ' O ' ' N ' ' A' ' 162' ' ' ALA . 44.7 mt -112.56 -61.54 1.71 Allowed 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.65 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 164' ' ' ASN . . . 44.44 -87.05 0.01 OUTLIER Glycine 0 N--CA 1.499 2.89 0 C-N-CA 119.553 -1.308 . . . . 0.0 111.156 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -37.61 -33.07 0.06 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.979 -0.689 . . . . 0.0 111.525 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.448 ' O ' ' C ' ' A' ' 164' ' ' ASN . 2.3 tpt -78.7 25.32 0.26 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.637 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.557 ' H ' ' C ' ' A' ' 162' ' ' ALA . 22.7 t-20 -32.41 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.426 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.531 ' ND2' ' H ' ' A' ' 167' ' ' THR . 11.4 t30 -122.02 119.36 31.22 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.687 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -45.08 -23.22 0.14 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.138 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.531 ' H ' ' ND2' ' A' ' 165' ' ' ASN . 47.3 m 42.76 73.88 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.419 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.3 m -78.29 -23.55 47.14 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.204 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.592 ' CB ' ' H ' ' A' ' 146' ' ' PHE . 0.2 OUTLIER -149.25 162.07 40.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.34 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 29.1 pt -143.46 161.33 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 119.159 -1.017 . . . . 0.0 111.029 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -143.42 104.01 4.18 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.452 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.8 mt -82.63 95.12 3.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.179 -1.009 . . . . 0.0 110.154 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.3 m . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.845 179.969 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 mtm . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.892 0.377 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -49.51 164.2 0.09 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.469 -0.893 . . . . 0.0 111.105 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -175.15 118.96 0.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.526 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.5 pt -69.14 154.7 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.233 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -126.56 135.44 51.27 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.81 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -121.89 138.73 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.971 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.52 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 29.6 m-85 -96.48 146.7 24.56 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.798 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.04 -56.78 17.02 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.25 -0.98 . . . . 0.0 112.21 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.547 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 12.2 m-20 -96.85 170.94 8.83 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.507 ' HG2' ' N ' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -76.6 -165.92 0.59 Allowed 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.976 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.507 ' N ' ' HG2' ' A' ' 10' ' ' GLU . 66.4 m-20 52.67 35.4 18.21 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.523 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.52 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 18.2 t80 56.68 7.11 0.35 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.436 -0.905 . . . . 0.0 112.16 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.446 ' HG3' ' H ' ' A' ' 14' ' ' GLY . 5.3 tp-100 -96.31 160.21 14.54 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.551 -0.859 . . . . 0.0 111.678 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.547 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 102.38 131.23 7.27 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.738 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 14' ' ' GLY . 25.2 mtmm -31.79 141.11 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.927 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.56 ' NE2' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -99.44 161.19 13.76 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.119 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.1 t -145.47 134.48 17.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.206 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.16 134.09 39.66 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.141 -1.024 . . . . 0.0 112.116 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.6 mt -122.1 127.57 25.88 Favored Pre-proline 0 N--CA 1.489 1.479 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.524 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.5 163.6 31.92 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 120.928 1.086 . . . . 0.0 111.268 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.39 -169.28 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.65 1.567 . . . . 0.0 111.019 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.459 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 87.96 -176.91 46.05 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.744 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.605 ' ND2' ' H ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -112.18 142.29 44.83 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.884 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.602 ' CE2' ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -156.03 -174.77 5.1 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.314 179.777 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 24' ' ' TYR . 4.7 p -156.35 -157.17 0.69 Allowed 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.921 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.9 ttt85 -52.29 -33.54 42.65 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.289 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.79 -63.59 1.21 Allowed 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.863 -1.135 . . . . 0.0 110.524 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.404 ' NE2' ' HB2' ' A' ' 31' ' ' ALA . 1.8 tm0? -57.23 -32.95 67.05 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.779 -1.169 . . . . 0.0 109.882 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.602 ' CD2' ' CE2' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -60.56 -47.27 86.92 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.011 -1.076 . . . . 0.0 109.433 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.41 -32.99 28.33 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.163 -1.015 . . . . 0.0 108.92 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.404 ' HB2' ' NE2' ' A' ' 28' ' ' GLN . . . -64.08 -42.79 96.83 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.848 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 mt -71.9 -80.31 0.06 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.941 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.77 -29.79 0.16 Allowed Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.465 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -82.2 169.75 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.894 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.64 ' H ' ' CG2' ' A' ' 38' ' ' THR . 4.7 pt-20 178.68 111.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.289 -0.965 . . . . 0.0 111.904 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 38' ' ' THR . 1.0 OUTLIER 61.66 140.57 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.527 ' H ' ' H ' ' A' ' 79' ' ' VAL . 9.6 t30 47.01 4.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.658 -1.156 . . . . 0.0 113.695 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.64 ' CG2' ' H ' ' A' ' 35' ' ' GLU . 76.2 p -82.34 -29.87 30.74 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 117.992 -1.483 . . . . 0.0 111.424 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -78.24 53.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.328 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 10' ' ' GLU . 30.4 t -50.98 -53.93 28.85 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.761 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.0 169.65 10.27 Favored 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.307 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.464 HG11 ' H ' ' A' ' 69' ' ' ALA . 1.1 t -153.3 151.43 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 117.856 -1.538 . . . . 0.0 113.139 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -138.64 102.69 4.66 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.194 -1.367 . . . . 0.0 108.805 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 73.9 t -117.94 107.8 43.5 Favored Pre-proline 0 N--CA 1.496 1.865 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.228 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.25 168.2 19.98 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 121.31 1.34 . . . . 0.0 110.939 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.11 -173.19 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.753 1.635 . . . . 0.0 111.177 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.63 -14.77 11.46 Favored Glycine 0 N--CA 1.481 1.699 0 C-N-CA 119.125 -1.512 . . . . 0.0 110.691 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.3 m -151.59 134.28 6.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 C-N-CA 118.851 -1.14 . . . . 0.0 112.086 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -105.83 143.52 33.85 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.32 150.75 49.44 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.024 -1.07 . . . . 0.0 112.928 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.9 mt -135.04 117.75 22.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.737 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.442 HD11 ' H ' ' A' ' 52' ' ' LEU . 3.6 mp -96.61 160.83 14.18 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 118.927 -1.109 . . . . 0.0 113.8 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -135.3 116.38 14.3 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.675 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -47.59 -88.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.081 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -61.69 147.26 46.58 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.54 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -55.54 174.51 0.1 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.389 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.16 30.59 75.87 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.127 -1.511 . . . . 0.0 110.03 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.641 ' H ' ' HG ' ' A' ' 81' ' ' SER . 2.2 m-85 48.42 40.46 14.83 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.767 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.37 -176.97 3.02 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.821 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.69 164.27 5.27 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.064 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -45.55 131.87 8.47 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.545 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -99.24 172.31 7.44 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.865 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.463 HG21 ' H ' ' A' ' 64' ' ' GLU . 3.9 mt -135.28 165.29 31.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.763 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' H ' HG21 ' A' ' 63' ' ' ILE . 28.2 mt-10 -143.92 129.89 19.49 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.4 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.1 m -150.03 159.61 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 118.489 -1.284 . . . . 0.0 112.524 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 t -146.23 2.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.238 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -131.51 -144.6 0.25 Allowed 'General case' 0 C--O 1.207 -1.132 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.086 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.481 ' ND2' ' C ' ' A' ' 68' ' ' ASN . 0.5 OUTLIER -103.37 119.55 39.09 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.849 -0.741 . . . . 0.0 111.578 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.464 ' H ' HG11 ' A' ' 42' ' ' VAL . . . -97.45 97.86 9.45 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.17 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -58.72 -87.61 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.48 -0.888 . . . . 0.0 112.096 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 43.7 mm-40 -68.02 -5.83 19.39 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.41 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.466 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 2.8 tp 70.83 -77.88 0.05 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.049 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.43 -175.21 43.75 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.51 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.432 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.7 Cg_endo -65.35 -38.43 26.48 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.193 1.929 . . . . 0.0 111.865 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.484 ' H ' HD22 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -78.96 30.67 0.2 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.395 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.775 ' H ' HD21 ' A' ' 76' ' ' ASN . 0.0 OUTLIER -77.14 10.26 2.52 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.561 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 75' ' ' LEU . 11.6 t30 -87.83 -2.17 58.44 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.83 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -170.7 122.23 0.6 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.024 -1.07 . . . . 0.0 111.546 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.527 ' H ' ' H ' ' A' ' 37' ' ' ASN . 2.4 t -147.92 121.93 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.494 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.1 t -150.58 -34.1 0.16 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.908 -1.117 . . . . 0.0 112.517 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.641 ' HG ' ' H ' ' A' ' 58' ' ' PHE . 3.8 m -93.19 136.31 33.58 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.818 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 83' ' ' ARG . 21.3 mt -148.08 160.95 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.287 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.815 HH22 ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -142.78 108.1 5.01 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.824 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.815 ' N ' HH22 ' A' ' 83' ' ' ARG . 10.5 t -114.59 142.39 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.823 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.465 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 7.2 mt -142.48 132.43 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.745 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 m -40.38 153.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.663 -0.698 . . . . 0.0 112.319 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -150.77 149.1 24.78 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.968 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.33 177.55 0.15 Allowed 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 121.546 1.497 . . . . 0.0 112.099 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.6 m -88.29 136.12 24.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.316 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -146.17 123.68 6.1 Favored Pre-proline 0 C--N 1.308 -1.2 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.844 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -57.06 178.84 0.13 Allowed 'Trans proline' 0 C--O 1.205 -1.146 0 C-N-CA 121.088 1.192 . . . . 0.0 110.978 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.5 ' HD3' ' N ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -151.42 -160.12 1.12 Allowed 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.566 0.698 . . . . 0.0 110.23 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.98 167.03 23.06 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -132.35 116.07 16.4 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.674 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -99.09 130.27 45.41 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 105' ' ' GLU . 24.8 m-85 -102.47 165.39 11.13 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.639 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -103.31 162.67 12.81 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.41 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.455 ' CB ' ' CB ' ' A' ' 102' ' ' ASP . 22.3 mmtp 58.14 157.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 122.24 1.019 . . . . 0.0 112.858 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.552 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 36.4 tt0 -72.92 107.58 5.38 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.3 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 92.26 56.52 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.603 0 O-C-N 124.524 1.14 . . . . 0.0 111.256 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.588 ' O ' ' CG ' ' A' ' 101' ' ' PHE . 1.3 t80 37.98 64.1 0.73 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.486 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.455 ' CB ' ' CB ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -111.77 17.03 20.21 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.193 179.838 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -160.01 155.4 26.53 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.485 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -44.77 162.11 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.135 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.456 ' CD ' ' C ' ' A' ' 105' ' ' GLU . 2.2 pp20? -120.12 179.46 4.27 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.532 0.682 . . . . 0.0 112.551 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -140.01 177.0 4.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.799 -1.092 . . . . 0.0 108.963 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.469 ' N ' HG12 ' A' ' 106' ' ' VAL . 19.5 p-10 -142.55 150.91 41.02 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.653 -1.219 . . . . 0.0 112.006 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.3 mt -141.98 148.46 48.86 Favored Pre-proline 0 N--CA 1.5 2.064 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.732 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -77.28 163.01 30.7 Favored 'Trans proline' 0 C--O 1.211 -0.83 0 C-N-CA 122.096 1.864 . . . . 0.0 111.963 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.38 158.54 35.37 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 122.415 2.077 . . . . 0.0 111.484 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.91 -170.5 14.96 Favored Glycine 0 N--CA 1.501 2.985 0 C-N-CA 119.465 -1.35 . . . . 0.0 111.43 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.594 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 18.8 tt0 -111.2 155.43 22.94 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.611 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 26.0 m-85 -142.35 151.87 42.34 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.83 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.4 p -87.24 -164.77 1.14 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.686 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 56.54 0.68 Allowed 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.179 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.441 ' N ' ' OE1' ' A' ' 119' ' ' GLU . . . -155.18 -71.57 0.12 Allowed 'General case' 0 C--N 1.294 -1.804 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.234 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.1 pt-20 -67.04 -44.73 79.47 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.488 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.588 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 1.2 tt -39.56 -69.83 0.12 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.5 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.67 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 25.4 mp0 -48.11 -59.41 3.41 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.913 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.416 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 1.5 mpt_? -70.95 0.79 6.61 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.96 -1.096 . . . . 0.0 112.814 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 117' ' ' GLU . 13.8 t80 -97.9 -17.58 19.17 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.072 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.55 -41.05 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 C-N-CA 118.55 -1.786 . . . . 0.0 111.665 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.46 HD11 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -134.73 -117.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.461 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.581 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 15.7 t70 -148.92 -163.72 1.85 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.599 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.581 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -106.07 31.45 5.09 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.028 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.577 ' C ' HD21 ' A' ' 126' ' ' ASN . 0.4 OUTLIER -176.27 17.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.756 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 128' ' ' ILE . 8.5 t -114.67 -132.11 0.33 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.386 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.506 ' H ' HG22 ' A' ' 127' ' ' THR . 3.4 mt 62.84 158.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.097 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.723 ' HG ' ' H ' ' A' ' 130' ' ' SER . 8.2 p -165.85 -97.29 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.846 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.723 ' H ' ' HG ' ' A' ' 129' ' ' SER . 0.2 OUTLIER -70.65 136.88 49.42 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.889 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.59 157.25 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -150.8 96.48 3.34 Favored Pre-proline 0 C--N 1.304 -1.398 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.893 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.431 ' C ' ' H ' ' A' ' 135' ' ' GLY . 10.2 Cg_exo -53.26 93.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.238 1.292 . . . . 0.0 110.79 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.467 ' CG ' ' NH2' ' A' ' 92' ' ' ARG . 1.4 tp-100 -71.85 7.69 1.47 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.1 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . 171.52 -40.56 0.18 Allowed Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.92 -1.61 . . . . 0.0 111.02 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.67 151.02 40.92 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.314 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.0 156.36 39.73 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.657 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.29 136.49 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.818 -0.753 . . . . 0.0 112.249 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.447 HG11 ' CE1' ' A' ' 141' ' ' PHE . 74.3 t -125.14 128.77 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.826 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 10.8 mp -102.72 142.01 34.58 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.372 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.543 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 4.0 m-85 -120.6 134.23 55.3 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.397 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -70.28 -71.58 0.24 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.914 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.41 ' CG ' ' H ' ' A' ' 144' ' ' ASP . 47.1 t30 -72.81 -176.32 1.98 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.889 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.625 ' C ' ' ND2' ' A' ' 145' ' ' ASN . 1.5 m-20 -77.12 -164.25 0.44 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.665 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 1.1 p30 36.65 29.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.518 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.665 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 2.5 p90 39.58 61.64 1.35 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.779 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.5 t -146.66 137.67 24.13 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.2 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.42 -139.55 14.23 Favored Glycine 0 N--CA 1.503 3.125 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.56 141.65 44.77 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.099 -1.041 . . . . 0.0 109.863 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 34.3 p -147.82 162.28 39.57 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.911 -1.116 . . . . 0.0 111.869 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.8 tp -130.12 89.34 45.53 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.922 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.06 108.87 1.59 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 121.849 1.699 . . . . 0.0 113.006 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.58 80.56 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.412 -0.915 . . . . 0.0 108.925 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.478 ' C ' ' OG ' ' A' ' 155' ' ' SER . 50.9 t30 -65.35 -9.91 28.66 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.478 ' OG ' ' C ' ' A' ' 154' ' ' ASN . 1.2 m -161.03 -155.44 0.41 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 117.594 -1.643 . . . . 0.0 113.232 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.51 142.48 44.16 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.824 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.577 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -162.05 61.82 1.3 Allowed Pre-proline 0 C--N 1.308 -1.21 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.449 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.2 Cg_endo -64.71 21.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.291 1.994 . . . . 0.0 112.316 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.577 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -170.45 113.17 0.44 Allowed 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.677 -1.209 . . . . 0.0 111.331 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 mt -143.1 -56.78 0.42 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.406 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 79.11 40.03 17.8 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.333 -1.413 . . . . 0.0 110.612 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 48.09 84.51 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.666 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 19.0 mmt -73.95 -44.79 53.69 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.858 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -67.93 170.17 8.66 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.736 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -60.74 -54.98 38.59 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.944 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -161.13 111.78 1.74 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.11 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.2 m -57.55 99.17 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.593 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 73.7 m -84.29 -56.29 3.72 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.517 ' HG ' ' H ' ' A' ' 146' ' ' PHE . 0.3 OUTLIER -122.68 158.39 30.18 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.176 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 35.1 pt -136.01 165.37 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.49 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -146.73 100.58 3.35 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.401 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.3 mt -78.97 105.13 7.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.256 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 51.6 m . . . . . 0 C--N 1.306 -1.324 0 CA-C-O 116.399 -1.762 . . . . 0.0 110.963 -179.937 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ptt? . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.42 ' C ' ' CG ' ' A' ' 3' ' ' ASN . . . -152.31 179.97 8.06 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.333 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.42 ' CG ' ' C ' ' A' ' 2' ' ' ALA . 9.0 m-80 -158.97 122.33 3.78 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.854 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.417 ' O ' ' CG1' ' A' ' 4' ' ' ILE . 2.2 pt -75.49 133.86 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.852 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 m -110.89 114.69 28.21 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.353 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.32 164.6 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.304 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.905 ' CE2' ' OE1' ' A' ' 16' ' ' GLN . 39.6 m-85 -123.85 148.85 46.42 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.998 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.432 ' HB2' ' N ' ' A' ' 15' ' ' LYS . 3.2 m-85 -79.04 0.41 27.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.54 HD21 ' CA ' ' A' ' 14' ' ' GLY . 22.8 m-80 -151.3 172.82 15.28 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.026 -1.47 . . . . 0.0 112.114 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.56 -174.82 1.81 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.519 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 13' ' ' GLN . 15.3 t70 52.67 31.08 9.67 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.159 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.526 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 1.5 t80 68.45 -8.73 0.58 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.136 -1.026 . . . . 0.0 111.349 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -78.25 167.93 20.62 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.287 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 1.134 ' O ' ' NE2' ' A' ' 16' ' ' GLN . . . 109.3 134.82 7.12 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 1.176 ' C ' HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -35.25 144.57 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.688 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 1.429 HE21 ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -98.6 148.05 24.19 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.258 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.3 t -147.45 123.37 2.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.676 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -94.78 115.82 27.98 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.803 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt -105.98 132.49 20.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.598 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -68.53 164.69 31.89 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 120.874 1.049 . . . . 0.0 111.439 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.68 -161.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 121.774 1.649 . . . . 0.0 111.057 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.682 ' C ' HD21 ' A' ' 23' ' ' ASN . . . 83.68 -177.64 52.43 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.109 -1.52 . . . . 0.0 111.354 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.723 ' N ' HD21 ' A' ' 23' ' ' ASN . 0.3 OUTLIER -105.92 137.08 44.42 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.786 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.492 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 4.0 p90 -158.55 160.2 36.37 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.294 -0.963 . . . . 0.0 109.689 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.445 ' CG2' ' CE2' ' A' ' 58' ' ' PHE . 68.9 p -122.83 -162.02 0.99 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.1 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -66.3 -16.99 64.48 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.876 -1.13 . . . . 0.0 110.776 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.39 -58.42 6.52 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 118.816 -1.154 . . . . 0.0 109.211 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.452 HE21 ' HA ' ' A' ' 28' ' ' GLN . 0.3 OUTLIER -55.57 -44.89 77.27 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 118.686 -1.206 . . . . 0.0 108.918 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 32' ' ' LEU . 39.4 mt -57.33 -41.27 79.64 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.966 -1.094 . . . . 0.0 109.425 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.49 -33.14 13.68 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.86 -1.136 . . . . 0.0 108.263 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.95 -37.91 72.83 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.489 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 29' ' ' LEU . 20.2 mt -72.6 -73.2 0.21 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.646 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.81 -27.2 0.65 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.285 -1.436 . . . . 0.0 110.596 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 tt -75.63 145.82 10.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.173 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.53 ' H ' HG22 ' A' ' 38' ' ' THR . 5.6 pt-20 -174.38 146.68 1.09 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.657 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.514 ' CG ' ' C ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER 74.56 -140.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.402 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.637 ' H ' HD21 ' A' ' 37' ' ' ASN . 2.4 m-80 -40.3 -87.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.282 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.704 ' O ' ' N ' ' A' ' 40' ' ' SER . 20.3 p 37.5 -96.26 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.761 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.666 ' H ' ' HG1' ' A' ' 38' ' ' THR . 5.6 mt -38.0 79.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 124.412 1.07 . . . . 0.0 111.442 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.704 ' N ' ' O ' ' A' ' 38' ' ' THR . 28.5 t -96.07 -39.05 9.93 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.447 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.99 167.55 16.52 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.503 HG13 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -153.08 151.14 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 117.849 -1.54 . . . . 0.0 113.012 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -135.46 99.96 4.37 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.837 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.55 108.38 39.6 Favored Pre-proline 0 N--CA 1.494 1.753 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.577 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.94 167.66 20.94 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.092 1.195 . . . . 0.0 110.692 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.65 -171.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.748 1.632 . . . . 0.0 111.108 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.73 -14.51 9.77 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 119.317 -1.421 . . . . 0.0 110.93 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 m -147.32 140.46 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.339 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.1 tttt -114.81 125.79 54.09 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.808 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -117.37 139.7 50.53 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.184 -1.007 . . . . 0.0 113.061 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.413 HD11 HH21 ' A' ' 83' ' ' ARG . 44.3 mt -116.26 119.3 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.631 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.456 HD22 ' H ' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -94.58 146.9 23.8 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.26 -0.976 . . . . 0.0 112.239 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.456 ' H ' HD22 ' A' ' 52' ' ' LEU . 43.9 m-85 -127.01 112.58 15.4 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.267 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' CD ' ' N ' ' A' ' 55' ' ' ASN . 1.5 tm0? -49.87 -76.27 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.345 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.523 ' N ' ' CD ' ' A' ' 54' ' ' GLN . 62.3 t30 -59.97 155.9 15.73 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.047 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -68.68 -179.69 1.48 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.467 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.36 36.77 78.0 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.195 -1.478 . . . . 0.0 110.191 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 25' ' ' THR . 35.6 m-85 49.13 63.78 2.0 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.794 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.55 -166.23 2.43 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.318 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 68.91 173.09 8.32 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.383 -1.389 . . . . 0.0 109.868 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 9.7 m-20 -42.19 119.44 1.37 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.397 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.664 ' NE2' ' N ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -90.04 164.51 14.48 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.349 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 8.8 mm -137.91 166.67 23.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.382 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.461 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 19.2 mp0 -148.26 126.08 11.91 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.619 -0.832 . . . . 0.0 109.64 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.1 159.97 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 118.859 -1.136 . . . . 0.0 112.557 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.2 t -149.36 -7.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 114.195 -1.366 . . . . 0.0 107.495 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.404 ' HB2' ' H ' ' A' ' 68' ' ' ASN . . . -124.8 -155.88 0.69 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.966 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.404 ' H ' ' HB2' ' A' ' 67' ' ' ALA . 11.2 m-20 -93.32 117.76 30.47 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.626 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.503 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -89.26 111.76 22.65 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.91 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -73.21 -77.9 0.1 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.418 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 73' ' ' GLY . 24.4 tp10 -79.24 -2.92 43.39 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.103 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.428 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 6.7 tp 54.95 -87.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.392 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 176.11 -170.15 42.95 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 118.967 -1.587 . . . . 0.0 110.924 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.564 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.0 Cg_endo -65.45 -36.22 35.59 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.159 1.906 . . . . 0.0 111.941 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.6 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 2.4 pt? -70.9 19.51 0.05 Allowed 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.981 -1.088 . . . . 0.0 111.274 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.564 ' H ' ' C ' ' A' ' 74' ' ' PRO . 34.9 p-10 -77.33 -18.16 57.68 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.519 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -86.65 2.04 49.82 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.429 -0.909 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -175.87 115.65 0.13 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.326 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -123.05 -174.72 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.156 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.466 ' N ' HG12 ' A' ' 79' ' ' VAL . 39.1 t -172.01 -64.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.296 -1.362 . . . . 0.0 113.541 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.5 m -111.7 150.95 29.47 Favored 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.444 ' HB ' ' CZ ' ' A' ' 24' ' ' TYR . 3.0 mp -146.61 161.49 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.445 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.682 ' NH1' ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -150.85 145.58 25.77 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.993 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.682 ' N ' ' NH1' ' A' ' 83' ' ' ARG . 5.8 t -148.09 146.92 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.695 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.589 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -143.54 134.27 22.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.657 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 85' ' ' ILE . 17.4 m -38.33 148.38 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.336 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.01 141.03 13.98 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.507 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -53.42 143.16 55.86 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.078 1.186 . . . . 0.0 110.954 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.556 ' CG2' ' N ' ' A' ' 90' ' ' GLN . 2.4 p -79.73 164.27 3.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.537 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.556 ' N ' ' CG2' ' A' ' 89' ' ' VAL . 11.5 mm100 -142.39 151.74 58.73 Favored Pre-proline 0 N--CA 1.487 1.4 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.154 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.6 -39.18 90.29 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.599 1.533 . . . . 0.0 111.87 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.656 ' NH1' HE22 ' A' ' 134' ' ' GLN . 15.6 mtm180 58.02 -168.47 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.434 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.475 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.33 178.65 7.43 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.603 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -148.57 130.36 15.13 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.411 -1.316 . . . . 0.0 112.024 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 20.1 m-85 -103.44 172.07 7.01 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.777 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -139.09 168.66 19.33 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.836 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -114.61 170.45 8.3 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.672 -0.811 . . . . 0.0 112.351 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.503 ' HA ' ' HZ1' ' A' ' 98' ' ' LYS . 0.5 OUTLIER 54.67 168.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.233 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.532 ' OE1' ' HG3' ' A' ' 100' ' ' GLN . 1.2 tm-20 -62.5 103.16 0.38 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.585 -1.189 . . . . 0.0 112.5 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 102' ' ' ASP . 2.7 mt-30 68.55 100.95 0.05 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.48 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.478 ' C ' ' O ' ' A' ' 100' ' ' GLN . 19.3 p90 20.94 44.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 124.364 1.04 . . . . 0.0 112.773 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 100' ' ' GLN . 0.7 OUTLIER -102.26 15.64 28.54 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.98 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -154.61 159.79 29.17 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 118.967 -1.587 . . . . 0.0 111.135 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -41.26 157.39 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.832 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.533 ' N ' ' CD ' ' A' ' 105' ' ' GLU . 1.2 pm0 -122.05 163.71 18.94 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.67 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.595 ' CG1' ' N ' ' A' ' 107' ' ' ASP . 37.4 t -138.11 170.99 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.33 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.595 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 2.5 p30 -133.44 156.35 47.87 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.034 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.5 mt -145.15 139.35 14.99 Favored Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.26 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -70.18 163.66 37.79 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 121.597 1.532 . . . . 0.0 111.305 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.47 145.99 95.57 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.418 1.412 . . . . 0.0 110.937 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.32 -153.22 24.29 Favored Glycine 0 N--CA 1.499 2.878 0 C-N-CA 119.064 -1.541 . . . . 0.0 111.328 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.609 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 8.3 tt0 -128.94 158.42 38.87 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.755 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.609 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 41.8 m-85 -145.93 151.99 38.72 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.267 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.6 p -103.83 178.56 4.52 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.243 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.08 44.63 0.49 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.174 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -142.45 -61.95 0.44 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 121' ' ' TYR . 4.5 mt-10 -74.11 -54.55 7.57 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.485 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.538 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -29.74 -66.5 0.09 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.635 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.635 ' CD ' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER -59.04 -60.84 3.23 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.747 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.635 HH11 ' CD ' ' A' ' 119' ' ' GLU . 7.9 mpt_? -75.81 26.17 0.11 Allowed 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.952 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 117' ' ' GLU . 35.3 t80 -127.79 -18.48 4.27 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.603 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -155.68 -26.8 0.03 OUTLIER Glycine 0 N--CA 1.484 1.86 0 C-N-CA 118.267 -1.92 . . . . 0.0 111.104 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.1 pt -150.2 -112.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.039 -1.064 . . . . 0.0 110.785 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.424 ' C ' ' HB3' ' A' ' 119' ' ' GLU . 0.9 OUTLIER -165.75 -165.91 0.88 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.284 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.49 ' C ' ' ND2' ' A' ' 125' ' ' ASN . 0.7 OUTLIER -65.21 -105.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -179.683 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.47 ' N ' ' CG ' ' A' ' 125' ' ' ASN . 1.7 m120 -67.23 32.32 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.46 ' H ' ' C ' ' A' ' 125' ' ' ASN . 0.6 OUTLIER -87.17 -103.7 0.07 Allowed 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.726 -1.19 . . . . 0.0 109.819 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.546 ' O ' ' CB ' ' A' ' 129' ' ' SER . 0.3 OUTLIER 41.66 -162.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.22 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.618 ' OG ' ' N ' ' A' ' 130' ' ' SER . 1.6 t 151.17 -96.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.061 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.618 ' N ' ' OG ' ' A' ' 129' ' ' SER . 3.5 m -90.24 143.63 26.59 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.047 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.11 151.82 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.575 0.702 . . . . 0.0 111.675 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -148.87 107.09 3.45 Favored Pre-proline 0 C--N 1.301 -1.515 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.617 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 135' ' ' GLY . 10.5 Cg_endo -71.88 90.48 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.348 1.366 . . . . 0.0 110.68 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.656 HE22 ' NH1' ' A' ' 92' ' ' ARG . 10.0 tt0 -49.64 -11.57 0.06 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.391 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . -179.07 -37.46 0.07 OUTLIER Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.305 -1.902 . . . . 0.0 111.783 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.475 HD13 ' H ' ' A' ' 92' ' ' ARG . 0.5 OUTLIER -107.04 163.83 12.66 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.359 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.76 148.22 31.55 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.993 -1.083 . . . . 0.0 109.811 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.1 t -112.6 150.34 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.786 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.457 HG11 ' CE1' ' A' ' 141' ' ' PHE . 60.6 t -136.22 128.53 45.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.572 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.5 mp -106.13 139.86 39.99 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.905 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.567 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 4.7 m-85 -120.23 133.78 55.4 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.52 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -72.94 -71.52 0.3 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.403 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -62.87 161.68 12.36 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.959 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 20.7 p-10 -62.5 -162.89 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.586 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.651 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 1.7 p-10 31.62 35.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.712 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.651 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 42.12 62.4 1.65 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.084 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.536 ' CB ' ' ND2' ' A' ' 145' ' ' ASN . 48.4 t -139.3 175.87 9.19 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.421 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 80.91 -160.33 42.78 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.039 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -60.54 160.57 8.79 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.263 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.8 p -150.59 162.51 40.5 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.902 -1.119 . . . . 0.0 111.574 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.6 tp -129.33 86.14 57.27 Favored Pre-proline 0 N--CA 1.484 1.261 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.497 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -63.29 107.8 0.73 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.828 1.686 . . . . 0.0 112.522 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 47.5 t -84.78 85.56 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.389 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.557 ' H ' ' ND2' ' A' ' 154' ' ' ASN . 0.8 OUTLIER -55.87 -26.56 47.6 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.498 ' OG ' ' C ' ' A' ' 154' ' ' ASN . 0.7 OUTLIER -162.68 -146.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 117.941 -1.503 . . . . 0.0 113.107 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.45 144.76 20.06 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.017 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.537 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -165.58 66.06 1.08 Allowed Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.572 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.1 Cg_endo -66.71 27.95 0.11 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.26 1.973 . . . . 0.0 112.274 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.537 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.1 t -169.83 136.06 1.51 Allowed 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.846 -1.142 . . . . 0.0 111.461 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 163' ' ' MET . 3.9 tt -151.55 -76.01 0.14 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.351 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.1 63.86 2.99 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.16 -1.495 . . . . 0.0 110.665 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 52.45 90.83 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.393 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.46 ' H ' HD23 ' A' ' 160' ' ' LEU . 1.1 tpt -81.32 -63.94 1.29 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.134 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.421 ' ND2' ' H ' ' A' ' 165' ' ' ASN . 3.2 p-10 -90.21 -54.33 4.07 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.817 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.421 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 5.2 t30 -168.87 -69.98 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.654 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -161.07 151.32 17.68 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.1 m -88.49 147.17 24.79 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.795 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 92.3 p -135.67 -38.63 0.73 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.434 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.54 158.13 44.85 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.533 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 24.6 pt -145.54 157.19 12.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 118.589 -1.244 . . . . 0.0 111.904 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -137.92 110.26 7.41 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.527 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -87.83 94.74 4.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.25 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.959 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.483 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.822 0.344 . . . . 0.0 110.114 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.87 136.48 2.45 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.912 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -176.78 112.79 0.1 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.322 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.44 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.3 pp -78.34 160.33 4.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.306 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 m -138.46 126.38 22.51 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.296 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.44 168.7 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.372 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 14.1 m-85 -134.8 138.73 44.52 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.343 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.9 -55.02 29.8 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.397 -0.921 . . . . 0.0 113.066 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.547 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 55.6 m-20 -92.37 167.06 12.24 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.375 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.577 ' N ' ' HG ' ' A' ' 40' ' ' SER . 7.4 tm-20 -79.98 160.66 25.83 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.199 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 10' ' ' GLU . 0.9 OUTLIER 81.41 38.97 0.06 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.546 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.456 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 5.0 t80 59.74 2.99 0.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.984 -1.086 . . . . 0.0 112.533 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -102.84 164.88 11.37 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.673 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.547 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 97.48 132.94 7.66 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.587 ' CB ' ' HZ1' ' A' ' 15' ' ' LYS . 8.2 mtpm? -29.27 135.98 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.755 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.94 171.72 7.42 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.301 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.0 t -144.37 145.96 20.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.511 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -91.85 128.08 37.55 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.74 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.494 HD13 ' CE2' ' A' ' 24' ' ' TYR . 2.3 mm? -118.14 107.2 44.0 Favored Pre-proline 0 N--CA 1.49 1.541 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.26 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -64.87 166.75 17.41 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 120.911 1.074 . . . . 0.0 111.265 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.28 176.25 1.65 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.732 1.621 . . . . 0.0 111.294 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.508 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 102.28 -167.92 18.41 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.391 -1.385 . . . . 0.0 110.788 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.781 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -110.98 141.93 43.78 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.022 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.644 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -156.67 152.84 27.61 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.243 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.4 p -132.02 -158.48 0.89 Allowed 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.079 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -58.74 -28.8 66.21 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.588 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.01 -54.74 33.59 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.034 -1.067 . . . . 0.0 110.895 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -52.79 -48.82 66.6 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.039 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.519 HD23 ' CE1' ' A' ' 24' ' ' TYR . 5.0 mt -59.48 -39.02 82.39 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.66 -1.216 . . . . 0.0 109.338 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.13 -29.06 4.83 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 118.564 -1.254 . . . . 0.0 108.397 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.14 -31.62 27.11 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.454 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 29' ' ' LEU . 10.2 mt -80.39 -86.4 0.08 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.333 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.74 -27.0 0.07 OUTLIER Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.226 -1.464 . . . . 0.0 110.787 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.47 -175.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 118.941 -1.103 . . . . 0.0 109.964 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.457 ' H ' HG22 ' A' ' 38' ' ' THR . 1.3 pt-20 177.48 113.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.708 -1.197 . . . . 0.0 112.604 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 42.31 -106.7 0.08 Allowed 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.558 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -50.46 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.947 -0.701 . . . . 0.0 112.391 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.667 ' C ' ' H ' ' A' ' 40' ' ' SER . 0.1 OUTLIER 170.44 -18.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.802 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.413 ' O ' ' C ' ' A' ' 40' ' ' SER . 7.8 mm -75.59 32.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.105 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.667 ' H ' ' C ' ' A' ' 38' ' ' THR . 29.6 t -37.62 -63.99 0.42 Allowed 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.326 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -116.03 165.09 13.52 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.447 HG11 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -148.2 156.67 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 118.342 -1.343 . . . . 0.0 113.44 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -137.82 110.92 7.8 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.523 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.44 HG23 ' CG2' ' A' ' 4' ' ' ILE . 88.4 t -133.95 106.25 11.53 Favored Pre-proline 0 N--CA 1.497 1.913 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.94 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.411 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 Cg_endo -70.16 171.5 14.79 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 121.647 1.564 . . . . 0.0 111.728 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.411 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.7 Cg_endo -62.78 -169.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 122.145 1.897 . . . . 0.0 111.204 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.87 -14.44 19.62 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 119.269 -1.444 . . . . 0.0 110.449 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.46 ' N ' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -152.93 157.14 4.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 118.836 -1.145 . . . . 0.0 111.697 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.454 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 31.7 ttpt -123.56 120.41 32.77 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.34 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.75 154.99 18.63 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.025 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 60.6 mt -138.91 119.79 15.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.338 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.449 HD11 ' H ' ' A' ' 52' ' ' LEU . 3.7 mp -94.79 155.37 16.84 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 118.683 -1.207 . . . . 0.0 112.352 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -133.55 114.97 14.17 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.053 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.451 ' CD ' ' N ' ' A' ' 55' ' ' ASN . 1.4 tm0? -53.64 -69.12 0.13 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.39 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.458 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 63.8 t30 -69.37 137.68 53.03 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.028 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -53.06 166.69 0.21 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.538 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.54 28.98 64.47 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.394 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 55.92 49.1 16.57 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.972 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.18 -171.16 2.62 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.795 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.458 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 74.16 171.75 25.69 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.355 -1.402 . . . . 0.0 109.743 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 60' ' ' GLY . 1.7 m-20 -42.57 116.14 0.81 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.491 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -89.75 155.02 19.47 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.361 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.477 HG21 ' H ' ' A' ' 64' ' ' GLU . 5.2 mt -130.18 167.08 26.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.761 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.477 ' H ' HG21 ' A' ' 63' ' ' ILE . 66.6 mt-10 -145.26 130.74 18.76 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.38 -0.928 . . . . 0.0 109.727 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.9 m -147.34 156.86 10.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 118.797 -1.161 . . . . 0.0 112.241 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.0 t -144.5 -2.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.137 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -125.32 -159.69 0.91 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.301 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.517 HD22 ' CG1' ' A' ' 106' ' ' VAL . 10.7 p-10 -94.28 118.59 31.82 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.476 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.447 ' H ' HG11 ' A' ' 42' ' ' VAL . . . -89.58 96.39 10.68 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.897 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -53.21 -70.99 0.08 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.821 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -90.55 3.21 54.65 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.239 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.404 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 14.7 tp 59.62 -90.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.634 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.404 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -177.2 -170.49 39.67 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.541 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.651 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.7 Cg_endo -67.16 -56.64 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.351 2.034 . . . . 0.0 112.266 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.661 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 2.1 pt? -64.75 19.52 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.321 -0.951 . . . . 0.0 111.409 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.651 ' H ' ' C ' ' A' ' 74' ' ' PRO . 45.3 p-10 -74.42 -17.12 60.84 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.387 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -77.88 4.93 10.71 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.577 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.536 HD21 ' N ' ' A' ' 79' ' ' VAL . 0.5 OUTLIER -167.9 115.01 0.72 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.172 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.727 ' CG1' ' H ' ' A' ' 80' ' ' SER . 26.3 t -132.32 -171.49 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.046 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.727 ' H ' ' CG1' ' A' ' 79' ' ' VAL . 21.0 p -176.31 -51.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.648 -1.221 . . . . 0.0 112.672 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.657 ' H ' ' HG ' ' A' ' 80' ' ' SER . 0.9 OUTLIER -124.96 162.2 25.0 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 119.148 -1.021 . . . . 0.0 112.854 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 10.2 mt -148.83 155.5 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.735 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.581 ' NH2' ' CG1' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -132.14 114.28 14.32 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.664 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.554 ' N ' ' NH2' ' A' ' 83' ' ' ARG . 37.1 t -121.38 136.56 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.756 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.581 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 4.0 mt -145.15 126.67 8.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.093 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 p -39.88 141.85 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.034 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 48' ' ' VAL . 1.3 p -134.09 138.58 30.87 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.339 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -47.21 136.66 18.68 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 121.207 1.271 . . . . 0.0 111.325 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.3 t -53.41 140.48 9.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.579 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -144.85 130.98 9.73 Favored Pre-proline 0 N--CA 1.487 1.387 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.906 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.45 -163.3 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.921 0 C-N-CA 121.039 1.159 . . . . 0.0 111.359 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.47 ' N ' HD13 ' A' ' 136' ' ' LEU . 9.6 ptt-85 -179.67 -158.17 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.939 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.532 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -137.4 166.97 22.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.65 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -120.81 140.78 51.25 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.456 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.417 ' CD2' HG11 ' A' ' 131' ' ' VAL . 80.5 m-85 -131.34 118.19 19.96 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.393 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -83.45 173.15 11.74 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.56 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.77 -70.34 0.72 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.991 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -62.36 163.98 7.82 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.901 -0.719 . . . . 0.0 112.249 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -89.89 63.62 6.08 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.808 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 101' ' ' PHE . 4.5 tt0 -176.0 50.1 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.713 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 100' ' ' GLN . 18.6 p90 41.44 44.2 2.4 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.111 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.449 ' CG ' ' N ' ' A' ' 103' ' ' GLY . 32.3 t70 -143.5 172.85 12.23 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.2 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 91.26 141.19 9.43 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.158 -1.496 . . . . 0.0 109.76 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 103' ' ' GLY . 47.0 mttp -28.66 130.3 0.06 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 123.971 0.454 . . . . 0.0 111.899 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -98.98 120.68 39.83 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.608 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.517 ' CG1' HD22 ' A' ' 68' ' ' ASN . 43.7 t -103.74 131.07 53.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.731 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -103.81 148.92 25.54 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.07 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.1 mt -138.11 123.15 12.22 Favored Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.154 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.424 ' CB ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -64.74 168.07 14.17 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.492 1.461 . . . . 0.0 111.797 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.424 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 6.1 Cg_exo -55.12 157.33 13.95 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 122.222 1.948 . . . . 0.0 111.973 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.38 178.89 15.73 Favored Glycine 0 N--CA 1.499 2.869 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.936 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.613 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 46.9 tt0 -109.31 157.1 19.2 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.125 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.613 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 33.2 m-85 -144.78 153.94 42.18 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.031 -1.067 . . . . 0.0 111.248 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.5 p -98.48 -161.43 0.87 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.008 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -101.34 54.38 0.83 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.958 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.33 -62.27 0.07 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.12 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.599 ' CG ' ' H ' ' A' ' 118' ' ' LEU . 6.4 pt-20 -69.18 -51.08 41.61 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.599 ' H ' ' CG ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -37.77 -69.51 0.12 Allowed 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.231 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -46.95 -66.5 0.4 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.66 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.446 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -70.33 4.77 2.06 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' A' ' 117' ' ' GLU . 17.0 t80 -98.61 -18.1 18.29 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 118.868 -1.133 . . . . 0.0 111.379 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.453 ' C ' ' CG1' ' A' ' 123' ' ' ILE . . . -165.79 -11.89 0.03 OUTLIER Glycine 0 C--N 1.289 -2.07 0 C-N-CA 118.152 -1.975 . . . . 0.0 111.043 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.453 ' CG1' ' C ' ' A' ' 122' ' ' GLY . 2.2 mt -148.89 -125.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 118.676 -1.21 . . . . 0.0 111.597 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.598 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 20.0 t70 -155.06 -162.58 1.39 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.832 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.598 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 12.4 p30 -71.44 -36.23 71.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.033 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -158.2 100.12 1.67 Allowed 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.955 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.4 t -177.22 25.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.309 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.8 mt -80.74 -60.35 2.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.409 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.7 m 59.32 -125.38 1.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 m -54.73 126.65 24.88 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.417 HG11 ' CD2' ' A' ' 95' ' ' PHE . 2.2 t -122.49 157.69 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.12 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -153.44 93.14 3.12 Favored Pre-proline 0 C--N 1.293 -1.862 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.178 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -53.73 124.21 15.27 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 121.125 1.217 . . . . 0.0 111.003 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.532 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 40.6 tp60 -89.22 -21.64 23.15 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.212 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -161.05 -29.55 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 C-N-CA 118.325 -1.893 . . . . 0.0 112.338 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 92' ' ' ARG . 0.5 OUTLIER -120.92 159.79 24.83 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.165 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.25 147.67 32.47 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.964 -1.094 . . . . 0.0 110.254 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 65.9 t -115.95 149.22 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.463 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.467 HG11 ' CE1' ' A' ' 141' ' ' PHE . 61.8 t -133.85 128.99 54.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.781 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.2 mp -102.72 138.2 39.93 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.963 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.836 ' CD2' ' CD1' ' A' ' 146' ' ' PHE . 8.6 m-85 -120.32 128.94 53.73 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.842 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.56 ' O ' ' CB ' ' A' ' 143' ' ' ASN . 53.9 mttm -85.33 102.12 13.12 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.049 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 142' ' ' LYS . 11.2 t-20 103.0 170.16 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.917 0 O-C-N 125.195 1.559 . . . . 0.0 111.292 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 146' ' ' PHE . 24.6 t70 -45.79 170.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.121 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.819 ' H ' HD21 ' A' ' 145' ' ' ASN . 1.2 m-80 -3.21 66.33 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 CA-C-N 113.921 -1.49 . . . . 0.0 113.986 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.836 ' CD1' ' CD2' ' A' ' 141' ' ' PHE . 0.9 OUTLIER 50.3 63.21 2.3 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.899 -1.121 . . . . 0.0 111.323 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.3 t -114.57 45.64 1.52 Allowed 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.557 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.24 -169.28 42.1 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.71 177.67 0.4 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.524 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.2 p -150.2 175.33 11.87 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.448 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -147.77 90.88 5.05 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.51 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.35 109.02 1.48 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.705 1.603 . . . . 0.0 112.272 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 49.5 t -80.98 90.84 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.004 -1.079 . . . . 0.0 109.92 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.565 ' N ' HD21 ' A' ' 154' ' ' ASN . 1.8 m120 -65.01 -20.45 66.5 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.569 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 11.0 t -168.33 -146.55 0.06 Allowed 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.063 -1.455 . . . . 0.0 112.634 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.4 m-20 -50.81 150.35 2.96 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.981 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.545 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -168.87 66.34 0.64 Allowed Pre-proline 0 C--N 1.31 -1.152 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.04 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.3 Cg_endo -62.46 23.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.323 2.015 . . . . 0.0 113.692 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER 176.86 91.23 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.45 -1.3 . . . . 0.0 111.394 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 162' ' ' ALA . 1.4 tp -94.52 -23.26 17.76 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.247 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 162' ' ' ALA . . . -43.63 93.94 0.01 OUTLIER Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.264 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . 163.25 0.1 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.974 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 31.4 tpp -151.05 -25.07 0.21 Allowed 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.934 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.452 ' ND2' ' H ' ' A' ' 167' ' ' THR . 0.7 OUTLIER -68.22 98.04 0.77 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.404 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.466 ' H ' ' HZ3' ' A' ' 142' ' ' LYS . 6.1 m120 -82.79 -40.22 20.71 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.209 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.421 ' O ' ' N ' ' A' ' 168' ' ' SER . 23.8 t-20 -172.93 63.95 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.767 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.452 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 9.1 m -40.0 99.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.601 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.476 ' HB2' ' H ' ' A' ' 143' ' ' ASN . 3.3 m -88.58 -55.86 3.54 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.407 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.489 ' HG ' ' H ' ' A' ' 146' ' ' PHE . 2.2 p -121.48 156.57 32.48 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.747 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 26.8 pt -139.37 165.14 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.49 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -146.45 106.07 3.95 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.332 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.81 95.46 4.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.401 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 116.458 -1.734 . . . . 0.0 111.076 -179.939 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mtm . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.49 -175.3 0.11 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.469 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -170.47 108.62 0.34 Allowed 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.228 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.414 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.6 pp -77.44 128.69 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.855 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.08 152.54 20.49 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.169 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 m -140.19 169.11 16.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.625 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 18.7 m-85 -128.93 153.71 47.26 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.93 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -78.17 -59.48 2.76 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.503 -0.879 . . . . 0.0 113.326 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.574 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 12.5 m120 -81.36 -178.02 6.75 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.811 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.579 ' CG ' ' H ' ' A' ' 11' ' ' ASP . 20.9 tt0 -74.03 179.32 4.44 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.829 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.615 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 1.5 p-10 40.53 67.16 0.53 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.339 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.615 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 43.7 p90 35.47 27.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.114 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' ASP . 7.2 tt0 -102.65 159.7 15.23 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.987 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.574 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 95.49 140.75 11.15 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.327 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 14' ' ' GLY . 5.5 mtpp -28.75 135.61 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.78 157.78 16.46 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.407 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.4 t -149.15 133.59 9.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.769 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -98.92 113.36 25.47 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.601 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 mt -102.01 136.87 19.4 Favored Pre-proline 0 N--CA 1.488 1.467 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.94 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -70.0 162.58 41.67 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 120.978 1.119 . . . . 0.0 111.137 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -66.33 -175.74 0.57 Allowed 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 121.694 1.596 . . . . 0.0 110.541 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.488 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 104.4 -166.54 15.24 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.242 -1.456 . . . . 0.0 111.263 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.592 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.4 OUTLIER -123.43 137.32 54.83 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.222 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 4.9 p90 -157.84 -179.93 8.61 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.445 -1.302 . . . . 0.0 111.676 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.444 ' HB ' ' H ' ' A' ' 26' ' ' ARG . 1.8 p -147.06 -157.55 0.82 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.461 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.444 ' H ' ' HB ' ' A' ' 25' ' ' THR . 34.7 ttt180 -61.27 -19.14 61.38 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.491 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.66 -66.59 0.53 Allowed 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.567 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -56.31 -43.12 78.62 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.782 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 30.9 mt -59.93 -40.49 89.08 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.154 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.02 -29.02 41.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 118.435 -1.306 . . . . 0.0 108.153 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.1 -35.47 64.18 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.696 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.27 -78.4 0.13 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.786 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.85 -25.25 0.56 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.153 -1.498 . . . . 0.0 110.688 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.458 ' C ' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -92.82 137.18 22.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.028 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.458 ' CG ' ' C ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER 168.61 158.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.198 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.696 HD21 ' ND2' ' A' ' 37' ' ' ASN . 6.0 t30 66.84 116.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.696 ' ND2' HD21 ' A' ' 36' ' ' ASN . 0.1 OUTLIER 56.42 3.99 0.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.098 -0.955 . . . . 0.0 113.045 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.469 ' O ' ' C ' ' A' ' 39' ' ' ILE . 39.9 p -82.98 -135.28 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.491 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 38' ' ' THR . 2.5 mt 25.37 52.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 123.902 0.751 . . . . 0.0 112.68 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.5 t -70.15 -41.51 73.74 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.214 -0.995 . . . . 0.0 110.118 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.4 166.25 15.02 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.312 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.515 HG13 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -145.3 149.68 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 118.533 -1.267 . . . . 0.0 112.666 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -140.05 87.25 2.14 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.609 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.414 HG23 ' CG2' ' A' ' 4' ' ' ILE . 78.0 t -109.44 115.48 56.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -69.7 168.5 21.3 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.207 1.271 . . . . 0.0 110.773 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.47 -177.09 0.36 Allowed 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 121.843 1.695 . . . . 0.0 111.126 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.07 -11.62 11.24 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.283 -1.437 . . . . 0.0 110.952 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.1 m -148.41 145.34 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.537 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.459 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 44.2 tttt -124.12 158.28 32.67 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.578 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.459 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -148.96 140.69 23.57 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.299 -1.361 . . . . 0.0 112.962 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.7 mt -119.06 124.19 72.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.591 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.491 HD11 ' H ' ' A' ' 52' ' ' LEU . 3.8 mp -93.9 165.91 12.43 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 118.641 -1.223 . . . . 0.0 112.341 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -141.22 108.95 5.64 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.956 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -47.28 -84.54 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.928 -0.709 . . . . 0.0 112.03 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.406 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 94.5 m-20 -59.34 142.55 51.84 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.476 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 11.9 p-10 -56.18 174.53 0.13 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.598 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.98 36.87 93.59 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.141 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 47.03 43.94 14.43 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.673 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.53 -165.5 1.25 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.901 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 65.01 165.19 1.08 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.364 -1.398 . . . . 0.0 109.855 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.49 130.1 19.79 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.586 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.462 ' C ' ' CD ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -101.07 161.87 13.29 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.106 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.566 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 7.7 mm -128.06 171.86 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.714 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.566 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 55.5 mt-10 -144.7 131.21 19.86 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.581 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.1 m -150.52 158.32 5.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.805 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 t -144.28 -4.31 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.56 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.517 ' CB ' ' HH ' ' A' ' 121' ' ' TYR . . . -128.72 -153.63 0.58 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.778 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.434 ' ND2' ' N ' ' A' ' 68' ' ' ASN . 3.2 m120 -92.32 125.74 37.11 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.353 -0.939 . . . . 0.0 109.754 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.515 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -97.3 133.95 41.23 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.356 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -74.55 -77.95 0.11 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.49 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -99.32 3.92 46.26 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.692 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.419 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 0.6 OUTLIER 63.95 -82.79 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.513 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.522 ' O ' ' ND2' ' A' ' 76' ' ' ASN . . . -172.67 -178.96 43.13 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.567 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.16 -18.05 56.05 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.149 1.899 . . . . 0.0 111.939 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.424 ' H ' HD21 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -85.08 41.47 0.88 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.06 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 73' ' ' GLY . 84.9 m-20 -79.89 -13.98 58.98 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.694 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -88.62 3.41 50.65 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.513 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -169.78 126.95 0.88 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 118.381 -1.328 . . . . 0.0 112.534 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.407 ' C ' ' OG ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -154.4 138.36 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.442 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.407 ' OG ' ' C ' ' A' ' 79' ' ' VAL . 1.7 m -157.76 -43.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.241 -1.383 . . . . 0.0 112.826 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.3 m -94.39 140.45 29.79 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.944 -1.103 . . . . 0.0 111.056 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -147.58 161.01 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 118.814 -1.155 . . . . 0.0 112.224 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.826 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -137.21 116.72 12.85 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.851 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.826 ' H ' HH12 ' A' ' 83' ' ' ARG . 12.8 t -120.37 127.68 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.873 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.493 HG13 ' NH2' ' A' ' 83' ' ' ARG . 27.8 mt -141.07 129.04 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.849 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 74.1 m -41.06 154.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.854 -0.739 . . . . 0.0 111.427 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.33 147.13 21.02 Favored Pre-proline 0 N--CA 1.487 1.419 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.203 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -54.12 145.32 54.34 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 121.27 1.313 . . . . 0.0 111.483 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.75 142.9 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.699 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -145.6 147.97 35.07 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.171 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.51 -166.62 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.911 0 C-N-CA 121.111 1.207 . . . . 0.0 110.394 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.452 ' CA ' HD13 ' A' ' 136' ' ' LEU . 12.6 ptt-85 -173.98 -162.44 0.14 Allowed 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.743 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.33 159.07 42.97 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.529 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -120.55 135.15 55.17 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.133 -1.027 . . . . 0.0 112.332 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -114.33 105.02 12.65 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.943 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.471 ' CZ ' ' CG ' ' A' ' 105' ' ' GLU . 26.2 m-85 -91.48 152.9 20.16 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.502 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 1.6 m-85 -97.05 157.93 15.68 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.739 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp 63.61 132.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.637 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.433 ' N ' ' HG ' ' A' ' 129' ' ' SER . 2.7 pt-20 -77.43 77.82 3.95 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.926 -1.109 . . . . 0.0 110.87 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 1.049 HE21 ' CA ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -172.58 16.19 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.096 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 42.9 t80 48.98 46.38 22.4 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.731 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 103' ' ' GLY . 38.7 t70 -116.85 -79.79 0.59 Allowed 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.768 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 102' ' ' ASP . . . -34.06 136.42 0.24 Allowed Glycine 0 N--CA 1.502 3.057 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.288 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -42.37 163.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.287 0.565 . . . . 0.0 112.336 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.471 ' CG ' ' CZ ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -115.72 165.07 13.46 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.501 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.2 t -130.35 132.03 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 23.2 p-10 -96.47 150.14 20.94 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.264 -0.974 . . . . 0.0 113.2 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.4 mt -143.81 127.97 9.28 Favored Pre-proline 0 N--CA 1.482 1.14 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.864 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -67.88 167.45 21.38 Favored 'Trans proline' 0 C--O 1.212 -0.825 0 C-N-CA 121.399 1.399 . . . . 0.0 111.727 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.57 151.03 78.54 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 122.055 1.837 . . . . 0.0 111.734 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.48 -173.72 21.02 Favored Glycine 0 N--CA 1.498 2.792 0 C-N-CA 119.448 -1.358 . . . . 0.0 111.16 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.592 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 39.9 tt0 -112.92 154.04 27.01 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.4 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.592 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 14.4 m-85 -139.48 151.57 46.29 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.105 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.8 p -92.71 -158.36 0.59 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.648 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -108.75 55.56 0.63 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.574 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.39 -68.8 0.13 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.989 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.553 ' O ' ' N ' ' A' ' 121' ' ' TYR . 8.0 pt-20 -70.39 -46.4 64.1 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.053 -1.059 . . . . 0.0 108.938 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.562 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -36.15 -71.55 0.07 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.858 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.569 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 22.9 mp0 -51.83 -56.43 14.01 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.99 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -73.74 14.48 0.37 Allowed 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.907 -1.117 . . . . 0.0 111.696 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 117' ' ' GLU . 16.1 t80 -122.46 -12.87 8.12 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.537 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -140.83 -51.48 0.05 OUTLIER Glycine 0 N--CA 1.485 1.955 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.189 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.471 HD11 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -137.48 -111.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.281 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -151.99 -151.96 0.41 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.062 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.15 10.1 13.14 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.451 -0.899 . . . . 0.0 111.205 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -157.78 -123.72 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.407 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.543 ' HG1' ' N ' ' A' ' 128' ' ' ILE . 7.3 p 51.11 -152.56 0.19 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.543 ' N ' ' HG1' ' A' ' 127' ' ' THR . 14.7 mt 65.62 159.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.977 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.433 ' HG ' ' N ' ' A' ' 99' ' ' GLU . 23.1 t -175.14 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.469 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.6 m -76.92 140.39 40.49 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.817 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.6 158.23 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 C-N-CA 119.924 -0.711 . . . . 0.0 111.16 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -156.29 85.5 3.13 Favored Pre-proline 0 C--N 1.306 -1.311 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.63 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.81 102.68 0.53 Allowed 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.093 1.195 . . . . 0.0 109.856 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.15 18.72 2.96 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.716 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -174.39 -47.63 0.05 OUTLIER Glycine 0 N--CA 1.489 2.197 0 C-N-CA 117.737 -2.173 . . . . 0.0 112.637 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.452 HD13 ' CA ' ' A' ' 92' ' ' ARG . 0.4 OUTLIER -121.33 169.62 10.42 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.245 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.8 151.79 24.1 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.078 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.6 t -121.88 144.09 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.231 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.415 HG11 ' CZ ' ' A' ' 141' ' ' PHE . 91.1 t -135.03 128.27 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.561 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 10.4 mp -106.4 140.44 39.32 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.674 -0.81 . . . . 0.0 112.744 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.472 ' CG ' ' HA ' ' A' ' 146' ' ' PHE . 62.9 m-85 -120.48 125.24 47.38 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.445 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -60.63 -65.1 0.74 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.172 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -70.33 -172.21 0.56 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.243 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.564 ' O ' ' N ' ' A' ' 146' ' ' PHE . 0.7 OUTLIER -66.32 -149.3 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.93 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.591 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 4.7 p-10 -15.68 75.76 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 O-C-N 124.386 1.054 . . . . 0.0 113.7 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.591 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.3 p90 37.07 64.95 0.54 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.229 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.456 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 28.6 t -128.49 173.7 10.01 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.949 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.456 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 64.17 -168.13 25.65 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.556 -1.306 . . . . 0.0 110.717 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -61.18 167.95 2.82 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.461 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.4 p -146.28 168.84 20.09 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.43 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.3 tt -138.24 84.59 19.89 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.471 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.59 107.93 1.13 Allowed 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 122.109 1.873 . . . . 0.0 113.094 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 40.2 t -83.9 89.96 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.308 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.442 ' H ' ' ND2' ' A' ' 154' ' ' ASN . 4.3 m-80 -64.45 -17.25 63.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 51.4 p -170.25 -141.28 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 117.735 -1.586 . . . . 0.0 112.929 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.438 ' N ' ' OG ' ' A' ' 155' ' ' SER . 20.7 m-20 -65.1 151.45 46.02 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.758 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.582 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -168.62 61.7 0.49 Allowed Pre-proline 0 C--N 1.305 -1.364 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.206 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.5 Cg_endo -62.13 17.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 122.173 1.916 . . . . 0.0 112.792 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.582 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -170.46 79.2 0.09 Allowed 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.612 -1.235 . . . . 0.0 111.384 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 162' ' ' ALA . 1.3 tt -91.77 -75.65 0.47 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.342 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 163' ' ' MET . . . 64.12 -81.93 0.05 OUTLIER Glycine 0 N--CA 1.492 2.418 0 C-N-CA 118.992 -1.575 . . . . 0.0 110.806 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -45.01 84.95 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.038 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.593 ' N ' ' O ' ' A' ' 161' ' ' GLY . 0.2 OUTLIER 179.27 84.3 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.489 ' C ' ' O ' ' A' ' 163' ' ' MET . 28.4 m120 -26.9 101.02 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 123.939 0.774 . . . . 0.0 112.121 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.58 101.15 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.243 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -158.15 13.13 0.19 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.855 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.2 m -47.23 99.25 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.902 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.1 m -86.99 -53.69 4.74 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.616 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.62 160.42 21.84 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.201 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.424 HG12 ' CD1' ' A' ' 118' ' ' LEU . 22.2 pt -145.33 162.75 12.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.907 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -145.35 104.7 3.95 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.247 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.0 mt -85.27 95.61 4.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.407 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 116.371 -1.776 . . . . 0.0 110.955 -179.982 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 tpt . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.892 0.377 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.81 162.2 4.81 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.849 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -177.72 118.25 0.1 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.305 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 pt -77.33 154.53 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.294 -0.962 . . . . 0.0 111.059 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -133.67 127.12 32.26 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.671 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 m -107.11 173.43 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.37 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.689 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 53.8 m-85 -131.46 145.83 51.96 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.439 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.32 -37.09 77.59 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.501 ' C ' ' OG ' ' A' ' 40' ' ' SER . 25.3 m120 -117.25 165.62 13.23 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 119.101 -1.039 . . . . 0.0 111.814 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.504 ' N ' ' OG ' ' A' ' 40' ' ' SER . 46.8 mm-40 -69.18 173.5 5.57 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.253 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 13' ' ' GLN . 4.6 t0 62.38 31.39 17.29 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.692 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.689 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 5.3 t80 68.13 -9.71 0.47 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.304 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 11' ' ' ASP . 10.2 tt0 -71.88 167.68 19.52 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.861 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.472 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 90.71 129.67 4.29 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.803 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 1.1 mppt? -39.34 149.72 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.729 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.81 165.1 12.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.653 -0.819 . . . . 0.0 112.714 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 t -144.57 144.51 22.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.194 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -104.33 139.14 39.74 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.899 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 mt -132.06 141.71 42.44 Favored Pre-proline 0 N--CA 1.494 1.773 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.774 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -71.62 162.4 42.29 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 121.186 1.257 . . . . 0.0 111.893 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -68.51 -157.68 0.04 OUTLIER 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 121.94 1.76 . . . . 0.0 111.356 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.55 -159.93 50.01 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.854 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.69 ' ND2' ' H ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -90.95 149.86 21.71 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.292 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.602 ' OH ' ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -166.42 146.41 6.01 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.7 p -148.52 -146.59 0.2 Allowed 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 118.66 -1.216 . . . . 0.0 112.803 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -37.0 86.21 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.553 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.15 -57.34 13.03 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.75 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -58.41 -50.77 72.51 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.728 -1.189 . . . . 0.0 109.333 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.602 ' CD2' ' OH ' ' A' ' 24' ' ' TYR . 15.4 mt -51.07 -39.22 55.53 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.759 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.43 -37.16 47.21 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.357 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.92 -35.45 78.48 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.75 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 32' ' ' LEU . 6.9 mt -77.03 -83.59 0.07 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.825 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.416 ' H ' ' HB2' ' A' ' 32' ' ' LEU . . . 164.14 -27.47 0.21 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 118.811 -1.662 . . . . 0.0 111.452 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.3 pt -89.4 167.18 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.196 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 1.9 pt-20 173.32 152.65 0.09 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.102 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.691 HD21 ' H ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER 70.94 -155.48 0.11 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.715 179.812 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.691 ' H ' HD21 ' A' ' 36' ' ' ASN . 20.5 t30 -48.8 93.73 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.156 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' SER . 35.4 p -148.5 -50.1 0.16 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.626 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.2 mt -60.67 75.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.315 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' THR . 32.1 t -75.18 -52.59 10.57 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.74 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.501 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -120.48 174.06 6.78 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.489 HG11 ' H ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -152.94 150.27 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 117.963 -1.495 . . . . 0.0 112.803 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -137.41 110.55 7.8 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.533 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.2 t -133.65 116.14 13.73 Favored Pre-proline 0 N--CA 1.495 1.807 0 C-N-CA 119.666 -0.813 . . . . 0.0 112.087 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.43 167.57 22.04 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 120.941 1.094 . . . . 0.0 110.809 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 48' ' ' VAL . 1.2 Cg_endo -64.92 -171.08 0.16 Allowed 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.744 1.63 . . . . 0.0 111.1 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.46 -10.31 12.2 Favored Glycine 0 N--CA 1.481 1.652 0 C-N-CA 119.273 -1.441 . . . . 0.0 110.907 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.404 ' H ' ' C ' ' A' ' 46' ' ' PRO . 30.5 m -151.9 131.77 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.236 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -104.28 124.68 49.6 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.339 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.47 134.11 50.98 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.481 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.3 mt -112.59 123.08 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.116 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.476 HD22 ' H ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -89.91 152.87 21.02 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.286 -0.966 . . . . 0.0 112.443 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.476 ' H ' HD22 ' A' ' 52' ' ' LEU . 13.8 m-85 -140.07 125.08 18.53 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.22 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -53.33 -88.46 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.327 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -64.44 154.3 36.15 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.748 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -61.3 172.56 1.07 Allowed 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.362 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.66 17.99 76.95 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.12 -1.514 . . . . 0.0 109.924 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 59.24 54.05 5.03 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.971 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.52 -173.71 2.94 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.8 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.7 -175.78 33.49 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.482 -1.342 . . . . 0.0 109.955 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -50.65 166.88 0.07 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.69 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.62 161.92 36.74 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.366 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.579 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 10.0 mm -138.78 172.76 13.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.571 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.579 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 20.4 mt-10 -148.15 130.88 15.99 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.839 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.5 m -145.7 161.75 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 118.768 -1.173 . . . . 0.0 112.552 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.35 -14.7 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.006 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.04 -148.76 0.41 Allowed 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.404 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.707 HD21 ' H ' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -99.82 136.12 40.22 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.022 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.489 ' H ' HG11 ' A' ' 42' ' ' VAL . . . -106.06 128.0 53.56 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.928 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -80.6 -74.79 0.3 Allowed 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 73' ' ' GLY . 20.2 mm-40 -89.95 3.32 53.47 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.975 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.427 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 1.7 tp 55.7 -83.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.715 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 176.02 -169.7 42.41 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.316 -1.421 . . . . 0.0 110.679 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.558 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.2 Cg_endo -65.05 -39.22 24.9 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 122.295 1.997 . . . . 0.0 112.17 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.71 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 1.9 pt? -71.94 31.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.942 -1.103 . . . . 0.0 111.202 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.558 ' H ' ' C ' ' A' ' 74' ' ' PRO . 16.2 p-10 -80.77 -17.92 49.35 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.739 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -88.6 14.02 10.88 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.688 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.675 ' N ' ' ND2' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -167.6 115.01 0.75 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.722 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.8 m -155.47 153.63 7.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.514 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.1 t -172.55 -33.59 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 118.683 -1.207 . . . . 0.0 112.35 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.8 140.98 40.07 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.894 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.9 mt -150.52 149.79 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.381 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.687 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -141.32 126.41 18.39 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.248 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.687 ' CA ' HH12 ' A' ' 83' ' ' ARG . 3.5 t -117.7 135.92 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.1 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.55 ' CG1' ' CZ ' ' A' ' 83' ' ' ARG . 13.7 mt -119.34 121.92 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.654 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.4 p -46.16 129.99 10.17 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.708 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.26 151.31 69.42 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.7 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -55.87 139.03 83.66 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 121.234 1.29 . . . . 0.0 110.731 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.32 133.78 31.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.34 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -143.63 150.99 52.62 Favored Pre-proline 0 N--CA 1.487 1.402 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.9 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 2.5 Cg_endo -59.29 -160.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.241 1.294 . . . . 0.0 111.611 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.475 ' N ' HD13 ' A' ' 136' ' ' LEU . 14.5 ptt180 -174.93 -158.75 0.08 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.849 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.23 165.04 28.99 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.622 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -128.98 152.24 48.82 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.87 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.485 ' CE1' HG21 ' A' ' 131' ' ' VAL . 98.0 m-85 -142.61 133.89 26.17 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.748 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.445 ' CD2' ' C ' ' A' ' 101' ' ' PHE . 18.6 m-85 -94.55 -177.12 4.12 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.14 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.8 -52.1 2.87 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.031 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.529 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 15.5 mmtp -93.18 163.9 13.45 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.541 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -82.9 78.47 9.49 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.379 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.65 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.3 OUTLIER 178.85 26.79 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.349 -1.296 . . . . 0.0 107.973 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.65 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 33.9 p90 37.78 49.1 1.06 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.237 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -138.44 -28.91 0.82 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.828 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.529 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -58.89 153.77 29.32 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.303 -1.427 . . . . 0.0 110.46 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 103' ' ' GLY . 42.8 tttm -31.03 140.03 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.903 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -96.47 147.7 23.56 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.585 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 95.0 t -142.85 117.88 4.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -104.14 162.27 13.32 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.095 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -141.11 150.93 60.54 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.195 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -78.08 163.51 28.03 Favored 'Trans proline' 0 C--O 1.212 -0.796 0 C-N-CA 121.652 1.568 . . . . 0.0 111.957 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.21 139.94 74.95 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.593 1.529 . . . . 0.0 110.696 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.51 -159.75 27.57 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 118.884 -1.626 . . . . 0.0 111.574 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.55 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 34.7 tt0 -118.03 156.16 29.06 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.149 -0.525 . . . . 0.0 110.828 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 49.6 m-85 -145.55 149.22 34.18 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.157 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.458 ' C ' ' H ' ' A' ' 116' ' ' ALA . 3.3 p -101.92 175.8 5.42 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.335 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -72.28 17.32 0.11 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.864 -0.734 . . . . 0.0 112.387 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.458 ' H ' ' C ' ' A' ' 114' ' ' THR . . . -111.21 -65.75 1.14 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.564 -0.854 . . . . 0.0 111.716 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.585 ' CG ' ' H ' ' A' ' 118' ' ' LEU . 6.0 pt-20 -70.55 -53.98 13.94 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.822 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.585 ' H ' ' CG ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -30.61 -72.43 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 123.925 0.765 . . . . 0.0 111.188 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -53.04 -57.14 11.39 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.268 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.451 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 8.0 mpt_? -78.37 26.69 0.21 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.553 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 117' ' ' GLU . 27.9 t80 -135.18 -8.28 2.29 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.315 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.68 -44.59 0.02 OUTLIER Glycine 0 N--CA 1.481 1.642 0 C-N-CA 119.019 -1.562 . . . . 0.0 110.323 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.464 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -143.75 -102.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.822 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.464 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 2.0 p-10 -172.63 179.97 2.3 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.493 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -63.91 123.03 17.91 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.113 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.619 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 0.7 OUTLIER 56.28 106.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.968 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 128' ' ' ILE . 0.1 OUTLIER 172.49 -92.77 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.565 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.598 ' N ' ' OG1' ' A' ' 127' ' ' THR . 6.5 mm 45.81 -110.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.191 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 1.1 t 86.93 120.99 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 123.816 0.697 . . . . 0.0 111.924 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.603 ' H ' ' H ' ' A' ' 160' ' ' LEU . 2.7 m 58.97 114.72 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.136 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.485 HG21 ' CE1' ' A' ' 95' ' ' PHE . 4.0 p -113.13 160.13 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.605 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -160.96 89.68 1.62 Allowed Pre-proline 0 C--N 1.291 -1.967 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.183 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -69.32 121.32 8.11 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.035 1.157 . . . . 0.0 110.704 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -91.05 11.19 23.83 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.592 -0.843 . . . . 0.0 112.19 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -175.7 -49.67 0.06 OUTLIER Glycine 0 N--CA 1.491 2.339 0 C-N-CA 118.262 -1.923 . . . . 0.0 112.137 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 92' ' ' ARG . 0.6 OUTLIER -107.8 171.41 7.41 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.143 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -93.16 145.0 24.74 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.681 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 153' ' ' VAL . 31.6 t -101.42 147.52 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.157 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.25 116.71 13.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.821 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.7 137.47 43.51 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.78 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.413 ' CD2' ' HB3' ' A' ' 146' ' ' PHE . 10.9 m-85 -108.34 145.31 34.65 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.82 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -75.6 -61.73 1.82 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.913 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -82.19 149.49 27.88 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.858 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 145' ' ' ASN . 29.4 t70 -54.04 175.38 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.989 -1.085 . . . . 0.0 110.739 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.645 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 3.3 t-20 36.09 35.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.254 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.645 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 43.11 65.86 0.89 Allowed 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.103 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.2 t -120.59 34.76 5.1 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.543 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.0 -160.29 12.24 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.167 -1.492 . . . . 0.0 110.415 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -59.33 171.93 0.71 Allowed 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.093 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.5 p -149.82 160.16 43.79 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.562 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.21 84.58 62.82 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.066 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.53 102.61 0.61 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.71 1.607 . . . . 0.0 112.405 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 138' ' ' VAL . 81.3 t -83.74 87.66 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.649 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -83.75 22.27 1.14 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.801 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 42.3 p -170.39 -156.12 0.13 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.596 -1.241 . . . . 0.0 112.033 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -90.56 150.99 21.52 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.621 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -159.42 84.99 2.25 Favored Pre-proline 0 C--N 1.308 -1.207 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.103 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.527 ' C ' ' OG ' ' A' ' 130' ' ' SER . 1.7 Cg_endo -67.93 37.92 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.045 1.83 . . . . 0.0 112.421 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.5 OUTLIER -178.55 65.83 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.704 0.764 . . . . 0.0 109.244 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.603 ' H ' ' H ' ' A' ' 130' ' ' SER . 3.4 tm? -80.98 -35.38 32.14 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.188 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.466 ' N ' ' HA ' ' A' ' 129' ' ' SER . . . -43.0 -38.92 3.55 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.743 -1.218 . . . . 0.0 111.563 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.56 -24.04 45.78 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.341 -0.944 . . . . 0.0 111.985 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -81.19 -51.71 8.14 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.606 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -86.84 142.48 28.04 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.282 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.546 HD21 ' N ' ' A' ' 165' ' ' ASN . 0.7 OUTLIER -97.77 -33.28 11.33 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.937 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.494 ' ND2' ' ND2' ' A' ' 126' ' ' ASN . 27.7 t-20 -160.6 106.59 1.48 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.545 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.3 m -92.64 113.5 25.8 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.376 -0.929 . . . . 0.0 111.18 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 41.6 t -99.73 -56.15 2.46 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.163 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.497 ' HG ' ' H ' ' A' ' 146' ' ' PHE . 1.9 p -123.24 159.42 28.76 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.465 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 30.9 pt -141.54 174.25 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.541 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -156.29 113.3 3.16 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.364 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 7.0 mt -89.28 103.14 13.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.004 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.1 m . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 116.289 -1.815 . . . . 0.0 110.801 -179.982 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 tpp . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.446 ' C ' ' ND2' ' A' ' 3' ' ' ASN . . . -136.42 159.18 42.55 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.799 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.446 ' ND2' ' C ' ' A' ' 2' ' ' ALA . 0.6 OUTLIER 179.9 129.57 0.09 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.38 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.0 pt -82.5 153.19 3.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.814 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.3 m -121.7 126.04 48.03 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.127 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.24 150.26 5.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.389 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 1.1 ' CD2' ' NE2' ' A' ' 16' ' ' GLN . 47.6 m-85 -116.97 148.19 41.63 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.325 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.0 2.5 42.8 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.504 ' C ' ' OG ' ' A' ' 40' ' ' SER . 66.0 m-20 -154.17 167.94 28.2 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 117.779 -1.568 . . . . 0.0 112.449 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 9.4 tp10 -74.07 158.38 34.37 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.973 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.584 ' C ' ' H ' ' A' ' 13' ' ' GLN . 2.8 t0 72.21 41.04 0.65 Allowed 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.903 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.1 t80 63.3 -8.06 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.335 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.584 ' H ' ' C ' ' A' ' 11' ' ' ASP . 8.9 tt0 -74.44 175.01 8.13 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.526 -0.87 . . . . 0.0 111.169 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.489 ' HA3' ' N ' ' A' ' 9' ' ' ASN . . . 95.96 130.61 6.39 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.672 -1.252 . . . . 0.0 110.866 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 14' ' ' GLY . 48.1 mttp -38.99 152.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.919 -0.713 . . . . 0.0 111.311 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 1.1 ' NE2' ' CD2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -99.4 154.6 18.08 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.498 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.595 ' CG1' ' N ' ' A' ' 18' ' ' ASP . 2.6 t -147.1 166.47 6.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.424 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.595 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 12.3 m-20 -131.09 131.95 44.54 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.199 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.7 mt -130.29 121.79 19.7 Favored Pre-proline 0 N--CA 1.489 1.482 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.608 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -64.81 164.82 22.99 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 120.988 1.125 . . . . 0.0 111.946 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.65 -157.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.732 1.621 . . . . 0.0 110.668 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.88 -178.44 53.18 Favored Glycine 0 N--CA 1.48 1.587 0 C-N-CA 118.911 -1.614 . . . . 0.0 110.571 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.822 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -107.44 128.83 54.83 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.83 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 1.3 p90 -153.58 146.89 24.78 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.331 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 26' ' ' ARG . 7.8 p -120.48 -155.09 0.61 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.088 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.433 ' H ' ' HB ' ' A' ' 25' ' ' THR . 6.3 ppt_? -56.92 -28.11 61.69 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.718 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.04 -57.17 12.79 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.663 -1.215 . . . . 0.0 110.177 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -58.3 -48.54 80.18 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.731 -1.188 . . . . 0.0 109.648 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 29' ' ' LEU . 4.8 mt -59.97 -29.47 68.46 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.515 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 26' ' ' ARG . . . -56.03 -30.2 61.55 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.03 -34.57 57.31 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.421 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.4 mt -83.16 -68.93 0.67 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.73 34.22 2.47 Favored Glycine 0 N--CA 1.504 3.187 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.463 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.515 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -121.13 8.58 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.669 0.747 . . . . 0.0 110.498 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.1 179.66 6.7 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.966 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.521 ' ND2' ' OD1' ' A' ' 37' ' ' ASN . 0.1 OUTLIER 68.93 99.59 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.16 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.521 ' OD1' ' ND2' ' A' ' 36' ' ' ASN . 1.0 OUTLIER 33.81 78.16 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.104 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 40' ' ' SER . 60.5 p -140.39 -39.76 0.43 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.317 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 mt -67.27 72.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.487 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.504 ' OG ' ' C ' ' A' ' 9' ' ' ASN . 31.1 t -69.64 -46.24 66.64 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.694 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.465 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -127.57 164.1 22.72 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.156 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.441 HG11 ' N ' ' A' ' 43' ' ' LYS . 1.2 t -149.89 154.31 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 118.151 -1.42 . . . . 0.0 113.124 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.441 ' N ' HG11 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -140.23 121.61 15.02 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.183 -1.371 . . . . 0.0 108.777 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.4 t -139.12 114.76 8.42 Favored Pre-proline 0 N--CA 1.499 1.976 0 C-N-CA 119.308 -0.957 . . . . 0.0 112.095 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -69.76 169.5 18.77 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.849 1.032 . . . . 0.0 110.701 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 48' ' ' VAL . 1.6 Cg_endo -63.72 -170.32 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.703 1.602 . . . . 0.0 110.872 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.19 -15.03 12.39 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 119.088 -1.53 . . . . 0.0 110.589 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.4 ' H ' ' C ' ' A' ' 46' ' ' PRO . 21.6 m -150.77 135.43 9.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 118.774 -1.17 . . . . 0.0 112.172 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -105.96 127.85 53.42 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.35 153.94 24.22 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.918 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 99.1 mt -137.3 116.95 15.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.479 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 mp -93.78 162.96 13.71 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.01 -1.076 . . . . 0.0 113.177 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -142.47 131.5 23.12 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.216 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -54.16 -84.41 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.764 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.443 ' N ' HD21 ' A' ' 55' ' ' ASN . 1.3 m-80 -75.69 166.6 23.31 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.17 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.32 -173.82 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.729 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 47.71 34.03 9.97 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.138 -1.506 . . . . 0.0 109.948 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.773 ' H ' ' HG ' ' A' ' 81' ' ' SER . 7.9 m-85 45.83 43.29 9.83 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.358 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.38 -172.34 2.32 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.721 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.08 178.96 1.2 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.538 -1.315 . . . . 0.0 109.818 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -54.1 177.53 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 118.831 -1.148 . . . . 0.0 110.195 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -147.45 161.34 41.25 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.806 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.477 HG21 ' H ' ' A' ' 64' ' ' GLU . 4.1 mt -125.85 164.39 25.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.21 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.477 ' H ' HG21 ' A' ' 63' ' ' ILE . 67.0 mt-10 -139.38 131.8 28.53 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -149.15 155.87 8.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.325 -1.35 . . . . 0.0 112.564 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.556 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 2.3 t -137.96 0.2 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.034 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.466 ' H ' ' HH ' ' A' ' 121' ' ' TYR . . . -132.96 -135.91 0.18 Allowed 'General case' 0 C--O 1.208 -1.109 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.441 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.437 ' ND2' ' OD1' ' A' ' 107' ' ' ASP . 2.2 m-20 -111.89 124.44 52.37 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.329 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.11 94.32 6.45 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.639 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -58.64 -68.59 0.25 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.741 -0.784 . . . . 0.0 112.522 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.18 -12.82 59.98 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.369 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 tp 67.06 -79.33 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.738 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 165.62 176.07 36.74 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.238 -1.458 . . . . 0.0 110.77 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.623 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.0 OUTLIER -65.71 -35.12 38.35 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.249 1.966 . . . . 0.0 112.184 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.5 ' H ' HD22 ' A' ' 75' ' ' LEU . 1.5 pt? -67.99 23.92 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.35 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.623 ' H ' ' C ' ' A' ' 74' ' ' PRO . 7.2 p30 -75.19 -1.08 21.64 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.668 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -73.04 -8.55 56.26 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.14 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -168.5 127.03 1.12 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.159 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.38 137.58 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.273 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 87.8 p -162.3 -30.67 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.656 -1.218 . . . . 0.0 112.697 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.773 ' HG ' ' H ' ' A' ' 58' ' ' PHE . 1.2 m -98.83 139.99 33.68 Favored 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.058 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.409 ' CG1' ' C ' ' A' ' 81' ' ' SER . 0.6 OUTLIER -150.64 156.12 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 118.571 -1.252 . . . . 0.0 111.575 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.765 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -150.21 130.09 13.36 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.444 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.765 ' CA ' HH12 ' A' ' 83' ' ' ARG . 10.0 t -128.77 143.19 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.614 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.441 ' CG1' ' CZ ' ' A' ' 83' ' ' ARG . 7.8 mt -132.51 126.42 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.975 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.7 p -40.8 149.9 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.053 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.61 151.33 32.86 Favored Pre-proline 0 N--CA 1.483 1.203 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.539 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -53.93 153.39 20.38 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 C-N-CA 121.287 1.325 . . . . 0.0 111.091 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.2 m -77.73 139.36 18.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.612 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -146.46 130.1 8.36 Favored Pre-proline 0 C--N 1.297 -1.674 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.142 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.67 -151.75 0.01 OUTLIER 'Trans proline' 0 C--O 1.207 -1.028 0 C-N-CA 121.465 1.444 . . . . 0.0 111.364 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.6 ptt-85 -178.03 -163.94 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.856 -1.138 . . . . 0.0 112.223 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.57 172.12 13.36 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.012 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.559 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 8.4 tpp180 -126.39 157.9 37.32 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.306 -0.957 . . . . 0.0 111.486 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.559 ' CD1' ' C ' ' A' ' 94' ' ' ARG . 26.3 m-85 -148.26 113.59 5.58 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.312 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.411 ' CD2' ' HB3' ' A' ' 105' ' ' GLU . 14.7 m-85 -89.53 161.77 16.03 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.093 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.655 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 0.6 OUTLIER -98.62 167.05 11.04 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.987 -1.085 . . . . 0.0 112.099 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt 59.69 147.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.072 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 30.5 tt0 -65.61 109.68 2.47 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.251 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.665 ' NE2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 100.53 49.79 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.814 0 O-C-N 124.92 1.388 . . . . 0.0 110.181 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.589 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 26.0 p90 29.66 53.21 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.053 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -98.95 30.37 3.41 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.936 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -162.57 151.77 21.76 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.457 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.565 ' O ' ' CE2' ' A' ' 97' ' ' TYR . 88.6 mttt -38.0 155.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.118 0.485 . . . . 0.0 112.1 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.411 ' HB3' ' CD2' ' A' ' 96' ' ' PHE . 10.8 pt-20 -111.23 167.09 10.55 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.194 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.66 178.55 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.224 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.437 ' OD1' ' ND2' ' A' ' 68' ' ' ASN . 14.3 p-10 -150.34 145.95 26.44 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.351 -1.339 . . . . 0.0 112.295 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.6 mt -139.17 133.06 16.0 Favored Pre-proline 0 N--CA 1.496 1.873 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.199 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.88 169.34 14.96 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 121.517 1.478 . . . . 0.0 111.677 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -57.91 149.29 71.03 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 122.094 1.863 . . . . 0.0 111.643 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.22 -155.29 25.52 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.649 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.569 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 37.9 mt-30 -131.12 155.97 46.04 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.809 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.569 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 40.1 m-85 -141.67 155.0 45.71 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.663 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.9 p -102.68 176.46 5.16 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.769 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -83.12 56.8 3.64 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.425 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -153.5 -74.34 0.13 Allowed 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 121' ' ' TYR . 7.3 pt-20 -68.02 -44.6 76.16 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.02 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.584 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -33.94 -72.17 0.05 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.29 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.612 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -53.92 -50.3 66.71 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.436 -1.306 . . . . 0.0 110.08 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -80.65 24.38 0.48 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 118.784 -1.166 . . . . 0.0 111.017 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.556 ' HH ' ' H ' ' A' ' 66' ' ' VAL . 25.3 t80 -129.28 -12.78 4.5 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.027 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -143.8 -45.33 0.05 OUTLIER Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.297 -1.43 . . . . 0.0 110.39 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.527 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -143.8 -104.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.847 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.527 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 7.4 m-20 -160.62 179.01 8.93 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.044 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -74.8 131.49 40.83 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.691 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 m120 50.18 89.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.449 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.5 t -175.38 -2.66 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.195 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.6 mt -95.83 144.01 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.671 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 67.5 m -155.22 -49.34 0.08 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.316 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.8 m -87.99 98.41 11.5 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.99 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' A' ' 95' ' ' PHE . 3.2 t -104.9 159.69 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.842 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -157.24 85.73 2.81 Favored Pre-proline 0 C--N 1.295 -1.777 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.187 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.67 96.98 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 121.413 1.408 . . . . 0.0 110.576 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -87.39 25.81 1.35 Allowed 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.422 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -161.59 -62.71 0.02 OUTLIER Glycine 0 N--CA 1.487 2.072 0 C-N-CA 118.553 -1.784 . . . . 0.0 111.452 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.2 mp -121.53 -169.02 1.79 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.826 -0.749 . . . . 0.0 111.749 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 173' ' ' SER . . . -86.79 158.48 19.37 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.6 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.7 t -126.67 137.94 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.624 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.3 t -133.32 124.89 49.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.961 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.503 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 9.2 mp -101.27 140.08 36.05 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.529 -0.868 . . . . 0.0 112.285 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.41 ' CZ ' ' CB ' ' A' ' 171' ' ' ARG . 19.0 m-85 -107.98 132.79 53.15 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.47 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -79.1 -31.09 44.15 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.3 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.494 ' CG ' ' H ' ' A' ' 144' ' ' ASP . 33.2 t30 -78.12 179.09 7.06 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.589 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.494 ' H ' ' CG ' ' A' ' 143' ' ' ASN . 2.9 m-20 -69.45 -85.21 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.62 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.606 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 16.0 p-10 -76.16 75.69 2.99 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.637 -0.825 . . . . 0.0 112.097 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.606 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 0.9 OUTLIER 37.62 71.62 0.14 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.898 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.448 ' HB3' ' ND2' ' A' ' 143' ' ' ASN . 0.3 OUTLIER -147.98 -173.2 4.24 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.163 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 62.37 -168.69 15.97 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.669 -1.253 . . . . 0.0 111.081 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 149' ' ' ASP . 0.8 OUTLIER -61.19 176.48 0.44 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.721 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.1 p -151.01 163.26 39.17 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.776 -1.17 . . . . 0.0 112.211 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.5 tp -123.55 83.42 53.3 Favored Pre-proline 0 N--CA 1.488 1.434 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.115 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.42 108.45 0.7 Allowed 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 122.148 1.899 . . . . 0.0 113.368 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 24.9 t -86.15 89.38 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.347 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -54.95 -24.81 25.62 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.7 p -170.69 -143.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 117.793 -1.563 . . . . 0.0 113.097 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -57.1 145.06 32.21 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.543 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.502 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -174.6 65.93 0.28 Allowed Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.876 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 3.3 Cg_endo -69.28 38.95 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 122.532 2.155 . . . . 0.0 112.583 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . 0.1 OUTLIER -166.67 -82.32 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.339 -1.344 . . . . 0.0 111.911 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 162' ' ' ALA . 79.0 mt 54.17 -84.35 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.572 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 159' ' ' THR . . . 57.77 -79.63 0.01 OUTLIER Glycine 0 N--CA 1.496 2.65 0 C-N-CA 118.979 -1.582 . . . . 0.0 110.253 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -52.23 99.49 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.659 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 165' ' ' ASN . 5.4 tpp -176.78 72.42 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.232 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 166' ' ' ASN . 1.6 t-20 -28.72 -39.43 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.929 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 163' ' ' MET . 2.6 m120 -58.87 84.22 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.181 -1.007 . . . . 0.0 110.457 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 164' ' ' ASN . 19.9 m120 -55.86 167.83 0.53 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.055 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 48.8 m -102.93 137.97 40.43 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.156 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.99 -60.84 1.13 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.856 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.01 167.01 12.17 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 24.7 pt -147.35 171.37 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 117.999 -1.481 . . . . 0.0 112.501 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.41 ' CB ' ' CZ ' ' A' ' 141' ' ' PHE . 23.7 ttm180 -152.29 106.0 3.1 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.262 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 11.4 mt -81.28 107.82 13.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 119.046 -1.061 . . . . 0.0 109.95 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 137' ' ' ALA . 36.1 m . . . . . 0 C--N 1.303 -1.419 0 CA-C-O 116.347 -1.787 . . . . 0.0 110.981 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 tpt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.46 160.75 20.88 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.316 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 0.6 OUTLIER 179.43 121.56 0.05 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.706 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pp -82.65 125.23 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 118.549 -1.261 . . . . 0.0 111.288 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.1 m -105.85 157.65 17.32 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.471 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.3 164.6 17.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.288 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 5.4 m-85 -126.39 147.47 49.76 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.94 -68.76 0.38 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.303 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.473 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 34.9 m120 -73.04 170.15 15.48 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.629 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.472 ' CG ' ' N ' ' A' ' 11' ' ' ASP . 32.3 tt0 -73.55 171.06 13.9 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.08 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.63 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 3.4 t70 59.19 55.26 4.42 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.622 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.63 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 23.9 p90 38.72 26.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.102 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 11' ' ' ASP . 9.4 tp-100 -103.93 162.2 13.33 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.655 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.473 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 89.63 134.88 5.54 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.64 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 14' ' ' GLY . 16.0 mtpp -30.44 136.93 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.56 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -110.93 169.54 8.7 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.779 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.3 t -141.19 133.21 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.425 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.17 111.61 23.77 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.728 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mt -105.86 128.72 25.87 Favored Pre-proline 0 N--CA 1.491 1.619 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.772 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -67.57 165.93 25.67 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 120.657 0.905 . . . . 0.0 110.456 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.82 -164.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 121.623 1.549 . . . . 0.0 111.391 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.648 ' C ' HD21 ' A' ' 23' ' ' ASN . . . 97.17 174.44 34.48 Favored Glycine 0 N--CA 1.498 2.813 0 C-N-CA 119.396 -1.383 . . . . 0.0 111.28 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.873 ' N ' HD21 ' A' ' 23' ' ' ASN . 0.2 OUTLIER -103.38 135.18 45.48 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.617 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.541 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 2.5 p90 -155.12 176.22 12.82 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 118.482 -1.287 . . . . 0.0 111.701 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.0 p -141.06 -156.46 0.68 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.121 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.521 ' CD ' ' H ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -69.03 -22.68 64.03 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.957 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.473 ' H ' ' HD3' ' A' ' 26' ' ' ARG . . . -64.55 -59.81 3.86 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.652 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -58.73 -45.77 88.87 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.204 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.4 mt -57.47 -37.77 73.43 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.902 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.28 -34.22 56.4 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 118.474 -1.291 . . . . 0.0 108.469 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.9 -31.24 66.2 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.947 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.9 mt -81.15 -76.76 0.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.763 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.77 -29.94 0.44 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.522 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.7 mm -71.5 133.56 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.578 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -171.93 147.62 2.19 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.868 -1.133 . . . . 0.0 111.885 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.583 ' N ' ' ND2' ' A' ' 36' ' ' ASN . 0.4 OUTLIER 68.47 -146.81 0.12 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.546 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.519 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -72.96 88.22 1.36 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.628 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.511 ' HG1' ' N ' ' A' ' 39' ' ' ILE . 77.2 p -142.77 -31.54 0.51 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.718 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.511 ' N ' ' HG1' ' A' ' 38' ' ' THR . 5.8 mt -77.25 62.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.072 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 38.7 t -64.61 -70.02 0.25 Allowed 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.547 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.458 ' HG ' ' HA ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -93.57 171.16 9.07 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.553 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.485 HG11 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -153.75 157.12 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 118.412 -1.315 . . . . 0.0 112.107 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -149.08 100.65 3.08 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.5 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.5 t -123.83 101.76 35.78 Favored Pre-proline 0 N--CA 1.496 1.84 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.407 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.44 171.8 11.22 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 120.943 1.096 . . . . 0.0 109.847 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.63 -169.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.567 1.511 . . . . 0.0 111.033 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.84 -18.24 9.6 Favored Glycine 0 N--CA 1.483 1.785 0 C-N-CA 119.18 -1.486 . . . . 0.0 110.679 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.9 m -147.79 139.98 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.292 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -110.13 119.24 38.66 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.644 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.85 157.57 17.37 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.29 -0.964 . . . . 0.0 113.158 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.49 HG23 ' CE2' ' A' ' 53' ' ' TYR . 44.2 mt -143.0 114.62 2.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.365 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.708 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 2.7 mp -92.24 158.1 16.32 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.935 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.49 ' CE2' HG23 ' A' ' 51' ' ' ILE . 41.5 m-85 -140.03 108.48 5.86 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.488 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.403 ' HB3' ' H ' ' A' ' 55' ' ' ASN . 3.8 tt0 -45.84 -83.4 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.023 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.403 ' H ' ' HB3' ' A' ' 54' ' ' GLN . 83.0 m-20 -59.17 152.34 20.72 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.763 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -58.98 -171.18 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.945 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 49.9 37.84 29.56 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.231 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.431 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . 8.6 m-85 45.33 48.63 10.43 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.607 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.96 -164.09 1.16 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.159 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 64.84 168.93 1.91 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.265 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 60' ' ' GLY . 10.0 t70 -39.05 118.11 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.684 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 62' ' ' GLN . 4.7 pp0? -97.74 151.57 20.02 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.743 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.625 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 4.5 mm -130.59 168.98 22.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.423 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.625 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -147.39 133.71 19.56 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.127 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -145.07 162.19 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 118.79 -1.164 . . . . 0.0 112.56 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 t -149.36 -5.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.535 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.431 ' HB2' ' H ' ' A' ' 68' ' ' ASN . . . -129.62 -159.51 0.97 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.209 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.431 ' H ' ' HB2' ' A' ' 67' ' ' ALA . 4.5 t30 -91.15 136.91 32.77 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.714 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.485 ' H ' HG11 ' A' ' 42' ' ' VAL . . . -113.92 105.03 12.76 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.424 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -54.29 -77.88 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.753 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -91.73 5.59 49.19 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.803 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.1 tp 54.04 -99.35 0.09 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.588 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.61 -176.55 36.45 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 118.964 -1.588 . . . . 0.0 111.03 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.681 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.0 OUTLIER -66.37 -37.34 23.96 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.483 2.122 . . . . 0.0 112.357 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.49 HD22 ' N ' ' A' ' 75' ' ' LEU . 2.7 pt? -57.53 8.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.502 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.681 ' H ' ' C ' ' A' ' 74' ' ' PRO . 10.5 p-10 -69.47 1.19 4.2 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.652 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.578 ' N ' HD21 ' A' ' 77' ' ' ASN . 1.8 m120 -82.82 -15.41 51.75 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.364 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -164.69 126.52 2.2 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.104 -1.039 . . . . 0.0 111.169 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.38 151.15 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.432 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.3 t -166.0 -51.14 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.728 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 m -94.14 135.55 35.39 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.977 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.485 ' HB ' ' CZ ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -150.25 157.19 6.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.371 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.654 ' HE ' ' CD1' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -150.59 153.08 35.07 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.386 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.645 ' C ' HH21 ' A' ' 83' ' ' ARG . 13.9 t -150.27 140.29 16.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.497 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.654 ' CD1' ' HE ' ' A' ' 83' ' ' ARG . 42.4 mt -134.52 129.57 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.7 m -40.82 139.71 0.81 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.052 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.57 141.78 19.65 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.635 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.75 143.77 68.6 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 121.065 1.176 . . . . 0.0 111.156 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.0 t -64.2 145.06 14.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.123 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -122.7 139.14 30.56 Favored Pre-proline 0 N--CA 1.489 1.491 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.132 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.75 -23.48 50.06 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 121.143 1.229 . . . . 0.0 111.309 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 35.3 -151.85 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.667 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.449 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -147.72 173.06 13.13 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.046 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -147.03 113.0 5.78 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.168 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 5.7 m-85 -97.29 162.63 13.25 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.555 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -123.0 156.72 34.23 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.618 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 104' ' ' LYS . 1.4 m-85 -75.46 -91.37 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.134 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 1.234 ' HB3' ' OE1' ' A' ' 100' ' ' GLN . 51.2 mttp -47.74 162.63 0.07 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.125 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -90.6 67.57 6.46 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.66 -0.816 . . . . 0.0 112.35 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 1.234 ' OE1' ' HB3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER 178.85 51.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.667 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.9 t80 47.99 35.06 4.6 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.951 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.773 ' OD1' ' HG2' ' A' ' 100' ' ' GLN . 18.3 p-10 -142.1 171.07 14.56 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.616 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 85.38 139.94 5.09 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.019 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.477 ' HZ1' ' HB2' ' A' ' 104' ' ' LYS . 1.0 OUTLIER -29.58 132.91 0.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 123.895 0.409 . . . . 0.0 112.07 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.499 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 1.7 pm0 -104.7 163.22 12.65 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.302 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.1 t -140.97 128.8 22.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.109 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.47 155.22 17.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.788 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.2 mt -143.93 138.5 15.14 Favored Pre-proline 0 N--CA 1.481 1.087 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.847 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -73.08 167.33 27.62 Favored 'Trans proline' 0 C--O 1.212 -0.789 0 C-N-CA 121.636 1.557 . . . . 0.0 111.718 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.36 141.74 76.03 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.93 1.754 . . . . 0.0 110.965 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 144.69 -155.63 26.48 Favored Glycine 0 N--CA 1.498 2.817 0 C-N-CA 118.862 -1.637 . . . . 0.0 111.328 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.444 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 6.0 tt0 -125.65 152.42 45.24 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.934 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.444 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 28.8 m-85 -145.53 147.32 32.0 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.278 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.663 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 1.4 p -95.31 -136.46 0.22 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.08 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.663 ' N ' ' OG1' ' A' ' 114' ' ' THR . 5.4 tt0 -113.98 -25.38 8.59 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.063 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.45 -64.06 1.26 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.966 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.3 pt-20 -70.94 -50.34 35.68 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.587 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.584 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 2.4 tt -39.28 -71.05 0.09 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.459 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.569 ' OE1' ' NH1' ' A' ' 120' ' ' ARG . 75.9 mt-10 -48.89 -56.12 9.74 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.639 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.569 ' NH1' ' OE1' ' A' ' 119' ' ' GLU . 4.1 mpt_? -71.76 0.31 9.24 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.893 -1.123 . . . . 0.0 112.361 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 117' ' ' GLU . 24.7 t80 -105.08 -12.23 16.23 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.487 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -146.21 -46.51 0.03 OUTLIER Glycine 0 N--CA 1.486 1.993 0 C-N-CA 118.915 -1.612 . . . . 0.0 111.288 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -136.78 -112.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.183 -1.007 . . . . 0.0 111.724 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -156.26 -155.53 0.55 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.338 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -80.61 3.67 21.13 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.975 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.556 ' ND2' HD21 ' A' ' 166' ' ' ASN . 8.6 m120 -157.15 -152.04 0.34 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.582 -1.247 . . . . 0.0 112.147 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 39.32 96.78 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.103 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 13.5 mt -155.1 -75.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.507 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.3 p 41.54 -98.16 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.7 m -44.55 116.68 1.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.89 146.35 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.7 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -144.09 82.58 10.8 Favored Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.413 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -63.07 108.61 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.262 1.308 . . . . 0.0 111.053 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.449 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 6.9 mm100 -62.56 -2.3 1.05 Allowed 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.911 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 175.32 -41.21 0.11 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 118.249 -1.929 . . . . 0.0 112.476 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.6 mt -88.13 176.33 7.32 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.512 -1.275 . . . . 0.0 111.299 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.1 129.66 54.14 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.308 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.7 t -98.24 149.44 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.323 -0.951 . . . . 0.0 112.404 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.1 t -133.04 113.96 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.448 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 mp -91.01 139.26 30.93 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.818 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.462 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 3.7 m-85 -118.64 131.8 56.17 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.461 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -61.18 -80.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.911 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.451 ' N ' HD21 ' A' ' 143' ' ' ASN . 1.8 m-80 -66.25 164.03 16.68 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.272 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 146' ' ' PHE . 4.7 p30 -61.92 -161.17 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.537 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.638 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 6.6 t-20 37.19 29.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.12 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.638 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.1 p90 42.15 62.19 1.73 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.162 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.94 174.07 11.01 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.017 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.99 -162.13 49.82 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.488 -1.339 . . . . 0.0 110.529 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -59.96 160.54 7.72 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.41 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 71.5 p -149.13 166.04 29.99 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.56 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.46 ' C ' ' CD2' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -133.2 86.53 41.56 Favored Pre-proline 0 N--CA 1.483 1.223 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.901 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -63.24 104.77 0.43 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 C-N-CA 121.54 1.493 . . . . 0.0 112.328 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.81 81.99 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.637 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -78.85 19.77 0.5 Allowed 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.338 -0.847 . . . . 0.0 112.06 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.5 t -169.97 -151.67 0.09 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.54 -1.264 . . . . 0.0 111.89 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -87.54 157.49 19.15 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.927 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.472 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -167.52 69.06 0.91 Allowed Pre-proline 0 C--N 1.304 -1.377 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.802 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.3 Cg_endo -68.14 34.35 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.622 2.214 . . . . 0.0 112.933 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.465 HG21 ' H ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -169.87 -68.29 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.716 -1.193 . . . . 0.0 111.665 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.465 ' H ' HG21 ' A' ' 159' ' ' THR . 1.9 mt 51.69 -93.55 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.605 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 159' ' ' THR . . . 43.43 57.78 4.26 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.595 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -152.61 -81.76 0.09 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.611 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.604 ' N ' ' SD ' ' A' ' 163' ' ' MET . 0.2 OUTLIER -67.17 -31.23 71.5 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.511 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -90.64 136.9 32.77 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -157.17 -6.17 0.1 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.524 -0.871 . . . . 0.0 110.754 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.556 HD21 ' ND2' ' A' ' 126' ' ' ASN . 7.8 t-20 -169.86 39.1 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.205 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -39.32 136.54 0.88 Allowed 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.29 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.8 m -107.53 -36.08 6.56 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.827 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 10.8 p -153.84 155.57 36.02 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.7 -1.2 . . . . 0.0 111.022 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.9 172.97 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.494 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -142.04 113.26 7.59 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.58 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 3.4 mt -80.52 91.89 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 118.437 -1.305 . . . . 0.0 109.548 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.6 t . . . . . 0 C--N 1.305 -1.33 0 CA-C-O 116.331 -1.795 . . . . 0.0 110.894 -179.969 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 mmm . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 120.976 0.417 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.06 167.67 2.22 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.571 -0.851 . . . . 0.0 110.935 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -176.68 127.55 0.18 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.782 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.2 pt -68.06 168.69 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.441 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.419 HG22 HE21 ' A' ' 16' ' ' GLN . 1.2 m -149.3 124.76 10.3 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.292 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 m -101.67 137.01 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.718 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.534 ' CE2' ' O ' ' A' ' 12' ' ' PHE . 5.2 m-85 -92.35 148.34 22.2 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.124 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.437 ' HB2' ' N ' ' A' ' 15' ' ' LYS . 1.8 m-85 -81.52 0.71 36.79 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.505 ' C ' ' OG ' ' A' ' 40' ' ' SER . 31.6 m120 -152.38 164.3 37.76 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.063 -1.455 . . . . 0.0 112.009 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.498 ' N ' ' OG ' ' A' ' 40' ' ' SER . 3.0 tp10 -71.63 163.64 27.38 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.462 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.477 ' CG ' ' C ' ' A' ' 10' ' ' GLU . 0.3 OUTLIER 71.87 40.92 0.71 Allowed 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.576 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.534 ' O ' ' CE2' ' A' ' 7' ' ' PHE . 55.8 t80 53.48 10.63 0.22 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.138 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.578 HE21 ' H ' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -96.97 171.89 8.21 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.81 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.578 ' H ' HE21 ' A' ' 13' ' ' GLN . . . 96.08 139.32 10.33 Favored Glycine 0 N--CA 1.495 2.625 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.633 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.437 ' N ' ' HB2' ' A' ' 8' ' ' TYR . 12.5 mtmm -37.11 147.84 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.215 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.419 HE21 HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -118.54 118.86 32.84 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.182 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.405 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 14.4 p -104.82 130.71 55.4 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.028 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.182 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -90.25 143.26 26.93 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.326 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt -138.61 134.74 17.46 Favored Pre-proline 0 N--CA 1.493 1.693 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.146 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.83 165.89 22.08 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.048 1.165 . . . . 0.0 111.264 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.17 -173.73 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 C-N-CA 121.87 1.713 . . . . 0.0 111.163 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.12 -167.26 16.85 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.239 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.674 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -134.81 136.65 42.69 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.203 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.433 ' HH ' HD11 ' A' ' 82' ' ' ILE . 3.6 p90 -152.13 -172.48 4.24 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.04 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 p -142.65 -162.77 1.48 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.658 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.434 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 11.0 ttt180 -60.44 -11.99 8.32 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.725 -1.19 . . . . 0.0 110.116 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.01 -66.48 0.59 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.415 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -59.49 -42.63 92.57 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.363 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.8 mt -64.37 -36.74 85.12 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.32 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 26' ' ' ARG . . . -55.78 -28.88 58.32 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 117.923 -1.511 . . . . 0.0 107.767 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.78 -35.53 70.07 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.819 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.6 mt -81.98 -75.45 0.3 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.487 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.51 16.93 0.06 OUTLIER Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.489 -1.338 . . . . 0.0 110.791 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.7 mm -102.34 127.67 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.047 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 4.7 pt-20 -178.19 158.54 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.277 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 0.5 OUTLIER 81.24 -144.62 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.404 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.634 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 0.5 OUTLIER -94.95 18.44 11.97 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.126 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.683 ' C ' ' H ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -66.32 -20.73 66.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.195 -1.402 . . . . 0.0 110.361 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.499 ' CG2' ' O ' ' A' ' 39' ' ' ILE . 78.8 mt -76.18 33.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.692 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.683 ' H ' ' C ' ' A' ' 38' ' ' THR . 11.0 t -35.45 -55.85 0.65 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.222 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.451 ' HG ' ' H ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -122.74 174.68 6.97 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.418 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.01 161.01 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 118.165 -1.414 . . . . 0.0 112.438 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -141.6 123.31 15.18 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.163 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.4 t -144.65 102.75 4.58 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.05 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -68.31 171.26 13.1 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 121.032 1.154 . . . . 0.0 110.356 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 48' ' ' VAL . 2.1 Cg_endo -61.59 -173.35 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.549 1.499 . . . . 0.0 110.815 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.9 -13.69 8.48 Favored Glycine 0 N--CA 1.483 1.788 0 C-N-CA 119.195 -1.479 . . . . 0.0 110.474 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.429 ' H ' ' C ' ' A' ' 46' ' ' PRO . 2.6 m -151.72 129.42 2.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 118.919 -1.112 . . . . 0.0 112.105 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -98.74 149.54 22.74 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.17 149.62 51.04 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.365 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.59 ' CD1' HH22 ' A' ' 83' ' ' ARG . 1.9 mp -137.66 116.2 14.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.383 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.484 HD11 ' H ' ' A' ' 52' ' ' LEU . 4.3 mp -88.2 156.94 18.96 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.669 -1.212 . . . . 0.0 111.655 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -133.47 110.66 10.12 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.122 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.434 ' HB3' ' H ' ' A' ' 55' ' ' ASN . 3.7 tt0 -49.42 -79.38 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.48 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.434 ' H ' ' HB3' ' A' ' 54' ' ' GLN . 11.6 m120 -62.4 153.88 29.94 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.987 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 21.7 p-10 -64.66 178.46 0.77 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.756 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.0 32.23 66.35 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.248 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.59 ' H ' ' HG ' ' A' ' 81' ' ' SER . 39.9 m-85 52.73 68.08 0.89 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.748 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.41 -170.92 3.62 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.121 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.38 175.01 6.17 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.287 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -44.27 111.66 0.32 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.623 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.563 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -95.62 128.32 42.39 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.146 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.5 mt -96.8 163.78 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.553 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -136.99 130.52 31.59 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.706 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.0 m -150.3 163.72 3.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 118.813 -1.155 . . . . 0.0 112.178 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 t -147.42 -3.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.389 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.22 -146.13 0.32 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.273 -1.331 . . . . 0.0 109.122 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -96.94 124.39 40.9 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.546 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.16 108.73 19.77 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.054 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -65.05 -85.58 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.709 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 73' ' ' GLY . 9.8 mm-40 -80.35 5.86 13.7 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.354 -0.939 . . . . 0.0 111.539 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 tp 60.49 -79.63 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.045 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 170.56 174.72 38.77 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.397 -1.383 . . . . 0.0 110.477 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.26 -27.72 64.03 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.086 1.857 . . . . 0.0 111.982 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.511 ' C ' ' H ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER -83.4 18.81 1.69 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.549 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -68.89 7.59 0.66 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.511 ' H ' ' C ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -83.86 -10.48 57.99 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.519 -0.872 . . . . 0.0 111.269 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -165.75 122.94 1.44 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.381 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 t -149.49 142.79 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.657 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.7 m -158.35 -35.36 0.07 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.196 -1.001 . . . . 0.0 111.855 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.59 ' HG ' ' H ' ' A' ' 58' ' ' PHE . 14.5 m -94.58 143.14 26.67 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.164 -1.014 . . . . 0.0 111.468 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.433 HD11 ' HH ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -148.98 143.74 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.234 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.748 ' NH1' ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -125.0 135.07 52.44 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.81 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.748 ' CA ' ' NH1' ' A' ' 83' ' ' ARG . 13.2 t -141.22 142.92 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.391 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 68.6 mt -140.32 138.62 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.593 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.0 m -55.24 146.23 19.53 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.191 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.1 t -140.91 149.33 55.79 Favored Pre-proline 0 N--CA 1.483 1.225 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.626 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -56.79 157.76 18.75 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.491 1.461 . . . . 0.0 111.58 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.4 m -71.52 136.7 25.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.333 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -145.71 130.89 9.16 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.438 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -60.81 -154.34 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.877 0 C-N-CA 121.276 1.317 . . . . 0.0 111.09 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.464 ' N ' HD13 ' A' ' 136' ' ' LEU . 16.7 ptt180 178.28 -161.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.017 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.435 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.71 173.25 11.71 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.36 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.422 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 10.7 mtm180 -134.79 148.47 50.21 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.002 -1.079 . . . . 0.0 112.148 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 10.9 m-85 -133.79 133.34 41.56 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.764 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.496 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 27.2 m-85 -94.62 179.09 5.38 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.342 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.36 -64.7 1.02 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.431 -0.907 . . . . 0.0 112.973 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.492 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 46.4 tttm -81.02 158.19 25.21 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.94 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.575 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 42.2 mt-10 -64.65 108.31 1.66 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.567 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 1.141 ' NE2' ' HD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 106.04 57.14 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.208 0 O-C-N 125.109 1.505 . . . . 0.0 110.327 179.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 1.141 ' HD1' ' NE2' ' A' ' 100' ' ' GLN . 13.9 p90 26.41 40.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.672 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 100' ' ' GLN . 65.4 m-20 -100.72 -9.42 21.82 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.014 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.492 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -105.92 150.73 16.97 Favored Glycine 0 N--CA 1.499 2.9 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.395 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 103' ' ' GLY . 94.8 mttt -35.04 145.53 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.498 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.33 160.81 14.1 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.961 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.513 ' CG1' ' N ' ' A' ' 107' ' ' ASP . 1.5 t -143.6 165.38 14.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.232 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.513 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 5.7 p-10 -145.37 153.78 41.59 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 118.571 -1.252 . . . . 0.0 112.311 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.415 HD21 ' CE2' ' A' ' 121' ' ' TYR . 60.6 mt -139.39 146.38 48.23 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.371 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -73.15 165.75 31.84 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 121.676 1.584 . . . . 0.0 112.645 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.12 146.87 95.21 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 122.394 2.063 . . . . 0.0 111.491 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.11 -166.21 23.78 Favored Glycine 0 N--CA 1.501 2.973 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.154 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.587 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 55.3 mt-30 -113.37 159.22 19.66 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.737 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.587 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 44.9 m-85 -144.97 148.53 33.89 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.072 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.3 p -87.91 -165.68 1.38 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.879 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.91 57.0 0.73 Allowed 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.901 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.08 -68.16 0.13 Allowed 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.426 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 121' ' ' TYR . 9.7 pt-20 -69.8 -42.61 73.51 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.431 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.575 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -37.16 -74.49 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.529 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.628 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -52.08 -51.57 56.84 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.727 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 2.4 mpt_? -76.88 18.66 0.34 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.754 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 117' ' ' GLU . 16.7 t80 -127.71 -10.11 5.57 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.23 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -141.69 -49.77 0.05 OUTLIER Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.114 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.624 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -146.1 -102.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.627 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.624 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 20.1 m-20 -161.02 162.56 31.8 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.629 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.432 ' N ' ' HB3' ' A' ' 119' ' ' GLU . 17.3 p30 -60.47 -22.83 63.94 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.507 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.607 ' ND2' ' H ' ' A' ' 127' ' ' THR . 9.8 t30 -97.63 -175.3 3.15 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.184 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.607 ' H ' ' ND2' ' A' ' 126' ' ' ASN . 10.1 t 55.04 -152.39 0.35 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.091 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.459 ' N ' HG21 ' A' ' 127' ' ' THR . 2.6 mt 76.43 127.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.295 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.436 ' HB3' ' CA ' ' A' ' 161' ' ' GLY . 47.6 m -160.58 -54.77 0.05 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.895 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.661 ' CB ' ' H ' ' A' ' 101' ' ' PHE . 1.7 m -84.08 117.18 23.27 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.789 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 t -119.46 143.58 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.885 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -139.7 106.6 6.98 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.257 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.55 122.37 9.35 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.103 1.202 . . . . 0.0 111.07 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.435 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 1.0 OUTLIER -90.15 -2.13 58.03 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.964 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -175.92 -36.24 0.05 OUTLIER Glycine 0 N--CA 1.493 2.448 0 C-N-CA 118.469 -1.824 . . . . 0.0 111.805 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.464 HD13 ' N ' ' A' ' 92' ' ' ARG . 0.5 OUTLIER -120.3 164.34 16.45 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.852 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 173' ' ' SER . . . -78.03 155.78 30.48 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.374 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.5 t -119.43 140.12 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.427 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 92.2 t -130.98 124.52 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.845 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.2 mp -103.01 141.23 36.15 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.43 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.419 ' CB ' ' HA ' ' A' ' 146' ' ' PHE . 48.3 m-85 -120.13 125.78 49.09 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.14 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -65.78 -64.69 0.8 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.947 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.54 165.63 23.5 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.4 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 146' ' ' PHE . 31.4 m-20 -63.18 -158.72 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.723 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.655 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 4.0 m120 42.89 22.89 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.753 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.655 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.9 p90 40.6 59.17 2.2 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.114 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 t -143.25 -150.8 0.33 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.334 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 54.4 -153.79 9.55 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.42 -1.371 . . . . 0.0 109.974 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.51 143.13 50.96 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.068 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.426 ' HG1' ' HD3' ' A' ' 152' ' ' PRO . 3.2 p -143.99 167.67 21.8 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.47 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.3 mt -138.03 83.41 23.05 Favored Pre-proline 0 N--CA 1.485 1.31 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.922 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.426 ' HD3' ' HG1' ' A' ' 150' ' ' THR . 3.1 Cg_exo -64.88 104.41 0.56 Allowed 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 121.615 1.543 . . . . 0.0 111.933 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.402 ' C ' ' H ' ' A' ' 155' ' ' SER . 2.6 t -86.0 81.83 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.959 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -71.84 12.55 0.38 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.326 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 13.4 t -169.83 -151.71 0.09 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.378 -1.329 . . . . 0.0 111.618 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.3 m-20 -85.22 155.02 21.59 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.628 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.506 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -171.9 62.64 0.34 Allowed Pre-proline 0 C--N 1.302 -1.469 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.404 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 10.2 Cg_endo -69.87 69.8 1.68 Allowed 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.954 1.769 . . . . 0.0 111.197 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.617 ' HG1' ' H ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER 173.97 -94.45 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.379 -0.928 . . . . 0.0 111.064 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.617 ' H ' ' HG1' ' A' ' 159' ' ' THR . 49.7 mt 53.26 -90.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.842 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 159' ' ' THR . . . 46.23 13.63 0.08 OUTLIER Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.764 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -95.0 46.83 1.13 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.801 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.453 ' O ' ' N ' ' A' ' 165' ' ' ASN . 2.0 ptt? -161.64 57.71 0.27 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.746 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -53.51 91.67 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.71 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 163' ' ' MET . 6.3 t-20 -154.13 -125.3 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.648 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.421 ' CG ' ' C ' ' A' ' 165' ' ' ASN . 3.4 m120 -158.28 102.85 1.78 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.959 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -55.74 122.28 11.07 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.222 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 73.0 m -91.23 -72.1 0.6 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.242 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.618 ' HG ' ' H ' ' A' ' 146' ' ' PHE . 0.1 OUTLIER -115.61 160.72 19.64 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.244 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.403 HG12 ' CD1' ' A' ' 118' ' ' LEU . 29.2 pt -142.37 169.87 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 119.506 -0.877 . . . . 0.0 110.633 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -154.1 107.0 2.86 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.052 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.5 mt -82.99 99.34 5.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.716 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 137' ' ' ALA . 11.0 t . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 116.328 -1.796 . . . . 0.0 110.966 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.3 tpp . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.426 ' CB ' HG13 ' A' ' 48' ' ' VAL . . . -161.37 158.02 26.22 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.212 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -179.97 115.33 0.05 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.18 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.4 pt -70.1 162.46 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.82 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -143.88 119.03 10.1 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.544 -0.863 . . . . 0.0 110.705 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 m -101.8 162.58 3.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.069 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.515 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 31.3 m-85 -120.62 152.7 37.81 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.934 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.98 -47.94 60.24 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.568 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 9.6 m120 -101.17 177.42 4.94 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.969 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 11' ' ' ASP . 5.5 tp10 -82.19 177.06 9.0 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.861 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.478 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 4.1 t70 61.58 36.26 16.9 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.15 -1.02 . . . . 0.0 110.756 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.515 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 1.3 t80 60.95 2.34 0.54 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.701 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.448 ' H ' ' C ' ' A' ' 11' ' ' ASP . 59.1 mt-30 -88.24 167.98 13.11 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.724 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.568 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 93.74 133.98 6.99 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 119.974 -1.107 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 14' ' ' GLY . 25.4 mtmm -30.15 139.47 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.095 0.474 . . . . 0.0 112.193 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.408 ' HB2' HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -96.38 162.07 13.65 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.935 -179.819 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 t -147.82 122.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.629 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 1.6 m-20 -90.25 138.78 31.25 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.798 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 mt -132.24 133.26 23.59 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.639 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -68.65 164.56 32.63 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 120.962 1.108 . . . . 0.0 111.494 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.02 -167.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.756 1.637 . . . . 0.0 110.533 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.474 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 89.56 178.8 45.19 Favored Glycine 0 N--CA 1.486 1.989 0 C-N-CA 118.79 -1.671 . . . . 0.0 110.88 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.898 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -110.52 141.84 43.13 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.359 -0.537 . . . . 0.0 112.2 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -155.77 178.87 9.77 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.879 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.414 ' HG1' ' H ' ' A' ' 27' ' ' ALA . 72.6 p -142.47 -168.65 2.79 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.616 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -57.97 -24.31 57.52 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.381 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.414 ' H ' ' HG1' ' A' ' 25' ' ' THR . . . -64.87 -63.4 1.12 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.003 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -56.73 -39.61 74.25 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.437 -1.305 . . . . 0.0 109.326 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 32' ' ' LEU . 46.1 mt -62.04 -40.1 94.6 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.324 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -48.76 -33.78 10.98 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 118.864 -1.135 . . . . 0.0 107.972 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.53 -38.68 71.05 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.575 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' LEU . 15.2 mt -71.89 -80.93 0.06 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.927 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.14 -21.87 0.1 OUTLIER Glycine 0 N--CA 1.491 2.324 0 C-N-CA 118.802 -1.666 . . . . 0.0 111.422 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -81.27 155.21 4.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.984 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 5.0 pt-20 174.32 117.88 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.468 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.641 ' CG ' ' N ' ' A' ' 37' ' ' ASN . 1.5 p-10 92.43 -150.67 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.966 0 O-C-N 124.299 0.999 . . . . 0.0 113.032 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.706 ' H ' HD21 ' A' ' 37' ' ' ASN . 1.9 m-80 -51.49 4.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.496 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.588 ' H ' ' C ' ' A' ' 36' ' ' ASN . 43.4 p -56.78 -54.26 48.36 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 117.801 -1.559 . . . . 0.0 110.944 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.505 ' N ' ' OG1' ' A' ' 38' ' ' THR . 3.6 mt -58.75 77.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.112 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 38' ' ' THR . 35.6 t -81.38 -58.53 3.0 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.101 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.76 169.49 8.79 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.489 HG11 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -149.68 148.79 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 118.137 -1.425 . . . . 0.0 112.919 -179.907 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -137.01 114.65 11.15 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.616 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.3 t -133.93 110.09 11.96 Favored Pre-proline 0 N--CA 1.498 1.955 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.063 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.405 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.0 OUTLIER -68.46 171.47 12.93 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.219 1.28 . . . . 0.0 111.223 179.879 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.405 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.5 Cg_endo -63.71 -171.92 0.15 Allowed 'Trans proline' 0 C--N 1.317 -1.079 0 C-N-CA 121.922 1.748 . . . . 0.0 111.131 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.38 -17.13 6.7 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.882 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.426 HG13 ' CB ' ' A' ' 2' ' ' ALA . 26.6 m -150.58 143.63 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.232 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -108.78 138.42 45.14 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.972 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -117.49 140.24 49.87 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.369 -0.932 . . . . 0.0 112.436 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -129.09 118.99 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.33 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.407 ' H ' HD11 ' A' ' 52' ' ' LEU . 3.8 mp -94.58 163.79 13.24 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.975 -1.09 . . . . 0.0 112.81 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -143.61 121.01 11.65 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.069 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -54.96 -85.87 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.665 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -59.88 154.07 19.45 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.28 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -62.45 -176.67 0.11 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.525 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.22 21.32 59.43 Favored Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.052 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 57.07 48.64 15.15 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.798 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -128.71 -177.83 4.35 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.591 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.41 171.68 36.44 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.076 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.5 m-20 -46.99 123.69 5.54 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.021 -1.071 . . . . 0.0 110.407 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.644 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -102.85 176.06 5.28 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.854 -0.739 . . . . 0.0 111.112 179.951 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.453 ' CG1' HD12 ' A' ' 75' ' ' LEU . 6.1 mt -143.65 164.31 15.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.625 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.567 ' CD ' ' N ' ' A' ' 64' ' ' GLU . 3.0 mp0 -142.94 132.16 23.26 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.191 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.3 m -149.95 162.95 3.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.645 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.669 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 2.9 t -145.46 -1.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.664 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -124.47 -125.07 0.25 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.877 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.539 ' C ' HD21 ' A' ' 68' ' ' ASN . 0.2 OUTLIER -121.64 115.83 23.47 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.201 179.915 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.489 ' H ' HG11 ' A' ' 42' ' ' VAL . . . -90.1 83.47 6.06 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.575 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -54.33 -51.16 65.59 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.444 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 72' ' ' LEU . 8.5 tp10 -111.93 81.46 1.46 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.87 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 71' ' ' GLU . 4.5 tp -31.17 -87.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.233 -0.894 . . . . 0.0 113.167 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.5 -168.17 38.56 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.007 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.664 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.1 Cg_endo -69.37 -50.38 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.402 2.068 . . . . 0.0 112.611 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.552 ' C ' ' H ' ' A' ' 77' ' ' ASN . 2.3 pt? -57.97 10.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.873 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.664 ' H ' ' C ' ' A' ' 74' ' ' PRO . 30.2 p30 -62.56 -0.58 0.63 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.861 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.552 ' H ' ' C ' ' A' ' 75' ' ' LEU . 55.0 t30 -71.22 -10.53 59.91 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.394 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -172.94 124.85 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.302 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.85 141.67 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.031 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.0 m -160.17 -41.77 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.748 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 m -94.6 139.03 31.73 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.244 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -146.25 162.59 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 118.919 -1.112 . . . . 0.0 111.728 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.827 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.24 114.42 5.85 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.116 -179.881 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.827 ' H ' HH22 ' A' ' 83' ' ' ARG . 10.9 t -110.11 130.31 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.613 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.446 HG13 ' NH1' ' A' ' 83' ' ' ARG . 4.9 mt -132.43 127.4 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.088 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.8 m -39.98 153.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.904 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -158.11 141.86 11.25 Favored Pre-proline 0 N--CA 1.488 1.437 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.98 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -50.46 153.79 7.04 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.346 1.364 . . . . 0.0 111.64 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 90' ' ' GLN . 3.1 p -90.51 158.59 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.96 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.521 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 52.5 mt-30 -142.25 150.46 55.31 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.432 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.528 ' C ' ' HE ' ' A' ' 92' ' ' ARG . 3.3 Cg_exo -59.71 -36.76 90.86 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.496 1.464 . . . . 0.0 111.299 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.528 ' HE ' ' C ' ' A' ' 91' ' ' PRO . 2.5 mtm180 57.21 -165.72 0.15 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.048 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.521 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -140.07 179.77 6.43 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.967 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -140.42 149.84 43.11 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.711 -1.195 . . . . 0.0 111.966 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -134.64 131.34 37.65 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.011 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.564 ' CZ ' ' CD ' ' A' ' 105' ' ' GLU . 5.4 m-85 -92.58 173.34 7.83 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.027 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.44 -68.89 0.75 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 118.893 -1.123 . . . . 0.0 112.117 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -75.46 166.7 23.19 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.319 -0.953 . . . . 0.0 111.844 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.71 ' C ' ' HG2' ' A' ' 100' ' ' GLN . 5.2 pt-20 -89.68 52.75 2.39 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.674 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.71 ' HG2' ' C ' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -159.32 33.24 0.2 Allowed 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.903 -179.995 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.7 t80 58.4 38.11 25.76 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.447 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -137.97 173.81 11.23 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 81.78 134.02 1.72 Allowed Glycine 0 N--CA 1.487 2.033 0 C-N-CA 119.38 -1.391 . . . . 0.0 109.893 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 103' ' ' GLY . 13.6 ptpt -32.69 148.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.066 0.509 . . . . 0.0 112.008 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.564 ' CD ' ' CZ ' ' A' ' 96' ' ' PHE . 20.9 mt-10 -108.52 167.54 9.97 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.737 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.6 t -137.19 130.0 43.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.768 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -102.1 155.87 17.92 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.338 -0.945 . . . . 0.0 113.103 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.1 mt -145.45 125.36 7.05 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.266 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.18 166.38 16.98 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 121.108 1.205 . . . . 0.0 111.756 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.97 150.24 84.96 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 121.78 1.653 . . . . 0.0 111.07 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 139.32 -140.62 11.03 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.188 -1.482 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.528 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 19.2 tt0 -147.55 159.46 43.72 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.791 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 53.5 m-85 -141.71 155.41 45.65 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.842 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.414 ' C ' ' H ' ' A' ' 116' ' ' ALA . 5.2 p -100.61 175.42 5.67 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.66 -0.816 . . . . 0.0 112.29 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.71 41.01 0.15 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.667 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.415 ' N ' ' OE2' ' A' ' 119' ' ' GLU . . . -154.32 -52.93 0.1 Allowed 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.273 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 118' ' ' LEU . 5.1 tp10 -71.83 -52.11 19.1 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.043 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.571 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -36.17 -72.09 0.06 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.435 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.616 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 1.2 pm0 -52.99 -54.93 27.82 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.728 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.437 ' H ' ' HG2' ' A' ' 119' ' ' GLU . 3.4 mpt_? -74.31 15.56 0.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.173 -1.011 . . . . 0.0 112.516 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.669 ' HH ' ' H ' ' A' ' 66' ' ' VAL . 41.0 t80 -121.1 -17.85 7.64 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.536 -0.865 . . . . 0.0 111.476 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -142.94 -40.61 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 C-N-CA 118.632 -1.747 . . . . 0.0 111.44 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.453 ' CD1' ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -139.01 -105.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.54 -179.867 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.571 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 19.1 t70 -162.61 -172.96 3.32 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.609 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.571 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 15.9 t-20 -59.09 -2.32 0.25 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.218 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 127' ' ' THR . 28.2 p30 -172.25 -134.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.754 -1.178 . . . . 0.0 111.948 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.55 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 9.1 t 41.0 33.98 0.25 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.877 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.484 ' C ' ' OG ' ' A' ' 129' ' ' SER . 3.0 mt -88.06 -75.75 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.122 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.484 ' OG ' ' C ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 77.22 -142.39 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 179.784 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.6 m -37.09 128.42 0.92 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.277 -1.329 . . . . 0.0 113.646 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.8 t -122.18 147.43 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.156 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -145.72 98.99 4.45 Favored Pre-proline 0 C--N 1.3 -1.549 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.125 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.02 110.13 1.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.044 1.163 . . . . 0.0 111.519 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.521 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 61.1 tp60 -57.95 -21.32 43.57 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.423 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.57 -36.32 0.03 OUTLIER Glycine 0 N--CA 1.495 2.602 0 C-N-CA 118.516 -1.802 . . . . 0.0 112.103 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.8 mt -92.11 -171.46 2.84 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.704 -1.198 . . . . 0.0 110.968 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.1 146.31 35.65 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.1 t -111.86 141.76 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 119.409 -0.916 . . . . 0.0 112.86 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.431 HG11 ' CE1' ' A' ' 141' ' ' PHE . 91.1 t -133.14 123.57 47.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.1 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.44 ' N ' HD13 ' A' ' 140' ' ' LEU . 5.2 mp -105.23 144.6 31.79 Favored 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 118.838 -1.145 . . . . 0.0 113.598 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.431 ' CE1' HG11 ' A' ' 139' ' ' VAL . 14.9 m-85 -120.14 132.51 55.43 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.047 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -73.91 -55.26 6.4 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.57 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.415 ' HB3' ' H ' ' A' ' 144' ' ' ASP . 9.4 m120 -74.58 -158.52 0.07 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.872 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.557 ' CG ' ' H ' ' A' ' 145' ' ' ASN . 17.8 t70 -64.49 -147.03 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.2 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.559 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 6.0 m-80 -51.59 88.57 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.559 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 8.1 p90 38.44 68.34 0.34 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.946 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 81.1 p -132.95 43.37 2.97 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.971 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -178.8 -155.53 14.88 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -65.73 152.88 43.26 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.234 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 22.5 p -149.83 163.1 38.91 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.806 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.25 97.91 14.46 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.275 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -70.55 109.93 2.59 Favored 'Trans proline' 0 C--N 1.325 -0.664 0 C-N-CA 121.536 1.491 . . . . 0.0 112.087 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.526 ' C ' ' H ' ' A' ' 155' ' ' SER . 3.3 t -89.02 74.73 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.504 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.73 31.07 0.08 Allowed 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.055 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 153' ' ' VAL . 10.5 t -170.31 -153.42 0.1 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.595 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -90.47 164.04 14.41 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.739 -0.785 . . . . 0.0 111.481 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.555 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -167.65 73.13 0.95 Allowed Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.784 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.8 23.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.07 1.846 . . . . 0.0 112.891 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.555 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -178.48 79.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.731 179.89 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.489 ' C ' ' H ' ' A' ' 162' ' ' ALA . 17.2 tp -70.71 -45.18 65.4 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.193 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 162' ' ' ALA . . . 73.52 -10.09 7.08 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.151 -1.5 . . . . 0.0 109.64 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 160' ' ' LEU . . . 70.16 110.27 0.06 Allowed 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.047 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.418 ' N ' ' SD ' ' A' ' 163' ' ' MET . 0.0 OUTLIER -74.6 -58.6 3.18 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.604 179.951 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.549 ' C ' HD21 ' A' ' 164' ' ' ASN . 0.4 OUTLIER -86.8 -156.19 0.31 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.503 -179.977 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.408 ' ND2' ' OD1' ' A' ' 166' ' ' ASN . 19.2 p-10 -73.27 -37.25 66.35 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.339 -0.945 . . . . 0.0 111.006 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.477 ' N ' HD21 ' A' ' 164' ' ' ASN . 41.8 p-10 -171.25 169.73 6.27 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.18 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.21 126.21 42.26 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.422 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.0 m -99.09 -73.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.635 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.509 ' HG ' ' H ' ' A' ' 146' ' ' PHE . 4.0 p -112.01 158.69 19.24 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.203 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.425 HG12 ' CD1' ' A' ' 118' ' ' LEU . 16.3 pt -139.81 170.56 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.748 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -147.95 109.0 4.25 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.97 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.2 mt -88.88 94.73 4.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.957 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 116.356 -1.783 . . . . 0.0 111.069 -179.966 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.0 mtm . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.885 0.374 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.95 166.74 18.6 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.849 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -178.57 127.39 0.11 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.61 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.24 147.65 6.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.331 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 1.154 HG22 ' NE2' ' A' ' 16' ' ' GLN . 22.6 m -128.64 139.15 52.4 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.515 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.13 173.69 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.821 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.448 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 52.7 m-85 -132.63 154.74 49.78 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.385 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -79.4 -19.17 50.72 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.023 1.119 . . . . 0.0 114.023 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.493 ' C ' ' OG ' ' A' ' 40' ' ' SER . 5.7 m120 -136.26 170.89 15.3 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.587 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.36 175.64 4.55 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.22 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 13' ' ' GLN . 6.9 t0 52.63 49.12 21.06 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.122 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.504 ' CE2' ' HG2' ' A' ' 70' ' ' GLU . 16.4 m-85 53.52 -4.25 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.745 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.585 ' H ' ' C ' ' A' ' 11' ' ' ASP . 29.4 mt-30 -75.58 169.05 18.86 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.613 -1.235 . . . . 0.0 111.24 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.6 134.13 5.73 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.495 -1.336 . . . . 0.0 110.498 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.604 ' CB ' ' NZ ' ' A' ' 15' ' ' LYS . 7.1 mtmp? -43.59 157.01 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.027 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 1.154 ' NE2' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -122.38 167.76 12.9 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.447 -0.901 . . . . 0.0 112.821 -179.79 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -145.06 130.35 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.675 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.37 118.09 30.88 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.38 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mt -112.67 139.78 23.15 Favored Pre-proline 0 N--CA 1.49 1.562 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.218 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -70.42 164.43 35.21 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 120.892 1.061 . . . . 0.0 111.075 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -163.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.037 0 C-N-CA 121.715 1.61 . . . . 0.0 110.723 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.24 176.12 50.59 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.779 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.738 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.4 OUTLIER -108.57 145.11 35.33 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.655 -179.885 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.6 p90 -159.03 -173.54 4.29 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.152 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 p -146.53 -162.46 1.53 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.067 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -62.67 -17.82 61.25 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.577 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.06 -62.86 1.26 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.258 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -56.06 -42.41 76.59 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.114 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 32' ' ' LEU . 68.9 mt -60.26 -39.86 88.27 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.454 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.56 -33.0 13.79 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 118.586 -1.246 . . . . 0.0 107.887 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.72 -39.43 80.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.151 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 29' ' ' LEU . 17.7 mt -74.88 -75.59 0.16 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.771 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.53 -24.87 0.66 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 118.801 -1.666 . . . . 0.0 111.471 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.459 HG12 ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -85.04 149.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.405 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.499 ' H ' HG22 ' A' ' 38' ' ' THR . 6.0 pt-20 176.95 151.87 0.18 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.473 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.496 ' CG ' ' C ' ' A' ' 35' ' ' GLU . 0.6 OUTLIER 80.37 -144.5 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 179.754 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -67.5 29.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.249 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.558 ' O ' ' N ' ' A' ' 40' ' ' SER . 80.6 p -87.01 -43.87 12.01 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.44 -1.304 . . . . 0.0 110.626 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.2 mt -60.05 78.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.779 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.558 ' N ' ' O ' ' A' ' 38' ' ' THR . 19.0 t -77.5 -69.65 0.52 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.967 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.448 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -104.49 170.2 8.03 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.486 179.862 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.462 HG13 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -147.49 146.92 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 118.498 -1.281 . . . . 0.0 112.895 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -132.62 117.69 18.24 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.168 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.637 ' H ' HD21 ' A' ' 68' ' ' ASN . 72.3 t -140.5 109.14 6.71 Favored Pre-proline 0 N--CA 1.495 1.801 0 C-N-CA 119.318 -0.953 . . . . 0.0 112.083 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.41 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.0 OUTLIER -69.67 170.94 15.3 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.404 1.403 . . . . 0.0 111.711 179.977 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.8 Cg_endo -62.69 -176.84 0.27 Allowed 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 122.263 1.975 . . . . 0.0 111.214 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.93 -12.25 18.2 Favored Glycine 0 N--CA 1.482 1.729 0 C-N-CA 119.189 -1.481 . . . . 0.0 110.563 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.409 ' H ' ' C ' ' A' ' 46' ' ' PRO . 18.1 m -149.27 131.72 6.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.799 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -105.85 136.78 44.87 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.125 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -117.87 151.98 36.3 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.351 -0.94 . . . . 0.0 112.627 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.1 mt -138.49 119.38 16.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 114.57 -1.196 . . . . 0.0 108.523 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.717 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 2.7 mp -91.97 161.85 14.63 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.535 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -142.75 108.95 5.24 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.785 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -48.17 -85.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.38 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.496 HD21 ' H ' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -59.47 150.2 27.41 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.421 -0.911 . . . . 0.0 111.225 -179.97 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.496 ' H ' HD21 ' A' ' 55' ' ' ASN . 20.6 p-10 -62.1 178.78 0.34 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.465 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.4 24.8 71.0 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.113 -1.518 . . . . 0.0 110.106 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 54.65 63.89 2.0 Allowed 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.72 -161.19 1.27 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.015 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.58 169.46 1.4 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.087 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -43.68 119.1 1.57 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.476 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -97.86 172.18 7.82 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.279 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.483 HG21 ' H ' ' A' ' 64' ' ' GLU . 3.4 mt -142.31 164.31 17.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.601 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.483 ' H ' HG21 ' A' ' 63' ' ' ILE . 14.3 mt-10 -141.86 130.7 22.97 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.796 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -147.66 159.18 8.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 118.758 -1.177 . . . . 0.0 112.43 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.31 -5.05 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.179 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -124.64 -147.58 0.37 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.534 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.637 HD21 ' H ' ' A' ' 44' ' ' VAL . 8.4 m120 -101.63 113.6 26.89 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.02 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.462 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -92.01 100.6 13.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.139 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.504 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 17.5 mt-10 -66.58 -86.34 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.773 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.437 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 28.3 tp10 -57.9 -16.11 10.9 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.533 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 4.6 tp 73.39 -83.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.528 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.405 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 172.58 -169.76 42.87 Favored Glycine 0 N--CA 1.5 2.901 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.583 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.8 Cg_endo -66.41 -47.78 2.88 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.385 2.056 . . . . 0.0 112.308 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.68 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 2.1 pt? -71.54 29.45 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.951 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.583 ' H ' ' C ' ' A' ' 74' ' ' PRO . 0.5 OUTLIER -82.64 55.63 3.05 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.902 179.951 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -145.92 1.48 0.88 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -171.76 115.55 0.37 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.249 -0.981 . . . . 0.0 111.012 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.2 t -139.14 156.12 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.463 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.5 t -166.41 -41.14 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 118.952 -1.099 . . . . 0.0 112.152 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 m -99.77 144.29 29.0 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.304 -0.959 . . . . 0.0 111.349 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -149.23 163.47 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.779 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.826 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -146.89 113.99 6.2 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.834 -179.972 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.826 ' H ' HH22 ' A' ' 83' ' ' ARG . 45.0 t -121.33 138.46 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.701 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.66 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 2.3 mt -143.43 132.43 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.269 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.6 m -40.17 153.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.917 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -149.24 149.88 30.43 Favored Pre-proline 0 N--CA 1.482 1.155 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.805 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.18 153.12 28.03 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 121.251 1.3 . . . . 0.0 111.354 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.14 134.73 27.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.776 -0.77 . . . . 0.0 111.236 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -145.25 126.12 7.47 Favored Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.366 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.62 -177.35 0.08 OUTLIER 'Trans proline' 0 C--O 1.212 -0.812 0 C-N-CA 120.851 1.034 . . . . 0.0 111.119 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.75 -160.33 0.69 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.713 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.49 161.23 27.58 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.157 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -119.42 147.94 43.8 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.981 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -134.75 136.63 42.78 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.564 -1.198 . . . . 0.0 107.889 179.813 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.498 ' CE2' ' OE2' ' A' ' 105' ' ' GLU . 18.3 m-85 -100.89 164.67 11.72 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 118.991 -1.084 . . . . 0.0 112.463 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.62 -56.88 3.59 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.421 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -93.34 167.0 12.02 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.043 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -87.98 68.33 9.19 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.563 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.656 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -175.59 49.56 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.555 -179.946 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.656 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 26.2 p90 39.58 40.31 0.61 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.644 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 20.9 p-10 -142.63 174.76 10.35 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.259 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 85.71 141.24 5.83 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.163 -1.494 . . . . 0.0 110.002 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 103' ' ' GLY . 11.9 tptt -28.49 123.15 0.12 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 124.016 0.48 . . . . 0.0 111.76 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.498 ' OE2' ' CE2' ' A' ' 96' ' ' PHE . 43.8 mt-10 -94.41 115.18 27.33 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.11 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.6 t -96.17 143.76 11.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.592 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -123.92 156.58 36.07 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.88 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.2 mt -143.4 137.96 15.08 Favored Pre-proline 0 N--CA 1.488 1.469 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.896 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -67.77 165.56 27.32 Favored 'Trans proline' 0 C--O 1.213 -0.762 0 C-N-CA 121.732 1.621 . . . . 0.0 112.018 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.69 153.11 51.57 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 C-N-CA 122.171 1.914 . . . . 0.0 111.599 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.97 -159.3 21.14 Favored Glycine 0 N--CA 1.503 3.107 0 C-N-CA 119.35 -1.405 . . . . 0.0 111.42 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.538 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 24.8 mt-30 -123.65 157.18 34.41 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.196 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 27.8 m-85 -138.43 143.92 39.91 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.156 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.2 p -91.37 176.25 6.63 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.838 -0.745 . . . . 0.0 112.604 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.408 ' C ' ' OE2' ' A' ' 119' ' ' GLU . 39.0 tt0 -77.72 46.01 0.53 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.543 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -146.76 -64.17 0.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.073 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.6 pt-20 -71.16 -49.1 47.42 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.927 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.553 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -31.9 -70.33 0.07 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.424 -179.999 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -58.18 -55.98 28.0 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.63 179.956 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.499 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.8 OUTLIER -75.1 21.27 0.12 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.526 -0.869 . . . . 0.0 111.806 -179.876 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' A' ' 117' ' ' GLU . 30.0 t80 -128.75 -15.95 4.3 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.206 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -143.87 -39.36 0.06 OUTLIER Glycine 0 N--CA 1.491 2.331 0 C-N-CA 118.742 -1.694 . . . . 0.0 111.09 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.576 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -144.57 -104.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.5 -179.968 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.576 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 0.3 OUTLIER -162.51 -169.81 2.23 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.013 179.931 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -88.8 36.37 0.8 Allowed 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.008 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.53 ' O ' ' N ' ' A' ' 128' ' ' ILE . 63.2 t30 -172.33 -74.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.418 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -40.62 85.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' A' ' 126' ' ' ASN . 42.3 mt -158.43 143.33 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.657 179.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.9 m -159.51 -119.84 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.267 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.3 m -38.5 128.11 1.45 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.014 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -122.22 154.48 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.714 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -147.59 100.68 3.76 Favored Pre-proline 0 C--N 1.302 -1.467 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.369 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -54.4 94.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 120.976 1.118 . . . . 0.0 110.461 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -57.65 -15.87 8.93 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.307 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.34 -25.6 0.05 OUTLIER Glycine 0 N--CA 1.488 2.131 0 C-N-CA 118.747 -1.692 . . . . 0.0 111.461 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 mt -120.87 148.28 44.26 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.539 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -66.38 161.96 21.42 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.496 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 40.4 t -131.39 147.83 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.482 -0.887 . . . . 0.0 112.259 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.494 HG11 ' CE1' ' A' ' 141' ' ' PHE . 76.2 t -138.82 124.02 22.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.442 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.9 mp -104.34 142.17 35.03 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 119.642 -0.823 . . . . 0.0 112.755 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.494 ' CE1' HG11 ' A' ' 139' ' ' VAL . 18.6 m-85 -120.68 135.06 55.23 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.621 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -72.63 -47.2 49.62 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.527 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.585 ' CG ' ' H ' ' A' ' 144' ' ' ASP . 5.1 t-20 -83.22 -157.33 0.23 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.703 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.585 ' H ' ' CG ' ' A' ' 143' ' ' ASN . 1.0 OUTLIER -69.25 -140.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.927 -179.924 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.604 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 6.0 m120 -52.67 86.09 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.053 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.604 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 6.2 p90 38.73 68.96 0.3 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.953 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 p -136.24 60.05 1.69 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.733 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 160.04 -151.68 22.38 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.134 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -59.41 156.81 12.22 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.336 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.5 p -149.01 170.14 19.03 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.754 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tt -144.24 83.04 10.32 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.449 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.85 105.92 0.71 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 121.999 1.799 . . . . 0.0 113.207 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 38.5 t -82.32 89.97 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.136 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.59 ' N ' HD21 ' A' ' 154' ' ' ASN . 0.0 OUTLIER -68.66 -7.48 33.6 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -179.831 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.53 ' N ' HD21 ' A' ' 154' ' ' ASN . 21.0 t -169.62 -135.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 117.666 -1.614 . . . . 0.0 113.293 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.462 ' N ' ' OG ' ' A' ' 155' ' ' SER . 23.7 m-20 -77.18 152.72 34.68 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.987 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.595 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -167.86 67.14 0.79 Allowed Pre-proline 0 C--N 1.307 -1.247 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.035 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.453 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.4 Cg_endo -62.72 20.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.231 1.954 . . . . 0.0 112.847 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.595 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -175.32 83.62 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.755 -1.178 . . . . 0.0 110.953 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 30.2 tp -98.78 -47.66 5.23 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.297 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 56.03 -165.15 4.5 Favored Glycine 0 N--CA 1.484 1.875 0 C-N-CA 119.212 -1.471 . . . . 0.0 110.043 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.49 105.13 12.42 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.214 -0.995 . . . . 0.0 110.861 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 3.4 mmt -90.27 -77.47 0.4 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.186 -1.005 . . . . 0.0 109.491 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -91.71 -43.8 9.37 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.264 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -177.07 -161.81 0.07 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.328 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -77.13 172.05 13.86 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.374 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.5 m -103.26 150.82 23.36 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.745 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.9 p -124.44 -68.04 0.88 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.157 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 77.3 p -116.33 153.19 32.43 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.611 -0.835 . . . . 0.0 108.819 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 19.2 pt -137.04 175.52 9.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.717 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -155.65 103.97 2.32 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.227 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.3 mt -78.23 103.38 5.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.791 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.0 t . . . . . 0 C--N 1.305 -1.349 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.777 -179.898 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.896 0.379 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.524 ' C ' HD21 ' A' ' 3' ' ' ASN . . . -95.21 175.21 6.69 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.822 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.524 HD21 ' C ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER -175.04 118.32 0.18 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.365 -179.97 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.5 pt -69.27 145.8 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.684 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -121.56 112.87 19.01 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.003 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 m -91.12 175.47 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.238 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.511 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 23.9 m-85 -132.24 151.18 51.94 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.449 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.17 -6.77 59.27 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 118.824 -1.15 . . . . 0.0 113.289 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.52 ' C ' ' OG ' ' A' ' 40' ' ' SER . 34.1 m120 -147.13 161.85 40.04 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.646 -1.222 . . . . 0.0 111.536 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.449 ' N ' ' OG ' ' A' ' 40' ' ' SER . 26.2 mt-10 -70.85 179.02 2.84 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.394 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 13' ' ' GLN . 13.9 t70 59.37 39.33 22.32 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.402 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.6 t80 57.48 5.45 0.3 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.272 -0.971 . . . . 0.0 111.792 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.444 ' HG2' ' H ' ' A' ' 14' ' ' GLY . 6.7 tt0 -92.45 176.66 6.39 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.291 -0.963 . . . . 0.0 111.217 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.444 ' H ' ' HG2' ' A' ' 13' ' ' GLN . . . 88.47 131.43 3.84 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.993 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -42.78 157.64 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.572 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.23 166.96 13.24 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.461 -0.895 . . . . 0.0 112.545 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -143.86 135.41 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.929 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -94.1 113.28 25.21 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.419 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.8 mt -107.35 137.68 19.69 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.572 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -71.15 155.76 60.64 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 121.072 1.181 . . . . 0.0 110.972 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.44 -161.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 121.576 1.517 . . . . 0.0 110.533 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.54 178.45 49.43 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 119.175 -1.488 . . . . 0.0 111.038 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.758 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.5 OUTLIER -103.11 134.3 46.77 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.671 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 7.4 p90 -153.71 174.77 14.08 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.143 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.492 HG21 ' HG ' ' A' ' 81' ' ' SER . 26.5 p -145.67 -154.21 0.53 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.98 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.446 HH11 ' HB1' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -62.72 -30.92 71.77 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.973 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.98 -61.77 2.36 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -56.47 -47.4 79.28 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.502 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.2 mt -54.98 -39.48 69.03 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.528 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.446 ' HB1' HH11 ' A' ' 26' ' ' ARG . . . -51.68 -34.2 37.34 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 118.948 -1.101 . . . . 0.0 108.359 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.77 -39.49 87.87 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.696 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.3 mt -74.8 -75.07 0.17 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.617 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.59 -34.91 0.54 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.094 -1.526 . . . . 0.0 110.909 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.5 tt -79.89 150.76 4.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.735 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 179.92 150.74 0.38 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.605 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.69 -146.8 0.14 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.913 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -55.33 92.62 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.998 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 40' ' ' SER . 73.1 p -153.18 -46.97 0.1 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.106 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.3 mt -61.86 75.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 C-N-CA 119.661 -0.815 . . . . 0.0 109.764 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 38' ' ' THR . 8.6 t -74.21 -59.74 2.59 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.429 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.511 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -116.81 177.29 4.76 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.709 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.485 HG13 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -156.43 152.64 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 117.549 -1.66 . . . . 0.0 113.486 -179.896 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -140.17 106.97 5.38 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.595 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -126.08 108.21 24.71 Favored Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.598 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.411 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -69.81 171.04 15.25 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.042 1.162 . . . . 0.0 110.549 179.86 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.411 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.9 Cg_endo -62.39 -170.87 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.841 1.694 . . . . 0.0 110.91 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.9 -14.61 12.97 Favored Glycine 0 N--CA 1.478 1.468 0 C-N-CA 119.024 -1.56 . . . . 0.0 111.005 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.66 131.72 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 118.716 -1.194 . . . . 0.0 112.588 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -101.73 130.8 48.21 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.35 158.09 20.22 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.025 -1.07 . . . . 0.0 113.519 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.6 mt -144.71 116.24 2.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.242 179.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.7 mp -94.42 159.46 15.1 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.167 -1.013 . . . . 0.0 113.368 -179.685 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.419 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 83.2 m-85 -139.33 114.77 9.82 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.111 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -44.61 -87.05 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.459 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -59.45 151.02 24.98 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.338 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -58.99 -178.99 0.06 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.169 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.666 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 55.61 37.31 67.31 Favored Glycine 0 N--CA 1.484 1.853 0 C-N-CA 118.906 -1.616 . . . . 0.0 109.437 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.688 ' H ' ' CB ' ' A' ' 81' ' ' SER . 0.3 OUTLIER 41.1 69.08 0.37 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.838 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.02 174.39 10.63 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.767 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.71 173.61 40.64 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.236 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -48.46 122.28 5.29 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 118.999 -1.081 . . . . 0.0 110.352 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -99.05 173.32 6.88 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.93 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.478 HG23 ' H ' ' A' ' 64' ' ' GLU . 7.3 mt -138.66 169.93 17.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.711 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.478 ' H ' HG23 ' A' ' 63' ' ' ILE . 22.0 mt-10 -147.21 130.88 16.9 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.394 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.64 164.74 2.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.441 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.67 -9.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.658 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -118.01 -153.21 0.52 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.837 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -95.48 120.7 36.18 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.637 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.485 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -89.73 108.37 19.65 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.174 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 8.2 tp10 -73.62 -76.78 0.12 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.95 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.472 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 23.1 tp10 -76.86 2.02 15.8 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.038 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.1 tp 51.83 -97.55 0.06 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.111 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.5 -173.83 40.77 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 118.937 -1.601 . . . . 0.0 110.979 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.656 ' C ' ' H ' ' A' ' 76' ' ' ASN . 3.8 Cg_endo -71.86 -53.8 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.649 2.233 . . . . 0.0 112.306 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.479 ' H ' HD21 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -60.82 14.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.775 -179.853 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.656 ' H ' ' C ' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -67.51 0.81 2.74 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.453 179.943 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.433 ' H ' ' C ' ' A' ' 75' ' ' LEU . 25.8 t-20 -80.82 -8.77 59.79 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.091 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -164.75 122.54 1.66 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.596 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 t -148.33 137.47 15.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.72 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.5 p -145.11 -47.4 0.23 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.65 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.688 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 7.4 m -93.61 142.76 26.98 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.334 -179.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -147.98 160.38 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.01 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.774 ' NH2' ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.92 137.4 21.09 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.151 180.0 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.774 ' N ' ' NH2' ' A' ' 83' ' ' ARG . 5.4 t -140.74 143.87 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.7 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.478 HG12 ' NH2' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -135.71 135.13 51.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.125 -179.928 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.1 t -42.87 154.41 0.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.108 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.7 143.72 13.59 Favored Pre-proline 0 C--N 1.307 -1.27 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.118 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.54 130.12 28.83 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.091 1.194 . . . . 0.0 110.73 179.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.406 ' H ' HG11 ' A' ' 89' ' ' VAL . 2.3 p -59.48 140.24 17.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -117.33 152.44 49.25 Favored Pre-proline 0 N--CA 1.49 1.57 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.25 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.33 -34.27 97.74 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.287 1.324 . . . . 0.0 111.207 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 52.15 -161.96 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.359 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.53 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.1 175.86 9.42 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.867 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.487 ' NH2' HE22 ' A' ' 134' ' ' GLN . 28.3 ttm180 -143.68 120.15 11.01 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.45 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.405 ' CD1' HG12 ' A' ' 131' ' ' VAL . 6.7 m-30 -95.77 164.54 12.71 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.028 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.638 ' CD1' ' CE1' ' A' ' 101' ' ' PHE . 2.8 m-85 -143.41 149.06 37.12 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.468 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -93.68 160.43 14.77 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.597 -179.895 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.423 ' C ' ' OG ' ' A' ' 129' ' ' SER . 10.3 tttm 67.19 136.52 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.004 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.532 ' N ' ' OG ' ' A' ' 129' ' ' SER . 5.1 pt-20 -77.27 70.99 3.73 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.626 -1.23 . . . . 0.0 111.003 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.642 ' NE2' ' OD2' ' A' ' 102' ' ' ASP . 6.3 tt0 -173.67 19.02 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.515 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.638 ' CE1' ' CD1' ' A' ' 96' ' ' PHE . 33.8 t80 49.34 40.35 18.27 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.424 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.642 ' OD2' ' NE2' ' A' ' 100' ' ' GLN . 90.3 m-20 -104.09 -87.22 0.44 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.556 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 102' ' ' ASP . . . -30.68 145.88 0.01 OUTLIER Glycine 0 N--CA 1.507 3.402 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.917 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -34.72 155.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 114.587 -0.807 . . . . 0.0 112.998 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.473 ' HB3' ' CE1' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -116.4 164.74 14.1 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.411 -179.849 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.65 141.16 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -102.53 157.69 16.75 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.965 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.8 mt -144.27 140.01 16.37 Favored Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.964 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -72.86 164.39 35.71 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 121.756 1.637 . . . . 0.0 111.825 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.5 143.79 70.52 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.603 1.535 . . . . 0.0 110.72 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.9 -160.78 27.52 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 118.795 -1.669 . . . . 0.0 111.573 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.561 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 29.3 tt0 -117.63 158.13 25.19 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.216 -0.492 . . . . 0.0 111.038 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.561 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 56.0 m-85 -145.52 151.47 38.22 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.765 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.4 p -103.02 -168.24 1.49 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.322 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.47 ' CG ' ' OG ' ' A' ' 168' ' ' SER . 6.6 tt0 -92.23 49.64 1.54 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.146 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -151.19 -63.51 0.19 Allowed 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.744 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -70.2 -54.07 14.39 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.326 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.558 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -30.82 -69.34 0.07 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.012 -179.99 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.641 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 21.2 mp0 -54.92 -59.29 4.94 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.173 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.42 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 12.3 mpt_? -74.73 19.54 0.14 Allowed 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.71 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.543 ' N ' ' O ' ' A' ' 117' ' ' GLU . 16.1 t80 -121.22 -15.4 8.17 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.881 -0.727 . . . . 0.0 110.773 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.07 -37.19 0.05 OUTLIER Glycine 0 N--CA 1.483 1.817 0 C-N-CA 118.928 -1.606 . . . . 0.0 110.337 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.455 HD11 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -146.01 -112.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.527 -179.843 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.433 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 9.1 t70 -151.98 -147.3 0.22 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.275 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.716 HD21 ' N ' ' A' ' 126' ' ' ASN . 0.2 OUTLIER -73.81 -108.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.52 179.935 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.716 ' N ' HD21 ' A' ' 125' ' ' ASN . 23.7 t-20 -80.2 55.17 2.13 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.074 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 127' ' ' THR . 18.7 m -100.58 4.58 43.53 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.482 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.428 ' H ' HG12 ' A' ' 128' ' ' ILE . 2.3 mm -76.73 161.81 4.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.665 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 99' ' ' GLU . 2.4 t -161.91 -47.98 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.1 m -137.34 134.98 36.63 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.149 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.405 HG12 ' CD1' ' A' ' 95' ' ' PHE . 3.0 t -120.7 145.31 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.572 0.701 . . . . 0.0 111.855 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -146.18 93.56 5.06 Favored Pre-proline 0 C--N 1.296 -1.753 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.986 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -59.15 105.71 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.164 1.243 . . . . 0.0 111.877 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.53 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 8.2 tt0 -56.52 -9.52 0.75 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.568 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.44 -41.93 0.08 OUTLIER Glycine 0 N--CA 1.494 2.536 0 C-N-CA 118.49 -1.814 . . . . 0.0 111.933 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.9 mt -88.05 -167.12 1.78 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.105 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -115.79 142.64 46.5 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 153' ' ' VAL . 53.6 t -107.75 144.91 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.696 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.467 HG13 ' CE1' ' A' ' 141' ' ' PHE . 88.1 t -132.62 120.61 42.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.033 179.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.8 mp -97.84 139.33 33.85 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.343 -179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.467 ' CE1' HG13 ' A' ' 139' ' ' VAL . 29.4 m-85 -115.48 129.23 56.48 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.689 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -61.44 -75.02 0.07 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.653 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -76.22 167.98 20.88 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.259 -0.977 . . . . 0.0 110.513 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 146' ' ' PHE . 1.4 p30 -63.48 -158.43 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.59 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.643 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 0.4 OUTLIER 39.33 26.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.248 179.953 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.643 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 41.87 57.89 3.02 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.343 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.0 t -136.45 -172.93 3.27 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.028 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.48 -161.94 53.49 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.169 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -59.77 156.31 14.27 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.104 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.5 p -148.16 170.39 17.95 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.476 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.7 mt -137.93 82.56 25.32 Favored Pre-proline 0 C--N 1.303 -1.419 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.463 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -62.13 103.93 0.32 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.848 1.699 . . . . 0.0 112.231 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 138' ' ' VAL . 3.1 t -89.34 74.1 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.883 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -79.22 36.29 0.29 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.001 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 153' ' ' VAL . 13.6 t -170.97 -155.85 0.11 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.328 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.2 155.89 19.91 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.136 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.599 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.97 69.51 1.38 Allowed Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.526 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.4 Cg_endo -66.44 23.84 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.075 1.85 . . . . 0.0 111.313 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.599 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.3 t -168.76 134.34 1.7 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.412 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 129' ' ' SER . 0.2 OUTLIER -141.74 -55.57 0.46 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.949 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 79.06 -94.01 1.33 Allowed Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.106 -1.521 . . . . 0.0 110.154 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -171.47 96.15 0.18 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.254 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 32.6 mmt -90.04 -69.24 0.73 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.285 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.522 ' C ' ' CG ' ' A' ' 165' ' ' ASN . 24.2 m120 -87.23 38.73 0.83 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.23 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.566 ' O ' ' ND2' ' A' ' 166' ' ' ASN . 0.1 OUTLIER 42.98 88.79 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.347 -179.997 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.566 ' ND2' ' O ' ' A' ' 165' ' ' ASN . 0.1 OUTLIER 69.12 153.57 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.961 179.813 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.45 125.61 51.22 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.838 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.47 ' OG ' ' CG ' ' A' ' 115' ' ' GLN . 36.8 t -91.15 -62.03 1.53 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.223 -0.991 . . . . 0.0 112.09 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.42 ' HG ' ' H ' ' A' ' 146' ' ' PHE . 0.5 OUTLIER -116.49 161.0 19.78 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.819 -179.936 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.401 HG12 ' CD1' ' A' ' 118' ' ' LEU . 45.7 pt -143.16 174.64 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.729 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.5 ttt85 -160.66 114.25 2.08 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.492 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 11.7 mt -86.87 101.41 11.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.466 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.5 t . . . . . 0 C--N 1.306 -1.307 0 CA-C-O 116.284 -1.817 . . . . 0.0 110.874 179.949 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttm . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 120.761 0.315 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.423 ' C ' ' ND2' ' A' ' 3' ' ' ASN . . . -86.74 123.67 32.15 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.028 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.423 ' ND2' ' C ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER 179.83 125.89 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.683 179.969 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 pt -82.04 128.02 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.06 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -105.69 112.25 25.25 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.2 m -90.11 169.5 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 119.591 -0.844 . . . . 0.0 113.206 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -129.14 141.61 51.13 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.407 -1.27 . . . . 0.0 108.196 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.17 -21.72 58.55 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -179.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -123.95 169.73 11.32 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.028 -1.069 . . . . 0.0 112.477 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.437 ' HG2' ' H ' ' A' ' 11' ' ' ASP . 25.4 tt0 -67.21 173.77 3.64 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.888 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.558 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 14.5 m-20 52.01 58.2 5.69 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.774 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 7.3 p90 33.59 28.69 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.506 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 11' ' ' ASP . 8.7 tp-100 -106.55 168.44 9.17 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.92 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.537 ' H ' ' CD ' ' A' ' 13' ' ' GLN . . . 93.94 136.81 8.26 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.995 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -30.54 140.82 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 O-C-N 123.922 0.425 . . . . 0.0 111.712 -179.931 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 1.203 ' OE1' ' CD ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -100.52 151.71 21.26 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.498 -0.881 . . . . 0.0 113.17 -179.802 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -135.9 142.99 37.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.822 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -107.79 133.71 51.79 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.659 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 mt -129.3 126.81 23.08 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.982 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -67.91 163.59 35.0 Favored 'Trans proline' 0 C--N 1.327 -0.599 0 C-N-CA 120.629 0.886 . . . . 0.0 110.961 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.05 -162.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.493 1.462 . . . . 0.0 111.06 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.23 172.94 37.11 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.073 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.556 ' ND2' ' H ' ' A' ' 23' ' ' ASN . 0.9 OUTLIER -106.12 133.9 50.09 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.564 -179.947 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -155.24 177.12 11.71 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.394 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 p -137.88 -159.78 0.99 Allowed 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.85 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.86 -20.78 66.07 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.614 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.97 -58.9 5.78 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.216 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -56.67 -45.2 81.84 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.007 -1.077 . . . . 0.0 109.738 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 13.7 mt -58.73 -39.09 79.88 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.567 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.15 -32.66 48.8 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.853 -1.139 . . . . 0.0 108.589 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.1 -42.31 76.3 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.095 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.3 mt -69.93 -71.39 0.24 Allowed 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.666 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.64 -34.67 0.81 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.117 -1.516 . . . . 0.0 110.923 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.5 tt -83.32 141.62 14.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.27 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 175.82 154.96 0.19 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.031 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.1 t30 60.76 104.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.643 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.5 t30 51.23 69.99 0.59 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.586 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.539 ' C ' ' H ' ' A' ' 40' ' ' SER . 77.9 p -146.57 -32.23 0.33 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.339 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 40' ' ' SER . 8.9 mt -78.09 42.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.516 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 38' ' ' THR . 32.6 t -38.78 -53.73 1.65 Allowed 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.026 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.59 163.98 29.88 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.211 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.1 m -143.89 171.66 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 118.502 -1.279 . . . . 0.0 113.444 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -142.23 95.06 2.74 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.559 -1.655 . . . . 0.0 107.461 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 51.8 t -115.63 110.25 44.82 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -70.28 169.64 19.1 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.065 1.177 . . . . 0.0 110.311 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.85 -170.28 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.715 1.61 . . . . 0.0 111.207 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.86 -15.34 15.6 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.392 -1.385 . . . . 0.0 111.016 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.518 ' HA ' ' H ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -152.97 148.48 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.414 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -123.8 128.67 49.87 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.137 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.77 165.06 11.84 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.83 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.488 HG23 ' CE2' ' A' ' 53' ' ' TYR . 66.7 mt -138.73 125.09 24.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.661 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.17 122.65 42.66 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.647 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.488 ' CE2' HG23 ' A' ' 51' ' ' ILE . 32.9 m-85 -109.78 119.55 39.72 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.318 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -54.76 -77.01 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.144 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -62.28 156.16 22.94 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.0 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 19.2 p-10 -68.1 174.53 3.78 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.623 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.422 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 62.13 31.31 78.43 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.236 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.422 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.2 OUTLIER 54.2 67.18 1.05 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.619 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.42 -170.53 3.47 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.332 -0.947 . . . . 0.0 111.195 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 67.43 174.52 7.28 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.377 -1.392 . . . . 0.0 109.858 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 60' ' ' GLY . 13.4 m-20 -42.98 118.67 1.32 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.136 -1.026 . . . . 0.0 110.33 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.36 160.8 15.3 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.259 -0.977 . . . . 0.0 111.33 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 7.2 mm -137.53 168.63 20.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.353 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.517 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 20.2 mp0 -147.96 134.19 19.45 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.306 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.7 m -149.76 147.5 16.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 118.676 -1.21 . . . . 0.0 112.252 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.0 t -140.77 -0.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.6 ' H ' ' HH ' ' A' ' 121' ' ' TYR . . . -126.49 -153.85 0.59 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.686 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -93.49 144.05 25.72 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.437 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.17 108.98 18.83 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.732 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -78.29 -63.34 1.42 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.401 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -100.45 4.43 43.73 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.259 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 tp 46.18 -98.93 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.097 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -168.95 -177.24 39.63 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 118.778 -1.677 . . . . 0.0 110.842 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.632 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.0 OUTLIER -67.16 -46.02 3.4 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.169 1.913 . . . . 0.0 112.055 -179.983 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.58 ' C ' ' H ' ' A' ' 77' ' ' ASN . 2.4 pt? -56.72 3.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.403 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.632 ' H ' ' C ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -65.04 5.79 0.31 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.403 179.945 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.619 ' N ' HD21 ' A' ' 76' ' ' ASN . 26.3 t30 -86.92 -11.01 51.93 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.725 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -166.15 98.94 0.63 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.665 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -97.09 171.0 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.582 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.1 t -171.31 -69.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 118.348 -1.341 . . . . 0.0 112.901 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.402 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 4.4 m -96.99 148.64 22.77 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.72 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.68 153.05 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.311 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.79 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -145.91 140.42 26.96 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.753 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.79 ' CA ' HH12 ' A' ' 83' ' ' ARG . 10.1 t -138.82 140.45 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.99 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.549 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 2.8 mt -136.99 125.61 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.57 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -50.12 126.85 15.52 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.579 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.518 ' H ' ' HA ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -114.97 145.32 33.79 Favored Pre-proline 0 N--CA 1.49 1.545 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.302 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -52.61 120.29 7.26 Favored 'Trans proline' 0 C--N 1.326 -0.618 0 C-N-CA 121.356 1.37 . . . . 0.0 111.354 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.47 130.59 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.841 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -139.35 150.21 63.28 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.394 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.434 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 1.7 Cg_endo -59.13 -166.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.106 1.204 . . . . 0.0 111.102 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.457 ' N ' HD13 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -172.89 -157.56 0.1 Allowed 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.049 -179.9 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.68 162.08 36.24 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.156 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -129.99 117.43 20.05 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.043 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 10.5 m-85 -102.85 131.11 49.97 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.116 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -99.42 159.99 14.61 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.848 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.478 ' CE1' HG23 ' A' ' 127' ' ' THR . 1.0 OUTLIER -97.43 158.68 15.35 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.629 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt 62.47 138.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.815 0.816 . . . . 0.0 111.514 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.588 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 10.6 tp10 -71.12 102.44 2.49 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.605 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.838 ' NE2' ' HB2' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 129.67 39.25 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.467 0 O-C-N 125.286 1.616 . . . . 0.0 109.654 179.766 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.65 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 28.5 p90 33.96 48.33 0.23 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.124 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.838 ' HB2' ' NE2' ' A' ' 100' ' ' GLN . 53.5 t0 -124.36 57.58 1.23 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.472 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -177.01 156.42 20.39 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.902 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.45 ' H ' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -28.81 139.9 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.827 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -94.67 154.5 17.3 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.902 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.553 ' CG1' ' N ' ' A' ' 107' ' ' ASP . 2.5 t -140.31 165.67 20.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.888 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.553 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 17.7 p-10 -149.24 159.37 44.32 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.759 -1.176 . . . . 0.0 111.651 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.4 mt -142.07 149.08 51.07 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 119.639 -0.825 . . . . 0.0 111.23 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.41 165.93 24.79 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.044 1.829 . . . . 0.0 111.661 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.36 142.9 67.96 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.566 1.511 . . . . 0.0 110.687 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.422 ' C ' ' NE2' ' A' ' 112' ' ' GLN . . . 144.75 -158.72 27.66 Favored Glycine 0 N--CA 1.502 3.063 0 C-N-CA 118.787 -1.673 . . . . 0.0 111.711 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.541 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 11.2 mp0 -116.77 153.4 32.49 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.759 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 50.8 m-85 -145.84 146.68 31.22 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.633 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.9 p -89.47 -147.93 0.18 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.435 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.69 ' H ' ' CD ' ' A' ' 115' ' ' GLN . 0.3 OUTLIER -116.06 27.35 9.32 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.783 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.422 ' HB3' HE21 ' A' ' 115' ' ' GLN . . . -129.54 -64.56 0.88 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.762 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.495 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 8.1 pt-20 -68.67 -42.64 77.61 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.42 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.569 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -38.04 -72.65 0.06 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.77 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -52.55 -54.41 33.16 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.168 -179.969 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -72.93 16.66 0.14 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.432 -179.791 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.6 ' HH ' ' H ' ' A' ' 67' ' ' ALA . 13.9 t80 -124.49 -17.9 5.88 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.912 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -133.91 -49.75 0.08 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.114 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.581 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -144.99 -99.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.628 -179.934 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.581 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 13.3 t70 -168.73 177.69 4.99 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.172 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.608 HD21 ' N ' ' A' ' 126' ' ' ASN . 0.5 OUTLIER -59.15 135.14 57.54 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.701 -179.84 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.608 ' N ' HD21 ' A' ' 125' ' ' ASN . 5.7 p-10 35.85 81.28 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.812 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.478 HG23 ' CE1' ' A' ' 97' ' ' TYR . 97.9 m -161.56 -11.0 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.394 -0.923 . . . . 0.0 111.012 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.452 HD11 ' N ' ' A' ' 128' ' ' ILE . 1.5 mp -53.84 -56.32 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.256 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.9 m 55.35 -113.63 0.8 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.682 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.413 ' H ' ' HG ' ' A' ' 130' ' ' SER . 4.2 m -63.06 122.42 16.03 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.93 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.76 159.76 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.427 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -153.15 85.46 4.24 Favored Pre-proline 0 C--N 1.301 -1.518 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -62.42 97.06 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.416 1.41 . . . . 0.0 110.723 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -81.83 22.4 0.76 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.35 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.8 -54.44 0.04 OUTLIER Glycine 0 N--CA 1.498 2.778 0 C-N-CA 118.042 -2.027 . . . . 0.0 112.38 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 92' ' ' ARG . 1.3 mp -115.87 -172.07 2.09 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.002 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.75 143.11 31.31 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.652 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.6 t -110.0 139.09 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.765 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.97 138.02 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.036 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 9.3 mp -112.26 134.5 53.76 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.926 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.58 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 7.2 m-85 -115.0 131.92 56.77 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.78 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -64.21 -79.16 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.028 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -60.35 160.66 8.3 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.357 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 146' ' ' PHE . 10.0 m-20 -63.9 -156.19 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.554 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.686 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 6.3 t-20 41.13 24.44 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.017 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.686 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.1 OUTLIER 44.08 59.82 3.03 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.822 -179.946 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.6 t -141.83 -174.49 4.09 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.358 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.91 -163.22 54.2 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.591 -1.29 . . . . 0.0 110.025 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -59.81 160.47 7.52 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.952 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.0 p -150.34 174.73 12.54 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.809 -179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.5 tp -141.78 89.45 9.04 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.53 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.21 106.27 0.8 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 121.699 1.599 . . . . 0.0 113.23 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.98 92.42 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.537 179.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -55.79 -34.57 65.41 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.8 t -164.15 -149.82 0.14 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 117.907 -1.517 . . . . 0.0 112.665 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -43.72 146.51 0.54 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.31 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.582 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -172.45 69.15 0.41 Allowed Pre-proline 0 C--N 1.307 -1.244 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.343 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.2 Cg_endo -64.9 23.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.197 1.931 . . . . 0.0 112.481 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.582 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -177.72 102.3 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.139 179.967 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 3.7 mm? -99.37 -56.42 2.41 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.705 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 68.69 -171.66 37.42 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.375 -1.393 . . . . 0.0 110.53 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.39 137.93 57.81 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.994 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.633 ' CG ' ' H ' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -138.69 -80.55 0.33 Allowed 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.301 179.894 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.633 ' H ' ' CG ' ' A' ' 163' ' ' MET . 49.9 m-80 -90.75 -54.36 4.01 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.736 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -174.14 -67.23 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.847 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -163.13 141.55 8.2 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.812 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.5 m -86.31 107.84 18.15 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.826 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 27.5 m -95.33 -53.16 3.87 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.172 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.54 160.91 21.51 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.032 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.41 HG12 ' CD1' ' A' ' 118' ' ' LEU . 31.4 pt -138.96 166.51 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -148.75 103.36 3.37 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.591 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.0 mt -81.17 97.55 3.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 118.978 -1.089 . . . . 0.0 109.347 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 C--N 1.305 -1.343 0 CA-C-O 116.324 -1.798 . . . . 0.0 111.026 -179.993 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.405 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.42 ' C ' ' ND2' ' A' ' 3' ' ' ASN . . . 68.7 168.13 0.28 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.696 -0.801 . . . . 0.0 111.088 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.42 ' ND2' ' C ' ' A' ' 2' ' ' ALA . 31.3 m-80 -159.28 125.62 4.48 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.156 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.0 pt -72.01 155.17 7.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.513 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.407 HG21 ' N ' ' A' ' 6' ' ' VAL . 2.0 m -134.0 156.5 48.08 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.067 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.407 ' N ' HG21 ' A' ' 5' ' ' THR . 2.2 m -147.26 171.41 3.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 119.086 -1.045 . . . . 0.0 111.062 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -131.97 156.15 46.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.744 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -72.17 -51.6 20.52 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -179.525 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.646 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 73.2 m-80 -87.22 179.23 6.67 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.842 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -80.31 166.05 21.71 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.189 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.5 ' C ' ' H ' ' A' ' 13' ' ' GLN . 3.7 t0 66.15 45.35 2.36 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.782 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER 56.71 0.7 0.07 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.128 -1.029 . . . . 0.0 112.075 179.893 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.5 ' H ' ' C ' ' A' ' 11' ' ' ASP . 6.9 tt0 -87.97 162.96 16.57 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.199 -1.0 . . . . 0.0 112.287 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.646 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 98.06 147.67 22.62 Favored Glycine 0 N--CA 1.503 3.107 0 C-N-CA 120.259 -0.972 . . . . 0.0 110.926 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 14' ' ' GLY . 3.7 mptp? -29.26 139.0 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 O-C-N 123.956 0.445 . . . . 0.0 112.137 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 1.011 ' NE2' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -103.92 160.19 15.02 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.459 -179.775 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.613 ' CG1' ' N ' ' A' ' 18' ' ' ASP . 6.9 t -147.53 165.69 5.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.62 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.613 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 14.9 t70 -135.49 124.6 24.41 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.268 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mt -122.85 129.92 24.82 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.017 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -67.35 165.31 27.38 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.123 1.216 . . . . 0.0 111.317 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.99 -165.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 121.542 1.494 . . . . 0.0 110.289 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.53 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 94.95 -175.22 33.57 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 118.836 -1.649 . . . . 0.0 111.176 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.769 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.2 OUTLIER -113.2 134.02 54.78 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.153 -179.795 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.418 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 3.4 p90 -154.54 175.89 13.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.673 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.0 p -146.82 -155.43 0.62 Allowed 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.984 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -60.33 -20.92 61.22 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.692 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.96 -63.11 1.16 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.474 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -56.02 -46.73 78.71 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.486 -1.286 . . . . 0.0 109.805 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.9 mt -59.4 -38.95 81.89 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.539 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.57 -26.92 56.57 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 118.328 -1.349 . . . . 0.0 108.419 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.41 -37.95 60.16 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.739 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 mt -73.34 -74.97 0.16 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.525 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.29 -32.82 0.65 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.248 -1.454 . . . . 0.0 110.692 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.436 HG12 ' HG1' ' A' ' 38' ' ' THR . 7.8 tt -85.26 139.42 17.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 3.4 pt-20 174.24 142.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.195 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.596 ' ND2' ' ND2' ' A' ' 78' ' ' ASN . 1.7 t-20 75.57 116.31 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 47.14 9.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.735 179.74 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 40' ' ' SER . 71.4 p -83.35 -57.67 3.16 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 117.941 -1.503 . . . . 0.0 111.206 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.417 ' N ' ' OG1' ' A' ' 38' ' ' THR . 30.2 mt -57.92 78.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.23 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 38' ' ' THR . 13.7 t -77.79 -48.3 16.89 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.562 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.7 t -126.87 132.02 51.04 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.487 HG11 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -105.54 158.8 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 C-N-CA 119.492 -0.883 . . . . 0.0 113.052 -179.742 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.733 ' HZ1' HD22 ' A' ' 68' ' ' ASN . 33.4 tttp -143.38 98.43 3.25 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.788 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.1 t -121.78 109.37 34.19 Favored Pre-proline 0 N--CA 1.496 1.842 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.318 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -69.07 168.43 20.69 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 120.989 1.126 . . . . 0.0 110.898 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 48' ' ' VAL . 2.2 Cg_endo -61.42 -175.7 0.15 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 121.818 1.678 . . . . 0.0 111.097 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.69 -14.54 17.98 Favored Glycine 0 N--CA 1.481 1.688 0 C-N-CA 119.178 -1.487 . . . . 0.0 110.295 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 46' ' ' PRO . 15.5 m -149.28 135.42 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.685 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.414 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 37.4 tttm -110.32 156.2 21.06 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.249 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -149.7 158.62 44.34 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 118.139 -1.424 . . . . 0.0 112.916 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 78.4 mt -133.19 123.05 46.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 114.317 -1.311 . . . . 0.0 108.846 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.466 HD13 ' H ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -100.37 138.97 36.71 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.725 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.435 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 49.2 m-85 -113.73 114.05 25.82 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.712 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -46.72 -83.1 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.721 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -59.23 141.96 53.01 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.272 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -53.65 178.0 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.271 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.671 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 59.08 37.74 92.07 Favored Glycine 0 N--CA 1.487 2.049 0 C-N-CA 118.95 -1.595 . . . . 0.0 109.69 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.671 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.3 OUTLIER 41.08 70.52 0.25 Allowed 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.987 -179.943 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.05 -162.67 1.61 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.11 -178.03 5.14 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.325 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -49.46 123.79 8.23 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.45 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -95.54 158.3 15.51 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.101 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.525 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 7.7 mm -133.42 168.38 24.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.766 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 20.2 mt-10 -146.4 135.02 22.17 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.986 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.5 m -150.09 161.12 4.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.687 -1.205 . . . . 0.0 112.103 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 t -147.55 -3.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 114.402 -1.272 . . . . 0.0 107.799 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -131.31 -152.13 0.49 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.024 -1.443 . . . . 0.0 109.188 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.733 HD22 ' HZ1' ' A' ' 43' ' ' LYS . 3.2 m-20 -90.94 121.0 32.4 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.544 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.487 ' H ' HG11 ' A' ' 42' ' ' VAL . . . -89.01 81.22 6.87 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.51 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -45.56 -69.48 0.13 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.594 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.67 -3.47 56.27 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.606 -0.837 . . . . 0.0 111.868 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.43 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 2.7 tp 60.74 -93.61 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.164 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.43 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -177.76 -174.61 44.25 Favored Glycine 0 N--CA 1.491 2.367 0 C-N-CA 118.915 -1.612 . . . . 0.0 110.628 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.603 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.9 Cg_endo -65.27 -29.81 54.73 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.18 1.92 . . . . 0.0 112.092 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.544 ' C ' ' H ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER -65.41 13.25 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.219 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.603 ' H ' ' C ' ' A' ' 74' ' ' PRO . 3.6 t-20 -60.25 -2.12 0.42 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.071 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.544 ' H ' ' C ' ' A' ' 75' ' ' LEU . 9.6 t-20 -77.35 -24.17 50.76 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.852 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.64 HD21 ' N ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -171.45 133.3 0.81 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.303 -179.99 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.64 ' N ' HD21 ' A' ' 78' ' ' ASN . 5.9 t -127.86 157.47 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.332 179.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.6 m -165.68 -61.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 117.915 -1.514 . . . . 0.0 114.136 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.528 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 11.7 m -93.92 148.24 22.34 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.027 -1.069 . . . . 0.0 112.88 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -148.57 158.64 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.858 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.739 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -139.29 120.18 14.42 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.519 -179.887 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.739 ' H ' HH12 ' A' ' 83' ' ' ARG . 3.1 t -119.4 133.79 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.706 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.512 ' CD1' HH21 ' A' ' 83' ' ' ARG . 3.2 mp -135.88 121.32 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.886 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.6 m -40.63 151.82 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.623 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -147.76 149.33 33.18 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.681 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -52.81 160.53 3.91 Favored 'Trans proline' 0 C--N 1.326 -0.643 0 C-N-CA 121.296 1.331 . . . . 0.0 111.672 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.0 137.81 21.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.701 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -146.11 131.67 9.3 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.657 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -59.84 -156.42 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.85 0 C-N-CA 121.245 1.297 . . . . 0.0 110.715 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.457 ' HE ' ' HB2' ' A' ' 107' ' ' ASP . 5.7 ptm180 -174.36 -157.96 0.08 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.044 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.499 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.5 168.06 20.74 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.854 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.45 ' HE ' ' CB ' ' A' ' 105' ' ' GLU . 38.5 ttt180 -129.13 128.6 43.79 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.954 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.404 ' CD2' HG11 ' A' ' 131' ' ' VAL . 71.8 m-85 -120.44 134.12 55.32 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.2 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.544 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 66.9 m-85 -89.43 175.21 7.4 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.969 -1.092 . . . . 0.0 111.237 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.72 -28.87 51.0 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 118.772 -1.171 . . . . 0.0 113.032 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -156.79 -178.82 7.64 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 117.363 -1.735 . . . . 0.0 113.585 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.613 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -62.61 108.1 1.08 Allowed 'General case' 0 C--O 1.202 -1.425 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.857 -179.83 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 1.321 ' NE2' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 121.97 41.33 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.434 0 O-C-N 125.081 1.488 . . . . 0.0 109.881 179.802 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 1.321 ' CD1' ' NE2' ' A' ' 100' ' ' GLN . 37.2 p90 30.32 34.51 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.878 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 100' ' ' GLN . 21.3 t70 -106.54 169.61 8.42 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.338 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 77.2 136.68 0.82 Allowed Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.203 -1.475 . . . . 0.0 109.727 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.47 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.7 OUTLIER -29.1 136.94 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.236 0.541 . . . . 0.0 112.097 -179.778 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 1.4 pm0 -93.31 164.28 13.28 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.619 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 107' ' ' ASP . 3.9 t -140.04 167.83 18.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.691 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.557 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 2.8 p30 -148.16 159.28 44.11 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.346 -1.342 . . . . 0.0 111.81 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.8 mt -141.49 149.55 54.66 Favored Pre-proline 0 N--CA 1.495 1.776 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -76.99 166.34 26.93 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 121.763 1.642 . . . . 0.0 111.422 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.33 140.8 78.83 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 121.7 1.6 . . . . 0.0 110.928 179.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 145.52 -164.08 28.12 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 118.927 -1.606 . . . . 0.0 111.36 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.586 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 33.4 tt0 -115.99 157.25 24.88 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.211 -0.494 . . . . 0.0 110.783 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.586 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 53.8 m-85 -146.08 153.85 41.18 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.9 p -98.71 -159.62 0.75 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.412 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.504 ' HB2' ' HG ' ' A' ' 168' ' ' SER . 0.1 OUTLIER -106.91 54.3 0.68 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.211 -179.925 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.55 -67.43 0.13 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.346 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 121' ' ' TYR . 4.8 pt-20 -67.33 -50.05 61.6 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.359 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.514 ' H ' ' CG ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -36.23 -57.41 0.72 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.859 179.784 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -53.15 -66.52 0.37 Allowed 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.171 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.457 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 14.8 mmm-85 -73.66 7.23 2.56 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.641 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.547 ' N ' ' O ' ' A' ' 117' ' ' GLU . 15.0 t80 -99.95 -17.65 17.46 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.203 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -163.62 -28.32 0.02 OUTLIER Glycine 0 N--CA 1.484 1.841 0 C-N-CA 117.771 -2.156 . . . . 0.0 112.107 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.409 ' CD1' ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -135.83 -101.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.362 -179.848 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.627 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 25.2 t70 -173.28 -163.97 0.21 Allowed 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.663 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.627 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 1.5 t30 -72.17 -22.36 61.31 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.125 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -170.21 89.95 0.17 Allowed 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.8 t -168.05 14.05 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.968 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 129' ' ' SER . 4.6 mt -68.98 -70.66 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.508 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 69.9 -135.01 0.06 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.819 -0.752 . . . . 0.0 112.338 179.881 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.64 ' HG ' ' H ' ' A' ' 100' ' ' GLN . 16.2 m -45.29 128.36 7.65 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.7 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.404 HG11 ' CD2' ' A' ' 95' ' ' PHE . 5.5 t -121.67 160.35 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.183 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.553 ' CB ' ' HZ1' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -154.91 89.55 3.12 Favored Pre-proline 0 C--N 1.29 -1.981 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.784 179.913 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.22 121.54 10.09 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.091 1.194 . . . . 0.0 110.608 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.499 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 29.0 tt0 -90.96 -8.67 48.6 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.183 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.8 -32.68 0.02 OUTLIER Glycine 0 N--CA 1.494 2.502 0 C-N-CA 118.026 -2.035 . . . . 0.0 112.476 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.28 156.93 28.0 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.904 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.98 145.36 42.6 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.007 -1.077 . . . . 0.0 109.214 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.4 t -112.42 148.61 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.021 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.429 HG13 ' CZ ' ' A' ' 141' ' ' PHE . 59.2 t -137.36 118.53 17.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.02 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.2 mp -98.94 142.42 30.46 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.883 -179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.473 ' CB ' ' HA ' ' A' ' 146' ' ' PHE . 63.9 m-85 -120.02 134.46 55.24 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.402 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -65.88 -68.53 0.36 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.08 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -78.34 169.3 18.48 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.392 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 146' ' ' PHE . 11.1 p-10 -64.34 -160.99 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.014 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.645 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 5.8 m120 42.66 21.03 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.938 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.645 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.4 OUTLIER 40.77 58.65 2.38 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.677 -179.91 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.6 t -148.09 149.32 31.83 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.335 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 108.43 -146.67 16.5 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -65.36 105.02 1.05 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.171 -1.011 . . . . 0.0 110.204 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.0 p -103.18 168.93 8.86 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.781 -0.767 . . . . 0.0 111.826 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 tt -139.37 81.14 21.09 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.139 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.24 108.37 0.58 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.961 1.774 . . . . 0.0 112.968 -179.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.7 87.25 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.294 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -58.33 -21.97 51.53 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.886 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 12.9 t -168.9 -141.59 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 117.979 -1.489 . . . . 0.0 112.895 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.8 OUTLIER -57.66 141.19 49.18 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.159 -179.811 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.533 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -162.24 61.12 1.17 Allowed Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.294 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.5 Cg_endo -65.31 19.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 122.222 1.948 . . . . 0.0 112.856 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.509 ' H ' ' C ' ' A' ' 157' ' ' ALA . 4.7 t -169.12 101.92 0.37 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.385 -1.326 . . . . 0.0 111.867 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.5 mt -128.03 -48.9 1.34 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.646 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 51.06 -135.43 31.12 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.316 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.09 126.9 29.19 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.66 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 10.8 mmt -153.43 -80.71 0.09 Allowed 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.354 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 165' ' ' ASN . 30.2 p-10 -92.11 20.15 6.18 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.168 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 164' ' ' ASN . 0.3 OUTLIER 77.71 -47.24 0.48 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.787 -179.922 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -175.07 137.81 0.42 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.141 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 m -82.39 114.96 21.19 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.446 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.504 ' HG ' ' HB2' ' A' ' 115' ' ' GLN . 36.1 t -86.86 -47.51 8.97 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.104 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.401 ' H ' ' HG ' ' A' ' 169' ' ' SER . 0.9 OUTLIER -134.19 165.96 23.89 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.152 179.982 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 38.1 pt -145.93 167.07 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 118.652 -1.219 . . . . 0.0 111.463 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -149.42 109.74 4.18 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.02 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mt -88.18 96.81 6.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.095 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 116.304 -1.808 . . . . 0.0 110.931 -179.973 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.6 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.4 mpp? . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.45 153.73 36.44 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.8 120.76 0.06 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.496 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.6 pt -67.72 146.73 12.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 118.723 -1.191 . . . . 0.0 110.263 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.9 m -123.96 117.57 25.09 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.186 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.492 ' O ' ' CB ' ' A' ' 16' ' ' GLN . 1.2 m -92.1 174.18 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.434 -0.906 . . . . 0.0 111.167 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 61.1 m-85 -135.98 146.67 47.48 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.231 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -75.02 -28.1 60.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.63 -0.828 . . . . 0.0 112.764 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.499 ' C ' ' OG ' ' A' ' 40' ' ' SER . 33.6 m120 -126.76 163.0 24.5 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.451 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.592 ' N ' ' OG ' ' A' ' 40' ' ' SER . 18.9 mm-40 -63.56 -163.57 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.928 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.662 ' C ' ' H ' ' A' ' 13' ' ' GLN . 8.7 m-20 40.5 39.59 0.75 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.852 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER 56.22 -5.86 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.327 179.991 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.662 ' H ' ' C ' ' A' ' 11' ' ' ASP . 21.9 mt-30 -73.84 174.33 8.63 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.296 -0.961 . . . . 0.0 110.745 179.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 86.21 129.87 2.54 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.339 -1.41 . . . . 0.0 111.027 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' N ' ' HD3' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -37.79 147.93 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.964 179.907 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.893 HE21 ' C ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -119.91 162.1 19.73 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.724 -0.79 . . . . 0.0 112.286 -179.868 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.07 139.35 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.882 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -94.41 134.47 36.89 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.421 -179.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.9 mt -129.86 126.47 22.53 Favored Pre-proline 0 N--CA 1.496 1.851 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.202 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.21 164.37 28.22 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 121.053 1.169 . . . . 0.0 111.157 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.24 -172.25 0.14 Allowed 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 121.648 1.565 . . . . 0.0 111.14 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.479 ' N ' ' HB ' ' A' ' 84' ' ' VAL . . . 103.65 -166.38 15.88 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.356 179.987 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.467 ' N ' HD21 ' A' ' 23' ' ' ASN . 0.4 OUTLIER -130.93 132.41 45.07 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.069 -179.978 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -148.12 -177.05 5.53 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.037 -179.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.577 ' CG2' ' CE2' ' A' ' 58' ' ' PHE . 20.3 p -141.26 -159.28 0.94 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.87 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -63.78 -24.23 67.68 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.061 -1.055 . . . . 0.0 110.361 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.03 -61.84 2.29 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.555 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -55.59 -44.14 76.66 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.543 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 23.1 mt -61.95 -32.84 73.31 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.789 -1.164 . . . . 0.0 109.633 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.8 -31.7 62.88 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 118.601 -1.24 . . . . 0.0 108.231 179.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.28 -37.28 69.06 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.38 179.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 mt -74.98 -77.07 0.13 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.471 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.09 -28.17 0.72 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.296 -1.43 . . . . 0.0 111.058 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.579 ' C ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -87.69 133.3 30.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.748 -179.988 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.567 ' C ' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 169.72 174.51 0.05 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.492 -179.905 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 1.5 t-20 70.91 -28.84 0.18 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.117 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.567 ' H ' ' C ' ' A' ' 35' ' ' GLU . 16.1 m120 -160.17 -108.61 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.767 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.63 ' OG1' ' N ' ' A' ' 39' ' ' ILE . 2.6 p 42.71 -134.98 0.4 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.572 179.943 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.63 ' N ' ' OG1' ' A' ' 38' ' ' THR . 1.9 mt 30.26 49.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.291 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.592 ' OG ' ' N ' ' A' ' 10' ' ' GLU . 44.1 t -61.11 -44.3 97.56 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.598 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.451 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -129.82 170.22 14.16 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.116 179.774 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.454 HG13 ' H ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -148.94 146.73 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 118.596 -1.242 . . . . 0.0 112.255 -179.838 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -136.67 102.59 4.96 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.897 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.4 t -120.98 106.16 39.37 Favored Pre-proline 0 N--CA 1.497 1.898 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.876 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -67.59 169.28 16.16 Favored 'Trans proline' 0 C--N 1.326 -0.633 0 C-N-CA 121.091 1.194 . . . . 0.0 110.458 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 48' ' ' VAL . 1.6 Cg_endo -61.03 -173.7 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.766 1.644 . . . . 0.0 110.683 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.25 -20.62 10.01 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 118.878 -1.629 . . . . 0.0 109.944 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.409 ' H ' ' C ' ' A' ' 46' ' ' PRO . 24.2 m -149.22 145.15 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.892 -179.963 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.4 tttt -120.97 152.46 38.51 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.604 179.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.92 147.81 30.12 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.896 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 84.9 mt -122.88 120.46 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.021 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.5 mt -89.07 154.46 20.17 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.752 -179.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -130.51 111.77 12.58 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.887 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.28 -79.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.032 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -59.16 139.06 57.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.089 -179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.99 170.65 0.17 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.917 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.24 33.16 86.49 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.425 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CE2' ' CG2' ' A' ' 25' ' ' THR . 19.4 m-85 53.74 65.11 1.61 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.931 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.65 -162.63 1.53 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.689 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 56.04 178.72 0.35 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.274 -1.441 . . . . 0.0 110.002 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -44.77 153.19 0.18 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.897 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -130.17 151.96 50.13 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.014 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.597 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 51.1 mt -123.65 173.16 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.876 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.597 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -150.09 130.3 13.64 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.03 179.988 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.3 m -148.36 156.59 8.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 118.806 -1.158 . . . . 0.0 112.565 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.507 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 3.8 t -140.49 -5.7 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.524 ' H ' ' HH ' ' A' ' 121' ' ' TYR . . . -128.7 -148.33 0.37 Allowed 'General case' 0 C--O 1.209 -1.07 0 CA-C-N 113.822 -1.536 . . . . 0.0 109.228 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.508 HD22 HG11 ' A' ' 106' ' ' VAL . 14.2 p-10 -99.57 120.44 39.66 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.038 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.454 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -90.84 96.44 10.64 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.218 179.865 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -56.01 -86.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.973 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 13.8 mm-40 -67.61 -11.46 58.18 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.915 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.487 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 4.0 tp 75.54 -84.57 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.724 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.12 -169.48 42.51 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.202 -1.475 . . . . 0.0 110.629 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.529 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.0 Cg_endo -66.02 -50.45 1.59 Allowed 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.208 1.938 . . . . 0.0 112.299 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.673 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 1.9 pt? -72.53 33.45 0.06 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.026 -1.069 . . . . 0.0 111.503 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 74' ' ' PRO . 1.8 t30 -76.63 -6.01 50.23 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.388 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.511 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 20.7 m120 -95.49 6.46 48.91 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.028 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -158.45 119.51 3.41 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.204 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 t -150.17 154.34 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 119.254 -0.979 . . . . 0.0 110.668 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.8 p -174.04 -41.92 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 118.981 -1.088 . . . . 0.0 111.549 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.3 t -99.0 141.49 31.69 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.556 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.4 mt -148.6 158.0 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.004 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.762 ' NH1' ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -135.61 135.15 40.01 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.3 -179.876 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.762 ' CA ' ' NH1' ' A' ' 83' ' ' ARG . 11.2 t -139.96 135.8 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.956 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.4 HG13 ' NH1' ' A' ' 83' ' ' ARG . 42.9 mt -140.08 129.48 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.665 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 53.1 m -43.1 151.94 0.13 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.487 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.1 t -151.44 150.22 26.26 Favored Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.647 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.55 166.24 6.6 Favored 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.166 1.244 . . . . 0.0 111.263 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.0 p -102.23 145.75 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.845 -179.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -130.53 150.63 76.85 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.458 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.34 -22.18 70.05 Favored 'Trans proline' 0 C--O 1.209 -0.928 0 C-N-CA 121.347 1.365 . . . . 0.0 111.302 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.669 HH11 ' CB ' ' A' ' 107' ' ' ASP . 31.4 ptt180 38.29 -158.77 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.995 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.478 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.46 176.66 9.01 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.848 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -150.29 121.65 7.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.912 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 18.2 m-85 -96.58 170.09 9.45 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.952 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.87 155.92 47.0 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.709 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -88.34 154.84 20.07 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.86 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt 60.08 158.59 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.438 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -90.44 69.82 6.93 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.03 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 1.434 ' NE2' ' CE1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -174.26 34.88 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.417 179.999 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 1.434 ' CE1' ' NE2' ' A' ' 100' ' ' GLN . 42.1 p90 39.82 27.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.188 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 100' ' ' GLN . 32.0 t70 -127.53 117.55 22.29 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.947 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 137.57 140.98 4.14 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.991 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.0 OUTLIER -32.73 124.44 0.35 Allowed 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.273 179.987 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -100.75 158.79 15.7 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.771 -179.875 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.591 ' CG1' ' N ' ' A' ' 107' ' ' ASP . 18.1 t -118.99 168.32 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.497 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.669 ' CB ' HH11 ' A' ' 92' ' ' ARG . 5.8 p-10 -145.24 143.68 30.38 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.13 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.2 mt -140.45 137.34 17.54 Favored Pre-proline 0 N--CA 1.499 1.994 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.944 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.419 ' CB ' ' HD2' ' A' ' 110' ' ' PRO . 2.4 Cg_endo -65.68 169.82 12.29 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 C-N-CA 121.522 1.481 . . . . 0.0 111.902 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 1.8 Cg_endo -61.12 142.8 98.05 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.106 1.871 . . . . 0.0 111.468 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.02 -146.6 16.88 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.013 -1.565 . . . . 0.0 111.163 179.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.649 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 64.6 mt-30 -137.95 156.36 47.94 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.649 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 10.0 m-85 -145.0 142.97 30.25 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.91 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.702 ' HG1' ' H ' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -94.24 174.03 7.35 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.378 -179.789 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -61.26 -24.05 66.11 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.941 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.702 ' H ' ' HG1' ' A' ' 114' ' ' THR . . . -90.3 -45.68 8.89 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.209 -0.996 . . . . 0.0 112.026 -179.852 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.463 ' O ' ' C ' ' A' ' 118' ' ' LEU . 8.6 tp10 -73.55 -65.21 0.85 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.707 -179.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.563 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -33.9 -68.62 0.11 Allowed 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.015 0.822 . . . . 0.0 110.547 179.961 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.507 ' N ' ' CD ' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -44.7 -68.37 0.2 Allowed 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.798 -179.95 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.425 ' HD3' ' H ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -75.07 20.89 0.13 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.159 -1.016 . . . . 0.0 113.249 -179.426 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.524 ' HH ' ' H ' ' A' ' 67' ' ' ALA . 15.8 t80 -114.01 -21.0 10.79 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.952 179.848 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.422 ' C ' ' CG1' ' A' ' 123' ' ' ILE . . . -166.46 -6.01 0.03 OUTLIER Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.318 -1.896 . . . . 0.0 110.764 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.475 ' C ' ' CG ' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -149.93 -134.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.605 -179.959 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.475 ' CG ' ' C ' ' A' ' 123' ' ' ILE . 0.7 OUTLIER -159.64 -173.36 4.09 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.615 179.909 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -58.49 109.51 0.8 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.442 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 128' ' ' ILE . 5.1 t-20 63.2 -125.64 0.58 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.905 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.0 t 39.78 24.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.868 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.69 ' C ' ' HG ' ' A' ' 129' ' ' SER . 3.5 mt -82.21 -71.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.611 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.69 ' HG ' ' C ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 69.91 -147.57 0.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.88 179.819 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 129' ' ' SER . 5.6 m -27.73 127.36 0.07 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.622 -179.862 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.3 t -121.87 136.89 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.843 179.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.28 86.69 29.88 Favored Pre-proline 0 C--N 1.302 -1.483 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.307 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.499 ' C ' ' H ' ' A' ' 135' ' ' GLY . 5.6 Cg_exo -59.0 101.49 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 121.105 1.204 . . . . 0.0 111.093 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.478 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 30.6 tp60 -56.63 -0.16 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.208 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . 172.3 -42.98 0.17 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 118.048 -2.025 . . . . 0.0 112.532 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.0 mt -92.2 -173.79 3.54 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.771 -1.171 . . . . 0.0 111.38 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.6 126.8 54.84 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 9.3 t -95.1 145.08 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.191 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.47 HG13 ' CZ ' ' A' ' 141' ' ' PHE . 96.2 t -129.77 110.29 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.13 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.9 mp -89.29 138.26 31.59 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.376 -0.93 . . . . 0.0 113.03 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.481 ' CE2' ' HB3' ' A' ' 146' ' ' PHE . 53.1 m-85 -120.8 136.23 54.95 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.7 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.453 ' HZ1' ' HB3' ' A' ' 164' ' ' ASN . 0.1 OUTLIER -65.42 -73.97 0.12 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.278 -179.906 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -64.42 -174.96 0.14 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.201 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 146' ' ' PHE . 2.0 m-20 -84.77 -168.28 2.14 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.769 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.677 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 44.1 m-80 35.9 31.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.021 179.882 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.677 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.0 OUTLIER 58.47 52.93 6.61 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.46 179.981 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 10.3 t -119.59 171.7 8.19 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.333 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.498 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 73.91 -165.63 54.77 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.214 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.411 ' C ' ' CG2' ' A' ' 150' ' ' THR . 1.0 OUTLIER -59.8 170.54 1.11 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.395 179.947 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.411 ' CG2' ' C ' ' A' ' 149' ' ' ASP . 2.2 p -150.19 158.08 43.78 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.593 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 tt -132.24 83.59 54.91 Favored Pre-proline 0 N--CA 1.483 1.214 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.346 179.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -63.18 104.42 0.41 Allowed 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 121.717 1.611 . . . . 0.0 112.761 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.33 78.77 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.986 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 154' ' ' ASN . 1.8 p-10 -83.64 27.98 0.59 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.394 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.427 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 19.0 t -170.28 -164.15 0.38 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.972 -1.091 . . . . 0.0 111.199 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.427 ' N ' ' OG ' ' A' ' 155' ' ' SER . 1.3 m-20 -79.94 154.89 27.99 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.15 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.584 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -165.1 69.98 1.37 Allowed Pre-proline 0 C--N 1.304 -1.391 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.904 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.8 Cg_endo -64.18 23.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.062 1.841 . . . . 0.0 112.579 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.584 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.3 OUTLIER -170.34 143.82 2.41 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.753 179.98 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.9 tp -163.92 -48.15 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.836 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 50.58 -163.59 0.88 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.541 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -58.9 105.19 0.29 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.678 -179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -97.63 -79.01 0.47 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.56 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.457 ' C ' HD21 ' A' ' 164' ' ' ASN . 0.5 OUTLIER -91.1 -68.53 0.79 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.829 -179.955 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.448 ' OD1' ' ND2' ' A' ' 166' ' ' ASN . 6.3 t-20 -154.06 -53.36 0.1 Allowed 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.637 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.448 ' ND2' ' OD1' ' A' ' 165' ' ' ASN . 0.8 OUTLIER 175.4 113.66 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.449 -0.901 . . . . 0.0 110.874 -179.973 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 168' ' ' SER . 1.2 m -61.63 155.01 23.49 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.583 ' OG ' ' N ' ' A' ' 169' ' ' SER . 24.8 p -136.38 -53.73 0.73 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.164 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.583 ' N ' ' OG ' ' A' ' 168' ' ' SER . 20.7 p -127.58 149.98 49.92 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.213 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.452 HG12 ' N ' ' A' ' 171' ' ' ARG . 0.2 OUTLIER -140.72 -172.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.658 179.95 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.452 ' N ' HG12 ' A' ' 170' ' ' ILE . 43.7 ttt85 -155.05 106.7 2.65 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.062 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -75.38 94.16 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.008 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.305 -1.345 0 CA-C-O 116.326 -1.797 . . . . 0.0 110.754 -179.974 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.811 0.338 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.39 165.2 1.56 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.791 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.478 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 4.8 p30 -177.99 130.82 0.14 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.493 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.6 pt -78.49 160.01 4.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.3 m -134.99 119.41 17.93 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.476 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -103.36 172.03 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.975 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -133.4 148.81 51.83 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.726 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -37.07 84.59 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.5 -0.88 . . . . 0.0 112.991 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.454 ' C ' ' OG ' ' A' ' 40' ' ' SER . 2.3 m-20 -121.48 173.73 7.21 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.979 -179.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.446 ' N ' ' OG ' ' A' ' 40' ' ' SER . 15.6 pt-20 -70.35 -173.87 0.76 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.742 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.557 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 4.8 t70 49.64 48.0 22.05 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.655 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.557 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 54.4 p90 40.65 20.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.424 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 11' ' ' ASP . 3.7 tt0 -97.76 166.14 11.62 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.582 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 92.54 141.56 10.53 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.363 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' GLY . 1.1 tptp -33.97 144.66 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.769 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.03 156.42 20.54 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.556 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.2 t -145.04 127.2 9.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.264 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -93.07 125.89 37.89 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.059 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.4 mt -119.21 125.09 27.8 Favored Pre-proline 0 N--CA 1.491 1.58 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.455 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.73 167.24 19.82 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 120.932 1.088 . . . . 0.0 111.098 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.8 170.4 10.14 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 121.636 1.558 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' H ' ' HB ' ' A' ' 84' ' ' VAL . . . 116.65 170.91 15.71 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 119.728 -1.225 . . . . 0.0 111.054 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.82 ' CB ' ' HE ' ' A' ' 83' ' ' ARG . 1.1 p30 -97.78 128.87 44.72 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.846 ' N ' HH21 ' A' ' 83' ' ' ARG . 27.6 p90 -153.04 178.98 9.11 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.096 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.441 ' HB ' ' H ' ' A' ' 26' ' ' ARG . 1.5 p -151.1 -159.37 1.02 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.101 -179.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.441 ' H ' ' HB ' ' A' ' 25' ' ' THR . 72.0 ttt180 -57.99 -21.73 46.08 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.675 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.19 -69.48 0.29 Allowed 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.828 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -56.83 -45.31 82.43 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.461 -1.296 . . . . 0.0 109.696 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.0 mt -55.92 -41.62 74.84 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.615 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.47 -31.68 56.24 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 118.128 -1.429 . . . . 0.0 108.49 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.27 -30.74 65.12 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.611 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 mt -79.54 -77.8 0.17 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.718 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.97 -28.21 0.08 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.127 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 mm -75.54 152.84 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 119.544 -0.863 . . . . 0.0 110.241 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 4.4 pt-20 -178.93 116.69 0.07 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 118.761 -1.175 . . . . 0.0 112.196 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.781 HD21 HD21 ' A' ' 37' ' ' ASN . 3.0 t30 68.2 -145.94 0.12 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.76 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.781 HD21 HD21 ' A' ' 36' ' ' ASN . 0.7 OUTLIER -49.22 95.55 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.394 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.584 ' O ' ' N ' ' A' ' 40' ' ' SER . 2.2 p -157.78 -61.55 0.09 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.653 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.5 mt -56.72 79.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.979 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 38' ' ' THR . 43.6 t -81.47 -52.62 7.06 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.661 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.61 168.56 9.9 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.58 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -151.33 159.86 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 118.305 -1.358 . . . . 0.0 112.919 -179.89 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.42 ' N ' HG12 ' A' ' 42' ' ' VAL . 43.2 tttm -150.46 113.16 4.74 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.387 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.1 t -134.03 111.88 12.2 Favored Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 119.525 -0.87 . . . . 0.0 112.619 -179.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -69.57 169.97 17.44 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 121.145 1.23 . . . . 0.0 110.696 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.96 -175.12 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 121.989 1.793 . . . . 0.0 111.464 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.86 -14.27 10.93 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.569 -1.301 . . . . 0.0 110.622 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.2 m -147.46 139.46 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.156 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.466 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -116.76 155.37 29.03 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.639 179.999 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.466 ' N ' ' HG2' ' A' ' 49' ' ' LYS . . . -144.88 154.8 43.01 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.652 -1.219 . . . . 0.0 112.413 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.1 mp -132.39 121.35 45.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.84 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 mp -93.95 154.72 17.53 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 118.936 -1.106 . . . . 0.0 112.536 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.417 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 54.0 m-85 -140.24 116.65 10.69 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -46.61 -88.87 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.904 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -59.59 144.0 48.83 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.178 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -54.21 175.64 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.631 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.435 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 63.96 32.62 84.78 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 119.22 -1.467 . . . . 0.0 109.959 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.672 ' H ' ' HG ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 48.64 35.95 6.96 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.678 -179.938 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.78 -163.29 0.97 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.423 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 56.06 -174.0 1.34 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.027 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 62' ' ' GLN . 18.1 t70 -54.47 174.42 0.06 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.697 -1.201 . . . . 0.0 109.949 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.436 ' N ' ' OD1' ' A' ' 61' ' ' ASP . 20.6 pt20 -147.96 161.86 40.49 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.052 -1.059 . . . . 0.0 111.282 -179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.443 HG21 ' H ' ' A' ' 64' ' ' GLU . 3.9 mt -137.05 160.87 36.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.905 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 64' ' ' GLU . 2.6 mp0 -135.53 127.55 29.68 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.281 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.9 m -144.83 162.94 13.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 118.737 -1.185 . . . . 0.0 112.787 -179.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -150.04 -7.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.011 -1.449 . . . . 0.0 107.642 179.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.42 ' HB2' ' H ' ' A' ' 68' ' ' ASN . . . -121.29 -146.35 0.37 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.944 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.42 ' H ' ' HB2' ' A' ' 67' ' ' ALA . 36.2 t-20 -101.03 134.55 43.86 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.109 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.407 ' H ' HG11 ' A' ' 42' ' ' VAL . . . -114.89 101.82 9.4 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.046 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -65.27 -77.68 0.06 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.792 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -74.56 -9.77 58.9 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.529 -179.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.3 tp 64.98 -79.8 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.065 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.0 -177.0 44.95 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.111 -1.519 . . . . 0.0 110.626 -179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.58 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.0 Cg_endo -64.08 -42.44 18.62 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.247 1.965 . . . . 0.0 111.884 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.689 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 2.0 pt? -70.99 21.51 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.181 -1.007 . . . . 0.0 111.113 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.588 HD21 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -75.79 5.02 6.86 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.652 179.953 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.588 ' N ' HD21 ' A' ' 76' ' ' ASN . 29.9 m-80 -88.85 -2.29 58.52 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.031 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.412 ' C ' ' ND2' ' A' ' 78' ' ' ASN . 0.5 OUTLIER -169.29 128.67 1.03 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.035 -179.998 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.2 t -149.17 143.24 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.35 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.0 m -155.78 -40.93 0.08 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.22 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.672 ' HG ' ' H ' ' A' ' 58' ' ' PHE . 3.4 m -96.16 136.31 36.8 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.132 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.494 ' O ' ' CZ ' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -150.73 134.1 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 118.79 -1.164 . . . . 0.0 112.185 -179.94 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.846 HH21 ' N ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -110.02 120.08 41.32 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.025 179.877 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.469 ' HB ' ' H ' ' A' ' 22' ' ' GLY . 6.7 t -122.17 130.65 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.514 179.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mm -141.01 130.22 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.665 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 p -48.65 142.1 6.44 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.084 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.47 142.43 42.77 Favored Pre-proline 0 N--CA 1.492 1.638 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.513 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -53.62 129.81 35.76 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.133 1.222 . . . . 0.0 110.977 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 p -53.21 134.03 15.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.98 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -140.76 148.45 52.8 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.207 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.92 -167.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.104 1.203 . . . . 0.0 110.876 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.49 ' N ' HD13 ' A' ' 136' ' ' LEU . 24.8 ptt180 -172.88 -155.45 0.08 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.754 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.485 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.15 161.19 38.88 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.232 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -136.2 115.67 12.76 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.149 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 20.0 m-85 -100.29 150.54 22.45 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.897 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.448 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 39.4 m-85 -105.18 170.62 7.77 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.654 -0.819 . . . . 0.0 111.064 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.3 -57.55 2.57 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.919 -1.113 . . . . 0.0 111.988 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -83.06 154.2 24.52 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.377 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.604 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 30.3 tt0 -68.55 104.58 1.98 Allowed 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.03 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.604 ' CB ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 119.18 68.55 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.441 0 O-C-N 125.323 1.64 . . . . 0.0 110.918 179.755 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.562 ' CE1' ' HG2' ' A' ' 100' ' ' GLN . 33.2 p90 29.63 55.61 0.14 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.318 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.523 ' CG ' ' N ' ' A' ' 103' ' ' GLY . 4.5 t70 -144.57 170.52 15.91 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.706 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.523 ' N ' ' CG ' ' A' ' 102' ' ' ASP . . . 78.93 145.15 2.94 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 118.886 -1.626 . . . . 0.0 109.881 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 103' ' ' GLY . 5.0 tmtt? -28.76 131.24 0.06 Allowed 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 121.195 0.522 . . . . 0.0 112.106 -179.816 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -95.7 157.34 15.94 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.311 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.7 t -142.65 150.68 18.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.533 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 22.3 p-10 -130.9 159.28 37.86 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.806 -179.873 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.445 HD21 ' CE2' ' A' ' 121' ' ' TYR . 86.2 mt -141.77 151.18 59.22 Favored Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.144 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -78.96 167.37 22.14 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.976 1.784 . . . . 0.0 111.05 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.18 142.97 69.44 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 C-N-CA 121.4 1.4 . . . . 0.0 110.757 179.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.39 -157.23 26.06 Favored Glycine 0 N--CA 1.504 3.202 0 C-N-CA 119.021 -1.561 . . . . 0.0 111.572 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.504 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 11.2 mt-30 -116.12 158.79 22.67 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.141 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.504 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 79.2 m-85 -145.82 143.23 29.52 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.629 179.839 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.1 p -95.91 164.71 12.61 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.807 -179.718 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -58.97 -8.07 1.28 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.719 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.94 -48.68 3.56 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.347 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 118' ' ' LEU . 4.5 tp10 -70.34 -50.27 40.8 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.834 -179.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.565 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -40.62 -72.83 0.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.368 -179.916 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -55.95 10.03 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.041 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.443 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.5 OUTLIER -73.81 15.11 0.31 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.54 -179.716 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.445 ' CE2' HD21 ' A' ' 108' ' ' LEU . 16.8 t80 -126.77 -10.36 6.11 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.355 179.822 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -140.78 -48.49 0.05 OUTLIER Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.208 -1.472 . . . . 0.0 110.218 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.597 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -144.58 -97.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.664 -179.937 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.597 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 3.0 t70 -171.78 175.72 3.86 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -66.28 134.88 53.56 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.31 -179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.656 HD21 ' H ' ' A' ' 166' ' ' ASN . 4.0 t-20 52.24 94.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.602 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.7 t -174.01 -12.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.457 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 mm -73.53 163.27 4.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.17 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.9 t -169.83 -48.24 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.45 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.421 ' CB ' ' H ' ' A' ' 101' ' ' PHE . 49.7 m -122.93 127.61 49.15 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.044 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.54 159.63 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.569 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.448 ' HZ3' ' HG3' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -149.58 79.31 8.05 Favored Pre-proline 0 C--N 1.296 -1.731 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.746 179.921 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -53.21 96.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.215 1.277 . . . . 0.0 110.703 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.485 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 58.2 tp60 -45.91 -23.74 0.32 Allowed 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.54 -1.209 . . . . 0.0 113.064 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.91 -31.88 0.02 OUTLIER Glycine 0 N--CA 1.494 2.515 0 C-N-CA 117.738 -2.172 . . . . 0.0 112.942 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.49 HD13 ' N ' ' A' ' 92' ' ' ARG . 1.0 OUTLIER -98.66 179.4 4.69 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.659 -1.216 . . . . 0.0 111.161 -179.895 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -94.93 144.26 25.82 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.042 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 153' ' ' VAL . 7.5 t -115.54 147.97 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.849 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.469 HG13 ' CE1' ' A' ' 141' ' ' PHE . 98.3 t -136.53 129.3 45.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.897 179.842 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.8 mp -105.64 138.7 41.4 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.369 -0.932 . . . . 0.0 113.174 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.469 ' CE1' HG13 ' A' ' 139' ' ' VAL . 18.0 m-85 -117.39 121.59 41.49 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.778 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -63.44 -68.29 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.165 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -73.2 165.55 24.84 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.376 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 146' ' ' PHE . 16.7 m-20 -64.37 -157.82 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.796 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.643 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 10.9 p-10 32.0 35.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.216 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.643 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 2.0 p90 41.04 61.61 1.69 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.787 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 35.9 t -143.59 -176.22 4.87 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.121 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.531 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 75.87 -163.43 53.4 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.064 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 149' ' ' ASP . 1.4 m-20 -60.08 144.88 48.52 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.314 179.878 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.4 p -141.29 175.42 9.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.159 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.8 tp -152.78 95.05 3.08 Favored Pre-proline 0 C--N 1.305 -1.364 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.044 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.87 107.48 1.11 Allowed 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 121.385 1.39 . . . . 0.0 112.075 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 138' ' ' VAL . 47.0 t -79.08 91.28 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.145 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -44.33 -49.2 9.6 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.565 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.5 m -160.15 -133.9 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 118.728 -1.189 . . . . 0.0 111.923 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -48.05 137.61 10.17 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.119 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.36 63.96 1.13 Allowed Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.238 179.814 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.9 Cg_endo -67.08 24.83 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.126 1.884 . . . . 0.0 111.837 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.549 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.6 t -175.1 132.82 0.31 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.785 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.6 tp -165.23 -59.23 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.34 -179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 163' ' ' MET . . . 45.11 -152.31 0.72 Allowed Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.164 -1.493 . . . . 0.0 110.317 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 51.29 -91.09 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.647 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.69 ' C ' ' H ' ' A' ' 165' ' ' ASN . 32.8 tpp -59.43 -35.25 73.65 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.15 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 164' ' ' ASN . 1.6 m120 -58.41 7.87 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.817 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.69 ' H ' ' C ' ' A' ' 163' ' ' MET . 2.0 t-20 -68.21 113.01 5.47 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.477 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.656 ' H ' HD21 ' A' ' 126' ' ' ASN . 31.5 t30 64.14 60.69 0.97 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.633 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -70.32 119.22 14.17 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.743 -1.183 . . . . 0.0 109.269 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 72.4 m -89.08 -80.02 0.31 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.96 -179.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.466 ' HG ' ' HA ' ' A' ' 146' ' ' PHE . 1.9 p -108.87 160.75 15.74 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.225 -179.803 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 27.8 pt -139.67 173.18 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.729 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -152.47 110.16 3.61 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.2 mt -87.47 93.29 4.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.236 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 69.4 m . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 116.363 -1.78 . . . . 0.0 110.963 -179.971 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 tpt . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.868 0.366 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.91 123.46 28.87 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.149 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -159.98 123.99 3.72 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.429 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.3 pt -76.72 149.24 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.594 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.4 m -136.98 118.28 14.6 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.733 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.6 m -109.63 160.59 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.672 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.407 ' CE2' ' CD2' ' A' ' 12' ' ' PHE . 56.0 m-85 -115.98 162.06 17.94 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.304 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -87.44 3.8 45.74 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.456 ' N ' ' HB3' ' A' ' 40' ' ' SER . 15.2 m120 -147.27 168.25 22.22 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.502 -1.279 . . . . 0.0 111.809 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.74 177.14 1.72 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.224 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.614 ' C ' ' H ' ' A' ' 13' ' ' GLN . 6.6 t70 56.2 39.56 30.25 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.893 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.574 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER 56.17 -3.43 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.137 179.957 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.614 ' H ' ' C ' ' A' ' 11' ' ' ASP . 7.4 tt0 -80.73 172.66 13.47 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.269 -0.973 . . . . 0.0 111.241 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.583 ' N ' ' CG ' ' A' ' 13' ' ' GLN . . . 100.55 141.93 12.51 Favored Glycine 0 N--CA 1.5 2.94 0 C-N-CA 119.877 -1.154 . . . . 0.0 110.548 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -33.41 140.56 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 120.191 -0.603 . . . . 0.0 111.432 179.96 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.5 157.9 15.93 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.392 -179.788 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.5 t -148.75 118.5 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.731 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -92.54 132.75 36.57 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.734 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -132.46 137.46 29.96 Favored Pre-proline 0 N--CA 1.49 1.56 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.909 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -72.1 166.27 30.15 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 120.843 1.029 . . . . 0.0 110.789 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.23 -163.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 121.628 1.552 . . . . 0.0 110.63 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.71 176.19 39.87 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.129 -1.51 . . . . 0.0 111.366 179.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.572 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.9 OUTLIER -107.75 132.66 53.13 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.496 -179.921 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -154.7 -177.96 6.86 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.502 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.533 ' OG1' ' N ' ' A' ' 26' ' ' ARG . 8.3 t -151.95 -161.23 1.27 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.337 -179.721 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.533 ' N ' ' OG1' ' A' ' 25' ' ' THR . 0.1 OUTLIER -54.96 -15.5 2.06 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.065 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.446 ' H ' HG22 ' A' ' 25' ' ' THR . . . -69.23 -64.59 0.84 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.563 179.849 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -57.83 -42.12 83.68 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 117.964 -1.495 . . . . 0.0 109.567 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.6 mt -63.68 -37.57 87.83 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.301 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.26 -27.29 54.68 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 118.112 -1.435 . . . . 0.0 107.785 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.84 -36.21 64.88 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.95 179.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.6 mt -75.97 -70.51 0.43 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.512 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.21 -24.9 0.6 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.055 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.6 tt -80.44 156.61 4.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.546 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -147.82 -179.62 7.03 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.068 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 5.1 p30 -47.95 169.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.795 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.669 ' H ' ' H ' ' A' ' 79' ' ' VAL . 8.8 t30 78.25 -23.85 0.23 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.939 179.867 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 36' ' ' ASN . 80.6 p -85.66 -139.66 0.08 Allowed 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.861 -1.135 . . . . 0.0 110.789 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.405 HD11 ' CG1' ' A' ' 79' ' ' VAL . 43.5 mt 41.81 62.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.93 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.456 ' HB3' ' N ' ' A' ' 9' ' ' ASN . 32.4 t -62.32 -44.43 96.52 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.868 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -129.09 176.95 7.49 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.11 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.41 HG11 ' H ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -144.29 146.74 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 119.025 -1.07 . . . . 0.0 112.197 -179.966 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -132.79 118.65 19.28 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.753 179.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.7 t -146.55 107.82 4.1 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.049 -1.06 . . . . 0.0 112.293 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.414 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 2.0 Cg_endo -66.79 170.89 11.84 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 121.245 1.296 . . . . 0.0 110.719 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 2.9 Cg_endo -59.54 -167.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.851 1.7 . . . . 0.0 110.922 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.93 -9.71 23.14 Favored Glycine 0 N--CA 1.48 1.609 0 C-N-CA 118.905 -1.617 . . . . 0.0 110.915 179.798 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.459 ' N ' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -155.72 151.87 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 118.279 -1.368 . . . . 0.0 112.407 179.972 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.424 ' N ' HG21 ' A' ' 48' ' ' VAL . 18.9 ttmt -117.92 125.28 50.17 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.883 179.794 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.53 158.26 17.72 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.807 -179.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 51.9 mt -145.43 123.25 4.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.482 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.723 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 2.4 mp -95.37 165.79 12.2 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.712 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -142.33 105.14 4.54 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.882 179.853 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -43.57 -84.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.775 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -58.9 133.57 56.15 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.502 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -54.47 171.82 0.11 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.423 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.25 29.93 71.83 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.205 -1.474 . . . . 0.0 110.06 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 53.66 63.22 2.28 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.031 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.13 -177.77 6.01 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.21 168.16 13.37 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.439 -1.363 . . . . 0.0 110.22 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -47.26 144.27 2.88 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.94 -1.104 . . . . 0.0 110.145 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -121.48 163.26 19.1 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.175 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.54 ' CG2' ' H ' ' A' ' 64' ' ' GLU . 9.6 mm -125.26 174.46 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.5 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.54 ' H ' ' CG2' ' A' ' 63' ' ' ILE . 20.1 mt-10 -146.44 130.6 17.43 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.751 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.4 m -149.18 163.24 4.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.816 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 t -146.76 -8.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.74 -147.2 0.39 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.103 179.768 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.421 HD22 HG11 ' A' ' 106' ' ' VAL . 4.4 p-10 -103.03 113.39 26.83 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.943 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.41 ' H ' HG11 ' A' ' 42' ' ' VAL . . . -89.52 94.68 9.96 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.125 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -54.29 -63.08 1.27 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.141 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 73' ' ' GLY . 6.5 tp10 -103.96 99.48 9.24 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.906 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 tp -52.34 -5.86 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.979 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 71' ' ' GLU . . . 78.34 -149.09 33.39 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 118.94 -1.6 . . . . 0.0 110.464 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 76' ' ' ASN . 3.4 Cg_exo -63.53 -151.68 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 121.505 1.47 . . . . 0.0 111.658 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 74' ' ' PRO . 0.9 OUTLIER 30.34 35.04 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 123.964 0.79 . . . . 0.0 112.06 -179.942 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 74' ' ' PRO . 13.5 t-20 -89.31 -3.93 58.31 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.286 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -93.03 3.92 54.9 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.964 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -162.53 109.67 1.28 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.743 -1.183 . . . . 0.0 111.444 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.669 ' H ' ' H ' ' A' ' 37' ' ' ASN . 7.1 t -147.96 92.82 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.149 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.8 t -121.07 -33.24 3.76 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.547 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.446 ' HG ' ' HG1' ' A' ' 25' ' ' THR . 10.0 m -92.31 136.29 33.32 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.739 -1.185 . . . . 0.0 110.9 -179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -150.98 158.8 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 118.262 -1.375 . . . . 0.0 111.656 -179.857 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.776 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.45 140.11 23.65 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.637 -179.922 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.776 ' CA ' HH12 ' A' ' 83' ' ' ARG . 16.1 t -144.99 146.38 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.684 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.552 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 1.5 mt -144.58 135.47 20.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.492 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.4 m -44.74 161.5 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.899 -0.721 . . . . 0.0 111.544 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.459 HG11 ' N ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -162.01 140.58 7.03 Favored Pre-proline 0 N--CA 1.483 1.18 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.209 -179.986 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -47.38 139.53 16.71 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.116 1.211 . . . . 0.0 110.775 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.515 ' CG2' ' N ' ' A' ' 90' ' ' GLN . 3.8 p -74.99 160.79 5.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.661 -0.816 . . . . 0.0 112.353 -179.839 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.515 ' N ' ' CG2' ' A' ' 89' ' ' VAL . 23.1 mp0 -141.06 154.87 68.6 Favored Pre-proline 0 N--CA 1.49 1.534 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.405 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.3 -45.37 9.75 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 121.47 1.447 . . . . 0.0 111.739 179.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.491 ' H ' HD13 ' A' ' 136' ' ' LEU . 9.9 mtm180 64.7 -160.73 0.29 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.265 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.495 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.96 172.77 12.25 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.65 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -142.49 121.38 12.77 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.544 -1.262 . . . . 0.0 112.547 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -103.57 162.77 12.77 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -124.59 163.73 21.32 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.528 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.57 -77.41 0.22 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.149 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.483 ' C ' ' OG ' ' A' ' 129' ' ' SER . 34.3 mmtt -66.09 154.41 39.67 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.737 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.604 ' C ' ' HG2' ' A' ' 100' ' ' GLN . 29.0 tt0 -81.71 86.69 6.38 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.118 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.604 ' HG2' ' C ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 163.56 35.68 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.297 -179.946 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.7 t80 56.13 42.38 28.33 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 119.634 -0.827 . . . . 0.0 110.488 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.451 ' CG ' ' H ' ' A' ' 103' ' ' GLY . 25.1 t0 -143.14 178.36 7.76 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.565 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 81.58 139.24 2.73 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.157 -1.496 . . . . 0.0 109.724 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 103' ' ' GLY . 1.1 mppt? -28.63 132.91 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.729 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -97.8 159.33 14.99 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.106 -179.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.421 HG11 HD22 ' A' ' 68' ' ' ASN . 53.4 t -144.3 116.05 2.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.115 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -104.72 154.73 19.62 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.413 -179.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.9 mt -139.64 138.13 19.67 Favored Pre-proline 0 N--CA 1.492 1.675 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.436 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.72 168.77 12.66 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 121.237 1.291 . . . . 0.0 110.998 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.08 150.31 87.04 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.655 1.57 . . . . 0.0 111.06 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.04 -155.04 24.24 Favored Glycine 0 N--CA 1.498 2.817 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.969 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.601 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 35.7 tt0 -133.48 158.35 43.31 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.699 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.601 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 30.2 m-85 -142.51 155.1 45.0 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.185 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.2 p -102.91 -175.38 2.79 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.017 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.446 ' N ' ' OE1' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -88.1 53.89 2.9 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.686 179.977 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -152.12 -65.88 0.17 Allowed 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.593 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -72.61 -50.18 27.08 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.343 -0.943 . . . . 0.0 109.467 179.963 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.564 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -33.81 -71.73 0.06 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.897 179.962 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.535 ' OE2' ' CZ ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -52.27 -57.63 9.14 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.103 179.923 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' CZ ' ' OE2' ' A' ' 119' ' ' GLU . 3.3 mpt_? -76.36 23.07 0.15 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.92 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.564 ' N ' ' O ' ' A' ' 117' ' ' GLU . 24.7 t80 -127.11 -17.06 4.9 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.659 179.993 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.403 ' CA ' HG12 ' A' ' 106' ' ' VAL . . . -148.06 -42.6 0.03 OUTLIER Glycine 0 N--CA 1.482 1.705 0 C-N-CA 118.74 -1.695 . . . . 0.0 111.118 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.42 HD11 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -135.8 -105.7 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.225 -179.93 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.532 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 18.6 t70 -171.72 -168.45 0.59 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.77 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.532 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -86.03 35.14 0.63 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.45 -179.9 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -166.48 -155.0 0.19 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.532 -1.267 . . . . 0.0 112.133 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.571 ' OG1' ' N ' ' A' ' 128' ' ' ILE . 2.6 t 40.31 -125.96 0.44 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.267 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.571 ' N ' ' OG1' ' A' ' 127' ' ' THR . 98.2 mt 60.67 118.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 CA-C-O 121.041 0.448 . . . . 0.0 111.209 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.483 ' OG ' ' C ' ' A' ' 98' ' ' LYS . 59.2 p -160.99 140.85 10.84 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.419 -0.913 . . . . 0.0 111.124 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.41 ' HA ' ' H ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER 67.92 113.16 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.965 -179.884 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.0 t -120.27 149.85 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.732 -179.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.547 ' NZ ' ' OD2' ' A' ' 156' ' ' ASP . 13.1 tptp -142.4 93.66 7.03 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.793 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 135' ' ' GLY . 4.1 Cg_exo -59.37 99.75 0.12 Allowed 'Trans proline' 0 C--N 1.32 -0.942 0 C-N-CA 120.959 1.106 . . . . 0.0 111.474 -179.799 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.495 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 5.6 tt0 -47.43 -14.23 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.074 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 133' ' ' PRO . . . 175.56 -34.02 0.09 OUTLIER Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.467 -1.825 . . . . 0.0 111.936 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.491 HD13 ' H ' ' A' ' 92' ' ' ARG . 2.2 mt -93.13 -173.82 3.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.664 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.22 144.15 36.06 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.746 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.5 t -112.8 143.56 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.962 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.48 HG13 ' CE1' ' A' ' 141' ' ' PHE . 91.3 t -135.39 122.3 34.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.91 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.408 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 10.1 mp -99.75 144.79 28.41 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.761 -179.802 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.492 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 21.9 m-85 -120.47 129.47 53.87 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.101 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -73.72 -63.15 1.27 Allowed 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.144 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -71.32 170.95 12.05 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.608 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 146' ' ' PHE . 47.7 m-20 -67.73 -161.41 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.254 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.641 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 7.6 p-10 28.96 38.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.371 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.641 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 41.69 61.51 1.85 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.982 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.501 ' CB ' HD22 ' A' ' 145' ' ' ASN . 0.5 OUTLIER -139.52 -167.7 2.32 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.353 -179.865 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 65.02 -160.4 42.44 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.706 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.404 ' OD2' ' ND2' ' A' ' 164' ' ' ASN . 21.5 t70 -59.55 158.72 9.37 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.301 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.4 p -148.55 170.69 17.51 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.979 -1.088 . . . . 0.0 111.818 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 23.4 tp -138.9 85.0 16.79 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.315 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -61.74 105.77 0.39 Allowed 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.922 1.748 . . . . 0.0 113.049 -179.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.501 ' C ' ' H ' ' A' ' 155' ' ' SER . 2.0 t -95.09 57.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.758 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -70.54 32.85 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.819 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 153' ' ' VAL . 21.0 p -170.65 -169.06 0.75 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.705 -1.198 . . . . 0.0 111.605 180.0 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.547 ' OD2' ' NZ ' ' A' ' 132' ' ' LYS . 1.3 m-20 -75.86 153.23 36.93 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.556 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.58 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -168.65 72.17 0.79 Allowed Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.935 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.93 24.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.057 1.838 . . . . 0.0 112.385 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.58 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.9 OUTLIER -170.61 68.23 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.633 179.925 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.41 ' H ' ' HA ' ' A' ' 130' ' ' SER . 5.8 tp -80.76 -64.19 1.24 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.876 -179.95 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 77.59 -176.75 53.45 Favored Glycine 0 N--CA 1.485 1.905 0 C-N-CA 119.136 -1.507 . . . . 0.0 109.863 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -83.1 120.67 26.06 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.791 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.466 ' HG2' ' H ' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -89.03 -76.68 0.4 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.371 -0.932 . . . . 0.0 109.858 -179.98 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.466 ' H ' ' HG2' ' A' ' 163' ' ' MET . 74.9 m-20 -91.48 -64.12 1.16 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.318 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -172.17 96.99 0.16 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.545 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.1 m120 52.14 -165.06 0.06 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.731 -0.787 . . . . 0.0 111.274 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.7 124.31 20.96 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.949 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.423 ' OG ' ' N ' ' A' ' 169' ' ' SER . 57.3 p -86.18 -68.58 0.73 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.697 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.423 ' N ' ' OG ' ' A' ' 168' ' ' SER . 2.0 p -119.44 161.93 19.7 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.416 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 29.0 pt -141.01 171.59 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.199 -1.001 . . . . 0.0 111.649 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -153.21 110.92 3.56 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.76 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -89.17 92.92 4.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.107 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 116.313 -1.803 . . . . 0.0 111.088 -179.904 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.56 178.63 3.1 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.792 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.629 ' N ' ' ND2' ' A' ' 3' ' ' ASN . 0.1 OUTLIER 179.77 130.8 0.09 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.489 -179.906 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 pt -82.53 128.75 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.585 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.7 m -100.22 113.32 25.91 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.561 -0.856 . . . . 0.0 108.74 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.83 160.06 2.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.196 -1.002 . . . . 0.0 113.436 -179.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' A' ' 12' ' ' PHE . 87.9 m-85 -118.46 144.86 45.69 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.754 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -58.05 3.59 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.578 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 87.8 m-20 -85.52 -176.41 6.07 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.614 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -75.99 176.73 7.64 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.343 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.582 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 1.5 m-20 48.68 56.61 7.37 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.695 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 55.8 p90 40.19 20.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.23 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 11' ' ' ASP . 2.5 tp-100 -98.31 164.37 12.33 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.874 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.578 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 94.18 148.27 23.61 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.802 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.49 ' HE3' ' H ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -29.09 137.74 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.882 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.63 152.26 22.67 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.424 -179.889 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.1 t -149.42 138.79 15.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.884 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 1.1 m-20 -99.78 134.86 42.07 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.245 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 mt -123.89 122.57 26.3 Favored Pre-proline 0 N--CA 1.496 1.851 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.263 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.33 161.76 39.24 Favored 'Trans proline' 0 C--O 1.217 -0.533 0 C-N-CA 121.022 1.148 . . . . 0.0 111.247 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.54 -166.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.889 0 C-N-CA 121.602 1.534 . . . . 0.0 110.738 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.465 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 92.77 -163.59 27.18 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.989 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.733 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -117.96 133.22 56.13 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.432 -179.947 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.448 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 6.1 p90 -154.78 177.65 11.02 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.404 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.3 p -149.51 -150.12 0.33 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.415 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.442 ' HG3' ' HG ' ' A' ' 80' ' ' SER . 17.5 mtm-85 -62.82 -36.66 83.91 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.301 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.79 -61.51 2.38 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.44 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -56.02 -47.67 77.37 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.325 -1.35 . . . . 0.0 109.367 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.1 mt -57.87 -33.49 68.74 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.39 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.0 -33.02 55.99 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.4 -36.09 73.85 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.18 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.9 mt -78.48 -75.26 0.23 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.727 179.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 163.7 -29.47 0.24 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 118.898 -1.62 . . . . 0.0 111.244 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.484 HG13 ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -73.99 166.12 2.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.761 179.971 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.553 ' H ' ' CG2' ' A' ' 38' ' ' THR . 0.2 OUTLIER 174.66 103.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.403 179.946 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.548 ' ND2' ' ND2' ' A' ' 78' ' ' ASN . 2.1 t-20 69.23 140.61 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.7 p30 37.39 21.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.39 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.553 ' CG2' ' H ' ' A' ' 35' ' ' GLU . 40.9 p -93.95 -48.06 6.43 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.542 -1.263 . . . . 0.0 110.963 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 mt -62.6 74.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.148 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' THR . 26.8 t -72.06 -49.82 33.44 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.122 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.34 163.98 28.79 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.246 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.493 HG21 ' H ' ' A' ' 69' ' ' ALA . 25.1 m -148.94 167.82 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 C-N-CA 118.194 -1.402 . . . . 0.0 113.295 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -139.76 97.96 3.37 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 113.671 -1.604 . . . . 0.0 107.981 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 44.5 t -116.46 109.54 43.83 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.797 -179.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.83 169.11 16.9 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 121.227 1.284 . . . . 0.0 110.507 179.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.02 -172.44 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.708 1.605 . . . . 0.0 110.368 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.36 -15.37 35.02 Favored Glycine 0 C--N 1.3 -1.428 0 C-N-CA 118.654 -1.736 . . . . 0.0 110.486 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.449 HG21 ' N ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -148.53 151.76 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.951 179.938 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.449 ' N ' HG21 ' A' ' 48' ' ' VAL . 17.7 ttpp -127.17 126.23 42.5 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.869 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.16 160.34 17.02 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.873 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 62.4 mt -139.92 121.48 15.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.726 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.733 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 1.8 mp -90.17 159.8 16.57 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.927 -1.109 . . . . 0.0 112.584 -179.697 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -144.73 106.33 4.26 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.863 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -44.47 -81.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.298 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -58.87 138.2 57.43 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.544 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -54.92 173.39 0.09 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.439 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.31 27.69 72.72 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.184 -1.484 . . . . 0.0 110.156 -179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 55.13 67.91 0.94 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.8 -165.52 2.28 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.235 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.72 -170.01 14.35 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.021 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -51.34 167.89 0.08 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.818 -1.153 . . . . 0.0 109.805 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -147.03 162.71 38.24 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.477 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.485 ' CG2' ' H ' ' A' ' 64' ' ' GLU . 32.1 mt -142.23 173.61 7.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.944 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.536 ' OE2' ' N ' ' A' ' 65' ' ' VAL . 2.0 tm-20 -146.44 129.71 16.66 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.778 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.536 ' N ' ' OE2' ' A' ' 64' ' ' GLU . 32.2 m -145.64 158.02 12.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 118.629 -1.229 . . . . 0.0 112.465 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.572 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 3.8 t -146.61 -7.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-N 114.312 -1.313 . . . . 0.0 107.783 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.486 ' H ' ' HH ' ' A' ' 121' ' ' TYR . . . -117.13 -151.15 0.47 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.557 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -97.09 122.81 40.51 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.455 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.493 ' H ' HG21 ' A' ' 42' ' ' VAL . . . -89.81 113.46 25.03 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.1 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.465 ' C ' ' CD ' ' A' ' 70' ' ' GLU . 4.1 tp10 -72.33 -70.84 0.32 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.582 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.452 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 12.1 tt0 -96.69 -0.2 48.72 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.223 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.435 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 2.5 tp 69.74 -88.26 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.042 -0.663 . . . . 0.0 112.17 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.435 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 179.33 -162.08 28.61 Favored Glycine 0 N--CA 1.499 2.885 0 C-N-CA 118.99 -1.576 . . . . 0.0 111.086 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.2 Cg_endo -66.88 -49.84 1.34 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.168 1.912 . . . . 0.0 112.159 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.648 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 1.7 pt? -74.65 33.52 0.09 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.419 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 74' ' ' PRO . 21.8 p30 -70.28 -23.89 62.95 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.276 -0.97 . . . . 0.0 110.548 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.492 ' C ' HD21 ' A' ' 77' ' ' ASN . 0.1 OUTLIER -80.84 14.43 2.19 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.902 -179.99 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.548 ' ND2' ' ND2' ' A' ' 36' ' ' ASN . 0.5 OUTLIER -168.51 108.48 0.51 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.364 -179.975 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.528 ' N ' HD21 ' A' ' 78' ' ' ASN . 16.5 t -146.44 106.07 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.132 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.442 ' HG ' ' HG3' ' A' ' 26' ' ' ARG . 2.7 t -124.73 -44.66 1.94 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.679 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.4 m -94.5 138.86 31.9 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.597 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -146.94 152.03 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 119.069 -1.053 . . . . 0.0 111.873 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.799 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -130.09 123.24 29.97 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.272 -179.908 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.799 ' H ' HH12 ' A' ' 83' ' ' ARG . 13.3 t -136.01 137.75 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.59 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.54 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 1.4 mt -145.52 142.96 22.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.784 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.4 p -43.99 160.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.809 -0.756 . . . . 0.0 111.746 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -159.09 148.74 14.89 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.128 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -57.64 157.71 22.35 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.045 1.163 . . . . 0.0 110.067 179.735 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 90' ' ' GLN . 86.8 t -78.85 159.73 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.722 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.457 ' N ' ' CG1' ' A' ' 89' ' ' VAL . 30.0 mt-30 -143.41 145.63 32.71 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.607 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -65.3 -48.94 2.92 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 121.377 1.385 . . . . 0.0 111.854 179.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.501 ' H ' HD13 ' A' ' 136' ' ' LEU . 0.0 OUTLIER 64.81 -156.02 0.29 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.939 179.984 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.496 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -141.73 178.13 7.69 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.717 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -142.08 113.31 7.6 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.931 -1.107 . . . . 0.0 111.412 -179.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' CD2' HG11 ' A' ' 131' ' ' VAL . 96.8 m-85 -106.53 146.63 30.38 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.471 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -95.69 171.87 8.4 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.386 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.48 -66.86 0.87 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.889 -179.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -86.47 147.28 26.05 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.488 -0.885 . . . . 0.0 112.442 -179.778 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.585 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 5.8 tm-20 -71.51 101.43 2.45 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.262 -179.907 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.963 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 135.7 53.09 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.059 0 O-C-N 125.099 1.499 . . . . 0.0 109.94 179.891 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.504 ' O ' ' CG ' ' A' ' 101' ' ' PHE . 58.8 t80 43.12 52.54 5.43 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.689 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 103' ' ' GLY . 3.2 t70 -145.38 158.35 43.85 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.062 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.524 ' N ' ' OD1' ' A' ' 102' ' ' ASP . . . 85.16 133.29 2.85 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.87 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 103' ' ' GLY . 8.6 mtpm? -35.17 146.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.178 0.513 . . . . 0.0 111.813 -179.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -90.96 164.28 14.05 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.215 -179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.0 t -145.79 112.49 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.941 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -89.99 159.64 16.78 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.264 -0.975 . . . . 0.0 112.576 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.9 mt -143.93 131.39 10.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.986 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -66.82 168.66 16.38 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 121.36 1.374 . . . . 0.0 111.441 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.2 145.19 88.58 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 121.557 1.505 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.4 -171.87 24.1 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.137 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.596 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 16.7 tm0? -109.18 159.89 16.55 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.596 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 52.9 m-85 -146.18 148.66 32.77 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.441 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.6 p -102.25 170.99 7.74 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.423 -179.849 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -60.29 -8.92 2.88 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.604 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.38 -52.17 3.07 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 119.314 -0.954 . . . . 0.0 113.437 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 121' ' ' TYR . 23.9 mt-10 -72.79 -53.07 12.53 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.3 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.569 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -36.61 -67.48 0.17 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.807 0.813 . . . . 0.0 110.593 179.906 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -52.35 -60.86 2.72 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.13 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.417 ' HD3' ' N ' ' A' ' 120' ' ' ARG . 4.9 mpt_? -72.13 4.89 3.13 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.792 -179.634 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.572 ' HH ' ' H ' ' A' ' 66' ' ' VAL . 14.3 t80 -105.34 -16.28 14.8 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.973 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -151.36 -36.36 0.03 OUTLIER Glycine 0 N--CA 1.487 2.063 0 C-N-CA 117.684 -2.198 . . . . 0.0 112.141 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.99 -102.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.979 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 176.42 -173.91 0.1 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.975 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.505 ' C ' ' CG ' ' A' ' 126' ' ' ASN . 59.1 t30 -58.55 125.87 25.22 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.594 -1.243 . . . . 0.0 110.281 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.505 ' CG ' ' C ' ' A' ' 125' ' ' ASN . 0.4 OUTLIER 74.34 -139.02 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.967 -179.893 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.721 ' HG1' ' N ' ' A' ' 128' ' ' ILE . 1.4 p 59.28 -137.95 0.76 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.586 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.721 ' N ' ' HG1' ' A' ' 127' ' ' THR . 39.4 mt 59.37 -74.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.763 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 130' ' ' SER . 60.3 p 47.71 -123.41 1.55 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.239 -0.585 . . . . 0.0 112.335 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.552 ' N ' ' OG ' ' A' ' 129' ' ' SER . 0.8 OUTLIER -41.88 126.68 3.19 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.004 -179.847 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.449 HG11 ' CD2' ' A' ' 95' ' ' PHE . 6.8 t -122.42 156.71 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.262 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -150.39 84.46 5.65 Favored Pre-proline 0 C--N 1.296 -1.749 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.998 179.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.47 103.8 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.985 1.79 . . . . 0.0 111.706 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.496 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 52.1 tp60 -49.25 -30.6 7.41 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.215 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -169.91 -26.31 0.02 OUTLIER Glycine 0 N--CA 1.494 2.503 0 C-N-CA 118.407 -1.854 . . . . 0.0 112.322 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.501 HD13 ' H ' ' A' ' 92' ' ' ARG . 1.4 mt -96.57 165.02 12.36 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.492 -1.283 . . . . 0.0 110.425 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.86 143.72 26.44 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.464 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.3 t -110.05 148.49 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.654 -0.819 . . . . 0.0 112.616 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 46.8 t -137.37 125.54 32.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.926 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.465 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 8.8 mp -102.32 144.84 30.31 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.707 -179.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -117.75 131.38 56.61 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.544 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.72 ' HZ3' ' ND2' ' A' ' 143' ' ' ASN . 26.3 ttpp -67.85 -79.24 0.05 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.554 -179.739 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.72 ' ND2' ' HZ3' ' A' ' 142' ' ' LYS . 0.8 OUTLIER -51.92 166.03 0.17 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.19 -179.884 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -46.82 -100.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.893 -1.048 . . . . 0.0 113.264 -179.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.606 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 5.8 m120 -73.18 75.65 1.28 Allowed 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.578 -179.854 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.606 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.2 p90 34.22 72.47 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.358 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.0 m -141.5 64.67 1.4 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.719 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 171.77 -148.59 11.06 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.294 -1.432 . . . . 0.0 110.35 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -75.53 168.49 19.91 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.293 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.3 p -146.98 155.39 42.22 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.616 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 35.4 tp -123.79 90.93 50.21 Favored Pre-proline 0 N--CA 1.488 1.468 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.59 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.11 108.02 0.89 Allowed 'Trans proline' 0 C--N 1.321 -0.875 0 C-N-CA 121.738 1.625 . . . . 0.0 112.855 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 45.5 t -84.88 88.16 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.452 179.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.494 ' C ' ' OG ' ' A' ' 155' ' ' SER . 18.8 p-10 -52.28 -33.82 43.77 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.792 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.494 ' OG ' ' C ' ' A' ' 154' ' ' ASN . 0.8 OUTLIER -163.82 -130.93 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 117.867 -1.533 . . . . 0.0 113.232 -179.699 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -59.73 153.4 20.45 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.299 -179.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.607 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -176.06 69.91 0.25 Allowed Pre-proline 0 N--CA 1.48 1.061 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.657 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.76 20.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.039 1.826 . . . . 0.0 112.184 -179.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.607 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -176.38 117.42 0.13 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.285 179.935 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.1 tp -148.96 -63.97 0.23 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.214 -179.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 74.41 -173.81 50.89 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.2 -1.476 . . . . 0.0 109.606 -179.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.28 108.08 10.15 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.094 -1.042 . . . . 0.0 110.718 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 28.5 mmm -77.8 -56.18 4.71 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.788 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -81.72 -63.24 1.43 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.456 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -157.76 -59.57 0.08 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.685 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -161.93 127.83 3.61 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.412 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 m -68.48 105.93 2.37 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.754 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 28.6 m -87.74 -64.26 1.18 Allowed 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.218 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.543 ' HG ' ' H ' ' A' ' 146' ' ' PHE . 1.9 p -115.63 163.62 15.53 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.011 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.417 HG12 ' CD1' ' A' ' 118' ' ' LEU . 30.1 pt -142.74 177.19 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.934 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -156.56 111.08 2.78 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.325 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.3 mt -90.19 98.03 7.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.314 -0.955 . . . . 0.0 110.385 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 C--N 1.306 -1.31 0 CA-C-O 116.393 -1.765 . . . . 0.0 110.957 -179.99 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 mmm . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.497 ' O ' ' ND2' ' A' ' 3' ' ' ASN . . . -75.06 146.13 41.77 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.369 -0.933 . . . . 0.0 111.171 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 2' ' ' ALA . 45.6 m-80 -163.34 117.69 1.63 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.348 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.8 pt -70.31 149.79 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.532 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.2 m -128.86 116.04 18.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.581 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 m -93.6 171.04 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 C-N-CA 119.526 -0.869 . . . . 0.0 110.78 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.788 ' CE2' ' NE2' ' A' ' 16' ' ' GLN . 31.5 m-85 -133.83 154.21 51.18 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.73 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -83.77 -45.08 13.73 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.278 -0.969 . . . . 0.0 113.152 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.492 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 7.5 m120 -97.66 -175.69 3.26 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.54 -179.864 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.86 -178.14 7.0 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.54 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.614 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 0.9 OUTLIER 47.43 57.29 5.99 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.623 -179.946 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.614 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 48.3 p90 39.14 25.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.66 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 11' ' ' ASP . 7.6 tt0 -104.18 170.01 8.16 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.247 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.492 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 88.36 136.21 5.36 Favored Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.633 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 14' ' ' GLY . 25.8 mmtm -32.01 139.5 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.439 180.0 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.788 ' NE2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -115.27 170.07 8.66 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.805 -179.883 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 76.7 t -141.63 133.93 28.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.334 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -93.91 119.26 32.59 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.192 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.9 mt -116.6 138.25 24.34 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.376 179.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -72.11 164.94 34.11 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 120.973 1.116 . . . . 0.0 111.027 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.19 -162.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 121.691 1.594 . . . . 0.0 110.761 179.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.525 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 88.54 -178.95 46.02 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.098 -1.525 . . . . 0.0 111.164 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.598 ' N ' HH21 ' A' ' 83' ' ' ARG . 0.7 OUTLIER -109.99 137.47 47.71 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.818 -179.995 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 4.8 p90 -156.12 178.05 10.73 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.36 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.457 HG21 ' HG ' ' A' ' 81' ' ' SER . 1.3 p -151.25 -153.09 0.47 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.801 -179.801 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.424 ' H ' ' HB ' ' A' ' 25' ' ' THR . 35.0 ptt85 -58.61 -20.86 51.03 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.931 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.67 -64.11 0.92 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.244 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -58.38 -45.36 88.44 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.244 -1.383 . . . . 0.0 109.695 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.8 mt -61.93 -35.25 77.84 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.576 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.5 -25.41 64.43 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 118.098 -1.441 . . . . 0.0 107.879 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.85 -36.35 56.87 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.69 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.5 mt -76.23 -76.72 0.15 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.741 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.42 -26.94 0.87 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.684 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.598 ' C ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -88.14 139.01 18.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.842 180.0 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 2.9 pt-20 174.02 168.73 0.21 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.515 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.601 ' C ' ' H ' ' A' ' 38' ' ' THR . 1.7 t-20 80.91 -145.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 120.147 -0.621 . . . . 0.0 112.654 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -53.24 6.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.988 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.601 ' H ' ' C ' ' A' ' 36' ' ' ASN . 71.4 p -72.6 -149.05 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.358 -1.337 . . . . 0.0 110.75 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 38' ' ' THR . 2.8 mt 42.12 58.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.899 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t -72.92 -50.04 25.94 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.917 -179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.41 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -119.27 176.62 5.24 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.763 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.453 HG11 ' H ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -154.43 148.22 13.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 C-N-CA 117.856 -1.538 . . . . 0.0 112.813 -179.95 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -136.6 109.88 7.85 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.513 -1.222 . . . . 0.0 108.607 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.2 t -132.54 110.86 13.66 Favored Pre-proline 0 N--CA 1.495 1.803 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.322 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.13 167.96 20.43 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.007 1.138 . . . . 0.0 110.726 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.465 ' CG ' HH21 ' A' ' 92' ' ' ARG . 1.6 Cg_endo -62.18 -168.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.781 1.654 . . . . 0.0 111.326 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.89 -17.47 9.13 Favored Glycine 0 N--CA 1.482 1.73 0 C-N-CA 119.365 -1.397 . . . . 0.0 110.854 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.45 HG13 ' CB ' ' A' ' 2' ' ' ALA . 27.3 m -148.59 140.35 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.825 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -104.82 127.14 52.52 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.49 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.57 149.19 28.32 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.539 -0.864 . . . . 0.0 112.283 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.8 mt -139.87 114.58 7.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.569 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.471 HD11 ' H ' ' A' ' 52' ' ' LEU . 3.6 mp -94.11 164.95 12.86 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.942 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -140.46 116.37 10.37 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.006 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -49.22 -84.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.363 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -59.01 141.26 54.42 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.521 -179.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -60.92 -169.87 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.318 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.81 31.97 32.34 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.137 -1.506 . . . . 0.0 110.005 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.436 ' H ' ' HG ' ' A' ' 81' ' ' SER . 25.3 m-85 51.29 65.59 1.44 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.087 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.06 -174.14 4.19 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.171 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.67 177.9 15.39 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.037 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -50.89 170.72 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.212 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -143.58 133.03 23.41 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.058 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.5 mm -98.91 167.64 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.097 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -145.29 129.16 17.35 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.163 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -149.24 164.52 4.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 118.598 -1.241 . . . . 0.0 112.609 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.33 -11.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 114.372 -1.285 . . . . 0.0 107.69 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.405 ' HB2' ' H ' ' A' ' 68' ' ' ASN . . . -119.69 -152.19 0.5 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.144 179.884 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.604 HD22 ' H ' ' A' ' 107' ' ' ASP . 1.3 p30 -101.51 122.57 44.05 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.886 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.453 ' H ' HG11 ' A' ' 42' ' ' VAL . . . -89.53 121.85 32.13 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.723 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -74.33 -83.67 0.05 Allowed 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.328 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -77.32 -0.25 24.84 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.962 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.465 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 5.8 tp 59.24 -97.47 0.07 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.717 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.465 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -173.43 -174.83 40.73 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 118.893 -1.622 . . . . 0.0 111.117 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.616 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.4 Cg_endo -66.9 -34.04 31.25 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.688 2.259 . . . . 0.0 112.587 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.613 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 2.0 pt? -67.91 24.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.457 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.616 ' H ' ' C ' ' A' ' 74' ' ' PRO . 4.3 t30 -74.73 -6.35 48.35 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.201 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' ND2' ' A' ' 78' ' ' ASN . 4.6 t-20 -74.54 -25.11 59.11 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.992 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 31.9 m120 -158.14 132.03 7.9 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.384 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t -147.81 138.52 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.843 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.9 m -162.53 -34.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.44 -1.304 . . . . 0.0 112.831 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.457 ' HG ' HG21 ' A' ' 25' ' ' THR . 3.5 m -95.7 138.81 32.83 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.023 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -150.02 159.86 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 118.581 -1.248 . . . . 0.0 112.497 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.819 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -149.94 116.84 5.92 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.417 -179.977 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.819 ' H ' HH22 ' A' ' 83' ' ' ARG . 14.1 t -120.63 139.54 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.438 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.603 ' CD1' ' NH1' ' A' ' 83' ' ' ARG . 1.4 mp -138.72 129.25 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.562 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 p -40.5 152.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.989 -0.685 . . . . 0.0 111.609 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.47 141.25 13.26 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.266 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -52.37 132.55 45.05 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.168 1.246 . . . . 0.0 111.28 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.528 ' CG2' ' N ' ' A' ' 90' ' ' GLN . 4.0 p -59.13 163.96 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.639 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.528 ' N ' ' CG2' ' A' ' 89' ' ' VAL . 82.5 mm-40 -145.21 148.08 36.63 Favored Pre-proline 0 N--CA 1.487 1.387 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.045 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.64 -20.12 67.63 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 121.503 1.469 . . . . 0.0 111.846 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.465 HH21 ' CG ' ' A' ' 46' ' ' PRO . 20.3 ptt180 38.07 -158.31 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -147.87 172.76 13.65 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.61 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -141.21 115.48 9.37 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.865 -1.134 . . . . 0.0 112.087 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CD2' HG12 ' A' ' 131' ' ' VAL . 66.7 m-85 -99.97 159.17 15.29 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.634 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.442 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 26.0 m-85 -109.83 179.66 4.06 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.267 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.29 -66.97 0.91 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.438 -0.905 . . . . 0.0 112.755 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.513 ' CG ' ' N ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -87.49 163.05 16.91 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.918 0.866 . . . . 0.0 113.083 -179.735 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 13.6 tp10 -62.25 108.86 1.16 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.703 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 96.66 61.54 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.934 0 O-C-N 124.725 1.265 . . . . 0.0 111.113 179.895 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' A' ' 101' ' ' PHE . 9.1 p90 29.4 33.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.422 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 100' ' ' GLN . 23.8 t70 -96.93 32.85 2.01 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.754 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -161.2 144.48 9.88 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 103' ' ' GLY . 15.7 tptm -34.5 144.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.929 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.468 ' OE1' ' C ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -99.14 164.99 11.93 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.712 -0.795 . . . . 0.0 112.806 -179.803 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.422 HG12 ' CA ' ' A' ' 122' ' ' GLY . 7.0 t -140.28 118.57 10.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.495 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.604 ' H ' HD22 ' A' ' 68' ' ' ASN . 2.2 p-10 -93.83 163.08 13.66 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.535 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.2 mt -144.08 144.44 26.27 Favored Pre-proline 0 N--CA 1.486 1.339 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.632 179.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.21 163.48 32.6 Favored 'Trans proline' 0 C--O 1.213 -0.771 0 C-N-CA 121.708 1.605 . . . . 0.0 111.095 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.68 142.73 95.24 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 121.452 1.435 . . . . 0.0 110.892 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.87 -157.13 26.97 Favored Glycine 0 N--CA 1.501 3.026 0 C-N-CA 118.758 -1.687 . . . . 0.0 111.522 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.66 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 46.1 tt0 -128.26 157.27 41.37 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.518 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.66 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 13.4 m-85 -142.43 155.99 45.15 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.799 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.4 p -99.61 176.47 5.47 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -179.674 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.531 ' NE2' ' OD2' ' A' ' 144' ' ' ASP . 20.9 pt20 -73.42 37.63 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.866 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.32 -56.3 0.08 Allowed 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.615 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.11 -42.61 75.86 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.163 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.617 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -45.25 -74.1 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.159 179.912 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.601 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.1 OUTLIER -50.69 -55.45 16.48 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.011 -1.076 . . . . 0.0 112.796 -179.63 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -10.59 6.45 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.319 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -100.04 -8.08 24.25 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.471 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.422 ' CA ' HG12 ' A' ' 106' ' ' VAL . . . -152.0 -62.08 0.01 OUTLIER Glycine 0 N--CA 1.484 1.887 0 C-N-CA 118.498 -1.81 . . . . 0.0 111.989 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.754 ' N ' ' CD1' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -140.63 127.82 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.968 -179.746 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.582 ' C ' ' H ' ' A' ' 126' ' ' ASN . 36.9 t70 -39.48 161.41 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.84 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -58.29 13.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.105 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.582 ' H ' ' C ' ' A' ' 124' ' ' ASP . 1.6 p-10 -167.7 77.99 0.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.552 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 126' ' ' ASN . 1.1 p -163.66 -15.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.37 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -64.68 160.4 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.143 -179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.4 t -170.38 -87.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.55 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 m -81.93 138.02 35.07 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.487 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.479 HG12 ' CD2' ' A' ' 95' ' ' PHE . 2.1 t -121.14 156.84 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.509 0.671 . . . . 0.0 111.703 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -154.02 79.06 5.23 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.963 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.78 102.42 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.533 1.489 . . . . 0.0 110.834 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.446 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 3.5 mm-40 -51.55 -12.92 0.19 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.089 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 178.76 -34.86 0.08 OUTLIER Glycine 0 N--CA 1.49 2.278 0 C-N-CA 117.93 -2.081 . . . . 0.0 112.579 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 mt -87.35 171.87 10.27 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.185 -1.406 . . . . 0.0 111.824 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -95.16 123.21 38.53 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.41 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 153' ' ' VAL . 8.8 t -94.44 133.05 36.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.627 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.0 t -124.2 132.13 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.48 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.9 mp -107.31 134.13 50.83 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.435 -179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.431 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 25.8 m-85 -110.59 122.06 46.83 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.105 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -55.4 -84.19 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.988 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.408 HD22 ' HB3' ' A' ' 147' ' ' SER . 26.2 p-10 -71.91 173.58 8.13 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.193 179.98 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.531 ' OD2' ' NE2' ' A' ' 115' ' ' GLN . 2.3 m-20 -65.29 -153.35 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.175 -179.893 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.635 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 71.7 m-20 41.91 22.61 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.288 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.635 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.5 p90 40.08 57.12 2.44 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.154 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.408 ' HB3' HD22 ' A' ' 143' ' ' ASN . 8.4 t -138.66 -151.05 0.36 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.605 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 54.88 -166.02 2.87 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.377 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.5 157.14 11.87 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.88 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 p -148.12 174.68 11.71 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.568 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.3 mt -138.32 85.09 18.76 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.444 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -64.1 97.53 0.24 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 121.766 1.644 . . . . 0.0 112.387 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 138' ' ' VAL . 2.1 t -77.78 92.99 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.857 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -62.41 -21.49 65.42 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.808 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 52.3 p -169.84 -150.19 0.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 117.852 -1.539 . . . . 0.0 112.862 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -43.78 150.26 0.26 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.779 -179.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.575 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -171.8 65.07 0.39 Allowed Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.902 179.841 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.3 Cg_endo -61.95 19.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.267 1.978 . . . . 0.0 113.14 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.575 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER 178.67 111.76 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.053 179.873 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 13.5 mt -141.35 -42.97 0.37 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.467 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 74.37 -174.39 50.15 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.318 -1.42 . . . . 0.0 110.16 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.79 145.22 40.88 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.674 -179.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 2.4 tpt -88.62 -76.52 0.4 Allowed 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.483 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -91.6 -41.86 10.53 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.79 179.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.65 -32.85 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.152 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 176.24 134.23 0.05 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.802 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.37 131.12 45.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.504 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 169' ' ' SER . 97.0 p -93.69 -67.31 0.86 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.945 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.52 ' N ' ' OG ' ' A' ' 168' ' ' SER . 1.8 p -113.99 162.55 16.28 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.982 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.426 HG12 ' CD1' ' A' ' 118' ' ' LEU . 23.9 pt -143.01 175.73 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 118.735 -1.186 . . . . 0.0 112.037 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -154.51 109.18 3.04 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.477 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.4 mt -89.6 92.8 4.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.574 179.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 116.325 -1.798 . . . . 0.0 110.944 179.996 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.812 0.339 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -179.53 131.4 0.1 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.166 -1.013 . . . . 0.0 110.699 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.7 pt -73.44 153.22 7.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.453 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.0 m -130.44 116.43 18.23 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.886 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 m -96.67 172.08 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.515 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.821 ' CE2' ' OE1' ' A' ' 16' ' ' GLN . 16.1 m-85 -130.72 134.85 47.26 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.878 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -59.28 5.5 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.214 -0.995 . . . . 0.0 112.777 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.624 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 14.7 m-20 -89.03 167.04 13.48 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.478 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.556 ' CG ' ' H ' ' A' ' 11' ' ' ASP . 16.4 tt0 -77.16 -178.23 4.94 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.918 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.556 ' H ' ' CG ' ' A' ' 10' ' ' GLU . 4.7 t0 60.77 43.64 11.95 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.61 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.414 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 35.8 t80 49.3 15.47 0.12 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.497 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.503 ' CG ' ' N ' ' A' ' 14' ' ' GLY . 48.6 tt0 -103.02 168.93 8.87 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.833 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.624 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 89.53 124.49 2.56 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.816 -1.183 . . . . 0.0 111.143 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 14' ' ' GLY . 7.2 mmmm -29.95 137.76 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 123.921 0.424 . . . . 0.0 111.643 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.821 ' OE1' ' CE2' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -103.51 170.92 7.66 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.678 -0.809 . . . . 0.0 112.087 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.6 t -142.03 134.41 27.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.804 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -92.98 117.16 29.75 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.578 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.1 mt -113.03 132.99 22.12 Favored Pre-proline 0 N--CA 1.492 1.625 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.075 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.11 160.64 43.72 Favored 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 120.94 1.093 . . . . 0.0 111.208 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.85 -159.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 121.615 1.543 . . . . 0.0 111.017 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.437 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 84.32 176.36 51.06 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.318 -1.42 . . . . 0.0 111.001 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.646 ' CA ' HH21 ' A' ' 83' ' ' ARG . 7.8 p-10 -103.3 135.92 44.04 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.543 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.822 ' OH ' HD12 ' A' ' 82' ' ' ILE . 51.6 p90 -158.31 -174.61 4.89 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.119 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.842 HG23 ' N ' ' A' ' 26' ' ' ARG . 5.4 t -161.03 -150.02 0.19 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.396 -1.321 . . . . 0.0 112.297 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.842 ' N ' HG23 ' A' ' 25' ' ' THR . 11.9 ttt-85 -56.79 -31.04 64.27 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.253 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.612 ' H ' HG23 ' A' ' 25' ' ' THR . . . -60.99 -63.35 1.33 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.569 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.55 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 14.9 tp60 -57.48 -44.28 84.78 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.485 -1.286 . . . . 0.0 109.822 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.503 HD23 ' HA ' ' A' ' 29' ' ' LEU . 27.6 mt -58.78 -37.6 76.66 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.71 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.35 -33.71 44.19 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 118.537 -1.265 . . . . 0.0 107.762 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -66.44 -40.84 89.71 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.375 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.491 HD12 HD23 ' A' ' 29' ' ' LEU . 14.3 mt -72.81 -80.84 0.06 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.79 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 32' ' ' LEU . . . 161.58 -29.18 0.29 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.841 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.441 HD13 HG21 ' A' ' 34' ' ' ILE . 9.8 tt -82.64 151.13 4.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.724 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 4.3 pt-20 -179.93 146.25 0.24 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.552 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 1.6 t-20 74.61 -143.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.065 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -58.79 82.08 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.612 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 40' ' ' SER . 43.4 p -149.33 -46.36 0.14 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.226 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mt -68.45 71.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.623 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 38' ' ' THR . 33.5 t -75.31 -72.1 0.32 Allowed 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.403 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.446 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -95.64 167.43 11.3 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.965 -1.094 . . . . 0.0 109.626 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.32 154.37 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 118.786 -1.166 . . . . 0.0 112.394 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -145.1 104.01 3.92 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.75 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.6 t -126.5 111.26 23.14 Favored Pre-proline 0 N--CA 1.496 1.842 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.63 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.37 168.21 18.48 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 121.081 1.187 . . . . 0.0 110.808 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.93 -170.22 0.1 OUTLIER 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 121.843 1.695 . . . . 0.0 110.971 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.85 -12.04 31.46 Favored Glycine 0 N--CA 1.48 1.614 0 C-N-CA 118.829 -1.653 . . . . 0.0 109.627 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.611 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -155.87 149.47 11.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.448 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.09 127.2 51.41 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.616 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.61 157.02 17.47 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.359 -0.936 . . . . 0.0 113.096 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.49 ' C ' HD12 ' A' ' 52' ' ' LEU . 60.3 mt -136.11 115.41 16.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.453 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.941 ' N ' HD12 ' A' ' 52' ' ' LEU . 2.1 mp -89.97 161.22 16.0 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.857 -1.137 . . . . 0.0 112.763 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.415 ' CE1' ' HB3' ' A' ' 62' ' ' GLN . 5.5 m-85 -140.58 109.95 6.25 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.782 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.407 ' HB3' ' H ' ' A' ' 55' ' ' ASN . 11.7 tt0 -43.52 -87.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.035 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.407 ' H ' ' HB3' ' A' ' 54' ' ' GLN . 58.8 m-20 -59.92 145.45 45.85 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.093 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.19 -174.92 0.06 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.518 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.84 26.7 58.25 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.178 -1.487 . . . . 0.0 110.025 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 55.31 65.03 1.59 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.51 175.35 10.63 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.439 -0.905 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.25 168.0 32.07 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.257 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -49.3 129.17 18.09 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.348 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.415 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 3.3 pt20 -101.0 179.04 4.5 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.119 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.808 HD11 HD11 ' A' ' 75' ' ' LEU . 4.7 mt -144.04 169.01 10.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.404 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.49 ' H ' HG22 ' A' ' 63' ' ' ILE . 38.7 tt0 -145.09 128.62 17.04 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.955 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.41 HG13 ' C ' ' A' ' 64' ' ' GLU . 18.7 m -149.31 167.14 3.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.902 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 48' ' ' VAL . 2.6 t -146.64 -2.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.527 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.549 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -126.42 -154.11 0.61 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.882 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.435 HD21 HG13 ' A' ' 106' ' ' VAL . 0.8 OUTLIER -96.05 155.18 16.86 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.566 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.42 87.06 2.35 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.225 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -51.9 -43.15 63.23 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.346 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 72' ' ' LEU . 5.5 mm-40 -123.88 81.19 1.88 Allowed 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.586 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 71' ' ' GLU . 1.2 tp -28.96 -81.22 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.702 0.626 . . . . 0.0 112.545 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.31 -165.92 36.63 Favored Glycine 0 N--CA 1.497 2.701 0 C-N-CA 118.901 -1.618 . . . . 0.0 111.09 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.459 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.8 Cg_endo -67.37 -44.21 5.02 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 122.148 1.899 . . . . 0.0 112.055 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.808 HD11 HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -69.74 10.45 0.38 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.059 -1.056 . . . . 0.0 111.289 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 74' ' ' PRO . 8.5 t30 -70.13 1.45 4.7 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.61 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -74.7 -5.2 41.85 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.712 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -167.3 124.42 1.2 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.295 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.4 t -145.97 140.24 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.67 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 m -159.7 -31.92 0.06 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.092 -1.043 . . . . 0.0 112.292 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.49 ' HG ' ' HG1' ' A' ' 25' ' ' THR . 3.0 m -103.86 142.93 33.54 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.439 -0.905 . . . . 0.0 111.339 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.822 HD12 ' OH ' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -149.15 162.2 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.73 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.851 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -146.06 116.38 7.49 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.396 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.851 ' H ' HH22 ' A' ' 83' ' ' ARG . 10.2 t -119.3 137.77 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 120.056 -0.657 . . . . 0.0 111.636 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.588 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 4.5 mt -139.13 126.67 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.51 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.5 p -40.54 154.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.585 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.491 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.9 OUTLIER -150.93 146.79 19.65 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.65 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.491 ' HD2' HG22 ' A' ' 87' ' ' VAL . 5.0 Cg_exo -51.18 159.35 2.82 Favored 'Trans proline' 0 C--N 1.325 -0.7 0 C-N-CA 121.805 1.67 . . . . 0.0 112.164 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 89' ' ' VAL . 33.8 m -69.67 134.68 29.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.326 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -140.25 124.58 10.85 Favored Pre-proline 0 N--CA 1.489 1.488 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.113 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -59.79 -164.11 0.03 OUTLIER 'Trans proline' 0 C--O 1.21 -0.912 0 C-N-CA 120.758 0.972 . . . . 0.0 110.516 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.4 ' CA ' HD12 ' A' ' 136' ' ' LEU . 20.8 ptt-85 -177.48 -160.29 0.05 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.913 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.435 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -138.81 154.25 48.45 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.92 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -123.94 122.26 37.49 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.812 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 24.8 m-85 -108.71 151.41 26.22 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.041 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.405 ' CD2' ' HA ' ' A' ' 101' ' ' PHE . 31.3 m-85 -118.53 159.06 24.22 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.927 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.45 ' HB2' ' N ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -78.68 -83.29 0.09 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 118.162 -1.415 . . . . 0.0 111.781 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.529 ' O ' ' OE1' ' A' ' 100' ' ' GLN . 4.6 mmmm -56.07 157.87 4.33 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.6 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 29.2 tt0 -79.62 86.62 5.23 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.524 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.738 ' OE1' ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 162.77 48.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.625 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 24.7 p90 39.96 41.06 0.82 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.102 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -142.75 -174.46 4.17 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.635 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.484 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 75.89 161.77 11.18 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 118.92 -1.609 . . . . 0.0 109.498 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 103' ' ' GLY . 7.3 mtpm? -27.58 122.82 0.1 Allowed 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 121.244 0.545 . . . . 0.0 112.09 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 105' ' ' GLU . 0.7 OUTLIER -102.09 137.21 40.66 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.572 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.836 HG21 ' O ' ' A' ' 122' ' ' GLY . 3.0 t -138.73 151.57 24.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.021 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -143.66 151.15 39.74 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.098 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.8 mt -139.25 143.81 37.88 Favored Pre-proline 0 N--CA 1.497 1.876 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.617 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 6.4 Cg_endo -71.23 170.17 18.9 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 121.724 1.616 . . . . 0.0 111.052 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.407 ' HA ' ' CG2' ' A' ' 172' ' ' ILE . 3.7 Cg_exo -60.44 141.55 95.83 Favored 'Trans proline' 0 C--N 1.321 -0.921 0 C-N-CA 121.728 1.619 . . . . 0.0 110.972 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.491 ' C ' ' OE1' ' A' ' 112' ' ' GLN . . . 150.2 -153.78 25.27 Favored Glycine 0 N--CA 1.497 2.759 0 C-N-CA 118.675 -1.726 . . . . 0.0 111.49 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.631 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 3.3 mp0 -131.36 148.16 52.64 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.614 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.631 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 3.3 m-85 -139.63 157.15 46.27 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.606 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.4 p -119.0 -175.46 2.91 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -77.88 47.78 0.66 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.216 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.41 -56.47 0.09 Allowed 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.329 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.482 ' HG2' ' N ' ' A' ' 118' ' ' LEU . 1.7 tt0 -76.77 -58.0 3.53 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.543 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -36.99 -69.5 0.11 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.74 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.45 ' OE1' ' ND2' ' A' ' 125' ' ' ASN . 0.6 OUTLIER -49.57 -63.12 1.2 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.166 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.435 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 0.1 OUTLIER -75.86 24.18 0.13 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.284 -0.966 . . . . 0.0 112.575 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.461 ' O ' ' CG ' ' A' ' 121' ' ' TYR . 33.7 t80 -131.81 -9.16 3.53 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.368 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.836 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -150.28 -46.94 0.02 OUTLIER Glycine 0 C--N 1.29 -1.998 0 C-N-CA 118.87 -1.633 . . . . 0.0 110.526 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.455 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -141.18 -98.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.281 -0.967 . . . . 0.0 110.66 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.455 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 7.4 t0 -168.37 -166.2 0.67 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.729 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.45 ' ND2' ' OE1' ' A' ' 119' ' ' GLU . 10.0 m120 -59.75 -6.79 1.32 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.134 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.464 ' CG ' ' H ' ' A' ' 127' ' ' THR . 44.5 t30 -172.09 -134.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.189 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.464 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 0.5 OUTLIER 36.56 69.07 0.22 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.203 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.5 ' O ' ' CB ' ' A' ' 129' ' ' SER . 8.0 mm -102.25 -86.68 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.388 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 84.83 -166.54 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' SER . 10.9 m -17.98 120.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.7 -1.591 . . . . 0.0 114.703 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.76 149.83 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.544 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -143.82 95.69 5.71 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 119.536 -0.865 . . . . 0.0 110.863 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -53.78 112.46 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.16 1.24 . . . . 0.0 111.099 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.435 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 44.6 tp60 -79.46 -17.27 54.59 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.84 -32.68 0.02 OUTLIER Glycine 0 N--CA 1.488 2.158 0 C-N-CA 118.752 -1.689 . . . . 0.0 111.93 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.4 HD12 ' CA ' ' A' ' 92' ' ' ARG . 0.4 OUTLIER -121.26 156.38 32.61 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.155 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.29 153.43 39.37 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 118.863 -1.135 . . . . 0.0 110.077 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.9 140.21 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.859 -0.736 . . . . 0.0 112.046 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.93 127.19 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.231 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 mp -105.79 148.95 26.92 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 119.396 -0.922 . . . . 0.0 113.211 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.545 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 2.4 m-85 -121.34 146.34 46.95 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.754 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -107.86 43.08 1.24 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.302 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 147' ' ' SER . 50.7 t30 -169.91 156.28 6.11 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.856 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 146' ' ' PHE . 32.0 t70 -57.75 175.83 0.17 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.298 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.642 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 8.0 p-10 34.59 32.44 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.964 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.642 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.3 p90 40.72 64.8 0.89 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.198 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.505 ' CB ' ' ND2' ' A' ' 145' ' ' ASN . 25.6 t -144.19 97.05 2.98 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.865 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.96 -156.79 28.03 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -60.21 157.62 13.01 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.963 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.5 p -150.14 170.94 17.73 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.984 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.471 HD23 ' C ' ' A' ' 151' ' ' LEU . 1.2 tt -142.44 91.33 7.69 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.035 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.32 107.37 1.57 Allowed 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.945 1.764 . . . . 0.0 113.598 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.6 t -84.12 89.15 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.089 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -80.73 11.58 3.76 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.4 p -170.04 -171.81 1.22 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.62 -1.632 . . . . 0.0 113.136 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -58.1 148.37 26.76 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.028 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.599 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -166.53 74.85 1.15 Allowed Pre-proline 0 C--N 1.304 -1.378 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.954 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.78 21.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.734 1.623 . . . . 0.0 111.999 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.599 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.4 OUTLIER -169.42 112.68 0.51 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.795 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.0 tp -146.64 17.95 1.3 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.195 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 C-N-CA 119.241 -1.457 . . . . 0.0 110.299 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.826 0.346 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 13.1 m -76.14 98.28 4.34 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.955 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 9.1 m -82.82 -40.1 20.82 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.72 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.49 159.83 41.7 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.619 -1.233 . . . . 0.0 111.139 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.414 HG12 ' CD1' ' A' ' 118' ' ' LEU . 15.5 pt -140.64 163.02 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.22 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -145.07 102.39 3.75 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.025 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.407 ' CG2' ' HA ' ' A' ' 110' ' ' PRO . 4.9 mt -81.63 100.66 5.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.439 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.896 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.523 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.843 0.354 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 2.0 p-10 -172.66 105.66 0.16 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.111 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.582 HG22 HG22 ' A' ' 44' ' ' VAL . 28.6 pt -72.09 156.75 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.622 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -139.75 126.91 21.13 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.818 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -107.28 179.0 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 119.848 -0.741 . . . . 0.0 112.412 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.769 ' CZ ' ' CE1' ' A' ' 12' ' ' PHE . 32.5 m-85 -132.47 144.7 50.64 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.112 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.94 -46.97 27.07 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.551 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 4.8 m120 -89.33 162.63 15.72 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.296 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.504 ' C ' ' CG ' ' A' ' 11' ' ' ASP . 12.8 mt-10 -72.94 158.48 35.39 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.245 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.1 OUTLIER 76.02 44.73 0.13 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.612 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.769 ' CE1' ' CZ ' ' A' ' 7' ' ' PHE . 70.2 t80 52.78 10.88 0.17 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.631 -0.828 . . . . 0.0 112.079 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.447 ' HG3' ' H ' ' A' ' 14' ' ' GLY . 1.6 tp60 -99.72 171.41 7.91 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.581 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.551 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 86.42 135.71 4.16 Favored Glycine 0 N--CA 1.502 3.072 0 C-N-CA 119.904 -1.141 . . . . 0.0 111.267 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 14' ' ' GLY . 15.9 mtpp -31.46 141.47 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.913 0.419 . . . . 0.0 111.727 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.588 ' NE2' ' CZ ' ' A' ' 7' ' ' PHE . 2.3 pt20 -110.14 172.52 6.81 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.873 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.3 t -146.79 133.91 14.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.414 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -89.93 139.94 30.11 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.312 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.0 mt -135.69 133.02 19.85 Favored Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 120.026 -0.669 . . . . 0.0 110.714 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -69.69 155.16 66.88 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 121.081 1.187 . . . . 0.0 110.999 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.66 -166.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.497 1.464 . . . . 0.0 110.803 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.39 -161.03 26.08 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.951 -1.595 . . . . 0.0 110.671 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -128.04 127.42 43.13 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.997 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.435 ' OH ' HD12 ' A' ' 82' ' ' ILE . 7.9 p90 -144.46 -171.58 3.62 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.92 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.0 p -142.62 -170.54 3.23 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.262 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -59.41 -22.07 60.89 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.883 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -60.96 -58.86 6.65 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.882 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.73 ' OE1' HD21 ' A' ' 32' ' ' LEU . 2.7 tp-100 -54.92 -44.54 74.31 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.029 -1.069 . . . . 0.0 109.398 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.529 HD22 ' CG2' ' A' ' 34' ' ' ILE . 31.4 mt -57.08 -42.34 80.51 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.294 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -51.3 -30.54 18.46 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.825 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -73.75 -34.76 64.88 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.941 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.73 HD21 ' OE1' ' A' ' 28' ' ' GLN . 11.7 mt -78.88 -72.97 0.36 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.579 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.56 -40.91 0.21 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.529 ' CG2' HD22 ' A' ' 29' ' ' LEU . 10.2 tt -68.89 178.48 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.49 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.634 ' CG ' ' N ' ' A' ' 36' ' ' ASN . 5.5 tt0 178.53 167.32 0.85 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.057 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.634 ' N ' ' CG ' ' A' ' 35' ' ' GLU . 24.4 p30 -36.33 152.75 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.533 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.759 ' H ' ' H ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER 78.07 32.76 0.36 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.484 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 39' ' ' ILE . 72.0 p -147.19 -121.61 0.06 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.767 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.891 HD12 HG11 ' A' ' 79' ' ' VAL . 4.5 mt 32.58 62.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.402 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.646 ' OG ' ' N ' ' A' ' 41' ' ' SER . 22.7 p -64.69 -62.3 1.66 Allowed 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.733 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.646 ' N ' ' OG ' ' A' ' 40' ' ' SER . 0.7 OUTLIER -106.73 171.45 7.35 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.262 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -145.48 140.55 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.096 -1.041 . . . . 0.0 111.643 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -129.14 102.19 6.36 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.917 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.582 HG22 HG22 ' A' ' 4' ' ' ILE . 71.5 t -126.62 109.39 22.95 Favored Pre-proline 0 N--CA 1.49 1.537 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.618 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -67.6 169.76 15.2 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 121.049 1.166 . . . . 0.0 110.633 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.21 -170.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.844 1.696 . . . . 0.0 111.185 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.2 -11.8 7.94 Favored Glycine 0 N--CA 1.483 1.827 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.698 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.523 HG11 ' HB3' ' A' ' 2' ' ' ALA . 35.3 m -150.18 134.95 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 118.944 -1.102 . . . . 0.0 111.799 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -104.35 132.03 51.05 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.247 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.619 ' HB3' HG23 ' A' ' 65' ' ' VAL . . . -110.8 154.86 23.36 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.479 -0.889 . . . . 0.0 112.844 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.585 HG22 ' CE1' ' A' ' 53' ' ' TYR . 12.0 mt -146.32 112.01 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.103 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 mp -89.56 152.09 21.6 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.704 -1.198 . . . . 0.0 112.477 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.585 ' CE1' HG22 ' A' ' 51' ' ' ILE . 53.5 m-85 -129.48 110.9 12.25 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.315 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -48.61 -55.45 11.19 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.631 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -85.67 147.67 26.26 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.032 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -56.38 178.1 0.06 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.776 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.34 27.22 60.29 Favored Glycine 0 N--CA 1.488 2.105 0 C-N-CA 119.346 -1.407 . . . . 0.0 110.173 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.497 ' C ' ' CD2' ' A' ' 53' ' ' TYR . 12.4 m-85 56.29 67.44 1.0 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.876 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.23 -170.43 3.65 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.97 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.09 -177.23 39.36 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.425 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -45.19 107.64 0.1 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.355 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -91.05 151.35 21.06 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.642 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.736 HG22 ' N ' ' A' ' 64' ' ' GLU . 8.5 mm -131.31 170.3 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.36 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.736 ' N ' HG22 ' A' ' 63' ' ' ILE . 27.8 mt-10 -146.48 132.61 19.34 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.694 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 50' ' ' ALA . 17.6 m -150.45 147.91 15.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 118.964 -1.094 . . . . 0.0 111.698 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 t -130.61 0.93 2.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.432 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -134.41 -151.19 0.42 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.684 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -97.25 119.12 35.18 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.105 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.539 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.58 101.7 14.38 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.178 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -55.13 -35.98 65.26 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.346 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 72' ' ' LEU . 8.6 tp10 -140.16 96.51 3.06 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.611 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.42 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 1.5 tp -37.97 -84.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.099 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 178.91 -168.64 39.64 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.095 -1.526 . . . . 0.0 110.719 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.21 -6.3 15.87 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.097 1.865 . . . . 0.0 111.859 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.683 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -92.11 13.98 17.34 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.022 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -72.55 -5.16 35.15 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.518 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -89.21 -6.84 56.57 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.107 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -166.1 104.88 0.66 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 118.714 -1.194 . . . . 0.0 111.711 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.981 HG12 ' H ' ' A' ' 80' ' ' SER . 11.6 t -113.5 -167.81 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.415 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.981 ' H ' HG12 ' A' ' 79' ' ' VAL . 0.3 OUTLIER 159.48 -59.33 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.449 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.413 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 2.6 m -108.5 145.83 34.12 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.307 -0.957 . . . . 0.0 113.317 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.435 HD12 ' OH ' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -141.21 154.26 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.915 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.737 ' NH1' ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.61 128.5 25.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.333 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.737 ' CA ' ' NH1' ' A' ' 83' ' ' ARG . 6.5 t -138.1 132.94 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.329 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 68.1 mt -129.31 128.69 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.806 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 m -42.3 153.49 0.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.213 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.598 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.5 OUTLIER -147.56 148.62 31.56 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.753 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.598 ' HD2' HG22 ' A' ' 87' ' ' VAL . 5.4 Cg_exo -55.48 127.76 27.57 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.229 1.286 . . . . 0.0 110.946 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 p -59.43 136.38 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.478 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -139.71 152.76 69.14 Favored Pre-proline 0 N--CA 1.486 1.355 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.695 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.485 ' HG2' HD21 ' A' ' 136' ' ' LEU . 3.3 Cg_exo -60.15 -156.88 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.818 0 C-N-CA 121.064 1.176 . . . . 0.0 110.941 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 175.71 -162.05 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.266 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.03 158.57 43.97 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.013 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.91 147.5 35.71 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.935 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.469 ' CE1' HD12 ' A' ' 108' ' ' LEU . 29.9 m-85 -130.48 100.89 5.5 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.425 ' CG ' ' HB3' ' A' ' 105' ' ' GLU . 33.7 m-85 -74.93 177.06 6.57 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.581 -0.847 . . . . 0.0 113.111 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -110.54 159.73 17.27 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.635 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt 59.3 153.98 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.048 0.927 . . . . 0.0 113.182 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.555 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 30.7 tp10 -71.99 105.99 4.1 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.459 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 1.282 ' NE2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 103.83 46.2 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.01 0 O-C-N 124.981 1.426 . . . . 0.0 109.076 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.631 ' CE1' ' CD ' ' A' ' 100' ' ' GLN . 27.0 p90 31.56 58.56 0.3 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.669 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 102' ' ' ASP . 0.4 OUTLIER -94.54 19.85 9.24 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.939 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -159.64 159.02 30.21 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -48.59 171.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.64 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -129.72 169.69 14.78 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.053 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.35 151.81 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.764 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 23.3 p-10 -98.43 152.78 19.14 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.965 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.469 HD12 ' CE1' ' A' ' 95' ' ' PHE . 54.0 mt -146.09 113.27 4.51 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.268 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 1.6 Cg_endo -65.83 164.43 27.03 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 121.421 1.414 . . . . 0.0 112.061 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.97 146.39 57.87 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 122.268 1.979 . . . . 0.0 111.787 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.11 -156.33 25.52 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.699 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.638 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 18.0 tt0 -135.75 156.99 47.95 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.648 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.638 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 12.0 m-85 -141.07 156.41 46.0 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.428 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.4 p -108.89 -179.2 3.79 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.712 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -75.9 44.1 0.29 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.19 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.22 -58.94 0.12 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.976 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 121' ' ' TYR . 31.2 tp10 -71.59 -51.44 23.3 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.413 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.63 ' C ' HD23 ' A' ' 118' ' ' LEU . 1.4 tt -36.88 -73.37 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.142 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.532 ' HG3' ' H ' ' A' ' 120' ' ' ARG . 5.4 pt-20 -49.78 -55.54 13.7 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.696 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.532 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -76.66 16.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.752 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.474 ' O ' ' CG ' ' A' ' 121' ' ' TYR . 28.2 t80 -123.64 -12.75 7.62 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.488 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -145.26 -42.65 0.05 OUTLIER Glycine 0 N--CA 1.496 2.636 0 C-N-CA 118.84 -1.648 . . . . 0.0 110.963 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.468 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -142.57 -97.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.606 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.555 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 23.8 t70 -167.4 -170.01 1.36 Allowed 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.745 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.555 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 27.8 t-20 -62.1 -105.63 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.63 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.456 ' N ' ' OD1' ' A' ' 125' ' ' ASN . 1.8 p-10 -67.11 107.9 2.46 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.396 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.772 HG23 HG13 ' A' ' 128' ' ' ILE . 3.1 t -172.9 -165.75 0.32 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.358 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.772 HG13 HG23 ' A' ' 127' ' ' THR . 1.4 mt 66.52 140.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.806 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 160' ' ' LEU . 4.8 m -154.67 -5.51 0.15 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.333 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.5 m -150.94 127.98 11.11 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.176 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -120.26 148.0 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.475 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.93 78.59 19.52 Favored Pre-proline 0 N--CA 1.483 1.198 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.402 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -61.19 97.64 0.13 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.264 1.31 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -91.51 33.23 1.01 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.413 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.72 -58.85 0.04 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 118.691 -1.718 . . . . 0.0 111.356 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.485 HD21 ' HG2' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -120.32 178.05 4.8 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.028 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.62 138.33 31.65 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.701 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.9 141.13 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.73 -0.788 . . . . 0.0 112.152 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.567 HG12 ' CE1' ' A' ' 141' ' ' PHE . 57.7 t -125.54 130.96 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.495 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.0 mp -105.47 137.05 43.92 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.646 -0.822 . . . . 0.0 113.085 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.567 ' CE1' HG12 ' A' ' 139' ' ' VAL . 2.3 m-85 -120.95 128.03 52.36 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.207 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -79.86 -30.64 40.32 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.141 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -83.08 177.77 8.44 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.785 -1.166 . . . . 0.0 111.86 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 146' ' ' PHE . 21.7 t0 -61.73 -105.99 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.875 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.642 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 28.9 m-20 -58.54 75.56 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.457 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.642 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.5 p90 32.76 70.39 0.1 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.143 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.18 -161.65 1.18 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.325 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 50.58 -148.66 7.14 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.745 -1.217 . . . . 0.0 111.127 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -78.18 162.39 26.64 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.124 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.0 p -150.66 165.39 33.55 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.539 HD23 ' C ' ' A' ' 151' ' ' LEU . 3.2 tt -133.19 90.91 29.33 Favored Pre-proline 0 N--CA 1.484 1.238 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.08 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -64.41 105.52 0.62 Allowed 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 121.589 1.526 . . . . 0.0 112.748 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.45 84.44 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.551 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -77.05 12.83 1.25 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.624 -0.83 . . . . 0.0 112.407 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -170.69 -167.49 0.59 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 118.214 -1.395 . . . . 0.0 112.361 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.55 152.05 19.13 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.576 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.564 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -169.13 65.47 0.58 Allowed Pre-proline 0 C--N 1.308 -1.225 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.269 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.0 OUTLIER -65.76 23.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 122.171 1.914 . . . . 0.0 112.046 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.652 ' O ' HD12 ' A' ' 160' ' ' LEU . 3.0 t -166.5 138.7 3.68 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.782 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.652 HD12 ' O ' ' A' ' 159' ' ' THR . 0.3 OUTLIER -160.11 -78.22 0.06 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.221 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.479 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.77 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 36.9 t30 . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.659 0.266 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 85.2 m -42.27 104.43 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.32 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.89 -61.3 1.75 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.017 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.4 p -123.61 158.99 30.23 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.947 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.427 HG12 ' CD1' ' A' ' 118' ' ' LEU . 13.1 pt -142.0 162.21 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.176 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.441 ' CZ ' ' OG ' ' A' ' 173' ' ' SER . 2.6 ttt-85 -142.44 102.7 4.13 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.015 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 172' ' ' ILE . 7.9 mt -84.01 93.81 3.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.757 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.441 ' OG ' ' CZ ' ' A' ' 171' ' ' ARG . 4.4 m . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 116.363 -1.78 . . . . 0.0 110.813 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.6 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.952 0.406 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -178.22 115.93 0.08 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.545 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.412 ' H ' HG23 ' A' ' 4' ' ' ILE . 2.9 pt -61.98 129.12 24.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.707 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -107.67 122.33 46.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.407 HG12 HG22 ' A' ' 42' ' ' VAL . 5.1 m -112.49 150.65 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.726 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.611 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 12.5 m-85 -103.92 156.13 18.09 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.654 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.9 -35.8 23.82 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.247 -0.981 . . . . 0.0 113.048 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.489 ' C ' ' OG ' ' A' ' 40' ' ' SER . 77.1 m-20 -104.49 170.89 7.63 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.259 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' A' ' 11' ' ' ASP . 4.2 tp10 -76.52 -176.34 3.69 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.471 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.458 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 1.1 m-20 51.79 42.48 29.98 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.073 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.611 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 21.4 t80 54.1 6.57 0.1 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.652 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.453 ' H ' ' C ' ' A' ' 11' ' ' ASP . 25.6 tt0 -87.13 170.99 11.03 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.503 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 89.19 120.35 1.84 Allowed Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.587 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 14' ' ' GLY . 6.9 mtpm? -28.85 137.54 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 O-C-N 123.95 0.441 . . . . 0.0 111.731 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 7.5 pm0 -105.43 133.07 50.79 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 p -108.1 153.41 9.6 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.039 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.811 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.07 140.2 34.64 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.543 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 mt -132.05 126.84 20.81 Favored Pre-proline 0 N--CA 1.493 1.688 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.205 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.54 151.3 83.21 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 121.026 1.151 . . . . 0.0 111.579 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.33 -164.6 0.06 OUTLIER 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 121.609 1.539 . . . . 0.0 111.484 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.57 179.93 46.29 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.454 -1.355 . . . . 0.0 111.066 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.84 ' CB ' ' HE ' ' A' ' 83' ' ' ARG . 10.5 m-20 -90.4 121.95 32.83 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.914 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.8 ' N ' HH21 ' A' ' 83' ' ' ARG . 0.2 OUTLIER -144.33 154.99 43.6 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.315 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.42 HG22 ' OG ' ' A' ' 81' ' ' SER . 21.0 p -144.4 -150.76 0.33 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.858 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 30' ' ' ALA . 10.0 mtm180 -55.89 -37.16 68.47 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.18 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.653 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -53.44 -59.11 5.0 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.269 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.09 -47.32 75.1 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 118.695 -1.202 . . . . 0.0 109.411 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 32' ' ' LEU . 21.5 mt -61.09 -28.58 69.19 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.442 -1.303 . . . . 0.0 109.023 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -54.34 -33.43 58.96 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.2 -29.94 60.48 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.587 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 29' ' ' LEU . 14.7 mt -85.75 -91.72 0.09 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.338 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.45 13.45 0.26 Allowed Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.225 -1.464 . . . . 0.0 111.54 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.573 HG13 HG21 ' A' ' 38' ' ' THR . 1.0 OUTLIER -95.08 -38.81 9.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.635 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.558 ' N ' ' CG1' ' A' ' 34' ' ' ILE . 3.7 pt-20 -12.9 132.21 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.803 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.615 ' O ' HG23 ' A' ' 38' ' ' THR . 0.1 OUTLIER 84.77 135.06 0.05 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 114.359 -1.291 . . . . 0.0 113.737 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 40.27 39.23 0.64 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.72 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.862 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 52.5 p -106.38 -141.3 0.37 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.929 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.491 ' H ' HD13 ' A' ' 39' ' ' ILE . 1.4 mm 30.86 41.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.958 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.489 ' OG ' ' C ' ' A' ' 9' ' ' ASN . 2.1 t -48.77 -38.98 23.41 Favored 'General case' 0 C--N 1.282 -2.342 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.064 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.67 176.56 8.59 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -150.63 146.63 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 117.76 -1.576 . . . . 0.0 113.075 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -136.09 102.1 4.92 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.359 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.6 t -122.71 104.33 36.6 Favored Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.381 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -69.48 171.01 14.92 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.077 1.185 . . . . 0.0 109.991 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.0 -173.19 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.494 1.463 . . . . 0.0 110.907 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.77 -21.72 7.38 Favored Glycine 0 N--CA 1.484 1.849 0 C-N-CA 119.109 -1.52 . . . . 0.0 110.551 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.6 HG11 ' CB ' ' A' ' 2' ' ' ALA . 25.1 m -148.97 141.98 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 118.921 -1.112 . . . . 0.0 112.176 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -110.18 139.2 45.58 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.739 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.21 155.03 42.46 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 118.964 -1.094 . . . . 0.0 113.2 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 63' ' ' ILE . 4.4 mp -134.34 120.84 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.199 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.915 ' N ' HD12 ' A' ' 52' ' ' LEU . 2.2 mp -94.62 155.66 16.78 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 118.744 -1.182 . . . . 0.0 112.942 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.478 ' CE1' ' HB3' ' A' ' 62' ' ' GLN . 40.5 m-85 -140.7 117.5 11.03 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.723 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.498 ' HG3' ' N ' ' A' ' 55' ' ' ASN . 6.4 pt20 -57.58 -41.94 82.12 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.363 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.521 ' HB3' ' HB3' ' A' ' 59' ' ' ALA . 7.0 t-20 -93.26 142.99 26.7 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.24 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 0.3 OUTLIER -54.49 171.09 0.13 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.487 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.663 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 58.82 34.83 79.59 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.162 -1.494 . . . . 0.0 109.43 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.795 ' H ' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER 44.26 74.16 0.13 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.316 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 55' ' ' ASN . . . -147.22 168.18 22.35 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.082 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.24 -166.69 48.37 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.525 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.448 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 3.7 m-20 -50.92 117.09 2.29 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.448 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.478 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 3.9 pt20 -99.82 151.45 21.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.887 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.603 ' O ' HG23 ' A' ' 51' ' ' ILE . 1.8 mt -127.79 166.0 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.922 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.558 ' OE1' ' N ' ' A' ' 64' ' ' GLU . 46.0 mp0 -142.77 130.52 21.51 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.24 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.402 HG13 ' C ' ' A' ' 64' ' ' GLU . 35.2 m -150.45 164.8 2.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.936 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.0 t -149.94 -1.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.158 -1.383 . . . . 0.0 107.881 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.72 -153.36 0.56 Allowed 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.624 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -98.32 114.03 26.19 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.53 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.574 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.72 98.9 12.03 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.425 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -54.78 -73.96 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.726 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 73' ' ' GLY . 24.6 mm-40 -80.9 -0.16 37.9 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.797 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.44 HD22 ' O ' ' A' ' 39' ' ' ILE . 5.2 tp 60.09 -79.88 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.219 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 171.08 -179.06 43.17 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.129 -1.51 . . . . 0.0 110.804 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.2 Cg_endo -65.1 -40.14 21.23 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.433 2.089 . . . . 0.0 112.421 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.955 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.1 pt? -71.3 27.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.16 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.525 ' H ' ' C ' ' A' ' 74' ' ' PRO . 15.1 p-10 -76.98 6.97 5.38 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.573 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -88.52 -9.41 52.47 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.967 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -157.85 130.69 7.42 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.136 -1.026 . . . . 0.0 111.219 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.862 ' CG2' ' H ' ' A' ' 38' ' ' THR . 15.3 m -140.09 164.93 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.533 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 174.64 -56.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.872 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.795 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 22.3 m -96.67 141.08 30.35 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.347 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.731 HD12 ' OH ' ' A' ' 24' ' ' TYR . 18.3 mt -150.57 128.25 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.974 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.84 ' HE ' ' CB ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -103.94 125.93 50.7 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.808 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -133.27 133.72 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.978 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.87 139.87 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.635 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.2 p -45.94 149.82 0.62 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.234 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.622 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -153.29 142.89 14.99 Favored Pre-proline 0 N--CA 1.484 1.264 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.866 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.622 ' HD2' HG22 ' A' ' 87' ' ' VAL . 2.7 Cg_exo -52.29 148.5 25.2 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 121.432 1.421 . . . . 0.0 111.811 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.403 HG13 ' H ' ' A' ' 89' ' ' VAL . 2.2 m -76.23 145.38 10.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.993 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -146.13 136.51 12.15 Favored Pre-proline 0 C--N 1.304 -1.388 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.963 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -60.33 -156.67 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.869 0 C-N-CA 121.178 1.252 . . . . 0.0 110.687 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.559 ' N ' ' CD ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -175.55 -164.53 0.14 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.354 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.37 165.47 25.4 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.027 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.616 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -128.66 151.46 49.48 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.777 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 1.2 m-85 -142.43 139.92 31.79 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.534 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.517 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 27.7 m-85 -95.09 179.74 5.1 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 118.414 -1.314 . . . . 0.0 112.492 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.456 ' CE1' HG22 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -101.65 -74.75 0.61 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.023 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.521 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 25.9 tttm -63.29 160.6 15.48 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.858 0.837 . . . . 0.0 112.499 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.587 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -71.7 103.45 3.07 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.477 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.587 ' CB ' ' O ' ' A' ' 99' ' ' GLU . 9.1 tp60 113.1 55.48 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.496 0 O-C-N 125.245 1.591 . . . . 0.0 111.056 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.561 ' CD2' ' O ' ' A' ' 101' ' ' PHE . 17.9 p90 28.52 41.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.492 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.566 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 6.4 p-10 -115.26 24.15 11.88 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.66 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.521 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -139.42 150.45 21.34 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.8 OUTLIER -33.34 142.21 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.598 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.404 ' O ' ' CD ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -105.66 162.95 13.06 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.635 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.787 HG21 ' O ' ' A' ' 122' ' ' GLY . 1.4 t -132.62 167.57 26.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.476 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.536 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 2.6 p30 -150.18 149.0 29.61 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.099 -1.44 . . . . 0.0 112.438 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.437 HD22 ' CD2' ' A' ' 121' ' ' TYR . 14.2 mt -137.22 143.2 40.73 Favored Pre-proline 0 N--CA 1.499 1.98 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.446 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.81 166.43 27.69 Favored 'Trans proline' 0 C--O 1.212 -0.782 0 C-N-CA 121.789 1.66 . . . . 0.0 112.346 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.89 145.98 95.01 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 122.296 1.997 . . . . 0.0 111.233 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.17 -143.27 12.63 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.279 -1.438 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.692 ' NE2' ' CE1' ' A' ' 146' ' ' PHE . 42.3 tt0 -146.46 154.27 41.39 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.165 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.597 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 8.4 m-85 -138.64 152.89 48.49 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.102 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.6 p -88.43 -166.84 1.7 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.669 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -96.57 51.17 1.16 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.389 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.58 -68.81 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.35 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 121' ' ' TYR . 8.6 pt-20 -68.54 -41.68 79.52 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.891 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.61 ' C ' HD23 ' A' ' 118' ' ' LEU . 0.9 OUTLIER -37.49 -75.07 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.633 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.697 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -51.68 -52.2 49.97 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.574 -0.851 . . . . 0.0 110.855 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -74.57 16.33 0.28 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.961 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 117' ' ' GLU . 17.8 t80 -124.52 -13.8 6.99 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.517 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.787 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -138.13 -52.94 0.05 OUTLIER Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.506 -1.33 . . . . 0.0 110.603 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.679 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -138.4 -101.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.407 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.511 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 32.0 t70 -164.41 176.79 8.73 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.162 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.541 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 14.4 t-20 -59.83 137.61 58.01 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.843 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.677 ' O ' HG22 ' A' ' 127' ' ' THR . 7.4 p30 43.59 -151.07 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.914 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.677 HG22 ' O ' ' A' ' 126' ' ' ASN . 13.7 t 48.35 20.09 0.26 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.59 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.487 ' O ' ' CB ' ' A' ' 129' ' ' SER . 7.4 mm -50.57 -84.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.927 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 1.2 p 80.51 120.01 0.05 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.444 ' H ' ' H ' ' A' ' 160' ' ' LEU . 0.9 OUTLIER 51.44 114.16 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.022 -1.445 . . . . 0.0 114.197 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.409 HG13 ' CD2' ' A' ' 95' ' ' PHE . 3.6 t -121.47 134.55 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.571 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.4 ttmm -131.32 99.37 17.57 Favored Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.664 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.85 107.43 1.87 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.018 1.145 . . . . 0.0 110.47 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -86.29 11.14 12.82 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.843 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.5 -45.73 0.04 OUTLIER Glycine 0 N--CA 1.494 2.564 0 C-N-CA 118.097 -2.001 . . . . 0.0 111.762 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.23 163.17 18.17 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.154 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 173' ' ' SER . . . -80.44 159.94 25.47 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.79 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 20.8 t -122.41 141.68 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.921 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.421 ' C ' HD12 ' A' ' 140' ' ' LEU . 47.5 t -128.86 130.86 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.71 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 140' ' ' LEU . 11.0 mp -105.22 139.33 40.04 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.319 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 3.0 m-85 -121.44 129.23 52.87 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.987 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.469 ' HD2' ' H ' ' A' ' 142' ' ' LYS . 0.1 OUTLIER -77.07 -48.44 17.81 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.484 -0.887 . . . . 0.0 112.228 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' A' ' 144' ' ' ASP . 3.8 m120 -74.32 135.78 42.56 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.069 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 143' ' ' ASN . 6.4 m-20 -9.16 -110.42 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.589 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 11.0 m120 -68.45 86.69 0.3 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.692 ' CE1' ' NE2' ' A' ' 112' ' ' GLN . 1.1 p90 30.32 72.55 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.889 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.7 m -142.67 -160.64 1.12 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.091 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 44.25 -158.01 0.16 Allowed Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.81 -1.186 . . . . 0.0 111.106 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -62.08 163.71 7.65 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.932 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.5 p -150.34 162.9 39.63 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.409 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.7 88.58 53.98 Favored Pre-proline 0 N--CA 1.485 1.296 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.041 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -66.08 105.3 0.81 Allowed 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.433 1.422 . . . . 0.0 111.965 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.43 69.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.238 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 154' ' ' ASN . 2.6 m120 -81.06 37.28 0.43 Allowed 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.127 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.604 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 13.7 t -170.9 -175.15 1.7 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.061 -1.055 . . . . 0.0 111.161 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.604 ' N ' ' OG ' ' A' ' 155' ' ' SER . 16.3 m-20 -76.78 142.12 40.49 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.559 -0.857 . . . . 0.0 111.141 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.559 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -154.96 74.33 5.62 Favored Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.458 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.23 23.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 122.065 1.843 . . . . 0.0 112.317 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.559 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -171.43 115.71 0.4 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.701 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.444 ' H ' ' H ' ' A' ' 130' ' ' SER . 0.2 OUTLIER -128.74 4.47 5.48 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.719 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.831 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.086 0.469 . . . . 0.0 111.907 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.4 m -75.97 104.77 6.66 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.835 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.3 t -82.17 -68.0 0.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.732 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.612 ' CB ' ' H ' ' A' ' 146' ' ' PHE . 28.6 m -114.03 163.73 14.76 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.926 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.47 HG23 HD11 ' A' ' 118' ' ' LEU . 22.0 pt -141.02 161.29 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.089 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.409 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 25.1 ttt180 -141.8 98.7 3.39 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.6 mt -77.71 99.49 2.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.037 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 137' ' ' ALA . 39.7 m . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.814 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.544 ' HB1' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.876 0.369 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -173.93 123.46 0.33 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.464 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 4' ' ' ILE . 25.9 pt -76.05 148.54 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.5 m -122.89 109.82 14.64 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.243 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 m -100.75 150.93 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.924 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.791 ' CZ ' ' CE1' ' A' ' 12' ' ' PHE . 25.9 m-85 -109.51 163.64 13.25 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.636 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.29 -3.21 47.84 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.051 -1.06 . . . . 0.0 113.681 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.51 ' C ' ' OG ' ' A' ' 40' ' ' SER . 83.4 m-20 -136.0 164.32 28.26 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.945 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -70.63 176.68 3.97 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.69 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 13' ' ' GLN . 5.9 m-20 57.44 46.55 17.91 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.344 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.791 ' CE1' ' CZ ' ' A' ' 7' ' ' PHE . 85.4 t80 49.91 7.24 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.341 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.69 ' CD ' ' H ' ' A' ' 14' ' ' GLY . 10.1 tm0? -92.06 174.27 7.41 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.434 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.69 ' H ' ' CD ' ' A' ' 13' ' ' GLN . . . 93.84 127.33 4.69 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.053 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' GLY . 13.7 mptt -31.38 141.49 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.056 0.455 . . . . 0.0 111.914 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -93.17 162.71 13.91 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.834 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -148.09 125.22 2.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.964 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -93.15 128.49 39.1 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.971 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.4 mt -122.28 129.82 24.94 Favored Pre-proline 0 N--CA 1.491 1.615 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.728 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -67.96 162.44 39.83 Favored 'Trans proline' 0 C--N 1.325 -0.684 0 C-N-CA 120.806 1.004 . . . . 0.0 111.141 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.04 -161.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 121.667 1.578 . . . . 0.0 110.864 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.4 -179.46 49.32 Favored Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.295 -1.431 . . . . 0.0 111.082 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -106.21 135.47 47.63 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.204 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.482 ' HE1' HD12 ' A' ' 82' ' ' ILE . 16.5 p90 -152.23 167.75 27.57 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.104 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.6 p -142.05 -161.44 1.23 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.108 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -56.71 -29.2 62.22 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.054 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.18 -67.68 0.43 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.125 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.535 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.7 tp-100 -57.56 -41.46 81.1 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.428 -1.309 . . . . 0.0 110.003 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.466 HD22 ' CG1' ' A' ' 34' ' ' ILE . 28.6 mt -61.04 -39.76 91.01 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.892 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.95 -32.61 33.93 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 118.035 -1.466 . . . . 0.0 107.807 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -68.39 -36.66 79.46 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.318 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.452 HD12 HD23 ' A' ' 29' ' ' LEU . 14.3 mt -74.75 -80.01 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.872 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.46 -22.67 0.09 OUTLIER Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.854 -1.641 . . . . 0.0 111.222 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.466 ' CG1' HD22 ' A' ' 29' ' ' LEU . 6.5 pt -85.39 158.08 3.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.263 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER 170.27 137.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.708 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 8.1 t-20 74.97 -147.3 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.557 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.434 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 15.1 p30 -58.68 96.7 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.651 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 39' ' ' ILE . 60.6 p -152.1 -142.57 0.12 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.106 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.632 HG13 HG11 ' A' ' 79' ' ' VAL . 2.2 mm 36.82 44.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.323 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.51 ' OG ' ' C ' ' A' ' 9' ' ' ASN . 12.7 t -49.08 -43.01 40.72 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.502 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.2 171.74 13.82 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -152.1 141.85 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 118.093 -1.443 . . . . 0.0 112.954 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -134.05 103.77 5.94 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.943 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.3 t -120.48 108.31 37.8 Favored Pre-proline 0 N--CA 1.494 1.743 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.231 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -67.21 168.73 16.85 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.11 1.206 . . . . 0.0 110.746 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -59.35 -170.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.929 1.753 . . . . 0.0 111.179 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.18 -11.7 11.45 Favored Glycine 0 N--CA 1.483 1.81 0 C-N-CA 119.278 -1.439 . . . . 0.0 110.961 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.544 HG21 ' HB1' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -149.49 141.7 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.114 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.7 tttt -116.01 126.58 54.01 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.542 ' CB ' HG22 ' A' ' 84' ' ' VAL . . . -115.2 165.32 13.06 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.109 -1.036 . . . . 0.0 113.307 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.583 HG23 ' O ' ' A' ' 63' ' ' ILE . 63.2 mt -142.44 120.65 8.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 114.211 -1.359 . . . . 0.0 108.524 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.833 HD23 ' H ' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -92.19 148.38 22.2 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.104 -1.038 . . . . 0.0 112.074 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.833 ' H ' HD23 ' A' ' 52' ' ' LEU . 17.6 m-85 -132.83 114.71 14.4 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.183 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -53.16 -84.29 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.787 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -59.48 149.37 29.83 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.1 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -57.22 -173.01 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.637 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.1 32.43 35.42 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.19 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 49.53 45.13 24.27 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.732 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.54 -169.45 1.67 Allowed 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.011 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 68.0 166.38 3.54 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.892 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 60' ' ' GLY . 26.6 t70 -42.78 130.37 4.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.535 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.681 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 5.9 pm0 -99.86 166.06 11.26 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.052 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.711 HG13 HD11 ' A' ' 75' ' ' LEU . 5.5 mm -135.13 169.5 21.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.534 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.658 ' N ' HG22 ' A' ' 63' ' ' ILE . 36.7 mt-10 -146.34 132.45 19.33 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.003 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 m -149.32 151.59 12.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.358 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.3 t -140.2 -0.26 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . . . -130.8 -147.61 0.33 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.669 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.5 119.1 38.0 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.671 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.57 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.36 104.41 16.96 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.861 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -64.32 -77.68 0.05 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.003 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 73' ' ' GLY . 6.5 mm-40 -83.41 1.31 42.11 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.5 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.403 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 3.0 tp 56.63 -89.22 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.55 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 177.82 -166.48 36.76 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.155 -1.498 . . . . 0.0 110.621 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.571 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.9 Cg_endo -66.45 -40.96 12.9 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 122.135 1.89 . . . . 0.0 112.163 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.838 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.9 pt? -68.13 26.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.465 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.571 ' H ' ' C ' ' A' ' 74' ' ' PRO . 34.0 t-20 -68.55 -34.89 76.62 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.574 -0.85 . . . . 0.0 111.277 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -87.98 29.78 0.9 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.098 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -171.88 112.92 0.32 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.335 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.632 HG11 HG13 ' A' ' 39' ' ' ILE . 57.5 t -147.38 155.38 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.902 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.42 ' N ' HG12 ' A' ' 79' ' ' VAL . 21.2 t -171.62 -34.85 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 118.744 -1.182 . . . . 0.0 112.265 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.1 m -116.66 137.91 51.84 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.956 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.482 HD12 ' HE1' ' A' ' 24' ' ' TYR . 1.3 mt -148.6 155.18 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.511 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.849 HH12 ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -149.71 133.49 16.88 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.889 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.849 ' N ' HH12 ' A' ' 83' ' ' ARG . 13.9 t -140.68 148.25 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.911 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.932 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -142.41 136.46 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.846 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.6 m -39.91 152.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.166 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.59 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -153.24 141.36 13.85 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.224 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.59 ' HD2' HG22 ' A' ' 87' ' ' VAL . 7.8 Cg_exo -49.25 151.08 6.82 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.451 1.434 . . . . 0.0 111.706 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 89' ' ' VAL . 17.6 m -71.51 147.22 11.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.903 -0.719 . . . . 0.0 112.309 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -145.87 129.73 8.55 Favored Pre-proline 0 C--N 1.301 -1.523 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.922 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -58.17 -159.4 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.874 0 C-N-CA 120.987 1.125 . . . . 0.0 110.801 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.481 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.58 -161.82 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.162 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.412 ' H ' ' HB2' ' A' ' 92' ' ' ARG . . . -136.27 164.72 27.43 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.841 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 39.7 ttm-85 -121.99 126.17 47.94 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.714 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 11.4 m-85 -116.8 125.31 51.41 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.797 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -84.65 168.07 15.63 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.191 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.437 ' HB3' ' H ' ' A' ' 98' ' ' LYS . 1.2 t80 -80.35 -92.11 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 118.502 -1.279 . . . . 0.0 112.939 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 97' ' ' TYR . 18.8 mmmt -68.22 156.05 38.41 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.932 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.942 ' O ' ' OE1' ' A' ' 100' ' ' GLN . 3.5 tm-20 -66.57 85.01 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.127 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.942 ' OE1' ' O ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER 173.86 30.05 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.202 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.61 ' O ' ' CD1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER 47.81 11.51 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.797 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 100' ' ' GLN . 34.7 t70 -104.4 -177.47 3.37 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.316 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 72.41 128.81 0.1 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.068 -1.539 . . . . 0.0 109.998 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 103' ' ' GLY . 48.1 mttt -30.06 136.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 123.99 0.465 . . . . 0.0 111.438 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -98.96 170.39 8.76 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.502 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 122' ' ' GLY . 29.9 t -137.36 155.31 31.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.69 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -129.24 147.01 51.04 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.654 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.43 HD12 ' CE1' ' A' ' 95' ' ' PHE . 11.1 mt -136.42 139.31 29.25 Favored Pre-proline 0 N--CA 1.501 2.106 0 C-N-CA 119.724 -0.791 . . . . 0.0 110.811 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -71.04 167.75 25.2 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 121.662 1.575 . . . . 0.0 112.193 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.32 150.83 85.71 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 122.101 1.868 . . . . 0.0 111.573 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.18 -168.81 23.6 Favored Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.03 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.594 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 21.8 mp0 -113.74 159.1 20.11 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.6 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 40.7 m-85 -144.84 149.89 36.16 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.755 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.4 p -89.64 -153.06 0.26 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.123 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.422 ' C ' ' CD ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -110.95 31.81 5.75 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.67 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -134.93 -64.31 0.66 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.953 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.6 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 17.2 pt-20 -66.21 -49.37 67.5 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.066 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.6 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -37.12 -67.15 0.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.293 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.736 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 20.6 mp0 -48.2 -66.74 0.35 Allowed 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.14 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -72.44 12.32 0.48 Allowed 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.06 -1.056 . . . . 0.0 113.301 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 117' ' ' GLU . 12.8 t80 -101.97 -21.86 14.41 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.007 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.421 ' O ' HG11 ' A' ' 106' ' ' VAL . . . -165.36 -12.97 0.03 OUTLIER Glycine 0 N--CA 1.486 2.014 0 C-N-CA 118.237 -1.935 . . . . 0.0 110.93 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 123' ' ' ILE . 2.8 mt -145.69 -125.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.876 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -156.98 -160.38 0.96 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.457 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -59.55 -53.62 56.0 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.809 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -155.62 123.68 5.77 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.601 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.41 ' H ' ' H ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 177.71 0.81 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.042 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 130' ' ' SER . 70.5 mt -56.43 -72.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.285 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m 55.7 -85.1 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.776 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 128' ' ' ILE . 15.1 m -72.62 115.74 12.26 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.488 -0.885 . . . . 0.0 112.391 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.4 t -122.7 161.78 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.779 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -165.08 80.51 1.24 Allowed Pre-proline 0 C--N 1.296 -1.726 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.293 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -60.59 102.9 0.2 Allowed 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 121.568 1.512 . . . . 0.0 110.242 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -87.82 19.71 3.38 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.467 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.12 -50.93 0.03 OUTLIER Glycine 0 N--CA 1.491 2.352 0 C-N-CA 117.91 -2.09 . . . . 0.0 112.191 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.86 179.85 3.96 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.454 -0.899 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -92.1 152.33 19.98 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.776 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 68.2 t -124.11 138.86 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.127 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.503 ' C ' HD12 ' A' ' 140' ' ' LEU . 78.3 t -131.71 128.42 60.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.417 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.503 HD12 ' C ' ' A' ' 139' ' ' VAL . 8.3 mp -103.99 141.77 35.6 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.365 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -114.16 126.98 55.68 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.515 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -59.21 -78.62 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -73.71 155.54 38.85 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.816 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 146' ' ' PHE . 5.3 p-10 -62.49 -162.18 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.567 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.497 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 43.7 t30 42.5 24.15 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.675 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.497 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.4 OUTLIER 57.17 54.82 6.45 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.703 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.8 t -130.73 -171.68 2.62 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.305 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 64.11 -177.9 8.27 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.024 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 150' ' ' THR . 25.5 t0 -59.68 177.23 0.22 Allowed 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.262 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.437 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 19.5 p -146.56 178.59 8.17 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.193 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' A' ' 151' ' ' LEU . 11.0 tp -153.07 86.61 4.09 Favored Pre-proline 0 C--N 1.306 -1.303 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.778 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.46 108.07 1.13 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.871 1.714 . . . . 0.0 113.131 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.7 t -82.72 93.59 2.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.788 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -58.8 -29.35 66.77 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 48.0 p -170.38 -146.36 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 117.986 -1.486 . . . . 0.0 112.854 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 1.1 m-20 -48.98 153.24 0.91 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.99 -1.004 . . . . 0.0 112.491 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.5 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -179.89 65.24 0.14 Allowed Pre-proline 0 N--CA 1.486 1.37 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.206 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.696 ' C ' HG22 ' A' ' 159' ' ' THR . 6.4 Cg_endo -69.03 66.29 1.34 Allowed 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 122.27 1.98 . . . . 0.0 111.959 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.785 HG23 ' H ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER 161.11 -68.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.56 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.785 ' H ' HG23 ' A' ' 159' ' ' THR . 0.9 OUTLIER 57.04 -81.41 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.829 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 159' ' ' THR . . . . . . . . 0 N--CA 1.489 2.207 0 C-N-CA 118.495 -1.812 . . . . 0.0 109.683 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.024 0.44 . . . . 0.0 111.562 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.0 m -70.44 104.91 2.87 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.836 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.2 m -80.98 -66.25 0.91 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.216 -0.993 . . . . 0.0 111.599 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.8 p -118.7 159.89 22.83 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.978 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 23.2 pt -135.53 179.8 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.246 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -159.5 100.99 1.51 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.821 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.8 mt -82.06 96.88 3.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.78 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 116.302 -1.808 . . . . 0.0 111.095 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.532 ' HB1' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 179.62 118.21 0.05 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.995 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.497 ' CG2' HG22 ' A' ' 44' ' ' VAL . 40.3 pt -79.27 164.8 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.388 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.5 m -138.93 123.02 17.96 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.729 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -104.62 168.12 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.285 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.418 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 68.9 m-85 -128.94 144.6 51.23 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.71 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -52.86 19.83 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.783 -0.767 . . . . 0.0 113.041 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.503 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 24.8 m120 -95.27 170.42 9.4 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.409 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.679 ' CG ' ' H ' ' A' ' 11' ' ' ASP . 16.6 tt0 -64.26 -178.7 0.38 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.778 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.679 ' H ' ' CG ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER 41.51 62.17 1.61 Allowed 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.325 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.655 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 44.9 p90 36.71 27.14 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.229 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ASP . 19.5 tp60 -101.46 162.46 12.88 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.729 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.503 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 89.37 137.32 6.3 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.472 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.482 ' N ' ' HE3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -30.04 137.52 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.057 0.456 . . . . 0.0 111.889 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -103.32 162.97 12.56 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.034 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -144.23 130.26 15.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.297 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.58 133.6 34.53 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.749 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 mt -126.13 123.73 24.44 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.578 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.94 162.22 29.92 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 120.975 1.117 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.27 -170.08 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 121.705 1.604 . . . . 0.0 110.967 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.3 -179.08 38.99 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.095 -1.526 . . . . 0.0 110.958 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -109.36 129.94 55.51 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.715 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.44 ' OH ' HD11 ' A' ' 4' ' ' ILE . 12.6 p90 -143.23 175.19 10.07 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.433 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.0 p -140.35 -160.0 1.02 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.475 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -61.15 -20.56 62.84 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.7 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.91 -62.35 1.7 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.157 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.476 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -55.64 -43.1 75.91 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.661 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 29' ' ' LEU . 20.4 mt -59.45 -41.2 89.11 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.424 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.65 -31.01 23.86 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 118.805 -1.158 . . . . 0.0 108.662 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -71.55 -38.16 71.02 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.0 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.403 ' HG ' ' H ' ' A' ' 32' ' ' LEU . 11.5 mt -73.13 -74.39 0.17 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.688 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.46 -34.87 0.47 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.057 -1.544 . . . . 0.0 110.841 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.44 HD11 ' H ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER -80.92 140.43 16.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.615 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.54 ' H ' HG21 ' A' ' 38' ' ' THR . 2.8 pt-20 178.54 131.72 0.07 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.78 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.72 ' O ' HG23 ' A' ' 38' ' ' THR . 1.5 t-20 78.22 127.49 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.511 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.4 ' N ' HG22 ' A' ' 79' ' ' VAL . 3.1 m-20 51.55 7.85 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.705 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 36' ' ' ASN . 67.2 p -91.48 -135.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.664 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.54 HG13 HG21 ' A' ' 79' ' ' VAL . 2.2 mt 35.74 39.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.604 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.52 -57.51 6.92 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.762 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.418 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -116.66 168.96 9.73 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.266 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -149.73 148.96 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 118.529 -1.269 . . . . 0.0 112.396 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -137.87 96.02 3.15 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.157 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.497 HG22 ' CG2' ' A' ' 4' ' ' ILE . 71.6 t -111.21 110.66 56.13 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.386 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -69.07 171.21 14.11 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.114 1.209 . . . . 0.0 110.411 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.45 -173.94 0.19 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.663 1.575 . . . . 0.0 111.082 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.04 -17.86 6.84 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.328 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.532 HG21 ' HB1' ' A' ' 2' ' ' ALA . 0.2 OUTLIER -146.81 138.85 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.312 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -105.9 119.7 39.86 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HB3' ' CG2' ' A' ' 65' ' ' VAL . . . -97.38 155.65 16.81 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.194 -1.002 . . . . 0.0 112.884 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.501 ' C ' HD12 ' A' ' 52' ' ' LEU . 53.1 mt -141.76 117.21 5.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.921 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.838 ' N ' HD12 ' A' ' 52' ' ' LEU . 2.0 mp -89.47 157.71 18.0 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.349 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.434 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 43.3 m-85 -138.47 107.36 5.97 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.553 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -40.93 -76.92 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.95 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.458 ' C ' ' OG ' ' A' ' 80' ' ' SER . 91.5 m-20 -68.45 153.33 43.97 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.311 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -59.99 -174.95 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.653 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 49.21 40.49 29.43 Favored Glycine 0 N--CA 1.484 1.891 0 C-N-CA 119.114 -1.517 . . . . 0.0 109.656 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.653 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.5 OUTLIER 41.5 69.19 0.37 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.452 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.69 -162.39 1.42 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.993 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.48 -176.59 0.63 Allowed Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.23 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.654 ' OD2' HD22 ' A' ' 75' ' ' LEU . 10.4 t0 -46.2 160.85 0.06 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.879 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -146.99 161.17 41.33 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.864 -1.135 . . . . 0.0 111.67 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.658 HG22 ' H ' ' A' ' 64' ' ' GLU . 38.4 mt -133.03 172.97 15.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.112 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.658 ' H ' HG22 ' A' ' 63' ' ' ILE . 3.3 tm-20 -144.81 130.44 18.99 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.154 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 50' ' ' ALA . 21.1 m -145.19 154.54 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 118.615 -1.234 . . . . 0.0 112.108 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.91 -1.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.491 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.38 -124.12 0.23 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.062 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.631 ' ND2' ' OD1' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -121.82 121.26 36.79 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.95 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.559 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -88.47 109.05 19.72 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.673 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -61.9 -87.69 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.307 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 18.4 mt-10 -78.81 1.01 24.75 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.428 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 2.2 tp 74.73 -82.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.835 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.82 -169.19 41.94 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.225 -1.464 . . . . 0.0 110.696 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.473 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.3 Cg_endo -65.91 -46.54 4.7 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.307 2.005 . . . . 0.0 112.384 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.697 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -73.62 34.9 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.291 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 74' ' ' PRO . 29.0 p-10 -75.34 -24.05 57.3 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.745 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -80.12 4.48 17.18 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.985 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -151.93 114.12 4.5 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.533 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.54 HG21 HG13 ' A' ' 39' ' ' ILE . 24.2 m -133.9 158.29 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.963 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 81' ' ' SER . 96.4 p -164.44 -69.43 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 118.391 -1.324 . . . . 0.0 112.453 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.541 ' N ' ' OG ' ' A' ' 80' ' ' SER . 73.7 m -107.42 160.89 15.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.49 -0.884 . . . . 0.0 112.485 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.514 HG23 ' HA ' ' A' ' 52' ' ' LEU . 1.7 mt -149.87 159.7 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.635 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.809 HH22 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.7 130.72 15.32 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 118.929 -1.108 . . . . 0.0 111.415 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.809 ' CA ' HH22 ' A' ' 83' ' ' ARG . 4.2 t -132.2 141.65 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.847 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.479 HG12 ' NH2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -136.17 140.32 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.047 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 90.2 p -43.27 151.05 0.17 Allowed 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.599 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.667 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -156.85 144.14 13.75 Favored Pre-proline 0 C--N 1.307 -1.273 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.638 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.667 ' HD2' HG22 ' A' ' 87' ' ' VAL . 6.3 Cg_exo -50.05 146.27 17.63 Favored 'Trans proline' 0 C--O 1.213 -0.763 0 C-N-CA 121.256 1.304 . . . . 0.0 111.345 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.95 145.94 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.053 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -145.28 153.66 52.7 Favored Pre-proline 0 N--CA 1.486 1.349 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.469 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.459 ' HG2' HD21 ' A' ' 136' ' ' LEU . 4.8 Cg_exo -60.52 -152.07 0.01 OUTLIER 'Trans proline' 0 C--O 1.211 -0.868 0 C-N-CA 121.061 1.174 . . . . 0.0 110.501 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 179.76 -163.39 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.826 -1.15 . . . . 0.0 110.86 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.76 169.92 16.33 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.201 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.513 ' HE ' ' HG3' ' A' ' 105' ' ' GLU . 66.7 ttt180 -137.91 110.02 7.29 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.969 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.56 ' CE1' HD12 ' A' ' 108' ' ' LEU . 19.3 m-85 -93.91 168.52 10.92 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.419 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.488 ' CD1' ' HB3' ' A' ' 105' ' ' GLU . 49.2 m-85 -137.87 177.08 8.15 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 119.033 -1.067 . . . . 0.0 112.075 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.691 ' CE2' HG21 ' A' ' 127' ' ' THR . 3.2 m-85 -115.63 133.21 56.26 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.4 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 19.4 tttp 78.59 137.72 0.07 Allowed 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.035 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.628 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -68.2 104.84 1.92 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.219 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.614 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 28.2 tp60 126.28 39.44 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.263 0 O-C-N 125.565 1.791 . . . . 0.0 109.721 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.614 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 25.7 p90 29.67 49.51 0.06 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.8 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -103.65 -17.67 15.04 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.076 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -102.41 164.07 16.67 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.594 -1.288 . . . . 0.0 110.976 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.46 ' CG ' ' N ' ' A' ' 105' ' ' GLU . 16.9 ttmt -40.7 160.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.823 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 105' ' ' GLU . 1.3 pm0 -127.14 158.97 35.64 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.613 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.4 156.43 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.741 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.631 ' OD1' ' ND2' ' A' ' 68' ' ' ASN . 4.8 p-10 -125.91 148.47 49.2 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.578 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.56 HD12 ' CE1' ' A' ' 95' ' ' PHE . 41.2 mt -139.19 124.69 11.95 Favored Pre-proline 0 N--CA 1.487 1.421 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.342 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.451 ' CB ' ' HD2' ' A' ' 110' ' ' PRO . 1.9 Cg_endo -64.39 171.59 7.78 Favored 'Trans proline' 0 C--O 1.213 -0.77 0 C-N-CA 121.476 1.451 . . . . 0.0 111.356 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 1.9 Cg_endo -60.78 146.41 97.42 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.875 1.717 . . . . 0.0 111.568 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.19 -154.92 25.74 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.674 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.591 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 28.5 mt-30 -133.24 161.29 34.85 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.842 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.591 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 24.0 m-85 -144.54 150.64 37.87 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.372 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 1.3 p -91.78 -142.17 0.19 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.697 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.597 ' N ' ' OG1' ' A' ' 114' ' ' THR . 13.7 mt-30 -90.31 -86.46 0.2 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.31 -28.2 62.86 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -70.09 -61.06 1.93 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.307 -1.357 . . . . 0.0 108.454 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.706 ' C ' HD23 ' A' ' 118' ' ' LEU . 2.2 tt -43.35 -64.04 0.71 Allowed 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.557 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.415 ' CD ' ' O ' ' A' ' 115' ' ' GLN . 1.1 mp0 -42.86 -68.3 0.21 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.36 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.554 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 10.6 mpt_? -68.43 0.33 4.09 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.624 -0.83 . . . . 0.0 113.199 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -89.03 -24.87 22.24 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 118.464 -1.295 . . . . 0.0 110.554 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -153.75 -20.75 0.05 OUTLIER Glycine 0 N--CA 1.485 1.951 0 C-N-CA 118.429 -1.844 . . . . 0.0 111.688 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.444 ' HB ' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -145.32 -115.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.329 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.444 ' H ' ' HB ' ' A' ' 123' ' ' ILE . 4.2 m-20 -167.57 -164.89 0.61 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -58.13 -76.09 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.163 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 127' ' ' THR . 3.7 t-20 -74.68 -138.11 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.123 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.691 HG21 ' CE2' ' A' ' 97' ' ' TYR . 0.5 OUTLIER 68.78 -138.45 0.09 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.785 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.441 ' C ' ' HG ' ' A' ' 129' ' ' SER . 3.9 mm 73.55 -49.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.477 0 O-C-N 124.168 0.918 . . . . 0.0 110.435 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 130' ' ' SER . 47.0 p 39.35 -135.32 0.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.937 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.542 ' N ' ' OG ' ' A' ' 129' ' ' SER . 24.1 m -63.37 143.9 57.42 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.381 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.03 151.46 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.489 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -150.31 81.67 6.62 Favored Pre-proline 0 C--N 1.304 -1.391 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.489 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -61.08 92.4 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.316 1.344 . . . . 0.0 110.043 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -73.64 26.18 0.07 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.118 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 176.71 -51.75 0.11 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 117.53 -2.272 . . . . 0.0 112.735 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.459 HD21 ' HG2' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -108.63 173.76 6.17 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.598 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -91.76 141.94 28.13 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.581 -0.848 . . . . 0.0 108.974 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 153' ' ' VAL . 66.9 t -109.89 139.99 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.547 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.03 127.17 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.701 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 mp -101.52 138.88 37.93 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.552 -0.859 . . . . 0.0 112.39 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.431 ' CG ' ' HA ' ' A' ' 146' ' ' PHE . 22.3 m-85 -114.07 118.56 34.42 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.082 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -48.19 -77.49 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.625 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.443 ' HB2' ' CB ' ' A' ' 147' ' ' SER . 3.3 m-20 -74.59 -156.49 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.341 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 146' ' ' PHE . 6.8 p-10 -62.07 -154.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.529 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 4.8 m120 -33.62 88.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.159 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.529 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 3.3 p90 36.31 66.07 0.41 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.663 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 92.5 p -61.0 -108.05 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.738 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.52 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . -115.4 -63.23 0.38 Allowed Glycine 0 N--CA 1.502 3.043 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.974 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.404 ' C ' ' CG2' ' A' ' 150' ' ' THR . 24.3 t70 -74.13 144.47 44.87 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.58 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.404 ' CG2' ' C ' ' A' ' 149' ' ' ASP . 6.7 p -151.67 173.74 14.32 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.491 -0.883 . . . . 0.0 111.187 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.547 HD23 ' C ' ' A' ' 151' ' ' LEU . 3.0 tt -144.25 87.51 7.78 Favored Pre-proline 0 C--N 1.31 -1.145 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.153 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.14 103.99 0.56 Allowed 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.671 1.581 . . . . 0.0 112.651 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 138' ' ' VAL . 2.8 t -77.75 93.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.154 -1.019 . . . . 0.0 109.912 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -43.78 -42.85 5.79 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.888 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.1 t -171.2 -130.09 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 118.456 -1.298 . . . . 0.0 112.229 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -46.44 141.89 3.36 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.681 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.85 64.13 1.06 Allowed Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.195 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.6 Cg_endo -63.08 21.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.279 1.986 . . . . 0.0 113.269 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 159' ' ' THR . 1.3 t -172.37 106.4 0.18 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.806 -1.157 . . . . 0.0 110.911 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.674 ' C ' HD13 ' A' ' 160' ' ' LEU . 3.0 tm? -103.6 -78.63 0.55 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.288 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.433 ' O ' ' CD1' ' A' ' 160' ' ' LEU . . . . . . . . 0 N--CA 1.494 2.539 0 C-N-CA 119.859 -1.163 . . . . 0.0 111.656 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.578 0.228 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.8 m 44.72 83.08 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.391 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.36 -52.22 8.37 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.846 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.2 p -123.66 163.77 20.41 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.68 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 36.2 pt -143.34 178.22 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.522 ' NH1' ' OE1' ' A' ' 112' ' ' GLN . 35.5 ttt85 -156.8 109.23 2.51 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.64 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.2 mt -85.95 95.8 4.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.149 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 C--N 1.303 -1.415 0 CA-C-O 116.379 -1.772 . . . . 0.0 110.825 -179.92 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.462 ' HB1' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.985 0.421 . . . . 0.0 111.506 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.579 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 0.5 OUTLIER 179.49 122.3 0.06 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.517 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 4' ' ' ILE . 1.7 pt -77.44 126.91 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.985 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.9 m -105.51 108.21 19.61 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.11 165.23 2.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.028 -1.069 . . . . 0.0 112.717 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.5 ' CE2' ' NE2' ' A' ' 16' ' ' GLN . 50.1 m-85 -123.37 145.15 48.99 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.837 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.46 ' HB2' ' N ' ' A' ' 15' ' ' LYS . 2.0 m-85 -83.91 8.45 15.0 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 13' ' ' GLN . 0.4 OUTLIER -150.19 171.08 17.49 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 118.132 -1.427 . . . . 0.0 111.979 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.497 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 11.6 mm-40 -78.36 146.88 34.39 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.348 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.587 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 2.1 t70 76.87 60.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.42 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.587 ' CG ' ' O ' ' A' ' 11' ' ' ASP . 54.7 p90 42.78 15.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.774 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 11' ' ' ASP . 46.9 mt-30 -101.42 154.5 18.75 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.193 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.994 ' O ' ' OE1' ' A' ' 16' ' ' GLN . . . 116.63 139.34 6.48 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 1.129 ' C ' ' OE1' ' A' ' 16' ' ' GLN . 9.3 mtpm? -36.41 147.38 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.491 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 1.129 ' OE1' ' C ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -99.88 142.25 31.61 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.584 -0.847 . . . . 0.0 112.25 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 t -144.48 123.72 6.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.523 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -95.47 119.39 33.89 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.414 -0.914 . . . . 0.0 112.106 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.1 125.7 30.1 Favored Pre-proline 0 N--CA 1.494 1.762 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.471 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -65.44 162.39 33.97 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 120.993 1.128 . . . . 0.0 111.724 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.31 -178.83 0.51 Allowed 'Trans proline' 0 C--N 1.322 -0.838 0 C-N-CA 121.768 1.645 . . . . 0.0 110.966 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.525 ' H ' ' HB ' ' A' ' 84' ' ' VAL . . . 108.4 -170.9 15.3 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.381 -1.39 . . . . 0.0 110.662 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.599 ' CB ' ' HE ' ' A' ' 83' ' ' ARG . 1.1 m-20 -117.21 124.69 49.72 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.96 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 3.2 p90 -144.3 169.43 17.91 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.786 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.7 p -140.75 -142.04 0.14 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.992 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -69.32 -38.5 78.25 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.031 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.591 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -54.7 -58.59 6.94 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.14 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -56.89 -51.18 70.1 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.484 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.55 HD23 HD12 ' A' ' 32' ' ' LEU . 28.4 mt -58.26 -28.8 65.27 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.446 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -56.26 -32.09 64.18 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.42 -36.04 63.41 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.72 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.55 HD12 HD23 ' A' ' 29' ' ' LEU . 13.3 mt -77.01 -83.65 0.07 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.89 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 32' ' ' LEU . . . 152.39 -16.91 0.77 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.033 -1.556 . . . . 0.0 111.225 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -91.36 138.98 18.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.073 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.505 ' C ' ' CG ' ' A' ' 36' ' ' ASN . 1.8 pt-20 172.42 150.31 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.403 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.747 ' O ' HG23 ' A' ' 38' ' ' THR . 0.4 OUTLIER 75.86 123.81 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 43.39 12.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.358 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.747 HG23 ' O ' ' A' ' 36' ' ' ASN . 64.3 p -88.86 -151.38 0.21 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.447 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.443 HD12 HG11 ' A' ' 79' ' ' VAL . 2.3 mt 42.49 60.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.736 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.8 t -80.14 -33.15 38.74 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.418 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.448 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -143.14 153.72 43.16 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.247 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.056 HG22 ' HB3' ' A' ' 69' ' ' ALA . 25.4 m -143.38 170.44 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 118.128 -1.429 . . . . 0.0 113.578 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -143.48 95.67 2.79 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.862 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.99 108.48 46.27 Favored Pre-proline 0 N--CA 1.493 1.716 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.73 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.414 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.6 Cg_endo -68.52 170.29 15.35 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 120.975 1.117 . . . . 0.0 110.321 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 2.5 Cg_endo -60.28 -170.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.877 1.718 . . . . 0.0 111.407 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.3 -12.34 10.11 Favored Glycine 0 N--CA 1.485 1.945 0 C-N-CA 119.407 -1.377 . . . . 0.0 111.13 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.462 HG21 ' HB1' ' A' ' 2' ' ' ALA . 4.4 m -148.77 139.55 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.142 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -115.38 120.23 38.89 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.03 155.25 19.58 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.287 -0.965 . . . . 0.0 112.808 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 63' ' ' ILE . 71.4 mt -142.22 118.28 6.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.094 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.451 ' H ' HD12 ' A' ' 52' ' ' LEU . 3.6 mp -88.8 159.37 17.78 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.008 -1.077 . . . . 0.0 112.504 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.441 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 72.1 m-85 -141.59 118.89 11.43 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.836 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -49.9 -82.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -58.59 155.06 13.06 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.386 -0.925 . . . . 0.0 111.799 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -59.89 -177.9 0.07 Allowed 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.705 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.581 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 50.45 38.71 35.23 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 39.17 71.12 0.18 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.521 0.677 . . . . 0.0 111.058 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.3 172.52 12.81 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.969 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.34 -174.64 55.0 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.445 -1.36 . . . . 0.0 109.981 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -44.87 158.1 0.06 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.895 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -149.84 168.41 23.81 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.812 -1.155 . . . . 0.0 111.499 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.72 HG22 ' N ' ' A' ' 64' ' ' GLU . 73.0 mt -134.85 174.11 13.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.723 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.72 ' N ' HG22 ' A' ' 63' ' ' ILE . 24.8 mt-10 -144.74 133.92 22.86 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.568 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.401 HG13 ' C ' ' A' ' 64' ' ' GLU . 25.4 m -150.55 152.89 11.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 118.628 -1.229 . . . . 0.0 112.224 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.4 ' H ' ' H ' ' A' ' 67' ' ' ALA . 1.0 OUTLIER -139.54 -10.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.494 ' HB1' ' OD1' ' A' ' 107' ' ' ASP . . . -119.92 -156.93 0.69 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.56 -1.655 . . . . 0.0 109.673 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.434 ' ND2' ' C ' ' A' ' 68' ' ' ASN . 0.5 OUTLIER -93.23 127.85 38.98 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.077 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.056 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -90.43 119.52 30.78 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.781 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -79.9 -58.74 3.02 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.445 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -106.52 19.47 20.44 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.612 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.0 tp 53.01 -98.4 0.07 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.466 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.82 -158.99 31.47 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.093 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.669 ' C ' HD23 ' A' ' 75' ' ' LEU . 1.5 Cg_endo -66.02 -157.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.451 1.434 . . . . 0.0 110.545 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.713 HD21 ' CG1' ' A' ' 63' ' ' ILE . 1.4 pt? 31.69 32.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 123.8 0.687 . . . . 0.0 111.79 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.546 ' N ' ' O ' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -80.22 -12.03 59.67 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.795 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -72.72 -12.84 61.18 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.085 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -160.29 134.67 7.43 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 118.889 -1.124 . . . . 0.0 111.69 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.443 HG11 HD12 ' A' ' 39' ' ' ILE . 3.3 t -145.39 153.18 14.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.845 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 81' ' ' SER . 86.9 p -164.89 -57.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.351 -1.34 . . . . 0.0 112.772 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.473 ' N ' ' OG ' ' A' ' 80' ' ' SER . 32.9 t -89.9 146.42 24.43 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.613 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 82' ' ' ILE . 0.3 OUTLIER -146.77 134.01 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 118.74 -1.184 . . . . 0.0 111.153 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.621 ' HA ' ' NE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -108.74 141.15 41.16 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.304 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.525 ' HB ' ' H ' ' A' ' 22' ' ' GLY . 9.4 t -144.33 123.55 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.226 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.5 mt -129.07 125.67 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.303 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.8 m -43.73 132.71 4.95 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.686 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.537 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -126.65 139.38 34.64 Favored Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.499 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.537 ' HD2' HG22 ' A' ' 87' ' ' VAL . 2.7 Cg_exo -52.76 143.55 47.16 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.127 1.218 . . . . 0.0 110.741 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.0 t -59.98 122.24 9.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.229 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -102.89 135.32 19.45 Favored Pre-proline 0 C--N 1.306 -1.326 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.987 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -52.53 -33.0 55.9 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 120.85 1.033 . . . . 0.0 110.283 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.443 HH22 ' HB2' ' A' ' 67' ' ' ALA . 17.9 mtt-85 50.68 -164.43 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.662 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.534 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.66 177.2 8.66 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.185 -1.37 . . . . 0.0 108.437 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -150.36 132.19 15.08 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 118.21 -1.396 . . . . 0.0 112.088 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.54 ' CE2' HG13 ' A' ' 131' ' ' VAL . 21.9 m-85 -118.68 147.65 43.58 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.757 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -121.15 159.29 26.13 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.185 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.658 ' OH ' HG22 ' A' ' 123' ' ' ILE . 8.0 m-30 -95.15 164.14 12.99 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.603 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 tttt 67.7 135.6 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.691 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.595 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 8.6 tp10 -63.69 100.94 0.31 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.273 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.675 ' NE2' ' HE1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 119.73 38.17 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.882 0 O-C-N 125.426 1.704 . . . . 0.0 108.47 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.675 ' HE1' ' NE2' ' A' ' 100' ' ' GLN . 22.5 p90 33.78 44.09 0.08 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.76 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -103.64 32.33 3.93 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.581 -0.847 . . . . 0.0 111.453 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -153.66 170.11 32.38 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.167 -1.492 . . . . 0.0 110.751 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.1 OUTLIER -35.03 151.13 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.428 ' CD ' ' C ' ' A' ' 105' ' ' GLU . 1.4 pp20? -121.92 168.31 12.04 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.847 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.88 139.41 19.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.283 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.494 ' OD1' ' HB1' ' A' ' 67' ' ' ALA . 6.3 p30 -108.98 151.44 26.31 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.748 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 72.3 mt -139.64 140.27 24.56 Favored Pre-proline 0 N--CA 1.497 1.877 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.804 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -76.03 164.13 31.97 Favored 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 121.944 1.763 . . . . 0.0 111.254 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.41 142.01 76.88 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.555 1.503 . . . . 0.0 110.581 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 144.05 -158.63 27.48 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 118.916 -1.612 . . . . 0.0 111.466 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.58 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 24.4 tt0 -125.28 154.97 40.9 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.88 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.58 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 25.3 m-85 -143.53 152.71 41.79 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.738 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.7 p -106.44 178.43 4.56 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.867 0.841 . . . . 0.0 112.97 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.644 ' NE2' ' CD ' ' A' ' 119' ' ' GLU . 24.1 tp60 -59.39 -20.85 58.12 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.558 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.44 -60.71 1.85 Allowed 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.901 -1.12 . . . . 0.0 114.01 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -67.4 -56.83 8.07 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.219 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.607 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -34.11 -74.02 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 O-C-N 123.801 0.688 . . . . 0.0 111.817 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.644 ' CD ' ' NE2' ' A' ' 115' ' ' GLN . 69.5 mt-10 -51.19 -56.36 13.24 Favored 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.739 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.461 ' HD3' ' H ' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -75.06 14.65 0.5 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.474 -1.291 . . . . 0.0 111.647 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 117' ' ' GLU . 18.4 t80 -119.39 -16.44 8.96 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.856 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.507 ' C ' HD13 ' A' ' 123' ' ' ILE . . . -139.49 -48.08 0.06 OUTLIER Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.676 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.658 HG22 ' OH ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -137.85 -108.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.969 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.554 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 18.3 t70 -161.75 -146.8 0.13 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.402 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.554 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 4.4 m-20 -60.67 -52.72 63.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.338 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -158.04 134.71 9.72 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.426 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.448 ' H ' ' H ' ' A' ' 128' ' ' ILE . 2.5 t -178.61 -10.1 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.507 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.448 ' H ' ' H ' ' A' ' 127' ' ' THR . 9.4 mt -70.42 141.39 17.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.528 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.3 t -157.33 12.55 0.23 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.026 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.3 m -170.7 117.12 0.49 Allowed 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.579 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.54 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.6 t -110.51 156.28 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.995 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.466 ' NZ ' ' HG3' ' A' ' 158' ' ' PRO . 1.6 tppt? -155.02 87.25 3.32 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.292 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.02 101.4 0.18 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.309 1.34 . . . . 0.0 111.678 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.534 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 38.2 tt0 -54.17 -12.21 0.6 Allowed 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.986 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -178.83 -36.6 0.06 OUTLIER Glycine 0 N--CA 1.497 2.76 0 C-N-CA 118.412 -1.852 . . . . 0.0 112.245 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mt -92.1 -174.97 3.93 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.998 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.45 137.04 48.68 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.459 ' CG1' ' CD1' ' A' ' 140' ' ' LEU . 7.2 t -103.1 140.49 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.413 -0.915 . . . . 0.0 112.866 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.467 ' C ' HD12 ' A' ' 140' ' ' LEU . 96.4 t -131.2 120.15 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.453 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 140' ' ' LEU . 10.1 mp -98.59 143.75 28.64 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.327 -0.949 . . . . 0.0 113.307 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.416 ' CD2' ' HB3' ' A' ' 146' ' ' PHE . 27.8 m-85 -120.27 130.89 54.68 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.111 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -67.21 -69.67 0.3 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.142 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -70.16 164.19 24.72 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.558 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 146' ' ' PHE . 3.6 m-20 -63.58 -160.05 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.606 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.654 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 2.5 p30 32.76 34.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 123.733 0.646 . . . . 0.0 111.57 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.654 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 42.82 61.24 2.17 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 44.5 t -136.26 -178.55 5.21 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.006 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.491 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 75.67 -163.13 53.47 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.354 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.76 164.12 3.94 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.144 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.2 p -148.2 170.16 18.48 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.944 -1.103 . . . . 0.0 111.668 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.1 tp -141.89 84.98 11.48 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.151 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -62.45 102.66 0.29 Allowed 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.076 1.85 . . . . 0.0 113.59 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 138' ' ' VAL . 6.8 t -89.19 80.36 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.346 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -76.88 14.09 0.91 Allowed 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.592 -0.843 . . . . 0.0 113.015 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 19.8 t -169.97 -169.67 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 117.785 -1.566 . . . . 0.0 112.959 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.454 ' N ' ' OG ' ' A' ' 155' ' ' SER . 64.3 m-20 -57.03 152.26 13.48 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.519 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.563 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -172.88 62.62 0.29 Allowed Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.072 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 5.8 Cg_endo -70.05 34.38 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 122.336 2.024 . . . . 0.0 112.2 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 159' ' ' THR . 0.6 OUTLIER -176.33 76.57 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.407 -1.317 . . . . 0.0 112.389 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -81.2 -87.51 0.08 Allowed 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.63 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.106 0 C-N-CA 119.585 -1.293 . . . . 0.0 111.857 179.786 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.861 0.363 . . . . 0.0 111.88 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.7 m -59.82 112.81 1.98 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.424 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.6 t -97.24 -63.13 1.16 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.549 -0.861 . . . . 0.0 112.043 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.06 162.39 17.47 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.04 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 25.6 pt -147.78 179.49 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.307 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -161.32 114.62 1.93 Allowed 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.302 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 42.9 mt -90.57 98.97 8.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.349 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--N 1.304 -1.405 0 CA-C-O 116.298 -1.81 . . . . 0.0 110.988 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.513 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.784 0.326 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 2' ' ' ALA . 21.9 m-80 -169.29 110.97 0.48 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.707 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.4 pt -70.68 140.87 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.102 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -115.35 120.31 39.18 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.715 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.511 ' CG2' HG23 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -104.3 155.79 5.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.923 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.448 ' N ' ' CG2' ' A' ' 6' ' ' VAL . 38.8 m-85 -115.64 139.98 49.61 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.191 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -62.92 1.36 Allowed 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.385 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.562 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 3.2 m120 -89.5 168.36 12.25 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.52 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.442 ' HG2' ' H ' ' A' ' 10' ' ' GLU . 10.2 pt-20 -70.35 -162.56 0.06 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.414 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.622 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 1.3 m-20 47.43 45.91 17.19 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.254 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.622 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 51.3 p90 38.63 24.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.951 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ASP . 3.8 pt20 -113.04 163.58 14.52 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.562 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 103.9 134.35 8.17 Favored Glycine 0 N--CA 1.501 2.996 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.457 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.519 ' H ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -28.99 132.88 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.02 0.438 . . . . 0.0 111.741 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.424 ' H ' ' CD ' ' A' ' 16' ' ' GLN . 7.1 pm0 -97.63 164.81 12.26 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.727 -0.789 . . . . 0.0 112.423 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 t -149.7 123.63 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.658 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.76 120.84 32.85 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.612 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mt -108.8 140.96 22.36 Favored Pre-proline 0 N--CA 1.489 1.513 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.081 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -72.2 165.72 31.8 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 120.909 1.072 . . . . 0.0 111.277 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.77 -158.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 121.905 1.736 . . . . 0.0 111.089 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.71 168.3 24.56 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 119.272 -1.442 . . . . 0.0 111.551 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.58 ' ND2' ' H ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -95.87 140.45 30.62 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.065 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.69 ' OH ' HD12 ' A' ' 82' ' ' ILE . 36.7 p90 -155.68 176.2 12.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.673 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.965 HG23 ' H ' ' A' ' 27' ' ' ALA . 6.3 t -138.09 -157.32 0.76 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.009 -1.077 . . . . 0.0 112.443 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.718 ' N ' HG23 ' A' ' 25' ' ' THR . 13.1 ptm180 -63.69 -25.82 68.38 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.358 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.965 ' H ' HG23 ' A' ' 25' ' ' THR . . . -58.56 -55.96 28.27 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.652 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -58.29 -45.1 88.6 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.637 -1.225 . . . . 0.0 109.555 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.443 HD23 HD12 ' A' ' 32' ' ' LEU . 30.2 mt -59.97 -34.09 72.82 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.518 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -54.74 -32.02 59.27 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -71.46 -40.55 70.24 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.675 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.443 HD12 HD23 ' A' ' 29' ' ' LEU . 15.0 mt -70.35 -81.04 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.967 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 32' ' ' LEU . . . 160.09 -26.43 0.32 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 118.952 -1.594 . . . . 0.0 111.049 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.557 ' C ' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -85.73 152.22 3.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.574 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.451 ' N ' HG12 ' A' ' 34' ' ' ILE . 3.4 pt-20 -178.51 154.31 0.78 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.357 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 38' ' ' THR . 1.3 m120 64.68 -149.93 0.27 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.549 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -56.21 81.43 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.724 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 36' ' ' ASN . 39.6 p -143.75 -33.56 0.42 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.664 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.621 ' CD1' HD11 ' A' ' 82' ' ' ILE . 3.9 mt -78.87 51.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 119.181 -1.008 . . . . 0.0 109.452 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.8 t -51.38 -46.98 62.99 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.573 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -125.21 167.29 15.06 Favored 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.79 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -155.45 149.69 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 118.197 -1.401 . . . . 0.0 113.05 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -133.59 126.92 31.98 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.492 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.2 t -144.0 113.62 5.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 C-N-CA 119.173 -1.011 . . . . 0.0 112.149 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.37 167.6 21.86 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 121.283 1.322 . . . . 0.0 111.082 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.67 -169.22 0.1 OUTLIER 'Trans proline' 0 C--N 1.32 -0.937 0 C-N-CA 121.97 1.78 . . . . 0.0 111.504 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.406 ' C ' HG13 ' A' ' 48' ' ' VAL . . . 77.66 -15.26 7.95 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.808 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.513 HG11 ' CB ' ' A' ' 2' ' ' ALA . 24.1 m -150.91 139.58 14.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.873 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -109.25 129.24 55.51 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.095 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.76 152.55 24.21 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.409 -0.916 . . . . 0.0 112.661 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.724 HD12 HH21 ' A' ' 83' ' ' ARG . 71.1 mt -139.57 121.3 16.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.992 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.782 HD23 HG23 ' A' ' 82' ' ' ILE . 0.4 OUTLIER -98.69 162.01 13.35 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 119.384 -0.926 . . . . 0.0 112.341 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 62' ' ' GLN . 11.6 m-85 -140.76 115.28 9.45 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.668 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -46.54 -78.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.871 -0.731 . . . . 0.0 112.044 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.417 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 51.3 m-20 -59.77 156.41 14.09 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.112 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -64.59 -173.69 0.11 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.726 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.86 36.31 33.23 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.355 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.481 ' CE1' ' O ' ' A' ' 24' ' ' TYR . 12.0 m-85 49.71 59.16 4.71 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.728 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.36 -176.88 4.54 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.417 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 76.51 170.22 31.04 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 60' ' ' GLY . 17.7 m-20 -42.41 125.85 3.31 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.147 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.426 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 9.5 pt20 -95.01 163.83 13.15 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.75 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.683 HG22 ' N ' ' A' ' 64' ' ' GLU . 4.6 mm -134.93 168.77 22.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.009 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.683 ' N ' HG22 ' A' ' 63' ' ' ILE . 30.8 tt0 -150.48 132.26 15.02 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.253 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.0 m -148.34 151.46 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.301 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.0 -7.73 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.768 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -122.99 -139.27 0.31 Allowed 'General case' 0 C--O 1.206 -1.237 0 CA-C-N 114.042 -1.436 . . . . 0.0 109.281 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -114.2 116.74 29.54 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.646 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.64 112.39 23.61 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.8 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -67.03 -85.79 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.451 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 7.8 mm-40 -72.56 -1.99 18.12 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.738 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.494 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 3.8 tp 75.99 -84.57 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.87 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.03 -161.67 30.29 Favored Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.151 -1.5 . . . . 0.0 110.753 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.547 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.6 Cg_endo -68.87 -55.41 0.21 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.121 1.881 . . . . 0.0 112.335 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -69.77 27.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.599 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.547 ' H ' ' C ' ' A' ' 74' ' ' PRO . 9.1 p-10 -70.91 10.76 0.48 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.118 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.5 ' H ' ' C ' ' A' ' 75' ' ' LEU . 23.3 t-20 -89.47 -9.98 48.07 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.096 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -166.49 132.68 2.41 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.726 -1.19 . . . . 0.0 111.697 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.402 ' CG1' HD12 ' A' ' 39' ' ' ILE . 2.1 t -147.95 142.47 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.057 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 m -154.63 -48.27 0.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.238 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.6 t -90.01 136.28 33.14 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.062 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.782 HG23 HD23 ' A' ' 52' ' ' LEU . 10.6 mt -151.76 149.94 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.434 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.724 HH21 HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -151.32 153.33 34.6 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.844 -1.142 . . . . 0.0 111.213 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.498 ' C ' HH12 ' A' ' 83' ' ' ARG . 3.3 t -142.7 147.19 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.394 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.502 HG12 ' NH1' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -138.77 132.25 39.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.389 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 85' ' ' ILE . 78.7 p -36.78 147.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.89 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.549 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -151.44 140.62 13.81 Favored Pre-proline 0 N--CA 1.487 1.385 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.27 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.549 ' HD2' HG22 ' A' ' 87' ' ' VAL . 6.9 Cg_exo -50.89 133.55 40.16 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 121.256 1.304 . . . . 0.0 111.372 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.555 HG22 ' N ' ' A' ' 90' ' ' GLN . 2.5 p -65.93 160.96 3.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.912 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.555 ' N ' HG22 ' A' ' 89' ' ' VAL . 62.4 mt-30 -143.51 151.31 53.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.157 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.453 ' HG2' HD21 ' A' ' 136' ' ' LEU . 1.8 Cg_endo -64.93 -40.58 20.45 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 121.587 1.525 . . . . 0.0 112.164 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.448 ' CG ' ' C ' ' A' ' 91' ' ' PRO . 3.0 mtm-85 57.98 -164.92 0.17 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.737 0.78 . . . . 0.0 112.431 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.513 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -138.89 173.31 11.7 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.812 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -150.85 123.03 8.29 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.291 -1.364 . . . . 0.0 112.339 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.478 ' O ' ' CB ' ' A' ' 105' ' ' GLU . 8.2 m-30 -95.92 166.39 11.81 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.275 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -135.47 154.65 51.35 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -95.57 146.53 24.39 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.424 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.9 tttt 66.97 126.06 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.564 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 28.6 tt0 -64.27 90.81 0.07 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.702 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.674 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.8 OUTLIER 169.71 21.78 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.734 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.674 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 28.5 p90 38.81 42.22 0.6 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.142 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -118.26 -57.86 2.04 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.533 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -44.52 159.58 0.13 Allowed Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.613 -1.28 . . . . 0.0 110.705 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -47.58 168.82 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.251 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -134.57 167.46 20.76 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.39 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.7 t -143.26 137.46 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.94 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -110.74 160.79 16.4 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 119.325 -0.95 . . . . 0.0 113.23 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.9 mt -145.94 139.01 14.24 Favored Pre-proline 0 N--CA 1.49 1.551 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.03 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -69.55 166.05 28.66 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 121.505 1.47 . . . . 0.0 111.156 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.99 144.68 99.63 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.734 1.622 . . . . 0.0 111.35 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 139.78 178.91 17.21 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 119.188 -1.482 . . . . 0.0 111.423 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.454 ' OE1' ' N ' ' A' ' 113' ' ' TYR . 14.4 tm0? -106.68 157.76 17.47 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.471 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.454 ' N ' ' OE1' ' A' ' 112' ' ' GLN . 67.8 m-85 -145.86 149.97 35.26 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.069 -1.053 . . . . 0.0 111.298 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.0 p -88.08 -157.27 0.4 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.347 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.39 52.22 0.72 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.019 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.18 -69.84 0.12 Allowed 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -70.54 -42.15 71.56 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.499 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.679 ' C ' HD23 ' A' ' 118' ' ' LEU . 2.4 tt -40.53 -73.55 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.254 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.751 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.7 OUTLIER -52.59 -49.87 64.16 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.955 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.404 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 1.8 mpt_? -70.99 -0.33 9.1 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.851 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.533 ' N ' ' O ' ' A' ' 117' ' ' GLU . 24.5 t80 -100.82 -22.81 14.73 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.497 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -131.12 -47.75 0.12 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.208 -1.473 . . . . 0.0 110.811 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.526 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -142.94 -107.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.113 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.526 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 7.0 m-20 -149.26 -178.67 6.53 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.998 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -63.07 10.61 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.473 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.489 ' H ' ' C ' ' A' ' 124' ' ' ASP . 15.5 p-10 -163.72 -139.23 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.511 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 126' ' ' ASN . 0.0 OUTLIER 33.78 87.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.275 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.9 mm -127.23 -41.98 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.071 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.7 m 46.1 -138.31 0.57 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.36 -0.836 . . . . 0.0 113.129 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.5 m -56.98 140.33 49.24 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.576 -1.193 . . . . 0.0 113.005 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.41 HG13 ' CD1' ' A' ' 95' ' ' PHE . 3.9 t -122.28 150.45 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.647 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -145.52 98.6 4.55 Favored Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.907 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -66.49 105.42 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.177 1.252 . . . . 0.0 110.969 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.513 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 28.0 mm-40 -57.97 -11.15 2.18 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.588 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 172.4 -30.31 0.11 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 118.226 -1.94 . . . . 0.0 112.352 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.453 HD21 ' HG2' ' A' ' 91' ' ' PRO . 4.3 mt -98.18 169.45 9.58 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.246 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -88.39 130.17 35.23 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.0 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.7 t -99.85 137.92 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.21 -0.996 . . . . 0.0 112.094 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.419 HG12 ' CE1' ' A' ' 141' ' ' PHE . 86.6 t -136.44 121.73 27.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.149 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.406 ' N ' HD12 ' A' ' 140' ' ' LEU . 5.0 mp -103.56 148.0 26.51 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.952 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.529 ' CD2' ' HB3' ' A' ' 146' ' ' PHE . 15.9 m-85 -120.79 130.54 54.03 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.134 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -66.32 -72.23 0.17 Allowed 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.476 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -75.17 164.74 26.17 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.59 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.617 ' CG ' ' H ' ' A' ' 145' ' ' ASN . 28.7 t0 -62.68 -161.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.831 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.641 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 7.1 m-20 41.16 26.33 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.192 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.641 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 3.1 p90 41.01 58.11 2.6 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.489 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.8 t -136.78 -172.05 3.08 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.237 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.9 -165.54 50.64 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.129 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -59.33 148.86 30.72 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.996 -1.081 . . . . 0.0 110.178 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.2 p -138.82 177.15 8.1 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.534 -0.867 . . . . 0.0 111.468 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.426 ' C ' HD13 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -142.64 84.81 10.68 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.608 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.28 104.4 0.88 Allowed 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 121.8 1.667 . . . . 0.0 112.736 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 26.0 t -85.17 86.53 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.403 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -58.02 -21.32 44.56 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.938 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 59.4 p -169.79 -149.32 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 117.841 -1.544 . . . . 0.0 113.046 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -49.51 142.49 7.92 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.769 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -161.7 64.44 1.78 Allowed Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.666 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.1 Cg_endo -62.08 19.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 122.199 1.933 . . . . 0.0 113.066 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.564 ' O ' HG23 ' A' ' 159' ' ' THR . 1.5 t -172.92 83.22 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 118.27 -1.372 . . . . 0.0 112.128 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.99 -67.45 0.85 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.739 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 C-N-CA 119.849 -1.167 . . . . 0.0 111.464 179.906 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 48.2 t30 . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 121.083 0.468 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 44.9 m -147.98 98.67 2.97 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.271 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.3 m -89.67 -38.86 13.59 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.657 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.1 p -146.31 152.4 39.09 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.754 -1.179 . . . . 0.0 110.103 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 118' ' ' LEU . 23.0 pt -134.07 175.96 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.331 -0.947 . . . . 0.0 111.015 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -153.48 108.76 3.2 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.438 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 11.1 mt -91.89 93.3 4.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.295 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 116.334 -1.793 . . . . 0.0 110.909 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.432 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.516 0.198 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 2' ' ' ALA . 10.7 m120 -159.67 128.75 5.19 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.842 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.481 ' CG1' ' O ' ' A' ' 4' ' ' ILE . 1.2 pt -73.28 124.93 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.127 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -97.86 106.24 18.51 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.256 -0.978 . . . . 0.0 108.511 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.541 ' HB ' HG23 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -90.47 166.38 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 119.195 -1.002 . . . . 0.0 113.257 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.678 ' CZ ' ' CE1' ' A' ' 12' ' ' PHE . 37.6 m-85 -122.7 134.44 54.46 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.358 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.69 -60.23 4.12 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.645 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 3.0 m120 -89.72 174.28 7.81 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.129 -1.028 . . . . 0.0 112.15 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 7.4 tp10 -81.96 165.25 20.89 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.779 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 10' ' ' GLU . 1.6 t70 76.17 42.01 0.2 Allowed 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.027 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.678 ' CE1' ' CZ ' ' A' ' 7' ' ' PHE . 78.1 t80 51.69 11.17 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.423 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -107.32 162.1 14.21 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.318 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.645 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 106.15 133.89 7.61 Favored Glycine 0 N--CA 1.503 3.142 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.853 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 14' ' ' GLY . 33.4 mttp -29.86 138.88 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.424 ' H ' ' HG3' ' A' ' 16' ' ' GLN . 1.5 pp0? -97.17 158.43 15.45 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.446 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 t -147.84 125.73 3.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.596 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -92.09 120.67 32.92 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.161 -1.016 . . . . 0.0 111.694 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.445 HD12 HG11 ' A' ' 6' ' ' VAL . 7.5 mt -114.3 133.17 22.47 Favored Pre-proline 0 N--CA 1.498 1.959 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.265 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -69.53 167.89 22.84 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 120.848 1.032 . . . . 0.0 111.155 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -67.2 -162.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.893 1.729 . . . . 0.0 110.767 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.18 172.8 48.93 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.138 -1.506 . . . . 0.0 111.079 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.56 ' HB3' ' NE ' ' A' ' 83' ' ' ARG . 6.7 p-10 -106.26 139.9 40.05 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.859 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.577 ' CZ ' HD12 ' A' ' 82' ' ' ILE . 4.0 p90 -155.75 -174.62 5.04 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.425 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.5 p -144.4 -156.29 0.68 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.036 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -65.67 -22.03 66.6 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.77 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -64.0 -60.67 2.96 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.501 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 27.8 tt0 -54.86 -45.65 74.59 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.498 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 29' ' ' LEU . 15.0 mt -56.89 -43.05 80.93 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.579 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.76 -34.25 18.67 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 118.878 -1.129 . . . . 0.0 108.826 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -66.55 -42.29 87.36 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.421 -0.911 . . . . 0.0 109.793 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.472 HD12 HD23 ' A' ' 29' ' ' LEU . 9.6 mt -71.71 -71.92 0.25 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.715 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.41 -37.76 0.68 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.329 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.503 ' H ' HG22 ' A' ' 34' ' ' ILE . 1.4 tt -79.3 146.35 8.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.367 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -179.89 161.63 0.98 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.53 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.652 ' O ' HG22 ' A' ' 38' ' ' THR . 7.9 m120 60.1 -128.43 1.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.094 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -51.98 90.67 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.874 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 36' ' ' ASN . 0.3 OUTLIER -178.91 -165.99 0.09 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.383 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.647 ' N ' ' OG1' ' A' ' 38' ' ' THR . 5.2 mt 46.77 37.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-O 122.208 1.004 . . . . 0.0 108.829 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.442 ' OG ' ' CD ' ' A' ' 10' ' ' GLU . 30.9 t -70.02 -31.99 69.92 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.394 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -134.81 154.97 51.4 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.972 HG22 ' HB3' ' A' ' 69' ' ' ALA . 15.5 m -147.45 168.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 117.894 -1.523 . . . . 0.0 113.785 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -141.93 91.06 2.32 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.27 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.4 t -107.91 108.94 61.95 Favored Pre-proline 0 N--CA 1.487 1.38 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.034 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.415 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 2.4 Cg_endo -67.21 172.01 10.66 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.146 1.231 . . . . 0.0 109.587 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.513 ' HB3' ' HE ' ' A' ' 92' ' ' ARG . 2.1 Cg_endo -60.81 -168.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.329 1.353 . . . . 0.0 110.712 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.05 -19.0 10.84 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.12 -1.514 . . . . 0.0 111.871 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.638 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -155.49 155.53 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 118.118 -1.433 . . . . 0.0 113.054 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.417 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 24.4 ttpt -123.61 129.74 51.61 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.257 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.96 134.11 52.85 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.385 -0.926 . . . . 0.0 113.175 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.3 mt -115.51 117.67 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.154 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.949 ' N ' HD12 ' A' ' 52' ' ' LEU . 1.0 OUTLIER -96.35 163.06 13.23 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.215 -0.994 . . . . 0.0 113.337 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -139.92 111.61 7.33 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.052 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -82.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.309 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.465 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 5.2 t-20 -59.99 137.56 58.05 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.546 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.599 ' CG ' ' H ' ' A' ' 57' ' ' GLY . 26.2 t70 -58.94 -168.77 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.384 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.599 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 56.97 27.59 57.08 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 118.885 -1.626 . . . . 0.0 109.758 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 53.9 61.76 2.93 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.114 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.96 -166.64 2.59 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.703 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.465 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 70.71 167.06 6.84 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.295 -1.431 . . . . 0.0 109.974 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -45.31 124.3 4.67 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.464 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -94.61 159.18 15.2 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.906 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.724 HG22 ' N ' ' A' ' 64' ' ' GLU . 7.5 mm -136.27 171.12 17.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.688 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.724 ' N ' HG22 ' A' ' 63' ' ' ILE . 2.3 pt-20 -150.57 132.28 14.94 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.346 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.408 HG13 ' C ' ' A' ' 64' ' ' GLU . 25.2 m -150.19 161.88 4.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.426 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 48' ' ' VAL . 3.0 t -145.57 -8.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.021 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -119.15 -149.01 0.43 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.105 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -90.36 141.55 28.62 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.908 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.972 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -109.62 94.47 5.05 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.843 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.64 -53.62 55.29 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.157 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.477 ' O ' ' C ' ' A' ' 72' ' ' LEU . 10.0 tp10 -128.85 66.64 1.42 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.18 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 71' ' ' GLU . 11.5 tp -21.14 -90.91 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.282 0.989 . . . . 0.0 113.071 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.66 -159.64 17.15 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 118.917 -1.611 . . . . 0.0 110.783 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.08 -34.48 46.46 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 121.911 1.741 . . . . 0.0 111.488 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.641 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -77.85 15.57 0.84 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.89 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.585 ' CG ' ' H ' ' A' ' 77' ' ' ASN . 14.2 p-10 -62.54 -61.18 2.61 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.854 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.585 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 3.5 t-20 -78.68 33.94 0.21 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.86 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 76' ' ' ASN . 46.5 t30 -171.42 71.66 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.241 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.631 HG13 ' N ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -94.59 -177.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.307 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.631 ' N ' HG13 ' A' ' 79' ' ' VAL . 1.5 t 174.82 -71.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.769 -1.172 . . . . 0.0 112.312 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 m -99.97 145.64 27.62 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.495 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.577 HD12 ' CZ ' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -149.65 160.88 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.812 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.815 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -144.03 110.1 5.38 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.732 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.815 ' H ' HH22 ' A' ' 83' ' ' ARG . 11.2 t -116.91 140.34 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.884 -0.727 . . . . 0.0 111.584 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.605 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 3.7 mt -144.97 135.11 19.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.413 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.2 m -41.88 157.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.488 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 48' ' ' VAL . 0.6 OUTLIER -154.61 139.86 12.13 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.318 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.47 ' HD2' HG22 ' A' ' 87' ' ' VAL . 8.0 Cg_exo -50.12 129.31 24.82 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 121.313 1.342 . . . . 0.0 111.071 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 90' ' ' GLN . 2.7 p -66.48 156.34 6.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.039 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.473 ' N ' HG22 ' A' ' 89' ' ' VAL . 10.1 mp0 -144.42 154.51 56.88 Favored Pre-proline 0 N--CA 1.487 1.388 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.872 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.11 -35.7 91.6 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 121.466 1.444 . . . . 0.0 111.142 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.513 ' HE ' ' HB3' ' A' ' 46' ' ' PRO . 86.5 mtt-85 54.72 -157.97 0.2 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.918 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.95 172.22 12.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.527 ' NE ' ' CD ' ' A' ' 105' ' ' GLU . 11.7 ttt180 -148.31 122.34 9.45 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.126 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.446 ' CD2' HG13 ' A' ' 131' ' ' VAL . 26.3 m-85 -105.05 165.54 11.01 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.503 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.541 ' CE2' ' O ' ' A' ' 101' ' ' PHE . 0.5 OUTLIER -125.69 172.76 9.52 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.513 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.447 ' CD1' ' O ' ' A' ' 104' ' ' LYS . 2.1 m-85 -92.32 -97.02 0.13 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.939 -1.104 . . . . 0.0 112.654 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -45.37 164.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.576 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -87.51 67.78 9.45 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.49 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -175.34 33.58 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.804 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.541 ' O ' ' CE2' ' A' ' 96' ' ' PHE . 29.1 t80 55.22 20.55 3.49 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.345 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -119.78 161.07 21.4 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.644 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 94.33 137.08 8.54 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.043 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.447 ' O ' ' CD1' ' A' ' 97' ' ' TYR . 52.7 mttm -28.0 138.93 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.527 ' CD ' ' NE ' ' A' ' 94' ' ' ARG . 11.6 pt-20 -99.48 175.94 5.67 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.26 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.582 HG11 ' C ' ' A' ' 122' ' ' GLY . 40.4 t -150.7 120.11 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.153 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 26.7 p-10 -96.62 155.75 16.64 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.597 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 108' ' ' LEU . 69.5 mt -142.75 149.4 49.93 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.147 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.408 ' O ' HD12 ' A' ' 172' ' ' ILE . 13.1 Cg_endo -77.27 165.03 28.37 Favored 'Trans proline' 0 C--O 1.213 -0.77 0 C-N-CA 121.84 1.693 . . . . 0.0 111.595 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -68.82 153.99 71.92 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 121.686 1.591 . . . . 0.0 110.843 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.45 -161.58 20.76 Favored Glycine 0 N--CA 1.509 3.521 0 C-N-CA 119.194 -1.479 . . . . 0.0 111.835 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.457 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 26.8 mp0 -116.13 161.67 18.57 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.261 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.512 ' HB2' HD12 ' A' ' 118' ' ' LEU . 85.8 m-85 -145.49 146.41 31.45 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.008 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 114' ' ' THR . 10.9 p -74.9 -159.1 0.09 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.442 ' NE2' ' HB3' ' A' ' 144' ' ' ASP . 1.2 pt20 -108.0 40.05 1.82 Allowed 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.22 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.478 ' C ' ' N ' ' A' ' 118' ' ' LEU . . . -157.55 -87.5 0.04 OUTLIER 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 118.684 -1.206 . . . . 0.0 110.88 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 116' ' ' ALA . 11.3 pt-20 -45.53 -25.49 0.45 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.036 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.805 ' C ' HD23 ' A' ' 118' ' ' LEU . 5.6 tt -57.86 -66.53 0.46 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.113 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.439 ' HB3' ' C ' ' A' ' 124' ' ' ASP . 8.1 mm-40 -49.2 -49.95 40.45 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.406 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.483 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 4.0 mmm-85 -67.17 -12.44 60.04 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 118.718 -1.193 . . . . 0.0 112.016 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -91.97 -24.95 19.08 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.154 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.582 ' C ' HG11 ' A' ' 106' ' ' VAL . . . -115.93 -67.43 0.41 Allowed Glycine 0 N--CA 1.483 1.791 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.486 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -138.64 -103.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.186 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.573 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 15.2 t70 -154.01 -165.48 2.12 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.314 -0.955 . . . . 0.0 111.198 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.573 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 8.9 m-20 -58.71 -100.08 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.34 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -80.41 127.68 32.69 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.582 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.684 HG23 ' H ' ' A' ' 128' ' ' ILE . 0.0 OUTLIER 175.48 -106.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.523 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.684 ' H ' HG23 ' A' ' 127' ' ' THR . 6.2 mm 48.62 -97.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.005 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER 78.1 -42.77 0.36 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.2 m -143.56 126.34 16.13 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.682 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.446 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.9 t -121.59 158.84 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-O 121.975 0.893 . . . . 0.0 113.015 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.422 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -146.14 99.32 4.28 Favored Pre-proline 0 C--N 1.3 -1.544 0 CA-C-N 113.865 -1.516 . . . . 0.0 107.86 179.755 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.63 ' C ' ' H ' ' A' ' 135' ' ' GLY . 2.8 Cg_exo -52.66 -15.79 4.75 Favored 'Trans proline' 0 C--O 1.209 -0.955 0 C-N-CA 121.181 1.254 . . . . 0.0 112.491 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 53.17 -6.19 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.764 -0.774 . . . . 0.0 112.498 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . 160.45 -47.36 0.4 Allowed Glycine 0 N--CA 1.483 1.802 0 C-N-CA 118.766 -1.683 . . . . 0.0 111.242 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.1 mt -84.49 -164.31 0.94 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 117.95 -1.5 . . . . 0.0 110.787 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -119.17 131.11 55.82 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.0 t -101.76 143.12 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.796 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.412 ' C ' HD12 ' A' ' 140' ' ' LEU . 57.6 t -137.32 117.76 16.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.315 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 140' ' ' LEU . 10.9 mp -97.71 142.85 29.0 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.483 -0.887 . . . . 0.0 112.37 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.528 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 34.6 m-85 -120.51 133.46 55.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.432 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -74.3 -61.1 1.98 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.488 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -71.46 -175.99 1.43 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.089 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 146' ' ' PHE . 1.8 m-20 -77.18 -165.06 0.52 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.691 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.668 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 16.4 t30 27.95 39.51 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 123.931 0.769 . . . . 0.0 112.138 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.668 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.6 p90 41.65 60.44 2.16 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.197 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.84 -168.11 1.98 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.233 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 63.51 -162.45 33.45 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.607 -1.282 . . . . 0.0 110.145 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -59.58 156.05 14.23 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.189 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.3 p -144.72 160.75 40.7 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.679 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.8 tp -126.39 82.83 65.45 Favored Pre-proline 0 N--CA 1.486 1.325 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.125 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.68 106.56 0.63 Allowed 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 121.884 1.722 . . . . 0.0 113.162 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 43.6 t -87.94 82.45 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 119.455 -0.898 . . . . 0.0 108.949 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -62.59 -9.6 9.4 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.6 p -169.4 -167.9 0.75 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 117.456 -1.698 . . . . 0.0 113.475 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -42.29 150.83 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.53 -1.213 . . . . 0.0 112.812 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.572 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -171.94 66.83 0.41 Allowed Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.65 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.5 Cg_endo -65.6 23.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.173 1.916 . . . . 0.0 112.02 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.572 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.3 t -175.42 57.23 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.042 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 129' ' ' SER . 18.8 tp -63.63 -11.18 23.17 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.895 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 160' ' ' LEU . . . . . . . . 0 N--CA 1.496 2.682 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.46 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 36.9 t30 . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.822 0.344 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 51.7 m -58.8 111.39 1.26 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.003 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 74.7 m -90.13 -69.28 0.73 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.618 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.0 p -116.0 158.09 23.61 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.593 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 1.4 pt -141.1 -178.59 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.856 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -160.59 114.9 2.15 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.677 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 109' ' ' PRO . 14.0 mt -90.34 95.51 5.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.08 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 116.291 -1.814 . . . . 0.0 110.835 179.98 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.515 ' HB1' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.903 0.383 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -116.1 115.86 26.84 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.391 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.446 HG21 HD13 ' A' ' 4' ' ' ILE . 8.3 pt -74.56 143.86 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.3 m -128.41 135.5 49.6 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.678 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.499 HG22 ' CG1' ' A' ' 17' ' ' VAL . 9.8 m -120.79 158.64 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.015 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 14.0 m-85 -114.03 157.83 22.0 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.133 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -89.06 9.9 23.65 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.518 ' C ' ' OG ' ' A' ' 40' ' ' SER . 20.1 m120 -151.32 173.29 14.67 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.732 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -78.41 169.93 17.46 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.83 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 13' ' ' GLN . 6.7 t70 65.46 38.08 5.81 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.602 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.539 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 9.0 t80 62.81 -4.67 0.23 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.483 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.489 ' H ' ' C ' ' A' ' 11' ' ' ASP . 69.4 mt-30 -87.69 166.75 14.43 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.129 -1.028 . . . . 0.0 110.906 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 113.95 137.66 6.68 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -29.35 138.28 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.578 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.533 ' O ' ' HG3' ' A' ' 16' ' ' GLN . 2.1 pt20 -103.17 123.7 47.2 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.499 ' CG1' HG22 ' A' ' 6' ' ' VAL . 9.9 p -126.45 138.5 54.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.861 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -100.92 146.6 27.15 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.856 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 mt -137.94 141.46 32.63 Favored Pre-proline 0 N--CA 1.485 1.306 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.676 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -71.86 166.87 28.23 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.794 0.996 . . . . 0.0 111.711 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -67.12 -172.92 0.37 Allowed 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 121.998 1.799 . . . . 0.0 110.934 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.425 ' H ' ' HB ' ' A' ' 84' ' ' VAL . . . 98.44 -156.08 20.27 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.634 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -146.48 150.5 35.72 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.835 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.495 ' OH ' HD12 ' A' ' 82' ' ' ILE . 12.8 p90 -164.15 -164.2 0.84 Allowed 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.417 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.6 p -139.7 175.48 9.53 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.612 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.4 ptt85 -58.1 -13.52 4.98 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.275 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -67.59 -59.3 3.46 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.478 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.483 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 4.2 tp-100 -52.69 -43.06 65.34 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 118.506 -1.278 . . . . 0.0 108.201 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 32' ' ' LEU . 29.7 mt -58.77 -43.74 90.44 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.039 -1.064 . . . . 0.0 109.011 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -47.65 -30.39 3.7 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.618 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -77.61 -36.86 51.31 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.864 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 29' ' ' LEU . 12.7 mt -76.43 -67.37 0.7 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.614 -0.835 . . . . 0.0 110.627 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.6 -7.0 0.13 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.699 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.754 HG22 ' H ' ' A' ' 35' ' ' GLU . 1.3 mt -98.61 -167.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.165 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.754 ' H ' HG22 ' A' ' 34' ' ' ILE . 3.0 pt-20 175.05 -168.23 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.88 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.645 ' HB2' ' H ' ' A' ' 79' ' ' VAL . 24.4 p-10 -77.06 -178.71 5.13 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.506 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.401 ' H ' ' H ' ' A' ' 79' ' ' VAL . 2.9 t30 71.05 -15.36 0.41 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.642 ' O ' ' N ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -86.84 -77.78 0.31 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.058 -1.457 . . . . 0.0 110.938 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.62 ' N ' ' OG1' ' A' ' 38' ' ' THR . 4.3 mt -13.96 75.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 124.924 1.39 . . . . 0.0 112.074 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.642 ' N ' ' O ' ' A' ' 38' ' ' THR . 43.0 t -81.89 -36.14 28.46 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.49 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.2 172.02 13.61 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.1 t -149.97 144.8 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 118.029 -1.468 . . . . 0.0 112.516 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -132.73 101.51 5.31 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.841 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.5 t -125.04 110.1 27.28 Favored Pre-proline 0 N--CA 1.491 1.617 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.267 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -69.19 166.78 25.72 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.129 1.219 . . . . 0.0 110.802 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -61.29 -168.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 121.754 1.636 . . . . 0.0 110.948 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.43 ' C ' ' CG1' ' A' ' 48' ' ' VAL . . . 76.21 -8.25 25.65 Favored Glycine 0 C--O 1.207 -1.578 0 C-N-CA 118.902 -1.618 . . . . 0.0 109.743 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.515 HG11 ' HB1' ' A' ' 2' ' ' ALA . 0.9 OUTLIER -151.24 134.41 7.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.143 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -107.37 121.16 44.03 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.91 159.38 20.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.01 -1.076 . . . . 0.0 113.095 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 63' ' ' ILE . 35.0 mt -142.92 124.21 11.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.603 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.523 HD13 ' HB ' ' A' ' 63' ' ' ILE . 5.2 mp -89.26 160.35 16.96 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.714 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -138.89 115.98 10.98 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.505 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -56.86 -80.26 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.771 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -59.47 148.17 33.91 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.175 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.506 ' OD1' ' CB ' ' A' ' 80' ' ' SER . 1.0 OUTLIER -60.26 172.44 0.83 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.725 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.05 31.69 80.16 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.11 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 50.56 47.32 24.38 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.779 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.24 -161.58 1.01 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.835 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.38 -178.87 2.01 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.317 -1.421 . . . . 0.0 109.889 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -48.24 163.62 0.06 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.217 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -148.12 141.07 24.81 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.544 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.599 HD11 HD21 ' A' ' 75' ' ' LEU . 3.0 mt -107.5 168.65 3.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.679 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.463 ' H ' HG22 ' A' ' 63' ' ' ILE . 48.9 tt0 -137.1 132.92 34.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.8 m -148.65 159.92 6.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 118.371 -1.332 . . . . 0.0 112.495 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 t -150.18 -1.48 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.483 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -132.57 -150.13 0.4 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.649 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -101.05 113.63 26.81 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.634 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.565 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.53 97.72 11.36 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.906 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -62.87 -74.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.397 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -67.51 -8.95 37.8 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.446 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.3 tp 66.78 -80.2 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.592 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 143.49 -158.51 27.32 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.438 -1.363 . . . . 0.0 110.138 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.6 ' C ' HD23 ' A' ' 75' ' ' LEU . 2.2 Cg_endo -64.56 -159.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.649 1.566 . . . . 0.0 110.814 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.6 HD23 ' C ' ' A' ' 74' ' ' PRO . 1.1 pt? 32.83 32.06 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.722 0.639 . . . . 0.0 111.945 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 74' ' ' PRO . 49.6 t30 -84.98 -15.47 44.14 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.098 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -86.98 0.43 55.16 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.273 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -172.02 122.34 0.48 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 118.51 -1.276 . . . . 0.0 112.162 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 80' ' ' SER . 1.9 t -122.8 -148.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.443 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.651 ' H ' HG12 ' A' ' 79' ' ' VAL . 1.0 OUTLIER 154.33 -59.57 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.416 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.1 m -111.98 156.07 22.72 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.511 -0.876 . . . . 0.0 113.137 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.495 HD12 ' OH ' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -148.22 163.78 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.933 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.741 HH11 ' C ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -143.12 133.47 24.69 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.651 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.741 ' C ' HH11 ' A' ' 83' ' ' ARG . 22.1 t -139.98 128.57 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.936 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.458 HD11 ' HE ' ' A' ' 83' ' ' ARG . 55.3 mt -130.69 124.44 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.415 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.4 p -45.25 148.02 0.68 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.558 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.488 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.9 OUTLIER -148.07 152.05 39.07 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.275 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.488 ' HD2' HG22 ' A' ' 87' ' ' VAL . 2.9 Cg_exo -55.45 155.57 20.36 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.14 1.227 . . . . 0.0 110.859 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.3 t -59.71 144.39 12.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.732 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -144.74 119.06 5.73 Favored Pre-proline 0 N--CA 1.487 1.415 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.461 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -61.65 -157.53 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.832 0 C-N-CA 121.07 1.18 . . . . 0.0 111.184 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.444 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER 178.98 -162.14 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.274 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.435 ' N ' ' HD3' ' A' ' 92' ' ' ARG . . . -138.39 173.31 11.73 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.094 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -119.95 149.98 41.25 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.158 -1.017 . . . . 0.0 112.513 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -141.46 115.44 9.22 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.608 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.42 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 55.5 m-85 -79.42 176.93 9.24 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.81 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.16 -46.9 3.5 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.409 -0.917 . . . . 0.0 112.15 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.514 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 14.8 ttmt -92.26 154.73 18.43 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.864 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.597 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -71.13 102.72 2.56 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.11 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.609 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 5.7 tm0? 123.96 47.13 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.113 0 O-C-N 125.356 1.66 . . . . 0.0 109.072 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.609 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 21.9 p90 30.15 59.44 0.2 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.65 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -130.64 -12.54 3.84 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.252 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.514 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -93.66 157.23 22.89 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.459 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.466 ' HD3' ' H ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -29.59 139.11 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.19 0.519 . . . . 0.0 112.258 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.466 ' H ' ' HD3' ' A' ' 104' ' ' LYS . 0.4 OUTLIER -93.85 105.42 17.44 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.229 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.468 HG11 ' C ' ' A' ' 122' ' ' GLY . 92.7 t -92.64 137.9 21.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.051 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -121.53 155.07 35.76 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.95 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.7 mt -144.3 132.51 10.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.026 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -66.5 166.63 21.18 Favored 'Trans proline' 0 C--O 1.214 -0.725 0 C-N-CA 121.643 1.562 . . . . 0.0 111.69 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.55 149.24 68.16 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.81 1.673 . . . . 0.0 111.565 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.55 -176.3 20.45 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 119.415 -1.374 . . . . 0.0 110.932 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.407 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 40.8 tt0 -110.89 154.57 23.86 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.482 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 61.7 m-85 -146.22 155.46 42.7 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.436 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 3.1 p -92.49 -142.44 0.2 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.34 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.52 ' N ' ' OG1' ' A' ' 114' ' ' THR . 36.4 tt0 -111.97 -20.97 11.79 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.658 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.78 -57.59 3.72 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.381 -0.928 . . . . 0.0 112.644 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.561 ' CG ' ' H ' ' A' ' 118' ' ' LEU . 4.6 pt-20 -71.36 -55.93 7.0 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.837 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.561 ' H ' ' CG ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -32.34 -67.42 0.11 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.976 0.798 . . . . 0.0 111.273 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' A' ' 121' ' ' TYR . 75.6 mt-10 -55.5 -61.55 2.27 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.726 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.476 ' NH1' ' OD1' ' A' ' 124' ' ' ASP . 1.7 mpt_? -73.86 19.88 0.11 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.199 -1.0 . . . . 0.0 112.344 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 117' ' ' GLU . 17.9 t80 -124.45 -15.59 6.6 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.858 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.468 ' C ' HG11 ' A' ' 106' ' ' VAL . . . -148.22 -38.45 0.04 OUTLIER Glycine 0 C--N 1.295 -1.735 0 C-N-CA 118.771 -1.681 . . . . 0.0 110.822 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.443 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -141.75 -113.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.316 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.596 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 28.8 t70 -156.5 -176.86 6.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.396 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.596 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 46.9 t30 -79.22 148.82 32.09 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.845 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.554 HD22 ' CB ' ' A' ' 166' ' ' ASN . 32.5 m120 44.9 45.64 8.63 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.412 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.4 m -163.42 107.25 1.02 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.872 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.1 mm -138.95 -45.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.606 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.587 ' OG ' ' N ' ' A' ' 130' ' ' SER . 1.2 p 66.02 -152.45 0.24 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.587 ' N ' ' OG ' ' A' ' 129' ' ' SER . 26.8 m -49.79 129.86 20.5 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.404 -1.271 . . . . 0.0 113.066 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.4 151.17 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.928 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -160.58 112.69 1.35 Allowed Pre-proline 0 C--N 1.292 -1.896 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.598 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.26 170.79 3.7 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 120.605 0.87 . . . . 0.0 111.777 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -156.26 5.74 0.18 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.776 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.57 -50.92 0.04 OUTLIER Glycine 0 N--CA 1.481 1.677 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.37 162.94 20.66 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.732 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.66 154.8 24.71 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.329 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.6 143.72 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.265 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.3 t -129.76 125.37 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.464 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.6 mp -99.4 145.28 27.56 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.829 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.559 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 3.3 m-85 -120.78 143.23 48.93 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.3 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -73.85 -76.17 0.14 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.553 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -74.82 157.12 35.68 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.611 ' CG ' ' H ' ' A' ' 145' ' ' ASN . 26.4 t70 -57.92 -174.4 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.47 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.636 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 21.9 t-20 40.34 27.18 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.094 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.636 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.9 p90 41.69 62.0 1.7 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.286 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.9 t -131.95 71.46 1.47 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.306 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 173.14 -163.12 34.65 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.277 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.52 162.76 4.66 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 118.914 -1.114 . . . . 0.0 109.788 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.7 p -149.35 164.2 35.56 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.732 -1.187 . . . . 0.0 111.612 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.5 mt -131.64 87.32 46.26 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.714 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -61.44 107.87 0.54 Allowed 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.487 1.458 . . . . 0.0 111.859 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.442 ' C ' ' H ' ' A' ' 155' ' ' SER . 2.2 t -91.84 65.64 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.887 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -79.07 33.49 0.22 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.219 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 153' ' ' VAL . 16.8 t -167.09 -156.87 0.23 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.195 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.416 ' N ' ' OG ' ' A' ' 155' ' ' SER . 6.0 m-20 -90.61 153.22 20.48 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.768 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.433 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -163.2 71.39 1.94 Allowed Pre-proline 0 N--CA 1.486 1.334 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.533 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.471 ' C ' ' HG ' ' A' ' 130' ' ' SER . 1.2 Cg_endo -67.73 35.77 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.535 2.157 . . . . 0.0 113.372 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.727 HG23 ' H ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -167.38 -83.34 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.336 -1.345 . . . . 0.0 111.852 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.727 ' H ' HG23 ' A' ' 159' ' ' THR . 2.3 tp 73.68 -69.65 0.18 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.424 -0.911 . . . . 0.0 110.544 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.431 0 C-N-CA 119.367 -1.397 . . . . 0.0 110.736 179.999 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.554 ' CB ' HD22 ' A' ' 126' ' ' ASN . 2.7 p-10 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.712 0.291 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.2 m -103.4 112.04 24.74 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.303 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 83.7 p -96.67 -35.35 11.06 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.75 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.67 154.44 50.92 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.898 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 16.8 pt -135.76 162.97 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.486 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.424 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 41.2 ttp85 -146.32 100.99 3.44 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.846 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.6 mt -81.73 99.54 4.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.055 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 116.448 -1.739 . . . . 0.0 111.02 -179.964 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 121.009 0.433 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -175.89 122.66 0.19 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.192 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -84.29 153.68 3.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.136 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.4 m -128.09 118.78 24.07 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.092 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 16' ' ' GLN . 3.7 m -98.25 170.12 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.335 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 1.305 ' CE2' ' NE2' ' A' ' 16' ' ' GLN . 24.8 m-85 -129.49 149.46 51.26 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.516 ' CD2' ' NZ ' ' A' ' 15' ' ' LYS . 2.7 m-85 -77.28 -57.78 3.64 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.978 -1.089 . . . . 0.0 113.233 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.517 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 19.0 m120 -87.58 162.28 17.26 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.721 -1.191 . . . . 0.0 111.923 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.54 -179.04 0.99 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.326 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.647 ' C ' ' CG ' ' A' ' 12' ' ' PHE . 6.0 t70 51.52 52.63 14.3 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 118.313 -1.355 . . . . 0.0 110.52 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.647 ' CG ' ' C ' ' A' ' 11' ' ' ASP . 1.2 p90 41.65 20.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 11' ' ' ASP . 22.2 mt-30 -93.77 173.88 7.45 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.85 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.517 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 79.01 128.09 0.55 Allowed Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.188 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.516 ' NZ ' ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -40.99 156.34 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.935 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 1.305 ' NE2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -112.16 177.03 4.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 t -141.65 137.9 31.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 114.332 -1.304 . . . . 0.0 109.379 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -95.47 114.51 26.29 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.663 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.0 mt -107.88 133.05 20.62 Favored Pre-proline 0 N--CA 1.492 1.657 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.043 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -71.41 156.57 58.28 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 120.837 1.025 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.53 -167.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 121.506 1.471 . . . . 0.0 110.67 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.447 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 100.14 -174.22 26.11 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.942 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.705 ' CA ' HH11 ' A' ' 83' ' ' ARG . 13.6 p-10 -109.69 122.88 48.48 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.926 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 7.7 p90 -147.86 173.9 12.38 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 118.746 -1.182 . . . . 0.0 111.005 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.7 p -147.79 -154.83 0.58 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.051 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -62.43 -28.28 69.69 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.802 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -62.39 -63.43 1.24 Allowed 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.71 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.9 tt0 -55.48 -49.59 72.13 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.603 -1.239 . . . . 0.0 109.481 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.618 HD23 HD12 ' A' ' 32' ' ' LEU . 26.9 mt -51.84 -41.27 61.68 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.57 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.53 -35.84 21.55 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 118.558 -1.257 . . . . 0.0 108.006 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -65.04 -40.31 94.61 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.554 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.618 HD12 HD23 ' A' ' 29' ' ' LEU . 17.0 mt -72.86 -74.12 0.18 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.601 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.12 -26.27 1.0 Allowed Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.995 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.0 142.41 13.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.194 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 9.1 pt-20 -177.86 155.0 0.96 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.642 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 33.4 t30 90.18 -149.62 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 O-C-N 124.265 0.978 . . . . 0.0 112.408 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.456 ' H ' ' CG ' ' A' ' 36' ' ' ASN . 12.1 p-10 -70.14 32.48 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.045 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 40' ' ' SER . 1.0 OUTLIER -88.13 -40.99 13.32 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.62 -1.232 . . . . 0.0 110.336 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.42 ' HB ' HG21 ' A' ' 79' ' ' VAL . 22.7 mt -64.88 74.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.38 -0.928 . . . . 0.0 108.976 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 38' ' ' THR . 28.0 t -76.33 -72.97 0.3 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.704 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.46 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -99.15 168.04 10.31 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.888 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.589 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.1 t -151.32 148.31 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 117.988 -1.485 . . . . 0.0 113.087 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -133.72 108.69 8.67 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.852 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.451 HG23 HG13 ' A' ' 42' ' ' VAL . 65.2 t -128.46 111.42 19.38 Favored Pre-proline 0 N--CA 1.5 2.05 0 C-N-CA 119.809 -0.756 . . . . 0.0 112.311 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.59 170.07 14.53 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.099 1.2 . . . . 0.0 110.851 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.16 -167.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.919 1.746 . . . . 0.0 110.978 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.434 ' C ' HG12 ' A' ' 48' ' ' VAL . . . 78.21 -11.34 23.7 Favored Glycine 0 N--CA 1.484 1.851 0 C-N-CA 119.104 -1.522 . . . . 0.0 110.982 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.676 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -154.76 148.66 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 118.725 -1.19 . . . . 0.0 112.074 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -115.14 142.3 46.84 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.974 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.84 143.03 46.8 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.026 -1.07 . . . . 0.0 112.274 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.551 HG23 ' O ' ' A' ' 63' ' ' ILE . 78.2 mt -121.04 121.75 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.284 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.599 HD23 ' H ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -91.99 147.21 23.13 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.306 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.599 ' H ' HD23 ' A' ' 52' ' ' LEU . 53.3 m-85 -134.45 132.61 39.51 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.142 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -58.94 -84.44 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.052 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -65.17 163.65 14.69 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.65 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -63.09 -177.94 0.2 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.586 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.614 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 53.96 33.1 50.0 Favored Glycine 0 N--CA 1.487 2.059 0 C-N-CA 118.957 -1.592 . . . . 0.0 109.158 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.614 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 41.99 69.78 0.33 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.576 0.703 . . . . 0.0 110.751 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.91 174.21 10.79 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.07 -177.21 54.36 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.483 -1.342 . . . . 0.0 110.088 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.14 118.14 1.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.18 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.423 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 15.9 pt20 -101.27 172.39 7.02 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.738 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.551 ' O ' HG23 ' A' ' 51' ' ' ILE . 4.8 mt -144.47 163.84 13.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.553 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -138.98 126.2 21.39 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.769 -0.773 . . . . 0.0 109.498 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.3 m -149.03 158.96 6.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 118.781 -1.168 . . . . 0.0 112.727 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 48' ' ' VAL . 3.9 t -149.78 -1.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.401 ' H ' ' H ' ' A' ' 66' ' ' VAL . . . -125.42 -135.97 0.27 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.722 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -105.93 112.0 24.88 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.24 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.589 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.54 80.33 6.71 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.768 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -52.33 -81.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.048 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -69.12 -10.44 57.67 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.603 -0.839 . . . . 0.0 112.008 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.547 ' HB3' HD22 ' A' ' 76' ' ' ASN . 2.5 tp 63.23 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.434 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.429 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 175.15 -175.25 47.11 Favored Glycine 0 N--CA 1.501 2.998 0 C-N-CA 119.183 -1.484 . . . . 0.0 110.999 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.531 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.2 Cg_endo -66.72 -39.92 14.21 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 122.375 2.05 . . . . 0.0 112.188 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.986 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.7 pt? -71.11 30.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.144 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.547 HD22 ' HB3' ' A' ' 72' ' ' LEU . 4.3 m-20 -72.67 -9.6 58.81 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.639 -0.825 . . . . 0.0 110.605 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -87.57 13.16 10.78 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.126 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.644 ' N ' ' ND2' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -177.91 116.79 0.09 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 118.691 -1.204 . . . . 0.0 111.699 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 36' ' ' ASN . 15.6 m -157.07 145.85 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.944 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.6 p -164.34 -36.86 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 118.562 -1.255 . . . . 0.0 113.131 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.43 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 4.1 m -94.61 142.99 26.81 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 118.773 -1.171 . . . . 0.0 111.577 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.415 ' CG1' ' C ' ' A' ' 81' ' ' SER . 2.1 mt -148.58 143.21 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 118.821 -1.152 . . . . 0.0 111.426 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.829 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -121.31 116.01 24.04 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.783 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.829 ' H ' HH12 ' A' ' 83' ' ' ARG . 3.9 t -123.69 136.36 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.943 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.514 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 3.8 mt -139.1 126.74 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.196 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.6 p -48.98 133.02 18.59 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.433 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.775 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -122.9 149.92 57.7 Favored Pre-proline 0 N--CA 1.49 1.566 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.599 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.775 ' HD2' HG22 ' A' ' 87' ' ' VAL . 6.0 Cg_exo -51.43 127.31 21.94 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 121.386 1.391 . . . . 0.0 111.216 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.3 p -58.51 136.87 21.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.881 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -145.91 151.46 45.56 Favored Pre-proline 0 N--CA 1.487 1.389 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.961 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.419 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 2.3 Cg_endo -58.89 -164.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 121.277 1.318 . . . . 0.0 111.111 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.467 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -175.79 -161.75 0.09 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.759 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -141.71 162.96 34.2 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.084 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.1 ttm-85 -135.82 107.48 6.99 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.05 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 18.5 m-85 -87.0 169.15 12.68 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.597 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.482 ' CE1' ' HB3' ' A' ' 105' ' ' GLU . 26.8 m-85 -137.09 167.64 21.15 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.581 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.409 ' OH ' HG23 ' A' ' 123' ' ' ILE . 3.4 m-85 -103.24 168.83 8.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.659 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.405 ' CB ' ' OD1' ' A' ' 102' ' ' ASP . 52.5 mttp 57.14 164.69 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.841 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 24.2 tt0 -90.85 75.78 6.41 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.683 ' HG2' ' CG ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 153.78 43.46 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 O-C-N 124.358 1.036 . . . . 0.0 109.376 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 100' ' ' GLN . 19.1 p90 33.47 32.67 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.284 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.683 ' CG ' ' HG2' ' A' ' 100' ' ' GLN . 22.7 p-10 -107.32 36.2 2.79 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.154 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -145.66 158.37 27.65 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.277 -1.439 . . . . 0.0 110.467 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.545 ' H ' ' HE3' ' A' ' 104' ' ' LYS . 1.2 mtmt -31.72 144.84 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.169 0.509 . . . . 0.0 112.318 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.482 ' HB3' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -105.86 149.49 26.48 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.175 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 45.4 t -143.91 150.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.761 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -136.8 156.53 48.37 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.241 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.431 HD22 ' CE2' ' A' ' 121' ' ' TYR . 11.8 mt -137.01 163.12 51.66 Favored Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.938 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -88.78 166.92 5.96 Favored 'Trans proline' 0 C--O 1.212 -0.78 0 C-N-CA 121.871 1.714 . . . . 0.0 112.74 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -63.58 140.56 75.89 Favored 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 121.745 1.63 . . . . 0.0 110.89 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.75 -154.96 25.59 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.19 -1.481 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.595 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 37.3 tt0 -125.35 156.77 38.21 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.367 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 48.5 m-85 -144.07 149.55 36.78 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.792 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.3 p -96.81 -159.49 0.74 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.717 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.702 ' H ' ' CD ' ' A' ' 115' ' ' GLN . 2.5 pm0 -105.51 56.29 0.68 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.213 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.74 -64.34 0.11 Allowed 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.741 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.572 ' CG ' ' H ' ' A' ' 118' ' ' LEU . 9.0 pt-20 -69.77 -52.19 27.44 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.577 ' C ' HD23 ' A' ' 118' ' ' LEU . 1.9 tt -33.67 -60.23 0.37 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.167 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 36.4 mt-10 -54.36 -69.42 0.13 Allowed 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.293 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.434 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 3.4 mpt_? -74.79 23.23 0.1 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.293 -0.963 . . . . 0.0 112.376 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 117' ' ' GLU . 13.0 t80 -114.13 -22.29 10.08 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.856 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.74 -21.55 0.02 OUTLIER Glycine 0 N--CA 1.488 2.117 0 C-N-CA 118.429 -1.844 . . . . 0.0 110.625 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.425 HG21 HD13 ' A' ' 123' ' ' ILE . 9.1 mt -139.79 -120.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.746 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 124' ' ' ASP . 11.7 p30 -159.08 -154.98 0.44 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.767 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -76.22 -35.23 59.13 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.803 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.424 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 25.5 t30 -162.11 118.01 1.99 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.798 -1.161 . . . . 0.0 112.154 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.412 ' CG2' ' CG2' ' A' ' 123' ' ' ILE . 6.1 t -179.2 -14.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.895 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.452 HG13 ' H ' ' A' ' 128' ' ' ILE . 2.1 mt -50.84 166.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.173 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.8 p -175.4 -115.11 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.536 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.1 m -54.39 131.27 41.84 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.854 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.13 155.83 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.47 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.11 83.83 4.57 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.835 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.58 107.46 1.44 Allowed 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.317 1.345 . . . . 0.0 110.638 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -88.86 24.34 2.08 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.973 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -173.01 -56.01 0.05 OUTLIER Glycine 0 N--CA 1.494 2.542 0 C-N-CA 118.208 -1.949 . . . . 0.0 112.095 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.419 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 0.9 OUTLIER -116.79 172.74 7.05 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.567 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -89.37 142.58 27.53 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.497 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.2 t -102.13 145.41 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.94 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.99 124.65 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.681 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 140' ' ' LEU . 4.5 mp -107.74 146.07 32.64 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.239 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 20.2 m-85 -120.02 137.51 54.05 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.591 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -71.03 -67.82 0.48 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.951 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -65.57 165.34 12.46 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.98 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 146' ' ' PHE . 3.0 m-20 -63.61 -162.51 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.735 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.665 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 35.1 m120 27.48 39.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 123.859 0.724 . . . . 0.0 112.101 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.665 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.2 OUTLIER 43.97 61.26 2.39 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.456 -0.897 . . . . 0.0 109.881 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -132.42 173.29 11.45 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.27 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.05 -166.3 53.86 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.347 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -59.41 172.97 0.57 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.026 -1.069 . . . . 0.0 109.944 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 43.1 p -151.67 177.33 10.47 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.972 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.512 ' HA ' HD22 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -137.63 79.72 33.98 Favored Pre-proline 0 N--CA 1.485 1.3 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.764 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.6 105.21 0.73 Allowed 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 122.025 1.817 . . . . 0.0 113.247 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 39.8 t -90.68 74.52 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.946 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 154' ' ' ASN . 1.8 m-20 -79.19 26.64 0.26 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.14 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 25.4 t -169.99 -174.06 1.7 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.626 -1.23 . . . . 0.0 111.839 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.433 ' N ' ' OG ' ' A' ' 155' ' ' SER . 1.8 m-20 -73.78 154.44 39.55 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.907 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.594 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -166.68 72.4 1.11 Allowed Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.239 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.32 20.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.968 1.779 . . . . 0.0 111.85 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.594 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.2 t -169.38 71.08 0.07 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.863 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.431 ' HA ' HD22 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -75.58 -83.76 0.06 Allowed 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.479 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.453 0 C-N-CA 118.902 -1.618 . . . . 0.0 110.083 -179.934 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.822 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 121.075 0.464 . . . . 0.0 111.994 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.18 120.81 14.36 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.865 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 54.4 p -92.78 -42.38 9.6 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.284 -0.967 . . . . 0.0 110.533 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.72 164.09 29.08 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.788 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 30.0 pt -143.61 165.91 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -148.43 109.73 4.37 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.875 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.9 mt -89.12 99.47 9.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 119.271 -0.971 . . . . 0.0 109.946 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.305 -1.346 0 CA-C-O 116.352 -1.785 . . . . 0.0 111.12 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.579 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.58 0.228 . . . . 0.0 110.588 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -175.87 119.75 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.673 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.482 ' CG1' ' O ' ' A' ' 4' ' ' ILE . 1.0 OUTLIER -77.57 122.42 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.821 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -95.93 106.53 18.69 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.131 -1.028 . . . . 0.0 108.602 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.453 ' CG1' HD12 ' A' ' 19' ' ' LEU . 1.4 m -88.43 170.06 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 118.974 -1.09 . . . . 0.0 112.344 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 1.189 ' CE2' ' HG2' ' A' ' 16' ' ' GLN . 40.3 m-85 -134.35 144.5 48.29 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.75 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -65.61 -62.18 1.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.975 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.512 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 29.8 m120 -90.52 160.57 15.91 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.754 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -58.88 -171.6 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.64 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.638 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 11.5 m-20 44.95 51.54 8.61 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.842 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.638 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 49.5 p90 39.48 24.38 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 11' ' ' ASP . 32.9 mm-40 -98.69 173.74 6.75 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.565 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.512 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 81.58 135.68 1.95 Allowed Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.389 -1.386 . . . . 0.0 110.352 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 14' ' ' GLY . 30.0 mmtm -29.82 136.83 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.957 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 1.189 ' HG2' ' CE2' ' A' ' 7' ' ' PHE . 1.7 mt-30 -97.53 160.8 14.1 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.339 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -146.22 129.05 9.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.131 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -91.14 124.59 35.48 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.863 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.453 HD12 ' CG1' ' A' ' 6' ' ' VAL . 7.9 mt -119.46 125.85 27.3 Favored Pre-proline 0 N--CA 1.497 1.898 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.892 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.4 158.83 47.04 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 120.98 1.12 . . . . 0.0 111.485 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.14 -166.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.911 1.741 . . . . 0.0 111.154 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.95 -171.28 29.88 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.222 -1.466 . . . . 0.0 110.481 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -117.83 131.57 56.54 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.087 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.56 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 1.1 p90 -149.47 -174.88 4.8 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.937 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.498 HG22 ' OG ' ' A' ' 81' ' ' SER . 4.1 p -155.7 -162.14 1.27 Allowed 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.908 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.471 ' CD ' ' C ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -54.08 -20.65 6.86 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.493 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.444 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . -67.58 -66.58 0.54 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.441 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.506 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -54.58 -44.83 73.34 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.796 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.696 HD23 HD12 ' A' ' 32' ' ' LEU . 19.6 mt -57.64 -42.74 84.04 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.005 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.03 -32.0 32.35 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 118.409 -1.317 . . . . 0.0 108.817 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -67.38 -39.31 85.61 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.638 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.696 HD12 HD23 ' A' ' 29' ' ' LEU . 6.1 mt -75.76 -71.87 0.35 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.326 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.62 -36.72 0.73 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.376 -1.393 . . . . 0.0 110.609 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 tt -81.99 143.15 12.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.849 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.491 ' H ' HG21 ' A' ' 38' ' ' THR . 0.6 OUTLIER -179.96 134.98 0.11 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.563 -1.255 . . . . 0.0 112.495 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.774 ' O ' HG23 ' A' ' 38' ' ' THR . 0.1 OUTLIER 74.76 128.94 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.075 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.501 ' H ' ' H ' ' A' ' 79' ' ' VAL . 2.6 t30 45.36 8.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.178 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.774 HG23 ' O ' ' A' ' 36' ' ' ASN . 66.3 p -89.3 -33.33 16.97 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.527 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.448 ' H ' HG12 ' A' ' 39' ' ' ILE . 4.8 mm -75.71 66.4 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.743 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.0 t -73.37 -55.3 6.57 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.153 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.9 160.06 29.72 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.147 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.001 HG22 ' HB3' ' A' ' 69' ' ' ALA . 18.6 m -149.73 168.01 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 118.356 -1.338 . . . . 0.0 113.409 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -142.62 98.37 3.28 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.87 -1.514 . . . . 0.0 108.099 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.408 HG22 HG22 ' A' ' 4' ' ' ILE . 42.0 t -116.17 113.28 41.51 Favored Pre-proline 0 N--CA 1.496 1.852 0 C-N-CA 119.873 -0.731 . . . . 0.0 112.81 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -69.3 171.7 13.5 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.041 1.161 . . . . 0.0 110.009 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.525 ' HG3' ' HE ' ' A' ' 92' ' ' ARG . 1.0 OUTLIER -64.88 -167.78 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.617 1.545 . . . . 0.0 111.158 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.59 -8.36 7.46 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.373 -1.394 . . . . 0.0 110.781 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.579 HG11 ' HB3' ' A' ' 2' ' ' ALA . 33.2 m -148.59 143.34 18.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.576 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -118.23 126.42 52.13 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.234 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.54 144.53 36.08 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.377 -0.929 . . . . 0.0 112.765 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.593 HD12 ' NH2' ' A' ' 83' ' ' ARG . 27.8 mt -133.11 112.39 17.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.097 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.523 ' H ' HD12 ' A' ' 52' ' ' LEU . 1.6 mp -89.72 160.45 16.57 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.68 -1.208 . . . . 0.0 112.773 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -138.54 108.55 6.36 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.107 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -49.38 -78.59 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.259 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.488 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 5.0 m120 -59.76 141.44 55.23 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.965 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -55.64 177.81 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.852 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.46 29.48 69.42 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.334 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.439 ' CZ ' HG23 ' A' ' 25' ' ' THR . 21.4 m-85 54.88 67.6 0.99 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.787 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.59 -162.65 1.6 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.958 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.488 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 64.42 176.09 4.59 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.363 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 60' ' ' GLY . 63.0 m-20 -42.68 112.92 0.4 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.613 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.745 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -93.0 155.68 17.37 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.401 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.706 HG22 ' N ' ' A' ' 64' ' ' GLU . 7.3 mm -134.71 169.42 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.747 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.706 ' N ' HG22 ' A' ' 63' ' ' ILE . 41.0 tt0 -150.8 130.71 13.33 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.718 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.517 HG12 ' CE1' ' A' ' 121' ' ' TYR . 17.6 m -149.95 159.94 4.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 118.942 -1.103 . . . . 0.0 111.808 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.93 -11.98 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.908 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -116.69 -149.42 0.44 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.892 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -94.04 128.51 40.44 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.508 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.001 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -92.48 95.69 9.79 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.423 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 7.0 tp10 -56.9 -78.16 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.538 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.45 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 7.3 tp10 -91.42 5.05 50.9 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.309 -0.957 . . . . 0.0 110.748 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.439 HD12 ' HB1' ' A' ' 69' ' ' ALA . 14.7 tp 53.2 -99.85 0.09 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.023 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.72 -169.95 34.39 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 118.897 -1.62 . . . . 0.0 111.166 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.638 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.2 Cg_endo -68.58 -37.44 12.7 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.574 2.183 . . . . 0.0 112.929 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.513 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.6 pt? -57.01 8.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.102 -1.039 . . . . 0.0 111.586 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.638 ' H ' ' C ' ' A' ' 74' ' ' PRO . 22.7 t-20 -59.52 -9.89 2.92 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.329 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -67.25 -24.26 65.79 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.014 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -168.53 133.87 1.73 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.064 -1.055 . . . . 0.0 111.482 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.501 ' H ' ' H ' ' A' ' 37' ' ' ASN . 2.3 t -146.75 125.97 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.237 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.3 t -146.29 -42.8 0.2 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.925 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.498 ' OG ' HG22 ' A' ' 25' ' ' THR . 5.2 m -90.93 135.21 33.89 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.057 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.439 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -141.02 159.51 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.196 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.778 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -143.91 106.21 4.39 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.749 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.778 ' CA ' HH12 ' A' ' 83' ' ' ARG . 11.3 t -123.33 131.63 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.545 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.492 HG12 ' NH1' ' A' ' 83' ' ' ARG . 1.5 pt -136.23 140.47 43.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.527 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.1 t -44.43 156.39 0.08 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.758 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.559 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -150.37 140.43 13.92 Favored Pre-proline 0 C--N 1.307 -1.248 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.505 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.559 ' HD2' HG22 ' A' ' 87' ' ' VAL . 3.4 Cg_exo -50.67 136.79 42.1 Favored 'Trans proline' 0 C--O 1.21 -0.892 0 C-N-CA 121.006 1.138 . . . . 0.0 111.464 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.4 t -50.15 141.27 3.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.933 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -119.51 131.62 24.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.505 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.88 -24.5 72.7 Favored 'Trans proline' 0 C--O 1.21 -0.876 0 C-N-CA 120.762 0.975 . . . . 0.0 110.592 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.525 ' HE ' ' HG3' ' A' ' 46' ' ' PRO . 7.2 ptt85 36.36 -157.79 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.222 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.72 173.27 11.69 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.886 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.424 ' CD ' ' OE1' ' A' ' 105' ' ' GLU . 30.1 ttp180 -145.0 109.83 5.05 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 118.484 -1.286 . . . . 0.0 112.574 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.589 ' CD2' HG13 ' A' ' 131' ' ' VAL . 17.3 m-85 -95.95 149.1 21.93 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.204 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.484 ' CD1' ' HB3' ' A' ' 105' ' ' GLU . 72.1 m-85 -115.16 -162.52 0.83 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 119.344 -0.943 . . . . 0.0 111.0 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -135.04 168.01 19.91 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.29 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt 58.05 157.94 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 122.064 0.935 . . . . 0.0 112.823 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.55 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 32.0 tt0 -67.46 106.32 2.09 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.404 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.561 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 8.2 tp60 97.92 59.51 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.976 0 O-C-N 124.721 1.263 . . . . 0.0 111.341 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.561 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 35.2 p90 31.51 38.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.48 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 100' ' ' GLN . 93.6 m-20 -100.62 49.7 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.851 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -169.47 157.52 29.33 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.773 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -40.73 158.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.704 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.484 ' HB3' ' CD1' ' A' ' 96' ' ' PHE . 5.9 pt-20 -123.45 165.44 17.06 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.663 0.744 . . . . 0.0 112.855 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.7 t -146.18 119.53 2.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.805 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.59 164.04 14.92 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.999 -1.08 . . . . 0.0 111.996 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 108' ' ' LEU . 79.3 mt -145.35 137.88 13.6 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.695 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -69.58 161.28 46.52 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 121.646 1.564 . . . . 0.0 111.787 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.84 149.04 91.71 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.812 1.675 . . . . 0.0 111.243 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.53 -164.36 25.14 Favored Glycine 0 N--CA 1.502 3.077 0 C-N-CA 119.288 -1.434 . . . . 0.0 111.368 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.594 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 24.2 mt-30 -119.06 156.49 29.6 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.205 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 29.0 m-85 -144.93 150.54 37.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.884 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.416 ' H ' HG23 ' A' ' 114' ' ' THR . 1.6 p -90.31 -162.62 0.91 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.548 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -102.83 46.78 0.91 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -150.59 -62.98 0.2 Allowed 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.636 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 121' ' ' TYR . 5.8 pt-20 -71.57 -42.75 67.41 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.399 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.589 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -40.19 -70.04 0.11 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.04 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 121' ' ' TYR . 52.4 mt-10 -53.06 -59.49 4.47 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.845 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.473 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -68.34 14.59 0.07 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.389 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.517 ' CE1' HG12 ' A' ' 65' ' ' VAL . 9.4 t80 -117.59 -26.83 6.48 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.27 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -129.35 -43.21 0.21 Allowed Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.521 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.484 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -146.29 -114.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.038 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -146.19 -160.82 1.2 Allowed 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.237 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -59.69 -99.91 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.64 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.634 ' CG ' ' H ' ' A' ' 127' ' ' THR . 19.5 p-10 -57.54 -111.31 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.634 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 1.6 t 43.75 -120.13 0.67 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.894 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.595 ' N ' ' OG1' ' A' ' 127' ' ' THR . 8.4 mm 54.79 -96.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.714 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.4 OUTLIER 76.12 -138.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.297 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.9 m -42.27 129.51 3.8 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.044 -0.663 . . . . 0.0 111.819 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.589 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.9 t -121.13 150.96 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.393 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.78 83.41 8.12 Favored Pre-proline 0 C--N 1.302 -1.49 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.431 ' C ' ' H ' ' A' ' 135' ' ' GLY . 4.3 Cg_exo -61.05 98.65 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.536 1.491 . . . . 0.0 110.433 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -55.27 -2.76 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.656 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . 175.21 -36.97 0.1 Allowed Glycine 0 N--CA 1.492 2.388 0 C-N-CA 117.87 -2.11 . . . . 0.0 112.588 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.501 HD12 ' C ' ' A' ' 92' ' ' ARG . 3.8 mt -90.24 171.53 9.42 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.414 -1.314 . . . . 0.0 111.894 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -94.91 127.25 40.8 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 153' ' ' VAL . 3.4 t -98.32 139.22 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.988 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 98.9 t -133.34 125.35 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.314 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.562 HD23 ' OG1' ' A' ' 167' ' ' THR . 10.5 mp -103.62 140.29 37.75 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.428 -0.909 . . . . 0.0 113.052 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -117.35 131.75 56.72 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.055 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -80.97 -44.12 18.65 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.419 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.445 ' HB3' ' CB ' ' A' ' 147' ' ' SER . 2.2 t-20 -71.95 -171.68 0.74 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.698 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.34 -128.52 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.603 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 146' ' ' PHE . 45.7 t30 -53.57 93.26 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.439 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 145' ' ' ASN . 3.8 m-85 37.39 67.38 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.314 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.445 ' CB ' ' HB3' ' A' ' 143' ' ' ASN . 0.4 OUTLIER -140.83 165.79 26.55 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.116 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 75.79 -163.73 53.6 Favored Glycine 0 N--CA 1.503 3.1 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.998 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.01 171.82 10.18 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.725 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 p -148.18 164.13 34.88 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.697 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 mt -124.67 82.94 59.14 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.344 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -63.05 100.75 0.26 Allowed 'Trans proline' 0 C--N 1.318 -1.054 0 C-N-CA 121.649 1.566 . . . . 0.0 112.652 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 138' ' ' VAL . 10.3 t -80.81 90.01 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.366 -0.933 . . . . 0.0 109.66 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -49.87 -31.64 12.55 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.998 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 13.3 t -170.39 -136.15 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.341 -1.344 . . . . 0.0 112.351 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.414 ' N ' ' OG ' ' A' ' 155' ' ' SER . 11.6 m-20 -50.55 141.62 12.11 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.18 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.535 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.44 63.43 1.07 Allowed Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.699 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.5 Cg_endo -63.22 21.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.214 1.943 . . . . 0.0 112.777 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.535 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -168.96 118.88 0.71 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.274 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.62 -40.64 0.14 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.407 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.602 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.91 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.126 0.488 . . . . 0.0 111.451 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.562 ' OG1' HD23 ' A' ' 140' ' ' LEU . 1.1 m -90.58 123.12 33.97 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.579 -0.849 . . . . 0.0 110.508 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.4 m -90.33 -79.55 0.34 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.141 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 7.0 m -105.29 159.87 15.55 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.437 HG12 ' CD1' ' A' ' 118' ' ' LEU . 32.8 pt -141.92 174.36 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.25 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -158.82 109.84 2.09 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.506 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.438 HG21 HD13 ' A' ' 136' ' ' LEU . 56.5 mt -88.08 92.27 3.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 118.832 -1.147 . . . . 0.0 109.414 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.939 -179.904 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.422 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.873 0.368 . . . . 0.0 110.73 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 2.7 p30 -173.24 107.45 0.15 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.191 -1.003 . . . . 0.0 111.159 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 pt -76.36 175.13 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.932 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 m -148.06 153.1 38.47 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.364 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 m -138.02 160.04 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.235 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.488 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 22.2 m-85 -119.42 145.91 45.83 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.904 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.85 -66.52 0.6 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.561 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 73.3 m-20 -76.1 179.82 5.43 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.311 -0.956 . . . . 0.0 112.364 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -73.93 176.81 6.08 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.226 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.654 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 16.8 t70 48.56 56.01 8.18 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.491 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.654 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 39.2 p90 38.23 27.42 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.451 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 11' ' ' ASP . 6.3 tp-100 -98.89 163.06 12.76 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.35 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.561 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 93.13 134.35 6.91 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.378 -1.391 . . . . 0.0 109.634 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 14' ' ' GLY . 38.7 mttp -29.45 140.82 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.47 164.55 12.23 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.322 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.3 t -145.58 129.94 11.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.664 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -92.94 137.09 32.67 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.231 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 mt -129.05 136.79 29.73 Favored Pre-proline 0 N--CA 1.49 1.558 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.33 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -72.44 156.72 54.1 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 121.087 1.191 . . . . 0.0 111.422 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.73 -161.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.463 1.442 . . . . 0.0 109.726 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.558 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 91.18 -162.47 28.46 Favored Glycine 0 N--CA 1.485 1.923 0 C-N-CA 118.528 -1.796 . . . . 0.0 110.991 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.54 ' HB3' HH11 ' A' ' 83' ' ' ARG . 17.1 p-10 -123.03 133.18 54.35 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.238 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.603 ' OH ' HD12 ' A' ' 82' ' ' ILE . 14.7 p90 -155.7 174.51 15.19 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.522 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.468 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 17.0 p -138.25 -156.64 0.7 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.071 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.469 ' CD ' ' H ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -66.79 -16.68 64.43 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.599 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -65.13 -59.88 3.62 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.637 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.554 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 15.3 tp60 -56.41 -43.78 79.68 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 118.754 -1.178 . . . . 0.0 109.261 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 29' ' ' LEU . 28.4 mt -59.21 -40.03 84.51 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.814 -1.155 . . . . 0.0 109.127 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.7 -32.73 14.08 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 118.735 -1.186 . . . . 0.0 108.077 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -69.87 -42.07 73.97 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.699 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 mt -70.58 -74.86 0.13 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.82 -29.67 0.74 Allowed Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.092 -1.527 . . . . 0.0 110.846 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.41 ' H ' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -92.08 139.99 16.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.882 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.615 ' O ' HG23 ' A' ' 38' ' ' THR . 2.2 pt-20 179.94 166.1 1.22 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.481 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.607 ' C ' ' H ' ' A' ' 38' ' ' THR . 0.6 OUTLIER 79.97 -143.54 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.545 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -56.38 10.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.623 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 35' ' ' GLU . 67.4 p -76.17 -142.4 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.618 -1.233 . . . . 0.0 111.023 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 38' ' ' THR . 9.1 mt 39.69 60.71 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.02 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.2 t -65.54 -50.39 65.4 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.12 172.26 8.38 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.355 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.62 154.48 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 118.529 -1.268 . . . . 0.0 112.607 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -138.66 125.28 20.76 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.457 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.9 t -140.0 114.43 7.74 Favored Pre-proline 0 N--CA 1.494 1.725 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.918 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -69.32 169.48 18.25 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 121.116 1.21 . . . . 0.0 111.231 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.63 -174.97 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 122.102 1.868 . . . . 0.0 111.387 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.86 -16.77 7.86 Favored Glycine 0 N--CA 1.482 1.766 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.985 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.422 HG11 ' CB ' ' A' ' 2' ' ' ALA . 18.4 m -149.25 146.4 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.779 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -119.55 139.35 52.28 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.55 159.43 20.41 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.199 -1.001 . . . . 0.0 112.937 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.495 HG23 ' O ' ' A' ' 63' ' ' ILE . 70.5 mt -141.29 117.96 7.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.447 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.472 ' H ' HD12 ' A' ' 52' ' ' LEU . 4.2 mp -92.32 163.12 14.0 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.824 -1.15 . . . . 0.0 113.222 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.45 ' CE2' ' CD ' ' A' ' 62' ' ' GLN . 30.7 m-85 -141.61 115.29 9.06 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.678 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -81.1 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.899 -0.72 . . . . 0.0 112.157 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -59.26 141.07 55.28 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.319 -0.953 . . . . 0.0 111.382 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.07 172.79 0.26 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.464 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.47 27.27 73.88 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.291 -1.433 . . . . 0.0 110.149 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.468 ' CZ ' HG23 ' A' ' 25' ' ' THR . 32.9 m-85 54.58 63.32 2.19 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.969 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.38 -161.6 1.34 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.01 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.0 170.02 1.21 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.462 -1.352 . . . . 0.0 110.106 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -44.74 121.44 2.71 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.343 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.45 ' CD ' ' CE2' ' A' ' 53' ' ' TYR . 23.0 mt-30 -94.86 173.21 7.71 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.068 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.807 HD11 HD11 ' A' ' 75' ' ' LEU . 2.9 mt -143.73 166.04 13.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.683 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -146.93 131.18 17.45 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.299 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.6 m -150.17 160.31 4.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.806 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.43 -15.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.543 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -111.1 -138.55 0.38 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.003 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -111.07 124.81 52.91 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.001 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.75 120.25 29.98 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.236 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.55 -85.18 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.108 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 6.5 mt-10 -85.51 3.56 39.84 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.69 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.454 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 1.6 tp 72.34 -89.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.584 -0.847 . . . . 0.0 111.74 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.428 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -179.13 -178.88 48.57 Favored Glycine 0 N--CA 1.499 2.876 0 C-N-CA 118.861 -1.638 . . . . 0.0 111.369 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -70.2 14.8 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.627 2.218 . . . . 0.0 112.99 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.807 HD11 HD11 ' A' ' 63' ' ' ILE . 1.4 pt? -132.49 38.95 3.41 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.269 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -83.46 -2.04 54.98 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.655 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -73.14 -7.99 53.79 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.805 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -164.07 117.74 1.45 Allowed 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.122 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.27 127.32 11.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.232 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.1 t -155.45 -35.32 0.09 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 118.857 -1.137 . . . . 0.0 112.362 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.2 m -93.69 136.49 33.91 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.943 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.603 HD12 ' OH ' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -144.84 155.99 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 118.839 -1.144 . . . . 0.0 112.282 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.817 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.87 120.74 15.43 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.358 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.817 ' H ' HH12 ' A' ' 83' ' ' ARG . 18.4 t -129.92 136.8 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.939 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.591 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 2.6 mt -143.87 132.77 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.027 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.5 m -38.18 150.81 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.928 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.509 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -148.03 139.89 14.14 Favored Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.328 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.509 ' HD2' HG22 ' A' ' 87' ' ' VAL . 10.7 Cg_exo -47.78 153.61 2.34 Favored 'Trans proline' 0 C--O 1.212 -0.821 0 C-N-CA 121.401 1.401 . . . . 0.0 111.512 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.34 141.25 15.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 119.756 -0.778 . . . . 0.0 112.312 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -145.97 136.41 12.16 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.582 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.404 ' HG2' HD21 ' A' ' 136' ' ' LEU . 5.4 Cg_exo -58.83 -155.39 0.01 OUTLIER 'Trans proline' 0 C--O 1.21 -0.904 0 C-N-CA 121.421 1.414 . . . . 0.0 111.274 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.411 ' NE ' HH21 ' A' ' 94' ' ' ARG . 5.2 ptt180 -178.76 -160.86 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 118.375 -1.33 . . . . 0.0 111.929 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.0 168.7 19.09 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.385 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.411 HH21 ' NE ' ' A' ' 92' ' ' ARG . 0.4 OUTLIER -125.15 156.52 38.25 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.635 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.432 ' CD2' HG13 ' A' ' 131' ' ' VAL . 73.7 m-85 -145.88 103.88 3.8 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.672 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -89.97 172.25 8.99 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.059 -1.057 . . . . 0.0 112.124 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.603 ' CE2' ' OG1' ' A' ' 127' ' ' THR . 0.3 OUTLIER -110.45 159.23 17.68 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.915 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 42.2 tttt 68.35 151.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.84 0.829 . . . . 0.0 112.359 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.562 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 26.8 tt0 -67.9 106.22 2.23 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.754 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.584 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 2.6 tt0 105.0 48.45 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.108 0 O-C-N 125.054 1.471 . . . . 0.0 110.637 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.584 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 33.9 p90 30.73 39.1 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.156 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 100' ' ' GLN . 24.9 t70 -99.41 26.75 5.76 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.465 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -146.94 179.99 23.46 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.141 -1.504 . . . . 0.0 111.28 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -29.72 145.12 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -119.08 137.65 53.42 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.322 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.682 HG21 ' O ' ' A' ' 122' ' ' GLY . 2.4 t -139.86 158.58 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.979 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.466 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 7.2 p-10 -144.86 156.35 43.96 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.646 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.478 HD22 ' CD2' ' A' ' 121' ' ' TYR . 32.2 mt -141.08 147.9 49.52 Favored Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.527 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -71.31 165.23 33.09 Favored 'Trans proline' 0 C--O 1.212 -0.819 0 C-N-CA 121.797 1.665 . . . . 0.0 111.08 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.54 149.42 82.18 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.646 1.564 . . . . 0.0 111.518 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.41 -151.38 22.6 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 119.069 -1.539 . . . . 0.0 111.436 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.678 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 8.1 tt0 -136.14 155.69 49.8 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.21 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.678 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 18.9 m-85 -145.6 155.32 42.96 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.51 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.9 p -96.45 -156.82 0.55 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.327 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.749 ' H ' ' CD ' ' A' ' 115' ' ' GLN . 3.8 pm0 -103.75 29.4 5.81 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.231 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.24 -65.48 0.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.769 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.55 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 9.6 pt-20 -70.33 -48.77 54.99 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.975 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.68 ' C ' HD23 ' A' ' 118' ' ' LEU . 1.9 tt -35.12 -73.25 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.502 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.54 -54.22 24.14 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.555 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -76.28 17.66 0.35 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.638 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.511 ' N ' ' O ' ' A' ' 117' ' ' GLU . 18.1 t80 -123.7 -12.62 7.6 Favored 'General case' 0 N--CA 1.502 2.175 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.625 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.682 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -142.47 -48.49 0.04 OUTLIER Glycine 0 N--CA 1.485 1.953 0 C-N-CA 119.223 -1.465 . . . . 0.0 110.173 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.595 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -145.13 -99.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.835 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.595 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 17.9 t70 -165.76 -164.88 0.76 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.15 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.533 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 53.5 t30 -64.53 -122.07 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.874 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.477 ' H ' ' CG ' ' A' ' 125' ' ' ASN . 3.6 m-20 -70.4 112.42 6.68 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.538 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.603 ' OG1' ' CE2' ' A' ' 97' ' ' TYR . 1.8 t -179.87 -5.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.744 -0.783 . . . . 0.0 110.798 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.2 mt -91.25 151.95 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.617 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.528 ' HB3' ' H ' ' A' ' 161' ' ' GLY . 19.3 m -153.42 -66.12 0.15 Allowed 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.373 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.24 112.37 19.18 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.037 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.432 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.0 t -120.5 163.3 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.189 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.0 tttp -154.34 125.64 3.62 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.647 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 6.2 Cg_endo -65.33 -50.04 2.22 Favored 'Trans proline' 0 C--O 1.203 -1.262 0 C-N-CA 121.034 1.156 . . . . 0.0 111.081 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.479 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 72.23 -37.72 0.4 Allowed 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.38 -0.928 . . . . 0.0 112.621 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . -150.35 -48.88 0.02 OUTLIER Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.236 -1.459 . . . . 0.0 111.113 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.404 HD21 ' HG2' ' A' ' 91' ' ' PRO . 0.7 OUTLIER -109.56 153.4 24.19 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.008 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.06 153.75 41.54 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.118 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.64 143.82 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 119.663 -0.815 . . . . 0.0 112.321 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.43 HG12 ' CE1' ' A' ' 141' ' ' PHE . 93.3 t -135.94 123.07 33.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.984 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 140' ' ' LEU . 10.3 mp -103.23 142.75 33.64 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.812 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.528 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 14.0 m-85 -120.61 136.52 54.79 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.082 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -75.05 -62.62 1.49 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.565 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.409 ' HB2' ' C ' ' A' ' 147' ' ' SER . 5.1 m120 -61.01 159.99 10.65 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.271 -0.972 . . . . 0.0 112.362 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -27.35 -108.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.519 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 9.0 m120 -74.7 89.82 2.28 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.219 -0.901 . . . . 0.0 113.273 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.66 ' H ' ' CB ' ' A' ' 169' ' ' SER . 1.5 p90 33.04 73.11 0.07 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.131 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.409 ' C ' ' HB2' ' A' ' 143' ' ' ASN . 10.3 t -145.83 -170.76 3.55 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.158 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 51.26 -157.97 2.54 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.124 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.406 ' C ' HG23 ' A' ' 150' ' ' THR . 2.3 m-20 -59.99 174.1 0.54 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.654 -0.819 . . . . 0.0 110.833 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 149' ' ' ASP . 55.3 p -155.05 174.5 15.09 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.914 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.7 tp -138.32 79.54 30.46 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.026 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -59.66 110.26 0.71 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.817 1.678 . . . . 0.0 112.945 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 155' ' ' SER . 20.5 t -93.24 70.77 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.356 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -65.06 8.2 0.14 Allowed 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.219 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.595 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 9.3 t -170.94 177.68 3.67 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.282 -1.367 . . . . 0.0 112.211 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.595 ' N ' ' OG ' ' A' ' 155' ' ' SER . 3.2 m-20 -51.0 151.59 2.53 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.431 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.531 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -164.32 61.71 0.92 Allowed Pre-proline 0 C--N 1.309 -1.165 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.407 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.2 Cg_endo -63.72 22.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.534 2.156 . . . . 0.0 113.314 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -175.96 95.49 0.06 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 117.759 -1.576 . . . . 0.0 112.504 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 160' ' ' LEU . 44.7 mt -112.56 -61.54 1.71 Allowed 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.65 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.528 ' H ' ' HB3' ' A' ' 129' ' ' SER . . . . . . . . 0 N--CA 1.499 2.89 0 C-N-CA 119.553 -1.308 . . . . 0.0 111.156 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.6 p30 . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 120.575 0.226 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 47.3 m 42.76 73.88 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.419 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.3 m -78.29 -23.55 47.14 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.204 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.66 ' CB ' ' H ' ' A' ' 146' ' ' PHE . 0.2 OUTLIER -149.25 162.07 40.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.34 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 29.1 pt -143.46 161.33 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 119.159 -1.017 . . . . 0.0 111.029 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -143.42 104.01 4.18 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.452 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.8 mt -82.63 95.12 3.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.179 -1.009 . . . . 0.0 110.154 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.3 m . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.845 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.599 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.873 0.368 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -175.15 118.96 0.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.526 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.5 pt -69.14 154.7 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.233 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -126.56 135.44 51.27 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.81 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.622 ' HB ' HG23 ' A' ' 39' ' ' ILE . 2.3 m -121.89 138.73 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.971 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.52 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 29.6 m-85 -96.48 146.7 24.56 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.798 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.04 -56.78 17.02 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.25 -0.98 . . . . 0.0 112.21 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.606 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 4.6 m120 -96.85 170.94 8.83 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.504 ' HG2' ' N ' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -76.6 -165.92 0.59 Allowed 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.976 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.504 ' N ' ' HG2' ' A' ' 10' ' ' GLU . 66.4 m-20 52.67 35.4 18.21 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.523 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.52 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 18.2 t80 56.68 7.11 0.35 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.436 -0.905 . . . . 0.0 112.16 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.43 ' HG3' ' N ' ' A' ' 14' ' ' GLY . 5.3 tp-100 -96.31 160.21 14.54 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.551 -0.859 . . . . 0.0 111.678 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.606 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 102.38 131.23 7.27 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.738 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 14' ' ' GLY . 25.2 mtmm -31.79 141.11 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.927 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.9 pm0 -99.44 161.19 13.76 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.119 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.1 t -145.47 134.48 17.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.206 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.16 134.09 39.66 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.141 -1.024 . . . . 0.0 112.116 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.6 mt -122.1 127.57 25.88 Favored Pre-proline 0 N--CA 1.489 1.479 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.524 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.5 163.6 31.92 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 120.928 1.086 . . . . 0.0 111.268 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.39 -169.28 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.65 1.567 . . . . 0.0 111.019 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.462 ' C ' HH21 ' A' ' 83' ' ' ARG . . . 87.96 -176.91 46.05 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.744 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.57 ' N ' HH21 ' A' ' 83' ' ' ARG . 14.0 p-10 -112.18 142.29 44.83 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.884 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.616 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -156.03 -174.77 5.1 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.314 179.777 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 24' ' ' TYR . 4.7 p -156.35 -157.17 0.69 Allowed 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.921 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.43 ' H ' ' HB ' ' A' ' 25' ' ' THR . 43.9 ttt85 -52.29 -33.54 42.65 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.289 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.79 -63.59 1.21 Allowed 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.863 -1.135 . . . . 0.0 110.524 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.8 tm0? -57.23 -32.95 67.05 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.779 -1.169 . . . . 0.0 109.882 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.616 HD21 ' CZ ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -60.56 -47.27 86.92 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.011 -1.076 . . . . 0.0 109.433 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.41 -32.99 28.33 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.163 -1.015 . . . . 0.0 108.92 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -64.08 -42.79 96.83 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.848 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 mt -71.9 -80.31 0.06 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.941 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.77 -29.79 0.16 Allowed Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.465 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.455 HG23 ' H ' ' A' ' 34' ' ' ILE . 0.9 OUTLIER -82.2 169.75 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.894 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.959 ' H ' HG21 ' A' ' 38' ' ' THR . 4.7 pt-20 178.68 111.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.289 -0.965 . . . . 0.0 111.904 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.616 ' O ' HG23 ' A' ' 38' ' ' THR . 1.0 OUTLIER 61.66 140.57 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.555 ' H ' ' H ' ' A' ' 79' ' ' VAL . 9.6 t30 47.01 4.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.658 -1.156 . . . . 0.0 113.695 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.959 HG21 ' H ' ' A' ' 35' ' ' GLU . 76.2 p -82.34 -29.87 30.74 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 117.992 -1.483 . . . . 0.0 111.424 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.622 HG23 ' HB ' ' A' ' 6' ' ' VAL . 11.6 mt -78.24 53.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.328 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 10' ' ' GLU . 30.4 t -50.98 -53.93 28.85 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.761 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.0 169.65 10.27 Favored 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.307 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.1 t -153.3 151.43 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 117.856 -1.538 . . . . 0.0 113.139 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -138.64 102.69 4.66 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.194 -1.367 . . . . 0.0 108.805 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 73.9 t -117.94 107.8 43.5 Favored Pre-proline 0 N--CA 1.496 1.865 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.228 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.25 168.2 19.98 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 121.31 1.34 . . . . 0.0 110.939 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.11 -173.19 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.753 1.635 . . . . 0.0 111.177 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.63 -14.77 11.46 Favored Glycine 0 N--CA 1.481 1.699 0 C-N-CA 119.125 -1.512 . . . . 0.0 110.691 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.599 HG11 ' CB ' ' A' ' 2' ' ' ALA . 16.3 m -151.59 134.28 6.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 C-N-CA 118.851 -1.14 . . . . 0.0 112.086 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.436 ' O ' HG13 ' A' ' 84' ' ' VAL . 22.8 ttpp -105.83 143.52 33.85 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.32 150.75 49.44 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.024 -1.07 . . . . 0.0 112.928 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 63' ' ' ILE . 83.9 mt -135.04 117.75 22.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.737 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.476 ' H ' HD12 ' A' ' 52' ' ' LEU . 3.6 mp -96.61 160.83 14.18 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 118.927 -1.109 . . . . 0.0 113.8 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 62' ' ' GLN . 44.9 m-85 -135.3 116.38 14.3 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.675 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -47.59 -88.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.081 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -61.69 147.26 46.58 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.54 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -55.54 174.51 0.1 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.389 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.16 30.59 75.87 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.127 -1.511 . . . . 0.0 110.03 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 48.42 40.46 14.83 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.767 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.37 -176.97 3.02 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.821 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.69 164.27 5.27 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.064 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -45.55 131.87 8.47 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.545 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.413 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 5.6 pt20 -99.24 172.31 7.44 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.706 HD11 HD11 ' A' ' 75' ' ' LEU . 3.9 mt -135.28 165.29 31.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.763 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.414 ' C ' HG13 ' A' ' 65' ' ' VAL . 28.2 mt-10 -143.92 129.89 19.49 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.4 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.414 HG13 ' C ' ' A' ' 64' ' ' GLU . 35.1 m -150.03 159.61 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 118.489 -1.284 . . . . 0.0 112.524 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 t -146.23 2.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.238 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.49 ' HB3' ' OH ' ' A' ' 121' ' ' TYR . . . -131.51 -144.6 0.25 Allowed 'General case' 0 C--O 1.207 -1.132 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.086 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.481 ' ND2' ' C ' ' A' ' 68' ' ' ASN . 0.5 OUTLIER -103.37 119.55 39.09 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.849 -0.741 . . . . 0.0 111.578 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.542 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -97.45 97.86 9.45 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.17 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -58.72 -87.61 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.48 -0.888 . . . . 0.0 112.096 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 43.7 mm-40 -68.02 -5.83 19.39 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.41 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.466 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 2.8 tp 70.83 -77.88 0.05 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.049 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.43 -175.21 43.75 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.51 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -65.35 -38.43 26.48 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.193 1.929 . . . . 0.0 111.865 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -78.96 30.67 0.2 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.395 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -77.14 10.26 2.52 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.561 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -87.83 -2.17 58.44 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.83 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -170.7 122.23 0.6 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.024 -1.07 . . . . 0.0 111.546 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.555 ' H ' ' H ' ' A' ' 37' ' ' ASN . 2.4 t -147.92 121.93 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.494 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.1 t -150.58 -34.1 0.16 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.908 -1.117 . . . . 0.0 112.517 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.425 ' OG ' HG22 ' A' ' 25' ' ' THR . 3.8 m -93.19 136.31 33.58 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.818 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.524 HD12 ' CE1' ' A' ' 24' ' ' TYR . 21.3 mt -148.08 160.95 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.287 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.835 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -142.78 108.1 5.01 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.824 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.835 ' H ' HH22 ' A' ' 83' ' ' ARG . 10.5 t -114.59 142.39 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.823 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.465 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 7.2 mt -142.48 132.43 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.745 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 m -40.38 153.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.663 -0.698 . . . . 0.0 112.319 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -150.77 149.1 24.78 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.968 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.33 177.55 0.15 Allowed 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 121.546 1.497 . . . . 0.0 112.099 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 89' ' ' VAL . 34.6 m -88.29 136.12 24.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.316 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -146.17 123.68 6.1 Favored Pre-proline 0 C--N 1.308 -1.2 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.844 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -57.06 178.84 0.13 Allowed 'Trans proline' 0 C--O 1.205 -1.146 0 C-N-CA 121.088 1.192 . . . . 0.0 110.978 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.504 ' HD3' ' N ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -151.42 -160.12 1.12 Allowed 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.566 0.698 . . . . 0.0 110.23 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.98 167.03 23.06 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -132.35 116.07 16.4 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.674 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -99.09 130.27 45.41 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.456 ' CD2' ' HB3' ' A' ' 105' ' ' GLU . 24.8 m-85 -102.47 165.39 11.13 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.639 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -103.31 162.67 12.81 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.41 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.467 ' HB2' ' CB ' ' A' ' 102' ' ' ASP . 22.3 mmtp 58.14 157.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 122.24 1.019 . . . . 0.0 112.858 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.552 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 36.4 tt0 -72.92 107.58 5.38 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.3 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 92.26 56.52 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.603 0 O-C-N 124.524 1.14 . . . . 0.0 111.256 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.588 ' O ' ' CG ' ' A' ' 101' ' ' PHE . 1.3 t80 37.98 64.1 0.73 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.486 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.467 ' CB ' ' HB2' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -111.77 17.03 20.21 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.193 179.838 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -160.01 155.4 26.53 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.485 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -44.77 162.11 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.135 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.456 ' CD ' ' C ' ' A' ' 105' ' ' GLU . 2.2 pp20? -120.12 179.46 4.27 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.532 0.682 . . . . 0.0 112.551 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.636 HG13 ' N ' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -140.01 177.0 4.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.799 -1.092 . . . . 0.0 108.963 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.636 ' N ' HG13 ' A' ' 106' ' ' VAL . 19.5 p-10 -142.55 150.91 41.02 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.653 -1.219 . . . . 0.0 112.006 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.3 mt -141.98 148.46 48.86 Favored Pre-proline 0 N--CA 1.5 2.064 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.732 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.414 ' O ' HD12 ' A' ' 172' ' ' ILE . 11.8 Cg_endo -77.28 163.01 30.7 Favored 'Trans proline' 0 C--O 1.211 -0.83 0 C-N-CA 122.096 1.864 . . . . 0.0 111.963 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.38 158.54 35.37 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 122.415 2.077 . . . . 0.0 111.484 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.91 -170.5 14.96 Favored Glycine 0 N--CA 1.501 2.985 0 C-N-CA 119.465 -1.35 . . . . 0.0 111.43 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.594 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 18.8 tt0 -111.2 155.43 22.94 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.611 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 26.0 m-85 -142.35 151.87 42.34 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.83 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.4 p -87.24 -164.77 1.14 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.686 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 56.54 0.68 Allowed 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.179 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.441 ' N ' ' OE1' ' A' ' 119' ' ' GLU . . . -155.18 -71.57 0.12 Allowed 'General case' 0 C--N 1.294 -1.804 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.234 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.1 pt-20 -67.04 -44.73 79.47 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.488 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.653 ' C ' HD23 ' A' ' 118' ' ' LEU . 1.2 tt -39.56 -69.83 0.12 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.5 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.751 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 25.4 mp0 -48.11 -59.41 3.41 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.913 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.416 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 1.5 mpt_? -70.95 0.79 6.61 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.96 -1.096 . . . . 0.0 112.814 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 117' ' ' GLU . 13.8 t80 -97.9 -17.58 19.17 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.072 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.55 -41.05 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 C-N-CA 118.55 -1.786 . . . . 0.0 111.665 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.596 HG13 HD11 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -134.73 -117.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.461 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.55 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 15.7 t70 -148.92 -163.72 1.85 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.599 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.55 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 37.7 p-10 -106.07 31.45 5.09 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.028 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.473 ' ND2' ' OD1' ' A' ' 125' ' ' ASN . 19.2 p30 -176.27 17.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.756 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.699 HG23 ' N ' ' A' ' 128' ' ' ILE . 8.5 t -114.67 -132.11 0.33 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.386 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.699 ' N ' HG23 ' A' ' 127' ' ' THR . 3.4 mt 62.84 158.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.097 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.2 p -165.85 -97.29 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.65 136.88 49.42 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.889 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.59 157.25 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -150.8 96.48 3.34 Favored Pre-proline 0 C--N 1.304 -1.398 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.893 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -53.26 93.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.238 1.292 . . . . 0.0 110.79 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.467 ' CG ' ' NH2' ' A' ' 92' ' ' ARG . 5.1 tp60 -71.85 7.69 1.47 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.1 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 171.52 -40.56 0.18 Allowed Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.92 -1.61 . . . . 0.0 111.02 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.415 ' HB2' ' CG2' ' A' ' 172' ' ' ILE . 0.4 OUTLIER -121.67 151.02 40.92 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.314 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.0 156.36 39.73 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.657 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.29 136.49 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.818 -0.753 . . . . 0.0 112.249 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.481 ' C ' HD12 ' A' ' 140' ' ' LEU . 74.3 t -125.14 128.77 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.826 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 140' ' ' LEU . 10.8 mp -102.72 142.01 34.58 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.372 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.543 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 4.0 m-85 -120.6 134.23 55.3 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.397 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -70.28 -71.58 0.24 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.914 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -72.81 -176.32 1.98 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.889 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 146' ' ' PHE . 1.5 m-20 -77.12 -164.25 0.44 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.665 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 7.7 p-10 36.65 29.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.518 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.665 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 2.5 p90 39.58 61.64 1.35 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.779 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.471 ' CB ' ' ND2' ' A' ' 145' ' ' ASN . 3.5 t -146.66 137.67 24.13 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.2 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.42 -139.55 14.23 Favored Glycine 0 N--CA 1.503 3.125 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.56 141.65 44.77 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.099 -1.041 . . . . 0.0 109.863 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 34.3 p -147.82 162.28 39.57 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.911 -1.116 . . . . 0.0 111.869 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 151' ' ' LEU . 64.8 tp -130.12 89.34 45.53 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.922 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.06 108.87 1.59 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 121.849 1.699 . . . . 0.0 113.006 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.58 80.56 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.412 -0.915 . . . . 0.0 108.925 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.478 ' C ' ' OG ' ' A' ' 155' ' ' SER . 50.9 t30 -65.35 -9.91 28.66 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.478 ' OG ' ' C ' ' A' ' 154' ' ' ASN . 1.2 m -161.03 -155.44 0.41 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 117.594 -1.643 . . . . 0.0 113.232 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.51 142.48 44.16 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.824 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.545 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -162.05 61.82 1.3 Allowed Pre-proline 0 C--N 1.308 -1.21 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.449 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.2 Cg_endo -64.71 21.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.291 1.994 . . . . 0.0 112.316 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -170.45 113.17 0.44 Allowed 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.677 -1.209 . . . . 0.0 111.331 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 mt -143.1 -56.78 0.42 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.406 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 C-N-CA 119.333 -1.413 . . . . 0.0 110.612 179.96 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 40.2 t30 . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.942 0.401 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.2 m -57.55 99.17 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.593 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 73.7 m -84.29 -56.29 3.72 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.68 158.39 30.18 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.176 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.405 HG23 HD11 ' A' ' 118' ' ' LEU . 35.1 pt -136.01 165.37 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.49 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -146.73 100.58 3.35 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.401 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 172' ' ' ILE . 10.3 mt -78.97 105.13 7.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.256 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 51.6 m . . . . . 0 C--N 1.306 -1.324 0 CA-C-O 116.399 -1.762 . . . . 0.0 110.963 -179.937 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.764 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 121.068 0.461 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.42 ' CG ' ' C ' ' A' ' 2' ' ' ALA . 9.0 m-80 -158.97 122.33 3.78 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.854 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.417 ' O ' ' CG1' ' A' ' 4' ' ' ILE . 2.2 pt -75.49 133.86 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.852 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 m -110.89 114.69 28.21 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.353 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.32 164.6 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.304 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 1.055 ' CE2' ' NE2' ' A' ' 16' ' ' GLN . 39.6 m-85 -123.85 148.85 46.42 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.998 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.443 ' HB2' ' N ' ' A' ' 15' ' ' LYS . 3.2 m-85 -79.04 0.41 27.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.472 ' N ' ' HA3' ' A' ' 14' ' ' GLY . 13.3 m120 -151.3 172.82 15.28 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.026 -1.47 . . . . 0.0 112.114 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.56 -174.82 1.81 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.519 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 13' ' ' GLN . 15.3 t70 52.67 31.08 9.67 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.159 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.526 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 1.5 t80 68.45 -8.73 0.58 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.136 -1.026 . . . . 0.0 111.349 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.465 ' H ' ' C ' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -78.25 167.93 20.62 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.287 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.984 ' O ' ' OE1' ' A' ' 16' ' ' GLN . . . 109.3 134.82 7.12 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.935 ' C ' ' OE1' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -35.25 144.57 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.688 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 1.055 ' NE2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -98.6 148.05 24.19 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.258 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.3 t -147.45 123.37 2.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.676 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -94.78 115.82 27.98 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.803 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt -105.98 132.49 20.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.598 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -68.53 164.69 31.89 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 120.874 1.049 . . . . 0.0 111.439 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.68 -161.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 121.774 1.649 . . . . 0.0 111.057 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.68 -177.64 52.43 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.109 -1.52 . . . . 0.0 111.354 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.557 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -105.92 137.08 44.42 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.786 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.564 ' CE2' HD13 ' A' ' 82' ' ' ILE . 4.0 p90 -158.55 160.2 36.37 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.294 -0.963 . . . . 0.0 109.689 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.445 ' CG2' ' CE2' ' A' ' 58' ' ' PHE . 68.9 p -122.83 -162.02 0.99 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.1 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -66.3 -16.99 64.48 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.876 -1.13 . . . . 0.0 110.776 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -64.39 -58.42 6.52 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 118.816 -1.154 . . . . 0.0 109.211 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.526 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -55.57 -44.89 77.27 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 118.686 -1.206 . . . . 0.0 108.918 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.433 HD23 HD12 ' A' ' 32' ' ' LEU . 39.4 mt -57.33 -41.27 79.64 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.966 -1.094 . . . . 0.0 109.425 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.49 -33.14 13.68 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.86 -1.136 . . . . 0.0 108.263 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -70.95 -37.91 72.83 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.489 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.433 HD12 HD23 ' A' ' 29' ' ' LEU . 20.2 mt -72.6 -73.2 0.21 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.646 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.81 -27.2 0.65 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.285 -1.436 . . . . 0.0 110.596 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.45 HD13 HG21 ' A' ' 34' ' ' ILE . 8.0 tt -75.63 145.82 10.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.173 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.514 ' C ' ' CG ' ' A' ' 36' ' ' ASN . 5.6 pt-20 -174.38 146.68 1.09 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.657 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.514 ' CG ' ' C ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER 74.56 -140.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.402 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 39' ' ' ILE . 7.1 m120 -40.3 -87.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.282 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.704 ' O ' ' N ' ' A' ' 40' ' ' SER . 20.3 p 37.5 -96.26 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.761 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 37' ' ' ASN . 5.6 mt -38.0 79.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 124.412 1.07 . . . . 0.0 111.442 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.704 ' N ' ' O ' ' A' ' 38' ' ' THR . 28.5 t -96.07 -39.05 9.93 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.447 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -127.99 167.55 16.52 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.603 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -153.08 151.14 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 117.849 -1.54 . . . . 0.0 113.012 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -135.46 99.96 4.37 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.837 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.55 108.38 39.6 Favored Pre-proline 0 N--CA 1.494 1.753 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.577 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.94 167.66 20.94 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.092 1.195 . . . . 0.0 110.692 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.65 -171.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.748 1.632 . . . . 0.0 111.108 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.73 -14.51 9.77 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 119.317 -1.421 . . . . 0.0 110.93 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.764 HG11 ' HB3' ' A' ' 2' ' ' ALA . 2.7 m -147.32 140.46 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.339 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.1 tttt -114.81 125.79 54.09 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.808 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.402 ' CB ' HG22 ' A' ' 84' ' ' VAL . . . -117.37 139.7 50.53 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.184 -1.007 . . . . 0.0 113.061 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.564 HD12 HH21 ' A' ' 83' ' ' ARG . 44.3 mt -116.26 119.3 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.631 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -94.58 146.9 23.8 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.26 -0.976 . . . . 0.0 112.239 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.489 ' H ' HD23 ' A' ' 52' ' ' LEU . 43.9 m-85 -127.01 112.58 15.4 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.267 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.523 ' CD ' ' N ' ' A' ' 55' ' ' ASN . 8.5 tm0? -49.87 -76.27 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.345 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.523 ' N ' ' CD ' ' A' ' 54' ' ' GLN . 62.3 t30 -59.97 155.9 15.73 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.047 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -68.68 -179.69 1.48 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.467 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.36 36.77 78.0 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.195 -1.478 . . . . 0.0 110.191 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 25' ' ' THR . 35.6 m-85 49.13 63.78 2.0 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.794 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.55 -166.23 2.43 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.318 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.43 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 68.91 173.09 8.32 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.383 -1.389 . . . . 0.0 109.868 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 9.7 m-20 -42.19 119.44 1.37 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.397 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.619 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 7.1 pm0 -90.04 164.51 14.48 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.349 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.667 HG13 HD11 ' A' ' 75' ' ' LEU . 8.8 mm -137.91 166.67 23.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.382 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.66 ' N ' HG22 ' A' ' 63' ' ' ILE . 19.2 mp0 -148.26 126.08 11.91 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.619 -0.832 . . . . 0.0 109.64 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.1 159.97 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 118.859 -1.136 . . . . 0.0 112.557 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.435 ' H ' ' H ' ' A' ' 67' ' ' ALA . 2.2 t -149.36 -7.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 114.195 -1.366 . . . . 0.0 107.495 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.435 ' H ' ' H ' ' A' ' 66' ' ' VAL . . . -124.8 -155.88 0.69 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.966 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -93.32 117.76 30.47 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.626 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.603 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.26 111.76 22.65 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.91 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -73.21 -77.9 0.1 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.418 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 73' ' ' GLY . 24.4 tp10 -79.24 -2.92 43.39 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.103 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.475 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 6.7 tp 54.95 -87.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.392 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.475 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 176.11 -170.15 42.95 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 118.967 -1.587 . . . . 0.0 110.924 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.516 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.0 Cg_endo -65.45 -36.22 35.59 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.159 1.906 . . . . 0.0 111.941 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.885 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.4 pt? -70.9 19.51 0.05 Allowed 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.981 -1.088 . . . . 0.0 111.274 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 74' ' ' PRO . 34.9 p-10 -77.33 -18.16 57.68 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.519 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.42 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 3.1 m-80 -86.65 2.04 49.82 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.429 -0.909 . . . . 0.0 110.894 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -175.87 115.65 0.13 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.326 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.695 HG13 ' N ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -123.05 -174.72 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.156 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.695 ' N ' HG13 ' A' ' 79' ' ' VAL . 39.1 t -172.01 -64.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.296 -1.362 . . . . 0.0 113.541 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.5 m -111.7 150.95 29.47 Favored 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.564 HD13 ' CE2' ' A' ' 24' ' ' TYR . 3.0 mp -146.61 161.49 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.445 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.682 ' NH1' ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -150.85 145.58 25.77 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.993 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.682 ' N ' ' NH1' ' A' ' 83' ' ' ARG . 5.8 t -148.09 146.92 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.695 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.589 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -143.54 134.27 22.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.657 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 85' ' ' ILE . 17.4 m -38.33 148.38 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.336 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.554 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -152.01 141.03 13.98 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.507 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.554 ' HD2' HG22 ' A' ' 87' ' ' VAL . 3.0 Cg_exo -53.42 143.16 55.86 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.078 1.186 . . . . 0.0 110.954 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.586 HG22 ' N ' ' A' ' 90' ' ' GLN . 2.4 p -79.73 164.27 3.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.537 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.586 ' N ' HG22 ' A' ' 89' ' ' VAL . 66.4 mm-40 -142.39 151.74 58.73 Favored Pre-proline 0 N--CA 1.487 1.4 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.154 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.432 ' C ' ' HE ' ' A' ' 92' ' ' ARG . 6.3 Cg_exo -57.6 -39.18 90.29 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.599 1.533 . . . . 0.0 111.87 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.54 ' NE ' ' O ' ' A' ' 90' ' ' GLN . 15.6 mtm180 58.02 -168.47 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.434 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.53 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.33 178.65 7.43 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.603 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -148.57 130.36 15.13 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.411 -1.316 . . . . 0.0 112.024 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 20.1 m-85 -103.44 172.07 7.01 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.777 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -139.09 168.66 19.33 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.836 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -114.61 170.45 8.3 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.672 -0.811 . . . . 0.0 112.351 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.49 ' HZ2' ' HB3' ' A' ' 98' ' ' LYS . 0.5 OUTLIER 54.67 168.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.233 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.504 ' OE1' ' HG3' ' A' ' 100' ' ' GLN . 1.2 tm-20 -62.5 103.16 0.38 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.585 -1.189 . . . . 0.0 112.5 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 102' ' ' ASP . 2.7 mt-30 68.55 100.95 0.05 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.48 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.478 ' C ' ' O ' ' A' ' 100' ' ' GLN . 19.3 p90 20.94 44.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 124.364 1.04 . . . . 0.0 112.773 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 100' ' ' GLN . 0.7 OUTLIER -102.26 15.64 28.54 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.98 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -154.61 159.79 29.17 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 118.967 -1.587 . . . . 0.0 111.135 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -41.26 157.39 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.832 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.553 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 1.2 pm0 -122.05 163.71 18.94 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.67 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.648 HG12 ' N ' ' A' ' 107' ' ' ASP . 37.4 t -138.11 170.99 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.33 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.648 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.5 p30 -133.44 156.35 47.87 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.034 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.5 mt -145.15 139.35 14.99 Favored Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.26 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -70.18 163.66 37.79 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 121.597 1.532 . . . . 0.0 111.305 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.47 145.99 95.57 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.418 1.412 . . . . 0.0 110.937 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.32 -153.22 24.29 Favored Glycine 0 N--CA 1.499 2.878 0 C-N-CA 119.064 -1.541 . . . . 0.0 111.328 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.609 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 8.3 tt0 -128.94 158.42 38.87 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.755 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.609 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 41.8 m-85 -145.93 151.99 38.72 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.267 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.6 p -103.83 178.56 4.52 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.243 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.08 44.63 0.49 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.174 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -142.45 -61.95 0.44 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 121' ' ' TYR . 4.5 mt-10 -74.11 -54.55 7.57 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.485 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.538 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -29.74 -66.5 0.09 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.635 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.654 ' CD ' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER -59.04 -60.84 3.23 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.747 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.654 HH11 ' CD ' ' A' ' 119' ' ' GLU . 7.9 mpt_? -75.81 26.17 0.11 Allowed 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.952 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 117' ' ' GLU . 35.3 t80 -127.79 -18.48 4.27 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.603 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.528 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -155.68 -26.8 0.03 OUTLIER Glycine 0 N--CA 1.484 1.86 0 C-N-CA 118.267 -1.92 . . . . 0.0 111.104 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.479 HD12 HD13 ' A' ' 128' ' ' ILE . 1.1 pt -150.2 -112.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.039 -1.064 . . . . 0.0 110.785 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.461 ' C ' ' HB3' ' A' ' 119' ' ' GLU . 0.9 OUTLIER -165.75 -165.91 0.88 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.284 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.47 ' CG ' ' N ' ' A' ' 126' ' ' ASN . 45.3 t-20 -65.21 -105.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.47 ' N ' ' CG ' ' A' ' 125' ' ' ASN . 1.7 m120 -67.23 32.32 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 125' ' ' ASN . 0.6 OUTLIER -87.17 -103.7 0.07 Allowed 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.726 -1.19 . . . . 0.0 109.819 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.546 ' O ' ' CB ' ' A' ' 129' ' ' SER . 0.3 OUTLIER 41.66 -162.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.22 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.618 ' OG ' ' N ' ' A' ' 130' ' ' SER . 1.6 t 151.17 -96.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.061 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.618 ' N ' ' OG ' ' A' ' 129' ' ' SER . 3.5 m -90.24 143.63 26.59 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.047 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.11 151.82 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.575 0.702 . . . . 0.0 111.675 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -148.87 107.09 3.45 Favored Pre-proline 0 C--N 1.301 -1.515 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.617 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 135' ' ' GLY . 10.5 Cg_endo -71.88 90.48 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.348 1.366 . . . . 0.0 110.68 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.53 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 13.3 tt0 -49.64 -11.57 0.06 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.391 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 133' ' ' PRO . . . -179.07 -37.46 0.07 OUTLIER Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.305 -1.902 . . . . 0.0 111.783 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.436 HD11 ' H ' ' A' ' 92' ' ' ARG . 0.5 OUTLIER -107.04 163.83 12.66 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.359 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.76 148.22 31.55 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.993 -1.083 . . . . 0.0 109.811 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.1 t -112.6 150.34 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.786 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.55 HG12 ' CE1' ' A' ' 141' ' ' PHE . 60.6 t -136.22 128.53 45.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.572 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.5 mp -106.13 139.86 39.99 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.905 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.567 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 4.7 m-85 -120.23 133.78 55.4 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.52 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -72.94 -71.52 0.3 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.403 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -62.87 161.68 12.36 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.959 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 20.7 p-10 -62.5 -162.89 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.586 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.651 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 3.6 p30 31.62 35.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.712 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.651 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 42.12 62.4 1.65 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.084 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.421 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 48.4 t -139.3 175.87 9.19 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.421 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 80.91 -160.33 42.78 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.039 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -60.54 160.57 8.79 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.263 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.8 p -150.59 162.51 40.5 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.902 -1.119 . . . . 0.0 111.574 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.6 tp -129.33 86.14 57.27 Favored Pre-proline 0 N--CA 1.484 1.261 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.497 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -63.29 107.8 0.73 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.828 1.686 . . . . 0.0 112.522 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 47.5 t -84.78 85.56 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.389 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.498 ' C ' ' OG ' ' A' ' 155' ' ' SER . 2.7 p-10 -55.87 -26.56 47.6 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.498 ' OG ' ' C ' ' A' ' 154' ' ' ASN . 0.7 OUTLIER -162.68 -146.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 117.941 -1.503 . . . . 0.0 113.107 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.45 144.76 20.06 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.017 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -165.58 66.06 1.08 Allowed Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.572 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.1 Cg_endo -66.71 27.95 0.11 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.26 1.973 . . . . 0.0 112.274 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.512 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.1 t -169.83 136.06 1.51 Allowed 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.846 -1.142 . . . . 0.0 111.461 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.445 HD23 ' C ' ' A' ' 160' ' ' LEU . 3.9 tt -151.55 -76.01 0.14 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.351 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.404 ' H ' ' HB3' ' A' ' 160' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.338 0 C-N-CA 119.16 -1.495 . . . . 0.0 110.665 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.885 0.374 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.1 m -88.49 147.17 24.79 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.795 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 92.3 p -135.67 -38.63 0.73 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.434 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.54 158.13 44.85 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.533 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 24.6 pt -145.54 157.19 12.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 118.589 -1.244 . . . . 0.0 111.904 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -137.92 110.26 7.41 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.527 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -87.83 94.74 4.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.25 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.959 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.416 ' HB1' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.902 0.382 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -176.78 112.79 0.1 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.322 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.473 ' HB ' HG22 ' A' ' 44' ' ' VAL . 1.3 pp -78.34 160.33 4.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.306 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 m -138.46 126.38 22.51 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.296 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.44 168.7 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.372 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 14.1 m-85 -134.8 138.73 44.52 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.343 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.9 -55.02 29.8 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.397 -0.921 . . . . 0.0 113.066 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.613 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 55.6 m-20 -92.37 167.06 12.24 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.375 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.533 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 7.4 tm-20 -79.98 160.66 25.83 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.199 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 10' ' ' GLU . 0.9 OUTLIER 81.41 38.97 0.06 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.546 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.456 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 5.0 t80 59.74 2.99 0.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.984 -1.086 . . . . 0.0 112.533 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -102.84 164.88 11.37 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.673 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.613 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 97.48 132.94 7.66 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 14' ' ' GLY . 8.2 mtpm? -29.27 135.98 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.755 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -113.94 171.72 7.42 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.301 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.0 t -144.37 145.96 20.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.511 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -91.85 128.08 37.55 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.74 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 19' ' ' LEU . 2.3 mm? -118.14 107.2 44.0 Favored Pre-proline 0 N--CA 1.49 1.541 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.26 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -64.87 166.75 17.41 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 120.911 1.074 . . . . 0.0 111.265 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.28 176.25 1.65 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.732 1.621 . . . . 0.0 111.294 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.508 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 102.28 -167.92 18.41 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.391 -1.385 . . . . 0.0 110.788 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.46 ' CA ' HH11 ' A' ' 83' ' ' ARG . 15.3 p-10 -110.98 141.93 43.78 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.022 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.644 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -156.67 152.84 27.61 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.243 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.4 p -132.02 -158.48 0.89 Allowed 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.079 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -58.74 -28.8 66.21 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.588 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -63.01 -54.74 33.59 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.034 -1.067 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -52.79 -48.82 66.6 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.039 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.619 HD21 ' CE1' ' A' ' 24' ' ' TYR . 5.0 mt -59.48 -39.02 82.39 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.66 -1.216 . . . . 0.0 109.338 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.13 -29.06 4.83 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 118.564 -1.254 . . . . 0.0 108.397 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.14 -31.62 27.11 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.454 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 29' ' ' LEU . 10.2 mt -80.39 -86.4 0.08 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.333 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 32' ' ' LEU . . . 176.74 -27.0 0.07 OUTLIER Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.226 -1.464 . . . . 0.0 110.787 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.478 HG22 HG21 ' A' ' 38' ' ' THR . 0.2 OUTLIER -79.47 -175.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 118.941 -1.103 . . . . 0.0 109.964 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.65 ' H ' HG21 ' A' ' 38' ' ' THR . 1.3 pt-20 177.48 113.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.708 -1.197 . . . . 0.0 112.604 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.438 ' O ' HG22 ' A' ' 38' ' ' THR . 2.1 m-20 42.31 -106.7 0.08 Allowed 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.558 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.499 ' C ' HG22 ' A' ' 38' ' ' THR . 61.8 t-20 -50.46 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.947 -0.701 . . . . 0.0 112.391 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.65 HG21 ' H ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER 170.44 -18.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.802 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.488 ' O ' HD22 ' A' ' 72' ' ' LEU . 7.8 mm -75.59 32.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.105 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.646 ' H ' ' C ' ' A' ' 38' ' ' THR . 29.6 t -37.62 -63.99 0.42 Allowed 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.326 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.402 ' HB2' ' H ' ' A' ' 12' ' ' PHE . 1.1 t -116.03 165.09 13.52 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -148.2 156.67 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 118.342 -1.343 . . . . 0.0 113.44 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -137.82 110.92 7.8 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.523 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.473 HG22 ' HB ' ' A' ' 4' ' ' ILE . 88.4 t -133.95 106.25 11.53 Favored Pre-proline 0 N--CA 1.497 1.913 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.94 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.417 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 Cg_endo -70.16 171.5 14.79 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 121.647 1.564 . . . . 0.0 111.728 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.417 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.7 Cg_endo -62.78 -169.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 122.145 1.897 . . . . 0.0 111.204 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.87 -14.44 19.62 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 119.269 -1.444 . . . . 0.0 110.449 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.691 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -152.93 157.14 4.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 118.836 -1.145 . . . . 0.0 111.697 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.454 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 31.7 ttpt -123.56 120.41 32.77 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.34 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.75 154.99 18.63 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.025 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 63' ' ' ILE . 60.6 mt -138.91 119.79 15.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.338 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.461 ' H ' HD12 ' A' ' 52' ' ' LEU . 3.7 mp -94.79 155.37 16.84 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 118.683 -1.207 . . . . 0.0 112.352 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -133.55 114.97 14.17 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.053 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.451 ' CD ' ' N ' ' A' ' 55' ' ' ASN . 7.0 tm0? -53.64 -69.12 0.13 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.39 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.514 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 63.8 t30 -69.37 137.68 53.03 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.028 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -53.06 166.69 0.21 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.538 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.54 28.98 64.47 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.394 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 55.92 49.1 16.57 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.972 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.18 -171.16 2.62 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.795 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.514 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 74.16 171.75 25.69 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.355 -1.402 . . . . 0.0 109.743 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 60' ' ' GLY . 1.7 m-20 -42.57 116.14 0.81 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.491 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.4 ' HG2' ' H ' ' A' ' 62' ' ' GLN . 13.5 pt20 -89.75 155.02 19.47 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.361 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.668 HD11 HD11 ' A' ' 75' ' ' LEU . 5.2 mt -130.18 167.08 26.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.761 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.456 ' H ' HG22 ' A' ' 63' ' ' ILE . 66.6 mt-10 -145.26 130.74 18.76 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.38 -0.928 . . . . 0.0 109.727 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.9 m -147.34 156.86 10.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 118.797 -1.161 . . . . 0.0 112.241 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 48' ' ' VAL . 4.0 t -144.5 -2.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.137 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -125.32 -159.69 0.91 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.301 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.828 HD21 HG13 ' A' ' 106' ' ' VAL . 10.7 p-10 -94.28 118.59 31.82 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.476 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.699 ' HB1' ' HA ' ' A' ' 72' ' ' LEU . . . -89.58 96.39 10.68 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.897 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -53.21 -70.99 0.08 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.821 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -90.55 3.21 54.65 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.239 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.699 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 14.7 tp 59.62 -90.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.634 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.429 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -177.2 -170.49 39.67 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.541 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.613 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.7 Cg_endo -67.16 -56.64 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.351 2.034 . . . . 0.0 112.266 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.903 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.1 pt? -64.75 19.52 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.321 -0.951 . . . . 0.0 111.409 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.613 ' H ' ' C ' ' A' ' 74' ' ' PRO . 45.3 p-10 -74.42 -17.12 60.84 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.387 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -77.88 4.93 10.71 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.577 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -167.9 115.01 0.72 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.172 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 1.022 HG12 ' H ' ' A' ' 80' ' ' SER . 26.3 t -132.32 -171.49 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.046 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . 1.022 ' H ' HG12 ' A' ' 79' ' ' VAL . 21.0 p -176.31 -51.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.648 -1.221 . . . . 0.0 112.672 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.96 162.2 25.0 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 119.148 -1.021 . . . . 0.0 112.854 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 82' ' ' ILE . 10.2 mt -148.83 155.5 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.735 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.59 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -132.14 114.28 14.32 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.664 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.59 ' H ' HH12 ' A' ' 83' ' ' ARG . 37.1 t -121.38 136.56 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.756 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.581 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 4.0 mt -145.15 126.67 8.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.093 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 p -39.88 141.85 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.034 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 48' ' ' VAL . 1.3 p -134.09 138.58 30.87 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.339 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HD2' HG22 ' A' ' 87' ' ' VAL . 11.7 Cg_exo -47.21 136.66 18.68 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 121.207 1.271 . . . . 0.0 111.325 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.3 t -53.41 140.48 9.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.579 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -144.85 130.98 9.73 Favored Pre-proline 0 N--CA 1.487 1.387 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.906 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.45 ' HB2' HD11 ' A' ' 136' ' ' LEU . 6.3 Cg_exo -58.45 -163.3 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.921 0 C-N-CA 121.039 1.159 . . . . 0.0 111.359 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.429 ' CA ' HD12 ' A' ' 136' ' ' LEU . 9.6 ptt-85 -179.67 -158.17 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.939 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.562 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -137.4 166.97 22.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.65 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -120.81 140.78 51.25 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.456 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.511 ' CD2' HG13 ' A' ' 131' ' ' VAL . 80.5 m-85 -131.34 118.19 19.96 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.393 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -83.45 173.15 11.74 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.56 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.77 -70.34 0.72 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.991 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -62.36 163.98 7.82 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.901 -0.719 . . . . 0.0 112.249 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -89.89 63.62 6.08 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.808 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 101' ' ' PHE . 4.5 tt0 -176.0 50.1 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.713 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 100' ' ' GLN . 18.6 p90 41.44 44.2 2.4 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.111 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.449 ' CG ' ' N ' ' A' ' 103' ' ' GLY . 32.3 t70 -143.5 172.85 12.23 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.2 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 91.26 141.19 9.43 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.158 -1.496 . . . . 0.0 109.76 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 103' ' ' GLY . 47.0 mttp -28.66 130.3 0.06 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 123.971 0.454 . . . . 0.0 111.899 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -98.98 120.68 39.83 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.608 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.828 HG13 HD21 ' A' ' 68' ' ' ASN . 43.7 t -103.74 131.07 53.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.731 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -103.81 148.92 25.54 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.07 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.1 mt -138.11 123.15 12.22 Favored Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.154 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.428 ' CB ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -64.74 168.07 14.17 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.492 1.461 . . . . 0.0 111.797 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 6.1 Cg_exo -55.12 157.33 13.95 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 122.222 1.948 . . . . 0.0 111.973 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.38 178.89 15.73 Favored Glycine 0 N--CA 1.499 2.869 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.936 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.613 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 46.9 tt0 -109.31 157.1 19.2 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.125 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.613 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 33.2 m-85 -144.78 153.94 42.18 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.031 -1.067 . . . . 0.0 111.248 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.5 p -98.48 -161.43 0.87 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.008 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.34 54.38 0.83 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.958 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.33 -62.27 0.07 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.12 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.574 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 6.4 pt-20 -69.18 -51.08 41.61 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.574 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -37.77 -69.51 0.12 Allowed 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.231 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 119' ' ' GLU . 79.0 mt-10 -46.95 -66.5 0.4 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.66 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.465 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -70.33 4.77 2.06 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' A' ' 117' ' ' GLU . 17.0 t80 -98.61 -18.1 18.29 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 118.868 -1.133 . . . . 0.0 111.379 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.554 ' O ' HG11 ' A' ' 106' ' ' VAL . . . -165.79 -11.89 0.03 OUTLIER Glycine 0 C--N 1.289 -2.07 0 C-N-CA 118.152 -1.975 . . . . 0.0 111.043 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.453 ' CG1' ' C ' ' A' ' 122' ' ' GLY . 2.2 mt -148.89 -125.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 118.676 -1.21 . . . . 0.0 111.597 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.569 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 20.0 t70 -155.06 -162.58 1.39 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.832 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.569 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 12.4 p30 -71.44 -36.23 71.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.033 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -158.2 100.12 1.67 Allowed 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.955 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.428 ' CG2' HG22 ' A' ' 123' ' ' ILE . 9.4 t -177.22 25.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.309 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.8 mt -80.74 -60.35 2.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.409 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.7 m 59.32 -125.38 1.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 m -54.73 126.65 24.88 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.511 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.2 t -122.49 157.69 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.12 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -153.44 93.14 3.12 Favored Pre-proline 0 C--N 1.293 -1.862 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.178 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -53.73 124.21 15.27 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 121.125 1.217 . . . . 0.0 111.003 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.562 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 40.6 tp60 -89.22 -21.64 23.15 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.212 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -161.05 -29.55 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 C-N-CA 118.325 -1.893 . . . . 0.0 112.338 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.45 HD11 ' HB2' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -120.92 159.79 24.83 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.165 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.25 147.67 32.47 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.964 -1.094 . . . . 0.0 110.254 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 65.9 t -115.95 149.22 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.463 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.604 HG12 ' CE1' ' A' ' 141' ' ' PHE . 61.8 t -133.85 128.99 54.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.781 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.2 mp -102.72 138.2 39.93 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.963 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.836 ' CD2' ' CD1' ' A' ' 146' ' ' PHE . 8.6 m-85 -120.32 128.94 53.73 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.842 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.56 ' O ' ' CB ' ' A' ' 143' ' ' ASN . 53.9 mttm -85.33 102.12 13.12 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.049 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 142' ' ' LYS . 11.2 t-20 103.0 170.16 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.917 0 O-C-N 125.195 1.559 . . . . 0.0 111.292 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 146' ' ' PHE . 24.6 t70 -45.79 170.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.121 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' A' ' 144' ' ' ASP . 3.4 m120 -3.21 66.33 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 CA-C-N 113.921 -1.49 . . . . 0.0 113.986 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.836 ' CD1' ' CD2' ' A' ' 141' ' ' PHE . 0.9 OUTLIER 50.3 63.21 2.3 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.899 -1.121 . . . . 0.0 111.323 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.3 t -114.57 45.64 1.52 Allowed 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.557 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.24 -169.28 42.1 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.71 177.67 0.4 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.524 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.2 p -150.2 175.33 11.87 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.448 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.593 ' C ' HD13 ' A' ' 151' ' ' LEU . 3.4 tm? -147.77 90.88 5.05 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.51 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.35 109.02 1.48 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.705 1.603 . . . . 0.0 112.272 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 49.5 t -80.98 90.84 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.004 -1.079 . . . . 0.0 109.92 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -65.01 -20.45 66.5 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.569 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 11.0 t -168.33 -146.55 0.06 Allowed 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.063 -1.455 . . . . 0.0 112.634 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.4 m-20 -50.81 150.35 2.96 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.981 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -168.87 66.34 0.64 Allowed Pre-proline 0 C--N 1.31 -1.152 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.04 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.484 ' C ' HG22 ' A' ' 159' ' ' THR . 2.3 Cg_endo -62.46 23.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.323 2.015 . . . . 0.0 113.692 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.507 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER 176.86 91.23 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.45 -1.3 . . . . 0.0 111.394 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 tp -94.52 -23.26 17.76 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.247 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.264 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.421 ' O ' ' N ' ' A' ' 168' ' ' SER . 23.8 t-20 . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.424 0.154 . . . . 0.0 110.767 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 166' ' ' ASN . 9.1 m -40.0 99.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.601 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.527 ' HB2' ' H ' ' A' ' 143' ' ' ASN . 3.3 m -88.58 -55.86 3.54 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.407 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.2 p -121.48 156.57 32.48 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.747 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.402 HG12 ' CD1' ' A' ' 118' ' ' LEU . 26.8 pt -139.37 165.14 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.49 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -146.45 106.07 3.95 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.332 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.81 95.46 4.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.401 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 116.458 -1.734 . . . . 0.0 111.076 -179.939 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.521 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -170.47 108.62 0.34 Allowed 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.228 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pp -77.44 128.69 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.855 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.08 152.54 20.49 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.169 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 m -140.19 169.11 16.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.625 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 18.7 m-85 -128.93 153.71 47.26 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.93 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -78.17 -59.48 2.76 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.503 -0.879 . . . . 0.0 113.326 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.638 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 81.7 m-20 -81.36 -178.02 6.75 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.811 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.552 ' CG ' ' H ' ' A' ' 11' ' ' ASP . 20.9 tt0 -74.03 179.32 4.44 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.829 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.615 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 1.5 p-10 40.53 67.16 0.53 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.339 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.615 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 43.7 p90 35.47 27.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.114 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' ASP . 49.8 tt0 -102.65 159.7 15.23 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.987 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.638 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 95.49 140.75 11.15 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.327 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 14' ' ' GLY . 5.5 mtpp -28.75 135.61 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.78 157.78 16.46 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.407 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.4 t -149.15 133.59 9.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.769 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -98.92 113.36 25.47 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.601 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 mt -102.01 136.87 19.4 Favored Pre-proline 0 N--CA 1.488 1.467 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.94 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -70.0 162.58 41.67 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 120.978 1.119 . . . . 0.0 111.137 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -66.33 -175.74 0.57 Allowed 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 121.694 1.596 . . . . 0.0 110.541 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.488 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 104.4 -166.54 15.24 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.242 -1.456 . . . . 0.0 111.263 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.524 ' HB3' HH11 ' A' ' 83' ' ' ARG . 16.2 p-10 -123.43 137.32 54.83 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.222 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.499 ' CE2' HD12 ' A' ' 82' ' ' ILE . 4.9 p90 -157.84 -179.93 8.61 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.445 -1.302 . . . . 0.0 111.676 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.417 ' HB ' ' H ' ' A' ' 26' ' ' ARG . 1.8 p -147.06 -157.55 0.82 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.461 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.417 ' H ' ' HB ' ' A' ' 25' ' ' THR . 34.7 ttt180 -61.27 -19.14 61.38 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.491 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.66 -66.59 0.53 Allowed 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.567 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.539 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 6.9 tp60 -56.31 -43.12 78.62 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.782 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 29' ' ' LEU . 30.9 mt -59.93 -40.49 89.08 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.154 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.02 -29.02 41.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 118.435 -1.306 . . . . 0.0 108.153 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -74.1 -35.47 64.18 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.696 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.27 -78.4 0.13 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.786 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.85 -25.25 0.56 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.153 -1.498 . . . . 0.0 110.688 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.548 HG12 HG21 ' A' ' 38' ' ' THR . 0.0 OUTLIER -92.82 137.18 22.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.028 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.458 ' CG ' ' C ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER 168.61 158.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.198 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.492 ' OD1' ' ND2' ' A' ' 37' ' ' ASN . 2.6 t-20 66.84 116.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.492 ' ND2' ' OD1' ' A' ' 36' ' ' ASN . 0.1 OUTLIER 56.42 3.99 0.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.098 -0.955 . . . . 0.0 113.045 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.548 HG21 HG12 ' A' ' 34' ' ' ILE . 39.9 p -82.98 -135.28 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.491 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 38' ' ' THR . 2.5 mt 25.37 52.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 123.902 0.751 . . . . 0.0 112.68 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.5 t -70.15 -41.51 73.74 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.214 -0.995 . . . . 0.0 110.118 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.4 166.25 15.02 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.312 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -145.3 149.68 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 118.533 -1.267 . . . . 0.0 112.666 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -140.05 87.25 2.14 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.609 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.0 t -109.44 115.48 56.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -69.7 168.5 21.3 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.207 1.271 . . . . 0.0 110.773 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.47 -177.09 0.36 Allowed 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 121.843 1.695 . . . . 0.0 111.126 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.07 -11.62 11.24 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.283 -1.437 . . . . 0.0 110.952 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.521 HG11 ' CB ' ' A' ' 2' ' ' ALA . 33.1 m -148.41 145.34 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.537 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.459 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 44.2 tttt -124.12 158.28 32.67 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.578 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.459 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -148.96 140.69 23.57 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.299 -1.361 . . . . 0.0 112.962 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 63' ' ' ILE . 35.7 mt -119.06 124.19 72.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.591 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.507 ' H ' HD12 ' A' ' 52' ' ' LEU . 3.8 mp -93.9 165.91 12.43 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 118.641 -1.223 . . . . 0.0 112.341 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -141.22 108.95 5.64 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.956 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -47.28 -84.54 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.928 -0.709 . . . . 0.0 112.03 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.476 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 94.5 m-20 -59.34 142.55 51.84 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.476 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 11.9 p-10 -56.18 174.53 0.13 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.598 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.98 36.87 93.59 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.141 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.404 ' CZ ' HG23 ' A' ' 25' ' ' THR . 40.1 m-85 47.03 43.94 14.43 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.673 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.53 -165.5 1.25 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.901 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.476 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 65.01 165.19 1.08 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.364 -1.398 . . . . 0.0 109.855 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.49 130.1 19.79 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.586 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.462 ' C ' ' CD ' ' A' ' 62' ' ' GLN . 3.1 pp0? -101.07 161.87 13.29 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.106 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.74 HG22 ' N ' ' A' ' 64' ' ' GLU . 7.7 mm -128.06 171.86 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.714 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.74 ' N ' HG22 ' A' ' 63' ' ' ILE . 55.5 mt-10 -144.7 131.21 19.86 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.581 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.1 m -150.52 158.32 5.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.805 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 t -144.28 -4.31 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.56 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.72 -153.63 0.58 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.778 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -92.32 125.74 37.11 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.353 -0.939 . . . . 0.0 109.754 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.568 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -97.3 133.95 41.23 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.356 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -74.55 -77.95 0.11 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.49 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -99.32 3.92 46.26 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.692 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.402 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 0.6 OUTLIER 63.95 -82.79 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.513 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.522 ' O ' ' ND2' ' A' ' 76' ' ' ASN . . . -172.67 -178.96 43.13 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.567 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.16 -18.05 56.05 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.149 1.899 . . . . 0.0 111.939 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.686 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -85.08 41.47 0.88 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.06 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 73' ' ' GLY . 84.9 m-20 -79.89 -13.98 58.98 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.694 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -88.62 3.41 50.65 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.513 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.466 ' HA ' ' H ' ' A' ' 37' ' ' ASN . 14.6 t-20 -169.78 126.95 0.88 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 118.381 -1.328 . . . . 0.0 112.534 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.407 ' C ' ' OG ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -154.4 138.36 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.442 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.407 ' OG ' ' C ' ' A' ' 79' ' ' VAL . 1.7 m -157.76 -43.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.241 -1.383 . . . . 0.0 112.826 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.406 ' OG ' HG22 ' A' ' 25' ' ' THR . 17.3 m -94.39 140.45 29.79 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.944 -1.103 . . . . 0.0 111.056 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -147.58 161.01 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 118.814 -1.155 . . . . 0.0 112.224 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.876 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -137.21 116.72 12.85 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.851 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.876 ' H ' HH12 ' A' ' 83' ' ' ARG . 12.8 t -120.37 127.68 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.873 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.49 HG13 ' NH2' ' A' ' 83' ' ' ARG . 27.8 mt -141.07 129.04 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.849 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 74.1 m -41.06 154.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.854 -0.739 . . . . 0.0 111.427 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.729 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -150.33 147.13 21.02 Favored Pre-proline 0 N--CA 1.487 1.419 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.203 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.729 ' HD2' HG22 ' A' ' 87' ' ' VAL . 2.7 Cg_exo -54.12 145.32 54.34 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 121.27 1.313 . . . . 0.0 111.483 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.75 142.9 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.699 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -145.6 147.97 35.07 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.171 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.434 ' HG2' HD21 ' A' ' 136' ' ' LEU . 6.0 Cg_exo -57.51 -166.62 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.911 0 C-N-CA 121.111 1.207 . . . . 0.0 110.394 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.6 ptt-85 -173.98 -162.44 0.14 Allowed 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.743 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.33 159.07 42.97 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.529 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -120.55 135.15 55.17 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.133 -1.027 . . . . 0.0 112.332 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -114.33 105.02 12.65 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.943 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.485 ' CD1' ' HB3' ' A' ' 105' ' ' GLU . 26.2 m-85 -91.48 152.9 20.16 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.502 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 1.6 m-85 -97.05 157.93 15.68 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.739 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp 63.61 132.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.637 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 99' ' ' GLU . 2.7 pt-20 -77.43 77.82 3.95 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.926 -1.109 . . . . 0.0 110.87 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.568 ' HA ' ' OE1' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -172.58 16.19 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.096 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 42.9 t80 48.98 46.38 22.4 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.731 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 103' ' ' GLY . 38.7 t70 -116.85 -79.79 0.59 Allowed 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.768 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 102' ' ' ASP . . . -34.06 136.42 0.24 Allowed Glycine 0 N--CA 1.502 3.057 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.288 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -42.37 163.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.287 0.565 . . . . 0.0 112.336 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -115.72 165.07 13.46 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.501 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 122' ' ' GLY . 1.2 t -130.35 132.03 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 23.2 p-10 -96.47 150.14 20.94 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.264 -0.974 . . . . 0.0 113.2 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.4 mt -143.81 127.97 9.28 Favored Pre-proline 0 N--CA 1.482 1.14 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.864 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -67.88 167.45 21.38 Favored 'Trans proline' 0 C--O 1.212 -0.825 0 C-N-CA 121.399 1.399 . . . . 0.0 111.727 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.57 151.03 78.54 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 122.055 1.837 . . . . 0.0 111.734 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.48 -173.72 21.02 Favored Glycine 0 N--CA 1.498 2.792 0 C-N-CA 119.448 -1.358 . . . . 0.0 111.16 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.592 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 39.9 tt0 -112.92 154.04 27.01 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.4 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.592 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 14.4 m-85 -139.48 151.57 46.29 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.105 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.8 p -92.71 -158.36 0.59 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.648 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -108.75 55.56 0.63 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.574 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.39 -68.8 0.13 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.989 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.553 ' O ' ' N ' ' A' ' 121' ' ' TYR . 8.0 pt-20 -70.39 -46.4 64.1 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.053 -1.059 . . . . 0.0 108.938 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.562 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -36.15 -71.55 0.07 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.858 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.658 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 22.9 mp0 -51.83 -56.43 14.01 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.99 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -73.74 14.48 0.37 Allowed 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.907 -1.117 . . . . 0.0 111.696 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 117' ' ' GLU . 16.1 t80 -122.46 -12.87 8.12 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.537 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.566 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -140.83 -51.48 0.05 OUTLIER Glycine 0 N--CA 1.485 1.955 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.189 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.49 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -137.48 -111.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.281 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -151.99 -151.96 0.41 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.062 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -85.15 10.1 13.14 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.451 -0.899 . . . . 0.0 111.205 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -157.78 -123.72 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.407 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.3 p 51.11 -152.56 0.19 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 129' ' ' SER . 14.7 mt 65.62 159.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.977 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 128' ' ' ILE . 23.1 t -175.14 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.469 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.6 m -76.92 140.39 40.49 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.817 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.6 158.23 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 C-N-CA 119.924 -0.711 . . . . 0.0 111.16 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -156.29 85.5 3.13 Favored Pre-proline 0 C--N 1.306 -1.311 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.63 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.81 102.68 0.53 Allowed 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.093 1.195 . . . . 0.0 109.856 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -86.15 18.72 2.96 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.716 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -174.39 -47.63 0.05 OUTLIER Glycine 0 N--CA 1.489 2.197 0 C-N-CA 117.737 -2.173 . . . . 0.0 112.637 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.434 HD21 ' HG2' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -121.33 169.62 10.42 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.245 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.8 151.79 24.1 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.078 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.6 t -121.88 144.09 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.231 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.545 ' C ' HD12 ' A' ' 140' ' ' LEU . 91.1 t -135.03 128.27 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.561 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.545 HD12 ' C ' ' A' ' 139' ' ' VAL . 10.4 mp -106.4 140.44 39.32 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.674 -0.81 . . . . 0.0 112.744 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.475 ' CG ' ' HA ' ' A' ' 146' ' ' PHE . 62.9 m-85 -120.48 125.24 47.38 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.445 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -60.63 -65.1 0.74 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.172 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -70.33 -172.21 0.56 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.243 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.564 ' O ' ' N ' ' A' ' 146' ' ' PHE . 0.7 OUTLIER -66.32 -149.3 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.93 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.591 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 4.7 p-10 -15.68 75.76 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 O-C-N 124.386 1.054 . . . . 0.0 113.7 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.591 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.3 p90 37.07 64.95 0.54 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.229 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.456 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 28.6 t -128.49 173.7 10.01 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.949 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.456 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 64.17 -168.13 25.65 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.556 -1.306 . . . . 0.0 110.717 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -61.18 167.95 2.82 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.461 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.4 p -146.28 168.84 20.09 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.43 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.534 HD23 ' C ' ' A' ' 151' ' ' LEU . 3.3 tt -138.24 84.59 19.89 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.471 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.59 107.93 1.13 Allowed 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 122.109 1.873 . . . . 0.0 113.094 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 40.2 t -83.9 89.96 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.308 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -64.45 -17.25 63.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 51.4 p -170.25 -141.28 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 117.735 -1.586 . . . . 0.0 112.929 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.438 ' N ' ' OG ' ' A' ' 155' ' ' SER . 20.7 m-20 -65.1 151.45 46.02 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.758 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -168.62 61.7 0.49 Allowed Pre-proline 0 C--N 1.305 -1.364 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.206 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.5 Cg_endo -62.13 17.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 122.173 1.916 . . . . 0.0 112.792 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.546 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -170.46 79.2 0.09 Allowed 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.612 -1.235 . . . . 0.0 111.384 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 tt -91.77 -75.65 0.47 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.342 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.418 0 C-N-CA 118.992 -1.575 . . . . 0.0 110.806 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 18.8 m120 . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 121.216 0.531 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.2 m -47.23 99.25 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.902 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.1 m -86.99 -53.69 4.74 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.616 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.62 160.42 21.84 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.201 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.437 HG12 ' CD1' ' A' ' 118' ' ' LEU . 22.2 pt -145.33 162.75 12.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.907 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -145.35 104.7 3.95 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.247 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.0 mt -85.27 95.61 4.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.407 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 116.371 -1.776 . . . . 0.0 110.955 -179.982 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.456 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.971 0.415 . . . . 0.0 110.849 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -177.72 118.25 0.1 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.305 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 4' ' ' ILE . 2.9 pt -77.33 154.53 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.294 -0.962 . . . . 0.0 111.059 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -133.67 127.12 32.26 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.671 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 m -107.11 173.43 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.37 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.689 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 53.8 m-85 -131.46 145.83 51.96 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.439 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.32 -37.09 77.59 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.501 ' C ' ' OG ' ' A' ' 40' ' ' SER . 25.3 m120 -117.25 165.62 13.23 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 119.101 -1.039 . . . . 0.0 111.814 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.504 ' N ' ' OG ' ' A' ' 40' ' ' SER . 46.8 mm-40 -69.18 173.5 5.57 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.253 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' A' ' 13' ' ' GLN . 4.6 t0 62.38 31.39 17.29 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.692 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.689 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 5.3 t80 68.13 -9.71 0.47 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.304 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.463 ' H ' ' C ' ' A' ' 11' ' ' ASP . 10.2 tt0 -71.88 167.68 19.52 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.861 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.491 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 90.71 129.67 4.29 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.803 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.447 ' HE2' ' H ' ' A' ' 15' ' ' LYS . 1.1 mppt? -39.34 149.72 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.729 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -112.81 165.1 12.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.653 -0.819 . . . . 0.0 112.714 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 t -144.57 144.51 22.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.194 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -104.33 139.14 39.74 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.899 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 mt -132.06 141.71 42.44 Favored Pre-proline 0 N--CA 1.494 1.773 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.774 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -71.62 162.4 42.29 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 121.186 1.257 . . . . 0.0 111.893 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -68.51 -157.68 0.04 OUTLIER 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 121.94 1.76 . . . . 0.0 111.356 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.55 -159.93 50.01 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.854 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -90.95 149.86 21.71 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.292 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.9 ' OH ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -166.42 146.41 6.01 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.7 p -148.52 -146.59 0.2 Allowed 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 118.66 -1.216 . . . . 0.0 112.803 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -37.0 86.21 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.553 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.551 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -57.15 -57.34 13.03 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.75 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.45 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 24.0 tt0 -58.41 -50.77 72.51 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.728 -1.189 . . . . 0.0 109.333 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.9 HD21 ' OH ' ' A' ' 24' ' ' TYR . 15.4 mt -51.07 -39.22 55.53 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.759 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -51.43 -37.16 47.21 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.357 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -67.92 -35.45 78.48 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.75 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.519 HD23 ' N ' ' A' ' 32' ' ' LEU . 6.9 mt -77.03 -83.59 0.07 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.825 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.14 -27.47 0.21 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 118.811 -1.662 . . . . 0.0 111.452 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.485 HG12 HD22 ' A' ' 29' ' ' LEU . 2.3 pt -89.4 167.18 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.196 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 1.9 pt-20 173.32 152.65 0.09 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.102 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 3.1 t-20 70.94 -155.48 0.11 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.715 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -48.8 93.73 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.156 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' SER . 35.4 p -148.5 -50.1 0.16 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.626 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.416 HD11 HD11 ' A' ' 82' ' ' ILE . 11.2 mt -60.67 75.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.315 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' THR . 32.1 t -75.18 -52.59 10.57 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.74 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.506 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -120.48 174.06 6.78 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -152.94 150.27 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 117.963 -1.495 . . . . 0.0 112.803 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -137.41 110.55 7.8 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.533 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.2 t -133.65 116.14 13.73 Favored Pre-proline 0 N--CA 1.495 1.807 0 C-N-CA 119.666 -0.813 . . . . 0.0 112.087 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.43 167.57 22.04 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 120.941 1.094 . . . . 0.0 110.809 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.92 -171.08 0.16 Allowed 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.744 1.63 . . . . 0.0 111.1 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.414 ' C ' HG13 ' A' ' 48' ' ' VAL . . . 75.46 -10.31 12.2 Favored Glycine 0 N--CA 1.481 1.652 0 C-N-CA 119.273 -1.441 . . . . 0.0 110.907 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.456 HG11 ' CB ' ' A' ' 2' ' ' ALA . 30.5 m -151.9 131.77 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.236 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -104.28 124.68 49.6 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.339 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.47 134.11 50.98 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.481 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.57 HD12 ' NH2' ' A' ' 83' ' ' ARG . 71.3 mt -112.59 123.08 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.116 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.898 HD23 ' H ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -89.91 152.87 21.02 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.286 -0.966 . . . . 0.0 112.443 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.898 ' H ' HD23 ' A' ' 52' ' ' LEU . 13.8 m-85 -140.07 125.08 18.53 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.22 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -53.33 -88.46 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.327 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -64.44 154.3 36.15 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.748 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -61.3 172.56 1.07 Allowed 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.362 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.66 17.99 76.95 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.12 -1.514 . . . . 0.0 109.924 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 59.24 54.05 5.03 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.971 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.52 -173.71 2.94 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.8 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.7 -175.78 33.49 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.482 -1.342 . . . . 0.0 109.955 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -50.65 166.88 0.07 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.69 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.62 161.92 36.74 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.366 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.746 HG22 ' N ' ' A' ' 64' ' ' GLU . 10.0 mm -138.78 172.76 13.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.571 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.746 ' N ' HG22 ' A' ' 63' ' ' ILE . 20.4 mt-10 -148.15 130.88 15.99 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.839 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.5 m -145.7 161.75 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 118.768 -1.173 . . . . 0.0 112.552 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.35 -14.7 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.006 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.04 -148.76 0.41 Allowed 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.404 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.697 HD22 HG13 ' A' ' 106' ' ' VAL . 14.3 p-10 -99.82 136.12 40.22 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.022 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.538 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -106.06 128.0 53.56 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.928 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -80.6 -74.79 0.3 Allowed 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 73' ' ' GLY . 20.2 mm-40 -89.95 3.32 53.47 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.975 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.417 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 1.7 tp 55.7 -83.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.715 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 176.02 -169.7 42.41 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.316 -1.421 . . . . 0.0 110.679 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.526 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.2 Cg_endo -65.05 -39.22 24.9 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 122.295 1.997 . . . . 0.0 112.17 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.022 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.9 pt? -71.94 31.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.942 -1.103 . . . . 0.0 111.202 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 74' ' ' PRO . 16.2 p-10 -80.77 -17.92 49.35 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.739 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -88.6 14.02 10.88 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.688 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.544 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -167.6 115.01 0.75 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.722 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 78' ' ' ASN . 15.8 m -155.47 153.63 7.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.514 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.1 t -172.55 -33.59 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 118.683 -1.207 . . . . 0.0 112.35 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.8 140.98 40.07 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.894 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.416 HG23 ' HA ' ' A' ' 52' ' ' LEU . 3.9 mt -150.52 149.79 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.381 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.703 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -141.32 126.41 18.39 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.248 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.703 ' CA ' HH12 ' A' ' 83' ' ' ARG . 3.5 t -117.7 135.92 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.1 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.55 ' CG1' ' CZ ' ' A' ' 83' ' ' ARG . 13.7 mt -119.34 121.92 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.654 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.4 p -46.16 129.99 10.17 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.708 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.515 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.9 OUTLIER -125.26 151.31 69.42 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.7 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.515 ' HD2' HG22 ' A' ' 87' ' ' VAL . 4.1 Cg_exo -55.87 139.03 83.66 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 121.234 1.29 . . . . 0.0 110.731 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.32 133.78 31.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.34 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -143.63 150.99 52.62 Favored Pre-proline 0 N--CA 1.487 1.402 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.9 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 2.5 Cg_endo -59.29 -160.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.241 1.294 . . . . 0.0 111.611 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -174.93 -158.75 0.08 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.849 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.23 165.04 28.99 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.622 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.409 HH11 ' CD ' ' A' ' 105' ' ' GLU . 6.8 ttt180 -128.98 152.24 48.82 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.87 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.571 ' CE1' HG23 ' A' ' 131' ' ' VAL . 98.0 m-85 -142.61 133.89 26.17 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.748 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.445 ' CD2' ' C ' ' A' ' 101' ' ' PHE . 18.6 m-85 -94.55 -177.12 4.12 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.14 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.8 -52.1 2.87 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.031 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.562 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 15.5 mmtp -93.18 163.9 13.45 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.541 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -82.9 78.47 9.49 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.379 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.65 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.3 OUTLIER 178.85 26.79 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.349 -1.296 . . . . 0.0 107.973 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.65 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 33.9 p90 37.78 49.1 1.06 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.237 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -138.44 -28.91 0.82 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.828 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.562 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -58.89 153.77 29.32 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.303 -1.427 . . . . 0.0 110.46 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 103' ' ' GLY . 42.8 tttm -31.03 140.03 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.903 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.409 ' CD ' HH11 ' A' ' 94' ' ' ARG . 63.6 mt-10 -96.47 147.7 23.56 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.585 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.697 HG13 HD22 ' A' ' 68' ' ' ASN . 95.0 t -142.85 117.88 4.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -104.14 162.27 13.32 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.095 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -141.11 150.93 60.54 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.195 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -78.08 163.51 28.03 Favored 'Trans proline' 0 C--O 1.212 -0.796 0 C-N-CA 121.652 1.568 . . . . 0.0 111.957 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.21 139.94 74.95 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.593 1.529 . . . . 0.0 110.696 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.51 -159.75 27.57 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 118.884 -1.626 . . . . 0.0 111.574 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.55 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 34.7 tt0 -118.03 156.16 29.06 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.149 -0.525 . . . . 0.0 110.828 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 49.6 m-85 -145.55 149.22 34.18 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.157 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.434 ' C ' ' H ' ' A' ' 116' ' ' ALA . 3.3 p -101.92 175.8 5.42 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.335 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -72.28 17.32 0.11 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.864 -0.734 . . . . 0.0 112.387 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 114' ' ' THR . . . -111.21 -65.75 1.14 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.564 -0.854 . . . . 0.0 111.716 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.0 pt-20 -70.55 -53.98 13.94 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.822 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.572 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -30.61 -72.43 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 123.925 0.765 . . . . 0.0 111.188 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.52 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -53.04 -57.14 11.39 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.268 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.451 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 8.0 mpt_? -78.37 26.69 0.21 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.553 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 117' ' ' GLU . 27.9 t80 -135.18 -8.28 2.29 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.315 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.651 ' O ' HG11 ' A' ' 106' ' ' VAL . . . -150.68 -44.59 0.02 OUTLIER Glycine 0 N--CA 1.481 1.642 0 C-N-CA 119.019 -1.562 . . . . 0.0 110.323 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -143.75 -102.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.822 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.444 ' C ' ' HB3' ' A' ' 119' ' ' GLU . 2.0 p-10 -172.63 179.97 2.3 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.493 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -63.91 123.03 17.91 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.113 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.547 ' C ' HG22 ' A' ' 127' ' ' THR . 1.9 m-20 56.28 106.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.968 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.692 HG23 ' H ' ' A' ' 128' ' ' ILE . 0.1 OUTLIER 172.49 -92.77 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.565 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.692 ' H ' HG23 ' A' ' 127' ' ' THR . 6.5 mm 45.81 -110.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.191 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 1.1 t 86.93 120.99 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 123.816 0.697 . . . . 0.0 111.924 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.731 ' H ' ' H ' ' A' ' 160' ' ' LEU . 2.7 m 58.97 114.72 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.136 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.75 HG12 ' HB3' ' A' ' 157' ' ' ALA . 4.0 p -113.13 160.13 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.605 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -160.96 89.68 1.62 Allowed Pre-proline 0 C--N 1.291 -1.967 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.183 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -69.32 121.32 8.11 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.035 1.157 . . . . 0.0 110.704 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -91.05 11.19 23.83 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.592 -0.843 . . . . 0.0 112.19 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -175.7 -49.67 0.06 OUTLIER Glycine 0 N--CA 1.491 2.339 0 C-N-CA 118.262 -1.923 . . . . 0.0 112.137 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.402 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -107.8 171.41 7.41 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.143 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -93.16 145.0 24.74 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.681 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 153' ' ' VAL . 31.6 t -101.42 147.52 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.157 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.427 HG12 ' CE1' ' A' ' 141' ' ' PHE . 59.8 t -138.25 116.71 13.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.821 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.438 ' H ' HD12 ' A' ' 140' ' ' LEU . 2.6 mp -105.7 137.47 43.51 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.78 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.427 ' CE1' HG12 ' A' ' 139' ' ' VAL . 10.9 m-85 -108.34 145.31 34.65 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.82 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -75.6 -61.73 1.82 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.913 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -82.19 149.49 27.88 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.858 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 145' ' ' ASN . 29.4 t70 -54.04 175.38 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.989 -1.085 . . . . 0.0 110.739 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.645 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 3.3 t-20 36.09 35.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.254 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.645 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 43.11 65.86 0.89 Allowed 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.103 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.2 t -120.59 34.76 5.1 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.543 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.0 -160.29 12.24 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.167 -1.492 . . . . 0.0 110.415 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -59.33 171.93 0.71 Allowed 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.093 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.5 p -149.82 160.16 43.79 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.562 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.21 84.58 62.82 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.066 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.53 102.61 0.61 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.71 1.607 . . . . 0.0 112.405 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.684 HG11 HG11 ' A' ' 131' ' ' VAL . 81.3 t -83.74 87.66 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.649 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -83.75 22.27 1.14 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.801 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 42.3 p -170.39 -156.12 0.13 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.596 -1.241 . . . . 0.0 112.033 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -90.56 150.99 21.52 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.621 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.75 ' HB3' HG12 ' A' ' 131' ' ' VAL . . . -159.42 84.99 2.25 Favored Pre-proline 0 C--N 1.308 -1.207 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.103 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.527 ' C ' ' OG ' ' A' ' 130' ' ' SER . 1.7 Cg_endo -67.93 37.92 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.045 1.83 . . . . 0.0 112.421 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.462 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.5 OUTLIER -178.55 65.83 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.704 0.764 . . . . 0.0 109.244 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.731 ' H ' ' H ' ' A' ' 130' ' ' SER . 3.4 tm? -80.98 -35.38 32.14 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.188 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.506 ' H ' ' HA ' ' A' ' 129' ' ' SER . . . . . . . . 0 N--CA 1.496 2.65 0 C-N-CA 119.743 -1.218 . . . . 0.0 111.563 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.1 t30 . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.854 0.359 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.3 m -92.64 113.5 25.8 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.376 -0.929 . . . . 0.0 111.18 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 41.6 t -99.73 -56.15 2.46 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.163 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 p -123.24 159.42 28.76 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.465 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 30.9 pt -141.54 174.25 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.541 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -156.29 113.3 3.16 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.364 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 7.0 mt -89.28 103.14 13.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.004 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.1 m . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 116.289 -1.815 . . . . 0.0 110.801 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.576 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 121.054 0.454 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 179.9 129.57 0.09 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.38 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.756 HG22 HG13 ' A' ' 44' ' ' VAL . 9.0 pt -82.5 153.19 3.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.814 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.3 m -121.7 126.04 48.03 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.127 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.527 HG11 HD11 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -101.24 150.26 5.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.389 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.957 ' CD2' ' OE1' ' A' ' 16' ' ' GLN . 47.6 m-85 -116.97 148.19 41.63 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.325 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.0 2.5 42.8 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.509 ' N ' ' HA3' ' A' ' 14' ' ' GLY . 16.8 m120 -154.17 167.94 28.2 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 117.779 -1.568 . . . . 0.0 112.449 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 9.4 tp10 -74.07 158.38 34.37 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.973 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.541 ' C ' ' H ' ' A' ' 13' ' ' GLN . 2.8 t0 72.21 41.04 0.65 Allowed 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.903 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.1 t80 63.3 -8.06 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.335 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.541 ' H ' ' C ' ' A' ' 11' ' ' ASP . 8.9 tt0 -74.44 175.01 8.13 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.526 -0.87 . . . . 0.0 111.169 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.509 ' HA3' ' N ' ' A' ' 9' ' ' ASN . . . 95.96 130.61 6.39 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.672 -1.252 . . . . 0.0 110.866 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 14' ' ' GLY . 48.1 mttp -38.99 152.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.919 -0.713 . . . . 0.0 111.311 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.957 ' OE1' ' CD2' ' A' ' 7' ' ' PHE . 1.7 mm-40 -99.4 154.6 18.08 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.498 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.595 ' CG1' ' N ' ' A' ' 18' ' ' ASP . 2.6 t -147.1 166.47 6.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.424 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.595 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 12.3 m-20 -131.09 131.95 44.54 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.199 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.527 HD11 HG11 ' A' ' 6' ' ' VAL . 13.7 mt -130.29 121.79 19.7 Favored Pre-proline 0 N--CA 1.489 1.482 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.608 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -64.81 164.82 22.99 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 120.988 1.125 . . . . 0.0 111.946 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.65 -157.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.732 1.621 . . . . 0.0 110.668 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.88 -178.44 53.18 Favored Glycine 0 N--CA 1.48 1.587 0 C-N-CA 118.911 -1.614 . . . . 0.0 110.571 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 23' ' ' ASN . 30.2 p-10 -107.44 128.83 54.83 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.83 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 1.3 p90 -153.58 146.89 24.78 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.331 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.447 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 7.8 p -120.48 -155.09 0.61 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.088 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -56.92 -28.11 61.69 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.718 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -55.04 -57.17 12.79 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.663 -1.215 . . . . 0.0 110.177 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.425 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 71.3 tp60 -58.3 -48.54 80.18 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.731 -1.188 . . . . 0.0 109.648 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 29' ' ' LEU . 4.8 mt -59.97 -29.47 68.46 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.515 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -56.03 -30.2 61.55 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -77.03 -34.57 57.31 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.421 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.469 HD12 HD22 ' A' ' 29' ' ' LEU . 13.4 mt -83.16 -68.93 0.67 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.921 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.73 34.22 2.47 Favored Glycine 0 N--CA 1.504 3.187 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.463 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.714 HD13 ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -121.13 8.58 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.669 0.747 . . . . 0.0 110.498 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 35' ' ' GLU . 11.8 pt-20 -78.1 179.66 6.7 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.966 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.59 ' O ' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER 68.93 99.59 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.16 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.515 ' ND2' ' OD1' ' A' ' 36' ' ' ASN . 1.6 p30 33.81 78.16 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.104 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.674 HG21 ' O ' ' A' ' 34' ' ' ILE . 60.5 p -140.39 -39.76 0.43 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.317 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 mt -67.27 72.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.487 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.504 ' OG ' ' C ' ' A' ' 9' ' ' ASN . 31.1 t -69.64 -46.24 66.64 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.694 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.49 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -127.57 164.1 22.72 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.156 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 t -149.89 154.31 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 118.151 -1.42 . . . . 0.0 113.124 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.23 121.61 15.02 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.183 -1.371 . . . . 0.0 108.777 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.756 HG13 HG22 ' A' ' 4' ' ' ILE . 6.4 t -139.12 114.76 8.42 Favored Pre-proline 0 N--CA 1.499 1.976 0 C-N-CA 119.308 -0.957 . . . . 0.0 112.095 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -69.76 169.5 18.77 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.849 1.032 . . . . 0.0 110.701 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.72 -170.32 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.703 1.602 . . . . 0.0 110.872 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.19 -15.03 12.39 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 119.088 -1.53 . . . . 0.0 110.589 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.576 HG11 ' CB ' ' A' ' 2' ' ' ALA . 21.6 m -150.77 135.43 9.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 118.774 -1.17 . . . . 0.0 112.172 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -105.96 127.85 53.42 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.35 153.94 24.22 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.918 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.549 HD12 ' NH2' ' A' ' 83' ' ' ARG . 99.1 mt -137.3 116.95 15.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.479 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.49 ' HA ' HG23 ' A' ' 82' ' ' ILE . 3.3 mp -93.78 162.96 13.71 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.01 -1.076 . . . . 0.0 113.177 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.44 ' CE1' HG22 ' A' ' 51' ' ' ILE . 88.4 m-85 -142.47 131.5 23.12 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.216 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.403 ' CG ' HD12 ' A' ' 75' ' ' LEU . 28.6 mt-30 -54.16 -84.41 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.764 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -75.69 166.6 23.31 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.17 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.32 -173.82 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.729 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 47.71 34.03 9.97 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.138 -1.506 . . . . 0.0 109.948 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.447 ' CZ ' HG23 ' A' ' 25' ' ' THR . 7.9 m-85 45.83 43.29 9.83 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.358 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.38 -172.34 2.32 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.721 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.08 178.96 1.2 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.538 -1.315 . . . . 0.0 109.818 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -54.1 177.53 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 118.831 -1.148 . . . . 0.0 110.195 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -147.45 161.34 41.25 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.806 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.451 HD11 HD11 ' A' ' 75' ' ' LEU . 4.1 mt -125.85 164.39 25.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.21 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -139.38 131.8 28.53 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -149.15 155.87 8.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.325 -1.35 . . . . 0.0 112.564 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.96 0.2 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.034 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.449 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -132.96 -135.91 0.18 Allowed 'General case' 0 C--O 1.208 -1.109 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.441 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.437 ' ND2' ' OD1' ' A' ' 107' ' ' ASP . 2.2 m-20 -111.89 124.44 52.37 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.329 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.11 94.32 6.45 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.639 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -58.64 -68.59 0.25 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.741 -0.784 . . . . 0.0 112.522 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.18 -12.82 59.98 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.369 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.416 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 1.3 tp 67.06 -79.33 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.738 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.416 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 165.62 176.07 36.74 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.238 -1.458 . . . . 0.0 110.77 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.591 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.0 OUTLIER -65.71 -35.12 38.35 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.249 1.966 . . . . 0.0 112.184 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.816 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.5 pt? -67.99 23.92 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.35 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.591 ' H ' ' C ' ' A' ' 74' ' ' PRO . 4.9 p-10 -75.19 -1.08 21.64 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.668 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -73.04 -8.55 56.26 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.14 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -168.5 127.03 1.12 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.159 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.38 137.58 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.273 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 87.8 p -162.3 -30.67 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.656 -1.218 . . . . 0.0 112.697 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.409 ' C ' ' CG1' ' A' ' 82' ' ' ILE . 1.2 m -98.83 139.99 33.68 Favored 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.058 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.49 HG23 ' HA ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -150.64 156.12 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 118.571 -1.252 . . . . 0.0 111.575 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.782 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -150.21 130.09 13.36 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.444 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.782 ' CA ' HH12 ' A' ' 83' ' ' ARG . 10.0 t -128.77 143.19 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.614 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.441 ' CG1' ' CZ ' ' A' ' 83' ' ' ARG . 7.8 mt -132.51 126.42 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.975 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.7 p -40.8 149.9 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.053 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.485 HG22 ' HD2' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -149.61 151.33 32.86 Favored Pre-proline 0 N--CA 1.483 1.203 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.539 179.847 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HD2' HG22 ' A' ' 87' ' ' VAL . 3.5 Cg_exo -53.93 153.39 20.38 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 C-N-CA 121.287 1.325 . . . . 0.0 111.091 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 89' ' ' VAL . 4.2 m -77.73 139.36 18.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.612 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -146.46 130.1 8.36 Favored Pre-proline 0 C--N 1.297 -1.674 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.142 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.404 ' HB2' HD11 ' A' ' 136' ' ' LEU . 2.7 Cg_exo -58.67 -151.75 0.01 OUTLIER 'Trans proline' 0 C--O 1.207 -1.028 0 C-N-CA 121.465 1.444 . . . . 0.0 111.364 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.6 ptt-85 -178.03 -163.94 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.856 -1.138 . . . . 0.0 112.223 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.57 172.12 13.36 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.012 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.559 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 8.4 tpp180 -126.39 157.9 37.32 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.306 -0.957 . . . . 0.0 111.486 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.559 ' CD1' ' C ' ' A' ' 94' ' ' ARG . 26.3 m-85 -148.26 113.59 5.58 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.312 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 105' ' ' GLU . 14.7 m-85 -89.53 161.77 16.03 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.093 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.655 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 0.6 OUTLIER -98.62 167.05 11.04 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.987 -1.085 . . . . 0.0 112.099 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt 59.69 147.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.072 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 30.5 tt0 -65.61 109.68 2.47 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.251 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.665 ' NE2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 100.53 49.79 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.814 0 O-C-N 124.92 1.388 . . . . 0.0 110.181 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.589 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 26.0 p90 29.66 53.21 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.053 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -98.95 30.37 3.41 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.936 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -162.57 151.77 21.76 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.457 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.565 ' O ' ' CE2' ' A' ' 97' ' ' TYR . 88.6 mttt -38.0 155.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.118 0.485 . . . . 0.0 112.1 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.453 ' HG2' ' H ' ' A' ' 105' ' ' GLU . 10.8 pt-20 -111.23 167.09 10.55 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.194 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.49 HG22 ' H ' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -136.66 178.55 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.224 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.49 ' H ' HG22 ' A' ' 106' ' ' VAL . 14.3 p-10 -150.34 145.95 26.44 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.351 -1.339 . . . . 0.0 112.295 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.6 mt -139.17 133.06 16.0 Favored Pre-proline 0 N--CA 1.496 1.873 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.199 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.449 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 2.7 Cg_endo -66.88 169.34 14.96 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 121.517 1.478 . . . . 0.0 111.677 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 5.1 Cg_exo -57.91 149.29 71.03 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 122.094 1.863 . . . . 0.0 111.643 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.22 -155.29 25.52 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.649 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.569 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 37.9 mt-30 -131.12 155.97 46.04 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.809 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.569 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 40.1 m-85 -141.67 155.0 45.71 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.663 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.9 p -102.68 176.46 5.16 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.769 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -83.12 56.8 3.64 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.425 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -153.5 -74.34 0.13 Allowed 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 121' ' ' TYR . 7.3 pt-20 -68.02 -44.6 76.16 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.02 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.584 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -33.94 -72.17 0.05 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.29 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.699 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -53.92 -50.3 66.71 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.436 -1.306 . . . . 0.0 110.08 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.401 ' H ' ' HG2' ' A' ' 120' ' ' ARG . 6.3 mmm180 -80.65 24.38 0.48 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 118.784 -1.166 . . . . 0.0 111.017 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.548 ' N ' ' O ' ' A' ' 117' ' ' GLU . 25.3 t80 -129.28 -12.78 4.5 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.027 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -143.8 -45.33 0.05 OUTLIER Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.297 -1.43 . . . . 0.0 110.39 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.498 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -143.8 -104.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.847 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.483 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 7.4 m-20 -160.62 179.01 8.93 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.044 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -74.8 131.49 40.83 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.691 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 50.18 89.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.449 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.5 t -175.38 -2.66 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.195 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 128' ' ' ILE . 11.6 mt -95.83 144.01 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.671 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 67.5 m -155.22 -49.34 0.08 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.316 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.8 m -87.99 98.41 11.5 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.99 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.508 HG13 ' CD2' ' A' ' 95' ' ' PHE . 3.2 t -104.9 159.69 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.842 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -157.24 85.73 2.81 Favored Pre-proline 0 C--N 1.295 -1.777 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.187 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.67 96.98 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 121.413 1.408 . . . . 0.0 110.576 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -87.39 25.81 1.35 Allowed 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.422 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -161.59 -62.71 0.02 OUTLIER Glycine 0 N--CA 1.487 2.072 0 C-N-CA 118.553 -1.784 . . . . 0.0 111.452 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 91' ' ' PRO . 1.2 mp -121.53 -169.02 1.79 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.826 -0.749 . . . . 0.0 111.749 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -86.79 158.48 19.37 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.6 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.7 t -126.67 137.94 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.624 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.519 ' C ' HD12 ' A' ' 140' ' ' LEU . 62.3 t -133.32 124.89 49.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.961 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 140' ' ' LEU . 9.2 mp -101.27 140.08 36.05 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.529 -0.868 . . . . 0.0 112.285 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 171' ' ' ARG . 19.0 m-85 -107.98 132.79 53.15 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.47 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -79.1 -31.09 44.15 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.3 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.463 ' CG ' ' H ' ' A' ' 144' ' ' ASP . 10.7 t-20 -78.12 179.09 7.06 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.589 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.463 ' H ' ' CG ' ' A' ' 143' ' ' ASN . 2.9 m-20 -69.45 -85.21 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.62 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.606 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 16.0 p-10 -76.16 75.69 2.99 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.637 -0.825 . . . . 0.0 112.097 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.606 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 0.9 OUTLIER 37.62 71.62 0.14 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.898 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.98 -173.2 4.24 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.163 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 62.37 -168.69 15.97 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.669 -1.253 . . . . 0.0 111.081 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 149' ' ' ASP . 0.8 OUTLIER -61.19 176.48 0.44 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.721 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.1 p -151.01 163.26 39.17 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.776 -1.17 . . . . 0.0 112.211 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.5 tp -123.55 83.42 53.3 Favored Pre-proline 0 N--CA 1.488 1.434 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.115 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.42 108.45 0.7 Allowed 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 122.148 1.899 . . . . 0.0 113.368 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 24.9 t -86.15 89.38 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.347 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -54.95 -24.81 25.62 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.7 p -170.69 -143.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 117.793 -1.563 . . . . 0.0 113.097 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -57.1 145.06 32.21 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.543 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.52 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -174.6 65.93 0.28 Allowed Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.876 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 3.3 Cg_endo -69.28 38.95 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 122.532 2.155 . . . . 0.0 112.583 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.76 HG23 ' H ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -166.67 -82.32 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.339 -1.344 . . . . 0.0 111.911 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.76 ' H ' HG23 ' A' ' 159' ' ' THR . 79.0 mt 54.17 -84.35 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.572 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 159' ' ' THR . . . . . . . . 0 N--CA 1.496 2.65 0 C-N-CA 118.979 -1.582 . . . . 0.0 110.253 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 19.9 m120 . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.768 0.318 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.415 ' OG1' HD23 ' A' ' 140' ' ' LEU . 48.8 m -102.93 137.97 40.43 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.156 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.99 -60.84 1.13 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.856 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.01 167.01 12.17 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 24.7 pt -147.35 171.37 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 117.999 -1.481 . . . . 0.0 112.501 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 141' ' ' PHE . 23.7 ttm180 -152.29 106.0 3.1 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.262 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 172' ' ' ILE . 11.4 mt -81.28 107.82 13.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 119.046 -1.061 . . . . 0.0 109.95 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 36.1 m . . . . . 0 C--N 1.303 -1.419 0 CA-C-O 116.347 -1.787 . . . . 0.0 110.981 -179.976 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 121.157 0.503 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 0.6 OUTLIER 179.43 121.56 0.05 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.706 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.605 HG22 HG22 ' A' ' 44' ' ' VAL . 1.6 pp -82.65 125.23 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 118.549 -1.261 . . . . 0.0 111.288 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.439 HG22 ' N ' ' A' ' 6' ' ' VAL . 38.1 m -105.85 157.65 17.32 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.471 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.492 ' HB ' HG23 ' A' ' 39' ' ' ILE . 1.6 m -142.3 164.6 17.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.288 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 5.4 m-85 -126.39 147.47 49.76 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.94 -68.76 0.38 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.303 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.533 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 34.9 m120 -73.04 170.15 15.48 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.629 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.472 ' CG ' ' N ' ' A' ' 11' ' ' ASP . 32.3 tt0 -73.55 171.06 13.9 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.08 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.63 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 3.4 t70 59.19 55.26 4.42 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.622 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.63 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 23.9 p90 38.72 26.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.102 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 11' ' ' ASP . 59.1 tp60 -103.93 162.2 13.33 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.655 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.533 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 89.63 134.88 5.54 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.64 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 14' ' ' GLY . 16.0 mtpp -30.44 136.93 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.56 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.93 169.54 8.7 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.779 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.3 t -141.19 133.21 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.425 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.17 111.61 23.77 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.728 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mt -105.86 128.72 25.87 Favored Pre-proline 0 N--CA 1.491 1.619 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.772 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -67.57 165.93 25.67 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 120.657 0.905 . . . . 0.0 110.456 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.82 -164.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 121.623 1.549 . . . . 0.0 111.391 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.17 174.44 34.48 Favored Glycine 0 N--CA 1.498 2.813 0 C-N-CA 119.396 -1.383 . . . . 0.0 111.28 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -103.38 135.18 45.48 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.617 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.541 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 2.5 p90 -155.12 176.22 12.82 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 118.482 -1.287 . . . . 0.0 111.701 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.0 p -141.06 -156.46 0.68 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.121 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.588 ' CD ' ' H ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -69.03 -22.68 64.03 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.957 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.47 ' H ' ' HD3' ' A' ' 26' ' ' ARG . . . -64.55 -59.81 3.86 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.652 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -58.73 -45.77 88.87 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.204 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.556 HD23 HD12 ' A' ' 32' ' ' LEU . 12.4 mt -57.47 -37.77 73.43 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.902 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.28 -34.22 56.4 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 118.474 -1.291 . . . . 0.0 108.469 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.9 -31.24 66.2 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.947 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.556 HD12 HD23 ' A' ' 29' ' ' LEU . 18.9 mt -81.15 -76.76 0.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.763 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.77 -29.94 0.44 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.522 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.456 ' O ' HD22 ' A' ' 29' ' ' LEU . 4.7 mm -71.5 133.56 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.578 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -171.93 147.62 2.19 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.868 -1.133 . . . . 0.0 111.885 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 36' ' ' ASN . 0.5 OUTLIER 68.47 -146.81 0.12 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.546 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -72.96 88.22 1.36 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.628 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.2 p -142.77 -31.54 0.51 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.718 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.625 HD12 HG11 ' A' ' 79' ' ' VAL . 5.8 mt -77.25 62.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.072 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 38.7 t -64.61 -70.02 0.25 Allowed 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.547 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.43 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -93.57 171.16 9.07 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.553 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -153.75 157.12 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 118.412 -1.315 . . . . 0.0 112.107 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -149.08 100.65 3.08 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.5 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.605 HG22 HG22 ' A' ' 4' ' ' ILE . 86.5 t -123.83 101.76 35.78 Favored Pre-proline 0 N--CA 1.496 1.84 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.407 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.44 171.8 11.22 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 120.943 1.096 . . . . 0.0 109.847 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.63 -169.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.567 1.511 . . . . 0.0 111.033 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.84 -18.24 9.6 Favored Glycine 0 N--CA 1.483 1.785 0 C-N-CA 119.18 -1.486 . . . . 0.0 110.679 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.473 HG21 ' HB1' ' A' ' 2' ' ' ALA . 1.9 m -147.79 139.98 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.292 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -110.13 119.24 38.66 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.644 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.85 157.57 17.37 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.29 -0.964 . . . . 0.0 113.158 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.6 HD12 ' NH1' ' A' ' 83' ' ' ARG . 44.2 mt -143.0 114.62 2.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.365 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.93 ' N ' HD12 ' A' ' 52' ' ' LEU . 2.7 mp -92.24 158.1 16.32 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.935 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.494 ' CE2' HG22 ' A' ' 51' ' ' ILE . 41.5 m-85 -140.03 108.48 5.86 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.488 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -45.84 -83.4 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.023 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -59.17 152.34 20.72 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.763 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -58.98 -171.18 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.945 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 49.9 37.84 29.56 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.231 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.438 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . 8.6 m-85 45.33 48.63 10.43 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.607 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.96 -164.09 1.16 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.159 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 64.84 168.93 1.91 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.265 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 60' ' ' GLY . 10.0 t70 -39.05 118.11 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.684 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.459 ' H ' ' HG3' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -97.74 151.57 20.02 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.743 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.663 HG22 ' N ' ' A' ' 64' ' ' GLU . 4.5 mm -130.59 168.98 22.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.423 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.663 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -147.39 133.71 19.56 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.127 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -145.07 162.19 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 118.79 -1.164 . . . . 0.0 112.56 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 t -149.36 -5.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.535 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.446 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -129.62 -159.51 0.97 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.209 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -91.15 136.91 32.77 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.714 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.605 ' HB1' ' HA ' ' A' ' 72' ' ' LEU . . . -113.92 105.03 12.76 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.424 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -54.29 -77.88 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.753 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -91.73 5.59 49.19 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.803 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.605 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 19.1 tp 54.04 -99.35 0.09 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.588 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.61 -176.55 36.45 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 118.964 -1.588 . . . . 0.0 111.03 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.646 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.0 OUTLIER -66.37 -37.34 23.96 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.483 2.122 . . . . 0.0 112.357 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 75' ' ' LEU . 2.7 pt? -57.53 8.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.502 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.646 ' H ' ' C ' ' A' ' 74' ' ' PRO . 10.5 p-10 -69.47 1.19 4.2 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.652 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -82.82 -15.41 51.75 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.364 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -164.69 126.52 2.2 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.104 -1.039 . . . . 0.0 111.169 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.625 HG11 HD12 ' A' ' 39' ' ' ILE . 2.7 t -138.38 151.15 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.432 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.3 t -166.0 -51.14 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.728 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 m -94.14 135.55 35.39 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.977 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.523 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -150.25 157.19 6.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.371 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.831 ' HE ' HD11 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -150.59 153.08 35.07 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.386 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.659 ' C ' HH21 ' A' ' 83' ' ' ARG . 13.9 t -150.27 140.29 16.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.497 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.831 HD11 ' HE ' ' A' ' 83' ' ' ARG . 42.4 mt -134.52 129.57 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.7 m -40.82 139.71 0.81 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.052 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.589 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -143.57 141.78 19.65 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.635 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.589 ' HD2' HG22 ' A' ' 87' ' ' VAL . 5.7 Cg_exo -54.75 143.77 68.6 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 121.065 1.176 . . . . 0.0 111.156 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.0 t -64.2 145.06 14.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.123 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -122.7 139.14 30.56 Favored Pre-proline 0 N--CA 1.489 1.491 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.132 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.75 -23.48 50.06 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 121.143 1.229 . . . . 0.0 111.309 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 35.3 -151.85 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.667 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.481 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -147.72 173.06 13.13 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.046 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -147.03 113.0 5.78 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.168 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 5.7 m-85 -97.29 162.63 13.25 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.555 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -123.0 156.72 34.23 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.618 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 104' ' ' LYS . 1.4 m-85 -75.46 -91.37 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.134 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 1.247 ' HB3' ' OE1' ' A' ' 100' ' ' GLN . 51.2 mttp -47.74 162.63 0.07 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.125 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -90.6 67.57 6.46 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.66 -0.816 . . . . 0.0 112.35 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 1.247 ' OE1' ' HB3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER 178.85 51.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.667 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.9 t80 47.99 35.06 4.6 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.951 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.734 ' OD1' ' HG2' ' A' ' 100' ' ' GLN . 18.3 p-10 -142.1 171.07 14.56 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.616 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 85.38 139.94 5.09 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.019 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.538 ' HB2' ' HZ2' ' A' ' 104' ' ' LYS . 1.0 OUTLIER -29.58 132.91 0.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 123.895 0.409 . . . . 0.0 112.07 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.563 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 1.7 pm0 -104.7 163.22 12.65 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.302 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.73 HG21 ' O ' ' A' ' 122' ' ' GLY . 2.1 t -140.97 128.8 22.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.109 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.47 155.22 17.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.788 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 108' ' ' LEU . 46.2 mt -143.93 138.5 15.14 Favored Pre-proline 0 N--CA 1.481 1.087 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.847 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 10.9 Cg_endo -73.08 167.33 27.62 Favored 'Trans proline' 0 C--O 1.212 -0.789 0 C-N-CA 121.636 1.557 . . . . 0.0 111.718 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.36 141.74 76.03 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.93 1.754 . . . . 0.0 110.965 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 144.69 -155.63 26.48 Favored Glycine 0 N--CA 1.498 2.817 0 C-N-CA 118.862 -1.637 . . . . 0.0 111.328 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.444 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 6.0 tt0 -125.65 152.42 45.24 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.934 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.444 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 28.8 m-85 -145.53 147.32 32.0 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.278 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.663 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 1.4 p -95.31 -136.46 0.22 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.08 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.663 ' N ' ' OG1' ' A' ' 114' ' ' THR . 39.9 tt0 -113.98 -25.38 8.59 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.063 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.45 -64.06 1.26 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.966 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.3 pt-20 -70.94 -50.34 35.68 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.587 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.695 ' C ' HD23 ' A' ' 118' ' ' LEU . 2.4 tt -39.28 -71.05 0.09 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.459 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.569 ' OE1' ' NH1' ' A' ' 120' ' ' ARG . 75.9 mt-10 -48.89 -56.12 9.74 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.639 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.569 ' NH1' ' OE1' ' A' ' 119' ' ' GLU . 4.1 mpt_? -71.76 0.31 9.24 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.893 -1.123 . . . . 0.0 112.361 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 117' ' ' GLU . 24.7 t80 -105.08 -12.23 16.23 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.487 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.73 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -146.21 -46.51 0.03 OUTLIER Glycine 0 N--CA 1.486 1.993 0 C-N-CA 118.915 -1.612 . . . . 0.0 111.288 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.647 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -136.78 -112.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.183 -1.007 . . . . 0.0 111.724 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -156.26 -155.53 0.55 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.338 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -80.61 3.67 21.13 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.975 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -157.15 -152.04 0.34 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.582 -1.247 . . . . 0.0 112.147 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 39.32 96.78 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.103 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 13.5 mt -155.1 -75.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.507 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.715 ' O ' HG23 ' A' ' 131' ' ' VAL . 8.3 p 41.54 -98.16 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.7 m -44.55 116.68 1.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 129' ' ' SER . 21.2 t -121.89 146.35 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.7 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -144.09 82.58 10.8 Favored Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.413 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -63.07 108.61 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.262 1.308 . . . . 0.0 111.053 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.481 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 6.9 mm100 -62.56 -2.3 1.05 Allowed 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.911 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 175.32 -41.21 0.11 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 118.249 -1.929 . . . . 0.0 112.476 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.6 mt -88.13 176.33 7.32 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.512 -1.275 . . . . 0.0 111.299 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.1 129.66 54.14 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.308 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.7 t -98.24 149.44 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.323 -0.951 . . . . 0.0 112.404 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.585 HG12 ' CE1' ' A' ' 141' ' ' PHE . 58.1 t -133.04 113.96 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.448 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 mp -91.01 139.26 30.93 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.818 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.585 ' CE1' HG12 ' A' ' 139' ' ' VAL . 3.7 m-85 -118.64 131.8 56.17 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.461 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -61.18 -80.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.911 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.25 164.03 16.68 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.272 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 146' ' ' PHE . 4.7 p30 -61.92 -161.17 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.537 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.638 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 6.6 t-20 37.19 29.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.12 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.638 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.1 p90 42.15 62.19 1.73 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.162 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.94 174.07 11.01 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.017 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.99 -162.13 49.82 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.488 -1.339 . . . . 0.0 110.529 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -59.96 160.54 7.72 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.41 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 71.5 p -149.13 166.04 29.99 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.56 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.46 ' C ' ' CD2' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -133.2 86.53 41.56 Favored Pre-proline 0 N--CA 1.483 1.223 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.901 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -63.24 104.77 0.43 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 C-N-CA 121.54 1.493 . . . . 0.0 112.328 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.81 81.99 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.637 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.85 19.77 0.5 Allowed 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.338 -0.847 . . . . 0.0 112.06 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.412 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 11.5 t -169.97 -151.67 0.09 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.54 -1.264 . . . . 0.0 111.89 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.412 ' N ' ' OG ' ' A' ' 155' ' ' SER . 4.3 m-20 -87.54 157.49 19.15 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.927 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.479 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -167.52 69.06 0.91 Allowed Pre-proline 0 C--N 1.304 -1.377 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.802 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.3 Cg_endo -68.14 34.35 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.622 2.214 . . . . 0.0 112.933 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.654 HG23 ' H ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -169.87 -68.29 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.716 -1.193 . . . . 0.0 111.665 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.654 ' H ' HG23 ' A' ' 159' ' ' THR . 1.9 mt 51.69 -93.55 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.605 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 159' ' ' THR . . . . . . . . 0 N--CA 1.493 2.438 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.595 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 54.3 t30 . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.953 0.406 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -39.32 136.54 0.88 Allowed 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.29 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.8 m -107.53 -36.08 6.56 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.827 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 10.8 p -153.84 155.57 36.02 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.7 -1.2 . . . . 0.0 111.022 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.668 HD12 HD11 ' A' ' 118' ' ' LEU . 0.2 OUTLIER -143.9 172.97 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.494 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -142.04 113.26 7.59 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.58 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 3.4 mt -80.52 91.89 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 118.437 -1.305 . . . . 0.0 109.548 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.6 t . . . . . 0 C--N 1.305 -1.33 0 CA-C-O 116.331 -1.795 . . . . 0.0 110.894 -179.969 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.597 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.934 0.397 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -176.68 127.55 0.18 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.782 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.2 pt -68.06 168.69 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.441 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -149.3 124.76 10.3 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.292 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.53 ' HB ' HG23 ' A' ' 39' ' ' ILE . 1.3 m -101.67 137.01 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.718 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.534 ' CE2' ' O ' ' A' ' 12' ' ' PHE . 5.2 m-85 -92.35 148.34 22.2 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.124 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.451 ' HB2' ' N ' ' A' ' 15' ' ' LYS . 1.8 m-85 -81.52 0.71 36.79 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.505 ' C ' ' OG ' ' A' ' 40' ' ' SER . 31.6 m120 -152.38 164.3 37.76 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.063 -1.455 . . . . 0.0 112.009 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.498 ' N ' ' OG ' ' A' ' 40' ' ' SER . 3.0 tp10 -71.63 163.64 27.38 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.462 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.477 ' CG ' ' C ' ' A' ' 10' ' ' GLU . 0.3 OUTLIER 71.87 40.92 0.71 Allowed 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.576 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.534 ' O ' ' CE2' ' A' ' 7' ' ' PHE . 55.8 t80 53.48 10.63 0.22 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.138 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 11' ' ' ASP . 17.5 mm-40 -96.97 171.89 8.21 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.81 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 96.08 139.32 10.33 Favored Glycine 0 N--CA 1.495 2.625 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.633 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.451 ' N ' ' HB2' ' A' ' 8' ' ' TYR . 12.5 mtmm -37.11 147.84 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.215 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -118.54 118.86 32.84 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.182 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 17' ' ' VAL . 14.4 p -104.82 130.71 55.4 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.028 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.182 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -90.25 143.26 26.93 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.326 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt -138.61 134.74 17.46 Favored Pre-proline 0 N--CA 1.493 1.693 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.146 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.83 165.89 22.08 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.048 1.165 . . . . 0.0 111.264 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.17 -173.73 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 C-N-CA 121.87 1.713 . . . . 0.0 111.163 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.12 -167.26 16.85 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.239 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.405 ' HB3' ' CD ' ' A' ' 83' ' ' ARG . 19.5 p-10 -134.81 136.65 42.69 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.203 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -152.13 -172.48 4.24 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.04 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 p -142.65 -162.77 1.48 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.658 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.627 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 11.0 ttt180 -60.44 -11.99 8.32 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.725 -1.19 . . . . 0.0 110.116 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.01 -66.48 0.59 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.415 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.476 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 8.5 tp-100 -59.49 -42.63 92.57 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.363 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 29' ' ' LEU . 58.8 mt -64.37 -36.74 85.12 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.32 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 26' ' ' ARG . . . -55.78 -28.88 58.32 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 117.923 -1.511 . . . . 0.0 107.767 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -71.78 -35.53 70.07 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.819 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.6 mt -81.98 -75.45 0.3 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.487 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.51 16.93 0.06 OUTLIER Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.489 -1.338 . . . . 0.0 110.791 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.423 HD12 HG23 ' A' ' 34' ' ' ILE . 28.7 mm -102.34 127.67 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.047 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.667 ' O ' HG22 ' A' ' 38' ' ' THR . 4.7 pt-20 -178.19 158.54 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.277 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 0.5 OUTLIER 81.24 -144.62 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.404 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -94.95 18.44 11.97 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.126 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -66.32 -20.73 66.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.195 -1.402 . . . . 0.0 110.361 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.756 ' O ' HG22 ' A' ' 39' ' ' ILE . 78.8 mt -76.18 33.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.692 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.651 ' H ' ' C ' ' A' ' 38' ' ' THR . 11.0 t -35.45 -55.85 0.65 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.222 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -122.74 174.68 6.97 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.418 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -151.01 161.01 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 118.165 -1.414 . . . . 0.0 112.438 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.439 ' N ' HG13 ' A' ' 42' ' ' VAL . 78.3 tttt -141.6 123.31 15.18 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.163 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.4 t -144.65 102.75 4.58 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.05 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.4 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.8 Cg_endo -68.31 171.26 13.1 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 121.032 1.154 . . . . 0.0 110.356 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 2.1 Cg_endo -61.59 -173.35 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.549 1.499 . . . . 0.0 110.815 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.9 -13.69 8.48 Favored Glycine 0 N--CA 1.483 1.788 0 C-N-CA 119.195 -1.479 . . . . 0.0 110.474 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.597 HG11 ' HB3' ' A' ' 2' ' ' ALA . 2.6 m -151.72 129.42 2.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 118.919 -1.112 . . . . 0.0 112.105 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.495 ' O ' HG13 ' A' ' 84' ' ' VAL . 15.8 ttpt -98.74 149.54 22.74 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.847 ' C ' HD12 ' A' ' 51' ' ' ILE . . . -134.17 149.62 51.04 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.365 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 1.066 HD13 HH22 ' A' ' 83' ' ' ARG . 1.9 mp -137.66 116.2 14.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.383 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.479 ' H ' HD12 ' A' ' 52' ' ' LEU . 4.3 mp -88.2 156.94 18.96 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.669 -1.212 . . . . 0.0 111.655 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -133.47 110.66 10.12 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.122 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -49.42 -79.38 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.48 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -62.4 153.88 29.94 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.987 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 21.7 p-10 -64.66 178.46 0.77 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.756 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.0 32.23 66.35 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.248 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 52.73 68.08 0.89 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.748 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.41 -170.92 3.62 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.121 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.38 175.01 6.17 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.287 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -44.27 111.66 0.32 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.623 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.605 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -95.62 128.32 42.39 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.146 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.573 HD11 HD11 ' A' ' 75' ' ' LEU . 2.5 mt -96.8 163.78 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.553 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -136.99 130.52 31.59 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.706 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 50' ' ' ALA . 11.0 m -150.3 163.72 3.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 118.813 -1.155 . . . . 0.0 112.178 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 t -147.42 -3.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.389 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.22 -146.13 0.32 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.273 -1.331 . . . . 0.0 109.122 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -96.94 124.39 40.9 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.546 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.433 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.16 108.73 19.77 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.054 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -65.05 -85.58 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.709 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 73' ' ' GLY . 9.8 mm-40 -80.35 5.86 13.7 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.354 -0.939 . . . . 0.0 111.539 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.408 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 3.0 tp 60.49 -79.63 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.045 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 170.56 174.72 38.77 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.397 -1.383 . . . . 0.0 110.477 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.26 -27.72 64.03 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.086 1.857 . . . . 0.0 111.982 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.573 HD11 HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -83.4 18.81 1.69 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.549 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -68.89 7.59 0.66 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 75' ' ' LEU . 6.3 m-20 -83.86 -10.48 57.99 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.519 -0.872 . . . . 0.0 111.269 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -165.75 122.94 1.44 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.381 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.589 ' HB ' HD12 ' A' ' 39' ' ' ILE . 3.5 t -149.49 142.79 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.657 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.7 m -158.35 -35.36 0.07 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.196 -1.001 . . . . 0.0 111.855 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.5 m -94.58 143.14 26.67 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.164 -1.014 . . . . 0.0 111.468 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.98 143.74 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.234 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 1.066 HH22 HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -125.0 135.07 52.44 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.81 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.748 ' CA ' ' NH1' ' A' ' 83' ' ' ARG . 13.2 t -141.22 142.92 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.391 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 68.6 mt -140.32 138.62 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.593 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.0 m -55.24 146.23 19.53 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.191 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.428 HG22 ' HD2' ' A' ' 88' ' ' PRO . 1.1 t -140.91 149.33 55.79 Favored Pre-proline 0 N--CA 1.483 1.225 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.626 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.428 ' HD2' HG22 ' A' ' 87' ' ' VAL . 3.1 Cg_exo -56.79 157.76 18.75 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.491 1.461 . . . . 0.0 111.58 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 89' ' ' VAL . 10.4 m -71.52 136.7 25.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.333 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -145.71 130.89 9.16 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.438 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -60.81 -154.34 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.877 0 C-N-CA 121.276 1.317 . . . . 0.0 111.09 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 178.28 -161.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.017 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.483 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.71 173.25 11.71 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.36 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.422 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 10.7 mtm180 -134.79 148.47 50.21 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.002 -1.079 . . . . 0.0 112.148 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 10.9 m-85 -133.79 133.34 41.56 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.764 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.492 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 27.2 m-85 -94.62 179.09 5.38 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.342 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.546 ' CE1' HG21 ' A' ' 127' ' ' THR . 0.2 OUTLIER -100.36 -64.7 1.02 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.431 -0.907 . . . . 0.0 112.973 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.503 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 46.4 tttm -81.02 158.19 25.21 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.94 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.575 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 42.2 mt-10 -64.65 108.31 1.66 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.567 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.995 ' OE1' ' HD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 106.04 57.14 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.208 0 O-C-N 125.109 1.505 . . . . 0.0 110.327 179.755 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.995 ' HD1' ' OE1' ' A' ' 100' ' ' GLN . 13.9 p90 26.41 40.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.672 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 100' ' ' GLN . 65.4 m-20 -100.72 -9.42 21.82 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.014 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.503 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -105.92 150.73 16.97 Favored Glycine 0 N--CA 1.499 2.9 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.395 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 103' ' ' GLY . 94.8 mttt -35.04 145.53 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.498 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.33 160.81 14.1 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.961 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.8 HG21 ' O ' ' A' ' 122' ' ' GLY . 1.5 t -143.6 165.38 14.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.232 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.513 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 5.7 p-10 -145.37 153.78 41.59 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 118.571 -1.252 . . . . 0.0 112.311 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.472 HD22 ' CD2' ' A' ' 121' ' ' TYR . 60.6 mt -139.39 146.38 48.23 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.371 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -73.15 165.75 31.84 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 121.676 1.584 . . . . 0.0 112.645 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.12 146.87 95.21 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 122.394 2.063 . . . . 0.0 111.491 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.11 -166.21 23.78 Favored Glycine 0 N--CA 1.501 2.973 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.154 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.587 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 55.3 mt-30 -113.37 159.22 19.66 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.737 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.587 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 44.9 m-85 -144.97 148.53 33.89 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.072 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.3 p -87.91 -165.68 1.38 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.879 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.91 57.0 0.73 Allowed 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.901 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.08 -68.16 0.13 Allowed 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.426 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 121' ' ' TYR . 9.7 pt-20 -69.8 -42.61 73.51 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.431 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.575 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -37.16 -74.49 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.529 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.722 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -52.08 -51.57 56.84 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.727 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 2.4 mpt_? -76.88 18.66 0.34 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.754 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 117' ' ' GLU . 16.7 t80 -127.71 -10.11 5.57 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.23 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.8 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -141.69 -49.77 0.05 OUTLIER Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.114 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.6 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -146.1 -102.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.627 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.6 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 20.1 m-20 -161.02 162.56 31.8 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.629 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.457 ' N ' ' HB3' ' A' ' 119' ' ' GLU . 17.3 p30 -60.47 -22.83 63.94 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.507 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.769 ' O ' HG22 ' A' ' 127' ' ' THR . 6.6 t-20 -97.63 -175.3 3.15 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.184 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 126' ' ' ASN . 10.1 t 55.04 -152.39 0.35 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.091 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.573 ' N ' HG23 ' A' ' 127' ' ' THR . 2.6 mt 76.43 127.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.295 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.426 ' HB3' ' CA ' ' A' ' 161' ' ' GLY . 47.6 m -160.58 -54.77 0.05 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.895 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.732 ' CB ' ' H ' ' A' ' 101' ' ' PHE . 1.7 m -84.08 117.18 23.27 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.789 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 t -119.46 143.58 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.885 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -139.7 106.6 6.98 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.257 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.55 122.37 9.35 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.103 1.202 . . . . 0.0 111.07 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.483 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 1.0 OUTLIER -90.15 -2.13 58.03 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.964 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -175.92 -36.24 0.05 OUTLIER Glycine 0 N--CA 1.493 2.448 0 C-N-CA 118.469 -1.824 . . . . 0.0 111.805 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.3 164.34 16.45 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.852 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 173' ' ' SER . . . -78.03 155.78 30.48 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.374 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.5 t -119.43 140.12 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.427 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.451 ' C ' HD12 ' A' ' 140' ' ' LEU . 92.2 t -130.98 124.52 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.845 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 140' ' ' LEU . 11.2 mp -103.01 141.23 36.15 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.43 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.426 ' CB ' ' HA ' ' A' ' 146' ' ' PHE . 48.3 m-85 -120.13 125.78 49.09 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.14 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -65.78 -64.69 0.8 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.947 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.54 165.63 23.5 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.4 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 146' ' ' PHE . 31.4 m-20 -63.18 -158.72 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.723 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.655 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 4.0 m120 42.89 22.89 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.753 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.655 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.9 p90 40.6 59.17 2.2 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.114 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 t -143.25 -150.8 0.33 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.334 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 54.4 -153.79 9.55 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.42 -1.371 . . . . 0.0 109.974 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.51 143.13 50.96 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.068 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.2 p -143.99 167.67 21.8 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.47 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.3 mt -138.03 83.41 23.05 Favored Pre-proline 0 N--CA 1.485 1.31 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.922 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -64.88 104.41 0.56 Allowed 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 121.615 1.543 . . . . 0.0 111.933 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.6 t -86.0 81.83 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.959 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -71.84 12.55 0.38 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.326 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 13.4 t -169.83 -151.71 0.09 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.378 -1.329 . . . . 0.0 111.618 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.3 m-20 -85.22 155.02 21.59 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.628 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.519 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -171.9 62.64 0.34 Allowed Pre-proline 0 C--N 1.302 -1.469 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.404 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 10.2 Cg_endo -69.87 69.8 1.68 Allowed 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.954 1.769 . . . . 0.0 111.197 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.714 HG23 ' H ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER 173.97 -94.45 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.379 -0.928 . . . . 0.0 111.064 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.714 ' H ' HG23 ' A' ' 159' ' ' THR . 49.7 mt 53.26 -90.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.842 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 159' ' ' THR . . . . . . . . 0 N--CA 1.494 2.507 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.764 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.4 m120 . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.86 0.362 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -55.74 122.28 11.07 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.222 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 73.0 m -91.23 -72.1 0.6 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.242 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.61 160.72 19.64 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.244 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.407 HG12 ' CD1' ' A' ' 118' ' ' LEU . 29.2 pt -142.37 169.87 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 119.506 -0.877 . . . . 0.0 110.633 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -154.1 107.0 2.86 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.052 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.5 mt -82.99 99.34 5.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.716 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 137' ' ' ALA . 11.0 t . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 116.328 -1.796 . . . . 0.0 110.966 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.538 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 121.065 0.459 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -179.97 115.33 0.05 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.18 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.4 pt -70.1 162.46 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.82 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -143.88 119.03 10.1 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.544 -0.863 . . . . 0.0 110.705 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 m -101.8 162.58 3.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.069 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.515 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 31.3 m-85 -120.62 152.7 37.81 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.934 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.98 -47.94 60.24 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.642 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 9.6 m120 -101.17 177.42 4.94 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.969 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 11' ' ' ASP . 5.5 tp10 -82.19 177.06 9.0 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.861 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.457 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 4.1 t70 61.58 36.26 16.9 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.15 -1.02 . . . . 0.0 110.756 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.515 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 1.3 t80 60.95 2.34 0.54 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.701 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -88.24 167.98 13.11 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.724 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.642 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 93.74 133.98 6.99 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 119.974 -1.107 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 14' ' ' GLY . 25.4 mtmm -30.15 139.47 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.095 0.474 . . . . 0.0 112.193 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -96.38 162.07 13.65 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.935 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 t -147.82 122.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.629 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 1.6 m-20 -90.25 138.78 31.25 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.798 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 mt -132.24 133.26 23.59 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.639 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -68.65 164.56 32.63 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 120.962 1.108 . . . . 0.0 111.494 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.02 -167.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.756 1.637 . . . . 0.0 110.533 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.474 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 89.56 178.8 45.19 Favored Glycine 0 N--CA 1.486 1.989 0 C-N-CA 118.79 -1.671 . . . . 0.0 110.88 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.599 ' N ' HH21 ' A' ' 83' ' ' ARG . 34.0 p-10 -110.52 141.84 43.13 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.359 -0.537 . . . . 0.0 112.2 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.455 ' OH ' HD12 ' A' ' 82' ' ' ILE . 17.2 p90 -155.77 178.87 9.77 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.879 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.6 p -142.47 -168.65 2.79 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.616 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -57.97 -24.31 57.52 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.381 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -64.87 -63.4 1.12 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.003 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 8.9 tp-100 -56.73 -39.61 74.25 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.437 -1.305 . . . . 0.0 109.326 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.645 HD13 HD11 ' A' ' 34' ' ' ILE . 46.1 mt -62.04 -40.1 94.6 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.324 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -48.76 -33.78 10.98 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 118.864 -1.135 . . . . 0.0 107.972 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -71.53 -38.68 71.05 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.575 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.509 HD12 HD23 ' A' ' 29' ' ' LEU . 15.2 mt -71.89 -80.93 0.06 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.927 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.14 -21.87 0.1 OUTLIER Glycine 0 N--CA 1.491 2.324 0 C-N-CA 118.802 -1.666 . . . . 0.0 111.422 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.645 HD11 HD13 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -81.27 155.21 4.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.984 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.765 ' H ' HG21 ' A' ' 38' ' ' THR . 5.0 pt-20 174.32 117.88 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.468 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.641 ' CG ' ' N ' ' A' ' 37' ' ' ASN . 1.5 p-10 92.43 -150.67 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.966 0 O-C-N 124.299 0.999 . . . . 0.0 113.032 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.641 ' N ' ' CG ' ' A' ' 36' ' ' ASN . 6.5 m120 -51.49 4.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.496 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.765 HG21 ' H ' ' A' ' 35' ' ' GLU . 43.4 p -56.78 -54.26 48.36 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 117.801 -1.559 . . . . 0.0 110.944 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.505 ' N ' ' OG1' ' A' ' 38' ' ' THR . 3.6 mt -58.75 77.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.112 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 38' ' ' THR . 35.6 t -81.38 -58.53 3.0 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.101 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.76 169.49 8.79 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -149.68 148.79 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 118.137 -1.425 . . . . 0.0 112.919 -179.907 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.481 ' HG3' HD21 ' A' ' 68' ' ' ASN . 22.0 ttpt -137.01 114.65 11.15 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.616 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.3 t -133.93 110.09 11.96 Favored Pre-proline 0 N--CA 1.498 1.955 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.063 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.414 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.0 OUTLIER -68.46 171.47 12.93 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.219 1.28 . . . . 0.0 111.223 179.879 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.5 Cg_endo -63.71 -171.92 0.15 Allowed 'Trans proline' 0 C--N 1.317 -1.079 0 C-N-CA 121.922 1.748 . . . . 0.0 111.131 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.418 ' C ' HG13 ' A' ' 48' ' ' VAL . . . 78.38 -17.13 6.7 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.538 HG11 ' CB ' ' A' ' 2' ' ' ALA . 26.6 m -150.58 143.63 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.232 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -108.78 138.42 45.14 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.972 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -117.49 140.24 49.87 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.369 -0.932 . . . . 0.0 112.436 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -129.09 118.99 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.33 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.47 ' HA ' HG23 ' A' ' 82' ' ' ILE . 3.8 mp -94.58 163.79 13.24 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.975 -1.09 . . . . 0.0 112.81 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -143.61 121.01 11.65 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.069 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -54.96 -85.87 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.665 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -59.88 154.07 19.45 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.28 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -62.45 -176.67 0.11 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.525 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.22 21.32 59.43 Favored Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.052 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 57.07 48.64 15.15 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.798 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -128.71 -177.83 4.35 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.591 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.41 171.68 36.44 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.076 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.5 m-20 -46.99 123.69 5.54 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.021 -1.071 . . . . 0.0 110.407 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.728 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 3.8 pm0 -102.85 176.06 5.28 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.854 -0.739 . . . . 0.0 111.112 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.626 HD11 HD11 ' A' ' 75' ' ' LEU . 6.1 mt -143.65 164.31 15.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.625 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.567 ' CD ' ' N ' ' A' ' 64' ' ' GLU . 3.0 mp0 -142.94 132.16 23.26 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.191 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.3 m -149.95 162.95 3.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.645 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 t -145.46 -1.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.664 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -124.47 -125.07 0.25 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.877 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.481 HD21 ' HG3' ' A' ' 43' ' ' LYS . 29.7 t-20 -121.64 115.83 23.47 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.201 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.57 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -90.1 83.47 6.06 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.575 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -54.33 -51.16 65.59 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.444 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 72' ' ' LEU . 8.5 tp10 -111.93 81.46 1.46 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.87 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.441 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 4.5 tp -31.17 -87.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.233 -0.894 . . . . 0.0 113.167 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.441 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 179.5 -168.17 38.56 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.007 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.64 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.1 Cg_endo -69.37 -50.38 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.402 2.068 . . . . 0.0 112.611 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.798 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.3 pt? -57.97 10.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.873 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.64 ' H ' ' C ' ' A' ' 74' ' ' PRO . 30.2 p30 -62.56 -0.58 0.63 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.861 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.509 ' H ' ' C ' ' A' ' 75' ' ' LEU . 55.0 t30 -71.22 -10.53 59.91 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.394 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -172.94 124.85 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.302 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.85 141.67 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.031 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.0 m -160.17 -41.77 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.748 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 m -94.6 139.03 31.73 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.244 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.47 HG23 ' HA ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -146.25 162.59 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 118.919 -1.112 . . . . 0.0 111.728 -179.952 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.892 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.24 114.42 5.85 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.116 -179.881 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.892 ' H ' HH22 ' A' ' 83' ' ' ARG . 10.9 t -110.11 130.31 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.613 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.438 HG13 ' NH1' ' A' ' 83' ' ' ARG . 4.9 mt -132.43 127.4 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.088 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.8 m -39.98 153.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.904 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.586 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -158.11 141.86 11.25 Favored Pre-proline 0 N--CA 1.488 1.437 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.98 179.935 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.586 ' HD2' HG22 ' A' ' 87' ' ' VAL . 7.6 Cg_exo -50.46 153.79 7.04 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.346 1.364 . . . . 0.0 111.64 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.531 HG22 ' N ' ' A' ' 90' ' ' GLN . 3.1 p -90.51 158.59 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.96 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.531 ' N ' HG22 ' A' ' 89' ' ' VAL . 52.5 mt-30 -142.25 150.46 55.31 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.432 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.567 ' C ' ' HE ' ' A' ' 92' ' ' ARG . 3.3 Cg_exo -59.71 -36.76 90.86 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.496 1.464 . . . . 0.0 111.299 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.567 ' HE ' ' C ' ' A' ' 91' ' ' PRO . 2.5 mtm180 57.21 -165.72 0.15 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.048 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.544 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -140.07 179.77 6.43 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.967 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -140.42 149.84 43.11 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.711 -1.195 . . . . 0.0 111.966 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -134.64 131.34 37.65 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.011 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.564 ' CZ ' ' CD ' ' A' ' 105' ' ' GLU . 5.4 m-85 -92.58 173.34 7.83 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.027 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.44 -68.89 0.75 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 118.893 -1.123 . . . . 0.0 112.117 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -75.46 166.7 23.19 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.319 -0.953 . . . . 0.0 111.844 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.725 ' C ' ' HG2' ' A' ' 100' ' ' GLN . 5.2 pt-20 -89.68 52.75 2.39 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.674 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.725 ' HG2' ' C ' ' A' ' 99' ' ' GLU . 15.2 mm-40 -159.32 33.24 0.2 Allowed 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.903 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.7 t80 58.4 38.11 25.76 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.447 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -137.97 173.81 11.23 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 81.78 134.02 1.72 Allowed Glycine 0 N--CA 1.487 2.033 0 C-N-CA 119.38 -1.391 . . . . 0.0 109.893 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 103' ' ' GLY . 13.6 ptpt -32.69 148.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.066 0.509 . . . . 0.0 112.008 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.564 ' CD ' ' CZ ' ' A' ' 96' ' ' PHE . 20.9 mt-10 -108.52 167.54 9.97 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.737 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 122' ' ' GLY . 2.6 t -137.19 130.0 43.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.768 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -102.1 155.87 17.92 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.338 -0.945 . . . . 0.0 113.103 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 108' ' ' LEU . 89.1 mt -145.45 125.36 7.05 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.266 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.18 166.38 16.98 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 121.108 1.205 . . . . 0.0 111.756 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.97 150.24 84.96 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 121.78 1.653 . . . . 0.0 111.07 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 139.32 -140.62 11.03 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.188 -1.482 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.528 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 19.2 tt0 -147.55 159.46 43.72 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.791 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 53.5 m-85 -141.71 155.41 45.65 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.842 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.2 p -100.61 175.42 5.67 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.66 -0.816 . . . . 0.0 112.29 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.71 41.01 0.15 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.667 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.415 ' N ' ' OE2' ' A' ' 119' ' ' GLU . . . -154.32 -52.93 0.1 Allowed 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.273 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 118' ' ' LEU . 5.1 tp10 -71.83 -52.11 19.1 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.043 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.571 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -36.17 -72.09 0.06 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.435 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.695 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 1.2 pm0 -52.99 -54.93 27.82 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.728 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.419 ' H ' ' HG2' ' A' ' 119' ' ' GLU . 3.4 mpt_? -74.31 15.56 0.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.173 -1.011 . . . . 0.0 112.516 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.401 ' O ' ' CG ' ' A' ' 121' ' ' TYR . 41.0 t80 -121.1 -17.85 7.64 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.536 -0.865 . . . . 0.0 111.476 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.537 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -142.94 -40.61 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 C-N-CA 118.632 -1.747 . . . . 0.0 111.44 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.623 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -139.01 -105.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.54 -179.867 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.538 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 19.1 t70 -162.61 -172.96 3.32 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.609 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.538 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 15.9 t-20 -59.09 -2.32 0.25 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.218 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 127' ' ' THR . 28.2 p30 -172.25 -134.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.754 -1.178 . . . . 0.0 111.948 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.55 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 9.1 t 41.0 33.98 0.25 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.877 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.484 ' C ' ' OG ' ' A' ' 129' ' ' SER . 3.0 mt -88.06 -75.75 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.122 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.484 ' OG ' ' C ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 77.22 -142.39 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 179.784 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.6 m -37.09 128.42 0.92 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.277 -1.329 . . . . 0.0 113.646 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.8 t -122.18 147.43 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.156 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -145.72 98.99 4.45 Favored Pre-proline 0 C--N 1.3 -1.549 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.125 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.02 110.13 1.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.044 1.163 . . . . 0.0 111.519 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.544 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 61.1 tp60 -57.95 -21.32 43.57 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.423 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.57 -36.32 0.03 OUTLIER Glycine 0 N--CA 1.495 2.602 0 C-N-CA 118.516 -1.802 . . . . 0.0 112.103 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.415 HD21 ' HG2' ' A' ' 91' ' ' PRO . 1.8 mt -92.11 -171.46 2.84 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.704 -1.198 . . . . 0.0 110.968 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.1 146.31 35.65 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.1 t -111.86 141.76 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 119.409 -0.916 . . . . 0.0 112.86 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.465 HG12 ' CE1' ' A' ' 141' ' ' PHE . 91.1 t -133.14 123.57 47.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.1 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 140' ' ' LEU . 5.2 mp -105.23 144.6 31.79 Favored 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 118.838 -1.145 . . . . 0.0 113.598 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.465 ' CE1' HG12 ' A' ' 139' ' ' VAL . 14.9 m-85 -120.14 132.51 55.43 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.047 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -73.91 -55.26 6.4 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.57 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -74.58 -158.52 0.07 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.872 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 145' ' ' ASN . 17.8 t70 -64.49 -147.03 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.2 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.559 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 6.0 m-80 -51.59 88.57 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.559 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 8.1 p90 38.44 68.34 0.34 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.946 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 81.1 p -132.95 43.37 2.97 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.971 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -178.8 -155.53 14.88 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -65.73 152.88 43.26 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.234 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 22.5 p -149.83 163.1 38.91 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.806 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.25 97.91 14.46 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.275 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -70.55 109.93 2.59 Favored 'Trans proline' 0 C--N 1.325 -0.664 0 C-N-CA 121.536 1.491 . . . . 0.0 112.087 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' A' ' 155' ' ' SER . 3.3 t -89.02 74.73 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.504 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -73.73 31.07 0.08 Allowed 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.055 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 153' ' ' VAL . 10.5 t -170.31 -153.42 0.1 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.595 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -90.47 164.04 14.41 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.739 -0.785 . . . . 0.0 111.481 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.532 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -167.65 73.13 0.95 Allowed Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.784 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.8 23.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.07 1.846 . . . . 0.0 112.891 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -178.48 79.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.731 179.89 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 17.2 tp -70.71 -45.18 65.4 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.193 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.031 0 C-N-CA 119.151 -1.5 . . . . 0.0 109.64 -179.949 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.942 0.401 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.21 126.21 42.26 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.422 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.0 m -99.09 -73.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.635 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 4.0 p -112.01 158.69 19.24 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.203 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.429 HG12 ' CD1' ' A' ' 118' ' ' LEU . 16.3 pt -139.81 170.56 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.748 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -147.95 109.0 4.25 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.97 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.2 mt -88.88 94.73 4.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.957 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 116.356 -1.783 . . . . 0.0 111.069 -179.966 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.623 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.914 0.387 . . . . 0.0 110.849 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.57 127.39 0.11 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.61 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.449 HD11 HD12 ' A' ' 19' ' ' LEU . 2.0 pp -81.24 147.65 6.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.331 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.935 HG21 ' OE1' ' A' ' 16' ' ' GLN . 22.6 m -128.64 139.15 52.4 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.515 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.13 173.69 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.821 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.47 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 52.7 m-85 -132.63 154.74 49.78 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.385 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -79.4 -19.17 50.72 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.023 1.119 . . . . 0.0 114.023 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.493 ' C ' ' OG ' ' A' ' 40' ' ' SER . 5.7 m120 -136.26 170.89 15.3 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.587 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.36 175.64 4.55 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.22 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 13' ' ' GLN . 6.9 t0 52.63 49.12 21.06 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.122 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.516 ' CE2' ' HG2' ' A' ' 70' ' ' GLU . 16.4 m-85 53.52 -4.25 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.745 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.554 ' H ' ' C ' ' A' ' 11' ' ' ASP . 29.4 mt-30 -75.58 169.05 18.86 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.613 -1.235 . . . . 0.0 111.24 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.6 134.13 5.73 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.495 -1.336 . . . . 0.0 110.498 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.604 ' CB ' ' NZ ' ' A' ' 15' ' ' LYS . 7.1 mtmp? -43.59 157.01 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.027 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.935 ' OE1' HG21 ' A' ' 5' ' ' THR . 1.1 pt20 -122.38 167.76 12.9 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.447 -0.901 . . . . 0.0 112.821 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -145.06 130.35 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.675 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.37 118.09 30.88 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.38 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.449 HD12 HD11 ' A' ' 4' ' ' ILE . 5.9 mt -112.67 139.78 23.15 Favored Pre-proline 0 N--CA 1.49 1.562 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.218 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -70.42 164.43 35.21 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 120.892 1.061 . . . . 0.0 111.075 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -163.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.037 0 C-N-CA 121.715 1.61 . . . . 0.0 110.723 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.24 176.12 50.59 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.779 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.565 ' HB3' ' NE ' ' A' ' 83' ' ' ARG . 15.9 p-10 -108.57 145.11 35.33 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.655 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.603 ' CE2' HD12 ' A' ' 82' ' ' ILE . 2.6 p90 -159.03 -173.54 4.29 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.152 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 p -146.53 -162.46 1.53 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.067 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.432 ' HG2' ' H ' ' A' ' 26' ' ' ARG . 7.3 ptp180 -62.67 -17.82 61.25 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.577 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -66.06 -62.86 1.26 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.258 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.549 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 36.1 tt0 -56.06 -42.41 76.59 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.114 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.576 HD23 HD12 ' A' ' 32' ' ' LEU . 68.9 mt -60.26 -39.86 88.27 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.454 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.56 -33.0 13.79 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 118.586 -1.246 . . . . 0.0 107.887 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -68.72 -39.43 80.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.151 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.576 HD12 HD23 ' A' ' 29' ' ' LEU . 17.7 mt -74.88 -75.59 0.16 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.771 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.53 -24.87 0.66 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 118.801 -1.666 . . . . 0.0 111.471 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.533 ' C ' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -85.04 149.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.405 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.567 ' O ' HG23 ' A' ' 38' ' ' THR . 6.0 pt-20 176.95 151.87 0.18 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.473 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.496 ' CG ' ' C ' ' A' ' 35' ' ' GLU . 0.6 OUTLIER 80.37 -144.5 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 179.754 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -67.5 29.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.249 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 35' ' ' GLU . 80.6 p -87.01 -43.87 12.01 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.44 -1.304 . . . . 0.0 110.626 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.404 HD12 ' CG1' ' A' ' 79' ' ' VAL . 9.2 mt -60.05 78.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.779 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.558 ' N ' ' O ' ' A' ' 38' ' ' THR . 19.0 t -77.5 -69.65 0.52 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.967 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.47 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -104.49 170.2 8.03 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.486 179.862 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -147.49 146.92 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 118.498 -1.281 . . . . 0.0 112.895 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -132.62 117.69 18.24 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.168 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 72.3 t -140.5 109.14 6.71 Favored Pre-proline 0 N--CA 1.495 1.801 0 C-N-CA 119.318 -0.953 . . . . 0.0 112.083 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.413 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.0 OUTLIER -69.67 170.94 15.3 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.404 1.403 . . . . 0.0 111.711 179.977 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.8 Cg_endo -62.69 -176.84 0.27 Allowed 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 122.263 1.975 . . . . 0.0 111.214 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.93 -12.25 18.2 Favored Glycine 0 N--CA 1.482 1.729 0 C-N-CA 119.189 -1.481 . . . . 0.0 110.563 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.623 HG11 ' CB ' ' A' ' 2' ' ' ALA . 18.1 m -149.27 131.72 6.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.799 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -105.85 136.78 44.87 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.125 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -117.87 151.98 36.3 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.351 -0.94 . . . . 0.0 112.627 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.527 ' C ' HD12 ' A' ' 52' ' ' LEU . 97.1 mt -138.49 119.38 16.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 114.57 -1.196 . . . . 0.0 108.523 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.893 ' N ' HD12 ' A' ' 52' ' ' LEU . 2.7 mp -91.97 161.85 14.63 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.535 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -142.75 108.95 5.24 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.785 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -48.17 -85.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.38 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -59.47 150.2 27.41 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.421 -0.911 . . . . 0.0 111.225 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 20.6 p-10 -62.1 178.78 0.34 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.465 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.4 24.8 71.0 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.113 -1.518 . . . . 0.0 110.106 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 54.65 63.89 2.0 Allowed 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.72 -161.19 1.27 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.015 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.58 169.46 1.4 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.087 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -43.68 119.1 1.57 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.476 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -97.86 172.18 7.82 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.279 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.525 HD12 HD22 ' A' ' 52' ' ' LEU . 3.4 mt -142.31 164.31 17.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.601 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -141.86 130.7 22.97 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.796 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -147.66 159.18 8.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 118.758 -1.177 . . . . 0.0 112.43 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.31 -5.05 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.179 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -124.64 -147.58 0.37 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.534 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -101.63 113.6 26.89 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.02 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.556 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -92.01 100.6 13.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.139 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.516 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 17.5 mt-10 -66.58 -86.34 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.773 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.437 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 28.3 tp10 -57.9 -16.11 10.9 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.533 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 4.6 tp 73.39 -83.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.528 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.58 -169.76 42.87 Favored Glycine 0 N--CA 1.5 2.901 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.552 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.8 Cg_endo -66.41 -47.78 2.88 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.385 2.056 . . . . 0.0 112.308 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.964 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.1 pt? -71.54 29.45 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.951 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.552 ' H ' ' C ' ' A' ' 74' ' ' PRO . 54.7 t-20 -82.64 55.63 3.05 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -145.92 1.48 0.88 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -171.76 115.55 0.37 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.249 -0.981 . . . . 0.0 111.012 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.404 ' CG1' HD12 ' A' ' 39' ' ' ILE . 2.2 t -139.14 156.12 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.463 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.5 t -166.41 -41.14 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 118.952 -1.099 . . . . 0.0 112.152 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 m -99.77 144.29 29.0 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.304 -0.959 . . . . 0.0 111.349 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.603 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -149.23 163.47 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.779 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.86 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -146.89 113.99 6.2 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.834 -179.972 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.86 ' H ' HH22 ' A' ' 83' ' ' ARG . 45.0 t -121.33 138.46 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.701 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.66 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 2.3 mt -143.43 132.43 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.269 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.6 m -40.17 153.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.917 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -149.24 149.88 30.43 Favored Pre-proline 0 N--CA 1.482 1.155 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.805 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.18 153.12 28.03 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 121.251 1.3 . . . . 0.0 111.354 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.14 134.73 27.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.776 -0.77 . . . . 0.0 111.236 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -145.25 126.12 7.47 Favored Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.366 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.62 -177.35 0.08 OUTLIER 'Trans proline' 0 C--O 1.212 -0.812 0 C-N-CA 120.851 1.034 . . . . 0.0 111.119 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.75 -160.33 0.69 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.713 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.49 161.23 27.58 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.157 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -119.42 147.94 43.8 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.981 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -134.75 136.63 42.78 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.564 -1.198 . . . . 0.0 107.889 179.813 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.498 ' CE2' ' OE2' ' A' ' 105' ' ' GLU . 18.3 m-85 -100.89 164.67 11.72 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 118.991 -1.084 . . . . 0.0 112.463 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.62 -56.88 3.59 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.421 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -93.34 167.0 12.02 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.043 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -87.98 68.33 9.19 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.563 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.656 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 1.7 tt0 -175.59 49.56 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.555 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.656 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 26.2 p90 39.58 40.31 0.61 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.644 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 20.9 p-10 -142.63 174.76 10.35 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.259 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 85.71 141.24 5.83 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.163 -1.494 . . . . 0.0 110.002 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 103' ' ' GLY . 11.9 tptt -28.49 123.15 0.12 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 124.016 0.48 . . . . 0.0 111.76 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.498 ' OE2' ' CE2' ' A' ' 96' ' ' PHE . 43.8 mt-10 -94.41 115.18 27.33 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.11 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.705 HG21 ' O ' ' A' ' 122' ' ' GLY . 3.6 t -96.17 143.76 11.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.592 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -123.92 156.58 36.07 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.88 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.2 mt -143.4 137.96 15.08 Favored Pre-proline 0 N--CA 1.488 1.469 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.896 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -67.77 165.56 27.32 Favored 'Trans proline' 0 C--O 1.213 -0.762 0 C-N-CA 121.732 1.621 . . . . 0.0 112.018 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.69 153.11 51.57 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 C-N-CA 122.171 1.914 . . . . 0.0 111.599 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.97 -159.3 21.14 Favored Glycine 0 N--CA 1.503 3.107 0 C-N-CA 119.35 -1.405 . . . . 0.0 111.42 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.538 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 24.8 mt-30 -123.65 157.18 34.41 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.196 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 27.8 m-85 -138.43 143.92 39.91 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.156 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.2 p -91.37 176.25 6.63 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.838 -0.745 . . . . 0.0 112.604 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.408 ' C ' ' OE2' ' A' ' 119' ' ' GLU . 39.0 tt0 -77.72 46.01 0.53 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.543 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -146.76 -64.17 0.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.073 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.6 pt-20 -71.16 -49.1 47.42 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.927 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.553 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -31.9 -70.33 0.07 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.424 -179.999 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.697 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -58.18 -55.98 28.0 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.63 179.956 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.499 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.8 OUTLIER -75.1 21.27 0.12 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.526 -0.869 . . . . 0.0 111.806 -179.876 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' A' ' 117' ' ' GLU . 30.0 t80 -128.75 -15.95 4.3 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.206 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.705 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -143.87 -39.36 0.06 OUTLIER Glycine 0 N--CA 1.491 2.331 0 C-N-CA 118.742 -1.694 . . . . 0.0 111.09 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.557 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -144.57 -104.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.5 -179.968 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.557 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 0.3 OUTLIER -162.51 -169.81 2.23 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.013 179.931 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -88.8 36.37 0.8 Allowed 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.008 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.53 ' O ' ' N ' ' A' ' 128' ' ' ILE . 63.2 t30 -172.33 -74.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.418 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -40.62 85.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' A' ' 126' ' ' ASN . 42.3 mt -158.43 143.33 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.657 179.818 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.9 m -159.51 -119.84 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.267 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.3 m -38.5 128.11 1.45 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.014 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -122.22 154.48 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.714 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -147.59 100.68 3.76 Favored Pre-proline 0 C--N 1.302 -1.467 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.369 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -54.4 94.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 120.976 1.118 . . . . 0.0 110.461 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -57.65 -15.87 8.93 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.307 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.34 -25.6 0.05 OUTLIER Glycine 0 N--CA 1.488 2.131 0 C-N-CA 118.747 -1.692 . . . . 0.0 111.461 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 mt -120.87 148.28 44.26 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.539 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -66.38 161.96 21.42 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.496 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 40.4 t -131.39 147.83 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.482 -0.887 . . . . 0.0 112.259 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.592 HG12 ' CE1' ' A' ' 141' ' ' PHE . 76.2 t -138.82 124.02 22.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.442 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.9 mp -104.34 142.17 35.03 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 119.642 -0.823 . . . . 0.0 112.755 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.592 ' CE1' HG12 ' A' ' 139' ' ' VAL . 18.6 m-85 -120.68 135.06 55.23 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.621 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -72.63 -47.2 49.62 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.527 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.556 ' CG ' ' H ' ' A' ' 144' ' ' ASP . 5.1 t-20 -83.22 -157.33 0.23 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.703 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.556 ' H ' ' CG ' ' A' ' 143' ' ' ASN . 1.0 OUTLIER -69.25 -140.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.927 -179.924 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.604 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 65.3 m-20 -52.67 86.09 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.053 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.604 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 6.2 p90 38.73 68.96 0.3 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.953 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 p -136.24 60.05 1.69 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.733 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 160.04 -151.68 22.38 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.134 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -59.41 156.81 12.22 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.336 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.5 p -149.01 170.14 19.03 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.754 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.507 HD23 ' C ' ' A' ' 151' ' ' LEU . 3.2 tt -144.24 83.04 10.32 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.449 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.85 105.92 0.71 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 121.999 1.799 . . . . 0.0 113.207 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 38.5 t -82.32 89.97 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.136 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -68.66 -7.48 33.6 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 21.0 t -169.62 -135.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 117.666 -1.614 . . . . 0.0 113.293 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.462 ' N ' ' OG ' ' A' ' 155' ' ' SER . 23.7 m-20 -77.18 152.72 34.68 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.987 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -167.86 67.14 0.79 Allowed Pre-proline 0 C--N 1.307 -1.247 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.035 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.4 Cg_endo -62.72 20.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.231 1.954 . . . . 0.0 112.847 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.551 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -175.32 83.62 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.755 -1.178 . . . . 0.0 110.953 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 30.2 tp -98.78 -47.66 5.23 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.297 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.875 0 C-N-CA 119.212 -1.471 . . . . 0.0 110.043 -179.942 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.1 p30 . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.61 0.243 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.5 m -103.26 150.82 23.36 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.745 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.9 p -124.44 -68.04 0.88 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.157 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.408 ' OG ' ' HB2' ' A' ' 141' ' ' PHE . 77.3 p -116.33 153.19 32.43 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.611 -0.835 . . . . 0.0 108.819 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 19.2 pt -137.04 175.52 9.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.717 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -155.65 103.97 2.32 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.227 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.3 mt -78.23 103.38 5.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.791 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.0 t . . . . . 0 C--N 1.305 -1.349 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.777 -179.898 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.543 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.878 0.371 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -175.04 118.32 0.18 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.365 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 4' ' ' ILE . 24.5 pt -69.27 145.8 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.684 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -121.56 112.87 19.01 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.003 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 m -91.12 175.47 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.238 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.544 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 23.9 m-85 -132.24 151.18 51.94 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.449 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.17 -6.77 59.27 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 118.824 -1.15 . . . . 0.0 113.289 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.52 ' C ' ' OG ' ' A' ' 40' ' ' SER . 34.1 m120 -147.13 161.85 40.04 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.646 -1.222 . . . . 0.0 111.536 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.449 ' N ' ' OG ' ' A' ' 40' ' ' SER . 26.2 mt-10 -70.85 179.02 2.84 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.394 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.9 t70 59.37 39.33 22.32 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.402 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.6 t80 57.48 5.45 0.3 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.272 -0.971 . . . . 0.0 111.792 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.465 ' HG2' ' H ' ' A' ' 14' ' ' GLY . 36.4 tt0 -92.45 176.66 6.39 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.291 -0.963 . . . . 0.0 111.217 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.465 ' H ' ' HG2' ' A' ' 13' ' ' GLN . . . 88.47 131.43 3.84 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.993 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -42.78 157.64 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.572 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -121.23 166.96 13.24 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.461 -0.895 . . . . 0.0 112.545 -179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -143.86 135.41 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.929 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -94.1 113.28 25.21 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.419 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.8 mt -107.35 137.68 19.69 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.572 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -71.15 155.76 60.64 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 121.072 1.181 . . . . 0.0 110.972 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.44 -161.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 121.576 1.517 . . . . 0.0 110.533 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.54 178.45 49.43 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 119.175 -1.488 . . . . 0.0 111.038 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -103.11 134.3 46.77 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.671 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 7.4 p90 -153.71 174.77 14.08 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.143 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.5 p -145.67 -154.21 0.53 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.98 -179.786 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.837 HH11 ' HB2' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -62.72 -30.92 71.77 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.973 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -59.98 -61.77 2.36 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.95 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.506 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.9 tp60 -56.47 -47.4 79.28 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.502 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.679 HD23 HD12 ' A' ' 32' ' ' LEU . 20.2 mt -54.98 -39.48 69.03 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.528 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.837 ' HB2' HH11 ' A' ' 26' ' ' ARG . . . -51.68 -34.2 37.34 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 118.948 -1.101 . . . . 0.0 108.359 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -66.77 -39.49 87.87 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.696 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.679 HD12 HD23 ' A' ' 29' ' ' LEU . 10.3 mt -74.8 -75.07 0.17 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.617 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.59 -34.91 0.54 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.094 -1.526 . . . . 0.0 110.909 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.444 HG21 HD13 ' A' ' 34' ' ' ILE . 8.5 tt -79.89 150.76 4.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.735 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 179.92 150.74 0.38 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.605 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.69 -146.8 0.14 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.913 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -55.33 92.62 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.998 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 40' ' ' SER . 73.1 p -153.18 -46.97 0.1 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.106 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.406 HD12 HG11 ' A' ' 79' ' ' VAL . 7.3 mt -61.86 75.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 C-N-CA 119.661 -0.815 . . . . 0.0 109.764 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.549 ' O ' HD22 ' A' ' 72' ' ' LEU . 8.6 t -74.21 -59.74 2.59 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.429 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.544 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -116.81 177.29 4.76 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.709 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -156.43 152.64 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 117.549 -1.66 . . . . 0.0 113.486 -179.896 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -140.17 106.97 5.38 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.595 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -126.08 108.21 24.71 Favored Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.598 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.419 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -69.81 171.04 15.25 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.042 1.162 . . . . 0.0 110.549 179.86 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.9 Cg_endo -62.39 -170.87 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.841 1.694 . . . . 0.0 110.91 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.9 -14.61 12.97 Favored Glycine 0 N--CA 1.478 1.468 0 C-N-CA 119.024 -1.56 . . . . 0.0 111.005 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.543 HG11 ' HB3' ' A' ' 2' ' ' ALA . 0.5 OUTLIER -151.66 131.72 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 118.716 -1.194 . . . . 0.0 112.588 -179.832 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.445 ' HA ' HG13 ' A' ' 66' ' ' VAL . 57.7 tttt -101.73 130.8 48.21 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.35 158.09 20.22 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.025 -1.07 . . . . 0.0 113.519 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.545 HD12 ' NH1' ' A' ' 83' ' ' ARG . 33.6 mt -144.71 116.24 2.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.242 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.546 ' HA ' HG23 ' A' ' 82' ' ' ILE . 2.7 mp -94.42 159.46 15.1 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.167 -1.013 . . . . 0.0 113.368 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.488 ' CE1' HG22 ' A' ' 51' ' ' ILE . 83.2 m-85 -139.33 114.77 9.82 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.111 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -44.61 -87.05 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.459 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -59.45 151.02 24.98 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.338 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -58.99 -178.99 0.06 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.169 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.666 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 55.61 37.31 67.31 Favored Glycine 0 N--CA 1.484 1.853 0 C-N-CA 118.906 -1.616 . . . . 0.0 109.437 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.771 ' H ' ' CB ' ' A' ' 81' ' ' SER . 0.3 OUTLIER 41.1 69.08 0.37 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.838 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.02 174.39 10.63 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.767 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.71 173.61 40.64 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.236 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -48.46 122.28 5.29 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 118.999 -1.081 . . . . 0.0 110.352 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.401 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 1.9 pt20 -99.05 173.32 6.88 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.93 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.878 HD11 HD11 ' A' ' 75' ' ' LEU . 7.3 mt -138.66 169.93 17.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.711 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.517 ' H ' HG22 ' A' ' 63' ' ' ILE . 22.0 mt-10 -147.21 130.88 16.9 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.394 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.64 164.74 2.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.441 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.622 HG12 ' NH2' ' A' ' 92' ' ' ARG . 0.5 OUTLIER -146.67 -9.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.658 179.856 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -118.01 -153.21 0.52 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.837 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -95.48 120.7 36.18 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.637 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.573 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.73 108.37 19.65 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.174 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 8.2 tp10 -73.62 -76.78 0.12 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.95 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.464 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 23.1 tp10 -76.86 2.02 15.8 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.038 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.549 HD22 ' O ' ' A' ' 40' ' ' SER . 10.1 tp 51.83 -97.55 0.06 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.111 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.465 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -174.5 -173.83 40.77 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 118.937 -1.601 . . . . 0.0 110.979 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.629 ' C ' ' H ' ' A' ' 76' ' ' ASN . 3.8 Cg_endo -71.86 -53.8 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.649 2.233 . . . . 0.0 112.306 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.878 HD11 HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -60.82 14.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.775 -179.853 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.629 ' H ' ' C ' ' A' ' 74' ' ' PRO . 13.2 p30 -67.51 0.81 2.74 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.453 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 75' ' ' LEU . 25.8 t-20 -80.82 -8.77 59.79 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.091 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -164.75 122.54 1.66 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.596 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.406 HG11 HD12 ' A' ' 39' ' ' ILE . 2.8 t -148.33 137.47 15.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.72 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.5 p -145.11 -47.4 0.23 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.65 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.771 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 7.4 m -93.61 142.76 26.98 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.334 -179.813 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.546 HG23 ' HA ' ' A' ' 52' ' ' LEU . 0.8 OUTLIER -147.98 160.38 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.01 -179.923 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.78 HH22 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.92 137.4 21.09 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.151 180.0 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.78 ' CA ' HH22 ' A' ' 83' ' ' ARG . 5.4 t -140.74 143.87 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.7 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.494 HG12 ' NH2' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -135.71 135.13 51.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.125 -179.928 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.1 t -42.87 154.41 0.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.108 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.7 143.72 13.59 Favored Pre-proline 0 C--N 1.307 -1.27 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.118 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.54 130.12 28.83 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.091 1.194 . . . . 0.0 110.73 179.72 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.3 p -59.48 140.24 17.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -117.33 152.44 49.25 Favored Pre-proline 0 N--CA 1.49 1.57 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.25 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.442 ' HG2' HD21 ' A' ' 136' ' ' LEU . 2.5 Cg_endo -59.33 -34.27 97.74 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.287 1.324 . . . . 0.0 111.207 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.622 ' NH2' HG12 ' A' ' 66' ' ' VAL . 22.3 mtt180 52.15 -161.96 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.359 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.572 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.1 175.86 9.42 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.867 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -143.68 120.15 11.01 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.45 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.42 ' CD1' HG13 ' A' ' 131' ' ' VAL . 6.7 m-30 -95.77 164.54 12.71 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.028 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.638 ' CD1' ' CE1' ' A' ' 101' ' ' PHE . 2.8 m-85 -143.41 149.06 37.12 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.468 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -93.68 160.43 14.77 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.597 -179.895 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.423 ' C ' ' OG ' ' A' ' 129' ' ' SER . 10.3 tttm 67.19 136.52 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.004 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.532 ' N ' ' OG ' ' A' ' 129' ' ' SER . 5.1 pt-20 -77.27 70.99 3.73 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.626 -1.23 . . . . 0.0 111.003 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.492 ' OE1' ' OD2' ' A' ' 102' ' ' ASP . 50.0 tt0 -173.67 19.02 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.515 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.638 ' CE1' ' CD1' ' A' ' 96' ' ' PHE . 33.8 t80 49.34 40.35 18.27 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.424 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.492 ' OD2' ' OE1' ' A' ' 100' ' ' GLN . 90.3 m-20 -104.09 -87.22 0.44 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.556 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 102' ' ' ASP . . . -30.68 145.88 0.01 OUTLIER Glycine 0 N--CA 1.507 3.402 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.917 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -34.72 155.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 114.587 -0.807 . . . . 0.0 112.998 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.492 ' HB3' ' CE1' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -116.4 164.74 14.1 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.411 -179.849 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.65 141.16 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -102.53 157.69 16.75 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.965 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 108' ' ' LEU . 88.8 mt -144.27 140.01 16.37 Favored Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.964 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -72.86 164.39 35.71 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 121.756 1.637 . . . . 0.0 111.825 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.5 143.79 70.52 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.603 1.535 . . . . 0.0 110.72 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.9 -160.78 27.52 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 118.795 -1.669 . . . . 0.0 111.573 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.561 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 29.3 tt0 -117.63 158.13 25.19 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.216 -0.492 . . . . 0.0 111.038 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.561 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 56.0 m-85 -145.52 151.47 38.22 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.765 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.4 p -103.02 -168.24 1.49 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.322 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.47 ' CG ' ' OG ' ' A' ' 168' ' ' SER . 45.4 tt0 -92.23 49.64 1.54 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.146 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -151.19 -63.51 0.19 Allowed 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.744 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -70.2 -54.07 14.39 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.326 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.558 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -30.82 -69.34 0.07 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.012 -179.99 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.713 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 21.2 mp0 -54.92 -59.29 4.94 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.173 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.42 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 12.3 mpt_? -74.73 19.54 0.14 Allowed 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.71 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.543 ' N ' ' O ' ' A' ' 117' ' ' GLU . 16.1 t80 -121.22 -15.4 8.17 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.881 -0.727 . . . . 0.0 110.773 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.07 -37.19 0.05 OUTLIER Glycine 0 N--CA 1.483 1.817 0 C-N-CA 118.928 -1.606 . . . . 0.0 110.337 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.473 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -146.01 -112.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.527 -179.843 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -151.98 -147.3 0.22 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.275 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.436 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 46.9 t-20 -73.81 -108.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.52 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.436 ' N ' ' OD1' ' A' ' 125' ' ' ASN . 23.7 t-20 -80.2 55.17 2.13 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.074 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.601 ' O ' HG22 ' A' ' 127' ' ' THR . 18.7 m -100.58 4.58 43.53 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.482 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.42 HG12 ' H ' ' A' ' 128' ' ' ILE . 2.3 mm -76.73 161.81 4.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.665 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 99' ' ' GLU . 2.4 t -161.91 -47.98 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.1 m -137.34 134.98 36.63 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.149 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.42 HG13 ' CD1' ' A' ' 95' ' ' PHE . 3.0 t -120.7 145.31 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.572 0.701 . . . . 0.0 111.855 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -146.18 93.56 5.06 Favored Pre-proline 0 C--N 1.296 -1.753 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.986 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -59.15 105.71 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.164 1.243 . . . . 0.0 111.877 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.572 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 36.4 tt0 -56.52 -9.52 0.75 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.568 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.44 -41.93 0.08 OUTLIER Glycine 0 N--CA 1.494 2.536 0 C-N-CA 118.49 -1.814 . . . . 0.0 111.933 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.442 HD21 ' HG2' ' A' ' 91' ' ' PRO . 4.9 mt -88.05 -167.12 1.78 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.105 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -115.79 142.64 46.5 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 153' ' ' VAL . 53.6 t -107.75 144.91 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.696 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 88.1 t -132.62 120.61 42.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.033 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.8 mp -97.84 139.33 33.85 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.343 -179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.427 ' CD2' ' HB3' ' A' ' 146' ' ' PHE . 29.4 m-85 -115.48 129.23 56.48 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.689 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.455 ' HE3' ' H ' ' A' ' 149' ' ' ASP . 19.5 ttpp -61.44 -75.02 0.07 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.653 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -76.22 167.98 20.88 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.259 -0.977 . . . . 0.0 110.513 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 146' ' ' PHE . 1.4 p30 -63.48 -158.43 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.59 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.643 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 22.2 t-20 39.33 26.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.248 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.643 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 41.87 57.89 3.02 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.343 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.0 t -136.45 -172.93 3.27 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.028 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.48 -161.94 53.49 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.169 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.455 ' H ' ' HE3' ' A' ' 142' ' ' LYS . 5.9 t70 -59.77 156.31 14.27 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.104 179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.5 p -148.16 170.39 17.95 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.476 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.7 mt -137.93 82.56 25.32 Favored Pre-proline 0 C--N 1.303 -1.419 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.463 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -62.13 103.93 0.32 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.848 1.699 . . . . 0.0 112.231 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 138' ' ' VAL . 3.1 t -89.34 74.1 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.883 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -79.22 36.29 0.29 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.001 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.6 t -170.97 -155.85 0.11 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.328 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.2 155.89 19.91 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.136 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.97 69.51 1.38 Allowed Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.526 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.4 Cg_endo -66.44 23.84 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.075 1.85 . . . . 0.0 111.313 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.597 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.3 t -168.76 134.34 1.7 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.412 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 129' ' ' SER . 0.2 OUTLIER -141.74 -55.57 0.46 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.949 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.939 0 C-N-CA 119.106 -1.521 . . . . 0.0 110.154 -179.988 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.45 125.61 51.22 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.838 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.47 ' OG ' ' CG ' ' A' ' 115' ' ' GLN . 36.8 t -91.15 -62.03 1.53 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.223 -0.991 . . . . 0.0 112.09 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.49 161.0 19.78 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.819 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.406 HG12 ' CD1' ' A' ' 118' ' ' LEU . 45.7 pt -143.16 174.64 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.729 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.5 ttt85 -160.66 114.25 2.08 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.492 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 11.7 mt -86.87 101.41 11.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.466 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.5 t . . . . . 0 C--N 1.306 -1.307 0 CA-C-O 116.284 -1.817 . . . . 0.0 110.874 179.949 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.812 0.339 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 179.83 125.89 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.683 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 pt -82.04 128.02 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.06 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -105.69 112.25 25.25 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.2 m -90.11 169.5 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 119.591 -0.844 . . . . 0.0 113.206 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -129.14 141.61 51.13 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.407 -1.27 . . . . 0.0 108.196 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.17 -21.72 58.55 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -123.95 169.73 11.32 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.028 -1.069 . . . . 0.0 112.477 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 11' ' ' ASP . 25.4 tt0 -67.21 173.77 3.64 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.888 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.558 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 14.5 m-20 52.01 58.2 5.69 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.774 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 7.3 p90 33.59 28.69 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.506 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 11' ' ' ASP . 8.7 tp-100 -106.55 168.44 9.17 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.92 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.52 ' H ' ' CD ' ' A' ' 13' ' ' GLN . . . 93.94 136.81 8.26 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.995 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -30.54 140.82 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 O-C-N 123.922 0.425 . . . . 0.0 111.712 -179.931 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 1.203 ' OE1' ' CD ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -100.52 151.71 21.26 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.498 -0.881 . . . . 0.0 113.17 -179.802 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -135.9 142.99 37.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.822 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -107.79 133.71 51.79 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.659 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 mt -129.3 126.81 23.08 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.982 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -67.91 163.59 35.0 Favored 'Trans proline' 0 C--N 1.327 -0.599 0 C-N-CA 120.629 0.886 . . . . 0.0 110.961 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.05 -162.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.493 1.462 . . . . 0.0 111.06 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.23 172.94 37.11 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.073 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.41 ' CB ' ' HG3' ' A' ' 83' ' ' ARG . 12.7 p-10 -106.12 133.9 50.09 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.564 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -155.24 177.12 11.71 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.394 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 p -137.88 -159.78 0.99 Allowed 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.85 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.86 -20.78 66.07 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.614 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -62.97 -58.9 5.78 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.216 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.489 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 28.6 tp60 -56.67 -45.2 81.84 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.007 -1.077 . . . . 0.0 109.738 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.64 HD23 HD12 ' A' ' 32' ' ' LEU . 13.7 mt -58.73 -39.09 79.88 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.567 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -53.15 -32.66 48.8 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.853 -1.139 . . . . 0.0 108.589 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -69.1 -42.31 76.3 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.095 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.64 HD12 HD23 ' A' ' 29' ' ' LEU . 10.3 mt -69.93 -71.39 0.24 Allowed 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.666 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.64 -34.67 0.81 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.117 -1.516 . . . . 0.0 110.923 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 34' ' ' ILE . 12.5 tt -83.32 141.62 14.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.27 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 175.82 154.96 0.19 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.031 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.1 t30 60.76 104.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.643 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.471 ' H ' HG22 ' A' ' 79' ' ' VAL . 66.5 t30 51.23 69.99 0.59 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.586 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 40' ' ' SER . 77.9 p -146.57 -32.23 0.33 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.339 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 40' ' ' SER . 8.9 mt -78.09 42.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.516 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 38' ' ' THR . 32.6 t -38.78 -53.73 1.65 Allowed 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.026 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.59 163.98 29.88 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.211 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.964 HG22 ' HB3' ' A' ' 69' ' ' ALA . 20.1 m -143.89 171.66 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 118.502 -1.279 . . . . 0.0 113.444 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -142.23 95.06 2.74 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.559 -1.655 . . . . 0.0 107.461 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 51.8 t -115.63 110.25 44.82 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -70.28 169.64 19.1 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.065 1.177 . . . . 0.0 110.311 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.85 -170.28 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.715 1.61 . . . . 0.0 111.207 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.86 -15.34 15.6 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.392 -1.385 . . . . 0.0 111.016 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -152.97 148.48 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.414 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -123.8 128.67 49.87 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.137 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.77 165.06 11.84 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.83 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.675 HG23 ' O ' ' A' ' 63' ' ' ILE . 66.7 mt -138.73 125.09 24.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.661 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.17 122.65 42.66 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.647 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -109.78 119.55 39.72 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.318 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -54.76 -77.01 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.144 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -62.28 156.16 22.94 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.0 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 19.2 p-10 -68.1 174.53 3.78 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.623 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.422 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 62.13 31.31 78.43 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.236 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.48 ' H ' ' CB ' ' A' ' 81' ' ' SER . 0.2 OUTLIER 54.2 67.18 1.05 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.619 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.42 -170.53 3.47 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.332 -0.947 . . . . 0.0 111.195 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 67.43 174.52 7.28 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.377 -1.392 . . . . 0.0 109.858 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 60' ' ' GLY . 13.4 m-20 -42.98 118.67 1.32 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.136 -1.026 . . . . 0.0 110.33 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.412 ' CD ' ' H ' ' A' ' 62' ' ' GLN . 0.1 OUTLIER -91.36 160.8 15.3 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.259 -0.977 . . . . 0.0 111.33 -179.887 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.675 ' O ' HG23 ' A' ' 51' ' ' ILE . 7.2 mm -137.53 168.63 20.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.353 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.67 ' N ' HG22 ' A' ' 63' ' ' ILE . 20.2 mp0 -147.96 134.19 19.45 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.306 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.7 m -149.76 147.5 16.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 118.676 -1.21 . . . . 0.0 112.252 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 48' ' ' VAL . 2.0 t -140.77 -0.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.49 -153.85 0.59 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.686 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -93.49 144.05 25.72 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.437 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.964 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -111.17 108.98 18.83 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.732 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -78.29 -63.34 1.42 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.401 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -100.45 4.43 43.73 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.259 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 tp 46.18 -98.93 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.097 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -168.95 -177.24 39.63 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 118.778 -1.677 . . . . 0.0 110.842 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.583 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.0 OUTLIER -67.16 -46.02 3.4 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.169 1.913 . . . . 0.0 112.055 -179.983 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.728 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.4 pt? -56.72 3.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.403 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.583 ' H ' ' C ' ' A' ' 74' ' ' PRO . 53.2 p-10 -65.04 5.79 0.31 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.403 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.543 ' H ' ' C ' ' A' ' 75' ' ' LEU . 26.3 t30 -86.92 -11.01 51.93 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.725 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -166.15 98.94 0.63 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.665 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.471 HG22 ' H ' ' A' ' 37' ' ' ASN . 18.9 m -97.09 171.0 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.582 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.1 t -171.31 -69.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 118.348 -1.341 . . . . 0.0 112.901 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.48 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 4.4 m -96.99 148.64 22.77 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.72 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.68 153.05 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.311 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.809 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -145.91 140.42 26.96 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.753 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.809 ' CA ' HH12 ' A' ' 83' ' ' ARG . 10.1 t -138.82 140.45 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.99 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.549 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 2.8 mt -136.99 125.61 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.57 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -50.12 126.85 15.52 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.579 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.696 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -114.97 145.32 33.79 Favored Pre-proline 0 N--CA 1.49 1.545 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.302 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.696 ' HD2' HG22 ' A' ' 87' ' ' VAL . 5.8 Cg_exo -52.61 120.29 7.26 Favored 'Trans proline' 0 C--N 1.326 -0.618 0 C-N-CA 121.356 1.37 . . . . 0.0 111.354 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 89' ' ' VAL . 7.1 p -45.47 130.59 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.841 -179.814 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -139.35 150.21 63.28 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.394 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.438 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 1.7 Cg_endo -59.13 -166.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.106 1.204 . . . . 0.0 111.102 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.89 -157.56 0.1 Allowed 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.049 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.68 162.08 36.24 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.156 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -129.99 117.43 20.05 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.043 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 10.5 m-85 -102.85 131.11 49.97 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.116 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -99.42 159.99 14.61 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.848 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.524 ' CZ ' HG21 ' A' ' 127' ' ' THR . 1.0 OUTLIER -97.43 158.68 15.35 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.629 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt 62.47 138.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.815 0.816 . . . . 0.0 111.514 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.588 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 10.6 tp10 -71.12 102.44 2.49 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.605 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.704 ' OE1' ' HB2' ' A' ' 102' ' ' ASP . 4.2 tm0? 129.67 39.25 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.467 0 O-C-N 125.286 1.616 . . . . 0.0 109.654 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.65 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 28.5 p90 33.96 48.33 0.23 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.124 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.704 ' HB2' ' OE1' ' A' ' 100' ' ' GLN . 53.5 t0 -124.36 57.58 1.23 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.472 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -177.01 156.42 20.39 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.902 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.487 ' H ' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -28.81 139.9 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.827 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -94.67 154.5 17.3 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.902 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.636 HG21 ' O ' ' A' ' 122' ' ' GLY . 2.5 t -140.31 165.67 20.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.888 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.553 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 17.7 p-10 -149.24 159.37 44.32 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.759 -1.176 . . . . 0.0 111.651 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.4 mt -142.07 149.08 51.07 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 119.639 -0.825 . . . . 0.0 111.23 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.41 165.93 24.79 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.044 1.829 . . . . 0.0 111.661 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.36 142.9 67.96 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.566 1.511 . . . . 0.0 110.687 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 144.75 -158.72 27.66 Favored Glycine 0 N--CA 1.502 3.063 0 C-N-CA 118.787 -1.673 . . . . 0.0 111.711 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.541 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 3.9 mp0 -116.77 153.4 32.49 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.759 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 50.8 m-85 -145.84 146.68 31.22 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.633 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.9 p -89.47 -147.93 0.18 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.435 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.779 ' H ' ' CD ' ' A' ' 115' ' ' GLN . 0.3 OUTLIER -116.06 27.35 9.32 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.783 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.47 ' HB2' HE21 ' A' ' 115' ' ' GLN . . . -129.54 -64.56 0.88 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.762 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.495 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 8.1 pt-20 -68.67 -42.64 77.61 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.42 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.569 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -38.04 -72.65 0.06 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.77 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.438 ' HB3' ' C ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -52.55 -54.41 33.16 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.168 -179.969 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -72.93 16.66 0.14 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.432 -179.791 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 117' ' ' GLU . 13.9 t80 -124.49 -17.9 5.88 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.912 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.636 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -133.91 -49.75 0.08 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.114 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.533 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -144.99 -99.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.628 -179.934 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.533 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 13.3 t70 -168.73 177.69 4.99 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.172 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.521 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 46.0 t-20 -59.15 135.14 57.54 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.701 -179.84 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 35.85 81.28 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.812 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.524 HG21 ' CZ ' ' A' ' 97' ' ' TYR . 97.9 m -161.56 -11.0 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.394 -0.923 . . . . 0.0 111.012 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.477 ' CG2' HG22 ' A' ' 131' ' ' VAL . 1.5 mp -53.84 -56.32 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.256 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.9 m 55.35 -113.63 0.8 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.682 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.2 m -63.06 122.42 16.03 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.93 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.477 HG22 ' CG2' ' A' ' 128' ' ' ILE . 1.8 t -120.76 159.76 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.427 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -153.15 85.46 4.24 Favored Pre-proline 0 C--N 1.301 -1.518 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -62.42 97.06 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.416 1.41 . . . . 0.0 110.723 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -81.83 22.4 0.76 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.35 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.8 -54.44 0.04 OUTLIER Glycine 0 N--CA 1.498 2.778 0 C-N-CA 118.042 -2.027 . . . . 0.0 112.38 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.438 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 1.3 mp -115.87 -172.07 2.09 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.002 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.75 143.11 31.31 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.652 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.6 t -110.0 139.09 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.765 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.587 ' C ' HD12 ' A' ' 140' ' ' LEU . 59.6 t -125.97 138.02 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.036 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.587 HD12 ' C ' ' A' ' 139' ' ' VAL . 9.3 mp -112.26 134.5 53.76 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.926 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.58 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 7.2 m-85 -115.0 131.92 56.77 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.78 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -64.21 -79.16 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.028 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -60.35 160.66 8.3 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.357 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 146' ' ' PHE . 10.0 m-20 -63.9 -156.19 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.554 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.686 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 6.3 t-20 41.13 24.44 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.017 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.686 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.1 OUTLIER 44.08 59.82 3.03 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.822 -179.946 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.6 t -141.83 -174.49 4.09 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.358 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.91 -163.22 54.2 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.591 -1.29 . . . . 0.0 110.025 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -59.81 160.47 7.52 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.952 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.0 p -150.34 174.73 12.54 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.809 -179.864 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.5 tp -141.78 89.45 9.04 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.53 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.21 106.27 0.8 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 121.699 1.599 . . . . 0.0 113.23 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.98 92.42 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.537 179.722 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -55.79 -34.57 65.41 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.8 t -164.15 -149.82 0.14 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 117.907 -1.517 . . . . 0.0 112.665 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -43.72 146.51 0.54 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.31 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -172.45 69.15 0.41 Allowed Pre-proline 0 C--N 1.307 -1.244 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.343 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.442 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.2 Cg_endo -64.9 23.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.197 1.931 . . . . 0.0 112.481 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.569 ' O ' HG23 ' A' ' 159' ' ' THR . 0.8 OUTLIER -177.72 102.3 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.139 179.967 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 3.7 mm? -99.37 -56.42 2.41 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.705 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 C-N-CA 119.375 -1.393 . . . . 0.0 110.53 -179.996 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.834 0.35 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.528 ' OG1' HD23 ' A' ' 140' ' ' LEU . 1.5 m -86.31 107.84 18.15 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.826 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 27.5 m -95.33 -53.16 3.87 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.172 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.54 160.91 21.51 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.032 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.414 HG12 ' CD1' ' A' ' 118' ' ' LEU . 31.4 pt -138.96 166.51 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -148.75 103.36 3.37 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.591 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.0 mt -81.17 97.55 3.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 118.978 -1.089 . . . . 0.0 109.347 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 C--N 1.305 -1.343 0 CA-C-O 116.324 -1.798 . . . . 0.0 111.026 -179.993 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.8 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 121.014 0.435 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -159.28 125.62 4.48 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.156 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.501 HG22 HG22 ' A' ' 44' ' ' VAL . 7.0 pt -72.01 155.17 7.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.513 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -134.0 156.5 48.08 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.067 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 m -147.26 171.41 3.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 119.086 -1.045 . . . . 0.0 111.062 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -131.97 156.15 46.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.744 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -72.17 -51.6 20.52 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -179.525 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.713 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 30.9 m120 -87.22 179.23 6.67 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.842 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -80.31 166.05 21.71 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.189 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.471 ' C ' ' H ' ' A' ' 13' ' ' GLN . 3.7 t0 66.15 45.35 2.36 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.782 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER 56.71 0.7 0.07 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.128 -1.029 . . . . 0.0 112.075 179.893 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 11' ' ' ASP . 47.4 tt0 -87.97 162.96 16.57 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.199 -1.0 . . . . 0.0 112.287 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.713 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 98.06 147.67 22.62 Favored Glycine 0 N--CA 1.503 3.107 0 C-N-CA 120.259 -0.972 . . . . 0.0 110.926 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 14' ' ' GLY . 3.7 mptp? -29.26 139.0 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 O-C-N 123.956 0.445 . . . . 0.0 112.137 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.636 ' N ' ' OE1' ' A' ' 16' ' ' GLN . 5.8 pm0 -103.92 160.19 15.02 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.459 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.613 ' CG1' ' N ' ' A' ' 18' ' ' ASP . 6.9 t -147.53 165.69 5.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.62 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.613 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 14.9 t70 -135.49 124.6 24.41 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.268 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mt -122.85 129.92 24.82 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.017 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -67.35 165.31 27.38 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.123 1.216 . . . . 0.0 111.317 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.99 -165.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 121.542 1.494 . . . . 0.0 110.289 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.53 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 94.95 -175.22 33.57 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 118.836 -1.649 . . . . 0.0 111.176 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.693 ' CA ' HH11 ' A' ' 83' ' ' ARG . 16.6 p-10 -113.2 134.02 54.78 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.153 -179.795 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.565 ' CE2' HD12 ' A' ' 82' ' ' ILE . 3.4 p90 -154.54 175.89 13.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.673 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.475 HG22 ' OG ' ' A' ' 81' ' ' SER . 7.0 p -146.82 -155.43 0.62 Allowed 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.984 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -60.33 -20.92 61.22 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.692 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.96 -63.11 1.16 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.474 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.508 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 15.7 tt0 -56.02 -46.73 78.71 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.486 -1.286 . . . . 0.0 109.805 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.586 HD23 HD12 ' A' ' 32' ' ' LEU . 22.9 mt -59.4 -38.95 81.89 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.539 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.57 -26.92 56.57 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 118.328 -1.349 . . . . 0.0 108.419 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -75.41 -37.95 60.16 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.739 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.586 HD12 HD23 ' A' ' 29' ' ' LEU . 14.4 mt -73.34 -74.97 0.16 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.525 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.29 -32.82 0.65 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.248 -1.454 . . . . 0.0 110.692 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 34' ' ' ILE . 7.8 tt -85.26 139.42 17.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.59 ' H ' HG21 ' A' ' 38' ' ' THR . 3.4 pt-20 174.24 142.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.195 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.55 ' O ' HG23 ' A' ' 38' ' ' THR . 1.7 t-20 75.57 116.31 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 47.14 9.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.735 179.74 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.59 HG21 ' H ' ' A' ' 35' ' ' GLU . 71.4 p -83.35 -57.67 3.16 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 117.941 -1.503 . . . . 0.0 111.206 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.417 ' N ' ' OG1' ' A' ' 38' ' ' THR . 30.2 mt -57.92 78.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.23 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 38' ' ' THR . 13.7 t -77.79 -48.3 16.89 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.562 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.409 ' CB ' ' H ' ' A' ' 12' ' ' PHE . 42.7 t -126.87 132.02 51.04 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.58 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -105.54 158.8 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 C-N-CA 119.492 -0.883 . . . . 0.0 113.052 -179.742 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.411 ' N ' HG13 ' A' ' 42' ' ' VAL . 33.4 tttp -143.38 98.43 3.25 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.788 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.501 HG22 HG22 ' A' ' 4' ' ' ILE . 93.1 t -121.78 109.37 34.19 Favored Pre-proline 0 N--CA 1.496 1.842 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.318 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -69.07 168.43 20.69 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 120.989 1.126 . . . . 0.0 110.898 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.42 -175.7 0.15 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 121.818 1.678 . . . . 0.0 111.097 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.69 -14.54 17.98 Favored Glycine 0 N--CA 1.481 1.688 0 C-N-CA 119.178 -1.487 . . . . 0.0 110.295 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.8 HG11 ' HB3' ' A' ' 2' ' ' ALA . 15.5 m -149.28 135.42 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.685 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.414 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 37.4 tttm -110.32 156.2 21.06 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.249 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -149.7 158.62 44.34 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 118.139 -1.424 . . . . 0.0 112.916 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.687 HG23 ' O ' ' A' ' 63' ' ' ILE . 78.4 mt -133.19 123.05 46.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 114.317 -1.311 . . . . 0.0 108.846 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.542 ' H ' HD12 ' A' ' 52' ' ' LEU . 0.9 OUTLIER -100.37 138.97 36.71 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.725 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.45 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 49.2 m-85 -113.73 114.05 25.82 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.712 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -46.72 -83.1 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.721 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -59.23 141.96 53.01 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.272 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -53.65 178.0 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.271 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.671 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 59.08 37.74 92.07 Favored Glycine 0 N--CA 1.487 2.049 0 C-N-CA 118.95 -1.595 . . . . 0.0 109.69 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.671 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.3 OUTLIER 41.08 70.52 0.25 Allowed 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.987 -179.943 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.05 -162.67 1.61 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.11 -178.03 5.14 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.325 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -49.46 123.79 8.23 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.45 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 62' ' ' GLN . 16.7 pt20 -95.54 158.3 15.51 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.101 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.687 ' O ' HG23 ' A' ' 51' ' ' ILE . 7.7 mm -133.42 168.38 24.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.766 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.679 ' N ' HG22 ' A' ' 63' ' ' ILE . 20.2 mt-10 -146.4 135.02 22.17 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.986 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.5 m -150.09 161.12 4.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.687 -1.205 . . . . 0.0 112.103 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 t -147.55 -3.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 114.402 -1.272 . . . . 0.0 107.799 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -131.31 -152.13 0.49 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.024 -1.443 . . . . 0.0 109.188 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.702 ' N ' HD21 ' A' ' 68' ' ' ASN . 0.7 OUTLIER -90.94 121.0 32.4 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.544 179.888 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.58 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.01 81.22 6.87 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.51 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -45.56 -69.48 0.13 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.594 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.67 -3.47 56.27 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.606 -0.837 . . . . 0.0 111.868 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tp 60.74 -93.61 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.164 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.76 -174.61 44.25 Favored Glycine 0 N--CA 1.491 2.367 0 C-N-CA 118.915 -1.612 . . . . 0.0 110.628 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.543 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.9 Cg_endo -65.27 -29.81 54.73 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.18 1.92 . . . . 0.0 112.092 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.631 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -65.41 13.25 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.219 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.543 ' H ' ' C ' ' A' ' 74' ' ' PRO . 22.8 t30 -60.25 -2.12 0.42 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.071 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.518 ' H ' ' C ' ' A' ' 75' ' ' LEU . 9.6 t-20 -77.35 -24.17 50.76 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.852 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.458 ' OD1' ' ND2' ' A' ' 36' ' ' ASN . 41.6 t30 -171.45 133.3 0.81 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.303 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.86 157.47 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.332 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.6 m -165.68 -61.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 117.915 -1.514 . . . . 0.0 114.136 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.62 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 11.7 m -93.92 148.24 22.34 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.027 -1.069 . . . . 0.0 112.88 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.565 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -148.57 158.64 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.858 179.971 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.802 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -139.29 120.18 14.42 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.519 -179.887 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.802 ' H ' HH12 ' A' ' 83' ' ' ARG . 3.1 t -119.4 133.79 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.706 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.783 HD11 HH21 ' A' ' 83' ' ' ARG . 3.2 mp -135.88 121.32 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.886 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.6 m -40.63 151.82 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.623 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -147.76 149.33 33.18 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.681 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -52.81 160.53 3.91 Favored 'Trans proline' 0 C--N 1.326 -0.643 0 C-N-CA 121.296 1.331 . . . . 0.0 111.672 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.0 137.81 21.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.701 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -146.11 131.67 9.3 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.657 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -59.84 -156.42 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.85 0 C-N-CA 121.245 1.297 . . . . 0.0 110.715 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.491 ' HE ' ' HB2' ' A' ' 107' ' ' ASP . 5.7 ptm180 -174.36 -157.96 0.08 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.044 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.549 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.5 168.06 20.74 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.854 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.49 ' HE ' ' CB ' ' A' ' 105' ' ' GLU . 38.5 ttt180 -129.13 128.6 43.79 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.954 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.518 ' CD2' HG13 ' A' ' 131' ' ' VAL . 71.8 m-85 -120.44 134.12 55.32 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.2 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.555 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 66.9 m-85 -89.43 175.21 7.4 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.969 -1.092 . . . . 0.0 111.237 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.72 -28.87 51.0 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 118.772 -1.171 . . . . 0.0 113.032 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -156.79 -178.82 7.64 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 117.363 -1.735 . . . . 0.0 113.585 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.613 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -62.61 108.1 1.08 Allowed 'General case' 0 C--O 1.202 -1.425 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.857 -179.83 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 1.19 ' OE1' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 121.97 41.33 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.434 0 O-C-N 125.081 1.488 . . . . 0.0 109.881 179.802 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 1.19 ' CD1' ' OE1' ' A' ' 100' ' ' GLN . 37.2 p90 30.32 34.51 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.878 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 100' ' ' GLN . 21.3 t70 -106.54 169.61 8.42 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.338 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 77.2 136.68 0.82 Allowed Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.203 -1.475 . . . . 0.0 109.727 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.47 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.7 OUTLIER -29.1 136.94 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.236 0.541 . . . . 0.0 112.097 -179.778 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.597 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 1.4 pm0 -93.31 164.28 13.28 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.619 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 107' ' ' ASP . 3.9 t -140.04 167.83 18.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.691 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.557 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 2.8 p30 -148.16 159.28 44.11 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.346 -1.342 . . . . 0.0 111.81 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.8 mt -141.49 149.55 54.66 Favored Pre-proline 0 N--CA 1.495 1.776 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -76.99 166.34 26.93 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 121.763 1.642 . . . . 0.0 111.422 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.33 140.8 78.83 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 121.7 1.6 . . . . 0.0 110.928 179.871 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 145.52 -164.08 28.12 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 118.927 -1.606 . . . . 0.0 111.36 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.586 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 33.4 tt0 -115.99 157.25 24.88 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.211 -0.494 . . . . 0.0 110.783 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.586 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 53.8 m-85 -146.08 153.85 41.18 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.9 p -98.71 -159.62 0.75 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.412 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -106.91 54.3 0.68 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.211 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.55 -67.43 0.13 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.346 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 121' ' ' TYR . 4.8 pt-20 -67.33 -50.05 61.6 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.359 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.498 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -36.23 -57.41 0.72 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.859 179.784 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 119' ' ' GLU . 51.9 mt-10 -53.15 -66.52 0.37 Allowed 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.171 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.453 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 14.8 mmm-85 -73.66 7.23 2.56 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.641 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.547 ' N ' ' O ' ' A' ' 117' ' ' GLU . 15.0 t80 -99.95 -17.65 17.46 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.203 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.646 ' C ' HD13 ' A' ' 123' ' ' ILE . . . -163.62 -28.32 0.02 OUTLIER Glycine 0 N--CA 1.484 1.841 0 C-N-CA 117.771 -2.156 . . . . 0.0 112.107 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.646 HD13 ' C ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -135.83 -101.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.362 -179.848 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.597 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 25.2 t70 -173.28 -163.97 0.21 Allowed 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.663 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.597 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 18.7 t-20 -72.17 -22.36 61.31 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.125 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -170.21 89.95 0.17 Allowed 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.8 t -168.05 14.05 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.968 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 128' ' ' ILE . 4.6 mt -68.98 -70.66 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.508 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 69.9 -135.01 0.06 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.819 -0.752 . . . . 0.0 112.338 179.881 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.421 ' CB ' ' H ' ' A' ' 101' ' ' PHE . 16.2 m -45.29 128.36 7.65 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.7 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.518 HG13 ' CD2' ' A' ' 95' ' ' PHE . 5.5 t -121.67 160.35 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.183 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.413 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -154.91 89.55 3.12 Favored Pre-proline 0 C--N 1.29 -1.981 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.784 179.913 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.22 121.54 10.09 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.091 1.194 . . . . 0.0 110.608 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.549 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 29.0 tt0 -90.96 -8.67 48.6 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.183 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.8 -32.68 0.02 OUTLIER Glycine 0 N--CA 1.494 2.502 0 C-N-CA 118.026 -2.035 . . . . 0.0 112.476 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.28 156.93 28.0 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.904 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.98 145.36 42.6 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.007 -1.077 . . . . 0.0 109.214 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.4 t -112.42 148.61 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.021 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.2 t -137.36 118.53 17.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.02 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.479 ' N ' HD12 ' A' ' 140' ' ' LEU . 11.2 mp -98.94 142.42 30.46 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.883 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.489 ' CB ' ' HA ' ' A' ' 146' ' ' PHE . 63.9 m-85 -120.02 134.46 55.24 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.402 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -65.88 -68.53 0.36 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.08 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -78.34 169.3 18.48 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.392 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 146' ' ' PHE . 11.1 p-10 -64.34 -160.99 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.014 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.645 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 24.6 m-20 42.66 21.03 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.938 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.645 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.4 OUTLIER 40.77 58.65 2.38 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.677 -179.91 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.6 t -148.09 149.32 31.83 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.335 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 108.43 -146.67 16.5 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -65.36 105.02 1.05 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.171 -1.011 . . . . 0.0 110.204 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.0 p -103.18 168.93 8.86 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.781 -0.767 . . . . 0.0 111.826 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 tt -139.37 81.14 21.09 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.139 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.24 108.37 0.58 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.961 1.774 . . . . 0.0 112.968 -179.692 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.7 87.25 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.294 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -58.33 -21.97 51.53 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.886 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 12.9 t -168.9 -141.59 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 117.979 -1.489 . . . . 0.0 112.895 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.8 OUTLIER -57.66 141.19 49.18 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.159 -179.811 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.55 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -162.24 61.12 1.17 Allowed Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.294 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.5 Cg_endo -65.31 19.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 122.222 1.948 . . . . 0.0 112.856 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.685 ' O ' HG23 ' A' ' 159' ' ' THR . 4.7 t -169.12 101.92 0.37 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.385 -1.326 . . . . 0.0 111.867 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 160' ' ' LEU . 94.5 mt -128.03 -48.9 1.34 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.646 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.316 179.901 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.981 0.419 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.451 ' OG1' HD23 ' A' ' 140' ' ' LEU . 1.8 m -82.39 114.96 21.19 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.446 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 36.1 t -86.86 -47.51 8.97 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.104 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.19 165.96 23.89 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.152 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 38.1 pt -145.93 167.07 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 118.652 -1.219 . . . . 0.0 111.463 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -149.42 109.74 4.18 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.02 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mt -88.18 96.81 6.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.095 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 116.304 -1.808 . . . . 0.0 110.931 -179.973 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.611 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 120.882 0.372 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 179.8 120.76 0.06 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.496 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.6 pt -67.72 146.73 12.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 118.723 -1.191 . . . . 0.0 110.263 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.9 m -123.96 117.57 25.09 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.186 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.492 ' O ' ' CB ' ' A' ' 16' ' ' GLN . 1.2 m -92.1 174.18 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.434 -0.906 . . . . 0.0 111.167 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 61.1 m-85 -135.98 146.67 47.48 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.231 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -75.02 -28.1 60.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.63 -0.828 . . . . 0.0 112.764 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.499 ' C ' ' OG ' ' A' ' 40' ' ' SER . 33.6 m120 -126.76 163.0 24.5 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.451 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.592 ' N ' ' OG ' ' A' ' 40' ' ' SER . 18.9 mm-40 -63.56 -163.57 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.928 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.613 ' C ' ' H ' ' A' ' 13' ' ' GLN . 8.7 m-20 40.5 39.59 0.75 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.852 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER 56.22 -5.86 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.327 179.991 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.613 ' H ' ' C ' ' A' ' 11' ' ' ASP . 21.9 mt-30 -73.84 174.33 8.63 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.296 -0.961 . . . . 0.0 110.745 179.918 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 86.21 129.87 2.54 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.339 -1.41 . . . . 0.0 111.027 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.9 OUTLIER -37.79 147.93 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.964 179.907 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.552 ' OE1' ' O ' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -119.91 162.1 19.73 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.724 -0.79 . . . . 0.0 112.286 -179.868 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.07 139.35 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.882 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -94.41 134.47 36.89 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.421 -179.937 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.9 mt -129.86 126.47 22.53 Favored Pre-proline 0 N--CA 1.496 1.851 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.202 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.21 164.37 28.22 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 121.053 1.169 . . . . 0.0 111.157 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.24 -172.25 0.14 Allowed 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 121.648 1.565 . . . . 0.0 111.14 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.492 ' N ' ' HB ' ' A' ' 84' ' ' VAL . . . 103.65 -166.38 15.88 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.356 179.987 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -130.93 132.41 45.07 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.069 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -148.12 -177.05 5.53 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.037 -179.955 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.577 ' CG2' ' CE2' ' A' ' 58' ' ' PHE . 20.3 p -141.26 -159.28 0.94 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.87 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -63.78 -24.23 67.68 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.061 -1.055 . . . . 0.0 110.361 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -61.03 -61.84 2.29 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.555 179.987 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -55.59 -44.14 76.66 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.543 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.686 HD23 HD12 ' A' ' 32' ' ' LEU . 23.1 mt -61.95 -32.84 73.31 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.789 -1.164 . . . . 0.0 109.633 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -55.8 -31.7 62.88 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 118.601 -1.24 . . . . 0.0 108.231 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.28 -37.28 69.06 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.38 179.883 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.686 HD12 HD23 ' A' ' 29' ' ' LEU . 15.3 mt -74.98 -77.07 0.13 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.471 179.887 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.09 -28.17 0.72 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.296 -1.43 . . . . 0.0 111.058 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.847 ' C ' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -87.69 133.3 30.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.748 -179.988 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 169.72 174.51 0.05 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.492 -179.905 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 3.6 t30 70.91 -28.84 0.18 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.117 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.547 ' H ' ' C ' ' A' ' 35' ' ' GLU . 16.1 m120 -160.17 -108.61 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.767 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.658 HG21 HG12 ' A' ' 34' ' ' ILE . 2.6 p 42.71 -134.98 0.4 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.572 179.943 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.921 HD12 HG11 ' A' ' 79' ' ' VAL . 1.9 mt 30.26 49.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.291 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.592 ' OG ' ' N ' ' A' ' 10' ' ' GLU . 44.1 t -61.11 -44.3 97.56 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.598 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.47 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -129.82 170.22 14.16 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.116 179.774 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -148.94 146.73 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 118.596 -1.242 . . . . 0.0 112.255 -179.838 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -136.67 102.59 4.96 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.897 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.4 t -120.98 106.16 39.37 Favored Pre-proline 0 N--CA 1.497 1.898 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.876 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -67.59 169.28 16.16 Favored 'Trans proline' 0 C--N 1.326 -0.633 0 C-N-CA 121.091 1.194 . . . . 0.0 110.458 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.03 -173.7 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.766 1.644 . . . . 0.0 110.683 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.25 -20.62 10.01 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 118.878 -1.629 . . . . 0.0 109.944 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.611 HG11 ' CB ' ' A' ' 2' ' ' ALA . 24.2 m -149.22 145.15 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.892 -179.963 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.4 tttt -120.97 152.46 38.51 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.604 179.841 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.92 147.81 30.12 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.896 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 63' ' ' ILE . 84.9 mt -122.88 120.46 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.021 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.007 HD23 HG23 ' A' ' 82' ' ' ILE . 6.5 mt -89.07 154.46 20.17 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.752 -179.8 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -130.51 111.77 12.58 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.887 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.28 -79.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.032 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.573 ' HB3' ' HB3' ' A' ' 59' ' ' ALA . 18.0 t-20 -59.16 139.06 57.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.089 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.99 170.65 0.17 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.917 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.24 33.16 86.49 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.425 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CE2' ' CG2' ' A' ' 25' ' ' THR . 19.4 m-85 53.74 65.11 1.61 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.931 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.573 ' HB3' ' HB3' ' A' ' 55' ' ' ASN . . . -144.65 -162.63 1.53 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.689 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.4 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 56.04 178.72 0.35 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.274 -1.441 . . . . 0.0 110.002 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -44.77 153.19 0.18 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.897 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -130.17 151.96 50.13 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.014 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.798 HG22 ' N ' ' A' ' 64' ' ' GLU . 51.1 mt -123.65 173.16 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.876 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.798 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -150.09 130.3 13.64 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.03 179.988 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.3 m -148.36 156.59 8.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 118.806 -1.158 . . . . 0.0 112.565 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 t -140.49 -5.7 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.536 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -128.7 -148.33 0.37 Allowed 'General case' 0 C--O 1.209 -1.07 0 CA-C-N 113.822 -1.536 . . . . 0.0 109.228 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.653 HD21 HG13 ' A' ' 106' ' ' VAL . 14.2 p-10 -99.57 120.44 39.66 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.038 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.53 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -90.84 96.44 10.64 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.218 179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -56.01 -86.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.973 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 13.8 mm-40 -67.61 -11.46 58.18 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.915 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.487 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 4.0 tp 75.54 -84.57 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.724 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.461 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 171.12 -169.48 42.51 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.202 -1.475 . . . . 0.0 110.629 -179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.499 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.0 Cg_endo -66.02 -50.45 1.59 Allowed 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.208 1.938 . . . . 0.0 112.299 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.995 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.9 pt? -72.53 33.45 0.06 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.026 -1.069 . . . . 0.0 111.503 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.499 ' H ' ' C ' ' A' ' 74' ' ' PRO . 1.8 t30 -76.63 -6.01 50.23 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.388 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.511 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 20.7 m120 -95.49 6.46 48.91 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.028 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -158.45 119.51 3.41 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.204 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.921 HG11 HD12 ' A' ' 39' ' ' ILE . 4.1 t -150.17 154.34 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 119.254 -0.979 . . . . 0.0 110.668 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.8 p -174.04 -41.92 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 118.981 -1.088 . . . . 0.0 111.549 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.3 t -99.0 141.49 31.69 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.556 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 1.007 HG23 HD23 ' A' ' 52' ' ' LEU . 13.4 mt -148.6 158.0 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.004 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.762 ' NH1' ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -135.61 135.15 40.01 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.3 -179.876 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.762 ' CA ' ' NH1' ' A' ' 83' ' ' ARG . 11.2 t -139.96 135.8 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.956 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.9 mt -140.08 129.48 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.665 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 53.1 m -43.1 151.94 0.13 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.487 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.409 HG22 ' HD2' ' A' ' 88' ' ' PRO . 1.1 t -151.44 150.22 26.26 Favored Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.647 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD2' HG22 ' A' ' 87' ' ' VAL . 3.4 Cg_exo -58.55 166.24 6.6 Favored 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.166 1.244 . . . . 0.0 111.263 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 89' ' ' VAL . 2.0 p -102.23 145.75 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.845 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -130.53 150.63 76.85 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.458 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.34 -22.18 70.05 Favored 'Trans proline' 0 C--O 1.209 -0.928 0 C-N-CA 121.347 1.365 . . . . 0.0 111.302 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.685 HH11 ' CB ' ' A' ' 107' ' ' ASP . 31.4 ptt180 38.29 -158.77 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.995 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.501 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.46 176.66 9.01 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.848 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -150.29 121.65 7.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.912 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 18.2 m-85 -96.58 170.09 9.45 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.952 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.87 155.92 47.0 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.709 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -88.34 154.84 20.07 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.86 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt 60.08 158.59 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.438 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -90.44 69.82 6.93 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.03 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 1.295 ' OE1' ' CE1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -174.26 34.88 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.417 179.999 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 1.295 ' CE1' ' OE1' ' A' ' 100' ' ' GLN . 42.1 p90 39.82 27.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.188 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 100' ' ' GLN . 32.0 t70 -127.53 117.55 22.29 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.947 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 137.57 140.98 4.14 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.991 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.0 OUTLIER -32.73 124.44 0.35 Allowed 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.273 179.987 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.624 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -100.75 158.79 15.7 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.771 -179.875 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.796 HG21 ' O ' ' A' ' 122' ' ' GLY . 18.1 t -118.99 168.32 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.497 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.685 ' CB ' HH11 ' A' ' 92' ' ' ARG . 5.8 p-10 -145.24 143.68 30.38 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.13 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.467 HD22 ' CD2' ' A' ' 121' ' ' TYR . 11.2 mt -140.45 137.34 17.54 Favored Pre-proline 0 N--CA 1.499 1.994 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.944 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.536 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 2.4 Cg_endo -65.68 169.82 12.29 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 C-N-CA 121.522 1.481 . . . . 0.0 111.902 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 1.8 Cg_endo -61.12 142.8 98.05 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.106 1.871 . . . . 0.0 111.468 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.02 -146.6 16.88 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.013 -1.565 . . . . 0.0 111.163 179.881 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.649 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 64.6 mt-30 -137.95 156.36 47.94 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.649 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 10.0 m-85 -145.0 142.97 30.25 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.91 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 114' ' ' THR . 0.7 OUTLIER -94.24 174.03 7.35 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.378 -179.789 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -61.26 -24.05 66.11 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.941 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.3 -45.68 8.89 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.209 -0.996 . . . . 0.0 112.026 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.463 ' O ' ' C ' ' A' ' 118' ' ' LEU . 8.6 tp10 -73.55 -65.21 0.85 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.707 -179.789 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.563 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -33.9 -68.62 0.11 Allowed 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.015 0.822 . . . . 0.0 110.547 179.961 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.507 ' N ' ' CD ' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -44.7 -68.37 0.2 Allowed 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.798 -179.95 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.524 ' HD3' ' H ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -75.07 20.89 0.13 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.159 -1.016 . . . . 0.0 113.249 -179.426 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.467 ' CD2' HD22 ' A' ' 108' ' ' LEU . 15.8 t80 -114.01 -21.0 10.79 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.952 179.848 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.796 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -166.46 -6.01 0.03 OUTLIER Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.318 -1.896 . . . . 0.0 110.764 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.475 ' C ' ' CG ' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -149.93 -134.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.605 -179.959 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.475 ' CG ' ' C ' ' A' ' 123' ' ' ILE . 0.7 OUTLIER -159.64 -173.36 4.09 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.615 179.909 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -58.49 109.51 0.8 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.442 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 128' ' ' ILE . 23.1 t30 63.2 -125.64 0.58 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.905 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 126' ' ' ASN . 10.0 t 39.78 24.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.868 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.491 ' N ' ' O ' ' A' ' 126' ' ' ASN . 3.5 mt -82.21 -71.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.611 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.428 ' OG ' ' C ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 69.91 -147.57 0.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.88 179.819 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 129' ' ' SER . 5.6 m -27.73 127.36 0.07 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.622 -179.862 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.3 t -121.87 136.89 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.843 179.823 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.28 86.69 29.88 Favored Pre-proline 0 C--N 1.302 -1.483 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.307 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.456 ' C ' ' H ' ' A' ' 135' ' ' GLY . 5.6 Cg_exo -59.0 101.49 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 121.105 1.204 . . . . 0.0 111.093 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.501 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 30.6 tp60 -56.63 -0.16 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.208 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . 172.3 -42.98 0.17 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 118.048 -2.025 . . . . 0.0 112.532 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.42 HD12 ' CA ' ' A' ' 92' ' ' ARG . 2.0 mt -92.2 -173.79 3.54 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.771 -1.171 . . . . 0.0 111.38 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.6 126.8 54.84 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 9.3 t -95.1 145.08 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.191 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.466 HG12 ' CZ ' ' A' ' 141' ' ' PHE . 96.2 t -129.77 110.29 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.13 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 140' ' ' LEU . 7.9 mp -89.29 138.26 31.59 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.376 -0.93 . . . . 0.0 113.03 -179.727 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' A' ' 146' ' ' PHE . 53.1 m-85 -120.8 136.23 54.95 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.7 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -73.97 0.12 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.278 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 -64.42 -174.96 0.14 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.201 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 146' ' ' PHE . 2.0 m-20 -84.77 -168.28 2.14 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.769 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.677 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 44.1 m-80 35.9 31.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.021 179.882 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.677 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.0 OUTLIER 58.47 52.93 6.61 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.46 179.981 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 10.3 t -119.59 171.7 8.19 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.333 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.498 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 73.91 -165.63 54.77 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.214 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.411 ' C ' ' CG2' ' A' ' 150' ' ' THR . 1.0 OUTLIER -59.8 170.54 1.11 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.395 179.947 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.411 ' CG2' ' C ' ' A' ' 149' ' ' ASP . 2.2 p -150.19 158.08 43.78 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.593 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.474 HD23 ' C ' ' A' ' 151' ' ' LEU . 2.1 tt -132.24 83.59 54.91 Favored Pre-proline 0 N--CA 1.483 1.214 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.346 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -63.18 104.42 0.41 Allowed 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 121.717 1.611 . . . . 0.0 112.761 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.33 78.77 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.986 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 154' ' ' ASN . 1.8 p-10 -83.64 27.98 0.59 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.394 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.427 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 19.0 t -170.28 -164.15 0.38 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.972 -1.091 . . . . 0.0 111.199 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.427 ' N ' ' OG ' ' A' ' 155' ' ' SER . 1.3 m-20 -79.94 154.89 27.99 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.15 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -165.1 69.98 1.37 Allowed Pre-proline 0 C--N 1.304 -1.391 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.904 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.8 Cg_endo -64.18 23.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.062 1.841 . . . . 0.0 112.579 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.562 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.3 OUTLIER -170.34 143.82 2.41 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.753 179.98 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.9 tp -163.92 -48.15 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.836 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.541 179.961 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.818 0.342 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.496 ' OG1' HD23 ' A' ' 140' ' ' LEU . 1.2 m -61.63 155.01 23.49 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.583 ' OG ' ' N ' ' A' ' 169' ' ' SER . 24.8 p -136.38 -53.73 0.73 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.164 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.583 ' N ' ' OG ' ' A' ' 168' ' ' SER . 20.7 p -127.58 149.98 49.92 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.213 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.516 HD12 ' CD1' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -140.72 -172.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.658 179.95 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.468 ' N ' HG12 ' A' ' 170' ' ' ILE . 43.7 ttt85 -155.05 106.7 2.65 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.062 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -75.38 94.16 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.008 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.305 -1.345 0 CA-C-O 116.326 -1.797 . . . . 0.0 110.754 -179.974 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.629 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.928 0.394 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.478 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 4.8 p30 -177.99 130.82 0.14 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.493 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.752 HG22 HG22 ' A' ' 44' ' ' VAL . 18.6 pt -78.49 160.01 4.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.909 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.3 m -134.99 119.41 17.93 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.476 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -103.36 172.03 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.975 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -133.4 148.81 51.83 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.726 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -37.07 84.59 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.5 -0.88 . . . . 0.0 112.991 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.454 ' C ' ' OG ' ' A' ' 40' ' ' SER . 2.3 m-20 -121.48 173.73 7.21 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.979 -179.893 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.446 ' N ' ' OG ' ' A' ' 40' ' ' SER . 15.6 pt-20 -70.35 -173.87 0.76 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.742 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.557 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 4.8 t70 49.64 48.0 22.05 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.655 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.557 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 54.4 p90 40.65 20.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.424 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 11' ' ' ASP . 12.9 tt0 -97.76 166.14 11.62 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.582 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 92.54 141.56 10.53 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.363 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' GLY . 1.1 tptp -33.97 144.66 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.769 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -110.03 156.42 20.54 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.556 -179.952 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.2 t -145.04 127.2 9.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.264 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -93.07 125.89 37.89 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.059 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.4 mt -119.21 125.09 27.8 Favored Pre-proline 0 N--CA 1.491 1.58 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.455 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.73 167.24 19.82 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 120.932 1.088 . . . . 0.0 111.098 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.8 170.4 10.14 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 121.636 1.558 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.474 ' H ' ' HB ' ' A' ' 84' ' ' VAL . . . 116.65 170.91 15.71 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 119.728 -1.225 . . . . 0.0 111.054 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.875 ' CB ' ' HE ' ' A' ' 83' ' ' ARG . 9.6 p-10 -97.78 128.87 44.72 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.862 ' N ' HH21 ' A' ' 83' ' ' ARG . 27.6 p90 -153.04 178.98 9.11 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.096 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.51 HG22 ' OG ' ' A' ' 81' ' ' SER . 1.5 p -151.1 -159.37 1.02 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.101 -179.809 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.425 ' H ' ' HB ' ' A' ' 25' ' ' THR . 72.0 ttt180 -57.99 -21.73 46.08 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.675 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.19 -69.48 0.29 Allowed 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.828 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 49.0 tt0 -56.83 -45.31 82.43 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.461 -1.296 . . . . 0.0 109.696 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.579 HD23 HD12 ' A' ' 32' ' ' LEU . 20.0 mt -55.92 -41.62 74.84 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.615 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.47 -31.68 56.24 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 118.128 -1.429 . . . . 0.0 108.49 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -72.27 -30.74 65.12 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.611 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.579 HD12 HD23 ' A' ' 29' ' ' LEU . 15.6 mt -79.54 -77.8 0.17 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.718 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.97 -28.21 0.08 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.127 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.469 ' HB ' HD22 ' A' ' 29' ' ' LEU . 6.9 mm -75.54 152.84 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 119.544 -0.863 . . . . 0.0 110.241 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 4.4 pt-20 -178.93 116.69 0.07 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 118.761 -1.175 . . . . 0.0 112.196 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 3.0 t30 68.2 -145.94 0.12 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.76 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.467 ' O ' HG23 ' A' ' 38' ' ' THR . 9.6 p-10 -49.22 95.55 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.394 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.584 ' O ' ' N ' ' A' ' 40' ' ' SER . 2.2 p -157.78 -61.55 0.09 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.653 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.471 ' O ' HG22 ' A' ' 39' ' ' ILE . 72.5 mt -56.72 79.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.979 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 38' ' ' THR . 43.6 t -81.47 -52.62 7.06 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.661 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.61 168.56 9.9 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.58 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -151.33 159.86 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 118.305 -1.358 . . . . 0.0 112.919 -179.89 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.449 ' N ' HG13 ' A' ' 42' ' ' VAL . 43.2 tttm -150.46 113.16 4.74 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.387 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.752 HG22 HG22 ' A' ' 4' ' ' ILE . 76.1 t -134.03 111.88 12.2 Favored Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 119.525 -0.87 . . . . 0.0 112.619 -179.689 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -69.57 169.97 17.44 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 121.145 1.23 . . . . 0.0 110.696 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.96 -175.12 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 121.989 1.793 . . . . 0.0 111.464 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.86 -14.27 10.93 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.569 -1.301 . . . . 0.0 110.622 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.629 HG11 ' CB ' ' A' ' 2' ' ' ALA . 23.2 m -147.46 139.46 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.156 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.457 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -116.76 155.37 29.03 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.639 179.999 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.457 ' N ' ' HG2' ' A' ' 49' ' ' LYS . . . -144.88 154.8 43.01 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.652 -1.219 . . . . 0.0 112.413 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 63' ' ' ILE . 4.1 mp -132.39 121.35 45.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.84 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.53 ' HA ' HG23 ' A' ' 82' ' ' ILE . 3.5 mp -93.95 154.72 17.53 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 118.936 -1.106 . . . . 0.0 112.536 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.426 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 54.0 m-85 -140.24 116.65 10.69 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -46.61 -88.87 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.904 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -59.59 144.0 48.83 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.178 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -54.21 175.64 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.631 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.435 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 63.96 32.62 84.78 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 119.22 -1.467 . . . . 0.0 109.959 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.573 ' H ' ' CB ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 48.64 35.95 6.96 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.678 -179.938 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.78 -163.29 0.97 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.423 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 56.06 -174.0 1.34 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.027 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 62' ' ' GLN . 18.1 t70 -54.47 174.42 0.06 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.697 -1.201 . . . . 0.0 109.949 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.436 ' N ' ' OD1' ' A' ' 61' ' ' ASP . 20.6 pt20 -147.96 161.86 40.49 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.052 -1.059 . . . . 0.0 111.282 -179.883 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.558 ' CG1' HD11 ' A' ' 75' ' ' LEU . 3.9 mt -137.05 160.87 36.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.905 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 64' ' ' GLU . 2.6 mp0 -135.53 127.55 29.68 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.281 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.509 HG12 ' CE1' ' A' ' 121' ' ' TYR . 22.9 m -144.83 162.94 13.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 118.737 -1.185 . . . . 0.0 112.787 -179.796 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.437 ' H ' ' H ' ' A' ' 67' ' ' ALA . 2.1 t -150.04 -7.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.011 -1.449 . . . . 0.0 107.642 179.819 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.437 ' H ' ' H ' ' A' ' 66' ' ' VAL . . . -121.29 -146.35 0.37 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.944 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.409 HD22 ' HG3' ' A' ' 43' ' ' LYS . 36.2 t-20 -101.03 134.55 43.86 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.109 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.466 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -114.89 101.82 9.4 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.046 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -65.27 -77.68 0.06 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.792 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -74.56 -9.77 58.9 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.529 -179.88 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.408 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 6.3 tp 64.98 -79.8 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.065 -179.925 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 172.0 -177.0 44.95 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.111 -1.519 . . . . 0.0 110.626 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.538 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.0 Cg_endo -64.08 -42.44 18.62 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.247 1.965 . . . . 0.0 111.884 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.843 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.0 pt? -70.99 21.51 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.181 -1.007 . . . . 0.0 111.113 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.538 ' H ' ' C ' ' A' ' 74' ' ' PRO . 35.4 p30 -75.79 5.02 6.86 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.652 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -88.85 -2.29 58.52 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.031 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -169.29 128.67 1.03 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.035 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.2 t -149.17 143.24 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.35 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.0 m -155.78 -40.93 0.08 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.22 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.573 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 3.4 m -96.16 136.31 36.8 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.132 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.53 HG23 ' HA ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -150.73 134.1 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 118.79 -1.164 . . . . 0.0 112.185 -179.94 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.875 ' HE ' ' CB ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -110.02 120.08 41.32 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.025 179.877 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.474 ' HB ' ' H ' ' A' ' 22' ' ' GLY . 6.7 t -122.17 130.65 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.514 179.911 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.4 HD13 ' O ' ' A' ' 84' ' ' VAL . 4.6 mm -141.01 130.22 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.665 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 p -48.65 142.1 6.44 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.084 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.597 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -134.47 142.43 42.77 Favored Pre-proline 0 N--CA 1.492 1.638 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.513 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.597 ' HD2' HG22 ' A' ' 87' ' ' VAL . 2.8 Cg_exo -53.62 129.81 35.76 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.133 1.222 . . . . 0.0 110.977 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 p -53.21 134.03 15.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.98 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -140.76 148.45 52.8 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.207 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.422 ' C ' HD11 ' A' ' 136' ' ' LEU . 1.6 Cg_endo -59.92 -167.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.104 1.203 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.412 ' CA ' HD12 ' A' ' 136' ' ' LEU . 24.8 ptt180 -172.88 -155.45 0.08 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.754 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.496 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.15 161.19 38.88 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.232 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -136.2 115.67 12.76 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.149 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 20.0 m-85 -100.29 150.54 22.45 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.897 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.454 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 39.4 m-85 -105.18 170.62 7.77 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.654 -0.819 . . . . 0.0 111.064 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.3 -57.55 2.57 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.919 -1.113 . . . . 0.0 111.988 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -83.06 154.2 24.52 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.377 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.604 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 30.3 tt0 -68.55 104.58 1.98 Allowed 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.03 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.604 ' CB ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 119.18 68.55 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.441 0 O-C-N 125.323 1.64 . . . . 0.0 110.918 179.755 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 101' ' ' PHE . 33.2 p90 29.63 55.61 0.14 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.318 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.523 ' CG ' ' N ' ' A' ' 103' ' ' GLY . 4.5 t70 -144.57 170.52 15.91 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.706 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.523 ' N ' ' CG ' ' A' ' 102' ' ' ASP . . . 78.93 145.15 2.94 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 118.886 -1.626 . . . . 0.0 109.881 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 103' ' ' GLY . 5.0 tmtt? -28.76 131.24 0.06 Allowed 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 121.195 0.522 . . . . 0.0 112.106 -179.816 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -95.7 157.34 15.94 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.311 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.765 HG21 ' O ' ' A' ' 122' ' ' GLY . 1.7 t -142.65 150.68 18.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.533 179.875 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 22.3 p-10 -130.9 159.28 37.86 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.806 -179.873 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.414 HD22 ' CD2' ' A' ' 121' ' ' TYR . 86.2 mt -141.77 151.18 59.22 Favored Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.144 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -78.96 167.37 22.14 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.976 1.784 . . . . 0.0 111.05 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.18 142.97 69.44 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 C-N-CA 121.4 1.4 . . . . 0.0 110.757 179.822 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.39 -157.23 26.06 Favored Glycine 0 N--CA 1.504 3.202 0 C-N-CA 119.021 -1.561 . . . . 0.0 111.572 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.504 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 49.7 mt-30 -116.12 158.79 22.67 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.141 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.504 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 79.2 m-85 -145.82 143.23 29.52 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.629 179.839 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.1 p -95.91 164.71 12.61 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.807 -179.718 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.412 ' NE2' ' O ' ' A' ' 115' ' ' GLN . 12.3 tm0? -58.97 -8.07 1.28 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.719 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.94 -48.68 3.56 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.347 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 118' ' ' LEU . 4.5 tp10 -70.34 -50.27 40.8 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.834 -179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.565 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -40.62 -72.83 0.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.368 -179.916 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -55.95 10.03 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.041 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.443 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.5 OUTLIER -73.81 15.11 0.31 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.54 -179.716 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.509 ' CE1' HG12 ' A' ' 65' ' ' VAL . 16.8 t80 -126.77 -10.36 6.11 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.355 179.822 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -140.78 -48.49 0.05 OUTLIER Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.208 -1.472 . . . . 0.0 110.218 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.566 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -144.58 -97.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.664 -179.937 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.566 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 3.0 t70 -171.78 175.72 3.86 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -66.28 134.88 53.56 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.31 -179.871 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 61.9 t30 52.24 94.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.602 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.7 t -174.01 -12.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.457 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 129' ' ' SER . 4.2 mm -73.53 163.27 4.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.17 -179.886 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.436 ' N ' HG22 ' A' ' 128' ' ' ILE . 29.9 t -169.83 -48.24 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.45 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.474 ' CB ' ' H ' ' A' ' 101' ' ' PHE . 49.7 m -122.93 127.61 49.15 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.044 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.443 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.5 t -120.54 159.63 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.569 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.58 79.31 8.05 Favored Pre-proline 0 C--N 1.296 -1.731 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.746 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -53.21 96.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.215 1.277 . . . . 0.0 110.703 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.496 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 58.2 tp60 -45.91 -23.74 0.32 Allowed 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.54 -1.209 . . . . 0.0 113.064 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.91 -31.88 0.02 OUTLIER Glycine 0 N--CA 1.494 2.515 0 C-N-CA 117.738 -2.172 . . . . 0.0 112.942 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.422 HD11 ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -98.66 179.4 4.69 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.659 -1.216 . . . . 0.0 111.161 -179.895 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -94.93 144.26 25.82 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.042 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 153' ' ' VAL . 7.5 t -115.54 147.97 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.849 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.485 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.3 t -136.53 129.3 45.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.897 179.842 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.485 HD12 ' C ' ' A' ' 139' ' ' VAL . 10.8 mp -105.64 138.7 41.4 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.369 -0.932 . . . . 0.0 113.174 -179.766 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 146' ' ' PHE . 18.0 m-85 -117.39 121.59 41.49 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.778 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -63.44 -68.29 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.165 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -73.2 165.55 24.84 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.376 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.512 ' C ' ' ND2' ' A' ' 145' ' ' ASN . 16.7 m-20 -64.37 -157.82 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.796 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.643 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 1.9 p30 32.0 35.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.216 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.643 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 2.0 p90 41.04 61.61 1.69 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.787 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 35.9 t -143.59 -176.22 4.87 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.121 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.531 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 75.87 -163.43 53.4 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.064 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 149' ' ' ASP . 1.4 m-20 -60.08 144.88 48.52 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.314 179.878 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.4 p -141.29 175.42 9.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.159 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.51 ' CD2' HD21 ' A' ' 160' ' ' LEU . 24.8 tp -152.78 95.05 3.08 Favored Pre-proline 0 C--N 1.305 -1.364 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.044 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.87 107.48 1.11 Allowed 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 121.385 1.39 . . . . 0.0 112.075 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 138' ' ' VAL . 47.0 t -79.08 91.28 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.145 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -44.33 -49.2 9.6 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.565 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.5 m -160.15 -133.9 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 118.728 -1.189 . . . . 0.0 111.923 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -48.05 137.61 10.17 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.119 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.536 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.36 63.96 1.13 Allowed Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.238 179.814 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.9 Cg_endo -67.08 24.83 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.126 1.884 . . . . 0.0 111.837 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.536 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.6 t -175.1 132.82 0.31 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.785 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.51 HD21 ' CD2' ' A' ' 151' ' ' LEU . 1.6 tp -165.23 -59.23 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.34 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.139 0 C-N-CA 119.164 -1.493 . . . . 0.0 110.317 -179.979 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.5 t30 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -70.32 119.22 14.17 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.743 -1.183 . . . . 0.0 109.269 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 72.4 m -89.08 -80.02 0.31 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.96 -179.819 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 p -108.87 160.75 15.74 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.225 -179.803 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 27.8 pt -139.67 173.18 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.729 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -152.47 110.16 3.61 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.2 mt -87.47 93.29 4.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.236 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 69.4 m . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 116.363 -1.78 . . . . 0.0 110.963 -179.971 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 121.04 0.447 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -159.98 123.99 3.72 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.429 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.403 HG22 HG22 ' A' ' 44' ' ' VAL . 40.3 pt -76.72 149.24 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.594 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.4 m -136.98 118.28 14.6 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.733 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.485 ' HB ' HG23 ' A' ' 39' ' ' ILE . 1.6 m -109.63 160.59 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.672 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.407 ' CE2' ' CD2' ' A' ' 12' ' ' PHE . 56.0 m-85 -115.98 162.06 17.94 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.304 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -87.44 3.8 45.74 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.638 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.483 ' N ' ' HB3' ' A' ' 40' ' ' SER . 15.2 m120 -147.27 168.25 22.22 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.502 -1.279 . . . . 0.0 111.809 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.74 177.14 1.72 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.224 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 13' ' ' GLN . 6.6 t70 56.2 39.56 30.25 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.893 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.574 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER 56.17 -3.43 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.137 179.957 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.596 ' H ' ' C ' ' A' ' 11' ' ' ASP . 45.9 tt0 -80.73 172.66 13.47 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.269 -0.973 . . . . 0.0 111.241 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.583 ' N ' ' CG ' ' A' ' 13' ' ' GLN . . . 100.55 141.93 12.51 Favored Glycine 0 N--CA 1.5 2.94 0 C-N-CA 119.877 -1.154 . . . . 0.0 110.548 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -33.41 140.56 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 120.191 -0.603 . . . . 0.0 111.432 179.96 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -98.5 157.9 15.93 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.392 -179.788 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.5 t -148.75 118.5 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.731 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -92.54 132.75 36.57 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.734 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -132.46 137.46 29.96 Favored Pre-proline 0 N--CA 1.49 1.56 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.909 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -72.1 166.27 30.15 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 120.843 1.029 . . . . 0.0 110.789 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.23 -163.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 121.628 1.552 . . . . 0.0 110.63 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.71 176.19 39.87 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.129 -1.51 . . . . 0.0 111.366 179.87 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.432 ' CB ' ' HG3' ' A' ' 83' ' ' ARG . 13.2 p-10 -107.75 132.66 53.13 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.496 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.705 ' OH ' HD12 ' A' ' 82' ' ' ILE . 35.7 p90 -154.7 -177.96 6.86 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.502 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.964 HG23 ' H ' ' A' ' 27' ' ' ALA . 8.3 t -151.95 -161.23 1.27 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.337 -179.721 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.533 ' N ' ' OG1' ' A' ' 25' ' ' THR . 0.1 OUTLIER -54.96 -15.5 2.06 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.065 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.964 ' H ' HG23 ' A' ' 25' ' ' THR . . . -69.23 -64.59 0.84 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.563 179.849 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.551 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 19.9 tt0 -57.83 -42.12 83.68 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 117.964 -1.495 . . . . 0.0 109.567 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.6 mt -63.68 -37.57 87.83 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.301 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 26' ' ' ARG . . . -56.26 -27.29 54.68 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 118.112 -1.435 . . . . 0.0 107.785 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -73.84 -36.21 64.88 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.95 179.795 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.6 mt -75.97 -70.51 0.43 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.512 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.21 -24.9 0.6 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.055 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.6 tt -80.44 156.61 4.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.546 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -147.82 -179.62 7.03 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.068 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 6.8 p-10 -47.95 169.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.795 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.642 ' H ' ' H ' ' A' ' 79' ' ' VAL . 2.8 t-20 78.25 -23.85 0.23 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.939 179.867 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 80.6 p -85.66 -139.66 0.08 Allowed 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.861 -1.135 . . . . 0.0 110.789 179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.485 HG23 ' HB ' ' A' ' 6' ' ' VAL . 43.5 mt 41.81 62.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.93 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.483 ' HB3' ' N ' ' A' ' 9' ' ' ASN . 32.4 t -62.32 -44.43 96.52 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.868 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -129.09 176.95 7.49 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.11 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -144.29 146.74 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 119.025 -1.07 . . . . 0.0 112.197 -179.966 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -132.79 118.65 19.28 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.753 179.829 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.403 HG22 HG22 ' A' ' 4' ' ' ILE . 69.7 t -146.55 107.82 4.1 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.049 -1.06 . . . . 0.0 112.293 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.418 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 2.0 Cg_endo -66.79 170.89 11.84 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 121.245 1.296 . . . . 0.0 110.719 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.418 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 2.9 Cg_endo -59.54 -167.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.851 1.7 . . . . 0.0 110.922 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.93 -9.71 23.14 Favored Glycine 0 N--CA 1.48 1.609 0 C-N-CA 118.905 -1.617 . . . . 0.0 110.915 179.798 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.67 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -155.72 151.87 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 118.279 -1.368 . . . . 0.0 112.407 179.972 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -117.92 125.28 50.17 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.883 179.794 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.53 158.26 17.72 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.807 -179.739 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.585 ' C ' HD12 ' A' ' 52' ' ' LEU . 51.9 mt -145.43 123.25 4.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.482 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.904 ' N ' HD12 ' A' ' 52' ' ' LEU . 2.4 mp -95.37 165.79 12.2 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.712 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -142.33 105.14 4.54 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.882 179.853 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -43.57 -84.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.775 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -58.9 133.57 56.15 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.502 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -54.47 171.82 0.11 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.423 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.25 29.93 71.83 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.205 -1.474 . . . . 0.0 110.06 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 53.66 63.22 2.28 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.031 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.13 -177.77 6.01 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.21 168.16 13.37 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.439 -1.363 . . . . 0.0 110.22 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -47.26 144.27 2.88 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.94 -1.104 . . . . 0.0 110.145 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -121.48 163.26 19.1 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.175 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.798 HD11 HD21 ' A' ' 75' ' ' LEU . 9.6 mm -125.26 174.46 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.5 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.709 ' N ' HG22 ' A' ' 63' ' ' ILE . 20.1 mt-10 -146.44 130.6 17.43 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.751 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.4 m -149.18 163.24 4.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.816 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.67 HG13 ' O ' ' A' ' 48' ' ' VAL . 3.3 t -146.76 -8.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.826 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.74 -147.2 0.39 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.103 179.768 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.484 ' ND2' ' H ' ' A' ' 68' ' ' ASN . 1.9 p30 -103.03 113.39 26.83 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.943 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.487 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.52 94.68 9.96 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.125 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -54.29 -63.08 1.27 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.141 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' A' ' 73' ' ' GLY . 6.5 tp10 -103.96 99.48 9.24 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.906 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 tp -52.34 -5.86 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.979 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 71' ' ' GLU . . . 78.34 -149.09 33.39 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 118.94 -1.6 . . . . 0.0 110.464 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 76' ' ' ASN . 3.4 Cg_exo -63.53 -151.68 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 121.505 1.47 . . . . 0.0 111.658 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.798 HD21 HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER 30.34 35.04 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 123.964 0.79 . . . . 0.0 112.06 -179.942 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 74' ' ' PRO . 13.5 t-20 -89.31 -3.93 58.31 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.286 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -93.03 3.92 54.9 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.964 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.451 ' HA ' ' H ' ' A' ' 37' ' ' ASN . 17.1 t-20 -162.53 109.67 1.28 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.743 -1.183 . . . . 0.0 111.444 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.642 ' H ' ' H ' ' A' ' 37' ' ' ASN . 7.1 t -147.96 92.82 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.149 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.8 t -121.07 -33.24 3.76 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.547 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.0 m -92.31 136.29 33.32 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.739 -1.185 . . . . 0.0 110.9 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.705 HD12 ' OH ' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -150.98 158.8 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 118.262 -1.375 . . . . 0.0 111.656 -179.857 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.794 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.45 140.11 23.65 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.637 -179.922 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.794 ' CA ' HH12 ' A' ' 83' ' ' ARG . 16.1 t -144.99 146.38 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.684 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.552 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 1.5 mt -144.58 135.47 20.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.492 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.4 m -44.74 161.5 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.899 -0.721 . . . . 0.0 111.544 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.533 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -162.01 140.58 7.03 Favored Pre-proline 0 N--CA 1.483 1.18 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.209 -179.986 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.533 ' HD2' HG22 ' A' ' 87' ' ' VAL . 12.5 Cg_exo -47.38 139.53 16.71 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.116 1.211 . . . . 0.0 110.775 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.574 HG22 ' N ' ' A' ' 90' ' ' GLN . 3.8 p -74.99 160.79 5.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.661 -0.816 . . . . 0.0 112.353 -179.839 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.574 ' N ' HG22 ' A' ' 89' ' ' VAL . 23.1 mp0 -141.06 154.87 68.6 Favored Pre-proline 0 N--CA 1.49 1.534 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.405 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.428 ' HG2' HD21 ' A' ' 136' ' ' LEU . 1.9 Cg_endo -64.3 -45.37 9.75 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 121.47 1.447 . . . . 0.0 111.739 179.829 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.493 ' H ' HD11 ' A' ' 136' ' ' LEU . 9.9 mtm180 64.7 -160.73 0.29 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.265 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.527 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.96 172.77 12.25 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.65 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -142.49 121.38 12.77 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.544 -1.262 . . . . 0.0 112.547 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -103.57 162.77 12.77 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.774 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -124.59 163.73 21.32 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.528 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.57 -77.41 0.22 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.149 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.483 ' C ' ' OG ' ' A' ' 129' ' ' SER . 34.3 mmtt -66.09 154.41 39.67 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.737 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.627 ' C ' ' HG2' ' A' ' 100' ' ' GLN . 29.0 tt0 -81.71 86.69 6.38 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.118 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.627 ' HG2' ' C ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 163.56 35.68 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.297 -179.946 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.7 t80 56.13 42.38 28.33 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 119.634 -0.827 . . . . 0.0 110.488 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 103' ' ' GLY . 25.1 t0 -143.14 178.36 7.76 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.565 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 81.58 139.24 2.73 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.157 -1.496 . . . . 0.0 109.724 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 103' ' ' GLY . 1.1 mppt? -28.63 132.91 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.729 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -97.8 159.33 14.99 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.106 -179.8 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 53.4 t -144.3 116.05 2.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.115 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -104.72 154.73 19.62 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.413 -179.704 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.9 mt -139.64 138.13 19.67 Favored Pre-proline 0 N--CA 1.492 1.675 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.436 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.72 168.77 12.66 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 121.237 1.291 . . . . 0.0 110.998 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.08 150.31 87.04 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.655 1.57 . . . . 0.0 111.06 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.04 -155.04 24.24 Favored Glycine 0 N--CA 1.498 2.817 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.969 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.601 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 6.6 tt0 -133.48 158.35 43.31 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.699 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.601 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 30.2 m-85 -142.51 155.1 45.0 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.185 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.2 p -102.91 -175.38 2.79 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.017 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.446 ' N ' ' OE1' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -88.1 53.89 2.9 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.686 179.977 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -152.12 -65.88 0.17 Allowed 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.593 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -72.61 -50.18 27.08 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.343 -0.943 . . . . 0.0 109.467 179.963 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.564 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -33.81 -71.73 0.06 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.897 179.962 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.535 ' OE2' ' CZ ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -52.27 -57.63 9.14 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.103 179.923 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.535 ' CZ ' ' OE2' ' A' ' 119' ' ' GLU . 3.3 mpt_? -76.36 23.07 0.15 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.92 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.564 ' N ' ' O ' ' A' ' 117' ' ' GLU . 24.7 t80 -127.11 -17.06 4.9 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.659 179.993 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.06 -42.6 0.03 OUTLIER Glycine 0 N--CA 1.482 1.705 0 C-N-CA 118.74 -1.695 . . . . 0.0 111.118 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.574 HG13 HD11 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -135.8 -105.7 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.225 -179.93 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 18.6 t70 -171.72 -168.45 0.59 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.77 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.491 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 52.9 p-10 -86.03 35.14 0.63 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.45 -179.9 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.405 ' C ' HG22 ' A' ' 127' ' ' THR . 5.5 p30 -166.48 -155.0 0.19 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.532 -1.267 . . . . 0.0 112.133 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.571 ' OG1' ' N ' ' A' ' 128' ' ' ILE . 2.6 t 40.31 -125.96 0.44 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.267 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.574 HD11 HG13 ' A' ' 123' ' ' ILE . 98.2 mt 60.67 118.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 CA-C-O 121.041 0.448 . . . . 0.0 111.209 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.483 ' OG ' ' C ' ' A' ' 98' ' ' LYS . 59.2 p -160.99 140.85 10.84 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.419 -0.913 . . . . 0.0 111.124 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 67.92 113.16 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.965 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.0 t -120.27 149.85 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.732 -179.795 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.547 ' NZ ' ' OD2' ' A' ' 156' ' ' ASP . 13.1 tptp -142.4 93.66 7.03 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.793 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 135' ' ' GLY . 4.1 Cg_exo -59.37 99.75 0.12 Allowed 'Trans proline' 0 C--N 1.32 -0.942 0 C-N-CA 120.959 1.106 . . . . 0.0 111.474 -179.799 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.527 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 37.5 tt0 -47.43 -14.23 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.074 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 133' ' ' PRO . . . 175.56 -34.02 0.09 OUTLIER Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.467 -1.825 . . . . 0.0 111.936 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.493 HD11 ' H ' ' A' ' 92' ' ' ARG . 2.2 mt -93.13 -173.82 3.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.664 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.22 144.15 36.06 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.746 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.5 t -112.8 143.56 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.962 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.4 ' C ' HD12 ' A' ' 140' ' ' LEU . 91.3 t -135.39 122.3 34.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.91 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 140' ' ' LEU . 10.1 mp -99.75 144.79 28.41 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.761 -179.802 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.492 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 21.9 m-85 -120.47 129.47 53.87 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.101 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -73.72 -63.15 1.27 Allowed 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.144 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -71.32 170.95 12.05 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.608 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 146' ' ' PHE . 47.7 m-20 -67.73 -161.41 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.254 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.641 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 2.2 p30 28.96 38.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.371 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.641 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 41.69 61.51 1.85 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.982 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.52 -167.7 2.32 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.353 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 65.02 -160.4 42.44 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.706 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.55 158.72 9.37 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.301 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.4 p -148.55 170.69 17.51 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.979 -1.088 . . . . 0.0 111.818 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 151' ' ' LEU . 23.4 tp -138.9 85.0 16.79 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.315 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -61.74 105.77 0.39 Allowed 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.922 1.748 . . . . 0.0 113.049 -179.85 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.467 ' C ' ' H ' ' A' ' 155' ' ' SER . 2.0 t -95.09 57.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.758 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -70.54 32.85 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.819 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 153' ' ' VAL . 21.0 p -170.65 -169.06 0.75 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.705 -1.198 . . . . 0.0 111.605 180.0 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.547 ' OD2' ' NZ ' ' A' ' 132' ' ' LYS . 1.3 m-20 -75.86 153.23 36.93 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.556 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.532 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -168.65 72.17 0.79 Allowed Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.935 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.93 24.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.057 1.838 . . . . 0.0 112.385 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.9 OUTLIER -170.61 68.23 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.633 179.925 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.8 tp -80.76 -64.19 1.24 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.905 0 C-N-CA 119.136 -1.507 . . . . 0.0 109.863 -179.983 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 121.082 0.467 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.7 124.31 20.96 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.949 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 169' ' ' SER . 57.3 p -86.18 -68.58 0.73 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.697 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.426 ' N ' ' OG ' ' A' ' 168' ' ' SER . 2.0 p -119.44 161.93 19.7 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.416 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 29.0 pt -141.01 171.59 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.199 -1.001 . . . . 0.0 111.649 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -153.21 110.92 3.56 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.76 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -89.17 92.92 4.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.107 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 116.313 -1.803 . . . . 0.0 111.088 -179.904 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.792 0.33 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 0.3 OUTLIER 179.77 130.8 0.09 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.489 -179.906 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.665 HG22 HG22 ' A' ' 44' ' ' VAL . 2.9 pt -82.53 128.75 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.585 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.7 m -100.22 113.32 25.91 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.561 -0.856 . . . . 0.0 108.74 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.518 HG11 HD11 ' A' ' 19' ' ' LEU . 1.5 m -96.83 160.06 2.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.196 -1.002 . . . . 0.0 113.436 -179.688 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' A' ' 12' ' ' PHE . 87.9 m-85 -118.46 144.86 45.69 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.754 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -58.05 3.59 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.634 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 87.8 m-20 -85.52 -176.41 6.07 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.614 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -75.99 176.73 7.64 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.343 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.582 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 1.5 m-20 48.68 56.61 7.37 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.695 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 55.8 p90 40.19 20.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.23 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 11' ' ' ASP . 2.5 tp-100 -98.31 164.37 12.33 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.874 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.634 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 94.18 148.27 23.61 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.802 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.567 ' HE3' ' H ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -29.09 137.74 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.882 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.434 ' H ' ' HG3' ' A' ' 16' ' ' GLN . 1.3 pp0? -104.63 152.26 22.67 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.424 -179.889 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.1 t -149.42 138.79 15.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.884 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 1.1 m-20 -99.78 134.86 42.07 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.245 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.518 HD11 HG11 ' A' ' 6' ' ' VAL . 6.4 mt -123.89 122.57 26.3 Favored Pre-proline 0 N--CA 1.496 1.851 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.263 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.33 161.76 39.24 Favored 'Trans proline' 0 C--O 1.217 -0.533 0 C-N-CA 121.022 1.148 . . . . 0.0 111.247 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.54 -166.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.889 0 C-N-CA 121.602 1.534 . . . . 0.0 110.738 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.465 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 92.77 -163.59 27.18 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.989 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.496 ' HB3' HH11 ' A' ' 83' ' ' ARG . 16.7 p-10 -117.96 133.22 56.13 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.432 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.614 ' CE2' HD12 ' A' ' 82' ' ' ILE . 6.1 p90 -154.78 177.65 11.02 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.404 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.422 HG22 ' OG ' ' A' ' 81' ' ' SER . 14.3 p -149.51 -150.12 0.33 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.415 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.5 mtm-85 -62.82 -36.66 83.91 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.301 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -56.79 -61.51 2.38 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.44 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.449 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.7 tp60 -56.02 -47.67 77.37 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.325 -1.35 . . . . 0.0 109.367 -179.902 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 29' ' ' LEU . 90.1 mt -57.87 -33.49 68.74 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.39 179.839 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -54.0 -33.02 55.99 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.86 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -70.4 -36.09 73.85 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.18 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.401 HD12 HD23 ' A' ' 29' ' ' LEU . 11.9 mt -78.48 -75.26 0.23 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.727 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 163.7 -29.47 0.24 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 118.898 -1.62 . . . . 0.0 111.244 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -73.99 166.12 2.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.761 179.971 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.898 ' H ' HG21 ' A' ' 38' ' ' THR . 0.2 OUTLIER 174.66 103.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.403 179.946 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.804 ' O ' HG23 ' A' ' 38' ' ' THR . 12.2 t30 69.23 140.61 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.401 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 1.6 p-10 37.39 21.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.39 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.898 HG21 ' H ' ' A' ' 35' ' ' GLU . 40.9 p -93.95 -48.06 6.43 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.542 -1.263 . . . . 0.0 110.963 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 mt -62.6 74.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.148 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' THR . 26.8 t -72.06 -49.82 33.44 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.122 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.34 163.98 28.79 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.246 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.137 HG22 ' HB3' ' A' ' 69' ' ' ALA . 25.1 m -148.94 167.82 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 C-N-CA 118.194 -1.402 . . . . 0.0 113.295 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -139.76 97.96 3.37 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 113.671 -1.604 . . . . 0.0 107.981 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.665 HG22 HG22 ' A' ' 4' ' ' ILE . 44.5 t -116.46 109.54 43.83 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.797 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.83 169.11 16.9 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 121.227 1.284 . . . . 0.0 110.507 179.726 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.02 -172.44 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.708 1.605 . . . . 0.0 110.368 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.36 -15.37 35.02 Favored Glycine 0 C--N 1.3 -1.428 0 C-N-CA 118.654 -1.736 . . . . 0.0 110.486 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.722 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -148.53 151.76 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.951 179.938 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -127.17 126.23 42.5 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.869 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.16 160.34 17.02 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.873 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.524 ' C ' HD12 ' A' ' 52' ' ' LEU . 62.4 mt -139.92 121.48 15.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.726 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.826 ' N ' HD12 ' A' ' 52' ' ' LEU . 1.8 mp -90.17 159.8 16.57 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.927 -1.109 . . . . 0.0 112.584 -179.697 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -144.73 106.33 4.26 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.863 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -44.47 -81.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.298 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -58.87 138.2 57.43 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.544 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -54.92 173.39 0.09 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.439 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.31 27.69 72.72 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.184 -1.484 . . . . 0.0 110.156 -179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 55.13 67.91 0.94 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.8 -165.52 2.28 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.235 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.72 -170.01 14.35 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.021 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -51.34 167.89 0.08 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.818 -1.153 . . . . 0.0 109.805 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -147.03 162.71 38.24 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.477 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.93 HD11 HD21 ' A' ' 75' ' ' LEU . 32.1 mt -142.23 173.61 7.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.944 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.736 ' H ' HG22 ' A' ' 63' ' ' ILE . 2.0 tm-20 -146.44 129.71 16.66 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.778 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.536 ' N ' ' OE2' ' A' ' 64' ' ' GLU . 32.2 m -145.64 158.02 12.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 118.629 -1.229 . . . . 0.0 112.465 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' ' 48' ' ' VAL . 3.8 t -146.61 -7.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-N 114.312 -1.313 . . . . 0.0 107.783 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.418 ' H ' ' H ' ' A' ' 66' ' ' VAL . . . -117.13 -151.15 0.47 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.557 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -97.09 122.81 40.51 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.455 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.137 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -89.81 113.46 25.03 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.1 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.465 ' C ' ' CD ' ' A' ' 70' ' ' GLU . 4.1 tp10 -72.33 -70.84 0.32 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.582 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.441 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 12.1 tt0 -96.69 -0.2 48.72 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.223 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.4 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 2.5 tp 69.74 -88.26 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.042 -0.663 . . . . 0.0 112.17 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.4 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 179.33 -162.08 28.61 Favored Glycine 0 N--CA 1.499 2.885 0 C-N-CA 118.99 -1.576 . . . . 0.0 111.086 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.46 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.2 Cg_endo -66.88 -49.84 1.34 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.168 1.912 . . . . 0.0 112.159 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.043 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.7 pt? -74.65 33.52 0.09 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.419 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.46 ' H ' ' C ' ' A' ' 74' ' ' PRO . 21.8 p30 -70.28 -23.89 62.95 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.276 -0.97 . . . . 0.0 110.548 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -80.84 14.43 2.19 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.902 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -168.51 108.48 0.51 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.364 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.5 t -146.44 106.07 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.132 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.7 t -124.73 -44.66 1.94 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.679 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.422 ' OG ' HG22 ' A' ' 25' ' ' THR . 3.4 m -94.5 138.86 31.9 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.597 -179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.614 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -146.94 152.03 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 119.069 -1.053 . . . . 0.0 111.873 -179.971 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.854 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -130.09 123.24 29.97 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.272 -179.908 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.854 ' H ' HH12 ' A' ' 83' ' ' ARG . 13.3 t -136.01 137.75 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.59 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.54 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 1.4 mt -145.52 142.96 22.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.784 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.4 p -43.99 160.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.809 -0.756 . . . . 0.0 111.746 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -159.09 148.74 14.89 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.128 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -57.64 157.71 22.35 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.045 1.163 . . . . 0.0 110.067 179.735 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.567 HG12 ' N ' ' A' ' 90' ' ' GLN . 86.8 t -78.85 159.73 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.722 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.567 ' N ' HG12 ' A' ' 89' ' ' VAL . 30.0 mt-30 -143.41 145.63 32.71 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.607 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.4 ' HG2' HD21 ' A' ' 136' ' ' LEU . 3.6 Cg_exo -65.3 -48.94 2.92 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 121.377 1.385 . . . . 0.0 111.854 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.515 ' H ' HD11 ' A' ' 136' ' ' LEU . 0.0 OUTLIER 64.81 -156.02 0.29 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.939 179.984 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.525 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -141.73 178.13 7.69 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.717 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -142.08 113.31 7.6 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.931 -1.107 . . . . 0.0 111.412 -179.852 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.682 ' CD2' HG13 ' A' ' 131' ' ' VAL . 96.8 m-85 -106.53 146.63 30.38 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.471 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -95.69 171.87 8.4 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.386 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.48 -66.86 0.87 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.889 -179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -86.47 147.28 26.05 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.488 -0.885 . . . . 0.0 112.442 -179.778 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.585 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 5.8 tm-20 -71.51 101.43 2.45 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.262 -179.907 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.585 ' CB ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 135.7 53.09 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.059 0 O-C-N 125.099 1.499 . . . . 0.0 109.94 179.891 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.504 ' O ' ' CG ' ' A' ' 101' ' ' PHE . 58.8 t80 43.12 52.54 5.43 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.689 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 103' ' ' GLY . 3.2 t70 -145.38 158.35 43.85 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.062 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.524 ' N ' ' OD1' ' A' ' 102' ' ' ASP . . . 85.16 133.29 2.85 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.87 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 103' ' ' GLY . 8.6 mtpm? -35.17 146.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.178 0.513 . . . . 0.0 111.813 -179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -90.96 164.28 14.05 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.215 -179.885 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.0 t -145.79 112.49 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.941 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -89.99 159.64 16.78 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.264 -0.975 . . . . 0.0 112.576 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.9 mt -143.93 131.39 10.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.986 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -66.82 168.66 16.38 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 121.36 1.374 . . . . 0.0 111.441 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.2 145.19 88.58 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 121.557 1.505 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.4 -171.87 24.1 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.137 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.596 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 16.7 tm0? -109.18 159.89 16.55 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.596 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 52.9 m-85 -146.18 148.66 32.77 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.441 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.6 p -102.25 170.99 7.74 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.423 -179.849 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -60.29 -8.92 2.88 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.604 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.38 -52.17 3.07 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 119.314 -0.954 . . . . 0.0 113.437 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 121' ' ' TYR . 23.9 mt-10 -72.79 -53.07 12.53 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.3 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.569 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -36.61 -67.48 0.17 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.807 0.813 . . . . 0.0 110.593 179.906 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 28.2 mp0 -52.35 -60.86 2.72 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.13 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.475 ' HD3' ' H ' ' A' ' 120' ' ' ARG . 4.9 mpt_? -72.13 4.89 3.13 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.792 -179.634 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 117' ' ' GLU . 14.3 t80 -105.34 -16.28 14.8 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.973 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -151.36 -36.36 0.03 OUTLIER Glycine 0 N--CA 1.487 2.063 0 C-N-CA 117.684 -2.198 . . . . 0.0 112.141 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.99 -102.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.979 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 176.42 -173.91 0.1 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.975 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.505 ' C ' ' CG ' ' A' ' 126' ' ' ASN . 4.6 t-20 -58.55 125.87 25.22 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.594 -1.243 . . . . 0.0 110.281 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.599 ' C ' HG23 ' A' ' 127' ' ' THR . 0.3 OUTLIER 74.34 -139.02 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.967 -179.893 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.635 ' OG1' ' N ' ' A' ' 128' ' ' ILE . 1.4 p 59.28 -137.95 0.76 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.586 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.635 ' N ' ' OG1' ' A' ' 127' ' ' THR . 39.4 mt 59.37 -74.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.763 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 130' ' ' SER . 60.3 p 47.71 -123.41 1.55 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.239 -0.585 . . . . 0.0 112.335 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.552 ' N ' ' OG ' ' A' ' 129' ' ' SER . 0.8 OUTLIER -41.88 126.68 3.19 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.004 -179.847 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.682 HG13 ' CD2' ' A' ' 95' ' ' PHE . 6.8 t -122.42 156.71 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.262 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.404 ' N ' HG12 ' A' ' 131' ' ' VAL . 1.5 ttmp? -150.39 84.46 5.65 Favored Pre-proline 0 C--N 1.296 -1.749 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.998 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.47 103.8 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.985 1.79 . . . . 0.0 111.706 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.525 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 52.1 tp60 -49.25 -30.6 7.41 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.215 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -169.91 -26.31 0.02 OUTLIER Glycine 0 N--CA 1.494 2.503 0 C-N-CA 118.407 -1.854 . . . . 0.0 112.322 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.515 HD11 ' H ' ' A' ' 92' ' ' ARG . 1.4 mt -96.57 165.02 12.36 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.492 -1.283 . . . . 0.0 110.425 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.86 143.72 26.44 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.464 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.3 t -110.05 148.49 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.654 -0.819 . . . . 0.0 112.616 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.497 ' C ' HD12 ' A' ' 140' ' ' LEU . 46.8 t -137.37 125.54 32.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.926 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 139' ' ' VAL . 8.8 mp -102.32 144.84 30.31 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.707 -179.745 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -117.75 131.38 56.61 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.544 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.543 ' NZ ' ' OD1' ' A' ' 143' ' ' ASN . 26.3 ttpp -67.85 -79.24 0.05 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.554 -179.739 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.543 ' OD1' ' NZ ' ' A' ' 142' ' ' LYS . 7.9 m-20 -51.92 166.03 0.17 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.19 -179.884 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -46.82 -100.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.893 -1.048 . . . . 0.0 113.264 -179.879 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.606 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 5.8 m120 -73.18 75.65 1.28 Allowed 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.578 -179.854 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.606 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.2 p90 34.22 72.47 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.358 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.401 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 61.0 m -141.5 64.67 1.4 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.719 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 171.77 -148.59 11.06 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.294 -1.432 . . . . 0.0 110.35 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -75.53 168.49 19.91 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.293 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.3 p -146.98 155.39 42.22 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.616 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.427 ' HA ' HD12 ' A' ' 151' ' ' LEU . 35.4 tp -123.79 90.93 50.21 Favored Pre-proline 0 N--CA 1.488 1.468 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.59 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.11 108.02 0.89 Allowed 'Trans proline' 0 C--N 1.321 -0.875 0 C-N-CA 121.738 1.625 . . . . 0.0 112.855 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 45.5 t -84.88 88.16 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.452 179.877 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.494 ' C ' ' OG ' ' A' ' 155' ' ' SER . 18.8 p-10 -52.28 -33.82 43.77 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.792 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.494 ' OG ' ' C ' ' A' ' 154' ' ' ASN . 0.8 OUTLIER -163.82 -130.93 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 117.867 -1.533 . . . . 0.0 113.232 -179.699 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -59.73 153.4 20.45 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.299 -179.83 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.603 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -176.06 69.91 0.25 Allowed Pre-proline 0 N--CA 1.48 1.061 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.657 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.76 20.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.039 1.826 . . . . 0.0 112.184 -179.847 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.603 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -176.38 117.42 0.13 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.285 179.935 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.1 tp -148.96 -63.97 0.23 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.214 -179.84 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.998 0 C-N-CA 119.2 -1.476 . . . . 0.0 109.606 -179.861 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.764 0.316 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 m -68.48 105.93 2.37 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.754 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 28.6 m -87.74 -64.26 1.18 Allowed 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.218 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 p -115.63 163.62 15.53 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.011 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.418 HG12 ' CD1' ' A' ' 118' ' ' LEU . 30.1 pt -142.74 177.19 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.934 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -156.56 111.08 2.78 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.325 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.3 mt -90.19 98.03 7.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.314 -0.955 . . . . 0.0 110.385 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 C--N 1.306 -1.31 0 CA-C-O 116.393 -1.765 . . . . 0.0 110.957 -179.99 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.605 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.992 0.425 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 2' ' ' ALA . 45.6 m-80 -163.34 117.69 1.63 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.348 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.8 pt -70.31 149.79 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.532 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.2 m -128.86 116.04 18.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.581 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 m -93.6 171.04 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 C-N-CA 119.526 -0.869 . . . . 0.0 110.78 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.637 ' CE2' ' OE1' ' A' ' 16' ' ' GLN . 31.5 m-85 -133.83 154.21 51.18 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.73 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -83.77 -45.08 13.73 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.278 -0.969 . . . . 0.0 113.152 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.534 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 82.4 m-20 -97.66 -175.69 3.26 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.54 -179.864 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.86 -178.14 7.0 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.54 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.614 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 0.9 OUTLIER 47.43 57.29 5.99 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.623 -179.946 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.614 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 48.3 p90 39.14 25.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.66 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 11' ' ' ASP . 46.9 tt0 -104.18 170.01 8.16 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.247 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.534 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 88.36 136.21 5.36 Favored Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.633 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 14' ' ' GLY . 25.8 mmtm -32.01 139.5 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.439 180.0 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.637 ' OE1' ' CE2' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -115.27 170.07 8.66 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.805 -179.883 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 76.7 t -141.63 133.93 28.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.334 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -93.91 119.26 32.59 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.192 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.9 mt -116.6 138.25 24.34 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.376 179.895 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -72.11 164.94 34.11 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 120.973 1.116 . . . . 0.0 111.027 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.19 -162.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 121.691 1.594 . . . . 0.0 110.761 179.827 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.525 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 88.54 -178.95 46.02 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.098 -1.525 . . . . 0.0 111.164 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.615 ' N ' HH21 ' A' ' 83' ' ' ARG . 13.2 p-10 -109.99 137.47 47.71 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.818 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.638 ' CE2' HD12 ' A' ' 82' ' ' ILE . 4.8 p90 -156.12 178.05 10.73 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.36 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.481 ' HB ' ' H ' ' A' ' 26' ' ' ARG . 1.3 p -151.25 -153.09 0.47 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.801 -179.801 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.481 ' H ' ' HB ' ' A' ' 25' ' ' THR . 35.0 ptt85 -58.61 -20.86 51.03 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.931 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.67 -64.11 0.92 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.244 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.513 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 31.1 tt0 -58.38 -45.36 88.44 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.244 -1.383 . . . . 0.0 109.695 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 29' ' ' LEU . 27.8 mt -61.93 -35.25 77.84 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.576 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' ARG . . . -59.5 -25.41 64.43 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 118.098 -1.441 . . . . 0.0 107.879 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -76.85 -36.35 56.87 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.69 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.5 mt -76.23 -76.72 0.15 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.741 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.42 -26.94 0.87 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.684 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.883 ' C ' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -88.14 139.01 18.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.842 180.0 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.721 ' N ' HD13 ' A' ' 34' ' ' ILE . 2.9 pt-20 174.02 168.73 0.21 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.515 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' C ' ' H ' ' A' ' 38' ' ' THR . 1.7 t-20 80.91 -145.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 120.147 -0.621 . . . . 0.0 112.654 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -53.24 6.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.988 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 35' ' ' GLU . 71.4 p -72.6 -149.05 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.358 -1.337 . . . . 0.0 110.75 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 38' ' ' THR . 2.8 mt 42.12 58.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.899 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t -72.92 -50.04 25.94 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.917 -179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.434 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -119.27 176.62 5.24 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.763 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -154.43 148.22 13.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 C-N-CA 117.856 -1.538 . . . . 0.0 112.813 -179.95 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -136.6 109.88 7.85 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.513 -1.222 . . . . 0.0 108.607 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.2 t -132.54 110.86 13.66 Favored Pre-proline 0 N--CA 1.495 1.803 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.322 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.13 167.96 20.43 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.007 1.138 . . . . 0.0 110.726 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.483 ' CG ' HH21 ' A' ' 92' ' ' ARG . 1.6 Cg_endo -62.18 -168.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.781 1.654 . . . . 0.0 111.326 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.89 -17.47 9.13 Favored Glycine 0 N--CA 1.482 1.73 0 C-N-CA 119.365 -1.397 . . . . 0.0 110.854 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.605 HG11 ' CB ' ' A' ' 2' ' ' ALA . 27.3 m -148.59 140.35 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.825 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -104.82 127.14 52.52 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.49 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.57 149.19 28.32 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.539 -0.864 . . . . 0.0 112.283 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.8 mt -139.87 114.58 7.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.569 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.502 ' HA ' HG23 ' A' ' 82' ' ' ILE . 3.6 mp -94.11 164.95 12.86 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.942 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -140.46 116.37 10.37 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.006 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -49.22 -84.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.363 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 59' ' ' ALA . 14.9 t-20 -59.01 141.26 54.42 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.521 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -60.92 -169.87 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.318 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.81 31.97 32.34 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.137 -1.506 . . . . 0.0 110.005 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.429 ' CE1' ' HG3' ' A' ' 83' ' ' ARG . 25.3 m-85 51.29 65.59 1.44 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.087 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 55' ' ' ASN . . . -144.06 -174.14 4.19 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.171 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.67 177.9 15.39 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.037 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -50.89 170.72 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.212 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -143.58 133.03 23.41 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.058 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.549 HG22 ' N ' ' A' ' 64' ' ' GLU . 6.5 mm -98.91 167.64 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.097 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.549 ' N ' HG22 ' A' ' 63' ' ' ILE . 51.5 mt-10 -145.29 129.16 17.35 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.163 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -149.24 164.52 4.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 118.598 -1.241 . . . . 0.0 112.609 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.33 -11.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 114.372 -1.285 . . . . 0.0 107.69 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -119.69 -152.19 0.5 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.144 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -101.51 122.57 44.05 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.886 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.531 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.53 121.85 32.13 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.723 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -74.33 -83.67 0.05 Allowed 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.328 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -77.32 -0.25 24.84 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.962 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.4 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 5.8 tp 59.24 -97.47 0.07 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.717 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.4 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -173.43 -174.83 40.73 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 118.893 -1.622 . . . . 0.0 111.117 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.595 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.4 Cg_endo -66.9 -34.04 31.25 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.688 2.259 . . . . 0.0 112.587 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.752 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.0 pt? -67.91 24.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.457 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.595 ' H ' ' C ' ' A' ' 74' ' ' PRO . 4.3 t30 -74.73 -6.35 48.35 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.201 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' ND2' ' A' ' 78' ' ' ASN . 4.6 t-20 -74.54 -25.11 59.11 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.992 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 31.9 m120 -158.14 132.03 7.9 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.384 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t -147.81 138.52 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.843 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.9 m -162.53 -34.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.44 -1.304 . . . . 0.0 112.831 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.5 m -95.7 138.81 32.83 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.023 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.638 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -150.02 159.86 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 118.581 -1.248 . . . . 0.0 112.497 -179.869 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.846 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -149.94 116.84 5.92 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.417 -179.977 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.846 ' H ' HH22 ' A' ' 83' ' ' ARG . 14.1 t -120.63 139.54 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.438 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.77 HD11 HH11 ' A' ' 83' ' ' ARG . 1.4 mp -138.72 129.25 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.562 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 p -40.5 152.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.989 -0.685 . . . . 0.0 111.609 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.565 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -154.47 141.25 13.26 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.266 179.989 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.565 ' HD2' HG22 ' A' ' 87' ' ' VAL . 4.8 Cg_exo -52.37 132.55 45.05 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.168 1.246 . . . . 0.0 111.28 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.589 HG22 ' N ' ' A' ' 90' ' ' GLN . 4.0 p -59.13 163.96 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.639 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.589 ' N ' HG22 ' A' ' 89' ' ' VAL . 82.5 mm-40 -145.21 148.08 36.63 Favored Pre-proline 0 N--CA 1.487 1.387 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.045 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.64 -20.12 67.63 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 121.503 1.469 . . . . 0.0 111.846 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.483 HH21 ' CG ' ' A' ' 46' ' ' PRO . 20.3 ptt180 38.07 -158.31 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.463 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -147.87 172.76 13.65 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.61 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -141.21 115.48 9.37 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.865 -1.134 . . . . 0.0 112.087 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.42 ' CD2' HG13 ' A' ' 131' ' ' VAL . 66.7 m-85 -99.97 159.17 15.29 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.634 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 101' ' ' PHE . 26.0 m-85 -109.83 179.66 4.06 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.267 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.29 -66.97 0.91 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.438 -0.905 . . . . 0.0 112.755 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.513 ' CG ' ' N ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -87.49 163.05 16.91 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.918 0.866 . . . . 0.0 113.083 -179.735 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 13.6 tp10 -62.25 108.86 1.16 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.703 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 102' ' ' ASP . 3.6 mt-30 96.66 61.54 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.934 0 O-C-N 124.725 1.265 . . . . 0.0 111.113 179.895 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' A' ' 101' ' ' PHE . 9.1 p90 29.4 33.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.422 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 100' ' ' GLN . 23.8 t70 -96.93 32.85 2.01 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.754 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -161.2 144.48 9.88 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 103' ' ' GLY . 15.7 tptm -34.5 144.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.929 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.468 ' OE1' ' C ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -99.14 164.99 11.93 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.712 -0.795 . . . . 0.0 112.806 -179.803 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.417 HG11 ' CA ' ' A' ' 122' ' ' GLY . 7.0 t -140.28 118.57 10.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.495 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -93.83 163.08 13.66 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.535 -179.673 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 108' ' ' LEU . 94.2 mt -144.08 144.44 26.27 Favored Pre-proline 0 N--CA 1.486 1.339 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.632 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.21 163.48 32.6 Favored 'Trans proline' 0 C--O 1.213 -0.771 0 C-N-CA 121.708 1.605 . . . . 0.0 111.095 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.68 142.73 95.24 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 121.452 1.435 . . . . 0.0 110.892 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.87 -157.13 26.97 Favored Glycine 0 N--CA 1.501 3.026 0 C-N-CA 118.758 -1.687 . . . . 0.0 111.522 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.66 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 46.1 tt0 -128.26 157.27 41.37 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.518 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.66 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 13.4 m-85 -142.43 155.99 45.15 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.799 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.4 p -99.61 176.47 5.47 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -179.674 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.531 ' NE2' ' OD2' ' A' ' 144' ' ' ASP . 20.9 pt20 -73.42 37.63 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.866 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.32 -56.3 0.08 Allowed 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.615 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.11 -42.61 75.86 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.163 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.617 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -45.25 -74.1 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.159 179.912 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.69 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.1 OUTLIER -50.69 -55.45 16.48 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.011 -1.076 . . . . 0.0 112.796 -179.63 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -10.59 6.45 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.319 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -100.04 -8.08 24.25 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.471 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.58 ' C ' HD13 ' A' ' 123' ' ' ILE . . . -152.0 -62.08 0.01 OUTLIER Glycine 0 N--CA 1.484 1.887 0 C-N-CA 118.498 -1.81 . . . . 0.0 111.989 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 1.062 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -140.63 127.82 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.968 -179.746 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 126' ' ' ASN . 36.9 t70 -39.48 161.41 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.84 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -58.29 13.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.105 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.637 ' O ' HG23 ' A' ' 127' ' ' THR . 1.6 p-10 -167.7 77.99 0.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.552 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 126' ' ' ASN . 1.1 p -163.66 -15.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.37 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -64.68 160.4 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.143 -179.854 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.4 t -170.38 -87.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.55 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 m -81.93 138.02 35.07 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.487 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.42 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.1 t -121.14 156.84 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.509 0.671 . . . . 0.0 111.703 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -154.02 79.06 5.23 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.963 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.78 102.42 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.533 1.489 . . . . 0.0 110.834 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.463 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 5.1 mm100 -51.55 -12.92 0.19 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.089 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 178.76 -34.86 0.08 OUTLIER Glycine 0 N--CA 1.49 2.278 0 C-N-CA 117.93 -2.081 . . . . 0.0 112.579 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.452 HD12 ' CA ' ' A' ' 92' ' ' ARG . 6.4 mt -87.35 171.87 10.27 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.185 -1.406 . . . . 0.0 111.824 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -95.16 123.21 38.53 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.41 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 153' ' ' VAL . 8.8 t -94.44 133.05 36.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.627 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.488 ' C ' HD12 ' A' ' 140' ' ' LEU . 62.0 t -124.2 132.13 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.48 179.805 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 139' ' ' VAL . 9.9 mp -107.31 134.13 50.83 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.435 -179.783 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.431 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 25.8 m-85 -110.59 122.06 46.83 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.105 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -55.4 -84.19 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.988 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.447 HD21 ' HB3' ' A' ' 147' ' ' SER . 26.2 p-10 -71.91 173.58 8.13 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.193 179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.531 ' OD2' ' NE2' ' A' ' 115' ' ' GLN . 2.3 m-20 -65.29 -153.35 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.175 -179.893 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.635 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 71.7 m-20 41.91 22.61 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.288 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.635 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.5 p90 40.08 57.12 2.44 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.154 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.447 ' HB3' HD21 ' A' ' 143' ' ' ASN . 8.4 t -138.66 -151.05 0.36 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.605 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 54.88 -166.02 2.87 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.377 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.5 157.14 11.87 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.88 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 p -148.12 174.68 11.71 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.568 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.3 mt -138.32 85.09 18.76 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.444 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -64.1 97.53 0.24 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 121.766 1.644 . . . . 0.0 112.387 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 138' ' ' VAL . 2.1 t -77.78 92.99 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.857 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -62.41 -21.49 65.42 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.808 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 52.3 p -169.84 -150.19 0.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 117.852 -1.539 . . . . 0.0 112.862 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -43.78 150.26 0.26 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.779 -179.818 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.554 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -171.8 65.07 0.39 Allowed Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.902 179.841 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.3 Cg_endo -61.95 19.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.267 1.978 . . . . 0.0 113.14 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.554 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER 178.67 111.76 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.053 179.873 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 13.5 mt -141.35 -42.97 0.37 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.467 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.026 0 C-N-CA 119.318 -1.42 . . . . 0.0 110.16 -179.994 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.961 0.41 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.37 131.12 45.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.504 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 169' ' ' SER . 97.0 p -93.69 -67.31 0.86 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.945 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.52 ' N ' ' OG ' ' A' ' 168' ' ' SER . 1.8 p -113.99 162.55 16.28 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.982 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.43 HG12 ' CD1' ' A' ' 118' ' ' LEU . 23.9 pt -143.01 175.73 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 118.735 -1.186 . . . . 0.0 112.037 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.403 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 3.2 ttp85 -154.51 109.18 3.04 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.477 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 172' ' ' ILE . 9.4 mt -89.6 92.8 4.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.574 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 116.325 -1.798 . . . . 0.0 110.944 179.996 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ptm . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.922 0.391 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.64 163.24 16.68 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.662 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -179.53 131.4 0.1 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.166 -1.013 . . . . 0.0 110.699 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.7 pt -73.44 153.22 7.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.453 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.0 m -130.44 116.43 18.23 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.886 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 m -96.67 172.08 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.515 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.821 ' CE2' ' OE1' ' A' ' 16' ' ' GLN . 16.1 m-85 -130.72 134.85 47.26 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.878 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -59.28 5.5 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.214 -0.995 . . . . 0.0 112.777 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.624 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 14.7 m-20 -89.03 167.04 13.48 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.478 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.556 ' CG ' ' H ' ' A' ' 11' ' ' ASP . 16.4 tt0 -77.16 -178.23 4.94 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.918 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.556 ' H ' ' CG ' ' A' ' 10' ' ' GLU . 4.7 t0 60.77 43.64 11.95 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.61 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.414 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 35.8 t80 49.3 15.47 0.12 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.497 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.503 ' CG ' ' N ' ' A' ' 14' ' ' GLY . 48.6 tt0 -103.02 168.93 8.87 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.833 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.624 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 89.53 124.49 2.56 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.816 -1.183 . . . . 0.0 111.143 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 14' ' ' GLY . 7.2 mmmm -29.95 137.76 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 123.921 0.424 . . . . 0.0 111.643 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.821 ' OE1' ' CE2' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -103.51 170.92 7.66 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.678 -0.809 . . . . 0.0 112.087 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.6 t -142.03 134.41 27.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.804 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -92.98 117.16 29.75 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.578 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.1 mt -113.03 132.99 22.12 Favored Pre-proline 0 N--CA 1.492 1.625 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.075 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.11 160.64 43.72 Favored 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 120.94 1.093 . . . . 0.0 111.208 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.85 -159.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 121.615 1.543 . . . . 0.0 111.017 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.437 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 84.32 176.36 51.06 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.318 -1.42 . . . . 0.0 111.001 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.646 ' CA ' HH21 ' A' ' 83' ' ' ARG . 7.8 p-10 -103.3 135.92 44.04 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.543 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.822 ' OH ' HD12 ' A' ' 82' ' ' ILE . 51.6 p90 -158.31 -174.61 4.89 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.119 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.842 HG23 ' N ' ' A' ' 26' ' ' ARG . 5.4 t -161.03 -150.02 0.19 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.396 -1.321 . . . . 0.0 112.297 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.842 ' N ' HG23 ' A' ' 25' ' ' THR . 11.9 ttt-85 -56.79 -31.04 64.27 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.253 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.612 ' H ' HG23 ' A' ' 25' ' ' THR . . . -60.99 -63.35 1.33 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.569 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.55 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 14.9 tp60 -57.48 -44.28 84.78 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.485 -1.286 . . . . 0.0 109.822 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.503 HD23 ' HA ' ' A' ' 29' ' ' LEU . 27.6 mt -58.78 -37.6 76.66 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.71 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.35 -33.71 44.19 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 118.537 -1.265 . . . . 0.0 107.762 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -66.44 -40.84 89.71 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.375 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.491 HD12 HD23 ' A' ' 29' ' ' LEU . 14.3 mt -72.81 -80.84 0.06 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.79 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 32' ' ' LEU . . . 161.58 -29.18 0.29 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.841 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.441 HD13 HG21 ' A' ' 34' ' ' ILE . 9.8 tt -82.64 151.13 4.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.724 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 4.3 pt-20 -179.93 146.25 0.24 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.552 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 1.6 t-20 74.61 -143.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.065 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -58.79 82.08 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.612 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 40' ' ' SER . 43.4 p -149.33 -46.36 0.14 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.226 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mt -68.45 71.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.623 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 38' ' ' THR . 33.5 t -75.31 -72.1 0.32 Allowed 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.403 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.446 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -95.64 167.43 11.3 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.965 -1.094 . . . . 0.0 109.626 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.32 154.37 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 118.786 -1.166 . . . . 0.0 112.394 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -145.1 104.01 3.92 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.75 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.6 t -126.5 111.26 23.14 Favored Pre-proline 0 N--CA 1.496 1.842 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.63 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.37 168.21 18.48 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 121.081 1.187 . . . . 0.0 110.808 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.93 -170.22 0.1 OUTLIER 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 121.843 1.695 . . . . 0.0 110.971 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.85 -12.04 31.46 Favored Glycine 0 N--CA 1.48 1.614 0 C-N-CA 118.829 -1.653 . . . . 0.0 109.627 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.611 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -155.87 149.47 11.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.448 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.09 127.2 51.41 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.616 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.61 157.02 17.47 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.359 -0.936 . . . . 0.0 113.096 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.49 ' C ' HD12 ' A' ' 52' ' ' LEU . 60.3 mt -136.11 115.41 16.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.453 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.941 ' N ' HD12 ' A' ' 52' ' ' LEU . 2.1 mp -89.97 161.22 16.0 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.857 -1.137 . . . . 0.0 112.763 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.415 ' CE1' ' HB3' ' A' ' 62' ' ' GLN . 5.5 m-85 -140.58 109.95 6.25 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.782 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.407 ' HB3' ' H ' ' A' ' 55' ' ' ASN . 11.7 tt0 -43.52 -87.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.035 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.407 ' H ' ' HB3' ' A' ' 54' ' ' GLN . 58.8 m-20 -59.92 145.45 45.85 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.093 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.19 -174.92 0.06 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.518 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.84 26.7 58.25 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.178 -1.487 . . . . 0.0 110.025 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 55.31 65.03 1.59 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.51 175.35 10.63 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.439 -0.905 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.25 168.0 32.07 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.257 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -49.3 129.17 18.09 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.348 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.415 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 3.3 pt20 -101.0 179.04 4.5 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.119 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.808 HD11 HD11 ' A' ' 75' ' ' LEU . 4.7 mt -144.04 169.01 10.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.404 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.49 ' H ' HG22 ' A' ' 63' ' ' ILE . 38.7 tt0 -145.09 128.62 17.04 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.955 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.41 HG13 ' C ' ' A' ' 64' ' ' GLU . 18.7 m -149.31 167.14 3.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.902 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 48' ' ' VAL . 2.6 t -146.64 -2.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.527 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.549 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -126.42 -154.11 0.61 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.882 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.435 HD21 HG13 ' A' ' 106' ' ' VAL . 0.8 OUTLIER -96.05 155.18 16.86 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.566 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.42 87.06 2.35 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.225 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -51.9 -43.15 63.23 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.346 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 72' ' ' LEU . 5.5 mm-40 -123.88 81.19 1.88 Allowed 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.586 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 71' ' ' GLU . 1.2 tp -28.96 -81.22 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.702 0.626 . . . . 0.0 112.545 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.31 -165.92 36.63 Favored Glycine 0 N--CA 1.497 2.701 0 C-N-CA 118.901 -1.618 . . . . 0.0 111.09 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.459 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.8 Cg_endo -67.37 -44.21 5.02 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 122.148 1.899 . . . . 0.0 112.055 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.808 HD11 HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -69.74 10.45 0.38 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.059 -1.056 . . . . 0.0 111.289 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 74' ' ' PRO . 8.5 t30 -70.13 1.45 4.7 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.61 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -74.7 -5.2 41.85 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.712 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -167.3 124.42 1.2 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.295 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.4 t -145.97 140.24 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.67 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 m -159.7 -31.92 0.06 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.092 -1.043 . . . . 0.0 112.292 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.49 ' HG ' ' HG1' ' A' ' 25' ' ' THR . 3.0 m -103.86 142.93 33.54 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.439 -0.905 . . . . 0.0 111.339 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.822 HD12 ' OH ' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -149.15 162.2 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.73 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.851 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -146.06 116.38 7.49 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.396 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.851 ' H ' HH22 ' A' ' 83' ' ' ARG . 10.2 t -119.3 137.77 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 120.056 -0.657 . . . . 0.0 111.636 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.588 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 4.5 mt -139.13 126.67 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.51 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.5 p -40.54 154.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.585 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.491 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.9 OUTLIER -150.93 146.79 19.65 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.65 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.491 ' HD2' HG22 ' A' ' 87' ' ' VAL . 5.0 Cg_exo -51.18 159.35 2.82 Favored 'Trans proline' 0 C--N 1.325 -0.7 0 C-N-CA 121.805 1.67 . . . . 0.0 112.164 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 89' ' ' VAL . 33.8 m -69.67 134.68 29.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.326 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -140.25 124.58 10.85 Favored Pre-proline 0 N--CA 1.489 1.488 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.113 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -59.79 -164.11 0.03 OUTLIER 'Trans proline' 0 C--O 1.21 -0.912 0 C-N-CA 120.758 0.972 . . . . 0.0 110.516 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.4 ' CA ' HD12 ' A' ' 136' ' ' LEU . 20.8 ptt-85 -177.48 -160.29 0.05 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.913 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.435 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -138.81 154.25 48.45 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.92 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -123.94 122.26 37.49 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.812 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 24.8 m-85 -108.71 151.41 26.22 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.041 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.405 ' CD2' ' HA ' ' A' ' 101' ' ' PHE . 31.3 m-85 -118.53 159.06 24.22 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.927 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.45 ' HB2' ' N ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -78.68 -83.29 0.09 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 118.162 -1.415 . . . . 0.0 111.781 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.529 ' O ' ' OE1' ' A' ' 100' ' ' GLN . 4.6 mmmm -56.07 157.87 4.33 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.6 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 29.2 tt0 -79.62 86.62 5.23 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.524 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.738 ' OE1' ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 162.77 48.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.625 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 24.7 p90 39.96 41.06 0.82 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.102 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -142.75 -174.46 4.17 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.635 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.484 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 75.89 161.77 11.18 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 118.92 -1.609 . . . . 0.0 109.498 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 103' ' ' GLY . 7.3 mtpm? -27.58 122.82 0.1 Allowed 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 121.244 0.545 . . . . 0.0 112.09 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 105' ' ' GLU . 0.7 OUTLIER -102.09 137.21 40.66 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.572 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.836 HG21 ' O ' ' A' ' 122' ' ' GLY . 3.0 t -138.73 151.57 24.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.021 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -143.66 151.15 39.74 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.098 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.8 mt -139.25 143.81 37.88 Favored Pre-proline 0 N--CA 1.497 1.876 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.617 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 6.4 Cg_endo -71.23 170.17 18.9 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 121.724 1.616 . . . . 0.0 111.052 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.407 ' HA ' ' CG2' ' A' ' 172' ' ' ILE . 3.7 Cg_exo -60.44 141.55 95.83 Favored 'Trans proline' 0 C--N 1.321 -0.921 0 C-N-CA 121.728 1.619 . . . . 0.0 110.972 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.491 ' C ' ' OE1' ' A' ' 112' ' ' GLN . . . 150.2 -153.78 25.27 Favored Glycine 0 N--CA 1.497 2.759 0 C-N-CA 118.675 -1.726 . . . . 0.0 111.49 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.631 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 3.3 mp0 -131.36 148.16 52.64 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.614 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.631 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 3.3 m-85 -139.63 157.15 46.27 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.606 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.4 p -119.0 -175.46 2.91 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -77.88 47.78 0.66 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.216 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.41 -56.47 0.09 Allowed 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.329 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.482 ' HG2' ' N ' ' A' ' 118' ' ' LEU . 1.7 tt0 -76.77 -58.0 3.53 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.543 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -36.99 -69.5 0.11 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.74 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.45 ' OE1' ' ND2' ' A' ' 125' ' ' ASN . 0.6 OUTLIER -49.57 -63.12 1.2 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.166 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.435 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 0.1 OUTLIER -75.86 24.18 0.13 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.284 -0.966 . . . . 0.0 112.575 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.461 ' O ' ' CG ' ' A' ' 121' ' ' TYR . 33.7 t80 -131.81 -9.16 3.53 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.368 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.836 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -150.28 -46.94 0.02 OUTLIER Glycine 0 C--N 1.29 -1.998 0 C-N-CA 118.87 -1.633 . . . . 0.0 110.526 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.455 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -141.18 -98.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.281 -0.967 . . . . 0.0 110.66 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.455 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 7.4 t0 -168.37 -166.2 0.67 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.729 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.45 ' ND2' ' OE1' ' A' ' 119' ' ' GLU . 10.0 m120 -59.75 -6.79 1.32 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.134 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.464 ' CG ' ' H ' ' A' ' 127' ' ' THR . 44.5 t30 -172.09 -134.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.189 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.464 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 0.5 OUTLIER 36.56 69.07 0.22 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.203 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.5 ' O ' ' CB ' ' A' ' 129' ' ' SER . 8.0 mm -102.25 -86.68 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.388 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 84.83 -166.54 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' SER . 10.9 m -17.98 120.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.7 -1.591 . . . . 0.0 114.703 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.76 149.83 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.544 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -143.82 95.69 5.71 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 119.536 -0.865 . . . . 0.0 110.863 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -53.78 112.46 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.16 1.24 . . . . 0.0 111.099 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.435 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 44.6 tp60 -79.46 -17.27 54.59 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.84 -32.68 0.02 OUTLIER Glycine 0 N--CA 1.488 2.158 0 C-N-CA 118.752 -1.689 . . . . 0.0 111.93 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.4 HD12 ' CA ' ' A' ' 92' ' ' ARG . 0.4 OUTLIER -121.26 156.38 32.61 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.155 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.29 153.43 39.37 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 118.863 -1.135 . . . . 0.0 110.077 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.9 140.21 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.859 -0.736 . . . . 0.0 112.046 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.93 127.19 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.231 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 mp -105.79 148.95 26.92 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 119.396 -0.922 . . . . 0.0 113.211 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.545 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 2.4 m-85 -121.34 146.34 46.95 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.754 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -107.86 43.08 1.24 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.302 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 147' ' ' SER . 50.7 t30 -169.91 156.28 6.11 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.856 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 146' ' ' PHE . 32.0 t70 -57.75 175.83 0.17 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.298 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.642 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 8.0 p-10 34.59 32.44 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.964 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.642 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.3 p90 40.72 64.8 0.89 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.198 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.505 ' CB ' ' ND2' ' A' ' 145' ' ' ASN . 25.6 t -144.19 97.05 2.98 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.865 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.96 -156.79 28.03 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -60.21 157.62 13.01 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.963 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.5 p -150.14 170.94 17.73 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.984 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.471 HD23 ' C ' ' A' ' 151' ' ' LEU . 1.2 tt -142.44 91.33 7.69 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.035 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.32 107.37 1.57 Allowed 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.945 1.764 . . . . 0.0 113.598 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.6 t -84.12 89.15 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.089 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -80.73 11.58 3.76 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.4 p -170.04 -171.81 1.22 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.62 -1.632 . . . . 0.0 113.136 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -58.1 148.37 26.76 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.028 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.599 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -166.53 74.85 1.15 Allowed Pre-proline 0 C--N 1.304 -1.378 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.954 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.78 21.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.734 1.623 . . . . 0.0 111.999 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.599 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.4 OUTLIER -169.42 112.68 0.51 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.795 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.0 tp -146.64 17.95 1.3 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.195 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -82.43 48.17 3.9 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.241 -1.457 . . . . 0.0 110.299 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.98 32.68 0.1 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 119.256 -0.977 . . . . 0.0 111.117 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 11.7 tpt -156.77 -51.27 0.08 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.606 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.444 ' N ' ' OD1' ' A' ' 164' ' ' ASN . 23.5 p-10 -65.66 96.26 0.26 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.502 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -83.67 115.83 22.35 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.216 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.7 m120 49.43 89.13 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.509 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 13.1 m -76.14 98.28 4.34 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.955 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 9.1 m -82.82 -40.1 20.82 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.72 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.49 159.83 41.7 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.619 -1.233 . . . . 0.0 111.139 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.414 HG12 ' CD1' ' A' ' 118' ' ' LEU . 15.5 pt -140.64 163.02 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.22 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -145.07 102.39 3.75 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.025 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.407 ' CG2' ' HA ' ' A' ' 110' ' ' PRO . 4.9 mt -81.63 100.66 5.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.439 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.896 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.939 0.399 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.523 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . -168.85 -155.06 0.14 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.879 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 2.0 p-10 -172.66 105.66 0.16 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.111 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.582 HG22 HG22 ' A' ' 44' ' ' VAL . 28.6 pt -72.09 156.75 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.622 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -139.75 126.91 21.13 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.818 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -107.28 179.0 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 119.848 -0.741 . . . . 0.0 112.412 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.769 ' CZ ' ' CE1' ' A' ' 12' ' ' PHE . 32.5 m-85 -132.47 144.7 50.64 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.112 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.94 -46.97 27.07 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.551 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 4.8 m120 -89.33 162.63 15.72 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.296 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.504 ' C ' ' CG ' ' A' ' 11' ' ' ASP . 12.8 mt-10 -72.94 158.48 35.39 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.245 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.1 OUTLIER 76.02 44.73 0.13 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.612 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.769 ' CE1' ' CZ ' ' A' ' 7' ' ' PHE . 70.2 t80 52.78 10.88 0.17 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.631 -0.828 . . . . 0.0 112.079 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.447 ' HG3' ' H ' ' A' ' 14' ' ' GLY . 1.6 tp60 -99.72 171.41 7.91 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.581 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.551 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 86.42 135.71 4.16 Favored Glycine 0 N--CA 1.502 3.072 0 C-N-CA 119.904 -1.141 . . . . 0.0 111.267 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 14' ' ' GLY . 15.9 mtpp -31.46 141.47 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.913 0.419 . . . . 0.0 111.727 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.588 ' NE2' ' CZ ' ' A' ' 7' ' ' PHE . 2.3 pt20 -110.14 172.52 6.81 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.873 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.3 t -146.79 133.91 14.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.414 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -89.93 139.94 30.11 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.312 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.0 mt -135.69 133.02 19.85 Favored Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 120.026 -0.669 . . . . 0.0 110.714 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -69.69 155.16 66.88 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 121.081 1.187 . . . . 0.0 110.999 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.66 -166.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.497 1.464 . . . . 0.0 110.803 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.39 -161.03 26.08 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.951 -1.595 . . . . 0.0 110.671 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -128.04 127.42 43.13 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.997 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.435 ' OH ' HD12 ' A' ' 82' ' ' ILE . 7.9 p90 -144.46 -171.58 3.62 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.92 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.0 p -142.62 -170.54 3.23 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.262 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -59.41 -22.07 60.89 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.883 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -60.96 -58.86 6.65 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.882 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.73 ' OE1' HD21 ' A' ' 32' ' ' LEU . 2.7 tp-100 -54.92 -44.54 74.31 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.029 -1.069 . . . . 0.0 109.398 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.529 HD22 ' CG2' ' A' ' 34' ' ' ILE . 31.4 mt -57.08 -42.34 80.51 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.294 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -51.3 -30.54 18.46 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.825 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -73.75 -34.76 64.88 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.941 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.73 HD21 ' OE1' ' A' ' 28' ' ' GLN . 11.7 mt -78.88 -72.97 0.36 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.579 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.56 -40.91 0.21 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.529 ' CG2' HD22 ' A' ' 29' ' ' LEU . 10.2 tt -68.89 178.48 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.49 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.634 ' CG ' ' N ' ' A' ' 36' ' ' ASN . 5.5 tt0 178.53 167.32 0.85 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.057 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.634 ' N ' ' CG ' ' A' ' 35' ' ' GLU . 24.4 p30 -36.33 152.75 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.533 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.759 ' H ' ' H ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER 78.07 32.76 0.36 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.484 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 39' ' ' ILE . 72.0 p -147.19 -121.61 0.06 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.767 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.891 HD12 HG11 ' A' ' 79' ' ' VAL . 4.5 mt 32.58 62.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.402 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.646 ' OG ' ' N ' ' A' ' 41' ' ' SER . 22.7 p -64.69 -62.3 1.66 Allowed 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.733 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.646 ' N ' ' OG ' ' A' ' 40' ' ' SER . 0.7 OUTLIER -106.73 171.45 7.35 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.262 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -145.48 140.55 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.096 -1.041 . . . . 0.0 111.643 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -129.14 102.19 6.36 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.917 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.582 HG22 HG22 ' A' ' 4' ' ' ILE . 71.5 t -126.62 109.39 22.95 Favored Pre-proline 0 N--CA 1.49 1.537 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.618 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -67.6 169.76 15.2 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 121.049 1.166 . . . . 0.0 110.633 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.21 -170.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.844 1.696 . . . . 0.0 111.185 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.2 -11.8 7.94 Favored Glycine 0 N--CA 1.483 1.827 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.698 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.523 HG11 ' HB3' ' A' ' 2' ' ' ALA . 35.3 m -150.18 134.95 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 118.944 -1.102 . . . . 0.0 111.799 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -104.35 132.03 51.05 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.247 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.619 ' HB3' HG23 ' A' ' 65' ' ' VAL . . . -110.8 154.86 23.36 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.479 -0.889 . . . . 0.0 112.844 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.585 HG22 ' CE1' ' A' ' 53' ' ' TYR . 12.0 mt -146.32 112.01 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.103 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 mp -89.56 152.09 21.6 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.704 -1.198 . . . . 0.0 112.477 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.585 ' CE1' HG22 ' A' ' 51' ' ' ILE . 53.5 m-85 -129.48 110.9 12.25 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.315 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -48.61 -55.45 11.19 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.631 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -85.67 147.67 26.26 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.032 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -56.38 178.1 0.06 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.776 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.34 27.22 60.29 Favored Glycine 0 N--CA 1.488 2.105 0 C-N-CA 119.346 -1.407 . . . . 0.0 110.173 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.497 ' C ' ' CD2' ' A' ' 53' ' ' TYR . 12.4 m-85 56.29 67.44 1.0 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.876 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.23 -170.43 3.65 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.97 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.09 -177.23 39.36 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.425 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -45.19 107.64 0.1 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.355 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -91.05 151.35 21.06 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.642 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.736 HG22 ' N ' ' A' ' 64' ' ' GLU . 8.5 mm -131.31 170.3 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.36 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.736 ' N ' HG22 ' A' ' 63' ' ' ILE . 27.8 mt-10 -146.48 132.61 19.34 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.694 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 50' ' ' ALA . 17.6 m -150.45 147.91 15.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 118.964 -1.094 . . . . 0.0 111.698 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 t -130.61 0.93 2.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.432 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -134.41 -151.19 0.42 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.684 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -97.25 119.12 35.18 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.105 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.539 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.58 101.7 14.38 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.178 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -55.13 -35.98 65.26 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.346 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 72' ' ' LEU . 8.6 tp10 -140.16 96.51 3.06 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.611 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.42 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 1.5 tp -37.97 -84.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.099 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 178.91 -168.64 39.64 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.095 -1.526 . . . . 0.0 110.719 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.21 -6.3 15.87 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.097 1.865 . . . . 0.0 111.859 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.683 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -92.11 13.98 17.34 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.022 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -72.55 -5.16 35.15 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.518 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -89.21 -6.84 56.57 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.107 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -166.1 104.88 0.66 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 118.714 -1.194 . . . . 0.0 111.711 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.981 HG12 ' H ' ' A' ' 80' ' ' SER . 11.6 t -113.5 -167.81 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.415 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.981 ' H ' HG12 ' A' ' 79' ' ' VAL . 0.3 OUTLIER 159.48 -59.33 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.449 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.413 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 2.6 m -108.5 145.83 34.12 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.307 -0.957 . . . . 0.0 113.317 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.435 HD12 ' OH ' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -141.21 154.26 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.915 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.737 ' NH1' ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.61 128.5 25.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.333 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.737 ' CA ' ' NH1' ' A' ' 83' ' ' ARG . 6.5 t -138.1 132.94 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.329 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 68.1 mt -129.31 128.69 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.806 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 m -42.3 153.49 0.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.213 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.598 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.5 OUTLIER -147.56 148.62 31.56 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.753 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.598 ' HD2' HG22 ' A' ' 87' ' ' VAL . 5.4 Cg_exo -55.48 127.76 27.57 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.229 1.286 . . . . 0.0 110.946 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 p -59.43 136.38 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.478 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -139.71 152.76 69.14 Favored Pre-proline 0 N--CA 1.486 1.355 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.695 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.485 ' HG2' HD21 ' A' ' 136' ' ' LEU . 3.3 Cg_exo -60.15 -156.88 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.818 0 C-N-CA 121.064 1.176 . . . . 0.0 110.941 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 175.71 -162.05 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.266 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.03 158.57 43.97 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.013 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.91 147.5 35.71 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.935 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.469 ' CE1' HD12 ' A' ' 108' ' ' LEU . 29.9 m-85 -130.48 100.89 5.5 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.425 ' CG ' ' HB3' ' A' ' 105' ' ' GLU . 33.7 m-85 -74.93 177.06 6.57 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.581 -0.847 . . . . 0.0 113.111 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -110.54 159.73 17.27 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.635 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt 59.3 153.98 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.048 0.927 . . . . 0.0 113.182 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.555 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 30.7 tp10 -71.99 105.99 4.1 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.459 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 1.282 ' NE2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 103.83 46.2 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.01 0 O-C-N 124.981 1.426 . . . . 0.0 109.076 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.631 ' CE1' ' CD ' ' A' ' 100' ' ' GLN . 27.0 p90 31.56 58.56 0.3 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.669 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 102' ' ' ASP . 0.4 OUTLIER -94.54 19.85 9.24 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.939 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -159.64 159.02 30.21 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -48.59 171.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.64 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -129.72 169.69 14.78 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.053 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.35 151.81 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.764 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 23.3 p-10 -98.43 152.78 19.14 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.965 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.469 HD12 ' CE1' ' A' ' 95' ' ' PHE . 54.0 mt -146.09 113.27 4.51 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.268 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 1.6 Cg_endo -65.83 164.43 27.03 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 121.421 1.414 . . . . 0.0 112.061 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.97 146.39 57.87 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 122.268 1.979 . . . . 0.0 111.787 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.11 -156.33 25.52 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.699 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.638 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 18.0 tt0 -135.75 156.99 47.95 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.648 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.638 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 12.0 m-85 -141.07 156.41 46.0 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.428 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.4 p -108.89 -179.2 3.79 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.712 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -75.9 44.1 0.29 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.19 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.22 -58.94 0.12 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.976 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 121' ' ' TYR . 31.2 tp10 -71.59 -51.44 23.3 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.413 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.63 ' C ' HD23 ' A' ' 118' ' ' LEU . 1.4 tt -36.88 -73.37 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.142 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.532 ' HG3' ' H ' ' A' ' 120' ' ' ARG . 5.4 pt-20 -49.78 -55.54 13.7 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.696 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.532 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -76.66 16.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.752 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.474 ' O ' ' CG ' ' A' ' 121' ' ' TYR . 28.2 t80 -123.64 -12.75 7.62 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.488 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -145.26 -42.65 0.05 OUTLIER Glycine 0 N--CA 1.496 2.636 0 C-N-CA 118.84 -1.648 . . . . 0.0 110.963 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.468 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -142.57 -97.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.606 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.555 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 23.8 t70 -167.4 -170.01 1.36 Allowed 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.745 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.555 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 27.8 t-20 -62.1 -105.63 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.63 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.456 ' N ' ' OD1' ' A' ' 125' ' ' ASN . 1.8 p-10 -67.11 107.9 2.46 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.396 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.772 HG23 HG13 ' A' ' 128' ' ' ILE . 3.1 t -172.9 -165.75 0.32 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.358 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.772 HG13 HG23 ' A' ' 127' ' ' THR . 1.4 mt 66.52 140.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.806 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 160' ' ' LEU . 4.8 m -154.67 -5.51 0.15 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.333 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.5 m -150.94 127.98 11.11 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.176 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -120.26 148.0 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.475 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.93 78.59 19.52 Favored Pre-proline 0 N--CA 1.483 1.198 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.402 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -61.19 97.64 0.13 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.264 1.31 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -91.51 33.23 1.01 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.413 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.72 -58.85 0.04 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 118.691 -1.718 . . . . 0.0 111.356 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.485 HD21 ' HG2' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -120.32 178.05 4.8 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.028 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.62 138.33 31.65 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.701 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.9 141.13 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.73 -0.788 . . . . 0.0 112.152 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.567 HG12 ' CE1' ' A' ' 141' ' ' PHE . 57.7 t -125.54 130.96 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.495 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.0 mp -105.47 137.05 43.92 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.646 -0.822 . . . . 0.0 113.085 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.567 ' CE1' HG12 ' A' ' 139' ' ' VAL . 2.3 m-85 -120.95 128.03 52.36 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.207 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -79.86 -30.64 40.32 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.141 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -83.08 177.77 8.44 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.785 -1.166 . . . . 0.0 111.86 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 146' ' ' PHE . 21.7 t0 -61.73 -105.99 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.875 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.642 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 28.9 m-20 -58.54 75.56 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.457 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.642 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.5 p90 32.76 70.39 0.1 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.143 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.18 -161.65 1.18 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.325 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 50.58 -148.66 7.14 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.745 -1.217 . . . . 0.0 111.127 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -78.18 162.39 26.64 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.124 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.0 p -150.66 165.39 33.55 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.539 HD23 ' C ' ' A' ' 151' ' ' LEU . 3.2 tt -133.19 90.91 29.33 Favored Pre-proline 0 N--CA 1.484 1.238 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.08 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -64.41 105.52 0.62 Allowed 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 121.589 1.526 . . . . 0.0 112.748 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.45 84.44 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.551 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -77.05 12.83 1.25 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.624 -0.83 . . . . 0.0 112.407 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -170.69 -167.49 0.59 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 118.214 -1.395 . . . . 0.0 112.361 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.55 152.05 19.13 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.576 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.564 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -169.13 65.47 0.58 Allowed Pre-proline 0 C--N 1.308 -1.225 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.269 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.0 OUTLIER -65.76 23.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 122.171 1.914 . . . . 0.0 112.046 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.652 ' O ' HD12 ' A' ' 160' ' ' LEU . 3.0 t -166.5 138.7 3.68 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.782 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.652 HD12 ' O ' ' A' ' 159' ' ' THR . 0.3 OUTLIER -160.11 -78.22 0.06 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.221 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 163' ' ' MET . . . 42.97 -92.46 0.01 OUTLIER Glycine 0 N--CA 1.493 2.479 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.77 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -37.54 -25.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.291 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 161' ' ' GLY . 0.8 OUTLIER -75.61 -58.91 3.0 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.63 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -90.46 173.56 8.02 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.022 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -156.12 -12.1 0.1 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.271 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -169.69 58.19 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.473 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 85.2 m -42.27 104.43 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.32 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.89 -61.3 1.75 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.017 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.4 p -123.61 158.99 30.23 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.947 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.427 HG12 ' CD1' ' A' ' 118' ' ' LEU . 13.1 pt -142.0 162.21 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.176 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.441 ' CZ ' ' OG ' ' A' ' 173' ' ' SER . 2.6 ttt-85 -142.44 102.7 4.13 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.015 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 172' ' ' ILE . 7.9 mt -84.01 93.81 3.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.757 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.441 ' OG ' ' CZ ' ' A' ' 171' ' ' ARG . 4.4 m . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 116.363 -1.78 . . . . 0.0 110.813 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptp . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.6 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -150.11 156.64 42.01 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.187 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -178.22 115.93 0.08 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.545 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.412 ' H ' HG23 ' A' ' 4' ' ' ILE . 2.9 pt -61.98 129.12 24.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.707 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -107.67 122.33 46.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.407 HG12 HG22 ' A' ' 42' ' ' VAL . 5.1 m -112.49 150.65 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.726 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.611 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 12.5 m-85 -103.92 156.13 18.09 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.654 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.9 -35.8 23.82 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.247 -0.981 . . . . 0.0 113.048 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.489 ' C ' ' OG ' ' A' ' 40' ' ' SER . 77.1 m-20 -104.49 170.89 7.63 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.259 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' A' ' 11' ' ' ASP . 4.2 tp10 -76.52 -176.34 3.69 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.471 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.458 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 1.1 m-20 51.79 42.48 29.98 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.073 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.611 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 21.4 t80 54.1 6.57 0.1 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.652 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.453 ' H ' ' C ' ' A' ' 11' ' ' ASP . 25.6 tt0 -87.13 170.99 11.03 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.503 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 89.19 120.35 1.84 Allowed Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.587 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 14' ' ' GLY . 6.9 mtpm? -28.85 137.54 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 O-C-N 123.95 0.441 . . . . 0.0 111.731 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 7.5 pm0 -105.43 133.07 50.79 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 p -108.1 153.41 9.6 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.039 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.811 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.07 140.2 34.64 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.543 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 mt -132.05 126.84 20.81 Favored Pre-proline 0 N--CA 1.493 1.688 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.205 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.54 151.3 83.21 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 121.026 1.151 . . . . 0.0 111.579 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.33 -164.6 0.06 OUTLIER 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 121.609 1.539 . . . . 0.0 111.484 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.57 179.93 46.29 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.454 -1.355 . . . . 0.0 111.066 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.84 ' CB ' ' HE ' ' A' ' 83' ' ' ARG . 10.5 m-20 -90.4 121.95 32.83 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.914 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.8 ' N ' HH21 ' A' ' 83' ' ' ARG . 0.2 OUTLIER -144.33 154.99 43.6 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.315 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.42 HG22 ' OG ' ' A' ' 81' ' ' SER . 21.0 p -144.4 -150.76 0.33 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.858 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 30' ' ' ALA . 10.0 mtm180 -55.89 -37.16 68.47 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.18 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.653 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -53.44 -59.11 5.0 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.269 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.09 -47.32 75.1 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 118.695 -1.202 . . . . 0.0 109.411 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 32' ' ' LEU . 21.5 mt -61.09 -28.58 69.19 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.442 -1.303 . . . . 0.0 109.023 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -54.34 -33.43 58.96 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.2 -29.94 60.48 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.587 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 29' ' ' LEU . 14.7 mt -85.75 -91.72 0.09 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.338 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.45 13.45 0.26 Allowed Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.225 -1.464 . . . . 0.0 111.54 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.573 HG13 HG21 ' A' ' 38' ' ' THR . 1.0 OUTLIER -95.08 -38.81 9.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.635 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.558 ' N ' ' CG1' ' A' ' 34' ' ' ILE . 3.7 pt-20 -12.9 132.21 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.803 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.615 ' O ' HG23 ' A' ' 38' ' ' THR . 0.1 OUTLIER 84.77 135.06 0.05 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 114.359 -1.291 . . . . 0.0 113.737 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 40.27 39.23 0.64 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.72 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.862 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 52.5 p -106.38 -141.3 0.37 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.929 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.491 ' H ' HD13 ' A' ' 39' ' ' ILE . 1.4 mm 30.86 41.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.958 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.489 ' OG ' ' C ' ' A' ' 9' ' ' ASN . 2.1 t -48.77 -38.98 23.41 Favored 'General case' 0 C--N 1.282 -2.342 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.064 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.67 176.56 8.59 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -150.63 146.63 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 117.76 -1.576 . . . . 0.0 113.075 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -136.09 102.1 4.92 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.359 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.6 t -122.71 104.33 36.6 Favored Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.381 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -69.48 171.01 14.92 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.077 1.185 . . . . 0.0 109.991 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.0 -173.19 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.494 1.463 . . . . 0.0 110.907 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.77 -21.72 7.38 Favored Glycine 0 N--CA 1.484 1.849 0 C-N-CA 119.109 -1.52 . . . . 0.0 110.551 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.6 HG11 ' CB ' ' A' ' 2' ' ' ALA . 25.1 m -148.97 141.98 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 118.921 -1.112 . . . . 0.0 112.176 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -110.18 139.2 45.58 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.739 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.21 155.03 42.46 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 118.964 -1.094 . . . . 0.0 113.2 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 63' ' ' ILE . 4.4 mp -134.34 120.84 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.199 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.915 ' N ' HD12 ' A' ' 52' ' ' LEU . 2.2 mp -94.62 155.66 16.78 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 118.744 -1.182 . . . . 0.0 112.942 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.478 ' CE1' ' HB3' ' A' ' 62' ' ' GLN . 40.5 m-85 -140.7 117.5 11.03 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.723 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.498 ' HG3' ' N ' ' A' ' 55' ' ' ASN . 6.4 pt20 -57.58 -41.94 82.12 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.363 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.521 ' HB3' ' HB3' ' A' ' 59' ' ' ALA . 7.0 t-20 -93.26 142.99 26.7 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.24 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 0.3 OUTLIER -54.49 171.09 0.13 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.487 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.663 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 58.82 34.83 79.59 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.162 -1.494 . . . . 0.0 109.43 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.795 ' H ' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER 44.26 74.16 0.13 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.316 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 55' ' ' ASN . . . -147.22 168.18 22.35 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.082 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.24 -166.69 48.37 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.525 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.448 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 3.7 m-20 -50.92 117.09 2.29 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.448 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.478 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 3.9 pt20 -99.82 151.45 21.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.887 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.603 ' O ' HG23 ' A' ' 51' ' ' ILE . 1.8 mt -127.79 166.0 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.922 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.558 ' OE1' ' N ' ' A' ' 64' ' ' GLU . 46.0 mp0 -142.77 130.52 21.51 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.24 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.402 HG13 ' C ' ' A' ' 64' ' ' GLU . 35.2 m -150.45 164.8 2.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.936 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.0 t -149.94 -1.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.158 -1.383 . . . . 0.0 107.881 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.72 -153.36 0.56 Allowed 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.624 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -98.32 114.03 26.19 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.53 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.574 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.72 98.9 12.03 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.425 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -54.78 -73.96 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.726 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 73' ' ' GLY . 24.6 mm-40 -80.9 -0.16 37.9 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.797 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.44 HD22 ' O ' ' A' ' 39' ' ' ILE . 5.2 tp 60.09 -79.88 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.219 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 171.08 -179.06 43.17 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.129 -1.51 . . . . 0.0 110.804 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.2 Cg_endo -65.1 -40.14 21.23 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.433 2.089 . . . . 0.0 112.421 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.955 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.1 pt? -71.3 27.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.16 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.525 ' H ' ' C ' ' A' ' 74' ' ' PRO . 15.1 p-10 -76.98 6.97 5.38 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.573 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -88.52 -9.41 52.47 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.967 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -157.85 130.69 7.42 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.136 -1.026 . . . . 0.0 111.219 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.862 ' CG2' ' H ' ' A' ' 38' ' ' THR . 15.3 m -140.09 164.93 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.533 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 174.64 -56.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.872 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.795 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 22.3 m -96.67 141.08 30.35 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.347 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.731 HD12 ' OH ' ' A' ' 24' ' ' TYR . 18.3 mt -150.57 128.25 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.974 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.84 ' HE ' ' CB ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -103.94 125.93 50.7 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.808 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -133.27 133.72 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.978 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.87 139.87 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.635 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.2 p -45.94 149.82 0.62 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.234 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.622 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -153.29 142.89 14.99 Favored Pre-proline 0 N--CA 1.484 1.264 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.866 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.622 ' HD2' HG22 ' A' ' 87' ' ' VAL . 2.7 Cg_exo -52.29 148.5 25.2 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 121.432 1.421 . . . . 0.0 111.811 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.403 HG13 ' H ' ' A' ' 89' ' ' VAL . 2.2 m -76.23 145.38 10.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.993 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -146.13 136.51 12.15 Favored Pre-proline 0 C--N 1.304 -1.388 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.963 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -60.33 -156.67 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.869 0 C-N-CA 121.178 1.252 . . . . 0.0 110.687 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.559 ' N ' ' CD ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -175.55 -164.53 0.14 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.354 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.37 165.47 25.4 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.027 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.616 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -128.66 151.46 49.48 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.777 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 1.2 m-85 -142.43 139.92 31.79 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.534 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.517 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 27.7 m-85 -95.09 179.74 5.1 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 118.414 -1.314 . . . . 0.0 112.492 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.456 ' CE1' HG22 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -101.65 -74.75 0.61 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.023 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.521 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 25.9 tttm -63.29 160.6 15.48 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.858 0.837 . . . . 0.0 112.499 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.587 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -71.7 103.45 3.07 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.477 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.587 ' CB ' ' O ' ' A' ' 99' ' ' GLU . 9.1 tp60 113.1 55.48 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.496 0 O-C-N 125.245 1.591 . . . . 0.0 111.056 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.561 ' CD2' ' O ' ' A' ' 101' ' ' PHE . 17.9 p90 28.52 41.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.492 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.566 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 6.4 p-10 -115.26 24.15 11.88 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.66 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.521 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -139.42 150.45 21.34 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.8 OUTLIER -33.34 142.21 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.598 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.404 ' O ' ' CD ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -105.66 162.95 13.06 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.635 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.787 HG21 ' O ' ' A' ' 122' ' ' GLY . 1.4 t -132.62 167.57 26.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.476 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.536 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 2.6 p30 -150.18 149.0 29.61 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.099 -1.44 . . . . 0.0 112.438 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.437 HD22 ' CD2' ' A' ' 121' ' ' TYR . 14.2 mt -137.22 143.2 40.73 Favored Pre-proline 0 N--CA 1.499 1.98 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.446 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.81 166.43 27.69 Favored 'Trans proline' 0 C--O 1.212 -0.782 0 C-N-CA 121.789 1.66 . . . . 0.0 112.346 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.89 145.98 95.01 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 122.296 1.997 . . . . 0.0 111.233 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.17 -143.27 12.63 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.279 -1.438 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.692 ' NE2' ' CE1' ' A' ' 146' ' ' PHE . 42.3 tt0 -146.46 154.27 41.39 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.165 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.597 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 8.4 m-85 -138.64 152.89 48.49 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.102 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.6 p -88.43 -166.84 1.7 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.669 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -96.57 51.17 1.16 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.389 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.58 -68.81 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.35 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 121' ' ' TYR . 8.6 pt-20 -68.54 -41.68 79.52 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.891 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.61 ' C ' HD23 ' A' ' 118' ' ' LEU . 0.9 OUTLIER -37.49 -75.07 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.633 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.697 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -51.68 -52.2 49.97 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.574 -0.851 . . . . 0.0 110.855 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -74.57 16.33 0.28 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.961 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 117' ' ' GLU . 17.8 t80 -124.52 -13.8 6.99 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.517 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.787 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -138.13 -52.94 0.05 OUTLIER Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.506 -1.33 . . . . 0.0 110.603 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.679 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -138.4 -101.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.407 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.511 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 32.0 t70 -164.41 176.79 8.73 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.162 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.541 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 14.4 t-20 -59.83 137.61 58.01 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.843 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.677 ' O ' HG22 ' A' ' 127' ' ' THR . 7.4 p30 43.59 -151.07 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.914 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.677 HG22 ' O ' ' A' ' 126' ' ' ASN . 13.7 t 48.35 20.09 0.26 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.59 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.487 ' O ' ' CB ' ' A' ' 129' ' ' SER . 7.4 mm -50.57 -84.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.927 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 1.2 p 80.51 120.01 0.05 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.444 ' H ' ' H ' ' A' ' 160' ' ' LEU . 0.9 OUTLIER 51.44 114.16 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.022 -1.445 . . . . 0.0 114.197 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.409 HG13 ' CD2' ' A' ' 95' ' ' PHE . 3.6 t -121.47 134.55 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.571 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.4 ttmm -131.32 99.37 17.57 Favored Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.664 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.85 107.43 1.87 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.018 1.145 . . . . 0.0 110.47 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -86.29 11.14 12.82 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.843 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.5 -45.73 0.04 OUTLIER Glycine 0 N--CA 1.494 2.564 0 C-N-CA 118.097 -2.001 . . . . 0.0 111.762 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.23 163.17 18.17 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.154 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 173' ' ' SER . . . -80.44 159.94 25.47 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.79 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 20.8 t -122.41 141.68 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.921 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.421 ' C ' HD12 ' A' ' 140' ' ' LEU . 47.5 t -128.86 130.86 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.71 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 140' ' ' LEU . 11.0 mp -105.22 139.33 40.04 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.319 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 3.0 m-85 -121.44 129.23 52.87 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.987 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.469 ' HD2' ' H ' ' A' ' 142' ' ' LYS . 0.1 OUTLIER -77.07 -48.44 17.81 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.484 -0.887 . . . . 0.0 112.228 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' A' ' 144' ' ' ASP . 3.8 m120 -74.32 135.78 42.56 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.069 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 143' ' ' ASN . 6.4 m-20 -9.16 -110.42 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.589 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 11.0 m120 -68.45 86.69 0.3 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.692 ' CE1' ' NE2' ' A' ' 112' ' ' GLN . 1.1 p90 30.32 72.55 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.889 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.7 m -142.67 -160.64 1.12 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.091 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 44.25 -158.01 0.16 Allowed Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.81 -1.186 . . . . 0.0 111.106 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -62.08 163.71 7.65 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.932 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.5 p -150.34 162.9 39.63 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.409 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.7 88.58 53.98 Favored Pre-proline 0 N--CA 1.485 1.296 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.041 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -66.08 105.3 0.81 Allowed 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.433 1.422 . . . . 0.0 111.965 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.43 69.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.238 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 154' ' ' ASN . 2.6 m120 -81.06 37.28 0.43 Allowed 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.127 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.604 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 13.7 t -170.9 -175.15 1.7 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.061 -1.055 . . . . 0.0 111.161 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.604 ' N ' ' OG ' ' A' ' 155' ' ' SER . 16.3 m-20 -76.78 142.12 40.49 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.559 -0.857 . . . . 0.0 111.141 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.559 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -154.96 74.33 5.62 Favored Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.458 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.23 23.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 122.065 1.843 . . . . 0.0 112.317 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.559 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -171.43 115.71 0.4 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.701 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.444 ' H ' ' H ' ' A' ' 130' ' ' SER . 0.2 OUTLIER -128.74 4.47 5.48 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.719 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -76.03 41.61 1.53 Allowed Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.831 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.52 ' O ' ' SD ' ' A' ' 163' ' ' MET . . . -134.06 24.7 3.9 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.197 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.52 ' SD ' ' O ' ' A' ' 162' ' ' ALA . 63.0 mmm -142.93 59.66 1.42 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.468 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.442 ' C ' ' O ' ' A' ' 163' ' ' MET . 0.6 OUTLIER -29.19 90.02 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.352 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 163' ' ' MET . 8.2 t-20 -160.55 151.8 19.2 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.808 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -96.25 121.05 37.62 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.907 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.4 m -75.97 104.77 6.66 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.835 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.3 t -82.17 -68.0 0.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.732 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.612 ' CB ' ' H ' ' A' ' 146' ' ' PHE . 28.6 m -114.03 163.73 14.76 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.926 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.47 HG23 HD11 ' A' ' 118' ' ' LEU . 22.0 pt -141.02 161.29 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.089 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.409 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 25.1 ttt180 -141.8 98.7 3.39 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.6 mt -77.71 99.49 2.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.037 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 137' ' ' ALA . 39.7 m . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.814 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttt . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.91 0.386 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.544 ' HB1' HG21 ' A' ' 48' ' ' VAL . . . -76.2 167.72 21.34 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.895 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -173.93 123.46 0.33 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.464 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 4' ' ' ILE . 25.9 pt -76.05 148.54 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.5 m -122.89 109.82 14.64 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.243 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 m -100.75 150.93 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.924 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.791 ' CZ ' ' CE1' ' A' ' 12' ' ' PHE . 25.9 m-85 -109.51 163.64 13.25 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.636 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.29 -3.21 47.84 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.051 -1.06 . . . . 0.0 113.681 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.51 ' C ' ' OG ' ' A' ' 40' ' ' SER . 83.4 m-20 -136.0 164.32 28.26 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.945 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -70.63 176.68 3.97 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.69 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 13' ' ' GLN . 5.9 m-20 57.44 46.55 17.91 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.344 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.791 ' CE1' ' CZ ' ' A' ' 7' ' ' PHE . 85.4 t80 49.91 7.24 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.341 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.69 ' CD ' ' H ' ' A' ' 14' ' ' GLY . 10.1 tm0? -92.06 174.27 7.41 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.434 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.69 ' H ' ' CD ' ' A' ' 13' ' ' GLN . . . 93.84 127.33 4.69 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.053 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' GLY . 13.7 mptt -31.38 141.49 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.056 0.455 . . . . 0.0 111.914 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -93.17 162.71 13.91 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.834 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -148.09 125.22 2.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.964 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -93.15 128.49 39.1 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.971 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.4 mt -122.28 129.82 24.94 Favored Pre-proline 0 N--CA 1.491 1.615 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.728 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -67.96 162.44 39.83 Favored 'Trans proline' 0 C--N 1.325 -0.684 0 C-N-CA 120.806 1.004 . . . . 0.0 111.141 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.04 -161.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 121.667 1.578 . . . . 0.0 110.864 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.4 -179.46 49.32 Favored Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.295 -1.431 . . . . 0.0 111.082 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -106.21 135.47 47.63 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.204 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.482 ' HE1' HD12 ' A' ' 82' ' ' ILE . 16.5 p90 -152.23 167.75 27.57 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.104 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.6 p -142.05 -161.44 1.23 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.108 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -56.71 -29.2 62.22 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.054 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.18 -67.68 0.43 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.125 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.535 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.7 tp-100 -57.56 -41.46 81.1 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.428 -1.309 . . . . 0.0 110.003 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.466 HD22 ' CG1' ' A' ' 34' ' ' ILE . 28.6 mt -61.04 -39.76 91.01 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.892 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.95 -32.61 33.93 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 118.035 -1.466 . . . . 0.0 107.807 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -68.39 -36.66 79.46 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.318 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.452 HD12 HD23 ' A' ' 29' ' ' LEU . 14.3 mt -74.75 -80.01 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.872 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.46 -22.67 0.09 OUTLIER Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.854 -1.641 . . . . 0.0 111.222 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.466 ' CG1' HD22 ' A' ' 29' ' ' LEU . 6.5 pt -85.39 158.08 3.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.263 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER 170.27 137.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.708 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 8.1 t-20 74.97 -147.3 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.557 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.434 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 15.1 p30 -58.68 96.7 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.651 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 39' ' ' ILE . 60.6 p -152.1 -142.57 0.12 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.106 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.632 HG13 HG11 ' A' ' 79' ' ' VAL . 2.2 mm 36.82 44.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.323 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.51 ' OG ' ' C ' ' A' ' 9' ' ' ASN . 12.7 t -49.08 -43.01 40.72 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.502 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.2 171.74 13.82 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -152.1 141.85 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 118.093 -1.443 . . . . 0.0 112.954 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -134.05 103.77 5.94 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.943 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.3 t -120.48 108.31 37.8 Favored Pre-proline 0 N--CA 1.494 1.743 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.231 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -67.21 168.73 16.85 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.11 1.206 . . . . 0.0 110.746 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -59.35 -170.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.929 1.753 . . . . 0.0 111.179 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.18 -11.7 11.45 Favored Glycine 0 N--CA 1.483 1.81 0 C-N-CA 119.278 -1.439 . . . . 0.0 110.961 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.544 HG21 ' HB1' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -149.49 141.7 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.114 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.7 tttt -116.01 126.58 54.01 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.542 ' CB ' HG22 ' A' ' 84' ' ' VAL . . . -115.2 165.32 13.06 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.109 -1.036 . . . . 0.0 113.307 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.583 HG23 ' O ' ' A' ' 63' ' ' ILE . 63.2 mt -142.44 120.65 8.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 114.211 -1.359 . . . . 0.0 108.524 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.833 HD23 ' H ' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -92.19 148.38 22.2 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.104 -1.038 . . . . 0.0 112.074 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.833 ' H ' HD23 ' A' ' 52' ' ' LEU . 17.6 m-85 -132.83 114.71 14.4 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.183 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -53.16 -84.29 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.787 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -59.48 149.37 29.83 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.1 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -57.22 -173.01 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.637 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.1 32.43 35.42 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.19 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 49.53 45.13 24.27 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.732 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.54 -169.45 1.67 Allowed 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.011 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 68.0 166.38 3.54 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.892 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 60' ' ' GLY . 26.6 t70 -42.78 130.37 4.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.535 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.681 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 5.9 pm0 -99.86 166.06 11.26 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.052 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.711 HG13 HD11 ' A' ' 75' ' ' LEU . 5.5 mm -135.13 169.5 21.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.534 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.658 ' N ' HG22 ' A' ' 63' ' ' ILE . 36.7 mt-10 -146.34 132.45 19.33 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.003 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 m -149.32 151.59 12.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.358 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.3 t -140.2 -0.26 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . . . -130.8 -147.61 0.33 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.669 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.5 119.1 38.0 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.671 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.57 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.36 104.41 16.96 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.861 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -64.32 -77.68 0.05 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.003 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 73' ' ' GLY . 6.5 mm-40 -83.41 1.31 42.11 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.5 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.403 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 3.0 tp 56.63 -89.22 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.55 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 177.82 -166.48 36.76 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.155 -1.498 . . . . 0.0 110.621 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.571 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.9 Cg_endo -66.45 -40.96 12.9 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 122.135 1.89 . . . . 0.0 112.163 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.838 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.9 pt? -68.13 26.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.465 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.571 ' H ' ' C ' ' A' ' 74' ' ' PRO . 34.0 t-20 -68.55 -34.89 76.62 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.574 -0.85 . . . . 0.0 111.277 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -87.98 29.78 0.9 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.098 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -171.88 112.92 0.32 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.335 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.632 HG11 HG13 ' A' ' 39' ' ' ILE . 57.5 t -147.38 155.38 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.902 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.42 ' N ' HG12 ' A' ' 79' ' ' VAL . 21.2 t -171.62 -34.85 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 118.744 -1.182 . . . . 0.0 112.265 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.1 m -116.66 137.91 51.84 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.956 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.482 HD12 ' HE1' ' A' ' 24' ' ' TYR . 1.3 mt -148.6 155.18 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.511 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.849 HH12 ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -149.71 133.49 16.88 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.889 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.849 ' N ' HH12 ' A' ' 83' ' ' ARG . 13.9 t -140.68 148.25 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.911 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.932 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -142.41 136.46 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.846 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.6 m -39.91 152.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.166 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.59 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -153.24 141.36 13.85 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.224 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.59 ' HD2' HG22 ' A' ' 87' ' ' VAL . 7.8 Cg_exo -49.25 151.08 6.82 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.451 1.434 . . . . 0.0 111.706 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 89' ' ' VAL . 17.6 m -71.51 147.22 11.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.903 -0.719 . . . . 0.0 112.309 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -145.87 129.73 8.55 Favored Pre-proline 0 C--N 1.301 -1.523 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.922 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -58.17 -159.4 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.874 0 C-N-CA 120.987 1.125 . . . . 0.0 110.801 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.481 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.58 -161.82 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.162 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.412 ' H ' ' HB2' ' A' ' 92' ' ' ARG . . . -136.27 164.72 27.43 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.841 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 39.7 ttm-85 -121.99 126.17 47.94 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.714 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 11.4 m-85 -116.8 125.31 51.41 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.797 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -84.65 168.07 15.63 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.191 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.437 ' HB3' ' H ' ' A' ' 98' ' ' LYS . 1.2 t80 -80.35 -92.11 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 118.502 -1.279 . . . . 0.0 112.939 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 97' ' ' TYR . 18.8 mmmt -68.22 156.05 38.41 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.932 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 1.091 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 3.5 tm-20 -66.57 85.01 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.127 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 1.091 ' NE2' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 173.86 30.05 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.202 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.61 ' O ' ' CD1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER 47.81 11.51 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.797 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 100' ' ' GLN . 34.7 t70 -104.4 -177.47 3.37 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.316 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 72.41 128.81 0.1 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.068 -1.539 . . . . 0.0 109.998 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 103' ' ' GLY . 48.1 mttt -30.06 136.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 123.99 0.465 . . . . 0.0 111.438 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -98.96 170.39 8.76 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.502 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 122' ' ' GLY . 29.9 t -137.36 155.31 31.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.69 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -129.24 147.01 51.04 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.654 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.43 HD12 ' CE1' ' A' ' 95' ' ' PHE . 11.1 mt -136.42 139.31 29.25 Favored Pre-proline 0 N--CA 1.501 2.106 0 C-N-CA 119.724 -0.791 . . . . 0.0 110.811 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -71.04 167.75 25.2 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 121.662 1.575 . . . . 0.0 112.193 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.32 150.83 85.71 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 122.101 1.868 . . . . 0.0 111.573 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.18 -168.81 23.6 Favored Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.03 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.594 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 21.8 mp0 -113.74 159.1 20.11 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.6 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 40.7 m-85 -144.84 149.89 36.16 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.755 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.4 p -89.64 -153.06 0.26 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.123 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.422 ' C ' ' CD ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -110.95 31.81 5.75 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.67 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -134.93 -64.31 0.66 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.953 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.6 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 17.2 pt-20 -66.21 -49.37 67.5 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.066 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.6 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -37.12 -67.15 0.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.293 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.736 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 20.6 mp0 -48.2 -66.74 0.35 Allowed 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.14 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -72.44 12.32 0.48 Allowed 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.06 -1.056 . . . . 0.0 113.301 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 117' ' ' GLU . 12.8 t80 -101.97 -21.86 14.41 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.007 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.421 ' O ' HG11 ' A' ' 106' ' ' VAL . . . -165.36 -12.97 0.03 OUTLIER Glycine 0 N--CA 1.486 2.014 0 C-N-CA 118.237 -1.935 . . . . 0.0 110.93 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 123' ' ' ILE . 2.8 mt -145.69 -125.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.876 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -156.98 -160.38 0.96 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.457 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -59.55 -53.62 56.0 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.809 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -155.62 123.68 5.77 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.601 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.41 ' H ' ' H ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 177.71 0.81 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.042 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 130' ' ' SER . 70.5 mt -56.43 -72.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.285 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m 55.7 -85.1 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.776 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 128' ' ' ILE . 15.1 m -72.62 115.74 12.26 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.488 -0.885 . . . . 0.0 112.391 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.4 t -122.7 161.78 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.779 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -165.08 80.51 1.24 Allowed Pre-proline 0 C--N 1.296 -1.726 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.293 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -60.59 102.9 0.2 Allowed 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 121.568 1.512 . . . . 0.0 110.242 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -87.82 19.71 3.38 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.467 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.12 -50.93 0.03 OUTLIER Glycine 0 N--CA 1.491 2.352 0 C-N-CA 117.91 -2.09 . . . . 0.0 112.191 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.86 179.85 3.96 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.454 -0.899 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -92.1 152.33 19.98 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.776 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 68.2 t -124.11 138.86 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.127 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.503 ' C ' HD12 ' A' ' 140' ' ' LEU . 78.3 t -131.71 128.42 60.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.417 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.503 HD12 ' C ' ' A' ' 139' ' ' VAL . 8.3 mp -103.99 141.77 35.6 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.365 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -114.16 126.98 55.68 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.515 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -59.21 -78.62 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -73.71 155.54 38.85 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.816 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 146' ' ' PHE . 5.3 p-10 -62.49 -162.18 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.567 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.497 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 43.7 t30 42.5 24.15 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.675 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.497 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.4 OUTLIER 57.17 54.82 6.45 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.703 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.8 t -130.73 -171.68 2.62 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.305 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 64.11 -177.9 8.27 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.024 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 150' ' ' THR . 25.5 t0 -59.68 177.23 0.22 Allowed 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.262 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.437 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 19.5 p -146.56 178.59 8.17 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.193 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' A' ' 151' ' ' LEU . 11.0 tp -153.07 86.61 4.09 Favored Pre-proline 0 C--N 1.306 -1.303 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.778 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.46 108.07 1.13 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.871 1.714 . . . . 0.0 113.131 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.7 t -82.72 93.59 2.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.788 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -58.8 -29.35 66.77 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 48.0 p -170.38 -146.36 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 117.986 -1.486 . . . . 0.0 112.854 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 1.1 m-20 -48.98 153.24 0.91 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.99 -1.004 . . . . 0.0 112.491 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.5 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -179.89 65.24 0.14 Allowed Pre-proline 0 N--CA 1.486 1.37 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.206 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.696 ' C ' HG22 ' A' ' 159' ' ' THR . 6.4 Cg_endo -69.03 66.29 1.34 Allowed 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 122.27 1.98 . . . . 0.0 111.959 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.785 HG23 ' H ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER 161.11 -68.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.56 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.785 ' H ' HG23 ' A' ' 159' ' ' THR . 0.9 OUTLIER 57.04 -81.41 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.829 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 159' ' ' THR . . . 47.49 -150.67 2.41 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 118.495 -1.812 . . . . 0.0 109.683 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 44.37 40.93 4.11 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.489 ' C ' ' SD ' ' A' ' 163' ' ' MET . 0.0 OUTLIER -172.92 66.68 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.746 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -60.63 -111.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.75 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 54.49 -123.45 2.08 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.305 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -173.96 121.31 0.3 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.562 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.0 m -70.44 104.91 2.87 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.836 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.2 m -80.98 -66.25 0.91 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.216 -0.993 . . . . 0.0 111.599 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.8 p -118.7 159.89 22.83 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.978 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 23.2 pt -135.53 179.8 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.246 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -159.5 100.99 1.51 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.821 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.8 mt -82.06 96.88 3.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.78 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 116.302 -1.808 . . . . 0.0 111.095 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . 0.614 'CA ' ' OE2' ' A' ' 99' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.475 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.532 ' HB1' HG21 ' A' ' 48' ' ' VAL . . . -76.19 170.21 16.75 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 179.62 118.21 0.05 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.995 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.497 ' CG2' HG22 ' A' ' 44' ' ' VAL . 40.3 pt -79.27 164.8 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.388 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.5 m -138.93 123.02 17.96 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.729 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -104.62 168.12 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.285 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.418 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 68.9 m-85 -128.94 144.6 51.23 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.71 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -52.86 19.83 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.783 -0.767 . . . . 0.0 113.041 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.503 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 24.8 m120 -95.27 170.42 9.4 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.409 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.679 ' CG ' ' H ' ' A' ' 11' ' ' ASP . 16.6 tt0 -64.26 -178.7 0.38 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.778 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.679 ' H ' ' CG ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER 41.51 62.17 1.61 Allowed 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.325 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.655 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 44.9 p90 36.71 27.14 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.229 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ASP . 19.5 tp60 -101.46 162.46 12.88 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.729 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.503 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 89.37 137.32 6.3 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.472 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.482 ' N ' ' HE3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -30.04 137.52 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.057 0.456 . . . . 0.0 111.889 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -103.32 162.97 12.56 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.034 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -144.23 130.26 15.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.297 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.58 133.6 34.53 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.749 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 mt -126.13 123.73 24.44 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.578 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.94 162.22 29.92 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 120.975 1.117 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.27 -170.08 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 121.705 1.604 . . . . 0.0 110.967 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.3 -179.08 38.99 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.095 -1.526 . . . . 0.0 110.958 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -109.36 129.94 55.51 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.715 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.44 ' OH ' HD11 ' A' ' 4' ' ' ILE . 12.6 p90 -143.23 175.19 10.07 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.433 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.0 p -140.35 -160.0 1.02 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.475 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -61.15 -20.56 62.84 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.7 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.91 -62.35 1.7 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.157 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.476 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -55.64 -43.1 75.91 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.661 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 29' ' ' LEU . 20.4 mt -59.45 -41.2 89.11 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.424 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.65 -31.01 23.86 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 118.805 -1.158 . . . . 0.0 108.662 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -71.55 -38.16 71.02 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.0 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.403 ' HG ' ' H ' ' A' ' 32' ' ' LEU . 11.5 mt -73.13 -74.39 0.17 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.688 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.46 -34.87 0.47 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.057 -1.544 . . . . 0.0 110.841 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.44 HD11 ' H ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER -80.92 140.43 16.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.615 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.54 ' H ' HG21 ' A' ' 38' ' ' THR . 2.8 pt-20 178.54 131.72 0.07 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.78 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.72 ' O ' HG23 ' A' ' 38' ' ' THR . 1.5 t-20 78.22 127.49 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.511 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.4 ' N ' HG22 ' A' ' 79' ' ' VAL . 3.1 m-20 51.55 7.85 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.705 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 36' ' ' ASN . 67.2 p -91.48 -135.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.664 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.54 HG13 HG21 ' A' ' 79' ' ' VAL . 2.2 mt 35.74 39.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.604 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.52 -57.51 6.92 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.762 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.418 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -116.66 168.96 9.73 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.266 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -149.73 148.96 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 118.529 -1.269 . . . . 0.0 112.396 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -137.87 96.02 3.15 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.157 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.497 HG22 ' CG2' ' A' ' 4' ' ' ILE . 71.6 t -111.21 110.66 56.13 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.386 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -69.07 171.21 14.11 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.114 1.209 . . . . 0.0 110.411 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.45 -173.94 0.19 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.663 1.575 . . . . 0.0 111.082 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.04 -17.86 6.84 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.328 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.532 HG21 ' HB1' ' A' ' 2' ' ' ALA . 0.2 OUTLIER -146.81 138.85 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.312 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -105.9 119.7 39.86 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HB3' ' CG2' ' A' ' 65' ' ' VAL . . . -97.38 155.65 16.81 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.194 -1.002 . . . . 0.0 112.884 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.501 ' C ' HD12 ' A' ' 52' ' ' LEU . 53.1 mt -141.76 117.21 5.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.921 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.838 ' N ' HD12 ' A' ' 52' ' ' LEU . 2.0 mp -89.47 157.71 18.0 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.349 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.434 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 43.3 m-85 -138.47 107.36 5.97 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.553 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -40.93 -76.92 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.95 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.458 ' C ' ' OG ' ' A' ' 80' ' ' SER . 91.5 m-20 -68.45 153.33 43.97 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.311 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -59.99 -174.95 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.653 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 49.21 40.49 29.43 Favored Glycine 0 N--CA 1.484 1.891 0 C-N-CA 119.114 -1.517 . . . . 0.0 109.656 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.653 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.5 OUTLIER 41.5 69.19 0.37 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.452 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.69 -162.39 1.42 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.993 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.48 -176.59 0.63 Allowed Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.23 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.654 ' OD2' HD22 ' A' ' 75' ' ' LEU . 10.4 t0 -46.2 160.85 0.06 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.879 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -146.99 161.17 41.33 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.864 -1.135 . . . . 0.0 111.67 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.658 HG22 ' H ' ' A' ' 64' ' ' GLU . 38.4 mt -133.03 172.97 15.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.112 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.658 ' H ' HG22 ' A' ' 63' ' ' ILE . 3.3 tm-20 -144.81 130.44 18.99 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.154 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 50' ' ' ALA . 21.1 m -145.19 154.54 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 118.615 -1.234 . . . . 0.0 112.108 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.91 -1.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.491 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.38 -124.12 0.23 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.062 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.631 ' ND2' ' OD1' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -121.82 121.26 36.79 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.95 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.559 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -88.47 109.05 19.72 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.673 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -61.9 -87.69 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.307 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 18.4 mt-10 -78.81 1.01 24.75 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.428 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 2.2 tp 74.73 -82.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.835 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.82 -169.19 41.94 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.225 -1.464 . . . . 0.0 110.696 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.473 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.3 Cg_endo -65.91 -46.54 4.7 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.307 2.005 . . . . 0.0 112.384 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.697 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -73.62 34.9 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.291 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 74' ' ' PRO . 29.0 p-10 -75.34 -24.05 57.3 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.745 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -80.12 4.48 17.18 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.985 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -151.93 114.12 4.5 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.533 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.54 HG21 HG13 ' A' ' 39' ' ' ILE . 24.2 m -133.9 158.29 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.963 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 81' ' ' SER . 96.4 p -164.44 -69.43 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 118.391 -1.324 . . . . 0.0 112.453 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.541 ' N ' ' OG ' ' A' ' 80' ' ' SER . 73.7 m -107.42 160.89 15.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.49 -0.884 . . . . 0.0 112.485 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.514 HG23 ' HA ' ' A' ' 52' ' ' LEU . 1.7 mt -149.87 159.7 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.635 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.809 HH22 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.7 130.72 15.32 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 118.929 -1.108 . . . . 0.0 111.415 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.809 ' CA ' HH22 ' A' ' 83' ' ' ARG . 4.2 t -132.2 141.65 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.847 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.479 HG12 ' NH2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -136.17 140.32 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.047 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 90.2 p -43.27 151.05 0.17 Allowed 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.599 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.667 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -156.85 144.14 13.75 Favored Pre-proline 0 C--N 1.307 -1.273 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.638 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.667 ' HD2' HG22 ' A' ' 87' ' ' VAL . 6.3 Cg_exo -50.05 146.27 17.63 Favored 'Trans proline' 0 C--O 1.213 -0.763 0 C-N-CA 121.256 1.304 . . . . 0.0 111.345 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.95 145.94 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.053 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -145.28 153.66 52.7 Favored Pre-proline 0 N--CA 1.486 1.349 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.469 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.459 ' HG2' HD21 ' A' ' 136' ' ' LEU . 4.8 Cg_exo -60.52 -152.07 0.01 OUTLIER 'Trans proline' 0 C--O 1.211 -0.868 0 C-N-CA 121.061 1.174 . . . . 0.0 110.501 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 179.76 -163.39 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.826 -1.15 . . . . 0.0 110.86 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.76 169.92 16.33 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.201 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.513 ' HE ' ' HG3' ' A' ' 105' ' ' GLU . 66.7 ttt180 -137.91 110.02 7.29 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.969 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.56 ' CE1' HD12 ' A' ' 108' ' ' LEU . 19.3 m-85 -93.91 168.52 10.92 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.419 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.488 ' CD1' ' HB3' ' A' ' 105' ' ' GLU . 49.2 m-85 -137.87 177.08 8.15 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 119.033 -1.067 . . . . 0.0 112.075 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.691 ' CE2' HG21 ' A' ' 127' ' ' THR . 3.2 m-85 -115.63 133.21 56.26 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.4 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 19.4 tttp 78.59 137.72 0.07 Allowed 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.035 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.628 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -68.2 104.84 1.92 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.219 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.614 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 28.2 tp60 126.28 39.44 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.263 0 O-C-N 125.565 1.791 . . . . 0.0 109.721 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.614 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 25.7 p90 29.67 49.51 0.06 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.8 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -103.65 -17.67 15.04 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.076 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -102.41 164.07 16.67 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.594 -1.288 . . . . 0.0 110.976 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.46 ' CG ' ' N ' ' A' ' 105' ' ' GLU . 16.9 ttmt -40.7 160.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.823 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 105' ' ' GLU . 1.3 pm0 -127.14 158.97 35.64 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.613 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.4 156.43 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.741 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.631 ' OD1' ' ND2' ' A' ' 68' ' ' ASN . 4.8 p-10 -125.91 148.47 49.2 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.578 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.56 HD12 ' CE1' ' A' ' 95' ' ' PHE . 41.2 mt -139.19 124.69 11.95 Favored Pre-proline 0 N--CA 1.487 1.421 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.342 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.451 ' CB ' ' HD2' ' A' ' 110' ' ' PRO . 1.9 Cg_endo -64.39 171.59 7.78 Favored 'Trans proline' 0 C--O 1.213 -0.77 0 C-N-CA 121.476 1.451 . . . . 0.0 111.356 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 1.9 Cg_endo -60.78 146.41 97.42 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.875 1.717 . . . . 0.0 111.568 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.19 -154.92 25.74 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.674 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.591 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 28.5 mt-30 -133.24 161.29 34.85 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.842 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.591 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 24.0 m-85 -144.54 150.64 37.87 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.372 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 1.3 p -91.78 -142.17 0.19 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.697 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.597 ' N ' ' OG1' ' A' ' 114' ' ' THR . 13.7 mt-30 -90.31 -86.46 0.2 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.31 -28.2 62.86 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -70.09 -61.06 1.93 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.307 -1.357 . . . . 0.0 108.454 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.706 ' C ' HD23 ' A' ' 118' ' ' LEU . 2.2 tt -43.35 -64.04 0.71 Allowed 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.557 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.415 ' CD ' ' O ' ' A' ' 115' ' ' GLN . 1.1 mp0 -42.86 -68.3 0.21 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.36 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.554 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 10.6 mpt_? -68.43 0.33 4.09 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.624 -0.83 . . . . 0.0 113.199 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -89.03 -24.87 22.24 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 118.464 -1.295 . . . . 0.0 110.554 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -153.75 -20.75 0.05 OUTLIER Glycine 0 N--CA 1.485 1.951 0 C-N-CA 118.429 -1.844 . . . . 0.0 111.688 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.444 ' HB ' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -145.32 -115.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.329 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.444 ' H ' ' HB ' ' A' ' 123' ' ' ILE . 4.2 m-20 -167.57 -164.89 0.61 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -58.13 -76.09 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.163 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 127' ' ' THR . 3.7 t-20 -74.68 -138.11 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.123 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.691 HG21 ' CE2' ' A' ' 97' ' ' TYR . 0.5 OUTLIER 68.78 -138.45 0.09 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.785 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.441 ' C ' ' HG ' ' A' ' 129' ' ' SER . 3.9 mm 73.55 -49.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.477 0 O-C-N 124.168 0.918 . . . . 0.0 110.435 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 130' ' ' SER . 47.0 p 39.35 -135.32 0.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.937 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.542 ' N ' ' OG ' ' A' ' 129' ' ' SER . 24.1 m -63.37 143.9 57.42 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.381 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.03 151.46 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.489 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -150.31 81.67 6.62 Favored Pre-proline 0 C--N 1.304 -1.391 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.489 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -61.08 92.4 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.316 1.344 . . . . 0.0 110.043 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -73.64 26.18 0.07 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.118 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 176.71 -51.75 0.11 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 117.53 -2.272 . . . . 0.0 112.735 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.459 HD21 ' HG2' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -108.63 173.76 6.17 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.598 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -91.76 141.94 28.13 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.581 -0.848 . . . . 0.0 108.974 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 153' ' ' VAL . 66.9 t -109.89 139.99 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.547 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.03 127.17 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.701 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 mp -101.52 138.88 37.93 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.552 -0.859 . . . . 0.0 112.39 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.431 ' CG ' ' HA ' ' A' ' 146' ' ' PHE . 22.3 m-85 -114.07 118.56 34.42 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.082 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -48.19 -77.49 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.625 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.443 ' HB2' ' CB ' ' A' ' 147' ' ' SER . 3.3 m-20 -74.59 -156.49 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.341 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 146' ' ' PHE . 6.8 p-10 -62.07 -154.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.529 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 4.8 m120 -33.62 88.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.159 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.529 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 3.3 p90 36.31 66.07 0.41 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.663 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 92.5 p -61.0 -108.05 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.738 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.52 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . -115.4 -63.23 0.38 Allowed Glycine 0 N--CA 1.502 3.043 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.974 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.404 ' C ' ' CG2' ' A' ' 150' ' ' THR . 24.3 t70 -74.13 144.47 44.87 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.58 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.404 ' CG2' ' C ' ' A' ' 149' ' ' ASP . 6.7 p -151.67 173.74 14.32 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.491 -0.883 . . . . 0.0 111.187 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.547 HD23 ' C ' ' A' ' 151' ' ' LEU . 3.0 tt -144.25 87.51 7.78 Favored Pre-proline 0 C--N 1.31 -1.145 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.153 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.14 103.99 0.56 Allowed 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.671 1.581 . . . . 0.0 112.651 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 138' ' ' VAL . 2.8 t -77.75 93.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.154 -1.019 . . . . 0.0 109.912 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -43.78 -42.85 5.79 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.888 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.1 t -171.2 -130.09 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 118.456 -1.298 . . . . 0.0 112.229 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -46.44 141.89 3.36 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.681 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.85 64.13 1.06 Allowed Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.195 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.6 Cg_endo -63.08 21.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.279 1.986 . . . . 0.0 113.269 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 159' ' ' THR . 1.3 t -172.37 106.4 0.18 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.806 -1.157 . . . . 0.0 110.911 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.674 ' C ' HD13 ' A' ' 160' ' ' LEU . 3.0 tm? -103.6 -78.63 0.55 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.288 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 164' ' ' ASN . . . 61.44 -127.98 42.9 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.859 -1.163 . . . . 0.0 111.656 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.651 ' C ' ' H ' ' A' ' 164' ' ' ASN . . . -14.24 -57.08 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 163' ' ' MET . 3.4 mmt -64.49 17.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.078 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.651 ' H ' ' C ' ' A' ' 162' ' ' ALA . 30.7 t-20 -64.73 -54.08 37.07 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.629 -0.829 . . . . 0.0 110.635 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 47.19 -88.8 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.86 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 164' ' ' ASN . 21.1 t-20 -159.11 -33.77 0.06 Allowed 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.195 -1.002 . . . . 0.0 111.425 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.8 m 44.72 83.08 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.391 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.36 -52.22 8.37 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.846 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.2 p -123.66 163.77 20.41 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.68 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 36.2 pt -143.34 178.22 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.522 ' NH1' ' OE1' ' A' ' 112' ' ' GLN . 35.5 ttt85 -156.8 109.23 2.51 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.64 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.2 mt -85.95 95.8 4.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.149 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 C--N 1.303 -1.415 0 CA-C-O 116.379 -1.772 . . . . 0.0 110.825 -179.92 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mtt . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 121.055 0.455 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.462 ' HB1' HG21 ' A' ' 48' ' ' VAL . . . -90.2 165.56 13.88 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.506 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.579 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 0.5 OUTLIER 179.49 122.3 0.06 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.517 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 4' ' ' ILE . 1.7 pt -77.44 126.91 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.985 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.9 m -105.51 108.21 19.61 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.11 165.23 2.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.028 -1.069 . . . . 0.0 112.717 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.5 ' CE2' ' NE2' ' A' ' 16' ' ' GLN . 50.1 m-85 -123.37 145.15 48.99 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.837 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.46 ' HB2' ' N ' ' A' ' 15' ' ' LYS . 2.0 m-85 -83.91 8.45 15.0 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 13' ' ' GLN . 0.4 OUTLIER -150.19 171.08 17.49 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 118.132 -1.427 . . . . 0.0 111.979 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.497 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 11.6 mm-40 -78.36 146.88 34.39 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.348 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.587 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 2.1 t70 76.87 60.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.42 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.587 ' CG ' ' O ' ' A' ' 11' ' ' ASP . 54.7 p90 42.78 15.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.774 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 11' ' ' ASP . 46.9 mt-30 -101.42 154.5 18.75 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.193 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.994 ' O ' ' OE1' ' A' ' 16' ' ' GLN . . . 116.63 139.34 6.48 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 1.129 ' C ' ' OE1' ' A' ' 16' ' ' GLN . 9.3 mtpm? -36.41 147.38 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.491 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 1.129 ' OE1' ' C ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -99.88 142.25 31.61 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.584 -0.847 . . . . 0.0 112.25 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 t -144.48 123.72 6.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.523 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -95.47 119.39 33.89 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.414 -0.914 . . . . 0.0 112.106 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.1 125.7 30.1 Favored Pre-proline 0 N--CA 1.494 1.762 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.471 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -65.44 162.39 33.97 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 120.993 1.128 . . . . 0.0 111.724 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.31 -178.83 0.51 Allowed 'Trans proline' 0 C--N 1.322 -0.838 0 C-N-CA 121.768 1.645 . . . . 0.0 110.966 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.525 ' H ' ' HB ' ' A' ' 84' ' ' VAL . . . 108.4 -170.9 15.3 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.381 -1.39 . . . . 0.0 110.662 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.599 ' CB ' ' HE ' ' A' ' 83' ' ' ARG . 1.1 m-20 -117.21 124.69 49.72 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.96 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 3.2 p90 -144.3 169.43 17.91 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.786 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.7 p -140.75 -142.04 0.14 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.992 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -69.32 -38.5 78.25 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.031 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.591 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -54.7 -58.59 6.94 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.14 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -56.89 -51.18 70.1 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.484 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.55 HD23 HD12 ' A' ' 32' ' ' LEU . 28.4 mt -58.26 -28.8 65.27 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.446 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -56.26 -32.09 64.18 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.42 -36.04 63.41 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.72 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.55 HD12 HD23 ' A' ' 29' ' ' LEU . 13.3 mt -77.01 -83.65 0.07 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.89 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 32' ' ' LEU . . . 152.39 -16.91 0.77 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.033 -1.556 . . . . 0.0 111.225 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -91.36 138.98 18.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.073 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' C ' ' CG ' ' A' ' 36' ' ' ASN . 1.8 pt-20 172.42 150.31 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.403 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.747 ' O ' HG23 ' A' ' 38' ' ' THR . 0.4 OUTLIER 75.86 123.81 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 43.39 12.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.358 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.747 HG23 ' O ' ' A' ' 36' ' ' ASN . 64.3 p -88.86 -151.38 0.21 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.447 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.443 HD12 HG11 ' A' ' 79' ' ' VAL . 2.3 mt 42.49 60.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.736 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.8 t -80.14 -33.15 38.74 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.418 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.448 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -143.14 153.72 43.16 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.247 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.056 HG22 ' HB3' ' A' ' 69' ' ' ALA . 25.4 m -143.38 170.44 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 118.128 -1.429 . . . . 0.0 113.578 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -143.48 95.67 2.79 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.862 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.99 108.48 46.27 Favored Pre-proline 0 N--CA 1.493 1.716 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.73 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.414 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.6 Cg_endo -68.52 170.29 15.35 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 120.975 1.117 . . . . 0.0 110.321 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 2.5 Cg_endo -60.28 -170.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.877 1.718 . . . . 0.0 111.407 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.3 -12.34 10.11 Favored Glycine 0 N--CA 1.485 1.945 0 C-N-CA 119.407 -1.377 . . . . 0.0 111.13 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.462 HG21 ' HB1' ' A' ' 2' ' ' ALA . 4.4 m -148.77 139.55 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.142 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -115.38 120.23 38.89 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.03 155.25 19.58 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.287 -0.965 . . . . 0.0 112.808 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 63' ' ' ILE . 71.4 mt -142.22 118.28 6.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.094 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.451 ' H ' HD12 ' A' ' 52' ' ' LEU . 3.6 mp -88.8 159.37 17.78 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.008 -1.077 . . . . 0.0 112.504 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.441 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 72.1 m-85 -141.59 118.89 11.43 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.836 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -49.9 -82.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -58.59 155.06 13.06 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.386 -0.925 . . . . 0.0 111.799 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -59.89 -177.9 0.07 Allowed 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.705 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.581 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 50.45 38.71 35.23 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 39.17 71.12 0.18 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.521 0.677 . . . . 0.0 111.058 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.3 172.52 12.81 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.969 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.34 -174.64 55.0 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.445 -1.36 . . . . 0.0 109.981 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -44.87 158.1 0.06 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.895 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -149.84 168.41 23.81 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.812 -1.155 . . . . 0.0 111.499 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.72 HG22 ' N ' ' A' ' 64' ' ' GLU . 73.0 mt -134.85 174.11 13.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.723 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.72 ' N ' HG22 ' A' ' 63' ' ' ILE . 24.8 mt-10 -144.74 133.92 22.86 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.568 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.401 HG13 ' C ' ' A' ' 64' ' ' GLU . 25.4 m -150.55 152.89 11.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 118.628 -1.229 . . . . 0.0 112.224 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.4 ' H ' ' H ' ' A' ' 67' ' ' ALA . 1.0 OUTLIER -139.54 -10.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.494 ' HB1' ' OD1' ' A' ' 107' ' ' ASP . . . -119.92 -156.93 0.69 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.56 -1.655 . . . . 0.0 109.673 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.434 ' ND2' ' C ' ' A' ' 68' ' ' ASN . 0.5 OUTLIER -93.23 127.85 38.98 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.077 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.056 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -90.43 119.52 30.78 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.781 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -79.9 -58.74 3.02 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.445 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -106.52 19.47 20.44 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.612 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.0 tp 53.01 -98.4 0.07 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.466 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.82 -158.99 31.47 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.093 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.669 ' C ' HD23 ' A' ' 75' ' ' LEU . 1.5 Cg_endo -66.02 -157.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.451 1.434 . . . . 0.0 110.545 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.713 HD21 ' CG1' ' A' ' 63' ' ' ILE . 1.4 pt? 31.69 32.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 123.8 0.687 . . . . 0.0 111.79 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.546 ' N ' ' O ' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -80.22 -12.03 59.67 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.795 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -72.72 -12.84 61.18 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.085 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -160.29 134.67 7.43 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 118.889 -1.124 . . . . 0.0 111.69 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.443 HG11 HD12 ' A' ' 39' ' ' ILE . 3.3 t -145.39 153.18 14.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.845 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 81' ' ' SER . 86.9 p -164.89 -57.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.351 -1.34 . . . . 0.0 112.772 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.473 ' N ' ' OG ' ' A' ' 80' ' ' SER . 32.9 t -89.9 146.42 24.43 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.613 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 82' ' ' ILE . 0.3 OUTLIER -146.77 134.01 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 118.74 -1.184 . . . . 0.0 111.153 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.621 ' HA ' ' NE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -108.74 141.15 41.16 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.304 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.525 ' HB ' ' H ' ' A' ' 22' ' ' GLY . 9.4 t -144.33 123.55 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.226 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.5 mt -129.07 125.67 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.303 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.8 m -43.73 132.71 4.95 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.686 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.537 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -126.65 139.38 34.64 Favored Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.499 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.537 ' HD2' HG22 ' A' ' 87' ' ' VAL . 2.7 Cg_exo -52.76 143.55 47.16 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.127 1.218 . . . . 0.0 110.741 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.0 t -59.98 122.24 9.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.229 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -102.89 135.32 19.45 Favored Pre-proline 0 C--N 1.306 -1.326 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.987 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -52.53 -33.0 55.9 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 120.85 1.033 . . . . 0.0 110.283 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.443 HH22 ' HB2' ' A' ' 67' ' ' ALA . 17.9 mtt-85 50.68 -164.43 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.662 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.534 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.66 177.2 8.66 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.185 -1.37 . . . . 0.0 108.437 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -150.36 132.19 15.08 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 118.21 -1.396 . . . . 0.0 112.088 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.54 ' CE2' HG13 ' A' ' 131' ' ' VAL . 21.9 m-85 -118.68 147.65 43.58 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.757 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -121.15 159.29 26.13 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.185 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.658 ' OH ' HG22 ' A' ' 123' ' ' ILE . 8.0 m-30 -95.15 164.14 12.99 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.603 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 tttt 67.7 135.6 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.691 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.595 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 8.6 tp10 -63.69 100.94 0.31 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.273 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.675 ' NE2' ' HE1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 119.73 38.17 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.882 0 O-C-N 125.426 1.704 . . . . 0.0 108.47 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.675 ' HE1' ' NE2' ' A' ' 100' ' ' GLN . 22.5 p90 33.78 44.09 0.08 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.76 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -103.64 32.33 3.93 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.581 -0.847 . . . . 0.0 111.453 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -153.66 170.11 32.38 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.167 -1.492 . . . . 0.0 110.751 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.1 OUTLIER -35.03 151.13 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.428 ' CD ' ' C ' ' A' ' 105' ' ' GLU . 1.4 pp20? -121.92 168.31 12.04 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.847 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.88 139.41 19.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.283 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.494 ' OD1' ' HB1' ' A' ' 67' ' ' ALA . 6.3 p30 -108.98 151.44 26.31 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.748 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 72.3 mt -139.64 140.27 24.56 Favored Pre-proline 0 N--CA 1.497 1.877 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.804 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -76.03 164.13 31.97 Favored 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 121.944 1.763 . . . . 0.0 111.254 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.41 142.01 76.88 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.555 1.503 . . . . 0.0 110.581 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 144.05 -158.63 27.48 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 118.916 -1.612 . . . . 0.0 111.466 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.58 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 24.4 tt0 -125.28 154.97 40.9 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.88 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.58 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 25.3 m-85 -143.53 152.71 41.79 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.738 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.7 p -106.44 178.43 4.56 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.867 0.841 . . . . 0.0 112.97 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.644 ' NE2' ' CD ' ' A' ' 119' ' ' GLU . 24.1 tp60 -59.39 -20.85 58.12 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.558 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.44 -60.71 1.85 Allowed 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.901 -1.12 . . . . 0.0 114.01 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -67.4 -56.83 8.07 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.219 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.607 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -34.11 -74.02 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 O-C-N 123.801 0.688 . . . . 0.0 111.817 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.644 ' CD ' ' NE2' ' A' ' 115' ' ' GLN . 69.5 mt-10 -51.19 -56.36 13.24 Favored 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.739 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.461 ' HD3' ' H ' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -75.06 14.65 0.5 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.474 -1.291 . . . . 0.0 111.647 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 117' ' ' GLU . 18.4 t80 -119.39 -16.44 8.96 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.856 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.507 ' C ' HD13 ' A' ' 123' ' ' ILE . . . -139.49 -48.08 0.06 OUTLIER Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.676 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.658 HG22 ' OH ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -137.85 -108.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.969 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.554 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 18.3 t70 -161.75 -146.8 0.13 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.402 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.554 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 4.4 m-20 -60.67 -52.72 63.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.338 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -158.04 134.71 9.72 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.426 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.448 ' H ' ' H ' ' A' ' 128' ' ' ILE . 2.5 t -178.61 -10.1 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.507 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.448 ' H ' ' H ' ' A' ' 127' ' ' THR . 9.4 mt -70.42 141.39 17.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.528 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.3 t -157.33 12.55 0.23 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.026 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.3 m -170.7 117.12 0.49 Allowed 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.579 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.54 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.6 t -110.51 156.28 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.995 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.466 ' NZ ' ' HG3' ' A' ' 158' ' ' PRO . 1.6 tppt? -155.02 87.25 3.32 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.292 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.02 101.4 0.18 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.309 1.34 . . . . 0.0 111.678 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.534 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 38.2 tt0 -54.17 -12.21 0.6 Allowed 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.986 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -178.83 -36.6 0.06 OUTLIER Glycine 0 N--CA 1.497 2.76 0 C-N-CA 118.412 -1.852 . . . . 0.0 112.245 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mt -92.1 -174.97 3.93 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.998 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.45 137.04 48.68 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.459 ' CG1' ' CD1' ' A' ' 140' ' ' LEU . 7.2 t -103.1 140.49 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.413 -0.915 . . . . 0.0 112.866 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.467 ' C ' HD12 ' A' ' 140' ' ' LEU . 96.4 t -131.2 120.15 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.453 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 140' ' ' LEU . 10.1 mp -98.59 143.75 28.64 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.327 -0.949 . . . . 0.0 113.307 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.416 ' CD2' ' HB3' ' A' ' 146' ' ' PHE . 27.8 m-85 -120.27 130.89 54.68 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.111 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -67.21 -69.67 0.3 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.142 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -70.16 164.19 24.72 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.558 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 146' ' ' PHE . 3.6 m-20 -63.58 -160.05 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.606 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.654 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 2.5 p30 32.76 34.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 123.733 0.646 . . . . 0.0 111.57 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.654 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 42.82 61.24 2.17 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 44.5 t -136.26 -178.55 5.21 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.006 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.491 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 75.67 -163.13 53.47 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.354 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.76 164.12 3.94 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.144 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.2 p -148.2 170.16 18.48 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.944 -1.103 . . . . 0.0 111.668 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.1 tp -141.89 84.98 11.48 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.151 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -62.45 102.66 0.29 Allowed 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.076 1.85 . . . . 0.0 113.59 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 138' ' ' VAL . 6.8 t -89.19 80.36 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.346 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -76.88 14.09 0.91 Allowed 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.592 -0.843 . . . . 0.0 113.015 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 19.8 t -169.97 -169.67 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 117.785 -1.566 . . . . 0.0 112.959 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.454 ' N ' ' OG ' ' A' ' 155' ' ' SER . 64.3 m-20 -57.03 152.26 13.48 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.519 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.563 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -172.88 62.62 0.29 Allowed Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.072 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 5.8 Cg_endo -70.05 34.38 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 122.336 2.024 . . . . 0.0 112.2 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 159' ' ' THR . 0.6 OUTLIER -176.33 76.57 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.407 -1.317 . . . . 0.0 112.389 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 162' ' ' ALA . 2.8 mm? -81.2 -87.51 0.08 Allowed 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.63 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' A' ' 163' ' ' MET . . . 65.56 -70.59 0.11 Allowed Glycine 0 N--CA 1.503 3.106 0 C-N-CA 119.585 -1.293 . . . . 0.0 111.857 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -52.49 4.73 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.465 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.633 ' H ' ' C ' ' A' ' 161' ' ' GLY . 14.6 mmt -115.38 40.38 2.72 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.082 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 165' ' ' ASN . 4.9 m120 -41.84 -18.78 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.64 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 163' ' ' MET . 86.0 m-20 -40.88 120.98 1.41 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.451 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -56.82 95.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.88 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.7 m -59.82 112.81 1.98 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.424 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.6 t -97.24 -63.13 1.16 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.549 -0.861 . . . . 0.0 112.043 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.06 162.39 17.47 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.04 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 25.6 pt -147.78 179.49 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.307 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -161.32 114.62 1.93 Allowed 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.302 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 42.9 mt -90.57 98.97 8.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.349 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--N 1.304 -1.405 0 CA-C-O 116.298 -1.81 . . . . 0.0 110.988 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 tmm? . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.513 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -72.22 167.16 20.94 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.657 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 2' ' ' ALA . 21.9 m-80 -169.29 110.97 0.48 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.707 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.4 pt -70.68 140.87 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.102 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -115.35 120.31 39.18 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.715 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.511 ' CG2' HG23 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -104.3 155.79 5.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.923 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.448 ' N ' ' CG2' ' A' ' 6' ' ' VAL . 38.8 m-85 -115.64 139.98 49.61 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.191 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -62.92 1.36 Allowed 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.385 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.562 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 3.2 m120 -89.5 168.36 12.25 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.52 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.442 ' HG2' ' H ' ' A' ' 10' ' ' GLU . 10.2 pt-20 -70.35 -162.56 0.06 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.414 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.622 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 1.3 m-20 47.43 45.91 17.19 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.254 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.622 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 51.3 p90 38.63 24.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.951 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ASP . 3.8 pt20 -113.04 163.58 14.52 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.562 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 103.9 134.35 8.17 Favored Glycine 0 N--CA 1.501 2.996 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.457 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.519 ' H ' ' CD ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -28.99 132.88 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.02 0.438 . . . . 0.0 111.741 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.424 ' H ' ' CD ' ' A' ' 16' ' ' GLN . 7.1 pm0 -97.63 164.81 12.26 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.727 -0.789 . . . . 0.0 112.423 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 t -149.7 123.63 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.658 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.76 120.84 32.85 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.612 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mt -108.8 140.96 22.36 Favored Pre-proline 0 N--CA 1.489 1.513 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.081 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -72.2 165.72 31.8 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 120.909 1.072 . . . . 0.0 111.277 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.77 -158.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 121.905 1.736 . . . . 0.0 111.089 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.71 168.3 24.56 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 119.272 -1.442 . . . . 0.0 111.551 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.58 ' ND2' ' H ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -95.87 140.45 30.62 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.065 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.69 ' OH ' HD12 ' A' ' 82' ' ' ILE . 36.7 p90 -155.68 176.2 12.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.673 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.965 HG23 ' H ' ' A' ' 27' ' ' ALA . 6.3 t -138.09 -157.32 0.76 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.009 -1.077 . . . . 0.0 112.443 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.718 ' N ' HG23 ' A' ' 25' ' ' THR . 13.1 ptm180 -63.69 -25.82 68.38 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.358 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.965 ' H ' HG23 ' A' ' 25' ' ' THR . . . -58.56 -55.96 28.27 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.652 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -58.29 -45.1 88.6 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.637 -1.225 . . . . 0.0 109.555 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.443 HD23 HD12 ' A' ' 32' ' ' LEU . 30.2 mt -59.97 -34.09 72.82 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.518 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -54.74 -32.02 59.27 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -71.46 -40.55 70.24 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.675 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.443 HD12 HD23 ' A' ' 29' ' ' LEU . 15.0 mt -70.35 -81.04 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.967 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 32' ' ' LEU . . . 160.09 -26.43 0.32 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 118.952 -1.594 . . . . 0.0 111.049 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.557 ' C ' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -85.73 152.22 3.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.574 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.451 ' N ' HG12 ' A' ' 34' ' ' ILE . 3.4 pt-20 -178.51 154.31 0.78 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.357 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 38' ' ' THR . 1.3 m120 64.68 -149.93 0.27 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.549 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -56.21 81.43 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.724 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 36' ' ' ASN . 39.6 p -143.75 -33.56 0.42 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.664 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.621 ' CD1' HD11 ' A' ' 82' ' ' ILE . 3.9 mt -78.87 51.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 119.181 -1.008 . . . . 0.0 109.452 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.8 t -51.38 -46.98 62.99 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.573 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -125.21 167.29 15.06 Favored 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.79 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -155.45 149.69 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 118.197 -1.401 . . . . 0.0 113.05 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -133.59 126.92 31.98 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.492 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.2 t -144.0 113.62 5.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 C-N-CA 119.173 -1.011 . . . . 0.0 112.149 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.37 167.6 21.86 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 121.283 1.322 . . . . 0.0 111.082 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.67 -169.22 0.1 OUTLIER 'Trans proline' 0 C--N 1.32 -0.937 0 C-N-CA 121.97 1.78 . . . . 0.0 111.504 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.406 ' C ' HG13 ' A' ' 48' ' ' VAL . . . 77.66 -15.26 7.95 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.808 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.513 HG11 ' CB ' ' A' ' 2' ' ' ALA . 24.1 m -150.91 139.58 14.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.873 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -109.25 129.24 55.51 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.095 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.76 152.55 24.21 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.409 -0.916 . . . . 0.0 112.661 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.724 HD12 HH21 ' A' ' 83' ' ' ARG . 71.1 mt -139.57 121.3 16.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.992 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.782 HD23 HG23 ' A' ' 82' ' ' ILE . 0.4 OUTLIER -98.69 162.01 13.35 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 119.384 -0.926 . . . . 0.0 112.341 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 62' ' ' GLN . 11.6 m-85 -140.76 115.28 9.45 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.668 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -46.54 -78.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.871 -0.731 . . . . 0.0 112.044 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.417 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 51.3 m-20 -59.77 156.41 14.09 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.112 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -64.59 -173.69 0.11 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.726 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.86 36.31 33.23 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.355 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.481 ' CE1' ' O ' ' A' ' 24' ' ' TYR . 12.0 m-85 49.71 59.16 4.71 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.728 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.36 -176.88 4.54 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.417 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 76.51 170.22 31.04 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 60' ' ' GLY . 17.7 m-20 -42.41 125.85 3.31 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.147 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.426 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 9.5 pt20 -95.01 163.83 13.15 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.75 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.683 HG22 ' N ' ' A' ' 64' ' ' GLU . 4.6 mm -134.93 168.77 22.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.009 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.683 ' N ' HG22 ' A' ' 63' ' ' ILE . 30.8 tt0 -150.48 132.26 15.02 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.253 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.0 m -148.34 151.46 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.301 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.0 -7.73 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.768 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -122.99 -139.27 0.31 Allowed 'General case' 0 C--O 1.206 -1.237 0 CA-C-N 114.042 -1.436 . . . . 0.0 109.281 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -114.2 116.74 29.54 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.646 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.64 112.39 23.61 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.8 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -67.03 -85.79 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.451 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 7.8 mm-40 -72.56 -1.99 18.12 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.738 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.494 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 3.8 tp 75.99 -84.57 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.87 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.03 -161.67 30.29 Favored Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.151 -1.5 . . . . 0.0 110.753 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.547 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.6 Cg_endo -68.87 -55.41 0.21 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.121 1.881 . . . . 0.0 112.335 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -69.77 27.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.599 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.547 ' H ' ' C ' ' A' ' 74' ' ' PRO . 9.1 p-10 -70.91 10.76 0.48 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.118 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.5 ' H ' ' C ' ' A' ' 75' ' ' LEU . 23.3 t-20 -89.47 -9.98 48.07 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.096 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -166.49 132.68 2.41 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.726 -1.19 . . . . 0.0 111.697 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.402 ' CG1' HD12 ' A' ' 39' ' ' ILE . 2.1 t -147.95 142.47 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.057 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 m -154.63 -48.27 0.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.238 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.6 t -90.01 136.28 33.14 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.062 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.782 HG23 HD23 ' A' ' 52' ' ' LEU . 10.6 mt -151.76 149.94 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.434 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.724 HH21 HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -151.32 153.33 34.6 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.844 -1.142 . . . . 0.0 111.213 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.498 ' C ' HH12 ' A' ' 83' ' ' ARG . 3.3 t -142.7 147.19 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.394 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.502 HG12 ' NH1' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -138.77 132.25 39.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.389 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 85' ' ' ILE . 78.7 p -36.78 147.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.89 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.549 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -151.44 140.62 13.81 Favored Pre-proline 0 N--CA 1.487 1.385 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.27 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.549 ' HD2' HG22 ' A' ' 87' ' ' VAL . 6.9 Cg_exo -50.89 133.55 40.16 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 121.256 1.304 . . . . 0.0 111.372 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.555 HG22 ' N ' ' A' ' 90' ' ' GLN . 2.5 p -65.93 160.96 3.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.912 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.555 ' N ' HG22 ' A' ' 89' ' ' VAL . 62.4 mt-30 -143.51 151.31 53.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.157 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.453 ' HG2' HD21 ' A' ' 136' ' ' LEU . 1.8 Cg_endo -64.93 -40.58 20.45 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 121.587 1.525 . . . . 0.0 112.164 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.448 ' CG ' ' C ' ' A' ' 91' ' ' PRO . 3.0 mtm-85 57.98 -164.92 0.17 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.737 0.78 . . . . 0.0 112.431 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.513 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -138.89 173.31 11.7 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.812 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -150.85 123.03 8.29 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.291 -1.364 . . . . 0.0 112.339 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.478 ' O ' ' CB ' ' A' ' 105' ' ' GLU . 8.2 m-30 -95.92 166.39 11.81 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.275 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -135.47 154.65 51.35 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -95.57 146.53 24.39 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.424 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.9 tttt 66.97 126.06 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.564 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 28.6 tt0 -64.27 90.81 0.07 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.702 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.674 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.8 OUTLIER 169.71 21.78 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.734 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.674 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 28.5 p90 38.81 42.22 0.6 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.142 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -118.26 -57.86 2.04 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.533 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -44.52 159.58 0.13 Allowed Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.613 -1.28 . . . . 0.0 110.705 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -47.58 168.82 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.251 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -134.57 167.46 20.76 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.39 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.7 t -143.26 137.46 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.94 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -110.74 160.79 16.4 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 119.325 -0.95 . . . . 0.0 113.23 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.9 mt -145.94 139.01 14.24 Favored Pre-proline 0 N--CA 1.49 1.551 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.03 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -69.55 166.05 28.66 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 121.505 1.47 . . . . 0.0 111.156 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.99 144.68 99.63 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.734 1.622 . . . . 0.0 111.35 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 139.78 178.91 17.21 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 119.188 -1.482 . . . . 0.0 111.423 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.454 ' OE1' ' N ' ' A' ' 113' ' ' TYR . 14.4 tm0? -106.68 157.76 17.47 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.471 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.454 ' N ' ' OE1' ' A' ' 112' ' ' GLN . 67.8 m-85 -145.86 149.97 35.26 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.069 -1.053 . . . . 0.0 111.298 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.0 p -88.08 -157.27 0.4 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.347 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.39 52.22 0.72 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.019 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.18 -69.84 0.12 Allowed 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -70.54 -42.15 71.56 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.499 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.679 ' C ' HD23 ' A' ' 118' ' ' LEU . 2.4 tt -40.53 -73.55 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.254 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.751 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.7 OUTLIER -52.59 -49.87 64.16 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.955 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.404 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 1.8 mpt_? -70.99 -0.33 9.1 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.851 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.533 ' N ' ' O ' ' A' ' 117' ' ' GLU . 24.5 t80 -100.82 -22.81 14.73 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.497 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -131.12 -47.75 0.12 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.208 -1.473 . . . . 0.0 110.811 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.526 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -142.94 -107.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.113 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.526 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 7.0 m-20 -149.26 -178.67 6.53 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.998 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -63.07 10.61 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.473 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.489 ' H ' ' C ' ' A' ' 124' ' ' ASP . 15.5 p-10 -163.72 -139.23 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.511 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 126' ' ' ASN . 0.0 OUTLIER 33.78 87.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.275 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.9 mm -127.23 -41.98 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.071 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.7 m 46.1 -138.31 0.57 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.36 -0.836 . . . . 0.0 113.129 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.5 m -56.98 140.33 49.24 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.576 -1.193 . . . . 0.0 113.005 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.41 HG13 ' CD1' ' A' ' 95' ' ' PHE . 3.9 t -122.28 150.45 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.647 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -145.52 98.6 4.55 Favored Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.907 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -66.49 105.42 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.177 1.252 . . . . 0.0 110.969 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.513 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 28.0 mm-40 -57.97 -11.15 2.18 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.588 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 172.4 -30.31 0.11 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 118.226 -1.94 . . . . 0.0 112.352 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.453 HD21 ' HG2' ' A' ' 91' ' ' PRO . 4.3 mt -98.18 169.45 9.58 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.246 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -88.39 130.17 35.23 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.0 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.7 t -99.85 137.92 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.21 -0.996 . . . . 0.0 112.094 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.419 HG12 ' CE1' ' A' ' 141' ' ' PHE . 86.6 t -136.44 121.73 27.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.149 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.406 ' N ' HD12 ' A' ' 140' ' ' LEU . 5.0 mp -103.56 148.0 26.51 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.952 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.529 ' CD2' ' HB3' ' A' ' 146' ' ' PHE . 15.9 m-85 -120.79 130.54 54.03 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.134 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -66.32 -72.23 0.17 Allowed 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.476 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -75.17 164.74 26.17 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.59 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.617 ' CG ' ' H ' ' A' ' 145' ' ' ASN . 28.7 t0 -62.68 -161.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.831 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.641 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 7.1 m-20 41.16 26.33 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.192 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.641 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 3.1 p90 41.01 58.11 2.6 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.489 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.8 t -136.78 -172.05 3.08 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.237 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.9 -165.54 50.64 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.129 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -59.33 148.86 30.72 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.996 -1.081 . . . . 0.0 110.178 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.2 p -138.82 177.15 8.1 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.534 -0.867 . . . . 0.0 111.468 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.426 ' C ' HD13 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -142.64 84.81 10.68 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.608 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.28 104.4 0.88 Allowed 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 121.8 1.667 . . . . 0.0 112.736 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 26.0 t -85.17 86.53 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.403 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -58.02 -21.32 44.56 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.938 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 59.4 p -169.79 -149.32 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 117.841 -1.544 . . . . 0.0 113.046 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -49.51 142.49 7.92 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.769 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -161.7 64.44 1.78 Allowed Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.666 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.1 Cg_endo -62.08 19.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 122.199 1.933 . . . . 0.0 113.066 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.564 ' O ' HG23 ' A' ' 159' ' ' THR . 1.5 t -172.92 83.22 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 118.27 -1.372 . . . . 0.0 112.128 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.99 -67.45 0.85 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.739 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 163' ' ' MET . . . 43.2 -131.13 5.68 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.849 -1.167 . . . . 0.0 111.464 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -32.88 85.62 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.558 ' N ' ' O ' ' A' ' 161' ' ' GLY . 9.2 tpp -177.42 -73.8 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.61 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.561 ' C ' ' H ' ' A' ' 166' ' ' ASN . 3.3 t-20 -92.22 70.49 5.27 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.58 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -60.42 4.12 0.06 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.071 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.561 ' H ' ' C ' ' A' ' 164' ' ' ASN . 48.2 t30 -162.09 154.02 18.95 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.242 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 44.9 m -147.98 98.67 2.97 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.271 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.3 m -89.67 -38.86 13.59 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.657 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.1 p -146.31 152.4 39.09 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.754 -1.179 . . . . 0.0 110.103 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 118' ' ' LEU . 23.0 pt -134.07 175.96 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.331 -0.947 . . . . 0.0 111.015 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -153.48 108.76 3.2 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.438 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 11.1 mt -91.89 93.3 4.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.295 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 116.334 -1.793 . . . . 0.0 110.909 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 mtt . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.904 0.383 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.432 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . -73.02 173.52 9.2 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.717 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 2' ' ' ALA . 10.7 m120 -159.67 128.75 5.19 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.842 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.481 ' CG1' ' O ' ' A' ' 4' ' ' ILE . 1.2 pt -73.28 124.93 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.127 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -97.86 106.24 18.51 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.256 -0.978 . . . . 0.0 108.511 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.541 ' HB ' HG23 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -90.47 166.38 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 119.195 -1.002 . . . . 0.0 113.257 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.678 ' CZ ' ' CE1' ' A' ' 12' ' ' PHE . 37.6 m-85 -122.7 134.44 54.46 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.358 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.69 -60.23 4.12 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.645 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 3.0 m120 -89.72 174.28 7.81 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.129 -1.028 . . . . 0.0 112.15 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 7.4 tp10 -81.96 165.25 20.89 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.779 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 10' ' ' GLU . 1.6 t70 76.17 42.01 0.2 Allowed 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.027 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.678 ' CE1' ' CZ ' ' A' ' 7' ' ' PHE . 78.1 t80 51.69 11.17 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.423 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -107.32 162.1 14.21 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.318 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.645 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 106.15 133.89 7.61 Favored Glycine 0 N--CA 1.503 3.142 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.853 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 14' ' ' GLY . 33.4 mttp -29.86 138.88 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.424 ' H ' ' HG3' ' A' ' 16' ' ' GLN . 1.5 pp0? -97.17 158.43 15.45 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.446 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 t -147.84 125.73 3.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.596 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -92.09 120.67 32.92 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.161 -1.016 . . . . 0.0 111.694 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.445 HD12 HG11 ' A' ' 6' ' ' VAL . 7.5 mt -114.3 133.17 22.47 Favored Pre-proline 0 N--CA 1.498 1.959 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.265 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -69.53 167.89 22.84 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 120.848 1.032 . . . . 0.0 111.155 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -67.2 -162.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.893 1.729 . . . . 0.0 110.767 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.18 172.8 48.93 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.138 -1.506 . . . . 0.0 111.079 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.56 ' HB3' ' NE ' ' A' ' 83' ' ' ARG . 6.7 p-10 -106.26 139.9 40.05 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.859 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.577 ' CZ ' HD12 ' A' ' 82' ' ' ILE . 4.0 p90 -155.75 -174.62 5.04 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.425 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.5 p -144.4 -156.29 0.68 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.036 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -65.67 -22.03 66.6 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.77 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -64.0 -60.67 2.96 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.501 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 27.8 tt0 -54.86 -45.65 74.59 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.498 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 29' ' ' LEU . 15.0 mt -56.89 -43.05 80.93 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.579 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.76 -34.25 18.67 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 118.878 -1.129 . . . . 0.0 108.826 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -66.55 -42.29 87.36 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.421 -0.911 . . . . 0.0 109.793 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.472 HD12 HD23 ' A' ' 29' ' ' LEU . 9.6 mt -71.71 -71.92 0.25 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.715 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.41 -37.76 0.68 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.329 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.503 ' H ' HG22 ' A' ' 34' ' ' ILE . 1.4 tt -79.3 146.35 8.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.367 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -179.89 161.63 0.98 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.53 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.652 ' O ' HG22 ' A' ' 38' ' ' THR . 7.9 m120 60.1 -128.43 1.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.094 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -51.98 90.67 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.874 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 36' ' ' ASN . 0.3 OUTLIER -178.91 -165.99 0.09 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.383 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.647 ' N ' ' OG1' ' A' ' 38' ' ' THR . 5.2 mt 46.77 37.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-O 122.208 1.004 . . . . 0.0 108.829 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.442 ' OG ' ' CD ' ' A' ' 10' ' ' GLU . 30.9 t -70.02 -31.99 69.92 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.394 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -134.81 154.97 51.4 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.972 HG22 ' HB3' ' A' ' 69' ' ' ALA . 15.5 m -147.45 168.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 117.894 -1.523 . . . . 0.0 113.785 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -141.93 91.06 2.32 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.27 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.4 t -107.91 108.94 61.95 Favored Pre-proline 0 N--CA 1.487 1.38 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.034 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.415 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 2.4 Cg_endo -67.21 172.01 10.66 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.146 1.231 . . . . 0.0 109.587 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.513 ' HB3' ' HE ' ' A' ' 92' ' ' ARG . 2.1 Cg_endo -60.81 -168.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.329 1.353 . . . . 0.0 110.712 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.05 -19.0 10.84 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.12 -1.514 . . . . 0.0 111.871 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.638 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -155.49 155.53 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 118.118 -1.433 . . . . 0.0 113.054 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.417 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 24.4 ttpt -123.61 129.74 51.61 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.257 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.96 134.11 52.85 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.385 -0.926 . . . . 0.0 113.175 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.3 mt -115.51 117.67 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.154 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.949 ' N ' HD12 ' A' ' 52' ' ' LEU . 1.0 OUTLIER -96.35 163.06 13.23 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.215 -0.994 . . . . 0.0 113.337 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -139.92 111.61 7.33 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.052 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -82.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.309 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.465 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 5.2 t-20 -59.99 137.56 58.05 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.546 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.599 ' CG ' ' H ' ' A' ' 57' ' ' GLY . 26.2 t70 -58.94 -168.77 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.384 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.599 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 56.97 27.59 57.08 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 118.885 -1.626 . . . . 0.0 109.758 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 53.9 61.76 2.93 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.114 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.96 -166.64 2.59 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.703 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.465 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 70.71 167.06 6.84 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.295 -1.431 . . . . 0.0 109.974 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -45.31 124.3 4.67 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.464 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -94.61 159.18 15.2 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.906 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.724 HG22 ' N ' ' A' ' 64' ' ' GLU . 7.5 mm -136.27 171.12 17.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.688 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.724 ' N ' HG22 ' A' ' 63' ' ' ILE . 2.3 pt-20 -150.57 132.28 14.94 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.346 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.408 HG13 ' C ' ' A' ' 64' ' ' GLU . 25.2 m -150.19 161.88 4.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.426 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 48' ' ' VAL . 3.0 t -145.57 -8.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.021 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -119.15 -149.01 0.43 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.105 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -90.36 141.55 28.62 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.908 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.972 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -109.62 94.47 5.05 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.843 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.64 -53.62 55.29 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.157 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.477 ' O ' ' C ' ' A' ' 72' ' ' LEU . 10.0 tp10 -128.85 66.64 1.42 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.18 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 71' ' ' GLU . 11.5 tp -21.14 -90.91 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.282 0.989 . . . . 0.0 113.071 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.66 -159.64 17.15 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 118.917 -1.611 . . . . 0.0 110.783 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.08 -34.48 46.46 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 121.911 1.741 . . . . 0.0 111.488 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.641 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -77.85 15.57 0.84 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.89 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.585 ' CG ' ' H ' ' A' ' 77' ' ' ASN . 14.2 p-10 -62.54 -61.18 2.61 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.854 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.585 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 3.5 t-20 -78.68 33.94 0.21 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.86 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 76' ' ' ASN . 46.5 t30 -171.42 71.66 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.241 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.631 HG13 ' N ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -94.59 -177.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.307 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.631 ' N ' HG13 ' A' ' 79' ' ' VAL . 1.5 t 174.82 -71.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.769 -1.172 . . . . 0.0 112.312 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 m -99.97 145.64 27.62 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.495 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.577 HD12 ' CZ ' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -149.65 160.88 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.812 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.815 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -144.03 110.1 5.38 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.732 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.815 ' H ' HH22 ' A' ' 83' ' ' ARG . 11.2 t -116.91 140.34 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.884 -0.727 . . . . 0.0 111.584 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.605 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 3.7 mt -144.97 135.11 19.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.413 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.2 m -41.88 157.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.488 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 48' ' ' VAL . 0.6 OUTLIER -154.61 139.86 12.13 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.318 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.47 ' HD2' HG22 ' A' ' 87' ' ' VAL . 8.0 Cg_exo -50.12 129.31 24.82 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 121.313 1.342 . . . . 0.0 111.071 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 90' ' ' GLN . 2.7 p -66.48 156.34 6.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.039 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.473 ' N ' HG22 ' A' ' 89' ' ' VAL . 10.1 mp0 -144.42 154.51 56.88 Favored Pre-proline 0 N--CA 1.487 1.388 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.872 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.11 -35.7 91.6 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 121.466 1.444 . . . . 0.0 111.142 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.513 ' HE ' ' HB3' ' A' ' 46' ' ' PRO . 86.5 mtt-85 54.72 -157.97 0.2 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.918 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.95 172.22 12.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.527 ' NE ' ' CD ' ' A' ' 105' ' ' GLU . 11.7 ttt180 -148.31 122.34 9.45 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.126 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.446 ' CD2' HG13 ' A' ' 131' ' ' VAL . 26.3 m-85 -105.05 165.54 11.01 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.503 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.541 ' CE2' ' O ' ' A' ' 101' ' ' PHE . 0.5 OUTLIER -125.69 172.76 9.52 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.513 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.447 ' CD1' ' O ' ' A' ' 104' ' ' LYS . 2.1 m-85 -92.32 -97.02 0.13 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.939 -1.104 . . . . 0.0 112.654 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -45.37 164.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.576 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -87.51 67.78 9.45 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.49 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -175.34 33.58 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.804 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.541 ' O ' ' CE2' ' A' ' 96' ' ' PHE . 29.1 t80 55.22 20.55 3.49 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.345 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -119.78 161.07 21.4 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.644 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 94.33 137.08 8.54 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.043 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.447 ' O ' ' CD1' ' A' ' 97' ' ' TYR . 52.7 mttm -28.0 138.93 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.527 ' CD ' ' NE ' ' A' ' 94' ' ' ARG . 11.6 pt-20 -99.48 175.94 5.67 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.26 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.582 HG11 ' C ' ' A' ' 122' ' ' GLY . 40.4 t -150.7 120.11 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.153 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 26.7 p-10 -96.62 155.75 16.64 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.597 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 108' ' ' LEU . 69.5 mt -142.75 149.4 49.93 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.147 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.408 ' O ' HD12 ' A' ' 172' ' ' ILE . 13.1 Cg_endo -77.27 165.03 28.37 Favored 'Trans proline' 0 C--O 1.213 -0.77 0 C-N-CA 121.84 1.693 . . . . 0.0 111.595 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -68.82 153.99 71.92 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 121.686 1.591 . . . . 0.0 110.843 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.45 -161.58 20.76 Favored Glycine 0 N--CA 1.509 3.521 0 C-N-CA 119.194 -1.479 . . . . 0.0 111.835 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.457 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 26.8 mp0 -116.13 161.67 18.57 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.261 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.512 ' HB2' HD12 ' A' ' 118' ' ' LEU . 85.8 m-85 -145.49 146.41 31.45 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.008 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 114' ' ' THR . 10.9 p -74.9 -159.1 0.09 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.442 ' NE2' ' HB3' ' A' ' 144' ' ' ASP . 1.2 pt20 -108.0 40.05 1.82 Allowed 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.22 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.478 ' C ' ' N ' ' A' ' 118' ' ' LEU . . . -157.55 -87.5 0.04 OUTLIER 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 118.684 -1.206 . . . . 0.0 110.88 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 116' ' ' ALA . 11.3 pt-20 -45.53 -25.49 0.45 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.036 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.805 ' C ' HD23 ' A' ' 118' ' ' LEU . 5.6 tt -57.86 -66.53 0.46 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.113 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.439 ' HB3' ' C ' ' A' ' 124' ' ' ASP . 8.1 mm-40 -49.2 -49.95 40.45 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.406 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.483 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 4.0 mmm-85 -67.17 -12.44 60.04 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 118.718 -1.193 . . . . 0.0 112.016 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -91.97 -24.95 19.08 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.154 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.582 ' C ' HG11 ' A' ' 106' ' ' VAL . . . -115.93 -67.43 0.41 Allowed Glycine 0 N--CA 1.483 1.791 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.486 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -138.64 -103.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.186 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.573 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 15.2 t70 -154.01 -165.48 2.12 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.314 -0.955 . . . . 0.0 111.198 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.573 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 8.9 m-20 -58.71 -100.08 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.34 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -80.41 127.68 32.69 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.582 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.684 HG23 ' H ' ' A' ' 128' ' ' ILE . 0.0 OUTLIER 175.48 -106.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.523 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.684 ' H ' HG23 ' A' ' 127' ' ' THR . 6.2 mm 48.62 -97.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.005 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER 78.1 -42.77 0.36 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.2 m -143.56 126.34 16.13 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.682 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.446 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.9 t -121.59 158.84 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-O 121.975 0.893 . . . . 0.0 113.015 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.422 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -146.14 99.32 4.28 Favored Pre-proline 0 C--N 1.3 -1.544 0 CA-C-N 113.865 -1.516 . . . . 0.0 107.86 179.755 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.63 ' C ' ' H ' ' A' ' 135' ' ' GLY . 2.8 Cg_exo -52.66 -15.79 4.75 Favored 'Trans proline' 0 C--O 1.209 -0.955 0 C-N-CA 121.181 1.254 . . . . 0.0 112.491 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 53.17 -6.19 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.764 -0.774 . . . . 0.0 112.498 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . 160.45 -47.36 0.4 Allowed Glycine 0 N--CA 1.483 1.802 0 C-N-CA 118.766 -1.683 . . . . 0.0 111.242 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.1 mt -84.49 -164.31 0.94 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 117.95 -1.5 . . . . 0.0 110.787 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -119.17 131.11 55.82 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.0 t -101.76 143.12 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.796 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.412 ' C ' HD12 ' A' ' 140' ' ' LEU . 57.6 t -137.32 117.76 16.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.315 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 140' ' ' LEU . 10.9 mp -97.71 142.85 29.0 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.483 -0.887 . . . . 0.0 112.37 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.528 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 34.6 m-85 -120.51 133.46 55.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.432 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -74.3 -61.1 1.98 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.488 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -71.46 -175.99 1.43 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.089 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 146' ' ' PHE . 1.8 m-20 -77.18 -165.06 0.52 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.691 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.668 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 16.4 t30 27.95 39.51 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 123.931 0.769 . . . . 0.0 112.138 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.668 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.6 p90 41.65 60.44 2.16 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.197 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.84 -168.11 1.98 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.233 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 63.51 -162.45 33.45 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.607 -1.282 . . . . 0.0 110.145 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -59.58 156.05 14.23 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.189 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.3 p -144.72 160.75 40.7 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.679 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.8 tp -126.39 82.83 65.45 Favored Pre-proline 0 N--CA 1.486 1.325 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.125 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.68 106.56 0.63 Allowed 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 121.884 1.722 . . . . 0.0 113.162 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 43.6 t -87.94 82.45 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 119.455 -0.898 . . . . 0.0 108.949 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -62.59 -9.6 9.4 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.6 p -169.4 -167.9 0.75 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 117.456 -1.698 . . . . 0.0 113.475 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -42.29 150.83 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.53 -1.213 . . . . 0.0 112.812 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.572 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -171.94 66.83 0.41 Allowed Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.65 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.5 Cg_endo -65.6 23.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.173 1.916 . . . . 0.0 112.02 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.572 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.3 t -175.42 57.23 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.042 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 129' ' ' SER . 18.8 tp -63.63 -11.18 23.17 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.895 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 160' ' ' LEU . . . -40.04 97.19 0.01 OUTLIER Glycine 0 N--CA 1.496 2.682 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.46 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -177.27 -6.91 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.771 -0.771 . . . . 0.0 110.362 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -157.74 38.69 0.27 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.272 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.736 ' ND2' ' H ' ' A' ' 165' ' ' ASN . 3.4 p-10 -43.83 -73.55 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.735 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.736 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 1.0 OUTLIER 51.34 -95.48 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.359 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 164' ' ' ASN . 36.9 t30 -172.36 86.03 0.07 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 119.043 -1.063 . . . . 0.0 111.556 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 51.7 m -58.8 111.39 1.26 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.003 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 74.7 m -90.13 -69.28 0.73 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.618 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.0 p -116.0 158.09 23.61 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.593 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 1.4 pt -141.1 -178.59 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.856 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -160.59 114.9 2.15 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.677 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 109' ' ' PRO . 14.0 mt -90.34 95.51 5.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.08 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 116.291 -1.814 . . . . 0.0 110.835 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.515 ' HB1' HG11 ' A' ' 48' ' ' VAL . . . -160.49 57.23 0.33 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.941 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -116.1 115.86 26.84 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.391 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.446 HG21 HD13 ' A' ' 4' ' ' ILE . 8.3 pt -74.56 143.86 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.3 m -128.41 135.5 49.6 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.678 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.499 HG22 ' CG1' ' A' ' 17' ' ' VAL . 9.8 m -120.79 158.64 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.015 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 14.0 m-85 -114.03 157.83 22.0 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.133 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -89.06 9.9 23.65 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.518 ' C ' ' OG ' ' A' ' 40' ' ' SER . 20.1 m120 -151.32 173.29 14.67 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.732 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -78.41 169.93 17.46 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.83 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 13' ' ' GLN . 6.7 t70 65.46 38.08 5.81 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.602 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.539 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 9.0 t80 62.81 -4.67 0.23 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.483 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.489 ' H ' ' C ' ' A' ' 11' ' ' ASP . 69.4 mt-30 -87.69 166.75 14.43 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.129 -1.028 . . . . 0.0 110.906 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 113.95 137.66 6.68 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -29.35 138.28 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.578 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.533 ' O ' ' HG3' ' A' ' 16' ' ' GLN . 2.1 pt20 -103.17 123.7 47.2 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.499 ' CG1' HG22 ' A' ' 6' ' ' VAL . 9.9 p -126.45 138.5 54.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.861 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -100.92 146.6 27.15 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.856 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 mt -137.94 141.46 32.63 Favored Pre-proline 0 N--CA 1.485 1.306 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.676 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -71.86 166.87 28.23 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.794 0.996 . . . . 0.0 111.711 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -67.12 -172.92 0.37 Allowed 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 121.998 1.799 . . . . 0.0 110.934 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.425 ' H ' ' HB ' ' A' ' 84' ' ' VAL . . . 98.44 -156.08 20.27 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.634 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -146.48 150.5 35.72 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.835 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.495 ' OH ' HD12 ' A' ' 82' ' ' ILE . 12.8 p90 -164.15 -164.2 0.84 Allowed 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.417 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.6 p -139.7 175.48 9.53 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.612 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.4 ptt85 -58.1 -13.52 4.98 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.275 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -67.59 -59.3 3.46 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.478 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.483 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 4.2 tp-100 -52.69 -43.06 65.34 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 118.506 -1.278 . . . . 0.0 108.201 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 32' ' ' LEU . 29.7 mt -58.77 -43.74 90.44 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.039 -1.064 . . . . 0.0 109.011 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -47.65 -30.39 3.7 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.618 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -77.61 -36.86 51.31 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.864 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 29' ' ' LEU . 12.7 mt -76.43 -67.37 0.7 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.614 -0.835 . . . . 0.0 110.627 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.6 -7.0 0.13 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.699 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.754 HG22 ' H ' ' A' ' 35' ' ' GLU . 1.3 mt -98.61 -167.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.165 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.754 ' H ' HG22 ' A' ' 34' ' ' ILE . 3.0 pt-20 175.05 -168.23 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.88 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.645 ' HB2' ' H ' ' A' ' 79' ' ' VAL . 24.4 p-10 -77.06 -178.71 5.13 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.506 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.401 ' H ' ' H ' ' A' ' 79' ' ' VAL . 2.9 t30 71.05 -15.36 0.41 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.642 ' O ' ' N ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -86.84 -77.78 0.31 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.058 -1.457 . . . . 0.0 110.938 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.62 ' N ' ' OG1' ' A' ' 38' ' ' THR . 4.3 mt -13.96 75.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 124.924 1.39 . . . . 0.0 112.074 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.642 ' N ' ' O ' ' A' ' 38' ' ' THR . 43.0 t -81.89 -36.14 28.46 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.49 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.2 172.02 13.61 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.1 t -149.97 144.8 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 118.029 -1.468 . . . . 0.0 112.516 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -132.73 101.51 5.31 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.841 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.5 t -125.04 110.1 27.28 Favored Pre-proline 0 N--CA 1.491 1.617 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.267 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -69.19 166.78 25.72 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.129 1.219 . . . . 0.0 110.802 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -61.29 -168.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 121.754 1.636 . . . . 0.0 110.948 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.43 ' C ' ' CG1' ' A' ' 48' ' ' VAL . . . 76.21 -8.25 25.65 Favored Glycine 0 C--O 1.207 -1.578 0 C-N-CA 118.902 -1.618 . . . . 0.0 109.743 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.515 HG11 ' HB1' ' A' ' 2' ' ' ALA . 0.9 OUTLIER -151.24 134.41 7.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.143 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -107.37 121.16 44.03 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.91 159.38 20.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.01 -1.076 . . . . 0.0 113.095 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 63' ' ' ILE . 35.0 mt -142.92 124.21 11.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.603 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.523 HD13 ' HB ' ' A' ' 63' ' ' ILE . 5.2 mp -89.26 160.35 16.96 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.714 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -138.89 115.98 10.98 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.505 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -56.86 -80.26 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.771 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -59.47 148.17 33.91 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.175 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.506 ' OD1' ' CB ' ' A' ' 80' ' ' SER . 1.0 OUTLIER -60.26 172.44 0.83 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.725 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.05 31.69 80.16 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.11 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 50.56 47.32 24.38 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.779 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.24 -161.58 1.01 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.835 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.38 -178.87 2.01 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.317 -1.421 . . . . 0.0 109.889 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -48.24 163.62 0.06 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.217 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -148.12 141.07 24.81 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.544 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.599 HD11 HD21 ' A' ' 75' ' ' LEU . 3.0 mt -107.5 168.65 3.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.679 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' H ' HG22 ' A' ' 63' ' ' ILE . 48.9 tt0 -137.1 132.92 34.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.8 m -148.65 159.92 6.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 118.371 -1.332 . . . . 0.0 112.495 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 t -150.18 -1.48 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.483 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -132.57 -150.13 0.4 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.649 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -101.05 113.63 26.81 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.634 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.565 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.53 97.72 11.36 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.906 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -62.87 -74.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.397 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -67.51 -8.95 37.8 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.446 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.3 tp 66.78 -80.2 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.592 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 143.49 -158.51 27.32 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.438 -1.363 . . . . 0.0 110.138 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.6 ' C ' HD23 ' A' ' 75' ' ' LEU . 2.2 Cg_endo -64.56 -159.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.649 1.566 . . . . 0.0 110.814 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.6 HD23 ' C ' ' A' ' 74' ' ' PRO . 1.1 pt? 32.83 32.06 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.722 0.639 . . . . 0.0 111.945 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 74' ' ' PRO . 49.6 t30 -84.98 -15.47 44.14 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.098 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -86.98 0.43 55.16 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.273 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -172.02 122.34 0.48 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 118.51 -1.276 . . . . 0.0 112.162 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 80' ' ' SER . 1.9 t -122.8 -148.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.443 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.651 ' H ' HG12 ' A' ' 79' ' ' VAL . 1.0 OUTLIER 154.33 -59.57 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.416 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.1 m -111.98 156.07 22.72 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.511 -0.876 . . . . 0.0 113.137 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.495 HD12 ' OH ' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -148.22 163.78 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.933 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.741 HH11 ' C ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -143.12 133.47 24.69 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.651 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.741 ' C ' HH11 ' A' ' 83' ' ' ARG . 22.1 t -139.98 128.57 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.936 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.458 HD11 ' HE ' ' A' ' 83' ' ' ARG . 55.3 mt -130.69 124.44 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.415 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.4 p -45.25 148.02 0.68 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.558 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.488 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.9 OUTLIER -148.07 152.05 39.07 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.275 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.488 ' HD2' HG22 ' A' ' 87' ' ' VAL . 2.9 Cg_exo -55.45 155.57 20.36 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.14 1.227 . . . . 0.0 110.859 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.3 t -59.71 144.39 12.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.732 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -144.74 119.06 5.73 Favored Pre-proline 0 N--CA 1.487 1.415 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.461 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -61.65 -157.53 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.832 0 C-N-CA 121.07 1.18 . . . . 0.0 111.184 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.444 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER 178.98 -162.14 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.274 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.435 ' N ' ' HD3' ' A' ' 92' ' ' ARG . . . -138.39 173.31 11.73 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.094 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -119.95 149.98 41.25 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.158 -1.017 . . . . 0.0 112.513 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -141.46 115.44 9.22 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.608 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.42 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 55.5 m-85 -79.42 176.93 9.24 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.81 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.16 -46.9 3.5 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.409 -0.917 . . . . 0.0 112.15 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.514 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 14.8 ttmt -92.26 154.73 18.43 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.864 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.597 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -71.13 102.72 2.56 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.11 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.609 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 5.7 tm0? 123.96 47.13 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.113 0 O-C-N 125.356 1.66 . . . . 0.0 109.072 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.609 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 21.9 p90 30.15 59.44 0.2 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.65 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -130.64 -12.54 3.84 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.252 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.514 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -93.66 157.23 22.89 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.459 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.466 ' HD3' ' H ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -29.59 139.11 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.19 0.519 . . . . 0.0 112.258 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.466 ' H ' ' HD3' ' A' ' 104' ' ' LYS . 0.4 OUTLIER -93.85 105.42 17.44 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.229 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.468 HG11 ' C ' ' A' ' 122' ' ' GLY . 92.7 t -92.64 137.9 21.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.051 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -121.53 155.07 35.76 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.95 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.7 mt -144.3 132.51 10.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.026 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -66.5 166.63 21.18 Favored 'Trans proline' 0 C--O 1.214 -0.725 0 C-N-CA 121.643 1.562 . . . . 0.0 111.69 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.55 149.24 68.16 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.81 1.673 . . . . 0.0 111.565 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.55 -176.3 20.45 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 119.415 -1.374 . . . . 0.0 110.932 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.407 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 40.8 tt0 -110.89 154.57 23.86 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.482 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 61.7 m-85 -146.22 155.46 42.7 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.436 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 3.1 p -92.49 -142.44 0.2 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.34 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.52 ' N ' ' OG1' ' A' ' 114' ' ' THR . 36.4 tt0 -111.97 -20.97 11.79 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.658 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.78 -57.59 3.72 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.381 -0.928 . . . . 0.0 112.644 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.561 ' CG ' ' H ' ' A' ' 118' ' ' LEU . 4.6 pt-20 -71.36 -55.93 7.0 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.837 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.561 ' H ' ' CG ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -32.34 -67.42 0.11 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.976 0.798 . . . . 0.0 111.273 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' A' ' 121' ' ' TYR . 75.6 mt-10 -55.5 -61.55 2.27 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.726 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.476 ' NH1' ' OD1' ' A' ' 124' ' ' ASP . 1.7 mpt_? -73.86 19.88 0.11 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.199 -1.0 . . . . 0.0 112.344 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 117' ' ' GLU . 17.9 t80 -124.45 -15.59 6.6 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.858 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.468 ' C ' HG11 ' A' ' 106' ' ' VAL . . . -148.22 -38.45 0.04 OUTLIER Glycine 0 C--N 1.295 -1.735 0 C-N-CA 118.771 -1.681 . . . . 0.0 110.822 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.443 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -141.75 -113.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.316 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.596 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 28.8 t70 -156.5 -176.86 6.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.396 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.596 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 46.9 t30 -79.22 148.82 32.09 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.845 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.554 HD22 ' CB ' ' A' ' 166' ' ' ASN . 32.5 m120 44.9 45.64 8.63 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.412 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.4 m -163.42 107.25 1.02 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.872 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.1 mm -138.95 -45.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.606 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.587 ' OG ' ' N ' ' A' ' 130' ' ' SER . 1.2 p 66.02 -152.45 0.24 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.587 ' N ' ' OG ' ' A' ' 129' ' ' SER . 26.8 m -49.79 129.86 20.5 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.404 -1.271 . . . . 0.0 113.066 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.4 151.17 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.928 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -160.58 112.69 1.35 Allowed Pre-proline 0 C--N 1.292 -1.896 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.598 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.26 170.79 3.7 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 120.605 0.87 . . . . 0.0 111.777 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -156.26 5.74 0.18 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.776 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.57 -50.92 0.04 OUTLIER Glycine 0 N--CA 1.481 1.677 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.37 162.94 20.66 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.732 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.66 154.8 24.71 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.329 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.6 143.72 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.265 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.3 t -129.76 125.37 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.464 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.6 mp -99.4 145.28 27.56 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.829 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.559 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 3.3 m-85 -120.78 143.23 48.93 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.3 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -73.85 -76.17 0.14 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.553 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -74.82 157.12 35.68 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.611 ' CG ' ' H ' ' A' ' 145' ' ' ASN . 26.4 t70 -57.92 -174.4 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.47 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.636 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 21.9 t-20 40.34 27.18 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.094 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.636 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.9 p90 41.69 62.0 1.7 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.286 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.9 t -131.95 71.46 1.47 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.306 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 173.14 -163.12 34.65 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.277 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.52 162.76 4.66 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 118.914 -1.114 . . . . 0.0 109.788 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.7 p -149.35 164.2 35.56 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.732 -1.187 . . . . 0.0 111.612 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.5 mt -131.64 87.32 46.26 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.714 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -61.44 107.87 0.54 Allowed 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.487 1.458 . . . . 0.0 111.859 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.442 ' C ' ' H ' ' A' ' 155' ' ' SER . 2.2 t -91.84 65.64 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.887 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -79.07 33.49 0.22 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.219 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 153' ' ' VAL . 16.8 t -167.09 -156.87 0.23 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.195 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.416 ' N ' ' OG ' ' A' ' 155' ' ' SER . 6.0 m-20 -90.61 153.22 20.48 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.768 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.433 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -163.2 71.39 1.94 Allowed Pre-proline 0 N--CA 1.486 1.334 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.533 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.471 ' C ' ' HG ' ' A' ' 130' ' ' SER . 1.2 Cg_endo -67.73 35.77 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.535 2.157 . . . . 0.0 113.372 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.727 HG23 ' H ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -167.38 -83.34 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.336 -1.345 . . . . 0.0 111.852 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.727 ' H ' HG23 ' A' ' 159' ' ' THR . 2.3 tp 73.68 -69.65 0.18 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.424 -0.911 . . . . 0.0 110.544 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 54.97 55.55 27.44 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.367 -1.397 . . . . 0.0 110.736 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 50.7 89.78 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.889 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 2.3 mmt -74.54 -63.02 1.33 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.665 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -90.33 -59.61 2.14 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.678 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -155.31 -79.18 0.09 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.701 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.554 ' CB ' HD22 ' A' ' 126' ' ' ASN . 2.7 p-10 -157.82 163.69 37.75 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.916 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.2 m -103.4 112.04 24.74 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.303 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 83.7 p -96.67 -35.35 11.06 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.75 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.67 154.44 50.92 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.898 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 16.8 pt -135.76 162.97 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.486 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.424 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 41.2 ttp85 -146.32 100.99 3.44 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.846 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.6 mt -81.73 99.54 4.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.055 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 116.448 -1.739 . . . . 0.0 111.02 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 mtt . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.855 0.359 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.22 115.88 2.06 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.991 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -175.89 122.66 0.19 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.192 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -84.29 153.68 3.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.136 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.4 m -128.09 118.78 24.07 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.092 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 16' ' ' GLN . 3.7 m -98.25 170.12 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.335 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 1.305 ' CE2' ' NE2' ' A' ' 16' ' ' GLN . 24.8 m-85 -129.49 149.46 51.26 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.516 ' CD2' ' NZ ' ' A' ' 15' ' ' LYS . 2.7 m-85 -77.28 -57.78 3.64 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.978 -1.089 . . . . 0.0 113.233 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.517 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 19.0 m120 -87.58 162.28 17.26 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.721 -1.191 . . . . 0.0 111.923 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.54 -179.04 0.99 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.326 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.647 ' C ' ' CG ' ' A' ' 12' ' ' PHE . 6.0 t70 51.52 52.63 14.3 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 118.313 -1.355 . . . . 0.0 110.52 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.647 ' CG ' ' C ' ' A' ' 11' ' ' ASP . 1.2 p90 41.65 20.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 11' ' ' ASP . 22.2 mt-30 -93.77 173.88 7.45 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.85 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.517 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 79.01 128.09 0.55 Allowed Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.188 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.516 ' NZ ' ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -40.99 156.34 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.935 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 1.305 ' NE2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -112.16 177.03 4.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 t -141.65 137.9 31.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 114.332 -1.304 . . . . 0.0 109.379 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -95.47 114.51 26.29 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.663 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.0 mt -107.88 133.05 20.62 Favored Pre-proline 0 N--CA 1.492 1.657 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.043 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -71.41 156.57 58.28 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 120.837 1.025 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.53 -167.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 121.506 1.471 . . . . 0.0 110.67 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.447 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 100.14 -174.22 26.11 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.942 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.705 ' CA ' HH11 ' A' ' 83' ' ' ARG . 13.6 p-10 -109.69 122.88 48.48 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.926 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 7.7 p90 -147.86 173.9 12.38 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 118.746 -1.182 . . . . 0.0 111.005 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.7 p -147.79 -154.83 0.58 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.051 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -62.43 -28.28 69.69 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.802 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -62.39 -63.43 1.24 Allowed 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.71 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.9 tt0 -55.48 -49.59 72.13 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.603 -1.239 . . . . 0.0 109.481 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.618 HD23 HD12 ' A' ' 32' ' ' LEU . 26.9 mt -51.84 -41.27 61.68 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.57 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.53 -35.84 21.55 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 118.558 -1.257 . . . . 0.0 108.006 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -65.04 -40.31 94.61 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.554 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.618 HD12 HD23 ' A' ' 29' ' ' LEU . 17.0 mt -72.86 -74.12 0.18 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.601 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.12 -26.27 1.0 Allowed Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.995 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.0 142.41 13.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.194 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 9.1 pt-20 -177.86 155.0 0.96 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.642 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 33.4 t30 90.18 -149.62 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 O-C-N 124.265 0.978 . . . . 0.0 112.408 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.456 ' H ' ' CG ' ' A' ' 36' ' ' ASN . 12.1 p-10 -70.14 32.48 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.045 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 40' ' ' SER . 1.0 OUTLIER -88.13 -40.99 13.32 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.62 -1.232 . . . . 0.0 110.336 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.42 ' HB ' HG21 ' A' ' 79' ' ' VAL . 22.7 mt -64.88 74.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.38 -0.928 . . . . 0.0 108.976 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 38' ' ' THR . 28.0 t -76.33 -72.97 0.3 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.704 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.46 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -99.15 168.04 10.31 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.888 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.589 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.1 t -151.32 148.31 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 117.988 -1.485 . . . . 0.0 113.087 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -133.72 108.69 8.67 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.852 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.451 HG23 HG13 ' A' ' 42' ' ' VAL . 65.2 t -128.46 111.42 19.38 Favored Pre-proline 0 N--CA 1.5 2.05 0 C-N-CA 119.809 -0.756 . . . . 0.0 112.311 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.59 170.07 14.53 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.099 1.2 . . . . 0.0 110.851 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.16 -167.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.919 1.746 . . . . 0.0 110.978 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.434 ' C ' HG12 ' A' ' 48' ' ' VAL . . . 78.21 -11.34 23.7 Favored Glycine 0 N--CA 1.484 1.851 0 C-N-CA 119.104 -1.522 . . . . 0.0 110.982 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.676 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -154.76 148.66 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 118.725 -1.19 . . . . 0.0 112.074 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -115.14 142.3 46.84 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.974 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.84 143.03 46.8 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.026 -1.07 . . . . 0.0 112.274 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.551 HG23 ' O ' ' A' ' 63' ' ' ILE . 78.2 mt -121.04 121.75 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.284 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.599 HD23 ' H ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -91.99 147.21 23.13 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.306 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.599 ' H ' HD23 ' A' ' 52' ' ' LEU . 53.3 m-85 -134.45 132.61 39.51 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.142 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -58.94 -84.44 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.052 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -65.17 163.65 14.69 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.65 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -63.09 -177.94 0.2 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.586 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.614 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 53.96 33.1 50.0 Favored Glycine 0 N--CA 1.487 2.059 0 C-N-CA 118.957 -1.592 . . . . 0.0 109.158 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.614 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 41.99 69.78 0.33 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.576 0.703 . . . . 0.0 110.751 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.91 174.21 10.79 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.07 -177.21 54.36 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.483 -1.342 . . . . 0.0 110.088 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.14 118.14 1.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.18 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.423 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 15.9 pt20 -101.27 172.39 7.02 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.738 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.551 ' O ' HG23 ' A' ' 51' ' ' ILE . 4.8 mt -144.47 163.84 13.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.553 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -138.98 126.2 21.39 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.769 -0.773 . . . . 0.0 109.498 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.3 m -149.03 158.96 6.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 118.781 -1.168 . . . . 0.0 112.727 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 48' ' ' VAL . 3.9 t -149.78 -1.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.401 ' H ' ' H ' ' A' ' 66' ' ' VAL . . . -125.42 -135.97 0.27 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.722 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -105.93 112.0 24.88 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.24 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.589 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.54 80.33 6.71 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.768 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -52.33 -81.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.048 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -69.12 -10.44 57.67 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.603 -0.839 . . . . 0.0 112.008 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.547 ' HB3' HD22 ' A' ' 76' ' ' ASN . 2.5 tp 63.23 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.434 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.429 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 175.15 -175.25 47.11 Favored Glycine 0 N--CA 1.501 2.998 0 C-N-CA 119.183 -1.484 . . . . 0.0 110.999 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.531 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.2 Cg_endo -66.72 -39.92 14.21 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 122.375 2.05 . . . . 0.0 112.188 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.986 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.7 pt? -71.11 30.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.144 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.547 HD22 ' HB3' ' A' ' 72' ' ' LEU . 4.3 m-20 -72.67 -9.6 58.81 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.639 -0.825 . . . . 0.0 110.605 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -87.57 13.16 10.78 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.126 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.644 ' N ' ' ND2' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -177.91 116.79 0.09 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 118.691 -1.204 . . . . 0.0 111.699 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 36' ' ' ASN . 15.6 m -157.07 145.85 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.944 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.6 p -164.34 -36.86 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 118.562 -1.255 . . . . 0.0 113.131 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.43 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 4.1 m -94.61 142.99 26.81 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 118.773 -1.171 . . . . 0.0 111.577 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.415 ' CG1' ' C ' ' A' ' 81' ' ' SER . 2.1 mt -148.58 143.21 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 118.821 -1.152 . . . . 0.0 111.426 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.829 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -121.31 116.01 24.04 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.783 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.829 ' H ' HH12 ' A' ' 83' ' ' ARG . 3.9 t -123.69 136.36 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.943 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.514 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 3.8 mt -139.1 126.74 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.196 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.6 p -48.98 133.02 18.59 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.433 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.775 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -122.9 149.92 57.7 Favored Pre-proline 0 N--CA 1.49 1.566 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.599 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.775 ' HD2' HG22 ' A' ' 87' ' ' VAL . 6.0 Cg_exo -51.43 127.31 21.94 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 121.386 1.391 . . . . 0.0 111.216 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.3 p -58.51 136.87 21.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.881 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -145.91 151.46 45.56 Favored Pre-proline 0 N--CA 1.487 1.389 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.961 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.419 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 2.3 Cg_endo -58.89 -164.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 121.277 1.318 . . . . 0.0 111.111 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.467 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -175.79 -161.75 0.09 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.759 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -141.71 162.96 34.2 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.084 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.1 ttm-85 -135.82 107.48 6.99 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.05 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 18.5 m-85 -87.0 169.15 12.68 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.597 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.482 ' CE1' ' HB3' ' A' ' 105' ' ' GLU . 26.8 m-85 -137.09 167.64 21.15 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.581 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.409 ' OH ' HG23 ' A' ' 123' ' ' ILE . 3.4 m-85 -103.24 168.83 8.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.659 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.405 ' CB ' ' OD1' ' A' ' 102' ' ' ASP . 52.5 mttp 57.14 164.69 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.841 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 24.2 tt0 -90.85 75.78 6.41 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.683 ' HG2' ' CG ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 153.78 43.46 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 O-C-N 124.358 1.036 . . . . 0.0 109.376 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 100' ' ' GLN . 19.1 p90 33.47 32.67 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.284 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.683 ' CG ' ' HG2' ' A' ' 100' ' ' GLN . 22.7 p-10 -107.32 36.2 2.79 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.154 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -145.66 158.37 27.65 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.277 -1.439 . . . . 0.0 110.467 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.545 ' H ' ' HE3' ' A' ' 104' ' ' LYS . 1.2 mtmt -31.72 144.84 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.169 0.509 . . . . 0.0 112.318 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.482 ' HB3' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -105.86 149.49 26.48 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.175 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 45.4 t -143.91 150.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.761 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -136.8 156.53 48.37 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.241 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.431 HD22 ' CE2' ' A' ' 121' ' ' TYR . 11.8 mt -137.01 163.12 51.66 Favored Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.938 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -88.78 166.92 5.96 Favored 'Trans proline' 0 C--O 1.212 -0.78 0 C-N-CA 121.871 1.714 . . . . 0.0 112.74 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -63.58 140.56 75.89 Favored 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 121.745 1.63 . . . . 0.0 110.89 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.75 -154.96 25.59 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.19 -1.481 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.595 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 37.3 tt0 -125.35 156.77 38.21 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.367 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 48.5 m-85 -144.07 149.55 36.78 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.792 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.3 p -96.81 -159.49 0.74 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.717 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.702 ' H ' ' CD ' ' A' ' 115' ' ' GLN . 2.5 pm0 -105.51 56.29 0.68 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.213 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.74 -64.34 0.11 Allowed 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.741 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.572 ' CG ' ' H ' ' A' ' 118' ' ' LEU . 9.0 pt-20 -69.77 -52.19 27.44 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.577 ' C ' HD23 ' A' ' 118' ' ' LEU . 1.9 tt -33.67 -60.23 0.37 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.167 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 36.4 mt-10 -54.36 -69.42 0.13 Allowed 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.293 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.434 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 3.4 mpt_? -74.79 23.23 0.1 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.293 -0.963 . . . . 0.0 112.376 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 117' ' ' GLU . 13.0 t80 -114.13 -22.29 10.08 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.856 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.74 -21.55 0.02 OUTLIER Glycine 0 N--CA 1.488 2.117 0 C-N-CA 118.429 -1.844 . . . . 0.0 110.625 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.425 HG21 HD13 ' A' ' 123' ' ' ILE . 9.1 mt -139.79 -120.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.746 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 124' ' ' ASP . 11.7 p30 -159.08 -154.98 0.44 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.767 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -76.22 -35.23 59.13 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.803 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.424 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 25.5 t30 -162.11 118.01 1.99 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.798 -1.161 . . . . 0.0 112.154 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.412 ' CG2' ' CG2' ' A' ' 123' ' ' ILE . 6.1 t -179.2 -14.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.895 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.452 HG13 ' H ' ' A' ' 128' ' ' ILE . 2.1 mt -50.84 166.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.173 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.8 p -175.4 -115.11 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.536 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.1 m -54.39 131.27 41.84 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.854 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.13 155.83 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.47 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.11 83.83 4.57 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.835 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.58 107.46 1.44 Allowed 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.317 1.345 . . . . 0.0 110.638 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -88.86 24.34 2.08 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.973 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -173.01 -56.01 0.05 OUTLIER Glycine 0 N--CA 1.494 2.542 0 C-N-CA 118.208 -1.949 . . . . 0.0 112.095 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.419 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 0.9 OUTLIER -116.79 172.74 7.05 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.567 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -89.37 142.58 27.53 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.497 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.2 t -102.13 145.41 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.94 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.99 124.65 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.681 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 140' ' ' LEU . 4.5 mp -107.74 146.07 32.64 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.239 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 20.2 m-85 -120.02 137.51 54.05 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.591 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -71.03 -67.82 0.48 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.951 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -65.57 165.34 12.46 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.98 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 146' ' ' PHE . 3.0 m-20 -63.61 -162.51 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.735 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.665 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 35.1 m120 27.48 39.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 123.859 0.724 . . . . 0.0 112.101 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.665 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.2 OUTLIER 43.97 61.26 2.39 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.456 -0.897 . . . . 0.0 109.881 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -132.42 173.29 11.45 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.27 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.05 -166.3 53.86 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.347 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -59.41 172.97 0.57 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.026 -1.069 . . . . 0.0 109.944 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 43.1 p -151.67 177.33 10.47 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.972 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.512 ' HA ' HD22 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -137.63 79.72 33.98 Favored Pre-proline 0 N--CA 1.485 1.3 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.764 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.6 105.21 0.73 Allowed 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 122.025 1.817 . . . . 0.0 113.247 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 39.8 t -90.68 74.52 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.946 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 154' ' ' ASN . 1.8 m-20 -79.19 26.64 0.26 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.14 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 25.4 t -169.99 -174.06 1.7 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.626 -1.23 . . . . 0.0 111.839 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.433 ' N ' ' OG ' ' A' ' 155' ' ' SER . 1.8 m-20 -73.78 154.44 39.55 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.907 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.594 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -166.68 72.4 1.11 Allowed Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.239 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.32 20.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.968 1.779 . . . . 0.0 111.85 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.594 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.2 t -169.38 71.08 0.07 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.863 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.431 ' HA ' HD22 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -75.58 -83.76 0.06 Allowed 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.479 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 56.46 176.06 0.27 Allowed Glycine 0 N--CA 1.493 2.453 0 C-N-CA 118.902 -1.618 . . . . 0.0 110.083 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 55.33 98.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.917 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 4.1 ptm -176.33 73.46 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.475 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -44.0 161.51 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.709 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 59.4 89.47 0.06 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.006 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.425 ' N ' ' OD1' ' A' ' 166' ' ' ASN . 29.3 p-10 -38.98 151.4 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.994 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.18 120.81 14.36 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.865 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 54.4 p -92.78 -42.38 9.6 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.284 -0.967 . . . . 0.0 110.533 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.72 164.09 29.08 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.788 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 30.0 pt -143.61 165.91 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -148.43 109.73 4.37 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.875 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.9 mt -89.12 99.47 9.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 119.271 -0.971 . . . . 0.0 109.946 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.305 -1.346 0 CA-C-O 116.352 -1.785 . . . . 0.0 111.12 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.2 mmm . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.937 0.399 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.579 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . -160.43 -148.05 0.16 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.588 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -175.87 119.75 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.673 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.482 ' CG1' ' O ' ' A' ' 4' ' ' ILE . 1.0 OUTLIER -77.57 122.42 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.821 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -95.93 106.53 18.69 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.131 -1.028 . . . . 0.0 108.602 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.453 ' CG1' HD12 ' A' ' 19' ' ' LEU . 1.4 m -88.43 170.06 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 118.974 -1.09 . . . . 0.0 112.344 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 1.189 ' CE2' ' HG2' ' A' ' 16' ' ' GLN . 40.3 m-85 -134.35 144.5 48.29 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.75 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -65.61 -62.18 1.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.975 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.512 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 29.8 m120 -90.52 160.57 15.91 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.754 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -58.88 -171.6 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.64 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.638 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 11.5 m-20 44.95 51.54 8.61 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.842 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.638 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 49.5 p90 39.48 24.38 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 11' ' ' ASP . 32.9 mm-40 -98.69 173.74 6.75 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.565 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.512 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 81.58 135.68 1.95 Allowed Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.389 -1.386 . . . . 0.0 110.352 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 14' ' ' GLY . 30.0 mmtm -29.82 136.83 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.957 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 1.189 ' HG2' ' CE2' ' A' ' 7' ' ' PHE . 1.7 mt-30 -97.53 160.8 14.1 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.339 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -146.22 129.05 9.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.131 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -91.14 124.59 35.48 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.863 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.453 HD12 ' CG1' ' A' ' 6' ' ' VAL . 7.9 mt -119.46 125.85 27.3 Favored Pre-proline 0 N--CA 1.497 1.898 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.892 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.4 158.83 47.04 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 120.98 1.12 . . . . 0.0 111.485 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.14 -166.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.911 1.741 . . . . 0.0 111.154 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.95 -171.28 29.88 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.222 -1.466 . . . . 0.0 110.481 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -117.83 131.57 56.54 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.087 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.56 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 1.1 p90 -149.47 -174.88 4.8 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.937 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.498 HG22 ' OG ' ' A' ' 81' ' ' SER . 4.1 p -155.7 -162.14 1.27 Allowed 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.908 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.471 ' CD ' ' C ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -54.08 -20.65 6.86 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.493 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.444 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . -67.58 -66.58 0.54 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.441 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.506 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -54.58 -44.83 73.34 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.796 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.696 HD23 HD12 ' A' ' 32' ' ' LEU . 19.6 mt -57.64 -42.74 84.04 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.005 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.03 -32.0 32.35 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 118.409 -1.317 . . . . 0.0 108.817 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -67.38 -39.31 85.61 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.638 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.696 HD12 HD23 ' A' ' 29' ' ' LEU . 6.1 mt -75.76 -71.87 0.35 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.326 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.62 -36.72 0.73 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.376 -1.393 . . . . 0.0 110.609 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 tt -81.99 143.15 12.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.849 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.491 ' H ' HG21 ' A' ' 38' ' ' THR . 0.6 OUTLIER -179.96 134.98 0.11 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.563 -1.255 . . . . 0.0 112.495 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.774 ' O ' HG23 ' A' ' 38' ' ' THR . 0.1 OUTLIER 74.76 128.94 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.075 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.501 ' H ' ' H ' ' A' ' 79' ' ' VAL . 2.6 t30 45.36 8.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.178 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.774 HG23 ' O ' ' A' ' 36' ' ' ASN . 66.3 p -89.3 -33.33 16.97 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.527 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.448 ' H ' HG12 ' A' ' 39' ' ' ILE . 4.8 mm -75.71 66.4 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.743 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.0 t -73.37 -55.3 6.57 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.153 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.9 160.06 29.72 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.147 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.001 HG22 ' HB3' ' A' ' 69' ' ' ALA . 18.6 m -149.73 168.01 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 118.356 -1.338 . . . . 0.0 113.409 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -142.62 98.37 3.28 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.87 -1.514 . . . . 0.0 108.099 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.408 HG22 HG22 ' A' ' 4' ' ' ILE . 42.0 t -116.17 113.28 41.51 Favored Pre-proline 0 N--CA 1.496 1.852 0 C-N-CA 119.873 -0.731 . . . . 0.0 112.81 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -69.3 171.7 13.5 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.041 1.161 . . . . 0.0 110.009 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.525 ' HG3' ' HE ' ' A' ' 92' ' ' ARG . 1.0 OUTLIER -64.88 -167.78 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.617 1.545 . . . . 0.0 111.158 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.59 -8.36 7.46 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.373 -1.394 . . . . 0.0 110.781 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.579 HG11 ' HB3' ' A' ' 2' ' ' ALA . 33.2 m -148.59 143.34 18.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.576 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -118.23 126.42 52.13 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.234 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.54 144.53 36.08 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.377 -0.929 . . . . 0.0 112.765 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.593 HD12 ' NH2' ' A' ' 83' ' ' ARG . 27.8 mt -133.11 112.39 17.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.097 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.523 ' H ' HD12 ' A' ' 52' ' ' LEU . 1.6 mp -89.72 160.45 16.57 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.68 -1.208 . . . . 0.0 112.773 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -138.54 108.55 6.36 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.107 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -49.38 -78.59 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.259 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.488 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 5.0 m120 -59.76 141.44 55.23 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.965 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -55.64 177.81 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.852 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.46 29.48 69.42 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.334 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.439 ' CZ ' HG23 ' A' ' 25' ' ' THR . 21.4 m-85 54.88 67.6 0.99 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.787 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.59 -162.65 1.6 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.958 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.488 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 64.42 176.09 4.59 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.363 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 60' ' ' GLY . 63.0 m-20 -42.68 112.92 0.4 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.613 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.745 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -93.0 155.68 17.37 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.401 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.706 HG22 ' N ' ' A' ' 64' ' ' GLU . 7.3 mm -134.71 169.42 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.747 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.706 ' N ' HG22 ' A' ' 63' ' ' ILE . 41.0 tt0 -150.8 130.71 13.33 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.718 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.517 HG12 ' CE1' ' A' ' 121' ' ' TYR . 17.6 m -149.95 159.94 4.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 118.942 -1.103 . . . . 0.0 111.808 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.93 -11.98 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.908 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -116.69 -149.42 0.44 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.892 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -94.04 128.51 40.44 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.508 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.001 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -92.48 95.69 9.79 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.423 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 7.0 tp10 -56.9 -78.16 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.538 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.45 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 7.3 tp10 -91.42 5.05 50.9 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.309 -0.957 . . . . 0.0 110.748 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.439 HD12 ' HB1' ' A' ' 69' ' ' ALA . 14.7 tp 53.2 -99.85 0.09 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.023 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.72 -169.95 34.39 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 118.897 -1.62 . . . . 0.0 111.166 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.638 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.2 Cg_endo -68.58 -37.44 12.7 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.574 2.183 . . . . 0.0 112.929 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.513 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.6 pt? -57.01 8.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.102 -1.039 . . . . 0.0 111.586 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.638 ' H ' ' C ' ' A' ' 74' ' ' PRO . 22.7 t-20 -59.52 -9.89 2.92 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.329 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -67.25 -24.26 65.79 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.014 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -168.53 133.87 1.73 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.064 -1.055 . . . . 0.0 111.482 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.501 ' H ' ' H ' ' A' ' 37' ' ' ASN . 2.3 t -146.75 125.97 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.237 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.3 t -146.29 -42.8 0.2 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.925 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.498 ' OG ' HG22 ' A' ' 25' ' ' THR . 5.2 m -90.93 135.21 33.89 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.057 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.439 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -141.02 159.51 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.196 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.778 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -143.91 106.21 4.39 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.749 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.778 ' CA ' HH12 ' A' ' 83' ' ' ARG . 11.3 t -123.33 131.63 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.545 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.492 HG12 ' NH1' ' A' ' 83' ' ' ARG . 1.5 pt -136.23 140.47 43.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.527 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.1 t -44.43 156.39 0.08 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.758 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.559 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -150.37 140.43 13.92 Favored Pre-proline 0 C--N 1.307 -1.248 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.505 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.559 ' HD2' HG22 ' A' ' 87' ' ' VAL . 3.4 Cg_exo -50.67 136.79 42.1 Favored 'Trans proline' 0 C--O 1.21 -0.892 0 C-N-CA 121.006 1.138 . . . . 0.0 111.464 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.4 t -50.15 141.27 3.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.933 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -119.51 131.62 24.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.505 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.88 -24.5 72.7 Favored 'Trans proline' 0 C--O 1.21 -0.876 0 C-N-CA 120.762 0.975 . . . . 0.0 110.592 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.525 ' HE ' ' HG3' ' A' ' 46' ' ' PRO . 7.2 ptt85 36.36 -157.79 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.222 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.72 173.27 11.69 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.886 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.424 ' CD ' ' OE1' ' A' ' 105' ' ' GLU . 30.1 ttp180 -145.0 109.83 5.05 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 118.484 -1.286 . . . . 0.0 112.574 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.589 ' CD2' HG13 ' A' ' 131' ' ' VAL . 17.3 m-85 -95.95 149.1 21.93 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.204 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.484 ' CD1' ' HB3' ' A' ' 105' ' ' GLU . 72.1 m-85 -115.16 -162.52 0.83 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 119.344 -0.943 . . . . 0.0 111.0 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -135.04 168.01 19.91 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.29 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt 58.05 157.94 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 122.064 0.935 . . . . 0.0 112.823 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.55 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 32.0 tt0 -67.46 106.32 2.09 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.404 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.561 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 8.2 tp60 97.92 59.51 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.976 0 O-C-N 124.721 1.263 . . . . 0.0 111.341 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.561 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 35.2 p90 31.51 38.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.48 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 100' ' ' GLN . 93.6 m-20 -100.62 49.7 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.851 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -169.47 157.52 29.33 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.773 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -40.73 158.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.704 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.484 ' HB3' ' CD1' ' A' ' 96' ' ' PHE . 5.9 pt-20 -123.45 165.44 17.06 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.663 0.744 . . . . 0.0 112.855 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.7 t -146.18 119.53 2.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.805 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.59 164.04 14.92 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.999 -1.08 . . . . 0.0 111.996 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 108' ' ' LEU . 79.3 mt -145.35 137.88 13.6 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.695 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -69.58 161.28 46.52 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 121.646 1.564 . . . . 0.0 111.787 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.84 149.04 91.71 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.812 1.675 . . . . 0.0 111.243 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.53 -164.36 25.14 Favored Glycine 0 N--CA 1.502 3.077 0 C-N-CA 119.288 -1.434 . . . . 0.0 111.368 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.594 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 24.2 mt-30 -119.06 156.49 29.6 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.205 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 29.0 m-85 -144.93 150.54 37.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.884 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.416 ' H ' HG23 ' A' ' 114' ' ' THR . 1.6 p -90.31 -162.62 0.91 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.548 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -102.83 46.78 0.91 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -150.59 -62.98 0.2 Allowed 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.636 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 121' ' ' TYR . 5.8 pt-20 -71.57 -42.75 67.41 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.399 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.589 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -40.19 -70.04 0.11 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.04 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 121' ' ' TYR . 52.4 mt-10 -53.06 -59.49 4.47 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.845 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.473 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -68.34 14.59 0.07 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.389 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.517 ' CE1' HG12 ' A' ' 65' ' ' VAL . 9.4 t80 -117.59 -26.83 6.48 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.27 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -129.35 -43.21 0.21 Allowed Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.521 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.484 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -146.29 -114.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.038 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -146.19 -160.82 1.2 Allowed 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.237 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -59.69 -99.91 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.64 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.634 ' CG ' ' H ' ' A' ' 127' ' ' THR . 19.5 p-10 -57.54 -111.31 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.634 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 1.6 t 43.75 -120.13 0.67 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.894 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.595 ' N ' ' OG1' ' A' ' 127' ' ' THR . 8.4 mm 54.79 -96.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.714 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.4 OUTLIER 76.12 -138.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.297 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.9 m -42.27 129.51 3.8 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.044 -0.663 . . . . 0.0 111.819 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.589 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.9 t -121.13 150.96 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.393 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.78 83.41 8.12 Favored Pre-proline 0 C--N 1.302 -1.49 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.431 ' C ' ' H ' ' A' ' 135' ' ' GLY . 4.3 Cg_exo -61.05 98.65 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.536 1.491 . . . . 0.0 110.433 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -55.27 -2.76 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.656 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . 175.21 -36.97 0.1 Allowed Glycine 0 N--CA 1.492 2.388 0 C-N-CA 117.87 -2.11 . . . . 0.0 112.588 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.501 HD12 ' C ' ' A' ' 92' ' ' ARG . 3.8 mt -90.24 171.53 9.42 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.414 -1.314 . . . . 0.0 111.894 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -94.91 127.25 40.8 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 153' ' ' VAL . 3.4 t -98.32 139.22 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.988 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 98.9 t -133.34 125.35 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.314 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.562 HD23 ' OG1' ' A' ' 167' ' ' THR . 10.5 mp -103.62 140.29 37.75 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.428 -0.909 . . . . 0.0 113.052 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -117.35 131.75 56.72 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.055 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.487 ' NZ ' ' CG ' ' A' ' 164' ' ' ASN . 43.8 mttm -80.97 -44.12 18.65 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.419 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.445 ' HB3' ' CB ' ' A' ' 147' ' ' SER . 2.2 t-20 -71.95 -171.68 0.74 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.698 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.34 -128.52 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.603 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 146' ' ' PHE . 45.7 t30 -53.57 93.26 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.439 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 145' ' ' ASN . 3.8 m-85 37.39 67.38 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.314 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.445 ' CB ' ' HB3' ' A' ' 143' ' ' ASN . 0.4 OUTLIER -140.83 165.79 26.55 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.116 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 75.79 -163.73 53.6 Favored Glycine 0 N--CA 1.503 3.1 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.998 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.01 171.82 10.18 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.725 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 p -148.18 164.13 34.88 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.697 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 mt -124.67 82.94 59.14 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.344 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -63.05 100.75 0.26 Allowed 'Trans proline' 0 C--N 1.318 -1.054 0 C-N-CA 121.649 1.566 . . . . 0.0 112.652 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 138' ' ' VAL . 10.3 t -80.81 90.01 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.366 -0.933 . . . . 0.0 109.66 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -49.87 -31.64 12.55 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.998 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 13.3 t -170.39 -136.15 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.341 -1.344 . . . . 0.0 112.351 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.414 ' N ' ' OG ' ' A' ' 155' ' ' SER . 11.6 m-20 -50.55 141.62 12.11 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.18 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.535 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.44 63.43 1.07 Allowed Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.699 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.5 Cg_endo -63.22 21.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.214 1.943 . . . . 0.0 112.777 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.535 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -168.96 118.88 0.71 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.274 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.62 -40.64 0.14 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.407 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 50.58 -171.57 0.16 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.602 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.09 109.21 1.23 Allowed 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.39 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 6.1 tpt -91.22 -75.42 0.47 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.412 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.487 ' CG ' ' NZ ' ' A' ' 142' ' ' LYS . 4.1 m120 -91.31 -78.57 0.39 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.726 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.403 ' C ' ' OD1' ' A' ' 166' ' ' ASN . 3.0 m120 -168.8 81.59 0.14 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.807 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 166' ' ' ASN . 0.6 OUTLIER 63.37 141.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.451 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.562 ' OG1' HD23 ' A' ' 140' ' ' LEU . 1.1 m -90.58 123.12 33.97 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.579 -0.849 . . . . 0.0 110.508 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.4 m -90.33 -79.55 0.34 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.141 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 7.0 m -105.29 159.87 15.55 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.437 HG12 ' CD1' ' A' ' 118' ' ' LEU . 32.8 pt -141.92 174.36 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.25 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -158.82 109.84 2.09 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.506 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.438 HG21 HD13 ' A' ' 136' ' ' LEU . 56.5 mt -88.08 92.27 3.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 118.832 -1.147 . . . . 0.0 109.414 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.939 -179.904 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.422 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -75.0 -141.39 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.73 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 2.7 p30 -173.24 107.45 0.15 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.191 -1.003 . . . . 0.0 111.159 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 pt -76.36 175.13 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.932 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 m -148.06 153.1 38.47 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.364 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 m -138.02 160.04 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.235 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.488 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 22.2 m-85 -119.42 145.91 45.83 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.904 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.85 -66.52 0.6 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.561 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 73.3 m-20 -76.1 179.82 5.43 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.311 -0.956 . . . . 0.0 112.364 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -73.93 176.81 6.08 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.226 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.654 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 16.8 t70 48.56 56.01 8.18 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.491 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.654 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 39.2 p90 38.23 27.42 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.451 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 11' ' ' ASP . 6.3 tp-100 -98.89 163.06 12.76 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.35 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.561 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 93.13 134.35 6.91 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.378 -1.391 . . . . 0.0 109.634 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 14' ' ' GLY . 38.7 mttp -29.45 140.82 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.47 164.55 12.23 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.322 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.3 t -145.58 129.94 11.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.664 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -92.94 137.09 32.67 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.231 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 mt -129.05 136.79 29.73 Favored Pre-proline 0 N--CA 1.49 1.558 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.33 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -72.44 156.72 54.1 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 121.087 1.191 . . . . 0.0 111.422 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.73 -161.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.463 1.442 . . . . 0.0 109.726 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.558 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 91.18 -162.47 28.46 Favored Glycine 0 N--CA 1.485 1.923 0 C-N-CA 118.528 -1.796 . . . . 0.0 110.991 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.54 ' HB3' HH11 ' A' ' 83' ' ' ARG . 17.1 p-10 -123.03 133.18 54.35 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.238 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.603 ' OH ' HD12 ' A' ' 82' ' ' ILE . 14.7 p90 -155.7 174.51 15.19 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.522 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.468 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 17.0 p -138.25 -156.64 0.7 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.071 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.469 ' CD ' ' H ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -66.79 -16.68 64.43 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.599 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -65.13 -59.88 3.62 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.637 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.554 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 15.3 tp60 -56.41 -43.78 79.68 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 118.754 -1.178 . . . . 0.0 109.261 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 29' ' ' LEU . 28.4 mt -59.21 -40.03 84.51 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.814 -1.155 . . . . 0.0 109.127 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.7 -32.73 14.08 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 118.735 -1.186 . . . . 0.0 108.077 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -69.87 -42.07 73.97 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.699 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 mt -70.58 -74.86 0.13 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.82 -29.67 0.74 Allowed Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.092 -1.527 . . . . 0.0 110.846 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.41 ' H ' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -92.08 139.99 16.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.882 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.615 ' O ' HG23 ' A' ' 38' ' ' THR . 2.2 pt-20 179.94 166.1 1.22 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.481 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.607 ' C ' ' H ' ' A' ' 38' ' ' THR . 0.6 OUTLIER 79.97 -143.54 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.545 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -56.38 10.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.623 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 35' ' ' GLU . 67.4 p -76.17 -142.4 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.618 -1.233 . . . . 0.0 111.023 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 38' ' ' THR . 9.1 mt 39.69 60.71 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.02 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.2 t -65.54 -50.39 65.4 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.12 172.26 8.38 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.355 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.62 154.48 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 118.529 -1.268 . . . . 0.0 112.607 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -138.66 125.28 20.76 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.457 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.9 t -140.0 114.43 7.74 Favored Pre-proline 0 N--CA 1.494 1.725 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.918 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -69.32 169.48 18.25 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 121.116 1.21 . . . . 0.0 111.231 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.63 -174.97 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 122.102 1.868 . . . . 0.0 111.387 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.86 -16.77 7.86 Favored Glycine 0 N--CA 1.482 1.766 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.985 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.422 HG11 ' CB ' ' A' ' 2' ' ' ALA . 18.4 m -149.25 146.4 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.779 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -119.55 139.35 52.28 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.55 159.43 20.41 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.199 -1.001 . . . . 0.0 112.937 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.495 HG23 ' O ' ' A' ' 63' ' ' ILE . 70.5 mt -141.29 117.96 7.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.447 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.472 ' H ' HD12 ' A' ' 52' ' ' LEU . 4.2 mp -92.32 163.12 14.0 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.824 -1.15 . . . . 0.0 113.222 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.45 ' CE2' ' CD ' ' A' ' 62' ' ' GLN . 30.7 m-85 -141.61 115.29 9.06 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.678 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -81.1 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.899 -0.72 . . . . 0.0 112.157 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -59.26 141.07 55.28 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.319 -0.953 . . . . 0.0 111.382 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.07 172.79 0.26 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.464 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.47 27.27 73.88 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.291 -1.433 . . . . 0.0 110.149 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.468 ' CZ ' HG23 ' A' ' 25' ' ' THR . 32.9 m-85 54.58 63.32 2.19 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.969 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.38 -161.6 1.34 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.01 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.0 170.02 1.21 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.462 -1.352 . . . . 0.0 110.106 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -44.74 121.44 2.71 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.343 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.45 ' CD ' ' CE2' ' A' ' 53' ' ' TYR . 23.0 mt-30 -94.86 173.21 7.71 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.068 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.807 HD11 HD11 ' A' ' 75' ' ' LEU . 2.9 mt -143.73 166.04 13.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.683 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -146.93 131.18 17.45 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.299 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.6 m -150.17 160.31 4.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.806 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.43 -15.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.543 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -111.1 -138.55 0.38 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.003 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -111.07 124.81 52.91 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.001 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.75 120.25 29.98 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.236 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.55 -85.18 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.108 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 6.5 mt-10 -85.51 3.56 39.84 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.69 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.454 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 1.6 tp 72.34 -89.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.584 -0.847 . . . . 0.0 111.74 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.428 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -179.13 -178.88 48.57 Favored Glycine 0 N--CA 1.499 2.876 0 C-N-CA 118.861 -1.638 . . . . 0.0 111.369 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -70.2 14.8 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.627 2.218 . . . . 0.0 112.99 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.807 HD11 HD11 ' A' ' 63' ' ' ILE . 1.4 pt? -132.49 38.95 3.41 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.269 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -83.46 -2.04 54.98 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.655 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -73.14 -7.99 53.79 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.805 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -164.07 117.74 1.45 Allowed 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.122 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.27 127.32 11.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.232 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.1 t -155.45 -35.32 0.09 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 118.857 -1.137 . . . . 0.0 112.362 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.2 m -93.69 136.49 33.91 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.943 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.603 HD12 ' OH ' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -144.84 155.99 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 118.839 -1.144 . . . . 0.0 112.282 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.817 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.87 120.74 15.43 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.358 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.817 ' H ' HH12 ' A' ' 83' ' ' ARG . 18.4 t -129.92 136.8 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.939 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.591 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 2.6 mt -143.87 132.77 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.027 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.5 m -38.18 150.81 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.928 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.509 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -148.03 139.89 14.14 Favored Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.328 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.509 ' HD2' HG22 ' A' ' 87' ' ' VAL . 10.7 Cg_exo -47.78 153.61 2.34 Favored 'Trans proline' 0 C--O 1.212 -0.821 0 C-N-CA 121.401 1.401 . . . . 0.0 111.512 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.34 141.25 15.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 119.756 -0.778 . . . . 0.0 112.312 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -145.97 136.41 12.16 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.582 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.404 ' HG2' HD21 ' A' ' 136' ' ' LEU . 5.4 Cg_exo -58.83 -155.39 0.01 OUTLIER 'Trans proline' 0 C--O 1.21 -0.904 0 C-N-CA 121.421 1.414 . . . . 0.0 111.274 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.411 ' NE ' HH21 ' A' ' 94' ' ' ARG . 5.2 ptt180 -178.76 -160.86 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 118.375 -1.33 . . . . 0.0 111.929 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.0 168.7 19.09 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.385 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.411 HH21 ' NE ' ' A' ' 92' ' ' ARG . 0.4 OUTLIER -125.15 156.52 38.25 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.635 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.432 ' CD2' HG13 ' A' ' 131' ' ' VAL . 73.7 m-85 -145.88 103.88 3.8 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.672 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -89.97 172.25 8.99 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.059 -1.057 . . . . 0.0 112.124 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.603 ' CE2' ' OG1' ' A' ' 127' ' ' THR . 0.3 OUTLIER -110.45 159.23 17.68 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.915 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 42.2 tttt 68.35 151.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.84 0.829 . . . . 0.0 112.359 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.562 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 26.8 tt0 -67.9 106.22 2.23 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.754 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.584 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 2.6 tt0 105.0 48.45 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.108 0 O-C-N 125.054 1.471 . . . . 0.0 110.637 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.584 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 33.9 p90 30.73 39.1 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.156 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 100' ' ' GLN . 24.9 t70 -99.41 26.75 5.76 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.465 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -146.94 179.99 23.46 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.141 -1.504 . . . . 0.0 111.28 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -29.72 145.12 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -119.08 137.65 53.42 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.322 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.682 HG21 ' O ' ' A' ' 122' ' ' GLY . 2.4 t -139.86 158.58 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.979 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.466 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 7.2 p-10 -144.86 156.35 43.96 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.646 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.478 HD22 ' CD2' ' A' ' 121' ' ' TYR . 32.2 mt -141.08 147.9 49.52 Favored Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.527 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -71.31 165.23 33.09 Favored 'Trans proline' 0 C--O 1.212 -0.819 0 C-N-CA 121.797 1.665 . . . . 0.0 111.08 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.54 149.42 82.18 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.646 1.564 . . . . 0.0 111.518 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.41 -151.38 22.6 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 119.069 -1.539 . . . . 0.0 111.436 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.678 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 8.1 tt0 -136.14 155.69 49.8 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.21 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.678 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 18.9 m-85 -145.6 155.32 42.96 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.51 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.9 p -96.45 -156.82 0.55 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.327 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.749 ' H ' ' CD ' ' A' ' 115' ' ' GLN . 3.8 pm0 -103.75 29.4 5.81 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.231 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.24 -65.48 0.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.769 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.55 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 9.6 pt-20 -70.33 -48.77 54.99 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.975 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.68 ' C ' HD23 ' A' ' 118' ' ' LEU . 1.9 tt -35.12 -73.25 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.502 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.54 -54.22 24.14 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.555 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -76.28 17.66 0.35 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.638 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.511 ' N ' ' O ' ' A' ' 117' ' ' GLU . 18.1 t80 -123.7 -12.62 7.6 Favored 'General case' 0 N--CA 1.502 2.175 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.625 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.682 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -142.47 -48.49 0.04 OUTLIER Glycine 0 N--CA 1.485 1.953 0 C-N-CA 119.223 -1.465 . . . . 0.0 110.173 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.595 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -145.13 -99.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.835 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.595 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 17.9 t70 -165.76 -164.88 0.76 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.15 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.533 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 53.5 t30 -64.53 -122.07 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.874 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.477 ' H ' ' CG ' ' A' ' 125' ' ' ASN . 3.6 m-20 -70.4 112.42 6.68 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.538 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.603 ' OG1' ' CE2' ' A' ' 97' ' ' TYR . 1.8 t -179.87 -5.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.744 -0.783 . . . . 0.0 110.798 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.2 mt -91.25 151.95 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.617 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.528 ' HB3' ' H ' ' A' ' 161' ' ' GLY . 19.3 m -153.42 -66.12 0.15 Allowed 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.373 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.24 112.37 19.18 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.037 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.432 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.0 t -120.5 163.3 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.189 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.0 tttp -154.34 125.64 3.62 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.647 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 6.2 Cg_endo -65.33 -50.04 2.22 Favored 'Trans proline' 0 C--O 1.203 -1.262 0 C-N-CA 121.034 1.156 . . . . 0.0 111.081 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.479 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 72.23 -37.72 0.4 Allowed 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.38 -0.928 . . . . 0.0 112.621 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . -150.35 -48.88 0.02 OUTLIER Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.236 -1.459 . . . . 0.0 111.113 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.404 HD21 ' HG2' ' A' ' 91' ' ' PRO . 0.7 OUTLIER -109.56 153.4 24.19 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.008 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.06 153.75 41.54 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.118 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.64 143.82 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 119.663 -0.815 . . . . 0.0 112.321 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.43 HG12 ' CE1' ' A' ' 141' ' ' PHE . 93.3 t -135.94 123.07 33.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.984 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 140' ' ' LEU . 10.3 mp -103.23 142.75 33.64 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.812 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.528 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 14.0 m-85 -120.61 136.52 54.79 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.082 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -75.05 -62.62 1.49 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.565 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.409 ' HB2' ' C ' ' A' ' 147' ' ' SER . 5.1 m120 -61.01 159.99 10.65 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.271 -0.972 . . . . 0.0 112.362 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -27.35 -108.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.519 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 9.0 m120 -74.7 89.82 2.28 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.219 -0.901 . . . . 0.0 113.273 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.66 ' H ' ' CB ' ' A' ' 169' ' ' SER . 1.5 p90 33.04 73.11 0.07 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.131 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.409 ' C ' ' HB2' ' A' ' 143' ' ' ASN . 10.3 t -145.83 -170.76 3.55 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.158 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 51.26 -157.97 2.54 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.124 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.406 ' C ' HG23 ' A' ' 150' ' ' THR . 2.3 m-20 -59.99 174.1 0.54 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.654 -0.819 . . . . 0.0 110.833 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 149' ' ' ASP . 55.3 p -155.05 174.5 15.09 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.914 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.7 tp -138.32 79.54 30.46 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.026 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -59.66 110.26 0.71 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.817 1.678 . . . . 0.0 112.945 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 155' ' ' SER . 20.5 t -93.24 70.77 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.356 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -65.06 8.2 0.14 Allowed 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.219 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.595 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 9.3 t -170.94 177.68 3.67 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.282 -1.367 . . . . 0.0 112.211 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.595 ' N ' ' OG ' ' A' ' 155' ' ' SER . 3.2 m-20 -51.0 151.59 2.53 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.431 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.531 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -164.32 61.71 0.92 Allowed Pre-proline 0 C--N 1.309 -1.165 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.407 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.2 Cg_endo -63.72 22.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.534 2.156 . . . . 0.0 113.314 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -175.96 95.49 0.06 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 117.759 -1.576 . . . . 0.0 112.504 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.578 ' O ' ' N ' ' A' ' 162' ' ' ALA . 44.7 mt -112.56 -61.54 1.71 Allowed 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.65 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.528 ' H ' ' HB3' ' A' ' 129' ' ' SER . . . 44.44 -87.05 0.01 OUTLIER Glycine 0 N--CA 1.499 2.89 0 C-N-CA 119.553 -1.308 . . . . 0.0 111.156 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -37.61 -33.07 0.06 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.979 -0.689 . . . . 0.0 111.525 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.448 ' O ' ' C ' ' A' ' 164' ' ' ASN . 2.3 tpt -78.7 25.32 0.26 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.637 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 161' ' ' GLY . 22.7 t-20 -32.41 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.426 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.401 ' O ' ' N ' ' A' ' 167' ' ' THR . 19.2 t-20 -122.02 119.36 31.22 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.687 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -45.08 -23.22 0.14 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.138 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 165' ' ' ASN . 47.3 m 42.76 73.88 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.419 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.3 m -78.29 -23.55 47.14 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.204 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.66 ' CB ' ' H ' ' A' ' 146' ' ' PHE . 0.2 OUTLIER -149.25 162.07 40.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.34 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 29.1 pt -143.46 161.33 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 119.159 -1.017 . . . . 0.0 111.029 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -143.42 104.01 4.18 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.452 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.8 mt -82.63 95.12 3.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.179 -1.009 . . . . 0.0 110.154 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.3 m . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.845 179.969 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 mtm . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.892 0.377 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.599 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -49.51 164.2 0.09 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.469 -0.893 . . . . 0.0 111.105 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -175.15 118.96 0.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.526 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.5 pt -69.14 154.7 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.233 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -126.56 135.44 51.27 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.81 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.622 ' HB ' HG23 ' A' ' 39' ' ' ILE . 2.3 m -121.89 138.73 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.971 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.52 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 29.6 m-85 -96.48 146.7 24.56 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.798 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.04 -56.78 17.02 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.25 -0.98 . . . . 0.0 112.21 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.606 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 4.6 m120 -96.85 170.94 8.83 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.504 ' HG2' ' N ' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -76.6 -165.92 0.59 Allowed 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.976 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.504 ' N ' ' HG2' ' A' ' 10' ' ' GLU . 66.4 m-20 52.67 35.4 18.21 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.523 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.52 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 18.2 t80 56.68 7.11 0.35 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.436 -0.905 . . . . 0.0 112.16 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.43 ' HG3' ' N ' ' A' ' 14' ' ' GLY . 5.3 tp-100 -96.31 160.21 14.54 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.551 -0.859 . . . . 0.0 111.678 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.606 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 102.38 131.23 7.27 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.738 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 14' ' ' GLY . 25.2 mtmm -31.79 141.11 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.927 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.9 pm0 -99.44 161.19 13.76 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.119 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.1 t -145.47 134.48 17.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.206 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.16 134.09 39.66 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.141 -1.024 . . . . 0.0 112.116 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.6 mt -122.1 127.57 25.88 Favored Pre-proline 0 N--CA 1.489 1.479 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.524 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.5 163.6 31.92 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 120.928 1.086 . . . . 0.0 111.268 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.39 -169.28 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.65 1.567 . . . . 0.0 111.019 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.462 ' C ' HH21 ' A' ' 83' ' ' ARG . . . 87.96 -176.91 46.05 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.744 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.57 ' N ' HH21 ' A' ' 83' ' ' ARG . 14.0 p-10 -112.18 142.29 44.83 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.884 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.616 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -156.03 -174.77 5.1 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.314 179.777 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 24' ' ' TYR . 4.7 p -156.35 -157.17 0.69 Allowed 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.921 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.43 ' H ' ' HB ' ' A' ' 25' ' ' THR . 43.9 ttt85 -52.29 -33.54 42.65 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.289 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.79 -63.59 1.21 Allowed 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.863 -1.135 . . . . 0.0 110.524 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.8 tm0? -57.23 -32.95 67.05 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.779 -1.169 . . . . 0.0 109.882 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.616 HD21 ' CZ ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -60.56 -47.27 86.92 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.011 -1.076 . . . . 0.0 109.433 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.41 -32.99 28.33 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.163 -1.015 . . . . 0.0 108.92 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -64.08 -42.79 96.83 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.848 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 mt -71.9 -80.31 0.06 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.941 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.77 -29.79 0.16 Allowed Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.465 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.455 HG23 ' H ' ' A' ' 34' ' ' ILE . 0.9 OUTLIER -82.2 169.75 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.894 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.959 ' H ' HG21 ' A' ' 38' ' ' THR . 4.7 pt-20 178.68 111.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.289 -0.965 . . . . 0.0 111.904 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.616 ' O ' HG23 ' A' ' 38' ' ' THR . 1.0 OUTLIER 61.66 140.57 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.555 ' H ' ' H ' ' A' ' 79' ' ' VAL . 9.6 t30 47.01 4.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.658 -1.156 . . . . 0.0 113.695 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.959 HG21 ' H ' ' A' ' 35' ' ' GLU . 76.2 p -82.34 -29.87 30.74 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 117.992 -1.483 . . . . 0.0 111.424 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.622 HG23 ' HB ' ' A' ' 6' ' ' VAL . 11.6 mt -78.24 53.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.328 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 10' ' ' GLU . 30.4 t -50.98 -53.93 28.85 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.761 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.0 169.65 10.27 Favored 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.307 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.1 t -153.3 151.43 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 117.856 -1.538 . . . . 0.0 113.139 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -138.64 102.69 4.66 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.194 -1.367 . . . . 0.0 108.805 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 73.9 t -117.94 107.8 43.5 Favored Pre-proline 0 N--CA 1.496 1.865 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.228 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.25 168.2 19.98 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 121.31 1.34 . . . . 0.0 110.939 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.11 -173.19 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.753 1.635 . . . . 0.0 111.177 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.63 -14.77 11.46 Favored Glycine 0 N--CA 1.481 1.699 0 C-N-CA 119.125 -1.512 . . . . 0.0 110.691 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.599 HG11 ' CB ' ' A' ' 2' ' ' ALA . 16.3 m -151.59 134.28 6.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 C-N-CA 118.851 -1.14 . . . . 0.0 112.086 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.436 ' O ' HG13 ' A' ' 84' ' ' VAL . 22.8 ttpp -105.83 143.52 33.85 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.32 150.75 49.44 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.024 -1.07 . . . . 0.0 112.928 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 63' ' ' ILE . 83.9 mt -135.04 117.75 22.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.737 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.476 ' H ' HD12 ' A' ' 52' ' ' LEU . 3.6 mp -96.61 160.83 14.18 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 118.927 -1.109 . . . . 0.0 113.8 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 62' ' ' GLN . 44.9 m-85 -135.3 116.38 14.3 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.675 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -47.59 -88.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.081 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -61.69 147.26 46.58 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.54 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -55.54 174.51 0.1 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.389 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.16 30.59 75.87 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.127 -1.511 . . . . 0.0 110.03 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 48.42 40.46 14.83 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.767 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.37 -176.97 3.02 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.821 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.69 164.27 5.27 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.064 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -45.55 131.87 8.47 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.545 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.413 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 5.6 pt20 -99.24 172.31 7.44 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.706 HD11 HD11 ' A' ' 75' ' ' LEU . 3.9 mt -135.28 165.29 31.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.763 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.414 ' C ' HG13 ' A' ' 65' ' ' VAL . 28.2 mt-10 -143.92 129.89 19.49 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.4 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.414 HG13 ' C ' ' A' ' 64' ' ' GLU . 35.1 m -150.03 159.61 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 118.489 -1.284 . . . . 0.0 112.524 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 t -146.23 2.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.238 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.49 ' HB3' ' OH ' ' A' ' 121' ' ' TYR . . . -131.51 -144.6 0.25 Allowed 'General case' 0 C--O 1.207 -1.132 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.086 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.481 ' ND2' ' C ' ' A' ' 68' ' ' ASN . 0.5 OUTLIER -103.37 119.55 39.09 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.849 -0.741 . . . . 0.0 111.578 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.542 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -97.45 97.86 9.45 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.17 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -58.72 -87.61 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.48 -0.888 . . . . 0.0 112.096 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 43.7 mm-40 -68.02 -5.83 19.39 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.41 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.466 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 2.8 tp 70.83 -77.88 0.05 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.049 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.43 -175.21 43.75 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.51 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -65.35 -38.43 26.48 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.193 1.929 . . . . 0.0 111.865 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -78.96 30.67 0.2 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.395 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -77.14 10.26 2.52 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.561 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -87.83 -2.17 58.44 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.83 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -170.7 122.23 0.6 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.024 -1.07 . . . . 0.0 111.546 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.555 ' H ' ' H ' ' A' ' 37' ' ' ASN . 2.4 t -147.92 121.93 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.494 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.1 t -150.58 -34.1 0.16 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.908 -1.117 . . . . 0.0 112.517 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.425 ' OG ' HG22 ' A' ' 25' ' ' THR . 3.8 m -93.19 136.31 33.58 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.818 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.524 HD12 ' CE1' ' A' ' 24' ' ' TYR . 21.3 mt -148.08 160.95 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.287 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.835 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -142.78 108.1 5.01 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.824 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.835 ' H ' HH22 ' A' ' 83' ' ' ARG . 10.5 t -114.59 142.39 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.823 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.465 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 7.2 mt -142.48 132.43 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.745 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 m -40.38 153.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.663 -0.698 . . . . 0.0 112.319 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -150.77 149.1 24.78 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.968 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.33 177.55 0.15 Allowed 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 121.546 1.497 . . . . 0.0 112.099 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 89' ' ' VAL . 34.6 m -88.29 136.12 24.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.316 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -146.17 123.68 6.1 Favored Pre-proline 0 C--N 1.308 -1.2 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.844 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -57.06 178.84 0.13 Allowed 'Trans proline' 0 C--O 1.205 -1.146 0 C-N-CA 121.088 1.192 . . . . 0.0 110.978 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.504 ' HD3' ' N ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -151.42 -160.12 1.12 Allowed 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.566 0.698 . . . . 0.0 110.23 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.98 167.03 23.06 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -132.35 116.07 16.4 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.674 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -99.09 130.27 45.41 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.456 ' CD2' ' HB3' ' A' ' 105' ' ' GLU . 24.8 m-85 -102.47 165.39 11.13 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.639 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -103.31 162.67 12.81 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.41 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.467 ' HB2' ' CB ' ' A' ' 102' ' ' ASP . 22.3 mmtp 58.14 157.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 122.24 1.019 . . . . 0.0 112.858 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.552 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 36.4 tt0 -72.92 107.58 5.38 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.3 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 92.26 56.52 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.603 0 O-C-N 124.524 1.14 . . . . 0.0 111.256 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.588 ' O ' ' CG ' ' A' ' 101' ' ' PHE . 1.3 t80 37.98 64.1 0.73 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.486 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.467 ' CB ' ' HB2' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -111.77 17.03 20.21 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.193 179.838 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -160.01 155.4 26.53 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.485 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -44.77 162.11 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.135 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.456 ' CD ' ' C ' ' A' ' 105' ' ' GLU . 2.2 pp20? -120.12 179.46 4.27 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.532 0.682 . . . . 0.0 112.551 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.636 HG13 ' N ' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -140.01 177.0 4.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.799 -1.092 . . . . 0.0 108.963 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.636 ' N ' HG13 ' A' ' 106' ' ' VAL . 19.5 p-10 -142.55 150.91 41.02 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.653 -1.219 . . . . 0.0 112.006 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.3 mt -141.98 148.46 48.86 Favored Pre-proline 0 N--CA 1.5 2.064 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.732 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.414 ' O ' HD12 ' A' ' 172' ' ' ILE . 11.8 Cg_endo -77.28 163.01 30.7 Favored 'Trans proline' 0 C--O 1.211 -0.83 0 C-N-CA 122.096 1.864 . . . . 0.0 111.963 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.38 158.54 35.37 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 122.415 2.077 . . . . 0.0 111.484 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.91 -170.5 14.96 Favored Glycine 0 N--CA 1.501 2.985 0 C-N-CA 119.465 -1.35 . . . . 0.0 111.43 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.594 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 18.8 tt0 -111.2 155.43 22.94 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.611 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 26.0 m-85 -142.35 151.87 42.34 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.83 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.4 p -87.24 -164.77 1.14 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.686 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 56.54 0.68 Allowed 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.179 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.441 ' N ' ' OE1' ' A' ' 119' ' ' GLU . . . -155.18 -71.57 0.12 Allowed 'General case' 0 C--N 1.294 -1.804 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.234 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.1 pt-20 -67.04 -44.73 79.47 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.488 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.653 ' C ' HD23 ' A' ' 118' ' ' LEU . 1.2 tt -39.56 -69.83 0.12 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.5 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.751 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 25.4 mp0 -48.11 -59.41 3.41 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.913 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.416 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 1.5 mpt_? -70.95 0.79 6.61 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.96 -1.096 . . . . 0.0 112.814 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 117' ' ' GLU . 13.8 t80 -97.9 -17.58 19.17 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.072 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.55 -41.05 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 C-N-CA 118.55 -1.786 . . . . 0.0 111.665 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.596 HG13 HD11 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -134.73 -117.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.461 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.55 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 15.7 t70 -148.92 -163.72 1.85 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.599 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.55 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 37.7 p-10 -106.07 31.45 5.09 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.028 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.473 ' ND2' ' OD1' ' A' ' 125' ' ' ASN . 19.2 p30 -176.27 17.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.756 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.699 HG23 ' N ' ' A' ' 128' ' ' ILE . 8.5 t -114.67 -132.11 0.33 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.386 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.699 ' N ' HG23 ' A' ' 127' ' ' THR . 3.4 mt 62.84 158.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.097 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.2 p -165.85 -97.29 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.65 136.88 49.42 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.889 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.59 157.25 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -150.8 96.48 3.34 Favored Pre-proline 0 C--N 1.304 -1.398 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.893 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -53.26 93.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.238 1.292 . . . . 0.0 110.79 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.467 ' CG ' ' NH2' ' A' ' 92' ' ' ARG . 5.1 tp60 -71.85 7.69 1.47 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.1 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 171.52 -40.56 0.18 Allowed Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.92 -1.61 . . . . 0.0 111.02 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.415 ' HB2' ' CG2' ' A' ' 172' ' ' ILE . 0.4 OUTLIER -121.67 151.02 40.92 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.314 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.0 156.36 39.73 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.657 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.29 136.49 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.818 -0.753 . . . . 0.0 112.249 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.481 ' C ' HD12 ' A' ' 140' ' ' LEU . 74.3 t -125.14 128.77 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.826 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 140' ' ' LEU . 10.8 mp -102.72 142.01 34.58 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.372 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.543 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 4.0 m-85 -120.6 134.23 55.3 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.397 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -70.28 -71.58 0.24 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.914 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -72.81 -176.32 1.98 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.889 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 146' ' ' PHE . 1.5 m-20 -77.12 -164.25 0.44 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.665 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 7.7 p-10 36.65 29.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.518 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.665 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 2.5 p90 39.58 61.64 1.35 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.779 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.471 ' CB ' ' ND2' ' A' ' 145' ' ' ASN . 3.5 t -146.66 137.67 24.13 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.2 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.42 -139.55 14.23 Favored Glycine 0 N--CA 1.503 3.125 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.56 141.65 44.77 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.099 -1.041 . . . . 0.0 109.863 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 34.3 p -147.82 162.28 39.57 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.911 -1.116 . . . . 0.0 111.869 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 151' ' ' LEU . 64.8 tp -130.12 89.34 45.53 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.922 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.06 108.87 1.59 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 121.849 1.699 . . . . 0.0 113.006 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.58 80.56 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.412 -0.915 . . . . 0.0 108.925 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.478 ' C ' ' OG ' ' A' ' 155' ' ' SER . 50.9 t30 -65.35 -9.91 28.66 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.478 ' OG ' ' C ' ' A' ' 154' ' ' ASN . 1.2 m -161.03 -155.44 0.41 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 117.594 -1.643 . . . . 0.0 113.232 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.51 142.48 44.16 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.824 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.545 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -162.05 61.82 1.3 Allowed Pre-proline 0 C--N 1.308 -1.21 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.449 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.2 Cg_endo -64.71 21.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.291 1.994 . . . . 0.0 112.316 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -170.45 113.17 0.44 Allowed 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.677 -1.209 . . . . 0.0 111.331 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 mt -143.1 -56.78 0.42 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.406 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 79.11 40.03 17.8 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.333 -1.413 . . . . 0.0 110.612 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 48.09 84.51 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.666 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 19.0 mmt -73.95 -44.79 53.69 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.858 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -67.93 170.17 8.66 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.736 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -60.74 -54.98 38.59 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.944 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -161.13 111.78 1.74 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.11 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.2 m -57.55 99.17 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.593 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 73.7 m -84.29 -56.29 3.72 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.68 158.39 30.18 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.176 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.405 HG23 HD11 ' A' ' 118' ' ' LEU . 35.1 pt -136.01 165.37 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.49 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -146.73 100.58 3.35 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.401 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 172' ' ' ILE . 10.3 mt -78.97 105.13 7.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.256 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 51.6 m . . . . . 0 C--N 1.306 -1.324 0 CA-C-O 116.399 -1.762 . . . . 0.0 110.963 -179.937 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ptt? . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.764 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . -152.31 179.97 8.06 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.333 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.42 ' CG ' ' C ' ' A' ' 2' ' ' ALA . 9.0 m-80 -158.97 122.33 3.78 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.854 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.417 ' O ' ' CG1' ' A' ' 4' ' ' ILE . 2.2 pt -75.49 133.86 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.852 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 m -110.89 114.69 28.21 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.353 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.32 164.6 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.304 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 1.055 ' CE2' ' NE2' ' A' ' 16' ' ' GLN . 39.6 m-85 -123.85 148.85 46.42 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.998 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.443 ' HB2' ' N ' ' A' ' 15' ' ' LYS . 3.2 m-85 -79.04 0.41 27.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.472 ' N ' ' HA3' ' A' ' 14' ' ' GLY . 13.3 m120 -151.3 172.82 15.28 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.026 -1.47 . . . . 0.0 112.114 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.56 -174.82 1.81 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.519 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 13' ' ' GLN . 15.3 t70 52.67 31.08 9.67 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.159 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.526 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 1.5 t80 68.45 -8.73 0.58 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.136 -1.026 . . . . 0.0 111.349 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.465 ' H ' ' C ' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -78.25 167.93 20.62 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.287 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.984 ' O ' ' OE1' ' A' ' 16' ' ' GLN . . . 109.3 134.82 7.12 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.935 ' C ' ' OE1' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -35.25 144.57 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.688 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 1.055 ' NE2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -98.6 148.05 24.19 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.258 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.3 t -147.45 123.37 2.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.676 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -94.78 115.82 27.98 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.803 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt -105.98 132.49 20.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.598 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -68.53 164.69 31.89 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 120.874 1.049 . . . . 0.0 111.439 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.68 -161.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 121.774 1.649 . . . . 0.0 111.057 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.68 -177.64 52.43 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.109 -1.52 . . . . 0.0 111.354 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.557 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -105.92 137.08 44.42 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.786 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.564 ' CE2' HD13 ' A' ' 82' ' ' ILE . 4.0 p90 -158.55 160.2 36.37 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.294 -0.963 . . . . 0.0 109.689 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.445 ' CG2' ' CE2' ' A' ' 58' ' ' PHE . 68.9 p -122.83 -162.02 0.99 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.1 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -66.3 -16.99 64.48 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.876 -1.13 . . . . 0.0 110.776 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -64.39 -58.42 6.52 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 118.816 -1.154 . . . . 0.0 109.211 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.526 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -55.57 -44.89 77.27 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 118.686 -1.206 . . . . 0.0 108.918 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.433 HD23 HD12 ' A' ' 32' ' ' LEU . 39.4 mt -57.33 -41.27 79.64 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.966 -1.094 . . . . 0.0 109.425 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.49 -33.14 13.68 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.86 -1.136 . . . . 0.0 108.263 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -70.95 -37.91 72.83 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.489 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.433 HD12 HD23 ' A' ' 29' ' ' LEU . 20.2 mt -72.6 -73.2 0.21 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.646 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.81 -27.2 0.65 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.285 -1.436 . . . . 0.0 110.596 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.45 HD13 HG21 ' A' ' 34' ' ' ILE . 8.0 tt -75.63 145.82 10.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.173 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.514 ' C ' ' CG ' ' A' ' 36' ' ' ASN . 5.6 pt-20 -174.38 146.68 1.09 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.657 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.514 ' CG ' ' C ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER 74.56 -140.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.402 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 39' ' ' ILE . 7.1 m120 -40.3 -87.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.282 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.704 ' O ' ' N ' ' A' ' 40' ' ' SER . 20.3 p 37.5 -96.26 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.761 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 37' ' ' ASN . 5.6 mt -38.0 79.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 124.412 1.07 . . . . 0.0 111.442 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.704 ' N ' ' O ' ' A' ' 38' ' ' THR . 28.5 t -96.07 -39.05 9.93 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.447 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -127.99 167.55 16.52 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.603 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -153.08 151.14 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 117.849 -1.54 . . . . 0.0 113.012 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -135.46 99.96 4.37 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.837 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.55 108.38 39.6 Favored Pre-proline 0 N--CA 1.494 1.753 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.577 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.94 167.66 20.94 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.092 1.195 . . . . 0.0 110.692 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.65 -171.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.748 1.632 . . . . 0.0 111.108 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.73 -14.51 9.77 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 119.317 -1.421 . . . . 0.0 110.93 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.764 HG11 ' HB3' ' A' ' 2' ' ' ALA . 2.7 m -147.32 140.46 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.339 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.1 tttt -114.81 125.79 54.09 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.808 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.402 ' CB ' HG22 ' A' ' 84' ' ' VAL . . . -117.37 139.7 50.53 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.184 -1.007 . . . . 0.0 113.061 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.564 HD12 HH21 ' A' ' 83' ' ' ARG . 44.3 mt -116.26 119.3 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.631 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -94.58 146.9 23.8 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.26 -0.976 . . . . 0.0 112.239 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.489 ' H ' HD23 ' A' ' 52' ' ' LEU . 43.9 m-85 -127.01 112.58 15.4 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.267 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' CD ' ' N ' ' A' ' 55' ' ' ASN . 8.5 tm0? -49.87 -76.27 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.345 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.523 ' N ' ' CD ' ' A' ' 54' ' ' GLN . 62.3 t30 -59.97 155.9 15.73 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.047 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -68.68 -179.69 1.48 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.467 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.36 36.77 78.0 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.195 -1.478 . . . . 0.0 110.191 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 25' ' ' THR . 35.6 m-85 49.13 63.78 2.0 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.794 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.55 -166.23 2.43 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.318 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.43 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 68.91 173.09 8.32 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.383 -1.389 . . . . 0.0 109.868 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 9.7 m-20 -42.19 119.44 1.37 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.397 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.619 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 7.1 pm0 -90.04 164.51 14.48 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.349 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.667 HG13 HD11 ' A' ' 75' ' ' LEU . 8.8 mm -137.91 166.67 23.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.382 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.66 ' N ' HG22 ' A' ' 63' ' ' ILE . 19.2 mp0 -148.26 126.08 11.91 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.619 -0.832 . . . . 0.0 109.64 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.1 159.97 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 118.859 -1.136 . . . . 0.0 112.557 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.435 ' H ' ' H ' ' A' ' 67' ' ' ALA . 2.2 t -149.36 -7.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 114.195 -1.366 . . . . 0.0 107.495 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.435 ' H ' ' H ' ' A' ' 66' ' ' VAL . . . -124.8 -155.88 0.69 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.966 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -93.32 117.76 30.47 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.626 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.603 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.26 111.76 22.65 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.91 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -73.21 -77.9 0.1 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.418 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 73' ' ' GLY . 24.4 tp10 -79.24 -2.92 43.39 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.103 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.475 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 6.7 tp 54.95 -87.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.392 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.475 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 176.11 -170.15 42.95 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 118.967 -1.587 . . . . 0.0 110.924 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.516 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.0 Cg_endo -65.45 -36.22 35.59 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.159 1.906 . . . . 0.0 111.941 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.885 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.4 pt? -70.9 19.51 0.05 Allowed 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.981 -1.088 . . . . 0.0 111.274 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 74' ' ' PRO . 34.9 p-10 -77.33 -18.16 57.68 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.519 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.42 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 3.1 m-80 -86.65 2.04 49.82 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.429 -0.909 . . . . 0.0 110.894 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -175.87 115.65 0.13 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.326 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.695 HG13 ' N ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -123.05 -174.72 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.156 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.695 ' N ' HG13 ' A' ' 79' ' ' VAL . 39.1 t -172.01 -64.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.296 -1.362 . . . . 0.0 113.541 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.5 m -111.7 150.95 29.47 Favored 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.564 HD13 ' CE2' ' A' ' 24' ' ' TYR . 3.0 mp -146.61 161.49 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.445 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.682 ' NH1' ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -150.85 145.58 25.77 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.993 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.682 ' N ' ' NH1' ' A' ' 83' ' ' ARG . 5.8 t -148.09 146.92 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.695 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.589 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -143.54 134.27 22.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.657 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 85' ' ' ILE . 17.4 m -38.33 148.38 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.336 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.554 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -152.01 141.03 13.98 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.507 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.554 ' HD2' HG22 ' A' ' 87' ' ' VAL . 3.0 Cg_exo -53.42 143.16 55.86 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.078 1.186 . . . . 0.0 110.954 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.586 HG22 ' N ' ' A' ' 90' ' ' GLN . 2.4 p -79.73 164.27 3.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.537 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.586 ' N ' HG22 ' A' ' 89' ' ' VAL . 66.4 mm-40 -142.39 151.74 58.73 Favored Pre-proline 0 N--CA 1.487 1.4 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.154 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.432 ' C ' ' HE ' ' A' ' 92' ' ' ARG . 6.3 Cg_exo -57.6 -39.18 90.29 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.599 1.533 . . . . 0.0 111.87 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.54 ' NE ' ' O ' ' A' ' 90' ' ' GLN . 15.6 mtm180 58.02 -168.47 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.434 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.53 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.33 178.65 7.43 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.603 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -148.57 130.36 15.13 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.411 -1.316 . . . . 0.0 112.024 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 20.1 m-85 -103.44 172.07 7.01 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.777 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -139.09 168.66 19.33 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.836 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -114.61 170.45 8.3 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.672 -0.811 . . . . 0.0 112.351 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.49 ' HZ2' ' HB3' ' A' ' 98' ' ' LYS . 0.5 OUTLIER 54.67 168.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.233 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.504 ' OE1' ' HG3' ' A' ' 100' ' ' GLN . 1.2 tm-20 -62.5 103.16 0.38 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.585 -1.189 . . . . 0.0 112.5 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 102' ' ' ASP . 2.7 mt-30 68.55 100.95 0.05 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.48 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.478 ' C ' ' O ' ' A' ' 100' ' ' GLN . 19.3 p90 20.94 44.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 124.364 1.04 . . . . 0.0 112.773 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 100' ' ' GLN . 0.7 OUTLIER -102.26 15.64 28.54 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.98 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -154.61 159.79 29.17 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 118.967 -1.587 . . . . 0.0 111.135 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -41.26 157.39 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.832 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.553 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 1.2 pm0 -122.05 163.71 18.94 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.67 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.648 HG12 ' N ' ' A' ' 107' ' ' ASP . 37.4 t -138.11 170.99 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.33 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.648 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.5 p30 -133.44 156.35 47.87 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.034 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.5 mt -145.15 139.35 14.99 Favored Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.26 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -70.18 163.66 37.79 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 121.597 1.532 . . . . 0.0 111.305 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.47 145.99 95.57 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.418 1.412 . . . . 0.0 110.937 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.32 -153.22 24.29 Favored Glycine 0 N--CA 1.499 2.878 0 C-N-CA 119.064 -1.541 . . . . 0.0 111.328 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.609 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 8.3 tt0 -128.94 158.42 38.87 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.755 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.609 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 41.8 m-85 -145.93 151.99 38.72 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.267 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.6 p -103.83 178.56 4.52 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.243 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.08 44.63 0.49 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.174 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -142.45 -61.95 0.44 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 121' ' ' TYR . 4.5 mt-10 -74.11 -54.55 7.57 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.485 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.538 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -29.74 -66.5 0.09 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.635 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.654 ' CD ' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER -59.04 -60.84 3.23 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.747 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.654 HH11 ' CD ' ' A' ' 119' ' ' GLU . 7.9 mpt_? -75.81 26.17 0.11 Allowed 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.952 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 117' ' ' GLU . 35.3 t80 -127.79 -18.48 4.27 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.603 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.528 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -155.68 -26.8 0.03 OUTLIER Glycine 0 N--CA 1.484 1.86 0 C-N-CA 118.267 -1.92 . . . . 0.0 111.104 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.479 HD12 HD13 ' A' ' 128' ' ' ILE . 1.1 pt -150.2 -112.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.039 -1.064 . . . . 0.0 110.785 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.461 ' C ' ' HB3' ' A' ' 119' ' ' GLU . 0.9 OUTLIER -165.75 -165.91 0.88 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.284 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.47 ' CG ' ' N ' ' A' ' 126' ' ' ASN . 45.3 t-20 -65.21 -105.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.47 ' N ' ' CG ' ' A' ' 125' ' ' ASN . 1.7 m120 -67.23 32.32 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 125' ' ' ASN . 0.6 OUTLIER -87.17 -103.7 0.07 Allowed 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.726 -1.19 . . . . 0.0 109.819 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.546 ' O ' ' CB ' ' A' ' 129' ' ' SER . 0.3 OUTLIER 41.66 -162.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.22 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.618 ' OG ' ' N ' ' A' ' 130' ' ' SER . 1.6 t 151.17 -96.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.061 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.618 ' N ' ' OG ' ' A' ' 129' ' ' SER . 3.5 m -90.24 143.63 26.59 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.047 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.11 151.82 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.575 0.702 . . . . 0.0 111.675 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -148.87 107.09 3.45 Favored Pre-proline 0 C--N 1.301 -1.515 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.617 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 135' ' ' GLY . 10.5 Cg_endo -71.88 90.48 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.348 1.366 . . . . 0.0 110.68 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.53 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 13.3 tt0 -49.64 -11.57 0.06 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.391 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 133' ' ' PRO . . . -179.07 -37.46 0.07 OUTLIER Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.305 -1.902 . . . . 0.0 111.783 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.436 HD11 ' H ' ' A' ' 92' ' ' ARG . 0.5 OUTLIER -107.04 163.83 12.66 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.359 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.76 148.22 31.55 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.993 -1.083 . . . . 0.0 109.811 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.1 t -112.6 150.34 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.786 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.55 HG12 ' CE1' ' A' ' 141' ' ' PHE . 60.6 t -136.22 128.53 45.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.572 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.5 mp -106.13 139.86 39.99 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.905 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.567 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 4.7 m-85 -120.23 133.78 55.4 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.52 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -72.94 -71.52 0.3 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.403 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -62.87 161.68 12.36 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.959 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 20.7 p-10 -62.5 -162.89 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.586 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.651 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 3.6 p30 31.62 35.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.712 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.651 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 42.12 62.4 1.65 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.084 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.421 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 48.4 t -139.3 175.87 9.19 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.421 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 80.91 -160.33 42.78 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.039 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -60.54 160.57 8.79 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.263 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.8 p -150.59 162.51 40.5 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.902 -1.119 . . . . 0.0 111.574 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.6 tp -129.33 86.14 57.27 Favored Pre-proline 0 N--CA 1.484 1.261 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.497 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -63.29 107.8 0.73 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.828 1.686 . . . . 0.0 112.522 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 47.5 t -84.78 85.56 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.389 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.498 ' C ' ' OG ' ' A' ' 155' ' ' SER . 2.7 p-10 -55.87 -26.56 47.6 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.498 ' OG ' ' C ' ' A' ' 154' ' ' ASN . 0.7 OUTLIER -162.68 -146.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 117.941 -1.503 . . . . 0.0 113.107 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.45 144.76 20.06 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.017 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -165.58 66.06 1.08 Allowed Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.572 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.1 Cg_endo -66.71 27.95 0.11 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.26 1.973 . . . . 0.0 112.274 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.512 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.1 t -169.83 136.06 1.51 Allowed 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.846 -1.142 . . . . 0.0 111.461 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.6 HD21 ' CB ' ' A' ' 163' ' ' MET . 3.9 tt -151.55 -76.01 0.14 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.351 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.404 ' H ' ' HB3' ' A' ' 160' ' ' LEU . . . 71.1 63.86 2.99 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.16 -1.495 . . . . 0.0 110.665 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 52.45 90.83 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.393 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.6 ' CB ' HD21 ' A' ' 160' ' ' LEU . 1.1 tpt -81.32 -63.94 1.29 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.134 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 165' ' ' ASN . 3.2 p-10 -90.21 -54.33 4.07 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.817 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.423 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 5.2 t30 -168.87 -69.98 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.654 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -161.07 151.32 17.68 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.1 m -88.49 147.17 24.79 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.795 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 92.3 p -135.67 -38.63 0.73 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.434 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.54 158.13 44.85 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.533 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 24.6 pt -145.54 157.19 12.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 118.589 -1.244 . . . . 0.0 111.904 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -137.92 110.26 7.41 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.527 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -87.83 94.74 4.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.25 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.959 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.483 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.822 0.344 . . . . 0.0 110.114 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.416 ' HB1' HG11 ' A' ' 48' ' ' VAL . . . -167.87 136.48 2.45 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -176.78 112.79 0.1 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.322 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.473 ' HB ' HG22 ' A' ' 44' ' ' VAL . 1.3 pp -78.34 160.33 4.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.306 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 m -138.46 126.38 22.51 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.296 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.44 168.7 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.372 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 14.1 m-85 -134.8 138.73 44.52 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.343 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.9 -55.02 29.8 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.397 -0.921 . . . . 0.0 113.066 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.613 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 55.6 m-20 -92.37 167.06 12.24 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.375 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.533 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 7.4 tm-20 -79.98 160.66 25.83 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.199 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 10' ' ' GLU . 0.9 OUTLIER 81.41 38.97 0.06 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.546 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.456 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 5.0 t80 59.74 2.99 0.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.984 -1.086 . . . . 0.0 112.533 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -102.84 164.88 11.37 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.673 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.613 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 97.48 132.94 7.66 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 14' ' ' GLY . 8.2 mtpm? -29.27 135.98 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.755 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -113.94 171.72 7.42 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.301 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.0 t -144.37 145.96 20.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.511 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -91.85 128.08 37.55 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.74 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 19' ' ' LEU . 2.3 mm? -118.14 107.2 44.0 Favored Pre-proline 0 N--CA 1.49 1.541 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.26 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -64.87 166.75 17.41 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 120.911 1.074 . . . . 0.0 111.265 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.28 176.25 1.65 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.732 1.621 . . . . 0.0 111.294 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.508 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 102.28 -167.92 18.41 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.391 -1.385 . . . . 0.0 110.788 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.46 ' CA ' HH11 ' A' ' 83' ' ' ARG . 15.3 p-10 -110.98 141.93 43.78 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.022 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.644 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -156.67 152.84 27.61 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.243 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.4 p -132.02 -158.48 0.89 Allowed 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.079 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -58.74 -28.8 66.21 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.588 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -63.01 -54.74 33.59 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.034 -1.067 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -52.79 -48.82 66.6 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.039 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.619 HD21 ' CE1' ' A' ' 24' ' ' TYR . 5.0 mt -59.48 -39.02 82.39 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.66 -1.216 . . . . 0.0 109.338 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.13 -29.06 4.83 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 118.564 -1.254 . . . . 0.0 108.397 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.14 -31.62 27.11 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.454 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 29' ' ' LEU . 10.2 mt -80.39 -86.4 0.08 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.333 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 32' ' ' LEU . . . 176.74 -27.0 0.07 OUTLIER Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.226 -1.464 . . . . 0.0 110.787 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.478 HG22 HG21 ' A' ' 38' ' ' THR . 0.2 OUTLIER -79.47 -175.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 118.941 -1.103 . . . . 0.0 109.964 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.65 ' H ' HG21 ' A' ' 38' ' ' THR . 1.3 pt-20 177.48 113.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.708 -1.197 . . . . 0.0 112.604 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.438 ' O ' HG22 ' A' ' 38' ' ' THR . 2.1 m-20 42.31 -106.7 0.08 Allowed 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.558 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.499 ' C ' HG22 ' A' ' 38' ' ' THR . 61.8 t-20 -50.46 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.947 -0.701 . . . . 0.0 112.391 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.65 HG21 ' H ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER 170.44 -18.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.802 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.488 ' O ' HD22 ' A' ' 72' ' ' LEU . 7.8 mm -75.59 32.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.105 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.646 ' H ' ' C ' ' A' ' 38' ' ' THR . 29.6 t -37.62 -63.99 0.42 Allowed 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.326 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.402 ' HB2' ' H ' ' A' ' 12' ' ' PHE . 1.1 t -116.03 165.09 13.52 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -148.2 156.67 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 118.342 -1.343 . . . . 0.0 113.44 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -137.82 110.92 7.8 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.523 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.473 HG22 ' HB ' ' A' ' 4' ' ' ILE . 88.4 t -133.95 106.25 11.53 Favored Pre-proline 0 N--CA 1.497 1.913 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.94 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.417 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 Cg_endo -70.16 171.5 14.79 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 121.647 1.564 . . . . 0.0 111.728 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.417 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.7 Cg_endo -62.78 -169.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 122.145 1.897 . . . . 0.0 111.204 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.87 -14.44 19.62 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 119.269 -1.444 . . . . 0.0 110.449 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.691 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -152.93 157.14 4.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 118.836 -1.145 . . . . 0.0 111.697 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.454 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 31.7 ttpt -123.56 120.41 32.77 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.34 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.75 154.99 18.63 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.025 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 63' ' ' ILE . 60.6 mt -138.91 119.79 15.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.338 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.461 ' H ' HD12 ' A' ' 52' ' ' LEU . 3.7 mp -94.79 155.37 16.84 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 118.683 -1.207 . . . . 0.0 112.352 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -133.55 114.97 14.17 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.053 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.451 ' CD ' ' N ' ' A' ' 55' ' ' ASN . 7.0 tm0? -53.64 -69.12 0.13 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.39 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.514 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 63.8 t30 -69.37 137.68 53.03 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.028 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -53.06 166.69 0.21 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.538 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.54 28.98 64.47 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.394 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 55.92 49.1 16.57 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.972 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.18 -171.16 2.62 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.795 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.514 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 74.16 171.75 25.69 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.355 -1.402 . . . . 0.0 109.743 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 60' ' ' GLY . 1.7 m-20 -42.57 116.14 0.81 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.491 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.4 ' HG2' ' H ' ' A' ' 62' ' ' GLN . 13.5 pt20 -89.75 155.02 19.47 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.361 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.668 HD11 HD11 ' A' ' 75' ' ' LEU . 5.2 mt -130.18 167.08 26.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.761 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.456 ' H ' HG22 ' A' ' 63' ' ' ILE . 66.6 mt-10 -145.26 130.74 18.76 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.38 -0.928 . . . . 0.0 109.727 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.9 m -147.34 156.86 10.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 118.797 -1.161 . . . . 0.0 112.241 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 48' ' ' VAL . 4.0 t -144.5 -2.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.137 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -125.32 -159.69 0.91 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.301 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.828 HD21 HG13 ' A' ' 106' ' ' VAL . 10.7 p-10 -94.28 118.59 31.82 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.476 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.699 ' HB1' ' HA ' ' A' ' 72' ' ' LEU . . . -89.58 96.39 10.68 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.897 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -53.21 -70.99 0.08 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.821 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -90.55 3.21 54.65 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.239 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.699 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 14.7 tp 59.62 -90.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.634 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.429 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -177.2 -170.49 39.67 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.541 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.613 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.7 Cg_endo -67.16 -56.64 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.351 2.034 . . . . 0.0 112.266 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.903 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.1 pt? -64.75 19.52 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.321 -0.951 . . . . 0.0 111.409 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.613 ' H ' ' C ' ' A' ' 74' ' ' PRO . 45.3 p-10 -74.42 -17.12 60.84 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.387 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -77.88 4.93 10.71 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.577 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -167.9 115.01 0.72 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.172 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 1.022 HG12 ' H ' ' A' ' 80' ' ' SER . 26.3 t -132.32 -171.49 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.046 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . 1.022 ' H ' HG12 ' A' ' 79' ' ' VAL . 21.0 p -176.31 -51.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.648 -1.221 . . . . 0.0 112.672 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.96 162.2 25.0 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 119.148 -1.021 . . . . 0.0 112.854 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 82' ' ' ILE . 10.2 mt -148.83 155.5 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.735 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.59 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -132.14 114.28 14.32 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.664 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.59 ' H ' HH12 ' A' ' 83' ' ' ARG . 37.1 t -121.38 136.56 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.756 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.581 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 4.0 mt -145.15 126.67 8.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.093 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 p -39.88 141.85 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.034 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 48' ' ' VAL . 1.3 p -134.09 138.58 30.87 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.339 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HD2' HG22 ' A' ' 87' ' ' VAL . 11.7 Cg_exo -47.21 136.66 18.68 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 121.207 1.271 . . . . 0.0 111.325 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.3 t -53.41 140.48 9.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.579 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -144.85 130.98 9.73 Favored Pre-proline 0 N--CA 1.487 1.387 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.906 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.45 ' HB2' HD11 ' A' ' 136' ' ' LEU . 6.3 Cg_exo -58.45 -163.3 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.921 0 C-N-CA 121.039 1.159 . . . . 0.0 111.359 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.429 ' CA ' HD12 ' A' ' 136' ' ' LEU . 9.6 ptt-85 -179.67 -158.17 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.939 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.562 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -137.4 166.97 22.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.65 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -120.81 140.78 51.25 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.456 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.511 ' CD2' HG13 ' A' ' 131' ' ' VAL . 80.5 m-85 -131.34 118.19 19.96 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.393 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -83.45 173.15 11.74 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.56 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.77 -70.34 0.72 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.991 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -62.36 163.98 7.82 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.901 -0.719 . . . . 0.0 112.249 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -89.89 63.62 6.08 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.808 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 101' ' ' PHE . 4.5 tt0 -176.0 50.1 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.713 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 100' ' ' GLN . 18.6 p90 41.44 44.2 2.4 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.111 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.449 ' CG ' ' N ' ' A' ' 103' ' ' GLY . 32.3 t70 -143.5 172.85 12.23 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.2 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 91.26 141.19 9.43 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.158 -1.496 . . . . 0.0 109.76 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 103' ' ' GLY . 47.0 mttp -28.66 130.3 0.06 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 123.971 0.454 . . . . 0.0 111.899 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -98.98 120.68 39.83 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.608 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.828 HG13 HD21 ' A' ' 68' ' ' ASN . 43.7 t -103.74 131.07 53.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.731 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -103.81 148.92 25.54 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.07 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.1 mt -138.11 123.15 12.22 Favored Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.154 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.428 ' CB ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -64.74 168.07 14.17 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.492 1.461 . . . . 0.0 111.797 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 6.1 Cg_exo -55.12 157.33 13.95 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 122.222 1.948 . . . . 0.0 111.973 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.38 178.89 15.73 Favored Glycine 0 N--CA 1.499 2.869 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.936 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.613 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 46.9 tt0 -109.31 157.1 19.2 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.125 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.613 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 33.2 m-85 -144.78 153.94 42.18 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.031 -1.067 . . . . 0.0 111.248 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.5 p -98.48 -161.43 0.87 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.008 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.34 54.38 0.83 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.958 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.33 -62.27 0.07 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.12 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.574 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 6.4 pt-20 -69.18 -51.08 41.61 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.574 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -37.77 -69.51 0.12 Allowed 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.231 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 119' ' ' GLU . 79.0 mt-10 -46.95 -66.5 0.4 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.66 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.465 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -70.33 4.77 2.06 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' A' ' 117' ' ' GLU . 17.0 t80 -98.61 -18.1 18.29 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 118.868 -1.133 . . . . 0.0 111.379 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.554 ' O ' HG11 ' A' ' 106' ' ' VAL . . . -165.79 -11.89 0.03 OUTLIER Glycine 0 C--N 1.289 -2.07 0 C-N-CA 118.152 -1.975 . . . . 0.0 111.043 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.453 ' CG1' ' C ' ' A' ' 122' ' ' GLY . 2.2 mt -148.89 -125.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 118.676 -1.21 . . . . 0.0 111.597 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.569 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 20.0 t70 -155.06 -162.58 1.39 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.832 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.569 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 12.4 p30 -71.44 -36.23 71.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.033 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -158.2 100.12 1.67 Allowed 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.955 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.428 ' CG2' HG22 ' A' ' 123' ' ' ILE . 9.4 t -177.22 25.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.309 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.8 mt -80.74 -60.35 2.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.409 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.7 m 59.32 -125.38 1.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 m -54.73 126.65 24.88 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.511 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.2 t -122.49 157.69 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.12 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -153.44 93.14 3.12 Favored Pre-proline 0 C--N 1.293 -1.862 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.178 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -53.73 124.21 15.27 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 121.125 1.217 . . . . 0.0 111.003 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.562 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 40.6 tp60 -89.22 -21.64 23.15 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.212 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -161.05 -29.55 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 C-N-CA 118.325 -1.893 . . . . 0.0 112.338 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.45 HD11 ' HB2' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -120.92 159.79 24.83 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.165 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.25 147.67 32.47 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.964 -1.094 . . . . 0.0 110.254 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 65.9 t -115.95 149.22 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.463 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.604 HG12 ' CE1' ' A' ' 141' ' ' PHE . 61.8 t -133.85 128.99 54.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.781 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.2 mp -102.72 138.2 39.93 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.963 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.836 ' CD2' ' CD1' ' A' ' 146' ' ' PHE . 8.6 m-85 -120.32 128.94 53.73 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.842 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.56 ' O ' ' CB ' ' A' ' 143' ' ' ASN . 53.9 mttm -85.33 102.12 13.12 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.049 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 142' ' ' LYS . 11.2 t-20 103.0 170.16 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.917 0 O-C-N 125.195 1.559 . . . . 0.0 111.292 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 146' ' ' PHE . 24.6 t70 -45.79 170.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.121 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' A' ' 144' ' ' ASP . 3.4 m120 -3.21 66.33 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 CA-C-N 113.921 -1.49 . . . . 0.0 113.986 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.836 ' CD1' ' CD2' ' A' ' 141' ' ' PHE . 0.9 OUTLIER 50.3 63.21 2.3 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.899 -1.121 . . . . 0.0 111.323 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.3 t -114.57 45.64 1.52 Allowed 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.557 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.24 -169.28 42.1 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.71 177.67 0.4 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.524 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.2 p -150.2 175.33 11.87 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.448 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.593 ' C ' HD13 ' A' ' 151' ' ' LEU . 3.4 tm? -147.77 90.88 5.05 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.51 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.35 109.02 1.48 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.705 1.603 . . . . 0.0 112.272 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 49.5 t -80.98 90.84 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.004 -1.079 . . . . 0.0 109.92 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -65.01 -20.45 66.5 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.569 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 11.0 t -168.33 -146.55 0.06 Allowed 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.063 -1.455 . . . . 0.0 112.634 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.4 m-20 -50.81 150.35 2.96 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.981 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -168.87 66.34 0.64 Allowed Pre-proline 0 C--N 1.31 -1.152 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.04 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.484 ' C ' HG22 ' A' ' 159' ' ' THR . 2.3 Cg_endo -62.46 23.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.323 2.015 . . . . 0.0 113.692 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.507 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER 176.86 91.23 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.45 -1.3 . . . . 0.0 111.394 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 162' ' ' ALA . 1.4 tp -94.52 -23.26 17.76 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.247 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.69 ' O ' ' HB2' ' A' ' 162' ' ' ALA . . . -43.63 93.94 0.01 OUTLIER Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.264 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 161' ' ' GLY . . . 163.25 0.1 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.974 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.406 ' H ' ' H ' ' A' ' 162' ' ' ALA . 31.4 tpp -151.05 -25.07 0.21 Allowed 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.934 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.457 ' ND2' ' OG1' ' A' ' 167' ' ' THR . 3.1 t-20 -68.22 98.04 0.77 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.404 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -82.79 -40.22 20.71 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.209 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.421 ' O ' ' N ' ' A' ' 168' ' ' SER . 23.8 t-20 -172.93 63.95 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.767 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.457 ' OG1' ' ND2' ' A' ' 164' ' ' ASN . 9.1 m -40.0 99.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.601 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.527 ' HB2' ' H ' ' A' ' 143' ' ' ASN . 3.3 m -88.58 -55.86 3.54 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.407 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.2 p -121.48 156.57 32.48 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.747 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.402 HG12 ' CD1' ' A' ' 118' ' ' LEU . 26.8 pt -139.37 165.14 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.49 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -146.45 106.07 3.95 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.332 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.81 95.46 4.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.401 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 116.458 -1.734 . . . . 0.0 111.076 -179.939 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mtm . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.521 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -63.49 -175.3 0.11 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.469 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -170.47 108.62 0.34 Allowed 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.228 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pp -77.44 128.69 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.855 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.08 152.54 20.49 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.169 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 m -140.19 169.11 16.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.625 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 18.7 m-85 -128.93 153.71 47.26 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.93 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -78.17 -59.48 2.76 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.503 -0.879 . . . . 0.0 113.326 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.638 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 81.7 m-20 -81.36 -178.02 6.75 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.811 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.552 ' CG ' ' H ' ' A' ' 11' ' ' ASP . 20.9 tt0 -74.03 179.32 4.44 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.829 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.615 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 1.5 p-10 40.53 67.16 0.53 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.339 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.615 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 43.7 p90 35.47 27.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.114 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' ASP . 49.8 tt0 -102.65 159.7 15.23 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.987 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.638 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 95.49 140.75 11.15 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.327 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 14' ' ' GLY . 5.5 mtpp -28.75 135.61 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.78 157.78 16.46 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.407 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.4 t -149.15 133.59 9.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.769 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -98.92 113.36 25.47 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.601 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 mt -102.01 136.87 19.4 Favored Pre-proline 0 N--CA 1.488 1.467 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.94 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -70.0 162.58 41.67 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 120.978 1.119 . . . . 0.0 111.137 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -66.33 -175.74 0.57 Allowed 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 121.694 1.596 . . . . 0.0 110.541 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.488 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 104.4 -166.54 15.24 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.242 -1.456 . . . . 0.0 111.263 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.524 ' HB3' HH11 ' A' ' 83' ' ' ARG . 16.2 p-10 -123.43 137.32 54.83 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.222 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.499 ' CE2' HD12 ' A' ' 82' ' ' ILE . 4.9 p90 -157.84 -179.93 8.61 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.445 -1.302 . . . . 0.0 111.676 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.417 ' HB ' ' H ' ' A' ' 26' ' ' ARG . 1.8 p -147.06 -157.55 0.82 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.461 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.417 ' H ' ' HB ' ' A' ' 25' ' ' THR . 34.7 ttt180 -61.27 -19.14 61.38 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.491 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.66 -66.59 0.53 Allowed 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.567 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.539 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 6.9 tp60 -56.31 -43.12 78.62 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.782 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 29' ' ' LEU . 30.9 mt -59.93 -40.49 89.08 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.154 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.02 -29.02 41.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 118.435 -1.306 . . . . 0.0 108.153 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -74.1 -35.47 64.18 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.696 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.27 -78.4 0.13 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.786 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.85 -25.25 0.56 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.153 -1.498 . . . . 0.0 110.688 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.548 HG12 HG21 ' A' ' 38' ' ' THR . 0.0 OUTLIER -92.82 137.18 22.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.028 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.458 ' CG ' ' C ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER 168.61 158.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.198 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.492 ' OD1' ' ND2' ' A' ' 37' ' ' ASN . 2.6 t-20 66.84 116.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.492 ' ND2' ' OD1' ' A' ' 36' ' ' ASN . 0.1 OUTLIER 56.42 3.99 0.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.098 -0.955 . . . . 0.0 113.045 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.548 HG21 HG12 ' A' ' 34' ' ' ILE . 39.9 p -82.98 -135.28 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.491 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 38' ' ' THR . 2.5 mt 25.37 52.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 123.902 0.751 . . . . 0.0 112.68 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.5 t -70.15 -41.51 73.74 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.214 -0.995 . . . . 0.0 110.118 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.4 166.25 15.02 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.312 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -145.3 149.68 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 118.533 -1.267 . . . . 0.0 112.666 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -140.05 87.25 2.14 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.609 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.0 t -109.44 115.48 56.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -69.7 168.5 21.3 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.207 1.271 . . . . 0.0 110.773 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.47 -177.09 0.36 Allowed 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 121.843 1.695 . . . . 0.0 111.126 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.07 -11.62 11.24 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.283 -1.437 . . . . 0.0 110.952 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.521 HG11 ' CB ' ' A' ' 2' ' ' ALA . 33.1 m -148.41 145.34 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.537 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.459 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 44.2 tttt -124.12 158.28 32.67 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.578 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.459 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -148.96 140.69 23.57 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.299 -1.361 . . . . 0.0 112.962 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 63' ' ' ILE . 35.7 mt -119.06 124.19 72.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.591 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.507 ' H ' HD12 ' A' ' 52' ' ' LEU . 3.8 mp -93.9 165.91 12.43 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 118.641 -1.223 . . . . 0.0 112.341 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -141.22 108.95 5.64 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.956 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -47.28 -84.54 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.928 -0.709 . . . . 0.0 112.03 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.476 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 94.5 m-20 -59.34 142.55 51.84 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.476 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 11.9 p-10 -56.18 174.53 0.13 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.598 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.98 36.87 93.59 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.141 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.404 ' CZ ' HG23 ' A' ' 25' ' ' THR . 40.1 m-85 47.03 43.94 14.43 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.673 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.53 -165.5 1.25 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.901 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.476 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 65.01 165.19 1.08 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.364 -1.398 . . . . 0.0 109.855 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.49 130.1 19.79 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.586 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.462 ' C ' ' CD ' ' A' ' 62' ' ' GLN . 3.1 pp0? -101.07 161.87 13.29 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.106 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.74 HG22 ' N ' ' A' ' 64' ' ' GLU . 7.7 mm -128.06 171.86 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.714 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.74 ' N ' HG22 ' A' ' 63' ' ' ILE . 55.5 mt-10 -144.7 131.21 19.86 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.581 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.1 m -150.52 158.32 5.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.805 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 t -144.28 -4.31 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.56 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.72 -153.63 0.58 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.778 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -92.32 125.74 37.11 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.353 -0.939 . . . . 0.0 109.754 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.568 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -97.3 133.95 41.23 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.356 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -74.55 -77.95 0.11 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.49 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -99.32 3.92 46.26 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.692 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.402 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 0.6 OUTLIER 63.95 -82.79 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.513 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.522 ' O ' ' ND2' ' A' ' 76' ' ' ASN . . . -172.67 -178.96 43.13 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.567 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.16 -18.05 56.05 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.149 1.899 . . . . 0.0 111.939 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.686 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -85.08 41.47 0.88 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.06 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 73' ' ' GLY . 84.9 m-20 -79.89 -13.98 58.98 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.694 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -88.62 3.41 50.65 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.513 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.466 ' HA ' ' H ' ' A' ' 37' ' ' ASN . 14.6 t-20 -169.78 126.95 0.88 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 118.381 -1.328 . . . . 0.0 112.534 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.407 ' C ' ' OG ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -154.4 138.36 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.442 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.407 ' OG ' ' C ' ' A' ' 79' ' ' VAL . 1.7 m -157.76 -43.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.241 -1.383 . . . . 0.0 112.826 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.406 ' OG ' HG22 ' A' ' 25' ' ' THR . 17.3 m -94.39 140.45 29.79 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.944 -1.103 . . . . 0.0 111.056 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -147.58 161.01 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 118.814 -1.155 . . . . 0.0 112.224 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.876 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -137.21 116.72 12.85 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.851 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.876 ' H ' HH12 ' A' ' 83' ' ' ARG . 12.8 t -120.37 127.68 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.873 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.49 HG13 ' NH2' ' A' ' 83' ' ' ARG . 27.8 mt -141.07 129.04 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.849 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 74.1 m -41.06 154.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.854 -0.739 . . . . 0.0 111.427 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.729 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -150.33 147.13 21.02 Favored Pre-proline 0 N--CA 1.487 1.419 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.203 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.729 ' HD2' HG22 ' A' ' 87' ' ' VAL . 2.7 Cg_exo -54.12 145.32 54.34 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 121.27 1.313 . . . . 0.0 111.483 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.75 142.9 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.699 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -145.6 147.97 35.07 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.171 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.434 ' HG2' HD21 ' A' ' 136' ' ' LEU . 6.0 Cg_exo -57.51 -166.62 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.911 0 C-N-CA 121.111 1.207 . . . . 0.0 110.394 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.6 ptt-85 -173.98 -162.44 0.14 Allowed 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.743 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.33 159.07 42.97 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.529 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -120.55 135.15 55.17 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.133 -1.027 . . . . 0.0 112.332 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -114.33 105.02 12.65 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.943 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.485 ' CD1' ' HB3' ' A' ' 105' ' ' GLU . 26.2 m-85 -91.48 152.9 20.16 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.502 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 1.6 m-85 -97.05 157.93 15.68 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.739 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp 63.61 132.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.637 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 99' ' ' GLU . 2.7 pt-20 -77.43 77.82 3.95 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.926 -1.109 . . . . 0.0 110.87 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.568 ' HA ' ' OE1' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -172.58 16.19 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.096 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 42.9 t80 48.98 46.38 22.4 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.731 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 103' ' ' GLY . 38.7 t70 -116.85 -79.79 0.59 Allowed 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.768 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 102' ' ' ASP . . . -34.06 136.42 0.24 Allowed Glycine 0 N--CA 1.502 3.057 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.288 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -42.37 163.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.287 0.565 . . . . 0.0 112.336 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -115.72 165.07 13.46 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.501 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 122' ' ' GLY . 1.2 t -130.35 132.03 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 23.2 p-10 -96.47 150.14 20.94 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.264 -0.974 . . . . 0.0 113.2 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.4 mt -143.81 127.97 9.28 Favored Pre-proline 0 N--CA 1.482 1.14 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.864 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -67.88 167.45 21.38 Favored 'Trans proline' 0 C--O 1.212 -0.825 0 C-N-CA 121.399 1.399 . . . . 0.0 111.727 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.57 151.03 78.54 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 122.055 1.837 . . . . 0.0 111.734 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.48 -173.72 21.02 Favored Glycine 0 N--CA 1.498 2.792 0 C-N-CA 119.448 -1.358 . . . . 0.0 111.16 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.592 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 39.9 tt0 -112.92 154.04 27.01 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.4 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.592 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 14.4 m-85 -139.48 151.57 46.29 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.105 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.8 p -92.71 -158.36 0.59 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.648 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -108.75 55.56 0.63 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.574 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.39 -68.8 0.13 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.989 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.553 ' O ' ' N ' ' A' ' 121' ' ' TYR . 8.0 pt-20 -70.39 -46.4 64.1 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.053 -1.059 . . . . 0.0 108.938 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.562 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -36.15 -71.55 0.07 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.858 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.658 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 22.9 mp0 -51.83 -56.43 14.01 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.99 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -73.74 14.48 0.37 Allowed 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.907 -1.117 . . . . 0.0 111.696 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 117' ' ' GLU . 16.1 t80 -122.46 -12.87 8.12 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.537 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.566 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -140.83 -51.48 0.05 OUTLIER Glycine 0 N--CA 1.485 1.955 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.189 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.49 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -137.48 -111.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.281 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -151.99 -151.96 0.41 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.062 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -85.15 10.1 13.14 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.451 -0.899 . . . . 0.0 111.205 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -157.78 -123.72 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.407 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.3 p 51.11 -152.56 0.19 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 129' ' ' SER . 14.7 mt 65.62 159.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.977 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 128' ' ' ILE . 23.1 t -175.14 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.469 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.6 m -76.92 140.39 40.49 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.817 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.6 158.23 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 C-N-CA 119.924 -0.711 . . . . 0.0 111.16 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -156.29 85.5 3.13 Favored Pre-proline 0 C--N 1.306 -1.311 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.63 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.81 102.68 0.53 Allowed 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.093 1.195 . . . . 0.0 109.856 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -86.15 18.72 2.96 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.716 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -174.39 -47.63 0.05 OUTLIER Glycine 0 N--CA 1.489 2.197 0 C-N-CA 117.737 -2.173 . . . . 0.0 112.637 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.434 HD21 ' HG2' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -121.33 169.62 10.42 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.245 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.8 151.79 24.1 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.078 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.6 t -121.88 144.09 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.231 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.545 ' C ' HD12 ' A' ' 140' ' ' LEU . 91.1 t -135.03 128.27 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.561 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.545 HD12 ' C ' ' A' ' 139' ' ' VAL . 10.4 mp -106.4 140.44 39.32 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.674 -0.81 . . . . 0.0 112.744 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.475 ' CG ' ' HA ' ' A' ' 146' ' ' PHE . 62.9 m-85 -120.48 125.24 47.38 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.445 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -60.63 -65.1 0.74 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.172 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -70.33 -172.21 0.56 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.243 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.564 ' O ' ' N ' ' A' ' 146' ' ' PHE . 0.7 OUTLIER -66.32 -149.3 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.93 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.591 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 4.7 p-10 -15.68 75.76 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 O-C-N 124.386 1.054 . . . . 0.0 113.7 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.591 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.3 p90 37.07 64.95 0.54 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.229 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.456 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 28.6 t -128.49 173.7 10.01 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.949 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.456 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 64.17 -168.13 25.65 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.556 -1.306 . . . . 0.0 110.717 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -61.18 167.95 2.82 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.461 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.4 p -146.28 168.84 20.09 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.43 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.534 HD23 ' C ' ' A' ' 151' ' ' LEU . 3.3 tt -138.24 84.59 19.89 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.471 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.59 107.93 1.13 Allowed 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 122.109 1.873 . . . . 0.0 113.094 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 40.2 t -83.9 89.96 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.308 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -64.45 -17.25 63.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 51.4 p -170.25 -141.28 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 117.735 -1.586 . . . . 0.0 112.929 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.438 ' N ' ' OG ' ' A' ' 155' ' ' SER . 20.7 m-20 -65.1 151.45 46.02 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.758 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -168.62 61.7 0.49 Allowed Pre-proline 0 C--N 1.305 -1.364 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.206 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.5 Cg_endo -62.13 17.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 122.173 1.916 . . . . 0.0 112.792 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.546 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -170.46 79.2 0.09 Allowed 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.612 -1.235 . . . . 0.0 111.384 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 162' ' ' ALA . 1.3 tt -91.77 -75.65 0.47 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.342 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 163' ' ' MET . . . 64.12 -81.93 0.05 OUTLIER Glycine 0 N--CA 1.492 2.418 0 C-N-CA 118.992 -1.575 . . . . 0.0 110.806 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -45.01 84.95 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.038 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.593 ' N ' ' O ' ' A' ' 161' ' ' GLY . 0.2 OUTLIER 179.27 84.3 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.489 ' C ' ' O ' ' A' ' 163' ' ' MET . 28.4 m120 -26.9 101.02 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 123.939 0.774 . . . . 0.0 112.121 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.58 101.15 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.243 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -158.15 13.13 0.19 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.855 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.2 m -47.23 99.25 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.902 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.1 m -86.99 -53.69 4.74 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.616 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.62 160.42 21.84 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.201 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.437 HG12 ' CD1' ' A' ' 118' ' ' LEU . 22.2 pt -145.33 162.75 12.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.907 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -145.35 104.7 3.95 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.247 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.0 mt -85.27 95.61 4.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.407 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 116.371 -1.776 . . . . 0.0 110.955 -179.982 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 tpt . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.892 0.377 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -172.81 162.2 4.81 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.849 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -177.72 118.25 0.1 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.305 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 4' ' ' ILE . 2.9 pt -77.33 154.53 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.294 -0.962 . . . . 0.0 111.059 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -133.67 127.12 32.26 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.671 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 m -107.11 173.43 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.37 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.689 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 53.8 m-85 -131.46 145.83 51.96 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.439 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.32 -37.09 77.59 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.501 ' C ' ' OG ' ' A' ' 40' ' ' SER . 25.3 m120 -117.25 165.62 13.23 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 119.101 -1.039 . . . . 0.0 111.814 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.504 ' N ' ' OG ' ' A' ' 40' ' ' SER . 46.8 mm-40 -69.18 173.5 5.57 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.253 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' A' ' 13' ' ' GLN . 4.6 t0 62.38 31.39 17.29 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.692 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.689 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 5.3 t80 68.13 -9.71 0.47 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.304 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.463 ' H ' ' C ' ' A' ' 11' ' ' ASP . 10.2 tt0 -71.88 167.68 19.52 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.861 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.491 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 90.71 129.67 4.29 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.803 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.447 ' HE2' ' H ' ' A' ' 15' ' ' LYS . 1.1 mppt? -39.34 149.72 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.729 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -112.81 165.1 12.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.653 -0.819 . . . . 0.0 112.714 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 t -144.57 144.51 22.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.194 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -104.33 139.14 39.74 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.899 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 mt -132.06 141.71 42.44 Favored Pre-proline 0 N--CA 1.494 1.773 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.774 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -71.62 162.4 42.29 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 121.186 1.257 . . . . 0.0 111.893 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -68.51 -157.68 0.04 OUTLIER 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 121.94 1.76 . . . . 0.0 111.356 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.55 -159.93 50.01 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.854 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -90.95 149.86 21.71 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.292 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.9 ' OH ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -166.42 146.41 6.01 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.7 p -148.52 -146.59 0.2 Allowed 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 118.66 -1.216 . . . . 0.0 112.803 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -37.0 86.21 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.553 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.551 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -57.15 -57.34 13.03 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.75 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.45 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 24.0 tt0 -58.41 -50.77 72.51 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.728 -1.189 . . . . 0.0 109.333 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.9 HD21 ' OH ' ' A' ' 24' ' ' TYR . 15.4 mt -51.07 -39.22 55.53 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.759 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -51.43 -37.16 47.21 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.357 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -67.92 -35.45 78.48 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.75 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.519 HD23 ' N ' ' A' ' 32' ' ' LEU . 6.9 mt -77.03 -83.59 0.07 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.825 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.14 -27.47 0.21 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 118.811 -1.662 . . . . 0.0 111.452 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.485 HG12 HD22 ' A' ' 29' ' ' LEU . 2.3 pt -89.4 167.18 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.196 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 1.9 pt-20 173.32 152.65 0.09 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.102 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 3.1 t-20 70.94 -155.48 0.11 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.715 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -48.8 93.73 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.156 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' SER . 35.4 p -148.5 -50.1 0.16 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.626 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.416 HD11 HD11 ' A' ' 82' ' ' ILE . 11.2 mt -60.67 75.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.315 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' THR . 32.1 t -75.18 -52.59 10.57 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.74 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.506 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -120.48 174.06 6.78 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -152.94 150.27 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 117.963 -1.495 . . . . 0.0 112.803 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -137.41 110.55 7.8 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.533 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.2 t -133.65 116.14 13.73 Favored Pre-proline 0 N--CA 1.495 1.807 0 C-N-CA 119.666 -0.813 . . . . 0.0 112.087 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.43 167.57 22.04 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 120.941 1.094 . . . . 0.0 110.809 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.92 -171.08 0.16 Allowed 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.744 1.63 . . . . 0.0 111.1 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.414 ' C ' HG13 ' A' ' 48' ' ' VAL . . . 75.46 -10.31 12.2 Favored Glycine 0 N--CA 1.481 1.652 0 C-N-CA 119.273 -1.441 . . . . 0.0 110.907 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.456 HG11 ' CB ' ' A' ' 2' ' ' ALA . 30.5 m -151.9 131.77 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.236 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -104.28 124.68 49.6 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.339 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.47 134.11 50.98 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.481 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.57 HD12 ' NH2' ' A' ' 83' ' ' ARG . 71.3 mt -112.59 123.08 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.116 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.898 HD23 ' H ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -89.91 152.87 21.02 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.286 -0.966 . . . . 0.0 112.443 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.898 ' H ' HD23 ' A' ' 52' ' ' LEU . 13.8 m-85 -140.07 125.08 18.53 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.22 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -53.33 -88.46 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.327 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -64.44 154.3 36.15 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.748 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -61.3 172.56 1.07 Allowed 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.362 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.66 17.99 76.95 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.12 -1.514 . . . . 0.0 109.924 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 59.24 54.05 5.03 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.971 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.52 -173.71 2.94 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.8 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.7 -175.78 33.49 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.482 -1.342 . . . . 0.0 109.955 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -50.65 166.88 0.07 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.69 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.62 161.92 36.74 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.366 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.746 HG22 ' N ' ' A' ' 64' ' ' GLU . 10.0 mm -138.78 172.76 13.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.571 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.746 ' N ' HG22 ' A' ' 63' ' ' ILE . 20.4 mt-10 -148.15 130.88 15.99 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.839 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.5 m -145.7 161.75 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 118.768 -1.173 . . . . 0.0 112.552 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.35 -14.7 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.006 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.04 -148.76 0.41 Allowed 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.404 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.697 HD22 HG13 ' A' ' 106' ' ' VAL . 14.3 p-10 -99.82 136.12 40.22 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.022 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.538 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -106.06 128.0 53.56 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.928 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -80.6 -74.79 0.3 Allowed 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 73' ' ' GLY . 20.2 mm-40 -89.95 3.32 53.47 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.975 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.417 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 1.7 tp 55.7 -83.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.715 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 176.02 -169.7 42.41 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.316 -1.421 . . . . 0.0 110.679 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.526 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.2 Cg_endo -65.05 -39.22 24.9 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 122.295 1.997 . . . . 0.0 112.17 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.022 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.9 pt? -71.94 31.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.942 -1.103 . . . . 0.0 111.202 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 74' ' ' PRO . 16.2 p-10 -80.77 -17.92 49.35 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.739 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -88.6 14.02 10.88 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.688 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.544 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -167.6 115.01 0.75 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.722 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 78' ' ' ASN . 15.8 m -155.47 153.63 7.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.514 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.1 t -172.55 -33.59 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 118.683 -1.207 . . . . 0.0 112.35 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.8 140.98 40.07 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.894 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.416 HG23 ' HA ' ' A' ' 52' ' ' LEU . 3.9 mt -150.52 149.79 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.381 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.703 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -141.32 126.41 18.39 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.248 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.703 ' CA ' HH12 ' A' ' 83' ' ' ARG . 3.5 t -117.7 135.92 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.1 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.55 ' CG1' ' CZ ' ' A' ' 83' ' ' ARG . 13.7 mt -119.34 121.92 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.654 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.4 p -46.16 129.99 10.17 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.708 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.515 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.9 OUTLIER -125.26 151.31 69.42 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.7 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.515 ' HD2' HG22 ' A' ' 87' ' ' VAL . 4.1 Cg_exo -55.87 139.03 83.66 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 121.234 1.29 . . . . 0.0 110.731 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.32 133.78 31.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.34 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -143.63 150.99 52.62 Favored Pre-proline 0 N--CA 1.487 1.402 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.9 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 2.5 Cg_endo -59.29 -160.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.241 1.294 . . . . 0.0 111.611 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -174.93 -158.75 0.08 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.849 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.23 165.04 28.99 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.622 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.409 HH11 ' CD ' ' A' ' 105' ' ' GLU . 6.8 ttt180 -128.98 152.24 48.82 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.87 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.571 ' CE1' HG23 ' A' ' 131' ' ' VAL . 98.0 m-85 -142.61 133.89 26.17 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.748 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.445 ' CD2' ' C ' ' A' ' 101' ' ' PHE . 18.6 m-85 -94.55 -177.12 4.12 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.14 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.8 -52.1 2.87 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.031 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.562 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 15.5 mmtp -93.18 163.9 13.45 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.541 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -82.9 78.47 9.49 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.379 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.65 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.3 OUTLIER 178.85 26.79 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.349 -1.296 . . . . 0.0 107.973 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.65 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 33.9 p90 37.78 49.1 1.06 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.237 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -138.44 -28.91 0.82 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.828 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.562 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -58.89 153.77 29.32 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.303 -1.427 . . . . 0.0 110.46 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 103' ' ' GLY . 42.8 tttm -31.03 140.03 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.903 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.409 ' CD ' HH11 ' A' ' 94' ' ' ARG . 63.6 mt-10 -96.47 147.7 23.56 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.585 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.697 HG13 HD22 ' A' ' 68' ' ' ASN . 95.0 t -142.85 117.88 4.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -104.14 162.27 13.32 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.095 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -141.11 150.93 60.54 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.195 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -78.08 163.51 28.03 Favored 'Trans proline' 0 C--O 1.212 -0.796 0 C-N-CA 121.652 1.568 . . . . 0.0 111.957 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.21 139.94 74.95 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.593 1.529 . . . . 0.0 110.696 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.51 -159.75 27.57 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 118.884 -1.626 . . . . 0.0 111.574 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.55 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 34.7 tt0 -118.03 156.16 29.06 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.149 -0.525 . . . . 0.0 110.828 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 49.6 m-85 -145.55 149.22 34.18 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.157 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.434 ' C ' ' H ' ' A' ' 116' ' ' ALA . 3.3 p -101.92 175.8 5.42 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.335 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -72.28 17.32 0.11 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.864 -0.734 . . . . 0.0 112.387 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 114' ' ' THR . . . -111.21 -65.75 1.14 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.564 -0.854 . . . . 0.0 111.716 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.0 pt-20 -70.55 -53.98 13.94 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.822 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.572 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -30.61 -72.43 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 123.925 0.765 . . . . 0.0 111.188 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.52 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -53.04 -57.14 11.39 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.268 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.451 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 8.0 mpt_? -78.37 26.69 0.21 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.553 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 117' ' ' GLU . 27.9 t80 -135.18 -8.28 2.29 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.315 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.651 ' O ' HG11 ' A' ' 106' ' ' VAL . . . -150.68 -44.59 0.02 OUTLIER Glycine 0 N--CA 1.481 1.642 0 C-N-CA 119.019 -1.562 . . . . 0.0 110.323 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -143.75 -102.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.822 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.444 ' C ' ' HB3' ' A' ' 119' ' ' GLU . 2.0 p-10 -172.63 179.97 2.3 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.493 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -63.91 123.03 17.91 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.113 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.547 ' C ' HG22 ' A' ' 127' ' ' THR . 1.9 m-20 56.28 106.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.968 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.692 HG23 ' H ' ' A' ' 128' ' ' ILE . 0.1 OUTLIER 172.49 -92.77 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.565 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.692 ' H ' HG23 ' A' ' 127' ' ' THR . 6.5 mm 45.81 -110.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.191 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 1.1 t 86.93 120.99 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 123.816 0.697 . . . . 0.0 111.924 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.731 ' H ' ' H ' ' A' ' 160' ' ' LEU . 2.7 m 58.97 114.72 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.136 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.75 HG12 ' HB3' ' A' ' 157' ' ' ALA . 4.0 p -113.13 160.13 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.605 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -160.96 89.68 1.62 Allowed Pre-proline 0 C--N 1.291 -1.967 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.183 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -69.32 121.32 8.11 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.035 1.157 . . . . 0.0 110.704 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -91.05 11.19 23.83 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.592 -0.843 . . . . 0.0 112.19 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -175.7 -49.67 0.06 OUTLIER Glycine 0 N--CA 1.491 2.339 0 C-N-CA 118.262 -1.923 . . . . 0.0 112.137 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.402 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -107.8 171.41 7.41 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.143 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -93.16 145.0 24.74 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.681 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 153' ' ' VAL . 31.6 t -101.42 147.52 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.157 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.427 HG12 ' CE1' ' A' ' 141' ' ' PHE . 59.8 t -138.25 116.71 13.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.821 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.438 ' H ' HD12 ' A' ' 140' ' ' LEU . 2.6 mp -105.7 137.47 43.51 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.78 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.427 ' CE1' HG12 ' A' ' 139' ' ' VAL . 10.9 m-85 -108.34 145.31 34.65 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.82 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -75.6 -61.73 1.82 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.913 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -82.19 149.49 27.88 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.858 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 145' ' ' ASN . 29.4 t70 -54.04 175.38 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.989 -1.085 . . . . 0.0 110.739 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.645 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 3.3 t-20 36.09 35.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.254 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.645 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 43.11 65.86 0.89 Allowed 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.103 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.2 t -120.59 34.76 5.1 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.543 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.0 -160.29 12.24 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.167 -1.492 . . . . 0.0 110.415 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -59.33 171.93 0.71 Allowed 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.093 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.5 p -149.82 160.16 43.79 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.562 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.21 84.58 62.82 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.066 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.53 102.61 0.61 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.71 1.607 . . . . 0.0 112.405 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.684 HG11 HG11 ' A' ' 131' ' ' VAL . 81.3 t -83.74 87.66 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.649 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -83.75 22.27 1.14 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.801 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 42.3 p -170.39 -156.12 0.13 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.596 -1.241 . . . . 0.0 112.033 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -90.56 150.99 21.52 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.621 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.75 ' HB3' HG12 ' A' ' 131' ' ' VAL . . . -159.42 84.99 2.25 Favored Pre-proline 0 C--N 1.308 -1.207 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.103 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.527 ' C ' ' OG ' ' A' ' 130' ' ' SER . 1.7 Cg_endo -67.93 37.92 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.045 1.83 . . . . 0.0 112.421 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.462 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.5 OUTLIER -178.55 65.83 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.704 0.764 . . . . 0.0 109.244 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.731 ' H ' ' H ' ' A' ' 130' ' ' SER . 3.4 tm? -80.98 -35.38 32.14 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.188 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.506 ' H ' ' HA ' ' A' ' 129' ' ' SER . . . -43.0 -38.92 3.55 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.743 -1.218 . . . . 0.0 111.563 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.56 -24.04 45.78 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.341 -0.944 . . . . 0.0 111.985 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -81.19 -51.71 8.14 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.606 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -86.84 142.48 28.04 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.282 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -97.77 -33.28 11.33 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.937 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -160.6 106.59 1.48 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.545 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.3 m -92.64 113.5 25.8 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.376 -0.929 . . . . 0.0 111.18 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 41.6 t -99.73 -56.15 2.46 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.163 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 p -123.24 159.42 28.76 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.465 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 30.9 pt -141.54 174.25 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.541 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -156.29 113.3 3.16 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.364 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 7.0 mt -89.28 103.14 13.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.004 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.1 m . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 116.289 -1.815 . . . . 0.0 110.801 -179.982 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 tpp . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.576 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -136.42 159.18 42.55 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.799 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 179.9 129.57 0.09 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.38 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.756 HG22 HG13 ' A' ' 44' ' ' VAL . 9.0 pt -82.5 153.19 3.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.814 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.3 m -121.7 126.04 48.03 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.127 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.527 HG11 HD11 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -101.24 150.26 5.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.389 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.957 ' CD2' ' OE1' ' A' ' 16' ' ' GLN . 47.6 m-85 -116.97 148.19 41.63 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.325 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.0 2.5 42.8 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.509 ' N ' ' HA3' ' A' ' 14' ' ' GLY . 16.8 m120 -154.17 167.94 28.2 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 117.779 -1.568 . . . . 0.0 112.449 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 9.4 tp10 -74.07 158.38 34.37 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.973 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.541 ' C ' ' H ' ' A' ' 13' ' ' GLN . 2.8 t0 72.21 41.04 0.65 Allowed 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.903 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.1 t80 63.3 -8.06 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.335 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.541 ' H ' ' C ' ' A' ' 11' ' ' ASP . 8.9 tt0 -74.44 175.01 8.13 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.526 -0.87 . . . . 0.0 111.169 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.509 ' HA3' ' N ' ' A' ' 9' ' ' ASN . . . 95.96 130.61 6.39 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.672 -1.252 . . . . 0.0 110.866 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 14' ' ' GLY . 48.1 mttp -38.99 152.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.919 -0.713 . . . . 0.0 111.311 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.957 ' OE1' ' CD2' ' A' ' 7' ' ' PHE . 1.7 mm-40 -99.4 154.6 18.08 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.498 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.595 ' CG1' ' N ' ' A' ' 18' ' ' ASP . 2.6 t -147.1 166.47 6.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.424 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.595 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 12.3 m-20 -131.09 131.95 44.54 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.199 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.527 HD11 HG11 ' A' ' 6' ' ' VAL . 13.7 mt -130.29 121.79 19.7 Favored Pre-proline 0 N--CA 1.489 1.482 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.608 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -64.81 164.82 22.99 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 120.988 1.125 . . . . 0.0 111.946 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.65 -157.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.732 1.621 . . . . 0.0 110.668 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.88 -178.44 53.18 Favored Glycine 0 N--CA 1.48 1.587 0 C-N-CA 118.911 -1.614 . . . . 0.0 110.571 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 23' ' ' ASN . 30.2 p-10 -107.44 128.83 54.83 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.83 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 1.3 p90 -153.58 146.89 24.78 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.331 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.447 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 7.8 p -120.48 -155.09 0.61 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.088 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -56.92 -28.11 61.69 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.718 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -55.04 -57.17 12.79 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.663 -1.215 . . . . 0.0 110.177 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.425 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 71.3 tp60 -58.3 -48.54 80.18 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.731 -1.188 . . . . 0.0 109.648 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 29' ' ' LEU . 4.8 mt -59.97 -29.47 68.46 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.515 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -56.03 -30.2 61.55 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -77.03 -34.57 57.31 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.421 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.469 HD12 HD22 ' A' ' 29' ' ' LEU . 13.4 mt -83.16 -68.93 0.67 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.921 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.73 34.22 2.47 Favored Glycine 0 N--CA 1.504 3.187 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.463 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.714 HD13 ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -121.13 8.58 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.669 0.747 . . . . 0.0 110.498 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 35' ' ' GLU . 11.8 pt-20 -78.1 179.66 6.7 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.966 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.59 ' O ' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER 68.93 99.59 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.16 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.515 ' ND2' ' OD1' ' A' ' 36' ' ' ASN . 1.6 p30 33.81 78.16 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.104 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.674 HG21 ' O ' ' A' ' 34' ' ' ILE . 60.5 p -140.39 -39.76 0.43 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.317 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 mt -67.27 72.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.487 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.504 ' OG ' ' C ' ' A' ' 9' ' ' ASN . 31.1 t -69.64 -46.24 66.64 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.694 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.49 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -127.57 164.1 22.72 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.156 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 t -149.89 154.31 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 118.151 -1.42 . . . . 0.0 113.124 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.23 121.61 15.02 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.183 -1.371 . . . . 0.0 108.777 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.756 HG13 HG22 ' A' ' 4' ' ' ILE . 6.4 t -139.12 114.76 8.42 Favored Pre-proline 0 N--CA 1.499 1.976 0 C-N-CA 119.308 -0.957 . . . . 0.0 112.095 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -69.76 169.5 18.77 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.849 1.032 . . . . 0.0 110.701 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.72 -170.32 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.703 1.602 . . . . 0.0 110.872 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.19 -15.03 12.39 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 119.088 -1.53 . . . . 0.0 110.589 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.576 HG11 ' CB ' ' A' ' 2' ' ' ALA . 21.6 m -150.77 135.43 9.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 118.774 -1.17 . . . . 0.0 112.172 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -105.96 127.85 53.42 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.35 153.94 24.22 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.918 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.549 HD12 ' NH2' ' A' ' 83' ' ' ARG . 99.1 mt -137.3 116.95 15.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.479 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.49 ' HA ' HG23 ' A' ' 82' ' ' ILE . 3.3 mp -93.78 162.96 13.71 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.01 -1.076 . . . . 0.0 113.177 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.44 ' CE1' HG22 ' A' ' 51' ' ' ILE . 88.4 m-85 -142.47 131.5 23.12 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.216 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.403 ' CG ' HD12 ' A' ' 75' ' ' LEU . 28.6 mt-30 -54.16 -84.41 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.764 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -75.69 166.6 23.31 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.17 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.32 -173.82 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.729 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 47.71 34.03 9.97 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.138 -1.506 . . . . 0.0 109.948 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.447 ' CZ ' HG23 ' A' ' 25' ' ' THR . 7.9 m-85 45.83 43.29 9.83 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.358 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.38 -172.34 2.32 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.721 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.08 178.96 1.2 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.538 -1.315 . . . . 0.0 109.818 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -54.1 177.53 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 118.831 -1.148 . . . . 0.0 110.195 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -147.45 161.34 41.25 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.806 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.451 HD11 HD11 ' A' ' 75' ' ' LEU . 4.1 mt -125.85 164.39 25.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.21 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -139.38 131.8 28.53 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -149.15 155.87 8.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.325 -1.35 . . . . 0.0 112.564 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.96 0.2 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.034 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.449 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -132.96 -135.91 0.18 Allowed 'General case' 0 C--O 1.208 -1.109 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.441 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.437 ' ND2' ' OD1' ' A' ' 107' ' ' ASP . 2.2 m-20 -111.89 124.44 52.37 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.329 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.11 94.32 6.45 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.639 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -58.64 -68.59 0.25 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.741 -0.784 . . . . 0.0 112.522 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.18 -12.82 59.98 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.369 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.416 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 1.3 tp 67.06 -79.33 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.738 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.416 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 165.62 176.07 36.74 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.238 -1.458 . . . . 0.0 110.77 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.591 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.0 OUTLIER -65.71 -35.12 38.35 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.249 1.966 . . . . 0.0 112.184 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.816 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.5 pt? -67.99 23.92 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.35 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.591 ' H ' ' C ' ' A' ' 74' ' ' PRO . 4.9 p-10 -75.19 -1.08 21.64 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.668 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -73.04 -8.55 56.26 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.14 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -168.5 127.03 1.12 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.159 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.38 137.58 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.273 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 87.8 p -162.3 -30.67 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.656 -1.218 . . . . 0.0 112.697 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.409 ' C ' ' CG1' ' A' ' 82' ' ' ILE . 1.2 m -98.83 139.99 33.68 Favored 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.058 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.49 HG23 ' HA ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -150.64 156.12 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 118.571 -1.252 . . . . 0.0 111.575 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.782 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -150.21 130.09 13.36 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.444 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.782 ' CA ' HH12 ' A' ' 83' ' ' ARG . 10.0 t -128.77 143.19 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.614 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.441 ' CG1' ' CZ ' ' A' ' 83' ' ' ARG . 7.8 mt -132.51 126.42 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.975 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.7 p -40.8 149.9 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.053 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.485 HG22 ' HD2' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -149.61 151.33 32.86 Favored Pre-proline 0 N--CA 1.483 1.203 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.539 179.847 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HD2' HG22 ' A' ' 87' ' ' VAL . 3.5 Cg_exo -53.93 153.39 20.38 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 C-N-CA 121.287 1.325 . . . . 0.0 111.091 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 89' ' ' VAL . 4.2 m -77.73 139.36 18.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.612 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -146.46 130.1 8.36 Favored Pre-proline 0 C--N 1.297 -1.674 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.142 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.404 ' HB2' HD11 ' A' ' 136' ' ' LEU . 2.7 Cg_exo -58.67 -151.75 0.01 OUTLIER 'Trans proline' 0 C--O 1.207 -1.028 0 C-N-CA 121.465 1.444 . . . . 0.0 111.364 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.6 ptt-85 -178.03 -163.94 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.856 -1.138 . . . . 0.0 112.223 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.57 172.12 13.36 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.012 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.559 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 8.4 tpp180 -126.39 157.9 37.32 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.306 -0.957 . . . . 0.0 111.486 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.559 ' CD1' ' C ' ' A' ' 94' ' ' ARG . 26.3 m-85 -148.26 113.59 5.58 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.312 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 105' ' ' GLU . 14.7 m-85 -89.53 161.77 16.03 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.093 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.655 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 0.6 OUTLIER -98.62 167.05 11.04 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.987 -1.085 . . . . 0.0 112.099 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt 59.69 147.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.072 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 30.5 tt0 -65.61 109.68 2.47 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.251 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.665 ' NE2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 100.53 49.79 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.814 0 O-C-N 124.92 1.388 . . . . 0.0 110.181 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.589 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 26.0 p90 29.66 53.21 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.053 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -98.95 30.37 3.41 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.936 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -162.57 151.77 21.76 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.457 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.565 ' O ' ' CE2' ' A' ' 97' ' ' TYR . 88.6 mttt -38.0 155.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.118 0.485 . . . . 0.0 112.1 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.453 ' HG2' ' H ' ' A' ' 105' ' ' GLU . 10.8 pt-20 -111.23 167.09 10.55 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.194 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.49 HG22 ' H ' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -136.66 178.55 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.224 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.49 ' H ' HG22 ' A' ' 106' ' ' VAL . 14.3 p-10 -150.34 145.95 26.44 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.351 -1.339 . . . . 0.0 112.295 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.6 mt -139.17 133.06 16.0 Favored Pre-proline 0 N--CA 1.496 1.873 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.199 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.449 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 2.7 Cg_endo -66.88 169.34 14.96 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 121.517 1.478 . . . . 0.0 111.677 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 5.1 Cg_exo -57.91 149.29 71.03 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 122.094 1.863 . . . . 0.0 111.643 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.22 -155.29 25.52 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.649 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.569 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 37.9 mt-30 -131.12 155.97 46.04 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.809 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.569 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 40.1 m-85 -141.67 155.0 45.71 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.663 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.9 p -102.68 176.46 5.16 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.769 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -83.12 56.8 3.64 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.425 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -153.5 -74.34 0.13 Allowed 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 121' ' ' TYR . 7.3 pt-20 -68.02 -44.6 76.16 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.02 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.584 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -33.94 -72.17 0.05 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.29 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.699 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -53.92 -50.3 66.71 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.436 -1.306 . . . . 0.0 110.08 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.401 ' H ' ' HG2' ' A' ' 120' ' ' ARG . 6.3 mmm180 -80.65 24.38 0.48 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 118.784 -1.166 . . . . 0.0 111.017 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.548 ' N ' ' O ' ' A' ' 117' ' ' GLU . 25.3 t80 -129.28 -12.78 4.5 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.027 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -143.8 -45.33 0.05 OUTLIER Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.297 -1.43 . . . . 0.0 110.39 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.498 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -143.8 -104.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.847 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.483 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 7.4 m-20 -160.62 179.01 8.93 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.044 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -74.8 131.49 40.83 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.691 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 50.18 89.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.449 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.5 t -175.38 -2.66 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.195 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 128' ' ' ILE . 11.6 mt -95.83 144.01 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.671 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 67.5 m -155.22 -49.34 0.08 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.316 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.8 m -87.99 98.41 11.5 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.99 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.508 HG13 ' CD2' ' A' ' 95' ' ' PHE . 3.2 t -104.9 159.69 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.842 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -157.24 85.73 2.81 Favored Pre-proline 0 C--N 1.295 -1.777 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.187 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.67 96.98 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 121.413 1.408 . . . . 0.0 110.576 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -87.39 25.81 1.35 Allowed 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.422 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -161.59 -62.71 0.02 OUTLIER Glycine 0 N--CA 1.487 2.072 0 C-N-CA 118.553 -1.784 . . . . 0.0 111.452 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 91' ' ' PRO . 1.2 mp -121.53 -169.02 1.79 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.826 -0.749 . . . . 0.0 111.749 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -86.79 158.48 19.37 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.6 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.7 t -126.67 137.94 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.624 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.519 ' C ' HD12 ' A' ' 140' ' ' LEU . 62.3 t -133.32 124.89 49.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.961 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 140' ' ' LEU . 9.2 mp -101.27 140.08 36.05 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.529 -0.868 . . . . 0.0 112.285 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 171' ' ' ARG . 19.0 m-85 -107.98 132.79 53.15 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.47 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -79.1 -31.09 44.15 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.3 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.463 ' CG ' ' H ' ' A' ' 144' ' ' ASP . 10.7 t-20 -78.12 179.09 7.06 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.589 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.463 ' H ' ' CG ' ' A' ' 143' ' ' ASN . 2.9 m-20 -69.45 -85.21 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.62 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.606 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 16.0 p-10 -76.16 75.69 2.99 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.637 -0.825 . . . . 0.0 112.097 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.606 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 0.9 OUTLIER 37.62 71.62 0.14 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.898 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.98 -173.2 4.24 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.163 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 62.37 -168.69 15.97 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.669 -1.253 . . . . 0.0 111.081 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 149' ' ' ASP . 0.8 OUTLIER -61.19 176.48 0.44 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.721 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.1 p -151.01 163.26 39.17 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.776 -1.17 . . . . 0.0 112.211 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.431 HD22 ' HG2' ' A' ' 163' ' ' MET . 13.5 tp -123.55 83.42 53.3 Favored Pre-proline 0 N--CA 1.488 1.434 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.115 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.42 108.45 0.7 Allowed 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 122.148 1.899 . . . . 0.0 113.368 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 24.9 t -86.15 89.38 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.347 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -54.95 -24.81 25.62 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.7 p -170.69 -143.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 117.793 -1.563 . . . . 0.0 113.097 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -57.1 145.06 32.21 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.543 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.52 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -174.6 65.93 0.28 Allowed Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.876 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 3.3 Cg_endo -69.28 38.95 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 122.532 2.155 . . . . 0.0 112.583 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.76 HG23 ' H ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -166.67 -82.32 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.339 -1.344 . . . . 0.0 111.911 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.76 ' H ' HG23 ' A' ' 159' ' ' THR . 79.0 mt 54.17 -84.35 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.572 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 159' ' ' THR . . . 57.77 -79.63 0.01 OUTLIER Glycine 0 N--CA 1.496 2.65 0 C-N-CA 118.979 -1.582 . . . . 0.0 110.253 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -52.23 99.49 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.659 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 165' ' ' ASN . 5.4 tpp -176.78 72.42 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.232 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 166' ' ' ASN . 1.6 t-20 -28.72 -39.43 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.929 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 163' ' ' MET . 2.6 m120 -58.87 84.22 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.181 -1.007 . . . . 0.0 110.457 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 164' ' ' ASN . 19.9 m120 -55.86 167.83 0.53 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.055 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.415 ' OG1' HD23 ' A' ' 140' ' ' LEU . 48.8 m -102.93 137.97 40.43 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.156 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.99 -60.84 1.13 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.856 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.01 167.01 12.17 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 24.7 pt -147.35 171.37 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 117.999 -1.481 . . . . 0.0 112.501 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 141' ' ' PHE . 23.7 ttm180 -152.29 106.0 3.1 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.262 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 172' ' ' ILE . 11.4 mt -81.28 107.82 13.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 119.046 -1.061 . . . . 0.0 109.95 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 36.1 m . . . . . 0 C--N 1.303 -1.419 0 CA-C-O 116.347 -1.787 . . . . 0.0 110.981 -179.976 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 tpt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' A' ' 48' ' ' VAL . . . -164.46 160.75 20.88 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.316 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 0.6 OUTLIER 179.43 121.56 0.05 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.706 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.605 HG22 HG22 ' A' ' 44' ' ' VAL . 1.6 pp -82.65 125.23 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 118.549 -1.261 . . . . 0.0 111.288 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.439 HG22 ' N ' ' A' ' 6' ' ' VAL . 38.1 m -105.85 157.65 17.32 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.471 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.492 ' HB ' HG23 ' A' ' 39' ' ' ILE . 1.6 m -142.3 164.6 17.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.288 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 5.4 m-85 -126.39 147.47 49.76 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.94 -68.76 0.38 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.303 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.533 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 34.9 m120 -73.04 170.15 15.48 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.629 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.472 ' CG ' ' N ' ' A' ' 11' ' ' ASP . 32.3 tt0 -73.55 171.06 13.9 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.08 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.63 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 3.4 t70 59.19 55.26 4.42 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.622 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.63 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 23.9 p90 38.72 26.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.102 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 11' ' ' ASP . 59.1 tp60 -103.93 162.2 13.33 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.655 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.533 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 89.63 134.88 5.54 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.64 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 14' ' ' GLY . 16.0 mtpp -30.44 136.93 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.56 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.93 169.54 8.7 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.779 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.3 t -141.19 133.21 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.425 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.17 111.61 23.77 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.728 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mt -105.86 128.72 25.87 Favored Pre-proline 0 N--CA 1.491 1.619 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.772 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -67.57 165.93 25.67 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 120.657 0.905 . . . . 0.0 110.456 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.82 -164.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 121.623 1.549 . . . . 0.0 111.391 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.17 174.44 34.48 Favored Glycine 0 N--CA 1.498 2.813 0 C-N-CA 119.396 -1.383 . . . . 0.0 111.28 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -103.38 135.18 45.48 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.617 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.541 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 2.5 p90 -155.12 176.22 12.82 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 118.482 -1.287 . . . . 0.0 111.701 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.0 p -141.06 -156.46 0.68 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.121 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.588 ' CD ' ' H ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -69.03 -22.68 64.03 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.957 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.47 ' H ' ' HD3' ' A' ' 26' ' ' ARG . . . -64.55 -59.81 3.86 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.652 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -58.73 -45.77 88.87 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.204 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.556 HD23 HD12 ' A' ' 32' ' ' LEU . 12.4 mt -57.47 -37.77 73.43 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.902 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.28 -34.22 56.4 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 118.474 -1.291 . . . . 0.0 108.469 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.9 -31.24 66.2 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.947 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.556 HD12 HD23 ' A' ' 29' ' ' LEU . 18.9 mt -81.15 -76.76 0.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.763 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.77 -29.94 0.44 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.522 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.456 ' O ' HD22 ' A' ' 29' ' ' LEU . 4.7 mm -71.5 133.56 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.578 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -171.93 147.62 2.19 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.868 -1.133 . . . . 0.0 111.885 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 36' ' ' ASN . 0.5 OUTLIER 68.47 -146.81 0.12 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.546 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -72.96 88.22 1.36 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.628 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.2 p -142.77 -31.54 0.51 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.718 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.625 HD12 HG11 ' A' ' 79' ' ' VAL . 5.8 mt -77.25 62.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.072 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 38.7 t -64.61 -70.02 0.25 Allowed 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.547 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.43 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -93.57 171.16 9.07 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.553 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -153.75 157.12 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 118.412 -1.315 . . . . 0.0 112.107 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -149.08 100.65 3.08 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.5 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.605 HG22 HG22 ' A' ' 4' ' ' ILE . 86.5 t -123.83 101.76 35.78 Favored Pre-proline 0 N--CA 1.496 1.84 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.407 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.44 171.8 11.22 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 120.943 1.096 . . . . 0.0 109.847 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.63 -169.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.567 1.511 . . . . 0.0 111.033 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.84 -18.24 9.6 Favored Glycine 0 N--CA 1.483 1.785 0 C-N-CA 119.18 -1.486 . . . . 0.0 110.679 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.473 HG21 ' HB1' ' A' ' 2' ' ' ALA . 1.9 m -147.79 139.98 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.292 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -110.13 119.24 38.66 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.644 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.85 157.57 17.37 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.29 -0.964 . . . . 0.0 113.158 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.6 HD12 ' NH1' ' A' ' 83' ' ' ARG . 44.2 mt -143.0 114.62 2.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.365 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.93 ' N ' HD12 ' A' ' 52' ' ' LEU . 2.7 mp -92.24 158.1 16.32 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.935 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.494 ' CE2' HG22 ' A' ' 51' ' ' ILE . 41.5 m-85 -140.03 108.48 5.86 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.488 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -45.84 -83.4 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.023 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -59.17 152.34 20.72 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.763 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -58.98 -171.18 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.945 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 49.9 37.84 29.56 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.231 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.438 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . 8.6 m-85 45.33 48.63 10.43 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.607 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.96 -164.09 1.16 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.159 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 64.84 168.93 1.91 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.265 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 60' ' ' GLY . 10.0 t70 -39.05 118.11 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.684 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.459 ' H ' ' HG3' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -97.74 151.57 20.02 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.743 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.663 HG22 ' N ' ' A' ' 64' ' ' GLU . 4.5 mm -130.59 168.98 22.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.423 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.663 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -147.39 133.71 19.56 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.127 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -145.07 162.19 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 118.79 -1.164 . . . . 0.0 112.56 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 t -149.36 -5.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.535 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.446 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -129.62 -159.51 0.97 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.209 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -91.15 136.91 32.77 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.714 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.605 ' HB1' ' HA ' ' A' ' 72' ' ' LEU . . . -113.92 105.03 12.76 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.424 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -54.29 -77.88 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.753 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -91.73 5.59 49.19 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.803 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.605 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 19.1 tp 54.04 -99.35 0.09 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.588 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.61 -176.55 36.45 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 118.964 -1.588 . . . . 0.0 111.03 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.646 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.0 OUTLIER -66.37 -37.34 23.96 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.483 2.122 . . . . 0.0 112.357 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 75' ' ' LEU . 2.7 pt? -57.53 8.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.502 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.646 ' H ' ' C ' ' A' ' 74' ' ' PRO . 10.5 p-10 -69.47 1.19 4.2 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.652 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -82.82 -15.41 51.75 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.364 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -164.69 126.52 2.2 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.104 -1.039 . . . . 0.0 111.169 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.625 HG11 HD12 ' A' ' 39' ' ' ILE . 2.7 t -138.38 151.15 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.432 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.3 t -166.0 -51.14 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.728 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 m -94.14 135.55 35.39 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.977 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.523 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -150.25 157.19 6.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.371 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.831 ' HE ' HD11 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -150.59 153.08 35.07 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.386 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.659 ' C ' HH21 ' A' ' 83' ' ' ARG . 13.9 t -150.27 140.29 16.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.497 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.831 HD11 ' HE ' ' A' ' 83' ' ' ARG . 42.4 mt -134.52 129.57 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.7 m -40.82 139.71 0.81 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.052 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.589 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -143.57 141.78 19.65 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.635 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.589 ' HD2' HG22 ' A' ' 87' ' ' VAL . 5.7 Cg_exo -54.75 143.77 68.6 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 121.065 1.176 . . . . 0.0 111.156 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.0 t -64.2 145.06 14.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.123 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -122.7 139.14 30.56 Favored Pre-proline 0 N--CA 1.489 1.491 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.132 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.75 -23.48 50.06 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 121.143 1.229 . . . . 0.0 111.309 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 35.3 -151.85 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.667 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.481 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -147.72 173.06 13.13 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.046 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -147.03 113.0 5.78 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.168 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 5.7 m-85 -97.29 162.63 13.25 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.555 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -123.0 156.72 34.23 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.618 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 104' ' ' LYS . 1.4 m-85 -75.46 -91.37 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.134 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 1.247 ' HB3' ' OE1' ' A' ' 100' ' ' GLN . 51.2 mttp -47.74 162.63 0.07 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.125 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -90.6 67.57 6.46 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.66 -0.816 . . . . 0.0 112.35 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 1.247 ' OE1' ' HB3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER 178.85 51.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.667 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.9 t80 47.99 35.06 4.6 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.951 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.734 ' OD1' ' HG2' ' A' ' 100' ' ' GLN . 18.3 p-10 -142.1 171.07 14.56 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.616 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 85.38 139.94 5.09 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.019 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.538 ' HB2' ' HZ2' ' A' ' 104' ' ' LYS . 1.0 OUTLIER -29.58 132.91 0.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 123.895 0.409 . . . . 0.0 112.07 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.563 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 1.7 pm0 -104.7 163.22 12.65 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.302 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.73 HG21 ' O ' ' A' ' 122' ' ' GLY . 2.1 t -140.97 128.8 22.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.109 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.47 155.22 17.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.788 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 108' ' ' LEU . 46.2 mt -143.93 138.5 15.14 Favored Pre-proline 0 N--CA 1.481 1.087 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.847 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 10.9 Cg_endo -73.08 167.33 27.62 Favored 'Trans proline' 0 C--O 1.212 -0.789 0 C-N-CA 121.636 1.557 . . . . 0.0 111.718 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.36 141.74 76.03 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.93 1.754 . . . . 0.0 110.965 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 144.69 -155.63 26.48 Favored Glycine 0 N--CA 1.498 2.817 0 C-N-CA 118.862 -1.637 . . . . 0.0 111.328 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.444 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 6.0 tt0 -125.65 152.42 45.24 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.934 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.444 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 28.8 m-85 -145.53 147.32 32.0 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.278 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.663 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 1.4 p -95.31 -136.46 0.22 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.08 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.663 ' N ' ' OG1' ' A' ' 114' ' ' THR . 39.9 tt0 -113.98 -25.38 8.59 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.063 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.45 -64.06 1.26 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.966 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.3 pt-20 -70.94 -50.34 35.68 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.587 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.695 ' C ' HD23 ' A' ' 118' ' ' LEU . 2.4 tt -39.28 -71.05 0.09 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.459 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.569 ' OE1' ' NH1' ' A' ' 120' ' ' ARG . 75.9 mt-10 -48.89 -56.12 9.74 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.639 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.569 ' NH1' ' OE1' ' A' ' 119' ' ' GLU . 4.1 mpt_? -71.76 0.31 9.24 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.893 -1.123 . . . . 0.0 112.361 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 117' ' ' GLU . 24.7 t80 -105.08 -12.23 16.23 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.487 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.73 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -146.21 -46.51 0.03 OUTLIER Glycine 0 N--CA 1.486 1.993 0 C-N-CA 118.915 -1.612 . . . . 0.0 111.288 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.647 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -136.78 -112.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.183 -1.007 . . . . 0.0 111.724 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -156.26 -155.53 0.55 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.338 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -80.61 3.67 21.13 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.975 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -157.15 -152.04 0.34 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.582 -1.247 . . . . 0.0 112.147 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 39.32 96.78 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.103 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 13.5 mt -155.1 -75.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.507 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.715 ' O ' HG23 ' A' ' 131' ' ' VAL . 8.3 p 41.54 -98.16 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.7 m -44.55 116.68 1.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 129' ' ' SER . 21.2 t -121.89 146.35 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.7 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -144.09 82.58 10.8 Favored Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.413 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -63.07 108.61 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.262 1.308 . . . . 0.0 111.053 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.481 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 6.9 mm100 -62.56 -2.3 1.05 Allowed 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.911 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 175.32 -41.21 0.11 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 118.249 -1.929 . . . . 0.0 112.476 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.6 mt -88.13 176.33 7.32 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.512 -1.275 . . . . 0.0 111.299 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.1 129.66 54.14 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.308 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.7 t -98.24 149.44 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.323 -0.951 . . . . 0.0 112.404 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.585 HG12 ' CE1' ' A' ' 141' ' ' PHE . 58.1 t -133.04 113.96 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.448 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 mp -91.01 139.26 30.93 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.818 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.585 ' CE1' HG12 ' A' ' 139' ' ' VAL . 3.7 m-85 -118.64 131.8 56.17 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.461 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -61.18 -80.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.911 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.25 164.03 16.68 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.272 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 146' ' ' PHE . 4.7 p30 -61.92 -161.17 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.537 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.638 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 6.6 t-20 37.19 29.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.12 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.638 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.1 p90 42.15 62.19 1.73 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.162 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.94 174.07 11.01 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.017 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.99 -162.13 49.82 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.488 -1.339 . . . . 0.0 110.529 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -59.96 160.54 7.72 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.41 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 71.5 p -149.13 166.04 29.99 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.56 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.46 ' C ' ' CD2' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -133.2 86.53 41.56 Favored Pre-proline 0 N--CA 1.483 1.223 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.901 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -63.24 104.77 0.43 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 C-N-CA 121.54 1.493 . . . . 0.0 112.328 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.81 81.99 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.637 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.85 19.77 0.5 Allowed 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.338 -0.847 . . . . 0.0 112.06 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.412 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 11.5 t -169.97 -151.67 0.09 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.54 -1.264 . . . . 0.0 111.89 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.412 ' N ' ' OG ' ' A' ' 155' ' ' SER . 4.3 m-20 -87.54 157.49 19.15 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.927 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.479 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -167.52 69.06 0.91 Allowed Pre-proline 0 C--N 1.304 -1.377 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.802 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.3 Cg_endo -68.14 34.35 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.622 2.214 . . . . 0.0 112.933 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.654 HG23 ' H ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -169.87 -68.29 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.716 -1.193 . . . . 0.0 111.665 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.654 ' H ' HG23 ' A' ' 159' ' ' THR . 1.9 mt 51.69 -93.55 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.605 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 159' ' ' THR . . . 43.43 57.78 4.26 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.595 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.432 ' HB3' ' SD ' ' A' ' 163' ' ' MET . . . -152.61 -81.76 0.09 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.611 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.604 ' N ' ' SD ' ' A' ' 163' ' ' MET . 0.2 OUTLIER -67.17 -31.23 71.5 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.511 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -90.64 136.9 32.77 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -157.17 -6.17 0.1 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.524 -0.871 . . . . 0.0 110.754 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -169.86 39.1 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.205 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -39.32 136.54 0.88 Allowed 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.29 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.8 m -107.53 -36.08 6.56 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.827 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 10.8 p -153.84 155.57 36.02 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.7 -1.2 . . . . 0.0 111.022 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.668 HD12 HD11 ' A' ' 118' ' ' LEU . 0.2 OUTLIER -143.9 172.97 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.494 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -142.04 113.26 7.59 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.58 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 3.4 mt -80.52 91.89 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 118.437 -1.305 . . . . 0.0 109.548 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.6 t . . . . . 0 C--N 1.305 -1.33 0 CA-C-O 116.331 -1.795 . . . . 0.0 110.894 -179.969 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 mmm . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 120.976 0.417 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.597 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . -60.06 167.67 2.22 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.571 -0.851 . . . . 0.0 110.935 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -176.68 127.55 0.18 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.782 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.2 pt -68.06 168.69 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.441 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -149.3 124.76 10.3 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.292 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.53 ' HB ' HG23 ' A' ' 39' ' ' ILE . 1.3 m -101.67 137.01 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.718 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.534 ' CE2' ' O ' ' A' ' 12' ' ' PHE . 5.2 m-85 -92.35 148.34 22.2 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.124 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.451 ' HB2' ' N ' ' A' ' 15' ' ' LYS . 1.8 m-85 -81.52 0.71 36.79 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.505 ' C ' ' OG ' ' A' ' 40' ' ' SER . 31.6 m120 -152.38 164.3 37.76 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.063 -1.455 . . . . 0.0 112.009 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.498 ' N ' ' OG ' ' A' ' 40' ' ' SER . 3.0 tp10 -71.63 163.64 27.38 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.462 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.477 ' CG ' ' C ' ' A' ' 10' ' ' GLU . 0.3 OUTLIER 71.87 40.92 0.71 Allowed 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.576 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.534 ' O ' ' CE2' ' A' ' 7' ' ' PHE . 55.8 t80 53.48 10.63 0.22 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.138 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 11' ' ' ASP . 17.5 mm-40 -96.97 171.89 8.21 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.81 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 96.08 139.32 10.33 Favored Glycine 0 N--CA 1.495 2.625 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.633 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.451 ' N ' ' HB2' ' A' ' 8' ' ' TYR . 12.5 mtmm -37.11 147.84 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.215 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -118.54 118.86 32.84 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.182 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 17' ' ' VAL . 14.4 p -104.82 130.71 55.4 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.028 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.182 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -90.25 143.26 26.93 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.326 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt -138.61 134.74 17.46 Favored Pre-proline 0 N--CA 1.493 1.693 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.146 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.83 165.89 22.08 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.048 1.165 . . . . 0.0 111.264 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.17 -173.73 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 C-N-CA 121.87 1.713 . . . . 0.0 111.163 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.12 -167.26 16.85 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.239 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.405 ' HB3' ' CD ' ' A' ' 83' ' ' ARG . 19.5 p-10 -134.81 136.65 42.69 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.203 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -152.13 -172.48 4.24 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.04 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 p -142.65 -162.77 1.48 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.658 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.627 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 11.0 ttt180 -60.44 -11.99 8.32 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.725 -1.19 . . . . 0.0 110.116 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.01 -66.48 0.59 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.415 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.476 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 8.5 tp-100 -59.49 -42.63 92.57 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.363 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 29' ' ' LEU . 58.8 mt -64.37 -36.74 85.12 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.32 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 26' ' ' ARG . . . -55.78 -28.88 58.32 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 117.923 -1.511 . . . . 0.0 107.767 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -71.78 -35.53 70.07 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.819 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.6 mt -81.98 -75.45 0.3 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.487 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.51 16.93 0.06 OUTLIER Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.489 -1.338 . . . . 0.0 110.791 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.423 HD12 HG23 ' A' ' 34' ' ' ILE . 28.7 mm -102.34 127.67 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.047 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.667 ' O ' HG22 ' A' ' 38' ' ' THR . 4.7 pt-20 -178.19 158.54 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.277 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 0.5 OUTLIER 81.24 -144.62 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.404 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -94.95 18.44 11.97 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.126 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -66.32 -20.73 66.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.195 -1.402 . . . . 0.0 110.361 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.756 ' O ' HG22 ' A' ' 39' ' ' ILE . 78.8 mt -76.18 33.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.692 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.651 ' H ' ' C ' ' A' ' 38' ' ' THR . 11.0 t -35.45 -55.85 0.65 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.222 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -122.74 174.68 6.97 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.418 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -151.01 161.01 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 118.165 -1.414 . . . . 0.0 112.438 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.439 ' N ' HG13 ' A' ' 42' ' ' VAL . 78.3 tttt -141.6 123.31 15.18 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.163 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.4 t -144.65 102.75 4.58 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.05 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.4 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.8 Cg_endo -68.31 171.26 13.1 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 121.032 1.154 . . . . 0.0 110.356 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 2.1 Cg_endo -61.59 -173.35 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.549 1.499 . . . . 0.0 110.815 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.9 -13.69 8.48 Favored Glycine 0 N--CA 1.483 1.788 0 C-N-CA 119.195 -1.479 . . . . 0.0 110.474 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.597 HG11 ' HB3' ' A' ' 2' ' ' ALA . 2.6 m -151.72 129.42 2.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 118.919 -1.112 . . . . 0.0 112.105 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.495 ' O ' HG13 ' A' ' 84' ' ' VAL . 15.8 ttpt -98.74 149.54 22.74 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.847 ' C ' HD12 ' A' ' 51' ' ' ILE . . . -134.17 149.62 51.04 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.365 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 1.066 HD13 HH22 ' A' ' 83' ' ' ARG . 1.9 mp -137.66 116.2 14.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.383 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.479 ' H ' HD12 ' A' ' 52' ' ' LEU . 4.3 mp -88.2 156.94 18.96 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.669 -1.212 . . . . 0.0 111.655 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -133.47 110.66 10.12 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.122 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -49.42 -79.38 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.48 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -62.4 153.88 29.94 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.987 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 21.7 p-10 -64.66 178.46 0.77 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.756 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.0 32.23 66.35 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.248 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 52.73 68.08 0.89 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.748 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.41 -170.92 3.62 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.121 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.38 175.01 6.17 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.287 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -44.27 111.66 0.32 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.623 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.605 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -95.62 128.32 42.39 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.146 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.573 HD11 HD11 ' A' ' 75' ' ' LEU . 2.5 mt -96.8 163.78 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.553 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -136.99 130.52 31.59 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.706 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 50' ' ' ALA . 11.0 m -150.3 163.72 3.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 118.813 -1.155 . . . . 0.0 112.178 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 t -147.42 -3.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.389 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.22 -146.13 0.32 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.273 -1.331 . . . . 0.0 109.122 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -96.94 124.39 40.9 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.546 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.433 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.16 108.73 19.77 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.054 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -65.05 -85.58 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.709 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 73' ' ' GLY . 9.8 mm-40 -80.35 5.86 13.7 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.354 -0.939 . . . . 0.0 111.539 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.408 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 3.0 tp 60.49 -79.63 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.045 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 170.56 174.72 38.77 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.397 -1.383 . . . . 0.0 110.477 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.26 -27.72 64.03 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.086 1.857 . . . . 0.0 111.982 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.573 HD11 HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -83.4 18.81 1.69 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.549 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -68.89 7.59 0.66 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 75' ' ' LEU . 6.3 m-20 -83.86 -10.48 57.99 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.519 -0.872 . . . . 0.0 111.269 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -165.75 122.94 1.44 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.381 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.589 ' HB ' HD12 ' A' ' 39' ' ' ILE . 3.5 t -149.49 142.79 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.657 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.7 m -158.35 -35.36 0.07 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.196 -1.001 . . . . 0.0 111.855 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.5 m -94.58 143.14 26.67 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.164 -1.014 . . . . 0.0 111.468 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.98 143.74 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.234 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 1.066 HH22 HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -125.0 135.07 52.44 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.81 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.748 ' CA ' ' NH1' ' A' ' 83' ' ' ARG . 13.2 t -141.22 142.92 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.391 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 68.6 mt -140.32 138.62 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.593 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.0 m -55.24 146.23 19.53 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.191 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.428 HG22 ' HD2' ' A' ' 88' ' ' PRO . 1.1 t -140.91 149.33 55.79 Favored Pre-proline 0 N--CA 1.483 1.225 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.626 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.428 ' HD2' HG22 ' A' ' 87' ' ' VAL . 3.1 Cg_exo -56.79 157.76 18.75 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.491 1.461 . . . . 0.0 111.58 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 89' ' ' VAL . 10.4 m -71.52 136.7 25.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.333 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -145.71 130.89 9.16 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.438 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -60.81 -154.34 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.877 0 C-N-CA 121.276 1.317 . . . . 0.0 111.09 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 178.28 -161.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.017 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.483 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.71 173.25 11.71 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.36 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.422 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 10.7 mtm180 -134.79 148.47 50.21 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.002 -1.079 . . . . 0.0 112.148 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 10.9 m-85 -133.79 133.34 41.56 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.764 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.492 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 27.2 m-85 -94.62 179.09 5.38 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.342 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.546 ' CE1' HG21 ' A' ' 127' ' ' THR . 0.2 OUTLIER -100.36 -64.7 1.02 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.431 -0.907 . . . . 0.0 112.973 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.503 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 46.4 tttm -81.02 158.19 25.21 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.94 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.575 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 42.2 mt-10 -64.65 108.31 1.66 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.567 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.995 ' OE1' ' HD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 106.04 57.14 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.208 0 O-C-N 125.109 1.505 . . . . 0.0 110.327 179.755 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.995 ' HD1' ' OE1' ' A' ' 100' ' ' GLN . 13.9 p90 26.41 40.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.672 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 100' ' ' GLN . 65.4 m-20 -100.72 -9.42 21.82 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.014 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.503 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -105.92 150.73 16.97 Favored Glycine 0 N--CA 1.499 2.9 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.395 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 103' ' ' GLY . 94.8 mttt -35.04 145.53 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.498 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.33 160.81 14.1 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.961 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.8 HG21 ' O ' ' A' ' 122' ' ' GLY . 1.5 t -143.6 165.38 14.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.232 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.513 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 5.7 p-10 -145.37 153.78 41.59 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 118.571 -1.252 . . . . 0.0 112.311 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.472 HD22 ' CD2' ' A' ' 121' ' ' TYR . 60.6 mt -139.39 146.38 48.23 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.371 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -73.15 165.75 31.84 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 121.676 1.584 . . . . 0.0 112.645 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.12 146.87 95.21 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 122.394 2.063 . . . . 0.0 111.491 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.11 -166.21 23.78 Favored Glycine 0 N--CA 1.501 2.973 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.154 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.587 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 55.3 mt-30 -113.37 159.22 19.66 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.737 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.587 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 44.9 m-85 -144.97 148.53 33.89 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.072 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.3 p -87.91 -165.68 1.38 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.879 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.91 57.0 0.73 Allowed 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.901 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.08 -68.16 0.13 Allowed 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.426 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 121' ' ' TYR . 9.7 pt-20 -69.8 -42.61 73.51 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.431 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.575 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -37.16 -74.49 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.529 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.722 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -52.08 -51.57 56.84 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.727 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 2.4 mpt_? -76.88 18.66 0.34 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.754 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 117' ' ' GLU . 16.7 t80 -127.71 -10.11 5.57 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.23 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.8 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -141.69 -49.77 0.05 OUTLIER Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.114 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.6 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -146.1 -102.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.627 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.6 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 20.1 m-20 -161.02 162.56 31.8 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.629 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.457 ' N ' ' HB3' ' A' ' 119' ' ' GLU . 17.3 p30 -60.47 -22.83 63.94 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.507 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.769 ' O ' HG22 ' A' ' 127' ' ' THR . 6.6 t-20 -97.63 -175.3 3.15 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.184 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 126' ' ' ASN . 10.1 t 55.04 -152.39 0.35 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.091 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.573 ' N ' HG23 ' A' ' 127' ' ' THR . 2.6 mt 76.43 127.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.295 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.426 ' HB3' ' CA ' ' A' ' 161' ' ' GLY . 47.6 m -160.58 -54.77 0.05 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.895 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.732 ' CB ' ' H ' ' A' ' 101' ' ' PHE . 1.7 m -84.08 117.18 23.27 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.789 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 t -119.46 143.58 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.885 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -139.7 106.6 6.98 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.257 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.55 122.37 9.35 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.103 1.202 . . . . 0.0 111.07 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.483 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 1.0 OUTLIER -90.15 -2.13 58.03 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.964 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -175.92 -36.24 0.05 OUTLIER Glycine 0 N--CA 1.493 2.448 0 C-N-CA 118.469 -1.824 . . . . 0.0 111.805 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.3 164.34 16.45 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.852 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 173' ' ' SER . . . -78.03 155.78 30.48 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.374 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.5 t -119.43 140.12 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.427 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.451 ' C ' HD12 ' A' ' 140' ' ' LEU . 92.2 t -130.98 124.52 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.845 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 140' ' ' LEU . 11.2 mp -103.01 141.23 36.15 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.43 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.426 ' CB ' ' HA ' ' A' ' 146' ' ' PHE . 48.3 m-85 -120.13 125.78 49.09 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.14 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -65.78 -64.69 0.8 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.947 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.54 165.63 23.5 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.4 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 146' ' ' PHE . 31.4 m-20 -63.18 -158.72 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.723 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.655 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 4.0 m120 42.89 22.89 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.753 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.655 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.9 p90 40.6 59.17 2.2 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.114 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 t -143.25 -150.8 0.33 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.334 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 54.4 -153.79 9.55 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.42 -1.371 . . . . 0.0 109.974 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.51 143.13 50.96 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.068 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.2 p -143.99 167.67 21.8 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.47 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.3 mt -138.03 83.41 23.05 Favored Pre-proline 0 N--CA 1.485 1.31 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.922 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -64.88 104.41 0.56 Allowed 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 121.615 1.543 . . . . 0.0 111.933 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.6 t -86.0 81.83 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.959 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -71.84 12.55 0.38 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.326 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 13.4 t -169.83 -151.71 0.09 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.378 -1.329 . . . . 0.0 111.618 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.3 m-20 -85.22 155.02 21.59 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.628 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.519 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -171.9 62.64 0.34 Allowed Pre-proline 0 C--N 1.302 -1.469 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.404 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 10.2 Cg_endo -69.87 69.8 1.68 Allowed 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.954 1.769 . . . . 0.0 111.197 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.714 HG23 ' H ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER 173.97 -94.45 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.379 -0.928 . . . . 0.0 111.064 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.714 ' H ' HG23 ' A' ' 159' ' ' THR . 49.7 mt 53.26 -90.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.842 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 159' ' ' THR . . . 46.23 13.63 0.08 OUTLIER Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.764 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -95.0 46.83 1.13 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.801 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.453 ' O ' ' N ' ' A' ' 165' ' ' ASN . 2.0 ptt? -161.64 57.71 0.27 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.746 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -53.51 91.67 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.71 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 163' ' ' MET . 6.3 t-20 -154.13 -125.3 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.648 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.421 ' CG ' ' C ' ' A' ' 165' ' ' ASN . 3.4 m120 -158.28 102.85 1.78 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.959 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -55.74 122.28 11.07 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.222 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 73.0 m -91.23 -72.1 0.6 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.242 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.61 160.72 19.64 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.244 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.407 HG12 ' CD1' ' A' ' 118' ' ' LEU . 29.2 pt -142.37 169.87 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 119.506 -0.877 . . . . 0.0 110.633 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -154.1 107.0 2.86 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.052 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.5 mt -82.99 99.34 5.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.716 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 137' ' ' ALA . 11.0 t . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 116.328 -1.796 . . . . 0.0 110.966 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.3 tpp . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.538 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -161.37 158.02 26.22 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.212 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -179.97 115.33 0.05 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.18 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.4 pt -70.1 162.46 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.82 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -143.88 119.03 10.1 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.544 -0.863 . . . . 0.0 110.705 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 m -101.8 162.58 3.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.069 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.515 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 31.3 m-85 -120.62 152.7 37.81 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.934 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.98 -47.94 60.24 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.642 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 9.6 m120 -101.17 177.42 4.94 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.969 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 11' ' ' ASP . 5.5 tp10 -82.19 177.06 9.0 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.861 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.457 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 4.1 t70 61.58 36.26 16.9 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.15 -1.02 . . . . 0.0 110.756 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.515 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 1.3 t80 60.95 2.34 0.54 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.701 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -88.24 167.98 13.11 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.724 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.642 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 93.74 133.98 6.99 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 119.974 -1.107 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 14' ' ' GLY . 25.4 mtmm -30.15 139.47 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.095 0.474 . . . . 0.0 112.193 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -96.38 162.07 13.65 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.935 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 t -147.82 122.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.629 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 1.6 m-20 -90.25 138.78 31.25 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.798 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 mt -132.24 133.26 23.59 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.639 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -68.65 164.56 32.63 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 120.962 1.108 . . . . 0.0 111.494 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.02 -167.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.756 1.637 . . . . 0.0 110.533 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.474 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 89.56 178.8 45.19 Favored Glycine 0 N--CA 1.486 1.989 0 C-N-CA 118.79 -1.671 . . . . 0.0 110.88 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.599 ' N ' HH21 ' A' ' 83' ' ' ARG . 34.0 p-10 -110.52 141.84 43.13 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.359 -0.537 . . . . 0.0 112.2 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.455 ' OH ' HD12 ' A' ' 82' ' ' ILE . 17.2 p90 -155.77 178.87 9.77 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.879 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.6 p -142.47 -168.65 2.79 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.616 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -57.97 -24.31 57.52 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.381 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -64.87 -63.4 1.12 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.003 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 8.9 tp-100 -56.73 -39.61 74.25 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.437 -1.305 . . . . 0.0 109.326 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.645 HD13 HD11 ' A' ' 34' ' ' ILE . 46.1 mt -62.04 -40.1 94.6 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.324 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -48.76 -33.78 10.98 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 118.864 -1.135 . . . . 0.0 107.972 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -71.53 -38.68 71.05 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.575 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.509 HD12 HD23 ' A' ' 29' ' ' LEU . 15.2 mt -71.89 -80.93 0.06 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.927 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.14 -21.87 0.1 OUTLIER Glycine 0 N--CA 1.491 2.324 0 C-N-CA 118.802 -1.666 . . . . 0.0 111.422 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.645 HD11 HD13 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -81.27 155.21 4.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.984 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.765 ' H ' HG21 ' A' ' 38' ' ' THR . 5.0 pt-20 174.32 117.88 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.468 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.641 ' CG ' ' N ' ' A' ' 37' ' ' ASN . 1.5 p-10 92.43 -150.67 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.966 0 O-C-N 124.299 0.999 . . . . 0.0 113.032 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.641 ' N ' ' CG ' ' A' ' 36' ' ' ASN . 6.5 m120 -51.49 4.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.496 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.765 HG21 ' H ' ' A' ' 35' ' ' GLU . 43.4 p -56.78 -54.26 48.36 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 117.801 -1.559 . . . . 0.0 110.944 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.505 ' N ' ' OG1' ' A' ' 38' ' ' THR . 3.6 mt -58.75 77.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.112 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 38' ' ' THR . 35.6 t -81.38 -58.53 3.0 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.101 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.76 169.49 8.79 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -149.68 148.79 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 118.137 -1.425 . . . . 0.0 112.919 -179.907 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.481 ' HG3' HD21 ' A' ' 68' ' ' ASN . 22.0 ttpt -137.01 114.65 11.15 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.616 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.3 t -133.93 110.09 11.96 Favored Pre-proline 0 N--CA 1.498 1.955 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.063 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.414 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.0 OUTLIER -68.46 171.47 12.93 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.219 1.28 . . . . 0.0 111.223 179.879 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.5 Cg_endo -63.71 -171.92 0.15 Allowed 'Trans proline' 0 C--N 1.317 -1.079 0 C-N-CA 121.922 1.748 . . . . 0.0 111.131 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.418 ' C ' HG13 ' A' ' 48' ' ' VAL . . . 78.38 -17.13 6.7 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.538 HG11 ' CB ' ' A' ' 2' ' ' ALA . 26.6 m -150.58 143.63 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.232 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -108.78 138.42 45.14 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.972 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -117.49 140.24 49.87 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.369 -0.932 . . . . 0.0 112.436 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -129.09 118.99 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.33 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.47 ' HA ' HG23 ' A' ' 82' ' ' ILE . 3.8 mp -94.58 163.79 13.24 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.975 -1.09 . . . . 0.0 112.81 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -143.61 121.01 11.65 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.069 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -54.96 -85.87 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.665 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -59.88 154.07 19.45 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.28 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -62.45 -176.67 0.11 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.525 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.22 21.32 59.43 Favored Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.052 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 57.07 48.64 15.15 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.798 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -128.71 -177.83 4.35 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.591 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.41 171.68 36.44 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.076 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.5 m-20 -46.99 123.69 5.54 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.021 -1.071 . . . . 0.0 110.407 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.728 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 3.8 pm0 -102.85 176.06 5.28 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.854 -0.739 . . . . 0.0 111.112 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.626 HD11 HD11 ' A' ' 75' ' ' LEU . 6.1 mt -143.65 164.31 15.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.625 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.567 ' CD ' ' N ' ' A' ' 64' ' ' GLU . 3.0 mp0 -142.94 132.16 23.26 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.191 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.3 m -149.95 162.95 3.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.645 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 t -145.46 -1.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.664 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -124.47 -125.07 0.25 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.877 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.481 HD21 ' HG3' ' A' ' 43' ' ' LYS . 29.7 t-20 -121.64 115.83 23.47 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.201 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.57 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -90.1 83.47 6.06 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.575 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -54.33 -51.16 65.59 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.444 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 72' ' ' LEU . 8.5 tp10 -111.93 81.46 1.46 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.87 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.441 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 4.5 tp -31.17 -87.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.233 -0.894 . . . . 0.0 113.167 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.441 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 179.5 -168.17 38.56 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.007 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.64 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.1 Cg_endo -69.37 -50.38 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.402 2.068 . . . . 0.0 112.611 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.798 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.3 pt? -57.97 10.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.873 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.64 ' H ' ' C ' ' A' ' 74' ' ' PRO . 30.2 p30 -62.56 -0.58 0.63 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.861 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.509 ' H ' ' C ' ' A' ' 75' ' ' LEU . 55.0 t30 -71.22 -10.53 59.91 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.394 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -172.94 124.85 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.302 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.85 141.67 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.031 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.0 m -160.17 -41.77 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.748 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 m -94.6 139.03 31.73 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.244 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.47 HG23 ' HA ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -146.25 162.59 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 118.919 -1.112 . . . . 0.0 111.728 -179.952 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.892 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.24 114.42 5.85 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.116 -179.881 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.892 ' H ' HH22 ' A' ' 83' ' ' ARG . 10.9 t -110.11 130.31 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.613 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.438 HG13 ' NH1' ' A' ' 83' ' ' ARG . 4.9 mt -132.43 127.4 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.088 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.8 m -39.98 153.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.904 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.586 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -158.11 141.86 11.25 Favored Pre-proline 0 N--CA 1.488 1.437 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.98 179.935 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.586 ' HD2' HG22 ' A' ' 87' ' ' VAL . 7.6 Cg_exo -50.46 153.79 7.04 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.346 1.364 . . . . 0.0 111.64 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.531 HG22 ' N ' ' A' ' 90' ' ' GLN . 3.1 p -90.51 158.59 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.96 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.531 ' N ' HG22 ' A' ' 89' ' ' VAL . 52.5 mt-30 -142.25 150.46 55.31 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.432 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.567 ' C ' ' HE ' ' A' ' 92' ' ' ARG . 3.3 Cg_exo -59.71 -36.76 90.86 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.496 1.464 . . . . 0.0 111.299 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.567 ' HE ' ' C ' ' A' ' 91' ' ' PRO . 2.5 mtm180 57.21 -165.72 0.15 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.048 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.544 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -140.07 179.77 6.43 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.967 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -140.42 149.84 43.11 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.711 -1.195 . . . . 0.0 111.966 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -134.64 131.34 37.65 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.011 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.564 ' CZ ' ' CD ' ' A' ' 105' ' ' GLU . 5.4 m-85 -92.58 173.34 7.83 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.027 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.44 -68.89 0.75 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 118.893 -1.123 . . . . 0.0 112.117 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -75.46 166.7 23.19 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.319 -0.953 . . . . 0.0 111.844 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.725 ' C ' ' HG2' ' A' ' 100' ' ' GLN . 5.2 pt-20 -89.68 52.75 2.39 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.674 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.725 ' HG2' ' C ' ' A' ' 99' ' ' GLU . 15.2 mm-40 -159.32 33.24 0.2 Allowed 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.903 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.7 t80 58.4 38.11 25.76 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.447 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -137.97 173.81 11.23 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 81.78 134.02 1.72 Allowed Glycine 0 N--CA 1.487 2.033 0 C-N-CA 119.38 -1.391 . . . . 0.0 109.893 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 103' ' ' GLY . 13.6 ptpt -32.69 148.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.066 0.509 . . . . 0.0 112.008 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.564 ' CD ' ' CZ ' ' A' ' 96' ' ' PHE . 20.9 mt-10 -108.52 167.54 9.97 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.737 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 122' ' ' GLY . 2.6 t -137.19 130.0 43.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.768 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -102.1 155.87 17.92 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.338 -0.945 . . . . 0.0 113.103 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 108' ' ' LEU . 89.1 mt -145.45 125.36 7.05 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.266 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.18 166.38 16.98 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 121.108 1.205 . . . . 0.0 111.756 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.97 150.24 84.96 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 121.78 1.653 . . . . 0.0 111.07 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 139.32 -140.62 11.03 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.188 -1.482 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.528 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 19.2 tt0 -147.55 159.46 43.72 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.791 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 53.5 m-85 -141.71 155.41 45.65 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.842 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.2 p -100.61 175.42 5.67 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.66 -0.816 . . . . 0.0 112.29 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.71 41.01 0.15 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.667 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.415 ' N ' ' OE2' ' A' ' 119' ' ' GLU . . . -154.32 -52.93 0.1 Allowed 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.273 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 118' ' ' LEU . 5.1 tp10 -71.83 -52.11 19.1 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.043 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.571 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -36.17 -72.09 0.06 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.435 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.695 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 1.2 pm0 -52.99 -54.93 27.82 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.728 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.419 ' H ' ' HG2' ' A' ' 119' ' ' GLU . 3.4 mpt_? -74.31 15.56 0.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.173 -1.011 . . . . 0.0 112.516 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.401 ' O ' ' CG ' ' A' ' 121' ' ' TYR . 41.0 t80 -121.1 -17.85 7.64 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.536 -0.865 . . . . 0.0 111.476 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.537 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -142.94 -40.61 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 C-N-CA 118.632 -1.747 . . . . 0.0 111.44 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.623 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -139.01 -105.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.54 -179.867 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.538 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 19.1 t70 -162.61 -172.96 3.32 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.609 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.538 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 15.9 t-20 -59.09 -2.32 0.25 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.218 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 127' ' ' THR . 28.2 p30 -172.25 -134.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.754 -1.178 . . . . 0.0 111.948 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.55 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 9.1 t 41.0 33.98 0.25 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.877 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.484 ' C ' ' OG ' ' A' ' 129' ' ' SER . 3.0 mt -88.06 -75.75 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.122 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.484 ' OG ' ' C ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 77.22 -142.39 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 179.784 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.6 m -37.09 128.42 0.92 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.277 -1.329 . . . . 0.0 113.646 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.8 t -122.18 147.43 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.156 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -145.72 98.99 4.45 Favored Pre-proline 0 C--N 1.3 -1.549 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.125 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.02 110.13 1.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.044 1.163 . . . . 0.0 111.519 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.544 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 61.1 tp60 -57.95 -21.32 43.57 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.423 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.57 -36.32 0.03 OUTLIER Glycine 0 N--CA 1.495 2.602 0 C-N-CA 118.516 -1.802 . . . . 0.0 112.103 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.415 HD21 ' HG2' ' A' ' 91' ' ' PRO . 1.8 mt -92.11 -171.46 2.84 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.704 -1.198 . . . . 0.0 110.968 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.1 146.31 35.65 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.1 t -111.86 141.76 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 119.409 -0.916 . . . . 0.0 112.86 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.465 HG12 ' CE1' ' A' ' 141' ' ' PHE . 91.1 t -133.14 123.57 47.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.1 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 140' ' ' LEU . 5.2 mp -105.23 144.6 31.79 Favored 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 118.838 -1.145 . . . . 0.0 113.598 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.465 ' CE1' HG12 ' A' ' 139' ' ' VAL . 14.9 m-85 -120.14 132.51 55.43 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.047 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -73.91 -55.26 6.4 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.57 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -74.58 -158.52 0.07 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.872 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 145' ' ' ASN . 17.8 t70 -64.49 -147.03 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.2 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.559 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 6.0 m-80 -51.59 88.57 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.559 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 8.1 p90 38.44 68.34 0.34 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.946 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 81.1 p -132.95 43.37 2.97 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.971 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -178.8 -155.53 14.88 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -65.73 152.88 43.26 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.234 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 22.5 p -149.83 163.1 38.91 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.806 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.25 97.91 14.46 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.275 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -70.55 109.93 2.59 Favored 'Trans proline' 0 C--N 1.325 -0.664 0 C-N-CA 121.536 1.491 . . . . 0.0 112.087 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' A' ' 155' ' ' SER . 3.3 t -89.02 74.73 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.504 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -73.73 31.07 0.08 Allowed 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.055 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 153' ' ' VAL . 10.5 t -170.31 -153.42 0.1 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.595 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -90.47 164.04 14.41 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.739 -0.785 . . . . 0.0 111.481 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.532 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -167.65 73.13 0.95 Allowed Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.784 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.8 23.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.07 1.846 . . . . 0.0 112.891 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -178.48 79.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.731 179.89 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.456 ' C ' ' H ' ' A' ' 162' ' ' ALA . 17.2 tp -70.71 -45.18 65.4 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.193 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.63 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 73.52 -10.09 7.08 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.151 -1.5 . . . . 0.0 109.64 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 161' ' ' GLY . . . 70.16 110.27 0.06 Allowed 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.047 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.418 ' N ' ' SD ' ' A' ' 163' ' ' MET . 0.0 OUTLIER -74.6 -58.6 3.18 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.604 179.951 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -86.8 -156.19 0.31 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.503 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.408 ' ND2' ' OD1' ' A' ' 166' ' ' ASN . 19.2 p-10 -73.27 -37.25 66.35 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.339 -0.945 . . . . 0.0 111.006 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.408 ' OD1' ' ND2' ' A' ' 165' ' ' ASN . 41.8 p-10 -171.25 169.73 6.27 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.18 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.21 126.21 42.26 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.422 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.0 m -99.09 -73.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.635 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 4.0 p -112.01 158.69 19.24 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.203 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.429 HG12 ' CD1' ' A' ' 118' ' ' LEU . 16.3 pt -139.81 170.56 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.748 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -147.95 109.0 4.25 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.97 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.2 mt -88.88 94.73 4.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.957 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 116.356 -1.783 . . . . 0.0 111.069 -179.966 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.0 mtm . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.885 0.374 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.623 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -82.95 166.74 18.6 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.849 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.57 127.39 0.11 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.61 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.449 HD11 HD12 ' A' ' 19' ' ' LEU . 2.0 pp -81.24 147.65 6.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.331 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.935 HG21 ' OE1' ' A' ' 16' ' ' GLN . 22.6 m -128.64 139.15 52.4 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.515 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.13 173.69 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.821 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.47 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 52.7 m-85 -132.63 154.74 49.78 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.385 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -79.4 -19.17 50.72 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.023 1.119 . . . . 0.0 114.023 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.493 ' C ' ' OG ' ' A' ' 40' ' ' SER . 5.7 m120 -136.26 170.89 15.3 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.587 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.36 175.64 4.55 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.22 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 13' ' ' GLN . 6.9 t0 52.63 49.12 21.06 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.122 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.516 ' CE2' ' HG2' ' A' ' 70' ' ' GLU . 16.4 m-85 53.52 -4.25 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.745 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.554 ' H ' ' C ' ' A' ' 11' ' ' ASP . 29.4 mt-30 -75.58 169.05 18.86 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.613 -1.235 . . . . 0.0 111.24 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.6 134.13 5.73 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.495 -1.336 . . . . 0.0 110.498 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.604 ' CB ' ' NZ ' ' A' ' 15' ' ' LYS . 7.1 mtmp? -43.59 157.01 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.027 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.935 ' OE1' HG21 ' A' ' 5' ' ' THR . 1.1 pt20 -122.38 167.76 12.9 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.447 -0.901 . . . . 0.0 112.821 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -145.06 130.35 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.675 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.37 118.09 30.88 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.38 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.449 HD12 HD11 ' A' ' 4' ' ' ILE . 5.9 mt -112.67 139.78 23.15 Favored Pre-proline 0 N--CA 1.49 1.562 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.218 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -70.42 164.43 35.21 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 120.892 1.061 . . . . 0.0 111.075 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -163.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.037 0 C-N-CA 121.715 1.61 . . . . 0.0 110.723 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.24 176.12 50.59 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.779 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.565 ' HB3' ' NE ' ' A' ' 83' ' ' ARG . 15.9 p-10 -108.57 145.11 35.33 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.655 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.603 ' CE2' HD12 ' A' ' 82' ' ' ILE . 2.6 p90 -159.03 -173.54 4.29 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.152 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 p -146.53 -162.46 1.53 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.067 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.432 ' HG2' ' H ' ' A' ' 26' ' ' ARG . 7.3 ptp180 -62.67 -17.82 61.25 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.577 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -66.06 -62.86 1.26 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.258 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.549 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 36.1 tt0 -56.06 -42.41 76.59 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.114 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.576 HD23 HD12 ' A' ' 32' ' ' LEU . 68.9 mt -60.26 -39.86 88.27 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.454 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.56 -33.0 13.79 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 118.586 -1.246 . . . . 0.0 107.887 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -68.72 -39.43 80.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.151 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.576 HD12 HD23 ' A' ' 29' ' ' LEU . 17.7 mt -74.88 -75.59 0.16 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.771 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.53 -24.87 0.66 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 118.801 -1.666 . . . . 0.0 111.471 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.533 ' C ' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -85.04 149.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.405 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.567 ' O ' HG23 ' A' ' 38' ' ' THR . 6.0 pt-20 176.95 151.87 0.18 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.473 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.496 ' CG ' ' C ' ' A' ' 35' ' ' GLU . 0.6 OUTLIER 80.37 -144.5 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 179.754 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -67.5 29.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.249 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 35' ' ' GLU . 80.6 p -87.01 -43.87 12.01 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.44 -1.304 . . . . 0.0 110.626 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.404 HD12 ' CG1' ' A' ' 79' ' ' VAL . 9.2 mt -60.05 78.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.779 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.558 ' N ' ' O ' ' A' ' 38' ' ' THR . 19.0 t -77.5 -69.65 0.52 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.967 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.47 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -104.49 170.2 8.03 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.486 179.862 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -147.49 146.92 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 118.498 -1.281 . . . . 0.0 112.895 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -132.62 117.69 18.24 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.168 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 72.3 t -140.5 109.14 6.71 Favored Pre-proline 0 N--CA 1.495 1.801 0 C-N-CA 119.318 -0.953 . . . . 0.0 112.083 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.413 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.0 OUTLIER -69.67 170.94 15.3 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.404 1.403 . . . . 0.0 111.711 179.977 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.8 Cg_endo -62.69 -176.84 0.27 Allowed 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 122.263 1.975 . . . . 0.0 111.214 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.93 -12.25 18.2 Favored Glycine 0 N--CA 1.482 1.729 0 C-N-CA 119.189 -1.481 . . . . 0.0 110.563 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.623 HG11 ' CB ' ' A' ' 2' ' ' ALA . 18.1 m -149.27 131.72 6.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.799 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -105.85 136.78 44.87 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.125 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -117.87 151.98 36.3 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.351 -0.94 . . . . 0.0 112.627 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.527 ' C ' HD12 ' A' ' 52' ' ' LEU . 97.1 mt -138.49 119.38 16.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 114.57 -1.196 . . . . 0.0 108.523 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.893 ' N ' HD12 ' A' ' 52' ' ' LEU . 2.7 mp -91.97 161.85 14.63 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.535 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -142.75 108.95 5.24 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.785 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -48.17 -85.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.38 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -59.47 150.2 27.41 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.421 -0.911 . . . . 0.0 111.225 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 20.6 p-10 -62.1 178.78 0.34 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.465 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.4 24.8 71.0 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.113 -1.518 . . . . 0.0 110.106 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 54.65 63.89 2.0 Allowed 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.72 -161.19 1.27 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.015 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.58 169.46 1.4 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.087 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -43.68 119.1 1.57 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.476 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -97.86 172.18 7.82 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.279 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.525 HD12 HD22 ' A' ' 52' ' ' LEU . 3.4 mt -142.31 164.31 17.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.601 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -141.86 130.7 22.97 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.796 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -147.66 159.18 8.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 118.758 -1.177 . . . . 0.0 112.43 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.31 -5.05 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.179 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -124.64 -147.58 0.37 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.534 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -101.63 113.6 26.89 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.02 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.556 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -92.01 100.6 13.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.139 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.516 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 17.5 mt-10 -66.58 -86.34 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.773 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.437 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 28.3 tp10 -57.9 -16.11 10.9 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.533 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 4.6 tp 73.39 -83.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.528 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.58 -169.76 42.87 Favored Glycine 0 N--CA 1.5 2.901 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.552 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.8 Cg_endo -66.41 -47.78 2.88 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.385 2.056 . . . . 0.0 112.308 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.964 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.1 pt? -71.54 29.45 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.951 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.552 ' H ' ' C ' ' A' ' 74' ' ' PRO . 54.7 t-20 -82.64 55.63 3.05 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -145.92 1.48 0.88 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -171.76 115.55 0.37 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.249 -0.981 . . . . 0.0 111.012 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.404 ' CG1' HD12 ' A' ' 39' ' ' ILE . 2.2 t -139.14 156.12 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.463 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.5 t -166.41 -41.14 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 118.952 -1.099 . . . . 0.0 112.152 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 m -99.77 144.29 29.0 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.304 -0.959 . . . . 0.0 111.349 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.603 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -149.23 163.47 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.779 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.86 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -146.89 113.99 6.2 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.834 -179.972 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.86 ' H ' HH22 ' A' ' 83' ' ' ARG . 45.0 t -121.33 138.46 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.701 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.66 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 2.3 mt -143.43 132.43 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.269 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.6 m -40.17 153.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.917 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -149.24 149.88 30.43 Favored Pre-proline 0 N--CA 1.482 1.155 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.805 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.18 153.12 28.03 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 121.251 1.3 . . . . 0.0 111.354 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.14 134.73 27.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.776 -0.77 . . . . 0.0 111.236 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -145.25 126.12 7.47 Favored Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.366 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.62 -177.35 0.08 OUTLIER 'Trans proline' 0 C--O 1.212 -0.812 0 C-N-CA 120.851 1.034 . . . . 0.0 111.119 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.75 -160.33 0.69 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.713 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.49 161.23 27.58 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.157 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -119.42 147.94 43.8 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.981 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -134.75 136.63 42.78 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.564 -1.198 . . . . 0.0 107.889 179.813 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.498 ' CE2' ' OE2' ' A' ' 105' ' ' GLU . 18.3 m-85 -100.89 164.67 11.72 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 118.991 -1.084 . . . . 0.0 112.463 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.62 -56.88 3.59 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.421 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -93.34 167.0 12.02 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.043 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -87.98 68.33 9.19 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.563 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.656 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 1.7 tt0 -175.59 49.56 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.555 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.656 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 26.2 p90 39.58 40.31 0.61 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.644 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 20.9 p-10 -142.63 174.76 10.35 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.259 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 85.71 141.24 5.83 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.163 -1.494 . . . . 0.0 110.002 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 103' ' ' GLY . 11.9 tptt -28.49 123.15 0.12 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 124.016 0.48 . . . . 0.0 111.76 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.498 ' OE2' ' CE2' ' A' ' 96' ' ' PHE . 43.8 mt-10 -94.41 115.18 27.33 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.11 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.705 HG21 ' O ' ' A' ' 122' ' ' GLY . 3.6 t -96.17 143.76 11.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.592 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -123.92 156.58 36.07 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.88 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.2 mt -143.4 137.96 15.08 Favored Pre-proline 0 N--CA 1.488 1.469 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.896 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -67.77 165.56 27.32 Favored 'Trans proline' 0 C--O 1.213 -0.762 0 C-N-CA 121.732 1.621 . . . . 0.0 112.018 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.69 153.11 51.57 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 C-N-CA 122.171 1.914 . . . . 0.0 111.599 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.97 -159.3 21.14 Favored Glycine 0 N--CA 1.503 3.107 0 C-N-CA 119.35 -1.405 . . . . 0.0 111.42 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.538 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 24.8 mt-30 -123.65 157.18 34.41 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.196 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 27.8 m-85 -138.43 143.92 39.91 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.156 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.2 p -91.37 176.25 6.63 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.838 -0.745 . . . . 0.0 112.604 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.408 ' C ' ' OE2' ' A' ' 119' ' ' GLU . 39.0 tt0 -77.72 46.01 0.53 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.543 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -146.76 -64.17 0.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.073 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.6 pt-20 -71.16 -49.1 47.42 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.927 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.553 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -31.9 -70.33 0.07 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.424 -179.999 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.697 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -58.18 -55.98 28.0 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.63 179.956 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.499 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.8 OUTLIER -75.1 21.27 0.12 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.526 -0.869 . . . . 0.0 111.806 -179.876 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' A' ' 117' ' ' GLU . 30.0 t80 -128.75 -15.95 4.3 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.206 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.705 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -143.87 -39.36 0.06 OUTLIER Glycine 0 N--CA 1.491 2.331 0 C-N-CA 118.742 -1.694 . . . . 0.0 111.09 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.557 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -144.57 -104.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.5 -179.968 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.557 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 0.3 OUTLIER -162.51 -169.81 2.23 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.013 179.931 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -88.8 36.37 0.8 Allowed 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.008 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.53 ' O ' ' N ' ' A' ' 128' ' ' ILE . 63.2 t30 -172.33 -74.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.418 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -40.62 85.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' A' ' 126' ' ' ASN . 42.3 mt -158.43 143.33 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.657 179.818 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.9 m -159.51 -119.84 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.267 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.3 m -38.5 128.11 1.45 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.014 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -122.22 154.48 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.714 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -147.59 100.68 3.76 Favored Pre-proline 0 C--N 1.302 -1.467 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.369 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -54.4 94.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 120.976 1.118 . . . . 0.0 110.461 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -57.65 -15.87 8.93 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.307 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.34 -25.6 0.05 OUTLIER Glycine 0 N--CA 1.488 2.131 0 C-N-CA 118.747 -1.692 . . . . 0.0 111.461 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 mt -120.87 148.28 44.26 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.539 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -66.38 161.96 21.42 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.496 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 40.4 t -131.39 147.83 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.482 -0.887 . . . . 0.0 112.259 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.592 HG12 ' CE1' ' A' ' 141' ' ' PHE . 76.2 t -138.82 124.02 22.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.442 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.9 mp -104.34 142.17 35.03 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 119.642 -0.823 . . . . 0.0 112.755 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.592 ' CE1' HG12 ' A' ' 139' ' ' VAL . 18.6 m-85 -120.68 135.06 55.23 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.621 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -72.63 -47.2 49.62 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.527 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.556 ' CG ' ' H ' ' A' ' 144' ' ' ASP . 5.1 t-20 -83.22 -157.33 0.23 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.703 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.556 ' H ' ' CG ' ' A' ' 143' ' ' ASN . 1.0 OUTLIER -69.25 -140.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.927 -179.924 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.604 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 65.3 m-20 -52.67 86.09 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.053 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.604 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 6.2 p90 38.73 68.96 0.3 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.953 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 p -136.24 60.05 1.69 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.733 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 160.04 -151.68 22.38 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.134 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -59.41 156.81 12.22 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.336 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.5 p -149.01 170.14 19.03 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.754 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.507 HD23 ' C ' ' A' ' 151' ' ' LEU . 3.2 tt -144.24 83.04 10.32 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.449 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.85 105.92 0.71 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 121.999 1.799 . . . . 0.0 113.207 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 38.5 t -82.32 89.97 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.136 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -68.66 -7.48 33.6 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 21.0 t -169.62 -135.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 117.666 -1.614 . . . . 0.0 113.293 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.462 ' N ' ' OG ' ' A' ' 155' ' ' SER . 23.7 m-20 -77.18 152.72 34.68 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.987 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -167.86 67.14 0.79 Allowed Pre-proline 0 C--N 1.307 -1.247 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.035 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.4 Cg_endo -62.72 20.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.231 1.954 . . . . 0.0 112.847 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.551 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -175.32 83.62 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.755 -1.178 . . . . 0.0 110.953 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 30.2 tp -98.78 -47.66 5.23 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.297 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 56.03 -165.15 4.5 Favored Glycine 0 N--CA 1.484 1.875 0 C-N-CA 119.212 -1.471 . . . . 0.0 110.043 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.49 105.13 12.42 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.214 -0.995 . . . . 0.0 110.861 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 3.4 mmt -90.27 -77.47 0.4 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.186 -1.005 . . . . 0.0 109.491 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -91.71 -43.8 9.37 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.264 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -177.07 -161.81 0.07 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.328 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -77.13 172.05 13.86 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.374 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.5 m -103.26 150.82 23.36 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.745 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.9 p -124.44 -68.04 0.88 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.157 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.408 ' OG ' ' HB2' ' A' ' 141' ' ' PHE . 77.3 p -116.33 153.19 32.43 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.611 -0.835 . . . . 0.0 108.819 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 19.2 pt -137.04 175.52 9.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.717 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -155.65 103.97 2.32 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.227 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.3 mt -78.23 103.38 5.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.791 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.0 t . . . . . 0 C--N 1.305 -1.349 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.777 -179.898 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.896 0.379 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.543 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . -95.21 175.21 6.69 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.822 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -175.04 118.32 0.18 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.365 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 4' ' ' ILE . 24.5 pt -69.27 145.8 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.684 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -121.56 112.87 19.01 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.003 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 m -91.12 175.47 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.238 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.544 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 23.9 m-85 -132.24 151.18 51.94 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.449 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.17 -6.77 59.27 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 118.824 -1.15 . . . . 0.0 113.289 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.52 ' C ' ' OG ' ' A' ' 40' ' ' SER . 34.1 m120 -147.13 161.85 40.04 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.646 -1.222 . . . . 0.0 111.536 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.449 ' N ' ' OG ' ' A' ' 40' ' ' SER . 26.2 mt-10 -70.85 179.02 2.84 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.394 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.9 t70 59.37 39.33 22.32 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.402 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.6 t80 57.48 5.45 0.3 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.272 -0.971 . . . . 0.0 111.792 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.465 ' HG2' ' H ' ' A' ' 14' ' ' GLY . 36.4 tt0 -92.45 176.66 6.39 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.291 -0.963 . . . . 0.0 111.217 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.465 ' H ' ' HG2' ' A' ' 13' ' ' GLN . . . 88.47 131.43 3.84 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.993 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -42.78 157.64 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.572 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -121.23 166.96 13.24 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.461 -0.895 . . . . 0.0 112.545 -179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -143.86 135.41 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.929 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -94.1 113.28 25.21 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.419 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.8 mt -107.35 137.68 19.69 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.572 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -71.15 155.76 60.64 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 121.072 1.181 . . . . 0.0 110.972 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.44 -161.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 121.576 1.517 . . . . 0.0 110.533 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.54 178.45 49.43 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 119.175 -1.488 . . . . 0.0 111.038 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -103.11 134.3 46.77 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.671 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 7.4 p90 -153.71 174.77 14.08 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.143 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.5 p -145.67 -154.21 0.53 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.98 -179.786 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.837 HH11 ' HB2' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -62.72 -30.92 71.77 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.973 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -59.98 -61.77 2.36 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.95 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.506 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.9 tp60 -56.47 -47.4 79.28 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.502 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.679 HD23 HD12 ' A' ' 32' ' ' LEU . 20.2 mt -54.98 -39.48 69.03 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.528 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.837 ' HB2' HH11 ' A' ' 26' ' ' ARG . . . -51.68 -34.2 37.34 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 118.948 -1.101 . . . . 0.0 108.359 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -66.77 -39.49 87.87 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.696 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.679 HD12 HD23 ' A' ' 29' ' ' LEU . 10.3 mt -74.8 -75.07 0.17 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.617 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.59 -34.91 0.54 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.094 -1.526 . . . . 0.0 110.909 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.444 HG21 HD13 ' A' ' 34' ' ' ILE . 8.5 tt -79.89 150.76 4.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.735 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 179.92 150.74 0.38 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.605 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.69 -146.8 0.14 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.913 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -55.33 92.62 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.998 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 40' ' ' SER . 73.1 p -153.18 -46.97 0.1 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.106 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.406 HD12 HG11 ' A' ' 79' ' ' VAL . 7.3 mt -61.86 75.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 C-N-CA 119.661 -0.815 . . . . 0.0 109.764 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.549 ' O ' HD22 ' A' ' 72' ' ' LEU . 8.6 t -74.21 -59.74 2.59 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.429 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.544 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -116.81 177.29 4.76 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.709 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -156.43 152.64 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 117.549 -1.66 . . . . 0.0 113.486 -179.896 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -140.17 106.97 5.38 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.595 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -126.08 108.21 24.71 Favored Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.598 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.419 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -69.81 171.04 15.25 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.042 1.162 . . . . 0.0 110.549 179.86 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.9 Cg_endo -62.39 -170.87 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.841 1.694 . . . . 0.0 110.91 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.9 -14.61 12.97 Favored Glycine 0 N--CA 1.478 1.468 0 C-N-CA 119.024 -1.56 . . . . 0.0 111.005 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.543 HG11 ' HB3' ' A' ' 2' ' ' ALA . 0.5 OUTLIER -151.66 131.72 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 118.716 -1.194 . . . . 0.0 112.588 -179.832 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.445 ' HA ' HG13 ' A' ' 66' ' ' VAL . 57.7 tttt -101.73 130.8 48.21 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.35 158.09 20.22 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.025 -1.07 . . . . 0.0 113.519 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.545 HD12 ' NH1' ' A' ' 83' ' ' ARG . 33.6 mt -144.71 116.24 2.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.242 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.546 ' HA ' HG23 ' A' ' 82' ' ' ILE . 2.7 mp -94.42 159.46 15.1 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.167 -1.013 . . . . 0.0 113.368 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.488 ' CE1' HG22 ' A' ' 51' ' ' ILE . 83.2 m-85 -139.33 114.77 9.82 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.111 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -44.61 -87.05 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.459 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -59.45 151.02 24.98 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.338 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -58.99 -178.99 0.06 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.169 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.666 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 55.61 37.31 67.31 Favored Glycine 0 N--CA 1.484 1.853 0 C-N-CA 118.906 -1.616 . . . . 0.0 109.437 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.771 ' H ' ' CB ' ' A' ' 81' ' ' SER . 0.3 OUTLIER 41.1 69.08 0.37 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.838 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.02 174.39 10.63 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.767 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.71 173.61 40.64 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.236 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -48.46 122.28 5.29 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 118.999 -1.081 . . . . 0.0 110.352 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.401 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 1.9 pt20 -99.05 173.32 6.88 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.93 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.878 HD11 HD11 ' A' ' 75' ' ' LEU . 7.3 mt -138.66 169.93 17.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.711 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.517 ' H ' HG22 ' A' ' 63' ' ' ILE . 22.0 mt-10 -147.21 130.88 16.9 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.394 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.64 164.74 2.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.441 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.622 HG12 ' NH2' ' A' ' 92' ' ' ARG . 0.5 OUTLIER -146.67 -9.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.658 179.856 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -118.01 -153.21 0.52 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.837 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -95.48 120.7 36.18 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.637 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.573 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.73 108.37 19.65 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.174 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 8.2 tp10 -73.62 -76.78 0.12 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.95 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.464 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 23.1 tp10 -76.86 2.02 15.8 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.038 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.549 HD22 ' O ' ' A' ' 40' ' ' SER . 10.1 tp 51.83 -97.55 0.06 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.111 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.465 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -174.5 -173.83 40.77 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 118.937 -1.601 . . . . 0.0 110.979 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.629 ' C ' ' H ' ' A' ' 76' ' ' ASN . 3.8 Cg_endo -71.86 -53.8 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.649 2.233 . . . . 0.0 112.306 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.878 HD11 HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -60.82 14.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.775 -179.853 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.629 ' H ' ' C ' ' A' ' 74' ' ' PRO . 13.2 p30 -67.51 0.81 2.74 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.453 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 75' ' ' LEU . 25.8 t-20 -80.82 -8.77 59.79 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.091 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -164.75 122.54 1.66 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.596 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.406 HG11 HD12 ' A' ' 39' ' ' ILE . 2.8 t -148.33 137.47 15.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.72 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.5 p -145.11 -47.4 0.23 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.65 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.771 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 7.4 m -93.61 142.76 26.98 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.334 -179.813 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.546 HG23 ' HA ' ' A' ' 52' ' ' LEU . 0.8 OUTLIER -147.98 160.38 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.01 -179.923 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.78 HH22 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.92 137.4 21.09 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.151 180.0 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.78 ' CA ' HH22 ' A' ' 83' ' ' ARG . 5.4 t -140.74 143.87 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.7 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.494 HG12 ' NH2' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -135.71 135.13 51.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.125 -179.928 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.1 t -42.87 154.41 0.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.108 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.7 143.72 13.59 Favored Pre-proline 0 C--N 1.307 -1.27 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.118 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.54 130.12 28.83 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.091 1.194 . . . . 0.0 110.73 179.72 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.3 p -59.48 140.24 17.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -117.33 152.44 49.25 Favored Pre-proline 0 N--CA 1.49 1.57 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.25 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.442 ' HG2' HD21 ' A' ' 136' ' ' LEU . 2.5 Cg_endo -59.33 -34.27 97.74 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.287 1.324 . . . . 0.0 111.207 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.622 ' NH2' HG12 ' A' ' 66' ' ' VAL . 22.3 mtt180 52.15 -161.96 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.359 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.572 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.1 175.86 9.42 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.867 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -143.68 120.15 11.01 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.45 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.42 ' CD1' HG13 ' A' ' 131' ' ' VAL . 6.7 m-30 -95.77 164.54 12.71 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.028 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.638 ' CD1' ' CE1' ' A' ' 101' ' ' PHE . 2.8 m-85 -143.41 149.06 37.12 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.468 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -93.68 160.43 14.77 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.597 -179.895 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.423 ' C ' ' OG ' ' A' ' 129' ' ' SER . 10.3 tttm 67.19 136.52 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.004 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.532 ' N ' ' OG ' ' A' ' 129' ' ' SER . 5.1 pt-20 -77.27 70.99 3.73 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.626 -1.23 . . . . 0.0 111.003 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.492 ' OE1' ' OD2' ' A' ' 102' ' ' ASP . 50.0 tt0 -173.67 19.02 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.515 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.638 ' CE1' ' CD1' ' A' ' 96' ' ' PHE . 33.8 t80 49.34 40.35 18.27 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.424 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.492 ' OD2' ' OE1' ' A' ' 100' ' ' GLN . 90.3 m-20 -104.09 -87.22 0.44 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.556 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 102' ' ' ASP . . . -30.68 145.88 0.01 OUTLIER Glycine 0 N--CA 1.507 3.402 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.917 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -34.72 155.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 114.587 -0.807 . . . . 0.0 112.998 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.492 ' HB3' ' CE1' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -116.4 164.74 14.1 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.411 -179.849 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.65 141.16 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -102.53 157.69 16.75 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.965 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 108' ' ' LEU . 88.8 mt -144.27 140.01 16.37 Favored Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.964 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -72.86 164.39 35.71 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 121.756 1.637 . . . . 0.0 111.825 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.5 143.79 70.52 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.603 1.535 . . . . 0.0 110.72 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.9 -160.78 27.52 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 118.795 -1.669 . . . . 0.0 111.573 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.561 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 29.3 tt0 -117.63 158.13 25.19 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.216 -0.492 . . . . 0.0 111.038 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.561 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 56.0 m-85 -145.52 151.47 38.22 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.765 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.4 p -103.02 -168.24 1.49 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.322 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.47 ' CG ' ' OG ' ' A' ' 168' ' ' SER . 45.4 tt0 -92.23 49.64 1.54 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.146 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -151.19 -63.51 0.19 Allowed 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.744 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -70.2 -54.07 14.39 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.326 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.558 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -30.82 -69.34 0.07 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.012 -179.99 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.713 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 21.2 mp0 -54.92 -59.29 4.94 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.173 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.42 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 12.3 mpt_? -74.73 19.54 0.14 Allowed 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.71 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.543 ' N ' ' O ' ' A' ' 117' ' ' GLU . 16.1 t80 -121.22 -15.4 8.17 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.881 -0.727 . . . . 0.0 110.773 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.07 -37.19 0.05 OUTLIER Glycine 0 N--CA 1.483 1.817 0 C-N-CA 118.928 -1.606 . . . . 0.0 110.337 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.473 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -146.01 -112.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.527 -179.843 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -151.98 -147.3 0.22 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.275 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.436 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 46.9 t-20 -73.81 -108.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.52 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.436 ' N ' ' OD1' ' A' ' 125' ' ' ASN . 23.7 t-20 -80.2 55.17 2.13 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.074 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.601 ' O ' HG22 ' A' ' 127' ' ' THR . 18.7 m -100.58 4.58 43.53 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.482 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.42 HG12 ' H ' ' A' ' 128' ' ' ILE . 2.3 mm -76.73 161.81 4.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.665 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 99' ' ' GLU . 2.4 t -161.91 -47.98 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.1 m -137.34 134.98 36.63 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.149 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.42 HG13 ' CD1' ' A' ' 95' ' ' PHE . 3.0 t -120.7 145.31 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.572 0.701 . . . . 0.0 111.855 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -146.18 93.56 5.06 Favored Pre-proline 0 C--N 1.296 -1.753 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.986 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -59.15 105.71 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.164 1.243 . . . . 0.0 111.877 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.572 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 36.4 tt0 -56.52 -9.52 0.75 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.568 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.44 -41.93 0.08 OUTLIER Glycine 0 N--CA 1.494 2.536 0 C-N-CA 118.49 -1.814 . . . . 0.0 111.933 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.442 HD21 ' HG2' ' A' ' 91' ' ' PRO . 4.9 mt -88.05 -167.12 1.78 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.105 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -115.79 142.64 46.5 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 153' ' ' VAL . 53.6 t -107.75 144.91 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.696 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 88.1 t -132.62 120.61 42.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.033 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.8 mp -97.84 139.33 33.85 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.343 -179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.427 ' CD2' ' HB3' ' A' ' 146' ' ' PHE . 29.4 m-85 -115.48 129.23 56.48 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.689 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.455 ' HE3' ' H ' ' A' ' 149' ' ' ASP . 19.5 ttpp -61.44 -75.02 0.07 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.653 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -76.22 167.98 20.88 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.259 -0.977 . . . . 0.0 110.513 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 146' ' ' PHE . 1.4 p30 -63.48 -158.43 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.59 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.643 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 22.2 t-20 39.33 26.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.248 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.643 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 41.87 57.89 3.02 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.343 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.0 t -136.45 -172.93 3.27 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.028 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.48 -161.94 53.49 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.169 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.455 ' H ' ' HE3' ' A' ' 142' ' ' LYS . 5.9 t70 -59.77 156.31 14.27 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.104 179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.5 p -148.16 170.39 17.95 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.476 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.7 mt -137.93 82.56 25.32 Favored Pre-proline 0 C--N 1.303 -1.419 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.463 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -62.13 103.93 0.32 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.848 1.699 . . . . 0.0 112.231 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 138' ' ' VAL . 3.1 t -89.34 74.1 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.883 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -79.22 36.29 0.29 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.001 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.6 t -170.97 -155.85 0.11 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.328 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.2 155.89 19.91 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.136 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.97 69.51 1.38 Allowed Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.526 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.4 Cg_endo -66.44 23.84 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.075 1.85 . . . . 0.0 111.313 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.597 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.3 t -168.76 134.34 1.7 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.412 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 129' ' ' SER . 0.2 OUTLIER -141.74 -55.57 0.46 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.949 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 79.06 -94.01 1.33 Allowed Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.106 -1.521 . . . . 0.0 110.154 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -171.47 96.15 0.18 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.254 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 32.6 mmt -90.04 -69.24 0.73 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.285 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.522 ' C ' ' CG ' ' A' ' 165' ' ' ASN . 24.2 m120 -87.23 38.73 0.83 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.23 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.566 ' O ' ' ND2' ' A' ' 166' ' ' ASN . 0.1 OUTLIER 42.98 88.79 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.347 -179.997 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.566 ' ND2' ' O ' ' A' ' 165' ' ' ASN . 0.1 OUTLIER 69.12 153.57 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.961 179.813 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.45 125.61 51.22 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.838 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.47 ' OG ' ' CG ' ' A' ' 115' ' ' GLN . 36.8 t -91.15 -62.03 1.53 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.223 -0.991 . . . . 0.0 112.09 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.49 161.0 19.78 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.819 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.406 HG12 ' CD1' ' A' ' 118' ' ' LEU . 45.7 pt -143.16 174.64 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.729 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.5 ttt85 -160.66 114.25 2.08 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.492 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 11.7 mt -86.87 101.41 11.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.466 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.5 t . . . . . 0 C--N 1.306 -1.307 0 CA-C-O 116.284 -1.817 . . . . 0.0 110.874 179.949 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttm . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 120.761 0.315 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.74 123.67 32.15 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.028 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 179.83 125.89 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.683 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 pt -82.04 128.02 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.06 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -105.69 112.25 25.25 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.2 m -90.11 169.5 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 119.591 -0.844 . . . . 0.0 113.206 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -129.14 141.61 51.13 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.407 -1.27 . . . . 0.0 108.196 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.17 -21.72 58.55 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -123.95 169.73 11.32 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.028 -1.069 . . . . 0.0 112.477 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 11' ' ' ASP . 25.4 tt0 -67.21 173.77 3.64 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.888 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.558 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 14.5 m-20 52.01 58.2 5.69 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.774 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 7.3 p90 33.59 28.69 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.506 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 11' ' ' ASP . 8.7 tp-100 -106.55 168.44 9.17 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.92 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.52 ' H ' ' CD ' ' A' ' 13' ' ' GLN . . . 93.94 136.81 8.26 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.995 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -30.54 140.82 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 O-C-N 123.922 0.425 . . . . 0.0 111.712 -179.931 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 1.203 ' OE1' ' CD ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -100.52 151.71 21.26 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.498 -0.881 . . . . 0.0 113.17 -179.802 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -135.9 142.99 37.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.822 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -107.79 133.71 51.79 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.659 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 mt -129.3 126.81 23.08 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.982 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -67.91 163.59 35.0 Favored 'Trans proline' 0 C--N 1.327 -0.599 0 C-N-CA 120.629 0.886 . . . . 0.0 110.961 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.05 -162.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.493 1.462 . . . . 0.0 111.06 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.23 172.94 37.11 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.073 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.41 ' CB ' ' HG3' ' A' ' 83' ' ' ARG . 12.7 p-10 -106.12 133.9 50.09 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.564 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -155.24 177.12 11.71 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.394 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 p -137.88 -159.78 0.99 Allowed 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.85 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.86 -20.78 66.07 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.614 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -62.97 -58.9 5.78 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.216 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.489 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 28.6 tp60 -56.67 -45.2 81.84 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.007 -1.077 . . . . 0.0 109.738 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.64 HD23 HD12 ' A' ' 32' ' ' LEU . 13.7 mt -58.73 -39.09 79.88 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.567 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -53.15 -32.66 48.8 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.853 -1.139 . . . . 0.0 108.589 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -69.1 -42.31 76.3 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.095 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.64 HD12 HD23 ' A' ' 29' ' ' LEU . 10.3 mt -69.93 -71.39 0.24 Allowed 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.666 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.64 -34.67 0.81 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.117 -1.516 . . . . 0.0 110.923 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 34' ' ' ILE . 12.5 tt -83.32 141.62 14.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.27 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 175.82 154.96 0.19 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.031 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.1 t30 60.76 104.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.643 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.471 ' H ' HG22 ' A' ' 79' ' ' VAL . 66.5 t30 51.23 69.99 0.59 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.586 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 40' ' ' SER . 77.9 p -146.57 -32.23 0.33 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.339 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 40' ' ' SER . 8.9 mt -78.09 42.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.516 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 38' ' ' THR . 32.6 t -38.78 -53.73 1.65 Allowed 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.026 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.59 163.98 29.88 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.211 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.964 HG22 ' HB3' ' A' ' 69' ' ' ALA . 20.1 m -143.89 171.66 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 118.502 -1.279 . . . . 0.0 113.444 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -142.23 95.06 2.74 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.559 -1.655 . . . . 0.0 107.461 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 51.8 t -115.63 110.25 44.82 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -70.28 169.64 19.1 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.065 1.177 . . . . 0.0 110.311 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.85 -170.28 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.715 1.61 . . . . 0.0 111.207 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.86 -15.34 15.6 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.392 -1.385 . . . . 0.0 111.016 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -152.97 148.48 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.414 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -123.8 128.67 49.87 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.137 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.77 165.06 11.84 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.83 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.675 HG23 ' O ' ' A' ' 63' ' ' ILE . 66.7 mt -138.73 125.09 24.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.661 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.17 122.65 42.66 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.647 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -109.78 119.55 39.72 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.318 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -54.76 -77.01 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.144 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -62.28 156.16 22.94 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.0 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 19.2 p-10 -68.1 174.53 3.78 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.623 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.422 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 62.13 31.31 78.43 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.236 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.48 ' H ' ' CB ' ' A' ' 81' ' ' SER . 0.2 OUTLIER 54.2 67.18 1.05 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.619 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.42 -170.53 3.47 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.332 -0.947 . . . . 0.0 111.195 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 67.43 174.52 7.28 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.377 -1.392 . . . . 0.0 109.858 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 60' ' ' GLY . 13.4 m-20 -42.98 118.67 1.32 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.136 -1.026 . . . . 0.0 110.33 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.412 ' CD ' ' H ' ' A' ' 62' ' ' GLN . 0.1 OUTLIER -91.36 160.8 15.3 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.259 -0.977 . . . . 0.0 111.33 -179.887 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.675 ' O ' HG23 ' A' ' 51' ' ' ILE . 7.2 mm -137.53 168.63 20.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.353 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.67 ' N ' HG22 ' A' ' 63' ' ' ILE . 20.2 mp0 -147.96 134.19 19.45 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.306 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.7 m -149.76 147.5 16.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 118.676 -1.21 . . . . 0.0 112.252 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 48' ' ' VAL . 2.0 t -140.77 -0.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.49 -153.85 0.59 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.686 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -93.49 144.05 25.72 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.437 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.964 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -111.17 108.98 18.83 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.732 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -78.29 -63.34 1.42 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.401 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -100.45 4.43 43.73 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.259 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 tp 46.18 -98.93 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.097 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -168.95 -177.24 39.63 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 118.778 -1.677 . . . . 0.0 110.842 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.583 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.0 OUTLIER -67.16 -46.02 3.4 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.169 1.913 . . . . 0.0 112.055 -179.983 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.728 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.4 pt? -56.72 3.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.403 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.583 ' H ' ' C ' ' A' ' 74' ' ' PRO . 53.2 p-10 -65.04 5.79 0.31 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.403 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.543 ' H ' ' C ' ' A' ' 75' ' ' LEU . 26.3 t30 -86.92 -11.01 51.93 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.725 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -166.15 98.94 0.63 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.665 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.471 HG22 ' H ' ' A' ' 37' ' ' ASN . 18.9 m -97.09 171.0 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.582 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.1 t -171.31 -69.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 118.348 -1.341 . . . . 0.0 112.901 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.48 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 4.4 m -96.99 148.64 22.77 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.72 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.68 153.05 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.311 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.809 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -145.91 140.42 26.96 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.753 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.809 ' CA ' HH12 ' A' ' 83' ' ' ARG . 10.1 t -138.82 140.45 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.99 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.549 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 2.8 mt -136.99 125.61 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.57 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -50.12 126.85 15.52 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.579 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.696 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -114.97 145.32 33.79 Favored Pre-proline 0 N--CA 1.49 1.545 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.302 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.696 ' HD2' HG22 ' A' ' 87' ' ' VAL . 5.8 Cg_exo -52.61 120.29 7.26 Favored 'Trans proline' 0 C--N 1.326 -0.618 0 C-N-CA 121.356 1.37 . . . . 0.0 111.354 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 89' ' ' VAL . 7.1 p -45.47 130.59 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.841 -179.814 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -139.35 150.21 63.28 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.394 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.438 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 1.7 Cg_endo -59.13 -166.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.106 1.204 . . . . 0.0 111.102 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.89 -157.56 0.1 Allowed 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.049 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.68 162.08 36.24 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.156 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -129.99 117.43 20.05 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.043 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 10.5 m-85 -102.85 131.11 49.97 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.116 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -99.42 159.99 14.61 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.848 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.524 ' CZ ' HG21 ' A' ' 127' ' ' THR . 1.0 OUTLIER -97.43 158.68 15.35 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.629 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt 62.47 138.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.815 0.816 . . . . 0.0 111.514 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.588 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 10.6 tp10 -71.12 102.44 2.49 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.605 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.704 ' OE1' ' HB2' ' A' ' 102' ' ' ASP . 4.2 tm0? 129.67 39.25 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.467 0 O-C-N 125.286 1.616 . . . . 0.0 109.654 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.65 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 28.5 p90 33.96 48.33 0.23 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.124 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.704 ' HB2' ' OE1' ' A' ' 100' ' ' GLN . 53.5 t0 -124.36 57.58 1.23 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.472 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -177.01 156.42 20.39 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.902 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.487 ' H ' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -28.81 139.9 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.827 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -94.67 154.5 17.3 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.902 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.636 HG21 ' O ' ' A' ' 122' ' ' GLY . 2.5 t -140.31 165.67 20.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.888 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.553 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 17.7 p-10 -149.24 159.37 44.32 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.759 -1.176 . . . . 0.0 111.651 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.4 mt -142.07 149.08 51.07 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 119.639 -0.825 . . . . 0.0 111.23 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.41 165.93 24.79 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.044 1.829 . . . . 0.0 111.661 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.36 142.9 67.96 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.566 1.511 . . . . 0.0 110.687 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 144.75 -158.72 27.66 Favored Glycine 0 N--CA 1.502 3.063 0 C-N-CA 118.787 -1.673 . . . . 0.0 111.711 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.541 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 3.9 mp0 -116.77 153.4 32.49 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.759 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 50.8 m-85 -145.84 146.68 31.22 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.633 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.9 p -89.47 -147.93 0.18 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.435 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.779 ' H ' ' CD ' ' A' ' 115' ' ' GLN . 0.3 OUTLIER -116.06 27.35 9.32 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.783 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.47 ' HB2' HE21 ' A' ' 115' ' ' GLN . . . -129.54 -64.56 0.88 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.762 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.495 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 8.1 pt-20 -68.67 -42.64 77.61 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.42 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.569 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -38.04 -72.65 0.06 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.77 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.438 ' HB3' ' C ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -52.55 -54.41 33.16 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.168 -179.969 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -72.93 16.66 0.14 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.432 -179.791 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 117' ' ' GLU . 13.9 t80 -124.49 -17.9 5.88 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.912 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.636 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -133.91 -49.75 0.08 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.114 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.533 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -144.99 -99.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.628 -179.934 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.533 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 13.3 t70 -168.73 177.69 4.99 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.172 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.521 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 46.0 t-20 -59.15 135.14 57.54 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.701 -179.84 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 35.85 81.28 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.812 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.524 HG21 ' CZ ' ' A' ' 97' ' ' TYR . 97.9 m -161.56 -11.0 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.394 -0.923 . . . . 0.0 111.012 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.477 ' CG2' HG22 ' A' ' 131' ' ' VAL . 1.5 mp -53.84 -56.32 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.256 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.9 m 55.35 -113.63 0.8 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.682 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.2 m -63.06 122.42 16.03 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.93 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.477 HG22 ' CG2' ' A' ' 128' ' ' ILE . 1.8 t -120.76 159.76 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.427 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -153.15 85.46 4.24 Favored Pre-proline 0 C--N 1.301 -1.518 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -62.42 97.06 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.416 1.41 . . . . 0.0 110.723 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -81.83 22.4 0.76 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.35 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.8 -54.44 0.04 OUTLIER Glycine 0 N--CA 1.498 2.778 0 C-N-CA 118.042 -2.027 . . . . 0.0 112.38 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.438 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 1.3 mp -115.87 -172.07 2.09 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.002 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.75 143.11 31.31 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.652 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.6 t -110.0 139.09 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.765 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.587 ' C ' HD12 ' A' ' 140' ' ' LEU . 59.6 t -125.97 138.02 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.036 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.587 HD12 ' C ' ' A' ' 139' ' ' VAL . 9.3 mp -112.26 134.5 53.76 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.926 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.58 ' N ' ' CD1' ' A' ' 141' ' ' PHE . 7.2 m-85 -115.0 131.92 56.77 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.78 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -64.21 -79.16 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.028 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -60.35 160.66 8.3 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.357 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 146' ' ' PHE . 10.0 m-20 -63.9 -156.19 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.554 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.686 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 6.3 t-20 41.13 24.44 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.017 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.686 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.1 OUTLIER 44.08 59.82 3.03 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.822 -179.946 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.6 t -141.83 -174.49 4.09 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.358 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.91 -163.22 54.2 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.591 -1.29 . . . . 0.0 110.025 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -59.81 160.47 7.52 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.952 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.0 p -150.34 174.73 12.54 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.809 -179.864 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.5 tp -141.78 89.45 9.04 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.53 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.21 106.27 0.8 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 121.699 1.599 . . . . 0.0 113.23 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.98 92.42 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.537 179.722 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -55.79 -34.57 65.41 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.8 t -164.15 -149.82 0.14 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 117.907 -1.517 . . . . 0.0 112.665 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -43.72 146.51 0.54 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.31 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -172.45 69.15 0.41 Allowed Pre-proline 0 C--N 1.307 -1.244 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.343 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.442 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.2 Cg_endo -64.9 23.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.197 1.931 . . . . 0.0 112.481 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.569 ' O ' HG23 ' A' ' 159' ' ' THR . 0.8 OUTLIER -177.72 102.3 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.139 179.967 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 3.7 mm? -99.37 -56.42 2.41 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.705 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 68.69 -171.66 37.42 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.375 -1.393 . . . . 0.0 110.53 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.39 137.93 57.81 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.994 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.607 ' CG ' ' H ' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -138.69 -80.55 0.33 Allowed 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.301 179.894 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.607 ' H ' ' CG ' ' A' ' 163' ' ' MET . 49.9 m-80 -90.75 -54.36 4.01 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.736 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -174.14 -67.23 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.847 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -163.13 141.55 8.2 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.812 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.528 ' OG1' HD23 ' A' ' 140' ' ' LEU . 1.5 m -86.31 107.84 18.15 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.826 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 27.5 m -95.33 -53.16 3.87 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.172 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.54 160.91 21.51 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.032 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.414 HG12 ' CD1' ' A' ' 118' ' ' LEU . 31.4 pt -138.96 166.51 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -148.75 103.36 3.37 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.591 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.0 mt -81.17 97.55 3.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 118.978 -1.089 . . . . 0.0 109.347 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 C--N 1.305 -1.343 0 CA-C-O 116.324 -1.798 . . . . 0.0 111.026 -179.993 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.594 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.8 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . 68.7 168.13 0.28 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.696 -0.801 . . . . 0.0 111.088 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -159.28 125.62 4.48 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.156 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.501 HG22 HG22 ' A' ' 44' ' ' VAL . 7.0 pt -72.01 155.17 7.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.513 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -134.0 156.5 48.08 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.067 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 m -147.26 171.41 3.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 119.086 -1.045 . . . . 0.0 111.062 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -131.97 156.15 46.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.744 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -72.17 -51.6 20.52 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -179.525 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.713 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 30.9 m120 -87.22 179.23 6.67 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.842 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -80.31 166.05 21.71 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.189 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.471 ' C ' ' H ' ' A' ' 13' ' ' GLN . 3.7 t0 66.15 45.35 2.36 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.782 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER 56.71 0.7 0.07 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.128 -1.029 . . . . 0.0 112.075 179.893 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 11' ' ' ASP . 47.4 tt0 -87.97 162.96 16.57 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.199 -1.0 . . . . 0.0 112.287 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.713 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 98.06 147.67 22.62 Favored Glycine 0 N--CA 1.503 3.107 0 C-N-CA 120.259 -0.972 . . . . 0.0 110.926 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 14' ' ' GLY . 3.7 mptp? -29.26 139.0 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 O-C-N 123.956 0.445 . . . . 0.0 112.137 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.636 ' N ' ' OE1' ' A' ' 16' ' ' GLN . 5.8 pm0 -103.92 160.19 15.02 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.459 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.613 ' CG1' ' N ' ' A' ' 18' ' ' ASP . 6.9 t -147.53 165.69 5.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.62 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.613 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 14.9 t70 -135.49 124.6 24.41 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.268 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mt -122.85 129.92 24.82 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.017 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -67.35 165.31 27.38 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.123 1.216 . . . . 0.0 111.317 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.99 -165.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 121.542 1.494 . . . . 0.0 110.289 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.53 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 94.95 -175.22 33.57 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 118.836 -1.649 . . . . 0.0 111.176 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.693 ' CA ' HH11 ' A' ' 83' ' ' ARG . 16.6 p-10 -113.2 134.02 54.78 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.153 -179.795 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.565 ' CE2' HD12 ' A' ' 82' ' ' ILE . 3.4 p90 -154.54 175.89 13.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.673 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.475 HG22 ' OG ' ' A' ' 81' ' ' SER . 7.0 p -146.82 -155.43 0.62 Allowed 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.984 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -60.33 -20.92 61.22 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.692 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.96 -63.11 1.16 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.474 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.508 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 15.7 tt0 -56.02 -46.73 78.71 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.486 -1.286 . . . . 0.0 109.805 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.586 HD23 HD12 ' A' ' 32' ' ' LEU . 22.9 mt -59.4 -38.95 81.89 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.539 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.57 -26.92 56.57 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 118.328 -1.349 . . . . 0.0 108.419 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -75.41 -37.95 60.16 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.739 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.586 HD12 HD23 ' A' ' 29' ' ' LEU . 14.4 mt -73.34 -74.97 0.16 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.525 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.29 -32.82 0.65 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.248 -1.454 . . . . 0.0 110.692 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 34' ' ' ILE . 7.8 tt -85.26 139.42 17.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.59 ' H ' HG21 ' A' ' 38' ' ' THR . 3.4 pt-20 174.24 142.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.195 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.55 ' O ' HG23 ' A' ' 38' ' ' THR . 1.7 t-20 75.57 116.31 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 47.14 9.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.735 179.74 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.59 HG21 ' H ' ' A' ' 35' ' ' GLU . 71.4 p -83.35 -57.67 3.16 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 117.941 -1.503 . . . . 0.0 111.206 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.417 ' N ' ' OG1' ' A' ' 38' ' ' THR . 30.2 mt -57.92 78.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.23 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 38' ' ' THR . 13.7 t -77.79 -48.3 16.89 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.562 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.409 ' CB ' ' H ' ' A' ' 12' ' ' PHE . 42.7 t -126.87 132.02 51.04 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.58 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -105.54 158.8 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 C-N-CA 119.492 -0.883 . . . . 0.0 113.052 -179.742 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.411 ' N ' HG13 ' A' ' 42' ' ' VAL . 33.4 tttp -143.38 98.43 3.25 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.788 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.501 HG22 HG22 ' A' ' 4' ' ' ILE . 93.1 t -121.78 109.37 34.19 Favored Pre-proline 0 N--CA 1.496 1.842 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.318 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -69.07 168.43 20.69 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 120.989 1.126 . . . . 0.0 110.898 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.42 -175.7 0.15 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 121.818 1.678 . . . . 0.0 111.097 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.69 -14.54 17.98 Favored Glycine 0 N--CA 1.481 1.688 0 C-N-CA 119.178 -1.487 . . . . 0.0 110.295 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.8 HG11 ' HB3' ' A' ' 2' ' ' ALA . 15.5 m -149.28 135.42 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.685 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.414 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 37.4 tttm -110.32 156.2 21.06 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.249 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -149.7 158.62 44.34 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 118.139 -1.424 . . . . 0.0 112.916 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.687 HG23 ' O ' ' A' ' 63' ' ' ILE . 78.4 mt -133.19 123.05 46.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 114.317 -1.311 . . . . 0.0 108.846 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.542 ' H ' HD12 ' A' ' 52' ' ' LEU . 0.9 OUTLIER -100.37 138.97 36.71 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.725 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.45 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 49.2 m-85 -113.73 114.05 25.82 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.712 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -46.72 -83.1 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.721 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -59.23 141.96 53.01 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.272 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -53.65 178.0 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.271 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.671 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 59.08 37.74 92.07 Favored Glycine 0 N--CA 1.487 2.049 0 C-N-CA 118.95 -1.595 . . . . 0.0 109.69 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.671 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.3 OUTLIER 41.08 70.52 0.25 Allowed 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.987 -179.943 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.05 -162.67 1.61 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.11 -178.03 5.14 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.325 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -49.46 123.79 8.23 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.45 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 62' ' ' GLN . 16.7 pt20 -95.54 158.3 15.51 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.101 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.687 ' O ' HG23 ' A' ' 51' ' ' ILE . 7.7 mm -133.42 168.38 24.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.766 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.679 ' N ' HG22 ' A' ' 63' ' ' ILE . 20.2 mt-10 -146.4 135.02 22.17 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.986 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.5 m -150.09 161.12 4.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.687 -1.205 . . . . 0.0 112.103 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 t -147.55 -3.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 114.402 -1.272 . . . . 0.0 107.799 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -131.31 -152.13 0.49 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.024 -1.443 . . . . 0.0 109.188 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.702 ' N ' HD21 ' A' ' 68' ' ' ASN . 0.7 OUTLIER -90.94 121.0 32.4 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.544 179.888 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.58 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.01 81.22 6.87 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.51 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -45.56 -69.48 0.13 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.594 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.67 -3.47 56.27 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.606 -0.837 . . . . 0.0 111.868 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tp 60.74 -93.61 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.164 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.76 -174.61 44.25 Favored Glycine 0 N--CA 1.491 2.367 0 C-N-CA 118.915 -1.612 . . . . 0.0 110.628 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.543 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.9 Cg_endo -65.27 -29.81 54.73 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.18 1.92 . . . . 0.0 112.092 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.631 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -65.41 13.25 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.219 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.543 ' H ' ' C ' ' A' ' 74' ' ' PRO . 22.8 t30 -60.25 -2.12 0.42 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.071 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.518 ' H ' ' C ' ' A' ' 75' ' ' LEU . 9.6 t-20 -77.35 -24.17 50.76 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.852 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.458 ' OD1' ' ND2' ' A' ' 36' ' ' ASN . 41.6 t30 -171.45 133.3 0.81 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.303 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.86 157.47 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.332 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.6 m -165.68 -61.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 117.915 -1.514 . . . . 0.0 114.136 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.62 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 11.7 m -93.92 148.24 22.34 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.027 -1.069 . . . . 0.0 112.88 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.565 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -148.57 158.64 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.858 179.971 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.802 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -139.29 120.18 14.42 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.519 -179.887 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.802 ' H ' HH12 ' A' ' 83' ' ' ARG . 3.1 t -119.4 133.79 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.706 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.783 HD11 HH21 ' A' ' 83' ' ' ARG . 3.2 mp -135.88 121.32 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.886 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.6 m -40.63 151.82 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.623 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -147.76 149.33 33.18 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.681 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -52.81 160.53 3.91 Favored 'Trans proline' 0 C--N 1.326 -0.643 0 C-N-CA 121.296 1.331 . . . . 0.0 111.672 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.0 137.81 21.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.701 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -146.11 131.67 9.3 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.657 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -59.84 -156.42 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.85 0 C-N-CA 121.245 1.297 . . . . 0.0 110.715 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.491 ' HE ' ' HB2' ' A' ' 107' ' ' ASP . 5.7 ptm180 -174.36 -157.96 0.08 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.044 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.549 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.5 168.06 20.74 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.854 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.49 ' HE ' ' CB ' ' A' ' 105' ' ' GLU . 38.5 ttt180 -129.13 128.6 43.79 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.954 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.518 ' CD2' HG13 ' A' ' 131' ' ' VAL . 71.8 m-85 -120.44 134.12 55.32 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.2 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.555 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 66.9 m-85 -89.43 175.21 7.4 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.969 -1.092 . . . . 0.0 111.237 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.72 -28.87 51.0 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 118.772 -1.171 . . . . 0.0 113.032 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -156.79 -178.82 7.64 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 117.363 -1.735 . . . . 0.0 113.585 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.613 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -62.61 108.1 1.08 Allowed 'General case' 0 C--O 1.202 -1.425 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.857 -179.83 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 1.19 ' OE1' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 121.97 41.33 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.434 0 O-C-N 125.081 1.488 . . . . 0.0 109.881 179.802 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 1.19 ' CD1' ' OE1' ' A' ' 100' ' ' GLN . 37.2 p90 30.32 34.51 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.878 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 100' ' ' GLN . 21.3 t70 -106.54 169.61 8.42 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.338 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 77.2 136.68 0.82 Allowed Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.203 -1.475 . . . . 0.0 109.727 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.47 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.7 OUTLIER -29.1 136.94 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.236 0.541 . . . . 0.0 112.097 -179.778 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.597 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 1.4 pm0 -93.31 164.28 13.28 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.619 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 107' ' ' ASP . 3.9 t -140.04 167.83 18.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.691 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.557 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 2.8 p30 -148.16 159.28 44.11 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.346 -1.342 . . . . 0.0 111.81 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.8 mt -141.49 149.55 54.66 Favored Pre-proline 0 N--CA 1.495 1.776 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -76.99 166.34 26.93 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 121.763 1.642 . . . . 0.0 111.422 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.33 140.8 78.83 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 121.7 1.6 . . . . 0.0 110.928 179.871 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 145.52 -164.08 28.12 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 118.927 -1.606 . . . . 0.0 111.36 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.586 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 33.4 tt0 -115.99 157.25 24.88 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.211 -0.494 . . . . 0.0 110.783 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.586 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 53.8 m-85 -146.08 153.85 41.18 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.9 p -98.71 -159.62 0.75 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.412 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -106.91 54.3 0.68 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.211 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.55 -67.43 0.13 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.346 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 121' ' ' TYR . 4.8 pt-20 -67.33 -50.05 61.6 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.359 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.498 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -36.23 -57.41 0.72 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.859 179.784 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 119' ' ' GLU . 51.9 mt-10 -53.15 -66.52 0.37 Allowed 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.171 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.453 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 14.8 mmm-85 -73.66 7.23 2.56 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.641 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.547 ' N ' ' O ' ' A' ' 117' ' ' GLU . 15.0 t80 -99.95 -17.65 17.46 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.203 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.646 ' C ' HD13 ' A' ' 123' ' ' ILE . . . -163.62 -28.32 0.02 OUTLIER Glycine 0 N--CA 1.484 1.841 0 C-N-CA 117.771 -2.156 . . . . 0.0 112.107 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.646 HD13 ' C ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -135.83 -101.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.362 -179.848 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.597 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 25.2 t70 -173.28 -163.97 0.21 Allowed 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.663 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.597 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 18.7 t-20 -72.17 -22.36 61.31 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.125 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -170.21 89.95 0.17 Allowed 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.8 t -168.05 14.05 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.968 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 128' ' ' ILE . 4.6 mt -68.98 -70.66 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.508 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 69.9 -135.01 0.06 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.819 -0.752 . . . . 0.0 112.338 179.881 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.421 ' CB ' ' H ' ' A' ' 101' ' ' PHE . 16.2 m -45.29 128.36 7.65 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.7 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.518 HG13 ' CD2' ' A' ' 95' ' ' PHE . 5.5 t -121.67 160.35 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.183 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.413 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -154.91 89.55 3.12 Favored Pre-proline 0 C--N 1.29 -1.981 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.784 179.913 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.22 121.54 10.09 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.091 1.194 . . . . 0.0 110.608 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.549 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 29.0 tt0 -90.96 -8.67 48.6 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.183 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.8 -32.68 0.02 OUTLIER Glycine 0 N--CA 1.494 2.502 0 C-N-CA 118.026 -2.035 . . . . 0.0 112.476 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.28 156.93 28.0 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.904 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.98 145.36 42.6 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.007 -1.077 . . . . 0.0 109.214 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.4 t -112.42 148.61 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.021 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.2 t -137.36 118.53 17.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.02 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.479 ' N ' HD12 ' A' ' 140' ' ' LEU . 11.2 mp -98.94 142.42 30.46 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.883 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.489 ' CB ' ' HA ' ' A' ' 146' ' ' PHE . 63.9 m-85 -120.02 134.46 55.24 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.402 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -65.88 -68.53 0.36 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.08 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -78.34 169.3 18.48 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.392 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 146' ' ' PHE . 11.1 p-10 -64.34 -160.99 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.014 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.645 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 24.6 m-20 42.66 21.03 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.938 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.645 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.4 OUTLIER 40.77 58.65 2.38 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.677 -179.91 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.6 t -148.09 149.32 31.83 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.335 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 108.43 -146.67 16.5 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -65.36 105.02 1.05 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.171 -1.011 . . . . 0.0 110.204 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.0 p -103.18 168.93 8.86 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.781 -0.767 . . . . 0.0 111.826 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 tt -139.37 81.14 21.09 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.139 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.24 108.37 0.58 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.961 1.774 . . . . 0.0 112.968 -179.692 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.7 87.25 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.294 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -58.33 -21.97 51.53 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.886 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 12.9 t -168.9 -141.59 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 117.979 -1.489 . . . . 0.0 112.895 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.8 OUTLIER -57.66 141.19 49.18 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.159 -179.811 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.55 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -162.24 61.12 1.17 Allowed Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.294 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.5 Cg_endo -65.31 19.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 122.222 1.948 . . . . 0.0 112.856 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.685 ' O ' HG23 ' A' ' 159' ' ' THR . 4.7 t -169.12 101.92 0.37 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.385 -1.326 . . . . 0.0 111.867 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 160' ' ' LEU . 94.5 mt -128.03 -48.9 1.34 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.646 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 51.06 -135.43 31.12 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.316 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.09 126.9 29.19 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.66 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 10.8 mmt -153.43 -80.71 0.09 Allowed 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.354 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 165' ' ' ASN . 30.2 p-10 -92.11 20.15 6.18 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.168 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 164' ' ' ASN . 0.3 OUTLIER 77.71 -47.24 0.48 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.787 -179.922 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -175.07 137.81 0.42 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.141 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.451 ' OG1' HD23 ' A' ' 140' ' ' LEU . 1.8 m -82.39 114.96 21.19 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.446 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 36.1 t -86.86 -47.51 8.97 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.104 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.19 165.96 23.89 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.152 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 38.1 pt -145.93 167.07 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 118.652 -1.219 . . . . 0.0 111.463 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -149.42 109.74 4.18 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.02 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mt -88.18 96.81 6.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.095 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 116.304 -1.808 . . . . 0.0 110.931 -179.973 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.581 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpp? . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.611 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -150.45 153.73 36.44 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.882 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 179.8 120.76 0.06 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.496 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.6 pt -67.72 146.73 12.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 118.723 -1.191 . . . . 0.0 110.263 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.9 m -123.96 117.57 25.09 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.186 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.492 ' O ' ' CB ' ' A' ' 16' ' ' GLN . 1.2 m -92.1 174.18 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.434 -0.906 . . . . 0.0 111.167 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 61.1 m-85 -135.98 146.67 47.48 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.231 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -75.02 -28.1 60.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.63 -0.828 . . . . 0.0 112.764 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.499 ' C ' ' OG ' ' A' ' 40' ' ' SER . 33.6 m120 -126.76 163.0 24.5 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.451 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.592 ' N ' ' OG ' ' A' ' 40' ' ' SER . 18.9 mm-40 -63.56 -163.57 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.928 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.613 ' C ' ' H ' ' A' ' 13' ' ' GLN . 8.7 m-20 40.5 39.59 0.75 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.852 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER 56.22 -5.86 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.327 179.991 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.613 ' H ' ' C ' ' A' ' 11' ' ' ASP . 21.9 mt-30 -73.84 174.33 8.63 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.296 -0.961 . . . . 0.0 110.745 179.918 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 86.21 129.87 2.54 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.339 -1.41 . . . . 0.0 111.027 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.9 OUTLIER -37.79 147.93 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.964 179.907 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.552 ' OE1' ' O ' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -119.91 162.1 19.73 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.724 -0.79 . . . . 0.0 112.286 -179.868 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.07 139.35 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.882 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -94.41 134.47 36.89 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.421 -179.937 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.9 mt -129.86 126.47 22.53 Favored Pre-proline 0 N--CA 1.496 1.851 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.202 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.21 164.37 28.22 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 121.053 1.169 . . . . 0.0 111.157 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.24 -172.25 0.14 Allowed 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 121.648 1.565 . . . . 0.0 111.14 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.492 ' N ' ' HB ' ' A' ' 84' ' ' VAL . . . 103.65 -166.38 15.88 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.356 179.987 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -130.93 132.41 45.07 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.069 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -148.12 -177.05 5.53 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.037 -179.955 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.577 ' CG2' ' CE2' ' A' ' 58' ' ' PHE . 20.3 p -141.26 -159.28 0.94 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.87 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -63.78 -24.23 67.68 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.061 -1.055 . . . . 0.0 110.361 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -61.03 -61.84 2.29 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.555 179.987 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -55.59 -44.14 76.66 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.543 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.686 HD23 HD12 ' A' ' 32' ' ' LEU . 23.1 mt -61.95 -32.84 73.31 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.789 -1.164 . . . . 0.0 109.633 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -55.8 -31.7 62.88 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 118.601 -1.24 . . . . 0.0 108.231 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.28 -37.28 69.06 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.38 179.883 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.686 HD12 HD23 ' A' ' 29' ' ' LEU . 15.3 mt -74.98 -77.07 0.13 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.471 179.887 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.09 -28.17 0.72 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.296 -1.43 . . . . 0.0 111.058 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.847 ' C ' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -87.69 133.3 30.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.748 -179.988 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 169.72 174.51 0.05 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.492 -179.905 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 3.6 t30 70.91 -28.84 0.18 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.117 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.547 ' H ' ' C ' ' A' ' 35' ' ' GLU . 16.1 m120 -160.17 -108.61 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.767 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.658 HG21 HG12 ' A' ' 34' ' ' ILE . 2.6 p 42.71 -134.98 0.4 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.572 179.943 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.921 HD12 HG11 ' A' ' 79' ' ' VAL . 1.9 mt 30.26 49.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.291 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.592 ' OG ' ' N ' ' A' ' 10' ' ' GLU . 44.1 t -61.11 -44.3 97.56 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.598 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.47 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -129.82 170.22 14.16 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.116 179.774 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -148.94 146.73 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 118.596 -1.242 . . . . 0.0 112.255 -179.838 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -136.67 102.59 4.96 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.897 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.4 t -120.98 106.16 39.37 Favored Pre-proline 0 N--CA 1.497 1.898 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.876 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -67.59 169.28 16.16 Favored 'Trans proline' 0 C--N 1.326 -0.633 0 C-N-CA 121.091 1.194 . . . . 0.0 110.458 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.03 -173.7 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.766 1.644 . . . . 0.0 110.683 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.25 -20.62 10.01 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 118.878 -1.629 . . . . 0.0 109.944 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.611 HG11 ' CB ' ' A' ' 2' ' ' ALA . 24.2 m -149.22 145.15 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.892 -179.963 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.4 tttt -120.97 152.46 38.51 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.604 179.841 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.92 147.81 30.12 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.896 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 63' ' ' ILE . 84.9 mt -122.88 120.46 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.021 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.007 HD23 HG23 ' A' ' 82' ' ' ILE . 6.5 mt -89.07 154.46 20.17 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.752 -179.8 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -130.51 111.77 12.58 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.887 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.28 -79.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.032 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.573 ' HB3' ' HB3' ' A' ' 59' ' ' ALA . 18.0 t-20 -59.16 139.06 57.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.089 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.99 170.65 0.17 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.917 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.24 33.16 86.49 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.425 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CE2' ' CG2' ' A' ' 25' ' ' THR . 19.4 m-85 53.74 65.11 1.61 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.931 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.573 ' HB3' ' HB3' ' A' ' 55' ' ' ASN . . . -144.65 -162.63 1.53 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.689 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.4 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 56.04 178.72 0.35 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.274 -1.441 . . . . 0.0 110.002 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -44.77 153.19 0.18 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.897 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -130.17 151.96 50.13 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.014 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.798 HG22 ' N ' ' A' ' 64' ' ' GLU . 51.1 mt -123.65 173.16 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.876 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.798 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -150.09 130.3 13.64 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.03 179.988 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.3 m -148.36 156.59 8.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 118.806 -1.158 . . . . 0.0 112.565 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 t -140.49 -5.7 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.536 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -128.7 -148.33 0.37 Allowed 'General case' 0 C--O 1.209 -1.07 0 CA-C-N 113.822 -1.536 . . . . 0.0 109.228 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.653 HD21 HG13 ' A' ' 106' ' ' VAL . 14.2 p-10 -99.57 120.44 39.66 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.038 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.53 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -90.84 96.44 10.64 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.218 179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -56.01 -86.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.973 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 13.8 mm-40 -67.61 -11.46 58.18 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.915 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.487 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 4.0 tp 75.54 -84.57 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.724 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.461 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 171.12 -169.48 42.51 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.202 -1.475 . . . . 0.0 110.629 -179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.499 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.0 Cg_endo -66.02 -50.45 1.59 Allowed 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.208 1.938 . . . . 0.0 112.299 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.995 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.9 pt? -72.53 33.45 0.06 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.026 -1.069 . . . . 0.0 111.503 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.499 ' H ' ' C ' ' A' ' 74' ' ' PRO . 1.8 t30 -76.63 -6.01 50.23 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.388 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.511 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 20.7 m120 -95.49 6.46 48.91 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.028 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -158.45 119.51 3.41 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.204 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.921 HG11 HD12 ' A' ' 39' ' ' ILE . 4.1 t -150.17 154.34 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 119.254 -0.979 . . . . 0.0 110.668 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.8 p -174.04 -41.92 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 118.981 -1.088 . . . . 0.0 111.549 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.3 t -99.0 141.49 31.69 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.556 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 1.007 HG23 HD23 ' A' ' 52' ' ' LEU . 13.4 mt -148.6 158.0 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.004 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.762 ' NH1' ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -135.61 135.15 40.01 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.3 -179.876 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.762 ' CA ' ' NH1' ' A' ' 83' ' ' ARG . 11.2 t -139.96 135.8 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.956 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.9 mt -140.08 129.48 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.665 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 53.1 m -43.1 151.94 0.13 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.487 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.409 HG22 ' HD2' ' A' ' 88' ' ' PRO . 1.1 t -151.44 150.22 26.26 Favored Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.647 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD2' HG22 ' A' ' 87' ' ' VAL . 3.4 Cg_exo -58.55 166.24 6.6 Favored 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.166 1.244 . . . . 0.0 111.263 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 89' ' ' VAL . 2.0 p -102.23 145.75 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.845 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -130.53 150.63 76.85 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.458 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.34 -22.18 70.05 Favored 'Trans proline' 0 C--O 1.209 -0.928 0 C-N-CA 121.347 1.365 . . . . 0.0 111.302 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.685 HH11 ' CB ' ' A' ' 107' ' ' ASP . 31.4 ptt180 38.29 -158.77 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.995 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.501 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.46 176.66 9.01 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.848 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -150.29 121.65 7.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.912 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 18.2 m-85 -96.58 170.09 9.45 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.952 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.87 155.92 47.0 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.709 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -88.34 154.84 20.07 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.86 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt 60.08 158.59 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.438 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -90.44 69.82 6.93 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.03 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 1.295 ' OE1' ' CE1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -174.26 34.88 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.417 179.999 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 1.295 ' CE1' ' OE1' ' A' ' 100' ' ' GLN . 42.1 p90 39.82 27.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.188 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 100' ' ' GLN . 32.0 t70 -127.53 117.55 22.29 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.947 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 137.57 140.98 4.14 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.991 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.0 OUTLIER -32.73 124.44 0.35 Allowed 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.273 179.987 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.624 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -100.75 158.79 15.7 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.771 -179.875 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.796 HG21 ' O ' ' A' ' 122' ' ' GLY . 18.1 t -118.99 168.32 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.497 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.685 ' CB ' HH11 ' A' ' 92' ' ' ARG . 5.8 p-10 -145.24 143.68 30.38 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.13 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.467 HD22 ' CD2' ' A' ' 121' ' ' TYR . 11.2 mt -140.45 137.34 17.54 Favored Pre-proline 0 N--CA 1.499 1.994 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.944 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.536 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 2.4 Cg_endo -65.68 169.82 12.29 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 C-N-CA 121.522 1.481 . . . . 0.0 111.902 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 1.8 Cg_endo -61.12 142.8 98.05 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.106 1.871 . . . . 0.0 111.468 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.02 -146.6 16.88 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.013 -1.565 . . . . 0.0 111.163 179.881 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.649 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 64.6 mt-30 -137.95 156.36 47.94 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.649 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 10.0 m-85 -145.0 142.97 30.25 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.91 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 114' ' ' THR . 0.7 OUTLIER -94.24 174.03 7.35 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.378 -179.789 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -61.26 -24.05 66.11 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.941 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.3 -45.68 8.89 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.209 -0.996 . . . . 0.0 112.026 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.463 ' O ' ' C ' ' A' ' 118' ' ' LEU . 8.6 tp10 -73.55 -65.21 0.85 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.707 -179.789 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.563 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -33.9 -68.62 0.11 Allowed 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.015 0.822 . . . . 0.0 110.547 179.961 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.507 ' N ' ' CD ' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -44.7 -68.37 0.2 Allowed 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.798 -179.95 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.524 ' HD3' ' H ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -75.07 20.89 0.13 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.159 -1.016 . . . . 0.0 113.249 -179.426 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.467 ' CD2' HD22 ' A' ' 108' ' ' LEU . 15.8 t80 -114.01 -21.0 10.79 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.952 179.848 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.796 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -166.46 -6.01 0.03 OUTLIER Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.318 -1.896 . . . . 0.0 110.764 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.475 ' C ' ' CG ' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -149.93 -134.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.605 -179.959 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.475 ' CG ' ' C ' ' A' ' 123' ' ' ILE . 0.7 OUTLIER -159.64 -173.36 4.09 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.615 179.909 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -58.49 109.51 0.8 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.442 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 128' ' ' ILE . 23.1 t30 63.2 -125.64 0.58 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.905 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 126' ' ' ASN . 10.0 t 39.78 24.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.868 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.491 ' N ' ' O ' ' A' ' 126' ' ' ASN . 3.5 mt -82.21 -71.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.611 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.428 ' OG ' ' C ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 69.91 -147.57 0.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.88 179.819 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 129' ' ' SER . 5.6 m -27.73 127.36 0.07 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.622 -179.862 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.3 t -121.87 136.89 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.843 179.823 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.28 86.69 29.88 Favored Pre-proline 0 C--N 1.302 -1.483 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.307 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.456 ' C ' ' H ' ' A' ' 135' ' ' GLY . 5.6 Cg_exo -59.0 101.49 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 121.105 1.204 . . . . 0.0 111.093 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.501 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 30.6 tp60 -56.63 -0.16 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.208 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . 172.3 -42.98 0.17 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 118.048 -2.025 . . . . 0.0 112.532 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.42 HD12 ' CA ' ' A' ' 92' ' ' ARG . 2.0 mt -92.2 -173.79 3.54 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.771 -1.171 . . . . 0.0 111.38 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.6 126.8 54.84 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 9.3 t -95.1 145.08 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.191 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.466 HG12 ' CZ ' ' A' ' 141' ' ' PHE . 96.2 t -129.77 110.29 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.13 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 140' ' ' LEU . 7.9 mp -89.29 138.26 31.59 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.376 -0.93 . . . . 0.0 113.03 -179.727 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' A' ' 146' ' ' PHE . 53.1 m-85 -120.8 136.23 54.95 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.7 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -73.97 0.12 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.278 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 -64.42 -174.96 0.14 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.201 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 146' ' ' PHE . 2.0 m-20 -84.77 -168.28 2.14 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.769 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.677 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 44.1 m-80 35.9 31.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.021 179.882 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.677 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.0 OUTLIER 58.47 52.93 6.61 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.46 179.981 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 10.3 t -119.59 171.7 8.19 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.333 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.498 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 73.91 -165.63 54.77 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.214 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.411 ' C ' ' CG2' ' A' ' 150' ' ' THR . 1.0 OUTLIER -59.8 170.54 1.11 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.395 179.947 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.411 ' CG2' ' C ' ' A' ' 149' ' ' ASP . 2.2 p -150.19 158.08 43.78 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.593 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.474 HD23 ' C ' ' A' ' 151' ' ' LEU . 2.1 tt -132.24 83.59 54.91 Favored Pre-proline 0 N--CA 1.483 1.214 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.346 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -63.18 104.42 0.41 Allowed 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 121.717 1.611 . . . . 0.0 112.761 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.33 78.77 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.986 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 154' ' ' ASN . 1.8 p-10 -83.64 27.98 0.59 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.394 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.427 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 19.0 t -170.28 -164.15 0.38 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.972 -1.091 . . . . 0.0 111.199 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.427 ' N ' ' OG ' ' A' ' 155' ' ' SER . 1.3 m-20 -79.94 154.89 27.99 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.15 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -165.1 69.98 1.37 Allowed Pre-proline 0 C--N 1.304 -1.391 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.904 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.8 Cg_endo -64.18 23.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.062 1.841 . . . . 0.0 112.579 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.562 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.3 OUTLIER -170.34 143.82 2.41 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.753 179.98 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.9 tp -163.92 -48.15 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.836 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 50.58 -163.59 0.88 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.541 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -58.9 105.19 0.29 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.678 -179.994 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -97.63 -79.01 0.47 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.56 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -91.1 -68.53 0.79 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.829 -179.955 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.448 ' OD1' ' ND2' ' A' ' 166' ' ' ASN . 6.3 t-20 -154.06 -53.36 0.1 Allowed 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.637 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.448 ' ND2' ' OD1' ' A' ' 165' ' ' ASN . 0.8 OUTLIER 175.4 113.66 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.449 -0.901 . . . . 0.0 110.874 -179.973 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.496 ' OG1' HD23 ' A' ' 140' ' ' LEU . 1.2 m -61.63 155.01 23.49 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.583 ' OG ' ' N ' ' A' ' 169' ' ' SER . 24.8 p -136.38 -53.73 0.73 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.164 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.583 ' N ' ' OG ' ' A' ' 168' ' ' SER . 20.7 p -127.58 149.98 49.92 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.213 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.516 HD12 ' CD1' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -140.72 -172.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.658 179.95 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.468 ' N ' HG12 ' A' ' 170' ' ' ILE . 43.7 ttt85 -155.05 106.7 2.65 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.062 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -75.38 94.16 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.008 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.305 -1.345 0 CA-C-O 116.326 -1.797 . . . . 0.0 110.754 -179.974 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.811 0.338 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.629 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -57.39 165.2 1.56 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.791 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.478 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 4.8 p30 -177.99 130.82 0.14 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.493 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.752 HG22 HG22 ' A' ' 44' ' ' VAL . 18.6 pt -78.49 160.01 4.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.909 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.3 m -134.99 119.41 17.93 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.476 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -103.36 172.03 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.975 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -133.4 148.81 51.83 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.726 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -37.07 84.59 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.5 -0.88 . . . . 0.0 112.991 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.454 ' C ' ' OG ' ' A' ' 40' ' ' SER . 2.3 m-20 -121.48 173.73 7.21 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.979 -179.893 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.446 ' N ' ' OG ' ' A' ' 40' ' ' SER . 15.6 pt-20 -70.35 -173.87 0.76 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.742 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.557 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 4.8 t70 49.64 48.0 22.05 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.655 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.557 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 54.4 p90 40.65 20.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.424 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 11' ' ' ASP . 12.9 tt0 -97.76 166.14 11.62 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.582 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 92.54 141.56 10.53 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.363 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' GLY . 1.1 tptp -33.97 144.66 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.769 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -110.03 156.42 20.54 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.556 -179.952 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.2 t -145.04 127.2 9.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.264 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -93.07 125.89 37.89 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.059 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.4 mt -119.21 125.09 27.8 Favored Pre-proline 0 N--CA 1.491 1.58 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.455 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.73 167.24 19.82 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 120.932 1.088 . . . . 0.0 111.098 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.8 170.4 10.14 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 121.636 1.558 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.474 ' H ' ' HB ' ' A' ' 84' ' ' VAL . . . 116.65 170.91 15.71 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 119.728 -1.225 . . . . 0.0 111.054 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.875 ' CB ' ' HE ' ' A' ' 83' ' ' ARG . 9.6 p-10 -97.78 128.87 44.72 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.862 ' N ' HH21 ' A' ' 83' ' ' ARG . 27.6 p90 -153.04 178.98 9.11 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.096 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.51 HG22 ' OG ' ' A' ' 81' ' ' SER . 1.5 p -151.1 -159.37 1.02 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.101 -179.809 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.425 ' H ' ' HB ' ' A' ' 25' ' ' THR . 72.0 ttt180 -57.99 -21.73 46.08 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.675 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.19 -69.48 0.29 Allowed 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.828 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 49.0 tt0 -56.83 -45.31 82.43 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.461 -1.296 . . . . 0.0 109.696 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.579 HD23 HD12 ' A' ' 32' ' ' LEU . 20.0 mt -55.92 -41.62 74.84 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.615 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.47 -31.68 56.24 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 118.128 -1.429 . . . . 0.0 108.49 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -72.27 -30.74 65.12 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.611 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.579 HD12 HD23 ' A' ' 29' ' ' LEU . 15.6 mt -79.54 -77.8 0.17 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.718 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.97 -28.21 0.08 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.127 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.469 ' HB ' HD22 ' A' ' 29' ' ' LEU . 6.9 mm -75.54 152.84 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 119.544 -0.863 . . . . 0.0 110.241 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 4.4 pt-20 -178.93 116.69 0.07 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 118.761 -1.175 . . . . 0.0 112.196 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 3.0 t30 68.2 -145.94 0.12 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.76 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.467 ' O ' HG23 ' A' ' 38' ' ' THR . 9.6 p-10 -49.22 95.55 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.394 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.584 ' O ' ' N ' ' A' ' 40' ' ' SER . 2.2 p -157.78 -61.55 0.09 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.653 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.471 ' O ' HG22 ' A' ' 39' ' ' ILE . 72.5 mt -56.72 79.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.979 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 38' ' ' THR . 43.6 t -81.47 -52.62 7.06 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.661 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.61 168.56 9.9 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.58 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -151.33 159.86 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 118.305 -1.358 . . . . 0.0 112.919 -179.89 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.449 ' N ' HG13 ' A' ' 42' ' ' VAL . 43.2 tttm -150.46 113.16 4.74 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.387 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.752 HG22 HG22 ' A' ' 4' ' ' ILE . 76.1 t -134.03 111.88 12.2 Favored Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 119.525 -0.87 . . . . 0.0 112.619 -179.689 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -69.57 169.97 17.44 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 121.145 1.23 . . . . 0.0 110.696 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.96 -175.12 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 121.989 1.793 . . . . 0.0 111.464 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.86 -14.27 10.93 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.569 -1.301 . . . . 0.0 110.622 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.629 HG11 ' CB ' ' A' ' 2' ' ' ALA . 23.2 m -147.46 139.46 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.156 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.457 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -116.76 155.37 29.03 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.639 179.999 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.457 ' N ' ' HG2' ' A' ' 49' ' ' LYS . . . -144.88 154.8 43.01 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.652 -1.219 . . . . 0.0 112.413 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 63' ' ' ILE . 4.1 mp -132.39 121.35 45.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.84 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.53 ' HA ' HG23 ' A' ' 82' ' ' ILE . 3.5 mp -93.95 154.72 17.53 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 118.936 -1.106 . . . . 0.0 112.536 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.426 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 54.0 m-85 -140.24 116.65 10.69 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -46.61 -88.87 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.904 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -59.59 144.0 48.83 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.178 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -54.21 175.64 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.631 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.435 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 63.96 32.62 84.78 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 119.22 -1.467 . . . . 0.0 109.959 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.573 ' H ' ' CB ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 48.64 35.95 6.96 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.678 -179.938 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.78 -163.29 0.97 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.423 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 56.06 -174.0 1.34 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.027 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 62' ' ' GLN . 18.1 t70 -54.47 174.42 0.06 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.697 -1.201 . . . . 0.0 109.949 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.436 ' N ' ' OD1' ' A' ' 61' ' ' ASP . 20.6 pt20 -147.96 161.86 40.49 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.052 -1.059 . . . . 0.0 111.282 -179.883 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.558 ' CG1' HD11 ' A' ' 75' ' ' LEU . 3.9 mt -137.05 160.87 36.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.905 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 64' ' ' GLU . 2.6 mp0 -135.53 127.55 29.68 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.281 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.509 HG12 ' CE1' ' A' ' 121' ' ' TYR . 22.9 m -144.83 162.94 13.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 118.737 -1.185 . . . . 0.0 112.787 -179.796 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.437 ' H ' ' H ' ' A' ' 67' ' ' ALA . 2.1 t -150.04 -7.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.011 -1.449 . . . . 0.0 107.642 179.819 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.437 ' H ' ' H ' ' A' ' 66' ' ' VAL . . . -121.29 -146.35 0.37 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.944 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.409 HD22 ' HG3' ' A' ' 43' ' ' LYS . 36.2 t-20 -101.03 134.55 43.86 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.109 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.466 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -114.89 101.82 9.4 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.046 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -65.27 -77.68 0.06 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.792 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -74.56 -9.77 58.9 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.529 -179.88 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.408 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 6.3 tp 64.98 -79.8 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.065 -179.925 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 172.0 -177.0 44.95 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.111 -1.519 . . . . 0.0 110.626 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.538 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.0 Cg_endo -64.08 -42.44 18.62 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.247 1.965 . . . . 0.0 111.884 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.843 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.0 pt? -70.99 21.51 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.181 -1.007 . . . . 0.0 111.113 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.538 ' H ' ' C ' ' A' ' 74' ' ' PRO . 35.4 p30 -75.79 5.02 6.86 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.652 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -88.85 -2.29 58.52 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.031 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -169.29 128.67 1.03 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.035 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.2 t -149.17 143.24 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.35 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.0 m -155.78 -40.93 0.08 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.22 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.573 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 3.4 m -96.16 136.31 36.8 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.132 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.53 HG23 ' HA ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -150.73 134.1 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 118.79 -1.164 . . . . 0.0 112.185 -179.94 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.875 ' HE ' ' CB ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -110.02 120.08 41.32 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.025 179.877 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.474 ' HB ' ' H ' ' A' ' 22' ' ' GLY . 6.7 t -122.17 130.65 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.514 179.911 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.4 HD13 ' O ' ' A' ' 84' ' ' VAL . 4.6 mm -141.01 130.22 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.665 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 p -48.65 142.1 6.44 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.084 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.597 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -134.47 142.43 42.77 Favored Pre-proline 0 N--CA 1.492 1.638 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.513 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.597 ' HD2' HG22 ' A' ' 87' ' ' VAL . 2.8 Cg_exo -53.62 129.81 35.76 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.133 1.222 . . . . 0.0 110.977 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 p -53.21 134.03 15.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.98 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -140.76 148.45 52.8 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.207 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.422 ' C ' HD11 ' A' ' 136' ' ' LEU . 1.6 Cg_endo -59.92 -167.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.104 1.203 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.412 ' CA ' HD12 ' A' ' 136' ' ' LEU . 24.8 ptt180 -172.88 -155.45 0.08 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.754 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.496 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.15 161.19 38.88 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.232 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -136.2 115.67 12.76 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.149 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 20.0 m-85 -100.29 150.54 22.45 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.897 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.454 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 39.4 m-85 -105.18 170.62 7.77 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.654 -0.819 . . . . 0.0 111.064 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.3 -57.55 2.57 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.919 -1.113 . . . . 0.0 111.988 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -83.06 154.2 24.52 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.377 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.604 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 30.3 tt0 -68.55 104.58 1.98 Allowed 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.03 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.604 ' CB ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 119.18 68.55 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.441 0 O-C-N 125.323 1.64 . . . . 0.0 110.918 179.755 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 101' ' ' PHE . 33.2 p90 29.63 55.61 0.14 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.318 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.523 ' CG ' ' N ' ' A' ' 103' ' ' GLY . 4.5 t70 -144.57 170.52 15.91 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.706 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.523 ' N ' ' CG ' ' A' ' 102' ' ' ASP . . . 78.93 145.15 2.94 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 118.886 -1.626 . . . . 0.0 109.881 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 103' ' ' GLY . 5.0 tmtt? -28.76 131.24 0.06 Allowed 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 121.195 0.522 . . . . 0.0 112.106 -179.816 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -95.7 157.34 15.94 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.311 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.765 HG21 ' O ' ' A' ' 122' ' ' GLY . 1.7 t -142.65 150.68 18.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.533 179.875 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 22.3 p-10 -130.9 159.28 37.86 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.806 -179.873 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.414 HD22 ' CD2' ' A' ' 121' ' ' TYR . 86.2 mt -141.77 151.18 59.22 Favored Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.144 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -78.96 167.37 22.14 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.976 1.784 . . . . 0.0 111.05 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.18 142.97 69.44 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 C-N-CA 121.4 1.4 . . . . 0.0 110.757 179.822 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.39 -157.23 26.06 Favored Glycine 0 N--CA 1.504 3.202 0 C-N-CA 119.021 -1.561 . . . . 0.0 111.572 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.504 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 49.7 mt-30 -116.12 158.79 22.67 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.141 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.504 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 79.2 m-85 -145.82 143.23 29.52 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.629 179.839 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.1 p -95.91 164.71 12.61 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.807 -179.718 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.412 ' NE2' ' O ' ' A' ' 115' ' ' GLN . 12.3 tm0? -58.97 -8.07 1.28 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.719 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.94 -48.68 3.56 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.347 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 118' ' ' LEU . 4.5 tp10 -70.34 -50.27 40.8 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.834 -179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.565 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -40.62 -72.83 0.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.368 -179.916 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -55.95 10.03 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.041 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.443 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.5 OUTLIER -73.81 15.11 0.31 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.54 -179.716 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.509 ' CE1' HG12 ' A' ' 65' ' ' VAL . 16.8 t80 -126.77 -10.36 6.11 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.355 179.822 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -140.78 -48.49 0.05 OUTLIER Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.208 -1.472 . . . . 0.0 110.218 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.566 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -144.58 -97.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.664 -179.937 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.566 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 3.0 t70 -171.78 175.72 3.86 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -66.28 134.88 53.56 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.31 -179.871 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 61.9 t30 52.24 94.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.602 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.7 t -174.01 -12.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.457 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 129' ' ' SER . 4.2 mm -73.53 163.27 4.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.17 -179.886 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.436 ' N ' HG22 ' A' ' 128' ' ' ILE . 29.9 t -169.83 -48.24 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.45 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.474 ' CB ' ' H ' ' A' ' 101' ' ' PHE . 49.7 m -122.93 127.61 49.15 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.044 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.443 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.5 t -120.54 159.63 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.569 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.58 79.31 8.05 Favored Pre-proline 0 C--N 1.296 -1.731 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.746 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -53.21 96.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.215 1.277 . . . . 0.0 110.703 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.496 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 58.2 tp60 -45.91 -23.74 0.32 Allowed 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.54 -1.209 . . . . 0.0 113.064 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.91 -31.88 0.02 OUTLIER Glycine 0 N--CA 1.494 2.515 0 C-N-CA 117.738 -2.172 . . . . 0.0 112.942 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.422 HD11 ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -98.66 179.4 4.69 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.659 -1.216 . . . . 0.0 111.161 -179.895 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -94.93 144.26 25.82 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.042 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 153' ' ' VAL . 7.5 t -115.54 147.97 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.849 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.485 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.3 t -136.53 129.3 45.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.897 179.842 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.485 HD12 ' C ' ' A' ' 139' ' ' VAL . 10.8 mp -105.64 138.7 41.4 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.369 -0.932 . . . . 0.0 113.174 -179.766 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 146' ' ' PHE . 18.0 m-85 -117.39 121.59 41.49 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.778 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -63.44 -68.29 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.165 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -73.2 165.55 24.84 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.376 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.512 ' C ' ' ND2' ' A' ' 145' ' ' ASN . 16.7 m-20 -64.37 -157.82 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.796 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.643 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 1.9 p30 32.0 35.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.216 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.643 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 2.0 p90 41.04 61.61 1.69 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.787 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 35.9 t -143.59 -176.22 4.87 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.121 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.531 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 75.87 -163.43 53.4 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.064 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 149' ' ' ASP . 1.4 m-20 -60.08 144.88 48.52 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.314 179.878 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.4 p -141.29 175.42 9.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.159 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.51 ' CD2' HD21 ' A' ' 160' ' ' LEU . 24.8 tp -152.78 95.05 3.08 Favored Pre-proline 0 C--N 1.305 -1.364 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.044 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.87 107.48 1.11 Allowed 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 121.385 1.39 . . . . 0.0 112.075 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 138' ' ' VAL . 47.0 t -79.08 91.28 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.145 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -44.33 -49.2 9.6 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.565 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.5 m -160.15 -133.9 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 118.728 -1.189 . . . . 0.0 111.923 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -48.05 137.61 10.17 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.119 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.536 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.36 63.96 1.13 Allowed Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.238 179.814 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.9 Cg_endo -67.08 24.83 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.126 1.884 . . . . 0.0 111.837 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.536 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.6 t -175.1 132.82 0.31 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.785 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.51 HD21 ' CD2' ' A' ' 151' ' ' LEU . 1.6 tp -165.23 -59.23 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.34 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 163' ' ' MET . . . 45.11 -152.31 0.72 Allowed Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.164 -1.493 . . . . 0.0 110.317 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 51.29 -91.09 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.647 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.669 ' C ' ' H ' ' A' ' 165' ' ' ASN . 32.8 tpp -59.43 -35.25 73.65 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.15 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 164' ' ' ASN . 1.6 m120 -58.41 7.87 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.817 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.669 ' H ' ' C ' ' A' ' 163' ' ' MET . 20.0 t30 -68.21 113.01 5.47 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.477 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.5 t30 64.14 60.69 0.97 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.633 179.813 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -70.32 119.22 14.17 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.743 -1.183 . . . . 0.0 109.269 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 72.4 m -89.08 -80.02 0.31 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.96 -179.819 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 p -108.87 160.75 15.74 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.225 -179.803 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 27.8 pt -139.67 173.18 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.729 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -152.47 110.16 3.61 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.2 mt -87.47 93.29 4.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.236 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 69.4 m . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 116.363 -1.78 . . . . 0.0 110.963 -179.971 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 tpt . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.868 0.366 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.91 123.46 28.87 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.149 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -159.98 123.99 3.72 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.429 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.403 HG22 HG22 ' A' ' 44' ' ' VAL . 40.3 pt -76.72 149.24 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.594 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.4 m -136.98 118.28 14.6 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.733 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.485 ' HB ' HG23 ' A' ' 39' ' ' ILE . 1.6 m -109.63 160.59 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.672 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.407 ' CE2' ' CD2' ' A' ' 12' ' ' PHE . 56.0 m-85 -115.98 162.06 17.94 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.304 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -87.44 3.8 45.74 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.638 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.483 ' N ' ' HB3' ' A' ' 40' ' ' SER . 15.2 m120 -147.27 168.25 22.22 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.502 -1.279 . . . . 0.0 111.809 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.74 177.14 1.72 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.224 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 13' ' ' GLN . 6.6 t70 56.2 39.56 30.25 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.893 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.574 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER 56.17 -3.43 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.137 179.957 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.596 ' H ' ' C ' ' A' ' 11' ' ' ASP . 45.9 tt0 -80.73 172.66 13.47 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.269 -0.973 . . . . 0.0 111.241 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.583 ' N ' ' CG ' ' A' ' 13' ' ' GLN . . . 100.55 141.93 12.51 Favored Glycine 0 N--CA 1.5 2.94 0 C-N-CA 119.877 -1.154 . . . . 0.0 110.548 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -33.41 140.56 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 120.191 -0.603 . . . . 0.0 111.432 179.96 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -98.5 157.9 15.93 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.392 -179.788 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.5 t -148.75 118.5 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.731 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -92.54 132.75 36.57 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.734 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -132.46 137.46 29.96 Favored Pre-proline 0 N--CA 1.49 1.56 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.909 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -72.1 166.27 30.15 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 120.843 1.029 . . . . 0.0 110.789 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.23 -163.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 121.628 1.552 . . . . 0.0 110.63 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.71 176.19 39.87 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.129 -1.51 . . . . 0.0 111.366 179.87 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.432 ' CB ' ' HG3' ' A' ' 83' ' ' ARG . 13.2 p-10 -107.75 132.66 53.13 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.496 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.705 ' OH ' HD12 ' A' ' 82' ' ' ILE . 35.7 p90 -154.7 -177.96 6.86 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.502 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.964 HG23 ' H ' ' A' ' 27' ' ' ALA . 8.3 t -151.95 -161.23 1.27 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.337 -179.721 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.533 ' N ' ' OG1' ' A' ' 25' ' ' THR . 0.1 OUTLIER -54.96 -15.5 2.06 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.065 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.964 ' H ' HG23 ' A' ' 25' ' ' THR . . . -69.23 -64.59 0.84 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.563 179.849 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.551 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 19.9 tt0 -57.83 -42.12 83.68 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 117.964 -1.495 . . . . 0.0 109.567 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.6 mt -63.68 -37.57 87.83 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.301 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 26' ' ' ARG . . . -56.26 -27.29 54.68 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 118.112 -1.435 . . . . 0.0 107.785 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -73.84 -36.21 64.88 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.95 179.795 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.6 mt -75.97 -70.51 0.43 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.512 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.21 -24.9 0.6 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.055 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.6 tt -80.44 156.61 4.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.546 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -147.82 -179.62 7.03 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.068 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 6.8 p-10 -47.95 169.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.795 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.642 ' H ' ' H ' ' A' ' 79' ' ' VAL . 2.8 t-20 78.25 -23.85 0.23 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.939 179.867 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 80.6 p -85.66 -139.66 0.08 Allowed 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.861 -1.135 . . . . 0.0 110.789 179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.485 HG23 ' HB ' ' A' ' 6' ' ' VAL . 43.5 mt 41.81 62.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.93 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.483 ' HB3' ' N ' ' A' ' 9' ' ' ASN . 32.4 t -62.32 -44.43 96.52 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.868 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -129.09 176.95 7.49 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.11 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -144.29 146.74 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 119.025 -1.07 . . . . 0.0 112.197 -179.966 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -132.79 118.65 19.28 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.753 179.829 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.403 HG22 HG22 ' A' ' 4' ' ' ILE . 69.7 t -146.55 107.82 4.1 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.049 -1.06 . . . . 0.0 112.293 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.418 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 2.0 Cg_endo -66.79 170.89 11.84 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 121.245 1.296 . . . . 0.0 110.719 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.418 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 2.9 Cg_endo -59.54 -167.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.851 1.7 . . . . 0.0 110.922 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.93 -9.71 23.14 Favored Glycine 0 N--CA 1.48 1.609 0 C-N-CA 118.905 -1.617 . . . . 0.0 110.915 179.798 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.67 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -155.72 151.87 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 118.279 -1.368 . . . . 0.0 112.407 179.972 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -117.92 125.28 50.17 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.883 179.794 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.53 158.26 17.72 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.807 -179.739 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.585 ' C ' HD12 ' A' ' 52' ' ' LEU . 51.9 mt -145.43 123.25 4.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.482 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.904 ' N ' HD12 ' A' ' 52' ' ' LEU . 2.4 mp -95.37 165.79 12.2 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.712 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -142.33 105.14 4.54 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.882 179.853 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -43.57 -84.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.775 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -58.9 133.57 56.15 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.502 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -54.47 171.82 0.11 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.423 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.25 29.93 71.83 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.205 -1.474 . . . . 0.0 110.06 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 53.66 63.22 2.28 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.031 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.13 -177.77 6.01 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.21 168.16 13.37 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.439 -1.363 . . . . 0.0 110.22 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -47.26 144.27 2.88 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.94 -1.104 . . . . 0.0 110.145 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -121.48 163.26 19.1 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.175 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.798 HD11 HD21 ' A' ' 75' ' ' LEU . 9.6 mm -125.26 174.46 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.5 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.709 ' N ' HG22 ' A' ' 63' ' ' ILE . 20.1 mt-10 -146.44 130.6 17.43 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.751 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.4 m -149.18 163.24 4.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.816 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.67 HG13 ' O ' ' A' ' 48' ' ' VAL . 3.3 t -146.76 -8.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.826 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.74 -147.2 0.39 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.103 179.768 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.484 ' ND2' ' H ' ' A' ' 68' ' ' ASN . 1.9 p30 -103.03 113.39 26.83 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.943 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.487 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.52 94.68 9.96 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.125 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -54.29 -63.08 1.27 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.141 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' A' ' 73' ' ' GLY . 6.5 tp10 -103.96 99.48 9.24 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.906 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 tp -52.34 -5.86 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.979 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 71' ' ' GLU . . . 78.34 -149.09 33.39 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 118.94 -1.6 . . . . 0.0 110.464 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 76' ' ' ASN . 3.4 Cg_exo -63.53 -151.68 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 121.505 1.47 . . . . 0.0 111.658 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.798 HD21 HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER 30.34 35.04 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 123.964 0.79 . . . . 0.0 112.06 -179.942 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 74' ' ' PRO . 13.5 t-20 -89.31 -3.93 58.31 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.286 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -93.03 3.92 54.9 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.964 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.451 ' HA ' ' H ' ' A' ' 37' ' ' ASN . 17.1 t-20 -162.53 109.67 1.28 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.743 -1.183 . . . . 0.0 111.444 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.642 ' H ' ' H ' ' A' ' 37' ' ' ASN . 7.1 t -147.96 92.82 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.149 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.8 t -121.07 -33.24 3.76 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.547 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.0 m -92.31 136.29 33.32 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.739 -1.185 . . . . 0.0 110.9 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.705 HD12 ' OH ' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -150.98 158.8 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 118.262 -1.375 . . . . 0.0 111.656 -179.857 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.794 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.45 140.11 23.65 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.637 -179.922 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.794 ' CA ' HH12 ' A' ' 83' ' ' ARG . 16.1 t -144.99 146.38 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.684 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.552 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 1.5 mt -144.58 135.47 20.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.492 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.4 m -44.74 161.5 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.899 -0.721 . . . . 0.0 111.544 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.533 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -162.01 140.58 7.03 Favored Pre-proline 0 N--CA 1.483 1.18 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.209 -179.986 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.533 ' HD2' HG22 ' A' ' 87' ' ' VAL . 12.5 Cg_exo -47.38 139.53 16.71 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.116 1.211 . . . . 0.0 110.775 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.574 HG22 ' N ' ' A' ' 90' ' ' GLN . 3.8 p -74.99 160.79 5.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.661 -0.816 . . . . 0.0 112.353 -179.839 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.574 ' N ' HG22 ' A' ' 89' ' ' VAL . 23.1 mp0 -141.06 154.87 68.6 Favored Pre-proline 0 N--CA 1.49 1.534 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.405 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.428 ' HG2' HD21 ' A' ' 136' ' ' LEU . 1.9 Cg_endo -64.3 -45.37 9.75 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 121.47 1.447 . . . . 0.0 111.739 179.829 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.493 ' H ' HD11 ' A' ' 136' ' ' LEU . 9.9 mtm180 64.7 -160.73 0.29 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.265 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.527 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.96 172.77 12.25 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.65 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -142.49 121.38 12.77 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.544 -1.262 . . . . 0.0 112.547 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -103.57 162.77 12.77 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.774 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -124.59 163.73 21.32 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.528 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.57 -77.41 0.22 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.149 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.483 ' C ' ' OG ' ' A' ' 129' ' ' SER . 34.3 mmtt -66.09 154.41 39.67 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.737 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.627 ' C ' ' HG2' ' A' ' 100' ' ' GLN . 29.0 tt0 -81.71 86.69 6.38 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.118 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.627 ' HG2' ' C ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 163.56 35.68 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.297 -179.946 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.7 t80 56.13 42.38 28.33 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 119.634 -0.827 . . . . 0.0 110.488 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 103' ' ' GLY . 25.1 t0 -143.14 178.36 7.76 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.565 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 81.58 139.24 2.73 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.157 -1.496 . . . . 0.0 109.724 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 103' ' ' GLY . 1.1 mppt? -28.63 132.91 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.729 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -97.8 159.33 14.99 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.106 -179.8 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 53.4 t -144.3 116.05 2.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.115 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -104.72 154.73 19.62 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.413 -179.704 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.9 mt -139.64 138.13 19.67 Favored Pre-proline 0 N--CA 1.492 1.675 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.436 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.72 168.77 12.66 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 121.237 1.291 . . . . 0.0 110.998 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.08 150.31 87.04 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.655 1.57 . . . . 0.0 111.06 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.04 -155.04 24.24 Favored Glycine 0 N--CA 1.498 2.817 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.969 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.601 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 6.6 tt0 -133.48 158.35 43.31 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.699 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.601 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 30.2 m-85 -142.51 155.1 45.0 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.185 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.2 p -102.91 -175.38 2.79 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.017 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.446 ' N ' ' OE1' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -88.1 53.89 2.9 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.686 179.977 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -152.12 -65.88 0.17 Allowed 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.593 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -72.61 -50.18 27.08 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.343 -0.943 . . . . 0.0 109.467 179.963 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.564 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -33.81 -71.73 0.06 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.897 179.962 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.535 ' OE2' ' CZ ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -52.27 -57.63 9.14 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.103 179.923 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' CZ ' ' OE2' ' A' ' 119' ' ' GLU . 3.3 mpt_? -76.36 23.07 0.15 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.92 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.564 ' N ' ' O ' ' A' ' 117' ' ' GLU . 24.7 t80 -127.11 -17.06 4.9 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.659 179.993 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.06 -42.6 0.03 OUTLIER Glycine 0 N--CA 1.482 1.705 0 C-N-CA 118.74 -1.695 . . . . 0.0 111.118 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.574 HG13 HD11 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -135.8 -105.7 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.225 -179.93 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 18.6 t70 -171.72 -168.45 0.59 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.77 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.491 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 52.9 p-10 -86.03 35.14 0.63 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.45 -179.9 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.405 ' C ' HG22 ' A' ' 127' ' ' THR . 5.5 p30 -166.48 -155.0 0.19 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.532 -1.267 . . . . 0.0 112.133 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.571 ' OG1' ' N ' ' A' ' 128' ' ' ILE . 2.6 t 40.31 -125.96 0.44 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.267 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.574 HD11 HG13 ' A' ' 123' ' ' ILE . 98.2 mt 60.67 118.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 CA-C-O 121.041 0.448 . . . . 0.0 111.209 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.483 ' OG ' ' C ' ' A' ' 98' ' ' LYS . 59.2 p -160.99 140.85 10.84 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.419 -0.913 . . . . 0.0 111.124 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 67.92 113.16 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.965 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.0 t -120.27 149.85 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.732 -179.795 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.547 ' NZ ' ' OD2' ' A' ' 156' ' ' ASP . 13.1 tptp -142.4 93.66 7.03 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.793 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 135' ' ' GLY . 4.1 Cg_exo -59.37 99.75 0.12 Allowed 'Trans proline' 0 C--N 1.32 -0.942 0 C-N-CA 120.959 1.106 . . . . 0.0 111.474 -179.799 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.527 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 37.5 tt0 -47.43 -14.23 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.074 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 133' ' ' PRO . . . 175.56 -34.02 0.09 OUTLIER Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.467 -1.825 . . . . 0.0 111.936 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.493 HD11 ' H ' ' A' ' 92' ' ' ARG . 2.2 mt -93.13 -173.82 3.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.664 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.22 144.15 36.06 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.746 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.5 t -112.8 143.56 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.962 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.4 ' C ' HD12 ' A' ' 140' ' ' LEU . 91.3 t -135.39 122.3 34.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.91 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 140' ' ' LEU . 10.1 mp -99.75 144.79 28.41 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.761 -179.802 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.492 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 21.9 m-85 -120.47 129.47 53.87 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.101 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -73.72 -63.15 1.27 Allowed 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.144 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -71.32 170.95 12.05 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.608 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 146' ' ' PHE . 47.7 m-20 -67.73 -161.41 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.254 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.641 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 2.2 p30 28.96 38.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.371 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.641 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 41.69 61.51 1.85 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.982 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.52 -167.7 2.32 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.353 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 65.02 -160.4 42.44 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.706 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.404 ' OD2' ' ND2' ' A' ' 164' ' ' ASN . 21.5 t70 -59.55 158.72 9.37 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.301 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.4 p -148.55 170.69 17.51 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.979 -1.088 . . . . 0.0 111.818 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 151' ' ' LEU . 23.4 tp -138.9 85.0 16.79 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.315 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -61.74 105.77 0.39 Allowed 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.922 1.748 . . . . 0.0 113.049 -179.85 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.467 ' C ' ' H ' ' A' ' 155' ' ' SER . 2.0 t -95.09 57.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.758 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -70.54 32.85 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.819 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 153' ' ' VAL . 21.0 p -170.65 -169.06 0.75 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.705 -1.198 . . . . 0.0 111.605 180.0 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.547 ' OD2' ' NZ ' ' A' ' 132' ' ' LYS . 1.3 m-20 -75.86 153.23 36.93 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.556 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.532 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -168.65 72.17 0.79 Allowed Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.935 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.93 24.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.057 1.838 . . . . 0.0 112.385 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.9 OUTLIER -170.61 68.23 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.633 179.925 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.8 tp -80.76 -64.19 1.24 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 77.59 -176.75 53.45 Favored Glycine 0 N--CA 1.485 1.905 0 C-N-CA 119.136 -1.507 . . . . 0.0 109.863 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -83.1 120.67 26.06 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.791 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.445 ' HG2' ' H ' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -89.03 -76.68 0.4 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.371 -0.932 . . . . 0.0 109.858 -179.98 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.445 ' H ' ' HG2' ' A' ' 163' ' ' MET . 74.9 m-20 -91.48 -64.12 1.16 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.318 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -172.17 96.99 0.16 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.545 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 52.14 -165.06 0.06 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.731 -0.787 . . . . 0.0 111.274 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.7 124.31 20.96 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.949 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 169' ' ' SER . 57.3 p -86.18 -68.58 0.73 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.697 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.426 ' N ' ' OG ' ' A' ' 168' ' ' SER . 2.0 p -119.44 161.93 19.7 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.416 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 29.0 pt -141.01 171.59 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.199 -1.001 . . . . 0.0 111.649 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -153.21 110.92 3.56 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.76 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -89.17 92.92 4.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.107 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 116.313 -1.803 . . . . 0.0 111.088 -179.904 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.56 178.63 3.1 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.792 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 0.3 OUTLIER 179.77 130.8 0.09 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.489 -179.906 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.665 HG22 HG22 ' A' ' 44' ' ' VAL . 2.9 pt -82.53 128.75 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.585 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.7 m -100.22 113.32 25.91 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.561 -0.856 . . . . 0.0 108.74 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.518 HG11 HD11 ' A' ' 19' ' ' LEU . 1.5 m -96.83 160.06 2.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.196 -1.002 . . . . 0.0 113.436 -179.688 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' A' ' 12' ' ' PHE . 87.9 m-85 -118.46 144.86 45.69 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.754 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -58.05 3.59 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.634 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 87.8 m-20 -85.52 -176.41 6.07 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.614 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -75.99 176.73 7.64 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.343 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.582 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 1.5 m-20 48.68 56.61 7.37 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.695 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 55.8 p90 40.19 20.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.23 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 11' ' ' ASP . 2.5 tp-100 -98.31 164.37 12.33 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.874 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.634 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 94.18 148.27 23.61 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.802 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.567 ' HE3' ' H ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -29.09 137.74 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.882 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.434 ' H ' ' HG3' ' A' ' 16' ' ' GLN . 1.3 pp0? -104.63 152.26 22.67 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.424 -179.889 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.1 t -149.42 138.79 15.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.884 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 1.1 m-20 -99.78 134.86 42.07 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.245 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.518 HD11 HG11 ' A' ' 6' ' ' VAL . 6.4 mt -123.89 122.57 26.3 Favored Pre-proline 0 N--CA 1.496 1.851 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.263 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.33 161.76 39.24 Favored 'Trans proline' 0 C--O 1.217 -0.533 0 C-N-CA 121.022 1.148 . . . . 0.0 111.247 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.54 -166.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.889 0 C-N-CA 121.602 1.534 . . . . 0.0 110.738 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.465 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 92.77 -163.59 27.18 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.989 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.496 ' HB3' HH11 ' A' ' 83' ' ' ARG . 16.7 p-10 -117.96 133.22 56.13 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.432 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.614 ' CE2' HD12 ' A' ' 82' ' ' ILE . 6.1 p90 -154.78 177.65 11.02 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.404 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.422 HG22 ' OG ' ' A' ' 81' ' ' SER . 14.3 p -149.51 -150.12 0.33 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.415 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.5 mtm-85 -62.82 -36.66 83.91 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.301 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -56.79 -61.51 2.38 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.44 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.449 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.7 tp60 -56.02 -47.67 77.37 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.325 -1.35 . . . . 0.0 109.367 -179.902 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 29' ' ' LEU . 90.1 mt -57.87 -33.49 68.74 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.39 179.839 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -54.0 -33.02 55.99 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.86 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -70.4 -36.09 73.85 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.18 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.401 HD12 HD23 ' A' ' 29' ' ' LEU . 11.9 mt -78.48 -75.26 0.23 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.727 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 163.7 -29.47 0.24 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 118.898 -1.62 . . . . 0.0 111.244 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -73.99 166.12 2.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.761 179.971 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.898 ' H ' HG21 ' A' ' 38' ' ' THR . 0.2 OUTLIER 174.66 103.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.403 179.946 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.804 ' O ' HG23 ' A' ' 38' ' ' THR . 12.2 t30 69.23 140.61 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.401 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 1.6 p-10 37.39 21.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.39 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.898 HG21 ' H ' ' A' ' 35' ' ' GLU . 40.9 p -93.95 -48.06 6.43 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.542 -1.263 . . . . 0.0 110.963 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 mt -62.6 74.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.148 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' THR . 26.8 t -72.06 -49.82 33.44 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.122 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.34 163.98 28.79 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.246 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.137 HG22 ' HB3' ' A' ' 69' ' ' ALA . 25.1 m -148.94 167.82 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 C-N-CA 118.194 -1.402 . . . . 0.0 113.295 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -139.76 97.96 3.37 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 113.671 -1.604 . . . . 0.0 107.981 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.665 HG22 HG22 ' A' ' 4' ' ' ILE . 44.5 t -116.46 109.54 43.83 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.797 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.83 169.11 16.9 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 121.227 1.284 . . . . 0.0 110.507 179.726 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.02 -172.44 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.708 1.605 . . . . 0.0 110.368 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.36 -15.37 35.02 Favored Glycine 0 C--N 1.3 -1.428 0 C-N-CA 118.654 -1.736 . . . . 0.0 110.486 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.722 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -148.53 151.76 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.951 179.938 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -127.17 126.23 42.5 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.869 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.16 160.34 17.02 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.873 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.524 ' C ' HD12 ' A' ' 52' ' ' LEU . 62.4 mt -139.92 121.48 15.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.726 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.826 ' N ' HD12 ' A' ' 52' ' ' LEU . 1.8 mp -90.17 159.8 16.57 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.927 -1.109 . . . . 0.0 112.584 -179.697 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -144.73 106.33 4.26 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.863 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -44.47 -81.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.298 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -58.87 138.2 57.43 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.544 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -54.92 173.39 0.09 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.439 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.31 27.69 72.72 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.184 -1.484 . . . . 0.0 110.156 -179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 55.13 67.91 0.94 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.8 -165.52 2.28 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.235 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.72 -170.01 14.35 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.021 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -51.34 167.89 0.08 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.818 -1.153 . . . . 0.0 109.805 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -147.03 162.71 38.24 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.477 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.93 HD11 HD21 ' A' ' 75' ' ' LEU . 32.1 mt -142.23 173.61 7.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.944 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.736 ' H ' HG22 ' A' ' 63' ' ' ILE . 2.0 tm-20 -146.44 129.71 16.66 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.778 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.536 ' N ' ' OE2' ' A' ' 64' ' ' GLU . 32.2 m -145.64 158.02 12.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 118.629 -1.229 . . . . 0.0 112.465 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' ' 48' ' ' VAL . 3.8 t -146.61 -7.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-N 114.312 -1.313 . . . . 0.0 107.783 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.418 ' H ' ' H ' ' A' ' 66' ' ' VAL . . . -117.13 -151.15 0.47 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.557 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -97.09 122.81 40.51 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.455 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.137 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -89.81 113.46 25.03 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.1 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.465 ' C ' ' CD ' ' A' ' 70' ' ' GLU . 4.1 tp10 -72.33 -70.84 0.32 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.582 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.441 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 12.1 tt0 -96.69 -0.2 48.72 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.223 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.4 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 2.5 tp 69.74 -88.26 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.042 -0.663 . . . . 0.0 112.17 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.4 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 179.33 -162.08 28.61 Favored Glycine 0 N--CA 1.499 2.885 0 C-N-CA 118.99 -1.576 . . . . 0.0 111.086 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.46 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.2 Cg_endo -66.88 -49.84 1.34 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.168 1.912 . . . . 0.0 112.159 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.043 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.7 pt? -74.65 33.52 0.09 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.419 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.46 ' H ' ' C ' ' A' ' 74' ' ' PRO . 21.8 p30 -70.28 -23.89 62.95 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.276 -0.97 . . . . 0.0 110.548 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -80.84 14.43 2.19 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.902 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -168.51 108.48 0.51 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.364 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.5 t -146.44 106.07 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.132 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.7 t -124.73 -44.66 1.94 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.679 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.422 ' OG ' HG22 ' A' ' 25' ' ' THR . 3.4 m -94.5 138.86 31.9 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.597 -179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.614 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -146.94 152.03 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 119.069 -1.053 . . . . 0.0 111.873 -179.971 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.854 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -130.09 123.24 29.97 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.272 -179.908 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.854 ' H ' HH12 ' A' ' 83' ' ' ARG . 13.3 t -136.01 137.75 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.59 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.54 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 1.4 mt -145.52 142.96 22.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.784 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.4 p -43.99 160.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.809 -0.756 . . . . 0.0 111.746 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -159.09 148.74 14.89 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.128 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -57.64 157.71 22.35 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.045 1.163 . . . . 0.0 110.067 179.735 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.567 HG12 ' N ' ' A' ' 90' ' ' GLN . 86.8 t -78.85 159.73 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.722 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.567 ' N ' HG12 ' A' ' 89' ' ' VAL . 30.0 mt-30 -143.41 145.63 32.71 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.607 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.4 ' HG2' HD21 ' A' ' 136' ' ' LEU . 3.6 Cg_exo -65.3 -48.94 2.92 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 121.377 1.385 . . . . 0.0 111.854 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.515 ' H ' HD11 ' A' ' 136' ' ' LEU . 0.0 OUTLIER 64.81 -156.02 0.29 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.939 179.984 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.525 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -141.73 178.13 7.69 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.717 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -142.08 113.31 7.6 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.931 -1.107 . . . . 0.0 111.412 -179.852 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.682 ' CD2' HG13 ' A' ' 131' ' ' VAL . 96.8 m-85 -106.53 146.63 30.38 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.471 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -95.69 171.87 8.4 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.386 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.48 -66.86 0.87 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.889 -179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -86.47 147.28 26.05 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.488 -0.885 . . . . 0.0 112.442 -179.778 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.585 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 5.8 tm-20 -71.51 101.43 2.45 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.262 -179.907 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.585 ' CB ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 135.7 53.09 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.059 0 O-C-N 125.099 1.499 . . . . 0.0 109.94 179.891 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.504 ' O ' ' CG ' ' A' ' 101' ' ' PHE . 58.8 t80 43.12 52.54 5.43 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.689 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 103' ' ' GLY . 3.2 t70 -145.38 158.35 43.85 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.062 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.524 ' N ' ' OD1' ' A' ' 102' ' ' ASP . . . 85.16 133.29 2.85 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.87 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 103' ' ' GLY . 8.6 mtpm? -35.17 146.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.178 0.513 . . . . 0.0 111.813 -179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -90.96 164.28 14.05 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.215 -179.885 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.0 t -145.79 112.49 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.941 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -89.99 159.64 16.78 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.264 -0.975 . . . . 0.0 112.576 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.9 mt -143.93 131.39 10.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.986 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -66.82 168.66 16.38 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 121.36 1.374 . . . . 0.0 111.441 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.2 145.19 88.58 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 121.557 1.505 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.4 -171.87 24.1 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.137 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.596 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 16.7 tm0? -109.18 159.89 16.55 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.596 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 52.9 m-85 -146.18 148.66 32.77 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.441 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.6 p -102.25 170.99 7.74 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.423 -179.849 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -60.29 -8.92 2.88 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.604 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.38 -52.17 3.07 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 119.314 -0.954 . . . . 0.0 113.437 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 121' ' ' TYR . 23.9 mt-10 -72.79 -53.07 12.53 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.3 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.569 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -36.61 -67.48 0.17 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.807 0.813 . . . . 0.0 110.593 179.906 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 28.2 mp0 -52.35 -60.86 2.72 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.13 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.475 ' HD3' ' H ' ' A' ' 120' ' ' ARG . 4.9 mpt_? -72.13 4.89 3.13 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.792 -179.634 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 117' ' ' GLU . 14.3 t80 -105.34 -16.28 14.8 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.973 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -151.36 -36.36 0.03 OUTLIER Glycine 0 N--CA 1.487 2.063 0 C-N-CA 117.684 -2.198 . . . . 0.0 112.141 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.99 -102.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.979 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 176.42 -173.91 0.1 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.975 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.505 ' C ' ' CG ' ' A' ' 126' ' ' ASN . 4.6 t-20 -58.55 125.87 25.22 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.594 -1.243 . . . . 0.0 110.281 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.599 ' C ' HG23 ' A' ' 127' ' ' THR . 0.3 OUTLIER 74.34 -139.02 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.967 -179.893 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.635 ' OG1' ' N ' ' A' ' 128' ' ' ILE . 1.4 p 59.28 -137.95 0.76 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.586 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.635 ' N ' ' OG1' ' A' ' 127' ' ' THR . 39.4 mt 59.37 -74.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.763 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 130' ' ' SER . 60.3 p 47.71 -123.41 1.55 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.239 -0.585 . . . . 0.0 112.335 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.552 ' N ' ' OG ' ' A' ' 129' ' ' SER . 0.8 OUTLIER -41.88 126.68 3.19 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.004 -179.847 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.682 HG13 ' CD2' ' A' ' 95' ' ' PHE . 6.8 t -122.42 156.71 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.262 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.404 ' N ' HG12 ' A' ' 131' ' ' VAL . 1.5 ttmp? -150.39 84.46 5.65 Favored Pre-proline 0 C--N 1.296 -1.749 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.998 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.47 103.8 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.985 1.79 . . . . 0.0 111.706 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.525 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 52.1 tp60 -49.25 -30.6 7.41 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.215 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -169.91 -26.31 0.02 OUTLIER Glycine 0 N--CA 1.494 2.503 0 C-N-CA 118.407 -1.854 . . . . 0.0 112.322 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.515 HD11 ' H ' ' A' ' 92' ' ' ARG . 1.4 mt -96.57 165.02 12.36 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.492 -1.283 . . . . 0.0 110.425 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.86 143.72 26.44 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.464 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.3 t -110.05 148.49 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.654 -0.819 . . . . 0.0 112.616 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.497 ' C ' HD12 ' A' ' 140' ' ' LEU . 46.8 t -137.37 125.54 32.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.926 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 139' ' ' VAL . 8.8 mp -102.32 144.84 30.31 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.707 -179.745 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -117.75 131.38 56.61 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.544 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.543 ' NZ ' ' OD1' ' A' ' 143' ' ' ASN . 26.3 ttpp -67.85 -79.24 0.05 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.554 -179.739 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.543 ' OD1' ' NZ ' ' A' ' 142' ' ' LYS . 7.9 m-20 -51.92 166.03 0.17 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.19 -179.884 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -46.82 -100.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.893 -1.048 . . . . 0.0 113.264 -179.879 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.606 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 5.8 m120 -73.18 75.65 1.28 Allowed 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.578 -179.854 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.606 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.2 p90 34.22 72.47 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.358 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.401 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 61.0 m -141.5 64.67 1.4 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.719 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 171.77 -148.59 11.06 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.294 -1.432 . . . . 0.0 110.35 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -75.53 168.49 19.91 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.293 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.3 p -146.98 155.39 42.22 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.616 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.427 ' HA ' HD12 ' A' ' 151' ' ' LEU . 35.4 tp -123.79 90.93 50.21 Favored Pre-proline 0 N--CA 1.488 1.468 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.59 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.11 108.02 0.89 Allowed 'Trans proline' 0 C--N 1.321 -0.875 0 C-N-CA 121.738 1.625 . . . . 0.0 112.855 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 45.5 t -84.88 88.16 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.452 179.877 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.494 ' C ' ' OG ' ' A' ' 155' ' ' SER . 18.8 p-10 -52.28 -33.82 43.77 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.792 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.494 ' OG ' ' C ' ' A' ' 154' ' ' ASN . 0.8 OUTLIER -163.82 -130.93 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 117.867 -1.533 . . . . 0.0 113.232 -179.699 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -59.73 153.4 20.45 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.299 -179.83 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.603 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -176.06 69.91 0.25 Allowed Pre-proline 0 N--CA 1.48 1.061 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.657 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.76 20.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.039 1.826 . . . . 0.0 112.184 -179.847 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.603 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -176.38 117.42 0.13 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.285 179.935 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.1 tp -148.96 -63.97 0.23 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.214 -179.84 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 74.41 -173.81 50.89 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.2 -1.476 . . . . 0.0 109.606 -179.861 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.28 108.08 10.15 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.094 -1.042 . . . . 0.0 110.718 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 28.5 mmm -77.8 -56.18 4.71 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.788 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -81.72 -63.24 1.43 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.456 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -157.76 -59.57 0.08 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.685 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -161.93 127.83 3.61 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.412 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 m -68.48 105.93 2.37 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.754 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 28.6 m -87.74 -64.26 1.18 Allowed 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.218 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 p -115.63 163.62 15.53 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.011 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.418 HG12 ' CD1' ' A' ' 118' ' ' LEU . 30.1 pt -142.74 177.19 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.934 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -156.56 111.08 2.78 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.325 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.3 mt -90.19 98.03 7.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.314 -0.955 . . . . 0.0 110.385 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 C--N 1.306 -1.31 0 CA-C-O 116.393 -1.765 . . . . 0.0 110.957 -179.99 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 mmm . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.605 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -75.06 146.13 41.77 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.369 -0.933 . . . . 0.0 111.171 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 2' ' ' ALA . 45.6 m-80 -163.34 117.69 1.63 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.348 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.8 pt -70.31 149.79 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.532 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.2 m -128.86 116.04 18.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.581 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 m -93.6 171.04 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 C-N-CA 119.526 -0.869 . . . . 0.0 110.78 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.637 ' CE2' ' OE1' ' A' ' 16' ' ' GLN . 31.5 m-85 -133.83 154.21 51.18 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.73 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -83.77 -45.08 13.73 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.278 -0.969 . . . . 0.0 113.152 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.534 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 82.4 m-20 -97.66 -175.69 3.26 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.54 -179.864 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.86 -178.14 7.0 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.54 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.614 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 0.9 OUTLIER 47.43 57.29 5.99 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.623 -179.946 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.614 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 48.3 p90 39.14 25.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.66 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 11' ' ' ASP . 46.9 tt0 -104.18 170.01 8.16 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.247 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.534 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 88.36 136.21 5.36 Favored Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.633 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 14' ' ' GLY . 25.8 mmtm -32.01 139.5 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.439 180.0 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.637 ' OE1' ' CE2' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -115.27 170.07 8.66 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.805 -179.883 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 76.7 t -141.63 133.93 28.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.334 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -93.91 119.26 32.59 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.192 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.9 mt -116.6 138.25 24.34 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.376 179.895 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -72.11 164.94 34.11 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 120.973 1.116 . . . . 0.0 111.027 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.19 -162.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 121.691 1.594 . . . . 0.0 110.761 179.827 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.525 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 88.54 -178.95 46.02 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.098 -1.525 . . . . 0.0 111.164 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.615 ' N ' HH21 ' A' ' 83' ' ' ARG . 13.2 p-10 -109.99 137.47 47.71 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.818 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.638 ' CE2' HD12 ' A' ' 82' ' ' ILE . 4.8 p90 -156.12 178.05 10.73 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.36 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.481 ' HB ' ' H ' ' A' ' 26' ' ' ARG . 1.3 p -151.25 -153.09 0.47 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.801 -179.801 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.481 ' H ' ' HB ' ' A' ' 25' ' ' THR . 35.0 ptt85 -58.61 -20.86 51.03 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.931 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.67 -64.11 0.92 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.244 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.513 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 31.1 tt0 -58.38 -45.36 88.44 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.244 -1.383 . . . . 0.0 109.695 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 29' ' ' LEU . 27.8 mt -61.93 -35.25 77.84 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.576 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' ARG . . . -59.5 -25.41 64.43 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 118.098 -1.441 . . . . 0.0 107.879 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -76.85 -36.35 56.87 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.69 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.5 mt -76.23 -76.72 0.15 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.741 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.42 -26.94 0.87 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.684 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.883 ' C ' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -88.14 139.01 18.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.842 180.0 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.721 ' N ' HD13 ' A' ' 34' ' ' ILE . 2.9 pt-20 174.02 168.73 0.21 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.515 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' C ' ' H ' ' A' ' 38' ' ' THR . 1.7 t-20 80.91 -145.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 120.147 -0.621 . . . . 0.0 112.654 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -53.24 6.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.988 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 35' ' ' GLU . 71.4 p -72.6 -149.05 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.358 -1.337 . . . . 0.0 110.75 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 38' ' ' THR . 2.8 mt 42.12 58.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.899 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t -72.92 -50.04 25.94 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.917 -179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.434 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -119.27 176.62 5.24 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.763 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -154.43 148.22 13.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 C-N-CA 117.856 -1.538 . . . . 0.0 112.813 -179.95 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -136.6 109.88 7.85 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.513 -1.222 . . . . 0.0 108.607 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.2 t -132.54 110.86 13.66 Favored Pre-proline 0 N--CA 1.495 1.803 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.322 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.13 167.96 20.43 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.007 1.138 . . . . 0.0 110.726 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.483 ' CG ' HH21 ' A' ' 92' ' ' ARG . 1.6 Cg_endo -62.18 -168.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.781 1.654 . . . . 0.0 111.326 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.89 -17.47 9.13 Favored Glycine 0 N--CA 1.482 1.73 0 C-N-CA 119.365 -1.397 . . . . 0.0 110.854 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.605 HG11 ' CB ' ' A' ' 2' ' ' ALA . 27.3 m -148.59 140.35 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.825 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -104.82 127.14 52.52 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.49 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.57 149.19 28.32 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.539 -0.864 . . . . 0.0 112.283 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.8 mt -139.87 114.58 7.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.569 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.502 ' HA ' HG23 ' A' ' 82' ' ' ILE . 3.6 mp -94.11 164.95 12.86 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.942 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -140.46 116.37 10.37 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.006 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -49.22 -84.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.363 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 59' ' ' ALA . 14.9 t-20 -59.01 141.26 54.42 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.521 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -60.92 -169.87 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.318 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.81 31.97 32.34 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.137 -1.506 . . . . 0.0 110.005 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.429 ' CE1' ' HG3' ' A' ' 83' ' ' ARG . 25.3 m-85 51.29 65.59 1.44 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.087 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 55' ' ' ASN . . . -144.06 -174.14 4.19 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.171 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.67 177.9 15.39 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.037 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -50.89 170.72 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.212 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -143.58 133.03 23.41 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.058 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.549 HG22 ' N ' ' A' ' 64' ' ' GLU . 6.5 mm -98.91 167.64 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.097 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.549 ' N ' HG22 ' A' ' 63' ' ' ILE . 51.5 mt-10 -145.29 129.16 17.35 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.163 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -149.24 164.52 4.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 118.598 -1.241 . . . . 0.0 112.609 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.33 -11.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 114.372 -1.285 . . . . 0.0 107.69 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -119.69 -152.19 0.5 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.144 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -101.51 122.57 44.05 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.886 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.531 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.53 121.85 32.13 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.723 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -74.33 -83.67 0.05 Allowed 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.328 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -77.32 -0.25 24.84 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.962 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.4 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 5.8 tp 59.24 -97.47 0.07 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.717 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.4 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -173.43 -174.83 40.73 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 118.893 -1.622 . . . . 0.0 111.117 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.595 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.4 Cg_endo -66.9 -34.04 31.25 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.688 2.259 . . . . 0.0 112.587 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.752 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.0 pt? -67.91 24.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.457 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.595 ' H ' ' C ' ' A' ' 74' ' ' PRO . 4.3 t30 -74.73 -6.35 48.35 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.201 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' ND2' ' A' ' 78' ' ' ASN . 4.6 t-20 -74.54 -25.11 59.11 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.992 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 31.9 m120 -158.14 132.03 7.9 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.384 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t -147.81 138.52 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.843 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.9 m -162.53 -34.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.44 -1.304 . . . . 0.0 112.831 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.5 m -95.7 138.81 32.83 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.023 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.638 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -150.02 159.86 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 118.581 -1.248 . . . . 0.0 112.497 -179.869 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.846 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -149.94 116.84 5.92 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.417 -179.977 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.846 ' H ' HH22 ' A' ' 83' ' ' ARG . 14.1 t -120.63 139.54 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.438 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.77 HD11 HH11 ' A' ' 83' ' ' ARG . 1.4 mp -138.72 129.25 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.562 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 p -40.5 152.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.989 -0.685 . . . . 0.0 111.609 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.565 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -154.47 141.25 13.26 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.266 179.989 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.565 ' HD2' HG22 ' A' ' 87' ' ' VAL . 4.8 Cg_exo -52.37 132.55 45.05 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.168 1.246 . . . . 0.0 111.28 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.589 HG22 ' N ' ' A' ' 90' ' ' GLN . 4.0 p -59.13 163.96 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.639 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.589 ' N ' HG22 ' A' ' 89' ' ' VAL . 82.5 mm-40 -145.21 148.08 36.63 Favored Pre-proline 0 N--CA 1.487 1.387 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.045 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.64 -20.12 67.63 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 121.503 1.469 . . . . 0.0 111.846 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.483 HH21 ' CG ' ' A' ' 46' ' ' PRO . 20.3 ptt180 38.07 -158.31 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.463 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -147.87 172.76 13.65 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.61 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -141.21 115.48 9.37 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.865 -1.134 . . . . 0.0 112.087 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.42 ' CD2' HG13 ' A' ' 131' ' ' VAL . 66.7 m-85 -99.97 159.17 15.29 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.634 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 101' ' ' PHE . 26.0 m-85 -109.83 179.66 4.06 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.267 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.29 -66.97 0.91 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.438 -0.905 . . . . 0.0 112.755 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.513 ' CG ' ' N ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -87.49 163.05 16.91 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.918 0.866 . . . . 0.0 113.083 -179.735 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 13.6 tp10 -62.25 108.86 1.16 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.703 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 102' ' ' ASP . 3.6 mt-30 96.66 61.54 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.934 0 O-C-N 124.725 1.265 . . . . 0.0 111.113 179.895 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' A' ' 101' ' ' PHE . 9.1 p90 29.4 33.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.422 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 100' ' ' GLN . 23.8 t70 -96.93 32.85 2.01 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.754 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -161.2 144.48 9.88 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 103' ' ' GLY . 15.7 tptm -34.5 144.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.929 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.468 ' OE1' ' C ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -99.14 164.99 11.93 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.712 -0.795 . . . . 0.0 112.806 -179.803 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.417 HG11 ' CA ' ' A' ' 122' ' ' GLY . 7.0 t -140.28 118.57 10.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.495 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -93.83 163.08 13.66 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.535 -179.673 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 108' ' ' LEU . 94.2 mt -144.08 144.44 26.27 Favored Pre-proline 0 N--CA 1.486 1.339 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.632 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.21 163.48 32.6 Favored 'Trans proline' 0 C--O 1.213 -0.771 0 C-N-CA 121.708 1.605 . . . . 0.0 111.095 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.68 142.73 95.24 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 121.452 1.435 . . . . 0.0 110.892 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.87 -157.13 26.97 Favored Glycine 0 N--CA 1.501 3.026 0 C-N-CA 118.758 -1.687 . . . . 0.0 111.522 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.66 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 46.1 tt0 -128.26 157.27 41.37 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.518 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.66 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 13.4 m-85 -142.43 155.99 45.15 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.799 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.4 p -99.61 176.47 5.47 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -179.674 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.531 ' NE2' ' OD2' ' A' ' 144' ' ' ASP . 20.9 pt20 -73.42 37.63 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.866 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.32 -56.3 0.08 Allowed 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.615 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.11 -42.61 75.86 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.163 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.617 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -45.25 -74.1 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.159 179.912 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.69 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 0.1 OUTLIER -50.69 -55.45 16.48 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.011 -1.076 . . . . 0.0 112.796 -179.63 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -10.59 6.45 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.319 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -100.04 -8.08 24.25 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.471 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.58 ' C ' HD13 ' A' ' 123' ' ' ILE . . . -152.0 -62.08 0.01 OUTLIER Glycine 0 N--CA 1.484 1.887 0 C-N-CA 118.498 -1.81 . . . . 0.0 111.989 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 1.062 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -140.63 127.82 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.968 -179.746 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 126' ' ' ASN . 36.9 t70 -39.48 161.41 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.84 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -58.29 13.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.105 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.637 ' O ' HG23 ' A' ' 127' ' ' THR . 1.6 p-10 -167.7 77.99 0.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.552 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 126' ' ' ASN . 1.1 p -163.66 -15.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.37 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -64.68 160.4 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.143 -179.854 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.4 t -170.38 -87.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.55 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 m -81.93 138.02 35.07 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.487 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.42 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.1 t -121.14 156.84 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.509 0.671 . . . . 0.0 111.703 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -154.02 79.06 5.23 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.963 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.78 102.42 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.533 1.489 . . . . 0.0 110.834 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.463 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 5.1 mm100 -51.55 -12.92 0.19 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.089 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 178.76 -34.86 0.08 OUTLIER Glycine 0 N--CA 1.49 2.278 0 C-N-CA 117.93 -2.081 . . . . 0.0 112.579 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.452 HD12 ' CA ' ' A' ' 92' ' ' ARG . 6.4 mt -87.35 171.87 10.27 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.185 -1.406 . . . . 0.0 111.824 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -95.16 123.21 38.53 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.41 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 153' ' ' VAL . 8.8 t -94.44 133.05 36.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.627 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.488 ' C ' HD12 ' A' ' 140' ' ' LEU . 62.0 t -124.2 132.13 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.48 179.805 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 139' ' ' VAL . 9.9 mp -107.31 134.13 50.83 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.435 -179.783 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.431 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 25.8 m-85 -110.59 122.06 46.83 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.105 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -55.4 -84.19 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.988 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.447 HD21 ' HB3' ' A' ' 147' ' ' SER . 26.2 p-10 -71.91 173.58 8.13 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.193 179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.531 ' OD2' ' NE2' ' A' ' 115' ' ' GLN . 2.3 m-20 -65.29 -153.35 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.175 -179.893 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.635 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 71.7 m-20 41.91 22.61 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.288 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.635 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.5 p90 40.08 57.12 2.44 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.154 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.447 ' HB3' HD21 ' A' ' 143' ' ' ASN . 8.4 t -138.66 -151.05 0.36 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.605 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 54.88 -166.02 2.87 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.377 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.5 157.14 11.87 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.88 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 p -148.12 174.68 11.71 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.568 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.3 mt -138.32 85.09 18.76 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.444 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -64.1 97.53 0.24 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 121.766 1.644 . . . . 0.0 112.387 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 138' ' ' VAL . 2.1 t -77.78 92.99 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.857 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -62.41 -21.49 65.42 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.808 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 52.3 p -169.84 -150.19 0.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 117.852 -1.539 . . . . 0.0 112.862 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -43.78 150.26 0.26 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.779 -179.818 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.554 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -171.8 65.07 0.39 Allowed Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.902 179.841 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.3 Cg_endo -61.95 19.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.267 1.978 . . . . 0.0 113.14 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.554 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER 178.67 111.76 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.053 179.873 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 13.5 mt -141.35 -42.97 0.37 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.467 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 74.37 -174.39 50.15 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.318 -1.42 . . . . 0.0 110.16 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.79 145.22 40.88 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.674 -179.963 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 2.4 tpt -88.62 -76.52 0.4 Allowed 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.483 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -91.6 -41.86 10.53 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.79 179.845 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.65 -32.85 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.152 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 176.24 134.23 0.05 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.802 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.37 131.12 45.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.504 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 169' ' ' SER . 97.0 p -93.69 -67.31 0.86 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.945 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.52 ' N ' ' OG ' ' A' ' 168' ' ' SER . 1.8 p -113.99 162.55 16.28 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.982 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.43 HG12 ' CD1' ' A' ' 118' ' ' LEU . 23.9 pt -143.01 175.73 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 118.735 -1.186 . . . . 0.0 112.037 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.403 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 3.2 ttp85 -154.51 109.18 3.04 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.477 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 172' ' ' ILE . 9.4 mt -89.6 92.8 4.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.574 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 116.325 -1.798 . . . . 0.0 110.944 179.996 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.812 0.339 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -179.53 131.4 0.1 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.166 -1.013 . . . . 0.0 110.699 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.7 pt -73.44 153.22 7.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.453 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.0 m -130.44 116.43 18.23 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.886 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 m -96.67 172.08 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.515 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.971 ' CE2' ' NE2' ' A' ' 16' ' ' GLN . 16.1 m-85 -130.72 134.85 47.26 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.878 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -59.28 5.5 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.214 -0.995 . . . . 0.0 112.777 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.624 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 1.9 m120 -89.03 167.04 13.48 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.478 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.556 ' CG ' ' H ' ' A' ' 11' ' ' ASP . 16.4 tt0 -77.16 -178.23 4.94 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.918 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.556 ' H ' ' CG ' ' A' ' 10' ' ' GLU . 4.7 t0 60.77 43.64 11.95 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.61 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.414 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 35.8 t80 49.3 15.47 0.12 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.497 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.503 ' CG ' ' N ' ' A' ' 14' ' ' GLY . 8.1 tt0 -103.02 168.93 8.87 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.833 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.624 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 89.53 124.49 2.56 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.816 -1.183 . . . . 0.0 111.143 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 14' ' ' GLY . 7.2 mmmm -29.95 137.76 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 123.921 0.424 . . . . 0.0 111.643 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.971 ' NE2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -103.51 170.92 7.66 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.678 -0.809 . . . . 0.0 112.087 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.6 t -142.03 134.41 27.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.804 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -92.98 117.16 29.75 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.578 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.1 mt -113.03 132.99 22.12 Favored Pre-proline 0 N--CA 1.492 1.625 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.075 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.11 160.64 43.72 Favored 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 120.94 1.093 . . . . 0.0 111.208 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.85 -159.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 121.615 1.543 . . . . 0.0 111.017 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.437 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 84.32 176.36 51.06 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.318 -1.42 . . . . 0.0 111.001 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.646 ' CA ' HH21 ' A' ' 83' ' ' ARG . 1.4 p30 -103.3 135.92 44.04 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.543 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.822 ' OH ' HD12 ' A' ' 82' ' ' ILE . 51.6 p90 -158.31 -174.61 4.89 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.119 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.842 HG23 ' N ' ' A' ' 26' ' ' ARG . 5.4 t -161.03 -150.02 0.19 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.396 -1.321 . . . . 0.0 112.297 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.842 ' N ' HG23 ' A' ' 25' ' ' THR . 11.9 ttt-85 -56.79 -31.04 64.27 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.253 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.612 ' H ' HG23 ' A' ' 25' ' ' THR . . . -60.99 -63.35 1.33 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.569 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.55 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 14.9 tp60 -57.48 -44.28 84.78 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.485 -1.286 . . . . 0.0 109.822 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.503 ' HA ' HD23 ' A' ' 29' ' ' LEU . 27.6 mt -58.78 -37.6 76.66 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.71 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.35 -33.71 44.19 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 118.537 -1.265 . . . . 0.0 107.762 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -66.44 -40.84 89.71 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.375 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.491 HD12 HD23 ' A' ' 29' ' ' LEU . 14.3 mt -72.81 -80.84 0.06 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.79 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 32' ' ' LEU . . . 161.58 -29.18 0.29 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.841 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.441 HD13 HG21 ' A' ' 34' ' ' ILE . 9.8 tt -82.64 151.13 4.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.724 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 4.3 pt-20 -179.93 146.25 0.24 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.552 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 4.0 t30 74.61 -143.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.065 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.548 HD22 ' N ' ' A' ' 37' ' ' ASN . 1.3 m-80 -58.79 82.08 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.612 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 40' ' ' SER . 43.4 p -149.33 -46.36 0.14 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.226 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mt -68.45 71.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.623 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 38' ' ' THR . 33.5 t -75.31 -72.1 0.32 Allowed 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.403 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.446 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -95.64 167.43 11.3 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.965 -1.094 . . . . 0.0 109.626 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.32 154.37 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 118.786 -1.166 . . . . 0.0 112.394 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -145.1 104.01 3.92 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.75 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.6 t -126.5 111.26 23.14 Favored Pre-proline 0 N--CA 1.496 1.842 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.63 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.37 168.21 18.48 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 121.081 1.187 . . . . 0.0 110.808 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.93 -170.22 0.1 OUTLIER 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 121.843 1.695 . . . . 0.0 110.971 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.85 -12.04 31.46 Favored Glycine 0 N--CA 1.48 1.614 0 C-N-CA 118.829 -1.653 . . . . 0.0 109.627 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.611 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -155.87 149.47 11.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.448 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.09 127.2 51.41 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.616 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.61 157.02 17.47 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.359 -0.936 . . . . 0.0 113.096 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.49 ' C ' HD12 ' A' ' 52' ' ' LEU . 60.3 mt -136.11 115.41 16.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.453 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.941 HD12 ' N ' ' A' ' 52' ' ' LEU . 2.1 mp -89.97 161.22 16.0 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.857 -1.137 . . . . 0.0 112.763 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.506 ' OH ' ' NE2' ' A' ' 62' ' ' GLN . 5.5 m-85 -140.58 109.95 6.25 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.782 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.687 HE21 ' ND2' ' A' ' 55' ' ' ASN . 11.7 tt0 -43.52 -87.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.035 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.687 ' ND2' HE21 ' A' ' 54' ' ' GLN . 3.3 m120 -59.92 145.45 45.85 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.093 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.19 -174.92 0.06 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.518 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.84 26.7 58.25 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.178 -1.487 . . . . 0.0 110.025 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 55.31 65.03 1.59 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.51 175.35 10.63 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.439 -0.905 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.25 168.0 32.07 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.257 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -49.3 129.17 18.09 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.348 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.506 ' NE2' ' OH ' ' A' ' 53' ' ' TYR . 1.4 pt20 -101.0 179.04 4.5 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.119 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.808 HD11 HD11 ' A' ' 75' ' ' LEU . 4.7 mt -144.04 169.01 10.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.404 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.49 ' H ' HG22 ' A' ' 63' ' ' ILE . 38.7 tt0 -145.09 128.62 17.04 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.955 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.41 HG13 ' C ' ' A' ' 64' ' ' GLU . 18.7 m -149.31 167.14 3.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.902 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 48' ' ' VAL . 2.6 t -146.64 -2.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.527 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.549 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -126.42 -154.11 0.61 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.882 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.435 HD21 HG13 ' A' ' 106' ' ' VAL . 0.8 OUTLIER -96.05 155.18 16.86 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.566 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.42 87.06 2.35 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.225 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -51.9 -43.15 63.23 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.346 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 72' ' ' LEU . 5.5 mm-40 -123.88 81.19 1.88 Allowed 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.586 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.464 HD22 HD22 ' A' ' 76' ' ' ASN . 1.2 tp -28.96 -81.22 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.702 0.626 . . . . 0.0 112.545 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.31 -165.92 36.63 Favored Glycine 0 N--CA 1.497 2.701 0 C-N-CA 118.901 -1.618 . . . . 0.0 111.09 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.459 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.8 Cg_endo -67.37 -44.21 5.02 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 122.148 1.899 . . . . 0.0 112.055 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.808 HD11 HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -69.74 10.45 0.38 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.059 -1.056 . . . . 0.0 111.289 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.474 HD21 ' HA ' ' A' ' 40' ' ' SER . 20.4 t-20 -70.13 1.45 4.7 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.61 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -74.7 -5.2 41.85 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.712 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -167.3 124.42 1.2 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.295 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.4 t -145.97 140.24 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.67 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 m -159.7 -31.92 0.06 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.092 -1.043 . . . . 0.0 112.292 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.49 ' HG ' ' HG1' ' A' ' 25' ' ' THR . 3.0 m -103.86 142.93 33.54 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.439 -0.905 . . . . 0.0 111.339 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.822 HD12 ' OH ' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -149.15 162.2 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.73 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.851 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -146.06 116.38 7.49 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.396 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.851 ' H ' HH22 ' A' ' 83' ' ' ARG . 10.2 t -119.3 137.77 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 120.056 -0.657 . . . . 0.0 111.636 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.588 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 4.5 mt -139.13 126.67 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.51 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.5 p -40.54 154.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.585 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.491 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.9 OUTLIER -150.93 146.79 19.65 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.65 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.491 ' HD2' HG22 ' A' ' 87' ' ' VAL . 5.0 Cg_exo -51.18 159.35 2.82 Favored 'Trans proline' 0 C--N 1.325 -0.7 0 C-N-CA 121.805 1.67 . . . . 0.0 112.164 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 89' ' ' VAL . 33.8 m -69.67 134.68 29.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.326 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -140.25 124.58 10.85 Favored Pre-proline 0 N--CA 1.489 1.488 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.113 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -59.79 -164.11 0.03 OUTLIER 'Trans proline' 0 C--O 1.21 -0.912 0 C-N-CA 120.758 0.972 . . . . 0.0 110.516 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.4 ' CA ' HD12 ' A' ' 136' ' ' LEU . 20.8 ptt-85 -177.48 -160.29 0.05 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.913 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.435 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -138.81 154.25 48.45 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.92 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -123.94 122.26 37.49 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.812 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 24.8 m-85 -108.71 151.41 26.22 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.041 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.405 ' CD2' ' HA ' ' A' ' 101' ' ' PHE . 31.3 m-85 -118.53 159.06 24.22 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.927 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.45 ' HB2' ' N ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -78.68 -83.29 0.09 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 118.162 -1.415 . . . . 0.0 111.781 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.677 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 4.6 mmmm -56.07 157.87 4.33 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.6 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 29.2 tt0 -79.62 86.62 5.23 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.524 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.952 HE21 ' C ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 162.77 48.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.625 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 24.7 p90 39.96 41.06 0.82 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.102 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.602 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 43.1 m-20 -142.75 -174.46 4.17 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.635 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.484 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 75.89 161.77 11.18 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 118.92 -1.609 . . . . 0.0 109.498 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 103' ' ' GLY . 7.3 mtpm? -27.58 122.82 0.1 Allowed 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 121.244 0.545 . . . . 0.0 112.09 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 105' ' ' GLU . 0.7 OUTLIER -102.09 137.21 40.66 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.572 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.836 HG21 ' O ' ' A' ' 122' ' ' GLY . 3.0 t -138.73 151.57 24.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.021 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -143.66 151.15 39.74 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.098 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.8 mt -139.25 143.81 37.88 Favored Pre-proline 0 N--CA 1.497 1.876 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.617 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 6.4 Cg_endo -71.23 170.17 18.9 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 121.724 1.616 . . . . 0.0 111.052 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.407 ' HA ' ' CG2' ' A' ' 172' ' ' ILE . 3.7 Cg_exo -60.44 141.55 95.83 Favored 'Trans proline' 0 C--N 1.321 -0.921 0 C-N-CA 121.728 1.619 . . . . 0.0 110.972 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.649 ' C ' ' NE2' ' A' ' 112' ' ' GLN . . . 150.2 -153.78 25.27 Favored Glycine 0 N--CA 1.497 2.759 0 C-N-CA 118.675 -1.726 . . . . 0.0 111.49 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.649 ' NE2' ' C ' ' A' ' 111' ' ' GLY . 11.7 mp0 -131.36 148.16 52.64 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.614 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.631 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 3.3 m-85 -139.63 157.15 46.27 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.606 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.4 p -119.0 -175.46 2.91 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -77.88 47.78 0.66 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.216 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.41 -56.47 0.09 Allowed 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.329 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.482 ' HG2' ' N ' ' A' ' 118' ' ' LEU . 1.7 tt0 -76.77 -58.0 3.53 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.543 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -36.99 -69.5 0.11 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.74 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.45 ' OE1' ' ND2' ' A' ' 125' ' ' ASN . 0.6 OUTLIER -49.57 -63.12 1.2 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.166 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.435 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 0.1 OUTLIER -75.86 24.18 0.13 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.284 -0.966 . . . . 0.0 112.575 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.461 ' CG ' ' O ' ' A' ' 121' ' ' TYR . 33.7 t80 -131.81 -9.16 3.53 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.368 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.836 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -150.28 -46.94 0.02 OUTLIER Glycine 0 C--N 1.29 -1.998 0 C-N-CA 118.87 -1.633 . . . . 0.0 110.526 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.455 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -141.18 -98.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.281 -0.967 . . . . 0.0 110.66 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.455 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 7.4 t0 -168.37 -166.2 0.67 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.729 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.45 ' ND2' ' OE1' ' A' ' 119' ' ' GLU . 10.0 m120 -59.75 -6.79 1.32 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.134 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.464 ' CG ' ' H ' ' A' ' 127' ' ' THR . 44.5 t30 -172.09 -134.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.189 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.464 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 0.5 OUTLIER 36.56 69.07 0.22 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.203 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.5 ' O ' ' CB ' ' A' ' 129' ' ' SER . 8.0 mm -102.25 -86.68 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.388 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 84.83 -166.54 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' SER . 10.9 m -17.98 120.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.7 -1.591 . . . . 0.0 114.703 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.76 149.83 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.544 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -143.82 95.69 5.71 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 119.536 -0.865 . . . . 0.0 110.863 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -53.78 112.46 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.16 1.24 . . . . 0.0 111.099 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.435 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 44.6 tp60 -79.46 -17.27 54.59 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.84 -32.68 0.02 OUTLIER Glycine 0 N--CA 1.488 2.158 0 C-N-CA 118.752 -1.689 . . . . 0.0 111.93 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.4 HD12 ' CA ' ' A' ' 92' ' ' ARG . 0.4 OUTLIER -121.26 156.38 32.61 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.155 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.29 153.43 39.37 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 118.863 -1.135 . . . . 0.0 110.077 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.9 140.21 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.859 -0.736 . . . . 0.0 112.046 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.93 127.19 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.231 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 mp -105.79 148.95 26.92 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 119.396 -0.922 . . . . 0.0 113.211 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' A' ' 141' ' ' PHE . 2.4 m-85 -121.34 146.34 46.95 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.754 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -107.86 43.08 1.24 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.302 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -169.91 156.28 6.11 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.856 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 146' ' ' PHE . 32.0 t70 -57.75 175.83 0.17 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.298 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.642 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 8.0 p-10 34.59 32.44 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.964 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.642 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.3 p90 40.72 64.8 0.89 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.198 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.505 ' CB ' ' ND2' ' A' ' 145' ' ' ASN . 25.6 t -144.19 97.05 2.98 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.865 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.96 -156.79 28.03 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -60.21 157.62 13.01 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.963 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.5 p -150.14 170.94 17.73 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.984 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.471 ' C ' HD23 ' A' ' 151' ' ' LEU . 1.2 tt -142.44 91.33 7.69 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.035 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.32 107.37 1.57 Allowed 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.945 1.764 . . . . 0.0 113.598 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.6 t -84.12 89.15 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.089 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.62 HD22 ' C ' ' A' ' 154' ' ' ASN . 0.4 OUTLIER -80.73 11.58 3.76 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.4 p -170.04 -171.81 1.22 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.62 -1.632 . . . . 0.0 113.136 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -58.1 148.37 26.76 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.028 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.599 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -166.53 74.85 1.15 Allowed Pre-proline 0 C--N 1.304 -1.378 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.954 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.78 21.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.734 1.623 . . . . 0.0 111.999 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.599 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.4 OUTLIER -169.42 112.68 0.51 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.795 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.0 tp -146.64 17.95 1.3 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.195 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 C-N-CA 119.241 -1.457 . . . . 0.0 110.299 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.826 0.346 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 13.1 m -76.14 98.28 4.34 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.955 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 9.1 m -82.82 -40.1 20.82 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.72 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.49 159.83 41.7 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.619 -1.233 . . . . 0.0 111.139 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.414 HG12 ' CD1' ' A' ' 118' ' ' LEU . 15.5 pt -140.64 163.02 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.22 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -145.07 102.39 3.75 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.025 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.407 ' CG2' ' HA ' ' A' ' 110' ' ' PRO . 4.9 mt -81.63 100.66 5.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.439 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.896 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.523 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.843 0.354 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 2.0 p-10 -172.66 105.66 0.16 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.111 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.582 HG22 HG22 ' A' ' 44' ' ' VAL . 28.6 pt -72.09 156.75 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.622 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -139.75 126.91 21.13 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.818 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -107.28 179.0 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 119.848 -0.741 . . . . 0.0 112.412 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.769 ' CZ ' ' CE1' ' A' ' 12' ' ' PHE . 32.5 m-85 -132.47 144.7 50.64 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.112 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.94 -46.97 27.07 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.551 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 2.4 m-80 -89.33 162.63 15.72 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.296 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.504 ' C ' ' CG ' ' A' ' 11' ' ' ASP . 12.8 mt-10 -72.94 158.48 35.39 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.245 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.1 OUTLIER 76.02 44.73 0.13 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.612 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.769 ' CE1' ' CZ ' ' A' ' 7' ' ' PHE . 70.2 t80 52.78 10.88 0.17 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.631 -0.828 . . . . 0.0 112.079 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.447 ' HG3' ' H ' ' A' ' 14' ' ' GLY . 1.6 tp60 -99.72 171.41 7.91 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.581 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.551 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 86.42 135.71 4.16 Favored Glycine 0 N--CA 1.502 3.072 0 C-N-CA 119.904 -1.141 . . . . 0.0 111.267 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 14' ' ' GLY . 15.9 mtpp -31.46 141.47 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.913 0.419 . . . . 0.0 111.727 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.588 ' NE2' ' CZ ' ' A' ' 7' ' ' PHE . 2.3 pt20 -110.14 172.52 6.81 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.873 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.3 t -146.79 133.91 14.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.414 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -89.93 139.94 30.11 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.312 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.0 mt -135.69 133.02 19.85 Favored Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 120.026 -0.669 . . . . 0.0 110.714 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -69.69 155.16 66.88 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 121.081 1.187 . . . . 0.0 110.999 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.66 -166.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.497 1.464 . . . . 0.0 110.803 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.39 -161.03 26.08 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.951 -1.595 . . . . 0.0 110.671 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -128.04 127.42 43.13 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.997 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.435 ' OH ' HD12 ' A' ' 82' ' ' ILE . 7.9 p90 -144.46 -171.58 3.62 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.92 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.0 p -142.62 -170.54 3.23 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.262 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -59.41 -22.07 60.89 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.883 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -60.96 -58.86 6.65 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.882 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.88 ' NE2' HD21 ' A' ' 32' ' ' LEU . 29.2 tp60 -54.92 -44.54 74.31 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.029 -1.069 . . . . 0.0 109.398 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.529 HD22 ' CG2' ' A' ' 34' ' ' ILE . 31.4 mt -57.08 -42.34 80.51 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.294 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -51.3 -30.54 18.46 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.825 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -73.75 -34.76 64.88 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.941 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.88 HD21 ' NE2' ' A' ' 28' ' ' GLN . 11.7 mt -78.88 -72.97 0.36 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.579 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.56 -40.91 0.21 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.529 ' CG2' HD22 ' A' ' 29' ' ' LEU . 10.2 tt -68.89 178.48 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.49 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.634 ' CG ' ' N ' ' A' ' 36' ' ' ASN . 5.5 tt0 178.53 167.32 0.85 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.057 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.634 ' N ' ' CG ' ' A' ' 35' ' ' GLU . 24.4 p30 -36.33 152.75 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.533 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.844 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 78.07 32.76 0.36 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.484 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 39' ' ' ILE . 72.0 p -147.19 -121.61 0.06 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.767 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.891 HD12 HG11 ' A' ' 79' ' ' VAL . 4.5 mt 32.58 62.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.402 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.646 ' OG ' ' N ' ' A' ' 41' ' ' SER . 22.7 p -64.69 -62.3 1.66 Allowed 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.733 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.646 ' N ' ' OG ' ' A' ' 40' ' ' SER . 0.7 OUTLIER -106.73 171.45 7.35 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.262 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -145.48 140.55 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.096 -1.041 . . . . 0.0 111.643 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -129.14 102.19 6.36 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.917 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.582 HG22 HG22 ' A' ' 4' ' ' ILE . 71.5 t -126.62 109.39 22.95 Favored Pre-proline 0 N--CA 1.49 1.537 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.618 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -67.6 169.76 15.2 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 121.049 1.166 . . . . 0.0 110.633 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.21 -170.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.844 1.696 . . . . 0.0 111.185 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.2 -11.8 7.94 Favored Glycine 0 N--CA 1.483 1.827 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.698 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.523 HG11 ' HB3' ' A' ' 2' ' ' ALA . 35.3 m -150.18 134.95 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 118.944 -1.102 . . . . 0.0 111.799 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -104.35 132.03 51.05 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.247 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.619 ' HB3' HG23 ' A' ' 65' ' ' VAL . . . -110.8 154.86 23.36 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.479 -0.889 . . . . 0.0 112.844 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.585 HG22 ' CE1' ' A' ' 53' ' ' TYR . 12.0 mt -146.32 112.01 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.103 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 mp -89.56 152.09 21.6 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.704 -1.198 . . . . 0.0 112.477 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.585 ' CE1' HG22 ' A' ' 51' ' ' ILE . 53.5 m-85 -129.48 110.9 12.25 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.315 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.692 HE21 ' H ' ' A' ' 61' ' ' ASP . 3.2 tt0 -48.61 -55.45 11.19 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.631 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -85.67 147.67 26.26 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.032 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -56.38 178.1 0.06 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.776 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.34 27.22 60.29 Favored Glycine 0 N--CA 1.488 2.105 0 C-N-CA 119.346 -1.407 . . . . 0.0 110.173 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.497 ' C ' ' CD2' ' A' ' 53' ' ' TYR . 12.4 m-85 56.29 67.44 1.0 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.876 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.23 -170.43 3.65 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.97 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.09 -177.23 39.36 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.425 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.692 ' H ' HE21 ' A' ' 54' ' ' GLN . 38.1 t0 -45.19 107.64 0.1 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.355 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -91.05 151.35 21.06 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.642 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.736 HG22 ' N ' ' A' ' 64' ' ' GLU . 8.5 mm -131.31 170.3 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.36 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.736 ' N ' HG22 ' A' ' 63' ' ' ILE . 27.8 mt-10 -146.48 132.61 19.34 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.694 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 50' ' ' ALA . 17.6 m -150.45 147.91 15.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 118.964 -1.094 . . . . 0.0 111.698 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 t -130.61 0.93 2.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.432 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -134.41 -151.19 0.42 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.684 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -97.25 119.12 35.18 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.105 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.539 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.58 101.7 14.38 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.178 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -55.13 -35.98 65.26 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.346 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 72' ' ' LEU . 8.6 tp10 -140.16 96.51 3.06 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.611 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.42 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 1.5 tp -37.97 -84.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.099 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 178.91 -168.64 39.64 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.095 -1.526 . . . . 0.0 110.719 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.21 -6.3 15.87 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.097 1.865 . . . . 0.0 111.859 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.683 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -92.11 13.98 17.34 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.022 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -72.55 -5.16 35.15 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.518 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -89.21 -6.84 56.57 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.107 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -166.1 104.88 0.66 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 118.714 -1.194 . . . . 0.0 111.711 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.981 HG12 ' H ' ' A' ' 80' ' ' SER . 11.6 t -113.5 -167.81 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.415 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.981 ' H ' HG12 ' A' ' 79' ' ' VAL . 0.3 OUTLIER 159.48 -59.33 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.449 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.413 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 2.6 m -108.5 145.83 34.12 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.307 -0.957 . . . . 0.0 113.317 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.435 HD12 ' OH ' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -141.21 154.26 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.915 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.737 ' NH1' ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.61 128.5 25.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.333 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.737 ' CA ' ' NH1' ' A' ' 83' ' ' ARG . 6.5 t -138.1 132.94 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.329 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 68.1 mt -129.31 128.69 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.806 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 m -42.3 153.49 0.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.213 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.598 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.5 OUTLIER -147.56 148.62 31.56 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.753 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.598 ' HD2' HG22 ' A' ' 87' ' ' VAL . 5.4 Cg_exo -55.48 127.76 27.57 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.229 1.286 . . . . 0.0 110.946 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 p -59.43 136.38 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.478 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -139.71 152.76 69.14 Favored Pre-proline 0 N--CA 1.486 1.355 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.695 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.485 ' HG2' HD21 ' A' ' 136' ' ' LEU . 3.3 Cg_exo -60.15 -156.88 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.818 0 C-N-CA 121.064 1.176 . . . . 0.0 110.941 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 175.71 -162.05 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.266 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.03 158.57 43.97 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.013 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.91 147.5 35.71 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.935 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.469 ' CE1' HD12 ' A' ' 108' ' ' LEU . 29.9 m-85 -130.48 100.89 5.5 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.425 ' CG ' ' HB3' ' A' ' 105' ' ' GLU . 33.7 m-85 -74.93 177.06 6.57 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.581 -0.847 . . . . 0.0 113.111 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -110.54 159.73 17.27 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.635 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt 59.3 153.98 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.048 0.927 . . . . 0.0 113.182 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.555 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 30.7 tp10 -71.99 105.99 4.1 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.459 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 1.282 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 103.83 46.2 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.01 0 O-C-N 124.981 1.426 . . . . 0.0 109.076 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.631 ' CE1' ' CD ' ' A' ' 100' ' ' GLN . 27.0 p90 31.56 58.56 0.3 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.669 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 102' ' ' ASP . 0.4 OUTLIER -94.54 19.85 9.24 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.939 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -159.64 159.02 30.21 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -48.59 171.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.64 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -129.72 169.69 14.78 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.053 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.35 151.81 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.764 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 23.3 p-10 -98.43 152.78 19.14 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.965 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.469 HD12 ' CE1' ' A' ' 95' ' ' PHE . 54.0 mt -146.09 113.27 4.51 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.268 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 1.6 Cg_endo -65.83 164.43 27.03 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 121.421 1.414 . . . . 0.0 112.061 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.97 146.39 57.87 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 122.268 1.979 . . . . 0.0 111.787 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.11 -156.33 25.52 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.699 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.638 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 18.0 tt0 -135.75 156.99 47.95 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.648 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.638 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 12.0 m-85 -141.07 156.41 46.0 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.428 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.4 p -108.89 -179.2 3.79 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.712 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.431 ' NE2' ' HB3' ' A' ' 168' ' ' SER . 39.2 tt0 -75.9 44.1 0.29 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.19 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.22 -58.94 0.12 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.976 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 121' ' ' TYR . 31.2 tp10 -71.59 -51.44 23.3 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.413 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.63 ' C ' HD23 ' A' ' 118' ' ' LEU . 1.4 tt -36.88 -73.37 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.142 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.532 ' HG3' ' H ' ' A' ' 120' ' ' ARG . 5.4 pt-20 -49.78 -55.54 13.7 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.696 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.532 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -76.66 16.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.752 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.474 ' CG ' ' O ' ' A' ' 121' ' ' TYR . 28.2 t80 -123.64 -12.75 7.62 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.488 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -145.26 -42.65 0.05 OUTLIER Glycine 0 N--CA 1.496 2.636 0 C-N-CA 118.84 -1.648 . . . . 0.0 110.963 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.468 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -142.57 -97.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.606 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.555 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 23.8 t70 -167.4 -170.01 1.36 Allowed 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.745 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.555 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 27.8 t-20 -62.1 -105.63 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.63 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.456 ' N ' ' OD1' ' A' ' 125' ' ' ASN . 1.8 p-10 -67.11 107.9 2.46 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.396 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.772 HG23 HG13 ' A' ' 128' ' ' ILE . 3.1 t -172.9 -165.75 0.32 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.358 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.772 HG13 HG23 ' A' ' 127' ' ' THR . 1.4 mt 66.52 140.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.806 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 160' ' ' LEU . 4.8 m -154.67 -5.51 0.15 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.333 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.5 m -150.94 127.98 11.11 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.176 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -120.26 148.0 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.475 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.93 78.59 19.52 Favored Pre-proline 0 N--CA 1.483 1.198 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.402 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -61.19 97.64 0.13 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.264 1.31 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -91.51 33.23 1.01 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.413 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.72 -58.85 0.04 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 118.691 -1.718 . . . . 0.0 111.356 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.485 HD21 ' HG2' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -120.32 178.05 4.8 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.028 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.62 138.33 31.65 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.701 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.9 141.13 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.73 -0.788 . . . . 0.0 112.152 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.567 HG12 ' CE1' ' A' ' 141' ' ' PHE . 57.7 t -125.54 130.96 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.495 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.0 mp -105.47 137.05 43.92 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.646 -0.822 . . . . 0.0 113.085 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.567 ' CE1' HG12 ' A' ' 139' ' ' VAL . 2.3 m-85 -120.95 128.03 52.36 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.207 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -79.86 -30.64 40.32 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.141 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -83.08 177.77 8.44 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.785 -1.166 . . . . 0.0 111.86 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 146' ' ' PHE . 21.7 t0 -61.73 -105.99 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.875 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.642 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 2.2 m120 -58.54 75.56 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.457 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.642 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.5 p90 32.76 70.39 0.1 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.143 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.18 -161.65 1.18 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.325 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 50.58 -148.66 7.14 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.745 -1.217 . . . . 0.0 111.127 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -78.18 162.39 26.64 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.124 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.0 p -150.66 165.39 33.55 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.539 ' C ' HD23 ' A' ' 151' ' ' LEU . 3.2 tt -133.19 90.91 29.33 Favored Pre-proline 0 N--CA 1.484 1.238 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.08 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.4 ' HB2' HD21 ' A' ' 154' ' ' ASN . 3.9 Cg_exo -64.41 105.52 0.62 Allowed 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 121.589 1.526 . . . . 0.0 112.748 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.45 84.44 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.551 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.4 HD21 ' HB2' ' A' ' 152' ' ' PRO . 11.9 m-80 -77.05 12.83 1.25 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.624 -0.83 . . . . 0.0 112.407 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -170.69 -167.49 0.59 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 118.214 -1.395 . . . . 0.0 112.361 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.55 152.05 19.13 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.576 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.564 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -169.13 65.47 0.58 Allowed Pre-proline 0 C--N 1.308 -1.225 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.269 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.0 OUTLIER -65.76 23.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 122.171 1.914 . . . . 0.0 112.046 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.652 ' O ' HD12 ' A' ' 160' ' ' LEU . 3.0 t -166.5 138.7 3.68 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.782 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.652 HD12 ' O ' ' A' ' 159' ' ' THR . 0.3 OUTLIER -160.11 -78.22 0.06 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.221 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.479 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.77 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.461 HD21 ' ND2' ' A' ' 125' ' ' ASN . 2.6 t-20 . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.659 0.266 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 85.2 m -42.27 104.43 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.32 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.431 ' HB3' ' NE2' ' A' ' 115' ' ' GLN . 0.2 OUTLIER -87.89 -61.3 1.75 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.017 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.4 p -123.61 158.99 30.23 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.947 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.427 HG12 ' CD1' ' A' ' 118' ' ' LEU . 13.1 pt -142.0 162.21 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.176 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.441 ' CZ ' ' OG ' ' A' ' 173' ' ' SER . 2.6 ttt-85 -142.44 102.7 4.13 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.015 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 172' ' ' ILE . 7.9 mt -84.01 93.81 3.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.757 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.441 ' OG ' ' CZ ' ' A' ' 171' ' ' ARG . 4.4 m . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 116.363 -1.78 . . . . 0.0 110.813 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.6 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.952 0.406 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -178.22 115.93 0.08 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.545 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.412 ' H ' HG23 ' A' ' 4' ' ' ILE . 2.9 pt -61.98 129.12 24.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.707 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -107.67 122.33 46.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.407 HG12 HG22 ' A' ' 42' ' ' VAL . 5.1 m -112.49 150.65 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.726 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.611 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 12.5 m-85 -103.92 156.13 18.09 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.654 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.9 -35.8 23.82 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.247 -0.981 . . . . 0.0 113.048 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.489 ' C ' ' OG ' ' A' ' 40' ' ' SER . 14.1 m120 -104.49 170.89 7.63 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.259 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' A' ' 11' ' ' ASP . 4.2 tp10 -76.52 -176.34 3.69 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.471 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.458 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 1.1 m-20 51.79 42.48 29.98 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.073 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.611 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 21.4 t80 54.1 6.57 0.1 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.652 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.453 ' H ' ' C ' ' A' ' 11' ' ' ASP . 7.3 tt0 -87.13 170.99 11.03 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.503 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 89.19 120.35 1.84 Allowed Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.587 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 14' ' ' GLY . 6.9 mtpm? -28.85 137.54 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 O-C-N 123.95 0.441 . . . . 0.0 111.731 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -105.43 133.07 50.79 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 p -108.1 153.41 9.6 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.039 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.811 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.07 140.2 34.64 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.543 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 mt -132.05 126.84 20.81 Favored Pre-proline 0 N--CA 1.493 1.688 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.205 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.54 151.3 83.21 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 121.026 1.151 . . . . 0.0 111.579 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.33 -164.6 0.06 OUTLIER 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 121.609 1.539 . . . . 0.0 111.484 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.57 179.93 46.29 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.454 -1.355 . . . . 0.0 111.066 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.84 ' CB ' ' HE ' ' A' ' 83' ' ' ARG . 1.7 m120 -90.4 121.95 32.83 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.914 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.8 ' N ' HH21 ' A' ' 83' ' ' ARG . 0.2 OUTLIER -144.33 154.99 43.6 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.315 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.42 HG22 ' OG ' ' A' ' 81' ' ' SER . 21.0 p -144.4 -150.76 0.33 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.858 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 30' ' ' ALA . 10.0 mtm180 -55.89 -37.16 68.47 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.18 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.653 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -53.44 -59.11 5.0 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.269 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.09 -47.32 75.1 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 118.695 -1.202 . . . . 0.0 109.411 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 32' ' ' LEU . 21.5 mt -61.09 -28.58 69.19 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.442 -1.303 . . . . 0.0 109.023 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -54.34 -33.43 58.96 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.2 -29.94 60.48 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.587 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 29' ' ' LEU . 14.7 mt -85.75 -91.72 0.09 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.338 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.45 13.45 0.26 Allowed Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.225 -1.464 . . . . 0.0 111.54 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.573 HG13 HG21 ' A' ' 38' ' ' THR . 1.0 OUTLIER -95.08 -38.81 9.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.635 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.558 ' N ' ' CG1' ' A' ' 34' ' ' ILE . 3.7 pt-20 -12.9 132.21 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.803 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.677 ' C ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER 84.77 135.06 0.05 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 114.359 -1.291 . . . . 0.0 113.737 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 40.27 39.23 0.64 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.72 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.862 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 52.5 p -106.38 -141.3 0.37 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.929 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.491 ' H ' HD13 ' A' ' 39' ' ' ILE . 1.4 mm 30.86 41.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.958 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.489 ' OG ' ' C ' ' A' ' 9' ' ' ASN . 2.1 t -48.77 -38.98 23.41 Favored 'General case' 0 C--N 1.282 -2.342 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.064 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.67 176.56 8.59 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -150.63 146.63 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 117.76 -1.576 . . . . 0.0 113.075 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -136.09 102.1 4.92 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.359 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.6 t -122.71 104.33 36.6 Favored Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.381 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -69.48 171.01 14.92 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.077 1.185 . . . . 0.0 109.991 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.0 -173.19 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.494 1.463 . . . . 0.0 110.907 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.77 -21.72 7.38 Favored Glycine 0 N--CA 1.484 1.849 0 C-N-CA 119.109 -1.52 . . . . 0.0 110.551 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.6 HG11 ' CB ' ' A' ' 2' ' ' ALA . 25.1 m -148.97 141.98 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 118.921 -1.112 . . . . 0.0 112.176 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -110.18 139.2 45.58 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.739 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.21 155.03 42.46 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 118.964 -1.094 . . . . 0.0 113.2 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 63' ' ' ILE . 4.4 mp -134.34 120.84 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.199 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.915 HD12 ' N ' ' A' ' 52' ' ' LEU . 2.2 mp -94.62 155.66 16.78 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 118.744 -1.182 . . . . 0.0 112.942 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.478 ' CE1' ' HB3' ' A' ' 62' ' ' GLN . 40.5 m-85 -140.7 117.5 11.03 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.723 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.498 ' HG3' ' N ' ' A' ' 55' ' ' ASN . 6.4 pt20 -57.58 -41.94 82.12 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.363 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.521 ' HB3' ' HB3' ' A' ' 59' ' ' ALA . 19.7 t30 -93.26 142.99 26.7 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.24 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 0.3 OUTLIER -54.49 171.09 0.13 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.487 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.663 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 58.82 34.83 79.59 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.162 -1.494 . . . . 0.0 109.43 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.795 ' H ' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER 44.26 74.16 0.13 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.316 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 55' ' ' ASN . . . -147.22 168.18 22.35 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.082 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.24 -166.69 48.37 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.525 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.448 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 3.7 m-20 -50.92 117.09 2.29 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.448 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.478 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 3.9 pt20 -99.82 151.45 21.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.887 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.603 ' O ' HG23 ' A' ' 51' ' ' ILE . 1.8 mt -127.79 166.0 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.922 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.558 ' OE1' ' N ' ' A' ' 64' ' ' GLU . 46.0 mp0 -142.77 130.52 21.51 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.24 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.402 HG13 ' C ' ' A' ' 64' ' ' GLU . 35.2 m -150.45 164.8 2.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.936 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.0 t -149.94 -1.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.158 -1.383 . . . . 0.0 107.881 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.72 -153.36 0.56 Allowed 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.624 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 68' ' ' ASN . 1.2 p-10 -98.32 114.03 26.19 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.53 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.574 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.72 98.9 12.03 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.425 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -54.78 -73.96 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.726 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 73' ' ' GLY . 24.6 mm-40 -80.9 -0.16 37.9 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.797 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.44 HD22 ' O ' ' A' ' 39' ' ' ILE . 5.2 tp 60.09 -79.88 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.219 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 171.08 -179.06 43.17 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.129 -1.51 . . . . 0.0 110.804 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.2 Cg_endo -65.1 -40.14 21.23 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.433 2.089 . . . . 0.0 112.421 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.955 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.1 pt? -71.3 27.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.16 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.798 ' H ' HD22 ' A' ' 76' ' ' ASN . 0.7 OUTLIER -76.98 6.97 5.38 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.573 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -88.52 -9.41 52.47 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.967 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -157.85 130.69 7.42 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.136 -1.026 . . . . 0.0 111.219 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.862 ' CG2' ' H ' ' A' ' 38' ' ' THR . 15.3 m -140.09 164.93 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.533 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 174.64 -56.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.872 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.795 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 22.3 m -96.67 141.08 30.35 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.347 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.731 HD12 ' OH ' ' A' ' 24' ' ' TYR . 18.3 mt -150.57 128.25 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.974 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.84 ' HE ' ' CB ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -103.94 125.93 50.7 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.808 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -133.27 133.72 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.978 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.87 139.87 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.635 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.2 p -45.94 149.82 0.62 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.234 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.622 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -153.29 142.89 14.99 Favored Pre-proline 0 N--CA 1.484 1.264 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.866 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.622 ' HD2' HG22 ' A' ' 87' ' ' VAL . 2.7 Cg_exo -52.29 148.5 25.2 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 121.432 1.421 . . . . 0.0 111.811 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.403 HG13 ' H ' ' A' ' 89' ' ' VAL . 2.2 m -76.23 145.38 10.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.993 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -146.13 136.51 12.15 Favored Pre-proline 0 C--N 1.304 -1.388 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.963 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -60.33 -156.67 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.869 0 C-N-CA 121.178 1.252 . . . . 0.0 110.687 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.559 ' N ' ' CD ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -175.55 -164.53 0.14 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.354 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.37 165.47 25.4 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.027 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.616 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -128.66 151.46 49.48 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.777 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 1.2 m-85 -142.43 139.92 31.79 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.534 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.517 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 27.7 m-85 -95.09 179.74 5.1 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 118.414 -1.314 . . . . 0.0 112.492 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.456 ' CE1' HG22 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -101.65 -74.75 0.61 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.023 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.521 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 25.9 tttm -63.29 160.6 15.48 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.858 0.837 . . . . 0.0 112.499 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.587 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -71.7 103.45 3.07 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.477 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.868 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.8 OUTLIER 113.1 55.48 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.496 0 O-C-N 125.245 1.591 . . . . 0.0 111.056 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.561 ' O ' ' CD2' ' A' ' 101' ' ' PHE . 17.9 p90 28.52 41.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.492 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.566 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 6.4 p-10 -115.26 24.15 11.88 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.66 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.521 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -139.42 150.45 21.34 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.8 OUTLIER -33.34 142.21 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.598 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.404 ' O ' ' CD ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -105.66 162.95 13.06 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.635 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.787 HG21 ' O ' ' A' ' 122' ' ' GLY . 1.4 t -132.62 167.57 26.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.476 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.536 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 2.6 p30 -150.18 149.0 29.61 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.099 -1.44 . . . . 0.0 112.438 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.437 HD22 ' CD2' ' A' ' 121' ' ' TYR . 14.2 mt -137.22 143.2 40.73 Favored Pre-proline 0 N--CA 1.499 1.98 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.446 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.81 166.43 27.69 Favored 'Trans proline' 0 C--O 1.212 -0.782 0 C-N-CA 121.789 1.66 . . . . 0.0 112.346 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.89 145.98 95.01 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 122.296 1.997 . . . . 0.0 111.233 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.17 -143.27 12.63 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.279 -1.438 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.597 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 10.5 tt0 -146.46 154.27 41.39 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.165 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.597 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 8.4 m-85 -138.64 152.89 48.49 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.102 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.6 p -88.43 -166.84 1.7 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.669 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -96.57 51.17 1.16 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.389 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.58 -68.81 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.35 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 121' ' ' TYR . 8.6 pt-20 -68.54 -41.68 79.52 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.891 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.61 ' C ' HD23 ' A' ' 118' ' ' LEU . 0.9 OUTLIER -37.49 -75.07 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.633 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.697 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -51.68 -52.2 49.97 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.574 -0.851 . . . . 0.0 110.855 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -74.57 16.33 0.28 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.961 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 117' ' ' GLU . 17.8 t80 -124.52 -13.8 6.99 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.517 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.787 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -138.13 -52.94 0.05 OUTLIER Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.506 -1.33 . . . . 0.0 110.603 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.679 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -138.4 -101.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.407 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.511 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 32.0 t70 -164.41 176.79 8.73 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.162 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.541 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 45.7 t30 -59.83 137.61 58.01 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.843 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.677 ' O ' HG22 ' A' ' 127' ' ' THR . 7.4 p30 43.59 -151.07 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.914 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.677 HG22 ' O ' ' A' ' 126' ' ' ASN . 13.7 t 48.35 20.09 0.26 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.59 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.487 ' O ' ' CB ' ' A' ' 129' ' ' SER . 7.4 mm -50.57 -84.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.927 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 1.2 p 80.51 120.01 0.05 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.444 ' H ' ' H ' ' A' ' 160' ' ' LEU . 0.9 OUTLIER 51.44 114.16 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.022 -1.445 . . . . 0.0 114.197 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.409 HG13 ' CD2' ' A' ' 95' ' ' PHE . 3.6 t -121.47 134.55 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.571 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.4 ttmm -131.32 99.37 17.57 Favored Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.664 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.85 107.43 1.87 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.018 1.145 . . . . 0.0 110.47 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -86.29 11.14 12.82 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.843 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.5 -45.73 0.04 OUTLIER Glycine 0 N--CA 1.494 2.564 0 C-N-CA 118.097 -2.001 . . . . 0.0 111.762 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.23 163.17 18.17 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.154 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 173' ' ' SER . . . -80.44 159.94 25.47 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.79 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 20.8 t -122.41 141.68 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.921 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.421 ' C ' HD12 ' A' ' 140' ' ' LEU . 47.5 t -128.86 130.86 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.71 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 140' ' ' LEU . 11.0 mp -105.22 139.33 40.04 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.319 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 141' ' ' PHE . 3.0 m-85 -121.44 129.23 52.87 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.987 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.469 ' HD2' ' H ' ' A' ' 142' ' ' LYS . 0.1 OUTLIER -77.07 -48.44 17.81 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.484 -0.887 . . . . 0.0 112.228 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.478 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.8 m-80 -74.32 135.78 42.56 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.069 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 143' ' ' ASN . 6.4 m-20 -9.16 -110.42 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.589 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 16.7 m-80 -68.45 86.69 0.3 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 146' ' ' PHE . 1.1 p90 30.32 72.55 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.889 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.7 m -142.67 -160.64 1.12 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.091 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 44.25 -158.01 0.16 Allowed Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.81 -1.186 . . . . 0.0 111.106 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -62.08 163.71 7.65 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.932 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.5 p -150.34 162.9 39.63 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.409 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.7 88.58 53.98 Favored Pre-proline 0 N--CA 1.485 1.296 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.041 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.436 ' HB2' ' ND2' ' A' ' 154' ' ' ASN . 2.9 Cg_endo -66.08 105.3 0.81 Allowed 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.433 1.422 . . . . 0.0 111.965 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.43 69.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.238 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.758 ' H ' HD22 ' A' ' 154' ' ' ASN . 0.6 OUTLIER -81.06 37.28 0.43 Allowed 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.127 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.604 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 13.7 t -170.9 -175.15 1.7 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.061 -1.055 . . . . 0.0 111.161 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.604 ' N ' ' OG ' ' A' ' 155' ' ' SER . 16.3 m-20 -76.78 142.12 40.49 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.559 -0.857 . . . . 0.0 111.141 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.559 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -154.96 74.33 5.62 Favored Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.458 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.23 23.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 122.065 1.843 . . . . 0.0 112.317 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.559 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -171.43 115.71 0.4 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.701 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.444 ' H ' ' H ' ' A' ' 130' ' ' SER . 0.2 OUTLIER -128.74 4.47 5.48 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.719 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.831 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.3 p30 . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.086 0.469 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.4 m -75.97 104.77 6.66 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.835 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.3 t -82.17 -68.0 0.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.732 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.612 ' CB ' ' H ' ' A' ' 146' ' ' PHE . 28.6 m -114.03 163.73 14.76 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.926 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.47 HG23 HD11 ' A' ' 118' ' ' LEU . 22.0 pt -141.02 161.29 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.089 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.409 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 25.1 ttt180 -141.8 98.7 3.39 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.6 mt -77.71 99.49 2.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.037 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 137' ' ' ALA . 39.7 m . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.814 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.544 ' HB1' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.876 0.369 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -173.93 123.46 0.33 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.464 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 4' ' ' ILE . 25.9 pt -76.05 148.54 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.5 m -122.89 109.82 14.64 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.243 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 m -100.75 150.93 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.924 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.791 ' CZ ' ' CE1' ' A' ' 12' ' ' PHE . 25.9 m-85 -109.51 163.64 13.25 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.636 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.29 -3.21 47.84 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.051 -1.06 . . . . 0.0 113.681 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.734 HD22 HE22 ' A' ' 13' ' ' GLN . 83.4 m-20 -136.0 164.32 28.26 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.945 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -70.63 176.68 3.97 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.69 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 13' ' ' GLN . 5.9 m-20 57.44 46.55 17.91 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.344 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.791 ' CE1' ' CZ ' ' A' ' 7' ' ' PHE . 85.4 t80 49.91 7.24 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.341 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.734 HE22 HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -92.06 174.27 7.41 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.434 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.69 ' H ' ' CD ' ' A' ' 13' ' ' GLN . . . 93.84 127.33 4.69 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.053 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' GLY . 13.7 mptt -31.38 141.49 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.056 0.455 . . . . 0.0 111.914 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.17 162.71 13.91 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.834 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -148.09 125.22 2.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.964 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -93.15 128.49 39.1 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.971 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.4 mt -122.28 129.82 24.94 Favored Pre-proline 0 N--CA 1.491 1.615 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.728 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -67.96 162.44 39.83 Favored 'Trans proline' 0 C--N 1.325 -0.684 0 C-N-CA 120.806 1.004 . . . . 0.0 111.141 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.04 -161.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 121.667 1.578 . . . . 0.0 110.864 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.4 -179.46 49.32 Favored Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.295 -1.431 . . . . 0.0 111.082 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.729 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.6 OUTLIER -106.21 135.47 47.63 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.204 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.482 ' HE1' HD12 ' A' ' 82' ' ' ILE . 16.5 p90 -152.23 167.75 27.57 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.104 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.6 p -142.05 -161.44 1.23 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.108 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -56.71 -29.2 62.22 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.054 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.18 -67.68 0.43 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.125 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.535 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.7 tp-100 -57.56 -41.46 81.1 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.428 -1.309 . . . . 0.0 110.003 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.466 HD22 ' CG1' ' A' ' 34' ' ' ILE . 28.6 mt -61.04 -39.76 91.01 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.892 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.95 -32.61 33.93 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 118.035 -1.466 . . . . 0.0 107.807 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -68.39 -36.66 79.46 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.318 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.452 HD12 HD23 ' A' ' 29' ' ' LEU . 14.3 mt -74.75 -80.01 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.872 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.46 -22.67 0.09 OUTLIER Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.854 -1.641 . . . . 0.0 111.222 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.466 ' CG1' HD22 ' A' ' 29' ' ' LEU . 6.5 pt -85.39 158.08 3.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.263 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER 170.27 137.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.708 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 8.1 t-20 74.97 -147.3 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.557 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.665 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -58.68 96.7 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.651 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 39' ' ' ILE . 60.6 p -152.1 -142.57 0.12 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.106 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.632 HG13 HG11 ' A' ' 79' ' ' VAL . 2.2 mm 36.82 44.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.323 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.51 ' OG ' ' C ' ' A' ' 9' ' ' ASN . 12.7 t -49.08 -43.01 40.72 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.502 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.2 171.74 13.82 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -152.1 141.85 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 118.093 -1.443 . . . . 0.0 112.954 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -134.05 103.77 5.94 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.943 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.3 t -120.48 108.31 37.8 Favored Pre-proline 0 N--CA 1.494 1.743 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.231 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -67.21 168.73 16.85 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.11 1.206 . . . . 0.0 110.746 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -59.35 -170.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.929 1.753 . . . . 0.0 111.179 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.18 -11.7 11.45 Favored Glycine 0 N--CA 1.483 1.81 0 C-N-CA 119.278 -1.439 . . . . 0.0 110.961 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.544 HG21 ' HB1' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -149.49 141.7 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.114 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.7 tttt -116.01 126.58 54.01 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.542 ' CB ' HG22 ' A' ' 84' ' ' VAL . . . -115.2 165.32 13.06 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.109 -1.036 . . . . 0.0 113.307 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.583 HG23 ' O ' ' A' ' 63' ' ' ILE . 63.2 mt -142.44 120.65 8.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 114.211 -1.359 . . . . 0.0 108.524 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.833 HD23 ' H ' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -92.19 148.38 22.2 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.104 -1.038 . . . . 0.0 112.074 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.833 ' H ' HD23 ' A' ' 52' ' ' LEU . 17.6 m-85 -132.83 114.71 14.4 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.183 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -53.16 -84.29 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.787 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -59.48 149.37 29.83 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.1 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -57.22 -173.01 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.637 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.1 32.43 35.42 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.19 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 49.53 45.13 24.27 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.732 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.54 -169.45 1.67 Allowed 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.011 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 68.0 166.38 3.54 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.892 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 60' ' ' GLY . 26.6 t70 -42.78 130.37 4.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.535 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.681 ' CD ' ' H ' ' A' ' 62' ' ' GLN . 5.9 pm0 -99.86 166.06 11.26 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.052 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.711 HG13 HD11 ' A' ' 75' ' ' LEU . 5.5 mm -135.13 169.5 21.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.534 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.658 ' N ' HG22 ' A' ' 63' ' ' ILE . 36.7 mt-10 -146.34 132.45 19.33 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.003 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 m -149.32 151.59 12.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.358 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.3 t -140.2 -0.26 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . . . -130.8 -147.61 0.33 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.669 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.5 119.1 38.0 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.671 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.57 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.36 104.41 16.96 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.861 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -64.32 -77.68 0.05 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.003 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 73' ' ' GLY . 6.5 mm-40 -83.41 1.31 42.11 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.5 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.403 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 3.0 tp 56.63 -89.22 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.55 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 177.82 -166.48 36.76 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.155 -1.498 . . . . 0.0 110.621 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.571 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.9 Cg_endo -66.45 -40.96 12.9 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 122.135 1.89 . . . . 0.0 112.163 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.838 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.9 pt? -68.13 26.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.465 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.571 ' H ' ' C ' ' A' ' 74' ' ' PRO . 34.0 t-20 -68.55 -34.89 76.62 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.574 -0.85 . . . . 0.0 111.277 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -87.98 29.78 0.9 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.098 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -171.88 112.92 0.32 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.335 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.632 HG11 HG13 ' A' ' 39' ' ' ILE . 57.5 t -147.38 155.38 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.902 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.42 ' N ' HG12 ' A' ' 79' ' ' VAL . 21.2 t -171.62 -34.85 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 118.744 -1.182 . . . . 0.0 112.265 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.1 m -116.66 137.91 51.84 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.956 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.482 HD12 ' HE1' ' A' ' 24' ' ' TYR . 1.3 mt -148.6 155.18 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.511 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.849 HH12 ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -149.71 133.49 16.88 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.889 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.849 ' N ' HH12 ' A' ' 83' ' ' ARG . 13.9 t -140.68 148.25 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.911 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.932 HD12 ' H ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -142.41 136.46 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.846 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.6 m -39.91 152.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.166 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.59 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -153.24 141.36 13.85 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.224 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.59 ' HD2' HG22 ' A' ' 87' ' ' VAL . 7.8 Cg_exo -49.25 151.08 6.82 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.451 1.434 . . . . 0.0 111.706 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 89' ' ' VAL . 17.6 m -71.51 147.22 11.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.903 -0.719 . . . . 0.0 112.309 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -145.87 129.73 8.55 Favored Pre-proline 0 C--N 1.301 -1.523 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.922 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -58.17 -159.4 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.874 0 C-N-CA 120.987 1.125 . . . . 0.0 110.801 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.481 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.58 -161.82 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.162 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.412 ' H ' ' HB2' ' A' ' 92' ' ' ARG . . . -136.27 164.72 27.43 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.841 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 39.7 ttm-85 -121.99 126.17 47.94 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.714 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 11.4 m-85 -116.8 125.31 51.41 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.797 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -84.65 168.07 15.63 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.191 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.437 ' HB3' ' H ' ' A' ' 98' ' ' LYS . 1.2 t80 -80.35 -92.11 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 118.502 -1.279 . . . . 0.0 112.939 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 97' ' ' TYR . 18.8 mmmt -68.22 156.05 38.41 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.932 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 1.091 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 3.5 tm-20 -66.57 85.01 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.127 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 1.091 ' NE2' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 173.86 30.05 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.202 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.61 ' CD1' ' O ' ' A' ' 101' ' ' PHE . 0.1 OUTLIER 47.81 11.51 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.797 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 100' ' ' GLN . 34.7 t70 -104.4 -177.47 3.37 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.316 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 72.41 128.81 0.1 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.068 -1.539 . . . . 0.0 109.998 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 103' ' ' GLY . 48.1 mttt -30.06 136.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 123.99 0.465 . . . . 0.0 111.438 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -98.96 170.39 8.76 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.502 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 122' ' ' GLY . 29.9 t -137.36 155.31 31.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.69 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -129.24 147.01 51.04 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.654 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.43 HD12 ' CE1' ' A' ' 95' ' ' PHE . 11.1 mt -136.42 139.31 29.25 Favored Pre-proline 0 N--CA 1.501 2.106 0 C-N-CA 119.724 -0.791 . . . . 0.0 110.811 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -71.04 167.75 25.2 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 121.662 1.575 . . . . 0.0 112.193 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.32 150.83 85.71 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 122.101 1.868 . . . . 0.0 111.573 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.18 -168.81 23.6 Favored Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.03 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.594 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 2.2 mp0 -113.74 159.1 20.11 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.6 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 40.7 m-85 -144.84 149.89 36.16 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.755 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.4 p -89.64 -153.06 0.26 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.123 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.422 ' C ' ' CD ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -110.95 31.81 5.75 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.67 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -134.93 -64.31 0.66 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.953 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.6 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 17.2 pt-20 -66.21 -49.37 67.5 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.066 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.6 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -37.12 -67.15 0.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.293 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.736 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 20.6 mp0 -48.2 -66.74 0.35 Allowed 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.14 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -72.44 12.32 0.48 Allowed 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.06 -1.056 . . . . 0.0 113.301 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 117' ' ' GLU . 12.8 t80 -101.97 -21.86 14.41 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.007 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.421 ' O ' HG11 ' A' ' 106' ' ' VAL . . . -165.36 -12.97 0.03 OUTLIER Glycine 0 N--CA 1.486 2.014 0 C-N-CA 118.237 -1.935 . . . . 0.0 110.93 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 123' ' ' ILE . 2.8 mt -145.69 -125.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.876 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -156.98 -160.38 0.96 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.457 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -59.55 -53.62 56.0 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.809 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -155.62 123.68 5.77 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.601 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.41 ' H ' ' H ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 177.71 0.81 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.042 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 130' ' ' SER . 70.5 mt -56.43 -72.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.285 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m 55.7 -85.1 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.776 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 128' ' ' ILE . 15.1 m -72.62 115.74 12.26 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.488 -0.885 . . . . 0.0 112.391 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.4 t -122.7 161.78 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.779 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -165.08 80.51 1.24 Allowed Pre-proline 0 C--N 1.296 -1.726 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.293 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -60.59 102.9 0.2 Allowed 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 121.568 1.512 . . . . 0.0 110.242 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.82 19.71 3.38 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.467 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.12 -50.93 0.03 OUTLIER Glycine 0 N--CA 1.491 2.352 0 C-N-CA 117.91 -2.09 . . . . 0.0 112.191 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.86 179.85 3.96 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.454 -0.899 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -92.1 152.33 19.98 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.776 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 68.2 t -124.11 138.86 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.127 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.503 ' C ' HD12 ' A' ' 140' ' ' LEU . 78.3 t -131.71 128.42 60.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.417 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.503 HD12 ' C ' ' A' ' 139' ' ' VAL . 8.3 mp -103.99 141.77 35.6 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.365 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -114.16 126.98 55.68 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.515 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -59.21 -78.62 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.464 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.2 m-80 -73.71 155.54 38.85 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.816 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 146' ' ' PHE . 5.3 p-10 -62.49 -162.18 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.567 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.497 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 43.7 t30 42.5 24.15 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.675 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.497 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.4 OUTLIER 57.17 54.82 6.45 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.703 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.8 t -130.73 -171.68 2.62 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.305 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 64.11 -177.9 8.27 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.024 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 150' ' ' THR . 25.5 t0 -59.68 177.23 0.22 Allowed 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.262 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.437 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 19.5 p -146.56 178.59 8.17 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.193 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' A' ' 151' ' ' LEU . 11.0 tp -153.07 86.61 4.09 Favored Pre-proline 0 C--N 1.306 -1.303 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.778 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.46 108.07 1.13 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.871 1.714 . . . . 0.0 113.131 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.7 t -82.72 93.59 2.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.788 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.66 HD22 ' N ' ' A' ' 154' ' ' ASN . 1.3 m120 -58.8 -29.35 66.77 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 48.0 p -170.38 -146.36 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 117.986 -1.486 . . . . 0.0 112.854 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 1.1 m-20 -48.98 153.24 0.91 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.99 -1.004 . . . . 0.0 112.491 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.5 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -179.89 65.24 0.14 Allowed Pre-proline 0 N--CA 1.486 1.37 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.206 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.696 ' C ' HG22 ' A' ' 159' ' ' THR . 6.4 Cg_endo -69.03 66.29 1.34 Allowed 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 122.27 1.98 . . . . 0.0 111.959 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.785 HG23 ' H ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER 161.11 -68.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.56 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.785 ' H ' HG23 ' A' ' 159' ' ' THR . 0.9 OUTLIER 57.04 -81.41 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.829 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 159' ' ' THR . . . . . . . . 0 N--CA 1.489 2.207 0 C-N-CA 118.495 -1.812 . . . . 0.0 109.683 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.9 p30 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.024 0.44 . . . . 0.0 111.562 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.0 m -70.44 104.91 2.87 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.836 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.2 m -80.98 -66.25 0.91 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.216 -0.993 . . . . 0.0 111.599 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.8 p -118.7 159.89 22.83 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.978 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 23.2 pt -135.53 179.8 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.246 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -159.5 100.99 1.51 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.821 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.8 mt -82.06 96.88 3.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.78 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 116.302 -1.808 . . . . 0.0 111.095 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.532 ' HB1' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 179.62 118.21 0.05 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.995 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.497 ' CG2' HG22 ' A' ' 44' ' ' VAL . 40.3 pt -79.27 164.8 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.388 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.406 HG23 HE21 ' A' ' 16' ' ' GLN . 81.5 m -138.93 123.02 17.96 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.729 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -104.62 168.12 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.285 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.418 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 68.9 m-85 -128.94 144.6 51.23 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.71 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -52.86 19.83 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.783 -0.767 . . . . 0.0 113.041 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.503 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 24.8 m120 -95.27 170.42 9.4 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.409 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.679 ' CG ' ' H ' ' A' ' 11' ' ' ASP . 16.6 tt0 -64.26 -178.7 0.38 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.778 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.679 ' H ' ' CG ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER 41.51 62.17 1.61 Allowed 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.325 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.655 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 44.9 p90 36.71 27.14 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.229 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ASP . 2.0 tp-100 -101.46 162.46 12.88 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.729 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.503 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 89.37 137.32 6.3 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.472 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.482 ' HE3' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -30.04 137.52 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.057 0.456 . . . . 0.0 111.889 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.406 HE21 HG23 ' A' ' 5' ' ' THR . 0.0 OUTLIER -103.32 162.97 12.56 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.034 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -144.23 130.26 15.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.297 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.58 133.6 34.53 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.749 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 mt -126.13 123.73 24.44 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.578 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.94 162.22 29.92 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 120.975 1.117 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.27 -170.08 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 121.705 1.604 . . . . 0.0 110.967 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.3 -179.08 38.99 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.095 -1.526 . . . . 0.0 110.958 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.823 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.2 OUTLIER -109.36 129.94 55.51 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.715 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.44 ' OH ' HD11 ' A' ' 4' ' ' ILE . 12.6 p90 -143.23 175.19 10.07 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.433 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.0 p -140.35 -160.0 1.02 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.475 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -61.15 -20.56 62.84 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.7 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.91 -62.35 1.7 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.157 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.476 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -55.64 -43.1 75.91 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.661 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 29' ' ' LEU . 20.4 mt -59.45 -41.2 89.11 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.424 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.65 -31.01 23.86 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 118.805 -1.158 . . . . 0.0 108.662 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -71.55 -38.16 71.02 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.0 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.403 ' HG ' ' H ' ' A' ' 32' ' ' LEU . 11.5 mt -73.13 -74.39 0.17 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.688 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.46 -34.87 0.47 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.057 -1.544 . . . . 0.0 110.841 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.44 HD11 ' H ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER -80.92 140.43 16.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.615 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.54 ' H ' HG21 ' A' ' 38' ' ' THR . 2.8 pt-20 178.54 131.72 0.07 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.78 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.72 ' O ' HG23 ' A' ' 38' ' ' THR . 1.5 t-20 78.22 127.49 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.511 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.4 ' N ' HG22 ' A' ' 79' ' ' VAL . 3.1 m-20 51.55 7.85 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.705 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 36' ' ' ASN . 67.2 p -91.48 -135.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.664 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.54 HG13 HG21 ' A' ' 79' ' ' VAL . 2.2 mt 35.74 39.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.604 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.52 -57.51 6.92 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.762 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.418 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -116.66 168.96 9.73 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.266 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -149.73 148.96 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 118.529 -1.269 . . . . 0.0 112.396 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -137.87 96.02 3.15 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.157 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.497 HG22 ' CG2' ' A' ' 4' ' ' ILE . 71.6 t -111.21 110.66 56.13 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.386 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -69.07 171.21 14.11 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.114 1.209 . . . . 0.0 110.411 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.45 -173.94 0.19 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.663 1.575 . . . . 0.0 111.082 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.04 -17.86 6.84 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.328 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.532 HG21 ' HB1' ' A' ' 2' ' ' ALA . 0.2 OUTLIER -146.81 138.85 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.312 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -105.9 119.7 39.86 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HB3' ' CG2' ' A' ' 65' ' ' VAL . . . -97.38 155.65 16.81 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.194 -1.002 . . . . 0.0 112.884 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.501 ' C ' HD12 ' A' ' 52' ' ' LEU . 53.1 mt -141.76 117.21 5.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.921 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.838 HD12 ' N ' ' A' ' 52' ' ' LEU . 2.0 mp -89.47 157.71 18.0 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.349 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.434 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 43.3 m-85 -138.47 107.36 5.97 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.553 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -40.93 -76.92 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.95 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.458 ' C ' ' OG ' ' A' ' 80' ' ' SER . 12.6 m120 -68.45 153.33 43.97 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.311 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -59.99 -174.95 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.653 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 49.21 40.49 29.43 Favored Glycine 0 N--CA 1.484 1.891 0 C-N-CA 119.114 -1.517 . . . . 0.0 109.656 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.653 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.5 OUTLIER 41.5 69.19 0.37 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.452 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.69 -162.39 1.42 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.993 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.48 -176.59 0.63 Allowed Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.23 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.654 ' OD2' HD22 ' A' ' 75' ' ' LEU . 10.4 t0 -46.2 160.85 0.06 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.879 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -146.99 161.17 41.33 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.864 -1.135 . . . . 0.0 111.67 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.658 HG22 ' H ' ' A' ' 64' ' ' GLU . 38.4 mt -133.03 172.97 15.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.112 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.658 ' H ' HG22 ' A' ' 63' ' ' ILE . 3.3 tm-20 -144.81 130.44 18.99 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.154 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 50' ' ' ALA . 21.1 m -145.19 154.54 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 118.615 -1.234 . . . . 0.0 112.108 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.91 -1.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.491 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.38 -124.12 0.23 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.062 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.631 ' ND2' ' OD1' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -121.82 121.26 36.79 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.95 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.559 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -88.47 109.05 19.72 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.673 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -61.9 -87.69 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.307 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 18.4 mt-10 -78.81 1.01 24.75 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.428 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 2.2 tp 74.73 -82.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.835 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.82 -169.19 41.94 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.225 -1.464 . . . . 0.0 110.696 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.473 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.3 Cg_endo -65.91 -46.54 4.7 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.307 2.005 . . . . 0.0 112.384 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.697 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -73.62 34.9 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.291 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 74' ' ' PRO . 29.0 p-10 -75.34 -24.05 57.3 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.745 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -80.12 4.48 17.18 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.985 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -151.93 114.12 4.5 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.533 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.54 HG21 HG13 ' A' ' 39' ' ' ILE . 24.2 m -133.9 158.29 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.963 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 81' ' ' SER . 96.4 p -164.44 -69.43 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 118.391 -1.324 . . . . 0.0 112.453 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.541 ' N ' ' OG ' ' A' ' 80' ' ' SER . 73.7 m -107.42 160.89 15.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.49 -0.884 . . . . 0.0 112.485 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.514 HG23 ' HA ' ' A' ' 52' ' ' LEU . 1.7 mt -149.87 159.7 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.635 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.809 HH22 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.7 130.72 15.32 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 118.929 -1.108 . . . . 0.0 111.415 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.809 ' CA ' HH22 ' A' ' 83' ' ' ARG . 4.2 t -132.2 141.65 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.847 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.479 HG12 ' NH2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -136.17 140.32 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.047 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 90.2 p -43.27 151.05 0.17 Allowed 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.599 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.667 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -156.85 144.14 13.75 Favored Pre-proline 0 C--N 1.307 -1.273 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.638 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.667 ' HD2' HG22 ' A' ' 87' ' ' VAL . 6.3 Cg_exo -50.05 146.27 17.63 Favored 'Trans proline' 0 C--O 1.213 -0.763 0 C-N-CA 121.256 1.304 . . . . 0.0 111.345 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.95 145.94 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.053 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -145.28 153.66 52.7 Favored Pre-proline 0 N--CA 1.486 1.349 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.469 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.459 ' HG2' HD21 ' A' ' 136' ' ' LEU . 4.8 Cg_exo -60.52 -152.07 0.01 OUTLIER 'Trans proline' 0 C--O 1.211 -0.868 0 C-N-CA 121.061 1.174 . . . . 0.0 110.501 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 179.76 -163.39 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.826 -1.15 . . . . 0.0 110.86 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.76 169.92 16.33 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.201 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.513 ' HE ' ' HG3' ' A' ' 105' ' ' GLU . 66.7 ttt180 -137.91 110.02 7.29 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.969 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.56 ' CE1' HD12 ' A' ' 108' ' ' LEU . 19.3 m-85 -93.91 168.52 10.92 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.419 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.488 ' CD1' ' HB3' ' A' ' 105' ' ' GLU . 49.2 m-85 -137.87 177.08 8.15 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 119.033 -1.067 . . . . 0.0 112.075 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.691 ' CE2' HG21 ' A' ' 127' ' ' THR . 3.2 m-85 -115.63 133.21 56.26 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.4 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 19.4 tttp 78.59 137.72 0.07 Allowed 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.035 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.628 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -68.2 104.84 1.92 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.219 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.614 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 1.7 tp-100 126.28 39.44 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.263 0 O-C-N 125.565 1.791 . . . . 0.0 109.721 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.614 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 25.7 p90 29.67 49.51 0.06 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.8 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -103.65 -17.67 15.04 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.076 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -102.41 164.07 16.67 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.594 -1.288 . . . . 0.0 110.976 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.46 ' CG ' ' N ' ' A' ' 105' ' ' GLU . 16.9 ttmt -40.7 160.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.823 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 105' ' ' GLU . 1.3 pm0 -127.14 158.97 35.64 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.613 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.4 156.43 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.741 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.631 ' OD1' ' ND2' ' A' ' 68' ' ' ASN . 4.8 p-10 -125.91 148.47 49.2 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.578 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.56 HD12 ' CE1' ' A' ' 95' ' ' PHE . 41.2 mt -139.19 124.69 11.95 Favored Pre-proline 0 N--CA 1.487 1.421 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.342 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.451 ' CB ' ' HD2' ' A' ' 110' ' ' PRO . 1.9 Cg_endo -64.39 171.59 7.78 Favored 'Trans proline' 0 C--O 1.213 -0.77 0 C-N-CA 121.476 1.451 . . . . 0.0 111.356 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 1.9 Cg_endo -60.78 146.41 97.42 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.875 1.717 . . . . 0.0 111.568 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.19 -154.92 25.74 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.674 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.591 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 28.5 mt-30 -133.24 161.29 34.85 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.842 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.591 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 24.0 m-85 -144.54 150.64 37.87 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.372 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 1.3 p -91.78 -142.17 0.19 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.697 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.597 ' N ' ' OG1' ' A' ' 114' ' ' THR . 13.7 mt-30 -90.31 -86.46 0.2 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.31 -28.2 62.86 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -70.09 -61.06 1.93 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.307 -1.357 . . . . 0.0 108.454 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.706 ' C ' HD23 ' A' ' 118' ' ' LEU . 2.2 tt -43.35 -64.04 0.71 Allowed 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.557 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.415 ' CD ' ' O ' ' A' ' 115' ' ' GLN . 1.1 mp0 -42.86 -68.3 0.21 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.36 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.554 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 10.6 mpt_? -68.43 0.33 4.09 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.624 -0.83 . . . . 0.0 113.199 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -89.03 -24.87 22.24 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 118.464 -1.295 . . . . 0.0 110.554 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -153.75 -20.75 0.05 OUTLIER Glycine 0 N--CA 1.485 1.951 0 C-N-CA 118.429 -1.844 . . . . 0.0 111.688 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.444 ' HB ' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -145.32 -115.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.329 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.444 ' H ' ' HB ' ' A' ' 123' ' ' ILE . 4.2 m-20 -167.57 -164.89 0.61 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -58.13 -76.09 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.163 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 127' ' ' THR . 3.7 t-20 -74.68 -138.11 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.123 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.691 HG21 ' CE2' ' A' ' 97' ' ' TYR . 0.5 OUTLIER 68.78 -138.45 0.09 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.785 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.441 ' C ' ' HG ' ' A' ' 129' ' ' SER . 3.9 mm 73.55 -49.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.477 0 O-C-N 124.168 0.918 . . . . 0.0 110.435 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 130' ' ' SER . 47.0 p 39.35 -135.32 0.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.937 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.542 ' N ' ' OG ' ' A' ' 129' ' ' SER . 24.1 m -63.37 143.9 57.42 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.381 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.03 151.46 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.489 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -150.31 81.67 6.62 Favored Pre-proline 0 C--N 1.304 -1.391 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.489 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -61.08 92.4 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.316 1.344 . . . . 0.0 110.043 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -73.64 26.18 0.07 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.118 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 176.71 -51.75 0.11 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 117.53 -2.272 . . . . 0.0 112.735 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.459 HD21 ' HG2' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -108.63 173.76 6.17 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.598 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -91.76 141.94 28.13 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.581 -0.848 . . . . 0.0 108.974 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 153' ' ' VAL . 66.9 t -109.89 139.99 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.547 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.03 127.17 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.701 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 mp -101.52 138.88 37.93 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.552 -0.859 . . . . 0.0 112.39 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.431 ' CG ' ' HA ' ' A' ' 146' ' ' PHE . 22.3 m-85 -114.07 118.56 34.42 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.082 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -48.19 -77.49 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.625 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.443 ' HB2' ' CB ' ' A' ' 147' ' ' SER . 3.3 m-20 -74.59 -156.49 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.341 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 146' ' ' PHE . 6.8 p-10 -62.07 -154.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.819 HD22 ' H ' ' A' ' 145' ' ' ASN . 1.9 m-80 -33.62 88.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.159 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.529 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 3.3 p90 36.31 66.07 0.41 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.663 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 92.5 p -61.0 -108.05 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.738 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.52 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . -115.4 -63.23 0.38 Allowed Glycine 0 N--CA 1.502 3.043 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.974 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.404 ' C ' ' CG2' ' A' ' 150' ' ' THR . 24.3 t70 -74.13 144.47 44.87 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.58 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.404 ' CG2' ' C ' ' A' ' 149' ' ' ASP . 6.7 p -151.67 173.74 14.32 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.491 -0.883 . . . . 0.0 111.187 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.547 ' C ' HD23 ' A' ' 151' ' ' LEU . 3.0 tt -144.25 87.51 7.78 Favored Pre-proline 0 C--N 1.31 -1.145 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.153 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.14 103.99 0.56 Allowed 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.671 1.581 . . . . 0.0 112.651 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 138' ' ' VAL . 2.8 t -77.75 93.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.154 -1.019 . . . . 0.0 109.912 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -43.78 -42.85 5.79 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.888 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.1 t -171.2 -130.09 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 118.456 -1.298 . . . . 0.0 112.229 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -46.44 141.89 3.36 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.681 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.85 64.13 1.06 Allowed Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.195 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.6 Cg_endo -63.08 21.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.279 1.986 . . . . 0.0 113.269 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 159' ' ' THR . 1.3 t -172.37 106.4 0.18 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.806 -1.157 . . . . 0.0 110.911 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.674 HD13 ' C ' ' A' ' 160' ' ' LEU . 3.0 tm? -103.6 -78.63 0.55 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.288 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.433 ' O ' ' CD1' ' A' ' 160' ' ' LEU . . . . . . . . 0 N--CA 1.494 2.539 0 C-N-CA 119.859 -1.163 . . . . 0.0 111.656 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.578 0.228 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.8 m 44.72 83.08 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.391 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.36 -52.22 8.37 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.846 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.2 p -123.66 163.77 20.41 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.68 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 36.2 pt -143.34 178.22 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.522 ' NH1' ' OE1' ' A' ' 112' ' ' GLN . 35.5 ttt85 -156.8 109.23 2.51 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.64 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.2 mt -85.95 95.8 4.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.149 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 C--N 1.303 -1.415 0 CA-C-O 116.379 -1.772 . . . . 0.0 110.825 -179.92 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.462 ' HB1' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.985 0.421 . . . . 0.0 111.506 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.713 ' N ' ' ND2' ' A' ' 3' ' ' ASN . 0.1 OUTLIER 179.49 122.3 0.06 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.517 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 4' ' ' ILE . 1.7 pt -77.44 126.91 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.985 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.9 m -105.51 108.21 19.61 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.11 165.23 2.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.028 -1.069 . . . . 0.0 112.717 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.448 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 50.1 m-85 -123.37 145.15 48.99 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.837 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.46 ' HB2' ' N ' ' A' ' 15' ' ' LYS . 2.0 m-85 -83.91 8.45 15.0 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 13' ' ' GLN . 0.4 OUTLIER -150.19 171.08 17.49 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 118.132 -1.427 . . . . 0.0 111.979 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.497 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 11.6 mm-40 -78.36 146.88 34.39 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.348 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.587 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 2.1 t70 76.87 60.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.42 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.587 ' CG ' ' O ' ' A' ' 11' ' ' ASP . 54.7 p90 42.78 15.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.774 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 11' ' ' ASP . 14.2 mt-30 -101.42 154.5 18.75 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.193 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 1.144 ' O ' ' NE2' ' A' ' 16' ' ' GLN . . . 116.63 139.34 6.48 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 1.33 ' C ' HE21 ' A' ' 16' ' ' GLN . 9.3 mtpm? -36.41 147.38 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.491 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 1.407 HE21 ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -99.88 142.25 31.61 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.584 -0.847 . . . . 0.0 112.25 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 t -144.48 123.72 6.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.523 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -95.47 119.39 33.89 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.414 -0.914 . . . . 0.0 112.106 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.1 125.7 30.1 Favored Pre-proline 0 N--CA 1.494 1.762 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.471 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -65.44 162.39 33.97 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 120.993 1.128 . . . . 0.0 111.724 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.31 -178.83 0.51 Allowed 'Trans proline' 0 C--N 1.322 -0.838 0 C-N-CA 121.768 1.645 . . . . 0.0 110.966 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.711 ' C ' HD22 ' A' ' 23' ' ' ASN . . . 108.4 -170.9 15.3 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.381 -1.39 . . . . 0.0 110.662 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.711 HD22 ' C ' ' A' ' 22' ' ' GLY . 0.6 OUTLIER -117.21 124.69 49.72 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.96 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.2 p90 -144.3 169.43 17.91 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.786 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.7 p -140.75 -142.04 0.14 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.992 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.444 ' NH2' ' ND2' ' A' ' 36' ' ' ASN . 15.7 tpp180 -69.32 -38.5 78.25 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.031 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.591 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -54.7 -58.59 6.94 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.14 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -56.89 -51.18 70.1 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.484 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.55 HD23 HD12 ' A' ' 32' ' ' LEU . 28.4 mt -58.26 -28.8 65.27 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.446 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -56.26 -32.09 64.18 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.42 -36.04 63.41 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.72 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.55 HD12 HD23 ' A' ' 29' ' ' LEU . 13.3 mt -77.01 -83.65 0.07 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.89 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 32' ' ' LEU . . . 152.39 -16.91 0.77 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.033 -1.556 . . . . 0.0 111.225 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.407 ' H ' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -91.36 138.98 18.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.073 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.505 ' C ' ' CG ' ' A' ' 36' ' ' ASN . 1.8 pt-20 172.42 150.31 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.403 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.747 ' O ' HG23 ' A' ' 38' ' ' THR . 0.5 OUTLIER 75.86 123.81 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 43.39 12.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.358 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.747 HG23 ' O ' ' A' ' 36' ' ' ASN . 64.3 p -88.86 -151.38 0.21 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.447 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.443 HD12 HG11 ' A' ' 79' ' ' VAL . 2.3 mt 42.49 60.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.736 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.8 t -80.14 -33.15 38.74 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.418 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.448 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -143.14 153.72 43.16 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.247 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.056 HG22 ' HB3' ' A' ' 69' ' ' ALA . 25.4 m -143.38 170.44 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 118.128 -1.429 . . . . 0.0 113.578 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -143.48 95.67 2.79 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.862 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.99 108.48 46.27 Favored Pre-proline 0 N--CA 1.493 1.716 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.73 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.414 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.6 Cg_endo -68.52 170.29 15.35 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 120.975 1.117 . . . . 0.0 110.321 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 2.5 Cg_endo -60.28 -170.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.877 1.718 . . . . 0.0 111.407 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.3 -12.34 10.11 Favored Glycine 0 N--CA 1.485 1.945 0 C-N-CA 119.407 -1.377 . . . . 0.0 111.13 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.462 HG21 ' HB1' ' A' ' 2' ' ' ALA . 4.4 m -148.77 139.55 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.142 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -115.38 120.23 38.89 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.03 155.25 19.58 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.287 -0.965 . . . . 0.0 112.808 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 63' ' ' ILE . 71.4 mt -142.22 118.28 6.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.094 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.451 HD12 ' H ' ' A' ' 52' ' ' LEU . 3.6 mp -88.8 159.37 17.78 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.008 -1.077 . . . . 0.0 112.504 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.441 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 72.1 m-85 -141.59 118.89 11.43 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.836 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -49.9 -82.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.435 ' ND2' ' H ' ' A' ' 56' ' ' ASP . 2.7 t-20 -58.59 155.06 13.06 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.386 -0.925 . . . . 0.0 111.799 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.435 ' H ' ' ND2' ' A' ' 55' ' ' ASN . 21.1 p-10 -59.89 -177.9 0.07 Allowed 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.705 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.581 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 50.45 38.71 35.23 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 39.17 71.12 0.18 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.521 0.677 . . . . 0.0 111.058 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.3 172.52 12.81 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.969 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.34 -174.64 55.0 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.445 -1.36 . . . . 0.0 109.981 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -44.87 158.1 0.06 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.895 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.502 ' C ' ' NE2' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -149.84 168.41 23.81 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.812 -1.155 . . . . 0.0 111.499 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.72 HG22 ' N ' ' A' ' 64' ' ' GLU . 73.0 mt -134.85 174.11 13.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.723 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.72 ' N ' HG22 ' A' ' 63' ' ' ILE . 24.8 mt-10 -144.74 133.92 22.86 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.568 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.401 HG13 ' C ' ' A' ' 64' ' ' GLU . 25.4 m -150.55 152.89 11.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 118.628 -1.229 . . . . 0.0 112.224 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.4 ' H ' ' H ' ' A' ' 67' ' ' ALA . 1.0 OUTLIER -139.54 -10.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.494 ' HB1' ' OD1' ' A' ' 107' ' ' ASP . . . -119.92 -156.93 0.69 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.56 -1.655 . . . . 0.0 109.673 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.434 ' C ' ' ND2' ' A' ' 68' ' ' ASN . 0.5 OUTLIER -93.23 127.85 38.98 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.077 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.056 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -90.43 119.52 30.78 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.781 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -79.9 -58.74 3.02 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.445 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -106.52 19.47 20.44 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.612 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.544 HD23 ' ND2' ' A' ' 76' ' ' ASN . 15.0 tp 53.01 -98.4 0.07 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.466 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.82 -158.99 31.47 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.093 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.669 ' C ' HD23 ' A' ' 75' ' ' LEU . 1.5 Cg_endo -66.02 -157.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.451 1.434 . . . . 0.0 110.545 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.713 HD21 ' CG1' ' A' ' 63' ' ' ILE . 1.4 pt? 31.69 32.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 123.8 0.687 . . . . 0.0 111.79 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.546 ' N ' ' O ' ' A' ' 74' ' ' PRO . 8.5 t-20 -80.22 -12.03 59.67 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.795 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -72.72 -12.84 61.18 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.085 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -160.29 134.67 7.43 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 118.889 -1.124 . . . . 0.0 111.69 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.443 HG11 HD12 ' A' ' 39' ' ' ILE . 3.3 t -145.39 153.18 14.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.845 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 81' ' ' SER . 86.9 p -164.89 -57.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.351 -1.34 . . . . 0.0 112.772 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.473 ' N ' ' OG ' ' A' ' 80' ' ' SER . 32.9 t -89.9 146.42 24.43 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.613 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 82' ' ' ILE . 0.3 OUTLIER -146.77 134.01 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 118.74 -1.184 . . . . 0.0 111.153 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.621 ' NE ' ' HA ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -108.74 141.15 41.16 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.304 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.525 ' HB ' ' H ' ' A' ' 22' ' ' GLY . 9.4 t -144.33 123.55 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.226 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.5 mt -129.07 125.67 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.303 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.8 m -43.73 132.71 4.95 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.686 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.537 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -126.65 139.38 34.64 Favored Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.499 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.537 ' HD2' HG22 ' A' ' 87' ' ' VAL . 2.7 Cg_exo -52.76 143.55 47.16 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.127 1.218 . . . . 0.0 110.741 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.0 t -59.98 122.24 9.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.229 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -102.89 135.32 19.45 Favored Pre-proline 0 C--N 1.306 -1.326 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.987 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -52.53 -33.0 55.9 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 120.85 1.033 . . . . 0.0 110.283 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.443 HH22 ' HB2' ' A' ' 67' ' ' ALA . 17.9 mtt-85 50.68 -164.43 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.662 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.534 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.66 177.2 8.66 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.185 -1.37 . . . . 0.0 108.437 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -150.36 132.19 15.08 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 118.21 -1.396 . . . . 0.0 112.088 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.54 ' CE2' HG13 ' A' ' 131' ' ' VAL . 21.9 m-85 -118.68 147.65 43.58 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.757 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -121.15 159.29 26.13 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.185 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.658 ' OH ' HG22 ' A' ' 123' ' ' ILE . 8.0 m-30 -95.15 164.14 12.99 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.603 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 tttt 67.7 135.6 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.691 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.595 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 8.6 tp10 -63.69 100.94 0.31 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.273 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 1.037 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 119.73 38.17 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.882 0 O-C-N 125.426 1.704 . . . . 0.0 108.47 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.771 ' CD1' ' NE2' ' A' ' 100' ' ' GLN . 22.5 p90 33.78 44.09 0.08 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.76 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -103.64 32.33 3.93 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.581 -0.847 . . . . 0.0 111.453 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -153.66 170.11 32.38 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.167 -1.492 . . . . 0.0 110.751 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.1 OUTLIER -35.03 151.13 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.428 ' CD ' ' C ' ' A' ' 105' ' ' GLU . 1.4 pp20? -121.92 168.31 12.04 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.847 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.88 139.41 19.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.283 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.494 ' OD1' ' HB1' ' A' ' 67' ' ' ALA . 6.3 p30 -108.98 151.44 26.31 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.748 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 72.3 mt -139.64 140.27 24.56 Favored Pre-proline 0 N--CA 1.497 1.877 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.804 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -76.03 164.13 31.97 Favored 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 121.944 1.763 . . . . 0.0 111.254 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.41 142.01 76.88 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.555 1.503 . . . . 0.0 110.581 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 144.05 -158.63 27.48 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 118.916 -1.612 . . . . 0.0 111.466 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.58 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 24.4 tt0 -125.28 154.97 40.9 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.88 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.58 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 25.3 m-85 -143.53 152.71 41.79 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.738 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.7 p -106.44 178.43 4.56 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.867 0.841 . . . . 0.0 112.97 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.644 ' NE2' ' CD ' ' A' ' 119' ' ' GLU . 24.1 tp60 -59.39 -20.85 58.12 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.558 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.44 -60.71 1.85 Allowed 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.901 -1.12 . . . . 0.0 114.01 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -67.4 -56.83 8.07 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.219 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.607 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -34.11 -74.02 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 O-C-N 123.801 0.688 . . . . 0.0 111.817 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.644 ' CD ' ' NE2' ' A' ' 115' ' ' GLN . 69.5 mt-10 -51.19 -56.36 13.24 Favored 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.739 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.461 ' HD3' ' H ' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -75.06 14.65 0.5 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.474 -1.291 . . . . 0.0 111.647 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 117' ' ' GLU . 18.4 t80 -119.39 -16.44 8.96 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.856 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.507 ' C ' HD13 ' A' ' 123' ' ' ILE . . . -139.49 -48.08 0.06 OUTLIER Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.676 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.658 HG22 ' OH ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -137.85 -108.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.969 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.554 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 18.3 t70 -161.75 -146.8 0.13 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.402 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.554 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 4.4 m-20 -60.67 -52.72 63.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.338 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.76 HD22 HD22 ' A' ' 166' ' ' ASN . 29.4 t-20 -158.04 134.71 9.72 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.426 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.448 ' H ' ' H ' ' A' ' 128' ' ' ILE . 2.5 t -178.61 -10.1 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.507 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.448 ' H ' ' H ' ' A' ' 127' ' ' THR . 9.4 mt -70.42 141.39 17.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.528 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.3 t -157.33 12.55 0.23 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.026 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.3 m -170.7 117.12 0.49 Allowed 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.579 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.54 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.6 t -110.51 156.28 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.995 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.466 ' NZ ' ' HG3' ' A' ' 158' ' ' PRO . 1.6 tppt? -155.02 87.25 3.32 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.292 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.02 101.4 0.18 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.309 1.34 . . . . 0.0 111.678 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.534 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 38.2 tt0 -54.17 -12.21 0.6 Allowed 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.986 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -178.83 -36.6 0.06 OUTLIER Glycine 0 N--CA 1.497 2.76 0 C-N-CA 118.412 -1.852 . . . . 0.0 112.245 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mt -92.1 -174.97 3.93 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.998 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.45 137.04 48.68 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.459 ' CG1' ' CD1' ' A' ' 140' ' ' LEU . 7.2 t -103.1 140.49 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.413 -0.915 . . . . 0.0 112.866 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.467 ' C ' HD12 ' A' ' 140' ' ' LEU . 96.4 t -131.2 120.15 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.453 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 140' ' ' LEU . 10.1 mp -98.59 143.75 28.64 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.327 -0.949 . . . . 0.0 113.307 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.416 ' CD2' ' HB3' ' A' ' 146' ' ' PHE . 27.8 m-85 -120.27 130.89 54.68 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.111 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.404 ' HG2' HD22 ' A' ' 143' ' ' ASN . 51.0 tttp -67.21 -69.67 0.3 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.142 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.42 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.5 m-80 -70.16 164.19 24.72 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.558 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 146' ' ' PHE . 3.6 m-20 -63.58 -160.05 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.606 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.654 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 2.5 p30 32.76 34.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 123.733 0.646 . . . . 0.0 111.57 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.654 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 42.82 61.24 2.17 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 44.5 t -136.26 -178.55 5.21 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.006 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.491 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 75.67 -163.13 53.47 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.354 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.76 164.12 3.94 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.144 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.2 p -148.2 170.16 18.48 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.944 -1.103 . . . . 0.0 111.668 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.1 tp -141.89 84.98 11.48 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.151 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -62.45 102.66 0.29 Allowed 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.076 1.85 . . . . 0.0 113.59 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 138' ' ' VAL . 6.8 t -89.19 80.36 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.346 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -76.88 14.09 0.91 Allowed 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.592 -0.843 . . . . 0.0 113.015 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 19.8 t -169.97 -169.67 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 117.785 -1.566 . . . . 0.0 112.959 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.454 ' N ' ' OG ' ' A' ' 155' ' ' SER . 64.3 m-20 -57.03 152.26 13.48 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.519 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.563 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -172.88 62.62 0.29 Allowed Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.072 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 5.8 Cg_endo -70.05 34.38 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 122.336 2.024 . . . . 0.0 112.2 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 159' ' ' THR . 0.6 OUTLIER -176.33 76.57 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.407 -1.317 . . . . 0.0 112.389 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -81.2 -87.51 0.08 Allowed 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.63 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.106 0 C-N-CA 119.585 -1.293 . . . . 0.0 111.857 179.786 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.76 HD22 HD22 ' A' ' 126' ' ' ASN . 15.1 m120 . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.861 0.363 . . . . 0.0 111.88 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.7 m -59.82 112.81 1.98 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.424 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.6 t -97.24 -63.13 1.16 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.549 -0.861 . . . . 0.0 112.043 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.06 162.39 17.47 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.04 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 25.6 pt -147.78 179.49 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.307 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -161.32 114.62 1.93 Allowed 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.302 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 42.9 mt -90.57 98.97 8.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.349 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--N 1.304 -1.405 0 CA-C-O 116.298 -1.81 . . . . 0.0 110.988 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.513 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.784 0.326 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 2' ' ' ALA . 21.9 m-80 -169.29 110.97 0.48 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.707 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.4 pt -70.68 140.87 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.102 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -115.35 120.31 39.18 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.715 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.511 ' CG2' HG23 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -104.3 155.79 5.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.923 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.448 ' N ' ' CG2' ' A' ' 6' ' ' VAL . 38.8 m-85 -115.64 139.98 49.61 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.191 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -62.92 1.36 Allowed 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.385 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.562 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 3.2 m120 -89.5 168.36 12.25 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.52 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.442 ' HG2' ' H ' ' A' ' 10' ' ' GLU . 10.2 pt-20 -70.35 -162.56 0.06 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.414 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.622 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 1.3 m-20 47.43 45.91 17.19 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.254 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.622 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 51.3 p90 38.63 24.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.951 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ASP . 3.8 pt20 -113.04 163.58 14.52 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.562 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 103.9 134.35 8.17 Favored Glycine 0 N--CA 1.501 2.996 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.457 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.519 ' CD ' ' H ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -28.99 132.88 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.02 0.438 . . . . 0.0 111.741 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.705 ' H ' ' NE2' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -97.63 164.81 12.26 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.727 -0.789 . . . . 0.0 112.423 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 t -149.7 123.63 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.658 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.76 120.84 32.85 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.612 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mt -108.8 140.96 22.36 Favored Pre-proline 0 N--CA 1.489 1.513 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.081 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -72.2 165.72 31.8 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 120.909 1.072 . . . . 0.0 111.277 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.77 -158.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 121.905 1.736 . . . . 0.0 111.089 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.71 168.3 24.56 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 119.272 -1.442 . . . . 0.0 111.551 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.58 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -95.87 140.45 30.62 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.065 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.69 ' OH ' HD12 ' A' ' 82' ' ' ILE . 36.7 p90 -155.68 176.2 12.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.673 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.965 HG23 ' H ' ' A' ' 27' ' ' ALA . 6.3 t -138.09 -157.32 0.76 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.009 -1.077 . . . . 0.0 112.443 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.718 ' N ' HG23 ' A' ' 25' ' ' THR . 13.1 ptm180 -63.69 -25.82 68.38 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.358 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.965 ' H ' HG23 ' A' ' 25' ' ' THR . . . -58.56 -55.96 28.27 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.652 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -58.29 -45.1 88.6 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.637 -1.225 . . . . 0.0 109.555 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.443 HD23 HD12 ' A' ' 32' ' ' LEU . 30.2 mt -59.97 -34.09 72.82 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.518 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -54.74 -32.02 59.27 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -71.46 -40.55 70.24 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.675 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.443 HD12 HD23 ' A' ' 29' ' ' LEU . 15.0 mt -70.35 -81.04 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.967 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 32' ' ' LEU . . . 160.09 -26.43 0.32 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 118.952 -1.594 . . . . 0.0 111.049 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.557 HD13 ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -85.73 152.22 3.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.574 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.451 ' N ' HG12 ' A' ' 34' ' ' ILE . 3.4 pt-20 -178.51 154.31 0.78 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.357 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 38' ' ' THR . 1.3 m120 64.68 -149.93 0.27 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.549 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -56.21 81.43 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.724 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 36' ' ' ASN . 39.6 p -143.75 -33.56 0.42 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.664 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.621 ' CD1' HD11 ' A' ' 82' ' ' ILE . 3.9 mt -78.87 51.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 119.181 -1.008 . . . . 0.0 109.452 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.8 t -51.38 -46.98 62.99 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.573 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -125.21 167.29 15.06 Favored 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.79 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -155.45 149.69 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 118.197 -1.401 . . . . 0.0 113.05 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -133.59 126.92 31.98 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.492 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.2 t -144.0 113.62 5.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 C-N-CA 119.173 -1.011 . . . . 0.0 112.149 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.37 167.6 21.86 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 121.283 1.322 . . . . 0.0 111.082 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.67 -169.22 0.1 OUTLIER 'Trans proline' 0 C--N 1.32 -0.937 0 C-N-CA 121.97 1.78 . . . . 0.0 111.504 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.406 ' C ' HG13 ' A' ' 48' ' ' VAL . . . 77.66 -15.26 7.95 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.808 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.513 HG11 ' CB ' ' A' ' 2' ' ' ALA . 24.1 m -150.91 139.58 14.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.873 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -109.25 129.24 55.51 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.095 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.76 152.55 24.21 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.409 -0.916 . . . . 0.0 112.661 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.724 HD12 HH21 ' A' ' 83' ' ' ARG . 71.1 mt -139.57 121.3 16.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.992 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.782 HD23 HG23 ' A' ' 82' ' ' ILE . 0.4 OUTLIER -98.69 162.01 13.35 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 119.384 -0.926 . . . . 0.0 112.341 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 62' ' ' GLN . 11.6 m-85 -140.76 115.28 9.45 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.668 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -46.54 -78.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.871 -0.731 . . . . 0.0 112.044 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.417 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 6.9 m120 -59.77 156.41 14.09 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.112 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -64.59 -173.69 0.11 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.726 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.86 36.31 33.23 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.355 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.481 ' CE1' ' O ' ' A' ' 24' ' ' TYR . 12.0 m-85 49.71 59.16 4.71 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.728 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.36 -176.88 4.54 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.417 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 76.51 170.22 31.04 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 60' ' ' GLY . 17.7 m-20 -42.41 125.85 3.31 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.147 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.426 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.4 pt20 -95.01 163.83 13.15 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.75 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.683 HG22 ' N ' ' A' ' 64' ' ' GLU . 4.6 mm -134.93 168.77 22.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.009 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.683 ' N ' HG22 ' A' ' 63' ' ' ILE . 30.8 tt0 -150.48 132.26 15.02 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.253 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.0 m -148.34 151.46 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.301 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.0 -7.73 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.768 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -122.99 -139.27 0.31 Allowed 'General case' 0 C--O 1.206 -1.237 0 CA-C-N 114.042 -1.436 . . . . 0.0 109.281 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -114.2 116.74 29.54 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.646 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.64 112.39 23.61 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.8 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -67.03 -85.79 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.451 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 7.8 mm-40 -72.56 -1.99 18.12 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.738 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.494 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 3.8 tp 75.99 -84.57 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.87 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.03 -161.67 30.29 Favored Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.151 -1.5 . . . . 0.0 110.753 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.547 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.6 Cg_endo -68.87 -55.41 0.21 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.121 1.881 . . . . 0.0 112.335 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -69.77 27.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.599 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.547 ' H ' ' C ' ' A' ' 74' ' ' PRO . 3.2 p30 -70.91 10.76 0.48 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.118 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.5 ' H ' ' C ' ' A' ' 75' ' ' LEU . 23.3 t-20 -89.47 -9.98 48.07 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.096 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -166.49 132.68 2.41 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.726 -1.19 . . . . 0.0 111.697 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.402 ' CG1' HD12 ' A' ' 39' ' ' ILE . 2.1 t -147.95 142.47 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.057 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 m -154.63 -48.27 0.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.238 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.6 t -90.01 136.28 33.14 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.062 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.782 HG23 HD23 ' A' ' 52' ' ' LEU . 10.6 mt -151.76 149.94 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.434 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.724 HH21 HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -151.32 153.33 34.6 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.844 -1.142 . . . . 0.0 111.213 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.498 ' C ' HH12 ' A' ' 83' ' ' ARG . 3.3 t -142.7 147.19 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.394 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.502 HG12 ' NH1' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -138.77 132.25 39.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.389 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 85' ' ' ILE . 78.7 p -36.78 147.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.89 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.549 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -151.44 140.62 13.81 Favored Pre-proline 0 N--CA 1.487 1.385 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.27 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.549 ' HD2' HG22 ' A' ' 87' ' ' VAL . 6.9 Cg_exo -50.89 133.55 40.16 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 121.256 1.304 . . . . 0.0 111.372 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.555 HG22 ' N ' ' A' ' 90' ' ' GLN . 2.5 p -65.93 160.96 3.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.912 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.555 ' N ' HG22 ' A' ' 89' ' ' VAL . 62.4 mt-30 -143.51 151.31 53.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.157 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.453 ' HG2' HD21 ' A' ' 136' ' ' LEU . 1.8 Cg_endo -64.93 -40.58 20.45 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 121.587 1.525 . . . . 0.0 112.164 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.448 ' CG ' ' C ' ' A' ' 91' ' ' PRO . 3.0 mtm-85 57.98 -164.92 0.17 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.737 0.78 . . . . 0.0 112.431 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.513 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -138.89 173.31 11.7 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.812 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -150.85 123.03 8.29 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.291 -1.364 . . . . 0.0 112.339 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.478 ' O ' ' CB ' ' A' ' 105' ' ' GLU . 8.2 m-30 -95.92 166.39 11.81 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.275 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -135.47 154.65 51.35 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -95.57 146.53 24.39 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.424 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.9 tttt 66.97 126.06 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.564 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 28.6 tt0 -64.27 90.81 0.07 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.702 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.674 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 169.71 21.78 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.734 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.674 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 28.5 p90 38.81 42.22 0.6 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.142 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -118.26 -57.86 2.04 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.533 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -44.52 159.58 0.13 Allowed Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.613 -1.28 . . . . 0.0 110.705 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -47.58 168.82 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.251 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -134.57 167.46 20.76 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.39 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.7 t -143.26 137.46 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.94 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -110.74 160.79 16.4 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 119.325 -0.95 . . . . 0.0 113.23 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.9 mt -145.94 139.01 14.24 Favored Pre-proline 0 N--CA 1.49 1.551 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.03 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -69.55 166.05 28.66 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 121.505 1.47 . . . . 0.0 111.156 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.99 144.68 99.63 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.734 1.622 . . . . 0.0 111.35 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 139.78 178.91 17.21 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 119.188 -1.482 . . . . 0.0 111.423 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.454 ' OE1' ' N ' ' A' ' 113' ' ' TYR . 14.4 tm0? -106.68 157.76 17.47 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.471 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.454 ' N ' ' OE1' ' A' ' 112' ' ' GLN . 67.8 m-85 -145.86 149.97 35.26 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.069 -1.053 . . . . 0.0 111.298 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.0 p -88.08 -157.27 0.4 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.347 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.39 52.22 0.72 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.019 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.18 -69.84 0.12 Allowed 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -70.54 -42.15 71.56 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.499 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.679 ' C ' HD23 ' A' ' 118' ' ' LEU . 2.4 tt -40.53 -73.55 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.254 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.751 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 0.7 OUTLIER -52.59 -49.87 64.16 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.955 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.404 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 1.8 mpt_? -70.99 -0.33 9.1 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.851 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.533 ' N ' ' O ' ' A' ' 117' ' ' GLU . 24.5 t80 -100.82 -22.81 14.73 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.497 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -131.12 -47.75 0.12 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.208 -1.473 . . . . 0.0 110.811 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.526 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -142.94 -107.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.113 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.526 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 7.0 m-20 -149.26 -178.67 6.53 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.998 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.07 10.61 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.473 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.489 ' H ' ' C ' ' A' ' 124' ' ' ASP . 0.4 OUTLIER -163.72 -139.23 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.511 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 126' ' ' ASN . 0.0 OUTLIER 33.78 87.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.275 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.9 mm -127.23 -41.98 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.071 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.7 m 46.1 -138.31 0.57 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.36 -0.836 . . . . 0.0 113.129 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.5 m -56.98 140.33 49.24 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.576 -1.193 . . . . 0.0 113.005 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.41 HG13 ' CD1' ' A' ' 95' ' ' PHE . 3.9 t -122.28 150.45 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.647 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -145.52 98.6 4.55 Favored Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.907 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -66.49 105.42 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.177 1.252 . . . . 0.0 110.969 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.513 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 28.0 mm-40 -57.97 -11.15 2.18 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.588 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 172.4 -30.31 0.11 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 118.226 -1.94 . . . . 0.0 112.352 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.453 HD21 ' HG2' ' A' ' 91' ' ' PRO . 4.3 mt -98.18 169.45 9.58 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.246 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -88.39 130.17 35.23 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.0 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.7 t -99.85 137.92 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.21 -0.996 . . . . 0.0 112.094 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.419 HG12 ' CE1' ' A' ' 141' ' ' PHE . 86.6 t -136.44 121.73 27.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.149 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.406 ' N ' HD12 ' A' ' 140' ' ' LEU . 5.0 mp -103.56 148.0 26.51 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.952 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.529 ' CD2' ' HB3' ' A' ' 146' ' ' PHE . 15.9 m-85 -120.79 130.54 54.03 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.134 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -66.32 -72.23 0.17 Allowed 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.476 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -75.17 164.74 26.17 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.59 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.617 ' CG ' ' H ' ' A' ' 145' ' ' ASN . 28.7 t0 -62.68 -161.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.831 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.641 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 2.5 m120 41.16 26.33 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.192 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.641 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 3.1 p90 41.01 58.11 2.6 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.489 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.8 t -136.78 -172.05 3.08 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.237 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.9 -165.54 50.64 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.129 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -59.33 148.86 30.72 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.996 -1.081 . . . . 0.0 110.178 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.2 p -138.82 177.15 8.1 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.534 -0.867 . . . . 0.0 111.468 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.426 ' C ' HD13 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -142.64 84.81 10.68 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.608 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.28 104.4 0.88 Allowed 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 121.8 1.667 . . . . 0.0 112.736 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 26.0 t -85.17 86.53 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.403 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -58.02 -21.32 44.56 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.938 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 59.4 p -169.79 -149.32 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 117.841 -1.544 . . . . 0.0 113.046 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -49.51 142.49 7.92 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.769 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -161.7 64.44 1.78 Allowed Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.666 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.1 Cg_endo -62.08 19.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 122.199 1.933 . . . . 0.0 113.066 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.564 ' O ' HG23 ' A' ' 159' ' ' THR . 1.5 t -172.92 83.22 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 118.27 -1.372 . . . . 0.0 112.128 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.99 -67.45 0.85 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.739 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 C-N-CA 119.849 -1.167 . . . . 0.0 111.464 179.906 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 121.083 0.468 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 44.9 m -147.98 98.67 2.97 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.271 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.3 m -89.67 -38.86 13.59 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.657 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.1 p -146.31 152.4 39.09 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.754 -1.179 . . . . 0.0 110.103 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 118' ' ' LEU . 23.0 pt -134.07 175.96 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.331 -0.947 . . . . 0.0 111.015 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -153.48 108.76 3.2 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.438 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 11.1 mt -91.89 93.3 4.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.295 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 116.334 -1.793 . . . . 0.0 110.909 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.512 ' C ' ' ND2' ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.516 0.198 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.512 ' ND2' ' C ' ' A' ' 2' ' ' ALA . 11.2 m-80 -159.67 128.75 5.19 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.842 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.481 ' CG1' ' O ' ' A' ' 4' ' ' ILE . 1.2 pt -73.28 124.93 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.127 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -97.86 106.24 18.51 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.256 -0.978 . . . . 0.0 108.511 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.541 ' HB ' HG23 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -90.47 166.38 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 119.195 -1.002 . . . . 0.0 113.257 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.678 ' CZ ' ' CE1' ' A' ' 12' ' ' PHE . 37.6 m-85 -122.7 134.44 54.46 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.358 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.69 -60.23 4.12 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.645 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 3.0 m120 -89.72 174.28 7.81 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.129 -1.028 . . . . 0.0 112.15 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 7.4 tp10 -81.96 165.25 20.89 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.779 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 10' ' ' GLU . 1.6 t70 76.17 42.01 0.2 Allowed 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.027 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.678 ' CE1' ' CZ ' ' A' ' 7' ' ' PHE . 78.1 t80 51.69 11.17 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.423 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -107.32 162.1 14.21 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.318 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.645 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 106.15 133.89 7.61 Favored Glycine 0 N--CA 1.503 3.142 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.853 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 14' ' ' GLY . 33.4 mttp -29.86 138.88 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.424 ' H ' ' HG3' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -97.17 158.43 15.45 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.446 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 t -147.84 125.73 3.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.596 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -92.09 120.67 32.92 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.161 -1.016 . . . . 0.0 111.694 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.445 HD12 HG11 ' A' ' 6' ' ' VAL . 7.5 mt -114.3 133.17 22.47 Favored Pre-proline 0 N--CA 1.498 1.959 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.265 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -69.53 167.89 22.84 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 120.848 1.032 . . . . 0.0 111.155 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -67.2 -162.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.893 1.729 . . . . 0.0 110.767 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.18 172.8 48.93 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.138 -1.506 . . . . 0.0 111.079 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.56 ' HB3' ' NE ' ' A' ' 83' ' ' ARG . 2.7 p30 -106.26 139.9 40.05 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.859 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.577 ' CZ ' HD12 ' A' ' 82' ' ' ILE . 4.0 p90 -155.75 -174.62 5.04 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.425 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.5 p -144.4 -156.29 0.68 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.036 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -65.67 -22.03 66.6 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.77 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -64.0 -60.67 2.96 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.501 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 27.8 tt0 -54.86 -45.65 74.59 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.498 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.5 ' HA ' HD23 ' A' ' 29' ' ' LEU . 15.0 mt -56.89 -43.05 80.93 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.579 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.76 -34.25 18.67 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 118.878 -1.129 . . . . 0.0 108.826 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -66.55 -42.29 87.36 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.421 -0.911 . . . . 0.0 109.793 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.472 HD12 HD23 ' A' ' 29' ' ' LEU . 9.6 mt -71.71 -71.92 0.25 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.715 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.41 -37.76 0.68 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.329 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.503 ' H ' HG22 ' A' ' 34' ' ' ILE . 1.4 tt -79.3 146.35 8.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.367 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -179.89 161.63 0.98 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.53 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.652 ' O ' HG22 ' A' ' 38' ' ' THR . 7.9 m120 60.1 -128.43 1.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.094 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.669 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -51.98 90.67 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.874 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 36' ' ' ASN . 0.3 OUTLIER -178.91 -165.99 0.09 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.383 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.647 ' N ' ' OG1' ' A' ' 38' ' ' THR . 5.2 mt 46.77 37.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-O 122.208 1.004 . . . . 0.0 108.829 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.442 ' OG ' ' CD ' ' A' ' 10' ' ' GLU . 30.9 t -70.02 -31.99 69.92 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.394 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -134.81 154.97 51.4 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.972 HG22 ' HB3' ' A' ' 69' ' ' ALA . 15.5 m -147.45 168.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 117.894 -1.523 . . . . 0.0 113.785 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -141.93 91.06 2.32 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.27 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.4 t -107.91 108.94 61.95 Favored Pre-proline 0 N--CA 1.487 1.38 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.034 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.415 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 2.4 Cg_endo -67.21 172.01 10.66 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.146 1.231 . . . . 0.0 109.587 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.513 ' HB3' ' HE ' ' A' ' 92' ' ' ARG . 2.1 Cg_endo -60.81 -168.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.329 1.353 . . . . 0.0 110.712 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.05 -19.0 10.84 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.12 -1.514 . . . . 0.0 111.871 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.638 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -155.49 155.53 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 118.118 -1.433 . . . . 0.0 113.054 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.417 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 24.4 ttpt -123.61 129.74 51.61 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.257 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.96 134.11 52.85 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.385 -0.926 . . . . 0.0 113.175 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.3 mt -115.51 117.67 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.154 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.949 HD12 ' N ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -96.35 163.06 13.23 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.215 -0.994 . . . . 0.0 113.337 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -139.92 111.61 7.33 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.052 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -82.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.309 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.465 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 5.2 t-20 -59.99 137.56 58.05 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.546 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.599 ' CG ' ' H ' ' A' ' 57' ' ' GLY . 26.2 t70 -58.94 -168.77 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.384 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.599 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 56.97 27.59 57.08 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 118.885 -1.626 . . . . 0.0 109.758 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 53.9 61.76 2.93 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.114 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.96 -166.64 2.59 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.703 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.465 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 70.71 167.06 6.84 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.295 -1.431 . . . . 0.0 109.974 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -45.31 124.3 4.67 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.464 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -94.61 159.18 15.2 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.906 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.724 HG22 ' N ' ' A' ' 64' ' ' GLU . 7.5 mm -136.27 171.12 17.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.688 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.724 ' N ' HG22 ' A' ' 63' ' ' ILE . 2.3 pt-20 -150.57 132.28 14.94 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.346 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.408 HG13 ' C ' ' A' ' 64' ' ' GLU . 25.2 m -150.19 161.88 4.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.426 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 48' ' ' VAL . 3.0 t -145.57 -8.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.021 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -119.15 -149.01 0.43 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.105 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -90.36 141.55 28.62 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.908 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.972 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -109.62 94.47 5.05 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.843 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.64 -53.62 55.29 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.157 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.477 ' O ' ' C ' ' A' ' 72' ' ' LEU . 10.0 tp10 -128.85 66.64 1.42 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.18 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 71' ' ' GLU . 11.5 tp -21.14 -90.91 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.282 0.989 . . . . 0.0 113.071 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.53 ' O ' ' ND2' ' A' ' 76' ' ' ASN . . . -170.66 -159.64 17.15 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 118.917 -1.611 . . . . 0.0 110.783 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.472 ' C ' HD22 ' A' ' 76' ' ' ASN . 2.6 Cg_endo -65.08 -34.48 46.46 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 121.911 1.741 . . . . 0.0 111.488 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.641 ' H ' ' CD2' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -77.85 15.57 0.84 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.89 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.83 ' H ' HD22 ' A' ' 76' ' ' ASN . 0.3 OUTLIER -62.54 -61.18 2.61 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.854 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.585 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 1.9 t30 -78.68 33.94 0.21 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.86 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 76' ' ' ASN . 3.1 t-20 -171.42 71.66 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.241 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.631 HG13 ' N ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -94.59 -177.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.307 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.631 ' N ' HG13 ' A' ' 79' ' ' VAL . 1.5 t 174.82 -71.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.769 -1.172 . . . . 0.0 112.312 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 m -99.97 145.64 27.62 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.495 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.577 HD12 ' CZ ' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -149.65 160.88 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.812 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.815 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -144.03 110.1 5.38 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.732 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.815 ' H ' HH22 ' A' ' 83' ' ' ARG . 11.2 t -116.91 140.34 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.884 -0.727 . . . . 0.0 111.584 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.605 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 3.7 mt -144.97 135.11 19.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.413 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.2 m -41.88 157.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.488 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 48' ' ' VAL . 0.6 OUTLIER -154.61 139.86 12.13 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.318 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.506 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 8.0 Cg_exo -50.12 129.31 24.82 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 121.313 1.342 . . . . 0.0 111.071 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 90' ' ' GLN . 2.7 p -66.48 156.34 6.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.039 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -144.42 154.51 56.88 Favored Pre-proline 0 N--CA 1.487 1.388 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.872 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.11 -35.7 91.6 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 121.466 1.444 . . . . 0.0 111.142 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.513 ' HE ' ' HB3' ' A' ' 46' ' ' PRO . 86.5 mtt-85 54.72 -157.97 0.2 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.918 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.95 172.22 12.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.527 ' NE ' ' CD ' ' A' ' 105' ' ' GLU . 11.7 ttt180 -148.31 122.34 9.45 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.126 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.446 ' CD2' HG13 ' A' ' 131' ' ' VAL . 26.3 m-85 -105.05 165.54 11.01 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.503 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.541 ' CE2' ' O ' ' A' ' 101' ' ' PHE . 0.5 OUTLIER -125.69 172.76 9.52 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.513 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.447 ' CD1' ' O ' ' A' ' 104' ' ' LYS . 2.1 m-85 -92.32 -97.02 0.13 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.939 -1.104 . . . . 0.0 112.654 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -45.37 164.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.576 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -87.51 67.78 9.45 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.49 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.697 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -175.34 33.58 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.804 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.541 ' O ' ' CE2' ' A' ' 96' ' ' PHE . 29.1 t80 55.22 20.55 3.49 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.345 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -119.78 161.07 21.4 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.644 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 94.33 137.08 8.54 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.043 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.447 ' O ' ' CD1' ' A' ' 97' ' ' TYR . 52.7 mttm -28.0 138.93 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.527 ' CD ' ' NE ' ' A' ' 94' ' ' ARG . 11.6 pt-20 -99.48 175.94 5.67 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.26 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.582 HG11 ' C ' ' A' ' 122' ' ' GLY . 40.4 t -150.7 120.11 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.153 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 26.7 p-10 -96.62 155.75 16.64 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.597 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 108' ' ' LEU . 69.5 mt -142.75 149.4 49.93 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.147 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.408 ' O ' HD12 ' A' ' 172' ' ' ILE . 13.1 Cg_endo -77.27 165.03 28.37 Favored 'Trans proline' 0 C--O 1.213 -0.77 0 C-N-CA 121.84 1.693 . . . . 0.0 111.595 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -68.82 153.99 71.92 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 121.686 1.591 . . . . 0.0 110.843 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.45 -161.58 20.76 Favored Glycine 0 N--CA 1.509 3.521 0 C-N-CA 119.194 -1.479 . . . . 0.0 111.835 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.457 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 2.9 mp0 -116.13 161.67 18.57 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.261 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.512 ' HB2' HD12 ' A' ' 118' ' ' LEU . 85.8 m-85 -145.49 146.41 31.45 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.008 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 114' ' ' THR . 10.9 p -74.9 -159.1 0.09 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.442 ' NE2' ' HB3' ' A' ' 144' ' ' ASP . 1.2 pt20 -108.0 40.05 1.82 Allowed 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.22 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.478 ' C ' ' N ' ' A' ' 118' ' ' LEU . . . -157.55 -87.5 0.04 OUTLIER 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 118.684 -1.206 . . . . 0.0 110.88 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 116' ' ' ALA . 11.3 pt-20 -45.53 -25.49 0.45 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.036 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.805 ' C ' HD23 ' A' ' 118' ' ' LEU . 5.6 tt -57.86 -66.53 0.46 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.113 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.439 ' HB3' ' C ' ' A' ' 124' ' ' ASP . 8.1 mm-40 -49.2 -49.95 40.45 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.406 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.483 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 4.0 mmm-85 -67.17 -12.44 60.04 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 118.718 -1.193 . . . . 0.0 112.016 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -91.97 -24.95 19.08 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.154 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.582 ' C ' HG11 ' A' ' 106' ' ' VAL . . . -115.93 -67.43 0.41 Allowed Glycine 0 N--CA 1.483 1.791 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.486 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -138.64 -103.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.186 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.573 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 15.2 t70 -154.01 -165.48 2.12 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.314 -0.955 . . . . 0.0 111.198 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.573 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 1.0 OUTLIER -58.71 -100.08 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.34 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.679 HD22 ' N ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -80.41 127.68 32.69 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.582 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.684 HG23 ' H ' ' A' ' 128' ' ' ILE . 0.0 OUTLIER 175.48 -106.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.523 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.684 ' H ' HG23 ' A' ' 127' ' ' THR . 6.2 mm 48.62 -97.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.005 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER 78.1 -42.77 0.36 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.2 m -143.56 126.34 16.13 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.682 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.446 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.9 t -121.59 158.84 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-O 121.975 0.893 . . . . 0.0 113.015 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.422 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -146.14 99.32 4.28 Favored Pre-proline 0 C--N 1.3 -1.544 0 CA-C-N 113.865 -1.516 . . . . 0.0 107.86 179.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.63 ' C ' ' H ' ' A' ' 135' ' ' GLY . 2.8 Cg_exo -52.66 -15.79 4.75 Favored 'Trans proline' 0 C--O 1.209 -0.955 0 C-N-CA 121.181 1.254 . . . . 0.0 112.491 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.408 HE21 ' HB2' ' A' ' 94' ' ' ARG . 4.4 tt0 53.17 -6.19 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.764 -0.774 . . . . 0.0 112.498 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . 160.45 -47.36 0.4 Allowed Glycine 0 N--CA 1.483 1.802 0 C-N-CA 118.766 -1.683 . . . . 0.0 111.242 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.1 mt -84.49 -164.31 0.94 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 117.95 -1.5 . . . . 0.0 110.787 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -119.17 131.11 55.82 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.0 t -101.76 143.12 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.796 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.412 ' C ' HD12 ' A' ' 140' ' ' LEU . 57.6 t -137.32 117.76 16.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.315 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.591 HD12 ' N ' ' A' ' 140' ' ' LEU . 10.9 mp -97.71 142.85 29.0 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.483 -0.887 . . . . 0.0 112.37 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.528 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 34.6 m-85 -120.51 133.46 55.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.432 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -74.3 -61.1 1.98 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.488 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -71.46 -175.99 1.43 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.089 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 146' ' ' PHE . 1.8 m-20 -77.18 -165.06 0.52 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.691 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.668 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 16.4 t30 27.95 39.51 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 123.931 0.769 . . . . 0.0 112.138 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.668 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.6 p90 41.65 60.44 2.16 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.197 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.84 -168.11 1.98 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.233 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 63.51 -162.45 33.45 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.607 -1.282 . . . . 0.0 110.145 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -59.58 156.05 14.23 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.189 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.3 p -144.72 160.75 40.7 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.679 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.8 tp -126.39 82.83 65.45 Favored Pre-proline 0 N--CA 1.486 1.325 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.125 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.68 106.56 0.63 Allowed 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 121.884 1.722 . . . . 0.0 113.162 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 43.6 t -87.94 82.45 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 119.455 -0.898 . . . . 0.0 108.949 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.706 ' H ' HD22 ' A' ' 154' ' ' ASN . 0.8 OUTLIER -62.59 -9.6 9.4 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.6 p -169.4 -167.9 0.75 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 117.456 -1.698 . . . . 0.0 113.475 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -42.29 150.83 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.53 -1.213 . . . . 0.0 112.812 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.572 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -171.94 66.83 0.41 Allowed Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.65 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.5 Cg_endo -65.6 23.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.173 1.916 . . . . 0.0 112.02 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.572 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.3 t -175.42 57.23 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.042 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 129' ' ' SER . 18.8 tp -63.63 -11.18 23.17 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.895 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 160' ' ' LEU . . . . . . . . 0 N--CA 1.496 2.682 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.46 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.822 0.344 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 51.7 m -58.8 111.39 1.26 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.003 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 74.7 m -90.13 -69.28 0.73 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.618 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.0 p -116.0 158.09 23.61 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.593 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 1.4 pt -141.1 -178.59 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.856 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -160.59 114.9 2.15 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.677 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 109' ' ' PRO . 14.0 mt -90.34 95.51 5.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.08 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 116.291 -1.814 . . . . 0.0 110.835 179.98 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.515 ' HB1' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.903 0.383 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -116.1 115.86 26.84 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.391 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.446 HD13 HG21 ' A' ' 4' ' ' ILE . 8.3 pt -74.56 143.86 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.3 m -128.41 135.5 49.6 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.678 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.499 HG22 ' CG1' ' A' ' 17' ' ' VAL . 9.8 m -120.79 158.64 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.015 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 14.0 m-85 -114.03 157.83 22.0 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.133 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -89.06 9.9 23.65 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.518 ' C ' ' OG ' ' A' ' 40' ' ' SER . 20.1 m120 -151.32 173.29 14.67 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.732 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -78.41 169.93 17.46 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.83 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 13' ' ' GLN . 6.7 t70 65.46 38.08 5.81 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.602 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.539 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 9.0 t80 62.81 -4.67 0.23 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.483 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.489 ' H ' ' C ' ' A' ' 11' ' ' ASP . 32.6 mt-30 -87.69 166.75 14.43 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.129 -1.028 . . . . 0.0 110.906 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 113.95 137.66 6.68 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -29.35 138.28 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.578 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -103.17 123.7 47.2 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.499 ' CG1' HG22 ' A' ' 6' ' ' VAL . 9.9 p -126.45 138.5 54.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.861 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -100.92 146.6 27.15 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.856 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 mt -137.94 141.46 32.63 Favored Pre-proline 0 N--CA 1.485 1.306 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.676 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -71.86 166.87 28.23 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.794 0.996 . . . . 0.0 111.711 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -67.12 -172.92 0.37 Allowed 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 121.998 1.799 . . . . 0.0 110.934 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.425 ' H ' ' HB ' ' A' ' 84' ' ' VAL . . . 98.44 -156.08 20.27 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.634 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.49 ' N ' HD22 ' A' ' 23' ' ' ASN . 0.3 OUTLIER -146.48 150.5 35.72 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.835 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.495 ' OH ' HD12 ' A' ' 82' ' ' ILE . 12.8 p90 -164.15 -164.2 0.84 Allowed 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.417 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.6 p -139.7 175.48 9.53 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.612 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.4 ptt85 -58.1 -13.52 4.98 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.275 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -67.59 -59.3 3.46 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.478 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.483 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 4.2 tp-100 -52.69 -43.06 65.34 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 118.506 -1.278 . . . . 0.0 108.201 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 32' ' ' LEU . 29.7 mt -58.77 -43.74 90.44 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.039 -1.064 . . . . 0.0 109.011 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -47.65 -30.39 3.7 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.618 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -77.61 -36.86 51.31 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.864 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 29' ' ' LEU . 12.7 mt -76.43 -67.37 0.7 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.614 -0.835 . . . . 0.0 110.627 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.6 -7.0 0.13 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.699 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.754 HG22 ' H ' ' A' ' 35' ' ' GLU . 1.3 mt -98.61 -167.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.165 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.754 ' H ' HG22 ' A' ' 34' ' ' ILE . 3.0 pt-20 175.05 -168.23 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.88 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.794 HD22 ' ND2' ' A' ' 78' ' ' ASN . 24.4 p-10 -77.06 -178.71 5.13 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.506 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.401 ' H ' ' H ' ' A' ' 79' ' ' VAL . 2.9 t30 71.05 -15.36 0.41 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.642 ' O ' ' N ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -86.84 -77.78 0.31 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.058 -1.457 . . . . 0.0 110.938 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.62 ' N ' ' OG1' ' A' ' 38' ' ' THR . 4.3 mt -13.96 75.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 124.924 1.39 . . . . 0.0 112.074 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.642 ' N ' ' O ' ' A' ' 38' ' ' THR . 43.0 t -81.89 -36.14 28.46 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.49 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.2 172.02 13.61 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.1 t -149.97 144.8 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 118.029 -1.468 . . . . 0.0 112.516 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -132.73 101.51 5.31 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.841 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.5 t -125.04 110.1 27.28 Favored Pre-proline 0 N--CA 1.491 1.617 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.267 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -69.19 166.78 25.72 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.129 1.219 . . . . 0.0 110.802 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -61.29 -168.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 121.754 1.636 . . . . 0.0 110.948 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.43 ' C ' ' CG1' ' A' ' 48' ' ' VAL . . . 76.21 -8.25 25.65 Favored Glycine 0 C--O 1.207 -1.578 0 C-N-CA 118.902 -1.618 . . . . 0.0 109.743 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.515 HG11 ' HB1' ' A' ' 2' ' ' ALA . 0.9 OUTLIER -151.24 134.41 7.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.143 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -107.37 121.16 44.03 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.91 159.38 20.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.01 -1.076 . . . . 0.0 113.095 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 63' ' ' ILE . 35.0 mt -142.92 124.21 11.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.603 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.523 HD13 ' HB ' ' A' ' 63' ' ' ILE . 5.2 mp -89.26 160.35 16.96 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.714 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -138.89 115.98 10.98 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.505 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -56.86 -80.26 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.771 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.424 ' ND2' ' H ' ' A' ' 56' ' ' ASP . 2.8 t-20 -59.47 148.17 33.91 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.175 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.506 ' OD1' ' CB ' ' A' ' 80' ' ' SER . 1.0 OUTLIER -60.26 172.44 0.83 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.725 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.05 31.69 80.16 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.11 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 50.56 47.32 24.38 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.779 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.24 -161.58 1.01 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.835 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.38 -178.87 2.01 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.317 -1.421 . . . . 0.0 109.889 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -48.24 163.62 0.06 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.217 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.606 HE21 ' C ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -148.12 141.07 24.81 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.544 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.599 HD11 HD21 ' A' ' 75' ' ' LEU . 3.0 mt -107.5 168.65 3.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.679 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.463 ' H ' HG22 ' A' ' 63' ' ' ILE . 48.9 tt0 -137.1 132.92 34.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.8 m -148.65 159.92 6.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 118.371 -1.332 . . . . 0.0 112.495 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 t -150.18 -1.48 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.483 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -132.57 -150.13 0.4 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.649 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.431 HD21 ' CG ' ' A' ' 107' ' ' ASP . 1.5 p30 -101.05 113.63 26.81 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.634 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.565 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.53 97.72 11.36 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.906 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -62.87 -74.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.397 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -67.51 -8.95 37.8 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.446 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.3 tp 66.78 -80.2 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.592 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 143.49 -158.51 27.32 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.438 -1.363 . . . . 0.0 110.138 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.6 ' C ' HD23 ' A' ' 75' ' ' LEU . 2.2 Cg_endo -64.56 -159.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.649 1.566 . . . . 0.0 110.814 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.6 HD23 ' C ' ' A' ' 74' ' ' PRO . 1.1 pt? 32.83 32.06 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.722 0.639 . . . . 0.0 111.945 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 74' ' ' PRO . 49.6 t30 -84.98 -15.47 44.14 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.098 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -86.98 0.43 55.16 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.273 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.794 ' ND2' HD22 ' A' ' 36' ' ' ASN . 1.1 t-20 -172.02 122.34 0.48 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 118.51 -1.276 . . . . 0.0 112.162 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 80' ' ' SER . 1.9 t -122.8 -148.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.443 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.651 ' H ' HG12 ' A' ' 79' ' ' VAL . 1.0 OUTLIER 154.33 -59.57 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.416 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.1 m -111.98 156.07 22.72 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.511 -0.876 . . . . 0.0 113.137 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.495 HD12 ' OH ' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -148.22 163.78 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.933 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.741 HH11 ' C ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -143.12 133.47 24.69 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.651 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.741 ' C ' HH11 ' A' ' 83' ' ' ARG . 22.1 t -139.98 128.57 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.936 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.458 HD11 ' HE ' ' A' ' 83' ' ' ARG . 55.3 mt -130.69 124.44 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.415 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.4 p -45.25 148.02 0.68 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.558 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.488 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.9 OUTLIER -148.07 152.05 39.07 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.275 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.488 ' HD2' HG22 ' A' ' 87' ' ' VAL . 2.9 Cg_exo -55.45 155.57 20.36 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.14 1.227 . . . . 0.0 110.859 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.3 t -59.71 144.39 12.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.732 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -144.74 119.06 5.73 Favored Pre-proline 0 N--CA 1.487 1.415 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.461 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -61.65 -157.53 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.832 0 C-N-CA 121.07 1.18 . . . . 0.0 111.184 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.444 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER 178.98 -162.14 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.274 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.435 ' N ' ' HD3' ' A' ' 92' ' ' ARG . . . -138.39 173.31 11.73 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.094 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -119.95 149.98 41.25 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.158 -1.017 . . . . 0.0 112.513 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -141.46 115.44 9.22 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.608 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.42 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 55.5 m-85 -79.42 176.93 9.24 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.81 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.16 -46.9 3.5 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.409 -0.917 . . . . 0.0 112.15 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.514 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 14.8 ttmt -92.26 154.73 18.43 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.864 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.597 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -71.13 102.72 2.56 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.11 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.609 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 123.96 47.13 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.113 0 O-C-N 125.356 1.66 . . . . 0.0 109.072 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.609 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 21.9 p90 30.15 59.44 0.2 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.65 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.469 ' HB2' ' NE2' ' A' ' 100' ' ' GLN . 18.7 t70 -130.64 -12.54 3.84 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.252 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.514 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -93.66 157.23 22.89 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.459 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.466 ' HD3' ' H ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -29.59 139.11 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.19 0.519 . . . . 0.0 112.258 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.466 ' H ' ' HD3' ' A' ' 104' ' ' LYS . 0.4 OUTLIER -93.85 105.42 17.44 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.229 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.468 HG11 ' C ' ' A' ' 122' ' ' GLY . 92.7 t -92.64 137.9 21.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.051 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.431 ' CG ' HD21 ' A' ' 68' ' ' ASN . 1.9 p30 -121.53 155.07 35.76 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.95 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.7 mt -144.3 132.51 10.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.026 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -66.5 166.63 21.18 Favored 'Trans proline' 0 C--O 1.214 -0.725 0 C-N-CA 121.643 1.562 . . . . 0.0 111.69 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.55 149.24 68.16 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.81 1.673 . . . . 0.0 111.565 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.55 -176.3 20.45 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 119.415 -1.374 . . . . 0.0 110.932 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.407 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 40.8 tt0 -110.89 154.57 23.86 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.482 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 61.7 m-85 -146.22 155.46 42.7 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.436 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 3.1 p -92.49 -142.44 0.2 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.34 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.52 ' N ' ' OG1' ' A' ' 114' ' ' THR . 36.4 tt0 -111.97 -20.97 11.79 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.658 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.78 -57.59 3.72 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.381 -0.928 . . . . 0.0 112.644 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.561 ' CG ' ' H ' ' A' ' 118' ' ' LEU . 4.6 pt-20 -71.36 -55.93 7.0 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.837 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.561 ' H ' ' CG ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -32.34 -67.42 0.11 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.976 0.798 . . . . 0.0 111.273 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' A' ' 121' ' ' TYR . 75.6 mt-10 -55.5 -61.55 2.27 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.726 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.476 ' NH1' ' OD1' ' A' ' 124' ' ' ASP . 1.7 mpt_? -73.86 19.88 0.11 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.199 -1.0 . . . . 0.0 112.344 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 117' ' ' GLU . 17.9 t80 -124.45 -15.59 6.6 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.858 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.468 ' C ' HG11 ' A' ' 106' ' ' VAL . . . -148.22 -38.45 0.04 OUTLIER Glycine 0 C--N 1.295 -1.735 0 C-N-CA 118.771 -1.681 . . . . 0.0 110.822 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -141.75 -113.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.316 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.596 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 28.8 t70 -156.5 -176.86 6.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.396 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.596 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 46.9 t30 -79.22 148.82 32.09 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.845 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.554 HD22 ' CB ' ' A' ' 166' ' ' ASN . 32.5 m120 44.9 45.64 8.63 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.412 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.4 m -163.42 107.25 1.02 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.872 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.1 mm -138.95 -45.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.606 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.587 ' OG ' ' N ' ' A' ' 130' ' ' SER . 1.2 p 66.02 -152.45 0.24 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.587 ' N ' ' OG ' ' A' ' 129' ' ' SER . 26.8 m -49.79 129.86 20.5 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.404 -1.271 . . . . 0.0 113.066 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.4 151.17 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.928 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -160.58 112.69 1.35 Allowed Pre-proline 0 C--N 1.292 -1.896 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.598 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.26 170.79 3.7 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 120.605 0.87 . . . . 0.0 111.777 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -156.26 5.74 0.18 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.776 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.57 -50.92 0.04 OUTLIER Glycine 0 N--CA 1.481 1.677 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.37 162.94 20.66 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.732 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.66 154.8 24.71 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.329 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.6 143.72 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.265 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.3 t -129.76 125.37 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.464 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.6 mp -99.4 145.28 27.56 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.829 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.559 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 3.3 m-85 -120.78 143.23 48.93 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.3 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -73.85 -76.17 0.14 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.553 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -74.82 157.12 35.68 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.611 ' CG ' ' H ' ' A' ' 145' ' ' ASN . 26.4 t70 -57.92 -174.4 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.47 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.643 ' ND2' ' CZ ' ' A' ' 146' ' ' PHE . 0.4 OUTLIER 40.34 27.18 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.094 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.643 ' CZ ' ' ND2' ' A' ' 145' ' ' ASN . 1.9 p90 41.69 62.0 1.7 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.286 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.9 t -131.95 71.46 1.47 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.306 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 173.14 -163.12 34.65 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.277 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.52 162.76 4.66 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 118.914 -1.114 . . . . 0.0 109.788 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.7 p -149.35 164.2 35.56 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.732 -1.187 . . . . 0.0 111.612 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.5 mt -131.64 87.32 46.26 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.714 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -61.44 107.87 0.54 Allowed 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.487 1.458 . . . . 0.0 111.859 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.442 ' C ' ' H ' ' A' ' 155' ' ' SER . 2.2 t -91.84 65.64 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.887 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -79.07 33.49 0.22 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.219 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 153' ' ' VAL . 16.8 t -167.09 -156.87 0.23 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.195 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.416 ' N ' ' OG ' ' A' ' 155' ' ' SER . 6.0 m-20 -90.61 153.22 20.48 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.768 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.433 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -163.2 71.39 1.94 Allowed Pre-proline 0 N--CA 1.486 1.334 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.533 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.471 ' C ' ' HG ' ' A' ' 130' ' ' SER . 1.2 Cg_endo -67.73 35.77 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.535 2.157 . . . . 0.0 113.372 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.727 HG23 ' H ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -167.38 -83.34 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.336 -1.345 . . . . 0.0 111.852 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.727 ' H ' HG23 ' A' ' 159' ' ' THR . 2.3 tp 73.68 -69.65 0.18 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.424 -0.911 . . . . 0.0 110.544 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.431 0 C-N-CA 119.367 -1.397 . . . . 0.0 110.736 179.999 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.554 ' CB ' HD22 ' A' ' 126' ' ' ASN . 2.7 p-10 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.712 0.291 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.2 m -103.4 112.04 24.74 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.303 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 83.7 p -96.67 -35.35 11.06 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.75 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.67 154.44 50.92 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.898 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 16.8 pt -135.76 162.97 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.486 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.424 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 41.2 ttp85 -146.32 100.99 3.44 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.846 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.6 mt -81.73 99.54 4.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.055 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 116.448 -1.739 . . . . 0.0 111.02 -179.964 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.6 ' C ' HD22 ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 121.009 0.433 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.6 HD22 ' C ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER -175.89 122.66 0.19 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.192 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -84.29 153.68 3.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.136 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.4 m -128.09 118.78 24.07 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.092 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 16' ' ' GLN . 3.7 m -98.25 170.12 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.335 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 1.305 ' CE2' ' NE2' ' A' ' 16' ' ' GLN . 24.8 m-85 -129.49 149.46 51.26 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.516 ' CD2' ' NZ ' ' A' ' 15' ' ' LYS . 2.7 m-85 -77.28 -57.78 3.64 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.978 -1.089 . . . . 0.0 113.233 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.517 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 19.0 m120 -87.58 162.28 17.26 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.721 -1.191 . . . . 0.0 111.923 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.54 -179.04 0.99 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.326 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.647 ' C ' ' CG ' ' A' ' 12' ' ' PHE . 6.0 t70 51.52 52.63 14.3 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 118.313 -1.355 . . . . 0.0 110.52 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.647 ' CG ' ' C ' ' A' ' 11' ' ' ASP . 1.2 p90 41.65 20.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 11' ' ' ASP . 22.2 mt-30 -93.77 173.88 7.45 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.85 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.517 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 79.01 128.09 0.55 Allowed Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.188 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.516 ' NZ ' ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -40.99 156.34 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.935 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 1.305 ' NE2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -112.16 177.03 4.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 t -141.65 137.9 31.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 114.332 -1.304 . . . . 0.0 109.379 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -95.47 114.51 26.29 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.663 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.0 mt -107.88 133.05 20.62 Favored Pre-proline 0 N--CA 1.492 1.657 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.043 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -71.41 156.57 58.28 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 120.837 1.025 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.53 -167.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 121.506 1.471 . . . . 0.0 110.67 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.447 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 100.14 -174.22 26.11 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.942 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.705 ' CA ' HH11 ' A' ' 83' ' ' ARG . 0.6 OUTLIER -109.69 122.88 48.48 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.926 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 7.7 p90 -147.86 173.9 12.38 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 118.746 -1.182 . . . . 0.0 111.005 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.7 p -147.79 -154.83 0.58 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.051 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -62.43 -28.28 69.69 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.802 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -62.39 -63.43 1.24 Allowed 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.71 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.9 tt0 -55.48 -49.59 72.13 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.603 -1.239 . . . . 0.0 109.481 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.618 HD23 HD12 ' A' ' 32' ' ' LEU . 26.9 mt -51.84 -41.27 61.68 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.57 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.53 -35.84 21.55 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 118.558 -1.257 . . . . 0.0 108.006 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -65.04 -40.31 94.61 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.554 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.618 HD12 HD23 ' A' ' 29' ' ' LEU . 17.0 mt -72.86 -74.12 0.18 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.601 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.12 -26.27 1.0 Allowed Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.995 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.0 142.41 13.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.194 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 9.1 pt-20 -177.86 155.0 0.96 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.642 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 2.1 t-20 90.18 -149.62 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 O-C-N 124.265 0.978 . . . . 0.0 112.408 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.635 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.4 OUTLIER -70.14 32.48 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.045 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 40' ' ' SER . 1.0 OUTLIER -88.13 -40.99 13.32 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.62 -1.232 . . . . 0.0 110.336 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.42 ' HB ' HG21 ' A' ' 79' ' ' VAL . 22.7 mt -64.88 74.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.38 -0.928 . . . . 0.0 108.976 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 38' ' ' THR . 28.0 t -76.33 -72.97 0.3 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.704 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.46 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -99.15 168.04 10.31 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.888 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.589 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.1 t -151.32 148.31 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 117.988 -1.485 . . . . 0.0 113.087 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -133.72 108.69 8.67 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.852 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.451 HG23 HG13 ' A' ' 42' ' ' VAL . 65.2 t -128.46 111.42 19.38 Favored Pre-proline 0 N--CA 1.5 2.05 0 C-N-CA 119.809 -0.756 . . . . 0.0 112.311 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.59 170.07 14.53 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.099 1.2 . . . . 0.0 110.851 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.16 -167.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.919 1.746 . . . . 0.0 110.978 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.434 ' C ' HG12 ' A' ' 48' ' ' VAL . . . 78.21 -11.34 23.7 Favored Glycine 0 N--CA 1.484 1.851 0 C-N-CA 119.104 -1.522 . . . . 0.0 110.982 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.676 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -154.76 148.66 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 118.725 -1.19 . . . . 0.0 112.074 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -115.14 142.3 46.84 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.974 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.84 143.03 46.8 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.026 -1.07 . . . . 0.0 112.274 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.551 HG23 ' O ' ' A' ' 63' ' ' ILE . 78.2 mt -121.04 121.75 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.284 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.599 HD23 ' H ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -91.99 147.21 23.13 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.306 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.599 ' H ' HD23 ' A' ' 52' ' ' LEU . 53.3 m-85 -134.45 132.61 39.51 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.142 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -58.94 -84.44 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.052 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -65.17 163.65 14.69 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.65 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -63.09 -177.94 0.2 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.586 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.614 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 53.96 33.1 50.0 Favored Glycine 0 N--CA 1.487 2.059 0 C-N-CA 118.957 -1.592 . . . . 0.0 109.158 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.614 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 41.99 69.78 0.33 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.576 0.703 . . . . 0.0 110.751 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.91 174.21 10.79 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.07 -177.21 54.36 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.483 -1.342 . . . . 0.0 110.088 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.14 118.14 1.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.18 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.423 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 3.2 pt20 -101.27 172.39 7.02 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.738 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.551 ' O ' HG23 ' A' ' 51' ' ' ILE . 4.8 mt -144.47 163.84 13.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.553 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -138.98 126.2 21.39 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.769 -0.773 . . . . 0.0 109.498 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.3 m -149.03 158.96 6.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 118.781 -1.168 . . . . 0.0 112.727 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 48' ' ' VAL . 3.9 t -149.78 -1.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.401 ' H ' ' H ' ' A' ' 66' ' ' VAL . . . -125.42 -135.97 0.27 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.722 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -105.93 112.0 24.88 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.24 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.589 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.54 80.33 6.71 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.768 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -52.33 -81.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.048 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -69.12 -10.44 57.67 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.603 -0.839 . . . . 0.0 112.008 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.526 ' CD2' HD21 ' A' ' 76' ' ' ASN . 2.5 tp 63.23 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.434 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.429 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 175.15 -175.25 47.11 Favored Glycine 0 N--CA 1.501 2.998 0 C-N-CA 119.183 -1.484 . . . . 0.0 110.999 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.531 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.2 Cg_endo -66.72 -39.92 14.21 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 122.375 2.05 . . . . 0.0 112.188 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.986 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.7 pt? -71.11 30.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.144 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.531 ' H ' ' C ' ' A' ' 74' ' ' PRO . 0.6 OUTLIER -72.67 -9.6 58.81 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.639 -0.825 . . . . 0.0 110.605 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -87.57 13.16 10.78 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.126 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.644 ' ND2' ' N ' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -177.91 116.79 0.09 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 118.691 -1.204 . . . . 0.0 111.699 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 36' ' ' ASN . 15.6 m -157.07 145.85 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.944 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.6 p -164.34 -36.86 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 118.562 -1.255 . . . . 0.0 113.131 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.43 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 4.1 m -94.61 142.99 26.81 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 118.773 -1.171 . . . . 0.0 111.577 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.415 ' CG1' ' C ' ' A' ' 81' ' ' SER . 2.1 mt -148.58 143.21 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 118.821 -1.152 . . . . 0.0 111.426 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.829 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -121.31 116.01 24.04 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.783 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.829 ' H ' HH12 ' A' ' 83' ' ' ARG . 3.9 t -123.69 136.36 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.943 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.514 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 3.8 mt -139.1 126.74 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.196 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.6 p -48.98 133.02 18.59 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.433 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.775 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -122.9 149.92 57.7 Favored Pre-proline 0 N--CA 1.49 1.566 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.599 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.775 ' HD2' HG22 ' A' ' 87' ' ' VAL . 6.0 Cg_exo -51.43 127.31 21.94 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 121.386 1.391 . . . . 0.0 111.216 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.3 p -58.51 136.87 21.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.881 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -145.91 151.46 45.56 Favored Pre-proline 0 N--CA 1.487 1.389 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.961 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.419 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 2.3 Cg_endo -58.89 -164.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 121.277 1.318 . . . . 0.0 111.111 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.467 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -175.79 -161.75 0.09 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.759 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -141.71 162.96 34.2 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.084 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.1 ttm-85 -135.82 107.48 6.99 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.05 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 18.5 m-85 -87.0 169.15 12.68 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.597 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.482 ' CE1' ' HB3' ' A' ' 105' ' ' GLU . 26.8 m-85 -137.09 167.64 21.15 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.581 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.409 ' OH ' HG23 ' A' ' 123' ' ' ILE . 3.4 m-85 -103.24 168.83 8.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.659 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.405 ' CB ' ' OD1' ' A' ' 102' ' ' ASP . 52.5 mttp 57.14 164.69 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.841 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 24.2 tt0 -90.85 75.78 6.41 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.683 ' HG2' ' CG ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 153.78 43.46 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 O-C-N 124.358 1.036 . . . . 0.0 109.376 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 100' ' ' GLN . 19.1 p90 33.47 32.67 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.284 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.683 ' CG ' ' HG2' ' A' ' 100' ' ' GLN . 22.7 p-10 -107.32 36.2 2.79 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.154 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -145.66 158.37 27.65 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.277 -1.439 . . . . 0.0 110.467 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.545 ' H ' ' HE3' ' A' ' 104' ' ' LYS . 1.2 mtmt -31.72 144.84 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.169 0.509 . . . . 0.0 112.318 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.482 ' HB3' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -105.86 149.49 26.48 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.175 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 45.4 t -143.91 150.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.761 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -136.8 156.53 48.37 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.241 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.431 HD22 ' CE2' ' A' ' 121' ' ' TYR . 11.8 mt -137.01 163.12 51.66 Favored Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.938 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -88.78 166.92 5.96 Favored 'Trans proline' 0 C--O 1.212 -0.78 0 C-N-CA 121.871 1.714 . . . . 0.0 112.74 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -63.58 140.56 75.89 Favored 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 121.745 1.63 . . . . 0.0 110.89 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.75 -154.96 25.59 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.19 -1.481 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.595 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 37.3 tt0 -125.35 156.77 38.21 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.367 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 48.5 m-85 -144.07 149.55 36.78 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.792 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.3 p -96.81 -159.49 0.74 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.717 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.702 ' CD ' ' H ' ' A' ' 115' ' ' GLN . 2.5 pm0 -105.51 56.29 0.68 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.213 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.74 -64.34 0.11 Allowed 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.741 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.572 ' CG ' ' H ' ' A' ' 118' ' ' LEU . 9.0 pt-20 -69.77 -52.19 27.44 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.577 ' C ' HD23 ' A' ' 118' ' ' LEU . 1.9 tt -33.67 -60.23 0.37 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.167 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 36.4 mt-10 -54.36 -69.42 0.13 Allowed 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.293 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.434 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 3.4 mpt_? -74.79 23.23 0.1 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.293 -0.963 . . . . 0.0 112.376 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 117' ' ' GLU . 13.0 t80 -114.13 -22.29 10.08 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.856 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.74 -21.55 0.02 OUTLIER Glycine 0 N--CA 1.488 2.117 0 C-N-CA 118.429 -1.844 . . . . 0.0 110.625 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.425 HG21 HD13 ' A' ' 123' ' ' ILE . 9.1 mt -139.79 -120.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.746 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 124' ' ' ASP . 11.7 p30 -159.08 -154.98 0.44 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.767 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -76.22 -35.23 59.13 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.803 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.424 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 25.5 t30 -162.11 118.01 1.99 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.798 -1.161 . . . . 0.0 112.154 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.412 ' CG2' ' CG2' ' A' ' 123' ' ' ILE . 6.1 t -179.2 -14.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.895 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.452 HG13 ' H ' ' A' ' 128' ' ' ILE . 2.1 mt -50.84 166.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.173 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.8 p -175.4 -115.11 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.536 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.1 m -54.39 131.27 41.84 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.854 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.13 155.83 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.47 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.11 83.83 4.57 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.835 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.58 107.46 1.44 Allowed 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.317 1.345 . . . . 0.0 110.638 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -88.86 24.34 2.08 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.973 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -173.01 -56.01 0.05 OUTLIER Glycine 0 N--CA 1.494 2.542 0 C-N-CA 118.208 -1.949 . . . . 0.0 112.095 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.419 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 0.9 OUTLIER -116.79 172.74 7.05 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.567 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -89.37 142.58 27.53 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.497 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.2 t -102.13 145.41 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.94 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.99 124.65 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.681 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 140' ' ' LEU . 4.5 mp -107.74 146.07 32.64 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.239 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 141' ' ' PHE . 20.2 m-85 -120.02 137.51 54.05 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.591 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -71.03 -67.82 0.48 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.951 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -65.57 165.34 12.46 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.98 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 146' ' ' PHE . 3.0 m-20 -63.61 -162.51 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.735 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.665 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 35.1 m120 27.48 39.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 123.859 0.724 . . . . 0.0 112.101 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.665 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.2 OUTLIER 43.97 61.26 2.39 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.456 -0.897 . . . . 0.0 109.881 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -132.42 173.29 11.45 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.27 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.05 -166.3 53.86 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.347 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -59.41 172.97 0.57 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.026 -1.069 . . . . 0.0 109.944 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 43.1 p -151.67 177.33 10.47 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.972 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.512 HD22 ' HA ' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -137.63 79.72 33.98 Favored Pre-proline 0 N--CA 1.485 1.3 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.764 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.6 105.21 0.73 Allowed 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 122.025 1.817 . . . . 0.0 113.247 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 39.8 t -90.68 74.52 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.946 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 1.8 m-20 -79.19 26.64 0.26 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.14 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 25.4 t -169.99 -174.06 1.7 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.626 -1.23 . . . . 0.0 111.839 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.433 ' N ' ' OG ' ' A' ' 155' ' ' SER . 1.8 m-20 -73.78 154.44 39.55 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.907 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.594 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -166.68 72.4 1.11 Allowed Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.239 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.32 20.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.968 1.779 . . . . 0.0 111.85 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.594 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.2 t -169.38 71.08 0.07 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.863 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.431 ' HA ' HD22 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -75.58 -83.76 0.06 Allowed 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.479 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.453 0 C-N-CA 118.902 -1.618 . . . . 0.0 110.083 -179.934 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.425 ' N ' ' OD1' ' A' ' 166' ' ' ASN . 29.3 p-10 . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 121.075 0.464 . . . . 0.0 111.994 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.18 120.81 14.36 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.865 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 54.4 p -92.78 -42.38 9.6 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.284 -0.967 . . . . 0.0 110.533 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.72 164.09 29.08 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.788 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 30.0 pt -143.61 165.91 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -148.43 109.73 4.37 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.875 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.9 mt -89.12 99.47 9.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 119.271 -0.971 . . . . 0.0 109.946 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.305 -1.346 0 CA-C-O 116.352 -1.785 . . . . 0.0 111.12 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.579 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.58 0.228 . . . . 0.0 110.588 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -175.87 119.75 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.673 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.482 ' CG1' ' O ' ' A' ' 4' ' ' ILE . 1.0 OUTLIER -77.57 122.42 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.821 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -95.93 106.53 18.69 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.131 -1.028 . . . . 0.0 108.602 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.453 ' CG1' HD12 ' A' ' 19' ' ' LEU . 1.4 m -88.43 170.06 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 118.974 -1.09 . . . . 0.0 112.344 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 1.189 ' CE2' ' HG2' ' A' ' 16' ' ' GLN . 40.3 m-85 -134.35 144.5 48.29 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.75 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -65.61 -62.18 1.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.975 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.512 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 29.8 m120 -90.52 160.57 15.91 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.754 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -58.88 -171.6 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.64 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.638 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 11.5 m-20 44.95 51.54 8.61 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.842 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.638 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 49.5 p90 39.48 24.38 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 11' ' ' ASP . 32.9 mm-40 -98.69 173.74 6.75 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.565 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.512 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 81.58 135.68 1.95 Allowed Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.389 -1.386 . . . . 0.0 110.352 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 14' ' ' GLY . 30.0 mmtm -29.82 136.83 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.957 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 1.189 ' HG2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -97.53 160.8 14.1 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.339 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -146.22 129.05 9.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.131 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -91.14 124.59 35.48 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.863 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.453 HD12 ' CG1' ' A' ' 6' ' ' VAL . 7.9 mt -119.46 125.85 27.3 Favored Pre-proline 0 N--CA 1.497 1.898 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.892 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.4 158.83 47.04 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 120.98 1.12 . . . . 0.0 111.485 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.14 -166.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.911 1.741 . . . . 0.0 111.154 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.95 -171.28 29.88 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.222 -1.466 . . . . 0.0 110.481 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.638 ' ND2' ' N ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -117.83 131.57 56.54 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.087 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.56 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 1.1 p90 -149.47 -174.88 4.8 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.937 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.498 HG22 ' OG ' ' A' ' 81' ' ' SER . 4.1 p -155.7 -162.14 1.27 Allowed 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.908 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.471 ' C ' ' CD ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -54.08 -20.65 6.86 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.493 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.444 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . -67.58 -66.58 0.54 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.441 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.617 ' CA ' HE21 ' A' ' 28' ' ' GLN . 0.0 OUTLIER -54.58 -44.83 73.34 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.796 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.696 HD23 HD12 ' A' ' 32' ' ' LEU . 19.6 mt -57.64 -42.74 84.04 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.005 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.03 -32.0 32.35 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 118.409 -1.317 . . . . 0.0 108.817 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -67.38 -39.31 85.61 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.638 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.696 HD12 HD23 ' A' ' 29' ' ' LEU . 6.1 mt -75.76 -71.87 0.35 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.326 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.62 -36.72 0.73 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.376 -1.393 . . . . 0.0 110.609 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 tt -81.99 143.15 12.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.849 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.491 ' H ' HG21 ' A' ' 38' ' ' THR . 0.6 OUTLIER -179.96 134.98 0.11 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.563 -1.255 . . . . 0.0 112.495 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.774 ' O ' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER 74.76 128.94 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.075 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.501 ' H ' ' H ' ' A' ' 79' ' ' VAL . 2.6 t30 45.36 8.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.178 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.774 HG23 ' O ' ' A' ' 36' ' ' ASN . 66.3 p -89.3 -33.33 16.97 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.527 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.448 ' H ' HG12 ' A' ' 39' ' ' ILE . 4.8 mm -75.71 66.4 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.743 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.0 t -73.37 -55.3 6.57 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.153 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.9 160.06 29.72 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.147 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.001 HG22 ' HB3' ' A' ' 69' ' ' ALA . 18.6 m -149.73 168.01 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 118.356 -1.338 . . . . 0.0 113.409 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -142.62 98.37 3.28 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.87 -1.514 . . . . 0.0 108.099 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.408 HG22 HG22 ' A' ' 4' ' ' ILE . 42.0 t -116.17 113.28 41.51 Favored Pre-proline 0 N--CA 1.496 1.852 0 C-N-CA 119.873 -0.731 . . . . 0.0 112.81 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -69.3 171.7 13.5 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.041 1.161 . . . . 0.0 110.009 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.525 ' HG3' ' HE ' ' A' ' 92' ' ' ARG . 1.0 OUTLIER -64.88 -167.78 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.617 1.545 . . . . 0.0 111.158 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.59 -8.36 7.46 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.373 -1.394 . . . . 0.0 110.781 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.579 HG11 ' HB3' ' A' ' 2' ' ' ALA . 33.2 m -148.59 143.34 18.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.576 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -118.23 126.42 52.13 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.234 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.54 144.53 36.08 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.377 -0.929 . . . . 0.0 112.765 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.593 HD12 ' NH2' ' A' ' 83' ' ' ARG . 27.8 mt -133.11 112.39 17.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.097 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.523 HD12 ' H ' ' A' ' 52' ' ' LEU . 1.6 mp -89.72 160.45 16.57 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.68 -1.208 . . . . 0.0 112.773 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -138.54 108.55 6.36 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.107 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -49.38 -78.59 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.259 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.504 HD22 ' HA3' ' A' ' 60' ' ' GLY . 2.6 m-80 -59.76 141.44 55.23 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.965 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -55.64 177.81 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.852 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.46 29.48 69.42 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.334 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.439 ' CZ ' HG23 ' A' ' 25' ' ' THR . 21.4 m-85 54.88 67.6 0.99 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.787 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.59 -162.65 1.6 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.958 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.504 ' HA3' HD22 ' A' ' 55' ' ' ASN . . . 64.42 176.09 4.59 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.363 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 60' ' ' GLY . 63.0 m-20 -42.68 112.92 0.4 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.613 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.745 ' CD ' ' H ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -93.0 155.68 17.37 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.401 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.706 HG22 ' N ' ' A' ' 64' ' ' GLU . 7.3 mm -134.71 169.42 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.747 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.706 ' N ' HG22 ' A' ' 63' ' ' ILE . 41.0 tt0 -150.8 130.71 13.33 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.718 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.517 HG12 ' CE1' ' A' ' 121' ' ' TYR . 17.6 m -149.95 159.94 4.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 118.942 -1.103 . . . . 0.0 111.808 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.93 -11.98 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.908 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -116.69 -149.42 0.44 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.892 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -94.04 128.51 40.44 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.508 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.001 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -92.48 95.69 9.79 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.423 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 7.0 tp10 -56.9 -78.16 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.538 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.45 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 7.3 tp10 -91.42 5.05 50.9 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.309 -0.957 . . . . 0.0 110.748 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.439 HD12 ' HB1' ' A' ' 69' ' ' ALA . 14.7 tp 53.2 -99.85 0.09 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.023 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.72 -169.95 34.39 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 118.897 -1.62 . . . . 0.0 111.166 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.638 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.2 Cg_endo -68.58 -37.44 12.7 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.574 2.183 . . . . 0.0 112.929 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.513 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.6 pt? -57.01 8.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.102 -1.039 . . . . 0.0 111.586 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.638 ' H ' ' C ' ' A' ' 74' ' ' PRO . 22.7 t-20 -59.52 -9.89 2.92 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.329 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.535 ' ND2' ' N ' ' A' ' 77' ' ' ASN . 1.3 m120 -67.25 -24.26 65.79 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.014 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -168.53 133.87 1.73 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.064 -1.055 . . . . 0.0 111.482 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.501 ' H ' ' H ' ' A' ' 37' ' ' ASN . 2.3 t -146.75 125.97 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.237 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.3 t -146.29 -42.8 0.2 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.925 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.498 ' OG ' HG22 ' A' ' 25' ' ' THR . 5.2 m -90.93 135.21 33.89 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.057 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.439 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -141.02 159.51 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.196 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.778 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -143.91 106.21 4.39 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.749 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.778 ' CA ' HH12 ' A' ' 83' ' ' ARG . 11.3 t -123.33 131.63 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.545 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.492 HG12 ' NH1' ' A' ' 83' ' ' ARG . 1.5 pt -136.23 140.47 43.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.527 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.1 t -44.43 156.39 0.08 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.758 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.559 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -150.37 140.43 13.92 Favored Pre-proline 0 C--N 1.307 -1.248 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.505 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.559 ' HD2' HG22 ' A' ' 87' ' ' VAL . 3.4 Cg_exo -50.67 136.79 42.1 Favored 'Trans proline' 0 C--O 1.21 -0.892 0 C-N-CA 121.006 1.138 . . . . 0.0 111.464 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.4 t -50.15 141.27 3.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.933 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -119.51 131.62 24.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.505 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.88 -24.5 72.7 Favored 'Trans proline' 0 C--O 1.21 -0.876 0 C-N-CA 120.762 0.975 . . . . 0.0 110.592 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.525 ' HE ' ' HG3' ' A' ' 46' ' ' PRO . 7.2 ptt85 36.36 -157.79 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.222 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.72 173.27 11.69 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.886 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.424 ' CD ' ' OE1' ' A' ' 105' ' ' GLU . 30.1 ttp180 -145.0 109.83 5.05 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 118.484 -1.286 . . . . 0.0 112.574 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.589 ' CD2' HG13 ' A' ' 131' ' ' VAL . 17.3 m-85 -95.95 149.1 21.93 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.204 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.484 ' CD1' ' HB3' ' A' ' 105' ' ' GLU . 72.1 m-85 -115.16 -162.52 0.83 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 119.344 -0.943 . . . . 0.0 111.0 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -135.04 168.01 19.91 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.29 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt 58.05 157.94 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 122.064 0.935 . . . . 0.0 112.823 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.55 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 32.0 tt0 -67.46 106.32 2.09 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.404 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.582 HE21 ' HA ' ' A' ' 100' ' ' GLN . 1.0 OUTLIER 97.92 59.51 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.976 0 O-C-N 124.721 1.263 . . . . 0.0 111.341 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.561 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 35.2 p90 31.51 38.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.48 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 100' ' ' GLN . 93.6 m-20 -100.62 49.7 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.851 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -169.47 157.52 29.33 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.773 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -40.73 158.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.704 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.484 ' HB3' ' CD1' ' A' ' 96' ' ' PHE . 5.9 pt-20 -123.45 165.44 17.06 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.663 0.744 . . . . 0.0 112.855 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.7 t -146.18 119.53 2.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.805 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.59 164.04 14.92 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.999 -1.08 . . . . 0.0 111.996 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 108' ' ' LEU . 79.3 mt -145.35 137.88 13.6 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.695 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -69.58 161.28 46.52 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 121.646 1.564 . . . . 0.0 111.787 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.84 149.04 91.71 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.812 1.675 . . . . 0.0 111.243 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.53 -164.36 25.14 Favored Glycine 0 N--CA 1.502 3.077 0 C-N-CA 119.288 -1.434 . . . . 0.0 111.368 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.594 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 24.2 mt-30 -119.06 156.49 29.6 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.205 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 29.0 m-85 -144.93 150.54 37.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.884 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.416 ' H ' HG23 ' A' ' 114' ' ' THR . 1.6 p -90.31 -162.62 0.91 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.548 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -102.83 46.78 0.91 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -150.59 -62.98 0.2 Allowed 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.636 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 121' ' ' TYR . 5.8 pt-20 -71.57 -42.75 67.41 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.399 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.589 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -40.19 -70.04 0.11 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.04 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 121' ' ' TYR . 52.4 mt-10 -53.06 -59.49 4.47 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.845 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.473 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -68.34 14.59 0.07 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.389 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.517 ' CE1' HG12 ' A' ' 65' ' ' VAL . 9.4 t80 -117.59 -26.83 6.48 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.27 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -129.35 -43.21 0.21 Allowed Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.521 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.484 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -146.29 -114.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.038 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -146.19 -160.82 1.2 Allowed 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.237 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -59.69 -99.91 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.64 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.634 ' CG ' ' H ' ' A' ' 127' ' ' THR . 19.5 p-10 -57.54 -111.31 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.634 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 1.6 t 43.75 -120.13 0.67 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.894 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.595 ' N ' ' OG1' ' A' ' 127' ' ' THR . 8.4 mm 54.79 -96.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.714 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.4 OUTLIER 76.12 -138.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.297 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.9 m -42.27 129.51 3.8 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.044 -0.663 . . . . 0.0 111.819 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.589 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.9 t -121.13 150.96 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.393 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.78 83.41 8.12 Favored Pre-proline 0 C--N 1.302 -1.49 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.431 ' C ' ' H ' ' A' ' 135' ' ' GLY . 4.3 Cg_exo -61.05 98.65 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.536 1.491 . . . . 0.0 110.433 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -55.27 -2.76 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.656 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . 175.21 -36.97 0.1 Allowed Glycine 0 N--CA 1.492 2.388 0 C-N-CA 117.87 -2.11 . . . . 0.0 112.588 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.501 HD12 ' C ' ' A' ' 92' ' ' ARG . 3.8 mt -90.24 171.53 9.42 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.414 -1.314 . . . . 0.0 111.894 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -94.91 127.25 40.8 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 153' ' ' VAL . 3.4 t -98.32 139.22 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.988 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 98.9 t -133.34 125.35 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.314 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.562 HD23 ' OG1' ' A' ' 167' ' ' THR . 10.5 mp -103.62 140.29 37.75 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.428 -0.909 . . . . 0.0 113.052 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -117.35 131.75 56.72 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.055 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -80.97 -44.12 18.65 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.419 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.473 HD22 ' HB3' ' A' ' 147' ' ' SER . 13.7 t30 -71.95 -171.68 0.74 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.698 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.34 -128.52 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.603 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 146' ' ' PHE . 45.7 t30 -53.57 93.26 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.439 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 145' ' ' ASN . 3.8 m-85 37.39 67.38 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.314 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.473 ' HB3' HD22 ' A' ' 143' ' ' ASN . 0.4 OUTLIER -140.83 165.79 26.55 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.116 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 75.79 -163.73 53.6 Favored Glycine 0 N--CA 1.503 3.1 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.998 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.01 171.82 10.18 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.725 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 p -148.18 164.13 34.88 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.697 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 mt -124.67 82.94 59.14 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.344 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -63.05 100.75 0.26 Allowed 'Trans proline' 0 C--N 1.318 -1.054 0 C-N-CA 121.649 1.566 . . . . 0.0 112.652 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 138' ' ' VAL . 10.3 t -80.81 90.01 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.366 -0.933 . . . . 0.0 109.66 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -49.87 -31.64 12.55 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.998 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 13.3 t -170.39 -136.15 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.341 -1.344 . . . . 0.0 112.351 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.414 ' N ' ' OG ' ' A' ' 155' ' ' SER . 11.6 m-20 -50.55 141.62 12.11 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.18 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.535 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.44 63.43 1.07 Allowed Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.699 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.5 Cg_endo -63.22 21.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.214 1.943 . . . . 0.0 112.777 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.535 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -168.96 118.88 0.71 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.274 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.62 -40.64 0.14 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.407 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.602 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 166' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.126 0.488 . . . . 0.0 111.451 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.562 ' OG1' HD23 ' A' ' 140' ' ' LEU . 1.1 m -90.58 123.12 33.97 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.579 -0.849 . . . . 0.0 110.508 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.4 m -90.33 -79.55 0.34 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.141 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 7.0 m -105.29 159.87 15.55 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.437 HG12 ' CD1' ' A' ' 118' ' ' LEU . 32.8 pt -141.92 174.36 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.25 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -158.82 109.84 2.09 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.506 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.438 HG21 HD13 ' A' ' 136' ' ' LEU . 56.5 mt -88.08 92.27 3.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 118.832 -1.147 . . . . 0.0 109.414 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.939 -179.904 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.422 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.873 0.368 . . . . 0.0 110.73 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.458 ' N ' ' OD1' ' A' ' 3' ' ' ASN . 2.7 p30 -173.24 107.45 0.15 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.191 -1.003 . . . . 0.0 111.159 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 pt -76.36 175.13 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.932 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 m -148.06 153.1 38.47 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.364 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 m -138.02 160.04 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.235 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 22.2 m-85 -119.42 145.91 45.83 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.904 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.85 -66.52 0.6 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.561 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 13.4 m120 -76.1 179.82 5.43 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.311 -0.956 . . . . 0.0 112.364 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -73.93 176.81 6.08 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.226 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.654 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 16.8 t70 48.56 56.01 8.18 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.491 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.654 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 39.2 p90 38.23 27.42 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.451 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 11' ' ' ASP . 6.3 tp-100 -98.89 163.06 12.76 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.35 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.561 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 93.13 134.35 6.91 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.378 -1.391 . . . . 0.0 109.634 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 14' ' ' GLY . 38.7 mttp -29.45 140.82 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.47 164.55 12.23 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.322 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.3 t -145.58 129.94 11.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.664 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -92.94 137.09 32.67 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.231 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 mt -129.05 136.79 29.73 Favored Pre-proline 0 N--CA 1.49 1.558 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.33 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -72.44 156.72 54.1 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 121.087 1.191 . . . . 0.0 111.422 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.73 -161.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.463 1.442 . . . . 0.0 109.726 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.558 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 91.18 -162.47 28.46 Favored Glycine 0 N--CA 1.485 1.923 0 C-N-CA 118.528 -1.796 . . . . 0.0 110.991 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.723 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -123.03 133.18 54.35 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.238 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.603 ' OH ' HD12 ' A' ' 82' ' ' ILE . 14.7 p90 -155.7 174.51 15.19 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.522 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.468 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 17.0 p -138.25 -156.64 0.7 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.071 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.469 ' CD ' ' H ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -66.79 -16.68 64.43 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.599 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -65.13 -59.88 3.62 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.637 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.554 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 15.3 tp60 -56.41 -43.78 79.68 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 118.754 -1.178 . . . . 0.0 109.261 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 29' ' ' LEU . 28.4 mt -59.21 -40.03 84.51 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.814 -1.155 . . . . 0.0 109.127 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.7 -32.73 14.08 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 118.735 -1.186 . . . . 0.0 108.077 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -69.87 -42.07 73.97 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.699 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 mt -70.58 -74.86 0.13 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.82 -29.67 0.74 Allowed Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.092 -1.527 . . . . 0.0 110.846 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.41 ' H ' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -92.08 139.99 16.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.882 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.615 ' O ' HG23 ' A' ' 38' ' ' THR . 2.2 pt-20 179.94 166.1 1.22 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.481 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.607 ' C ' ' H ' ' A' ' 38' ' ' THR . 0.6 OUTLIER 79.97 -143.54 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.545 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.73 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -56.38 10.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.623 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 35' ' ' GLU . 67.4 p -76.17 -142.4 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.618 -1.233 . . . . 0.0 111.023 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 38' ' ' THR . 9.1 mt 39.69 60.71 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.02 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.2 t -65.54 -50.39 65.4 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.12 172.26 8.38 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.355 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.62 154.48 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 118.529 -1.268 . . . . 0.0 112.607 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -138.66 125.28 20.76 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.457 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.9 t -140.0 114.43 7.74 Favored Pre-proline 0 N--CA 1.494 1.725 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.918 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -69.32 169.48 18.25 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 121.116 1.21 . . . . 0.0 111.231 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.63 -174.97 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 122.102 1.868 . . . . 0.0 111.387 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.86 -16.77 7.86 Favored Glycine 0 N--CA 1.482 1.766 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.985 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.422 HG11 ' CB ' ' A' ' 2' ' ' ALA . 18.4 m -149.25 146.4 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.779 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -119.55 139.35 52.28 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.55 159.43 20.41 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.199 -1.001 . . . . 0.0 112.937 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.495 HG23 ' O ' ' A' ' 63' ' ' ILE . 70.5 mt -141.29 117.96 7.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.447 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.472 HD12 ' H ' ' A' ' 52' ' ' LEU . 4.2 mp -92.32 163.12 14.0 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.824 -1.15 . . . . 0.0 113.222 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.57 ' CZ ' ' NE2' ' A' ' 62' ' ' GLN . 30.7 m-85 -141.61 115.29 9.06 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.678 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -81.1 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.899 -0.72 . . . . 0.0 112.157 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -59.26 141.07 55.28 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.319 -0.953 . . . . 0.0 111.382 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.07 172.79 0.26 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.464 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.47 27.27 73.88 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.291 -1.433 . . . . 0.0 110.149 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.468 ' CZ ' HG23 ' A' ' 25' ' ' THR . 32.9 m-85 54.58 63.32 2.19 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.969 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.38 -161.6 1.34 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.01 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.0 170.02 1.21 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.462 -1.352 . . . . 0.0 110.106 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -44.74 121.44 2.71 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.343 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.57 ' NE2' ' CZ ' ' A' ' 53' ' ' TYR . 5.0 mt-30 -94.86 173.21 7.71 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.068 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.807 HD11 HD11 ' A' ' 75' ' ' LEU . 2.9 mt -143.73 166.04 13.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.683 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -146.93 131.18 17.45 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.299 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.6 m -150.17 160.31 4.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.806 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.43 -15.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.543 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -111.1 -138.55 0.38 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.003 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -111.07 124.81 52.91 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.001 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.75 120.25 29.98 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.236 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.55 -85.18 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.108 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 6.5 mt-10 -85.51 3.56 39.84 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.69 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.454 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 1.6 tp 72.34 -89.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.584 -0.847 . . . . 0.0 111.74 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.428 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -179.13 -178.88 48.57 Favored Glycine 0 N--CA 1.499 2.876 0 C-N-CA 118.861 -1.638 . . . . 0.0 111.369 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -70.2 14.8 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.627 2.218 . . . . 0.0 112.99 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.807 HD11 HD11 ' A' ' 63' ' ' ILE . 1.4 pt? -132.49 38.95 3.41 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.269 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -83.46 -2.04 54.98 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.655 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -73.14 -7.99 53.79 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.805 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -164.07 117.74 1.45 Allowed 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.122 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.27 127.32 11.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.232 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.1 t -155.45 -35.32 0.09 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 118.857 -1.137 . . . . 0.0 112.362 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.2 m -93.69 136.49 33.91 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.943 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.603 HD12 ' OH ' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -144.84 155.99 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 118.839 -1.144 . . . . 0.0 112.282 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.817 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.87 120.74 15.43 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.358 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.817 ' H ' HH12 ' A' ' 83' ' ' ARG . 18.4 t -129.92 136.8 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.939 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.591 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 2.6 mt -143.87 132.77 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.027 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.5 m -38.18 150.81 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.928 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.509 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -148.03 139.89 14.14 Favored Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.328 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.509 ' HD2' HG22 ' A' ' 87' ' ' VAL . 10.7 Cg_exo -47.78 153.61 2.34 Favored 'Trans proline' 0 C--O 1.212 -0.821 0 C-N-CA 121.401 1.401 . . . . 0.0 111.512 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.34 141.25 15.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 119.756 -0.778 . . . . 0.0 112.312 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -145.97 136.41 12.16 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.582 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.404 ' HG2' HD21 ' A' ' 136' ' ' LEU . 5.4 Cg_exo -58.83 -155.39 0.01 OUTLIER 'Trans proline' 0 C--O 1.21 -0.904 0 C-N-CA 121.421 1.414 . . . . 0.0 111.274 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.411 ' NE ' HH21 ' A' ' 94' ' ' ARG . 5.2 ptt180 -178.76 -160.86 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 118.375 -1.33 . . . . 0.0 111.929 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.0 168.7 19.09 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.385 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.411 HH21 ' NE ' ' A' ' 92' ' ' ARG . 0.4 OUTLIER -125.15 156.52 38.25 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.635 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.432 ' CD2' HG13 ' A' ' 131' ' ' VAL . 73.7 m-85 -145.88 103.88 3.8 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.672 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -89.97 172.25 8.99 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.059 -1.057 . . . . 0.0 112.124 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.603 ' CE2' ' OG1' ' A' ' 127' ' ' THR . 0.3 OUTLIER -110.45 159.23 17.68 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.915 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 42.2 tttt 68.35 151.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.84 0.829 . . . . 0.0 112.359 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.562 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 26.8 tt0 -67.9 106.22 2.23 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.754 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.584 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 105.0 48.45 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.108 0 O-C-N 125.054 1.471 . . . . 0.0 110.637 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.584 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 33.9 p90 30.73 39.1 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.156 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 100' ' ' GLN . 24.9 t70 -99.41 26.75 5.76 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.465 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -146.94 179.99 23.46 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.141 -1.504 . . . . 0.0 111.28 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -29.72 145.12 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -119.08 137.65 53.42 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.322 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.682 HG21 ' O ' ' A' ' 122' ' ' GLY . 2.4 t -139.86 158.58 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.979 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.466 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 7.2 p-10 -144.86 156.35 43.96 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.646 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.478 HD22 ' CD2' ' A' ' 121' ' ' TYR . 32.2 mt -141.08 147.9 49.52 Favored Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.527 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -71.31 165.23 33.09 Favored 'Trans proline' 0 C--O 1.212 -0.819 0 C-N-CA 121.797 1.665 . . . . 0.0 111.08 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.54 149.42 82.18 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.646 1.564 . . . . 0.0 111.518 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.41 -151.38 22.6 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 119.069 -1.539 . . . . 0.0 111.436 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.678 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 41.5 tt0 -136.14 155.69 49.8 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.21 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.678 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 18.9 m-85 -145.6 155.32 42.96 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.51 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.9 p -96.45 -156.82 0.55 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.327 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.749 ' CD ' ' H ' ' A' ' 115' ' ' GLN . 3.8 pm0 -103.75 29.4 5.81 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.231 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.24 -65.48 0.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.769 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.55 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 9.6 pt-20 -70.33 -48.77 54.99 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.975 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.68 ' C ' HD23 ' A' ' 118' ' ' LEU . 1.9 tt -35.12 -73.25 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.502 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.54 -54.22 24.14 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.555 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -76.28 17.66 0.35 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.638 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.511 ' N ' ' O ' ' A' ' 117' ' ' GLU . 18.1 t80 -123.7 -12.62 7.6 Favored 'General case' 0 N--CA 1.502 2.175 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.625 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.682 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -142.47 -48.49 0.04 OUTLIER Glycine 0 N--CA 1.485 1.953 0 C-N-CA 119.223 -1.465 . . . . 0.0 110.173 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.595 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -145.13 -99.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.835 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.595 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 17.9 t70 -165.76 -164.88 0.76 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.15 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.533 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 1.4 t-20 -64.53 -122.07 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.874 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.477 ' H ' ' CG ' ' A' ' 125' ' ' ASN . 3.6 m-20 -70.4 112.42 6.68 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.538 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.603 ' OG1' ' CE2' ' A' ' 97' ' ' TYR . 1.8 t -179.87 -5.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.744 -0.783 . . . . 0.0 110.798 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.2 mt -91.25 151.95 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.617 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.528 ' HB3' ' H ' ' A' ' 161' ' ' GLY . 19.3 m -153.42 -66.12 0.15 Allowed 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.373 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.24 112.37 19.18 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.037 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.432 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.0 t -120.5 163.3 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.189 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.0 tttp -154.34 125.64 3.62 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.647 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 6.2 Cg_endo -65.33 -50.04 2.22 Favored 'Trans proline' 0 C--O 1.203 -1.262 0 C-N-CA 121.034 1.156 . . . . 0.0 111.081 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.479 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 72.23 -37.72 0.4 Allowed 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.38 -0.928 . . . . 0.0 112.621 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . -150.35 -48.88 0.02 OUTLIER Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.236 -1.459 . . . . 0.0 111.113 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.404 HD21 ' HG2' ' A' ' 91' ' ' PRO . 0.7 OUTLIER -109.56 153.4 24.19 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.008 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.06 153.75 41.54 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.118 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.64 143.82 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 119.663 -0.815 . . . . 0.0 112.321 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.43 HG12 ' CE1' ' A' ' 141' ' ' PHE . 93.3 t -135.94 123.07 33.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.984 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 140' ' ' LEU . 10.3 mp -103.23 142.75 33.64 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.812 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 141' ' ' PHE . 14.0 m-85 -120.61 136.52 54.79 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.082 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -75.05 -62.62 1.49 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.565 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.442 ' ND2' ' HA3' ' A' ' 148' ' ' GLY . 2.6 m-80 -61.01 159.99 10.65 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.271 -0.972 . . . . 0.0 112.362 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -27.35 -108.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.519 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 9.0 m120 -74.7 89.82 2.28 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.219 -0.901 . . . . 0.0 113.273 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.66 ' H ' ' CB ' ' A' ' 169' ' ' SER . 1.5 p90 33.04 73.11 0.07 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.131 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.409 ' C ' ' HB2' ' A' ' 143' ' ' ASN . 10.3 t -145.83 -170.76 3.55 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.158 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.442 ' HA3' ' ND2' ' A' ' 143' ' ' ASN . . . 51.26 -157.97 2.54 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.124 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.406 ' C ' HG23 ' A' ' 150' ' ' THR . 2.3 m-20 -59.99 174.1 0.54 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.654 -0.819 . . . . 0.0 110.833 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 149' ' ' ASP . 55.3 p -155.05 174.5 15.09 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.914 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.7 tp -138.32 79.54 30.46 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.026 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -59.66 110.26 0.71 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.817 1.678 . . . . 0.0 112.945 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 155' ' ' SER . 20.5 t -93.24 70.77 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.356 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -65.06 8.2 0.14 Allowed 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.219 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.595 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 9.3 t -170.94 177.68 3.67 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.282 -1.367 . . . . 0.0 112.211 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.595 ' N ' ' OG ' ' A' ' 155' ' ' SER . 3.2 m-20 -51.0 151.59 2.53 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.431 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.531 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -164.32 61.71 0.92 Allowed Pre-proline 0 C--N 1.309 -1.165 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.407 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.2 Cg_endo -63.72 22.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.534 2.156 . . . . 0.0 113.314 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -175.96 95.49 0.06 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 117.759 -1.576 . . . . 0.0 112.504 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 160' ' ' LEU . 44.7 mt -112.56 -61.54 1.71 Allowed 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.65 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.528 ' H ' ' HB3' ' A' ' 129' ' ' SER . . . . . . . . 0 N--CA 1.499 2.89 0 C-N-CA 119.553 -1.308 . . . . 0.0 111.156 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.6 p30 . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 120.575 0.226 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 47.3 m 42.76 73.88 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.419 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.3 m -78.29 -23.55 47.14 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.204 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.66 ' CB ' ' H ' ' A' ' 146' ' ' PHE . 0.2 OUTLIER -149.25 162.07 40.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.34 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 29.1 pt -143.46 161.33 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 119.159 -1.017 . . . . 0.0 111.029 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -143.42 104.01 4.18 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.452 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.8 mt -82.63 95.12 3.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.179 -1.009 . . . . 0.0 110.154 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.3 m . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.845 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.599 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.873 0.368 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -175.15 118.96 0.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.526 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.5 pt -69.14 154.7 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.233 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -126.56 135.44 51.27 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.81 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.622 ' HB ' HG23 ' A' ' 39' ' ' ILE . 2.3 m -121.89 138.73 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.971 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.52 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 29.6 m-85 -96.48 146.7 24.56 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.798 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.04 -56.78 17.02 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.25 -0.98 . . . . 0.0 112.21 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.606 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 12.2 m-20 -96.85 170.94 8.83 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.504 ' HG2' ' N ' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -76.6 -165.92 0.59 Allowed 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.976 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.504 ' N ' ' HG2' ' A' ' 10' ' ' GLU . 66.4 m-20 52.67 35.4 18.21 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.523 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.52 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 18.2 t80 56.68 7.11 0.35 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.436 -0.905 . . . . 0.0 112.16 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.43 ' HG3' ' N ' ' A' ' 14' ' ' GLY . 5.3 tp-100 -96.31 160.21 14.54 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.551 -0.859 . . . . 0.0 111.678 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.606 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 102.38 131.23 7.27 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.738 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 14' ' ' GLY . 25.2 mtmm -31.79 141.11 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.927 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.588 ' H ' ' NE2' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -99.44 161.19 13.76 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.119 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.1 t -145.47 134.48 17.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.206 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.16 134.09 39.66 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.141 -1.024 . . . . 0.0 112.116 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.6 mt -122.1 127.57 25.88 Favored Pre-proline 0 N--CA 1.489 1.479 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.524 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.5 163.6 31.92 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 120.928 1.086 . . . . 0.0 111.268 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.39 -169.28 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.65 1.567 . . . . 0.0 111.019 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.462 ' C ' HH21 ' A' ' 83' ' ' ARG . . . 87.96 -176.91 46.05 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.744 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.672 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -112.18 142.29 44.83 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.884 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.616 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -156.03 -174.77 5.1 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.314 179.777 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 24' ' ' TYR . 4.7 p -156.35 -157.17 0.69 Allowed 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.921 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.43 ' H ' ' HB ' ' A' ' 25' ' ' THR . 43.9 ttt85 -52.29 -33.54 42.65 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.289 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.79 -63.59 1.21 Allowed 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.863 -1.135 . . . . 0.0 110.524 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.8 tm0? -57.23 -32.95 67.05 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.779 -1.169 . . . . 0.0 109.882 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.616 HD21 ' CZ ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -60.56 -47.27 86.92 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.011 -1.076 . . . . 0.0 109.433 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.41 -32.99 28.33 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.163 -1.015 . . . . 0.0 108.92 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -64.08 -42.79 96.83 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.848 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 mt -71.9 -80.31 0.06 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.941 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.77 -29.79 0.16 Allowed Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.465 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.455 HG23 ' H ' ' A' ' 34' ' ' ILE . 0.9 OUTLIER -82.2 169.75 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.894 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.959 ' H ' HG21 ' A' ' 38' ' ' THR . 4.7 pt-20 178.68 111.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.289 -0.965 . . . . 0.0 111.904 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.616 ' O ' HG23 ' A' ' 38' ' ' THR . 1.0 OUTLIER 61.66 140.57 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.555 ' H ' ' H ' ' A' ' 79' ' ' VAL . 9.6 t30 47.01 4.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.658 -1.156 . . . . 0.0 113.695 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.959 HG21 ' H ' ' A' ' 35' ' ' GLU . 76.2 p -82.34 -29.87 30.74 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 117.992 -1.483 . . . . 0.0 111.424 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.622 HG23 ' HB ' ' A' ' 6' ' ' VAL . 11.6 mt -78.24 53.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.328 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 10' ' ' GLU . 30.4 t -50.98 -53.93 28.85 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.761 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.0 169.65 10.27 Favored 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.307 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.1 t -153.3 151.43 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 117.856 -1.538 . . . . 0.0 113.139 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -138.64 102.69 4.66 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.194 -1.367 . . . . 0.0 108.805 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 73.9 t -117.94 107.8 43.5 Favored Pre-proline 0 N--CA 1.496 1.865 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.228 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.25 168.2 19.98 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 121.31 1.34 . . . . 0.0 110.939 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.11 -173.19 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.753 1.635 . . . . 0.0 111.177 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.63 -14.77 11.46 Favored Glycine 0 N--CA 1.481 1.699 0 C-N-CA 119.125 -1.512 . . . . 0.0 110.691 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.599 HG11 ' CB ' ' A' ' 2' ' ' ALA . 16.3 m -151.59 134.28 6.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 C-N-CA 118.851 -1.14 . . . . 0.0 112.086 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.436 ' O ' HG13 ' A' ' 84' ' ' VAL . 22.8 ttpp -105.83 143.52 33.85 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.32 150.75 49.44 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.024 -1.07 . . . . 0.0 112.928 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 63' ' ' ILE . 83.9 mt -135.04 117.75 22.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.737 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.476 HD12 ' H ' ' A' ' 52' ' ' LEU . 3.6 mp -96.61 160.83 14.18 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 118.927 -1.109 . . . . 0.0 113.8 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 62' ' ' GLN . 44.9 m-85 -135.3 116.38 14.3 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.675 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -47.59 -88.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.081 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -61.69 147.26 46.58 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.54 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -55.54 174.51 0.1 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.389 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.16 30.59 75.87 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.127 -1.511 . . . . 0.0 110.03 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 48.42 40.46 14.83 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.767 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.37 -176.97 3.02 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.821 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.69 164.27 5.27 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.064 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -45.55 131.87 8.47 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.545 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.413 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 5.6 pt20 -99.24 172.31 7.44 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.706 HD11 HD11 ' A' ' 75' ' ' LEU . 3.9 mt -135.28 165.29 31.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.763 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.414 ' C ' HG13 ' A' ' 65' ' ' VAL . 28.2 mt-10 -143.92 129.89 19.49 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.4 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.414 HG13 ' C ' ' A' ' 64' ' ' GLU . 35.1 m -150.03 159.61 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 118.489 -1.284 . . . . 0.0 112.524 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 t -146.23 2.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.238 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.49 ' HB3' ' OH ' ' A' ' 121' ' ' TYR . . . -131.51 -144.6 0.25 Allowed 'General case' 0 C--O 1.207 -1.132 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.086 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.481 ' C ' ' ND2' ' A' ' 68' ' ' ASN . 0.5 OUTLIER -103.37 119.55 39.09 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.849 -0.741 . . . . 0.0 111.578 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.542 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -97.45 97.86 9.45 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.17 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -58.72 -87.61 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.48 -0.888 . . . . 0.0 112.096 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 43.7 mm-40 -68.02 -5.83 19.39 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.41 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.466 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 2.8 tp 70.83 -77.88 0.05 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.049 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.43 -175.21 43.75 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.51 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -65.35 -38.43 26.48 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.193 1.929 . . . . 0.0 111.865 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -78.96 30.67 0.2 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.395 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.839 ' H ' HD22 ' A' ' 76' ' ' ASN . 0.0 OUTLIER -77.14 10.26 2.52 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.561 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -87.83 -2.17 58.44 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.83 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -170.7 122.23 0.6 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.024 -1.07 . . . . 0.0 111.546 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.555 ' H ' ' H ' ' A' ' 37' ' ' ASN . 2.4 t -147.92 121.93 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.494 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.1 t -150.58 -34.1 0.16 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.908 -1.117 . . . . 0.0 112.517 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.425 ' OG ' HG22 ' A' ' 25' ' ' THR . 3.8 m -93.19 136.31 33.58 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.818 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.524 HD12 ' CE1' ' A' ' 24' ' ' TYR . 21.3 mt -148.08 160.95 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.287 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.835 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -142.78 108.1 5.01 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.824 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.835 ' H ' HH22 ' A' ' 83' ' ' ARG . 10.5 t -114.59 142.39 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.823 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.465 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 7.2 mt -142.48 132.43 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.745 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 m -40.38 153.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.663 -0.698 . . . . 0.0 112.319 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -150.77 149.1 24.78 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.968 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.33 177.55 0.15 Allowed 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 121.546 1.497 . . . . 0.0 112.099 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 89' ' ' VAL . 34.6 m -88.29 136.12 24.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.316 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -146.17 123.68 6.1 Favored Pre-proline 0 C--N 1.308 -1.2 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.844 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -57.06 178.84 0.13 Allowed 'Trans proline' 0 C--O 1.205 -1.146 0 C-N-CA 121.088 1.192 . . . . 0.0 110.978 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.504 ' HD3' ' N ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -151.42 -160.12 1.12 Allowed 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.566 0.698 . . . . 0.0 110.23 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.98 167.03 23.06 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -132.35 116.07 16.4 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.674 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -99.09 130.27 45.41 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.456 ' CD2' ' HB3' ' A' ' 105' ' ' GLU . 24.8 m-85 -102.47 165.39 11.13 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.639 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -103.31 162.67 12.81 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.41 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.467 ' HB2' ' CB ' ' A' ' 102' ' ' ASP . 22.3 mmtp 58.14 157.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 122.24 1.019 . . . . 0.0 112.858 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.552 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 36.4 tt0 -72.92 107.58 5.38 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.3 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.569 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 92.26 56.52 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.603 0 O-C-N 124.524 1.14 . . . . 0.0 111.256 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.588 ' CG ' ' O ' ' A' ' 101' ' ' PHE . 1.3 t80 37.98 64.1 0.73 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.486 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.467 ' CB ' ' HB2' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -111.77 17.03 20.21 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.193 179.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -160.01 155.4 26.53 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.485 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -44.77 162.11 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.135 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.456 ' CD ' ' C ' ' A' ' 105' ' ' GLU . 2.2 pp20? -120.12 179.46 4.27 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.532 0.682 . . . . 0.0 112.551 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.636 HG13 ' N ' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -140.01 177.0 4.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.799 -1.092 . . . . 0.0 108.963 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.636 ' N ' HG13 ' A' ' 106' ' ' VAL . 19.5 p-10 -142.55 150.91 41.02 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.653 -1.219 . . . . 0.0 112.006 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.3 mt -141.98 148.46 48.86 Favored Pre-proline 0 N--CA 1.5 2.064 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.732 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.414 ' O ' HD12 ' A' ' 172' ' ' ILE . 11.8 Cg_endo -77.28 163.01 30.7 Favored 'Trans proline' 0 C--O 1.211 -0.83 0 C-N-CA 122.096 1.864 . . . . 0.0 111.963 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.38 158.54 35.37 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 122.415 2.077 . . . . 0.0 111.484 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.91 -170.5 14.96 Favored Glycine 0 N--CA 1.501 2.985 0 C-N-CA 119.465 -1.35 . . . . 0.0 111.43 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.594 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 18.8 tt0 -111.2 155.43 22.94 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.611 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 26.0 m-85 -142.35 151.87 42.34 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.83 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.4 p -87.24 -164.77 1.14 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.686 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 56.54 0.68 Allowed 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.179 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.441 ' N ' ' OE1' ' A' ' 119' ' ' GLU . . . -155.18 -71.57 0.12 Allowed 'General case' 0 C--N 1.294 -1.804 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.234 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.1 pt-20 -67.04 -44.73 79.47 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.488 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.653 ' C ' HD23 ' A' ' 118' ' ' LEU . 1.2 tt -39.56 -69.83 0.12 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.5 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.751 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 25.4 mp0 -48.11 -59.41 3.41 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.913 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.416 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 1.5 mpt_? -70.95 0.79 6.61 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.96 -1.096 . . . . 0.0 112.814 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 117' ' ' GLU . 13.8 t80 -97.9 -17.58 19.17 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.072 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.55 -41.05 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 C-N-CA 118.55 -1.786 . . . . 0.0 111.665 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.596 HG13 HD11 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -134.73 -117.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.461 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.55 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 15.7 t70 -148.92 -163.72 1.85 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.599 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.648 HD22 ' H ' ' A' ' 125' ' ' ASN . 0.1 OUTLIER -106.07 31.45 5.09 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.028 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.603 HD22 ' C ' ' A' ' 126' ' ' ASN . 0.4 OUTLIER -176.27 17.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.756 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.699 HG23 ' N ' ' A' ' 128' ' ' ILE . 8.5 t -114.67 -132.11 0.33 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.386 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.699 ' N ' HG23 ' A' ' 127' ' ' THR . 3.4 mt 62.84 158.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.097 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.2 p -165.85 -97.29 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.65 136.88 49.42 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.889 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.59 157.25 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -150.8 96.48 3.34 Favored Pre-proline 0 C--N 1.304 -1.398 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.893 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -53.26 93.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.238 1.292 . . . . 0.0 110.79 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.467 ' CG ' ' NH2' ' A' ' 92' ' ' ARG . 1.4 tp-100 -71.85 7.69 1.47 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.1 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 171.52 -40.56 0.18 Allowed Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.92 -1.61 . . . . 0.0 111.02 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.415 ' HB2' ' CG2' ' A' ' 172' ' ' ILE . 0.4 OUTLIER -121.67 151.02 40.92 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.314 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.0 156.36 39.73 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.657 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.29 136.49 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.818 -0.753 . . . . 0.0 112.249 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.481 ' C ' HD12 ' A' ' 140' ' ' LEU . 74.3 t -125.14 128.77 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.826 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 140' ' ' LEU . 10.8 mp -102.72 142.01 34.58 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.372 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 141' ' ' PHE . 4.0 m-85 -120.6 134.23 55.3 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.397 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -70.28 -71.58 0.24 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.914 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -72.81 -176.32 1.98 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.889 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.625 ' C ' ' ND2' ' A' ' 145' ' ' ASN . 1.5 m-20 -77.12 -164.25 0.44 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.665 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 1.1 p30 36.65 29.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.518 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.665 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 2.5 p90 39.58 61.64 1.35 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.779 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.5 t -146.66 137.67 24.13 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.2 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.42 -139.55 14.23 Favored Glycine 0 N--CA 1.503 3.125 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.56 141.65 44.77 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.099 -1.041 . . . . 0.0 109.863 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 34.3 p -147.82 162.28 39.57 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.911 -1.116 . . . . 0.0 111.869 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 151' ' ' LEU . 64.8 tp -130.12 89.34 45.53 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.922 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.06 108.87 1.59 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 121.849 1.699 . . . . 0.0 113.006 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.58 80.56 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.412 -0.915 . . . . 0.0 108.925 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.478 ' C ' ' OG ' ' A' ' 155' ' ' SER . 50.9 t30 -65.35 -9.91 28.66 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.478 ' OG ' ' C ' ' A' ' 154' ' ' ASN . 1.2 m -161.03 -155.44 0.41 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 117.594 -1.643 . . . . 0.0 113.232 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.51 142.48 44.16 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.824 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.545 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -162.05 61.82 1.3 Allowed Pre-proline 0 C--N 1.308 -1.21 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.449 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.2 Cg_endo -64.71 21.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.291 1.994 . . . . 0.0 112.316 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -170.45 113.17 0.44 Allowed 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.677 -1.209 . . . . 0.0 111.331 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 mt -143.1 -56.78 0.42 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.406 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 C-N-CA 119.333 -1.413 . . . . 0.0 110.612 179.96 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.942 0.401 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.2 m -57.55 99.17 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.593 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 73.7 m -84.29 -56.29 3.72 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.68 158.39 30.18 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.176 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.405 HG23 HD11 ' A' ' 118' ' ' LEU . 35.1 pt -136.01 165.37 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.49 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -146.73 100.58 3.35 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.401 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 172' ' ' ILE . 10.3 mt -78.97 105.13 7.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.256 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 51.6 m . . . . . 0 C--N 1.306 -1.324 0 CA-C-O 116.399 -1.762 . . . . 0.0 110.963 -179.937 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.764 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 121.068 0.461 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.42 ' CG ' ' C ' ' A' ' 2' ' ' ALA . 9.0 m-80 -158.97 122.33 3.78 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.854 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.417 ' O ' ' CG1' ' A' ' 4' ' ' ILE . 2.2 pt -75.49 133.86 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.852 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 m -110.89 114.69 28.21 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.353 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.32 164.6 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.304 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.905 ' CE2' ' OE1' ' A' ' 16' ' ' GLN . 39.6 m-85 -123.85 148.85 46.42 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.998 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.443 ' HB2' ' N ' ' A' ' 15' ' ' LYS . 3.2 m-85 -79.04 0.41 27.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.579 HD22 ' CA ' ' A' ' 14' ' ' GLY . 22.8 m-80 -151.3 172.82 15.28 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.026 -1.47 . . . . 0.0 112.114 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.56 -174.82 1.81 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.519 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 13' ' ' GLN . 15.3 t70 52.67 31.08 9.67 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.159 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.526 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 1.5 t80 68.45 -8.73 0.58 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.136 -1.026 . . . . 0.0 111.349 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.465 ' H ' ' C ' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -78.25 167.93 20.62 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.287 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 1.134 ' O ' ' NE2' ' A' ' 16' ' ' GLN . . . 109.3 134.82 7.12 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 1.237 ' C ' HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -35.25 144.57 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.688 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 1.388 HE21 ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -98.6 148.05 24.19 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.258 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.3 t -147.45 123.37 2.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.676 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -94.78 115.82 27.98 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.803 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt -105.98 132.49 20.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.598 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -68.53 164.69 31.89 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 120.874 1.049 . . . . 0.0 111.439 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.68 -161.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 121.774 1.649 . . . . 0.0 111.057 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.716 ' C ' HD22 ' A' ' 23' ' ' ASN . . . 83.68 -177.64 52.43 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.109 -1.52 . . . . 0.0 111.354 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.733 ' N ' HD22 ' A' ' 23' ' ' ASN . 0.3 OUTLIER -105.92 137.08 44.42 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.786 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.564 ' CE2' HD13 ' A' ' 82' ' ' ILE . 4.0 p90 -158.55 160.2 36.37 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.294 -0.963 . . . . 0.0 109.689 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.445 ' CG2' ' CE2' ' A' ' 58' ' ' PHE . 68.9 p -122.83 -162.02 0.99 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.1 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -66.3 -16.99 64.48 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.876 -1.13 . . . . 0.0 110.776 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -64.39 -58.42 6.52 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 118.816 -1.154 . . . . 0.0 109.211 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.526 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -55.57 -44.89 77.27 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 118.686 -1.206 . . . . 0.0 108.918 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.433 HD23 HD12 ' A' ' 32' ' ' LEU . 39.4 mt -57.33 -41.27 79.64 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.966 -1.094 . . . . 0.0 109.425 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.49 -33.14 13.68 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.86 -1.136 . . . . 0.0 108.263 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -70.95 -37.91 72.83 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.489 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.433 HD12 HD23 ' A' ' 29' ' ' LEU . 20.2 mt -72.6 -73.2 0.21 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.646 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.81 -27.2 0.65 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.285 -1.436 . . . . 0.0 110.596 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.45 HD13 HG21 ' A' ' 34' ' ' ILE . 8.0 tt -75.63 145.82 10.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.173 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.514 ' C ' ' CG ' ' A' ' 36' ' ' ASN . 5.6 pt-20 -174.38 146.68 1.09 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.657 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.514 ' CG ' ' C ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER 74.56 -140.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.402 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.744 HD22 ' H ' ' A' ' 37' ' ' ASN . 2.4 m-80 -40.3 -87.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.282 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.704 ' O ' ' N ' ' A' ' 40' ' ' SER . 20.3 p 37.5 -96.26 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.761 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 37' ' ' ASN . 5.6 mt -38.0 79.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 124.412 1.07 . . . . 0.0 111.442 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.704 ' N ' ' O ' ' A' ' 38' ' ' THR . 28.5 t -96.07 -39.05 9.93 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.447 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -127.99 167.55 16.52 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.603 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -153.08 151.14 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 117.849 -1.54 . . . . 0.0 113.012 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -135.46 99.96 4.37 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.837 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.55 108.38 39.6 Favored Pre-proline 0 N--CA 1.494 1.753 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.577 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.94 167.66 20.94 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.092 1.195 . . . . 0.0 110.692 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.65 -171.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.748 1.632 . . . . 0.0 111.108 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.73 -14.51 9.77 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 119.317 -1.421 . . . . 0.0 110.93 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.764 HG11 ' HB3' ' A' ' 2' ' ' ALA . 2.7 m -147.32 140.46 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.339 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.1 tttt -114.81 125.79 54.09 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.808 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.402 ' CB ' HG22 ' A' ' 84' ' ' VAL . . . -117.37 139.7 50.53 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.184 -1.007 . . . . 0.0 113.061 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.564 HD12 HH21 ' A' ' 83' ' ' ARG . 44.3 mt -116.26 119.3 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.631 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -94.58 146.9 23.8 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.26 -0.976 . . . . 0.0 112.239 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.489 ' H ' HD23 ' A' ' 52' ' ' LEU . 43.9 m-85 -127.01 112.58 15.4 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.267 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.523 ' CD ' ' N ' ' A' ' 55' ' ' ASN . 1.5 tm0? -49.87 -76.27 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.345 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.523 ' N ' ' CD ' ' A' ' 54' ' ' GLN . 62.3 t30 -59.97 155.9 15.73 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.047 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -68.68 -179.69 1.48 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.467 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.36 36.77 78.0 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.195 -1.478 . . . . 0.0 110.191 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 25' ' ' THR . 35.6 m-85 49.13 63.78 2.0 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.794 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.55 -166.23 2.43 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.318 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.43 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 68.91 173.09 8.32 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.383 -1.389 . . . . 0.0 109.868 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 9.7 m-20 -42.19 119.44 1.37 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.397 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.665 ' NE2' ' H ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -90.04 164.51 14.48 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.349 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.667 HG13 HD11 ' A' ' 75' ' ' LEU . 8.8 mm -137.91 166.67 23.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.382 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.66 ' N ' HG22 ' A' ' 63' ' ' ILE . 19.2 mp0 -148.26 126.08 11.91 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.619 -0.832 . . . . 0.0 109.64 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.1 159.97 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 118.859 -1.136 . . . . 0.0 112.557 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.435 ' H ' ' H ' ' A' ' 67' ' ' ALA . 2.2 t -149.36 -7.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 114.195 -1.366 . . . . 0.0 107.495 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.435 ' H ' ' H ' ' A' ' 66' ' ' VAL . . . -124.8 -155.88 0.69 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.966 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -93.32 117.76 30.47 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.626 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.603 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.26 111.76 22.65 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.91 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -73.21 -77.9 0.1 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.418 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 73' ' ' GLY . 24.4 tp10 -79.24 -2.92 43.39 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.103 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.475 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 6.7 tp 54.95 -87.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.392 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.475 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 176.11 -170.15 42.95 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 118.967 -1.587 . . . . 0.0 110.924 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.516 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.0 Cg_endo -65.45 -36.22 35.59 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.159 1.906 . . . . 0.0 111.941 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.885 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.4 pt? -70.9 19.51 0.05 Allowed 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.981 -1.088 . . . . 0.0 111.274 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 74' ' ' PRO . 34.9 p-10 -77.33 -18.16 57.68 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.519 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -86.65 2.04 49.82 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.429 -0.909 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -175.87 115.65 0.13 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.326 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.695 HG13 ' N ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -123.05 -174.72 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.156 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.695 ' N ' HG13 ' A' ' 79' ' ' VAL . 39.1 t -172.01 -64.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.296 -1.362 . . . . 0.0 113.541 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.5 m -111.7 150.95 29.47 Favored 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.564 HD13 ' CE2' ' A' ' 24' ' ' TYR . 3.0 mp -146.61 161.49 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.445 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.682 ' NH1' ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -150.85 145.58 25.77 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.993 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.682 ' N ' ' NH1' ' A' ' 83' ' ' ARG . 5.8 t -148.09 146.92 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.695 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.589 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -143.54 134.27 22.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.657 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 85' ' ' ILE . 17.4 m -38.33 148.38 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.336 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.554 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -152.01 141.03 13.98 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.507 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.554 ' HD2' HG22 ' A' ' 87' ' ' VAL . 3.0 Cg_exo -53.42 143.16 55.86 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.078 1.186 . . . . 0.0 110.954 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.586 HG22 ' N ' ' A' ' 90' ' ' GLN . 2.4 p -79.73 164.27 3.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.537 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.586 ' N ' HG22 ' A' ' 89' ' ' VAL . 11.5 mm100 -142.39 151.74 58.73 Favored Pre-proline 0 N--CA 1.487 1.4 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.154 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.432 ' C ' ' HE ' ' A' ' 92' ' ' ARG . 6.3 Cg_exo -57.6 -39.18 90.29 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.599 1.533 . . . . 0.0 111.87 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.696 ' NH1' HE22 ' A' ' 134' ' ' GLN . 15.6 mtm180 58.02 -168.47 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.434 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.53 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.33 178.65 7.43 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.603 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -148.57 130.36 15.13 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.411 -1.316 . . . . 0.0 112.024 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 20.1 m-85 -103.44 172.07 7.01 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.777 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -139.09 168.66 19.33 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.836 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -114.61 170.45 8.3 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.672 -0.811 . . . . 0.0 112.351 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.49 ' HZ2' ' HB3' ' A' ' 98' ' ' LYS . 0.5 OUTLIER 54.67 168.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.233 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.504 ' OE1' ' HG3' ' A' ' 100' ' ' GLN . 1.2 tm-20 -62.5 103.16 0.38 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.585 -1.189 . . . . 0.0 112.5 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 102' ' ' ASP . 2.7 mt-30 68.55 100.95 0.05 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.48 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.478 ' C ' ' O ' ' A' ' 100' ' ' GLN . 19.3 p90 20.94 44.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 124.364 1.04 . . . . 0.0 112.773 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 100' ' ' GLN . 0.7 OUTLIER -102.26 15.64 28.54 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.98 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -154.61 159.79 29.17 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 118.967 -1.587 . . . . 0.0 111.135 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -41.26 157.39 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.832 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.553 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 1.2 pm0 -122.05 163.71 18.94 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.67 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.648 HG12 ' N ' ' A' ' 107' ' ' ASP . 37.4 t -138.11 170.99 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.33 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.648 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.5 p30 -133.44 156.35 47.87 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.034 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.5 mt -145.15 139.35 14.99 Favored Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.26 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -70.18 163.66 37.79 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 121.597 1.532 . . . . 0.0 111.305 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.47 145.99 95.57 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.418 1.412 . . . . 0.0 110.937 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.32 -153.22 24.29 Favored Glycine 0 N--CA 1.499 2.878 0 C-N-CA 119.064 -1.541 . . . . 0.0 111.328 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.609 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 8.3 tt0 -128.94 158.42 38.87 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.755 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.609 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 41.8 m-85 -145.93 151.99 38.72 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.267 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.6 p -103.83 178.56 4.52 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.243 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.08 44.63 0.49 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.174 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -142.45 -61.95 0.44 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 121' ' ' TYR . 4.5 mt-10 -74.11 -54.55 7.57 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.485 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.538 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -29.74 -66.5 0.09 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.635 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.654 ' CD ' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER -59.04 -60.84 3.23 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.747 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.654 HH11 ' CD ' ' A' ' 119' ' ' GLU . 7.9 mpt_? -75.81 26.17 0.11 Allowed 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.952 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 117' ' ' GLU . 35.3 t80 -127.79 -18.48 4.27 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.603 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.528 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -155.68 -26.8 0.03 OUTLIER Glycine 0 N--CA 1.484 1.86 0 C-N-CA 118.267 -1.92 . . . . 0.0 111.104 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.479 HD12 HD13 ' A' ' 128' ' ' ILE . 1.1 pt -150.2 -112.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.039 -1.064 . . . . 0.0 110.785 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.461 ' C ' ' HB3' ' A' ' 119' ' ' GLU . 0.9 OUTLIER -165.75 -165.91 0.88 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.284 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.507 ' C ' HD22 ' A' ' 125' ' ' ASN . 0.7 OUTLIER -65.21 -105.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -179.683 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.47 ' N ' ' CG ' ' A' ' 125' ' ' ASN . 1.7 m120 -67.23 32.32 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 125' ' ' ASN . 0.6 OUTLIER -87.17 -103.7 0.07 Allowed 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.726 -1.19 . . . . 0.0 109.819 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.546 ' O ' ' CB ' ' A' ' 129' ' ' SER . 0.3 OUTLIER 41.66 -162.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.22 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.618 ' OG ' ' N ' ' A' ' 130' ' ' SER . 1.6 t 151.17 -96.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.061 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.618 ' N ' ' OG ' ' A' ' 129' ' ' SER . 3.5 m -90.24 143.63 26.59 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.047 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.11 151.82 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.575 0.702 . . . . 0.0 111.675 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -148.87 107.09 3.45 Favored Pre-proline 0 C--N 1.301 -1.515 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.617 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 135' ' ' GLY . 10.5 Cg_endo -71.88 90.48 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.348 1.366 . . . . 0.0 110.68 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.696 HE22 ' NH1' ' A' ' 92' ' ' ARG . 10.0 tt0 -49.64 -11.57 0.06 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.391 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 133' ' ' PRO . . . -179.07 -37.46 0.07 OUTLIER Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.305 -1.902 . . . . 0.0 111.783 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.436 HD11 ' H ' ' A' ' 92' ' ' ARG . 0.5 OUTLIER -107.04 163.83 12.66 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.359 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.76 148.22 31.55 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.993 -1.083 . . . . 0.0 109.811 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.1 t -112.6 150.34 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.786 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.55 HG12 ' CE1' ' A' ' 141' ' ' PHE . 60.6 t -136.22 128.53 45.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.572 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.5 mp -106.13 139.86 39.99 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.905 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' A' ' 141' ' ' PHE . 4.7 m-85 -120.23 133.78 55.4 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.52 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -72.94 -71.52 0.3 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.403 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -62.87 161.68 12.36 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.959 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 20.7 p-10 -62.5 -162.89 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.586 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.651 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 1.7 p-10 31.62 35.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.712 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.651 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 42.12 62.4 1.65 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.084 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.536 ' CB ' ' ND2' ' A' ' 145' ' ' ASN . 48.4 t -139.3 175.87 9.19 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.421 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 80.91 -160.33 42.78 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.039 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -60.54 160.57 8.79 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.263 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.8 p -150.59 162.51 40.5 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.902 -1.119 . . . . 0.0 111.574 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.6 tp -129.33 86.14 57.27 Favored Pre-proline 0 N--CA 1.484 1.261 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.497 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -63.29 107.8 0.73 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.828 1.686 . . . . 0.0 112.522 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 47.5 t -84.78 85.56 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.389 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.633 ' ND2' ' H ' ' A' ' 154' ' ' ASN . 0.8 OUTLIER -55.87 -26.56 47.6 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.498 ' OG ' ' C ' ' A' ' 154' ' ' ASN . 0.7 OUTLIER -162.68 -146.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 117.941 -1.503 . . . . 0.0 113.107 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.45 144.76 20.06 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.017 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -165.58 66.06 1.08 Allowed Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.572 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.1 Cg_endo -66.71 27.95 0.11 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.26 1.973 . . . . 0.0 112.274 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.512 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.1 t -169.83 136.06 1.51 Allowed 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.846 -1.142 . . . . 0.0 111.461 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.445 HD23 ' C ' ' A' ' 160' ' ' LEU . 3.9 tt -151.55 -76.01 0.14 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.351 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.404 ' H ' ' HB3' ' A' ' 160' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.338 0 C-N-CA 119.16 -1.495 . . . . 0.0 110.665 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.0 m120 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.885 0.374 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.1 m -88.49 147.17 24.79 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.795 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 92.3 p -135.67 -38.63 0.73 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.434 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.54 158.13 44.85 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.533 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 24.6 pt -145.54 157.19 12.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 118.589 -1.244 . . . . 0.0 111.904 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -137.92 110.26 7.41 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.527 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -87.83 94.74 4.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.25 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.959 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.416 ' HB1' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.902 0.382 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -176.78 112.79 0.1 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.322 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.473 ' HB ' HG22 ' A' ' 44' ' ' VAL . 1.3 pp -78.34 160.33 4.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.306 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 m -138.46 126.38 22.51 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.296 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.44 168.7 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.372 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 14.1 m-85 -134.8 138.73 44.52 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.343 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.9 -55.02 29.8 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.397 -0.921 . . . . 0.0 113.066 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.613 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 55.6 m-20 -92.37 167.06 12.24 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.375 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.533 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 7.4 tm-20 -79.98 160.66 25.83 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.199 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 10' ' ' GLU . 0.9 OUTLIER 81.41 38.97 0.06 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.546 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.456 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 5.0 t80 59.74 2.99 0.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.984 -1.086 . . . . 0.0 112.533 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -102.84 164.88 11.37 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.673 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.613 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 97.48 132.94 7.66 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 14' ' ' GLY . 8.2 mtpm? -29.27 135.98 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.755 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.94 171.72 7.42 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.301 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.0 t -144.37 145.96 20.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.511 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -91.85 128.08 37.55 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.74 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 19' ' ' LEU . 2.3 mm? -118.14 107.2 44.0 Favored Pre-proline 0 N--CA 1.49 1.541 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.26 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -64.87 166.75 17.41 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 120.911 1.074 . . . . 0.0 111.265 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.28 176.25 1.65 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.732 1.621 . . . . 0.0 111.294 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.508 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 102.28 -167.92 18.41 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.391 -1.385 . . . . 0.0 110.788 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.817 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -110.98 141.93 43.78 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.022 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.644 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -156.67 152.84 27.61 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.243 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.4 p -132.02 -158.48 0.89 Allowed 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.079 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -58.74 -28.8 66.21 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.588 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -63.01 -54.74 33.59 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.034 -1.067 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -52.79 -48.82 66.6 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.039 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.619 HD21 ' CE1' ' A' ' 24' ' ' TYR . 5.0 mt -59.48 -39.02 82.39 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.66 -1.216 . . . . 0.0 109.338 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.13 -29.06 4.83 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 118.564 -1.254 . . . . 0.0 108.397 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.14 -31.62 27.11 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.454 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 29' ' ' LEU . 10.2 mt -80.39 -86.4 0.08 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.333 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 32' ' ' LEU . . . 176.74 -27.0 0.07 OUTLIER Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.226 -1.464 . . . . 0.0 110.787 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.478 HG22 HG21 ' A' ' 38' ' ' THR . 0.2 OUTLIER -79.47 -175.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 118.941 -1.103 . . . . 0.0 109.964 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.65 ' H ' HG21 ' A' ' 38' ' ' THR . 1.3 pt-20 177.48 113.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.708 -1.197 . . . . 0.0 112.604 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.438 ' O ' HG22 ' A' ' 38' ' ' THR . 2.1 m-20 42.31 -106.7 0.08 Allowed 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.558 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.499 ' C ' HG22 ' A' ' 38' ' ' THR . 61.8 t-20 -50.46 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.947 -0.701 . . . . 0.0 112.391 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.65 HG21 ' H ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER 170.44 -18.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.802 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.488 ' O ' HD22 ' A' ' 72' ' ' LEU . 7.8 mm -75.59 32.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.105 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.646 ' H ' ' C ' ' A' ' 38' ' ' THR . 29.6 t -37.62 -63.99 0.42 Allowed 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.326 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.402 ' HB2' ' H ' ' A' ' 12' ' ' PHE . 1.1 t -116.03 165.09 13.52 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -148.2 156.67 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 118.342 -1.343 . . . . 0.0 113.44 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -137.82 110.92 7.8 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.523 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.473 HG22 ' HB ' ' A' ' 4' ' ' ILE . 88.4 t -133.95 106.25 11.53 Favored Pre-proline 0 N--CA 1.497 1.913 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.94 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.417 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 Cg_endo -70.16 171.5 14.79 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 121.647 1.564 . . . . 0.0 111.728 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.417 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.7 Cg_endo -62.78 -169.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 122.145 1.897 . . . . 0.0 111.204 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.87 -14.44 19.62 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 119.269 -1.444 . . . . 0.0 110.449 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.691 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -152.93 157.14 4.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 118.836 -1.145 . . . . 0.0 111.697 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.454 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 31.7 ttpt -123.56 120.41 32.77 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.34 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.75 154.99 18.63 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.025 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 63' ' ' ILE . 60.6 mt -138.91 119.79 15.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.338 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.461 HD12 ' H ' ' A' ' 52' ' ' LEU . 3.7 mp -94.79 155.37 16.84 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 118.683 -1.207 . . . . 0.0 112.352 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -133.55 114.97 14.17 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.053 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.451 ' CD ' ' N ' ' A' ' 55' ' ' ASN . 1.4 tm0? -53.64 -69.12 0.13 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.39 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.514 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 63.8 t30 -69.37 137.68 53.03 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.028 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -53.06 166.69 0.21 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.538 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.54 28.98 64.47 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.394 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 55.92 49.1 16.57 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.972 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.18 -171.16 2.62 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.795 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.514 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 74.16 171.75 25.69 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.355 -1.402 . . . . 0.0 109.743 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 60' ' ' GLY . 1.7 m-20 -42.57 116.14 0.81 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.491 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.4 ' HG2' ' H ' ' A' ' 62' ' ' GLN . 3.2 pt20 -89.75 155.02 19.47 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.361 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.668 HD11 HD11 ' A' ' 75' ' ' LEU . 5.2 mt -130.18 167.08 26.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.761 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.456 ' H ' HG22 ' A' ' 63' ' ' ILE . 66.6 mt-10 -145.26 130.74 18.76 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.38 -0.928 . . . . 0.0 109.727 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.9 m -147.34 156.86 10.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 118.797 -1.161 . . . . 0.0 112.241 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 48' ' ' VAL . 4.0 t -144.5 -2.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.137 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -125.32 -159.69 0.91 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.301 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.828 HD21 HG13 ' A' ' 106' ' ' VAL . 10.7 p-10 -94.28 118.59 31.82 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.476 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.699 ' HB1' ' HA ' ' A' ' 72' ' ' LEU . . . -89.58 96.39 10.68 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.897 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -53.21 -70.99 0.08 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.821 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -90.55 3.21 54.65 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.239 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.699 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 14.7 tp 59.62 -90.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.634 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.429 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -177.2 -170.49 39.67 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.541 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.613 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.7 Cg_endo -67.16 -56.64 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.351 2.034 . . . . 0.0 112.266 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.903 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.1 pt? -64.75 19.52 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.321 -0.951 . . . . 0.0 111.409 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.613 ' H ' ' C ' ' A' ' 74' ' ' PRO . 45.3 p-10 -74.42 -17.12 60.84 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.387 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -77.88 4.93 10.71 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.577 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.569 HD22 ' N ' ' A' ' 79' ' ' VAL . 0.5 OUTLIER -167.9 115.01 0.72 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.172 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 1.022 HG12 ' H ' ' A' ' 80' ' ' SER . 26.3 t -132.32 -171.49 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.046 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 1.022 ' H ' HG12 ' A' ' 79' ' ' VAL . 21.0 p -176.31 -51.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.648 -1.221 . . . . 0.0 112.672 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.96 162.2 25.0 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 119.148 -1.021 . . . . 0.0 112.854 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 82' ' ' ILE . 10.2 mt -148.83 155.5 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.735 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.59 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -132.14 114.28 14.32 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.664 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.59 ' H ' HH12 ' A' ' 83' ' ' ARG . 37.1 t -121.38 136.56 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.756 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.581 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 4.0 mt -145.15 126.67 8.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.093 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 p -39.88 141.85 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.034 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 48' ' ' VAL . 1.3 p -134.09 138.58 30.87 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.339 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HD2' HG22 ' A' ' 87' ' ' VAL . 11.7 Cg_exo -47.21 136.66 18.68 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 121.207 1.271 . . . . 0.0 111.325 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.3 t -53.41 140.48 9.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.579 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -144.85 130.98 9.73 Favored Pre-proline 0 N--CA 1.487 1.387 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.906 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.45 ' HB2' HD11 ' A' ' 136' ' ' LEU . 6.3 Cg_exo -58.45 -163.3 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.921 0 C-N-CA 121.039 1.159 . . . . 0.0 111.359 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.429 ' CA ' HD12 ' A' ' 136' ' ' LEU . 9.6 ptt-85 -179.67 -158.17 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.939 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.562 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -137.4 166.97 22.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.65 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -120.81 140.78 51.25 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.456 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.511 ' CD2' HG13 ' A' ' 131' ' ' VAL . 80.5 m-85 -131.34 118.19 19.96 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.393 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -83.45 173.15 11.74 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.56 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.77 -70.34 0.72 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.991 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -62.36 163.98 7.82 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.901 -0.719 . . . . 0.0 112.249 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -89.89 63.62 6.08 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.808 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 101' ' ' PHE . 4.5 tt0 -176.0 50.1 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.713 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 100' ' ' GLN . 18.6 p90 41.44 44.2 2.4 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.111 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.449 ' CG ' ' N ' ' A' ' 103' ' ' GLY . 32.3 t70 -143.5 172.85 12.23 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.2 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 91.26 141.19 9.43 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.158 -1.496 . . . . 0.0 109.76 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 103' ' ' GLY . 47.0 mttp -28.66 130.3 0.06 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 123.971 0.454 . . . . 0.0 111.899 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -98.98 120.68 39.83 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.608 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.828 HG13 HD21 ' A' ' 68' ' ' ASN . 43.7 t -103.74 131.07 53.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.731 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -103.81 148.92 25.54 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.07 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.1 mt -138.11 123.15 12.22 Favored Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.154 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.428 ' CB ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -64.74 168.07 14.17 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.492 1.461 . . . . 0.0 111.797 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 6.1 Cg_exo -55.12 157.33 13.95 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 122.222 1.948 . . . . 0.0 111.973 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.38 178.89 15.73 Favored Glycine 0 N--CA 1.499 2.869 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.936 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.613 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 46.9 tt0 -109.31 157.1 19.2 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.125 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.613 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 33.2 m-85 -144.78 153.94 42.18 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.031 -1.067 . . . . 0.0 111.248 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.5 p -98.48 -161.43 0.87 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.008 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -101.34 54.38 0.83 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.958 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.33 -62.27 0.07 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.12 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.574 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 6.4 pt-20 -69.18 -51.08 41.61 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.574 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -37.77 -69.51 0.12 Allowed 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.231 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 119' ' ' GLU . 79.0 mt-10 -46.95 -66.5 0.4 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.66 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.465 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -70.33 4.77 2.06 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' A' ' 117' ' ' GLU . 17.0 t80 -98.61 -18.1 18.29 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 118.868 -1.133 . . . . 0.0 111.379 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.554 ' O ' HG11 ' A' ' 106' ' ' VAL . . . -165.79 -11.89 0.03 OUTLIER Glycine 0 C--N 1.289 -2.07 0 C-N-CA 118.152 -1.975 . . . . 0.0 111.043 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.453 ' CG1' ' C ' ' A' ' 122' ' ' GLY . 2.2 mt -148.89 -125.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 118.676 -1.21 . . . . 0.0 111.597 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.569 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 20.0 t70 -155.06 -162.58 1.39 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.832 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.569 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 12.4 p30 -71.44 -36.23 71.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.033 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -158.2 100.12 1.67 Allowed 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.955 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.428 ' CG2' HG22 ' A' ' 123' ' ' ILE . 9.4 t -177.22 25.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.309 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.8 mt -80.74 -60.35 2.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.409 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.7 m 59.32 -125.38 1.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 m -54.73 126.65 24.88 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.511 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.2 t -122.49 157.69 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.12 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -153.44 93.14 3.12 Favored Pre-proline 0 C--N 1.293 -1.862 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.178 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -53.73 124.21 15.27 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 121.125 1.217 . . . . 0.0 111.003 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.562 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 40.6 tp60 -89.22 -21.64 23.15 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.212 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -161.05 -29.55 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 C-N-CA 118.325 -1.893 . . . . 0.0 112.338 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.45 HD11 ' HB2' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -120.92 159.79 24.83 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.165 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.25 147.67 32.47 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.964 -1.094 . . . . 0.0 110.254 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 65.9 t -115.95 149.22 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.463 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.604 HG12 ' CE1' ' A' ' 141' ' ' PHE . 61.8 t -133.85 128.99 54.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.781 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.2 mp -102.72 138.2 39.93 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.963 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.836 ' CD2' ' CD1' ' A' ' 146' ' ' PHE . 8.6 m-85 -120.32 128.94 53.73 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.842 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.56 ' O ' ' CB ' ' A' ' 143' ' ' ASN . 53.9 mttm -85.33 102.12 13.12 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.049 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 142' ' ' LYS . 11.2 t-20 103.0 170.16 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.917 0 O-C-N 125.195 1.559 . . . . 0.0 111.292 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 146' ' ' PHE . 24.6 t70 -45.79 170.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.121 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.846 HD22 ' H ' ' A' ' 145' ' ' ASN . 1.2 m-80 -3.21 66.33 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 CA-C-N 113.921 -1.49 . . . . 0.0 113.986 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.836 ' CD1' ' CD2' ' A' ' 141' ' ' PHE . 0.9 OUTLIER 50.3 63.21 2.3 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.899 -1.121 . . . . 0.0 111.323 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.3 t -114.57 45.64 1.52 Allowed 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.557 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.24 -169.28 42.1 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.71 177.67 0.4 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.524 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.2 p -150.2 175.33 11.87 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.448 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.593 HD13 ' C ' ' A' ' 151' ' ' LEU . 3.4 tm? -147.77 90.88 5.05 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.51 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.35 109.02 1.48 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.705 1.603 . . . . 0.0 112.272 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 49.5 t -80.98 90.84 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.004 -1.079 . . . . 0.0 109.92 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.581 HD22 ' N ' ' A' ' 154' ' ' ASN . 1.8 m120 -65.01 -20.45 66.5 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.569 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 11.0 t -168.33 -146.55 0.06 Allowed 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.063 -1.455 . . . . 0.0 112.634 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.4 m-20 -50.81 150.35 2.96 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.981 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -168.87 66.34 0.64 Allowed Pre-proline 0 C--N 1.31 -1.152 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.04 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.484 ' C ' HG22 ' A' ' 159' ' ' THR . 2.3 Cg_endo -62.46 23.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.323 2.015 . . . . 0.0 113.692 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.507 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER 176.86 91.23 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.45 -1.3 . . . . 0.0 111.394 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 tp -94.52 -23.26 17.76 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.247 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.264 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.421 ' O ' ' N ' ' A' ' 168' ' ' SER . 23.8 t-20 . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.424 0.154 . . . . 0.0 110.767 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 166' ' ' ASN . 9.1 m -40.0 99.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.601 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.527 ' HB2' ' H ' ' A' ' 143' ' ' ASN . 3.3 m -88.58 -55.86 3.54 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.407 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.2 p -121.48 156.57 32.48 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.747 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.402 HG12 ' CD1' ' A' ' 118' ' ' LEU . 26.8 pt -139.37 165.14 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.49 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -146.45 106.07 3.95 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.332 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.81 95.46 4.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.401 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 116.458 -1.734 . . . . 0.0 111.076 -179.939 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.521 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -170.47 108.62 0.34 Allowed 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.228 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pp -77.44 128.69 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.855 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.08 152.54 20.49 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.169 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 m -140.19 169.11 16.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.625 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 18.7 m-85 -128.93 153.71 47.26 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.93 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -78.17 -59.48 2.76 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.503 -0.879 . . . . 0.0 113.326 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.638 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 12.5 m120 -81.36 -178.02 6.75 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.811 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.552 ' CG ' ' H ' ' A' ' 11' ' ' ASP . 20.9 tt0 -74.03 179.32 4.44 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.829 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.615 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 1.5 p-10 40.53 67.16 0.53 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.339 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.615 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 43.7 p90 35.47 27.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.114 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' ASP . 7.2 tt0 -102.65 159.7 15.23 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.987 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.638 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 95.49 140.75 11.15 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.327 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 14' ' ' GLY . 5.5 mtpp -28.75 135.61 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.78 157.78 16.46 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.407 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.4 t -149.15 133.59 9.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.769 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -98.92 113.36 25.47 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.601 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 mt -102.01 136.87 19.4 Favored Pre-proline 0 N--CA 1.488 1.467 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.94 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -70.0 162.58 41.67 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 120.978 1.119 . . . . 0.0 111.137 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -66.33 -175.74 0.57 Allowed 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 121.694 1.596 . . . . 0.0 110.541 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.488 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 104.4 -166.54 15.24 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.242 -1.456 . . . . 0.0 111.263 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.635 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.4 OUTLIER -123.43 137.32 54.83 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.222 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.499 ' CE2' HD12 ' A' ' 82' ' ' ILE . 4.9 p90 -157.84 -179.93 8.61 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.445 -1.302 . . . . 0.0 111.676 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.417 ' HB ' ' H ' ' A' ' 26' ' ' ARG . 1.8 p -147.06 -157.55 0.82 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.461 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.417 ' H ' ' HB ' ' A' ' 25' ' ' THR . 34.7 ttt180 -61.27 -19.14 61.38 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.491 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.66 -66.59 0.53 Allowed 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.567 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.539 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 6.9 tp60 -56.31 -43.12 78.62 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.782 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.458 ' HA ' HD23 ' A' ' 29' ' ' LEU . 30.9 mt -59.93 -40.49 89.08 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.154 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.02 -29.02 41.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 118.435 -1.306 . . . . 0.0 108.153 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -74.1 -35.47 64.18 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.696 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.27 -78.4 0.13 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.786 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.85 -25.25 0.56 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.153 -1.498 . . . . 0.0 110.688 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.548 HG12 HG21 ' A' ' 38' ' ' THR . 0.0 OUTLIER -92.82 137.18 22.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.028 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.458 ' CG ' ' C ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER 168.61 158.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.198 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.714 HD22 ' ND2' ' A' ' 37' ' ' ASN . 6.0 t30 66.84 116.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.714 ' ND2' HD22 ' A' ' 36' ' ' ASN . 0.1 OUTLIER 56.42 3.99 0.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.098 -0.955 . . . . 0.0 113.045 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.548 HG21 HG12 ' A' ' 34' ' ' ILE . 39.9 p -82.98 -135.28 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.491 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 38' ' ' THR . 2.5 mt 25.37 52.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 123.902 0.751 . . . . 0.0 112.68 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.5 t -70.15 -41.51 73.74 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.214 -0.995 . . . . 0.0 110.118 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.4 166.25 15.02 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.312 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -145.3 149.68 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 118.533 -1.267 . . . . 0.0 112.666 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -140.05 87.25 2.14 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.609 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.0 t -109.44 115.48 56.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -69.7 168.5 21.3 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.207 1.271 . . . . 0.0 110.773 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.47 -177.09 0.36 Allowed 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 121.843 1.695 . . . . 0.0 111.126 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.07 -11.62 11.24 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.283 -1.437 . . . . 0.0 110.952 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.521 HG11 ' CB ' ' A' ' 2' ' ' ALA . 33.1 m -148.41 145.34 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.537 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.459 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 44.2 tttt -124.12 158.28 32.67 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.578 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.459 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -148.96 140.69 23.57 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.299 -1.361 . . . . 0.0 112.962 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 63' ' ' ILE . 35.7 mt -119.06 124.19 72.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.591 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.507 HD12 ' H ' ' A' ' 52' ' ' LEU . 3.8 mp -93.9 165.91 12.43 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 118.641 -1.223 . . . . 0.0 112.341 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -141.22 108.95 5.64 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.956 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.415 ' HG2' HD22 ' A' ' 78' ' ' ASN . 8.6 tt0 -47.28 -84.54 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.928 -0.709 . . . . 0.0 112.03 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.476 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 94.5 m-20 -59.34 142.55 51.84 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.476 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 11.9 p-10 -56.18 174.53 0.13 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.598 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.98 36.87 93.59 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.141 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.404 ' CZ ' HG23 ' A' ' 25' ' ' THR . 40.1 m-85 47.03 43.94 14.43 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.673 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.53 -165.5 1.25 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.901 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.476 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 65.01 165.19 1.08 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.364 -1.398 . . . . 0.0 109.855 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.49 130.1 19.79 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.586 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.462 ' C ' ' CD ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -101.07 161.87 13.29 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.106 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.74 HG22 ' N ' ' A' ' 64' ' ' GLU . 7.7 mm -128.06 171.86 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.714 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.74 ' N ' HG22 ' A' ' 63' ' ' ILE . 55.5 mt-10 -144.7 131.21 19.86 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.581 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.1 m -150.52 158.32 5.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.805 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 t -144.28 -4.31 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.56 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.72 -153.63 0.58 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.778 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.434 ' N ' ' ND2' ' A' ' 68' ' ' ASN . 3.2 m120 -92.32 125.74 37.11 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.353 -0.939 . . . . 0.0 109.754 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.568 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -97.3 133.95 41.23 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.356 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -74.55 -77.95 0.11 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.49 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -99.32 3.92 46.26 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.692 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.402 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 0.6 OUTLIER 63.95 -82.79 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.513 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.522 ' O ' ' ND2' ' A' ' 76' ' ' ASN . . . -172.67 -178.96 43.13 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.567 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.16 -18.05 56.05 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.149 1.899 . . . . 0.0 111.939 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.686 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -85.08 41.47 0.88 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.06 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 73' ' ' GLY . 84.9 m-20 -79.89 -13.98 58.98 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.694 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -88.62 3.41 50.65 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.513 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.466 ' HA ' ' H ' ' A' ' 37' ' ' ASN . 52.8 t30 -169.78 126.95 0.88 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 118.381 -1.328 . . . . 0.0 112.534 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.407 ' C ' ' OG ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -154.4 138.36 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.442 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.407 ' OG ' ' C ' ' A' ' 79' ' ' VAL . 1.7 m -157.76 -43.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.241 -1.383 . . . . 0.0 112.826 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.406 ' OG ' HG22 ' A' ' 25' ' ' THR . 17.3 m -94.39 140.45 29.79 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.944 -1.103 . . . . 0.0 111.056 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -147.58 161.01 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 118.814 -1.155 . . . . 0.0 112.224 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.876 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -137.21 116.72 12.85 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.851 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.876 ' H ' HH12 ' A' ' 83' ' ' ARG . 12.8 t -120.37 127.68 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.873 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.49 HG13 ' NH2' ' A' ' 83' ' ' ARG . 27.8 mt -141.07 129.04 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.849 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 74.1 m -41.06 154.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.854 -0.739 . . . . 0.0 111.427 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.729 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -150.33 147.13 21.02 Favored Pre-proline 0 N--CA 1.487 1.419 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.203 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.729 ' HD2' HG22 ' A' ' 87' ' ' VAL . 2.7 Cg_exo -54.12 145.32 54.34 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 121.27 1.313 . . . . 0.0 111.483 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.75 142.9 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.699 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -145.6 147.97 35.07 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.171 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.434 ' HG2' HD21 ' A' ' 136' ' ' LEU . 6.0 Cg_exo -57.51 -166.62 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.911 0 C-N-CA 121.111 1.207 . . . . 0.0 110.394 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.6 ptt-85 -173.98 -162.44 0.14 Allowed 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.743 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.33 159.07 42.97 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.529 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -120.55 135.15 55.17 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.133 -1.027 . . . . 0.0 112.332 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -114.33 105.02 12.65 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.943 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.485 ' CD1' ' HB3' ' A' ' 105' ' ' GLU . 26.2 m-85 -91.48 152.9 20.16 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.502 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 97' ' ' TYR . 1.6 m-85 -97.05 157.93 15.68 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.739 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp 63.61 132.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.637 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 99' ' ' GLU . 2.7 pt-20 -77.43 77.82 3.95 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.926 -1.109 . . . . 0.0 110.87 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 1.006 ' CA ' HE21 ' A' ' 100' ' ' GLN . 0.0 OUTLIER -172.58 16.19 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.096 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 42.9 t80 48.98 46.38 22.4 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.731 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 103' ' ' GLY . 38.7 t70 -116.85 -79.79 0.59 Allowed 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.768 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 102' ' ' ASP . . . -34.06 136.42 0.24 Allowed Glycine 0 N--CA 1.502 3.057 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.288 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -42.37 163.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.287 0.565 . . . . 0.0 112.336 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -115.72 165.07 13.46 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.501 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 122' ' ' GLY . 1.2 t -130.35 132.03 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.42 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 23.2 p-10 -96.47 150.14 20.94 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.264 -0.974 . . . . 0.0 113.2 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.4 mt -143.81 127.97 9.28 Favored Pre-proline 0 N--CA 1.482 1.14 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.864 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -67.88 167.45 21.38 Favored 'Trans proline' 0 C--O 1.212 -0.825 0 C-N-CA 121.399 1.399 . . . . 0.0 111.727 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.57 151.03 78.54 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 122.055 1.837 . . . . 0.0 111.734 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.48 -173.72 21.02 Favored Glycine 0 N--CA 1.498 2.792 0 C-N-CA 119.448 -1.358 . . . . 0.0 111.16 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.592 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 39.9 tt0 -112.92 154.04 27.01 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.4 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.592 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 14.4 m-85 -139.48 151.57 46.29 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.105 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.8 p -92.71 -158.36 0.59 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.648 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -108.75 55.56 0.63 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.574 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.39 -68.8 0.13 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.989 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.553 ' O ' ' N ' ' A' ' 121' ' ' TYR . 8.0 pt-20 -70.39 -46.4 64.1 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.053 -1.059 . . . . 0.0 108.938 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.562 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -36.15 -71.55 0.07 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.858 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.658 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 22.9 mp0 -51.83 -56.43 14.01 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.99 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -73.74 14.48 0.37 Allowed 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.907 -1.117 . . . . 0.0 111.696 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 117' ' ' GLU . 16.1 t80 -122.46 -12.87 8.12 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.537 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.566 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -140.83 -51.48 0.05 OUTLIER Glycine 0 N--CA 1.485 1.955 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.189 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.49 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -137.48 -111.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.281 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -151.99 -151.96 0.41 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.062 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.15 10.1 13.14 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.451 -0.899 . . . . 0.0 111.205 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -157.78 -123.72 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.407 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.3 p 51.11 -152.56 0.19 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 129' ' ' SER . 14.7 mt 65.62 159.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.977 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 128' ' ' ILE . 23.1 t -175.14 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.469 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.6 m -76.92 140.39 40.49 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.817 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.6 158.23 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 C-N-CA 119.924 -0.711 . . . . 0.0 111.16 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -156.29 85.5 3.13 Favored Pre-proline 0 C--N 1.306 -1.311 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.63 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.81 102.68 0.53 Allowed 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.093 1.195 . . . . 0.0 109.856 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.15 18.72 2.96 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.716 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -174.39 -47.63 0.05 OUTLIER Glycine 0 N--CA 1.489 2.197 0 C-N-CA 117.737 -2.173 . . . . 0.0 112.637 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.434 HD21 ' HG2' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -121.33 169.62 10.42 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.245 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.8 151.79 24.1 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.078 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.6 t -121.88 144.09 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.231 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.545 ' C ' HD12 ' A' ' 140' ' ' LEU . 91.1 t -135.03 128.27 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.561 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.545 HD12 ' C ' ' A' ' 139' ' ' VAL . 10.4 mp -106.4 140.44 39.32 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.674 -0.81 . . . . 0.0 112.744 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.475 ' CG ' ' HA ' ' A' ' 146' ' ' PHE . 62.9 m-85 -120.48 125.24 47.38 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.445 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -60.63 -65.1 0.74 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.172 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -70.33 -172.21 0.56 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.243 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.564 ' O ' ' N ' ' A' ' 146' ' ' PHE . 0.7 OUTLIER -66.32 -149.3 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.93 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.591 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 4.7 p-10 -15.68 75.76 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 O-C-N 124.386 1.054 . . . . 0.0 113.7 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.591 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.3 p90 37.07 64.95 0.54 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.229 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.456 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 28.6 t -128.49 173.7 10.01 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.949 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.456 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 64.17 -168.13 25.65 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.556 -1.306 . . . . 0.0 110.717 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -61.18 167.95 2.82 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.461 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.4 p -146.28 168.84 20.09 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.43 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.534 ' C ' HD23 ' A' ' 151' ' ' LEU . 3.3 tt -138.24 84.59 19.89 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.471 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.59 107.93 1.13 Allowed 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 122.109 1.873 . . . . 0.0 113.094 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 40.2 t -83.9 89.96 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.308 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.523 ' ND2' ' H ' ' A' ' 154' ' ' ASN . 4.3 m-80 -64.45 -17.25 63.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 51.4 p -170.25 -141.28 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 117.735 -1.586 . . . . 0.0 112.929 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.438 ' N ' ' OG ' ' A' ' 155' ' ' SER . 20.7 m-20 -65.1 151.45 46.02 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.758 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -168.62 61.7 0.49 Allowed Pre-proline 0 C--N 1.305 -1.364 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.206 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.5 Cg_endo -62.13 17.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 122.173 1.916 . . . . 0.0 112.792 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.546 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -170.46 79.2 0.09 Allowed 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.612 -1.235 . . . . 0.0 111.384 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.3 tt -91.77 -75.65 0.47 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.342 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.418 0 C-N-CA 118.992 -1.575 . . . . 0.0 110.806 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 18.8 m120 . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 121.216 0.531 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.2 m -47.23 99.25 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.902 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.1 m -86.99 -53.69 4.74 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.616 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.62 160.42 21.84 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.201 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.437 HG12 ' CD1' ' A' ' 118' ' ' LEU . 22.2 pt -145.33 162.75 12.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.907 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -145.35 104.7 3.95 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.247 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.0 mt -85.27 95.61 4.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.407 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 116.371 -1.776 . . . . 0.0 110.955 -179.982 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.456 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.971 0.415 . . . . 0.0 110.849 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -177.72 118.25 0.1 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.305 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 4' ' ' ILE . 2.9 pt -77.33 154.53 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.294 -0.962 . . . . 0.0 111.059 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -133.67 127.12 32.26 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.671 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 m -107.11 173.43 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.37 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.689 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 53.8 m-85 -131.46 145.83 51.96 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.439 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.32 -37.09 77.59 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.501 ' C ' ' OG ' ' A' ' 40' ' ' SER . 25.3 m120 -117.25 165.62 13.23 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 119.101 -1.039 . . . . 0.0 111.814 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.504 ' N ' ' OG ' ' A' ' 40' ' ' SER . 46.8 mm-40 -69.18 173.5 5.57 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.253 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' A' ' 13' ' ' GLN . 4.6 t0 62.38 31.39 17.29 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.692 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.689 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 5.3 t80 68.13 -9.71 0.47 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.304 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.463 ' H ' ' C ' ' A' ' 11' ' ' ASP . 10.2 tt0 -71.88 167.68 19.52 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.861 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.491 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 90.71 129.67 4.29 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.803 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.447 ' HE2' ' H ' ' A' ' 15' ' ' LYS . 1.1 mppt? -39.34 149.72 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.729 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.81 165.1 12.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.653 -0.819 . . . . 0.0 112.714 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 t -144.57 144.51 22.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.194 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -104.33 139.14 39.74 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.899 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 mt -132.06 141.71 42.44 Favored Pre-proline 0 N--CA 1.494 1.773 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.774 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -71.62 162.4 42.29 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 121.186 1.257 . . . . 0.0 111.893 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -68.51 -157.68 0.04 OUTLIER 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 121.94 1.76 . . . . 0.0 111.356 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.55 -159.93 50.01 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.854 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.751 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -90.95 149.86 21.71 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.292 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.9 ' OH ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -166.42 146.41 6.01 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.7 p -148.52 -146.59 0.2 Allowed 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 118.66 -1.216 . . . . 0.0 112.803 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -37.0 86.21 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.553 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.551 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -57.15 -57.34 13.03 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.75 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.45 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 24.0 tt0 -58.41 -50.77 72.51 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.728 -1.189 . . . . 0.0 109.333 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.9 HD21 ' OH ' ' A' ' 24' ' ' TYR . 15.4 mt -51.07 -39.22 55.53 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.759 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -51.43 -37.16 47.21 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.357 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -67.92 -35.45 78.48 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.75 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.519 ' N ' HD23 ' A' ' 32' ' ' LEU . 6.9 mt -77.03 -83.59 0.07 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.825 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.14 -27.47 0.21 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 118.811 -1.662 . . . . 0.0 111.452 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.485 HG12 HD22 ' A' ' 29' ' ' LEU . 2.3 pt -89.4 167.18 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.196 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 1.9 pt-20 173.32 152.65 0.09 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.102 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.709 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER 70.94 -155.48 0.11 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.715 179.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.709 ' H ' HD22 ' A' ' 36' ' ' ASN . 20.5 t30 -48.8 93.73 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.156 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' SER . 35.4 p -148.5 -50.1 0.16 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.626 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.416 HD11 HD11 ' A' ' 82' ' ' ILE . 11.2 mt -60.67 75.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.315 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' THR . 32.1 t -75.18 -52.59 10.57 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.74 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.506 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -120.48 174.06 6.78 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -152.94 150.27 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 117.963 -1.495 . . . . 0.0 112.803 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -137.41 110.55 7.8 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.533 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.2 t -133.65 116.14 13.73 Favored Pre-proline 0 N--CA 1.495 1.807 0 C-N-CA 119.666 -0.813 . . . . 0.0 112.087 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.43 167.57 22.04 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 120.941 1.094 . . . . 0.0 110.809 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.92 -171.08 0.16 Allowed 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.744 1.63 . . . . 0.0 111.1 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.414 ' C ' HG13 ' A' ' 48' ' ' VAL . . . 75.46 -10.31 12.2 Favored Glycine 0 N--CA 1.481 1.652 0 C-N-CA 119.273 -1.441 . . . . 0.0 110.907 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.456 HG11 ' CB ' ' A' ' 2' ' ' ALA . 30.5 m -151.9 131.77 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.236 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -104.28 124.68 49.6 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.339 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.47 134.11 50.98 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.481 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.57 HD12 ' NH2' ' A' ' 83' ' ' ARG . 71.3 mt -112.59 123.08 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.116 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.898 HD23 ' H ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -89.91 152.87 21.02 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.286 -0.966 . . . . 0.0 112.443 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.898 ' H ' HD23 ' A' ' 52' ' ' LEU . 13.8 m-85 -140.07 125.08 18.53 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.22 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -53.33 -88.46 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.327 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -64.44 154.3 36.15 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.748 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -61.3 172.56 1.07 Allowed 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.362 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.66 17.99 76.95 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.12 -1.514 . . . . 0.0 109.924 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 59.24 54.05 5.03 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.971 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.52 -173.71 2.94 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.8 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.7 -175.78 33.49 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.482 -1.342 . . . . 0.0 109.955 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -50.65 166.88 0.07 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.69 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.62 161.92 36.74 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.366 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.746 HG22 ' N ' ' A' ' 64' ' ' GLU . 10.0 mm -138.78 172.76 13.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.571 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.746 ' N ' HG22 ' A' ' 63' ' ' ILE . 20.4 mt-10 -148.15 130.88 15.99 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.839 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.5 m -145.7 161.75 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 118.768 -1.173 . . . . 0.0 112.552 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.35 -14.7 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.006 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.04 -148.76 0.41 Allowed 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.404 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.775 HD22 ' H ' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -99.82 136.12 40.22 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.022 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.538 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -106.06 128.0 53.56 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.928 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -80.6 -74.79 0.3 Allowed 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 73' ' ' GLY . 20.2 mm-40 -89.95 3.32 53.47 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.975 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.417 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 1.7 tp 55.7 -83.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.715 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 176.02 -169.7 42.41 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.316 -1.421 . . . . 0.0 110.679 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.526 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.2 Cg_endo -65.05 -39.22 24.9 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 122.295 1.997 . . . . 0.0 112.17 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.022 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.9 pt? -71.94 31.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.942 -1.103 . . . . 0.0 111.202 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 74' ' ' PRO . 16.2 p-10 -80.77 -17.92 49.35 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.739 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -88.6 14.02 10.88 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.688 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.675 ' ND2' ' N ' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -167.6 115.01 0.75 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.722 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 78' ' ' ASN . 15.8 m -155.47 153.63 7.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.514 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.1 t -172.55 -33.59 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 118.683 -1.207 . . . . 0.0 112.35 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.8 140.98 40.07 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.894 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.416 HD11 HD11 ' A' ' 39' ' ' ILE . 3.9 mt -150.52 149.79 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.381 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.703 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -141.32 126.41 18.39 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.248 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.703 ' CA ' HH12 ' A' ' 83' ' ' ARG . 3.5 t -117.7 135.92 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.1 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.55 ' CG1' ' CZ ' ' A' ' 83' ' ' ARG . 13.7 mt -119.34 121.92 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.654 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.4 p -46.16 129.99 10.17 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.708 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.515 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.9 OUTLIER -125.26 151.31 69.42 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.7 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.515 ' HD2' HG22 ' A' ' 87' ' ' VAL . 4.1 Cg_exo -55.87 139.03 83.66 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 121.234 1.29 . . . . 0.0 110.731 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.32 133.78 31.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.34 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -143.63 150.99 52.62 Favored Pre-proline 0 N--CA 1.487 1.402 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.9 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 2.5 Cg_endo -59.29 -160.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.241 1.294 . . . . 0.0 111.611 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -174.93 -158.75 0.08 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.849 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.23 165.04 28.99 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.622 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.409 HH11 ' CD ' ' A' ' 105' ' ' GLU . 6.8 ttt180 -128.98 152.24 48.82 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.87 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.571 ' CE1' HG23 ' A' ' 131' ' ' VAL . 98.0 m-85 -142.61 133.89 26.17 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.748 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.445 ' CD2' ' C ' ' A' ' 101' ' ' PHE . 18.6 m-85 -94.55 -177.12 4.12 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.14 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.8 -52.1 2.87 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.031 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.562 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 15.5 mmtp -93.18 163.9 13.45 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.541 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -82.9 78.47 9.49 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.379 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.65 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.3 OUTLIER 178.85 26.79 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.349 -1.296 . . . . 0.0 107.973 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.65 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 33.9 p90 37.78 49.1 1.06 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.237 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -138.44 -28.91 0.82 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.828 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.562 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -58.89 153.77 29.32 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.303 -1.427 . . . . 0.0 110.46 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 103' ' ' GLY . 42.8 tttm -31.03 140.03 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.903 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.409 ' CD ' HH11 ' A' ' 94' ' ' ARG . 63.6 mt-10 -96.47 147.7 23.56 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.585 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.651 HG11 ' O ' ' A' ' 122' ' ' GLY . 95.0 t -142.85 117.88 4.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -104.14 162.27 13.32 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.095 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -141.11 150.93 60.54 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.195 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -78.08 163.51 28.03 Favored 'Trans proline' 0 C--O 1.212 -0.796 0 C-N-CA 121.652 1.568 . . . . 0.0 111.957 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.21 139.94 74.95 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.593 1.529 . . . . 0.0 110.696 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.51 -159.75 27.57 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 118.884 -1.626 . . . . 0.0 111.574 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.55 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 34.7 tt0 -118.03 156.16 29.06 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.149 -0.525 . . . . 0.0 110.828 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 49.6 m-85 -145.55 149.22 34.18 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.157 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.434 ' C ' ' H ' ' A' ' 116' ' ' ALA . 3.3 p -101.92 175.8 5.42 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.335 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -72.28 17.32 0.11 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.864 -0.734 . . . . 0.0 112.387 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 114' ' ' THR . . . -111.21 -65.75 1.14 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.564 -0.854 . . . . 0.0 111.716 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.0 pt-20 -70.55 -53.98 13.94 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.822 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.572 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -30.61 -72.43 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 123.925 0.765 . . . . 0.0 111.188 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.52 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -53.04 -57.14 11.39 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.268 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.451 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 8.0 mpt_? -78.37 26.69 0.21 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.553 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 117' ' ' GLU . 27.9 t80 -135.18 -8.28 2.29 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.315 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.651 ' O ' HG11 ' A' ' 106' ' ' VAL . . . -150.68 -44.59 0.02 OUTLIER Glycine 0 N--CA 1.481 1.642 0 C-N-CA 119.019 -1.562 . . . . 0.0 110.323 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.424 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -143.75 -102.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.822 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.444 ' C ' ' HB3' ' A' ' 119' ' ' GLU . 2.0 p-10 -172.63 179.97 2.3 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.493 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -63.91 123.03 17.91 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.113 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.619 ' N ' ' ND2' ' A' ' 126' ' ' ASN . 0.7 OUTLIER 56.28 106.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.968 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.692 HG23 ' H ' ' A' ' 128' ' ' ILE . 0.1 OUTLIER 172.49 -92.77 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.565 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.692 ' H ' HG23 ' A' ' 127' ' ' THR . 6.5 mm 45.81 -110.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.191 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 1.1 t 86.93 120.99 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 123.816 0.697 . . . . 0.0 111.924 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.731 ' H ' ' H ' ' A' ' 160' ' ' LEU . 2.7 m 58.97 114.72 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.136 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.75 HG12 ' HB3' ' A' ' 157' ' ' ALA . 4.0 p -113.13 160.13 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.605 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -160.96 89.68 1.62 Allowed Pre-proline 0 C--N 1.291 -1.967 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.183 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -69.32 121.32 8.11 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.035 1.157 . . . . 0.0 110.704 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -91.05 11.19 23.83 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.592 -0.843 . . . . 0.0 112.19 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -175.7 -49.67 0.06 OUTLIER Glycine 0 N--CA 1.491 2.339 0 C-N-CA 118.262 -1.923 . . . . 0.0 112.137 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.402 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -107.8 171.41 7.41 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.143 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -93.16 145.0 24.74 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.681 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 153' ' ' VAL . 31.6 t -101.42 147.52 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.157 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.427 HG12 ' CE1' ' A' ' 141' ' ' PHE . 59.8 t -138.25 116.71 13.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.821 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.438 ' H ' HD12 ' A' ' 140' ' ' LEU . 2.6 mp -105.7 137.47 43.51 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.78 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.427 ' CE1' HG12 ' A' ' 139' ' ' VAL . 10.9 m-85 -108.34 145.31 34.65 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.82 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -75.6 -61.73 1.82 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.913 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -82.19 149.49 27.88 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.858 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 145' ' ' ASN . 29.4 t70 -54.04 175.38 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.989 -1.085 . . . . 0.0 110.739 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.645 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 3.3 t-20 36.09 35.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.254 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.645 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 43.11 65.86 0.89 Allowed 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.103 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.2 t -120.59 34.76 5.1 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.543 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.0 -160.29 12.24 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.167 -1.492 . . . . 0.0 110.415 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -59.33 171.93 0.71 Allowed 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.093 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.5 p -149.82 160.16 43.79 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.562 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.21 84.58 62.82 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.066 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.53 102.61 0.61 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.71 1.607 . . . . 0.0 112.405 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.684 HG11 HG11 ' A' ' 131' ' ' VAL . 81.3 t -83.74 87.66 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.649 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -83.75 22.27 1.14 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.801 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 42.3 p -170.39 -156.12 0.13 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.596 -1.241 . . . . 0.0 112.033 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -90.56 150.99 21.52 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.621 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.75 ' HB3' HG12 ' A' ' 131' ' ' VAL . . . -159.42 84.99 2.25 Favored Pre-proline 0 C--N 1.308 -1.207 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.103 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.527 ' C ' ' OG ' ' A' ' 130' ' ' SER . 1.7 Cg_endo -67.93 37.92 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.045 1.83 . . . . 0.0 112.421 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.462 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.5 OUTLIER -178.55 65.83 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.704 0.764 . . . . 0.0 109.244 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.731 ' H ' ' H ' ' A' ' 130' ' ' SER . 3.4 tm? -80.98 -35.38 32.14 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.188 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.506 ' H ' ' HA ' ' A' ' 129' ' ' SER . . . . . . . . 0 N--CA 1.496 2.65 0 C-N-CA 119.743 -1.218 . . . . 0.0 111.563 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.494 ' ND2' ' ND2' ' A' ' 126' ' ' ASN . 27.7 t-20 . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.854 0.359 . . . . 0.0 110.545 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.3 m -92.64 113.5 25.8 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.376 -0.929 . . . . 0.0 111.18 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 41.6 t -99.73 -56.15 2.46 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.163 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 p -123.24 159.42 28.76 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.465 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 30.9 pt -141.54 174.25 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.541 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -156.29 113.3 3.16 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.364 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 7.0 mt -89.28 103.14 13.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.004 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.1 m . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 116.289 -1.815 . . . . 0.0 110.801 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.576 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 121.054 0.454 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.446 ' ND2' ' C ' ' A' ' 2' ' ' ALA . 0.6 OUTLIER 179.9 129.57 0.09 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.38 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.756 HG22 HG13 ' A' ' 44' ' ' VAL . 9.0 pt -82.5 153.19 3.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.814 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.3 m -121.7 126.04 48.03 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.127 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.527 HG11 HD11 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -101.24 150.26 5.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.389 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 1.1 ' CD2' ' NE2' ' A' ' 16' ' ' GLN . 47.6 m-85 -116.97 148.19 41.63 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.325 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.0 2.5 42.8 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.509 ' N ' ' HA3' ' A' ' 14' ' ' GLY . 66.0 m-20 -154.17 167.94 28.2 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 117.779 -1.568 . . . . 0.0 112.449 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 9.4 tp10 -74.07 158.38 34.37 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.973 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.541 ' C ' ' H ' ' A' ' 13' ' ' GLN . 2.8 t0 72.21 41.04 0.65 Allowed 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.903 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.1 t80 63.3 -8.06 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.335 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.541 ' H ' ' C ' ' A' ' 11' ' ' ASP . 8.9 tt0 -74.44 175.01 8.13 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.526 -0.87 . . . . 0.0 111.169 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.509 ' HA3' ' N ' ' A' ' 9' ' ' ASN . . . 95.96 130.61 6.39 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.672 -1.252 . . . . 0.0 110.866 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 14' ' ' GLY . 48.1 mttp -38.99 152.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.919 -0.713 . . . . 0.0 111.311 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 1.1 ' NE2' ' CD2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -99.4 154.6 18.08 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.498 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.595 ' CG1' ' N ' ' A' ' 18' ' ' ASP . 2.6 t -147.1 166.47 6.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.424 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.595 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 12.3 m-20 -131.09 131.95 44.54 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.199 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.527 HD11 HG11 ' A' ' 6' ' ' VAL . 13.7 mt -130.29 121.79 19.7 Favored Pre-proline 0 N--CA 1.489 1.482 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.608 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -64.81 164.82 22.99 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 120.988 1.125 . . . . 0.0 111.946 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.65 -157.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.732 1.621 . . . . 0.0 110.668 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.88 -178.44 53.18 Favored Glycine 0 N--CA 1.48 1.587 0 C-N-CA 118.911 -1.614 . . . . 0.0 110.571 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.864 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -107.44 128.83 54.83 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.83 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 1.3 p90 -153.58 146.89 24.78 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.331 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.447 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 7.8 p -120.48 -155.09 0.61 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.088 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -56.92 -28.11 61.69 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.718 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -55.04 -57.17 12.79 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.663 -1.215 . . . . 0.0 110.177 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.425 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 71.3 tp60 -58.3 -48.54 80.18 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.731 -1.188 . . . . 0.0 109.648 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.51 ' N ' HD23 ' A' ' 29' ' ' LEU . 4.8 mt -59.97 -29.47 68.46 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.515 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -56.03 -30.2 61.55 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -77.03 -34.57 57.31 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.421 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.469 HD12 HD22 ' A' ' 29' ' ' LEU . 13.4 mt -83.16 -68.93 0.67 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.921 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.73 34.22 2.47 Favored Glycine 0 N--CA 1.504 3.187 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.463 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.714 HD13 ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -121.13 8.58 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.669 0.747 . . . . 0.0 110.498 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 35' ' ' GLU . 11.8 pt-20 -78.1 179.66 6.7 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.966 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.59 ' O ' HG23 ' A' ' 38' ' ' THR . 0.1 OUTLIER 68.93 99.59 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.16 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.521 ' OD1' ' ND2' ' A' ' 36' ' ' ASN . 1.0 OUTLIER 33.81 78.16 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.104 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.674 HG21 ' O ' ' A' ' 34' ' ' ILE . 60.5 p -140.39 -39.76 0.43 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.317 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 mt -67.27 72.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.487 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.504 ' OG ' ' C ' ' A' ' 9' ' ' ASN . 31.1 t -69.64 -46.24 66.64 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.694 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.49 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -127.57 164.1 22.72 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.156 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 t -149.89 154.31 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 118.151 -1.42 . . . . 0.0 113.124 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.23 121.61 15.02 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.183 -1.371 . . . . 0.0 108.777 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.756 HG13 HG22 ' A' ' 4' ' ' ILE . 6.4 t -139.12 114.76 8.42 Favored Pre-proline 0 N--CA 1.499 1.976 0 C-N-CA 119.308 -0.957 . . . . 0.0 112.095 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -69.76 169.5 18.77 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.849 1.032 . . . . 0.0 110.701 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.72 -170.32 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.703 1.602 . . . . 0.0 110.872 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.19 -15.03 12.39 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 119.088 -1.53 . . . . 0.0 110.589 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.576 HG11 ' CB ' ' A' ' 2' ' ' ALA . 21.6 m -150.77 135.43 9.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 118.774 -1.17 . . . . 0.0 112.172 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -105.96 127.85 53.42 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.35 153.94 24.22 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.918 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.549 HD12 ' NH2' ' A' ' 83' ' ' ARG . 99.1 mt -137.3 116.95 15.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.479 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.49 ' HA ' HG23 ' A' ' 82' ' ' ILE . 3.3 mp -93.78 162.96 13.71 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.01 -1.076 . . . . 0.0 113.177 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.44 ' CE1' HG22 ' A' ' 51' ' ' ILE . 88.4 m-85 -142.47 131.5 23.12 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.216 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.403 ' CG ' HD12 ' A' ' 75' ' ' LEU . 28.6 mt-30 -54.16 -84.41 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.764 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.47 HD22 ' N ' ' A' ' 55' ' ' ASN . 1.3 m-80 -75.69 166.6 23.31 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.17 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.32 -173.82 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.729 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 47.71 34.03 9.97 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.138 -1.506 . . . . 0.0 109.948 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.447 ' CZ ' HG23 ' A' ' 25' ' ' THR . 7.9 m-85 45.83 43.29 9.83 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.358 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.38 -172.34 2.32 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.721 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.08 178.96 1.2 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.538 -1.315 . . . . 0.0 109.818 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -54.1 177.53 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 118.831 -1.148 . . . . 0.0 110.195 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -147.45 161.34 41.25 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.806 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.451 HD11 HD11 ' A' ' 75' ' ' LEU . 4.1 mt -125.85 164.39 25.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.21 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -139.38 131.8 28.53 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -149.15 155.87 8.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.325 -1.35 . . . . 0.0 112.564 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.96 0.2 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.034 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.449 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -132.96 -135.91 0.18 Allowed 'General case' 0 C--O 1.208 -1.109 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.441 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.437 ' ND2' ' OD1' ' A' ' 107' ' ' ASP . 2.2 m-20 -111.89 124.44 52.37 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.329 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.11 94.32 6.45 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.639 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -58.64 -68.59 0.25 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.741 -0.784 . . . . 0.0 112.522 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.18 -12.82 59.98 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.369 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.416 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 1.3 tp 67.06 -79.33 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.738 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.416 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 165.62 176.07 36.74 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.238 -1.458 . . . . 0.0 110.77 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.591 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.0 OUTLIER -65.71 -35.12 38.35 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.249 1.966 . . . . 0.0 112.184 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.816 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.5 pt? -67.99 23.92 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.35 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.591 ' H ' ' C ' ' A' ' 74' ' ' PRO . 7.2 p30 -75.19 -1.08 21.64 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.668 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -73.04 -8.55 56.26 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.14 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -168.5 127.03 1.12 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.159 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.38 137.58 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.273 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 87.8 p -162.3 -30.67 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.656 -1.218 . . . . 0.0 112.697 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.409 ' C ' ' CG1' ' A' ' 82' ' ' ILE . 1.2 m -98.83 139.99 33.68 Favored 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.058 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.49 HG23 ' HA ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -150.64 156.12 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 118.571 -1.252 . . . . 0.0 111.575 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.782 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -150.21 130.09 13.36 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.444 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.782 ' CA ' HH12 ' A' ' 83' ' ' ARG . 10.0 t -128.77 143.19 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.614 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.441 ' CG1' ' CZ ' ' A' ' 83' ' ' ARG . 7.8 mt -132.51 126.42 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.975 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.7 p -40.8 149.9 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.053 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.485 HG22 ' HD2' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -149.61 151.33 32.86 Favored Pre-proline 0 N--CA 1.483 1.203 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.539 179.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HD2' HG22 ' A' ' 87' ' ' VAL . 3.5 Cg_exo -53.93 153.39 20.38 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 C-N-CA 121.287 1.325 . . . . 0.0 111.091 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 89' ' ' VAL . 4.2 m -77.73 139.36 18.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.612 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -146.46 130.1 8.36 Favored Pre-proline 0 C--N 1.297 -1.674 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.142 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.404 ' HB2' HD11 ' A' ' 136' ' ' LEU . 2.7 Cg_exo -58.67 -151.75 0.01 OUTLIER 'Trans proline' 0 C--O 1.207 -1.028 0 C-N-CA 121.465 1.444 . . . . 0.0 111.364 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.6 ptt-85 -178.03 -163.94 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.856 -1.138 . . . . 0.0 112.223 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.57 172.12 13.36 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.012 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.559 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 8.4 tpp180 -126.39 157.9 37.32 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.306 -0.957 . . . . 0.0 111.486 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.559 ' CD1' ' C ' ' A' ' 94' ' ' ARG . 26.3 m-85 -148.26 113.59 5.58 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.312 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 105' ' ' GLU . 14.7 m-85 -89.53 161.77 16.03 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.093 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.655 ' N ' ' CD1' ' A' ' 97' ' ' TYR . 0.6 OUTLIER -98.62 167.05 11.04 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.987 -1.085 . . . . 0.0 112.099 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt 59.69 147.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.072 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 30.5 tt0 -65.61 109.68 2.47 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.251 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.665 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 100.53 49.79 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.814 0 O-C-N 124.92 1.388 . . . . 0.0 110.181 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.589 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 26.0 p90 29.66 53.21 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.053 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -98.95 30.37 3.41 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.936 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -162.57 151.77 21.76 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.457 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.565 ' O ' ' CE2' ' A' ' 97' ' ' TYR . 88.6 mttt -38.0 155.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.118 0.485 . . . . 0.0 112.1 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.453 ' H ' ' HG2' ' A' ' 105' ' ' GLU . 10.8 pt-20 -111.23 167.09 10.55 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.194 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.49 HG22 ' H ' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -136.66 178.55 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.224 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.49 ' H ' HG22 ' A' ' 106' ' ' VAL . 14.3 p-10 -150.34 145.95 26.44 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.351 -1.339 . . . . 0.0 112.295 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.6 mt -139.17 133.06 16.0 Favored Pre-proline 0 N--CA 1.496 1.873 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.199 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.449 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 2.7 Cg_endo -66.88 169.34 14.96 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 121.517 1.478 . . . . 0.0 111.677 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 5.1 Cg_exo -57.91 149.29 71.03 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 122.094 1.863 . . . . 0.0 111.643 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.22 -155.29 25.52 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.649 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.569 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 37.9 mt-30 -131.12 155.97 46.04 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.809 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.569 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 40.1 m-85 -141.67 155.0 45.71 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.663 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.9 p -102.68 176.46 5.16 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.769 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.528 ' O ' ' NE2' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -83.12 56.8 3.64 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.425 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -153.5 -74.34 0.13 Allowed 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 121' ' ' TYR . 7.3 pt-20 -68.02 -44.6 76.16 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.02 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.584 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -33.94 -72.17 0.05 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.29 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.699 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -53.92 -50.3 66.71 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.436 -1.306 . . . . 0.0 110.08 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.401 ' H ' ' HG2' ' A' ' 120' ' ' ARG . 6.3 mmm180 -80.65 24.38 0.48 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 118.784 -1.166 . . . . 0.0 111.017 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.548 ' N ' ' O ' ' A' ' 117' ' ' GLU . 25.3 t80 -129.28 -12.78 4.5 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.027 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -143.8 -45.33 0.05 OUTLIER Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.297 -1.43 . . . . 0.0 110.39 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.498 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -143.8 -104.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.847 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.483 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 7.4 m-20 -160.62 179.01 8.93 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.044 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -74.8 131.49 40.83 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.691 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 m120 50.18 89.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.449 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.5 t -175.38 -2.66 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.195 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 128' ' ' ILE . 11.6 mt -95.83 144.01 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.671 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 67.5 m -155.22 -49.34 0.08 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.316 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.8 m -87.99 98.41 11.5 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.99 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.508 HG13 ' CD2' ' A' ' 95' ' ' PHE . 3.2 t -104.9 159.69 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.842 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -157.24 85.73 2.81 Favored Pre-proline 0 C--N 1.295 -1.777 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.187 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.67 96.98 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 121.413 1.408 . . . . 0.0 110.576 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -87.39 25.81 1.35 Allowed 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.422 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -161.59 -62.71 0.02 OUTLIER Glycine 0 N--CA 1.487 2.072 0 C-N-CA 118.553 -1.784 . . . . 0.0 111.452 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 91' ' ' PRO . 1.2 mp -121.53 -169.02 1.79 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.826 -0.749 . . . . 0.0 111.749 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -86.79 158.48 19.37 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.6 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.7 t -126.67 137.94 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.624 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.519 ' C ' HD12 ' A' ' 140' ' ' LEU . 62.3 t -133.32 124.89 49.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.961 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 140' ' ' LEU . 9.2 mp -101.27 140.08 36.05 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.529 -0.868 . . . . 0.0 112.285 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 171' ' ' ARG . 19.0 m-85 -107.98 132.79 53.15 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.47 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -79.1 -31.09 44.15 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.3 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.483 ' ND2' ' HB3' ' A' ' 147' ' ' SER . 33.2 t30 -78.12 179.09 7.06 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.589 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.463 ' H ' ' CG ' ' A' ' 143' ' ' ASN . 2.9 m-20 -69.45 -85.21 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.62 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.606 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 16.0 p-10 -76.16 75.69 2.99 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.637 -0.825 . . . . 0.0 112.097 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.606 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 0.9 OUTLIER 37.62 71.62 0.14 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.898 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.483 ' HB3' ' ND2' ' A' ' 143' ' ' ASN . 0.3 OUTLIER -147.98 -173.2 4.24 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.163 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 62.37 -168.69 15.97 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.669 -1.253 . . . . 0.0 111.081 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 0.8 OUTLIER -61.19 176.48 0.44 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.721 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.1 p -151.01 163.26 39.17 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.776 -1.17 . . . . 0.0 112.211 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.5 tp -123.55 83.42 53.3 Favored Pre-proline 0 N--CA 1.488 1.434 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.115 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.42 108.45 0.7 Allowed 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 122.148 1.899 . . . . 0.0 113.368 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 24.9 t -86.15 89.38 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.347 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -54.95 -24.81 25.62 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.7 p -170.69 -143.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 117.793 -1.563 . . . . 0.0 113.097 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -57.1 145.06 32.21 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.543 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.52 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -174.6 65.93 0.28 Allowed Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.876 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 3.3 Cg_endo -69.28 38.95 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 122.532 2.155 . . . . 0.0 112.583 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.76 HG23 ' H ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -166.67 -82.32 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.339 -1.344 . . . . 0.0 111.911 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.76 ' H ' HG23 ' A' ' 159' ' ' THR . 79.0 mt 54.17 -84.35 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.572 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 159' ' ' THR . . . . . . . . 0 N--CA 1.496 2.65 0 C-N-CA 118.979 -1.582 . . . . 0.0 110.253 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 19.9 m120 . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.768 0.318 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.415 ' OG1' HD23 ' A' ' 140' ' ' LEU . 48.8 m -102.93 137.97 40.43 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.156 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.99 -60.84 1.13 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.856 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.01 167.01 12.17 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 24.7 pt -147.35 171.37 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 117.999 -1.481 . . . . 0.0 112.501 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 141' ' ' PHE . 23.7 ttm180 -152.29 106.0 3.1 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.262 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 172' ' ' ILE . 11.4 mt -81.28 107.82 13.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 119.046 -1.061 . . . . 0.0 109.95 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 36.1 m . . . . . 0 C--N 1.303 -1.419 0 CA-C-O 116.347 -1.787 . . . . 0.0 110.981 -179.976 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 121.157 0.503 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 0.6 OUTLIER 179.43 121.56 0.05 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.706 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.605 HG22 HG22 ' A' ' 44' ' ' VAL . 1.6 pp -82.65 125.23 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 118.549 -1.261 . . . . 0.0 111.288 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.439 HG22 ' N ' ' A' ' 6' ' ' VAL . 38.1 m -105.85 157.65 17.32 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.471 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.492 ' HB ' HG23 ' A' ' 39' ' ' ILE . 1.6 m -142.3 164.6 17.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.288 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 5.4 m-85 -126.39 147.47 49.76 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.94 -68.76 0.38 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.303 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.533 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 34.9 m120 -73.04 170.15 15.48 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.629 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.472 ' CG ' ' N ' ' A' ' 11' ' ' ASP . 32.3 tt0 -73.55 171.06 13.9 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.08 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.63 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 3.4 t70 59.19 55.26 4.42 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.622 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.63 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 23.9 p90 38.72 26.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.102 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 11' ' ' ASP . 9.4 tp-100 -103.93 162.2 13.33 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.655 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.533 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 89.63 134.88 5.54 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.64 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 14' ' ' GLY . 16.0 mtpp -30.44 136.93 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.56 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.93 169.54 8.7 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.779 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.3 t -141.19 133.21 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.425 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.17 111.61 23.77 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.728 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mt -105.86 128.72 25.87 Favored Pre-proline 0 N--CA 1.491 1.619 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.772 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -67.57 165.93 25.67 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 120.657 0.905 . . . . 0.0 110.456 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.82 -164.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 121.623 1.549 . . . . 0.0 111.391 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.696 ' C ' HD22 ' A' ' 23' ' ' ASN . . . 97.17 174.44 34.48 Favored Glycine 0 N--CA 1.498 2.813 0 C-N-CA 119.396 -1.383 . . . . 0.0 111.28 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.901 ' N ' HD22 ' A' ' 23' ' ' ASN . 0.2 OUTLIER -103.38 135.18 45.48 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.617 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.541 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.5 p90 -155.12 176.22 12.82 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 118.482 -1.287 . . . . 0.0 111.701 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.0 p -141.06 -156.46 0.68 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.121 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.588 ' CD ' ' H ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -69.03 -22.68 64.03 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.957 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.47 ' H ' ' HD3' ' A' ' 26' ' ' ARG . . . -64.55 -59.81 3.86 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.652 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -58.73 -45.77 88.87 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.204 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.556 HD23 HD12 ' A' ' 32' ' ' LEU . 12.4 mt -57.47 -37.77 73.43 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.902 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.28 -34.22 56.4 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 118.474 -1.291 . . . . 0.0 108.469 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.9 -31.24 66.2 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.947 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.556 HD12 HD23 ' A' ' 29' ' ' LEU . 18.9 mt -81.15 -76.76 0.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.763 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.77 -29.94 0.44 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.522 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.456 ' O ' HD22 ' A' ' 29' ' ' LEU . 4.7 mm -71.5 133.56 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.578 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -171.93 147.62 2.19 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.868 -1.133 . . . . 0.0 111.885 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.583 ' N ' ' ND2' ' A' ' 36' ' ' ASN . 0.4 OUTLIER 68.47 -146.81 0.12 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.546 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.554 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -72.96 88.22 1.36 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.628 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.2 p -142.77 -31.54 0.51 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.718 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.625 HD12 HG11 ' A' ' 79' ' ' VAL . 5.8 mt -77.25 62.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.072 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 38.7 t -64.61 -70.02 0.25 Allowed 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.547 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.43 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -93.57 171.16 9.07 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.553 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -153.75 157.12 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 118.412 -1.315 . . . . 0.0 112.107 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -149.08 100.65 3.08 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.5 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.605 HG22 HG22 ' A' ' 4' ' ' ILE . 86.5 t -123.83 101.76 35.78 Favored Pre-proline 0 N--CA 1.496 1.84 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.407 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.44 171.8 11.22 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 120.943 1.096 . . . . 0.0 109.847 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.63 -169.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.567 1.511 . . . . 0.0 111.033 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.84 -18.24 9.6 Favored Glycine 0 N--CA 1.483 1.785 0 C-N-CA 119.18 -1.486 . . . . 0.0 110.679 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.473 HG21 ' HB1' ' A' ' 2' ' ' ALA . 1.9 m -147.79 139.98 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.292 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -110.13 119.24 38.66 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.644 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.85 157.57 17.37 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.29 -0.964 . . . . 0.0 113.158 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.6 HD12 ' NH1' ' A' ' 83' ' ' ARG . 44.2 mt -143.0 114.62 2.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.365 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.93 HD12 ' N ' ' A' ' 52' ' ' LEU . 2.7 mp -92.24 158.1 16.32 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.935 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.494 ' CE2' HG22 ' A' ' 51' ' ' ILE . 41.5 m-85 -140.03 108.48 5.86 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.488 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -45.84 -83.4 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.023 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -59.17 152.34 20.72 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.763 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -58.98 -171.18 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.945 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 49.9 37.84 29.56 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.231 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.438 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . 8.6 m-85 45.33 48.63 10.43 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.607 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.96 -164.09 1.16 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.159 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 64.84 168.93 1.91 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.265 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 60' ' ' GLY . 10.0 t70 -39.05 118.11 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.684 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.532 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 4.7 pp0? -97.74 151.57 20.02 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.743 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.663 HG22 ' N ' ' A' ' 64' ' ' GLU . 4.5 mm -130.59 168.98 22.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.423 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.663 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -147.39 133.71 19.56 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.127 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -145.07 162.19 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 118.79 -1.164 . . . . 0.0 112.56 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 t -149.36 -5.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.535 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.446 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -129.62 -159.51 0.97 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.209 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -91.15 136.91 32.77 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.714 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.605 ' HB1' ' HA ' ' A' ' 72' ' ' LEU . . . -113.92 105.03 12.76 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.424 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -54.29 -77.88 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.753 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -91.73 5.59 49.19 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.803 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.605 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 19.1 tp 54.04 -99.35 0.09 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.588 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.61 -176.55 36.45 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 118.964 -1.588 . . . . 0.0 111.03 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.646 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.0 OUTLIER -66.37 -37.34 23.96 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.483 2.122 . . . . 0.0 112.357 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 75' ' ' LEU . 2.7 pt? -57.53 8.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.502 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.646 ' H ' ' C ' ' A' ' 74' ' ' PRO . 10.5 p-10 -69.47 1.19 4.2 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.652 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.606 HD22 ' N ' ' A' ' 77' ' ' ASN . 1.8 m120 -82.82 -15.41 51.75 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.364 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -164.69 126.52 2.2 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.104 -1.039 . . . . 0.0 111.169 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.625 HG11 HD12 ' A' ' 39' ' ' ILE . 2.7 t -138.38 151.15 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.432 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.3 t -166.0 -51.14 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.728 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 m -94.14 135.55 35.39 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.977 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.523 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -150.25 157.19 6.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.371 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.831 ' HE ' HD11 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -150.59 153.08 35.07 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.386 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.659 ' C ' HH21 ' A' ' 83' ' ' ARG . 13.9 t -150.27 140.29 16.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.497 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.831 HD11 ' HE ' ' A' ' 83' ' ' ARG . 42.4 mt -134.52 129.57 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.7 m -40.82 139.71 0.81 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.052 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.589 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -143.57 141.78 19.65 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.635 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.589 ' HD2' HG22 ' A' ' 87' ' ' VAL . 5.7 Cg_exo -54.75 143.77 68.6 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 121.065 1.176 . . . . 0.0 111.156 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.0 t -64.2 145.06 14.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.123 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -122.7 139.14 30.56 Favored Pre-proline 0 N--CA 1.489 1.491 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.132 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.75 -23.48 50.06 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 121.143 1.229 . . . . 0.0 111.309 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 35.3 -151.85 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.667 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.481 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -147.72 173.06 13.13 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.046 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -147.03 113.0 5.78 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.168 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 5.7 m-85 -97.29 162.63 13.25 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.555 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -123.0 156.72 34.23 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.618 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 104' ' ' LYS . 1.4 m-85 -75.46 -91.37 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.134 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 1.247 ' HB3' ' OE1' ' A' ' 100' ' ' GLN . 51.2 mttp -47.74 162.63 0.07 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.125 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -90.6 67.57 6.46 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.66 -0.816 . . . . 0.0 112.35 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 1.247 ' OE1' ' HB3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER 178.85 51.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.667 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.9 t80 47.99 35.06 4.6 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.951 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.734 ' OD1' ' HG2' ' A' ' 100' ' ' GLN . 18.3 p-10 -142.1 171.07 14.56 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.616 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 85.38 139.94 5.09 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.019 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.538 ' HB2' ' HZ2' ' A' ' 104' ' ' LYS . 1.0 OUTLIER -29.58 132.91 0.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 123.895 0.409 . . . . 0.0 112.07 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.563 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 1.7 pm0 -104.7 163.22 12.65 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.302 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.73 HG21 ' O ' ' A' ' 122' ' ' GLY . 2.1 t -140.97 128.8 22.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.109 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.47 155.22 17.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.788 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 108' ' ' LEU . 46.2 mt -143.93 138.5 15.14 Favored Pre-proline 0 N--CA 1.481 1.087 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.847 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 10.9 Cg_endo -73.08 167.33 27.62 Favored 'Trans proline' 0 C--O 1.212 -0.789 0 C-N-CA 121.636 1.557 . . . . 0.0 111.718 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.36 141.74 76.03 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.93 1.754 . . . . 0.0 110.965 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 144.69 -155.63 26.48 Favored Glycine 0 N--CA 1.498 2.817 0 C-N-CA 118.862 -1.637 . . . . 0.0 111.328 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.444 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 6.0 tt0 -125.65 152.42 45.24 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.934 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.444 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 28.8 m-85 -145.53 147.32 32.0 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.278 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.663 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 1.4 p -95.31 -136.46 0.22 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.08 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.663 ' N ' ' OG1' ' A' ' 114' ' ' THR . 5.4 tt0 -113.98 -25.38 8.59 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.063 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.45 -64.06 1.26 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.966 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.3 pt-20 -70.94 -50.34 35.68 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.587 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.695 ' C ' HD23 ' A' ' 118' ' ' LEU . 2.4 tt -39.28 -71.05 0.09 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.459 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.569 ' OE1' ' NH1' ' A' ' 120' ' ' ARG . 75.9 mt-10 -48.89 -56.12 9.74 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.639 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.569 ' NH1' ' OE1' ' A' ' 119' ' ' GLU . 4.1 mpt_? -71.76 0.31 9.24 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.893 -1.123 . . . . 0.0 112.361 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 117' ' ' GLU . 24.7 t80 -105.08 -12.23 16.23 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.487 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.73 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -146.21 -46.51 0.03 OUTLIER Glycine 0 N--CA 1.486 1.993 0 C-N-CA 118.915 -1.612 . . . . 0.0 111.288 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.647 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -136.78 -112.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.183 -1.007 . . . . 0.0 111.724 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -156.26 -155.53 0.55 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.338 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -80.61 3.67 21.13 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.975 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.581 ' ND2' HD22 ' A' ' 166' ' ' ASN . 8.6 m120 -157.15 -152.04 0.34 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.582 -1.247 . . . . 0.0 112.147 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 39.32 96.78 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.103 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 13.5 mt -155.1 -75.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.507 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.715 ' O ' HG23 ' A' ' 131' ' ' VAL . 8.3 p 41.54 -98.16 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.7 m -44.55 116.68 1.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 129' ' ' SER . 21.2 t -121.89 146.35 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.7 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -144.09 82.58 10.8 Favored Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.413 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -63.07 108.61 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.262 1.308 . . . . 0.0 111.053 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.481 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 6.9 mm100 -62.56 -2.3 1.05 Allowed 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.911 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 175.32 -41.21 0.11 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 118.249 -1.929 . . . . 0.0 112.476 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.6 mt -88.13 176.33 7.32 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.512 -1.275 . . . . 0.0 111.299 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.1 129.66 54.14 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.308 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.7 t -98.24 149.44 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.323 -0.951 . . . . 0.0 112.404 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.585 HG12 ' CE1' ' A' ' 141' ' ' PHE . 58.1 t -133.04 113.96 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.448 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 mp -91.01 139.26 30.93 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.818 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.585 ' CE1' HG12 ' A' ' 139' ' ' VAL . 3.7 m-85 -118.64 131.8 56.17 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.461 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -61.18 -80.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.911 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.473 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.8 m-80 -66.25 164.03 16.68 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.272 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 146' ' ' PHE . 4.7 p30 -61.92 -161.17 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.537 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.638 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 6.6 t-20 37.19 29.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.12 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.638 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.1 p90 42.15 62.19 1.73 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.162 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.94 174.07 11.01 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.017 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.99 -162.13 49.82 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.488 -1.339 . . . . 0.0 110.529 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -59.96 160.54 7.72 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.41 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 71.5 p -149.13 166.04 29.99 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.56 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.46 ' C ' ' CD2' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -133.2 86.53 41.56 Favored Pre-proline 0 N--CA 1.483 1.223 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.901 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -63.24 104.77 0.43 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 C-N-CA 121.54 1.493 . . . . 0.0 112.328 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.81 81.99 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.637 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -78.85 19.77 0.5 Allowed 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.338 -0.847 . . . . 0.0 112.06 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.412 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 11.5 t -169.97 -151.67 0.09 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.54 -1.264 . . . . 0.0 111.89 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.412 ' N ' ' OG ' ' A' ' 155' ' ' SER . 4.3 m-20 -87.54 157.49 19.15 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.927 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.479 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -167.52 69.06 0.91 Allowed Pre-proline 0 C--N 1.304 -1.377 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.802 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.3 Cg_endo -68.14 34.35 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.622 2.214 . . . . 0.0 112.933 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.654 HG23 ' H ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -169.87 -68.29 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.716 -1.193 . . . . 0.0 111.665 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.654 ' H ' HG23 ' A' ' 159' ' ' THR . 1.9 mt 51.69 -93.55 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.605 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 159' ' ' THR . . . . . . . . 0 N--CA 1.493 2.438 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.595 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.581 HD22 ' ND2' ' A' ' 126' ' ' ASN . 7.8 t-20 . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.953 0.406 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -39.32 136.54 0.88 Allowed 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.29 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.8 m -107.53 -36.08 6.56 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.827 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 10.8 p -153.84 155.57 36.02 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.7 -1.2 . . . . 0.0 111.022 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.668 HD12 HD11 ' A' ' 118' ' ' LEU . 0.2 OUTLIER -143.9 172.97 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.494 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -142.04 113.26 7.59 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.58 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 3.4 mt -80.52 91.89 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 118.437 -1.305 . . . . 0.0 109.548 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.6 t . . . . . 0 C--N 1.305 -1.33 0 CA-C-O 116.331 -1.795 . . . . 0.0 110.894 -179.969 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.597 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.934 0.397 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -176.68 127.55 0.18 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.782 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.2 pt -68.06 168.69 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.441 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -149.3 124.76 10.3 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.292 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.53 ' HB ' HG23 ' A' ' 39' ' ' ILE . 1.3 m -101.67 137.01 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.718 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.534 ' CE2' ' O ' ' A' ' 12' ' ' PHE . 5.2 m-85 -92.35 148.34 22.2 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.124 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.451 ' HB2' ' N ' ' A' ' 15' ' ' LYS . 1.8 m-85 -81.52 0.71 36.79 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.505 ' C ' ' OG ' ' A' ' 40' ' ' SER . 31.6 m120 -152.38 164.3 37.76 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.063 -1.455 . . . . 0.0 112.009 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.498 ' N ' ' OG ' ' A' ' 40' ' ' SER . 3.0 tp10 -71.63 163.64 27.38 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.462 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.477 ' CG ' ' C ' ' A' ' 10' ' ' GLU . 0.3 OUTLIER 71.87 40.92 0.71 Allowed 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.576 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.534 ' O ' ' CE2' ' A' ' 7' ' ' PHE . 55.8 t80 53.48 10.63 0.22 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.138 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.577 HE21 ' H ' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -96.97 171.89 8.21 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.81 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.577 ' H ' HE21 ' A' ' 13' ' ' GLN . . . 96.08 139.32 10.33 Favored Glycine 0 N--CA 1.495 2.625 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.633 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.451 ' N ' ' HB2' ' A' ' 8' ' ' TYR . 12.5 mtmm -37.11 147.84 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.215 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.54 118.86 32.84 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.182 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.576 ' O ' HG13 ' A' ' 17' ' ' VAL . 14.4 p -104.82 130.71 55.4 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.028 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.182 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -90.25 143.26 26.93 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.326 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt -138.61 134.74 17.46 Favored Pre-proline 0 N--CA 1.493 1.693 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.146 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.83 165.89 22.08 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.048 1.165 . . . . 0.0 111.264 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.17 -173.73 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 C-N-CA 121.87 1.713 . . . . 0.0 111.163 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.12 -167.26 16.85 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.239 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.699 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -134.81 136.65 42.69 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.203 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -152.13 -172.48 4.24 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.04 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 p -142.65 -162.77 1.48 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.658 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.627 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 11.0 ttt180 -60.44 -11.99 8.32 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.725 -1.19 . . . . 0.0 110.116 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.01 -66.48 0.59 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.415 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.476 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 8.5 tp-100 -59.49 -42.63 92.57 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.363 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 29' ' ' LEU . 58.8 mt -64.37 -36.74 85.12 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.32 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 26' ' ' ARG . . . -55.78 -28.88 58.32 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 117.923 -1.511 . . . . 0.0 107.767 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -71.78 -35.53 70.07 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.819 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.6 mt -81.98 -75.45 0.3 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.487 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.51 16.93 0.06 OUTLIER Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.489 -1.338 . . . . 0.0 110.791 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.423 HD12 HG23 ' A' ' 34' ' ' ILE . 28.7 mm -102.34 127.67 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.047 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.667 ' O ' HG22 ' A' ' 38' ' ' THR . 4.7 pt-20 -178.19 158.54 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.277 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 0.5 OUTLIER 81.24 -144.62 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.404 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.708 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 0.5 OUTLIER -94.95 18.44 11.97 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.126 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -66.32 -20.73 66.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.195 -1.402 . . . . 0.0 110.361 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.756 HG22 ' O ' ' A' ' 39' ' ' ILE . 78.8 mt -76.18 33.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.692 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.651 ' H ' ' C ' ' A' ' 38' ' ' THR . 11.0 t -35.45 -55.85 0.65 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.222 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -122.74 174.68 6.97 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.418 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -151.01 161.01 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 118.165 -1.414 . . . . 0.0 112.438 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.439 ' N ' HG13 ' A' ' 42' ' ' VAL . 78.3 tttt -141.6 123.31 15.18 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.163 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.4 t -144.65 102.75 4.58 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.05 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.4 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.8 Cg_endo -68.31 171.26 13.1 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 121.032 1.154 . . . . 0.0 110.356 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 2.1 Cg_endo -61.59 -173.35 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.549 1.499 . . . . 0.0 110.815 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.9 -13.69 8.48 Favored Glycine 0 N--CA 1.483 1.788 0 C-N-CA 119.195 -1.479 . . . . 0.0 110.474 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.597 HG11 ' HB3' ' A' ' 2' ' ' ALA . 2.6 m -151.72 129.42 2.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 118.919 -1.112 . . . . 0.0 112.105 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.495 ' O ' HG13 ' A' ' 84' ' ' VAL . 15.8 ttpt -98.74 149.54 22.74 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.847 ' C ' HD12 ' A' ' 51' ' ' ILE . . . -134.17 149.62 51.04 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.365 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 1.066 HD13 HH22 ' A' ' 83' ' ' ARG . 1.9 mp -137.66 116.2 14.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.383 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.479 HD12 ' H ' ' A' ' 52' ' ' LEU . 4.3 mp -88.2 156.94 18.96 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.669 -1.212 . . . . 0.0 111.655 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -133.47 110.66 10.12 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.122 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -49.42 -79.38 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.48 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -62.4 153.88 29.94 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.987 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 21.7 p-10 -64.66 178.46 0.77 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.756 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.0 32.23 66.35 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.248 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 52.73 68.08 0.89 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.748 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.41 -170.92 3.62 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.121 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.38 175.01 6.17 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.287 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -44.27 111.66 0.32 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.623 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.605 ' CD ' ' H ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -95.62 128.32 42.39 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.146 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.573 HD11 HD11 ' A' ' 75' ' ' LEU . 2.5 mt -96.8 163.78 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.553 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -136.99 130.52 31.59 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.706 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 50' ' ' ALA . 11.0 m -150.3 163.72 3.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 118.813 -1.155 . . . . 0.0 112.178 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 t -147.42 -3.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.389 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.22 -146.13 0.32 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.273 -1.331 . . . . 0.0 109.122 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -96.94 124.39 40.9 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.546 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.433 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.16 108.73 19.77 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.054 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -65.05 -85.58 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.709 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 73' ' ' GLY . 9.8 mm-40 -80.35 5.86 13.7 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.354 -0.939 . . . . 0.0 111.539 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.408 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 3.0 tp 60.49 -79.63 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.045 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 170.56 174.72 38.77 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.397 -1.383 . . . . 0.0 110.477 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.26 -27.72 64.03 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.086 1.857 . . . . 0.0 111.982 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.573 HD11 HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -83.4 18.81 1.69 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.549 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -68.89 7.59 0.66 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -83.86 -10.48 57.99 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.519 -0.872 . . . . 0.0 111.269 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -165.75 122.94 1.44 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.381 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.589 ' HB ' HD12 ' A' ' 39' ' ' ILE . 3.5 t -149.49 142.79 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.657 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.7 m -158.35 -35.36 0.07 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.196 -1.001 . . . . 0.0 111.855 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.5 m -94.58 143.14 26.67 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.164 -1.014 . . . . 0.0 111.468 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.98 143.74 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.234 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 1.066 HH22 HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -125.0 135.07 52.44 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.81 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.748 ' CA ' ' NH1' ' A' ' 83' ' ' ARG . 13.2 t -141.22 142.92 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.391 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 68.6 mt -140.32 138.62 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.593 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.0 m -55.24 146.23 19.53 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.191 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.428 HG22 ' HD2' ' A' ' 88' ' ' PRO . 1.1 t -140.91 149.33 55.79 Favored Pre-proline 0 N--CA 1.483 1.225 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.626 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.428 ' HD2' HG22 ' A' ' 87' ' ' VAL . 3.1 Cg_exo -56.79 157.76 18.75 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.491 1.461 . . . . 0.0 111.58 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 89' ' ' VAL . 10.4 m -71.52 136.7 25.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.333 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -145.71 130.89 9.16 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.438 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -60.81 -154.34 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.877 0 C-N-CA 121.276 1.317 . . . . 0.0 111.09 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 178.28 -161.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.017 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.483 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.71 173.25 11.71 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.36 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.422 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 10.7 mtm180 -134.79 148.47 50.21 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.002 -1.079 . . . . 0.0 112.148 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 10.9 m-85 -133.79 133.34 41.56 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.764 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.492 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 27.2 m-85 -94.62 179.09 5.38 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.342 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.546 ' CE1' HG21 ' A' ' 127' ' ' THR . 0.2 OUTLIER -100.36 -64.7 1.02 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.431 -0.907 . . . . 0.0 112.973 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.503 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 46.4 tttm -81.02 158.19 25.21 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.94 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.575 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 42.2 mt-10 -64.65 108.31 1.66 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.567 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 1.145 ' NE2' ' HD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 106.04 57.14 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.208 0 O-C-N 125.109 1.505 . . . . 0.0 110.327 179.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 1.145 ' HD1' ' NE2' ' A' ' 100' ' ' GLN . 13.9 p90 26.41 40.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.672 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 100' ' ' GLN . 65.4 m-20 -100.72 -9.42 21.82 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.014 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.503 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -105.92 150.73 16.97 Favored Glycine 0 N--CA 1.499 2.9 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.395 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 103' ' ' GLY . 94.8 mttt -35.04 145.53 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.498 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.33 160.81 14.1 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.961 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.8 HG21 ' O ' ' A' ' 122' ' ' GLY . 1.5 t -143.6 165.38 14.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.232 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.513 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 5.7 p-10 -145.37 153.78 41.59 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 118.571 -1.252 . . . . 0.0 112.311 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.472 HD22 ' CD2' ' A' ' 121' ' ' TYR . 60.6 mt -139.39 146.38 48.23 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.371 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -73.15 165.75 31.84 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 121.676 1.584 . . . . 0.0 112.645 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.12 146.87 95.21 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 122.394 2.063 . . . . 0.0 111.491 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.11 -166.21 23.78 Favored Glycine 0 N--CA 1.501 2.973 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.154 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.587 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 55.3 mt-30 -113.37 159.22 19.66 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.737 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.587 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 44.9 m-85 -144.97 148.53 33.89 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.072 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.3 p -87.91 -165.68 1.38 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.879 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.91 57.0 0.73 Allowed 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.901 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.08 -68.16 0.13 Allowed 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.426 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 121' ' ' TYR . 9.7 pt-20 -69.8 -42.61 73.51 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.431 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.575 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -37.16 -74.49 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.529 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.722 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -52.08 -51.57 56.84 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.727 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 2.4 mpt_? -76.88 18.66 0.34 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.754 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 117' ' ' GLU . 16.7 t80 -127.71 -10.11 5.57 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.23 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.8 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -141.69 -49.77 0.05 OUTLIER Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.114 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.6 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -146.1 -102.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.627 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.6 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 20.1 m-20 -161.02 162.56 31.8 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.629 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.457 ' N ' ' HB3' ' A' ' 119' ' ' GLU . 17.3 p30 -60.47 -22.83 63.94 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.507 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.769 ' O ' HG22 ' A' ' 127' ' ' THR . 9.8 t30 -97.63 -175.3 3.15 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.184 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 126' ' ' ASN . 10.1 t 55.04 -152.39 0.35 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.091 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.573 ' N ' HG23 ' A' ' 127' ' ' THR . 2.6 mt 76.43 127.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.295 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.426 ' HB3' ' CA ' ' A' ' 161' ' ' GLY . 47.6 m -160.58 -54.77 0.05 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.895 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.732 ' CB ' ' H ' ' A' ' 101' ' ' PHE . 1.7 m -84.08 117.18 23.27 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.789 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 t -119.46 143.58 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.885 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -139.7 106.6 6.98 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.257 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.55 122.37 9.35 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.103 1.202 . . . . 0.0 111.07 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.483 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 1.0 OUTLIER -90.15 -2.13 58.03 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.964 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -175.92 -36.24 0.05 OUTLIER Glycine 0 N--CA 1.493 2.448 0 C-N-CA 118.469 -1.824 . . . . 0.0 111.805 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.3 164.34 16.45 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.852 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 173' ' ' SER . . . -78.03 155.78 30.48 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.374 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.5 t -119.43 140.12 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.427 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.451 ' C ' HD12 ' A' ' 140' ' ' LEU . 92.2 t -130.98 124.52 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.845 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 140' ' ' LEU . 11.2 mp -103.01 141.23 36.15 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.43 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.426 ' CB ' ' HA ' ' A' ' 146' ' ' PHE . 48.3 m-85 -120.13 125.78 49.09 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.14 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -65.78 -64.69 0.8 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.947 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.54 165.63 23.5 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.4 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 146' ' ' PHE . 31.4 m-20 -63.18 -158.72 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.723 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.655 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 4.0 m120 42.89 22.89 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.753 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.655 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.9 p90 40.6 59.17 2.2 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.114 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 t -143.25 -150.8 0.33 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.334 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 54.4 -153.79 9.55 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.42 -1.371 . . . . 0.0 109.974 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.51 143.13 50.96 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.068 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.2 p -143.99 167.67 21.8 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.47 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.3 mt -138.03 83.41 23.05 Favored Pre-proline 0 N--CA 1.485 1.31 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.922 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -64.88 104.41 0.56 Allowed 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 121.615 1.543 . . . . 0.0 111.933 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.6 t -86.0 81.83 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.959 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -71.84 12.55 0.38 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.326 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 13.4 t -169.83 -151.71 0.09 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.378 -1.329 . . . . 0.0 111.618 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.3 m-20 -85.22 155.02 21.59 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.628 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.519 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -171.9 62.64 0.34 Allowed Pre-proline 0 C--N 1.302 -1.469 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.404 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 10.2 Cg_endo -69.87 69.8 1.68 Allowed 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.954 1.769 . . . . 0.0 111.197 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.714 HG23 ' H ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER 173.97 -94.45 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.379 -0.928 . . . . 0.0 111.064 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.714 ' H ' HG23 ' A' ' 159' ' ' THR . 49.7 mt 53.26 -90.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.842 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 159' ' ' THR . . . . . . . . 0 N--CA 1.494 2.507 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.764 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.4 m120 . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.86 0.362 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -55.74 122.28 11.07 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.222 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 73.0 m -91.23 -72.1 0.6 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.242 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.61 160.72 19.64 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.244 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.407 HG12 ' CD1' ' A' ' 118' ' ' LEU . 29.2 pt -142.37 169.87 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 119.506 -0.877 . . . . 0.0 110.633 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -154.1 107.0 2.86 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.052 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.5 mt -82.99 99.34 5.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.716 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 137' ' ' ALA . 11.0 t . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 116.328 -1.796 . . . . 0.0 110.966 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.538 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 121.065 0.459 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -179.97 115.33 0.05 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.18 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.4 pt -70.1 162.46 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.82 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -143.88 119.03 10.1 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.544 -0.863 . . . . 0.0 110.705 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 m -101.8 162.58 3.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.069 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.515 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 31.3 m-85 -120.62 152.7 37.81 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.934 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.98 -47.94 60.24 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.642 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 9.6 m120 -101.17 177.42 4.94 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.969 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 11' ' ' ASP . 5.5 tp10 -82.19 177.06 9.0 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.861 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.457 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 4.1 t70 61.58 36.26 16.9 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.15 -1.02 . . . . 0.0 110.756 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.515 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 1.3 t80 60.95 2.34 0.54 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.701 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -88.24 167.98 13.11 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.724 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.642 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 93.74 133.98 6.99 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 119.974 -1.107 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 14' ' ' GLY . 25.4 mtmm -30.15 139.47 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.095 0.474 . . . . 0.0 112.193 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.38 162.07 13.65 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.935 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 t -147.82 122.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.629 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 1.6 m-20 -90.25 138.78 31.25 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.798 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 mt -132.24 133.26 23.59 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.639 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -68.65 164.56 32.63 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 120.962 1.108 . . . . 0.0 111.494 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.02 -167.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.756 1.637 . . . . 0.0 110.533 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.474 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 89.56 178.8 45.19 Favored Glycine 0 N--CA 1.486 1.989 0 C-N-CA 118.79 -1.671 . . . . 0.0 110.88 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.889 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -110.52 141.84 43.13 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.359 -0.537 . . . . 0.0 112.2 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.455 ' OH ' HD12 ' A' ' 82' ' ' ILE . 17.2 p90 -155.77 178.87 9.77 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.879 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.6 p -142.47 -168.65 2.79 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.616 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -57.97 -24.31 57.52 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.381 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -64.87 -63.4 1.12 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.003 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 8.9 tp-100 -56.73 -39.61 74.25 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.437 -1.305 . . . . 0.0 109.326 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.645 HD13 HD11 ' A' ' 34' ' ' ILE . 46.1 mt -62.04 -40.1 94.6 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.324 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -48.76 -33.78 10.98 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 118.864 -1.135 . . . . 0.0 107.972 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -71.53 -38.68 71.05 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.575 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.509 HD12 HD23 ' A' ' 29' ' ' LEU . 15.2 mt -71.89 -80.93 0.06 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.927 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.14 -21.87 0.1 OUTLIER Glycine 0 N--CA 1.491 2.324 0 C-N-CA 118.802 -1.666 . . . . 0.0 111.422 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.645 HD11 HD13 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -81.27 155.21 4.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.984 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.765 ' H ' HG21 ' A' ' 38' ' ' THR . 5.0 pt-20 174.32 117.88 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.468 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.641 ' CG ' ' N ' ' A' ' 37' ' ' ASN . 1.5 p-10 92.43 -150.67 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.966 0 O-C-N 124.299 0.999 . . . . 0.0 113.032 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.809 HD22 ' H ' ' A' ' 37' ' ' ASN . 1.9 m-80 -51.49 4.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.496 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.765 HG21 ' H ' ' A' ' 35' ' ' GLU . 43.4 p -56.78 -54.26 48.36 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 117.801 -1.559 . . . . 0.0 110.944 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.505 ' N ' ' OG1' ' A' ' 38' ' ' THR . 3.6 mt -58.75 77.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.112 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 38' ' ' THR . 35.6 t -81.38 -58.53 3.0 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.101 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.76 169.49 8.79 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -149.68 148.79 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 118.137 -1.425 . . . . 0.0 112.919 -179.907 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -137.01 114.65 11.15 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.616 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.3 t -133.93 110.09 11.96 Favored Pre-proline 0 N--CA 1.498 1.955 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.063 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.414 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.0 OUTLIER -68.46 171.47 12.93 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.219 1.28 . . . . 0.0 111.223 179.879 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.5 Cg_endo -63.71 -171.92 0.15 Allowed 'Trans proline' 0 C--N 1.317 -1.079 0 C-N-CA 121.922 1.748 . . . . 0.0 111.131 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.418 ' C ' HG13 ' A' ' 48' ' ' VAL . . . 78.38 -17.13 6.7 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.538 HG11 ' CB ' ' A' ' 2' ' ' ALA . 26.6 m -150.58 143.63 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.232 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -108.78 138.42 45.14 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.972 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -117.49 140.24 49.87 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.369 -0.932 . . . . 0.0 112.436 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -129.09 118.99 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.33 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.47 ' HA ' HG23 ' A' ' 82' ' ' ILE . 3.8 mp -94.58 163.79 13.24 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.975 -1.09 . . . . 0.0 112.81 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -143.61 121.01 11.65 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.069 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -54.96 -85.87 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.665 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -59.88 154.07 19.45 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.28 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -62.45 -176.67 0.11 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.525 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.22 21.32 59.43 Favored Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.052 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 57.07 48.64 15.15 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.798 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -128.71 -177.83 4.35 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.591 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.41 171.68 36.44 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.076 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.5 m-20 -46.99 123.69 5.54 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.021 -1.071 . . . . 0.0 110.407 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.728 ' CD ' ' H ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -102.85 176.06 5.28 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.854 -0.739 . . . . 0.0 111.112 179.951 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.626 HD11 HD11 ' A' ' 75' ' ' LEU . 6.1 mt -143.65 164.31 15.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.625 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.567 ' N ' ' CD ' ' A' ' 64' ' ' GLU . 3.0 mp0 -142.94 132.16 23.26 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.191 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.3 m -149.95 162.95 3.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.645 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 t -145.46 -1.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.664 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -124.47 -125.07 0.25 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.877 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.565 ' C ' HD22 ' A' ' 68' ' ' ASN . 0.2 OUTLIER -121.64 115.83 23.47 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.201 179.915 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.57 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -90.1 83.47 6.06 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.575 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -54.33 -51.16 65.59 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.444 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 72' ' ' LEU . 8.5 tp10 -111.93 81.46 1.46 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.87 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.441 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 4.5 tp -31.17 -87.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.233 -0.894 . . . . 0.0 113.167 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.441 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 179.5 -168.17 38.56 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.007 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.64 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.1 Cg_endo -69.37 -50.38 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.402 2.068 . . . . 0.0 112.611 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.798 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.3 pt? -57.97 10.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.873 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.64 ' H ' ' C ' ' A' ' 74' ' ' PRO . 30.2 p30 -62.56 -0.58 0.63 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.861 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.509 ' H ' ' C ' ' A' ' 75' ' ' LEU . 55.0 t30 -71.22 -10.53 59.91 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.394 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -172.94 124.85 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.302 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.85 141.67 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.031 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.0 m -160.17 -41.77 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.748 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 m -94.6 139.03 31.73 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.244 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.47 HG23 ' HA ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -146.25 162.59 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 118.919 -1.112 . . . . 0.0 111.728 -179.952 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.892 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.24 114.42 5.85 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.116 -179.881 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.892 ' H ' HH22 ' A' ' 83' ' ' ARG . 10.9 t -110.11 130.31 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.613 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.438 HG13 ' NH1' ' A' ' 83' ' ' ARG . 4.9 mt -132.43 127.4 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.088 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.8 m -39.98 153.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.904 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.586 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -158.11 141.86 11.25 Favored Pre-proline 0 N--CA 1.488 1.437 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.98 179.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.586 ' HD2' HG22 ' A' ' 87' ' ' VAL . 7.6 Cg_exo -50.46 153.79 7.04 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.346 1.364 . . . . 0.0 111.64 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.531 HG22 ' N ' ' A' ' 90' ' ' GLN . 3.1 p -90.51 158.59 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.96 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.531 ' N ' HG22 ' A' ' 89' ' ' VAL . 52.5 mt-30 -142.25 150.46 55.31 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.432 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.567 ' C ' ' HE ' ' A' ' 92' ' ' ARG . 3.3 Cg_exo -59.71 -36.76 90.86 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.496 1.464 . . . . 0.0 111.299 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.567 ' HE ' ' C ' ' A' ' 91' ' ' PRO . 2.5 mtm180 57.21 -165.72 0.15 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.048 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.544 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -140.07 179.77 6.43 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.967 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -140.42 149.84 43.11 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.711 -1.195 . . . . 0.0 111.966 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -134.64 131.34 37.65 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.011 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.564 ' CZ ' ' CD ' ' A' ' 105' ' ' GLU . 5.4 m-85 -92.58 173.34 7.83 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.027 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.44 -68.89 0.75 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 118.893 -1.123 . . . . 0.0 112.117 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -75.46 166.7 23.19 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.319 -0.953 . . . . 0.0 111.844 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.725 ' C ' ' HG2' ' A' ' 100' ' ' GLN . 5.2 pt-20 -89.68 52.75 2.39 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.674 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.725 ' HG2' ' C ' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -159.32 33.24 0.2 Allowed 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.903 -179.995 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.7 t80 58.4 38.11 25.76 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.447 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -137.97 173.81 11.23 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 81.78 134.02 1.72 Allowed Glycine 0 N--CA 1.487 2.033 0 C-N-CA 119.38 -1.391 . . . . 0.0 109.893 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 103' ' ' GLY . 13.6 ptpt -32.69 148.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.066 0.509 . . . . 0.0 112.008 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.564 ' CD ' ' CZ ' ' A' ' 96' ' ' PHE . 20.9 mt-10 -108.52 167.54 9.97 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.737 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 122' ' ' GLY . 2.6 t -137.19 130.0 43.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.768 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -102.1 155.87 17.92 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.338 -0.945 . . . . 0.0 113.103 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 108' ' ' LEU . 89.1 mt -145.45 125.36 7.05 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.266 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.18 166.38 16.98 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 121.108 1.205 . . . . 0.0 111.756 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.97 150.24 84.96 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 121.78 1.653 . . . . 0.0 111.07 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 139.32 -140.62 11.03 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.188 -1.482 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.528 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 19.2 tt0 -147.55 159.46 43.72 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.791 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 53.5 m-85 -141.71 155.41 45.65 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.842 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.2 p -100.61 175.42 5.67 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.66 -0.816 . . . . 0.0 112.29 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.71 41.01 0.15 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.667 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.415 ' N ' ' OE2' ' A' ' 119' ' ' GLU . . . -154.32 -52.93 0.1 Allowed 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.273 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 118' ' ' LEU . 5.1 tp10 -71.83 -52.11 19.1 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.043 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.571 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -36.17 -72.09 0.06 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.435 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.695 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 1.2 pm0 -52.99 -54.93 27.82 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.728 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.419 ' H ' ' HG2' ' A' ' 119' ' ' GLU . 3.4 mpt_? -74.31 15.56 0.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.173 -1.011 . . . . 0.0 112.516 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.401 ' O ' ' CG ' ' A' ' 121' ' ' TYR . 41.0 t80 -121.1 -17.85 7.64 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.536 -0.865 . . . . 0.0 111.476 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.537 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -142.94 -40.61 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 C-N-CA 118.632 -1.747 . . . . 0.0 111.44 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.623 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -139.01 -105.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.54 -179.867 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.538 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 19.1 t70 -162.61 -172.96 3.32 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.609 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.538 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 15.9 t-20 -59.09 -2.32 0.25 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.218 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 127' ' ' THR . 28.2 p30 -172.25 -134.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.754 -1.178 . . . . 0.0 111.948 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.55 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 9.1 t 41.0 33.98 0.25 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.877 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.484 ' C ' ' OG ' ' A' ' 129' ' ' SER . 3.0 mt -88.06 -75.75 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.122 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.484 ' OG ' ' C ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 77.22 -142.39 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 179.784 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.6 m -37.09 128.42 0.92 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.277 -1.329 . . . . 0.0 113.646 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.8 t -122.18 147.43 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.156 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -145.72 98.99 4.45 Favored Pre-proline 0 C--N 1.3 -1.549 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.125 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.02 110.13 1.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.044 1.163 . . . . 0.0 111.519 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.544 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 61.1 tp60 -57.95 -21.32 43.57 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.423 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.57 -36.32 0.03 OUTLIER Glycine 0 N--CA 1.495 2.602 0 C-N-CA 118.516 -1.802 . . . . 0.0 112.103 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.415 HD21 ' HG2' ' A' ' 91' ' ' PRO . 1.8 mt -92.11 -171.46 2.84 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.704 -1.198 . . . . 0.0 110.968 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.1 146.31 35.65 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.1 t -111.86 141.76 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 119.409 -0.916 . . . . 0.0 112.86 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.465 HG12 ' CE1' ' A' ' 141' ' ' PHE . 91.1 t -133.14 123.57 47.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.1 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 140' ' ' LEU . 5.2 mp -105.23 144.6 31.79 Favored 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 118.838 -1.145 . . . . 0.0 113.598 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.465 ' CE1' HG12 ' A' ' 139' ' ' VAL . 14.9 m-85 -120.14 132.51 55.43 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.047 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -73.91 -55.26 6.4 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.57 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -74.58 -158.52 0.07 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.872 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 145' ' ' ASN . 17.8 t70 -64.49 -147.03 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.2 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.559 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 6.0 m-80 -51.59 88.57 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.559 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 8.1 p90 38.44 68.34 0.34 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.946 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 81.1 p -132.95 43.37 2.97 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.971 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -178.8 -155.53 14.88 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -65.73 152.88 43.26 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.234 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 22.5 p -149.83 163.1 38.91 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.806 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.25 97.91 14.46 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.275 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -70.55 109.93 2.59 Favored 'Trans proline' 0 C--N 1.325 -0.664 0 C-N-CA 121.536 1.491 . . . . 0.0 112.087 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' A' ' 155' ' ' SER . 3.3 t -89.02 74.73 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.504 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.73 31.07 0.08 Allowed 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.055 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 153' ' ' VAL . 10.5 t -170.31 -153.42 0.1 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.595 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -90.47 164.04 14.41 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.739 -0.785 . . . . 0.0 111.481 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.532 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -167.65 73.13 0.95 Allowed Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.784 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.8 23.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.07 1.846 . . . . 0.0 112.891 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -178.48 79.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.731 179.89 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 17.2 tp -70.71 -45.18 65.4 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.193 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.031 0 C-N-CA 119.151 -1.5 . . . . 0.0 109.64 -179.949 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.942 0.401 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.21 126.21 42.26 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.422 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.0 m -99.09 -73.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.635 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 4.0 p -112.01 158.69 19.24 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.203 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.429 HG12 ' CD1' ' A' ' 118' ' ' LEU . 16.3 pt -139.81 170.56 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.748 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -147.95 109.0 4.25 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.97 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.2 mt -88.88 94.73 4.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.957 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 116.356 -1.783 . . . . 0.0 111.069 -179.966 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.623 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.914 0.387 . . . . 0.0 110.849 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -178.57 127.39 0.11 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.61 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.449 HD11 HD12 ' A' ' 19' ' ' LEU . 2.0 pp -81.24 147.65 6.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.331 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 1.085 HG21 ' NE2' ' A' ' 16' ' ' GLN . 22.6 m -128.64 139.15 52.4 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.515 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.13 173.69 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.821 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.47 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 52.7 m-85 -132.63 154.74 49.78 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.385 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -79.4 -19.17 50.72 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.023 1.119 . . . . 0.0 114.023 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.493 ' C ' ' OG ' ' A' ' 40' ' ' SER . 5.7 m120 -136.26 170.89 15.3 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.587 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.36 175.64 4.55 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.22 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 13' ' ' GLN . 6.9 t0 52.63 49.12 21.06 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.122 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.516 ' CE2' ' HG2' ' A' ' 70' ' ' GLU . 16.4 m-85 53.52 -4.25 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.745 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.554 ' H ' ' C ' ' A' ' 11' ' ' ASP . 29.4 mt-30 -75.58 169.05 18.86 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.613 -1.235 . . . . 0.0 111.24 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.6 134.13 5.73 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.495 -1.336 . . . . 0.0 110.498 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.604 ' NZ ' ' CB ' ' A' ' 15' ' ' LYS . 7.1 mtmp? -43.59 157.01 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.027 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 1.085 ' NE2' HG21 ' A' ' 5' ' ' THR . 0.0 OUTLIER -122.38 167.76 12.9 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.447 -0.901 . . . . 0.0 112.821 -179.79 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -145.06 130.35 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.675 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.37 118.09 30.88 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.38 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.449 HD12 HD11 ' A' ' 4' ' ' ILE . 5.9 mt -112.67 139.78 23.15 Favored Pre-proline 0 N--CA 1.49 1.562 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.218 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -70.42 164.43 35.21 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 120.892 1.061 . . . . 0.0 111.075 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -163.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.037 0 C-N-CA 121.715 1.61 . . . . 0.0 110.723 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.24 176.12 50.59 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.779 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.804 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.4 OUTLIER -108.57 145.11 35.33 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.655 -179.885 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.603 ' CE2' HD12 ' A' ' 82' ' ' ILE . 2.6 p90 -159.03 -173.54 4.29 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.152 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 p -146.53 -162.46 1.53 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.067 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.432 ' HG2' ' H ' ' A' ' 26' ' ' ARG . 7.3 ptp180 -62.67 -17.82 61.25 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.577 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -66.06 -62.86 1.26 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.258 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.549 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 36.1 tt0 -56.06 -42.41 76.59 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.114 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.576 HD23 HD12 ' A' ' 32' ' ' LEU . 68.9 mt -60.26 -39.86 88.27 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.454 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.56 -33.0 13.79 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 118.586 -1.246 . . . . 0.0 107.887 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -68.72 -39.43 80.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.151 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.576 HD12 HD23 ' A' ' 29' ' ' LEU . 17.7 mt -74.88 -75.59 0.16 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.771 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.53 -24.87 0.66 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 118.801 -1.666 . . . . 0.0 111.471 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.533 HD13 ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -85.04 149.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.405 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.567 ' O ' HG23 ' A' ' 38' ' ' THR . 6.0 pt-20 176.95 151.87 0.18 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.473 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.496 ' CG ' ' C ' ' A' ' 35' ' ' GLU . 0.6 OUTLIER 80.37 -144.5 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 179.754 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -67.5 29.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.249 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 35' ' ' GLU . 80.6 p -87.01 -43.87 12.01 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.44 -1.304 . . . . 0.0 110.626 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.404 HD12 ' CG1' ' A' ' 79' ' ' VAL . 9.2 mt -60.05 78.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.779 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.558 ' N ' ' O ' ' A' ' 38' ' ' THR . 19.0 t -77.5 -69.65 0.52 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.967 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.47 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -104.49 170.2 8.03 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.486 179.862 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -147.49 146.92 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 118.498 -1.281 . . . . 0.0 112.895 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -132.62 117.69 18.24 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.168 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.689 ' H ' HD22 ' A' ' 68' ' ' ASN . 72.3 t -140.5 109.14 6.71 Favored Pre-proline 0 N--CA 1.495 1.801 0 C-N-CA 119.318 -0.953 . . . . 0.0 112.083 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.413 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.0 OUTLIER -69.67 170.94 15.3 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.404 1.403 . . . . 0.0 111.711 179.977 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.8 Cg_endo -62.69 -176.84 0.27 Allowed 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 122.263 1.975 . . . . 0.0 111.214 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.93 -12.25 18.2 Favored Glycine 0 N--CA 1.482 1.729 0 C-N-CA 119.189 -1.481 . . . . 0.0 110.563 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.623 HG11 ' CB ' ' A' ' 2' ' ' ALA . 18.1 m -149.27 131.72 6.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.799 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -105.85 136.78 44.87 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.125 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -117.87 151.98 36.3 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.351 -0.94 . . . . 0.0 112.627 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.527 ' C ' HD12 ' A' ' 52' ' ' LEU . 97.1 mt -138.49 119.38 16.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 114.57 -1.196 . . . . 0.0 108.523 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.893 HD12 ' N ' ' A' ' 52' ' ' LEU . 2.7 mp -91.97 161.85 14.63 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.535 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -142.75 108.95 5.24 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.785 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -48.17 -85.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.38 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.514 HD22 ' H ' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -59.47 150.2 27.41 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.421 -0.911 . . . . 0.0 111.225 -179.97 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.514 ' H ' HD22 ' A' ' 55' ' ' ASN . 20.6 p-10 -62.1 178.78 0.34 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.465 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.4 24.8 71.0 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.113 -1.518 . . . . 0.0 110.106 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 54.65 63.89 2.0 Allowed 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.72 -161.19 1.27 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.015 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.58 169.46 1.4 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.087 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -43.68 119.1 1.57 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.476 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -97.86 172.18 7.82 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.279 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.525 HD12 HD22 ' A' ' 52' ' ' LEU . 3.4 mt -142.31 164.31 17.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.601 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -141.86 130.7 22.97 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.796 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -147.66 159.18 8.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 118.758 -1.177 . . . . 0.0 112.43 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.31 -5.05 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.179 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -124.64 -147.58 0.37 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.534 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.689 HD22 ' H ' ' A' ' 44' ' ' VAL . 8.4 m120 -101.63 113.6 26.89 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.02 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.556 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -92.01 100.6 13.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.139 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.516 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 17.5 mt-10 -66.58 -86.34 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.773 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.437 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 28.3 tp10 -57.9 -16.11 10.9 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.533 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 4.6 tp 73.39 -83.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.528 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.58 -169.76 42.87 Favored Glycine 0 N--CA 1.5 2.901 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.552 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.8 Cg_endo -66.41 -47.78 2.88 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.385 2.056 . . . . 0.0 112.308 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.964 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.1 pt? -71.54 29.45 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.951 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.562 HD22 ' C ' ' A' ' 76' ' ' ASN . 0.5 OUTLIER -82.64 55.63 3.05 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.902 179.951 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -145.92 1.48 0.88 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -171.76 115.55 0.37 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.249 -0.981 . . . . 0.0 111.012 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.404 ' CG1' HD12 ' A' ' 39' ' ' ILE . 2.2 t -139.14 156.12 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.463 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.5 t -166.41 -41.14 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 118.952 -1.099 . . . . 0.0 112.152 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 m -99.77 144.29 29.0 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.304 -0.959 . . . . 0.0 111.349 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.603 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -149.23 163.47 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.779 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.86 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -146.89 113.99 6.2 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.834 -179.972 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.86 ' H ' HH22 ' A' ' 83' ' ' ARG . 45.0 t -121.33 138.46 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.701 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.66 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 2.3 mt -143.43 132.43 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.269 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.6 m -40.17 153.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.917 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -149.24 149.88 30.43 Favored Pre-proline 0 N--CA 1.482 1.155 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.805 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.18 153.12 28.03 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 121.251 1.3 . . . . 0.0 111.354 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.14 134.73 27.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.776 -0.77 . . . . 0.0 111.236 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -145.25 126.12 7.47 Favored Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.366 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.62 -177.35 0.08 OUTLIER 'Trans proline' 0 C--O 1.212 -0.812 0 C-N-CA 120.851 1.034 . . . . 0.0 111.119 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.75 -160.33 0.69 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.713 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.49 161.23 27.58 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.157 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -119.42 147.94 43.8 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.981 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -134.75 136.63 42.78 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.564 -1.198 . . . . 0.0 107.889 179.813 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.498 ' CE2' ' OE2' ' A' ' 105' ' ' GLU . 18.3 m-85 -100.89 164.67 11.72 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 118.991 -1.084 . . . . 0.0 112.463 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.62 -56.88 3.59 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.421 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -93.34 167.0 12.02 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.043 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -87.98 68.33 9.19 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.563 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.656 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -175.59 49.56 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.555 -179.946 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.656 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 26.2 p90 39.58 40.31 0.61 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.644 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 20.9 p-10 -142.63 174.76 10.35 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.259 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 85.71 141.24 5.83 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.163 -1.494 . . . . 0.0 110.002 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 103' ' ' GLY . 11.9 tptt -28.49 123.15 0.12 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 124.016 0.48 . . . . 0.0 111.76 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.498 ' OE2' ' CE2' ' A' ' 96' ' ' PHE . 43.8 mt-10 -94.41 115.18 27.33 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.11 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.705 HG21 ' O ' ' A' ' 122' ' ' GLY . 3.6 t -96.17 143.76 11.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.592 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -123.92 156.58 36.07 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.88 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.2 mt -143.4 137.96 15.08 Favored Pre-proline 0 N--CA 1.488 1.469 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.896 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -67.77 165.56 27.32 Favored 'Trans proline' 0 C--O 1.213 -0.762 0 C-N-CA 121.732 1.621 . . . . 0.0 112.018 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.69 153.11 51.57 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 C-N-CA 122.171 1.914 . . . . 0.0 111.599 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.97 -159.3 21.14 Favored Glycine 0 N--CA 1.503 3.107 0 C-N-CA 119.35 -1.405 . . . . 0.0 111.42 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.538 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 24.8 mt-30 -123.65 157.18 34.41 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.196 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 27.8 m-85 -138.43 143.92 39.91 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.156 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.2 p -91.37 176.25 6.63 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.838 -0.745 . . . . 0.0 112.604 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.408 ' C ' ' OE2' ' A' ' 119' ' ' GLU . 39.0 tt0 -77.72 46.01 0.53 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.543 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -146.76 -64.17 0.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.073 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.6 pt-20 -71.16 -49.1 47.42 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.927 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.553 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -31.9 -70.33 0.07 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.424 -179.999 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.697 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -58.18 -55.98 28.0 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.63 179.956 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.499 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.8 OUTLIER -75.1 21.27 0.12 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.526 -0.869 . . . . 0.0 111.806 -179.876 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' A' ' 117' ' ' GLU . 30.0 t80 -128.75 -15.95 4.3 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.206 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.705 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -143.87 -39.36 0.06 OUTLIER Glycine 0 N--CA 1.491 2.331 0 C-N-CA 118.742 -1.694 . . . . 0.0 111.09 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.557 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -144.57 -104.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.5 -179.968 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.557 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 0.3 OUTLIER -162.51 -169.81 2.23 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.013 179.931 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -88.8 36.37 0.8 Allowed 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.008 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.53 ' O ' ' N ' ' A' ' 128' ' ' ILE . 63.2 t30 -172.33 -74.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.418 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -40.62 85.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' A' ' 126' ' ' ASN . 42.3 mt -158.43 143.33 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.657 179.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.9 m -159.51 -119.84 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.267 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.3 m -38.5 128.11 1.45 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.014 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -122.22 154.48 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.714 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -147.59 100.68 3.76 Favored Pre-proline 0 C--N 1.302 -1.467 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.369 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -54.4 94.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 120.976 1.118 . . . . 0.0 110.461 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -57.65 -15.87 8.93 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.307 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.34 -25.6 0.05 OUTLIER Glycine 0 N--CA 1.488 2.131 0 C-N-CA 118.747 -1.692 . . . . 0.0 111.461 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 mt -120.87 148.28 44.26 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.539 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -66.38 161.96 21.42 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.496 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 40.4 t -131.39 147.83 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.482 -0.887 . . . . 0.0 112.259 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.592 HG12 ' CE1' ' A' ' 141' ' ' PHE . 76.2 t -138.82 124.02 22.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.442 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.9 mp -104.34 142.17 35.03 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 119.642 -0.823 . . . . 0.0 112.755 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.592 ' CE1' HG12 ' A' ' 139' ' ' VAL . 18.6 m-85 -120.68 135.06 55.23 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.621 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -72.63 -47.2 49.62 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.527 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.556 ' CG ' ' H ' ' A' ' 144' ' ' ASP . 5.1 t-20 -83.22 -157.33 0.23 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.703 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.556 ' H ' ' CG ' ' A' ' 143' ' ' ASN . 1.0 OUTLIER -69.25 -140.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.927 -179.924 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.604 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 6.0 m120 -52.67 86.09 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.053 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.604 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 6.2 p90 38.73 68.96 0.3 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.953 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 p -136.24 60.05 1.69 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.733 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 160.04 -151.68 22.38 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.134 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -59.41 156.81 12.22 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.336 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.5 p -149.01 170.14 19.03 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.754 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.507 ' C ' HD23 ' A' ' 151' ' ' LEU . 3.2 tt -144.24 83.04 10.32 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.449 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.85 105.92 0.71 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 121.999 1.799 . . . . 0.0 113.207 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 38.5 t -82.32 89.97 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.136 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.61 HD22 ' N ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -68.66 -7.48 33.6 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -179.831 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.555 ' N ' HD22 ' A' ' 154' ' ' ASN . 21.0 t -169.62 -135.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 117.666 -1.614 . . . . 0.0 113.293 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.462 ' N ' ' OG ' ' A' ' 155' ' ' SER . 23.7 m-20 -77.18 152.72 34.68 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.987 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -167.86 67.14 0.79 Allowed Pre-proline 0 C--N 1.307 -1.247 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.035 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.4 Cg_endo -62.72 20.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.231 1.954 . . . . 0.0 112.847 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.551 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -175.32 83.62 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.755 -1.178 . . . . 0.0 110.953 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 30.2 tp -98.78 -47.66 5.23 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.297 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.875 0 C-N-CA 119.212 -1.471 . . . . 0.0 110.043 -179.942 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.1 p30 . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.61 0.243 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.5 m -103.26 150.82 23.36 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.745 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.9 p -124.44 -68.04 0.88 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.157 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.408 ' OG ' ' HB2' ' A' ' 141' ' ' PHE . 77.3 p -116.33 153.19 32.43 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.611 -0.835 . . . . 0.0 108.819 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 19.2 pt -137.04 175.52 9.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.717 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -155.65 103.97 2.32 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.227 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.3 mt -78.23 103.38 5.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.791 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.0 t . . . . . 0 C--N 1.305 -1.349 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.777 -179.898 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.555 ' C ' HD22 ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.878 0.371 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.555 HD22 ' C ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER -175.04 118.32 0.18 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.365 -179.97 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 4' ' ' ILE . 24.5 pt -69.27 145.8 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.684 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.427 HG23 ' NE2' ' A' ' 16' ' ' GLN . 3.5 m -121.56 112.87 19.01 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.003 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 m -91.12 175.47 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.238 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.544 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 23.9 m-85 -132.24 151.18 51.94 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.449 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.17 -6.77 59.27 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 118.824 -1.15 . . . . 0.0 113.289 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.52 ' C ' ' OG ' ' A' ' 40' ' ' SER . 34.1 m120 -147.13 161.85 40.04 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.646 -1.222 . . . . 0.0 111.536 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.449 ' N ' ' OG ' ' A' ' 40' ' ' SER . 26.2 mt-10 -70.85 179.02 2.84 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.394 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.9 t70 59.37 39.33 22.32 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.402 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.6 t80 57.48 5.45 0.3 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.272 -0.971 . . . . 0.0 111.792 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.465 ' HG2' ' H ' ' A' ' 14' ' ' GLY . 6.7 tt0 -92.45 176.66 6.39 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.291 -0.963 . . . . 0.0 111.217 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.465 ' H ' ' HG2' ' A' ' 13' ' ' GLN . . . 88.47 131.43 3.84 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.993 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -42.78 157.64 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.572 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.438 HE21 ' N ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -121.23 166.96 13.24 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.461 -0.895 . . . . 0.0 112.545 -179.758 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.438 ' N ' HE21 ' A' ' 16' ' ' GLN . 58.6 t -143.86 135.41 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.929 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -94.1 113.28 25.21 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.419 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.8 mt -107.35 137.68 19.69 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.572 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -71.15 155.76 60.64 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 121.072 1.181 . . . . 0.0 110.972 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.44 -161.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 121.576 1.517 . . . . 0.0 110.533 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.54 178.45 49.43 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 119.175 -1.488 . . . . 0.0 111.038 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.788 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.5 OUTLIER -103.11 134.3 46.77 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.671 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 7.4 p90 -153.71 174.77 14.08 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.143 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.5 p -145.67 -154.21 0.53 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.98 -179.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.837 HH11 ' HB2' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -62.72 -30.92 71.77 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.973 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -59.98 -61.77 2.36 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.95 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.506 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.9 tp60 -56.47 -47.4 79.28 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.502 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.679 HD23 HD12 ' A' ' 32' ' ' LEU . 20.2 mt -54.98 -39.48 69.03 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.528 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.837 ' HB2' HH11 ' A' ' 26' ' ' ARG . . . -51.68 -34.2 37.34 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 118.948 -1.101 . . . . 0.0 108.359 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -66.77 -39.49 87.87 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.696 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.679 HD12 HD23 ' A' ' 29' ' ' LEU . 10.3 mt -74.8 -75.07 0.17 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.617 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.59 -34.91 0.54 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.094 -1.526 . . . . 0.0 110.909 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.444 HG21 HD13 ' A' ' 34' ' ' ILE . 8.5 tt -79.89 150.76 4.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.735 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 179.92 150.74 0.38 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.605 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.69 -146.8 0.14 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.913 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -55.33 92.62 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.998 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 40' ' ' SER . 73.1 p -153.18 -46.97 0.1 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.106 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.406 HD12 HG11 ' A' ' 79' ' ' VAL . 7.3 mt -61.86 75.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 C-N-CA 119.661 -0.815 . . . . 0.0 109.764 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.549 ' O ' HD22 ' A' ' 72' ' ' LEU . 8.6 t -74.21 -59.74 2.59 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.429 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.544 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -116.81 177.29 4.76 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.709 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -156.43 152.64 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 117.549 -1.66 . . . . 0.0 113.486 -179.896 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -140.17 106.97 5.38 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.595 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -126.08 108.21 24.71 Favored Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.598 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.419 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -69.81 171.04 15.25 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.042 1.162 . . . . 0.0 110.549 179.86 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.9 Cg_endo -62.39 -170.87 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.841 1.694 . . . . 0.0 110.91 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.9 -14.61 12.97 Favored Glycine 0 N--CA 1.478 1.468 0 C-N-CA 119.024 -1.56 . . . . 0.0 111.005 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.543 HG11 ' HB3' ' A' ' 2' ' ' ALA . 0.5 OUTLIER -151.66 131.72 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 118.716 -1.194 . . . . 0.0 112.588 -179.832 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.445 ' HA ' HG13 ' A' ' 66' ' ' VAL . 57.7 tttt -101.73 130.8 48.21 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.35 158.09 20.22 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.025 -1.07 . . . . 0.0 113.519 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.545 HD12 ' NH1' ' A' ' 83' ' ' ARG . 33.6 mt -144.71 116.24 2.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.242 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.546 ' HA ' HG23 ' A' ' 82' ' ' ILE . 2.7 mp -94.42 159.46 15.1 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.167 -1.013 . . . . 0.0 113.368 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.488 ' CE1' HG22 ' A' ' 51' ' ' ILE . 83.2 m-85 -139.33 114.77 9.82 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.111 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -44.61 -87.05 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.459 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -59.45 151.02 24.98 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.338 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -58.99 -178.99 0.06 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.169 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.666 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 55.61 37.31 67.31 Favored Glycine 0 N--CA 1.484 1.853 0 C-N-CA 118.906 -1.616 . . . . 0.0 109.437 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.771 ' H ' ' CB ' ' A' ' 81' ' ' SER . 0.3 OUTLIER 41.1 69.08 0.37 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.838 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.02 174.39 10.63 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.767 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.71 173.61 40.64 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.236 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -48.46 122.28 5.29 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 118.999 -1.081 . . . . 0.0 110.352 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.401 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 1.9 pt20 -99.05 173.32 6.88 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.93 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.878 HD11 HD11 ' A' ' 75' ' ' LEU . 7.3 mt -138.66 169.93 17.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.711 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.517 ' H ' HG22 ' A' ' 63' ' ' ILE . 22.0 mt-10 -147.21 130.88 16.9 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.394 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.64 164.74 2.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.441 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.622 HG12 ' NH2' ' A' ' 92' ' ' ARG . 0.5 OUTLIER -146.67 -9.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.658 179.856 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -118.01 -153.21 0.52 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.837 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -95.48 120.7 36.18 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.637 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.573 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.73 108.37 19.65 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.174 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 8.2 tp10 -73.62 -76.78 0.12 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.95 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.464 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 23.1 tp10 -76.86 2.02 15.8 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.038 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.549 HD22 ' O ' ' A' ' 40' ' ' SER . 10.1 tp 51.83 -97.55 0.06 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.111 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.465 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -174.5 -173.83 40.77 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 118.937 -1.601 . . . . 0.0 110.979 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.629 ' C ' ' H ' ' A' ' 76' ' ' ASN . 3.8 Cg_endo -71.86 -53.8 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.649 2.233 . . . . 0.0 112.306 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.878 HD11 HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -60.82 14.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.775 -179.853 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.629 ' H ' ' C ' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -67.51 0.81 2.74 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.453 179.943 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 75' ' ' LEU . 25.8 t-20 -80.82 -8.77 59.79 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.091 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -164.75 122.54 1.66 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.596 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.406 HG11 HD12 ' A' ' 39' ' ' ILE . 2.8 t -148.33 137.47 15.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.72 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.5 p -145.11 -47.4 0.23 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.65 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.771 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 7.4 m -93.61 142.76 26.98 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.334 -179.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.546 HG23 ' HA ' ' A' ' 52' ' ' LEU . 0.8 OUTLIER -147.98 160.38 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.01 -179.923 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.78 HH22 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.92 137.4 21.09 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.151 180.0 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.78 ' CA ' HH22 ' A' ' 83' ' ' ARG . 5.4 t -140.74 143.87 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.7 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.494 HG12 ' NH2' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -135.71 135.13 51.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.125 -179.928 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.1 t -42.87 154.41 0.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.108 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.7 143.72 13.59 Favored Pre-proline 0 C--N 1.307 -1.27 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.118 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.54 130.12 28.83 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.091 1.194 . . . . 0.0 110.73 179.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.3 p -59.48 140.24 17.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -117.33 152.44 49.25 Favored Pre-proline 0 N--CA 1.49 1.57 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.25 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.442 ' HG2' HD21 ' A' ' 136' ' ' LEU . 2.5 Cg_endo -59.33 -34.27 97.74 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.287 1.324 . . . . 0.0 111.207 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.622 ' NH2' HG12 ' A' ' 66' ' ' VAL . 22.3 mtt180 52.15 -161.96 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.359 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.572 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.1 175.86 9.42 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.867 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.51 ' NH2' HE22 ' A' ' 134' ' ' GLN . 28.3 ttm180 -143.68 120.15 11.01 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.45 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.42 ' CD1' HG13 ' A' ' 131' ' ' VAL . 6.7 m-30 -95.77 164.54 12.71 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.028 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.638 ' CD1' ' CE1' ' A' ' 101' ' ' PHE . 2.8 m-85 -143.41 149.06 37.12 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.468 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.576 ' N ' ' CD1' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -93.68 160.43 14.77 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.597 -179.895 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.423 ' C ' ' OG ' ' A' ' 129' ' ' SER . 10.3 tttm 67.19 136.52 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.004 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.532 ' N ' ' OG ' ' A' ' 129' ' ' SER . 5.1 pt-20 -77.27 70.99 3.73 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.626 -1.23 . . . . 0.0 111.003 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.642 ' NE2' ' OD2' ' A' ' 102' ' ' ASP . 6.3 tt0 -173.67 19.02 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.515 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.638 ' CE1' ' CD1' ' A' ' 96' ' ' PHE . 33.8 t80 49.34 40.35 18.27 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.424 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.642 ' OD2' ' NE2' ' A' ' 100' ' ' GLN . 90.3 m-20 -104.09 -87.22 0.44 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.556 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 102' ' ' ASP . . . -30.68 145.88 0.01 OUTLIER Glycine 0 N--CA 1.507 3.402 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.917 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -34.72 155.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 114.587 -0.807 . . . . 0.0 112.998 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.492 ' HB3' ' CE1' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -116.4 164.74 14.1 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.411 -179.849 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.65 141.16 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -102.53 157.69 16.75 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.965 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 108' ' ' LEU . 88.8 mt -144.27 140.01 16.37 Favored Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.964 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -72.86 164.39 35.71 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 121.756 1.637 . . . . 0.0 111.825 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.5 143.79 70.52 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.603 1.535 . . . . 0.0 110.72 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.9 -160.78 27.52 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 118.795 -1.669 . . . . 0.0 111.573 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.561 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 29.3 tt0 -117.63 158.13 25.19 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.216 -0.492 . . . . 0.0 111.038 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.561 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 56.0 m-85 -145.52 151.47 38.22 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.765 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.4 p -103.02 -168.24 1.49 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.322 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.47 ' CG ' ' OG ' ' A' ' 168' ' ' SER . 6.6 tt0 -92.23 49.64 1.54 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.146 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -151.19 -63.51 0.19 Allowed 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.744 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -70.2 -54.07 14.39 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.326 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.558 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -30.82 -69.34 0.07 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.012 -179.99 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.713 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 21.2 mp0 -54.92 -59.29 4.94 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.173 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.42 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 12.3 mpt_? -74.73 19.54 0.14 Allowed 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.71 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.543 ' N ' ' O ' ' A' ' 117' ' ' GLU . 16.1 t80 -121.22 -15.4 8.17 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.881 -0.727 . . . . 0.0 110.773 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.07 -37.19 0.05 OUTLIER Glycine 0 N--CA 1.483 1.817 0 C-N-CA 118.928 -1.606 . . . . 0.0 110.337 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.473 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -146.01 -112.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.527 -179.843 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -151.98 -147.3 0.22 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.275 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.738 HD22 ' N ' ' A' ' 126' ' ' ASN . 0.2 OUTLIER -73.81 -108.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.52 179.935 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.738 ' N ' HD22 ' A' ' 125' ' ' ASN . 23.7 t-20 -80.2 55.17 2.13 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.074 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.601 ' O ' HG22 ' A' ' 127' ' ' THR . 18.7 m -100.58 4.58 43.53 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.482 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.42 HG12 ' H ' ' A' ' 128' ' ' ILE . 2.3 mm -76.73 161.81 4.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.665 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 99' ' ' GLU . 2.4 t -161.91 -47.98 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.1 m -137.34 134.98 36.63 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.149 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.42 HG13 ' CD1' ' A' ' 95' ' ' PHE . 3.0 t -120.7 145.31 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.572 0.701 . . . . 0.0 111.855 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -146.18 93.56 5.06 Favored Pre-proline 0 C--N 1.296 -1.753 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.986 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -59.15 105.71 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.164 1.243 . . . . 0.0 111.877 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.572 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 8.2 tt0 -56.52 -9.52 0.75 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.568 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.44 -41.93 0.08 OUTLIER Glycine 0 N--CA 1.494 2.536 0 C-N-CA 118.49 -1.814 . . . . 0.0 111.933 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.442 HD21 ' HG2' ' A' ' 91' ' ' PRO . 4.9 mt -88.05 -167.12 1.78 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.105 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -115.79 142.64 46.5 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 153' ' ' VAL . 53.6 t -107.75 144.91 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.696 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 88.1 t -132.62 120.61 42.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.033 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.8 mp -97.84 139.33 33.85 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.343 -179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.427 ' CD2' ' HB3' ' A' ' 146' ' ' PHE . 29.4 m-85 -115.48 129.23 56.48 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.689 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.455 ' HE3' ' H ' ' A' ' 149' ' ' ASP . 19.5 ttpp -61.44 -75.02 0.07 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.653 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -76.22 167.98 20.88 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.259 -0.977 . . . . 0.0 110.513 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 146' ' ' PHE . 1.4 p30 -63.48 -158.43 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.59 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.643 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 0.4 OUTLIER 39.33 26.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.248 179.953 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.643 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 41.87 57.89 3.02 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.343 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.0 t -136.45 -172.93 3.27 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.028 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.48 -161.94 53.49 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.169 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.455 ' H ' ' HE3' ' A' ' 142' ' ' LYS . 5.9 t70 -59.77 156.31 14.27 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.104 179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.5 p -148.16 170.39 17.95 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.476 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.7 mt -137.93 82.56 25.32 Favored Pre-proline 0 C--N 1.303 -1.419 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.463 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -62.13 103.93 0.32 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.848 1.699 . . . . 0.0 112.231 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 138' ' ' VAL . 3.1 t -89.34 74.1 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.883 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -79.22 36.29 0.29 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.001 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.6 t -170.97 -155.85 0.11 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.328 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.2 155.89 19.91 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.136 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.97 69.51 1.38 Allowed Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.526 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.4 Cg_endo -66.44 23.84 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.075 1.85 . . . . 0.0 111.313 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.597 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.3 t -168.76 134.34 1.7 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.412 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 129' ' ' SER . 0.2 OUTLIER -141.74 -55.57 0.46 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.949 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.939 0 C-N-CA 119.106 -1.521 . . . . 0.0 110.154 -179.988 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.45 125.61 51.22 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.838 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.47 ' OG ' ' CG ' ' A' ' 115' ' ' GLN . 36.8 t -91.15 -62.03 1.53 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.223 -0.991 . . . . 0.0 112.09 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.49 161.0 19.78 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.819 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.406 HG12 ' CD1' ' A' ' 118' ' ' LEU . 45.7 pt -143.16 174.64 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.729 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.5 ttt85 -160.66 114.25 2.08 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.492 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 11.7 mt -86.87 101.41 11.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.466 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.5 t . . . . . 0 C--N 1.306 -1.307 0 CA-C-O 116.284 -1.817 . . . . 0.0 110.874 179.949 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.423 ' C ' ' ND2' ' A' ' 3' ' ' ASN . . . . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.812 0.339 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.423 ' ND2' ' C ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER 179.83 125.89 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.683 179.969 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 pt -82.04 128.02 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.06 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -105.69 112.25 25.25 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.2 m -90.11 169.5 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 119.591 -0.844 . . . . 0.0 113.206 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -129.14 141.61 51.13 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.407 -1.27 . . . . 0.0 108.196 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.17 -21.72 58.55 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -123.95 169.73 11.32 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.028 -1.069 . . . . 0.0 112.477 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 11' ' ' ASP . 25.4 tt0 -67.21 173.77 3.64 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.888 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.558 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 14.5 m-20 52.01 58.2 5.69 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.774 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.563 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 7.3 p90 33.59 28.69 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.506 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 11' ' ' ASP . 8.7 tp-100 -106.55 168.44 9.17 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.92 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.52 ' H ' ' CD ' ' A' ' 13' ' ' GLN . . . 93.94 136.81 8.26 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.995 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -30.54 140.82 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 O-C-N 123.922 0.425 . . . . 0.0 111.712 -179.931 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 1.203 ' CD ' ' OE1' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -100.52 151.71 21.26 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.498 -0.881 . . . . 0.0 113.17 -179.802 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -135.9 142.99 37.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.822 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -107.79 133.71 51.79 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.659 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 mt -129.3 126.81 23.08 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.982 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -67.91 163.59 35.0 Favored 'Trans proline' 0 C--N 1.327 -0.599 0 C-N-CA 120.629 0.886 . . . . 0.0 110.961 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.05 -162.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.493 1.462 . . . . 0.0 111.06 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.23 172.94 37.11 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.073 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.633 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.9 OUTLIER -106.12 133.9 50.09 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.564 -179.947 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -155.24 177.12 11.71 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.394 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 p -137.88 -159.78 0.99 Allowed 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.85 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.86 -20.78 66.07 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.614 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -62.97 -58.9 5.78 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.216 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.489 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 28.6 tp60 -56.67 -45.2 81.84 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.007 -1.077 . . . . 0.0 109.738 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.64 HD23 HD12 ' A' ' 32' ' ' LEU . 13.7 mt -58.73 -39.09 79.88 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.567 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -53.15 -32.66 48.8 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.853 -1.139 . . . . 0.0 108.589 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -69.1 -42.31 76.3 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.095 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.64 HD12 HD23 ' A' ' 29' ' ' LEU . 10.3 mt -69.93 -71.39 0.24 Allowed 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.666 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.64 -34.67 0.81 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.117 -1.516 . . . . 0.0 110.923 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 34' ' ' ILE . 12.5 tt -83.32 141.62 14.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.27 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 175.82 154.96 0.19 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.031 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.1 t30 60.76 104.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.643 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.471 ' H ' HG22 ' A' ' 79' ' ' VAL . 66.5 t30 51.23 69.99 0.59 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.586 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 40' ' ' SER . 77.9 p -146.57 -32.23 0.33 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.339 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 40' ' ' SER . 8.9 mt -78.09 42.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.516 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 38' ' ' THR . 32.6 t -38.78 -53.73 1.65 Allowed 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.026 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.59 163.98 29.88 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.211 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.964 HG22 ' HB3' ' A' ' 69' ' ' ALA . 20.1 m -143.89 171.66 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 118.502 -1.279 . . . . 0.0 113.444 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -142.23 95.06 2.74 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.559 -1.655 . . . . 0.0 107.461 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 51.8 t -115.63 110.25 44.82 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -70.28 169.64 19.1 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.065 1.177 . . . . 0.0 110.311 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.85 -170.28 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.715 1.61 . . . . 0.0 111.207 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.86 -15.34 15.6 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.392 -1.385 . . . . 0.0 111.016 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -152.97 148.48 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.414 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -123.8 128.67 49.87 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.137 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.77 165.06 11.84 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.83 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.675 HG23 ' O ' ' A' ' 63' ' ' ILE . 66.7 mt -138.73 125.09 24.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.661 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.17 122.65 42.66 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.647 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -109.78 119.55 39.72 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.318 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -54.76 -77.01 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.144 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -62.28 156.16 22.94 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.0 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 19.2 p-10 -68.1 174.53 3.78 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.623 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.422 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 62.13 31.31 78.43 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.236 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.48 ' H ' ' CB ' ' A' ' 81' ' ' SER . 0.2 OUTLIER 54.2 67.18 1.05 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.619 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.42 -170.53 3.47 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.332 -0.947 . . . . 0.0 111.195 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 67.43 174.52 7.28 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.377 -1.392 . . . . 0.0 109.858 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 60' ' ' GLY . 13.4 m-20 -42.98 118.67 1.32 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.136 -1.026 . . . . 0.0 110.33 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.412 ' CD ' ' H ' ' A' ' 62' ' ' GLN . 0.1 OUTLIER -91.36 160.8 15.3 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.259 -0.977 . . . . 0.0 111.33 -179.887 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.675 ' O ' HG23 ' A' ' 51' ' ' ILE . 7.2 mm -137.53 168.63 20.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.353 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.67 ' N ' HG22 ' A' ' 63' ' ' ILE . 20.2 mp0 -147.96 134.19 19.45 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.306 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.7 m -149.76 147.5 16.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 118.676 -1.21 . . . . 0.0 112.252 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 48' ' ' VAL . 2.0 t -140.77 -0.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.49 -153.85 0.59 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.686 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -93.49 144.05 25.72 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.437 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.964 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -111.17 108.98 18.83 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.732 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -78.29 -63.34 1.42 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.401 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -100.45 4.43 43.73 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.259 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 tp 46.18 -98.93 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.097 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -168.95 -177.24 39.63 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 118.778 -1.677 . . . . 0.0 110.842 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.583 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.0 OUTLIER -67.16 -46.02 3.4 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.169 1.913 . . . . 0.0 112.055 -179.983 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.728 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.4 pt? -56.72 3.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.403 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.643 HD22 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -65.04 5.79 0.31 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.403 179.945 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.643 ' N ' HD22 ' A' ' 76' ' ' ASN . 26.3 t30 -86.92 -11.01 51.93 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.725 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -166.15 98.94 0.63 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.665 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.471 HG22 ' H ' ' A' ' 37' ' ' ASN . 18.9 m -97.09 171.0 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.582 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.1 t -171.31 -69.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 118.348 -1.341 . . . . 0.0 112.901 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.48 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 4.4 m -96.99 148.64 22.77 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.72 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.68 153.05 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.311 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.809 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -145.91 140.42 26.96 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.753 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.809 ' CA ' HH12 ' A' ' 83' ' ' ARG . 10.1 t -138.82 140.45 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.99 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.549 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 2.8 mt -136.99 125.61 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.57 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -50.12 126.85 15.52 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.579 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.696 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -114.97 145.32 33.79 Favored Pre-proline 0 N--CA 1.49 1.545 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.302 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.696 ' HD2' HG22 ' A' ' 87' ' ' VAL . 5.8 Cg_exo -52.61 120.29 7.26 Favored 'Trans proline' 0 C--N 1.326 -0.618 0 C-N-CA 121.356 1.37 . . . . 0.0 111.354 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 89' ' ' VAL . 7.1 p -45.47 130.59 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.841 -179.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -139.35 150.21 63.28 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.394 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.438 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 1.7 Cg_endo -59.13 -166.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.106 1.204 . . . . 0.0 111.102 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.89 -157.56 0.1 Allowed 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.049 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.68 162.08 36.24 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.156 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -129.99 117.43 20.05 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.043 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 10.5 m-85 -102.85 131.11 49.97 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.116 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -99.42 159.99 14.61 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.848 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.524 ' CZ ' HG21 ' A' ' 127' ' ' THR . 1.0 OUTLIER -97.43 158.68 15.35 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.629 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt 62.47 138.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.815 0.816 . . . . 0.0 111.514 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.588 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 10.6 tp10 -71.12 102.44 2.49 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.605 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.854 ' NE2' ' HB2' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 129.67 39.25 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.467 0 O-C-N 125.286 1.616 . . . . 0.0 109.654 179.766 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.65 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 28.5 p90 33.96 48.33 0.23 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.124 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.854 ' HB2' ' NE2' ' A' ' 100' ' ' GLN . 53.5 t0 -124.36 57.58 1.23 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.472 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -177.01 156.42 20.39 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.902 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.487 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -28.81 139.9 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.827 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -94.67 154.5 17.3 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.902 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.636 HG21 ' O ' ' A' ' 122' ' ' GLY . 2.5 t -140.31 165.67 20.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.888 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.553 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 17.7 p-10 -149.24 159.37 44.32 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.759 -1.176 . . . . 0.0 111.651 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.4 mt -142.07 149.08 51.07 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 119.639 -0.825 . . . . 0.0 111.23 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.41 165.93 24.79 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.044 1.829 . . . . 0.0 111.661 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.36 142.9 67.96 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.566 1.511 . . . . 0.0 110.687 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.422 ' C ' ' NE2' ' A' ' 112' ' ' GLN . . . 144.75 -158.72 27.66 Favored Glycine 0 N--CA 1.502 3.063 0 C-N-CA 118.787 -1.673 . . . . 0.0 111.711 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.541 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 11.2 mp0 -116.77 153.4 32.49 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.759 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 50.8 m-85 -145.84 146.68 31.22 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.633 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.9 p -89.47 -147.93 0.18 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.435 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.779 ' CD ' ' H ' ' A' ' 115' ' ' GLN . 0.3 OUTLIER -116.06 27.35 9.32 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.783 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.47 ' HB2' HE21 ' A' ' 115' ' ' GLN . . . -129.54 -64.56 0.88 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.762 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.495 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 8.1 pt-20 -68.67 -42.64 77.61 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.42 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.569 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -38.04 -72.65 0.06 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.77 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.438 ' HB3' ' C ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -52.55 -54.41 33.16 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.168 -179.969 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -72.93 16.66 0.14 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.432 -179.791 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 117' ' ' GLU . 13.9 t80 -124.49 -17.9 5.88 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.912 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.636 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -133.91 -49.75 0.08 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.114 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.533 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -144.99 -99.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.628 -179.934 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.533 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 13.3 t70 -168.73 177.69 4.99 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.172 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.638 HD22 ' N ' ' A' ' 126' ' ' ASN . 0.5 OUTLIER -59.15 135.14 57.54 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.701 -179.84 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.638 ' N ' HD22 ' A' ' 125' ' ' ASN . 5.7 p-10 35.85 81.28 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.812 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.524 HG21 ' CZ ' ' A' ' 97' ' ' TYR . 97.9 m -161.56 -11.0 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.394 -0.923 . . . . 0.0 111.012 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.477 ' CG2' HG22 ' A' ' 131' ' ' VAL . 1.5 mp -53.84 -56.32 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.256 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.9 m 55.35 -113.63 0.8 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.682 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.2 m -63.06 122.42 16.03 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.93 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.477 HG22 ' CG2' ' A' ' 128' ' ' ILE . 1.8 t -120.76 159.76 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.427 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -153.15 85.46 4.24 Favored Pre-proline 0 C--N 1.301 -1.518 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -62.42 97.06 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.416 1.41 . . . . 0.0 110.723 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -81.83 22.4 0.76 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.35 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.8 -54.44 0.04 OUTLIER Glycine 0 N--CA 1.498 2.778 0 C-N-CA 118.042 -2.027 . . . . 0.0 112.38 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.438 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 1.3 mp -115.87 -172.07 2.09 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.002 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.75 143.11 31.31 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.652 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.6 t -110.0 139.09 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.765 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.587 ' C ' HD12 ' A' ' 140' ' ' LEU . 59.6 t -125.97 138.02 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.036 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.587 HD12 ' C ' ' A' ' 139' ' ' VAL . 9.3 mp -112.26 134.5 53.76 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.926 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 141' ' ' PHE . 7.2 m-85 -115.0 131.92 56.77 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.78 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -64.21 -79.16 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.028 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -60.35 160.66 8.3 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.357 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 146' ' ' PHE . 10.0 m-20 -63.9 -156.19 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.554 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.686 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 6.3 t-20 41.13 24.44 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.017 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.686 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.1 OUTLIER 44.08 59.82 3.03 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.822 -179.946 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.6 t -141.83 -174.49 4.09 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.358 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.91 -163.22 54.2 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.591 -1.29 . . . . 0.0 110.025 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -59.81 160.47 7.52 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.952 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.0 p -150.34 174.73 12.54 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.809 -179.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.5 tp -141.78 89.45 9.04 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.53 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.21 106.27 0.8 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 121.699 1.599 . . . . 0.0 113.23 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.98 92.42 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.537 179.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -55.79 -34.57 65.41 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.8 t -164.15 -149.82 0.14 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 117.907 -1.517 . . . . 0.0 112.665 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -43.72 146.51 0.54 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.31 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -172.45 69.15 0.41 Allowed Pre-proline 0 C--N 1.307 -1.244 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.343 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.442 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.2 Cg_endo -64.9 23.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.197 1.931 . . . . 0.0 112.481 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.569 ' O ' HG23 ' A' ' 159' ' ' THR . 0.8 OUTLIER -177.72 102.3 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.139 179.967 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.498 ' CD2' ' N ' ' A' ' 160' ' ' LEU . 3.7 mm? -99.37 -56.42 2.41 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.705 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 C-N-CA 119.375 -1.393 . . . . 0.0 110.53 -179.996 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.834 0.35 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.528 ' OG1' HD23 ' A' ' 140' ' ' LEU . 1.5 m -86.31 107.84 18.15 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.826 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 27.5 m -95.33 -53.16 3.87 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.172 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.54 160.91 21.51 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.032 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.414 HG12 ' CD1' ' A' ' 118' ' ' LEU . 31.4 pt -138.96 166.51 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -148.75 103.36 3.37 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.591 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.0 mt -81.17 97.55 3.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 118.978 -1.089 . . . . 0.0 109.347 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 C--N 1.305 -1.343 0 CA-C-O 116.324 -1.798 . . . . 0.0 111.026 -179.993 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.8 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 121.014 0.435 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.42 ' ND2' ' C ' ' A' ' 2' ' ' ALA . 31.3 m-80 -159.28 125.62 4.48 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.156 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.501 HG22 HG22 ' A' ' 44' ' ' VAL . 7.0 pt -72.01 155.17 7.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.513 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -134.0 156.5 48.08 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.067 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 m -147.26 171.41 3.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 119.086 -1.045 . . . . 0.0 111.062 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -131.97 156.15 46.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.744 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -72.17 -51.6 20.52 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -179.525 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.713 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 73.2 m-80 -87.22 179.23 6.67 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.842 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -80.31 166.05 21.71 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.189 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.471 ' C ' ' H ' ' A' ' 13' ' ' GLN . 3.7 t0 66.15 45.35 2.36 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.782 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER 56.71 0.7 0.07 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.128 -1.029 . . . . 0.0 112.075 179.893 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 11' ' ' ASP . 6.9 tt0 -87.97 162.96 16.57 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.199 -1.0 . . . . 0.0 112.287 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.713 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 98.06 147.67 22.62 Favored Glycine 0 N--CA 1.503 3.107 0 C-N-CA 120.259 -0.972 . . . . 0.0 110.926 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 14' ' ' GLY . 3.7 mptp? -29.26 139.0 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 O-C-N 123.956 0.445 . . . . 0.0 112.137 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 1.026 ' H ' ' NE2' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -103.92 160.19 15.02 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.459 -179.775 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.613 ' CG1' ' N ' ' A' ' 18' ' ' ASP . 6.9 t -147.53 165.69 5.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.62 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.613 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 14.9 t70 -135.49 124.6 24.41 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.268 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mt -122.85 129.92 24.82 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.017 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -67.35 165.31 27.38 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.123 1.216 . . . . 0.0 111.317 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.99 -165.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 121.542 1.494 . . . . 0.0 110.289 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.53 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 94.95 -175.22 33.57 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 118.836 -1.649 . . . . 0.0 111.176 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.809 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.2 OUTLIER -113.2 134.02 54.78 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.153 -179.795 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.565 ' CE2' HD12 ' A' ' 82' ' ' ILE . 3.4 p90 -154.54 175.89 13.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.673 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.475 HG22 ' OG ' ' A' ' 81' ' ' SER . 7.0 p -146.82 -155.43 0.62 Allowed 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.984 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -60.33 -20.92 61.22 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.692 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.96 -63.11 1.16 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.474 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.508 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 15.7 tt0 -56.02 -46.73 78.71 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.486 -1.286 . . . . 0.0 109.805 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.586 HD23 HD12 ' A' ' 32' ' ' LEU . 22.9 mt -59.4 -38.95 81.89 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.539 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.57 -26.92 56.57 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 118.328 -1.349 . . . . 0.0 108.419 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -75.41 -37.95 60.16 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.739 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.586 HD12 HD23 ' A' ' 29' ' ' LEU . 14.4 mt -73.34 -74.97 0.16 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.525 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.29 -32.82 0.65 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.248 -1.454 . . . . 0.0 110.692 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 34' ' ' ILE . 7.8 tt -85.26 139.42 17.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.59 ' H ' HG21 ' A' ' 38' ' ' THR . 3.4 pt-20 174.24 142.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.195 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.596 ' ND2' ' ND2' ' A' ' 78' ' ' ASN . 1.7 t-20 75.57 116.31 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 47.14 9.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.735 179.74 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.59 HG21 ' H ' ' A' ' 35' ' ' GLU . 71.4 p -83.35 -57.67 3.16 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 117.941 -1.503 . . . . 0.0 111.206 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.417 ' N ' ' OG1' ' A' ' 38' ' ' THR . 30.2 mt -57.92 78.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.23 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 38' ' ' THR . 13.7 t -77.79 -48.3 16.89 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.562 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.409 ' CB ' ' H ' ' A' ' 12' ' ' PHE . 42.7 t -126.87 132.02 51.04 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.58 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -105.54 158.8 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 C-N-CA 119.492 -0.883 . . . . 0.0 113.052 -179.742 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.411 ' N ' HG13 ' A' ' 42' ' ' VAL . 33.4 tttp -143.38 98.43 3.25 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.788 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.501 HG22 HG22 ' A' ' 4' ' ' ILE . 93.1 t -121.78 109.37 34.19 Favored Pre-proline 0 N--CA 1.496 1.842 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.318 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -69.07 168.43 20.69 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 120.989 1.126 . . . . 0.0 110.898 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.42 -175.7 0.15 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 121.818 1.678 . . . . 0.0 111.097 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.69 -14.54 17.98 Favored Glycine 0 N--CA 1.481 1.688 0 C-N-CA 119.178 -1.487 . . . . 0.0 110.295 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.8 HG11 ' HB3' ' A' ' 2' ' ' ALA . 15.5 m -149.28 135.42 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.685 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.414 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 37.4 tttm -110.32 156.2 21.06 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.249 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -149.7 158.62 44.34 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 118.139 -1.424 . . . . 0.0 112.916 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.687 HG23 ' O ' ' A' ' 63' ' ' ILE . 78.4 mt -133.19 123.05 46.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 114.317 -1.311 . . . . 0.0 108.846 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.542 HD12 ' H ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -100.37 138.97 36.71 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.725 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.45 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 49.2 m-85 -113.73 114.05 25.82 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.712 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -46.72 -83.1 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.721 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -59.23 141.96 53.01 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.272 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -53.65 178.0 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.271 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.671 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 59.08 37.74 92.07 Favored Glycine 0 N--CA 1.487 2.049 0 C-N-CA 118.95 -1.595 . . . . 0.0 109.69 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.671 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.3 OUTLIER 41.08 70.52 0.25 Allowed 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.987 -179.943 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.05 -162.67 1.61 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.11 -178.03 5.14 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.325 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -49.46 123.79 8.23 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.45 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 62' ' ' GLN . 16.7 pt20 -95.54 158.3 15.51 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.101 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.687 ' O ' HG23 ' A' ' 51' ' ' ILE . 7.7 mm -133.42 168.38 24.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.766 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.679 ' N ' HG22 ' A' ' 63' ' ' ILE . 20.2 mt-10 -146.4 135.02 22.17 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.986 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.5 m -150.09 161.12 4.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.687 -1.205 . . . . 0.0 112.103 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 t -147.55 -3.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 114.402 -1.272 . . . . 0.0 107.799 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -131.31 -152.13 0.49 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.024 -1.443 . . . . 0.0 109.188 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -90.94 121.0 32.4 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.544 179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.58 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.01 81.22 6.87 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.51 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -45.56 -69.48 0.13 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.594 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.67 -3.47 56.27 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.606 -0.837 . . . . 0.0 111.868 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tp 60.74 -93.61 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.164 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.76 -174.61 44.25 Favored Glycine 0 N--CA 1.491 2.367 0 C-N-CA 118.915 -1.612 . . . . 0.0 110.628 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.543 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.9 Cg_endo -65.27 -29.81 54.73 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.18 1.92 . . . . 0.0 112.092 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.631 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -65.41 13.25 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.219 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.543 ' H ' ' C ' ' A' ' 74' ' ' PRO . 3.6 t-20 -60.25 -2.12 0.42 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.071 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.518 ' H ' ' C ' ' A' ' 75' ' ' LEU . 9.6 t-20 -77.35 -24.17 50.76 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.852 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.66 HD22 ' N ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -171.45 133.3 0.81 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.303 -179.99 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.66 ' N ' HD22 ' A' ' 78' ' ' ASN . 5.9 t -127.86 157.47 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.332 179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.6 m -165.68 -61.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 117.915 -1.514 . . . . 0.0 114.136 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.62 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 11.7 m -93.92 148.24 22.34 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.027 -1.069 . . . . 0.0 112.88 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.565 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -148.57 158.64 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.858 179.971 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.802 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -139.29 120.18 14.42 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.519 -179.887 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.802 ' H ' HH12 ' A' ' 83' ' ' ARG . 3.1 t -119.4 133.79 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.706 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.783 HD11 HH21 ' A' ' 83' ' ' ARG . 3.2 mp -135.88 121.32 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.886 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.6 m -40.63 151.82 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.623 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -147.76 149.33 33.18 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.681 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -52.81 160.53 3.91 Favored 'Trans proline' 0 C--N 1.326 -0.643 0 C-N-CA 121.296 1.331 . . . . 0.0 111.672 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.0 137.81 21.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.701 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -146.11 131.67 9.3 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.657 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -59.84 -156.42 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.85 0 C-N-CA 121.245 1.297 . . . . 0.0 110.715 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.491 ' HE ' ' HB2' ' A' ' 107' ' ' ASP . 5.7 ptm180 -174.36 -157.96 0.08 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.044 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.549 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.5 168.06 20.74 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.854 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.49 ' HE ' ' CB ' ' A' ' 105' ' ' GLU . 38.5 ttt180 -129.13 128.6 43.79 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.954 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.518 ' CD2' HG13 ' A' ' 131' ' ' VAL . 71.8 m-85 -120.44 134.12 55.32 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.2 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.555 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 66.9 m-85 -89.43 175.21 7.4 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.969 -1.092 . . . . 0.0 111.237 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.72 -28.87 51.0 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 118.772 -1.171 . . . . 0.0 113.032 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -156.79 -178.82 7.64 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 117.363 -1.735 . . . . 0.0 113.585 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.613 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -62.61 108.1 1.08 Allowed 'General case' 0 C--O 1.202 -1.425 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.857 -179.83 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 1.321 ' NE2' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 121.97 41.33 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.434 0 O-C-N 125.081 1.488 . . . . 0.0 109.881 179.802 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 1.321 ' CD1' ' NE2' ' A' ' 100' ' ' GLN . 37.2 p90 30.32 34.51 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.878 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 100' ' ' GLN . 21.3 t70 -106.54 169.61 8.42 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.338 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 77.2 136.68 0.82 Allowed Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.203 -1.475 . . . . 0.0 109.727 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.47 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.7 OUTLIER -29.1 136.94 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.236 0.541 . . . . 0.0 112.097 -179.778 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.597 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 1.4 pm0 -93.31 164.28 13.28 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.619 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 107' ' ' ASP . 3.9 t -140.04 167.83 18.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.691 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.557 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 2.8 p30 -148.16 159.28 44.11 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.346 -1.342 . . . . 0.0 111.81 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.8 mt -141.49 149.55 54.66 Favored Pre-proline 0 N--CA 1.495 1.776 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -76.99 166.34 26.93 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 121.763 1.642 . . . . 0.0 111.422 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.33 140.8 78.83 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 121.7 1.6 . . . . 0.0 110.928 179.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 145.52 -164.08 28.12 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 118.927 -1.606 . . . . 0.0 111.36 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.586 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 33.4 tt0 -115.99 157.25 24.88 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.211 -0.494 . . . . 0.0 110.783 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.586 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 53.8 m-85 -146.08 153.85 41.18 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.9 p -98.71 -159.62 0.75 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.412 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.91 54.3 0.68 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.211 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.55 -67.43 0.13 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.346 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 121' ' ' TYR . 4.8 pt-20 -67.33 -50.05 61.6 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.359 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.498 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -36.23 -57.41 0.72 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.859 179.784 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 51.9 mt-10 -53.15 -66.52 0.37 Allowed 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.171 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.453 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 14.8 mmm-85 -73.66 7.23 2.56 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.641 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.547 ' N ' ' O ' ' A' ' 117' ' ' GLU . 15.0 t80 -99.95 -17.65 17.46 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.203 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.646 ' C ' HD13 ' A' ' 123' ' ' ILE . . . -163.62 -28.32 0.02 OUTLIER Glycine 0 N--CA 1.484 1.841 0 C-N-CA 117.771 -2.156 . . . . 0.0 112.107 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.646 HD13 ' C ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -135.83 -101.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.362 -179.848 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.597 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 25.2 t70 -173.28 -163.97 0.21 Allowed 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.663 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.597 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 1.5 t30 -72.17 -22.36 61.31 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.125 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -170.21 89.95 0.17 Allowed 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.8 t -168.05 14.05 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.968 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 128' ' ' ILE . 4.6 mt -68.98 -70.66 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.508 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 69.9 -135.01 0.06 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.819 -0.752 . . . . 0.0 112.338 179.881 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.421 ' CB ' ' H ' ' A' ' 101' ' ' PHE . 16.2 m -45.29 128.36 7.65 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.7 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.518 HG13 ' CD2' ' A' ' 95' ' ' PHE . 5.5 t -121.67 160.35 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.183 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.413 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -154.91 89.55 3.12 Favored Pre-proline 0 C--N 1.29 -1.981 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.784 179.913 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.22 121.54 10.09 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.091 1.194 . . . . 0.0 110.608 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.549 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 29.0 tt0 -90.96 -8.67 48.6 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.183 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.8 -32.68 0.02 OUTLIER Glycine 0 N--CA 1.494 2.502 0 C-N-CA 118.026 -2.035 . . . . 0.0 112.476 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.28 156.93 28.0 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.904 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.98 145.36 42.6 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.007 -1.077 . . . . 0.0 109.214 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.4 t -112.42 148.61 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.021 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.2 t -137.36 118.53 17.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.02 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 140' ' ' LEU . 11.2 mp -98.94 142.42 30.46 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.883 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.489 ' CB ' ' HA ' ' A' ' 146' ' ' PHE . 63.9 m-85 -120.02 134.46 55.24 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.402 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -65.88 -68.53 0.36 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.08 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -78.34 169.3 18.48 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.392 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 146' ' ' PHE . 11.1 p-10 -64.34 -160.99 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.014 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.645 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 5.8 m120 42.66 21.03 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.938 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.645 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.4 OUTLIER 40.77 58.65 2.38 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.677 -179.91 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.6 t -148.09 149.32 31.83 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.335 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 108.43 -146.67 16.5 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -65.36 105.02 1.05 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.171 -1.011 . . . . 0.0 110.204 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.0 p -103.18 168.93 8.86 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.781 -0.767 . . . . 0.0 111.826 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 tt -139.37 81.14 21.09 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.139 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.24 108.37 0.58 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.961 1.774 . . . . 0.0 112.968 -179.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.7 87.25 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.294 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -58.33 -21.97 51.53 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.886 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 12.9 t -168.9 -141.59 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 117.979 -1.489 . . . . 0.0 112.895 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.8 OUTLIER -57.66 141.19 49.18 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.159 -179.811 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.55 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -162.24 61.12 1.17 Allowed Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.294 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.5 Cg_endo -65.31 19.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 122.222 1.948 . . . . 0.0 112.856 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.685 ' O ' HG23 ' A' ' 159' ' ' THR . 4.7 t -169.12 101.92 0.37 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.385 -1.326 . . . . 0.0 111.867 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 160' ' ' LEU . 94.5 mt -128.03 -48.9 1.34 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.646 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.316 179.901 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.981 0.419 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.451 ' OG1' HD23 ' A' ' 140' ' ' LEU . 1.8 m -82.39 114.96 21.19 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.446 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 36.1 t -86.86 -47.51 8.97 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.104 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.19 165.96 23.89 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.152 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 38.1 pt -145.93 167.07 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 118.652 -1.219 . . . . 0.0 111.463 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -149.42 109.74 4.18 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.02 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mt -88.18 96.81 6.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.095 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 116.304 -1.808 . . . . 0.0 110.931 -179.973 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.611 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 120.882 0.372 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.8 120.76 0.06 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.496 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.6 pt -67.72 146.73 12.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 118.723 -1.191 . . . . 0.0 110.263 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.9 m -123.96 117.57 25.09 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.186 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.492 ' O ' ' CB ' ' A' ' 16' ' ' GLN . 1.2 m -92.1 174.18 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.434 -0.906 . . . . 0.0 111.167 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 61.1 m-85 -135.98 146.67 47.48 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.231 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -75.02 -28.1 60.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.63 -0.828 . . . . 0.0 112.764 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.499 ' C ' ' OG ' ' A' ' 40' ' ' SER . 33.6 m120 -126.76 163.0 24.5 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.451 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.592 ' N ' ' OG ' ' A' ' 40' ' ' SER . 18.9 mm-40 -63.56 -163.57 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.928 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.613 ' C ' ' H ' ' A' ' 13' ' ' GLN . 8.7 m-20 40.5 39.59 0.75 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.852 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER 56.22 -5.86 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.327 179.991 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.613 ' H ' ' C ' ' A' ' 11' ' ' ASP . 21.9 mt-30 -73.84 174.33 8.63 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.296 -0.961 . . . . 0.0 110.745 179.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 86.21 129.87 2.54 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.339 -1.41 . . . . 0.0 111.027 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.9 OUTLIER -37.79 147.93 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.964 179.907 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.911 ' C ' HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -119.91 162.1 19.73 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.724 -0.79 . . . . 0.0 112.286 -179.868 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.07 139.35 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.882 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -94.41 134.47 36.89 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.421 -179.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.9 mt -129.86 126.47 22.53 Favored Pre-proline 0 N--CA 1.496 1.851 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.202 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.21 164.37 28.22 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 121.053 1.169 . . . . 0.0 111.157 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.24 -172.25 0.14 Allowed 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 121.648 1.565 . . . . 0.0 111.14 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.492 ' N ' ' HB ' ' A' ' 84' ' ' VAL . . . 103.65 -166.38 15.88 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.356 179.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.487 ' N ' HD22 ' A' ' 23' ' ' ASN . 0.4 OUTLIER -130.93 132.41 45.07 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.069 -179.978 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -148.12 -177.05 5.53 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.037 -179.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.577 ' CG2' ' CE2' ' A' ' 58' ' ' PHE . 20.3 p -141.26 -159.28 0.94 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.87 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -63.78 -24.23 67.68 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.061 -1.055 . . . . 0.0 110.361 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -61.03 -61.84 2.29 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.555 179.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -55.59 -44.14 76.66 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.543 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.686 HD23 HD12 ' A' ' 32' ' ' LEU . 23.1 mt -61.95 -32.84 73.31 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.789 -1.164 . . . . 0.0 109.633 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -55.8 -31.7 62.88 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 118.601 -1.24 . . . . 0.0 108.231 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.28 -37.28 69.06 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.38 179.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.686 HD12 HD23 ' A' ' 29' ' ' LEU . 15.3 mt -74.98 -77.07 0.13 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.471 179.887 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.09 -28.17 0.72 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.296 -1.43 . . . . 0.0 111.058 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.847 HD13 ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -87.69 133.3 30.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.748 -179.988 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 169.72 174.51 0.05 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.492 -179.905 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 1.5 t-20 70.91 -28.84 0.18 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.117 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.547 ' H ' ' C ' ' A' ' 35' ' ' GLU . 16.1 m120 -160.17 -108.61 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.767 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.658 HG21 HG12 ' A' ' 34' ' ' ILE . 2.6 p 42.71 -134.98 0.4 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.572 179.943 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.921 HD12 HG11 ' A' ' 79' ' ' VAL . 1.9 mt 30.26 49.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.291 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.592 ' OG ' ' N ' ' A' ' 10' ' ' GLU . 44.1 t -61.11 -44.3 97.56 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.598 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.47 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -129.82 170.22 14.16 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.116 179.774 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -148.94 146.73 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 118.596 -1.242 . . . . 0.0 112.255 -179.838 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -136.67 102.59 4.96 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.897 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.4 t -120.98 106.16 39.37 Favored Pre-proline 0 N--CA 1.497 1.898 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.876 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -67.59 169.28 16.16 Favored 'Trans proline' 0 C--N 1.326 -0.633 0 C-N-CA 121.091 1.194 . . . . 0.0 110.458 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.03 -173.7 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.766 1.644 . . . . 0.0 110.683 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.25 -20.62 10.01 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 118.878 -1.629 . . . . 0.0 109.944 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.611 HG11 ' CB ' ' A' ' 2' ' ' ALA . 24.2 m -149.22 145.15 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.892 -179.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.4 tttt -120.97 152.46 38.51 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.604 179.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.92 147.81 30.12 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.896 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 63' ' ' ILE . 84.9 mt -122.88 120.46 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.021 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.007 HD23 HG23 ' A' ' 82' ' ' ILE . 6.5 mt -89.07 154.46 20.17 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.752 -179.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -130.51 111.77 12.58 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.887 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.28 -79.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.032 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.573 ' HB3' ' HB3' ' A' ' 59' ' ' ALA . 18.0 t-20 -59.16 139.06 57.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.089 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.99 170.65 0.17 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.917 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.24 33.16 86.49 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.425 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CE2' ' CG2' ' A' ' 25' ' ' THR . 19.4 m-85 53.74 65.11 1.61 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.931 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.573 ' HB3' ' HB3' ' A' ' 55' ' ' ASN . . . -144.65 -162.63 1.53 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.689 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.4 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 56.04 178.72 0.35 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.274 -1.441 . . . . 0.0 110.002 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -44.77 153.19 0.18 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.897 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -130.17 151.96 50.13 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.014 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.798 HG22 ' N ' ' A' ' 64' ' ' GLU . 51.1 mt -123.65 173.16 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.876 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.798 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -150.09 130.3 13.64 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.03 179.988 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.3 m -148.36 156.59 8.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 118.806 -1.158 . . . . 0.0 112.565 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 t -140.49 -5.7 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.536 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -128.7 -148.33 0.37 Allowed 'General case' 0 C--O 1.209 -1.07 0 CA-C-N 113.822 -1.536 . . . . 0.0 109.228 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.653 HD21 HG13 ' A' ' 106' ' ' VAL . 14.2 p-10 -99.57 120.44 39.66 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.038 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.53 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -90.84 96.44 10.64 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.218 179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -56.01 -86.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.973 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 13.8 mm-40 -67.61 -11.46 58.18 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.915 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 39' ' ' ILE . 4.0 tp 75.54 -84.57 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.724 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.461 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 171.12 -169.48 42.51 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.202 -1.475 . . . . 0.0 110.629 -179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.499 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.0 Cg_endo -66.02 -50.45 1.59 Allowed 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.208 1.938 . . . . 0.0 112.299 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.995 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.9 pt? -72.53 33.45 0.06 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.026 -1.069 . . . . 0.0 111.503 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.499 ' H ' ' C ' ' A' ' 74' ' ' PRO . 1.8 t30 -76.63 -6.01 50.23 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.388 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.511 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 20.7 m120 -95.49 6.46 48.91 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.028 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -158.45 119.51 3.41 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.204 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.921 HG11 HD12 ' A' ' 39' ' ' ILE . 4.1 t -150.17 154.34 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 119.254 -0.979 . . . . 0.0 110.668 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.8 p -174.04 -41.92 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 118.981 -1.088 . . . . 0.0 111.549 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.3 t -99.0 141.49 31.69 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.556 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 1.007 HG23 HD23 ' A' ' 52' ' ' LEU . 13.4 mt -148.6 158.0 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.004 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.762 ' NH1' ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -135.61 135.15 40.01 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.3 -179.876 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.762 ' CA ' ' NH1' ' A' ' 83' ' ' ARG . 11.2 t -139.96 135.8 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.956 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.9 mt -140.08 129.48 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.665 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 53.1 m -43.1 151.94 0.13 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.487 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.409 HG22 ' HD2' ' A' ' 88' ' ' PRO . 1.1 t -151.44 150.22 26.26 Favored Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.647 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD2' HG22 ' A' ' 87' ' ' VAL . 3.4 Cg_exo -58.55 166.24 6.6 Favored 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.166 1.244 . . . . 0.0 111.263 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 89' ' ' VAL . 2.0 p -102.23 145.75 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.845 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -130.53 150.63 76.85 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.458 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.34 -22.18 70.05 Favored 'Trans proline' 0 C--O 1.209 -0.928 0 C-N-CA 121.347 1.365 . . . . 0.0 111.302 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.685 HH11 ' CB ' ' A' ' 107' ' ' ASP . 31.4 ptt180 38.29 -158.77 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.995 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.501 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.46 176.66 9.01 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.848 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -150.29 121.65 7.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.912 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 18.2 m-85 -96.58 170.09 9.45 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.952 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.87 155.92 47.0 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.709 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -88.34 154.84 20.07 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.86 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt 60.08 158.59 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.438 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -90.44 69.82 6.93 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.03 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 1.434 ' NE2' ' CE1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -174.26 34.88 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.417 179.999 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 1.434 ' CE1' ' NE2' ' A' ' 100' ' ' GLN . 42.1 p90 39.82 27.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.188 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 100' ' ' GLN . 32.0 t70 -127.53 117.55 22.29 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.947 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 137.57 140.98 4.14 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.0 OUTLIER -32.73 124.44 0.35 Allowed 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.273 179.987 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.624 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -100.75 158.79 15.7 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.771 -179.875 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.796 HG21 ' O ' ' A' ' 122' ' ' GLY . 18.1 t -118.99 168.32 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.497 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.685 ' CB ' HH11 ' A' ' 92' ' ' ARG . 5.8 p-10 -145.24 143.68 30.38 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.13 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.467 HD22 ' CD2' ' A' ' 121' ' ' TYR . 11.2 mt -140.45 137.34 17.54 Favored Pre-proline 0 N--CA 1.499 1.994 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.944 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.536 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 2.4 Cg_endo -65.68 169.82 12.29 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 C-N-CA 121.522 1.481 . . . . 0.0 111.902 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 1.8 Cg_endo -61.12 142.8 98.05 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.106 1.871 . . . . 0.0 111.468 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.02 -146.6 16.88 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.013 -1.565 . . . . 0.0 111.163 179.881 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.649 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 64.6 mt-30 -137.95 156.36 47.94 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.649 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 10.0 m-85 -145.0 142.97 30.25 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.91 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 114' ' ' THR . 0.7 OUTLIER -94.24 174.03 7.35 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.378 -179.789 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -61.26 -24.05 66.11 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.941 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.3 -45.68 8.89 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.209 -0.996 . . . . 0.0 112.026 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.463 ' O ' ' C ' ' A' ' 118' ' ' LEU . 8.6 tp10 -73.55 -65.21 0.85 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.707 -179.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.563 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -33.9 -68.62 0.11 Allowed 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.015 0.822 . . . . 0.0 110.547 179.961 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.507 ' N ' ' CD ' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -44.7 -68.37 0.2 Allowed 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.798 -179.95 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.524 ' HD3' ' H ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -75.07 20.89 0.13 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.159 -1.016 . . . . 0.0 113.249 -179.426 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.467 ' CD2' HD22 ' A' ' 108' ' ' LEU . 15.8 t80 -114.01 -21.0 10.79 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.952 179.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.796 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -166.46 -6.01 0.03 OUTLIER Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.318 -1.896 . . . . 0.0 110.764 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.475 ' C ' ' CG ' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -149.93 -134.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.605 -179.959 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.475 ' CG ' ' C ' ' A' ' 123' ' ' ILE . 0.7 OUTLIER -159.64 -173.36 4.09 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.615 179.909 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -58.49 109.51 0.8 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.442 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 128' ' ' ILE . 5.1 t-20 63.2 -125.64 0.58 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.905 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 126' ' ' ASN . 10.0 t 39.78 24.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.868 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.491 ' N ' ' O ' ' A' ' 126' ' ' ASN . 3.5 mt -82.21 -71.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.611 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.428 ' OG ' ' C ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 69.91 -147.57 0.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.88 179.819 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 129' ' ' SER . 5.6 m -27.73 127.36 0.07 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.622 -179.862 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.3 t -121.87 136.89 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.843 179.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.28 86.69 29.88 Favored Pre-proline 0 C--N 1.302 -1.483 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.307 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.456 ' C ' ' H ' ' A' ' 135' ' ' GLY . 5.6 Cg_exo -59.0 101.49 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 121.105 1.204 . . . . 0.0 111.093 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.501 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 30.6 tp60 -56.63 -0.16 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.208 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . 172.3 -42.98 0.17 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 118.048 -2.025 . . . . 0.0 112.532 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.42 HD12 ' CA ' ' A' ' 92' ' ' ARG . 2.0 mt -92.2 -173.79 3.54 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.771 -1.171 . . . . 0.0 111.38 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.6 126.8 54.84 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 9.3 t -95.1 145.08 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.191 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.466 HG12 ' CZ ' ' A' ' 141' ' ' PHE . 96.2 t -129.77 110.29 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.13 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 140' ' ' LEU . 7.9 mp -89.29 138.26 31.59 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.376 -0.93 . . . . 0.0 113.03 -179.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' A' ' 146' ' ' PHE . 53.1 m-85 -120.8 136.23 54.95 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.7 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -73.97 0.12 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.278 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -64.42 -174.96 0.14 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.201 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 146' ' ' PHE . 2.0 m-20 -84.77 -168.28 2.14 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.769 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.677 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 44.1 m-80 35.9 31.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.021 179.882 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.677 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.0 OUTLIER 58.47 52.93 6.61 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.46 179.981 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 10.3 t -119.59 171.7 8.19 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.333 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.498 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 73.91 -165.63 54.77 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.214 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.411 ' C ' ' CG2' ' A' ' 150' ' ' THR . 1.0 OUTLIER -59.8 170.54 1.11 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.395 179.947 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.411 ' CG2' ' C ' ' A' ' 149' ' ' ASP . 2.2 p -150.19 158.08 43.78 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.593 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 151' ' ' LEU . 2.1 tt -132.24 83.59 54.91 Favored Pre-proline 0 N--CA 1.483 1.214 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.346 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -63.18 104.42 0.41 Allowed 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 121.717 1.611 . . . . 0.0 112.761 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.33 78.77 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.986 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 154' ' ' ASN . 1.8 p-10 -83.64 27.98 0.59 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.394 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.427 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 19.0 t -170.28 -164.15 0.38 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.972 -1.091 . . . . 0.0 111.199 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.427 ' N ' ' OG ' ' A' ' 155' ' ' SER . 1.3 m-20 -79.94 154.89 27.99 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.15 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -165.1 69.98 1.37 Allowed Pre-proline 0 C--N 1.304 -1.391 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.904 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.8 Cg_endo -64.18 23.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.062 1.841 . . . . 0.0 112.579 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.562 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.3 OUTLIER -170.34 143.82 2.41 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.753 179.98 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.9 tp -163.92 -48.15 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.836 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.541 179.961 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.818 0.342 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.496 ' OG1' HD23 ' A' ' 140' ' ' LEU . 1.2 m -61.63 155.01 23.49 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.583 ' OG ' ' N ' ' A' ' 169' ' ' SER . 24.8 p -136.38 -53.73 0.73 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.164 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.583 ' N ' ' OG ' ' A' ' 168' ' ' SER . 20.7 p -127.58 149.98 49.92 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.213 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.516 HD12 ' CD1' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -140.72 -172.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.658 179.95 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.468 ' N ' HG12 ' A' ' 170' ' ' ILE . 43.7 ttt85 -155.05 106.7 2.65 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.062 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -75.38 94.16 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.008 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.305 -1.345 0 CA-C-O 116.326 -1.797 . . . . 0.0 110.754 -179.974 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.629 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.928 0.394 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.478 ' N ' ' OD1' ' A' ' 3' ' ' ASN . 4.8 p30 -177.99 130.82 0.14 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.493 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.752 HG22 HG22 ' A' ' 44' ' ' VAL . 18.6 pt -78.49 160.01 4.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.909 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.3 m -134.99 119.41 17.93 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.476 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -103.36 172.03 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.975 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -133.4 148.81 51.83 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.726 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -37.07 84.59 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.5 -0.88 . . . . 0.0 112.991 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.454 ' C ' ' OG ' ' A' ' 40' ' ' SER . 2.3 m-20 -121.48 173.73 7.21 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.979 -179.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.446 ' N ' ' OG ' ' A' ' 40' ' ' SER . 15.6 pt-20 -70.35 -173.87 0.76 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.742 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.557 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 4.8 t70 49.64 48.0 22.05 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.655 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.557 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 54.4 p90 40.65 20.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.424 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 11' ' ' ASP . 3.7 tt0 -97.76 166.14 11.62 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.582 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 92.54 141.56 10.53 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.363 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' GLY . 1.1 tptp -33.97 144.66 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.769 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.03 156.42 20.54 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.556 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.2 t -145.04 127.2 9.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.264 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -93.07 125.89 37.89 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.059 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.4 mt -119.21 125.09 27.8 Favored Pre-proline 0 N--CA 1.491 1.58 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.455 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.73 167.24 19.82 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 120.932 1.088 . . . . 0.0 111.098 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.8 170.4 10.14 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 121.636 1.558 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.474 ' H ' ' HB ' ' A' ' 84' ' ' VAL . . . 116.65 170.91 15.71 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 119.728 -1.225 . . . . 0.0 111.054 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.875 ' CB ' ' HE ' ' A' ' 83' ' ' ARG . 1.1 p30 -97.78 128.87 44.72 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.862 ' N ' HH21 ' A' ' 83' ' ' ARG . 27.6 p90 -153.04 178.98 9.11 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.096 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.51 HG22 ' OG ' ' A' ' 81' ' ' SER . 1.5 p -151.1 -159.37 1.02 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.101 -179.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.425 ' H ' ' HB ' ' A' ' 25' ' ' THR . 72.0 ttt180 -57.99 -21.73 46.08 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.675 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.19 -69.48 0.29 Allowed 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.828 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 7.5 tt0 -56.83 -45.31 82.43 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.461 -1.296 . . . . 0.0 109.696 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.579 HD23 HD12 ' A' ' 32' ' ' LEU . 20.0 mt -55.92 -41.62 74.84 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.615 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.47 -31.68 56.24 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 118.128 -1.429 . . . . 0.0 108.49 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -72.27 -30.74 65.12 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.611 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.579 HD12 HD23 ' A' ' 29' ' ' LEU . 15.6 mt -79.54 -77.8 0.17 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.718 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.97 -28.21 0.08 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.127 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.469 ' HB ' HD22 ' A' ' 29' ' ' LEU . 6.9 mm -75.54 152.84 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 119.544 -0.863 . . . . 0.0 110.241 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 4.4 pt-20 -178.93 116.69 0.07 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 118.761 -1.175 . . . . 0.0 112.196 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.849 HD22 HD22 ' A' ' 37' ' ' ASN . 3.0 t30 68.2 -145.94 0.12 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.76 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.849 HD22 HD22 ' A' ' 36' ' ' ASN . 0.7 OUTLIER -49.22 95.55 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.394 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.584 ' O ' ' N ' ' A' ' 40' ' ' SER . 2.2 p -157.78 -61.55 0.09 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.653 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 39' ' ' ILE . 72.5 mt -56.72 79.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.979 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 38' ' ' THR . 43.6 t -81.47 -52.62 7.06 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.661 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.61 168.56 9.9 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.58 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -151.33 159.86 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 118.305 -1.358 . . . . 0.0 112.919 -179.89 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.449 ' N ' HG13 ' A' ' 42' ' ' VAL . 43.2 tttm -150.46 113.16 4.74 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.387 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.752 HG22 HG22 ' A' ' 4' ' ' ILE . 76.1 t -134.03 111.88 12.2 Favored Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 119.525 -0.87 . . . . 0.0 112.619 -179.689 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -69.57 169.97 17.44 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 121.145 1.23 . . . . 0.0 110.696 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.96 -175.12 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 121.989 1.793 . . . . 0.0 111.464 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.86 -14.27 10.93 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.569 -1.301 . . . . 0.0 110.622 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.629 HG11 ' CB ' ' A' ' 2' ' ' ALA . 23.2 m -147.46 139.46 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.156 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.457 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -116.76 155.37 29.03 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.639 179.999 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.457 ' N ' ' HG2' ' A' ' 49' ' ' LYS . . . -144.88 154.8 43.01 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.652 -1.219 . . . . 0.0 112.413 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 63' ' ' ILE . 4.1 mp -132.39 121.35 45.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.84 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.53 ' HA ' HG23 ' A' ' 82' ' ' ILE . 3.5 mp -93.95 154.72 17.53 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 118.936 -1.106 . . . . 0.0 112.536 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.426 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 54.0 m-85 -140.24 116.65 10.69 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -46.61 -88.87 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.904 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -59.59 144.0 48.83 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.178 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -54.21 175.64 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.631 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.435 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 63.96 32.62 84.78 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 119.22 -1.467 . . . . 0.0 109.959 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.573 ' H ' ' CB ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 48.64 35.95 6.96 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.678 -179.938 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.78 -163.29 0.97 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.423 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 56.06 -174.0 1.34 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.027 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 62' ' ' GLN . 18.1 t70 -54.47 174.42 0.06 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.697 -1.201 . . . . 0.0 109.949 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.436 ' N ' ' OD1' ' A' ' 61' ' ' ASP . 20.6 pt20 -147.96 161.86 40.49 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.052 -1.059 . . . . 0.0 111.282 -179.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.558 ' CG1' HD11 ' A' ' 75' ' ' LEU . 3.9 mt -137.05 160.87 36.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.905 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 64' ' ' GLU . 2.6 mp0 -135.53 127.55 29.68 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.281 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.509 HG12 ' CE1' ' A' ' 121' ' ' TYR . 22.9 m -144.83 162.94 13.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 118.737 -1.185 . . . . 0.0 112.787 -179.796 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.437 ' H ' ' H ' ' A' ' 67' ' ' ALA . 2.1 t -150.04 -7.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.011 -1.449 . . . . 0.0 107.642 179.819 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.437 ' H ' ' H ' ' A' ' 66' ' ' VAL . . . -121.29 -146.35 0.37 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.944 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.409 HD22 ' HG3' ' A' ' 43' ' ' LYS . 36.2 t-20 -101.03 134.55 43.86 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.109 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.466 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -114.89 101.82 9.4 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.046 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -65.27 -77.68 0.06 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.792 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -74.56 -9.77 58.9 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.529 -179.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.408 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 6.3 tp 64.98 -79.8 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.065 -179.925 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 172.0 -177.0 44.95 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.111 -1.519 . . . . 0.0 110.626 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.538 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.0 Cg_endo -64.08 -42.44 18.62 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.247 1.965 . . . . 0.0 111.884 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.843 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.0 pt? -70.99 21.51 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.181 -1.007 . . . . 0.0 111.113 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.619 HD22 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -75.79 5.02 6.86 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.652 179.953 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.619 ' N ' HD22 ' A' ' 76' ' ' ASN . 29.9 m-80 -88.85 -2.29 58.52 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.031 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.412 ' C ' ' ND2' ' A' ' 78' ' ' ASN . 0.5 OUTLIER -169.29 128.67 1.03 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.035 -179.998 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.2 t -149.17 143.24 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.35 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.0 m -155.78 -40.93 0.08 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.22 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.573 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 3.4 m -96.16 136.31 36.8 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.132 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.53 HG23 ' HA ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -150.73 134.1 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 118.79 -1.164 . . . . 0.0 112.185 -179.94 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.875 ' HE ' ' CB ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -110.02 120.08 41.32 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.025 179.877 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.474 ' HB ' ' H ' ' A' ' 22' ' ' GLY . 6.7 t -122.17 130.65 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.514 179.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.4 HD13 ' O ' ' A' ' 84' ' ' VAL . 4.6 mm -141.01 130.22 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.665 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 p -48.65 142.1 6.44 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.084 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.597 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -134.47 142.43 42.77 Favored Pre-proline 0 N--CA 1.492 1.638 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.513 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.597 ' HD2' HG22 ' A' ' 87' ' ' VAL . 2.8 Cg_exo -53.62 129.81 35.76 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.133 1.222 . . . . 0.0 110.977 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 p -53.21 134.03 15.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.98 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -140.76 148.45 52.8 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.207 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.422 ' C ' HD11 ' A' ' 136' ' ' LEU . 1.6 Cg_endo -59.92 -167.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.104 1.203 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.412 ' CA ' HD12 ' A' ' 136' ' ' LEU . 24.8 ptt180 -172.88 -155.45 0.08 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.754 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.496 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.15 161.19 38.88 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.232 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -136.2 115.67 12.76 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.149 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 20.0 m-85 -100.29 150.54 22.45 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.897 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.454 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 39.4 m-85 -105.18 170.62 7.77 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.654 -0.819 . . . . 0.0 111.064 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.3 -57.55 2.57 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.919 -1.113 . . . . 0.0 111.988 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -83.06 154.2 24.52 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.377 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.604 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 30.3 tt0 -68.55 104.58 1.98 Allowed 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.03 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.604 ' CB ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 119.18 68.55 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.441 0 O-C-N 125.323 1.64 . . . . 0.0 110.918 179.755 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.556 ' O ' ' CD2' ' A' ' 101' ' ' PHE . 33.2 p90 29.63 55.61 0.14 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.318 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.523 ' CG ' ' N ' ' A' ' 103' ' ' GLY . 4.5 t70 -144.57 170.52 15.91 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.706 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.523 ' N ' ' CG ' ' A' ' 102' ' ' ASP . . . 78.93 145.15 2.94 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 118.886 -1.626 . . . . 0.0 109.881 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 103' ' ' GLY . 5.0 tmtt? -28.76 131.24 0.06 Allowed 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 121.195 0.522 . . . . 0.0 112.106 -179.816 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -95.7 157.34 15.94 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.311 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.765 HG21 ' O ' ' A' ' 122' ' ' GLY . 1.7 t -142.65 150.68 18.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.533 179.875 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 22.3 p-10 -130.9 159.28 37.86 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.806 -179.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.414 HD22 ' CD2' ' A' ' 121' ' ' TYR . 86.2 mt -141.77 151.18 59.22 Favored Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.144 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -78.96 167.37 22.14 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.976 1.784 . . . . 0.0 111.05 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.18 142.97 69.44 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 C-N-CA 121.4 1.4 . . . . 0.0 110.757 179.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.39 -157.23 26.06 Favored Glycine 0 N--CA 1.504 3.202 0 C-N-CA 119.021 -1.561 . . . . 0.0 111.572 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.504 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 11.2 mt-30 -116.12 158.79 22.67 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.141 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.504 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 79.2 m-85 -145.82 143.23 29.52 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.629 179.839 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.1 p -95.91 164.71 12.61 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.807 -179.718 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -58.97 -8.07 1.28 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.719 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.94 -48.68 3.56 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.347 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 118' ' ' LEU . 4.5 tp10 -70.34 -50.27 40.8 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.834 -179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.565 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -40.62 -72.83 0.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.368 -179.916 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -55.95 10.03 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.041 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.443 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.5 OUTLIER -73.81 15.11 0.31 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.54 -179.716 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.509 ' CE1' HG12 ' A' ' 65' ' ' VAL . 16.8 t80 -126.77 -10.36 6.11 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.355 179.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -140.78 -48.49 0.05 OUTLIER Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.208 -1.472 . . . . 0.0 110.218 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.566 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -144.58 -97.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.664 -179.937 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.566 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 3.0 t70 -171.78 175.72 3.86 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -66.28 134.88 53.56 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.31 -179.871 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 52.24 94.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.602 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.7 t -174.01 -12.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.457 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 129' ' ' SER . 4.2 mm -73.53 163.27 4.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.17 -179.886 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.436 ' N ' HG22 ' A' ' 128' ' ' ILE . 29.9 t -169.83 -48.24 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.45 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.474 ' CB ' ' H ' ' A' ' 101' ' ' PHE . 49.7 m -122.93 127.61 49.15 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.044 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.443 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.5 t -120.54 159.63 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.569 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.58 79.31 8.05 Favored Pre-proline 0 C--N 1.296 -1.731 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.746 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -53.21 96.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.215 1.277 . . . . 0.0 110.703 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.496 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 58.2 tp60 -45.91 -23.74 0.32 Allowed 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.54 -1.209 . . . . 0.0 113.064 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.91 -31.88 0.02 OUTLIER Glycine 0 N--CA 1.494 2.515 0 C-N-CA 117.738 -2.172 . . . . 0.0 112.942 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.422 HD11 ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -98.66 179.4 4.69 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.659 -1.216 . . . . 0.0 111.161 -179.895 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -94.93 144.26 25.82 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.042 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 153' ' ' VAL . 7.5 t -115.54 147.97 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.849 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.485 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.3 t -136.53 129.3 45.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.897 179.842 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.485 HD12 ' C ' ' A' ' 139' ' ' VAL . 10.8 mp -105.64 138.7 41.4 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.369 -0.932 . . . . 0.0 113.174 -179.766 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 146' ' ' PHE . 18.0 m-85 -117.39 121.59 41.49 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.778 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -63.44 -68.29 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.165 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -73.2 165.55 24.84 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.376 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 146' ' ' PHE . 16.7 m-20 -64.37 -157.82 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.796 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.643 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 10.9 p-10 32.0 35.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.216 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.643 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 2.0 p90 41.04 61.61 1.69 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.787 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 35.9 t -143.59 -176.22 4.87 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.121 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.531 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 75.87 -163.43 53.4 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.064 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 149' ' ' ASP . 1.4 m-20 -60.08 144.88 48.52 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.314 179.878 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.4 p -141.29 175.42 9.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.159 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.51 ' CD2' HD21 ' A' ' 160' ' ' LEU . 24.8 tp -152.78 95.05 3.08 Favored Pre-proline 0 C--N 1.305 -1.364 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.044 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.87 107.48 1.11 Allowed 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 121.385 1.39 . . . . 0.0 112.075 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 138' ' ' VAL . 47.0 t -79.08 91.28 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.145 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -44.33 -49.2 9.6 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.565 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.5 m -160.15 -133.9 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 118.728 -1.189 . . . . 0.0 111.923 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -48.05 137.61 10.17 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.119 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.536 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.36 63.96 1.13 Allowed Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.238 179.814 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.9 Cg_endo -67.08 24.83 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.126 1.884 . . . . 0.0 111.837 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.536 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.6 t -175.1 132.82 0.31 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.785 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.51 HD21 ' CD2' ' A' ' 151' ' ' LEU . 1.6 tp -165.23 -59.23 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.34 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.139 0 C-N-CA 119.164 -1.493 . . . . 0.0 110.317 -179.979 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.5 t30 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -70.32 119.22 14.17 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.743 -1.183 . . . . 0.0 109.269 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 72.4 m -89.08 -80.02 0.31 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.96 -179.819 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 p -108.87 160.75 15.74 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.225 -179.803 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 27.8 pt -139.67 173.18 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.729 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -152.47 110.16 3.61 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.2 mt -87.47 93.29 4.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.236 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 69.4 m . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 116.363 -1.78 . . . . 0.0 110.963 -179.971 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 121.04 0.447 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -159.98 123.99 3.72 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.429 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.403 HG22 HG22 ' A' ' 44' ' ' VAL . 40.3 pt -76.72 149.24 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.594 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.4 m -136.98 118.28 14.6 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.733 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.485 ' HB ' HG23 ' A' ' 39' ' ' ILE . 1.6 m -109.63 160.59 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.672 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.407 ' CE2' ' CD2' ' A' ' 12' ' ' PHE . 56.0 m-85 -115.98 162.06 17.94 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.304 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -87.44 3.8 45.74 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.483 ' N ' ' HB3' ' A' ' 40' ' ' SER . 15.2 m120 -147.27 168.25 22.22 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.502 -1.279 . . . . 0.0 111.809 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.74 177.14 1.72 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.224 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 13' ' ' GLN . 6.6 t70 56.2 39.56 30.25 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.893 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.574 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER 56.17 -3.43 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.137 179.957 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.596 ' H ' ' C ' ' A' ' 11' ' ' ASP . 7.4 tt0 -80.73 172.66 13.47 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.269 -0.973 . . . . 0.0 111.241 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.583 ' N ' ' CG ' ' A' ' 13' ' ' GLN . . . 100.55 141.93 12.51 Favored Glycine 0 N--CA 1.5 2.94 0 C-N-CA 119.877 -1.154 . . . . 0.0 110.548 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -33.41 140.56 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 120.191 -0.603 . . . . 0.0 111.432 179.96 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.5 157.9 15.93 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.392 -179.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.5 t -148.75 118.5 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.731 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -92.54 132.75 36.57 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.734 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -132.46 137.46 29.96 Favored Pre-proline 0 N--CA 1.49 1.56 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.909 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -72.1 166.27 30.15 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 120.843 1.029 . . . . 0.0 110.789 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.23 -163.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 121.628 1.552 . . . . 0.0 110.63 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.71 176.19 39.87 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.129 -1.51 . . . . 0.0 111.366 179.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.641 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.9 OUTLIER -107.75 132.66 53.13 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.496 -179.921 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.705 ' OH ' HD12 ' A' ' 82' ' ' ILE . 35.7 p90 -154.7 -177.96 6.86 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.502 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.964 HG23 ' H ' ' A' ' 27' ' ' ALA . 8.3 t -151.95 -161.23 1.27 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.337 -179.721 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.533 ' N ' ' OG1' ' A' ' 25' ' ' THR . 0.1 OUTLIER -54.96 -15.5 2.06 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.065 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.964 ' H ' HG23 ' A' ' 25' ' ' THR . . . -69.23 -64.59 0.84 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.563 179.849 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.551 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 19.9 tt0 -57.83 -42.12 83.68 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 117.964 -1.495 . . . . 0.0 109.567 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.6 mt -63.68 -37.57 87.83 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.301 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 26' ' ' ARG . . . -56.26 -27.29 54.68 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 118.112 -1.435 . . . . 0.0 107.785 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -73.84 -36.21 64.88 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.95 179.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.6 mt -75.97 -70.51 0.43 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.512 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.21 -24.9 0.6 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.055 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.6 tt -80.44 156.61 4.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.546 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -147.82 -179.62 7.03 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.068 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 5.1 p30 -47.95 169.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.795 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.642 ' H ' ' H ' ' A' ' 79' ' ' VAL . 8.8 t30 78.25 -23.85 0.23 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.939 179.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 80.6 p -85.66 -139.66 0.08 Allowed 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.861 -1.135 . . . . 0.0 110.789 179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.485 HG23 ' HB ' ' A' ' 6' ' ' VAL . 43.5 mt 41.81 62.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.93 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.483 ' HB3' ' N ' ' A' ' 9' ' ' ASN . 32.4 t -62.32 -44.43 96.52 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.868 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -129.09 176.95 7.49 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.11 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -144.29 146.74 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 119.025 -1.07 . . . . 0.0 112.197 -179.966 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -132.79 118.65 19.28 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.753 179.829 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.403 HG22 HG22 ' A' ' 4' ' ' ILE . 69.7 t -146.55 107.82 4.1 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.049 -1.06 . . . . 0.0 112.293 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.418 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 2.0 Cg_endo -66.79 170.89 11.84 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 121.245 1.296 . . . . 0.0 110.719 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.418 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 2.9 Cg_endo -59.54 -167.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.851 1.7 . . . . 0.0 110.922 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.93 -9.71 23.14 Favored Glycine 0 N--CA 1.48 1.609 0 C-N-CA 118.905 -1.617 . . . . 0.0 110.915 179.798 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.67 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -155.72 151.87 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 118.279 -1.368 . . . . 0.0 112.407 179.972 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -117.92 125.28 50.17 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.883 179.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.53 158.26 17.72 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.807 -179.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.585 ' C ' HD12 ' A' ' 52' ' ' LEU . 51.9 mt -145.43 123.25 4.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.482 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.904 HD12 ' N ' ' A' ' 52' ' ' LEU . 2.4 mp -95.37 165.79 12.2 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.712 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -142.33 105.14 4.54 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.882 179.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -43.57 -84.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.775 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -58.9 133.57 56.15 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.502 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -54.47 171.82 0.11 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.423 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.25 29.93 71.83 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.205 -1.474 . . . . 0.0 110.06 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 53.66 63.22 2.28 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.031 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.13 -177.77 6.01 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.21 168.16 13.37 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.439 -1.363 . . . . 0.0 110.22 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -47.26 144.27 2.88 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.94 -1.104 . . . . 0.0 110.145 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -121.48 163.26 19.1 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.175 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.798 HD11 HD21 ' A' ' 75' ' ' LEU . 9.6 mm -125.26 174.46 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.5 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.709 ' N ' HG22 ' A' ' 63' ' ' ILE . 20.1 mt-10 -146.44 130.6 17.43 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.751 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.4 m -149.18 163.24 4.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.816 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.67 HG13 ' O ' ' A' ' 48' ' ' VAL . 3.3 t -146.76 -8.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.826 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.74 -147.2 0.39 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.103 179.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.514 HD21 HG13 ' A' ' 106' ' ' VAL . 4.4 p-10 -103.03 113.39 26.83 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.943 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.487 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.52 94.68 9.96 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.125 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -54.29 -63.08 1.27 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.141 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' A' ' 73' ' ' GLY . 6.5 tp10 -103.96 99.48 9.24 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.906 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 tp -52.34 -5.86 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.979 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 71' ' ' GLU . . . 78.34 -149.09 33.39 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 118.94 -1.6 . . . . 0.0 110.464 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 76' ' ' ASN . 3.4 Cg_exo -63.53 -151.68 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 121.505 1.47 . . . . 0.0 111.658 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.798 HD21 HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER 30.34 35.04 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 123.964 0.79 . . . . 0.0 112.06 -179.942 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 74' ' ' PRO . 13.5 t-20 -89.31 -3.93 58.31 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.286 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -93.03 3.92 54.9 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.964 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.451 ' HA ' ' H ' ' A' ' 37' ' ' ASN . 17.1 t-20 -162.53 109.67 1.28 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.743 -1.183 . . . . 0.0 111.444 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.642 ' H ' ' H ' ' A' ' 37' ' ' ASN . 7.1 t -147.96 92.82 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.149 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.8 t -121.07 -33.24 3.76 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.547 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.0 m -92.31 136.29 33.32 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.739 -1.185 . . . . 0.0 110.9 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.705 HD12 ' OH ' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -150.98 158.8 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 118.262 -1.375 . . . . 0.0 111.656 -179.857 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.794 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.45 140.11 23.65 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.637 -179.922 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.794 ' CA ' HH12 ' A' ' 83' ' ' ARG . 16.1 t -144.99 146.38 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.684 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.552 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 1.5 mt -144.58 135.47 20.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.492 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.4 m -44.74 161.5 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.899 -0.721 . . . . 0.0 111.544 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.533 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -162.01 140.58 7.03 Favored Pre-proline 0 N--CA 1.483 1.18 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.209 -179.986 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.533 ' HD2' HG22 ' A' ' 87' ' ' VAL . 12.5 Cg_exo -47.38 139.53 16.71 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.116 1.211 . . . . 0.0 110.775 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.574 HG22 ' N ' ' A' ' 90' ' ' GLN . 3.8 p -74.99 160.79 5.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.661 -0.816 . . . . 0.0 112.353 -179.839 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.574 ' N ' HG22 ' A' ' 89' ' ' VAL . 23.1 mp0 -141.06 154.87 68.6 Favored Pre-proline 0 N--CA 1.49 1.534 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.405 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.428 ' HG2' HD21 ' A' ' 136' ' ' LEU . 1.9 Cg_endo -64.3 -45.37 9.75 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 121.47 1.447 . . . . 0.0 111.739 179.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.493 ' H ' HD11 ' A' ' 136' ' ' LEU . 9.9 mtm180 64.7 -160.73 0.29 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.265 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.527 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.96 172.77 12.25 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.65 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -142.49 121.38 12.77 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.544 -1.262 . . . . 0.0 112.547 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -103.57 162.77 12.77 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -124.59 163.73 21.32 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.528 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.57 -77.41 0.22 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.149 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.483 ' C ' ' OG ' ' A' ' 129' ' ' SER . 34.3 mmtt -66.09 154.41 39.67 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.737 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.627 ' C ' ' HG2' ' A' ' 100' ' ' GLN . 29.0 tt0 -81.71 86.69 6.38 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.118 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.627 ' HG2' ' C ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 163.56 35.68 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.297 -179.946 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.7 t80 56.13 42.38 28.33 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 119.634 -0.827 . . . . 0.0 110.488 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 103' ' ' GLY . 25.1 t0 -143.14 178.36 7.76 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.565 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 81.58 139.24 2.73 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.157 -1.496 . . . . 0.0 109.724 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 103' ' ' GLY . 1.1 mppt? -28.63 132.91 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.729 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -97.8 159.33 14.99 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.106 -179.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.514 HG13 HD21 ' A' ' 68' ' ' ASN . 53.4 t -144.3 116.05 2.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.115 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -104.72 154.73 19.62 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.413 -179.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.9 mt -139.64 138.13 19.67 Favored Pre-proline 0 N--CA 1.492 1.675 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.436 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.72 168.77 12.66 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 121.237 1.291 . . . . 0.0 110.998 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.08 150.31 87.04 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.655 1.57 . . . . 0.0 111.06 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.04 -155.04 24.24 Favored Glycine 0 N--CA 1.498 2.817 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.969 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.601 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 35.7 tt0 -133.48 158.35 43.31 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.699 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.601 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 30.2 m-85 -142.51 155.1 45.0 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.185 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.2 p -102.91 -175.38 2.79 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.017 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.446 ' N ' ' OE1' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -88.1 53.89 2.9 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.686 179.977 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -152.12 -65.88 0.17 Allowed 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.593 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -72.61 -50.18 27.08 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.343 -0.943 . . . . 0.0 109.467 179.963 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.564 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -33.81 -71.73 0.06 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.897 179.962 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.535 ' OE2' ' CZ ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -52.27 -57.63 9.14 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.103 179.923 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.535 ' CZ ' ' OE2' ' A' ' 119' ' ' GLU . 3.3 mpt_? -76.36 23.07 0.15 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.92 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.564 ' N ' ' O ' ' A' ' 117' ' ' GLU . 24.7 t80 -127.11 -17.06 4.9 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.659 179.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.06 -42.6 0.03 OUTLIER Glycine 0 N--CA 1.482 1.705 0 C-N-CA 118.74 -1.695 . . . . 0.0 111.118 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.574 HG13 HD11 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -135.8 -105.7 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.225 -179.93 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 18.6 t70 -171.72 -168.45 0.59 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.77 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.528 ' C ' HD22 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -86.03 35.14 0.63 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.45 -179.9 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.405 ' C ' HG22 ' A' ' 127' ' ' THR . 6.0 p-10 -166.48 -155.0 0.19 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.532 -1.267 . . . . 0.0 112.133 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.571 ' OG1' ' N ' ' A' ' 128' ' ' ILE . 2.6 t 40.31 -125.96 0.44 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.267 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.574 HD11 HG13 ' A' ' 123' ' ' ILE . 98.2 mt 60.67 118.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 CA-C-O 121.041 0.448 . . . . 0.0 111.209 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.483 ' OG ' ' C ' ' A' ' 98' ' ' LYS . 59.2 p -160.99 140.85 10.84 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.419 -0.913 . . . . 0.0 111.124 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 67.92 113.16 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.965 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.0 t -120.27 149.85 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.732 -179.795 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.547 ' NZ ' ' OD2' ' A' ' 156' ' ' ASP . 13.1 tptp -142.4 93.66 7.03 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.793 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 135' ' ' GLY . 4.1 Cg_exo -59.37 99.75 0.12 Allowed 'Trans proline' 0 C--N 1.32 -0.942 0 C-N-CA 120.959 1.106 . . . . 0.0 111.474 -179.799 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.527 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 5.6 tt0 -47.43 -14.23 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.074 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 133' ' ' PRO . . . 175.56 -34.02 0.09 OUTLIER Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.467 -1.825 . . . . 0.0 111.936 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.493 HD11 ' H ' ' A' ' 92' ' ' ARG . 2.2 mt -93.13 -173.82 3.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.664 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.22 144.15 36.06 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.746 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.5 t -112.8 143.56 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.962 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.4 ' C ' HD12 ' A' ' 140' ' ' LEU . 91.3 t -135.39 122.3 34.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.91 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 140' ' ' LEU . 10.1 mp -99.75 144.79 28.41 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.761 -179.802 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.492 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 21.9 m-85 -120.47 129.47 53.87 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.101 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -73.72 -63.15 1.27 Allowed 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.144 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -71.32 170.95 12.05 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.608 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 146' ' ' PHE . 47.7 m-20 -67.73 -161.41 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.254 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.641 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 7.6 p-10 28.96 38.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.371 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.641 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 41.69 61.51 1.85 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.982 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.524 ' CB ' HD21 ' A' ' 145' ' ' ASN . 0.5 OUTLIER -139.52 -167.7 2.32 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.353 -179.865 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 65.02 -160.4 42.44 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.706 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.55 158.72 9.37 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.301 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.4 p -148.55 170.69 17.51 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.979 -1.088 . . . . 0.0 111.818 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 151' ' ' LEU . 23.4 tp -138.9 85.0 16.79 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.315 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -61.74 105.77 0.39 Allowed 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.922 1.748 . . . . 0.0 113.049 -179.85 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.467 ' C ' ' H ' ' A' ' 155' ' ' SER . 2.0 t -95.09 57.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.758 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.405 ' ND2' ' H ' ' A' ' 154' ' ' ASN . 5.8 p30 -70.54 32.85 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.819 -179.862 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 153' ' ' VAL . 21.0 p -170.65 -169.06 0.75 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.705 -1.198 . . . . 0.0 111.605 180.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.547 ' OD2' ' NZ ' ' A' ' 132' ' ' LYS . 1.3 m-20 -75.86 153.23 36.93 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.556 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.532 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -168.65 72.17 0.79 Allowed Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.935 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.93 24.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.057 1.838 . . . . 0.0 112.385 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.9 OUTLIER -170.61 68.23 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.633 179.925 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.8 tp -80.76 -64.19 1.24 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.905 0 C-N-CA 119.136 -1.507 . . . . 0.0 109.863 -179.983 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.1 m120 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 121.082 0.467 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.7 124.31 20.96 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.949 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 169' ' ' SER . 57.3 p -86.18 -68.58 0.73 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.697 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.426 ' N ' ' OG ' ' A' ' 168' ' ' SER . 2.0 p -119.44 161.93 19.7 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.416 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 29.0 pt -141.01 171.59 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.199 -1.001 . . . . 0.0 111.649 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -153.21 110.92 3.56 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.76 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -89.17 92.92 4.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.107 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 116.313 -1.803 . . . . 0.0 111.088 -179.904 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.792 0.33 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.629 ' N ' ' ND2' ' A' ' 3' ' ' ASN . 0.1 OUTLIER 179.77 130.8 0.09 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.489 -179.906 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.665 HG22 HG22 ' A' ' 44' ' ' VAL . 2.9 pt -82.53 128.75 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.585 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.7 m -100.22 113.32 25.91 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.561 -0.856 . . . . 0.0 108.74 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.518 HG11 HD11 ' A' ' 19' ' ' LEU . 1.5 m -96.83 160.06 2.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.196 -1.002 . . . . 0.0 113.436 -179.688 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' A' ' 12' ' ' PHE . 87.9 m-85 -118.46 144.86 45.69 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.754 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -58.05 3.59 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.634 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 87.8 m-20 -85.52 -176.41 6.07 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.614 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -75.99 176.73 7.64 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.343 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.582 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 1.5 m-20 48.68 56.61 7.37 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.695 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 55.8 p90 40.19 20.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.23 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 11' ' ' ASP . 2.5 tp-100 -98.31 164.37 12.33 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.874 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.634 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 94.18 148.27 23.61 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.802 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.567 ' H ' ' HE3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -29.09 137.74 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.882 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.434 ' H ' ' HG3' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -104.63 152.26 22.67 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.424 -179.889 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.1 t -149.42 138.79 15.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.884 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 1.1 m-20 -99.78 134.86 42.07 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.245 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.518 HD11 HG11 ' A' ' 6' ' ' VAL . 6.4 mt -123.89 122.57 26.3 Favored Pre-proline 0 N--CA 1.496 1.851 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.263 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.33 161.76 39.24 Favored 'Trans proline' 0 C--O 1.217 -0.533 0 C-N-CA 121.022 1.148 . . . . 0.0 111.247 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.54 -166.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.889 0 C-N-CA 121.602 1.534 . . . . 0.0 110.738 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.465 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 92.77 -163.59 27.18 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.989 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.75 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -117.96 133.22 56.13 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.432 -179.947 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.614 ' CE2' HD12 ' A' ' 82' ' ' ILE . 6.1 p90 -154.78 177.65 11.02 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.404 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.422 HG22 ' OG ' ' A' ' 81' ' ' SER . 14.3 p -149.51 -150.12 0.33 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.415 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.5 mtm-85 -62.82 -36.66 83.91 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.301 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -56.79 -61.51 2.38 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.44 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.449 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.7 tp60 -56.02 -47.67 77.37 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.325 -1.35 . . . . 0.0 109.367 -179.902 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 29' ' ' LEU . 90.1 mt -57.87 -33.49 68.74 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.39 179.839 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -54.0 -33.02 55.99 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.86 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -70.4 -36.09 73.85 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.18 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.401 HD12 HD23 ' A' ' 29' ' ' LEU . 11.9 mt -78.48 -75.26 0.23 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.727 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 163.7 -29.47 0.24 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 118.898 -1.62 . . . . 0.0 111.244 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -73.99 166.12 2.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.761 179.971 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.898 ' H ' HG21 ' A' ' 38' ' ' THR . 0.2 OUTLIER 174.66 103.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.403 179.946 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.804 ' O ' HG23 ' A' ' 38' ' ' THR . 2.1 t-20 69.23 140.61 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.7 p30 37.39 21.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.39 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.898 HG21 ' H ' ' A' ' 35' ' ' GLU . 40.9 p -93.95 -48.06 6.43 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.542 -1.263 . . . . 0.0 110.963 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 mt -62.6 74.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.148 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' THR . 26.8 t -72.06 -49.82 33.44 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.122 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.34 163.98 28.79 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.246 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.137 HG22 ' HB3' ' A' ' 69' ' ' ALA . 25.1 m -148.94 167.82 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 C-N-CA 118.194 -1.402 . . . . 0.0 113.295 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -139.76 97.96 3.37 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 113.671 -1.604 . . . . 0.0 107.981 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.665 HG22 HG22 ' A' ' 4' ' ' ILE . 44.5 t -116.46 109.54 43.83 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.797 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.83 169.11 16.9 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 121.227 1.284 . . . . 0.0 110.507 179.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.02 -172.44 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.708 1.605 . . . . 0.0 110.368 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.36 -15.37 35.02 Favored Glycine 0 C--N 1.3 -1.428 0 C-N-CA 118.654 -1.736 . . . . 0.0 110.486 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.722 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -148.53 151.76 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.951 179.938 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -127.17 126.23 42.5 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.869 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.16 160.34 17.02 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.873 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.524 ' C ' HD12 ' A' ' 52' ' ' LEU . 62.4 mt -139.92 121.48 15.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.726 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.826 HD12 ' N ' ' A' ' 52' ' ' LEU . 1.8 mp -90.17 159.8 16.57 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.927 -1.109 . . . . 0.0 112.584 -179.697 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -144.73 106.33 4.26 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.863 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -44.47 -81.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.298 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -58.87 138.2 57.43 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.544 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -54.92 173.39 0.09 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.439 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.31 27.69 72.72 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.184 -1.484 . . . . 0.0 110.156 -179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 55.13 67.91 0.94 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.8 -165.52 2.28 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.235 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.72 -170.01 14.35 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.021 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -51.34 167.89 0.08 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.818 -1.153 . . . . 0.0 109.805 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -147.03 162.71 38.24 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.477 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.93 HD11 HD21 ' A' ' 75' ' ' LEU . 32.1 mt -142.23 173.61 7.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.944 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.736 ' H ' HG22 ' A' ' 63' ' ' ILE . 2.0 tm-20 -146.44 129.71 16.66 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.778 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.536 ' N ' ' OE2' ' A' ' 64' ' ' GLU . 32.2 m -145.64 158.02 12.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 118.629 -1.229 . . . . 0.0 112.465 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' ' 48' ' ' VAL . 3.8 t -146.61 -7.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-N 114.312 -1.313 . . . . 0.0 107.783 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.418 ' H ' ' H ' ' A' ' 66' ' ' VAL . . . -117.13 -151.15 0.47 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.557 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -97.09 122.81 40.51 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.455 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.137 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -89.81 113.46 25.03 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.1 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.465 ' C ' ' CD ' ' A' ' 70' ' ' GLU . 4.1 tp10 -72.33 -70.84 0.32 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.582 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.441 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 12.1 tt0 -96.69 -0.2 48.72 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.223 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.4 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 2.5 tp 69.74 -88.26 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.042 -0.663 . . . . 0.0 112.17 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.4 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 179.33 -162.08 28.61 Favored Glycine 0 N--CA 1.499 2.885 0 C-N-CA 118.99 -1.576 . . . . 0.0 111.086 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.46 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.2 Cg_endo -66.88 -49.84 1.34 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.168 1.912 . . . . 0.0 112.159 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.043 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.7 pt? -74.65 33.52 0.09 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.419 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.46 ' H ' ' C ' ' A' ' 74' ' ' PRO . 21.8 p30 -70.28 -23.89 62.95 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.276 -0.97 . . . . 0.0 110.548 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.514 HD22 ' C ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -80.84 14.43 2.19 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.902 -179.99 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.563 HD22 ' C ' ' A' ' 78' ' ' ASN . 0.5 OUTLIER -168.51 108.48 0.51 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.364 -179.975 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.562 ' N ' HD22 ' A' ' 78' ' ' ASN . 16.5 t -146.44 106.07 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.132 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.7 t -124.73 -44.66 1.94 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.679 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.422 ' OG ' HG22 ' A' ' 25' ' ' THR . 3.4 m -94.5 138.86 31.9 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.597 -179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.614 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -146.94 152.03 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 119.069 -1.053 . . . . 0.0 111.873 -179.971 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.854 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -130.09 123.24 29.97 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.272 -179.908 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.854 ' H ' HH12 ' A' ' 83' ' ' ARG . 13.3 t -136.01 137.75 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.59 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.54 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 1.4 mt -145.52 142.96 22.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.784 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.4 p -43.99 160.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.809 -0.756 . . . . 0.0 111.746 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -159.09 148.74 14.89 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.128 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -57.64 157.71 22.35 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.045 1.163 . . . . 0.0 110.067 179.735 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.567 HG12 ' N ' ' A' ' 90' ' ' GLN . 86.8 t -78.85 159.73 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.722 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.567 ' N ' HG12 ' A' ' 89' ' ' VAL . 30.0 mt-30 -143.41 145.63 32.71 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.607 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.4 ' HG2' HD21 ' A' ' 136' ' ' LEU . 3.6 Cg_exo -65.3 -48.94 2.92 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 121.377 1.385 . . . . 0.0 111.854 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.515 ' H ' HD11 ' A' ' 136' ' ' LEU . 0.0 OUTLIER 64.81 -156.02 0.29 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.939 179.984 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.525 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -141.73 178.13 7.69 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.717 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -142.08 113.31 7.6 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.931 -1.107 . . . . 0.0 111.412 -179.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.682 ' CD2' HG13 ' A' ' 131' ' ' VAL . 96.8 m-85 -106.53 146.63 30.38 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.471 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -95.69 171.87 8.4 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.386 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.48 -66.86 0.87 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.889 -179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -86.47 147.28 26.05 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.488 -0.885 . . . . 0.0 112.442 -179.778 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.585 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 5.8 tm-20 -71.51 101.43 2.45 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.262 -179.907 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.916 ' CA ' HE21 ' A' ' 100' ' ' GLN . 0.0 OUTLIER 135.7 53.09 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.059 0 O-C-N 125.099 1.499 . . . . 0.0 109.94 179.891 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.504 ' CG ' ' O ' ' A' ' 101' ' ' PHE . 58.8 t80 43.12 52.54 5.43 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.689 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 103' ' ' GLY . 3.2 t70 -145.38 158.35 43.85 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.062 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.524 ' N ' ' OD1' ' A' ' 102' ' ' ASP . . . 85.16 133.29 2.85 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.87 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 103' ' ' GLY . 8.6 mtpm? -35.17 146.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.178 0.513 . . . . 0.0 111.813 -179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -90.96 164.28 14.05 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.215 -179.885 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.0 t -145.79 112.49 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.941 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -89.99 159.64 16.78 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.264 -0.975 . . . . 0.0 112.576 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.9 mt -143.93 131.39 10.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.986 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -66.82 168.66 16.38 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 121.36 1.374 . . . . 0.0 111.441 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.2 145.19 88.58 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 121.557 1.505 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.4 -171.87 24.1 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.137 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.596 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 16.7 tm0? -109.18 159.89 16.55 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.596 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 52.9 m-85 -146.18 148.66 32.77 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.441 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.6 p -102.25 170.99 7.74 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.423 -179.849 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -60.29 -8.92 2.88 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.604 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.38 -52.17 3.07 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 119.314 -0.954 . . . . 0.0 113.437 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 121' ' ' TYR . 23.9 mt-10 -72.79 -53.07 12.53 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.3 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.569 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -36.61 -67.48 0.17 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.807 0.813 . . . . 0.0 110.593 179.906 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 28.2 mp0 -52.35 -60.86 2.72 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.13 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.475 ' HD3' ' H ' ' A' ' 120' ' ' ARG . 4.9 mpt_? -72.13 4.89 3.13 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.792 -179.634 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 117' ' ' GLU . 14.3 t80 -105.34 -16.28 14.8 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.973 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -151.36 -36.36 0.03 OUTLIER Glycine 0 N--CA 1.487 2.063 0 C-N-CA 117.684 -2.198 . . . . 0.0 112.141 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.99 -102.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.979 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 176.42 -173.91 0.1 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.975 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.505 ' C ' ' CG ' ' A' ' 126' ' ' ASN . 59.1 t30 -58.55 125.87 25.22 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.594 -1.243 . . . . 0.0 110.281 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.599 ' C ' HG23 ' A' ' 127' ' ' THR . 0.4 OUTLIER 74.34 -139.02 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.967 -179.893 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.635 ' OG1' ' N ' ' A' ' 128' ' ' ILE . 1.4 p 59.28 -137.95 0.76 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.586 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.635 ' N ' ' OG1' ' A' ' 127' ' ' THR . 39.4 mt 59.37 -74.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.763 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 130' ' ' SER . 60.3 p 47.71 -123.41 1.55 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.239 -0.585 . . . . 0.0 112.335 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.552 ' N ' ' OG ' ' A' ' 129' ' ' SER . 0.8 OUTLIER -41.88 126.68 3.19 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.004 -179.847 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.682 HG13 ' CD2' ' A' ' 95' ' ' PHE . 6.8 t -122.42 156.71 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.262 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.404 ' N ' HG12 ' A' ' 131' ' ' VAL . 1.5 ttmp? -150.39 84.46 5.65 Favored Pre-proline 0 C--N 1.296 -1.749 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.998 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.47 103.8 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.985 1.79 . . . . 0.0 111.706 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.525 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 52.1 tp60 -49.25 -30.6 7.41 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.215 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -169.91 -26.31 0.02 OUTLIER Glycine 0 N--CA 1.494 2.503 0 C-N-CA 118.407 -1.854 . . . . 0.0 112.322 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.515 HD11 ' H ' ' A' ' 92' ' ' ARG . 1.4 mt -96.57 165.02 12.36 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.492 -1.283 . . . . 0.0 110.425 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.86 143.72 26.44 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.464 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.3 t -110.05 148.49 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.654 -0.819 . . . . 0.0 112.616 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.497 ' C ' HD12 ' A' ' 140' ' ' LEU . 46.8 t -137.37 125.54 32.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.926 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 139' ' ' VAL . 8.8 mp -102.32 144.84 30.31 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.707 -179.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -117.75 131.38 56.61 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.544 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.693 ' NZ ' ' ND2' ' A' ' 143' ' ' ASN . 26.3 ttpp -67.85 -79.24 0.05 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.554 -179.739 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.693 ' ND2' ' NZ ' ' A' ' 142' ' ' LYS . 0.8 OUTLIER -51.92 166.03 0.17 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.19 -179.884 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -46.82 -100.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.893 -1.048 . . . . 0.0 113.264 -179.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.606 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 5.8 m120 -73.18 75.65 1.28 Allowed 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.578 -179.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.606 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.2 p90 34.22 72.47 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.358 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.0 m -141.5 64.67 1.4 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.719 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 171.77 -148.59 11.06 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.294 -1.432 . . . . 0.0 110.35 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -75.53 168.49 19.91 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.293 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.3 p -146.98 155.39 42.22 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.616 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.427 ' HA ' HD12 ' A' ' 151' ' ' LEU . 35.4 tp -123.79 90.93 50.21 Favored Pre-proline 0 N--CA 1.488 1.468 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.59 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.11 108.02 0.89 Allowed 'Trans proline' 0 C--N 1.321 -0.875 0 C-N-CA 121.738 1.625 . . . . 0.0 112.855 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 45.5 t -84.88 88.16 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.452 179.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.494 ' C ' ' OG ' ' A' ' 155' ' ' SER . 18.8 p-10 -52.28 -33.82 43.77 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.494 ' OG ' ' C ' ' A' ' 154' ' ' ASN . 0.8 OUTLIER -163.82 -130.93 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 117.867 -1.533 . . . . 0.0 113.232 -179.699 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -59.73 153.4 20.45 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.299 -179.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.603 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -176.06 69.91 0.25 Allowed Pre-proline 0 N--CA 1.48 1.061 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.657 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.76 20.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.039 1.826 . . . . 0.0 112.184 -179.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.603 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -176.38 117.42 0.13 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.285 179.935 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.1 tp -148.96 -63.97 0.23 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.214 -179.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.998 0 C-N-CA 119.2 -1.476 . . . . 0.0 109.606 -179.861 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.764 0.316 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 m -68.48 105.93 2.37 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.754 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 28.6 m -87.74 -64.26 1.18 Allowed 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.218 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 p -115.63 163.62 15.53 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.011 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.418 HG12 ' CD1' ' A' ' 118' ' ' LEU . 30.1 pt -142.74 177.19 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.934 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -156.56 111.08 2.78 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.325 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.3 mt -90.19 98.03 7.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.314 -0.955 . . . . 0.0 110.385 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 C--N 1.306 -1.31 0 CA-C-O 116.393 -1.765 . . . . 0.0 110.957 -179.99 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.605 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.992 0.425 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 2' ' ' ALA . 45.6 m-80 -163.34 117.69 1.63 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.348 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.8 pt -70.31 149.79 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.532 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.2 m -128.86 116.04 18.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.581 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 m -93.6 171.04 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 C-N-CA 119.526 -0.869 . . . . 0.0 110.78 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.788 ' CE2' ' NE2' ' A' ' 16' ' ' GLN . 31.5 m-85 -133.83 154.21 51.18 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.73 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -83.77 -45.08 13.73 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.278 -0.969 . . . . 0.0 113.152 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.534 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 7.5 m120 -97.66 -175.69 3.26 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.54 -179.864 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.86 -178.14 7.0 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.54 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.614 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 0.9 OUTLIER 47.43 57.29 5.99 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.623 -179.946 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.614 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 48.3 p90 39.14 25.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.66 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 11' ' ' ASP . 7.6 tt0 -104.18 170.01 8.16 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.247 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.534 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 88.36 136.21 5.36 Favored Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.633 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 14' ' ' GLY . 25.8 mmtm -32.01 139.5 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.439 180.0 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.788 ' NE2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -115.27 170.07 8.66 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.805 -179.883 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 76.7 t -141.63 133.93 28.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.334 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -93.91 119.26 32.59 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.192 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.9 mt -116.6 138.25 24.34 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.376 179.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -72.11 164.94 34.11 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 120.973 1.116 . . . . 0.0 111.027 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.19 -162.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 121.691 1.594 . . . . 0.0 110.761 179.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.525 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 88.54 -178.95 46.02 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.098 -1.525 . . . . 0.0 111.164 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.651 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -109.99 137.47 47.71 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.818 -179.995 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.638 ' CE2' HD12 ' A' ' 82' ' ' ILE . 4.8 p90 -156.12 178.05 10.73 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.36 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.481 ' HB ' ' H ' ' A' ' 26' ' ' ARG . 1.3 p -151.25 -153.09 0.47 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.801 -179.801 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.481 ' H ' ' HB ' ' A' ' 25' ' ' THR . 35.0 ptt85 -58.61 -20.86 51.03 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.931 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.67 -64.11 0.92 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.244 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.513 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 31.1 tt0 -58.38 -45.36 88.44 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.244 -1.383 . . . . 0.0 109.695 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 29' ' ' LEU . 27.8 mt -61.93 -35.25 77.84 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.576 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' ARG . . . -59.5 -25.41 64.43 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 118.098 -1.441 . . . . 0.0 107.879 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -76.85 -36.35 56.87 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.69 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.5 mt -76.23 -76.72 0.15 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.741 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.42 -26.94 0.87 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.684 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.883 HD13 ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -88.14 139.01 18.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.842 180.0 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.721 ' N ' HD13 ' A' ' 34' ' ' ILE . 2.9 pt-20 174.02 168.73 0.21 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.515 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' C ' ' H ' ' A' ' 38' ' ' THR . 1.7 t-20 80.91 -145.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 120.147 -0.621 . . . . 0.0 112.654 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -53.24 6.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.988 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 35' ' ' GLU . 71.4 p -72.6 -149.05 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.358 -1.337 . . . . 0.0 110.75 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 38' ' ' THR . 2.8 mt 42.12 58.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.899 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t -72.92 -50.04 25.94 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.917 -179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.434 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -119.27 176.62 5.24 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.763 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -154.43 148.22 13.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 C-N-CA 117.856 -1.538 . . . . 0.0 112.813 -179.95 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -136.6 109.88 7.85 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.513 -1.222 . . . . 0.0 108.607 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.2 t -132.54 110.86 13.66 Favored Pre-proline 0 N--CA 1.495 1.803 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.322 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.13 167.96 20.43 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.007 1.138 . . . . 0.0 110.726 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.483 ' CG ' HH21 ' A' ' 92' ' ' ARG . 1.6 Cg_endo -62.18 -168.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.781 1.654 . . . . 0.0 111.326 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.89 -17.47 9.13 Favored Glycine 0 N--CA 1.482 1.73 0 C-N-CA 119.365 -1.397 . . . . 0.0 110.854 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.605 HG11 ' CB ' ' A' ' 2' ' ' ALA . 27.3 m -148.59 140.35 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.825 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -104.82 127.14 52.52 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.49 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.57 149.19 28.32 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.539 -0.864 . . . . 0.0 112.283 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.8 mt -139.87 114.58 7.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.569 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.502 ' HA ' HG23 ' A' ' 82' ' ' ILE . 3.6 mp -94.11 164.95 12.86 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.942 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -140.46 116.37 10.37 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.006 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -49.22 -84.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.363 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 59' ' ' ALA . 14.9 t-20 -59.01 141.26 54.42 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.521 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -60.92 -169.87 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.318 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.81 31.97 32.34 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.137 -1.506 . . . . 0.0 110.005 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.429 ' CE1' ' HG3' ' A' ' 83' ' ' ARG . 25.3 m-85 51.29 65.59 1.44 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.087 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 55' ' ' ASN . . . -144.06 -174.14 4.19 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.171 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.67 177.9 15.39 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.037 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -50.89 170.72 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.212 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -143.58 133.03 23.41 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.058 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.549 HG22 ' N ' ' A' ' 64' ' ' GLU . 6.5 mm -98.91 167.64 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.097 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.549 ' N ' HG22 ' A' ' 63' ' ' ILE . 51.5 mt-10 -145.29 129.16 17.35 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.163 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -149.24 164.52 4.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 118.598 -1.241 . . . . 0.0 112.609 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.33 -11.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 114.372 -1.285 . . . . 0.0 107.69 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -119.69 -152.19 0.5 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.144 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.662 HD21 ' H ' ' A' ' 107' ' ' ASP . 1.3 p30 -101.51 122.57 44.05 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.886 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.531 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.53 121.85 32.13 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.723 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -74.33 -83.67 0.05 Allowed 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.328 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -77.32 -0.25 24.84 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.962 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.4 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 5.8 tp 59.24 -97.47 0.07 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.717 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.4 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -173.43 -174.83 40.73 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 118.893 -1.622 . . . . 0.0 111.117 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.595 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.4 Cg_endo -66.9 -34.04 31.25 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.688 2.259 . . . . 0.0 112.587 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.752 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.0 pt? -67.91 24.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.457 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.595 ' H ' ' C ' ' A' ' 74' ' ' PRO . 4.3 t30 -74.73 -6.35 48.35 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.201 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' ND2' ' A' ' 78' ' ' ASN . 4.6 t-20 -74.54 -25.11 59.11 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.992 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 31.9 m120 -158.14 132.03 7.9 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.384 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t -147.81 138.52 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.843 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.9 m -162.53 -34.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.44 -1.304 . . . . 0.0 112.831 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.5 m -95.7 138.81 32.83 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.023 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.638 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -150.02 159.86 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 118.581 -1.248 . . . . 0.0 112.497 -179.869 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.846 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -149.94 116.84 5.92 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.417 -179.977 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.846 ' H ' HH22 ' A' ' 83' ' ' ARG . 14.1 t -120.63 139.54 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.438 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.77 HD11 HH11 ' A' ' 83' ' ' ARG . 1.4 mp -138.72 129.25 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.562 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 p -40.5 152.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.989 -0.685 . . . . 0.0 111.609 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.565 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -154.47 141.25 13.26 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.266 179.989 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.565 ' HD2' HG22 ' A' ' 87' ' ' VAL . 4.8 Cg_exo -52.37 132.55 45.05 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.168 1.246 . . . . 0.0 111.28 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.589 HG22 ' N ' ' A' ' 90' ' ' GLN . 4.0 p -59.13 163.96 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.639 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.589 ' N ' HG22 ' A' ' 89' ' ' VAL . 82.5 mm-40 -145.21 148.08 36.63 Favored Pre-proline 0 N--CA 1.487 1.387 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.045 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.64 -20.12 67.63 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 121.503 1.469 . . . . 0.0 111.846 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.483 HH21 ' CG ' ' A' ' 46' ' ' PRO . 20.3 ptt180 38.07 -158.31 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.463 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -147.87 172.76 13.65 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.61 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -141.21 115.48 9.37 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.865 -1.134 . . . . 0.0 112.087 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.42 ' CD2' HG13 ' A' ' 131' ' ' VAL . 66.7 m-85 -99.97 159.17 15.29 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.634 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 101' ' ' PHE . 26.0 m-85 -109.83 179.66 4.06 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.267 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.29 -66.97 0.91 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.438 -0.905 . . . . 0.0 112.755 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.513 ' CG ' ' N ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -87.49 163.05 16.91 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.918 0.866 . . . . 0.0 113.083 -179.735 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 13.6 tp10 -62.25 108.86 1.16 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.703 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 96.66 61.54 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.934 0 O-C-N 124.725 1.265 . . . . 0.0 111.113 179.895 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.542 ' O ' ' CD2' ' A' ' 101' ' ' PHE . 9.1 p90 29.4 33.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.422 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 100' ' ' GLN . 23.8 t70 -96.93 32.85 2.01 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.754 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -161.2 144.48 9.88 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 103' ' ' GLY . 15.7 tptm -34.5 144.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.929 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.468 ' C ' ' OE1' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -99.14 164.99 11.93 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.712 -0.795 . . . . 0.0 112.806 -179.803 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.417 HG11 ' CA ' ' A' ' 122' ' ' GLY . 7.0 t -140.28 118.57 10.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.495 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.662 ' H ' HD21 ' A' ' 68' ' ' ASN . 2.2 p-10 -93.83 163.08 13.66 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.535 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 108' ' ' LEU . 94.2 mt -144.08 144.44 26.27 Favored Pre-proline 0 N--CA 1.486 1.339 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.632 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.21 163.48 32.6 Favored 'Trans proline' 0 C--O 1.213 -0.771 0 C-N-CA 121.708 1.605 . . . . 0.0 111.095 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.68 142.73 95.24 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 121.452 1.435 . . . . 0.0 110.892 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.87 -157.13 26.97 Favored Glycine 0 N--CA 1.501 3.026 0 C-N-CA 118.758 -1.687 . . . . 0.0 111.522 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.66 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 46.1 tt0 -128.26 157.27 41.37 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.518 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.66 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 13.4 m-85 -142.43 155.99 45.15 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.799 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.4 p -99.61 176.47 5.47 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -179.674 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.531 ' NE2' ' OD2' ' A' ' 144' ' ' ASP . 20.9 pt20 -73.42 37.63 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.866 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.32 -56.3 0.08 Allowed 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.615 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.11 -42.61 75.86 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.163 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.617 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -45.25 -74.1 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.159 179.912 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.69 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 0.1 OUTLIER -50.69 -55.45 16.48 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.011 -1.076 . . . . 0.0 112.796 -179.63 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -10.59 6.45 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.319 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -100.04 -8.08 24.25 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.471 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.58 ' C ' HD13 ' A' ' 123' ' ' ILE . . . -152.0 -62.08 0.01 OUTLIER Glycine 0 N--CA 1.484 1.887 0 C-N-CA 118.498 -1.81 . . . . 0.0 111.989 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 1.062 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -140.63 127.82 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.968 -179.746 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 126' ' ' ASN . 36.9 t70 -39.48 161.41 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.84 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -58.29 13.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.105 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.637 ' O ' HG23 ' A' ' 127' ' ' THR . 1.6 p-10 -167.7 77.99 0.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.552 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 126' ' ' ASN . 1.1 p -163.66 -15.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.37 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -64.68 160.4 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.143 -179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.4 t -170.38 -87.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.55 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 m -81.93 138.02 35.07 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.487 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.42 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.1 t -121.14 156.84 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.509 0.671 . . . . 0.0 111.703 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -154.02 79.06 5.23 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.963 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.78 102.42 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.533 1.489 . . . . 0.0 110.834 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.463 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 3.5 mm-40 -51.55 -12.92 0.19 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.089 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 178.76 -34.86 0.08 OUTLIER Glycine 0 N--CA 1.49 2.278 0 C-N-CA 117.93 -2.081 . . . . 0.0 112.579 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.452 HD12 ' CA ' ' A' ' 92' ' ' ARG . 6.4 mt -87.35 171.87 10.27 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.185 -1.406 . . . . 0.0 111.824 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -95.16 123.21 38.53 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.41 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 153' ' ' VAL . 8.8 t -94.44 133.05 36.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.627 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.488 ' C ' HD12 ' A' ' 140' ' ' LEU . 62.0 t -124.2 132.13 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.48 179.805 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 139' ' ' VAL . 9.9 mp -107.31 134.13 50.83 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.435 -179.783 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.431 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 25.8 m-85 -110.59 122.06 46.83 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.105 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -55.4 -84.19 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.988 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.447 HD21 ' HB3' ' A' ' 147' ' ' SER . 26.2 p-10 -71.91 173.58 8.13 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.193 179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.531 ' OD2' ' NE2' ' A' ' 115' ' ' GLN . 2.3 m-20 -65.29 -153.35 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.175 -179.893 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.635 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 71.7 m-20 41.91 22.61 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.288 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.635 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.5 p90 40.08 57.12 2.44 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.154 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.447 ' HB3' HD21 ' A' ' 143' ' ' ASN . 8.4 t -138.66 -151.05 0.36 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.605 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 54.88 -166.02 2.87 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.377 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.5 157.14 11.87 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.88 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 p -148.12 174.68 11.71 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.568 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.3 mt -138.32 85.09 18.76 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.444 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -64.1 97.53 0.24 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 121.766 1.644 . . . . 0.0 112.387 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 138' ' ' VAL . 2.1 t -77.78 92.99 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.857 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -62.41 -21.49 65.42 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.808 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 52.3 p -169.84 -150.19 0.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 117.852 -1.539 . . . . 0.0 112.862 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -43.78 150.26 0.26 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.779 -179.818 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.554 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -171.8 65.07 0.39 Allowed Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.902 179.841 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.3 Cg_endo -61.95 19.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.267 1.978 . . . . 0.0 113.14 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.554 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER 178.67 111.76 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.053 179.873 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 13.5 mt -141.35 -42.97 0.37 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.467 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.026 0 C-N-CA 119.318 -1.42 . . . . 0.0 110.16 -179.994 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.961 0.41 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.37 131.12 45.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.504 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 169' ' ' SER . 97.0 p -93.69 -67.31 0.86 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.945 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.52 ' N ' ' OG ' ' A' ' 168' ' ' SER . 1.8 p -113.99 162.55 16.28 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.982 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.43 HG12 ' CD1' ' A' ' 118' ' ' LEU . 23.9 pt -143.01 175.73 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 118.735 -1.186 . . . . 0.0 112.037 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.403 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 3.2 ttp85 -154.51 109.18 3.04 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.477 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 172' ' ' ILE . 9.4 mt -89.6 92.8 4.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.574 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 116.325 -1.798 . . . . 0.0 110.944 179.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ptm . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.922 0.391 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.64 163.24 16.68 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.662 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -179.53 131.4 0.1 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.166 -1.013 . . . . 0.0 110.699 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.7 pt -73.44 153.22 7.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.453 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.0 m -130.44 116.43 18.23 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.886 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 m -96.67 172.08 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.515 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.971 ' CE2' ' NE2' ' A' ' 16' ' ' GLN . 16.1 m-85 -130.72 134.85 47.26 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.878 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -59.28 5.5 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.214 -0.995 . . . . 0.0 112.777 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.624 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 1.9 m120 -89.03 167.04 13.48 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.478 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.556 ' CG ' ' H ' ' A' ' 11' ' ' ASP . 16.4 tt0 -77.16 -178.23 4.94 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.918 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.556 ' H ' ' CG ' ' A' ' 10' ' ' GLU . 4.7 t0 60.77 43.64 11.95 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.61 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.414 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 35.8 t80 49.3 15.47 0.12 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.497 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.503 ' CG ' ' N ' ' A' ' 14' ' ' GLY . 8.1 tt0 -103.02 168.93 8.87 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.833 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.624 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 89.53 124.49 2.56 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.816 -1.183 . . . . 0.0 111.143 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 14' ' ' GLY . 7.2 mmmm -29.95 137.76 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 123.921 0.424 . . . . 0.0 111.643 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.971 ' NE2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -103.51 170.92 7.66 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.678 -0.809 . . . . 0.0 112.087 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.6 t -142.03 134.41 27.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.804 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -92.98 117.16 29.75 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.578 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.1 mt -113.03 132.99 22.12 Favored Pre-proline 0 N--CA 1.492 1.625 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.075 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.11 160.64 43.72 Favored 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 120.94 1.093 . . . . 0.0 111.208 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.85 -159.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 121.615 1.543 . . . . 0.0 111.017 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.437 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 84.32 176.36 51.06 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.318 -1.42 . . . . 0.0 111.001 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.646 ' CA ' HH21 ' A' ' 83' ' ' ARG . 1.4 p30 -103.3 135.92 44.04 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.543 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.822 ' OH ' HD12 ' A' ' 82' ' ' ILE . 51.6 p90 -158.31 -174.61 4.89 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.119 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.842 HG23 ' N ' ' A' ' 26' ' ' ARG . 5.4 t -161.03 -150.02 0.19 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.396 -1.321 . . . . 0.0 112.297 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.842 ' N ' HG23 ' A' ' 25' ' ' THR . 11.9 ttt-85 -56.79 -31.04 64.27 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.253 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.612 ' H ' HG23 ' A' ' 25' ' ' THR . . . -60.99 -63.35 1.33 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.569 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.55 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 14.9 tp60 -57.48 -44.28 84.78 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.485 -1.286 . . . . 0.0 109.822 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.503 ' HA ' HD23 ' A' ' 29' ' ' LEU . 27.6 mt -58.78 -37.6 76.66 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.71 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.35 -33.71 44.19 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 118.537 -1.265 . . . . 0.0 107.762 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -66.44 -40.84 89.71 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.375 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.491 HD12 HD23 ' A' ' 29' ' ' LEU . 14.3 mt -72.81 -80.84 0.06 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.79 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 32' ' ' LEU . . . 161.58 -29.18 0.29 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.841 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.441 HD13 HG21 ' A' ' 34' ' ' ILE . 9.8 tt -82.64 151.13 4.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.724 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 4.3 pt-20 -179.93 146.25 0.24 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.552 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 4.0 t30 74.61 -143.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.065 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.548 HD22 ' N ' ' A' ' 37' ' ' ASN . 1.3 m-80 -58.79 82.08 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.612 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 40' ' ' SER . 43.4 p -149.33 -46.36 0.14 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.226 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mt -68.45 71.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.623 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 38' ' ' THR . 33.5 t -75.31 -72.1 0.32 Allowed 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.403 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.446 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -95.64 167.43 11.3 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.965 -1.094 . . . . 0.0 109.626 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.32 154.37 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 118.786 -1.166 . . . . 0.0 112.394 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -145.1 104.01 3.92 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.75 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.6 t -126.5 111.26 23.14 Favored Pre-proline 0 N--CA 1.496 1.842 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.63 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.37 168.21 18.48 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 121.081 1.187 . . . . 0.0 110.808 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.93 -170.22 0.1 OUTLIER 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 121.843 1.695 . . . . 0.0 110.971 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.85 -12.04 31.46 Favored Glycine 0 N--CA 1.48 1.614 0 C-N-CA 118.829 -1.653 . . . . 0.0 109.627 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.611 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -155.87 149.47 11.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.448 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.09 127.2 51.41 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.616 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.61 157.02 17.47 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.359 -0.936 . . . . 0.0 113.096 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.49 ' C ' HD12 ' A' ' 52' ' ' LEU . 60.3 mt -136.11 115.41 16.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.453 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.941 HD12 ' N ' ' A' ' 52' ' ' LEU . 2.1 mp -89.97 161.22 16.0 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.857 -1.137 . . . . 0.0 112.763 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.506 ' OH ' ' NE2' ' A' ' 62' ' ' GLN . 5.5 m-85 -140.58 109.95 6.25 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.782 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.687 HE21 ' ND2' ' A' ' 55' ' ' ASN . 11.7 tt0 -43.52 -87.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.035 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.687 ' ND2' HE21 ' A' ' 54' ' ' GLN . 3.3 m120 -59.92 145.45 45.85 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.093 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.19 -174.92 0.06 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.518 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.84 26.7 58.25 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.178 -1.487 . . . . 0.0 110.025 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 55.31 65.03 1.59 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.51 175.35 10.63 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.439 -0.905 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.25 168.0 32.07 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.257 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -49.3 129.17 18.09 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.348 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.506 ' NE2' ' OH ' ' A' ' 53' ' ' TYR . 1.4 pt20 -101.0 179.04 4.5 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.119 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.808 HD11 HD11 ' A' ' 75' ' ' LEU . 4.7 mt -144.04 169.01 10.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.404 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.49 ' H ' HG22 ' A' ' 63' ' ' ILE . 38.7 tt0 -145.09 128.62 17.04 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.955 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.41 HG13 ' C ' ' A' ' 64' ' ' GLU . 18.7 m -149.31 167.14 3.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.902 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 48' ' ' VAL . 2.6 t -146.64 -2.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.527 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.549 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -126.42 -154.11 0.61 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.882 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.435 HD21 HG13 ' A' ' 106' ' ' VAL . 0.8 OUTLIER -96.05 155.18 16.86 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.566 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.42 87.06 2.35 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.225 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -51.9 -43.15 63.23 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.346 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 72' ' ' LEU . 5.5 mm-40 -123.88 81.19 1.88 Allowed 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.586 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.464 HD22 HD22 ' A' ' 76' ' ' ASN . 1.2 tp -28.96 -81.22 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.702 0.626 . . . . 0.0 112.545 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.31 -165.92 36.63 Favored Glycine 0 N--CA 1.497 2.701 0 C-N-CA 118.901 -1.618 . . . . 0.0 111.09 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.459 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.8 Cg_endo -67.37 -44.21 5.02 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 122.148 1.899 . . . . 0.0 112.055 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.808 HD11 HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -69.74 10.45 0.38 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.059 -1.056 . . . . 0.0 111.289 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.474 HD21 ' HA ' ' A' ' 40' ' ' SER . 20.4 t-20 -70.13 1.45 4.7 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.61 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -74.7 -5.2 41.85 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.712 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -167.3 124.42 1.2 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.295 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.4 t -145.97 140.24 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.67 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 m -159.7 -31.92 0.06 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.092 -1.043 . . . . 0.0 112.292 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.49 ' HG ' ' HG1' ' A' ' 25' ' ' THR . 3.0 m -103.86 142.93 33.54 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.439 -0.905 . . . . 0.0 111.339 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.822 HD12 ' OH ' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -149.15 162.2 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.73 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.851 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -146.06 116.38 7.49 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.396 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.851 ' H ' HH22 ' A' ' 83' ' ' ARG . 10.2 t -119.3 137.77 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 120.056 -0.657 . . . . 0.0 111.636 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.588 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 4.5 mt -139.13 126.67 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.51 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.5 p -40.54 154.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.585 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.491 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.9 OUTLIER -150.93 146.79 19.65 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.65 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.491 ' HD2' HG22 ' A' ' 87' ' ' VAL . 5.0 Cg_exo -51.18 159.35 2.82 Favored 'Trans proline' 0 C--N 1.325 -0.7 0 C-N-CA 121.805 1.67 . . . . 0.0 112.164 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 89' ' ' VAL . 33.8 m -69.67 134.68 29.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.326 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -140.25 124.58 10.85 Favored Pre-proline 0 N--CA 1.489 1.488 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.113 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -59.79 -164.11 0.03 OUTLIER 'Trans proline' 0 C--O 1.21 -0.912 0 C-N-CA 120.758 0.972 . . . . 0.0 110.516 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.4 ' CA ' HD12 ' A' ' 136' ' ' LEU . 20.8 ptt-85 -177.48 -160.29 0.05 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.913 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.435 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -138.81 154.25 48.45 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.92 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -123.94 122.26 37.49 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.812 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 24.8 m-85 -108.71 151.41 26.22 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.041 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.405 ' CD2' ' HA ' ' A' ' 101' ' ' PHE . 31.3 m-85 -118.53 159.06 24.22 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.927 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.45 ' HB2' ' N ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -78.68 -83.29 0.09 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 118.162 -1.415 . . . . 0.0 111.781 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.677 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 4.6 mmmm -56.07 157.87 4.33 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.6 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 29.2 tt0 -79.62 86.62 5.23 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.524 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.952 HE21 ' C ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 162.77 48.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.625 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 24.7 p90 39.96 41.06 0.82 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.102 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.602 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 43.1 m-20 -142.75 -174.46 4.17 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.635 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.484 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 75.89 161.77 11.18 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 118.92 -1.609 . . . . 0.0 109.498 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 103' ' ' GLY . 7.3 mtpm? -27.58 122.82 0.1 Allowed 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 121.244 0.545 . . . . 0.0 112.09 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 105' ' ' GLU . 0.7 OUTLIER -102.09 137.21 40.66 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.572 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.836 HG21 ' O ' ' A' ' 122' ' ' GLY . 3.0 t -138.73 151.57 24.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.021 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -143.66 151.15 39.74 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.098 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.8 mt -139.25 143.81 37.88 Favored Pre-proline 0 N--CA 1.497 1.876 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.617 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 6.4 Cg_endo -71.23 170.17 18.9 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 121.724 1.616 . . . . 0.0 111.052 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.407 ' HA ' ' CG2' ' A' ' 172' ' ' ILE . 3.7 Cg_exo -60.44 141.55 95.83 Favored 'Trans proline' 0 C--N 1.321 -0.921 0 C-N-CA 121.728 1.619 . . . . 0.0 110.972 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.649 ' C ' ' NE2' ' A' ' 112' ' ' GLN . . . 150.2 -153.78 25.27 Favored Glycine 0 N--CA 1.497 2.759 0 C-N-CA 118.675 -1.726 . . . . 0.0 111.49 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.649 ' NE2' ' C ' ' A' ' 111' ' ' GLY . 11.7 mp0 -131.36 148.16 52.64 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.614 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.631 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 3.3 m-85 -139.63 157.15 46.27 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.606 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.4 p -119.0 -175.46 2.91 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -77.88 47.78 0.66 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.216 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.41 -56.47 0.09 Allowed 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.329 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.482 ' HG2' ' N ' ' A' ' 118' ' ' LEU . 1.7 tt0 -76.77 -58.0 3.53 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.543 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -36.99 -69.5 0.11 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.74 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.45 ' OE1' ' ND2' ' A' ' 125' ' ' ASN . 0.6 OUTLIER -49.57 -63.12 1.2 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.166 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.435 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 0.1 OUTLIER -75.86 24.18 0.13 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.284 -0.966 . . . . 0.0 112.575 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.461 ' CG ' ' O ' ' A' ' 121' ' ' TYR . 33.7 t80 -131.81 -9.16 3.53 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.368 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.836 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -150.28 -46.94 0.02 OUTLIER Glycine 0 C--N 1.29 -1.998 0 C-N-CA 118.87 -1.633 . . . . 0.0 110.526 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.455 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -141.18 -98.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.281 -0.967 . . . . 0.0 110.66 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.455 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 7.4 t0 -168.37 -166.2 0.67 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.729 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.45 ' ND2' ' OE1' ' A' ' 119' ' ' GLU . 10.0 m120 -59.75 -6.79 1.32 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.134 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.464 ' CG ' ' H ' ' A' ' 127' ' ' THR . 44.5 t30 -172.09 -134.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.189 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.464 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 0.5 OUTLIER 36.56 69.07 0.22 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.203 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.5 ' O ' ' CB ' ' A' ' 129' ' ' SER . 8.0 mm -102.25 -86.68 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.388 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 84.83 -166.54 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' SER . 10.9 m -17.98 120.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.7 -1.591 . . . . 0.0 114.703 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.76 149.83 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.544 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -143.82 95.69 5.71 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 119.536 -0.865 . . . . 0.0 110.863 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -53.78 112.46 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.16 1.24 . . . . 0.0 111.099 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.435 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 44.6 tp60 -79.46 -17.27 54.59 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.84 -32.68 0.02 OUTLIER Glycine 0 N--CA 1.488 2.158 0 C-N-CA 118.752 -1.689 . . . . 0.0 111.93 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.4 HD12 ' CA ' ' A' ' 92' ' ' ARG . 0.4 OUTLIER -121.26 156.38 32.61 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.155 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.29 153.43 39.37 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 118.863 -1.135 . . . . 0.0 110.077 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.9 140.21 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.859 -0.736 . . . . 0.0 112.046 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.93 127.19 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.231 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 mp -105.79 148.95 26.92 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 119.396 -0.922 . . . . 0.0 113.211 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' A' ' 141' ' ' PHE . 2.4 m-85 -121.34 146.34 46.95 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.754 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -107.86 43.08 1.24 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.302 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -169.91 156.28 6.11 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.856 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 146' ' ' PHE . 32.0 t70 -57.75 175.83 0.17 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.298 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.642 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 8.0 p-10 34.59 32.44 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.964 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.642 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.3 p90 40.72 64.8 0.89 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.198 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.505 ' CB ' ' ND2' ' A' ' 145' ' ' ASN . 25.6 t -144.19 97.05 2.98 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.865 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.96 -156.79 28.03 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -60.21 157.62 13.01 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.963 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.5 p -150.14 170.94 17.73 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.984 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.471 ' C ' HD23 ' A' ' 151' ' ' LEU . 1.2 tt -142.44 91.33 7.69 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.035 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.32 107.37 1.57 Allowed 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.945 1.764 . . . . 0.0 113.598 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.6 t -84.12 89.15 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.089 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.62 HD22 ' C ' ' A' ' 154' ' ' ASN . 0.4 OUTLIER -80.73 11.58 3.76 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.4 p -170.04 -171.81 1.22 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.62 -1.632 . . . . 0.0 113.136 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -58.1 148.37 26.76 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.028 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.599 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -166.53 74.85 1.15 Allowed Pre-proline 0 C--N 1.304 -1.378 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.954 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.78 21.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.734 1.623 . . . . 0.0 111.999 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.599 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.4 OUTLIER -169.42 112.68 0.51 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.795 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.0 tp -146.64 17.95 1.3 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.195 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -82.43 48.17 3.9 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.241 -1.457 . . . . 0.0 110.299 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.98 32.68 0.1 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 119.256 -0.977 . . . . 0.0 111.117 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 11.7 tpt -156.77 -51.27 0.08 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.606 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 164' ' ' ASN . 23.5 p-10 -65.66 96.26 0.26 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.502 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -83.67 115.83 22.35 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.216 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.7 m120 49.43 89.13 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.509 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 13.1 m -76.14 98.28 4.34 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.955 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 9.1 m -82.82 -40.1 20.82 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.72 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.49 159.83 41.7 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.619 -1.233 . . . . 0.0 111.139 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.414 HG12 ' CD1' ' A' ' 118' ' ' LEU . 15.5 pt -140.64 163.02 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.22 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -145.07 102.39 3.75 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.025 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.407 ' CG2' ' HA ' ' A' ' 110' ' ' PRO . 4.9 mt -81.63 100.66 5.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.439 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.896 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.939 0.399 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.523 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . -168.85 -155.06 0.14 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.879 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 2.0 p-10 -172.66 105.66 0.16 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.111 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.582 HG22 HG22 ' A' ' 44' ' ' VAL . 28.6 pt -72.09 156.75 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.622 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -139.75 126.91 21.13 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.818 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -107.28 179.0 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 119.848 -0.741 . . . . 0.0 112.412 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.769 ' CZ ' ' CE1' ' A' ' 12' ' ' PHE . 32.5 m-85 -132.47 144.7 50.64 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.112 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.94 -46.97 27.07 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.551 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 2.4 m-80 -89.33 162.63 15.72 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.296 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.504 ' C ' ' CG ' ' A' ' 11' ' ' ASP . 12.8 mt-10 -72.94 158.48 35.39 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.245 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.1 OUTLIER 76.02 44.73 0.13 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.612 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.769 ' CE1' ' CZ ' ' A' ' 7' ' ' PHE . 70.2 t80 52.78 10.88 0.17 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.631 -0.828 . . . . 0.0 112.079 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.447 ' HG3' ' H ' ' A' ' 14' ' ' GLY . 1.6 tp60 -99.72 171.41 7.91 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.581 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.551 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 86.42 135.71 4.16 Favored Glycine 0 N--CA 1.502 3.072 0 C-N-CA 119.904 -1.141 . . . . 0.0 111.267 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 14' ' ' GLY . 15.9 mtpp -31.46 141.47 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.913 0.419 . . . . 0.0 111.727 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.588 ' NE2' ' CZ ' ' A' ' 7' ' ' PHE . 2.3 pt20 -110.14 172.52 6.81 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.873 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.3 t -146.79 133.91 14.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.414 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -89.93 139.94 30.11 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.312 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.0 mt -135.69 133.02 19.85 Favored Pre-proline 0 N--CA 1.493 1.675 0 C-N-CA 120.026 -0.669 . . . . 0.0 110.714 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -69.69 155.16 66.88 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 121.081 1.187 . . . . 0.0 110.999 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.66 -166.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.497 1.464 . . . . 0.0 110.803 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.39 -161.03 26.08 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.951 -1.595 . . . . 0.0 110.671 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -128.04 127.42 43.13 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.997 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.435 ' OH ' HD12 ' A' ' 82' ' ' ILE . 7.9 p90 -144.46 -171.58 3.62 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.92 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.0 p -142.62 -170.54 3.23 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.262 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -59.41 -22.07 60.89 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.883 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -60.96 -58.86 6.65 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.882 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.88 ' NE2' HD21 ' A' ' 32' ' ' LEU . 29.2 tp60 -54.92 -44.54 74.31 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.029 -1.069 . . . . 0.0 109.398 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.529 HD22 ' CG2' ' A' ' 34' ' ' ILE . 31.4 mt -57.08 -42.34 80.51 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.294 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -51.3 -30.54 18.46 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.093 -1.043 . . . . 0.0 108.825 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -73.75 -34.76 64.88 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.941 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.88 HD21 ' NE2' ' A' ' 28' ' ' GLN . 11.7 mt -78.88 -72.97 0.36 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.579 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.56 -40.91 0.21 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.529 ' CG2' HD22 ' A' ' 29' ' ' LEU . 10.2 tt -68.89 178.48 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.49 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.634 ' CG ' ' N ' ' A' ' 36' ' ' ASN . 5.5 tt0 178.53 167.32 0.85 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.057 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.634 ' N ' ' CG ' ' A' ' 35' ' ' GLU . 24.4 p30 -36.33 152.75 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.533 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.844 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 78.07 32.76 0.36 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.484 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 39' ' ' ILE . 72.0 p -147.19 -121.61 0.06 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.767 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.891 HD12 HG11 ' A' ' 79' ' ' VAL . 4.5 mt 32.58 62.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.402 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.646 ' OG ' ' N ' ' A' ' 41' ' ' SER . 22.7 p -64.69 -62.3 1.66 Allowed 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.733 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.646 ' N ' ' OG ' ' A' ' 40' ' ' SER . 0.7 OUTLIER -106.73 171.45 7.35 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.262 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -145.48 140.55 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.096 -1.041 . . . . 0.0 111.643 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -129.14 102.19 6.36 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.917 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.582 HG22 HG22 ' A' ' 4' ' ' ILE . 71.5 t -126.62 109.39 22.95 Favored Pre-proline 0 N--CA 1.49 1.537 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.618 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -67.6 169.76 15.2 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 121.049 1.166 . . . . 0.0 110.633 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.21 -170.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.844 1.696 . . . . 0.0 111.185 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.2 -11.8 7.94 Favored Glycine 0 N--CA 1.483 1.827 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.698 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.523 HG11 ' HB3' ' A' ' 2' ' ' ALA . 35.3 m -150.18 134.95 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 118.944 -1.102 . . . . 0.0 111.799 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -104.35 132.03 51.05 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.247 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.619 ' HB3' HG23 ' A' ' 65' ' ' VAL . . . -110.8 154.86 23.36 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.479 -0.889 . . . . 0.0 112.844 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.585 HG22 ' CE1' ' A' ' 53' ' ' TYR . 12.0 mt -146.32 112.01 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.103 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 mp -89.56 152.09 21.6 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.704 -1.198 . . . . 0.0 112.477 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.585 ' CE1' HG22 ' A' ' 51' ' ' ILE . 53.5 m-85 -129.48 110.9 12.25 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.315 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.692 HE21 ' H ' ' A' ' 61' ' ' ASP . 3.2 tt0 -48.61 -55.45 11.19 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.631 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -85.67 147.67 26.26 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.032 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -56.38 178.1 0.06 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.776 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.34 27.22 60.29 Favored Glycine 0 N--CA 1.488 2.105 0 C-N-CA 119.346 -1.407 . . . . 0.0 110.173 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.497 ' C ' ' CD2' ' A' ' 53' ' ' TYR . 12.4 m-85 56.29 67.44 1.0 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.876 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.23 -170.43 3.65 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.97 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.09 -177.23 39.36 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.425 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.692 ' H ' HE21 ' A' ' 54' ' ' GLN . 38.1 t0 -45.19 107.64 0.1 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.355 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -91.05 151.35 21.06 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.642 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.736 HG22 ' N ' ' A' ' 64' ' ' GLU . 8.5 mm -131.31 170.3 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.36 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.736 ' N ' HG22 ' A' ' 63' ' ' ILE . 27.8 mt-10 -146.48 132.61 19.34 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.694 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 50' ' ' ALA . 17.6 m -150.45 147.91 15.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 118.964 -1.094 . . . . 0.0 111.698 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 t -130.61 0.93 2.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.432 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -134.41 -151.19 0.42 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.684 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -97.25 119.12 35.18 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.105 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.539 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.58 101.7 14.38 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.178 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -55.13 -35.98 65.26 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.346 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 72' ' ' LEU . 8.6 tp10 -140.16 96.51 3.06 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.611 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.42 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 1.5 tp -37.97 -84.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.099 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 178.91 -168.64 39.64 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.095 -1.526 . . . . 0.0 110.719 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.21 -6.3 15.87 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.097 1.865 . . . . 0.0 111.859 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.683 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -92.11 13.98 17.34 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.022 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -72.55 -5.16 35.15 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.518 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -89.21 -6.84 56.57 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.107 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -166.1 104.88 0.66 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 118.714 -1.194 . . . . 0.0 111.711 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.981 HG12 ' H ' ' A' ' 80' ' ' SER . 11.6 t -113.5 -167.81 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.415 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.981 ' H ' HG12 ' A' ' 79' ' ' VAL . 0.3 OUTLIER 159.48 -59.33 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.449 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.413 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 2.6 m -108.5 145.83 34.12 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.307 -0.957 . . . . 0.0 113.317 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.435 HD12 ' OH ' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -141.21 154.26 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.915 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.737 ' NH1' ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.61 128.5 25.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.333 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.737 ' CA ' ' NH1' ' A' ' 83' ' ' ARG . 6.5 t -138.1 132.94 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.329 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 68.1 mt -129.31 128.69 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.806 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 m -42.3 153.49 0.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.213 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.598 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.5 OUTLIER -147.56 148.62 31.56 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.753 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.598 ' HD2' HG22 ' A' ' 87' ' ' VAL . 5.4 Cg_exo -55.48 127.76 27.57 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.229 1.286 . . . . 0.0 110.946 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 p -59.43 136.38 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.478 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -139.71 152.76 69.14 Favored Pre-proline 0 N--CA 1.486 1.355 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.695 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.485 ' HG2' HD21 ' A' ' 136' ' ' LEU . 3.3 Cg_exo -60.15 -156.88 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.818 0 C-N-CA 121.064 1.176 . . . . 0.0 110.941 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 175.71 -162.05 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.266 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.03 158.57 43.97 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.013 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.91 147.5 35.71 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.935 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.469 ' CE1' HD12 ' A' ' 108' ' ' LEU . 29.9 m-85 -130.48 100.89 5.5 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.425 ' CG ' ' HB3' ' A' ' 105' ' ' GLU . 33.7 m-85 -74.93 177.06 6.57 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.581 -0.847 . . . . 0.0 113.111 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -110.54 159.73 17.27 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.635 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt 59.3 153.98 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.048 0.927 . . . . 0.0 113.182 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.555 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 30.7 tp10 -71.99 105.99 4.1 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.459 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 1.282 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 103.83 46.2 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.01 0 O-C-N 124.981 1.426 . . . . 0.0 109.076 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.631 ' CE1' ' CD ' ' A' ' 100' ' ' GLN . 27.0 p90 31.56 58.56 0.3 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.669 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 102' ' ' ASP . 0.4 OUTLIER -94.54 19.85 9.24 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.939 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -159.64 159.02 30.21 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -48.59 171.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.64 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -129.72 169.69 14.78 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.053 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.35 151.81 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.764 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 23.3 p-10 -98.43 152.78 19.14 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.965 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.469 HD12 ' CE1' ' A' ' 95' ' ' PHE . 54.0 mt -146.09 113.27 4.51 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.268 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 1.6 Cg_endo -65.83 164.43 27.03 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 121.421 1.414 . . . . 0.0 112.061 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.97 146.39 57.87 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 122.268 1.979 . . . . 0.0 111.787 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.11 -156.33 25.52 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.699 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.638 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 18.0 tt0 -135.75 156.99 47.95 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.648 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.638 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 12.0 m-85 -141.07 156.41 46.0 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.428 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.4 p -108.89 -179.2 3.79 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.712 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.431 ' NE2' ' HB3' ' A' ' 168' ' ' SER . 39.2 tt0 -75.9 44.1 0.29 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.19 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.22 -58.94 0.12 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.976 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 121' ' ' TYR . 31.2 tp10 -71.59 -51.44 23.3 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.413 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.63 ' C ' HD23 ' A' ' 118' ' ' LEU . 1.4 tt -36.88 -73.37 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.142 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.532 ' HG3' ' H ' ' A' ' 120' ' ' ARG . 5.4 pt-20 -49.78 -55.54 13.7 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.696 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.532 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -76.66 16.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.752 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.474 ' CG ' ' O ' ' A' ' 121' ' ' TYR . 28.2 t80 -123.64 -12.75 7.62 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.488 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -145.26 -42.65 0.05 OUTLIER Glycine 0 N--CA 1.496 2.636 0 C-N-CA 118.84 -1.648 . . . . 0.0 110.963 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.468 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -142.57 -97.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.606 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.555 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 23.8 t70 -167.4 -170.01 1.36 Allowed 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.745 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.555 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 27.8 t-20 -62.1 -105.63 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.63 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.456 ' N ' ' OD1' ' A' ' 125' ' ' ASN . 1.8 p-10 -67.11 107.9 2.46 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.396 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.772 HG23 HG13 ' A' ' 128' ' ' ILE . 3.1 t -172.9 -165.75 0.32 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.358 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.772 HG13 HG23 ' A' ' 127' ' ' THR . 1.4 mt 66.52 140.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.806 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 160' ' ' LEU . 4.8 m -154.67 -5.51 0.15 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.333 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.5 m -150.94 127.98 11.11 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.176 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -120.26 148.0 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.475 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.93 78.59 19.52 Favored Pre-proline 0 N--CA 1.483 1.198 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.402 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -61.19 97.64 0.13 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.264 1.31 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -91.51 33.23 1.01 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.413 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.72 -58.85 0.04 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 118.691 -1.718 . . . . 0.0 111.356 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.485 HD21 ' HG2' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -120.32 178.05 4.8 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.028 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.62 138.33 31.65 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.24 -0.984 . . . . 0.0 109.701 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.9 141.13 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.73 -0.788 . . . . 0.0 112.152 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.567 HG12 ' CE1' ' A' ' 141' ' ' PHE . 57.7 t -125.54 130.96 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.495 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.0 mp -105.47 137.05 43.92 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.646 -0.822 . . . . 0.0 113.085 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.567 ' CE1' HG12 ' A' ' 139' ' ' VAL . 2.3 m-85 -120.95 128.03 52.36 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.207 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -79.86 -30.64 40.32 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.141 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -83.08 177.77 8.44 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.785 -1.166 . . . . 0.0 111.86 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 146' ' ' PHE . 21.7 t0 -61.73 -105.99 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.875 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.642 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 2.2 m120 -58.54 75.56 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.457 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.642 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.5 p90 32.76 70.39 0.1 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.143 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.18 -161.65 1.18 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.325 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 50.58 -148.66 7.14 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.745 -1.217 . . . . 0.0 111.127 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -78.18 162.39 26.64 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.124 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.0 p -150.66 165.39 33.55 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.539 ' C ' HD23 ' A' ' 151' ' ' LEU . 3.2 tt -133.19 90.91 29.33 Favored Pre-proline 0 N--CA 1.484 1.238 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.08 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.4 ' HB2' HD21 ' A' ' 154' ' ' ASN . 3.9 Cg_exo -64.41 105.52 0.62 Allowed 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 121.589 1.526 . . . . 0.0 112.748 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.45 84.44 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.551 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.4 HD21 ' HB2' ' A' ' 152' ' ' PRO . 11.9 m-80 -77.05 12.83 1.25 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.624 -0.83 . . . . 0.0 112.407 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -170.69 -167.49 0.59 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 118.214 -1.395 . . . . 0.0 112.361 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.55 152.05 19.13 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.576 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.564 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -169.13 65.47 0.58 Allowed Pre-proline 0 C--N 1.308 -1.225 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.269 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.0 OUTLIER -65.76 23.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 122.171 1.914 . . . . 0.0 112.046 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.652 ' O ' HD12 ' A' ' 160' ' ' LEU . 3.0 t -166.5 138.7 3.68 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.782 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.652 HD12 ' O ' ' A' ' 159' ' ' THR . 0.3 OUTLIER -160.11 -78.22 0.06 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.221 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 163' ' ' MET . . . 42.97 -92.46 0.01 OUTLIER Glycine 0 N--CA 1.493 2.479 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.77 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -37.54 -25.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.291 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 161' ' ' GLY . 0.8 OUTLIER -75.61 -58.91 3.0 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.63 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.829 HD21 ' N ' ' A' ' 167' ' ' THR . 8.0 t30 -90.46 173.56 8.02 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.022 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.538 ' N ' ' ND2' ' A' ' 164' ' ' ASN . 2.7 t-20 -156.12 -12.1 0.1 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.271 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.461 HD21 ' ND2' ' A' ' 125' ' ' ASN . 2.6 t-20 -169.69 58.19 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.473 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.829 ' N ' HD21 ' A' ' 164' ' ' ASN . 85.2 m -42.27 104.43 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.32 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.431 ' HB3' ' NE2' ' A' ' 115' ' ' GLN . 0.2 OUTLIER -87.89 -61.3 1.75 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.017 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.4 p -123.61 158.99 30.23 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.947 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.427 HG12 ' CD1' ' A' ' 118' ' ' LEU . 13.1 pt -142.0 162.21 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.176 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.441 ' CZ ' ' OG ' ' A' ' 173' ' ' SER . 2.6 ttt-85 -142.44 102.7 4.13 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.015 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 172' ' ' ILE . 7.9 mt -84.01 93.81 3.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.757 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.441 ' OG ' ' CZ ' ' A' ' 171' ' ' ARG . 4.4 m . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 116.363 -1.78 . . . . 0.0 110.813 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptp . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.6 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -150.11 156.64 42.01 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.187 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -178.22 115.93 0.08 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.545 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.412 ' H ' HG23 ' A' ' 4' ' ' ILE . 2.9 pt -61.98 129.12 24.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.707 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -107.67 122.33 46.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.407 HG12 HG22 ' A' ' 42' ' ' VAL . 5.1 m -112.49 150.65 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.726 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.611 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 12.5 m-85 -103.92 156.13 18.09 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.654 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.9 -35.8 23.82 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.247 -0.981 . . . . 0.0 113.048 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.489 ' C ' ' OG ' ' A' ' 40' ' ' SER . 14.1 m120 -104.49 170.89 7.63 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.259 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' A' ' 11' ' ' ASP . 4.2 tp10 -76.52 -176.34 3.69 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.471 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.458 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 1.1 m-20 51.79 42.48 29.98 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.073 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.611 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 21.4 t80 54.1 6.57 0.1 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.652 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.453 ' H ' ' C ' ' A' ' 11' ' ' ASP . 7.3 tt0 -87.13 170.99 11.03 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.503 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 89.19 120.35 1.84 Allowed Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.587 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 14' ' ' GLY . 6.9 mtpm? -28.85 137.54 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 O-C-N 123.95 0.441 . . . . 0.0 111.731 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -105.43 133.07 50.79 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 p -108.1 153.41 9.6 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.039 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.811 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.07 140.2 34.64 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.543 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 mt -132.05 126.84 20.81 Favored Pre-proline 0 N--CA 1.493 1.688 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.205 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.54 151.3 83.21 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 121.026 1.151 . . . . 0.0 111.579 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.33 -164.6 0.06 OUTLIER 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 121.609 1.539 . . . . 0.0 111.484 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.57 179.93 46.29 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.454 -1.355 . . . . 0.0 111.066 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.84 ' CB ' ' HE ' ' A' ' 83' ' ' ARG . 1.7 m120 -90.4 121.95 32.83 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.914 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.8 ' N ' HH21 ' A' ' 83' ' ' ARG . 0.2 OUTLIER -144.33 154.99 43.6 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.315 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.42 HG22 ' OG ' ' A' ' 81' ' ' SER . 21.0 p -144.4 -150.76 0.33 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.858 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 30' ' ' ALA . 10.0 mtm180 -55.89 -37.16 68.47 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.18 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.653 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -53.44 -59.11 5.0 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.269 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.09 -47.32 75.1 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 118.695 -1.202 . . . . 0.0 109.411 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 32' ' ' LEU . 21.5 mt -61.09 -28.58 69.19 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.442 -1.303 . . . . 0.0 109.023 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -54.34 -33.43 58.96 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.2 -29.94 60.48 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.587 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 29' ' ' LEU . 14.7 mt -85.75 -91.72 0.09 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.338 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.45 13.45 0.26 Allowed Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.225 -1.464 . . . . 0.0 111.54 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.573 HG13 HG21 ' A' ' 38' ' ' THR . 1.0 OUTLIER -95.08 -38.81 9.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.635 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.558 ' N ' ' CG1' ' A' ' 34' ' ' ILE . 3.7 pt-20 -12.9 132.21 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.803 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.677 ' C ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER 84.77 135.06 0.05 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 114.359 -1.291 . . . . 0.0 113.737 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 40.27 39.23 0.64 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.72 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.862 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 52.5 p -106.38 -141.3 0.37 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.929 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.491 ' H ' HD13 ' A' ' 39' ' ' ILE . 1.4 mm 30.86 41.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.958 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.489 ' OG ' ' C ' ' A' ' 9' ' ' ASN . 2.1 t -48.77 -38.98 23.41 Favored 'General case' 0 C--N 1.282 -2.342 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.064 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.67 176.56 8.59 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -150.63 146.63 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 117.76 -1.576 . . . . 0.0 113.075 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -136.09 102.1 4.92 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.359 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.6 t -122.71 104.33 36.6 Favored Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.381 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -69.48 171.01 14.92 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.077 1.185 . . . . 0.0 109.991 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.0 -173.19 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.494 1.463 . . . . 0.0 110.907 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.77 -21.72 7.38 Favored Glycine 0 N--CA 1.484 1.849 0 C-N-CA 119.109 -1.52 . . . . 0.0 110.551 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.6 HG11 ' CB ' ' A' ' 2' ' ' ALA . 25.1 m -148.97 141.98 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 118.921 -1.112 . . . . 0.0 112.176 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -110.18 139.2 45.58 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.739 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.21 155.03 42.46 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 118.964 -1.094 . . . . 0.0 113.2 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 63' ' ' ILE . 4.4 mp -134.34 120.84 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.199 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.915 HD12 ' N ' ' A' ' 52' ' ' LEU . 2.2 mp -94.62 155.66 16.78 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 118.744 -1.182 . . . . 0.0 112.942 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.478 ' CE1' ' HB3' ' A' ' 62' ' ' GLN . 40.5 m-85 -140.7 117.5 11.03 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.723 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.498 ' HG3' ' N ' ' A' ' 55' ' ' ASN . 6.4 pt20 -57.58 -41.94 82.12 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.363 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.521 ' HB3' ' HB3' ' A' ' 59' ' ' ALA . 19.7 t30 -93.26 142.99 26.7 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.24 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 0.3 OUTLIER -54.49 171.09 0.13 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.487 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.663 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 58.82 34.83 79.59 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.162 -1.494 . . . . 0.0 109.43 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.795 ' H ' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER 44.26 74.16 0.13 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.316 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 55' ' ' ASN . . . -147.22 168.18 22.35 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.082 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.24 -166.69 48.37 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.525 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.448 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 3.7 m-20 -50.92 117.09 2.29 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.448 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.478 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 3.9 pt20 -99.82 151.45 21.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.887 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.603 ' O ' HG23 ' A' ' 51' ' ' ILE . 1.8 mt -127.79 166.0 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.922 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.558 ' OE1' ' N ' ' A' ' 64' ' ' GLU . 46.0 mp0 -142.77 130.52 21.51 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.24 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.402 HG13 ' C ' ' A' ' 64' ' ' GLU . 35.2 m -150.45 164.8 2.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.936 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.0 t -149.94 -1.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.158 -1.383 . . . . 0.0 107.881 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.72 -153.36 0.56 Allowed 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.624 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 68' ' ' ASN . 1.2 p-10 -98.32 114.03 26.19 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.53 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.574 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.72 98.9 12.03 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.425 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -54.78 -73.96 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.726 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 73' ' ' GLY . 24.6 mm-40 -80.9 -0.16 37.9 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.797 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.44 HD22 ' O ' ' A' ' 39' ' ' ILE . 5.2 tp 60.09 -79.88 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.219 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 171.08 -179.06 43.17 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.129 -1.51 . . . . 0.0 110.804 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.2 Cg_endo -65.1 -40.14 21.23 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.433 2.089 . . . . 0.0 112.421 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.955 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.1 pt? -71.3 27.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.16 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.798 ' H ' HD22 ' A' ' 76' ' ' ASN . 0.7 OUTLIER -76.98 6.97 5.38 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.573 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -88.52 -9.41 52.47 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.967 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -157.85 130.69 7.42 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.136 -1.026 . . . . 0.0 111.219 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.862 ' CG2' ' H ' ' A' ' 38' ' ' THR . 15.3 m -140.09 164.93 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.533 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 174.64 -56.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.872 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.795 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 22.3 m -96.67 141.08 30.35 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.347 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.731 HD12 ' OH ' ' A' ' 24' ' ' TYR . 18.3 mt -150.57 128.25 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.974 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.84 ' HE ' ' CB ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -103.94 125.93 50.7 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.808 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -133.27 133.72 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.978 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.87 139.87 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.635 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.2 p -45.94 149.82 0.62 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.234 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.622 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -153.29 142.89 14.99 Favored Pre-proline 0 N--CA 1.484 1.264 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.866 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.622 ' HD2' HG22 ' A' ' 87' ' ' VAL . 2.7 Cg_exo -52.29 148.5 25.2 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 121.432 1.421 . . . . 0.0 111.811 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.403 HG13 ' H ' ' A' ' 89' ' ' VAL . 2.2 m -76.23 145.38 10.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.993 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -146.13 136.51 12.15 Favored Pre-proline 0 C--N 1.304 -1.388 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.963 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -60.33 -156.67 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.869 0 C-N-CA 121.178 1.252 . . . . 0.0 110.687 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.559 ' N ' ' CD ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -175.55 -164.53 0.14 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.354 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.37 165.47 25.4 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.027 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.616 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -128.66 151.46 49.48 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.777 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 1.2 m-85 -142.43 139.92 31.79 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.534 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.517 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 27.7 m-85 -95.09 179.74 5.1 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 118.414 -1.314 . . . . 0.0 112.492 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.456 ' CE1' HG22 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -101.65 -74.75 0.61 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.023 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.521 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 25.9 tttm -63.29 160.6 15.48 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.858 0.837 . . . . 0.0 112.499 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.587 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -71.7 103.45 3.07 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.477 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.868 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.8 OUTLIER 113.1 55.48 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.496 0 O-C-N 125.245 1.591 . . . . 0.0 111.056 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.561 ' O ' ' CD2' ' A' ' 101' ' ' PHE . 17.9 p90 28.52 41.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.492 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.566 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 6.4 p-10 -115.26 24.15 11.88 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.66 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.521 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -139.42 150.45 21.34 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.8 OUTLIER -33.34 142.21 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.598 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.404 ' O ' ' CD ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -105.66 162.95 13.06 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.635 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.787 HG21 ' O ' ' A' ' 122' ' ' GLY . 1.4 t -132.62 167.57 26.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.476 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.536 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 2.6 p30 -150.18 149.0 29.61 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.099 -1.44 . . . . 0.0 112.438 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.437 HD22 ' CD2' ' A' ' 121' ' ' TYR . 14.2 mt -137.22 143.2 40.73 Favored Pre-proline 0 N--CA 1.499 1.98 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.446 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.81 166.43 27.69 Favored 'Trans proline' 0 C--O 1.212 -0.782 0 C-N-CA 121.789 1.66 . . . . 0.0 112.346 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.89 145.98 95.01 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 122.296 1.997 . . . . 0.0 111.233 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.17 -143.27 12.63 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.279 -1.438 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.597 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 10.5 tt0 -146.46 154.27 41.39 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.165 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.597 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 8.4 m-85 -138.64 152.89 48.49 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.102 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.6 p -88.43 -166.84 1.7 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.669 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -96.57 51.17 1.16 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.389 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.58 -68.81 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.35 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 121' ' ' TYR . 8.6 pt-20 -68.54 -41.68 79.52 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.891 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.61 ' C ' HD23 ' A' ' 118' ' ' LEU . 0.9 OUTLIER -37.49 -75.07 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.633 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.697 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -51.68 -52.2 49.97 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.574 -0.851 . . . . 0.0 110.855 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -74.57 16.33 0.28 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.961 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 117' ' ' GLU . 17.8 t80 -124.52 -13.8 6.99 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.517 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.787 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -138.13 -52.94 0.05 OUTLIER Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.506 -1.33 . . . . 0.0 110.603 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.679 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -138.4 -101.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.407 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.511 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 32.0 t70 -164.41 176.79 8.73 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.162 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.541 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 45.7 t30 -59.83 137.61 58.01 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.843 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.677 ' O ' HG22 ' A' ' 127' ' ' THR . 7.4 p30 43.59 -151.07 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.914 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.677 HG22 ' O ' ' A' ' 126' ' ' ASN . 13.7 t 48.35 20.09 0.26 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.59 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.487 ' O ' ' CB ' ' A' ' 129' ' ' SER . 7.4 mm -50.57 -84.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.927 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 1.2 p 80.51 120.01 0.05 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.444 ' H ' ' H ' ' A' ' 160' ' ' LEU . 0.9 OUTLIER 51.44 114.16 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.022 -1.445 . . . . 0.0 114.197 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.409 HG13 ' CD2' ' A' ' 95' ' ' PHE . 3.6 t -121.47 134.55 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.571 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.4 ttmm -131.32 99.37 17.57 Favored Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.664 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.85 107.43 1.87 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.018 1.145 . . . . 0.0 110.47 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -86.29 11.14 12.82 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.843 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.5 -45.73 0.04 OUTLIER Glycine 0 N--CA 1.494 2.564 0 C-N-CA 118.097 -2.001 . . . . 0.0 111.762 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.23 163.17 18.17 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.154 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 173' ' ' SER . . . -80.44 159.94 25.47 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.79 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 20.8 t -122.41 141.68 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.921 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.421 ' C ' HD12 ' A' ' 140' ' ' LEU . 47.5 t -128.86 130.86 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.71 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 140' ' ' LEU . 11.0 mp -105.22 139.33 40.04 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.319 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 141' ' ' PHE . 3.0 m-85 -121.44 129.23 52.87 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.987 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.469 ' HD2' ' H ' ' A' ' 142' ' ' LYS . 0.1 OUTLIER -77.07 -48.44 17.81 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.484 -0.887 . . . . 0.0 112.228 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.478 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.8 m-80 -74.32 135.78 42.56 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.069 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 143' ' ' ASN . 6.4 m-20 -9.16 -110.42 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.589 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 16.7 m-80 -68.45 86.69 0.3 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 146' ' ' PHE . 1.1 p90 30.32 72.55 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.889 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.7 m -142.67 -160.64 1.12 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.091 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 44.25 -158.01 0.16 Allowed Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.81 -1.186 . . . . 0.0 111.106 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -62.08 163.71 7.65 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.932 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.5 p -150.34 162.9 39.63 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.409 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.7 88.58 53.98 Favored Pre-proline 0 N--CA 1.485 1.296 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.041 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.436 ' HB2' ' ND2' ' A' ' 154' ' ' ASN . 2.9 Cg_endo -66.08 105.3 0.81 Allowed 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.433 1.422 . . . . 0.0 111.965 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.9 t -91.43 69.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.238 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.758 ' H ' HD22 ' A' ' 154' ' ' ASN . 0.6 OUTLIER -81.06 37.28 0.43 Allowed 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.127 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.604 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 13.7 t -170.9 -175.15 1.7 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.061 -1.055 . . . . 0.0 111.161 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.604 ' N ' ' OG ' ' A' ' 155' ' ' SER . 16.3 m-20 -76.78 142.12 40.49 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.559 -0.857 . . . . 0.0 111.141 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.559 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -154.96 74.33 5.62 Favored Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.458 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.23 23.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 122.065 1.843 . . . . 0.0 112.317 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.559 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -171.43 115.71 0.4 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.701 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.444 ' H ' ' H ' ' A' ' 130' ' ' SER . 0.2 OUTLIER -128.74 4.47 5.48 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.719 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -76.03 41.61 1.53 Allowed Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.831 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.52 ' O ' ' SD ' ' A' ' 163' ' ' MET . . . -134.06 24.7 3.9 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.197 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.52 ' SD ' ' O ' ' A' ' 162' ' ' ALA . 63.0 mmm -142.93 59.66 1.42 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.468 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.442 ' C ' ' O ' ' A' ' 163' ' ' MET . 0.6 OUTLIER -29.19 90.02 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.352 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 163' ' ' MET . 8.2 t-20 -160.55 151.8 19.2 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.808 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -96.25 121.05 37.62 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.907 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.4 m -75.97 104.77 6.66 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.835 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.3 t -82.17 -68.0 0.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.732 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.612 ' CB ' ' H ' ' A' ' 146' ' ' PHE . 28.6 m -114.03 163.73 14.76 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.926 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.47 HG23 HD11 ' A' ' 118' ' ' LEU . 22.0 pt -141.02 161.29 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.089 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.409 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 25.1 ttt180 -141.8 98.7 3.39 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.6 mt -77.71 99.49 2.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.037 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 137' ' ' ALA . 39.7 m . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.814 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttt . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.91 0.386 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.544 ' HB1' HG21 ' A' ' 48' ' ' VAL . . . -76.2 167.72 21.34 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.895 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -173.93 123.46 0.33 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.464 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 4' ' ' ILE . 25.9 pt -76.05 148.54 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.5 m -122.89 109.82 14.64 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.243 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 m -100.75 150.93 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.924 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.791 ' CZ ' ' CE1' ' A' ' 12' ' ' PHE . 25.9 m-85 -109.51 163.64 13.25 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.636 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.29 -3.21 47.84 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.051 -1.06 . . . . 0.0 113.681 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.734 HD22 HE22 ' A' ' 13' ' ' GLN . 83.4 m-20 -136.0 164.32 28.26 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.945 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -70.63 176.68 3.97 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.69 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 13' ' ' GLN . 5.9 m-20 57.44 46.55 17.91 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.344 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.791 ' CE1' ' CZ ' ' A' ' 7' ' ' PHE . 85.4 t80 49.91 7.24 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.341 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.734 HE22 HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -92.06 174.27 7.41 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.434 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.69 ' H ' ' CD ' ' A' ' 13' ' ' GLN . . . 93.84 127.33 4.69 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.053 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' GLY . 13.7 mptt -31.38 141.49 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.056 0.455 . . . . 0.0 111.914 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.17 162.71 13.91 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.834 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -148.09 125.22 2.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.964 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -93.15 128.49 39.1 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.971 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.4 mt -122.28 129.82 24.94 Favored Pre-proline 0 N--CA 1.491 1.615 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.728 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -67.96 162.44 39.83 Favored 'Trans proline' 0 C--N 1.325 -0.684 0 C-N-CA 120.806 1.004 . . . . 0.0 111.141 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.04 -161.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 121.667 1.578 . . . . 0.0 110.864 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.4 -179.46 49.32 Favored Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.295 -1.431 . . . . 0.0 111.082 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.729 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.6 OUTLIER -106.21 135.47 47.63 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.204 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.482 ' HE1' HD12 ' A' ' 82' ' ' ILE . 16.5 p90 -152.23 167.75 27.57 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.104 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.6 p -142.05 -161.44 1.23 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.108 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -56.71 -29.2 62.22 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.054 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.18 -67.68 0.43 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.125 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.535 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.7 tp-100 -57.56 -41.46 81.1 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.428 -1.309 . . . . 0.0 110.003 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.466 HD22 ' CG1' ' A' ' 34' ' ' ILE . 28.6 mt -61.04 -39.76 91.01 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.892 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.95 -32.61 33.93 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 118.035 -1.466 . . . . 0.0 107.807 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -68.39 -36.66 79.46 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.318 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.452 HD12 HD23 ' A' ' 29' ' ' LEU . 14.3 mt -74.75 -80.01 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.872 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.46 -22.67 0.09 OUTLIER Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.854 -1.641 . . . . 0.0 111.222 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.466 ' CG1' HD22 ' A' ' 29' ' ' LEU . 6.5 pt -85.39 158.08 3.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.263 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER 170.27 137.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.708 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 8.1 t-20 74.97 -147.3 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.847 -0.741 . . . . 0.0 112.557 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.665 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -58.68 96.7 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.651 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 39' ' ' ILE . 60.6 p -152.1 -142.57 0.12 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.106 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.632 HG13 HG11 ' A' ' 79' ' ' VAL . 2.2 mm 36.82 44.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.323 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.51 ' OG ' ' C ' ' A' ' 9' ' ' ASN . 12.7 t -49.08 -43.01 40.72 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.502 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.2 171.74 13.82 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -152.1 141.85 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 118.093 -1.443 . . . . 0.0 112.954 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -134.05 103.77 5.94 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.943 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.3 t -120.48 108.31 37.8 Favored Pre-proline 0 N--CA 1.494 1.743 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.231 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -67.21 168.73 16.85 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.11 1.206 . . . . 0.0 110.746 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -59.35 -170.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.929 1.753 . . . . 0.0 111.179 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.18 -11.7 11.45 Favored Glycine 0 N--CA 1.483 1.81 0 C-N-CA 119.278 -1.439 . . . . 0.0 110.961 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.544 HG21 ' HB1' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -149.49 141.7 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.114 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.7 tttt -116.01 126.58 54.01 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.542 ' CB ' HG22 ' A' ' 84' ' ' VAL . . . -115.2 165.32 13.06 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.109 -1.036 . . . . 0.0 113.307 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.583 HG23 ' O ' ' A' ' 63' ' ' ILE . 63.2 mt -142.44 120.65 8.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 114.211 -1.359 . . . . 0.0 108.524 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.833 HD23 ' H ' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -92.19 148.38 22.2 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.104 -1.038 . . . . 0.0 112.074 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.833 ' H ' HD23 ' A' ' 52' ' ' LEU . 17.6 m-85 -132.83 114.71 14.4 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.183 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -53.16 -84.29 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.787 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -59.48 149.37 29.83 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.1 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -57.22 -173.01 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.637 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 52.1 32.43 35.42 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.19 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 49.53 45.13 24.27 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.732 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.54 -169.45 1.67 Allowed 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.011 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 68.0 166.38 3.54 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.892 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 60' ' ' GLY . 26.6 t70 -42.78 130.37 4.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.535 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.681 ' CD ' ' H ' ' A' ' 62' ' ' GLN . 5.9 pm0 -99.86 166.06 11.26 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.052 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.711 HG13 HD11 ' A' ' 75' ' ' LEU . 5.5 mm -135.13 169.5 21.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.534 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.658 ' N ' HG22 ' A' ' 63' ' ' ILE . 36.7 mt-10 -146.34 132.45 19.33 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.003 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 m -149.32 151.59 12.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.358 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.3 t -140.2 -0.26 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . . . -130.8 -147.61 0.33 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.669 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.5 119.1 38.0 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.671 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.57 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.36 104.41 16.96 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.861 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -64.32 -77.68 0.05 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.003 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 73' ' ' GLY . 6.5 mm-40 -83.41 1.31 42.11 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.5 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.403 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 3.0 tp 56.63 -89.22 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.55 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 177.82 -166.48 36.76 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.155 -1.498 . . . . 0.0 110.621 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.571 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.9 Cg_endo -66.45 -40.96 12.9 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 122.135 1.89 . . . . 0.0 112.163 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.838 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.9 pt? -68.13 26.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.465 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.571 ' H ' ' C ' ' A' ' 74' ' ' PRO . 34.0 t-20 -68.55 -34.89 76.62 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.574 -0.85 . . . . 0.0 111.277 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -87.98 29.78 0.9 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.098 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -171.88 112.92 0.32 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.335 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.632 HG11 HG13 ' A' ' 39' ' ' ILE . 57.5 t -147.38 155.38 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.902 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.42 ' N ' HG12 ' A' ' 79' ' ' VAL . 21.2 t -171.62 -34.85 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 118.744 -1.182 . . . . 0.0 112.265 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.1 m -116.66 137.91 51.84 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.956 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.482 HD12 ' HE1' ' A' ' 24' ' ' TYR . 1.3 mt -148.6 155.18 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.511 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.849 HH12 ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -149.71 133.49 16.88 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.889 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.849 ' N ' HH12 ' A' ' 83' ' ' ARG . 13.9 t -140.68 148.25 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.911 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.932 HD12 ' H ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -142.41 136.46 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.846 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.6 m -39.91 152.9 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.166 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.59 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -153.24 141.36 13.85 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.224 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.59 ' HD2' HG22 ' A' ' 87' ' ' VAL . 7.8 Cg_exo -49.25 151.08 6.82 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.451 1.434 . . . . 0.0 111.706 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 89' ' ' VAL . 17.6 m -71.51 147.22 11.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.903 -0.719 . . . . 0.0 112.309 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -145.87 129.73 8.55 Favored Pre-proline 0 C--N 1.301 -1.523 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.922 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -58.17 -159.4 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.874 0 C-N-CA 120.987 1.125 . . . . 0.0 110.801 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.481 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -179.58 -161.82 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.162 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.412 ' H ' ' HB2' ' A' ' 92' ' ' ARG . . . -136.27 164.72 27.43 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.841 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 39.7 ttm-85 -121.99 126.17 47.94 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.714 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 11.4 m-85 -116.8 125.31 51.41 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.797 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -84.65 168.07 15.63 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.191 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.437 ' HB3' ' H ' ' A' ' 98' ' ' LYS . 1.2 t80 -80.35 -92.11 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 118.502 -1.279 . . . . 0.0 112.939 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 97' ' ' TYR . 18.8 mmmt -68.22 156.05 38.41 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.932 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 1.091 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 3.5 tm-20 -66.57 85.01 0.11 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.127 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 1.091 ' NE2' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 173.86 30.05 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.202 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.61 ' CD1' ' O ' ' A' ' 101' ' ' PHE . 0.1 OUTLIER 47.81 11.51 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.797 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 100' ' ' GLN . 34.7 t70 -104.4 -177.47 3.37 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.316 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 72.41 128.81 0.1 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.068 -1.539 . . . . 0.0 109.998 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 103' ' ' GLY . 48.1 mttt -30.06 136.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 123.99 0.465 . . . . 0.0 111.438 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -98.96 170.39 8.76 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.502 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 122' ' ' GLY . 29.9 t -137.36 155.31 31.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.69 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -129.24 147.01 51.04 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.654 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.43 HD12 ' CE1' ' A' ' 95' ' ' PHE . 11.1 mt -136.42 139.31 29.25 Favored Pre-proline 0 N--CA 1.501 2.106 0 C-N-CA 119.724 -0.791 . . . . 0.0 110.811 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -71.04 167.75 25.2 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 121.662 1.575 . . . . 0.0 112.193 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.32 150.83 85.71 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 122.101 1.868 . . . . 0.0 111.573 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.18 -168.81 23.6 Favored Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.03 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.594 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 2.2 mp0 -113.74 159.1 20.11 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.6 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 40.7 m-85 -144.84 149.89 36.16 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.755 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.4 p -89.64 -153.06 0.26 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.123 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.422 ' C ' ' CD ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -110.95 31.81 5.75 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.67 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -134.93 -64.31 0.66 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.953 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.6 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 17.2 pt-20 -66.21 -49.37 67.5 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.066 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.6 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -37.12 -67.15 0.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.293 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.736 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 20.6 mp0 -48.2 -66.74 0.35 Allowed 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.14 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -72.44 12.32 0.48 Allowed 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.06 -1.056 . . . . 0.0 113.301 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 117' ' ' GLU . 12.8 t80 -101.97 -21.86 14.41 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.007 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.421 ' O ' HG11 ' A' ' 106' ' ' VAL . . . -165.36 -12.97 0.03 OUTLIER Glycine 0 N--CA 1.486 2.014 0 C-N-CA 118.237 -1.935 . . . . 0.0 110.93 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 123' ' ' ILE . 2.8 mt -145.69 -125.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.876 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -156.98 -160.38 0.96 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.457 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -59.55 -53.62 56.0 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.809 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -155.62 123.68 5.77 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.601 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.41 ' H ' ' H ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 177.71 0.81 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.042 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 130' ' ' SER . 70.5 mt -56.43 -72.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.285 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m 55.7 -85.1 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.776 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 128' ' ' ILE . 15.1 m -72.62 115.74 12.26 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.488 -0.885 . . . . 0.0 112.391 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.4 t -122.7 161.78 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.779 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -165.08 80.51 1.24 Allowed Pre-proline 0 C--N 1.296 -1.726 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.293 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -60.59 102.9 0.2 Allowed 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 121.568 1.512 . . . . 0.0 110.242 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.82 19.71 3.38 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.467 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.12 -50.93 0.03 OUTLIER Glycine 0 N--CA 1.491 2.352 0 C-N-CA 117.91 -2.09 . . . . 0.0 112.191 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.86 179.85 3.96 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.454 -0.899 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -92.1 152.33 19.98 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.776 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 68.2 t -124.11 138.86 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.127 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.503 ' C ' HD12 ' A' ' 140' ' ' LEU . 78.3 t -131.71 128.42 60.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.417 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.503 HD12 ' C ' ' A' ' 139' ' ' VAL . 8.3 mp -103.99 141.77 35.6 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.365 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -114.16 126.98 55.68 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.515 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -59.21 -78.62 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.464 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.2 m-80 -73.71 155.54 38.85 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.816 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 146' ' ' PHE . 5.3 p-10 -62.49 -162.18 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.567 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.497 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 43.7 t30 42.5 24.15 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.675 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.497 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.4 OUTLIER 57.17 54.82 6.45 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.703 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.8 t -130.73 -171.68 2.62 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.305 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 64.11 -177.9 8.27 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.024 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 150' ' ' THR . 25.5 t0 -59.68 177.23 0.22 Allowed 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.262 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.437 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 19.5 p -146.56 178.59 8.17 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.193 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' A' ' 151' ' ' LEU . 11.0 tp -153.07 86.61 4.09 Favored Pre-proline 0 C--N 1.306 -1.303 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.778 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.46 108.07 1.13 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.871 1.714 . . . . 0.0 113.131 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.7 t -82.72 93.59 2.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.788 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.66 HD22 ' N ' ' A' ' 154' ' ' ASN . 1.3 m120 -58.8 -29.35 66.77 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 48.0 p -170.38 -146.36 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 117.986 -1.486 . . . . 0.0 112.854 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 1.1 m-20 -48.98 153.24 0.91 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.99 -1.004 . . . . 0.0 112.491 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.5 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -179.89 65.24 0.14 Allowed Pre-proline 0 N--CA 1.486 1.37 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.206 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.696 ' C ' HG22 ' A' ' 159' ' ' THR . 6.4 Cg_endo -69.03 66.29 1.34 Allowed 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 122.27 1.98 . . . . 0.0 111.959 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.785 HG23 ' H ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER 161.11 -68.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.56 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.785 ' H ' HG23 ' A' ' 159' ' ' THR . 0.9 OUTLIER 57.04 -81.41 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.829 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 159' ' ' THR . . . 47.49 -150.67 2.41 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 118.495 -1.812 . . . . 0.0 109.683 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 44.37 40.93 4.11 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.489 ' C ' ' SD ' ' A' ' 163' ' ' MET . 0.0 OUTLIER -172.92 66.68 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.746 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -60.63 -111.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.75 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 54.49 -123.45 2.08 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.305 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -173.96 121.31 0.3 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.562 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.0 m -70.44 104.91 2.87 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.836 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.2 m -80.98 -66.25 0.91 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.216 -0.993 . . . . 0.0 111.599 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.8 p -118.7 159.89 22.83 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.978 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 23.2 pt -135.53 179.8 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.246 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -159.5 100.99 1.51 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.821 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.8 mt -82.06 96.88 3.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.78 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 116.302 -1.808 . . . . 0.0 111.095 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . 0.614 'CA ' ' OE2' ' A' ' 99' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.475 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.532 ' HB1' HG21 ' A' ' 48' ' ' VAL . . . -76.19 170.21 16.75 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 179.62 118.21 0.05 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.995 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.497 ' CG2' HG22 ' A' ' 44' ' ' VAL . 40.3 pt -79.27 164.8 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.388 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.406 HG23 HE21 ' A' ' 16' ' ' GLN . 81.5 m -138.93 123.02 17.96 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.729 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -104.62 168.12 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.285 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.418 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 68.9 m-85 -128.94 144.6 51.23 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.71 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -52.86 19.83 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.783 -0.767 . . . . 0.0 113.041 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.503 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 24.8 m120 -95.27 170.42 9.4 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.409 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.679 ' CG ' ' H ' ' A' ' 11' ' ' ASP . 16.6 tt0 -64.26 -178.7 0.38 Allowed 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.778 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.679 ' H ' ' CG ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER 41.51 62.17 1.61 Allowed 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.325 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.655 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 44.9 p90 36.71 27.14 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.229 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ASP . 2.0 tp-100 -101.46 162.46 12.88 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.729 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.503 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 89.37 137.32 6.3 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.472 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.482 ' HE3' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -30.04 137.52 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.057 0.456 . . . . 0.0 111.889 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.406 HE21 HG23 ' A' ' 5' ' ' THR . 0.0 OUTLIER -103.32 162.97 12.56 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.034 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -144.23 130.26 15.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.297 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.58 133.6 34.53 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.749 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 mt -126.13 123.73 24.44 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.578 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.94 162.22 29.92 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 120.975 1.117 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.27 -170.08 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 121.705 1.604 . . . . 0.0 110.967 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.3 -179.08 38.99 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.095 -1.526 . . . . 0.0 110.958 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.823 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.2 OUTLIER -109.36 129.94 55.51 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.715 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.44 ' OH ' HD11 ' A' ' 4' ' ' ILE . 12.6 p90 -143.23 175.19 10.07 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.433 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.0 p -140.35 -160.0 1.02 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.475 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -61.15 -20.56 62.84 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.7 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.91 -62.35 1.7 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.157 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.476 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -55.64 -43.1 75.91 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.661 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 29' ' ' LEU . 20.4 mt -59.45 -41.2 89.11 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.424 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.65 -31.01 23.86 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 118.805 -1.158 . . . . 0.0 108.662 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -71.55 -38.16 71.02 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.0 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.403 ' HG ' ' H ' ' A' ' 32' ' ' LEU . 11.5 mt -73.13 -74.39 0.17 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.688 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.46 -34.87 0.47 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.057 -1.544 . . . . 0.0 110.841 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.44 HD11 ' H ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER -80.92 140.43 16.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.615 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.54 ' H ' HG21 ' A' ' 38' ' ' THR . 2.8 pt-20 178.54 131.72 0.07 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.78 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.72 ' O ' HG23 ' A' ' 38' ' ' THR . 1.5 t-20 78.22 127.49 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.511 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.4 ' N ' HG22 ' A' ' 79' ' ' VAL . 3.1 m-20 51.55 7.85 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.705 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 36' ' ' ASN . 67.2 p -91.48 -135.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.664 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.54 HG13 HG21 ' A' ' 79' ' ' VAL . 2.2 mt 35.74 39.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.604 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.52 -57.51 6.92 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.762 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.418 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -116.66 168.96 9.73 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.266 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -149.73 148.96 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 118.529 -1.269 . . . . 0.0 112.396 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -137.87 96.02 3.15 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.157 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.497 HG22 ' CG2' ' A' ' 4' ' ' ILE . 71.6 t -111.21 110.66 56.13 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.386 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -69.07 171.21 14.11 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.114 1.209 . . . . 0.0 110.411 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.45 -173.94 0.19 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.663 1.575 . . . . 0.0 111.082 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.04 -17.86 6.84 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.328 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.532 HG21 ' HB1' ' A' ' 2' ' ' ALA . 0.2 OUTLIER -146.81 138.85 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.312 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -105.9 119.7 39.86 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HB3' ' CG2' ' A' ' 65' ' ' VAL . . . -97.38 155.65 16.81 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.194 -1.002 . . . . 0.0 112.884 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.501 ' C ' HD12 ' A' ' 52' ' ' LEU . 53.1 mt -141.76 117.21 5.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.921 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.838 HD12 ' N ' ' A' ' 52' ' ' LEU . 2.0 mp -89.47 157.71 18.0 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.349 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.434 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 43.3 m-85 -138.47 107.36 5.97 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.553 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -40.93 -76.92 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.95 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.458 ' C ' ' OG ' ' A' ' 80' ' ' SER . 12.6 m120 -68.45 153.33 43.97 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.311 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -59.99 -174.95 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.653 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 49.21 40.49 29.43 Favored Glycine 0 N--CA 1.484 1.891 0 C-N-CA 119.114 -1.517 . . . . 0.0 109.656 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.653 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.5 OUTLIER 41.5 69.19 0.37 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.452 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.69 -162.39 1.42 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.993 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.48 -176.59 0.63 Allowed Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.23 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.654 ' OD2' HD22 ' A' ' 75' ' ' LEU . 10.4 t0 -46.2 160.85 0.06 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.879 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -146.99 161.17 41.33 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.864 -1.135 . . . . 0.0 111.67 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.658 HG22 ' H ' ' A' ' 64' ' ' GLU . 38.4 mt -133.03 172.97 15.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.112 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.658 ' H ' HG22 ' A' ' 63' ' ' ILE . 3.3 tm-20 -144.81 130.44 18.99 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.154 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 50' ' ' ALA . 21.1 m -145.19 154.54 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 118.615 -1.234 . . . . 0.0 112.108 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.91 -1.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.491 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.38 -124.12 0.23 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.062 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.631 ' ND2' ' OD1' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -121.82 121.26 36.79 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.95 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.559 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -88.47 109.05 19.72 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.673 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -61.9 -87.69 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.307 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 18.4 mt-10 -78.81 1.01 24.75 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.428 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 2.2 tp 74.73 -82.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.835 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.82 -169.19 41.94 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.225 -1.464 . . . . 0.0 110.696 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.473 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.3 Cg_endo -65.91 -46.54 4.7 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.307 2.005 . . . . 0.0 112.384 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.697 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -73.62 34.9 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.291 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 74' ' ' PRO . 29.0 p-10 -75.34 -24.05 57.3 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.745 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -80.12 4.48 17.18 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.985 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -151.93 114.12 4.5 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.533 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.54 HG21 HG13 ' A' ' 39' ' ' ILE . 24.2 m -133.9 158.29 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.963 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 81' ' ' SER . 96.4 p -164.44 -69.43 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 118.391 -1.324 . . . . 0.0 112.453 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.541 ' N ' ' OG ' ' A' ' 80' ' ' SER . 73.7 m -107.42 160.89 15.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.49 -0.884 . . . . 0.0 112.485 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.514 HG23 ' HA ' ' A' ' 52' ' ' LEU . 1.7 mt -149.87 159.7 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.635 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.809 HH22 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.7 130.72 15.32 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 118.929 -1.108 . . . . 0.0 111.415 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.809 ' CA ' HH22 ' A' ' 83' ' ' ARG . 4.2 t -132.2 141.65 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.847 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.479 HG12 ' NH2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -136.17 140.32 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.047 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 90.2 p -43.27 151.05 0.17 Allowed 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.599 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.667 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -156.85 144.14 13.75 Favored Pre-proline 0 C--N 1.307 -1.273 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.638 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.667 ' HD2' HG22 ' A' ' 87' ' ' VAL . 6.3 Cg_exo -50.05 146.27 17.63 Favored 'Trans proline' 0 C--O 1.213 -0.763 0 C-N-CA 121.256 1.304 . . . . 0.0 111.345 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.95 145.94 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.053 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -145.28 153.66 52.7 Favored Pre-proline 0 N--CA 1.486 1.349 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.469 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.459 ' HG2' HD21 ' A' ' 136' ' ' LEU . 4.8 Cg_exo -60.52 -152.07 0.01 OUTLIER 'Trans proline' 0 C--O 1.211 -0.868 0 C-N-CA 121.061 1.174 . . . . 0.0 110.501 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 179.76 -163.39 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.826 -1.15 . . . . 0.0 110.86 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.76 169.92 16.33 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.201 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.513 ' HE ' ' HG3' ' A' ' 105' ' ' GLU . 66.7 ttt180 -137.91 110.02 7.29 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.969 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.56 ' CE1' HD12 ' A' ' 108' ' ' LEU . 19.3 m-85 -93.91 168.52 10.92 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.419 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.488 ' CD1' ' HB3' ' A' ' 105' ' ' GLU . 49.2 m-85 -137.87 177.08 8.15 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 119.033 -1.067 . . . . 0.0 112.075 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.691 ' CE2' HG21 ' A' ' 127' ' ' THR . 3.2 m-85 -115.63 133.21 56.26 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.4 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 97' ' ' TYR . 19.4 tttp 78.59 137.72 0.07 Allowed 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.035 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.628 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -68.2 104.84 1.92 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.219 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.614 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 1.7 tp-100 126.28 39.44 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.263 0 O-C-N 125.565 1.791 . . . . 0.0 109.721 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.614 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 25.7 p90 29.67 49.51 0.06 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.8 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -103.65 -17.67 15.04 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.076 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -102.41 164.07 16.67 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.594 -1.288 . . . . 0.0 110.976 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.46 ' CG ' ' N ' ' A' ' 105' ' ' GLU . 16.9 ttmt -40.7 160.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.823 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 105' ' ' GLU . 1.3 pm0 -127.14 158.97 35.64 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.613 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.4 156.43 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.741 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.631 ' OD1' ' ND2' ' A' ' 68' ' ' ASN . 4.8 p-10 -125.91 148.47 49.2 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.578 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.56 HD12 ' CE1' ' A' ' 95' ' ' PHE . 41.2 mt -139.19 124.69 11.95 Favored Pre-proline 0 N--CA 1.487 1.421 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.342 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.451 ' CB ' ' HD2' ' A' ' 110' ' ' PRO . 1.9 Cg_endo -64.39 171.59 7.78 Favored 'Trans proline' 0 C--O 1.213 -0.77 0 C-N-CA 121.476 1.451 . . . . 0.0 111.356 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 1.9 Cg_endo -60.78 146.41 97.42 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.875 1.717 . . . . 0.0 111.568 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.19 -154.92 25.74 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.674 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.591 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 28.5 mt-30 -133.24 161.29 34.85 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.842 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.591 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 24.0 m-85 -144.54 150.64 37.87 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.372 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 1.3 p -91.78 -142.17 0.19 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.697 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.597 ' N ' ' OG1' ' A' ' 114' ' ' THR . 13.7 mt-30 -90.31 -86.46 0.2 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.31 -28.2 62.86 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -70.09 -61.06 1.93 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.307 -1.357 . . . . 0.0 108.454 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.706 ' C ' HD23 ' A' ' 118' ' ' LEU . 2.2 tt -43.35 -64.04 0.71 Allowed 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.557 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.415 ' CD ' ' O ' ' A' ' 115' ' ' GLN . 1.1 mp0 -42.86 -68.3 0.21 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.36 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.554 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 10.6 mpt_? -68.43 0.33 4.09 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.624 -0.83 . . . . 0.0 113.199 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -89.03 -24.87 22.24 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 118.464 -1.295 . . . . 0.0 110.554 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -153.75 -20.75 0.05 OUTLIER Glycine 0 N--CA 1.485 1.951 0 C-N-CA 118.429 -1.844 . . . . 0.0 111.688 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.444 ' HB ' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -145.32 -115.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.329 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.444 ' H ' ' HB ' ' A' ' 123' ' ' ILE . 4.2 m-20 -167.57 -164.89 0.61 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -58.13 -76.09 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.163 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.456 ' ND2' ' ND2' ' A' ' 164' ' ' ASN . 3.7 t-20 -74.68 -138.11 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.123 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.691 HG21 ' CE2' ' A' ' 97' ' ' TYR . 0.5 OUTLIER 68.78 -138.45 0.09 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.785 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.441 ' C ' ' HG ' ' A' ' 129' ' ' SER . 3.9 mm 73.55 -49.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.477 0 O-C-N 124.168 0.918 . . . . 0.0 110.435 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 130' ' ' SER . 47.0 p 39.35 -135.32 0.13 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.937 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.542 ' N ' ' OG ' ' A' ' 129' ' ' SER . 24.1 m -63.37 143.9 57.42 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.381 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.03 151.46 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.489 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -150.31 81.67 6.62 Favored Pre-proline 0 C--N 1.304 -1.391 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.489 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -61.08 92.4 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.316 1.344 . . . . 0.0 110.043 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -73.64 26.18 0.07 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.118 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 176.71 -51.75 0.11 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 117.53 -2.272 . . . . 0.0 112.735 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.459 HD21 ' HG2' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -108.63 173.76 6.17 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.598 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -91.76 141.94 28.13 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.581 -0.848 . . . . 0.0 108.974 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 153' ' ' VAL . 66.9 t -109.89 139.99 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.547 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.03 127.17 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.701 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 mp -101.52 138.88 37.93 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.552 -0.859 . . . . 0.0 112.39 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.431 ' CG ' ' HA ' ' A' ' 146' ' ' PHE . 22.3 m-85 -114.07 118.56 34.42 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.082 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -48.19 -77.49 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.625 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.443 ' HB2' ' CB ' ' A' ' 147' ' ' SER . 3.3 m-20 -74.59 -156.49 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.341 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 146' ' ' PHE . 6.8 p-10 -62.07 -154.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.819 HD22 ' H ' ' A' ' 145' ' ' ASN . 1.9 m-80 -33.62 88.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.159 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.529 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 3.3 p90 36.31 66.07 0.41 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.663 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 92.5 p -61.0 -108.05 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.738 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.52 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . -115.4 -63.23 0.38 Allowed Glycine 0 N--CA 1.502 3.043 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.974 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.404 ' C ' ' CG2' ' A' ' 150' ' ' THR . 24.3 t70 -74.13 144.47 44.87 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.58 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.404 ' CG2' ' C ' ' A' ' 149' ' ' ASP . 6.7 p -151.67 173.74 14.32 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.491 -0.883 . . . . 0.0 111.187 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.547 ' C ' HD23 ' A' ' 151' ' ' LEU . 3.0 tt -144.25 87.51 7.78 Favored Pre-proline 0 C--N 1.31 -1.145 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.153 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.14 103.99 0.56 Allowed 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.671 1.581 . . . . 0.0 112.651 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 138' ' ' VAL . 2.8 t -77.75 93.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.154 -1.019 . . . . 0.0 109.912 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -43.78 -42.85 5.79 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.888 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.1 t -171.2 -130.09 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 118.456 -1.298 . . . . 0.0 112.229 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -46.44 141.89 3.36 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.681 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.85 64.13 1.06 Allowed Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.195 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.6 Cg_endo -63.08 21.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.279 1.986 . . . . 0.0 113.269 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 159' ' ' THR . 1.3 t -172.37 106.4 0.18 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.806 -1.157 . . . . 0.0 110.911 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.674 HD13 ' C ' ' A' ' 160' ' ' LEU . 3.0 tm? -103.6 -78.63 0.55 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.288 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 164' ' ' ASN . . . 61.44 -127.98 42.9 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.859 -1.163 . . . . 0.0 111.656 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.651 ' C ' ' H ' ' A' ' 164' ' ' ASN . . . -14.24 -57.08 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 163' ' ' MET . 3.4 mmt -64.49 17.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.078 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.651 ' H ' ' C ' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -64.73 -54.08 37.07 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.629 -0.829 . . . . 0.0 110.635 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 11.5 m120 47.19 -88.8 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.86 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 164' ' ' ASN . 21.1 t-20 -159.11 -33.77 0.06 Allowed 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.195 -1.002 . . . . 0.0 111.425 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.8 m 44.72 83.08 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.391 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.36 -52.22 8.37 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.846 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.2 p -123.66 163.77 20.41 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.68 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 36.2 pt -143.34 178.22 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.522 ' NH1' ' OE1' ' A' ' 112' ' ' GLN . 35.5 ttt85 -156.8 109.23 2.51 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.64 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.2 mt -85.95 95.8 4.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.149 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 C--N 1.303 -1.415 0 CA-C-O 116.379 -1.772 . . . . 0.0 110.825 -179.92 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mtt . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 121.055 0.455 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.462 ' HB1' HG21 ' A' ' 48' ' ' VAL . . . -90.2 165.56 13.88 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.506 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.713 ' N ' ' ND2' ' A' ' 3' ' ' ASN . 0.1 OUTLIER 179.49 122.3 0.06 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.517 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 4' ' ' ILE . 1.7 pt -77.44 126.91 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.985 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.9 m -105.51 108.21 19.61 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.11 165.23 2.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.028 -1.069 . . . . 0.0 112.717 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.448 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 50.1 m-85 -123.37 145.15 48.99 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.837 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.46 ' HB2' ' N ' ' A' ' 15' ' ' LYS . 2.0 m-85 -83.91 8.45 15.0 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 13' ' ' GLN . 0.4 OUTLIER -150.19 171.08 17.49 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 118.132 -1.427 . . . . 0.0 111.979 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.497 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 11.6 mm-40 -78.36 146.88 34.39 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.348 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.587 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 2.1 t70 76.87 60.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.42 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.587 ' CG ' ' O ' ' A' ' 11' ' ' ASP . 54.7 p90 42.78 15.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.774 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 11' ' ' ASP . 14.2 mt-30 -101.42 154.5 18.75 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.193 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 1.144 ' O ' ' NE2' ' A' ' 16' ' ' GLN . . . 116.63 139.34 6.48 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 1.33 ' C ' HE21 ' A' ' 16' ' ' GLN . 9.3 mtpm? -36.41 147.38 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.491 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 1.407 HE21 ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -99.88 142.25 31.61 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.584 -0.847 . . . . 0.0 112.25 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 t -144.48 123.72 6.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.523 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -95.47 119.39 33.89 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.414 -0.914 . . . . 0.0 112.106 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.1 125.7 30.1 Favored Pre-proline 0 N--CA 1.494 1.762 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.471 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -65.44 162.39 33.97 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 120.993 1.128 . . . . 0.0 111.724 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.31 -178.83 0.51 Allowed 'Trans proline' 0 C--N 1.322 -0.838 0 C-N-CA 121.768 1.645 . . . . 0.0 110.966 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.711 ' C ' HD22 ' A' ' 23' ' ' ASN . . . 108.4 -170.9 15.3 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.381 -1.39 . . . . 0.0 110.662 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.711 HD22 ' C ' ' A' ' 22' ' ' GLY . 0.6 OUTLIER -117.21 124.69 49.72 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.96 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.2 p90 -144.3 169.43 17.91 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.786 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.7 p -140.75 -142.04 0.14 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.992 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.444 ' NH2' ' ND2' ' A' ' 36' ' ' ASN . 15.7 tpp180 -69.32 -38.5 78.25 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.031 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.591 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -54.7 -58.59 6.94 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.14 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -56.89 -51.18 70.1 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.484 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.55 HD23 HD12 ' A' ' 32' ' ' LEU . 28.4 mt -58.26 -28.8 65.27 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.446 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -56.26 -32.09 64.18 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.42 -36.04 63.41 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.72 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.55 HD12 HD23 ' A' ' 29' ' ' LEU . 13.3 mt -77.01 -83.65 0.07 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.89 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 32' ' ' LEU . . . 152.39 -16.91 0.77 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.033 -1.556 . . . . 0.0 111.225 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.407 ' H ' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -91.36 138.98 18.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.073 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' C ' ' CG ' ' A' ' 36' ' ' ASN . 1.8 pt-20 172.42 150.31 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.403 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.747 ' O ' HG23 ' A' ' 38' ' ' THR . 0.5 OUTLIER 75.86 123.81 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 43.39 12.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.358 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.747 HG23 ' O ' ' A' ' 36' ' ' ASN . 64.3 p -88.86 -151.38 0.21 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.447 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.443 HD12 HG11 ' A' ' 79' ' ' VAL . 2.3 mt 42.49 60.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.736 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.8 t -80.14 -33.15 38.74 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.418 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.448 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -143.14 153.72 43.16 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.247 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.056 HG22 ' HB3' ' A' ' 69' ' ' ALA . 25.4 m -143.38 170.44 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 118.128 -1.429 . . . . 0.0 113.578 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -143.48 95.67 2.79 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.862 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.99 108.48 46.27 Favored Pre-proline 0 N--CA 1.493 1.716 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.73 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.414 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.6 Cg_endo -68.52 170.29 15.35 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 120.975 1.117 . . . . 0.0 110.321 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 2.5 Cg_endo -60.28 -170.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.877 1.718 . . . . 0.0 111.407 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.3 -12.34 10.11 Favored Glycine 0 N--CA 1.485 1.945 0 C-N-CA 119.407 -1.377 . . . . 0.0 111.13 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.462 HG21 ' HB1' ' A' ' 2' ' ' ALA . 4.4 m -148.77 139.55 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.142 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 tttm -115.38 120.23 38.89 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.03 155.25 19.58 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.287 -0.965 . . . . 0.0 112.808 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 63' ' ' ILE . 71.4 mt -142.22 118.28 6.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.094 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.451 HD12 ' H ' ' A' ' 52' ' ' LEU . 3.6 mp -88.8 159.37 17.78 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.008 -1.077 . . . . 0.0 112.504 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.441 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 72.1 m-85 -141.59 118.89 11.43 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.836 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -49.9 -82.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.435 ' ND2' ' H ' ' A' ' 56' ' ' ASP . 2.7 t-20 -58.59 155.06 13.06 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.386 -0.925 . . . . 0.0 111.799 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.435 ' H ' ' ND2' ' A' ' 55' ' ' ASN . 21.1 p-10 -59.89 -177.9 0.07 Allowed 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.705 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.581 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 50.45 38.71 35.23 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 39.17 71.12 0.18 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.521 0.677 . . . . 0.0 111.058 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.3 172.52 12.81 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.969 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.34 -174.64 55.0 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.445 -1.36 . . . . 0.0 109.981 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -44.87 158.1 0.06 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.895 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.502 ' C ' ' NE2' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -149.84 168.41 23.81 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.812 -1.155 . . . . 0.0 111.499 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.72 HG22 ' N ' ' A' ' 64' ' ' GLU . 73.0 mt -134.85 174.11 13.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.723 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.72 ' N ' HG22 ' A' ' 63' ' ' ILE . 24.8 mt-10 -144.74 133.92 22.86 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.568 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.401 HG13 ' C ' ' A' ' 64' ' ' GLU . 25.4 m -150.55 152.89 11.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 118.628 -1.229 . . . . 0.0 112.224 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.4 ' H ' ' H ' ' A' ' 67' ' ' ALA . 1.0 OUTLIER -139.54 -10.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.494 ' HB1' ' OD1' ' A' ' 107' ' ' ASP . . . -119.92 -156.93 0.69 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.56 -1.655 . . . . 0.0 109.673 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.434 ' C ' ' ND2' ' A' ' 68' ' ' ASN . 0.5 OUTLIER -93.23 127.85 38.98 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.077 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.056 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -90.43 119.52 30.78 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.781 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -79.9 -58.74 3.02 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.445 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -106.52 19.47 20.44 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.612 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.544 HD23 ' ND2' ' A' ' 76' ' ' ASN . 15.0 tp 53.01 -98.4 0.07 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.466 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.82 -158.99 31.47 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.093 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.669 ' C ' HD23 ' A' ' 75' ' ' LEU . 1.5 Cg_endo -66.02 -157.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.451 1.434 . . . . 0.0 110.545 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.713 HD21 ' CG1' ' A' ' 63' ' ' ILE . 1.4 pt? 31.69 32.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 123.8 0.687 . . . . 0.0 111.79 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.546 ' N ' ' O ' ' A' ' 74' ' ' PRO . 8.5 t-20 -80.22 -12.03 59.67 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.795 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -72.72 -12.84 61.18 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.085 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -160.29 134.67 7.43 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 118.889 -1.124 . . . . 0.0 111.69 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.443 HG11 HD12 ' A' ' 39' ' ' ILE . 3.3 t -145.39 153.18 14.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.845 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 81' ' ' SER . 86.9 p -164.89 -57.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.351 -1.34 . . . . 0.0 112.772 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.473 ' N ' ' OG ' ' A' ' 80' ' ' SER . 32.9 t -89.9 146.42 24.43 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.613 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 82' ' ' ILE . 0.3 OUTLIER -146.77 134.01 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 118.74 -1.184 . . . . 0.0 111.153 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.621 ' NE ' ' HA ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -108.74 141.15 41.16 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.304 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.525 ' HB ' ' H ' ' A' ' 22' ' ' GLY . 9.4 t -144.33 123.55 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.226 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.5 mt -129.07 125.67 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.303 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.8 m -43.73 132.71 4.95 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.686 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.537 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -126.65 139.38 34.64 Favored Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.499 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.537 ' HD2' HG22 ' A' ' 87' ' ' VAL . 2.7 Cg_exo -52.76 143.55 47.16 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.127 1.218 . . . . 0.0 110.741 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.0 t -59.98 122.24 9.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.229 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -102.89 135.32 19.45 Favored Pre-proline 0 C--N 1.306 -1.326 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.987 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -52.53 -33.0 55.9 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 120.85 1.033 . . . . 0.0 110.283 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.443 HH22 ' HB2' ' A' ' 67' ' ' ALA . 17.9 mtt-85 50.68 -164.43 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.662 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.534 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.66 177.2 8.66 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.185 -1.37 . . . . 0.0 108.437 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -150.36 132.19 15.08 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 118.21 -1.396 . . . . 0.0 112.088 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.54 ' CE2' HG13 ' A' ' 131' ' ' VAL . 21.9 m-85 -118.68 147.65 43.58 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.757 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -121.15 159.29 26.13 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.185 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.658 ' OH ' HG22 ' A' ' 123' ' ' ILE . 8.0 m-30 -95.15 164.14 12.99 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.603 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 tttt 67.7 135.6 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.691 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.595 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 8.6 tp10 -63.69 100.94 0.31 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.273 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 1.037 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 119.73 38.17 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.882 0 O-C-N 125.426 1.704 . . . . 0.0 108.47 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.771 ' CD1' ' NE2' ' A' ' 100' ' ' GLN . 22.5 p90 33.78 44.09 0.08 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.76 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -103.64 32.33 3.93 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.581 -0.847 . . . . 0.0 111.453 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -153.66 170.11 32.38 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.167 -1.492 . . . . 0.0 110.751 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.1 OUTLIER -35.03 151.13 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.428 ' CD ' ' C ' ' A' ' 105' ' ' GLU . 1.4 pp20? -121.92 168.31 12.04 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.847 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.88 139.41 19.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.283 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.494 ' OD1' ' HB1' ' A' ' 67' ' ' ALA . 6.3 p30 -108.98 151.44 26.31 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.748 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 72.3 mt -139.64 140.27 24.56 Favored Pre-proline 0 N--CA 1.497 1.877 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.804 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -76.03 164.13 31.97 Favored 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 121.944 1.763 . . . . 0.0 111.254 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.41 142.01 76.88 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.555 1.503 . . . . 0.0 110.581 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 144.05 -158.63 27.48 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 118.916 -1.612 . . . . 0.0 111.466 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.58 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 24.4 tt0 -125.28 154.97 40.9 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.88 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.58 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 25.3 m-85 -143.53 152.71 41.79 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.738 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.7 p -106.44 178.43 4.56 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.867 0.841 . . . . 0.0 112.97 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.644 ' NE2' ' CD ' ' A' ' 119' ' ' GLU . 24.1 tp60 -59.39 -20.85 58.12 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.558 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.44 -60.71 1.85 Allowed 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.901 -1.12 . . . . 0.0 114.01 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -67.4 -56.83 8.07 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.219 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.607 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -34.11 -74.02 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 O-C-N 123.801 0.688 . . . . 0.0 111.817 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.644 ' CD ' ' NE2' ' A' ' 115' ' ' GLN . 69.5 mt-10 -51.19 -56.36 13.24 Favored 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.739 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.461 ' HD3' ' H ' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -75.06 14.65 0.5 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.474 -1.291 . . . . 0.0 111.647 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 117' ' ' GLU . 18.4 t80 -119.39 -16.44 8.96 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.856 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.507 ' C ' HD13 ' A' ' 123' ' ' ILE . . . -139.49 -48.08 0.06 OUTLIER Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.676 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.658 HG22 ' OH ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -137.85 -108.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.969 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.554 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 18.3 t70 -161.75 -146.8 0.13 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.402 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.554 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 4.4 m-20 -60.67 -52.72 63.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.338 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.76 HD22 HD22 ' A' ' 166' ' ' ASN . 29.4 t-20 -158.04 134.71 9.72 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.426 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.448 ' H ' ' H ' ' A' ' 128' ' ' ILE . 2.5 t -178.61 -10.1 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.507 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.448 ' H ' ' H ' ' A' ' 127' ' ' THR . 9.4 mt -70.42 141.39 17.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.528 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.3 t -157.33 12.55 0.23 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.026 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.3 m -170.7 117.12 0.49 Allowed 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.579 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.54 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.6 t -110.51 156.28 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.995 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.466 ' NZ ' ' HG3' ' A' ' 158' ' ' PRO . 1.6 tppt? -155.02 87.25 3.32 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.292 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.02 101.4 0.18 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.309 1.34 . . . . 0.0 111.678 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.534 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 38.2 tt0 -54.17 -12.21 0.6 Allowed 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.986 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -178.83 -36.6 0.06 OUTLIER Glycine 0 N--CA 1.497 2.76 0 C-N-CA 118.412 -1.852 . . . . 0.0 112.245 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mt -92.1 -174.97 3.93 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.998 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.45 137.04 48.68 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.459 ' CG1' ' CD1' ' A' ' 140' ' ' LEU . 7.2 t -103.1 140.49 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.413 -0.915 . . . . 0.0 112.866 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.467 ' C ' HD12 ' A' ' 140' ' ' LEU . 96.4 t -131.2 120.15 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.453 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 140' ' ' LEU . 10.1 mp -98.59 143.75 28.64 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.327 -0.949 . . . . 0.0 113.307 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.416 ' CD2' ' HB3' ' A' ' 146' ' ' PHE . 27.8 m-85 -120.27 130.89 54.68 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.111 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.404 ' HG2' HD22 ' A' ' 143' ' ' ASN . 51.0 tttp -67.21 -69.67 0.3 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.142 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.42 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.5 m-80 -70.16 164.19 24.72 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.558 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 146' ' ' PHE . 3.6 m-20 -63.58 -160.05 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.606 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.654 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 2.5 p30 32.76 34.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 123.733 0.646 . . . . 0.0 111.57 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.654 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 42.82 61.24 2.17 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 44.5 t -136.26 -178.55 5.21 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.006 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.491 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 75.67 -163.13 53.47 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.354 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.76 164.12 3.94 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.144 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.2 p -148.2 170.16 18.48 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.944 -1.103 . . . . 0.0 111.668 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.1 tp -141.89 84.98 11.48 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.151 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -62.45 102.66 0.29 Allowed 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.076 1.85 . . . . 0.0 113.59 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 138' ' ' VAL . 6.8 t -89.19 80.36 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.346 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -76.88 14.09 0.91 Allowed 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.592 -0.843 . . . . 0.0 113.015 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 19.8 t -169.97 -169.67 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 117.785 -1.566 . . . . 0.0 112.959 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.454 ' N ' ' OG ' ' A' ' 155' ' ' SER . 64.3 m-20 -57.03 152.26 13.48 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.519 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.563 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -172.88 62.62 0.29 Allowed Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.072 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 5.8 Cg_endo -70.05 34.38 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 122.336 2.024 . . . . 0.0 112.2 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 159' ' ' THR . 0.6 OUTLIER -176.33 76.57 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.407 -1.317 . . . . 0.0 112.389 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 162' ' ' ALA . 2.8 mm? -81.2 -87.51 0.08 Allowed 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.63 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' A' ' 163' ' ' MET . . . 65.56 -70.59 0.11 Allowed Glycine 0 N--CA 1.503 3.106 0 C-N-CA 119.585 -1.293 . . . . 0.0 111.857 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -52.49 4.73 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.465 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.633 ' H ' ' C ' ' A' ' 161' ' ' GLY . 14.6 mmt -115.38 40.38 2.72 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.082 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.645 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 2.7 m-80 -41.84 -18.78 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.64 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 163' ' ' MET . 17.0 m120 -40.88 120.98 1.41 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.451 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.76 HD22 HD22 ' A' ' 126' ' ' ASN . 15.1 m120 -56.82 95.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.88 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.7 m -59.82 112.81 1.98 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.424 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.6 t -97.24 -63.13 1.16 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.549 -0.861 . . . . 0.0 112.043 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.06 162.39 17.47 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.04 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 25.6 pt -147.78 179.49 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.307 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -161.32 114.62 1.93 Allowed 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.302 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 42.9 mt -90.57 98.97 8.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.349 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--N 1.304 -1.405 0 CA-C-O 116.298 -1.81 . . . . 0.0 110.988 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 tmm? . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.513 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -72.22 167.16 20.94 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.657 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 2' ' ' ALA . 21.9 m-80 -169.29 110.97 0.48 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.707 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.4 pt -70.68 140.87 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.102 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -115.35 120.31 39.18 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.715 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.511 ' CG2' HG23 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -104.3 155.79 5.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.923 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.448 ' N ' ' CG2' ' A' ' 6' ' ' VAL . 38.8 m-85 -115.64 139.98 49.61 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.191 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -62.92 1.36 Allowed 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.385 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.562 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 3.2 m120 -89.5 168.36 12.25 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.52 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.442 ' HG2' ' H ' ' A' ' 10' ' ' GLU . 10.2 pt-20 -70.35 -162.56 0.06 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.414 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.622 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 1.3 m-20 47.43 45.91 17.19 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.254 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.622 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 51.3 p90 38.63 24.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.951 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ASP . 3.8 pt20 -113.04 163.58 14.52 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.562 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 103.9 134.35 8.17 Favored Glycine 0 N--CA 1.501 2.996 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.457 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.519 ' CD ' ' H ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -28.99 132.88 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.02 0.438 . . . . 0.0 111.741 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.705 ' H ' ' NE2' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -97.63 164.81 12.26 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.727 -0.789 . . . . 0.0 112.423 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 t -149.7 123.63 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.658 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.76 120.84 32.85 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.612 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mt -108.8 140.96 22.36 Favored Pre-proline 0 N--CA 1.489 1.513 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.081 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -72.2 165.72 31.8 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 120.909 1.072 . . . . 0.0 111.277 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.77 -158.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 121.905 1.736 . . . . 0.0 111.089 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.71 168.3 24.56 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 119.272 -1.442 . . . . 0.0 111.551 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.58 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -95.87 140.45 30.62 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.065 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.69 ' OH ' HD12 ' A' ' 82' ' ' ILE . 36.7 p90 -155.68 176.2 12.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.673 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.965 HG23 ' H ' ' A' ' 27' ' ' ALA . 6.3 t -138.09 -157.32 0.76 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.009 -1.077 . . . . 0.0 112.443 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.718 ' N ' HG23 ' A' ' 25' ' ' THR . 13.1 ptm180 -63.69 -25.82 68.38 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.358 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.965 ' H ' HG23 ' A' ' 25' ' ' THR . . . -58.56 -55.96 28.27 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.652 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -58.29 -45.1 88.6 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.637 -1.225 . . . . 0.0 109.555 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.443 HD23 HD12 ' A' ' 32' ' ' LEU . 30.2 mt -59.97 -34.09 72.82 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.518 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -54.74 -32.02 59.27 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -71.46 -40.55 70.24 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.675 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.443 HD12 HD23 ' A' ' 29' ' ' LEU . 15.0 mt -70.35 -81.04 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.967 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 32' ' ' LEU . . . 160.09 -26.43 0.32 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 118.952 -1.594 . . . . 0.0 111.049 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.557 HD13 ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -85.73 152.22 3.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.574 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.451 ' N ' HG12 ' A' ' 34' ' ' ILE . 3.4 pt-20 -178.51 154.31 0.78 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.357 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 38' ' ' THR . 1.3 m120 64.68 -149.93 0.27 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.549 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -56.21 81.43 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.724 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 36' ' ' ASN . 39.6 p -143.75 -33.56 0.42 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.664 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.621 ' CD1' HD11 ' A' ' 82' ' ' ILE . 3.9 mt -78.87 51.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 119.181 -1.008 . . . . 0.0 109.452 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.8 t -51.38 -46.98 62.99 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.573 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -125.21 167.29 15.06 Favored 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.79 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -155.45 149.69 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 118.197 -1.401 . . . . 0.0 113.05 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -133.59 126.92 31.98 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.492 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.2 t -144.0 113.62 5.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 C-N-CA 119.173 -1.011 . . . . 0.0 112.149 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.37 167.6 21.86 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 121.283 1.322 . . . . 0.0 111.082 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.67 -169.22 0.1 OUTLIER 'Trans proline' 0 C--N 1.32 -0.937 0 C-N-CA 121.97 1.78 . . . . 0.0 111.504 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.406 ' C ' HG13 ' A' ' 48' ' ' VAL . . . 77.66 -15.26 7.95 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.808 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.513 HG11 ' CB ' ' A' ' 2' ' ' ALA . 24.1 m -150.91 139.58 14.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.873 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -109.25 129.24 55.51 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.095 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.76 152.55 24.21 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.409 -0.916 . . . . 0.0 112.661 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.724 HD12 HH21 ' A' ' 83' ' ' ARG . 71.1 mt -139.57 121.3 16.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.992 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.782 HD23 HG23 ' A' ' 82' ' ' ILE . 0.4 OUTLIER -98.69 162.01 13.35 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 119.384 -0.926 . . . . 0.0 112.341 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 62' ' ' GLN . 11.6 m-85 -140.76 115.28 9.45 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.668 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -46.54 -78.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.871 -0.731 . . . . 0.0 112.044 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.417 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 6.9 m120 -59.77 156.41 14.09 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.112 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -64.59 -173.69 0.11 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.726 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.86 36.31 33.23 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.355 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.481 ' CE1' ' O ' ' A' ' 24' ' ' TYR . 12.0 m-85 49.71 59.16 4.71 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.728 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.36 -176.88 4.54 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.417 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 76.51 170.22 31.04 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 60' ' ' GLY . 17.7 m-20 -42.41 125.85 3.31 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.147 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.426 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.4 pt20 -95.01 163.83 13.15 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.75 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.683 HG22 ' N ' ' A' ' 64' ' ' GLU . 4.6 mm -134.93 168.77 22.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.009 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.683 ' N ' HG22 ' A' ' 63' ' ' ILE . 30.8 tt0 -150.48 132.26 15.02 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.253 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.0 m -148.34 151.46 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.301 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.0 -7.73 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.768 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -122.99 -139.27 0.31 Allowed 'General case' 0 C--O 1.206 -1.237 0 CA-C-N 114.042 -1.436 . . . . 0.0 109.281 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -114.2 116.74 29.54 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.646 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.64 112.39 23.61 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.8 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -67.03 -85.79 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.451 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 7.8 mm-40 -72.56 -1.99 18.12 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.738 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.494 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 3.8 tp 75.99 -84.57 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.87 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.03 -161.67 30.29 Favored Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.151 -1.5 . . . . 0.0 110.753 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.547 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.6 Cg_endo -68.87 -55.41 0.21 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.121 1.881 . . . . 0.0 112.335 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -69.77 27.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.599 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.547 ' H ' ' C ' ' A' ' 74' ' ' PRO . 3.2 p30 -70.91 10.76 0.48 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.118 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.5 ' H ' ' C ' ' A' ' 75' ' ' LEU . 23.3 t-20 -89.47 -9.98 48.07 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.096 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -166.49 132.68 2.41 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.726 -1.19 . . . . 0.0 111.697 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.402 ' CG1' HD12 ' A' ' 39' ' ' ILE . 2.1 t -147.95 142.47 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.057 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 m -154.63 -48.27 0.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.238 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.6 t -90.01 136.28 33.14 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.062 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.782 HG23 HD23 ' A' ' 52' ' ' LEU . 10.6 mt -151.76 149.94 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.434 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.724 HH21 HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -151.32 153.33 34.6 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.844 -1.142 . . . . 0.0 111.213 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.498 ' C ' HH12 ' A' ' 83' ' ' ARG . 3.3 t -142.7 147.19 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.394 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.502 HG12 ' NH1' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -138.77 132.25 39.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.389 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 85' ' ' ILE . 78.7 p -36.78 147.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.89 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.549 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -151.44 140.62 13.81 Favored Pre-proline 0 N--CA 1.487 1.385 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.27 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.549 ' HD2' HG22 ' A' ' 87' ' ' VAL . 6.9 Cg_exo -50.89 133.55 40.16 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 121.256 1.304 . . . . 0.0 111.372 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.555 HG22 ' N ' ' A' ' 90' ' ' GLN . 2.5 p -65.93 160.96 3.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.912 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.555 ' N ' HG22 ' A' ' 89' ' ' VAL . 62.4 mt-30 -143.51 151.31 53.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.157 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.453 ' HG2' HD21 ' A' ' 136' ' ' LEU . 1.8 Cg_endo -64.93 -40.58 20.45 Favored 'Trans proline' 0 C--O 1.216 -0.577 0 C-N-CA 121.587 1.525 . . . . 0.0 112.164 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.448 ' CG ' ' C ' ' A' ' 91' ' ' PRO . 3.0 mtm-85 57.98 -164.92 0.17 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.737 0.78 . . . . 0.0 112.431 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.513 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -138.89 173.31 11.7 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.812 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -150.85 123.03 8.29 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.291 -1.364 . . . . 0.0 112.339 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.478 ' O ' ' CB ' ' A' ' 105' ' ' GLU . 8.2 m-30 -95.92 166.39 11.81 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.275 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -135.47 154.65 51.35 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -95.57 146.53 24.39 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.424 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.9 tttt 66.97 126.06 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.564 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 28.6 tt0 -64.27 90.81 0.07 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.702 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.674 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 169.71 21.78 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.734 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.674 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 28.5 p90 38.81 42.22 0.6 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.142 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -118.26 -57.86 2.04 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.533 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -44.52 159.58 0.13 Allowed Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.613 -1.28 . . . . 0.0 110.705 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -47.58 168.82 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.251 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -134.57 167.46 20.76 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.39 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.7 t -143.26 137.46 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.94 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -110.74 160.79 16.4 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 119.325 -0.95 . . . . 0.0 113.23 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.9 mt -145.94 139.01 14.24 Favored Pre-proline 0 N--CA 1.49 1.551 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.03 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -69.55 166.05 28.66 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 121.505 1.47 . . . . 0.0 111.156 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.99 144.68 99.63 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.734 1.622 . . . . 0.0 111.35 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 139.78 178.91 17.21 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 119.188 -1.482 . . . . 0.0 111.423 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.454 ' OE1' ' N ' ' A' ' 113' ' ' TYR . 14.4 tm0? -106.68 157.76 17.47 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.471 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.454 ' N ' ' OE1' ' A' ' 112' ' ' GLN . 67.8 m-85 -145.86 149.97 35.26 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.069 -1.053 . . . . 0.0 111.298 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.0 p -88.08 -157.27 0.4 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.347 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.39 52.22 0.72 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.019 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.18 -69.84 0.12 Allowed 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -70.54 -42.15 71.56 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.499 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.679 ' C ' HD23 ' A' ' 118' ' ' LEU . 2.4 tt -40.53 -73.55 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.254 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.751 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 0.7 OUTLIER -52.59 -49.87 64.16 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.955 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.404 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 1.8 mpt_? -70.99 -0.33 9.1 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.851 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.533 ' N ' ' O ' ' A' ' 117' ' ' GLU . 24.5 t80 -100.82 -22.81 14.73 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.497 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -131.12 -47.75 0.12 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.208 -1.473 . . . . 0.0 110.811 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.526 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -142.94 -107.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.113 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.526 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 7.0 m-20 -149.26 -178.67 6.53 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.998 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.07 10.61 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.473 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.489 ' H ' ' C ' ' A' ' 124' ' ' ASP . 0.4 OUTLIER -163.72 -139.23 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.511 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 126' ' ' ASN . 0.0 OUTLIER 33.78 87.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.275 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.9 mm -127.23 -41.98 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.071 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.7 m 46.1 -138.31 0.57 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.36 -0.836 . . . . 0.0 113.129 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.5 m -56.98 140.33 49.24 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.576 -1.193 . . . . 0.0 113.005 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.41 HG13 ' CD1' ' A' ' 95' ' ' PHE . 3.9 t -122.28 150.45 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.647 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -145.52 98.6 4.55 Favored Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.907 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -66.49 105.42 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.177 1.252 . . . . 0.0 110.969 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.513 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 28.0 mm-40 -57.97 -11.15 2.18 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.588 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 172.4 -30.31 0.11 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 118.226 -1.94 . . . . 0.0 112.352 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.453 HD21 ' HG2' ' A' ' 91' ' ' PRO . 4.3 mt -98.18 169.45 9.58 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.246 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -88.39 130.17 35.23 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.0 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.7 t -99.85 137.92 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.21 -0.996 . . . . 0.0 112.094 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.419 HG12 ' CE1' ' A' ' 141' ' ' PHE . 86.6 t -136.44 121.73 27.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.149 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.406 ' N ' HD12 ' A' ' 140' ' ' LEU . 5.0 mp -103.56 148.0 26.51 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.952 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.529 ' CD2' ' HB3' ' A' ' 146' ' ' PHE . 15.9 m-85 -120.79 130.54 54.03 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.134 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -66.32 -72.23 0.17 Allowed 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.476 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -75.17 164.74 26.17 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.59 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.617 ' CG ' ' H ' ' A' ' 145' ' ' ASN . 28.7 t0 -62.68 -161.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.831 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.641 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 2.5 m120 41.16 26.33 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.192 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.641 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 3.1 p90 41.01 58.11 2.6 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.489 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.8 t -136.78 -172.05 3.08 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.237 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.9 -165.54 50.64 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.129 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -59.33 148.86 30.72 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 118.996 -1.081 . . . . 0.0 110.178 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.2 p -138.82 177.15 8.1 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.534 -0.867 . . . . 0.0 111.468 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.426 ' C ' HD13 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -142.64 84.81 10.68 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.608 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.28 104.4 0.88 Allowed 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 121.8 1.667 . . . . 0.0 112.736 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 26.0 t -85.17 86.53 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.403 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -58.02 -21.32 44.56 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.938 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 59.4 p -169.79 -149.32 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 117.841 -1.544 . . . . 0.0 113.046 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -49.51 142.49 7.92 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.769 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -161.7 64.44 1.78 Allowed Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.666 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.1 Cg_endo -62.08 19.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 122.199 1.933 . . . . 0.0 113.066 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.564 ' O ' HG23 ' A' ' 159' ' ' THR . 1.5 t -172.92 83.22 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 118.27 -1.372 . . . . 0.0 112.128 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.99 -67.45 0.85 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.739 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 163' ' ' MET . . . 43.2 -131.13 5.68 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.849 -1.167 . . . . 0.0 111.464 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -32.88 85.62 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.558 ' N ' ' O ' ' A' ' 161' ' ' GLY . 9.2 tpp -177.42 -73.8 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.61 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.561 ' C ' ' H ' ' A' ' 166' ' ' ASN . 3.3 t-20 -92.22 70.49 5.27 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.58 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -60.42 4.12 0.06 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.071 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.561 ' H ' ' C ' ' A' ' 164' ' ' ASN . 4.6 t-20 -162.09 154.02 18.95 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.242 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 44.9 m -147.98 98.67 2.97 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.271 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.3 m -89.67 -38.86 13.59 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.657 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.1 p -146.31 152.4 39.09 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.754 -1.179 . . . . 0.0 110.103 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 118' ' ' LEU . 23.0 pt -134.07 175.96 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.331 -0.947 . . . . 0.0 111.015 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -153.48 108.76 3.2 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.438 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 11.1 mt -91.89 93.3 4.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.295 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 116.334 -1.793 . . . . 0.0 110.909 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 mtt . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.904 0.383 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.512 ' C ' ' ND2' ' A' ' 3' ' ' ASN . . . -73.02 173.52 9.2 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.717 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.512 ' ND2' ' C ' ' A' ' 2' ' ' ALA . 11.2 m-80 -159.67 128.75 5.19 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.842 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.481 ' CG1' ' O ' ' A' ' 4' ' ' ILE . 1.2 pt -73.28 124.93 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.127 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -97.86 106.24 18.51 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.256 -0.978 . . . . 0.0 108.511 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.541 ' HB ' HG23 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -90.47 166.38 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 119.195 -1.002 . . . . 0.0 113.257 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.678 ' CZ ' ' CE1' ' A' ' 12' ' ' PHE . 37.6 m-85 -122.7 134.44 54.46 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.358 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.69 -60.23 4.12 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.645 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 3.0 m120 -89.72 174.28 7.81 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.129 -1.028 . . . . 0.0 112.15 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 7.4 tp10 -81.96 165.25 20.89 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.779 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 10' ' ' GLU . 1.6 t70 76.17 42.01 0.2 Allowed 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.027 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.678 ' CE1' ' CZ ' ' A' ' 7' ' ' PHE . 78.1 t80 51.69 11.17 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.423 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -107.32 162.1 14.21 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.318 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.645 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 106.15 133.89 7.61 Favored Glycine 0 N--CA 1.503 3.142 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.853 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 14' ' ' GLY . 33.4 mttp -29.86 138.88 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.424 ' H ' ' HG3' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -97.17 158.43 15.45 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.446 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 t -147.84 125.73 3.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.596 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -92.09 120.67 32.92 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.161 -1.016 . . . . 0.0 111.694 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.445 HD12 HG11 ' A' ' 6' ' ' VAL . 7.5 mt -114.3 133.17 22.47 Favored Pre-proline 0 N--CA 1.498 1.959 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.265 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -69.53 167.89 22.84 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 120.848 1.032 . . . . 0.0 111.155 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -67.2 -162.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.893 1.729 . . . . 0.0 110.767 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.18 172.8 48.93 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.138 -1.506 . . . . 0.0 111.079 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.56 ' HB3' ' NE ' ' A' ' 83' ' ' ARG . 2.7 p30 -106.26 139.9 40.05 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.859 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.577 ' CZ ' HD12 ' A' ' 82' ' ' ILE . 4.0 p90 -155.75 -174.62 5.04 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.425 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.5 p -144.4 -156.29 0.68 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.036 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -65.67 -22.03 66.6 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.77 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -64.0 -60.67 2.96 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.501 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 27.8 tt0 -54.86 -45.65 74.59 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.498 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.5 ' HA ' HD23 ' A' ' 29' ' ' LEU . 15.0 mt -56.89 -43.05 80.93 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.579 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.76 -34.25 18.67 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 118.878 -1.129 . . . . 0.0 108.826 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -66.55 -42.29 87.36 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.421 -0.911 . . . . 0.0 109.793 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.472 HD12 HD23 ' A' ' 29' ' ' LEU . 9.6 mt -71.71 -71.92 0.25 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.715 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.41 -37.76 0.68 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.329 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.503 ' H ' HG22 ' A' ' 34' ' ' ILE . 1.4 tt -79.3 146.35 8.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.367 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -179.89 161.63 0.98 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.53 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.652 ' O ' HG22 ' A' ' 38' ' ' THR . 7.9 m120 60.1 -128.43 1.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.094 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.669 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -51.98 90.67 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.874 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 36' ' ' ASN . 0.3 OUTLIER -178.91 -165.99 0.09 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.383 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.647 ' N ' ' OG1' ' A' ' 38' ' ' THR . 5.2 mt 46.77 37.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-O 122.208 1.004 . . . . 0.0 108.829 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.442 ' OG ' ' CD ' ' A' ' 10' ' ' GLU . 30.9 t -70.02 -31.99 69.92 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.394 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -134.81 154.97 51.4 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.972 HG22 ' HB3' ' A' ' 69' ' ' ALA . 15.5 m -147.45 168.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 117.894 -1.523 . . . . 0.0 113.785 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -141.93 91.06 2.32 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.27 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.4 t -107.91 108.94 61.95 Favored Pre-proline 0 N--CA 1.487 1.38 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.034 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.415 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 2.4 Cg_endo -67.21 172.01 10.66 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.146 1.231 . . . . 0.0 109.587 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.513 ' HB3' ' HE ' ' A' ' 92' ' ' ARG . 2.1 Cg_endo -60.81 -168.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.329 1.353 . . . . 0.0 110.712 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.05 -19.0 10.84 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.12 -1.514 . . . . 0.0 111.871 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.638 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -155.49 155.53 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 118.118 -1.433 . . . . 0.0 113.054 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.417 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 24.4 ttpt -123.61 129.74 51.61 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.257 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.96 134.11 52.85 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.385 -0.926 . . . . 0.0 113.175 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.3 mt -115.51 117.67 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.154 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.949 HD12 ' N ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -96.35 163.06 13.23 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.215 -0.994 . . . . 0.0 113.337 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -139.92 111.61 7.33 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.052 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -82.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.309 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.465 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 5.2 t-20 -59.99 137.56 58.05 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.546 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.599 ' CG ' ' H ' ' A' ' 57' ' ' GLY . 26.2 t70 -58.94 -168.77 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.384 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.599 ' H ' ' CG ' ' A' ' 56' ' ' ASP . . . 56.97 27.59 57.08 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 118.885 -1.626 . . . . 0.0 109.758 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 53.9 61.76 2.93 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.114 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.96 -166.64 2.59 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.703 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.465 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 70.71 167.06 6.84 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.295 -1.431 . . . . 0.0 109.974 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -45.31 124.3 4.67 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.464 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -94.61 159.18 15.2 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.906 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.724 HG22 ' N ' ' A' ' 64' ' ' GLU . 7.5 mm -136.27 171.12 17.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.688 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.724 ' N ' HG22 ' A' ' 63' ' ' ILE . 2.3 pt-20 -150.57 132.28 14.94 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.346 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.408 HG13 ' C ' ' A' ' 64' ' ' GLU . 25.2 m -150.19 161.88 4.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.426 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 48' ' ' VAL . 3.0 t -145.57 -8.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.021 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -119.15 -149.01 0.43 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.105 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -90.36 141.55 28.62 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.908 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.972 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -109.62 94.47 5.05 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.843 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.64 -53.62 55.29 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.157 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.477 ' O ' ' C ' ' A' ' 72' ' ' LEU . 10.0 tp10 -128.85 66.64 1.42 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.18 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 71' ' ' GLU . 11.5 tp -21.14 -90.91 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.282 0.989 . . . . 0.0 113.071 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.53 ' O ' ' ND2' ' A' ' 76' ' ' ASN . . . -170.66 -159.64 17.15 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 118.917 -1.611 . . . . 0.0 110.783 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.472 ' C ' HD22 ' A' ' 76' ' ' ASN . 2.6 Cg_endo -65.08 -34.48 46.46 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 121.911 1.741 . . . . 0.0 111.488 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.641 ' H ' ' CD2' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -77.85 15.57 0.84 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.89 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.83 ' H ' HD22 ' A' ' 76' ' ' ASN . 0.3 OUTLIER -62.54 -61.18 2.61 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.854 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.585 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 1.9 t30 -78.68 33.94 0.21 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.86 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 76' ' ' ASN . 3.1 t-20 -171.42 71.66 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.241 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.631 HG13 ' N ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -94.59 -177.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.307 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.631 ' N ' HG13 ' A' ' 79' ' ' VAL . 1.5 t 174.82 -71.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.769 -1.172 . . . . 0.0 112.312 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 m -99.97 145.64 27.62 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.495 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.577 HD12 ' CZ ' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -149.65 160.88 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.812 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.815 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -144.03 110.1 5.38 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.732 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.815 ' H ' HH22 ' A' ' 83' ' ' ARG . 11.2 t -116.91 140.34 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.884 -0.727 . . . . 0.0 111.584 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.605 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 3.7 mt -144.97 135.11 19.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.413 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.2 m -41.88 157.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.488 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 48' ' ' VAL . 0.6 OUTLIER -154.61 139.86 12.13 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.318 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.506 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 8.0 Cg_exo -50.12 129.31 24.82 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 121.313 1.342 . . . . 0.0 111.071 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 90' ' ' GLN . 2.7 p -66.48 156.34 6.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.039 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -144.42 154.51 56.88 Favored Pre-proline 0 N--CA 1.487 1.388 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.872 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.11 -35.7 91.6 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 121.466 1.444 . . . . 0.0 111.142 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.513 ' HE ' ' HB3' ' A' ' 46' ' ' PRO . 86.5 mtt-85 54.72 -157.97 0.2 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.918 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.95 172.22 12.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.527 ' NE ' ' CD ' ' A' ' 105' ' ' GLU . 11.7 ttt180 -148.31 122.34 9.45 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.126 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.446 ' CD2' HG13 ' A' ' 131' ' ' VAL . 26.3 m-85 -105.05 165.54 11.01 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.503 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.541 ' CE2' ' O ' ' A' ' 101' ' ' PHE . 0.5 OUTLIER -125.69 172.76 9.52 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.513 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.447 ' CD1' ' O ' ' A' ' 104' ' ' LYS . 2.1 m-85 -92.32 -97.02 0.13 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.939 -1.104 . . . . 0.0 112.654 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -45.37 164.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.576 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -87.51 67.78 9.45 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.49 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.697 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -175.34 33.58 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.804 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.541 ' O ' ' CE2' ' A' ' 96' ' ' PHE . 29.1 t80 55.22 20.55 3.49 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.345 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -119.78 161.07 21.4 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.644 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 94.33 137.08 8.54 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.043 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.447 ' O ' ' CD1' ' A' ' 97' ' ' TYR . 52.7 mttm -28.0 138.93 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.527 ' CD ' ' NE ' ' A' ' 94' ' ' ARG . 11.6 pt-20 -99.48 175.94 5.67 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.26 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.582 HG11 ' C ' ' A' ' 122' ' ' GLY . 40.4 t -150.7 120.11 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.153 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 26.7 p-10 -96.62 155.75 16.64 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.597 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 108' ' ' LEU . 69.5 mt -142.75 149.4 49.93 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.147 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.408 ' O ' HD12 ' A' ' 172' ' ' ILE . 13.1 Cg_endo -77.27 165.03 28.37 Favored 'Trans proline' 0 C--O 1.213 -0.77 0 C-N-CA 121.84 1.693 . . . . 0.0 111.595 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -68.82 153.99 71.92 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 121.686 1.591 . . . . 0.0 110.843 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.45 -161.58 20.76 Favored Glycine 0 N--CA 1.509 3.521 0 C-N-CA 119.194 -1.479 . . . . 0.0 111.835 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.457 ' N ' ' CD ' ' A' ' 112' ' ' GLN . 2.9 mp0 -116.13 161.67 18.57 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.261 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.512 ' HB2' HD12 ' A' ' 118' ' ' LEU . 85.8 m-85 -145.49 146.41 31.45 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.008 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 114' ' ' THR . 10.9 p -74.9 -159.1 0.09 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.442 ' NE2' ' HB3' ' A' ' 144' ' ' ASP . 1.2 pt20 -108.0 40.05 1.82 Allowed 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.22 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.478 ' C ' ' N ' ' A' ' 118' ' ' LEU . . . -157.55 -87.5 0.04 OUTLIER 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 118.684 -1.206 . . . . 0.0 110.88 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 116' ' ' ALA . 11.3 pt-20 -45.53 -25.49 0.45 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.036 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.805 ' C ' HD23 ' A' ' 118' ' ' LEU . 5.6 tt -57.86 -66.53 0.46 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.113 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.439 ' HB3' ' C ' ' A' ' 124' ' ' ASP . 8.1 mm-40 -49.2 -49.95 40.45 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.406 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.483 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 4.0 mmm-85 -67.17 -12.44 60.04 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 118.718 -1.193 . . . . 0.0 112.016 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -91.97 -24.95 19.08 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.154 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.582 ' C ' HG11 ' A' ' 106' ' ' VAL . . . -115.93 -67.43 0.41 Allowed Glycine 0 N--CA 1.483 1.791 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.486 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -138.64 -103.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.186 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.573 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 15.2 t70 -154.01 -165.48 2.12 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.314 -0.955 . . . . 0.0 111.198 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.573 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 1.0 OUTLIER -58.71 -100.08 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.34 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.679 HD22 ' N ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -80.41 127.68 32.69 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.582 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.684 HG23 ' H ' ' A' ' 128' ' ' ILE . 0.0 OUTLIER 175.48 -106.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.523 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.684 ' H ' HG23 ' A' ' 127' ' ' THR . 6.2 mm 48.62 -97.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.005 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER 78.1 -42.77 0.36 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.2 m -143.56 126.34 16.13 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.682 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.446 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.9 t -121.59 158.84 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-O 121.975 0.893 . . . . 0.0 113.015 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.422 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -146.14 99.32 4.28 Favored Pre-proline 0 C--N 1.3 -1.544 0 CA-C-N 113.865 -1.516 . . . . 0.0 107.86 179.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.63 ' C ' ' H ' ' A' ' 135' ' ' GLY . 2.8 Cg_exo -52.66 -15.79 4.75 Favored 'Trans proline' 0 C--O 1.209 -0.955 0 C-N-CA 121.181 1.254 . . . . 0.0 112.491 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.408 HE21 ' HB2' ' A' ' 94' ' ' ARG . 4.4 tt0 53.17 -6.19 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.764 -0.774 . . . . 0.0 112.498 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . 160.45 -47.36 0.4 Allowed Glycine 0 N--CA 1.483 1.802 0 C-N-CA 118.766 -1.683 . . . . 0.0 111.242 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.1 mt -84.49 -164.31 0.94 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 117.95 -1.5 . . . . 0.0 110.787 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -119.17 131.11 55.82 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.0 t -101.76 143.12 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.796 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.412 ' C ' HD12 ' A' ' 140' ' ' LEU . 57.6 t -137.32 117.76 16.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.315 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.591 HD12 ' N ' ' A' ' 140' ' ' LEU . 10.9 mp -97.71 142.85 29.0 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.483 -0.887 . . . . 0.0 112.37 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.528 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 34.6 m-85 -120.51 133.46 55.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.432 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -74.3 -61.1 1.98 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.488 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -71.46 -175.99 1.43 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.089 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 146' ' ' PHE . 1.8 m-20 -77.18 -165.06 0.52 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.691 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.668 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 16.4 t30 27.95 39.51 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 123.931 0.769 . . . . 0.0 112.138 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.668 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.6 p90 41.65 60.44 2.16 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.197 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.84 -168.11 1.98 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.233 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 63.51 -162.45 33.45 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.607 -1.282 . . . . 0.0 110.145 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -59.58 156.05 14.23 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.189 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.3 p -144.72 160.75 40.7 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.679 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.8 tp -126.39 82.83 65.45 Favored Pre-proline 0 N--CA 1.486 1.325 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.125 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.68 106.56 0.63 Allowed 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 121.884 1.722 . . . . 0.0 113.162 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 43.6 t -87.94 82.45 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 119.455 -0.898 . . . . 0.0 108.949 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.706 ' H ' HD22 ' A' ' 154' ' ' ASN . 0.8 OUTLIER -62.59 -9.6 9.4 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.6 p -169.4 -167.9 0.75 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 117.456 -1.698 . . . . 0.0 113.475 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -42.29 150.83 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.53 -1.213 . . . . 0.0 112.812 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.572 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -171.94 66.83 0.41 Allowed Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.65 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.5 Cg_endo -65.6 23.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.173 1.916 . . . . 0.0 112.02 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.572 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.3 t -175.42 57.23 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.042 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 129' ' ' SER . 18.8 tp -63.63 -11.18 23.17 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.895 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 160' ' ' LEU . . . -40.04 97.19 0.01 OUTLIER Glycine 0 N--CA 1.496 2.682 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.46 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -177.27 -6.91 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.771 -0.771 . . . . 0.0 110.362 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -157.74 38.69 0.27 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.272 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.736 ' ND2' ' H ' ' A' ' 165' ' ' ASN . 3.4 p-10 -43.83 -73.55 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.735 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.736 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 1.0 OUTLIER 51.34 -95.48 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.359 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 164' ' ' ASN . 1.2 t-20 -172.36 86.03 0.07 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 119.043 -1.063 . . . . 0.0 111.556 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 51.7 m -58.8 111.39 1.26 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.003 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 74.7 m -90.13 -69.28 0.73 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.618 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.0 p -116.0 158.09 23.61 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.593 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 1.4 pt -141.1 -178.59 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.856 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -160.59 114.9 2.15 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.677 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 109' ' ' PRO . 14.0 mt -90.34 95.51 5.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.08 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 116.291 -1.814 . . . . 0.0 110.835 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.515 ' HB1' HG11 ' A' ' 48' ' ' VAL . . . -160.49 57.23 0.33 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.941 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -116.1 115.86 26.84 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.391 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.446 HD13 HG21 ' A' ' 4' ' ' ILE . 8.3 pt -74.56 143.86 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.3 m -128.41 135.5 49.6 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.678 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.499 HG22 ' CG1' ' A' ' 17' ' ' VAL . 9.8 m -120.79 158.64 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.015 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 14.0 m-85 -114.03 157.83 22.0 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.133 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -89.06 9.9 23.65 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.518 ' C ' ' OG ' ' A' ' 40' ' ' SER . 20.1 m120 -151.32 173.29 14.67 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.732 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -78.41 169.93 17.46 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.83 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 13' ' ' GLN . 6.7 t70 65.46 38.08 5.81 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.602 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.539 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 9.0 t80 62.81 -4.67 0.23 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.483 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.489 ' H ' ' C ' ' A' ' 11' ' ' ASP . 32.6 mt-30 -87.69 166.75 14.43 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.129 -1.028 . . . . 0.0 110.906 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 113.95 137.66 6.68 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -29.35 138.28 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.578 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -103.17 123.7 47.2 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.499 ' CG1' HG22 ' A' ' 6' ' ' VAL . 9.9 p -126.45 138.5 54.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.861 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -100.92 146.6 27.15 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.856 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 mt -137.94 141.46 32.63 Favored Pre-proline 0 N--CA 1.485 1.306 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.676 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -71.86 166.87 28.23 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.794 0.996 . . . . 0.0 111.711 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -67.12 -172.92 0.37 Allowed 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 121.998 1.799 . . . . 0.0 110.934 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.425 ' H ' ' HB ' ' A' ' 84' ' ' VAL . . . 98.44 -156.08 20.27 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.634 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.49 ' N ' HD22 ' A' ' 23' ' ' ASN . 0.3 OUTLIER -146.48 150.5 35.72 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.835 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.495 ' OH ' HD12 ' A' ' 82' ' ' ILE . 12.8 p90 -164.15 -164.2 0.84 Allowed 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.417 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.6 p -139.7 175.48 9.53 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.612 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.4 ptt85 -58.1 -13.52 4.98 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.275 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -67.59 -59.3 3.46 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.478 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.483 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 4.2 tp-100 -52.69 -43.06 65.34 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 118.506 -1.278 . . . . 0.0 108.201 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 32' ' ' LEU . 29.7 mt -58.77 -43.74 90.44 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.039 -1.064 . . . . 0.0 109.011 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -47.65 -30.39 3.7 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.618 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -77.61 -36.86 51.31 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.864 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 29' ' ' LEU . 12.7 mt -76.43 -67.37 0.7 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.614 -0.835 . . . . 0.0 110.627 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.6 -7.0 0.13 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.699 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.754 HG22 ' H ' ' A' ' 35' ' ' GLU . 1.3 mt -98.61 -167.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.165 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.754 ' H ' HG22 ' A' ' 34' ' ' ILE . 3.0 pt-20 175.05 -168.23 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.88 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.794 HD22 ' ND2' ' A' ' 78' ' ' ASN . 24.4 p-10 -77.06 -178.71 5.13 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.506 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.401 ' H ' ' H ' ' A' ' 79' ' ' VAL . 2.9 t30 71.05 -15.36 0.41 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.642 ' O ' ' N ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -86.84 -77.78 0.31 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.058 -1.457 . . . . 0.0 110.938 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.62 ' N ' ' OG1' ' A' ' 38' ' ' THR . 4.3 mt -13.96 75.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 124.924 1.39 . . . . 0.0 112.074 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.642 ' N ' ' O ' ' A' ' 38' ' ' THR . 43.0 t -81.89 -36.14 28.46 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.49 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.2 172.02 13.61 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.1 t -149.97 144.8 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 118.029 -1.468 . . . . 0.0 112.516 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -132.73 101.51 5.31 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.841 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.5 t -125.04 110.1 27.28 Favored Pre-proline 0 N--CA 1.491 1.617 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.267 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -69.19 166.78 25.72 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.129 1.219 . . . . 0.0 110.802 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -61.29 -168.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 121.754 1.636 . . . . 0.0 110.948 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.43 ' C ' ' CG1' ' A' ' 48' ' ' VAL . . . 76.21 -8.25 25.65 Favored Glycine 0 C--O 1.207 -1.578 0 C-N-CA 118.902 -1.618 . . . . 0.0 109.743 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.515 HG11 ' HB1' ' A' ' 2' ' ' ALA . 0.9 OUTLIER -151.24 134.41 7.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.143 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -107.37 121.16 44.03 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.91 159.38 20.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.01 -1.076 . . . . 0.0 113.095 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 63' ' ' ILE . 35.0 mt -142.92 124.21 11.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.603 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.523 HD13 ' HB ' ' A' ' 63' ' ' ILE . 5.2 mp -89.26 160.35 16.96 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.714 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -138.89 115.98 10.98 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.505 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -56.86 -80.26 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.771 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.424 ' ND2' ' H ' ' A' ' 56' ' ' ASP . 2.8 t-20 -59.47 148.17 33.91 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.175 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.506 ' OD1' ' CB ' ' A' ' 80' ' ' SER . 1.0 OUTLIER -60.26 172.44 0.83 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.725 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.05 31.69 80.16 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.11 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 50.56 47.32 24.38 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.779 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.24 -161.58 1.01 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.835 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.38 -178.87 2.01 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.317 -1.421 . . . . 0.0 109.889 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -48.24 163.62 0.06 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.217 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.606 HE21 ' C ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -148.12 141.07 24.81 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.544 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.599 HD11 HD21 ' A' ' 75' ' ' LEU . 3.0 mt -107.5 168.65 3.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.679 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' H ' HG22 ' A' ' 63' ' ' ILE . 48.9 tt0 -137.1 132.92 34.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.8 m -148.65 159.92 6.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 118.371 -1.332 . . . . 0.0 112.495 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 t -150.18 -1.48 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.483 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -132.57 -150.13 0.4 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.649 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.431 HD21 ' CG ' ' A' ' 107' ' ' ASP . 1.5 p30 -101.05 113.63 26.81 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.634 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.565 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.53 97.72 11.36 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.906 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -62.87 -74.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.397 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -67.51 -8.95 37.8 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.446 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.3 tp 66.78 -80.2 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.592 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 143.49 -158.51 27.32 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.438 -1.363 . . . . 0.0 110.138 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.6 ' C ' HD23 ' A' ' 75' ' ' LEU . 2.2 Cg_endo -64.56 -159.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.649 1.566 . . . . 0.0 110.814 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.6 HD23 ' C ' ' A' ' 74' ' ' PRO . 1.1 pt? 32.83 32.06 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.722 0.639 . . . . 0.0 111.945 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 74' ' ' PRO . 49.6 t30 -84.98 -15.47 44.14 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.098 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -86.98 0.43 55.16 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.273 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.794 ' ND2' HD22 ' A' ' 36' ' ' ASN . 1.1 t-20 -172.02 122.34 0.48 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 118.51 -1.276 . . . . 0.0 112.162 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 80' ' ' SER . 1.9 t -122.8 -148.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.443 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.651 ' H ' HG12 ' A' ' 79' ' ' VAL . 1.0 OUTLIER 154.33 -59.57 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.416 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.1 m -111.98 156.07 22.72 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 119.511 -0.876 . . . . 0.0 113.137 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.495 HD12 ' OH ' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -148.22 163.78 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.933 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.741 HH11 ' C ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -143.12 133.47 24.69 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.651 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.741 ' C ' HH11 ' A' ' 83' ' ' ARG . 22.1 t -139.98 128.57 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.936 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.458 HD11 ' HE ' ' A' ' 83' ' ' ARG . 55.3 mt -130.69 124.44 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.415 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.4 p -45.25 148.02 0.68 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.558 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.488 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.9 OUTLIER -148.07 152.05 39.07 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.275 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.488 ' HD2' HG22 ' A' ' 87' ' ' VAL . 2.9 Cg_exo -55.45 155.57 20.36 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.14 1.227 . . . . 0.0 110.859 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.3 t -59.71 144.39 12.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.732 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -144.74 119.06 5.73 Favored Pre-proline 0 N--CA 1.487 1.415 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.461 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -61.65 -157.53 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.832 0 C-N-CA 121.07 1.18 . . . . 0.0 111.184 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.444 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER 178.98 -162.14 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.274 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.435 ' N ' ' HD3' ' A' ' 92' ' ' ARG . . . -138.39 173.31 11.73 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.094 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -119.95 149.98 41.25 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.158 -1.017 . . . . 0.0 112.513 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -141.46 115.44 9.22 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.608 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.42 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 55.5 m-85 -79.42 176.93 9.24 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.81 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.16 -46.9 3.5 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.409 -0.917 . . . . 0.0 112.15 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.514 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 14.8 ttmt -92.26 154.73 18.43 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.864 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.597 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -71.13 102.72 2.56 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.11 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.609 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 123.96 47.13 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.113 0 O-C-N 125.356 1.66 . . . . 0.0 109.072 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.609 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 21.9 p90 30.15 59.44 0.2 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.65 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.469 ' HB2' ' NE2' ' A' ' 100' ' ' GLN . 18.7 t70 -130.64 -12.54 3.84 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.252 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.514 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -93.66 157.23 22.89 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.459 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.466 ' HD3' ' H ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -29.59 139.11 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.19 0.519 . . . . 0.0 112.258 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.466 ' H ' ' HD3' ' A' ' 104' ' ' LYS . 0.4 OUTLIER -93.85 105.42 17.44 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.229 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.468 HG11 ' C ' ' A' ' 122' ' ' GLY . 92.7 t -92.64 137.9 21.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.051 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.431 ' CG ' HD21 ' A' ' 68' ' ' ASN . 1.9 p30 -121.53 155.07 35.76 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.95 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.7 mt -144.3 132.51 10.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.026 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -66.5 166.63 21.18 Favored 'Trans proline' 0 C--O 1.214 -0.725 0 C-N-CA 121.643 1.562 . . . . 0.0 111.69 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.55 149.24 68.16 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.81 1.673 . . . . 0.0 111.565 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.55 -176.3 20.45 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 119.415 -1.374 . . . . 0.0 110.932 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.407 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 40.8 tt0 -110.89 154.57 23.86 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.482 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 61.7 m-85 -146.22 155.46 42.7 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.436 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 3.1 p -92.49 -142.44 0.2 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.34 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.52 ' N ' ' OG1' ' A' ' 114' ' ' THR . 36.4 tt0 -111.97 -20.97 11.79 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.658 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.78 -57.59 3.72 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.381 -0.928 . . . . 0.0 112.644 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.561 ' CG ' ' H ' ' A' ' 118' ' ' LEU . 4.6 pt-20 -71.36 -55.93 7.0 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.837 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.561 ' H ' ' CG ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -32.34 -67.42 0.11 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.976 0.798 . . . . 0.0 111.273 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' A' ' 121' ' ' TYR . 75.6 mt-10 -55.5 -61.55 2.27 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.726 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.476 ' NH1' ' OD1' ' A' ' 124' ' ' ASP . 1.7 mpt_? -73.86 19.88 0.11 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.199 -1.0 . . . . 0.0 112.344 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 117' ' ' GLU . 17.9 t80 -124.45 -15.59 6.6 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.858 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.468 ' C ' HG11 ' A' ' 106' ' ' VAL . . . -148.22 -38.45 0.04 OUTLIER Glycine 0 C--N 1.295 -1.735 0 C-N-CA 118.771 -1.681 . . . . 0.0 110.822 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -141.75 -113.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.316 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.596 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 28.8 t70 -156.5 -176.86 6.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.396 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.596 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 46.9 t30 -79.22 148.82 32.09 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.845 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.554 HD22 ' CB ' ' A' ' 166' ' ' ASN . 32.5 m120 44.9 45.64 8.63 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.412 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.4 m -163.42 107.25 1.02 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.872 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.1 mm -138.95 -45.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.606 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.587 ' OG ' ' N ' ' A' ' 130' ' ' SER . 1.2 p 66.02 -152.45 0.24 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.587 ' N ' ' OG ' ' A' ' 129' ' ' SER . 26.8 m -49.79 129.86 20.5 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.404 -1.271 . . . . 0.0 113.066 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.4 151.17 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.928 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -160.58 112.69 1.35 Allowed Pre-proline 0 C--N 1.292 -1.896 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.598 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.26 170.79 3.7 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 120.605 0.87 . . . . 0.0 111.777 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -156.26 5.74 0.18 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.776 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.57 -50.92 0.04 OUTLIER Glycine 0 N--CA 1.481 1.677 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.37 162.94 20.66 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.732 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.66 154.8 24.71 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.329 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.6 143.72 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.265 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.3 t -129.76 125.37 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.464 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.6 mp -99.4 145.28 27.56 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.829 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.559 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 3.3 m-85 -120.78 143.23 48.93 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.3 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -73.85 -76.17 0.14 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.553 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -74.82 157.12 35.68 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.611 ' CG ' ' H ' ' A' ' 145' ' ' ASN . 26.4 t70 -57.92 -174.4 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.47 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.643 ' ND2' ' CZ ' ' A' ' 146' ' ' PHE . 0.4 OUTLIER 40.34 27.18 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.094 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.643 ' CZ ' ' ND2' ' A' ' 145' ' ' ASN . 1.9 p90 41.69 62.0 1.7 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.286 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.9 t -131.95 71.46 1.47 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.306 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 173.14 -163.12 34.65 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.277 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.52 162.76 4.66 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 118.914 -1.114 . . . . 0.0 109.788 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.7 p -149.35 164.2 35.56 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.732 -1.187 . . . . 0.0 111.612 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 29.5 mt -131.64 87.32 46.26 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.714 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -61.44 107.87 0.54 Allowed 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.487 1.458 . . . . 0.0 111.859 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.442 ' C ' ' H ' ' A' ' 155' ' ' SER . 2.2 t -91.84 65.64 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.887 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -79.07 33.49 0.22 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.219 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 153' ' ' VAL . 16.8 t -167.09 -156.87 0.23 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.195 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.416 ' N ' ' OG ' ' A' ' 155' ' ' SER . 6.0 m-20 -90.61 153.22 20.48 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.768 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.433 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -163.2 71.39 1.94 Allowed Pre-proline 0 N--CA 1.486 1.334 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.533 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.471 ' C ' ' HG ' ' A' ' 130' ' ' SER . 1.2 Cg_endo -67.73 35.77 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.535 2.157 . . . . 0.0 113.372 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.727 HG23 ' H ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -167.38 -83.34 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.336 -1.345 . . . . 0.0 111.852 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.727 ' H ' HG23 ' A' ' 159' ' ' THR . 2.3 tp 73.68 -69.65 0.18 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.424 -0.911 . . . . 0.0 110.544 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 54.97 55.55 27.44 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.367 -1.397 . . . . 0.0 110.736 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 50.7 89.78 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.889 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 2.3 mmt -74.54 -63.02 1.33 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.665 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -90.33 -59.61 2.14 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.678 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -155.31 -79.18 0.09 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.701 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.554 ' CB ' HD22 ' A' ' 126' ' ' ASN . 2.7 p-10 -157.82 163.69 37.75 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.916 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.2 m -103.4 112.04 24.74 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.303 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 83.7 p -96.67 -35.35 11.06 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.75 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.67 154.44 50.92 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.898 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 16.8 pt -135.76 162.97 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.486 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.424 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 41.2 ttp85 -146.32 100.99 3.44 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.846 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.6 mt -81.73 99.54 4.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.055 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 116.448 -1.739 . . . . 0.0 111.02 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 mtt . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.855 0.359 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.6 ' C ' HD22 ' A' ' 3' ' ' ASN . . . -161.22 115.88 2.06 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.991 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.6 HD22 ' C ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER -175.89 122.66 0.19 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.192 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -84.29 153.68 3.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.136 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.4 m -128.09 118.78 24.07 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.092 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 16' ' ' GLN . 3.7 m -98.25 170.12 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.335 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 1.305 ' CE2' ' NE2' ' A' ' 16' ' ' GLN . 24.8 m-85 -129.49 149.46 51.26 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.516 ' CD2' ' NZ ' ' A' ' 15' ' ' LYS . 2.7 m-85 -77.28 -57.78 3.64 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.978 -1.089 . . . . 0.0 113.233 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.517 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 19.0 m120 -87.58 162.28 17.26 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.721 -1.191 . . . . 0.0 111.923 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.54 -179.04 0.99 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.326 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.647 ' C ' ' CG ' ' A' ' 12' ' ' PHE . 6.0 t70 51.52 52.63 14.3 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 118.313 -1.355 . . . . 0.0 110.52 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.647 ' CG ' ' C ' ' A' ' 11' ' ' ASP . 1.2 p90 41.65 20.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 11' ' ' ASP . 22.2 mt-30 -93.77 173.88 7.45 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.85 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.517 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 79.01 128.09 0.55 Allowed Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.188 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.516 ' NZ ' ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -40.99 156.34 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.935 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 1.305 ' NE2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -112.16 177.03 4.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 t -141.65 137.9 31.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 114.332 -1.304 . . . . 0.0 109.379 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -95.47 114.51 26.29 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.663 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.0 mt -107.88 133.05 20.62 Favored Pre-proline 0 N--CA 1.492 1.657 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.043 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -71.41 156.57 58.28 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 120.837 1.025 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.53 -167.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 121.506 1.471 . . . . 0.0 110.67 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.447 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 100.14 -174.22 26.11 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.942 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.705 ' CA ' HH11 ' A' ' 83' ' ' ARG . 0.6 OUTLIER -109.69 122.88 48.48 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.926 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 7.7 p90 -147.86 173.9 12.38 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 118.746 -1.182 . . . . 0.0 111.005 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.7 p -147.79 -154.83 0.58 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.051 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -62.43 -28.28 69.69 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.802 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -62.39 -63.43 1.24 Allowed 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.71 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.9 tt0 -55.48 -49.59 72.13 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.603 -1.239 . . . . 0.0 109.481 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.618 HD23 HD12 ' A' ' 32' ' ' LEU . 26.9 mt -51.84 -41.27 61.68 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.57 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.53 -35.84 21.55 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 118.558 -1.257 . . . . 0.0 108.006 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -65.04 -40.31 94.61 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.554 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.618 HD12 HD23 ' A' ' 29' ' ' LEU . 17.0 mt -72.86 -74.12 0.18 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.601 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.12 -26.27 1.0 Allowed Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.995 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.0 142.41 13.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.194 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 9.1 pt-20 -177.86 155.0 0.96 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.642 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 2.1 t-20 90.18 -149.62 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 O-C-N 124.265 0.978 . . . . 0.0 112.408 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.635 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.4 OUTLIER -70.14 32.48 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.045 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 40' ' ' SER . 1.0 OUTLIER -88.13 -40.99 13.32 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.62 -1.232 . . . . 0.0 110.336 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.42 ' HB ' HG21 ' A' ' 79' ' ' VAL . 22.7 mt -64.88 74.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.38 -0.928 . . . . 0.0 108.976 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 38' ' ' THR . 28.0 t -76.33 -72.97 0.3 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.704 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.46 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -99.15 168.04 10.31 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.888 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.589 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.1 t -151.32 148.31 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 117.988 -1.485 . . . . 0.0 113.087 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -133.72 108.69 8.67 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.852 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.451 HG23 HG13 ' A' ' 42' ' ' VAL . 65.2 t -128.46 111.42 19.38 Favored Pre-proline 0 N--CA 1.5 2.05 0 C-N-CA 119.809 -0.756 . . . . 0.0 112.311 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.59 170.07 14.53 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.099 1.2 . . . . 0.0 110.851 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.16 -167.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.919 1.746 . . . . 0.0 110.978 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.434 ' C ' HG12 ' A' ' 48' ' ' VAL . . . 78.21 -11.34 23.7 Favored Glycine 0 N--CA 1.484 1.851 0 C-N-CA 119.104 -1.522 . . . . 0.0 110.982 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.676 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -154.76 148.66 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 118.725 -1.19 . . . . 0.0 112.074 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -115.14 142.3 46.84 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.974 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.84 143.03 46.8 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.026 -1.07 . . . . 0.0 112.274 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.551 HG23 ' O ' ' A' ' 63' ' ' ILE . 78.2 mt -121.04 121.75 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.284 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.599 HD23 ' H ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -91.99 147.21 23.13 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.306 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.599 ' H ' HD23 ' A' ' 52' ' ' LEU . 53.3 m-85 -134.45 132.61 39.51 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.142 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -58.94 -84.44 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.052 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -65.17 163.65 14.69 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.65 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -63.09 -177.94 0.2 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.601 -0.839 . . . . 0.0 110.586 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.614 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 53.96 33.1 50.0 Favored Glycine 0 N--CA 1.487 2.059 0 C-N-CA 118.957 -1.592 . . . . 0.0 109.158 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.614 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 41.99 69.78 0.33 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.576 0.703 . . . . 0.0 110.751 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.91 174.21 10.79 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.07 -177.21 54.36 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.483 -1.342 . . . . 0.0 110.088 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.14 118.14 1.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.18 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.423 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 3.2 pt20 -101.27 172.39 7.02 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.738 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.551 ' O ' HG23 ' A' ' 51' ' ' ILE . 4.8 mt -144.47 163.84 13.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.553 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -138.98 126.2 21.39 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.769 -0.773 . . . . 0.0 109.498 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.3 m -149.03 158.96 6.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 118.781 -1.168 . . . . 0.0 112.727 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 48' ' ' VAL . 3.9 t -149.78 -1.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.401 ' H ' ' H ' ' A' ' 66' ' ' VAL . . . -125.42 -135.97 0.27 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.722 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -105.93 112.0 24.88 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.24 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.589 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.54 80.33 6.71 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.768 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -52.33 -81.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.048 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -69.12 -10.44 57.67 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.603 -0.839 . . . . 0.0 112.008 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.526 ' CD2' HD21 ' A' ' 76' ' ' ASN . 2.5 tp 63.23 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.434 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.429 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 175.15 -175.25 47.11 Favored Glycine 0 N--CA 1.501 2.998 0 C-N-CA 119.183 -1.484 . . . . 0.0 110.999 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.531 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.2 Cg_endo -66.72 -39.92 14.21 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 122.375 2.05 . . . . 0.0 112.188 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.986 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.7 pt? -71.11 30.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.144 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.531 ' H ' ' C ' ' A' ' 74' ' ' PRO . 0.6 OUTLIER -72.67 -9.6 58.81 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.639 -0.825 . . . . 0.0 110.605 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -87.57 13.16 10.78 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.126 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.644 ' ND2' ' N ' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -177.91 116.79 0.09 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 118.691 -1.204 . . . . 0.0 111.699 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 36' ' ' ASN . 15.6 m -157.07 145.85 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.944 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.6 p -164.34 -36.86 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 118.562 -1.255 . . . . 0.0 113.131 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.43 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 4.1 m -94.61 142.99 26.81 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 118.773 -1.171 . . . . 0.0 111.577 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.415 ' CG1' ' C ' ' A' ' 81' ' ' SER . 2.1 mt -148.58 143.21 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 118.821 -1.152 . . . . 0.0 111.426 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.829 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -121.31 116.01 24.04 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.783 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.829 ' H ' HH12 ' A' ' 83' ' ' ARG . 3.9 t -123.69 136.36 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.943 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.514 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 3.8 mt -139.1 126.74 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.196 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.6 p -48.98 133.02 18.59 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.433 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.775 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -122.9 149.92 57.7 Favored Pre-proline 0 N--CA 1.49 1.566 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.599 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.775 ' HD2' HG22 ' A' ' 87' ' ' VAL . 6.0 Cg_exo -51.43 127.31 21.94 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 121.386 1.391 . . . . 0.0 111.216 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.3 p -58.51 136.87 21.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.881 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -145.91 151.46 45.56 Favored Pre-proline 0 N--CA 1.487 1.389 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.961 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.419 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 2.3 Cg_endo -58.89 -164.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 121.277 1.318 . . . . 0.0 111.111 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.467 ' CD ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -175.79 -161.75 0.09 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.759 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -141.71 162.96 34.2 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.084 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.1 ttm-85 -135.82 107.48 6.99 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.05 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 18.5 m-85 -87.0 169.15 12.68 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.597 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.482 ' CE1' ' HB3' ' A' ' 105' ' ' GLU . 26.8 m-85 -137.09 167.64 21.15 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.581 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.409 ' OH ' HG23 ' A' ' 123' ' ' ILE . 3.4 m-85 -103.24 168.83 8.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.659 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.405 ' CB ' ' OD1' ' A' ' 102' ' ' ASP . 52.5 mttp 57.14 164.69 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.841 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 24.2 tt0 -90.85 75.78 6.41 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.683 ' HG2' ' CG ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 153.78 43.46 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 O-C-N 124.358 1.036 . . . . 0.0 109.376 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 100' ' ' GLN . 19.1 p90 33.47 32.67 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.284 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.683 ' CG ' ' HG2' ' A' ' 100' ' ' GLN . 22.7 p-10 -107.32 36.2 2.79 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.154 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -145.66 158.37 27.65 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.277 -1.439 . . . . 0.0 110.467 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.545 ' H ' ' HE3' ' A' ' 104' ' ' LYS . 1.2 mtmt -31.72 144.84 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.169 0.509 . . . . 0.0 112.318 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.482 ' HB3' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -105.86 149.49 26.48 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.175 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 45.4 t -143.91 150.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.761 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -136.8 156.53 48.37 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.241 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.431 HD22 ' CE2' ' A' ' 121' ' ' TYR . 11.8 mt -137.01 163.12 51.66 Favored Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.938 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -88.78 166.92 5.96 Favored 'Trans proline' 0 C--O 1.212 -0.78 0 C-N-CA 121.871 1.714 . . . . 0.0 112.74 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -63.58 140.56 75.89 Favored 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 121.745 1.63 . . . . 0.0 110.89 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.75 -154.96 25.59 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.19 -1.481 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.595 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 37.3 tt0 -125.35 156.77 38.21 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.367 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 48.5 m-85 -144.07 149.55 36.78 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.792 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.3 p -96.81 -159.49 0.74 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.717 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.702 ' CD ' ' H ' ' A' ' 115' ' ' GLN . 2.5 pm0 -105.51 56.29 0.68 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.213 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.74 -64.34 0.11 Allowed 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.741 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.572 ' CG ' ' H ' ' A' ' 118' ' ' LEU . 9.0 pt-20 -69.77 -52.19 27.44 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.577 ' C ' HD23 ' A' ' 118' ' ' LEU . 1.9 tt -33.67 -60.23 0.37 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.167 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 36.4 mt-10 -54.36 -69.42 0.13 Allowed 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.293 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.434 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 3.4 mpt_? -74.79 23.23 0.1 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.293 -0.963 . . . . 0.0 112.376 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 117' ' ' GLU . 13.0 t80 -114.13 -22.29 10.08 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.856 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.74 -21.55 0.02 OUTLIER Glycine 0 N--CA 1.488 2.117 0 C-N-CA 118.429 -1.844 . . . . 0.0 110.625 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.425 HG21 HD13 ' A' ' 123' ' ' ILE . 9.1 mt -139.79 -120.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.746 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 124' ' ' ASP . 11.7 p30 -159.08 -154.98 0.44 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.767 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -76.22 -35.23 59.13 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.803 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.424 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 25.5 t30 -162.11 118.01 1.99 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.798 -1.161 . . . . 0.0 112.154 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.412 ' CG2' ' CG2' ' A' ' 123' ' ' ILE . 6.1 t -179.2 -14.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.895 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.452 HG13 ' H ' ' A' ' 128' ' ' ILE . 2.1 mt -50.84 166.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.173 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.8 p -175.4 -115.11 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.536 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.1 m -54.39 131.27 41.84 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.854 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.13 155.83 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.47 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.11 83.83 4.57 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.835 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.58 107.46 1.44 Allowed 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.317 1.345 . . . . 0.0 110.638 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -88.86 24.34 2.08 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.973 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -173.01 -56.01 0.05 OUTLIER Glycine 0 N--CA 1.494 2.542 0 C-N-CA 118.208 -1.949 . . . . 0.0 112.095 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.419 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 0.9 OUTLIER -116.79 172.74 7.05 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.567 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -89.37 142.58 27.53 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.497 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.2 t -102.13 145.41 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.94 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.99 124.65 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.681 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 140' ' ' LEU . 4.5 mp -107.74 146.07 32.64 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.239 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 141' ' ' PHE . 20.2 m-85 -120.02 137.51 54.05 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.591 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -71.03 -67.82 0.48 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.951 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -65.57 165.34 12.46 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.98 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 146' ' ' PHE . 3.0 m-20 -63.61 -162.51 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.735 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.665 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 35.1 m120 27.48 39.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 123.859 0.724 . . . . 0.0 112.101 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.665 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.2 OUTLIER 43.97 61.26 2.39 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.456 -0.897 . . . . 0.0 109.881 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -132.42 173.29 11.45 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.27 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.05 -166.3 53.86 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.347 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -59.41 172.97 0.57 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.026 -1.069 . . . . 0.0 109.944 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 43.1 p -151.67 177.33 10.47 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.972 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.512 HD22 ' HA ' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -137.63 79.72 33.98 Favored Pre-proline 0 N--CA 1.485 1.3 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.764 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.6 105.21 0.73 Allowed 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 122.025 1.817 . . . . 0.0 113.247 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 39.8 t -90.68 74.52 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.946 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 1.8 m-20 -79.19 26.64 0.26 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.14 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 25.4 t -169.99 -174.06 1.7 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.626 -1.23 . . . . 0.0 111.839 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.433 ' N ' ' OG ' ' A' ' 155' ' ' SER . 1.8 m-20 -73.78 154.44 39.55 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.907 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.594 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -166.68 72.4 1.11 Allowed Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.239 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.32 20.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.968 1.779 . . . . 0.0 111.85 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.594 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.2 t -169.38 71.08 0.07 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.863 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.431 ' HA ' HD22 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -75.58 -83.76 0.06 Allowed 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.479 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 56.46 176.06 0.27 Allowed Glycine 0 N--CA 1.493 2.453 0 C-N-CA 118.902 -1.618 . . . . 0.0 110.083 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 55.33 98.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.917 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 4.1 ptm -176.33 73.46 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.475 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -44.0 161.51 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.709 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 59.4 89.47 0.06 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.006 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.425 ' N ' ' OD1' ' A' ' 166' ' ' ASN . 29.3 p-10 -38.98 151.4 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.994 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.18 120.81 14.36 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.865 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 54.4 p -92.78 -42.38 9.6 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.284 -0.967 . . . . 0.0 110.533 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.72 164.09 29.08 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.788 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 30.0 pt -143.61 165.91 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -148.43 109.73 4.37 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.875 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.9 mt -89.12 99.47 9.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 119.271 -0.971 . . . . 0.0 109.946 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.305 -1.346 0 CA-C-O 116.352 -1.785 . . . . 0.0 111.12 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.2 mmm . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.937 0.399 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.579 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . -160.43 -148.05 0.16 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.588 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -175.87 119.75 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.673 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.482 ' CG1' ' O ' ' A' ' 4' ' ' ILE . 1.0 OUTLIER -77.57 122.42 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.821 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -95.93 106.53 18.69 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.131 -1.028 . . . . 0.0 108.602 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.453 ' CG1' HD12 ' A' ' 19' ' ' LEU . 1.4 m -88.43 170.06 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 118.974 -1.09 . . . . 0.0 112.344 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 1.189 ' CE2' ' HG2' ' A' ' 16' ' ' GLN . 40.3 m-85 -134.35 144.5 48.29 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.75 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -65.61 -62.18 1.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.975 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.512 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 29.8 m120 -90.52 160.57 15.91 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.754 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -58.88 -171.6 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.64 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.638 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 11.5 m-20 44.95 51.54 8.61 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.842 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.638 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 49.5 p90 39.48 24.38 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 11' ' ' ASP . 32.9 mm-40 -98.69 173.74 6.75 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.565 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.512 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 81.58 135.68 1.95 Allowed Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.389 -1.386 . . . . 0.0 110.352 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 14' ' ' GLY . 30.0 mmtm -29.82 136.83 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.957 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 1.189 ' HG2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -97.53 160.8 14.1 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.339 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -146.22 129.05 9.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.131 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -91.14 124.59 35.48 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.863 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.453 HD12 ' CG1' ' A' ' 6' ' ' VAL . 7.9 mt -119.46 125.85 27.3 Favored Pre-proline 0 N--CA 1.497 1.898 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.892 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.4 158.83 47.04 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 120.98 1.12 . . . . 0.0 111.485 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.14 -166.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.911 1.741 . . . . 0.0 111.154 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.95 -171.28 29.88 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.222 -1.466 . . . . 0.0 110.481 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.638 ' ND2' ' N ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -117.83 131.57 56.54 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.087 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.56 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 1.1 p90 -149.47 -174.88 4.8 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.937 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.498 HG22 ' OG ' ' A' ' 81' ' ' SER . 4.1 p -155.7 -162.14 1.27 Allowed 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.908 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.471 ' C ' ' CD ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -54.08 -20.65 6.86 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.493 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.444 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . -67.58 -66.58 0.54 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.441 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.617 ' CA ' HE21 ' A' ' 28' ' ' GLN . 0.0 OUTLIER -54.58 -44.83 73.34 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.796 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.696 HD23 HD12 ' A' ' 32' ' ' LEU . 19.6 mt -57.64 -42.74 84.04 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.005 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.03 -32.0 32.35 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 118.409 -1.317 . . . . 0.0 108.817 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -67.38 -39.31 85.61 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.638 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.696 HD12 HD23 ' A' ' 29' ' ' LEU . 6.1 mt -75.76 -71.87 0.35 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.326 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.62 -36.72 0.73 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.376 -1.393 . . . . 0.0 110.609 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 tt -81.99 143.15 12.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.849 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.491 ' H ' HG21 ' A' ' 38' ' ' THR . 0.6 OUTLIER -179.96 134.98 0.11 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.563 -1.255 . . . . 0.0 112.495 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.774 ' O ' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER 74.76 128.94 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.075 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.501 ' H ' ' H ' ' A' ' 79' ' ' VAL . 2.6 t30 45.36 8.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.178 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.774 HG23 ' O ' ' A' ' 36' ' ' ASN . 66.3 p -89.3 -33.33 16.97 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.527 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.448 ' H ' HG12 ' A' ' 39' ' ' ILE . 4.8 mm -75.71 66.4 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.743 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.0 t -73.37 -55.3 6.57 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.153 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.9 160.06 29.72 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.147 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.001 HG22 ' HB3' ' A' ' 69' ' ' ALA . 18.6 m -149.73 168.01 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 118.356 -1.338 . . . . 0.0 113.409 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -142.62 98.37 3.28 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.87 -1.514 . . . . 0.0 108.099 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.408 HG22 HG22 ' A' ' 4' ' ' ILE . 42.0 t -116.17 113.28 41.51 Favored Pre-proline 0 N--CA 1.496 1.852 0 C-N-CA 119.873 -0.731 . . . . 0.0 112.81 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -69.3 171.7 13.5 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.041 1.161 . . . . 0.0 110.009 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.525 ' HG3' ' HE ' ' A' ' 92' ' ' ARG . 1.0 OUTLIER -64.88 -167.78 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.617 1.545 . . . . 0.0 111.158 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.59 -8.36 7.46 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.373 -1.394 . . . . 0.0 110.781 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.579 HG11 ' HB3' ' A' ' 2' ' ' ALA . 33.2 m -148.59 143.34 18.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.576 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -118.23 126.42 52.13 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.234 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.54 144.53 36.08 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.377 -0.929 . . . . 0.0 112.765 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.593 HD12 ' NH2' ' A' ' 83' ' ' ARG . 27.8 mt -133.11 112.39 17.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.097 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.523 HD12 ' H ' ' A' ' 52' ' ' LEU . 1.6 mp -89.72 160.45 16.57 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.68 -1.208 . . . . 0.0 112.773 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -138.54 108.55 6.36 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.107 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -49.38 -78.59 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.259 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.504 HD22 ' HA3' ' A' ' 60' ' ' GLY . 2.6 m-80 -59.76 141.44 55.23 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.965 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -55.64 177.81 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.852 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.46 29.48 69.42 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.334 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.439 ' CZ ' HG23 ' A' ' 25' ' ' THR . 21.4 m-85 54.88 67.6 0.99 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.787 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.59 -162.65 1.6 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.958 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.504 ' HA3' HD22 ' A' ' 55' ' ' ASN . . . 64.42 176.09 4.59 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.363 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 60' ' ' GLY . 63.0 m-20 -42.68 112.92 0.4 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.613 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.745 ' CD ' ' H ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -93.0 155.68 17.37 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.401 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.706 HG22 ' N ' ' A' ' 64' ' ' GLU . 7.3 mm -134.71 169.42 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.747 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.706 ' N ' HG22 ' A' ' 63' ' ' ILE . 41.0 tt0 -150.8 130.71 13.33 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.718 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.517 HG12 ' CE1' ' A' ' 121' ' ' TYR . 17.6 m -149.95 159.94 4.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 118.942 -1.103 . . . . 0.0 111.808 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.93 -11.98 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.908 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -116.69 -149.42 0.44 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.892 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -94.04 128.51 40.44 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.508 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.001 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -92.48 95.69 9.79 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.423 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 7.0 tp10 -56.9 -78.16 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.538 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.45 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 7.3 tp10 -91.42 5.05 50.9 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.309 -0.957 . . . . 0.0 110.748 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.439 HD12 ' HB1' ' A' ' 69' ' ' ALA . 14.7 tp 53.2 -99.85 0.09 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.023 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.72 -169.95 34.39 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 118.897 -1.62 . . . . 0.0 111.166 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.638 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.2 Cg_endo -68.58 -37.44 12.7 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.574 2.183 . . . . 0.0 112.929 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.513 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.6 pt? -57.01 8.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.102 -1.039 . . . . 0.0 111.586 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.638 ' H ' ' C ' ' A' ' 74' ' ' PRO . 22.7 t-20 -59.52 -9.89 2.92 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.329 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.535 ' ND2' ' N ' ' A' ' 77' ' ' ASN . 1.3 m120 -67.25 -24.26 65.79 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.014 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -168.53 133.87 1.73 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.064 -1.055 . . . . 0.0 111.482 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.501 ' H ' ' H ' ' A' ' 37' ' ' ASN . 2.3 t -146.75 125.97 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.237 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.3 t -146.29 -42.8 0.2 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.925 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.498 ' OG ' HG22 ' A' ' 25' ' ' THR . 5.2 m -90.93 135.21 33.89 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.057 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.439 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -141.02 159.51 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.196 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.778 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -143.91 106.21 4.39 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.749 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.778 ' CA ' HH12 ' A' ' 83' ' ' ARG . 11.3 t -123.33 131.63 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.545 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.492 HG12 ' NH1' ' A' ' 83' ' ' ARG . 1.5 pt -136.23 140.47 43.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.527 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.1 t -44.43 156.39 0.08 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.758 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.559 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -150.37 140.43 13.92 Favored Pre-proline 0 C--N 1.307 -1.248 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.505 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.559 ' HD2' HG22 ' A' ' 87' ' ' VAL . 3.4 Cg_exo -50.67 136.79 42.1 Favored 'Trans proline' 0 C--O 1.21 -0.892 0 C-N-CA 121.006 1.138 . . . . 0.0 111.464 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.4 t -50.15 141.27 3.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.933 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -119.51 131.62 24.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.505 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.88 -24.5 72.7 Favored 'Trans proline' 0 C--O 1.21 -0.876 0 C-N-CA 120.762 0.975 . . . . 0.0 110.592 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.525 ' HE ' ' HG3' ' A' ' 46' ' ' PRO . 7.2 ptt85 36.36 -157.79 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.222 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.72 173.27 11.69 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.886 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.424 ' CD ' ' OE1' ' A' ' 105' ' ' GLU . 30.1 ttp180 -145.0 109.83 5.05 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 118.484 -1.286 . . . . 0.0 112.574 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.589 ' CD2' HG13 ' A' ' 131' ' ' VAL . 17.3 m-85 -95.95 149.1 21.93 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.204 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.484 ' CD1' ' HB3' ' A' ' 105' ' ' GLU . 72.1 m-85 -115.16 -162.52 0.83 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 119.344 -0.943 . . . . 0.0 111.0 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -135.04 168.01 19.91 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.29 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt 58.05 157.94 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 122.064 0.935 . . . . 0.0 112.823 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.55 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 32.0 tt0 -67.46 106.32 2.09 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.404 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.582 HE21 ' HA ' ' A' ' 100' ' ' GLN . 1.0 OUTLIER 97.92 59.51 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.976 0 O-C-N 124.721 1.263 . . . . 0.0 111.341 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.561 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 35.2 p90 31.51 38.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.48 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 100' ' ' GLN . 93.6 m-20 -100.62 49.7 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.851 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -169.47 157.52 29.33 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.773 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -40.73 158.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.704 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.484 ' HB3' ' CD1' ' A' ' 96' ' ' PHE . 5.9 pt-20 -123.45 165.44 17.06 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.663 0.744 . . . . 0.0 112.855 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.7 t -146.18 119.53 2.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.805 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.59 164.04 14.92 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.999 -1.08 . . . . 0.0 111.996 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 108' ' ' LEU . 79.3 mt -145.35 137.88 13.6 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.695 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -69.58 161.28 46.52 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 121.646 1.564 . . . . 0.0 111.787 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.84 149.04 91.71 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.812 1.675 . . . . 0.0 111.243 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.53 -164.36 25.14 Favored Glycine 0 N--CA 1.502 3.077 0 C-N-CA 119.288 -1.434 . . . . 0.0 111.368 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.594 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 24.2 mt-30 -119.06 156.49 29.6 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.205 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 29.0 m-85 -144.93 150.54 37.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.884 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.416 ' H ' HG23 ' A' ' 114' ' ' THR . 1.6 p -90.31 -162.62 0.91 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.548 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -102.83 46.78 0.91 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -150.59 -62.98 0.2 Allowed 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.636 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 121' ' ' TYR . 5.8 pt-20 -71.57 -42.75 67.41 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.399 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.589 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -40.19 -70.04 0.11 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.04 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 121' ' ' TYR . 52.4 mt-10 -53.06 -59.49 4.47 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.845 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.473 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -68.34 14.59 0.07 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.29 -0.964 . . . . 0.0 112.389 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.517 ' CE1' HG12 ' A' ' 65' ' ' VAL . 9.4 t80 -117.59 -26.83 6.48 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.27 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -129.35 -43.21 0.21 Allowed Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.521 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.484 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -146.29 -114.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.038 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -146.19 -160.82 1.2 Allowed 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.237 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -59.69 -99.91 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.64 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.634 ' CG ' ' H ' ' A' ' 127' ' ' THR . 19.5 p-10 -57.54 -111.31 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.634 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 1.6 t 43.75 -120.13 0.67 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.894 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.595 ' N ' ' OG1' ' A' ' 127' ' ' THR . 8.4 mm 54.79 -96.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.714 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.4 OUTLIER 76.12 -138.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.297 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.9 m -42.27 129.51 3.8 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.044 -0.663 . . . . 0.0 111.819 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.589 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.9 t -121.13 150.96 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.393 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.78 83.41 8.12 Favored Pre-proline 0 C--N 1.302 -1.49 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.431 ' C ' ' H ' ' A' ' 135' ' ' GLY . 4.3 Cg_exo -61.05 98.65 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.536 1.491 . . . . 0.0 110.433 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -55.27 -2.76 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.656 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . 175.21 -36.97 0.1 Allowed Glycine 0 N--CA 1.492 2.388 0 C-N-CA 117.87 -2.11 . . . . 0.0 112.588 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.501 HD12 ' C ' ' A' ' 92' ' ' ARG . 3.8 mt -90.24 171.53 9.42 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.414 -1.314 . . . . 0.0 111.894 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -94.91 127.25 40.8 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 153' ' ' VAL . 3.4 t -98.32 139.22 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.988 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 98.9 t -133.34 125.35 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.314 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.562 HD23 ' OG1' ' A' ' 167' ' ' THR . 10.5 mp -103.62 140.29 37.75 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.428 -0.909 . . . . 0.0 113.052 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -117.35 131.75 56.72 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.055 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.675 ' NZ ' ' ND2' ' A' ' 164' ' ' ASN . 43.8 mttm -80.97 -44.12 18.65 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.419 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.473 HD22 ' HB3' ' A' ' 147' ' ' SER . 13.7 t30 -71.95 -171.68 0.74 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.698 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.34 -128.52 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.603 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 146' ' ' PHE . 45.7 t30 -53.57 93.26 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.439 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 145' ' ' ASN . 3.8 m-85 37.39 67.38 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.314 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.473 ' HB3' HD22 ' A' ' 143' ' ' ASN . 0.4 OUTLIER -140.83 165.79 26.55 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.116 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 75.79 -163.73 53.6 Favored Glycine 0 N--CA 1.503 3.1 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.998 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.01 171.82 10.18 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.725 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 p -148.18 164.13 34.88 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.697 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 mt -124.67 82.94 59.14 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.344 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -63.05 100.75 0.26 Allowed 'Trans proline' 0 C--N 1.318 -1.054 0 C-N-CA 121.649 1.566 . . . . 0.0 112.652 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 138' ' ' VAL . 10.3 t -80.81 90.01 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.366 -0.933 . . . . 0.0 109.66 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -49.87 -31.64 12.55 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.998 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 13.3 t -170.39 -136.15 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.341 -1.344 . . . . 0.0 112.351 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.414 ' N ' ' OG ' ' A' ' 155' ' ' SER . 11.6 m-20 -50.55 141.62 12.11 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.18 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.535 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.44 63.43 1.07 Allowed Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.699 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.5 Cg_endo -63.22 21.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.214 1.943 . . . . 0.0 112.777 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.535 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -168.96 118.88 0.71 Allowed 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.274 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.62 -40.64 0.14 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.407 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 50.58 -171.57 0.16 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.602 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.09 109.21 1.23 Allowed 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.39 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 6.1 tpt -91.22 -75.42 0.47 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.412 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.675 ' ND2' ' NZ ' ' A' ' 142' ' ' LYS . 3.5 m-80 -91.31 -78.57 0.39 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.726 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 164' ' ' ASN . 10.0 m-80 -168.8 81.59 0.14 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.807 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 166' ' ' ASN . 0.6 OUTLIER 63.37 141.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.451 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.562 ' OG1' HD23 ' A' ' 140' ' ' LEU . 1.1 m -90.58 123.12 33.97 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.579 -0.849 . . . . 0.0 110.508 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.4 m -90.33 -79.55 0.34 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.141 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 7.0 m -105.29 159.87 15.55 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.437 HG12 ' CD1' ' A' ' 118' ' ' LEU . 32.8 pt -141.92 174.36 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.25 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -158.82 109.84 2.09 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.506 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.438 HG21 HD13 ' A' ' 136' ' ' LEU . 56.5 mt -88.08 92.27 3.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 118.832 -1.147 . . . . 0.0 109.414 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.939 -179.904 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.422 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -75.0 -141.39 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.73 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.458 ' N ' ' OD1' ' A' ' 3' ' ' ASN . 2.7 p30 -173.24 107.45 0.15 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.191 -1.003 . . . . 0.0 111.159 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 pt -76.36 175.13 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.932 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 m -148.06 153.1 38.47 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.364 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 m -138.02 160.04 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.235 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 22.2 m-85 -119.42 145.91 45.83 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.904 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.85 -66.52 0.6 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.561 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 13.4 m120 -76.1 179.82 5.43 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.311 -0.956 . . . . 0.0 112.364 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -73.93 176.81 6.08 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.226 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.654 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 16.8 t70 48.56 56.01 8.18 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.491 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.654 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 39.2 p90 38.23 27.42 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.451 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 11' ' ' ASP . 6.3 tp-100 -98.89 163.06 12.76 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.35 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.561 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 93.13 134.35 6.91 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.378 -1.391 . . . . 0.0 109.634 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 14' ' ' GLY . 38.7 mttp -29.45 140.82 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.47 164.55 12.23 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.322 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.3 t -145.58 129.94 11.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.664 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -92.94 137.09 32.67 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.231 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 mt -129.05 136.79 29.73 Favored Pre-proline 0 N--CA 1.49 1.558 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.33 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -72.44 156.72 54.1 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 121.087 1.191 . . . . 0.0 111.422 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.73 -161.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.463 1.442 . . . . 0.0 109.726 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.558 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 91.18 -162.47 28.46 Favored Glycine 0 N--CA 1.485 1.923 0 C-N-CA 118.528 -1.796 . . . . 0.0 110.991 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.723 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -123.03 133.18 54.35 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.238 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.603 ' OH ' HD12 ' A' ' 82' ' ' ILE . 14.7 p90 -155.7 174.51 15.19 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.522 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.468 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 17.0 p -138.25 -156.64 0.7 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.071 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.469 ' CD ' ' H ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -66.79 -16.68 64.43 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.599 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -65.13 -59.88 3.62 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.637 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.554 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 15.3 tp60 -56.41 -43.78 79.68 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 118.754 -1.178 . . . . 0.0 109.261 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 29' ' ' LEU . 28.4 mt -59.21 -40.03 84.51 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.814 -1.155 . . . . 0.0 109.127 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.7 -32.73 14.08 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 118.735 -1.186 . . . . 0.0 108.077 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -69.87 -42.07 73.97 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.699 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 mt -70.58 -74.86 0.13 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.82 -29.67 0.74 Allowed Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.092 -1.527 . . . . 0.0 110.846 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.41 ' H ' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -92.08 139.99 16.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.882 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.615 ' O ' HG23 ' A' ' 38' ' ' THR . 2.2 pt-20 179.94 166.1 1.22 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.481 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.607 ' C ' ' H ' ' A' ' 38' ' ' THR . 0.6 OUTLIER 79.97 -143.54 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.545 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.73 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -56.38 10.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.623 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 35' ' ' GLU . 67.4 p -76.17 -142.4 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.618 -1.233 . . . . 0.0 111.023 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 38' ' ' THR . 9.1 mt 39.69 60.71 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.02 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.2 t -65.54 -50.39 65.4 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.12 172.26 8.38 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.355 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.62 154.48 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 118.529 -1.268 . . . . 0.0 112.607 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -138.66 125.28 20.76 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.457 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.9 t -140.0 114.43 7.74 Favored Pre-proline 0 N--CA 1.494 1.725 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.918 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -69.32 169.48 18.25 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 121.116 1.21 . . . . 0.0 111.231 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.63 -174.97 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 122.102 1.868 . . . . 0.0 111.387 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.86 -16.77 7.86 Favored Glycine 0 N--CA 1.482 1.766 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.985 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.422 HG11 ' CB ' ' A' ' 2' ' ' ALA . 18.4 m -149.25 146.4 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.779 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -119.55 139.35 52.28 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.55 159.43 20.41 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.199 -1.001 . . . . 0.0 112.937 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.495 HG23 ' O ' ' A' ' 63' ' ' ILE . 70.5 mt -141.29 117.96 7.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.447 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.472 HD12 ' H ' ' A' ' 52' ' ' LEU . 4.2 mp -92.32 163.12 14.0 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.824 -1.15 . . . . 0.0 113.222 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.57 ' CZ ' ' NE2' ' A' ' 62' ' ' GLN . 30.7 m-85 -141.61 115.29 9.06 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.678 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -81.1 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.899 -0.72 . . . . 0.0 112.157 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -59.26 141.07 55.28 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.319 -0.953 . . . . 0.0 111.382 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.07 172.79 0.26 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.464 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.47 27.27 73.88 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.291 -1.433 . . . . 0.0 110.149 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.468 ' CZ ' HG23 ' A' ' 25' ' ' THR . 32.9 m-85 54.58 63.32 2.19 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.969 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.38 -161.6 1.34 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.01 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.0 170.02 1.21 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.462 -1.352 . . . . 0.0 110.106 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -44.74 121.44 2.71 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.343 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.57 ' NE2' ' CZ ' ' A' ' 53' ' ' TYR . 5.0 mt-30 -94.86 173.21 7.71 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.068 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.807 HD11 HD11 ' A' ' 75' ' ' LEU . 2.9 mt -143.73 166.04 13.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.683 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -146.93 131.18 17.45 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.299 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.6 m -150.17 160.31 4.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.806 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.43 -15.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.543 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -111.1 -138.55 0.38 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.003 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -111.07 124.81 52.91 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.001 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.75 120.25 29.98 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.236 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.55 -85.18 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.108 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 6.5 mt-10 -85.51 3.56 39.84 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.69 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.454 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 1.6 tp 72.34 -89.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.584 -0.847 . . . . 0.0 111.74 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.428 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -179.13 -178.88 48.57 Favored Glycine 0 N--CA 1.499 2.876 0 C-N-CA 118.861 -1.638 . . . . 0.0 111.369 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -70.2 14.8 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.627 2.218 . . . . 0.0 112.99 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.807 HD11 HD11 ' A' ' 63' ' ' ILE . 1.4 pt? -132.49 38.95 3.41 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.269 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -83.46 -2.04 54.98 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.655 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -73.14 -7.99 53.79 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.805 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -164.07 117.74 1.45 Allowed 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.122 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.27 127.32 11.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.232 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.1 t -155.45 -35.32 0.09 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 118.857 -1.137 . . . . 0.0 112.362 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.2 m -93.69 136.49 33.91 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.943 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.603 HD12 ' OH ' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -144.84 155.99 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 118.839 -1.144 . . . . 0.0 112.282 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.817 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.87 120.74 15.43 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.358 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.817 ' H ' HH12 ' A' ' 83' ' ' ARG . 18.4 t -129.92 136.8 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.939 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.591 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 2.6 mt -143.87 132.77 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.027 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.5 m -38.18 150.81 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.928 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.509 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -148.03 139.89 14.14 Favored Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.328 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.509 ' HD2' HG22 ' A' ' 87' ' ' VAL . 10.7 Cg_exo -47.78 153.61 2.34 Favored 'Trans proline' 0 C--O 1.212 -0.821 0 C-N-CA 121.401 1.401 . . . . 0.0 111.512 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.34 141.25 15.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 119.756 -0.778 . . . . 0.0 112.312 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -145.97 136.41 12.16 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.582 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.404 ' HG2' HD21 ' A' ' 136' ' ' LEU . 5.4 Cg_exo -58.83 -155.39 0.01 OUTLIER 'Trans proline' 0 C--O 1.21 -0.904 0 C-N-CA 121.421 1.414 . . . . 0.0 111.274 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.411 ' NE ' HH21 ' A' ' 94' ' ' ARG . 5.2 ptt180 -178.76 -160.86 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 118.375 -1.33 . . . . 0.0 111.929 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.0 168.7 19.09 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.385 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.411 HH21 ' NE ' ' A' ' 92' ' ' ARG . 0.4 OUTLIER -125.15 156.52 38.25 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.635 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.432 ' CD2' HG13 ' A' ' 131' ' ' VAL . 73.7 m-85 -145.88 103.88 3.8 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.672 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -89.97 172.25 8.99 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.059 -1.057 . . . . 0.0 112.124 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.603 ' CE2' ' OG1' ' A' ' 127' ' ' THR . 0.3 OUTLIER -110.45 159.23 17.68 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.915 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 42.2 tttt 68.35 151.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.84 0.829 . . . . 0.0 112.359 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.562 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 26.8 tt0 -67.9 106.22 2.23 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.754 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.584 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 105.0 48.45 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.108 0 O-C-N 125.054 1.471 . . . . 0.0 110.637 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.584 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 33.9 p90 30.73 39.1 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.156 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 100' ' ' GLN . 24.9 t70 -99.41 26.75 5.76 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.465 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -146.94 179.99 23.46 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.141 -1.504 . . . . 0.0 111.28 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -29.72 145.12 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -119.08 137.65 53.42 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.322 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.682 HG21 ' O ' ' A' ' 122' ' ' GLY . 2.4 t -139.86 158.58 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.979 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.466 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 7.2 p-10 -144.86 156.35 43.96 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.646 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.478 HD22 ' CD2' ' A' ' 121' ' ' TYR . 32.2 mt -141.08 147.9 49.52 Favored Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.527 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -71.31 165.23 33.09 Favored 'Trans proline' 0 C--O 1.212 -0.819 0 C-N-CA 121.797 1.665 . . . . 0.0 111.08 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.54 149.42 82.18 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.646 1.564 . . . . 0.0 111.518 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.41 -151.38 22.6 Favored Glycine 0 N--CA 1.5 2.938 0 C-N-CA 119.069 -1.539 . . . . 0.0 111.436 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.678 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 41.5 tt0 -136.14 155.69 49.8 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.21 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.678 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 18.9 m-85 -145.6 155.32 42.96 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.51 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.9 p -96.45 -156.82 0.55 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.327 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.749 ' CD ' ' H ' ' A' ' 115' ' ' GLN . 3.8 pm0 -103.75 29.4 5.81 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.231 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.24 -65.48 0.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.769 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.55 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 9.6 pt-20 -70.33 -48.77 54.99 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.975 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.68 ' C ' HD23 ' A' ' 118' ' ' LEU . 1.9 tt -35.12 -73.25 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.502 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.54 -54.22 24.14 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.555 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.4 OUTLIER -76.28 17.66 0.35 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.638 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.511 ' N ' ' O ' ' A' ' 117' ' ' GLU . 18.1 t80 -123.7 -12.62 7.6 Favored 'General case' 0 N--CA 1.502 2.175 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.625 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.682 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -142.47 -48.49 0.04 OUTLIER Glycine 0 N--CA 1.485 1.953 0 C-N-CA 119.223 -1.465 . . . . 0.0 110.173 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.595 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -145.13 -99.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.835 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.595 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 17.9 t70 -165.76 -164.88 0.76 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.15 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.533 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 1.4 t-20 -64.53 -122.07 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.874 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.477 ' H ' ' CG ' ' A' ' 125' ' ' ASN . 3.6 m-20 -70.4 112.42 6.68 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.538 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.603 ' OG1' ' CE2' ' A' ' 97' ' ' TYR . 1.8 t -179.87 -5.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.744 -0.783 . . . . 0.0 110.798 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.2 mt -91.25 151.95 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.617 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.528 ' HB3' ' H ' ' A' ' 161' ' ' GLY . 19.3 m -153.42 -66.12 0.15 Allowed 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.373 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.24 112.37 19.18 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.037 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.432 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.0 t -120.5 163.3 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.189 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.0 tttp -154.34 125.64 3.62 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.647 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 6.2 Cg_endo -65.33 -50.04 2.22 Favored 'Trans proline' 0 C--O 1.203 -1.262 0 C-N-CA 121.034 1.156 . . . . 0.0 111.081 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.479 ' CB ' ' O ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 72.23 -37.72 0.4 Allowed 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.38 -0.928 . . . . 0.0 112.621 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . -150.35 -48.88 0.02 OUTLIER Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.236 -1.459 . . . . 0.0 111.113 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.404 HD21 ' HG2' ' A' ' 91' ' ' PRO . 0.7 OUTLIER -109.56 153.4 24.19 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.008 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.06 153.75 41.54 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.118 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.64 143.82 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 119.663 -0.815 . . . . 0.0 112.321 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.43 HG12 ' CE1' ' A' ' 141' ' ' PHE . 93.3 t -135.94 123.07 33.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.984 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 140' ' ' LEU . 10.3 mp -103.23 142.75 33.64 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.812 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 141' ' ' PHE . 14.0 m-85 -120.61 136.52 54.79 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.082 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -75.05 -62.62 1.49 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.565 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.442 ' ND2' ' HA3' ' A' ' 148' ' ' GLY . 2.6 m-80 -61.01 159.99 10.65 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.271 -0.972 . . . . 0.0 112.362 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -27.35 -108.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.519 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 9.0 m120 -74.7 89.82 2.28 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.219 -0.901 . . . . 0.0 113.273 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.66 ' H ' ' CB ' ' A' ' 169' ' ' SER . 1.5 p90 33.04 73.11 0.07 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.131 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.409 ' C ' ' HB2' ' A' ' 143' ' ' ASN . 10.3 t -145.83 -170.76 3.55 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.158 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.442 ' HA3' ' ND2' ' A' ' 143' ' ' ASN . . . 51.26 -157.97 2.54 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.124 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.406 ' C ' HG23 ' A' ' 150' ' ' THR . 2.3 m-20 -59.99 174.1 0.54 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.654 -0.819 . . . . 0.0 110.833 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 149' ' ' ASP . 55.3 p -155.05 174.5 15.09 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.914 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.7 tp -138.32 79.54 30.46 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.026 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -59.66 110.26 0.71 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.817 1.678 . . . . 0.0 112.945 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 155' ' ' SER . 20.5 t -93.24 70.77 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.356 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -65.06 8.2 0.14 Allowed 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.219 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.595 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 9.3 t -170.94 177.68 3.67 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.282 -1.367 . . . . 0.0 112.211 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.595 ' N ' ' OG ' ' A' ' 155' ' ' SER . 3.2 m-20 -51.0 151.59 2.53 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.431 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.531 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -164.32 61.71 0.92 Allowed Pre-proline 0 C--N 1.309 -1.165 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.407 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.2 Cg_endo -63.72 22.42 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.534 2.156 . . . . 0.0 113.314 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -175.96 95.49 0.06 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 117.759 -1.576 . . . . 0.0 112.504 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.578 ' O ' ' N ' ' A' ' 162' ' ' ALA . 44.7 mt -112.56 -61.54 1.71 Allowed 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.65 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.528 ' H ' ' HB3' ' A' ' 129' ' ' SER . . . 44.44 -87.05 0.01 OUTLIER Glycine 0 N--CA 1.499 2.89 0 C-N-CA 119.553 -1.308 . . . . 0.0 111.156 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -37.61 -33.07 0.06 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.979 -0.689 . . . . 0.0 111.525 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.448 ' O ' ' C ' ' A' ' 164' ' ' ASN . 2.3 tpt -78.7 25.32 0.26 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.637 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 161' ' ' GLY . 22.7 t-20 -32.41 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.426 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.611 ' ND2' ' H ' ' A' ' 167' ' ' THR . 11.4 t30 -122.02 119.36 31.22 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.687 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -45.08 -23.22 0.14 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.138 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.611 ' H ' ' ND2' ' A' ' 165' ' ' ASN . 47.3 m 42.76 73.88 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.419 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.3 m -78.29 -23.55 47.14 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.204 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.66 ' CB ' ' H ' ' A' ' 146' ' ' PHE . 0.2 OUTLIER -149.25 162.07 40.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.34 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 29.1 pt -143.46 161.33 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 119.159 -1.017 . . . . 0.0 111.029 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -143.42 104.01 4.18 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.452 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.8 mt -82.63 95.12 3.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.179 -1.009 . . . . 0.0 110.154 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.3 m . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.845 179.969 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 mtm . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.892 0.377 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.599 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -49.51 164.2 0.09 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.469 -0.893 . . . . 0.0 111.105 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -175.15 118.96 0.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.526 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.5 pt -69.14 154.7 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.233 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -126.56 135.44 51.27 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.81 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.622 ' HB ' HG23 ' A' ' 39' ' ' ILE . 2.3 m -121.89 138.73 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.971 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.52 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 29.6 m-85 -96.48 146.7 24.56 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.798 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.04 -56.78 17.02 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.25 -0.98 . . . . 0.0 112.21 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.606 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 12.2 m-20 -96.85 170.94 8.83 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.504 ' HG2' ' N ' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -76.6 -165.92 0.59 Allowed 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.976 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.504 ' N ' ' HG2' ' A' ' 10' ' ' GLU . 66.4 m-20 52.67 35.4 18.21 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.523 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.52 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 18.2 t80 56.68 7.11 0.35 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.436 -0.905 . . . . 0.0 112.16 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.43 ' HG3' ' N ' ' A' ' 14' ' ' GLY . 5.3 tp-100 -96.31 160.21 14.54 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.551 -0.859 . . . . 0.0 111.678 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.606 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 102.38 131.23 7.27 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.738 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 14' ' ' GLY . 25.2 mtmm -31.79 141.11 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.927 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.588 ' H ' ' NE2' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -99.44 161.19 13.76 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.119 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.1 t -145.47 134.48 17.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.206 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.16 134.09 39.66 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.141 -1.024 . . . . 0.0 112.116 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.6 mt -122.1 127.57 25.88 Favored Pre-proline 0 N--CA 1.489 1.479 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.524 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.5 163.6 31.92 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 120.928 1.086 . . . . 0.0 111.268 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.39 -169.28 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.65 1.567 . . . . 0.0 111.019 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.462 ' C ' HH21 ' A' ' 83' ' ' ARG . . . 87.96 -176.91 46.05 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.744 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.672 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -112.18 142.29 44.83 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.884 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.616 ' CZ ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -156.03 -174.77 5.1 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.314 179.777 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 24' ' ' TYR . 4.7 p -156.35 -157.17 0.69 Allowed 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.921 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.43 ' H ' ' HB ' ' A' ' 25' ' ' THR . 43.9 ttt85 -52.29 -33.54 42.65 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.289 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.79 -63.59 1.21 Allowed 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.863 -1.135 . . . . 0.0 110.524 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.8 tm0? -57.23 -32.95 67.05 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.779 -1.169 . . . . 0.0 109.882 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.616 HD21 ' CZ ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -60.56 -47.27 86.92 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.011 -1.076 . . . . 0.0 109.433 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -51.41 -32.99 28.33 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.163 -1.015 . . . . 0.0 108.92 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -64.08 -42.79 96.83 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.848 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 mt -71.9 -80.31 0.06 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.941 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.77 -29.79 0.16 Allowed Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.465 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.455 HG23 ' H ' ' A' ' 34' ' ' ILE . 0.9 OUTLIER -82.2 169.75 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.894 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.959 ' H ' HG21 ' A' ' 38' ' ' THR . 4.7 pt-20 178.68 111.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.289 -0.965 . . . . 0.0 111.904 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.616 ' O ' HG23 ' A' ' 38' ' ' THR . 1.0 OUTLIER 61.66 140.57 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.555 ' H ' ' H ' ' A' ' 79' ' ' VAL . 9.6 t30 47.01 4.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.658 -1.156 . . . . 0.0 113.695 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.959 HG21 ' H ' ' A' ' 35' ' ' GLU . 76.2 p -82.34 -29.87 30.74 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 117.992 -1.483 . . . . 0.0 111.424 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.622 HG23 ' HB ' ' A' ' 6' ' ' VAL . 11.6 mt -78.24 53.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.328 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 10' ' ' GLU . 30.4 t -50.98 -53.93 28.85 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.761 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.0 169.65 10.27 Favored 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.307 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.1 t -153.3 151.43 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 117.856 -1.538 . . . . 0.0 113.139 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -138.64 102.69 4.66 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.194 -1.367 . . . . 0.0 108.805 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 73.9 t -117.94 107.8 43.5 Favored Pre-proline 0 N--CA 1.496 1.865 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.228 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.25 168.2 19.98 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 121.31 1.34 . . . . 0.0 110.939 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.11 -173.19 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.753 1.635 . . . . 0.0 111.177 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.63 -14.77 11.46 Favored Glycine 0 N--CA 1.481 1.699 0 C-N-CA 119.125 -1.512 . . . . 0.0 110.691 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.599 HG11 ' CB ' ' A' ' 2' ' ' ALA . 16.3 m -151.59 134.28 6.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 C-N-CA 118.851 -1.14 . . . . 0.0 112.086 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.436 ' O ' HG13 ' A' ' 84' ' ' VAL . 22.8 ttpp -105.83 143.52 33.85 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.32 150.75 49.44 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.024 -1.07 . . . . 0.0 112.928 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 63' ' ' ILE . 83.9 mt -135.04 117.75 22.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.737 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.476 HD12 ' H ' ' A' ' 52' ' ' LEU . 3.6 mp -96.61 160.83 14.18 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 118.927 -1.109 . . . . 0.0 113.8 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 62' ' ' GLN . 44.9 m-85 -135.3 116.38 14.3 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.675 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -47.59 -88.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.081 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -61.69 147.26 46.58 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.54 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -55.54 174.51 0.1 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.389 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.16 30.59 75.87 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.127 -1.511 . . . . 0.0 110.03 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 48.42 40.46 14.83 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.767 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -114.37 -176.97 3.02 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.821 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.69 164.27 5.27 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.064 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -45.55 131.87 8.47 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.545 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.413 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 5.6 pt20 -99.24 172.31 7.44 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.865 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.706 HD11 HD11 ' A' ' 75' ' ' LEU . 3.9 mt -135.28 165.29 31.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.763 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.414 ' C ' HG13 ' A' ' 65' ' ' VAL . 28.2 mt-10 -143.92 129.89 19.49 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.4 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.414 HG13 ' C ' ' A' ' 64' ' ' GLU . 35.1 m -150.03 159.61 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 118.489 -1.284 . . . . 0.0 112.524 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 t -146.23 2.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.238 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.49 ' HB3' ' OH ' ' A' ' 121' ' ' TYR . . . -131.51 -144.6 0.25 Allowed 'General case' 0 C--O 1.207 -1.132 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.086 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.481 ' C ' ' ND2' ' A' ' 68' ' ' ASN . 0.5 OUTLIER -103.37 119.55 39.09 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.849 -0.741 . . . . 0.0 111.578 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.542 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -97.45 97.86 9.45 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.17 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -58.72 -87.61 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.48 -0.888 . . . . 0.0 112.096 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 43.7 mm-40 -68.02 -5.83 19.39 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.41 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.466 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 2.8 tp 70.83 -77.88 0.05 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.049 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.43 -175.21 43.75 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.51 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -65.35 -38.43 26.48 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.193 1.929 . . . . 0.0 111.865 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -78.96 30.67 0.2 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.395 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.839 ' H ' HD22 ' A' ' 76' ' ' ASN . 0.0 OUTLIER -77.14 10.26 2.52 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.561 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -87.83 -2.17 58.44 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.83 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -170.7 122.23 0.6 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.024 -1.07 . . . . 0.0 111.546 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.555 ' H ' ' H ' ' A' ' 37' ' ' ASN . 2.4 t -147.92 121.93 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.494 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.1 t -150.58 -34.1 0.16 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.908 -1.117 . . . . 0.0 112.517 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.425 ' OG ' HG22 ' A' ' 25' ' ' THR . 3.8 m -93.19 136.31 33.58 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.818 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.524 HD12 ' CE1' ' A' ' 24' ' ' TYR . 21.3 mt -148.08 160.95 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.287 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.835 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -142.78 108.1 5.01 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.824 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.835 ' H ' HH22 ' A' ' 83' ' ' ARG . 10.5 t -114.59 142.39 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.823 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.465 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 7.2 mt -142.48 132.43 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.745 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 m -40.38 153.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.663 -0.698 . . . . 0.0 112.319 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -150.77 149.1 24.78 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.968 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.33 177.55 0.15 Allowed 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 121.546 1.497 . . . . 0.0 112.099 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 89' ' ' VAL . 34.6 m -88.29 136.12 24.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.316 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -146.17 123.68 6.1 Favored Pre-proline 0 C--N 1.308 -1.2 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.844 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -57.06 178.84 0.13 Allowed 'Trans proline' 0 C--O 1.205 -1.146 0 C-N-CA 121.088 1.192 . . . . 0.0 110.978 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.504 ' HD3' ' N ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -151.42 -160.12 1.12 Allowed 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.566 0.698 . . . . 0.0 110.23 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.98 167.03 23.06 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -132.35 116.07 16.4 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.674 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -99.09 130.27 45.41 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.456 ' CD2' ' HB3' ' A' ' 105' ' ' GLU . 24.8 m-85 -102.47 165.39 11.13 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.639 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -103.31 162.67 12.81 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.41 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.467 ' HB2' ' CB ' ' A' ' 102' ' ' ASP . 22.3 mmtp 58.14 157.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 122.24 1.019 . . . . 0.0 112.858 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.552 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 36.4 tt0 -72.92 107.58 5.38 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.3 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.569 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 92.26 56.52 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.603 0 O-C-N 124.524 1.14 . . . . 0.0 111.256 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.588 ' CG ' ' O ' ' A' ' 101' ' ' PHE . 1.3 t80 37.98 64.1 0.73 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.486 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.467 ' CB ' ' HB2' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -111.77 17.03 20.21 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.193 179.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -160.01 155.4 26.53 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.485 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -44.77 162.11 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.135 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.456 ' CD ' ' C ' ' A' ' 105' ' ' GLU . 2.2 pp20? -120.12 179.46 4.27 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.532 0.682 . . . . 0.0 112.551 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.636 HG13 ' N ' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -140.01 177.0 4.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.799 -1.092 . . . . 0.0 108.963 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.636 ' N ' HG13 ' A' ' 106' ' ' VAL . 19.5 p-10 -142.55 150.91 41.02 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.653 -1.219 . . . . 0.0 112.006 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.3 mt -141.98 148.46 48.86 Favored Pre-proline 0 N--CA 1.5 2.064 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.732 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.414 ' O ' HD12 ' A' ' 172' ' ' ILE . 11.8 Cg_endo -77.28 163.01 30.7 Favored 'Trans proline' 0 C--O 1.211 -0.83 0 C-N-CA 122.096 1.864 . . . . 0.0 111.963 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.38 158.54 35.37 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 122.415 2.077 . . . . 0.0 111.484 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.91 -170.5 14.96 Favored Glycine 0 N--CA 1.501 2.985 0 C-N-CA 119.465 -1.35 . . . . 0.0 111.43 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.594 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 18.8 tt0 -111.2 155.43 22.94 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.611 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 26.0 m-85 -142.35 151.87 42.34 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.83 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.4 p -87.24 -164.77 1.14 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.686 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 56.54 0.68 Allowed 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.179 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.441 ' N ' ' OE1' ' A' ' 119' ' ' GLU . . . -155.18 -71.57 0.12 Allowed 'General case' 0 C--N 1.294 -1.804 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.234 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.1 pt-20 -67.04 -44.73 79.47 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.488 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.653 ' C ' HD23 ' A' ' 118' ' ' LEU . 1.2 tt -39.56 -69.83 0.12 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.5 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.751 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 25.4 mp0 -48.11 -59.41 3.41 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.913 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.416 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 1.5 mpt_? -70.95 0.79 6.61 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.96 -1.096 . . . . 0.0 112.814 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 117' ' ' GLU . 13.8 t80 -97.9 -17.58 19.17 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.072 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.55 -41.05 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 C-N-CA 118.55 -1.786 . . . . 0.0 111.665 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.596 HG13 HD11 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -134.73 -117.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.461 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.55 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 15.7 t70 -148.92 -163.72 1.85 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.599 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.648 HD22 ' H ' ' A' ' 125' ' ' ASN . 0.1 OUTLIER -106.07 31.45 5.09 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.028 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.603 HD22 ' C ' ' A' ' 126' ' ' ASN . 0.4 OUTLIER -176.27 17.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.756 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.699 HG23 ' N ' ' A' ' 128' ' ' ILE . 8.5 t -114.67 -132.11 0.33 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.386 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.699 ' N ' HG23 ' A' ' 127' ' ' THR . 3.4 mt 62.84 158.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.097 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.2 p -165.85 -97.29 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.65 136.88 49.42 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.889 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.59 157.25 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -150.8 96.48 3.34 Favored Pre-proline 0 C--N 1.304 -1.398 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.893 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -53.26 93.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.238 1.292 . . . . 0.0 110.79 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.467 ' CG ' ' NH2' ' A' ' 92' ' ' ARG . 1.4 tp-100 -71.85 7.69 1.47 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.1 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 171.52 -40.56 0.18 Allowed Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.92 -1.61 . . . . 0.0 111.02 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.415 ' HB2' ' CG2' ' A' ' 172' ' ' ILE . 0.4 OUTLIER -121.67 151.02 40.92 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.314 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.0 156.36 39.73 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.657 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.29 136.49 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.818 -0.753 . . . . 0.0 112.249 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.481 ' C ' HD12 ' A' ' 140' ' ' LEU . 74.3 t -125.14 128.77 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.826 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 140' ' ' LEU . 10.8 mp -102.72 142.01 34.58 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.372 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 141' ' ' PHE . 4.0 m-85 -120.6 134.23 55.3 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.397 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -70.28 -71.58 0.24 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.914 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -72.81 -176.32 1.98 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.889 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.625 ' C ' ' ND2' ' A' ' 145' ' ' ASN . 1.5 m-20 -77.12 -164.25 0.44 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.141 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.665 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 1.1 p30 36.65 29.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.518 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.665 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 2.5 p90 39.58 61.64 1.35 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.779 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.5 t -146.66 137.67 24.13 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.2 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.42 -139.55 14.23 Favored Glycine 0 N--CA 1.503 3.125 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.56 141.65 44.77 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.099 -1.041 . . . . 0.0 109.863 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 34.3 p -147.82 162.28 39.57 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.911 -1.116 . . . . 0.0 111.869 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 151' ' ' LEU . 64.8 tp -130.12 89.34 45.53 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.922 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.06 108.87 1.59 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 121.849 1.699 . . . . 0.0 113.006 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.58 80.56 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.412 -0.915 . . . . 0.0 108.925 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.478 ' C ' ' OG ' ' A' ' 155' ' ' SER . 50.9 t30 -65.35 -9.91 28.66 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.478 ' OG ' ' C ' ' A' ' 154' ' ' ASN . 1.2 m -161.03 -155.44 0.41 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 117.594 -1.643 . . . . 0.0 113.232 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.51 142.48 44.16 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.824 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.545 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -162.05 61.82 1.3 Allowed Pre-proline 0 C--N 1.308 -1.21 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.449 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.2 Cg_endo -64.71 21.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.291 1.994 . . . . 0.0 112.316 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -170.45 113.17 0.44 Allowed 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.677 -1.209 . . . . 0.0 111.331 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 mt -143.1 -56.78 0.42 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.406 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 79.11 40.03 17.8 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.333 -1.413 . . . . 0.0 110.612 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 48.09 84.51 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.666 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 19.0 mmt -73.95 -44.79 53.69 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.858 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -67.93 170.17 8.66 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.736 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -60.74 -54.98 38.59 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.944 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -161.13 111.78 1.74 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.11 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.2 m -57.55 99.17 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.593 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 73.7 m -84.29 -56.29 3.72 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.68 158.39 30.18 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.176 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.405 HG23 HD11 ' A' ' 118' ' ' LEU . 35.1 pt -136.01 165.37 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.49 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -146.73 100.58 3.35 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.401 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 172' ' ' ILE . 10.3 mt -78.97 105.13 7.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.256 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 51.6 m . . . . . 0 C--N 1.306 -1.324 0 CA-C-O 116.399 -1.762 . . . . 0.0 110.963 -179.937 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ptt? . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.764 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . -152.31 179.97 8.06 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.333 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.42 ' CG ' ' C ' ' A' ' 2' ' ' ALA . 9.0 m-80 -158.97 122.33 3.78 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.854 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.417 ' O ' ' CG1' ' A' ' 4' ' ' ILE . 2.2 pt -75.49 133.86 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.852 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 m -110.89 114.69 28.21 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.353 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.32 164.6 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.304 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.905 ' CE2' ' OE1' ' A' ' 16' ' ' GLN . 39.6 m-85 -123.85 148.85 46.42 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.998 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.443 ' HB2' ' N ' ' A' ' 15' ' ' LYS . 3.2 m-85 -79.04 0.41 27.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.579 HD22 ' CA ' ' A' ' 14' ' ' GLY . 22.8 m-80 -151.3 172.82 15.28 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.026 -1.47 . . . . 0.0 112.114 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.56 -174.82 1.81 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.519 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 13' ' ' GLN . 15.3 t70 52.67 31.08 9.67 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.159 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.526 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 1.5 t80 68.45 -8.73 0.58 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.136 -1.026 . . . . 0.0 111.349 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.465 ' H ' ' C ' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -78.25 167.93 20.62 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.287 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 1.134 ' O ' ' NE2' ' A' ' 16' ' ' GLN . . . 109.3 134.82 7.12 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 1.237 ' C ' HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -35.25 144.57 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.688 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 1.388 HE21 ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -98.6 148.05 24.19 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.258 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.3 t -147.45 123.37 2.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.676 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -94.78 115.82 27.98 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.803 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt -105.98 132.49 20.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.598 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -68.53 164.69 31.89 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 120.874 1.049 . . . . 0.0 111.439 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.68 -161.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 121.774 1.649 . . . . 0.0 111.057 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.716 ' C ' HD22 ' A' ' 23' ' ' ASN . . . 83.68 -177.64 52.43 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.109 -1.52 . . . . 0.0 111.354 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.733 ' N ' HD22 ' A' ' 23' ' ' ASN . 0.3 OUTLIER -105.92 137.08 44.42 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.786 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.564 ' CE2' HD13 ' A' ' 82' ' ' ILE . 4.0 p90 -158.55 160.2 36.37 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.294 -0.963 . . . . 0.0 109.689 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.445 ' CG2' ' CE2' ' A' ' 58' ' ' PHE . 68.9 p -122.83 -162.02 0.99 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.1 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -66.3 -16.99 64.48 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.876 -1.13 . . . . 0.0 110.776 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -64.39 -58.42 6.52 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 118.816 -1.154 . . . . 0.0 109.211 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.526 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -55.57 -44.89 77.27 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 118.686 -1.206 . . . . 0.0 108.918 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.433 HD23 HD12 ' A' ' 32' ' ' LEU . 39.4 mt -57.33 -41.27 79.64 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.966 -1.094 . . . . 0.0 109.425 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.49 -33.14 13.68 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.86 -1.136 . . . . 0.0 108.263 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -70.95 -37.91 72.83 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.489 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.433 HD12 HD23 ' A' ' 29' ' ' LEU . 20.2 mt -72.6 -73.2 0.21 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.646 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.81 -27.2 0.65 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.285 -1.436 . . . . 0.0 110.596 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.45 HD13 HG21 ' A' ' 34' ' ' ILE . 8.0 tt -75.63 145.82 10.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.173 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.514 ' C ' ' CG ' ' A' ' 36' ' ' ASN . 5.6 pt-20 -174.38 146.68 1.09 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.657 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.514 ' CG ' ' C ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER 74.56 -140.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.402 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.744 HD22 ' H ' ' A' ' 37' ' ' ASN . 2.4 m-80 -40.3 -87.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.282 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.704 ' O ' ' N ' ' A' ' 40' ' ' SER . 20.3 p 37.5 -96.26 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.761 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 37' ' ' ASN . 5.6 mt -38.0 79.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 124.412 1.07 . . . . 0.0 111.442 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.704 ' N ' ' O ' ' A' ' 38' ' ' THR . 28.5 t -96.07 -39.05 9.93 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.447 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -127.99 167.55 16.52 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.603 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -153.08 151.14 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 117.849 -1.54 . . . . 0.0 113.012 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -135.46 99.96 4.37 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.837 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.55 108.38 39.6 Favored Pre-proline 0 N--CA 1.494 1.753 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.577 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.94 167.66 20.94 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.092 1.195 . . . . 0.0 110.692 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.65 -171.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.748 1.632 . . . . 0.0 111.108 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.73 -14.51 9.77 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 119.317 -1.421 . . . . 0.0 110.93 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.764 HG11 ' HB3' ' A' ' 2' ' ' ALA . 2.7 m -147.32 140.46 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 118.861 -1.136 . . . . 0.0 112.339 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.1 tttt -114.81 125.79 54.09 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.808 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.402 ' CB ' HG22 ' A' ' 84' ' ' VAL . . . -117.37 139.7 50.53 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.184 -1.007 . . . . 0.0 113.061 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.564 HD12 HH21 ' A' ' 83' ' ' ARG . 44.3 mt -116.26 119.3 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.631 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 53' ' ' TYR . 0.4 OUTLIER -94.58 146.9 23.8 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.26 -0.976 . . . . 0.0 112.239 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.489 ' H ' HD23 ' A' ' 52' ' ' LEU . 43.9 m-85 -127.01 112.58 15.4 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.267 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' CD ' ' N ' ' A' ' 55' ' ' ASN . 1.5 tm0? -49.87 -76.27 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.345 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.523 ' N ' ' CD ' ' A' ' 54' ' ' GLN . 62.3 t30 -59.97 155.9 15.73 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.047 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -68.68 -179.69 1.48 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.467 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.36 36.77 78.0 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.195 -1.478 . . . . 0.0 110.191 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 25' ' ' THR . 35.6 m-85 49.13 63.78 2.0 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.794 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.55 -166.23 2.43 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.318 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.43 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 68.91 173.09 8.32 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.383 -1.389 . . . . 0.0 109.868 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 9.7 m-20 -42.19 119.44 1.37 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.397 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.665 ' NE2' ' H ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -90.04 164.51 14.48 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.349 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.667 HG13 HD11 ' A' ' 75' ' ' LEU . 8.8 mm -137.91 166.67 23.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.382 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.66 ' N ' HG22 ' A' ' 63' ' ' ILE . 19.2 mp0 -148.26 126.08 11.91 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.619 -0.832 . . . . 0.0 109.64 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.1 159.97 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 118.859 -1.136 . . . . 0.0 112.557 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.435 ' H ' ' H ' ' A' ' 67' ' ' ALA . 2.2 t -149.36 -7.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 114.195 -1.366 . . . . 0.0 107.495 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.435 ' H ' ' H ' ' A' ' 66' ' ' VAL . . . -124.8 -155.88 0.69 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.966 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -93.32 117.76 30.47 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.626 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.603 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.26 111.76 22.65 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.91 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -73.21 -77.9 0.1 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.418 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 73' ' ' GLY . 24.4 tp10 -79.24 -2.92 43.39 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.103 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.475 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 6.7 tp 54.95 -87.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.392 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.475 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 176.11 -170.15 42.95 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 118.967 -1.587 . . . . 0.0 110.924 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.516 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.0 Cg_endo -65.45 -36.22 35.59 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.159 1.906 . . . . 0.0 111.941 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.885 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.4 pt? -70.9 19.51 0.05 Allowed 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.981 -1.088 . . . . 0.0 111.274 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 74' ' ' PRO . 34.9 p-10 -77.33 -18.16 57.68 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.519 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -86.65 2.04 49.82 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.429 -0.909 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -175.87 115.65 0.13 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.326 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.695 HG13 ' N ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -123.05 -174.72 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.156 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.695 ' N ' HG13 ' A' ' 79' ' ' VAL . 39.1 t -172.01 -64.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.296 -1.362 . . . . 0.0 113.541 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.5 m -111.7 150.95 29.47 Favored 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.564 HD13 ' CE2' ' A' ' 24' ' ' TYR . 3.0 mp -146.61 161.49 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.445 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.682 ' NH1' ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -150.85 145.58 25.77 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.993 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.682 ' N ' ' NH1' ' A' ' 83' ' ' ARG . 5.8 t -148.09 146.92 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.695 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.589 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -143.54 134.27 22.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.657 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 85' ' ' ILE . 17.4 m -38.33 148.38 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.336 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.554 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -152.01 141.03 13.98 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.507 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.554 ' HD2' HG22 ' A' ' 87' ' ' VAL . 3.0 Cg_exo -53.42 143.16 55.86 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.078 1.186 . . . . 0.0 110.954 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.586 HG22 ' N ' ' A' ' 90' ' ' GLN . 2.4 p -79.73 164.27 3.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.537 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.586 ' N ' HG22 ' A' ' 89' ' ' VAL . 11.5 mm100 -142.39 151.74 58.73 Favored Pre-proline 0 N--CA 1.487 1.4 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.154 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.432 ' C ' ' HE ' ' A' ' 92' ' ' ARG . 6.3 Cg_exo -57.6 -39.18 90.29 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.599 1.533 . . . . 0.0 111.87 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.696 ' NH1' HE22 ' A' ' 134' ' ' GLN . 15.6 mtm180 58.02 -168.47 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.434 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.53 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.33 178.65 7.43 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.603 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -148.57 130.36 15.13 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.411 -1.316 . . . . 0.0 112.024 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 20.1 m-85 -103.44 172.07 7.01 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.777 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -139.09 168.66 19.33 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.836 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -114.61 170.45 8.3 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.672 -0.811 . . . . 0.0 112.351 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.49 ' HZ2' ' HB3' ' A' ' 98' ' ' LYS . 0.5 OUTLIER 54.67 168.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.233 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.504 ' OE1' ' HG3' ' A' ' 100' ' ' GLN . 1.2 tm-20 -62.5 103.16 0.38 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.585 -1.189 . . . . 0.0 112.5 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 102' ' ' ASP . 2.7 mt-30 68.55 100.95 0.05 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.48 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.478 ' C ' ' O ' ' A' ' 100' ' ' GLN . 19.3 p90 20.94 44.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 124.364 1.04 . . . . 0.0 112.773 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 100' ' ' GLN . 0.7 OUTLIER -102.26 15.64 28.54 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.98 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -154.61 159.79 29.17 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 118.967 -1.587 . . . . 0.0 111.135 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -41.26 157.39 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.832 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.553 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 1.2 pm0 -122.05 163.71 18.94 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.67 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.648 HG12 ' N ' ' A' ' 107' ' ' ASP . 37.4 t -138.11 170.99 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.33 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.648 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.5 p30 -133.44 156.35 47.87 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.034 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.5 mt -145.15 139.35 14.99 Favored Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.26 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -70.18 163.66 37.79 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 121.597 1.532 . . . . 0.0 111.305 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.47 145.99 95.57 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.418 1.412 . . . . 0.0 110.937 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.32 -153.22 24.29 Favored Glycine 0 N--CA 1.499 2.878 0 C-N-CA 119.064 -1.541 . . . . 0.0 111.328 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.609 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 8.3 tt0 -128.94 158.42 38.87 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.755 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.609 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 41.8 m-85 -145.93 151.99 38.72 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.267 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.6 p -103.83 178.56 4.52 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.243 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.08 44.63 0.49 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.174 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -142.45 -61.95 0.44 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 121' ' ' TYR . 4.5 mt-10 -74.11 -54.55 7.57 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.485 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.538 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -29.74 -66.5 0.09 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.635 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.654 ' CD ' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER -59.04 -60.84 3.23 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.747 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.654 HH11 ' CD ' ' A' ' 119' ' ' GLU . 7.9 mpt_? -75.81 26.17 0.11 Allowed 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.952 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 117' ' ' GLU . 35.3 t80 -127.79 -18.48 4.27 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.603 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.528 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -155.68 -26.8 0.03 OUTLIER Glycine 0 N--CA 1.484 1.86 0 C-N-CA 118.267 -1.92 . . . . 0.0 111.104 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.479 HD12 HD13 ' A' ' 128' ' ' ILE . 1.1 pt -150.2 -112.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.039 -1.064 . . . . 0.0 110.785 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.461 ' C ' ' HB3' ' A' ' 119' ' ' GLU . 0.9 OUTLIER -165.75 -165.91 0.88 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 118.525 -1.27 . . . . 0.0 112.284 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.507 ' C ' HD22 ' A' ' 125' ' ' ASN . 0.7 OUTLIER -65.21 -105.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -179.683 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.47 ' N ' ' CG ' ' A' ' 125' ' ' ASN . 1.7 m120 -67.23 32.32 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 125' ' ' ASN . 0.6 OUTLIER -87.17 -103.7 0.07 Allowed 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.726 -1.19 . . . . 0.0 109.819 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.546 ' O ' ' CB ' ' A' ' 129' ' ' SER . 0.3 OUTLIER 41.66 -162.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.22 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.618 ' OG ' ' N ' ' A' ' 130' ' ' SER . 1.6 t 151.17 -96.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.061 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.618 ' N ' ' OG ' ' A' ' 129' ' ' SER . 3.5 m -90.24 143.63 26.59 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.047 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.11 151.82 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.575 0.702 . . . . 0.0 111.675 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -148.87 107.09 3.45 Favored Pre-proline 0 C--N 1.301 -1.515 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.617 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 135' ' ' GLY . 10.5 Cg_endo -71.88 90.48 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.348 1.366 . . . . 0.0 110.68 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.696 HE22 ' NH1' ' A' ' 92' ' ' ARG . 10.0 tt0 -49.64 -11.57 0.06 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.391 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 133' ' ' PRO . . . -179.07 -37.46 0.07 OUTLIER Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.305 -1.902 . . . . 0.0 111.783 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.436 HD11 ' H ' ' A' ' 92' ' ' ARG . 0.5 OUTLIER -107.04 163.83 12.66 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.359 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.76 148.22 31.55 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.993 -1.083 . . . . 0.0 109.811 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.1 t -112.6 150.34 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.786 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.55 HG12 ' CE1' ' A' ' 141' ' ' PHE . 60.6 t -136.22 128.53 45.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.572 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.5 mp -106.13 139.86 39.99 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.905 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' A' ' 141' ' ' PHE . 4.7 m-85 -120.23 133.78 55.4 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.52 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -72.94 -71.52 0.3 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.403 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -62.87 161.68 12.36 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.959 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 20.7 p-10 -62.5 -162.89 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.586 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.651 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 1.7 p-10 31.62 35.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.712 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.651 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 42.12 62.4 1.65 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.084 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.536 ' CB ' ' ND2' ' A' ' 145' ' ' ASN . 48.4 t -139.3 175.87 9.19 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.421 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 80.91 -160.33 42.78 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.039 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -60.54 160.57 8.79 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.263 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.8 p -150.59 162.51 40.5 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.902 -1.119 . . . . 0.0 111.574 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.6 tp -129.33 86.14 57.27 Favored Pre-proline 0 N--CA 1.484 1.261 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.497 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -63.29 107.8 0.73 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.828 1.686 . . . . 0.0 112.522 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 47.5 t -84.78 85.56 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.389 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.633 ' ND2' ' H ' ' A' ' 154' ' ' ASN . 0.8 OUTLIER -55.87 -26.56 47.6 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.498 ' OG ' ' C ' ' A' ' 154' ' ' ASN . 0.7 OUTLIER -162.68 -146.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 117.941 -1.503 . . . . 0.0 113.107 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.45 144.76 20.06 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.017 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -165.58 66.06 1.08 Allowed Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.572 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.1 Cg_endo -66.71 27.95 0.11 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.26 1.973 . . . . 0.0 112.274 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.512 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.1 t -169.83 136.06 1.51 Allowed 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.846 -1.142 . . . . 0.0 111.461 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.6 HD21 ' CB ' ' A' ' 163' ' ' MET . 3.9 tt -151.55 -76.01 0.14 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.351 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.404 ' H ' ' HB3' ' A' ' 160' ' ' LEU . . . 71.1 63.86 2.99 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.16 -1.495 . . . . 0.0 110.665 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 52.45 90.83 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.393 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.6 ' CB ' HD21 ' A' ' 160' ' ' LEU . 1.1 tpt -81.32 -63.94 1.29 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.134 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 165' ' ' ASN . 3.2 p-10 -90.21 -54.33 4.07 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.817 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.423 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 5.2 t30 -168.87 -69.98 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.654 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -161.07 151.32 17.68 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.1 m -88.49 147.17 24.79 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.795 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 92.3 p -135.67 -38.63 0.73 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.434 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.54 158.13 44.85 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.533 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 24.6 pt -145.54 157.19 12.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 118.589 -1.244 . . . . 0.0 111.904 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -137.92 110.26 7.41 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.527 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -87.83 94.74 4.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.25 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.959 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.483 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.822 0.344 . . . . 0.0 110.114 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.416 ' HB1' HG11 ' A' ' 48' ' ' VAL . . . -167.87 136.48 2.45 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -176.78 112.79 0.1 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.322 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.473 ' HB ' HG22 ' A' ' 44' ' ' VAL . 1.3 pp -78.34 160.33 4.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.306 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.8 m -138.46 126.38 22.51 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.296 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.44 168.7 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.372 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 14.1 m-85 -134.8 138.73 44.52 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.343 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.9 -55.02 29.8 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.397 -0.921 . . . . 0.0 113.066 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.613 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 55.6 m-20 -92.37 167.06 12.24 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.375 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.533 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 7.4 tm-20 -79.98 160.66 25.83 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.199 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 10' ' ' GLU . 0.9 OUTLIER 81.41 38.97 0.06 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.546 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.456 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 5.0 t80 59.74 2.99 0.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.984 -1.086 . . . . 0.0 112.533 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -102.84 164.88 11.37 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.673 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.613 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 97.48 132.94 7.66 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 14' ' ' GLY . 8.2 mtpm? -29.27 135.98 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.755 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.94 171.72 7.42 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.301 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.0 t -144.37 145.96 20.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.511 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -91.85 128.08 37.55 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.74 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 19' ' ' LEU . 2.3 mm? -118.14 107.2 44.0 Favored Pre-proline 0 N--CA 1.49 1.541 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.26 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -64.87 166.75 17.41 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 120.911 1.074 . . . . 0.0 111.265 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.28 176.25 1.65 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.732 1.621 . . . . 0.0 111.294 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.508 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 102.28 -167.92 18.41 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.391 -1.385 . . . . 0.0 110.788 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.817 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -110.98 141.93 43.78 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.022 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.644 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -156.67 152.84 27.61 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.243 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.4 p -132.02 -158.48 0.89 Allowed 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.079 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -58.74 -28.8 66.21 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.588 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -63.01 -54.74 33.59 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.034 -1.067 . . . . 0.0 110.895 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -52.79 -48.82 66.6 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.039 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.619 HD21 ' CE1' ' A' ' 24' ' ' TYR . 5.0 mt -59.48 -39.02 82.39 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.66 -1.216 . . . . 0.0 109.338 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.13 -29.06 4.83 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 118.564 -1.254 . . . . 0.0 108.397 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.14 -31.62 27.11 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.454 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 29' ' ' LEU . 10.2 mt -80.39 -86.4 0.08 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.333 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 32' ' ' LEU . . . 176.74 -27.0 0.07 OUTLIER Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.226 -1.464 . . . . 0.0 110.787 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.478 HG22 HG21 ' A' ' 38' ' ' THR . 0.2 OUTLIER -79.47 -175.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 118.941 -1.103 . . . . 0.0 109.964 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.65 ' H ' HG21 ' A' ' 38' ' ' THR . 1.3 pt-20 177.48 113.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 118.708 -1.197 . . . . 0.0 112.604 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.438 ' O ' HG22 ' A' ' 38' ' ' THR . 2.1 m-20 42.31 -106.7 0.08 Allowed 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.558 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.499 ' C ' HG22 ' A' ' 38' ' ' THR . 61.8 t-20 -50.46 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.947 -0.701 . . . . 0.0 112.391 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.65 HG21 ' H ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER 170.44 -18.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.802 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.488 ' O ' HD22 ' A' ' 72' ' ' LEU . 7.8 mm -75.59 32.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 118.891 -1.124 . . . . 0.0 109.105 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.646 ' H ' ' C ' ' A' ' 38' ' ' THR . 29.6 t -37.62 -63.99 0.42 Allowed 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.326 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.402 ' HB2' ' H ' ' A' ' 12' ' ' PHE . 1.1 t -116.03 165.09 13.52 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -148.2 156.67 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 118.342 -1.343 . . . . 0.0 113.44 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -137.82 110.92 7.8 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.523 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.473 HG22 ' HB ' ' A' ' 4' ' ' ILE . 88.4 t -133.95 106.25 11.53 Favored Pre-proline 0 N--CA 1.497 1.913 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.94 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.417 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 Cg_endo -70.16 171.5 14.79 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 121.647 1.564 . . . . 0.0 111.728 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.417 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.7 Cg_endo -62.78 -169.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 122.145 1.897 . . . . 0.0 111.204 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.87 -14.44 19.62 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 119.269 -1.444 . . . . 0.0 110.449 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.691 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -152.93 157.14 4.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 118.836 -1.145 . . . . 0.0 111.697 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.454 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 31.7 ttpt -123.56 120.41 32.77 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.34 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.75 154.99 18.63 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.025 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 63' ' ' ILE . 60.6 mt -138.91 119.79 15.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.338 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.461 HD12 ' H ' ' A' ' 52' ' ' LEU . 3.7 mp -94.79 155.37 16.84 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 118.683 -1.207 . . . . 0.0 112.352 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -133.55 114.97 14.17 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.053 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.451 ' CD ' ' N ' ' A' ' 55' ' ' ASN . 1.4 tm0? -53.64 -69.12 0.13 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.39 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.514 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 63.8 t30 -69.37 137.68 53.03 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.028 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -53.06 166.69 0.21 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.538 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.54 28.98 64.47 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.394 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 55.92 49.1 16.57 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.972 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.18 -171.16 2.62 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.795 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.514 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 74.16 171.75 25.69 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.355 -1.402 . . . . 0.0 109.743 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 60' ' ' GLY . 1.7 m-20 -42.57 116.14 0.81 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.491 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.4 ' HG2' ' H ' ' A' ' 62' ' ' GLN . 3.2 pt20 -89.75 155.02 19.47 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.361 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.668 HD11 HD11 ' A' ' 75' ' ' LEU . 5.2 mt -130.18 167.08 26.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.761 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.456 ' H ' HG22 ' A' ' 63' ' ' ILE . 66.6 mt-10 -145.26 130.74 18.76 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.38 -0.928 . . . . 0.0 109.727 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.9 m -147.34 156.86 10.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 118.797 -1.161 . . . . 0.0 112.241 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 48' ' ' VAL . 4.0 t -144.5 -2.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.137 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -125.32 -159.69 0.91 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.301 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.828 HD21 HG13 ' A' ' 106' ' ' VAL . 10.7 p-10 -94.28 118.59 31.82 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.476 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.699 ' HB1' ' HA ' ' A' ' 72' ' ' LEU . . . -89.58 96.39 10.68 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.897 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -53.21 -70.99 0.08 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.821 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -90.55 3.21 54.65 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.239 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.699 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 14.7 tp 59.62 -90.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.634 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.429 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -177.2 -170.49 39.67 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.541 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.613 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.7 Cg_endo -67.16 -56.64 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.351 2.034 . . . . 0.0 112.266 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.903 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.1 pt? -64.75 19.52 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.321 -0.951 . . . . 0.0 111.409 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.613 ' H ' ' C ' ' A' ' 74' ' ' PRO . 45.3 p-10 -74.42 -17.12 60.84 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.387 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -77.88 4.93 10.71 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.577 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.569 HD22 ' N ' ' A' ' 79' ' ' VAL . 0.5 OUTLIER -167.9 115.01 0.72 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.172 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 1.022 HG12 ' H ' ' A' ' 80' ' ' SER . 26.3 t -132.32 -171.49 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.046 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 1.022 ' H ' HG12 ' A' ' 79' ' ' VAL . 21.0 p -176.31 -51.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.648 -1.221 . . . . 0.0 112.672 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.96 162.2 25.0 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 119.148 -1.021 . . . . 0.0 112.854 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 82' ' ' ILE . 10.2 mt -148.83 155.5 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.735 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.59 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -132.14 114.28 14.32 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.664 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.59 ' H ' HH12 ' A' ' 83' ' ' ARG . 37.1 t -121.38 136.56 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.756 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.581 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 4.0 mt -145.15 126.67 8.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.093 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 p -39.88 141.85 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.034 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 48' ' ' VAL . 1.3 p -134.09 138.58 30.87 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.339 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HD2' HG22 ' A' ' 87' ' ' VAL . 11.7 Cg_exo -47.21 136.66 18.68 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 121.207 1.271 . . . . 0.0 111.325 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.3 t -53.41 140.48 9.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.579 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -144.85 130.98 9.73 Favored Pre-proline 0 N--CA 1.487 1.387 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.906 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.45 ' HB2' HD11 ' A' ' 136' ' ' LEU . 6.3 Cg_exo -58.45 -163.3 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.921 0 C-N-CA 121.039 1.159 . . . . 0.0 111.359 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.429 ' CA ' HD12 ' A' ' 136' ' ' LEU . 9.6 ptt-85 -179.67 -158.17 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.939 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.562 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -137.4 166.97 22.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.65 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -120.81 140.78 51.25 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.456 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.511 ' CD2' HG13 ' A' ' 131' ' ' VAL . 80.5 m-85 -131.34 118.19 19.96 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.393 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -83.45 173.15 11.74 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.56 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.77 -70.34 0.72 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.991 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -62.36 163.98 7.82 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.901 -0.719 . . . . 0.0 112.249 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -89.89 63.62 6.08 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.808 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 101' ' ' PHE . 4.5 tt0 -176.0 50.1 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.713 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 100' ' ' GLN . 18.6 p90 41.44 44.2 2.4 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.111 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.449 ' CG ' ' N ' ' A' ' 103' ' ' GLY . 32.3 t70 -143.5 172.85 12.23 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.2 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 91.26 141.19 9.43 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.158 -1.496 . . . . 0.0 109.76 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 103' ' ' GLY . 47.0 mttp -28.66 130.3 0.06 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 123.971 0.454 . . . . 0.0 111.899 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -98.98 120.68 39.83 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.608 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.828 HG13 HD21 ' A' ' 68' ' ' ASN . 43.7 t -103.74 131.07 53.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.731 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -103.81 148.92 25.54 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.07 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.1 mt -138.11 123.15 12.22 Favored Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.154 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.428 ' CB ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -64.74 168.07 14.17 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.492 1.461 . . . . 0.0 111.797 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 6.1 Cg_exo -55.12 157.33 13.95 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 122.222 1.948 . . . . 0.0 111.973 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.38 178.89 15.73 Favored Glycine 0 N--CA 1.499 2.869 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.936 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.613 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 46.9 tt0 -109.31 157.1 19.2 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.125 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.613 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 33.2 m-85 -144.78 153.94 42.18 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.031 -1.067 . . . . 0.0 111.248 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.5 p -98.48 -161.43 0.87 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.008 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -101.34 54.38 0.83 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.958 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.33 -62.27 0.07 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.12 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.574 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 6.4 pt-20 -69.18 -51.08 41.61 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.574 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -37.77 -69.51 0.12 Allowed 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.231 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 119' ' ' GLU . 79.0 mt-10 -46.95 -66.5 0.4 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.66 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.465 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -70.33 4.77 2.06 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' A' ' 117' ' ' GLU . 17.0 t80 -98.61 -18.1 18.29 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 118.868 -1.133 . . . . 0.0 111.379 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.554 ' O ' HG11 ' A' ' 106' ' ' VAL . . . -165.79 -11.89 0.03 OUTLIER Glycine 0 C--N 1.289 -2.07 0 C-N-CA 118.152 -1.975 . . . . 0.0 111.043 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.453 ' CG1' ' C ' ' A' ' 122' ' ' GLY . 2.2 mt -148.89 -125.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 118.676 -1.21 . . . . 0.0 111.597 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.569 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 20.0 t70 -155.06 -162.58 1.39 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.832 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.569 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 12.4 p30 -71.44 -36.23 71.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.033 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -158.2 100.12 1.67 Allowed 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.955 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.428 ' CG2' HG22 ' A' ' 123' ' ' ILE . 9.4 t -177.22 25.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.309 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.8 mt -80.74 -60.35 2.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.409 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.7 m 59.32 -125.38 1.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 m -54.73 126.65 24.88 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.511 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.2 t -122.49 157.69 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.12 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -153.44 93.14 3.12 Favored Pre-proline 0 C--N 1.293 -1.862 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.178 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -53.73 124.21 15.27 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 121.125 1.217 . . . . 0.0 111.003 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.562 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 40.6 tp60 -89.22 -21.64 23.15 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.212 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -161.05 -29.55 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 C-N-CA 118.325 -1.893 . . . . 0.0 112.338 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.45 HD11 ' HB2' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -120.92 159.79 24.83 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.165 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -79.25 147.67 32.47 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.964 -1.094 . . . . 0.0 110.254 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 65.9 t -115.95 149.22 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.463 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.604 HG12 ' CE1' ' A' ' 141' ' ' PHE . 61.8 t -133.85 128.99 54.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.781 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.2 mp -102.72 138.2 39.93 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.963 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.836 ' CD2' ' CD1' ' A' ' 146' ' ' PHE . 8.6 m-85 -120.32 128.94 53.73 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.842 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.56 ' O ' ' CB ' ' A' ' 143' ' ' ASN . 53.9 mttm -85.33 102.12 13.12 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.049 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 142' ' ' LYS . 11.2 t-20 103.0 170.16 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.917 0 O-C-N 125.195 1.559 . . . . 0.0 111.292 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 146' ' ' PHE . 24.6 t70 -45.79 170.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.121 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.846 HD22 ' H ' ' A' ' 145' ' ' ASN . 1.2 m-80 -3.21 66.33 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 CA-C-N 113.921 -1.49 . . . . 0.0 113.986 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.836 ' CD1' ' CD2' ' A' ' 141' ' ' PHE . 0.9 OUTLIER 50.3 63.21 2.3 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.899 -1.121 . . . . 0.0 111.323 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.3 t -114.57 45.64 1.52 Allowed 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.557 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.24 -169.28 42.1 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.71 177.67 0.4 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.524 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.2 p -150.2 175.33 11.87 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.448 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.593 HD13 ' C ' ' A' ' 151' ' ' LEU . 3.4 tm? -147.77 90.88 5.05 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.51 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.35 109.02 1.48 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.705 1.603 . . . . 0.0 112.272 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 49.5 t -80.98 90.84 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.004 -1.079 . . . . 0.0 109.92 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.581 HD22 ' N ' ' A' ' 154' ' ' ASN . 1.8 m120 -65.01 -20.45 66.5 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.569 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 11.0 t -168.33 -146.55 0.06 Allowed 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.063 -1.455 . . . . 0.0 112.634 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.4 m-20 -50.81 150.35 2.96 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.981 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -168.87 66.34 0.64 Allowed Pre-proline 0 C--N 1.31 -1.152 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.04 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.484 ' C ' HG22 ' A' ' 159' ' ' THR . 2.3 Cg_endo -62.46 23.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.323 2.015 . . . . 0.0 113.692 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.507 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER 176.86 91.23 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.45 -1.3 . . . . 0.0 111.394 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 162' ' ' ALA . 1.4 tp -94.52 -23.26 17.76 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.247 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.69 ' O ' ' HB2' ' A' ' 162' ' ' ALA . . . -43.63 93.94 0.01 OUTLIER Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.264 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 161' ' ' GLY . . . 163.25 0.1 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.974 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.406 ' H ' ' H ' ' A' ' 162' ' ' ALA . 31.4 tpp -151.05 -25.07 0.21 Allowed 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.934 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.511 ' ND2' ' H ' ' A' ' 167' ' ' THR . 0.7 OUTLIER -68.22 98.04 0.77 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.404 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -82.79 -40.22 20.71 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.209 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.421 ' O ' ' N ' ' A' ' 168' ' ' SER . 23.8 t-20 -172.93 63.95 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.767 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.511 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 9.1 m -40.0 99.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.601 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.527 ' HB2' ' H ' ' A' ' 143' ' ' ASN . 3.3 m -88.58 -55.86 3.54 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.407 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.2 p -121.48 156.57 32.48 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.747 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.402 HG12 ' CD1' ' A' ' 118' ' ' LEU . 26.8 pt -139.37 165.14 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.49 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -146.45 106.07 3.95 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.332 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.81 95.46 4.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.401 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 116.458 -1.734 . . . . 0.0 111.076 -179.939 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mtm . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.521 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -63.49 -175.3 0.11 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.469 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -170.47 108.62 0.34 Allowed 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.228 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pp -77.44 128.69 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.855 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.08 152.54 20.49 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.169 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 m -140.19 169.11 16.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.625 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 18.7 m-85 -128.93 153.71 47.26 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.93 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -78.17 -59.48 2.76 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.503 -0.879 . . . . 0.0 113.326 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.638 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 12.5 m120 -81.36 -178.02 6.75 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.811 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.552 ' CG ' ' H ' ' A' ' 11' ' ' ASP . 20.9 tt0 -74.03 179.32 4.44 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.829 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.615 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 1.5 p-10 40.53 67.16 0.53 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.339 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.615 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 43.7 p90 35.47 27.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.114 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' ASP . 7.2 tt0 -102.65 159.7 15.23 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.987 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.638 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 95.49 140.75 11.15 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.327 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 14' ' ' GLY . 5.5 mtpp -28.75 135.61 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.78 157.78 16.46 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.407 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.4 t -149.15 133.59 9.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.769 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -98.92 113.36 25.47 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.601 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 mt -102.01 136.87 19.4 Favored Pre-proline 0 N--CA 1.488 1.467 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.94 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -70.0 162.58 41.67 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 120.978 1.119 . . . . 0.0 111.137 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -66.33 -175.74 0.57 Allowed 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 121.694 1.596 . . . . 0.0 110.541 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.488 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 104.4 -166.54 15.24 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.242 -1.456 . . . . 0.0 111.263 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.635 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.4 OUTLIER -123.43 137.32 54.83 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.222 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.499 ' CE2' HD12 ' A' ' 82' ' ' ILE . 4.9 p90 -157.84 -179.93 8.61 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.445 -1.302 . . . . 0.0 111.676 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.417 ' HB ' ' H ' ' A' ' 26' ' ' ARG . 1.8 p -147.06 -157.55 0.82 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.461 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.417 ' H ' ' HB ' ' A' ' 25' ' ' THR . 34.7 ttt180 -61.27 -19.14 61.38 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.491 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.66 -66.59 0.53 Allowed 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.567 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.539 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 6.9 tp60 -56.31 -43.12 78.62 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.782 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.458 ' HA ' HD23 ' A' ' 29' ' ' LEU . 30.9 mt -59.93 -40.49 89.08 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.154 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.02 -29.02 41.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 118.435 -1.306 . . . . 0.0 108.153 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -74.1 -35.47 64.18 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.696 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.27 -78.4 0.13 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.786 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.85 -25.25 0.56 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.153 -1.498 . . . . 0.0 110.688 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.548 HG12 HG21 ' A' ' 38' ' ' THR . 0.0 OUTLIER -92.82 137.18 22.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.028 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.458 ' CG ' ' C ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER 168.61 158.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.198 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.714 HD22 ' ND2' ' A' ' 37' ' ' ASN . 6.0 t30 66.84 116.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.714 ' ND2' HD22 ' A' ' 36' ' ' ASN . 0.1 OUTLIER 56.42 3.99 0.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.098 -0.955 . . . . 0.0 113.045 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.548 HG21 HG12 ' A' ' 34' ' ' ILE . 39.9 p -82.98 -135.28 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.491 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 38' ' ' THR . 2.5 mt 25.37 52.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 123.902 0.751 . . . . 0.0 112.68 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.5 t -70.15 -41.51 73.74 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.214 -0.995 . . . . 0.0 110.118 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.4 166.25 15.02 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.312 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -145.3 149.68 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 118.533 -1.267 . . . . 0.0 112.666 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -140.05 87.25 2.14 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.609 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.0 t -109.44 115.48 56.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -69.7 168.5 21.3 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.207 1.271 . . . . 0.0 110.773 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.47 -177.09 0.36 Allowed 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 121.843 1.695 . . . . 0.0 111.126 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.07 -11.62 11.24 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.283 -1.437 . . . . 0.0 110.952 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.521 HG11 ' CB ' ' A' ' 2' ' ' ALA . 33.1 m -148.41 145.34 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.537 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.459 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 44.2 tttt -124.12 158.28 32.67 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.578 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.459 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -148.96 140.69 23.57 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.299 -1.361 . . . . 0.0 112.962 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 63' ' ' ILE . 35.7 mt -119.06 124.19 72.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.591 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.507 HD12 ' H ' ' A' ' 52' ' ' LEU . 3.8 mp -93.9 165.91 12.43 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 118.641 -1.223 . . . . 0.0 112.341 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -141.22 108.95 5.64 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.956 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.415 ' HG2' HD22 ' A' ' 78' ' ' ASN . 8.6 tt0 -47.28 -84.54 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.928 -0.709 . . . . 0.0 112.03 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.476 ' H ' ' HA3' ' A' ' 60' ' ' GLY . 94.5 m-20 -59.34 142.55 51.84 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.476 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 11.9 p-10 -56.18 174.53 0.13 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.598 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.98 36.87 93.59 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.141 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.404 ' CZ ' HG23 ' A' ' 25' ' ' THR . 40.1 m-85 47.03 43.94 14.43 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.673 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.53 -165.5 1.25 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.901 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.476 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 65.01 165.19 1.08 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.364 -1.398 . . . . 0.0 109.855 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.49 130.1 19.79 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.586 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.462 ' C ' ' CD ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -101.07 161.87 13.29 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.106 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.74 HG22 ' N ' ' A' ' 64' ' ' GLU . 7.7 mm -128.06 171.86 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.714 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.74 ' N ' HG22 ' A' ' 63' ' ' ILE . 55.5 mt-10 -144.7 131.21 19.86 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.581 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.1 m -150.52 158.32 5.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.805 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 t -144.28 -4.31 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.56 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.72 -153.63 0.58 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.778 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.434 ' N ' ' ND2' ' A' ' 68' ' ' ASN . 3.2 m120 -92.32 125.74 37.11 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.353 -0.939 . . . . 0.0 109.754 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.568 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -97.3 133.95 41.23 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.356 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -74.55 -77.95 0.11 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.49 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -99.32 3.92 46.26 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.692 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.402 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 0.6 OUTLIER 63.95 -82.79 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.513 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.522 ' O ' ' ND2' ' A' ' 76' ' ' ASN . . . -172.67 -178.96 43.13 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.567 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.16 -18.05 56.05 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.149 1.899 . . . . 0.0 111.939 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.686 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -85.08 41.47 0.88 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.06 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 73' ' ' GLY . 84.9 m-20 -79.89 -13.98 58.98 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.694 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -88.62 3.41 50.65 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.513 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.466 ' HA ' ' H ' ' A' ' 37' ' ' ASN . 52.8 t30 -169.78 126.95 0.88 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 118.381 -1.328 . . . . 0.0 112.534 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.407 ' C ' ' OG ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -154.4 138.36 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.442 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.407 ' OG ' ' C ' ' A' ' 79' ' ' VAL . 1.7 m -157.76 -43.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.241 -1.383 . . . . 0.0 112.826 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.406 ' OG ' HG22 ' A' ' 25' ' ' THR . 17.3 m -94.39 140.45 29.79 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.944 -1.103 . . . . 0.0 111.056 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -147.58 161.01 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 118.814 -1.155 . . . . 0.0 112.224 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.876 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -137.21 116.72 12.85 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.851 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.876 ' H ' HH12 ' A' ' 83' ' ' ARG . 12.8 t -120.37 127.68 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.873 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.49 HG13 ' NH2' ' A' ' 83' ' ' ARG . 27.8 mt -141.07 129.04 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.849 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 74.1 m -41.06 154.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.854 -0.739 . . . . 0.0 111.427 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.729 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -150.33 147.13 21.02 Favored Pre-proline 0 N--CA 1.487 1.419 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.203 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.729 ' HD2' HG22 ' A' ' 87' ' ' VAL . 2.7 Cg_exo -54.12 145.32 54.34 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 121.27 1.313 . . . . 0.0 111.483 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.75 142.9 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.699 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -145.6 147.97 35.07 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.171 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.434 ' HG2' HD21 ' A' ' 136' ' ' LEU . 6.0 Cg_exo -57.51 -166.62 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.911 0 C-N-CA 121.111 1.207 . . . . 0.0 110.394 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.6 ptt-85 -173.98 -162.44 0.14 Allowed 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.743 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.33 159.07 42.97 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.529 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -120.55 135.15 55.17 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.133 -1.027 . . . . 0.0 112.332 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -114.33 105.02 12.65 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.943 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.485 ' CD1' ' HB3' ' A' ' 105' ' ' GLU . 26.2 m-85 -91.48 152.9 20.16 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.502 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 97' ' ' TYR . 1.6 m-85 -97.05 157.93 15.68 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.739 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp 63.61 132.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.637 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 99' ' ' GLU . 2.7 pt-20 -77.43 77.82 3.95 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.926 -1.109 . . . . 0.0 110.87 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 1.006 ' CA ' HE21 ' A' ' 100' ' ' GLN . 0.0 OUTLIER -172.58 16.19 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.096 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 42.9 t80 48.98 46.38 22.4 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.731 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 103' ' ' GLY . 38.7 t70 -116.85 -79.79 0.59 Allowed 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.768 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 102' ' ' ASP . . . -34.06 136.42 0.24 Allowed Glycine 0 N--CA 1.502 3.057 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.288 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -42.37 163.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.287 0.565 . . . . 0.0 112.336 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -115.72 165.07 13.46 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.501 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 122' ' ' GLY . 1.2 t -130.35 132.03 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.42 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 23.2 p-10 -96.47 150.14 20.94 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.264 -0.974 . . . . 0.0 113.2 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.4 mt -143.81 127.97 9.28 Favored Pre-proline 0 N--CA 1.482 1.14 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.864 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -67.88 167.45 21.38 Favored 'Trans proline' 0 C--O 1.212 -0.825 0 C-N-CA 121.399 1.399 . . . . 0.0 111.727 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.57 151.03 78.54 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 122.055 1.837 . . . . 0.0 111.734 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.48 -173.72 21.02 Favored Glycine 0 N--CA 1.498 2.792 0 C-N-CA 119.448 -1.358 . . . . 0.0 111.16 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.592 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 39.9 tt0 -112.92 154.04 27.01 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.4 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.592 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 14.4 m-85 -139.48 151.57 46.29 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.105 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 21.8 p -92.71 -158.36 0.59 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.648 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -108.75 55.56 0.63 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.574 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.39 -68.8 0.13 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.989 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.553 ' O ' ' N ' ' A' ' 121' ' ' TYR . 8.0 pt-20 -70.39 -46.4 64.1 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.053 -1.059 . . . . 0.0 108.938 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.562 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -36.15 -71.55 0.07 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.858 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.658 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 22.9 mp0 -51.83 -56.43 14.01 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.99 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -73.74 14.48 0.37 Allowed 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.907 -1.117 . . . . 0.0 111.696 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 117' ' ' GLU . 16.1 t80 -122.46 -12.87 8.12 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.537 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.566 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -140.83 -51.48 0.05 OUTLIER Glycine 0 N--CA 1.485 1.955 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.189 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.49 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -137.48 -111.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.281 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -151.99 -151.96 0.41 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.062 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.15 10.1 13.14 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.451 -0.899 . . . . 0.0 111.205 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -157.78 -123.72 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.407 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.3 p 51.11 -152.56 0.19 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 129' ' ' SER . 14.7 mt 65.62 159.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.977 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 128' ' ' ILE . 23.1 t -175.14 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.469 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.6 m -76.92 140.39 40.49 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.817 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.6 158.23 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 C-N-CA 119.924 -0.711 . . . . 0.0 111.16 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -156.29 85.5 3.13 Favored Pre-proline 0 C--N 1.306 -1.311 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.63 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.81 102.68 0.53 Allowed 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.093 1.195 . . . . 0.0 109.856 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.15 18.72 2.96 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.716 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -174.39 -47.63 0.05 OUTLIER Glycine 0 N--CA 1.489 2.197 0 C-N-CA 117.737 -2.173 . . . . 0.0 112.637 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.434 HD21 ' HG2' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -121.33 169.62 10.42 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.245 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.8 151.79 24.1 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.078 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.6 t -121.88 144.09 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.231 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.545 ' C ' HD12 ' A' ' 140' ' ' LEU . 91.1 t -135.03 128.27 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.561 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.545 HD12 ' C ' ' A' ' 139' ' ' VAL . 10.4 mp -106.4 140.44 39.32 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.674 -0.81 . . . . 0.0 112.744 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.475 ' CG ' ' HA ' ' A' ' 146' ' ' PHE . 62.9 m-85 -120.48 125.24 47.38 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.445 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -60.63 -65.1 0.74 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.172 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -70.33 -172.21 0.56 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.243 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.564 ' O ' ' N ' ' A' ' 146' ' ' PHE . 0.7 OUTLIER -66.32 -149.3 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.93 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.591 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 4.7 p-10 -15.68 75.76 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 O-C-N 124.386 1.054 . . . . 0.0 113.7 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.591 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.3 p90 37.07 64.95 0.54 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.229 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.456 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 28.6 t -128.49 173.7 10.01 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.949 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.456 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 64.17 -168.13 25.65 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.556 -1.306 . . . . 0.0 110.717 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -61.18 167.95 2.82 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.461 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.4 p -146.28 168.84 20.09 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.43 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.534 ' C ' HD23 ' A' ' 151' ' ' LEU . 3.3 tt -138.24 84.59 19.89 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.471 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.59 107.93 1.13 Allowed 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 122.109 1.873 . . . . 0.0 113.094 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 40.2 t -83.9 89.96 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.308 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.523 ' ND2' ' H ' ' A' ' 154' ' ' ASN . 4.3 m-80 -64.45 -17.25 63.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 51.4 p -170.25 -141.28 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 117.735 -1.586 . . . . 0.0 112.929 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.438 ' N ' ' OG ' ' A' ' 155' ' ' SER . 20.7 m-20 -65.1 151.45 46.02 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.758 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -168.62 61.7 0.49 Allowed Pre-proline 0 C--N 1.305 -1.364 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.206 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.5 Cg_endo -62.13 17.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 122.173 1.916 . . . . 0.0 112.792 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.546 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -170.46 79.2 0.09 Allowed 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.612 -1.235 . . . . 0.0 111.384 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 162' ' ' ALA . 1.3 tt -91.77 -75.65 0.47 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.342 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 163' ' ' MET . . . 64.12 -81.93 0.05 OUTLIER Glycine 0 N--CA 1.492 2.418 0 C-N-CA 118.992 -1.575 . . . . 0.0 110.806 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -45.01 84.95 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.038 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.593 ' N ' ' O ' ' A' ' 161' ' ' GLY . 0.2 OUTLIER 179.27 84.3 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.489 ' C ' ' O ' ' A' ' 163' ' ' MET . 28.4 m120 -26.9 101.02 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 123.939 0.774 . . . . 0.0 112.121 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.58 101.15 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.243 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -158.15 13.13 0.19 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.855 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.2 m -47.23 99.25 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.902 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.1 m -86.99 -53.69 4.74 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.616 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.62 160.42 21.84 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.201 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.437 HG12 ' CD1' ' A' ' 118' ' ' LEU . 22.2 pt -145.33 162.75 12.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.907 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -145.35 104.7 3.95 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.247 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.0 mt -85.27 95.61 4.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.407 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 116.371 -1.776 . . . . 0.0 110.955 -179.982 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 tpt . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.892 0.377 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -172.81 162.2 4.81 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.849 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -177.72 118.25 0.1 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.305 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 4' ' ' ILE . 2.9 pt -77.33 154.53 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.294 -0.962 . . . . 0.0 111.059 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -133.67 127.12 32.26 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.671 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 m -107.11 173.43 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.37 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.689 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 53.8 m-85 -131.46 145.83 51.96 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.439 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.32 -37.09 77.59 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.501 ' C ' ' OG ' ' A' ' 40' ' ' SER . 25.3 m120 -117.25 165.62 13.23 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 119.101 -1.039 . . . . 0.0 111.814 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.504 ' N ' ' OG ' ' A' ' 40' ' ' SER . 46.8 mm-40 -69.18 173.5 5.57 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.253 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' A' ' 13' ' ' GLN . 4.6 t0 62.38 31.39 17.29 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.692 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.689 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 5.3 t80 68.13 -9.71 0.47 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.304 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.463 ' H ' ' C ' ' A' ' 11' ' ' ASP . 10.2 tt0 -71.88 167.68 19.52 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.861 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.491 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 90.71 129.67 4.29 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.803 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.447 ' HE2' ' H ' ' A' ' 15' ' ' LYS . 1.1 mppt? -39.34 149.72 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.729 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.81 165.1 12.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.653 -0.819 . . . . 0.0 112.714 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 t -144.57 144.51 22.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.194 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -104.33 139.14 39.74 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.899 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 mt -132.06 141.71 42.44 Favored Pre-proline 0 N--CA 1.494 1.773 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.774 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -71.62 162.4 42.29 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 121.186 1.257 . . . . 0.0 111.893 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -68.51 -157.68 0.04 OUTLIER 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 121.94 1.76 . . . . 0.0 111.356 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.55 -159.93 50.01 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.854 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.751 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -90.95 149.86 21.71 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.292 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.9 ' OH ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -166.42 146.41 6.01 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.7 p -148.52 -146.59 0.2 Allowed 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 118.66 -1.216 . . . . 0.0 112.803 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -37.0 86.21 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.553 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.551 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -57.15 -57.34 13.03 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.75 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.45 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 24.0 tt0 -58.41 -50.77 72.51 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.728 -1.189 . . . . 0.0 109.333 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.9 HD21 ' OH ' ' A' ' 24' ' ' TYR . 15.4 mt -51.07 -39.22 55.53 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.759 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -51.43 -37.16 47.21 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.357 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -67.92 -35.45 78.48 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.75 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.519 ' N ' HD23 ' A' ' 32' ' ' LEU . 6.9 mt -77.03 -83.59 0.07 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.825 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.14 -27.47 0.21 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 118.811 -1.662 . . . . 0.0 111.452 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.485 HG12 HD22 ' A' ' 29' ' ' LEU . 2.3 pt -89.4 167.18 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.196 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 1.9 pt-20 173.32 152.65 0.09 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.102 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.709 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER 70.94 -155.48 0.11 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.715 179.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.709 ' H ' HD22 ' A' ' 36' ' ' ASN . 20.5 t30 -48.8 93.73 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.156 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' SER . 35.4 p -148.5 -50.1 0.16 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.626 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.416 HD11 HD11 ' A' ' 82' ' ' ILE . 11.2 mt -60.67 75.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.315 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 38' ' ' THR . 32.1 t -75.18 -52.59 10.57 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.74 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.506 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -120.48 174.06 6.78 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -152.94 150.27 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 117.963 -1.495 . . . . 0.0 112.803 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -137.41 110.55 7.8 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.533 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.2 t -133.65 116.14 13.73 Favored Pre-proline 0 N--CA 1.495 1.807 0 C-N-CA 119.666 -0.813 . . . . 0.0 112.087 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.43 167.57 22.04 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 120.941 1.094 . . . . 0.0 110.809 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.92 -171.08 0.16 Allowed 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.744 1.63 . . . . 0.0 111.1 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.414 ' C ' HG13 ' A' ' 48' ' ' VAL . . . 75.46 -10.31 12.2 Favored Glycine 0 N--CA 1.481 1.652 0 C-N-CA 119.273 -1.441 . . . . 0.0 110.907 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.456 HG11 ' CB ' ' A' ' 2' ' ' ALA . 30.5 m -151.9 131.77 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.236 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -104.28 124.68 49.6 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.339 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.47 134.11 50.98 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.481 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.57 HD12 ' NH2' ' A' ' 83' ' ' ARG . 71.3 mt -112.59 123.08 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.116 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.898 HD23 ' H ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -89.91 152.87 21.02 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.286 -0.966 . . . . 0.0 112.443 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.898 ' H ' HD23 ' A' ' 52' ' ' LEU . 13.8 m-85 -140.07 125.08 18.53 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.22 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -53.33 -88.46 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.327 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -64.44 154.3 36.15 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.748 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -61.3 172.56 1.07 Allowed 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.362 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.66 17.99 76.95 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.12 -1.514 . . . . 0.0 109.924 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 59.24 54.05 5.03 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.971 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.52 -173.71 2.94 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.8 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.7 -175.78 33.49 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.482 -1.342 . . . . 0.0 109.955 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -50.65 166.88 0.07 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.69 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.62 161.92 36.74 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.366 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.746 HG22 ' N ' ' A' ' 64' ' ' GLU . 10.0 mm -138.78 172.76 13.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.571 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.746 ' N ' HG22 ' A' ' 63' ' ' ILE . 20.4 mt-10 -148.15 130.88 15.99 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.839 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.5 m -145.7 161.75 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 118.768 -1.173 . . . . 0.0 112.552 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.35 -14.7 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.006 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.04 -148.76 0.41 Allowed 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.404 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.775 HD22 ' H ' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -99.82 136.12 40.22 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.022 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.538 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -106.06 128.0 53.56 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.928 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -80.6 -74.79 0.3 Allowed 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 73' ' ' GLY . 20.2 mm-40 -89.95 3.32 53.47 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.975 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.417 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 1.7 tp 55.7 -83.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.715 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 176.02 -169.7 42.41 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.316 -1.421 . . . . 0.0 110.679 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.526 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.2 Cg_endo -65.05 -39.22 24.9 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 122.295 1.997 . . . . 0.0 112.17 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.022 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.9 pt? -71.94 31.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.942 -1.103 . . . . 0.0 111.202 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 74' ' ' PRO . 16.2 p-10 -80.77 -17.92 49.35 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.739 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -88.6 14.02 10.88 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.688 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.675 ' ND2' ' N ' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -167.6 115.01 0.75 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.722 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 78' ' ' ASN . 15.8 m -155.47 153.63 7.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.514 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.1 t -172.55 -33.59 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 118.683 -1.207 . . . . 0.0 112.35 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.8 140.98 40.07 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.894 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.416 HD11 HD11 ' A' ' 39' ' ' ILE . 3.9 mt -150.52 149.79 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.381 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.703 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -141.32 126.41 18.39 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.248 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.703 ' CA ' HH12 ' A' ' 83' ' ' ARG . 3.5 t -117.7 135.92 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.1 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.55 ' CG1' ' CZ ' ' A' ' 83' ' ' ARG . 13.7 mt -119.34 121.92 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.654 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.4 p -46.16 129.99 10.17 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.708 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.515 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.9 OUTLIER -125.26 151.31 69.42 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.7 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.515 ' HD2' HG22 ' A' ' 87' ' ' VAL . 4.1 Cg_exo -55.87 139.03 83.66 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 121.234 1.29 . . . . 0.0 110.731 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.32 133.78 31.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.34 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -143.63 150.99 52.62 Favored Pre-proline 0 N--CA 1.487 1.402 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.9 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 2.5 Cg_endo -59.29 -160.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.241 1.294 . . . . 0.0 111.611 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -174.93 -158.75 0.08 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.849 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.23 165.04 28.99 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.622 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.409 HH11 ' CD ' ' A' ' 105' ' ' GLU . 6.8 ttt180 -128.98 152.24 48.82 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.87 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.571 ' CE1' HG23 ' A' ' 131' ' ' VAL . 98.0 m-85 -142.61 133.89 26.17 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.748 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.445 ' CD2' ' C ' ' A' ' 101' ' ' PHE . 18.6 m-85 -94.55 -177.12 4.12 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.14 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.8 -52.1 2.87 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.031 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.562 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 15.5 mmtp -93.18 163.9 13.45 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.541 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -82.9 78.47 9.49 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.379 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.65 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.3 OUTLIER 178.85 26.79 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.349 -1.296 . . . . 0.0 107.973 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.65 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 33.9 p90 37.78 49.1 1.06 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.237 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -138.44 -28.91 0.82 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.828 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.562 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -58.89 153.77 29.32 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 119.303 -1.427 . . . . 0.0 110.46 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 103' ' ' GLY . 42.8 tttm -31.03 140.03 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.903 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.409 ' CD ' HH11 ' A' ' 94' ' ' ARG . 63.6 mt-10 -96.47 147.7 23.56 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.585 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.651 HG11 ' O ' ' A' ' 122' ' ' GLY . 95.0 t -142.85 117.88 4.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -104.14 162.27 13.32 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.095 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -141.11 150.93 60.54 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.195 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -78.08 163.51 28.03 Favored 'Trans proline' 0 C--O 1.212 -0.796 0 C-N-CA 121.652 1.568 . . . . 0.0 111.957 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.21 139.94 74.95 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.593 1.529 . . . . 0.0 110.696 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.51 -159.75 27.57 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 118.884 -1.626 . . . . 0.0 111.574 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.55 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 34.7 tt0 -118.03 156.16 29.06 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.149 -0.525 . . . . 0.0 110.828 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 49.6 m-85 -145.55 149.22 34.18 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.157 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.434 ' C ' ' H ' ' A' ' 116' ' ' ALA . 3.3 p -101.92 175.8 5.42 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.335 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -72.28 17.32 0.11 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.864 -0.734 . . . . 0.0 112.387 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 114' ' ' THR . . . -111.21 -65.75 1.14 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.564 -0.854 . . . . 0.0 111.716 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.0 pt-20 -70.55 -53.98 13.94 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.822 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.572 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -30.61 -72.43 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 123.925 0.765 . . . . 0.0 111.188 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.52 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -53.04 -57.14 11.39 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.268 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.451 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 8.0 mpt_? -78.37 26.69 0.21 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.553 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 117' ' ' GLU . 27.9 t80 -135.18 -8.28 2.29 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.315 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.651 ' O ' HG11 ' A' ' 106' ' ' VAL . . . -150.68 -44.59 0.02 OUTLIER Glycine 0 N--CA 1.481 1.642 0 C-N-CA 119.019 -1.562 . . . . 0.0 110.323 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.424 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -143.75 -102.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.822 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.444 ' C ' ' HB3' ' A' ' 119' ' ' GLU . 2.0 p-10 -172.63 179.97 2.3 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.493 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -63.91 123.03 17.91 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.113 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.619 ' N ' ' ND2' ' A' ' 126' ' ' ASN . 0.7 OUTLIER 56.28 106.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.968 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.692 HG23 ' H ' ' A' ' 128' ' ' ILE . 0.1 OUTLIER 172.49 -92.77 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.565 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.692 ' H ' HG23 ' A' ' 127' ' ' THR . 6.5 mm 45.81 -110.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.191 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 1.1 t 86.93 120.99 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 123.816 0.697 . . . . 0.0 111.924 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.731 ' H ' ' H ' ' A' ' 160' ' ' LEU . 2.7 m 58.97 114.72 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.136 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.75 HG12 ' HB3' ' A' ' 157' ' ' ALA . 4.0 p -113.13 160.13 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.605 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -160.96 89.68 1.62 Allowed Pre-proline 0 C--N 1.291 -1.967 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.183 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -69.32 121.32 8.11 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.035 1.157 . . . . 0.0 110.704 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -91.05 11.19 23.83 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.592 -0.843 . . . . 0.0 112.19 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -175.7 -49.67 0.06 OUTLIER Glycine 0 N--CA 1.491 2.339 0 C-N-CA 118.262 -1.923 . . . . 0.0 112.137 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.402 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -107.8 171.41 7.41 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.143 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -93.16 145.0 24.74 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.681 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 153' ' ' VAL . 31.6 t -101.42 147.52 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.157 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.427 HG12 ' CE1' ' A' ' 141' ' ' PHE . 59.8 t -138.25 116.71 13.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.821 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.438 ' H ' HD12 ' A' ' 140' ' ' LEU . 2.6 mp -105.7 137.47 43.51 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.78 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.427 ' CE1' HG12 ' A' ' 139' ' ' VAL . 10.9 m-85 -108.34 145.31 34.65 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.82 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -75.6 -61.73 1.82 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.913 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -82.19 149.49 27.88 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.858 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 145' ' ' ASN . 29.4 t70 -54.04 175.38 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.989 -1.085 . . . . 0.0 110.739 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.645 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 3.3 t-20 36.09 35.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.254 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.645 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 43.11 65.86 0.89 Allowed 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.103 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.2 t -120.59 34.76 5.1 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.543 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.0 -160.29 12.24 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.167 -1.492 . . . . 0.0 110.415 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -59.33 171.93 0.71 Allowed 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.093 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.5 p -149.82 160.16 43.79 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.562 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.21 84.58 62.82 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.066 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.53 102.61 0.61 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.71 1.607 . . . . 0.0 112.405 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.684 HG11 HG11 ' A' ' 131' ' ' VAL . 81.3 t -83.74 87.66 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.649 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -83.75 22.27 1.14 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.801 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 42.3 p -170.39 -156.12 0.13 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.596 -1.241 . . . . 0.0 112.033 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -90.56 150.99 21.52 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.621 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.75 ' HB3' HG12 ' A' ' 131' ' ' VAL . . . -159.42 84.99 2.25 Favored Pre-proline 0 C--N 1.308 -1.207 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.103 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.527 ' C ' ' OG ' ' A' ' 130' ' ' SER . 1.7 Cg_endo -67.93 37.92 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.045 1.83 . . . . 0.0 112.421 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.462 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.5 OUTLIER -178.55 65.83 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.704 0.764 . . . . 0.0 109.244 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.731 ' H ' ' H ' ' A' ' 130' ' ' SER . 3.4 tm? -80.98 -35.38 32.14 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.188 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.506 ' H ' ' HA ' ' A' ' 129' ' ' SER . . . -43.0 -38.92 3.55 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.743 -1.218 . . . . 0.0 111.563 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.56 -24.04 45.78 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.341 -0.944 . . . . 0.0 111.985 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -81.19 -51.71 8.14 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.606 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -86.84 142.48 28.04 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.282 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.562 HD22 ' N ' ' A' ' 165' ' ' ASN . 0.7 OUTLIER -97.77 -33.28 11.33 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.937 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.494 ' ND2' ' ND2' ' A' ' 126' ' ' ASN . 27.7 t-20 -160.6 106.59 1.48 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.545 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.3 m -92.64 113.5 25.8 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.376 -0.929 . . . . 0.0 111.18 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 41.6 t -99.73 -56.15 2.46 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.163 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 p -123.24 159.42 28.76 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.465 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 30.9 pt -141.54 174.25 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.541 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -156.29 113.3 3.16 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.364 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 7.0 mt -89.28 103.14 13.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.004 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.1 m . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 116.289 -1.815 . . . . 0.0 110.801 -179.982 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 tpp . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.576 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -136.42 159.18 42.55 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.799 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.446 ' ND2' ' C ' ' A' ' 2' ' ' ALA . 0.6 OUTLIER 179.9 129.57 0.09 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.38 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.756 HG22 HG13 ' A' ' 44' ' ' VAL . 9.0 pt -82.5 153.19 3.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.814 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.3 m -121.7 126.04 48.03 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.127 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.527 HG11 HD11 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -101.24 150.26 5.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.389 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 1.1 ' CD2' ' NE2' ' A' ' 16' ' ' GLN . 47.6 m-85 -116.97 148.19 41.63 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.325 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.0 2.5 42.8 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.509 ' N ' ' HA3' ' A' ' 14' ' ' GLY . 66.0 m-20 -154.17 167.94 28.2 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 117.779 -1.568 . . . . 0.0 112.449 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 9.4 tp10 -74.07 158.38 34.37 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.973 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.541 ' C ' ' H ' ' A' ' 13' ' ' GLN . 2.8 t0 72.21 41.04 0.65 Allowed 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.903 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.1 t80 63.3 -8.06 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.335 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.541 ' H ' ' C ' ' A' ' 11' ' ' ASP . 8.9 tt0 -74.44 175.01 8.13 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.526 -0.87 . . . . 0.0 111.169 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.509 ' HA3' ' N ' ' A' ' 9' ' ' ASN . . . 95.96 130.61 6.39 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.672 -1.252 . . . . 0.0 110.866 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 14' ' ' GLY . 48.1 mttp -38.99 152.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.919 -0.713 . . . . 0.0 111.311 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 1.1 ' NE2' ' CD2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -99.4 154.6 18.08 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.498 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.595 ' CG1' ' N ' ' A' ' 18' ' ' ASP . 2.6 t -147.1 166.47 6.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.424 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.595 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 12.3 m-20 -131.09 131.95 44.54 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.199 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.527 HD11 HG11 ' A' ' 6' ' ' VAL . 13.7 mt -130.29 121.79 19.7 Favored Pre-proline 0 N--CA 1.489 1.482 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.608 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -64.81 164.82 22.99 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 120.988 1.125 . . . . 0.0 111.946 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.65 -157.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.732 1.621 . . . . 0.0 110.668 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.88 -178.44 53.18 Favored Glycine 0 N--CA 1.48 1.587 0 C-N-CA 118.911 -1.614 . . . . 0.0 110.571 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.864 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -107.44 128.83 54.83 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.83 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 1.3 p90 -153.58 146.89 24.78 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.331 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.447 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 7.8 p -120.48 -155.09 0.61 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.088 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -56.92 -28.11 61.69 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.718 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -55.04 -57.17 12.79 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.663 -1.215 . . . . 0.0 110.177 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.425 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 71.3 tp60 -58.3 -48.54 80.18 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.731 -1.188 . . . . 0.0 109.648 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.51 ' N ' HD23 ' A' ' 29' ' ' LEU . 4.8 mt -59.97 -29.47 68.46 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.515 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -56.03 -30.2 61.55 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -77.03 -34.57 57.31 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.421 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.469 HD12 HD22 ' A' ' 29' ' ' LEU . 13.4 mt -83.16 -68.93 0.67 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.921 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.73 34.22 2.47 Favored Glycine 0 N--CA 1.504 3.187 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.463 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.714 HD13 ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -121.13 8.58 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.669 0.747 . . . . 0.0 110.498 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 35' ' ' GLU . 11.8 pt-20 -78.1 179.66 6.7 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.966 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.59 ' O ' HG23 ' A' ' 38' ' ' THR . 0.1 OUTLIER 68.93 99.59 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.16 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.521 ' OD1' ' ND2' ' A' ' 36' ' ' ASN . 1.0 OUTLIER 33.81 78.16 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.104 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.674 HG21 ' O ' ' A' ' 34' ' ' ILE . 60.5 p -140.39 -39.76 0.43 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.317 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 mt -67.27 72.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.487 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.504 ' OG ' ' C ' ' A' ' 9' ' ' ASN . 31.1 t -69.64 -46.24 66.64 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.694 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.49 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -127.57 164.1 22.72 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.156 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 t -149.89 154.31 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 118.151 -1.42 . . . . 0.0 113.124 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.23 121.61 15.02 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.183 -1.371 . . . . 0.0 108.777 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.756 HG13 HG22 ' A' ' 4' ' ' ILE . 6.4 t -139.12 114.76 8.42 Favored Pre-proline 0 N--CA 1.499 1.976 0 C-N-CA 119.308 -0.957 . . . . 0.0 112.095 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -69.76 169.5 18.77 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.849 1.032 . . . . 0.0 110.701 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.72 -170.32 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.703 1.602 . . . . 0.0 110.872 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.19 -15.03 12.39 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 119.088 -1.53 . . . . 0.0 110.589 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.576 HG11 ' CB ' ' A' ' 2' ' ' ALA . 21.6 m -150.77 135.43 9.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 118.774 -1.17 . . . . 0.0 112.172 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -105.96 127.85 53.42 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.35 153.94 24.22 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.918 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.549 HD12 ' NH2' ' A' ' 83' ' ' ARG . 99.1 mt -137.3 116.95 15.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.479 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.49 ' HA ' HG23 ' A' ' 82' ' ' ILE . 3.3 mp -93.78 162.96 13.71 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.01 -1.076 . . . . 0.0 113.177 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.44 ' CE1' HG22 ' A' ' 51' ' ' ILE . 88.4 m-85 -142.47 131.5 23.12 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.216 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.403 ' CG ' HD12 ' A' ' 75' ' ' LEU . 28.6 mt-30 -54.16 -84.41 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.764 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.47 HD22 ' N ' ' A' ' 55' ' ' ASN . 1.3 m-80 -75.69 166.6 23.31 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.17 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.32 -173.82 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.729 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 47.71 34.03 9.97 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.138 -1.506 . . . . 0.0 109.948 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.447 ' CZ ' HG23 ' A' ' 25' ' ' THR . 7.9 m-85 45.83 43.29 9.83 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.358 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.38 -172.34 2.32 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.721 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.08 178.96 1.2 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.538 -1.315 . . . . 0.0 109.818 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -54.1 177.53 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 118.831 -1.148 . . . . 0.0 110.195 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -147.45 161.34 41.25 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.806 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.451 HD11 HD11 ' A' ' 75' ' ' LEU . 4.1 mt -125.85 164.39 25.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.21 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -139.38 131.8 28.53 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -149.15 155.87 8.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.325 -1.35 . . . . 0.0 112.564 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.96 0.2 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.034 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.449 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -132.96 -135.91 0.18 Allowed 'General case' 0 C--O 1.208 -1.109 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.441 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.437 ' ND2' ' OD1' ' A' ' 107' ' ' ASP . 2.2 m-20 -111.89 124.44 52.37 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.329 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.11 94.32 6.45 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.639 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -58.64 -68.59 0.25 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.741 -0.784 . . . . 0.0 112.522 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.18 -12.82 59.98 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.369 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.416 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 1.3 tp 67.06 -79.33 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.738 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.416 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 165.62 176.07 36.74 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.238 -1.458 . . . . 0.0 110.77 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.591 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.0 OUTLIER -65.71 -35.12 38.35 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.249 1.966 . . . . 0.0 112.184 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.816 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.5 pt? -67.99 23.92 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.35 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.591 ' H ' ' C ' ' A' ' 74' ' ' PRO . 7.2 p30 -75.19 -1.08 21.64 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.668 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -73.04 -8.55 56.26 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.14 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -168.5 127.03 1.12 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.159 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.38 137.58 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.273 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 87.8 p -162.3 -30.67 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.656 -1.218 . . . . 0.0 112.697 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.409 ' C ' ' CG1' ' A' ' 82' ' ' ILE . 1.2 m -98.83 139.99 33.68 Favored 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.058 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.49 HG23 ' HA ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -150.64 156.12 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 118.571 -1.252 . . . . 0.0 111.575 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.782 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -150.21 130.09 13.36 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.444 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.782 ' CA ' HH12 ' A' ' 83' ' ' ARG . 10.0 t -128.77 143.19 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.614 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.441 ' CG1' ' CZ ' ' A' ' 83' ' ' ARG . 7.8 mt -132.51 126.42 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.975 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.7 p -40.8 149.9 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.053 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.485 HG22 ' HD2' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -149.61 151.33 32.86 Favored Pre-proline 0 N--CA 1.483 1.203 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.539 179.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HD2' HG22 ' A' ' 87' ' ' VAL . 3.5 Cg_exo -53.93 153.39 20.38 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 C-N-CA 121.287 1.325 . . . . 0.0 111.091 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 89' ' ' VAL . 4.2 m -77.73 139.36 18.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.612 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -146.46 130.1 8.36 Favored Pre-proline 0 C--N 1.297 -1.674 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.142 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.404 ' HB2' HD11 ' A' ' 136' ' ' LEU . 2.7 Cg_exo -58.67 -151.75 0.01 OUTLIER 'Trans proline' 0 C--O 1.207 -1.028 0 C-N-CA 121.465 1.444 . . . . 0.0 111.364 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.6 ptt-85 -178.03 -163.94 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.856 -1.138 . . . . 0.0 112.223 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.57 172.12 13.36 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.012 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.559 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 8.4 tpp180 -126.39 157.9 37.32 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.306 -0.957 . . . . 0.0 111.486 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.559 ' CD1' ' C ' ' A' ' 94' ' ' ARG . 26.3 m-85 -148.26 113.59 5.58 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.312 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 105' ' ' GLU . 14.7 m-85 -89.53 161.77 16.03 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.093 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.655 ' N ' ' CD1' ' A' ' 97' ' ' TYR . 0.6 OUTLIER -98.62 167.05 11.04 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.987 -1.085 . . . . 0.0 112.099 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt 59.69 147.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.072 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.568 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 30.5 tt0 -65.61 109.68 2.47 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.251 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.665 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 100.53 49.79 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.814 0 O-C-N 124.92 1.388 . . . . 0.0 110.181 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.589 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 26.0 p90 29.66 53.21 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.053 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -98.95 30.37 3.41 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.936 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -162.57 151.77 21.76 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.457 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.565 ' O ' ' CE2' ' A' ' 97' ' ' TYR . 88.6 mttt -38.0 155.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.118 0.485 . . . . 0.0 112.1 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.453 ' H ' ' HG2' ' A' ' 105' ' ' GLU . 10.8 pt-20 -111.23 167.09 10.55 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.194 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.49 HG22 ' H ' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -136.66 178.55 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.224 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.49 ' H ' HG22 ' A' ' 106' ' ' VAL . 14.3 p-10 -150.34 145.95 26.44 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.351 -1.339 . . . . 0.0 112.295 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.6 mt -139.17 133.06 16.0 Favored Pre-proline 0 N--CA 1.496 1.873 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.199 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.449 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 2.7 Cg_endo -66.88 169.34 14.96 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 121.517 1.478 . . . . 0.0 111.677 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 5.1 Cg_exo -57.91 149.29 71.03 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 122.094 1.863 . . . . 0.0 111.643 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.22 -155.29 25.52 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.649 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.569 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 37.9 mt-30 -131.12 155.97 46.04 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.809 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.569 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 40.1 m-85 -141.67 155.0 45.71 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.663 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.9 p -102.68 176.46 5.16 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.769 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.528 ' O ' ' NE2' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -83.12 56.8 3.64 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.425 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -153.5 -74.34 0.13 Allowed 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 121' ' ' TYR . 7.3 pt-20 -68.02 -44.6 76.16 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.02 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.584 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -33.94 -72.17 0.05 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.29 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.699 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -53.92 -50.3 66.71 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.436 -1.306 . . . . 0.0 110.08 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.401 ' H ' ' HG2' ' A' ' 120' ' ' ARG . 6.3 mmm180 -80.65 24.38 0.48 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 118.784 -1.166 . . . . 0.0 111.017 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.548 ' N ' ' O ' ' A' ' 117' ' ' GLU . 25.3 t80 -129.28 -12.78 4.5 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.027 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -143.8 -45.33 0.05 OUTLIER Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.297 -1.43 . . . . 0.0 110.39 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.498 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -143.8 -104.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.847 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.483 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 7.4 m-20 -160.62 179.01 8.93 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.044 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -74.8 131.49 40.83 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.691 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 m120 50.18 89.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.449 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.5 t -175.38 -2.66 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.195 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 128' ' ' ILE . 11.6 mt -95.83 144.01 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.671 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 67.5 m -155.22 -49.34 0.08 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.316 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.8 m -87.99 98.41 11.5 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.99 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.508 HG13 ' CD2' ' A' ' 95' ' ' PHE . 3.2 t -104.9 159.69 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.842 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -157.24 85.73 2.81 Favored Pre-proline 0 C--N 1.295 -1.777 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.187 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.67 96.98 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 121.413 1.408 . . . . 0.0 110.576 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -87.39 25.81 1.35 Allowed 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.422 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -161.59 -62.71 0.02 OUTLIER Glycine 0 N--CA 1.487 2.072 0 C-N-CA 118.553 -1.784 . . . . 0.0 111.452 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 91' ' ' PRO . 1.2 mp -121.53 -169.02 1.79 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.826 -0.749 . . . . 0.0 111.749 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -86.79 158.48 19.37 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.6 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.7 t -126.67 137.94 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.624 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.519 ' C ' HD12 ' A' ' 140' ' ' LEU . 62.3 t -133.32 124.89 49.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.961 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 140' ' ' LEU . 9.2 mp -101.27 140.08 36.05 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.529 -0.868 . . . . 0.0 112.285 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 171' ' ' ARG . 19.0 m-85 -107.98 132.79 53.15 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.47 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -79.1 -31.09 44.15 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.3 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.483 ' ND2' ' HB3' ' A' ' 147' ' ' SER . 33.2 t30 -78.12 179.09 7.06 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.589 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.463 ' H ' ' CG ' ' A' ' 143' ' ' ASN . 2.9 m-20 -69.45 -85.21 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.62 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.606 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 16.0 p-10 -76.16 75.69 2.99 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.637 -0.825 . . . . 0.0 112.097 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.606 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 0.9 OUTLIER 37.62 71.62 0.14 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.898 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.483 ' HB3' ' ND2' ' A' ' 143' ' ' ASN . 0.3 OUTLIER -147.98 -173.2 4.24 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.163 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 62.37 -168.69 15.97 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.669 -1.253 . . . . 0.0 111.081 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 0.8 OUTLIER -61.19 176.48 0.44 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.721 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.1 p -151.01 163.26 39.17 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.776 -1.17 . . . . 0.0 112.211 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.431 HD22 ' HG2' ' A' ' 163' ' ' MET . 13.5 tp -123.55 83.42 53.3 Favored Pre-proline 0 N--CA 1.488 1.434 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.115 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.42 108.45 0.7 Allowed 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 122.148 1.899 . . . . 0.0 113.368 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 24.9 t -86.15 89.38 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.347 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -54.95 -24.81 25.62 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.7 p -170.69 -143.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 117.793 -1.563 . . . . 0.0 113.097 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -57.1 145.06 32.21 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.543 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.52 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -174.6 65.93 0.28 Allowed Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.876 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 3.3 Cg_endo -69.28 38.95 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 122.532 2.155 . . . . 0.0 112.583 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.76 HG23 ' H ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -166.67 -82.32 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.339 -1.344 . . . . 0.0 111.911 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.76 ' H ' HG23 ' A' ' 159' ' ' THR . 79.0 mt 54.17 -84.35 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.572 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 159' ' ' THR . . . 57.77 -79.63 0.01 OUTLIER Glycine 0 N--CA 1.496 2.65 0 C-N-CA 118.979 -1.582 . . . . 0.0 110.253 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -52.23 99.49 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.659 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 165' ' ' ASN . 5.4 tpp -176.78 72.42 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.232 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 166' ' ' ASN . 1.6 t-20 -28.72 -39.43 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.929 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 163' ' ' MET . 2.6 m120 -58.87 84.22 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.181 -1.007 . . . . 0.0 110.457 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 164' ' ' ASN . 19.9 m120 -55.86 167.83 0.53 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.055 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.415 ' OG1' HD23 ' A' ' 140' ' ' LEU . 48.8 m -102.93 137.97 40.43 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.156 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.99 -60.84 1.13 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.856 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.01 167.01 12.17 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 24.7 pt -147.35 171.37 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 117.999 -1.481 . . . . 0.0 112.501 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 141' ' ' PHE . 23.7 ttm180 -152.29 106.0 3.1 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.262 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 172' ' ' ILE . 11.4 mt -81.28 107.82 13.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 119.046 -1.061 . . . . 0.0 109.95 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 36.1 m . . . . . 0 C--N 1.303 -1.419 0 CA-C-O 116.347 -1.787 . . . . 0.0 110.981 -179.976 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 tpt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' A' ' 48' ' ' VAL . . . -164.46 160.75 20.88 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.316 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 0.6 OUTLIER 179.43 121.56 0.05 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.706 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.605 HG22 HG22 ' A' ' 44' ' ' VAL . 1.6 pp -82.65 125.23 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 118.549 -1.261 . . . . 0.0 111.288 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.439 HG22 ' N ' ' A' ' 6' ' ' VAL . 38.1 m -105.85 157.65 17.32 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.471 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.492 ' HB ' HG23 ' A' ' 39' ' ' ILE . 1.6 m -142.3 164.6 17.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.288 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 5.4 m-85 -126.39 147.47 49.76 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.94 -68.76 0.38 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.303 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.533 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 34.9 m120 -73.04 170.15 15.48 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.629 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.472 ' CG ' ' N ' ' A' ' 11' ' ' ASP . 32.3 tt0 -73.55 171.06 13.9 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.08 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.63 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 3.4 t70 59.19 55.26 4.42 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.622 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.63 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 23.9 p90 38.72 26.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.102 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 11' ' ' ASP . 9.4 tp-100 -103.93 162.2 13.33 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.655 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.533 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 89.63 134.88 5.54 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.64 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 14' ' ' GLY . 16.0 mtpp -30.44 136.93 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.56 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.93 169.54 8.7 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.779 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.3 t -141.19 133.21 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.425 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.17 111.61 23.77 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.728 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mt -105.86 128.72 25.87 Favored Pre-proline 0 N--CA 1.491 1.619 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.772 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -67.57 165.93 25.67 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 120.657 0.905 . . . . 0.0 110.456 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.82 -164.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 121.623 1.549 . . . . 0.0 111.391 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.696 ' C ' HD22 ' A' ' 23' ' ' ASN . . . 97.17 174.44 34.48 Favored Glycine 0 N--CA 1.498 2.813 0 C-N-CA 119.396 -1.383 . . . . 0.0 111.28 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.901 ' N ' HD22 ' A' ' 23' ' ' ASN . 0.2 OUTLIER -103.38 135.18 45.48 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.617 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.541 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.5 p90 -155.12 176.22 12.82 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 118.482 -1.287 . . . . 0.0 111.701 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.0 p -141.06 -156.46 0.68 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.121 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.588 ' CD ' ' H ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -69.03 -22.68 64.03 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.957 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.47 ' H ' ' HD3' ' A' ' 26' ' ' ARG . . . -64.55 -59.81 3.86 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.652 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -58.73 -45.77 88.87 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.204 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.556 HD23 HD12 ' A' ' 32' ' ' LEU . 12.4 mt -57.47 -37.77 73.43 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.902 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.28 -34.22 56.4 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 118.474 -1.291 . . . . 0.0 108.469 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.9 -31.24 66.2 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.947 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.556 HD12 HD23 ' A' ' 29' ' ' LEU . 18.9 mt -81.15 -76.76 0.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.763 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.77 -29.94 0.44 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.522 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.456 ' O ' HD22 ' A' ' 29' ' ' LEU . 4.7 mm -71.5 133.56 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.578 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -171.93 147.62 2.19 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.868 -1.133 . . . . 0.0 111.885 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.583 ' N ' ' ND2' ' A' ' 36' ' ' ASN . 0.4 OUTLIER 68.47 -146.81 0.12 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.546 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.554 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -72.96 88.22 1.36 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.628 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.2 p -142.77 -31.54 0.51 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.718 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.625 HD12 HG11 ' A' ' 79' ' ' VAL . 5.8 mt -77.25 62.85 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.072 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 38.7 t -64.61 -70.02 0.25 Allowed 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.547 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.43 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -93.57 171.16 9.07 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.553 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -153.75 157.12 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 118.412 -1.315 . . . . 0.0 112.107 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -149.08 100.65 3.08 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.5 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.605 HG22 HG22 ' A' ' 4' ' ' ILE . 86.5 t -123.83 101.76 35.78 Favored Pre-proline 0 N--CA 1.496 1.84 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.407 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.44 171.8 11.22 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 120.943 1.096 . . . . 0.0 109.847 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.63 -169.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.567 1.511 . . . . 0.0 111.033 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.84 -18.24 9.6 Favored Glycine 0 N--CA 1.483 1.785 0 C-N-CA 119.18 -1.486 . . . . 0.0 110.679 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.473 HG21 ' HB1' ' A' ' 2' ' ' ALA . 1.9 m -147.79 139.98 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.292 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -110.13 119.24 38.66 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.644 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.85 157.57 17.37 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.29 -0.964 . . . . 0.0 113.158 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.6 HD12 ' NH1' ' A' ' 83' ' ' ARG . 44.2 mt -143.0 114.62 2.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.365 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.93 HD12 ' N ' ' A' ' 52' ' ' LEU . 2.7 mp -92.24 158.1 16.32 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.935 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.494 ' CE2' HG22 ' A' ' 51' ' ' ILE . 41.5 m-85 -140.03 108.48 5.86 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.488 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -45.84 -83.4 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.023 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -59.17 152.34 20.72 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.763 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -58.98 -171.18 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.945 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 49.9 37.84 29.56 Favored Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.231 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.438 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . 8.6 m-85 45.33 48.63 10.43 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.607 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.96 -164.09 1.16 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.159 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 64.84 168.93 1.91 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.265 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 60' ' ' GLY . 10.0 t70 -39.05 118.11 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.684 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.532 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 4.7 pp0? -97.74 151.57 20.02 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.743 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.663 HG22 ' N ' ' A' ' 64' ' ' GLU . 4.5 mm -130.59 168.98 22.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.423 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.663 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -147.39 133.71 19.56 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.127 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -145.07 162.19 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 118.79 -1.164 . . . . 0.0 112.56 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 t -149.36 -5.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.535 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.446 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -129.62 -159.51 0.97 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.209 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -91.15 136.91 32.77 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.714 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.605 ' HB1' ' HA ' ' A' ' 72' ' ' LEU . . . -113.92 105.03 12.76 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.424 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -54.29 -77.88 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.753 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -91.73 5.59 49.19 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.803 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.605 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . 19.1 tp 54.04 -99.35 0.09 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.588 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.61 -176.55 36.45 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 118.964 -1.588 . . . . 0.0 111.03 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.646 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.0 OUTLIER -66.37 -37.34 23.96 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.483 2.122 . . . . 0.0 112.357 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 75' ' ' LEU . 2.7 pt? -57.53 8.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.502 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.646 ' H ' ' C ' ' A' ' 74' ' ' PRO . 10.5 p-10 -69.47 1.19 4.2 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.652 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.606 HD22 ' N ' ' A' ' 77' ' ' ASN . 1.8 m120 -82.82 -15.41 51.75 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.364 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -164.69 126.52 2.2 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.104 -1.039 . . . . 0.0 111.169 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.625 HG11 HD12 ' A' ' 39' ' ' ILE . 2.7 t -138.38 151.15 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.432 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.3 t -166.0 -51.14 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.728 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 m -94.14 135.55 35.39 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.977 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.523 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -150.25 157.19 6.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.371 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.831 ' HE ' HD11 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -150.59 153.08 35.07 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.386 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.659 ' C ' HH21 ' A' ' 83' ' ' ARG . 13.9 t -150.27 140.29 16.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.497 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.831 HD11 ' HE ' ' A' ' 83' ' ' ARG . 42.4 mt -134.52 129.57 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.7 m -40.82 139.71 0.81 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.052 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.589 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -143.57 141.78 19.65 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.635 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.589 ' HD2' HG22 ' A' ' 87' ' ' VAL . 5.7 Cg_exo -54.75 143.77 68.6 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 121.065 1.176 . . . . 0.0 111.156 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.0 t -64.2 145.06 14.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.123 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -122.7 139.14 30.56 Favored Pre-proline 0 N--CA 1.489 1.491 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.132 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.75 -23.48 50.06 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 121.143 1.229 . . . . 0.0 111.309 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 35.3 -151.85 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.667 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.481 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -147.72 173.06 13.13 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.046 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -147.03 113.0 5.78 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.168 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 5.7 m-85 -97.29 162.63 13.25 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.555 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -123.0 156.72 34.23 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.618 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 104' ' ' LYS . 1.4 m-85 -75.46 -91.37 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.134 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 1.247 ' HB3' ' OE1' ' A' ' 100' ' ' GLN . 51.2 mttp -47.74 162.63 0.07 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.125 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -90.6 67.57 6.46 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.66 -0.816 . . . . 0.0 112.35 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 1.247 ' OE1' ' HB3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER 178.85 51.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.667 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.9 t80 47.99 35.06 4.6 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.951 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.734 ' OD1' ' HG2' ' A' ' 100' ' ' GLN . 18.3 p-10 -142.1 171.07 14.56 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.616 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 85.38 139.94 5.09 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.019 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.538 ' HB2' ' HZ2' ' A' ' 104' ' ' LYS . 1.0 OUTLIER -29.58 132.91 0.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 123.895 0.409 . . . . 0.0 112.07 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.563 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 1.7 pm0 -104.7 163.22 12.65 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.302 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.73 HG21 ' O ' ' A' ' 122' ' ' GLY . 2.1 t -140.97 128.8 22.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.109 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.47 155.22 17.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.788 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 108' ' ' LEU . 46.2 mt -143.93 138.5 15.14 Favored Pre-proline 0 N--CA 1.481 1.087 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.847 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 10.9 Cg_endo -73.08 167.33 27.62 Favored 'Trans proline' 0 C--O 1.212 -0.789 0 C-N-CA 121.636 1.557 . . . . 0.0 111.718 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.36 141.74 76.03 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.93 1.754 . . . . 0.0 110.965 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 144.69 -155.63 26.48 Favored Glycine 0 N--CA 1.498 2.817 0 C-N-CA 118.862 -1.637 . . . . 0.0 111.328 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.444 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 6.0 tt0 -125.65 152.42 45.24 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.934 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.444 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 28.8 m-85 -145.53 147.32 32.0 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.278 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.663 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 1.4 p -95.31 -136.46 0.22 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.08 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.663 ' N ' ' OG1' ' A' ' 114' ' ' THR . 5.4 tt0 -113.98 -25.38 8.59 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.063 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.45 -64.06 1.26 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.966 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.3 pt-20 -70.94 -50.34 35.68 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.587 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.695 ' C ' HD23 ' A' ' 118' ' ' LEU . 2.4 tt -39.28 -71.05 0.09 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.459 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.569 ' OE1' ' NH1' ' A' ' 120' ' ' ARG . 75.9 mt-10 -48.89 -56.12 9.74 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.639 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.569 ' NH1' ' OE1' ' A' ' 119' ' ' GLU . 4.1 mpt_? -71.76 0.31 9.24 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.893 -1.123 . . . . 0.0 112.361 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 117' ' ' GLU . 24.7 t80 -105.08 -12.23 16.23 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.487 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.73 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -146.21 -46.51 0.03 OUTLIER Glycine 0 N--CA 1.486 1.993 0 C-N-CA 118.915 -1.612 . . . . 0.0 111.288 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.647 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -136.78 -112.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.183 -1.007 . . . . 0.0 111.724 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -156.26 -155.53 0.55 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.338 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -80.61 3.67 21.13 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.975 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.581 ' ND2' HD22 ' A' ' 166' ' ' ASN . 8.6 m120 -157.15 -152.04 0.34 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.582 -1.247 . . . . 0.0 112.147 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 39.32 96.78 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.103 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 13.5 mt -155.1 -75.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.507 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.715 ' O ' HG23 ' A' ' 131' ' ' VAL . 8.3 p 41.54 -98.16 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.7 m -44.55 116.68 1.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 129' ' ' SER . 21.2 t -121.89 146.35 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.7 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -144.09 82.58 10.8 Favored Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.413 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -63.07 108.61 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.262 1.308 . . . . 0.0 111.053 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.481 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 6.9 mm100 -62.56 -2.3 1.05 Allowed 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.911 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 175.32 -41.21 0.11 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 118.249 -1.929 . . . . 0.0 112.476 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.6 mt -88.13 176.33 7.32 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.512 -1.275 . . . . 0.0 111.299 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.1 129.66 54.14 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.308 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.7 t -98.24 149.44 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.323 -0.951 . . . . 0.0 112.404 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.585 HG12 ' CE1' ' A' ' 141' ' ' PHE . 58.1 t -133.04 113.96 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.448 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 mp -91.01 139.26 30.93 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.818 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.585 ' CE1' HG12 ' A' ' 139' ' ' VAL . 3.7 m-85 -118.64 131.8 56.17 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.461 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -61.18 -80.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.911 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.473 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.8 m-80 -66.25 164.03 16.68 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.272 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 146' ' ' PHE . 4.7 p30 -61.92 -161.17 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.537 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.638 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 6.6 t-20 37.19 29.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.12 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.638 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.1 p90 42.15 62.19 1.73 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.162 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.94 174.07 11.01 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.017 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.99 -162.13 49.82 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.488 -1.339 . . . . 0.0 110.529 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -59.96 160.54 7.72 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.41 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 71.5 p -149.13 166.04 29.99 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.56 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.46 ' C ' ' CD2' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -133.2 86.53 41.56 Favored Pre-proline 0 N--CA 1.483 1.223 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.901 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -63.24 104.77 0.43 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 C-N-CA 121.54 1.493 . . . . 0.0 112.328 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.81 81.99 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.637 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -78.85 19.77 0.5 Allowed 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.338 -0.847 . . . . 0.0 112.06 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.412 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 11.5 t -169.97 -151.67 0.09 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.54 -1.264 . . . . 0.0 111.89 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.412 ' N ' ' OG ' ' A' ' 155' ' ' SER . 4.3 m-20 -87.54 157.49 19.15 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.927 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.479 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -167.52 69.06 0.91 Allowed Pre-proline 0 C--N 1.304 -1.377 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.802 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.3 Cg_endo -68.14 34.35 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.622 2.214 . . . . 0.0 112.933 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.654 HG23 ' H ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -169.87 -68.29 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.716 -1.193 . . . . 0.0 111.665 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.654 ' H ' HG23 ' A' ' 159' ' ' THR . 1.9 mt 51.69 -93.55 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.605 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 159' ' ' THR . . . 43.43 57.78 4.26 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.595 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.432 ' HB3' ' SD ' ' A' ' 163' ' ' MET . . . -152.61 -81.76 0.09 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.611 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.604 ' N ' ' SD ' ' A' ' 163' ' ' MET . 0.2 OUTLIER -67.17 -31.23 71.5 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.511 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -90.64 136.9 32.77 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -157.17 -6.17 0.1 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.524 -0.871 . . . . 0.0 110.754 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.581 HD22 ' ND2' ' A' ' 126' ' ' ASN . 7.8 t-20 -169.86 39.1 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.205 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -39.32 136.54 0.88 Allowed 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.29 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.8 m -107.53 -36.08 6.56 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.827 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 10.8 p -153.84 155.57 36.02 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.7 -1.2 . . . . 0.0 111.022 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.668 HD12 HD11 ' A' ' 118' ' ' LEU . 0.2 OUTLIER -143.9 172.97 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.494 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -142.04 113.26 7.59 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.58 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 3.4 mt -80.52 91.89 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 118.437 -1.305 . . . . 0.0 109.548 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.6 t . . . . . 0 C--N 1.305 -1.33 0 CA-C-O 116.331 -1.795 . . . . 0.0 110.894 -179.969 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 mmm . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 120.976 0.417 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.597 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . -60.06 167.67 2.22 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.571 -0.851 . . . . 0.0 110.935 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -176.68 127.55 0.18 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.782 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.2 pt -68.06 168.69 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.441 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -149.3 124.76 10.3 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.292 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.53 ' HB ' HG23 ' A' ' 39' ' ' ILE . 1.3 m -101.67 137.01 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.718 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.534 ' CE2' ' O ' ' A' ' 12' ' ' PHE . 5.2 m-85 -92.35 148.34 22.2 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.124 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.451 ' HB2' ' N ' ' A' ' 15' ' ' LYS . 1.8 m-85 -81.52 0.71 36.79 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.505 ' C ' ' OG ' ' A' ' 40' ' ' SER . 31.6 m120 -152.38 164.3 37.76 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.063 -1.455 . . . . 0.0 112.009 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.498 ' N ' ' OG ' ' A' ' 40' ' ' SER . 3.0 tp10 -71.63 163.64 27.38 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.462 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.477 ' CG ' ' C ' ' A' ' 10' ' ' GLU . 0.3 OUTLIER 71.87 40.92 0.71 Allowed 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.576 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.534 ' O ' ' CE2' ' A' ' 7' ' ' PHE . 55.8 t80 53.48 10.63 0.22 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.138 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.577 HE21 ' H ' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -96.97 171.89 8.21 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.81 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.577 ' H ' HE21 ' A' ' 13' ' ' GLN . . . 96.08 139.32 10.33 Favored Glycine 0 N--CA 1.495 2.625 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.633 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.451 ' N ' ' HB2' ' A' ' 8' ' ' TYR . 12.5 mtmm -37.11 147.84 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.215 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.54 118.86 32.84 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.182 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.576 ' O ' HG13 ' A' ' 17' ' ' VAL . 14.4 p -104.82 130.71 55.4 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.028 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.182 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -90.25 143.26 26.93 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.326 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt -138.61 134.74 17.46 Favored Pre-proline 0 N--CA 1.493 1.693 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.146 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.83 165.89 22.08 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.048 1.165 . . . . 0.0 111.264 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.17 -173.73 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 C-N-CA 121.87 1.713 . . . . 0.0 111.163 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.12 -167.26 16.85 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.239 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.699 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -134.81 136.65 42.69 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.203 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -152.13 -172.48 4.24 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.04 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 p -142.65 -162.77 1.48 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.658 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.627 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 11.0 ttt180 -60.44 -11.99 8.32 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.725 -1.19 . . . . 0.0 110.116 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.01 -66.48 0.59 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.415 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.476 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 8.5 tp-100 -59.49 -42.63 92.57 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.363 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 29' ' ' LEU . 58.8 mt -64.37 -36.74 85.12 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.32 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 26' ' ' ARG . . . -55.78 -28.88 58.32 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 117.923 -1.511 . . . . 0.0 107.767 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -71.78 -35.53 70.07 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.819 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.6 mt -81.98 -75.45 0.3 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.487 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.51 16.93 0.06 OUTLIER Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.489 -1.338 . . . . 0.0 110.791 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.423 HD12 HG23 ' A' ' 34' ' ' ILE . 28.7 mm -102.34 127.67 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.047 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.667 ' O ' HG22 ' A' ' 38' ' ' THR . 4.7 pt-20 -178.19 158.54 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.277 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 0.5 OUTLIER 81.24 -144.62 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.404 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.708 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 0.5 OUTLIER -94.95 18.44 11.97 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.126 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -66.32 -20.73 66.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.195 -1.402 . . . . 0.0 110.361 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.756 HG22 ' O ' ' A' ' 39' ' ' ILE . 78.8 mt -76.18 33.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.692 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.651 ' H ' ' C ' ' A' ' 38' ' ' THR . 11.0 t -35.45 -55.85 0.65 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.222 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -122.74 174.68 6.97 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.418 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -151.01 161.01 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 118.165 -1.414 . . . . 0.0 112.438 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.439 ' N ' HG13 ' A' ' 42' ' ' VAL . 78.3 tttt -141.6 123.31 15.18 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.163 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.4 t -144.65 102.75 4.58 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.05 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.4 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.8 Cg_endo -68.31 171.26 13.1 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 121.032 1.154 . . . . 0.0 110.356 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 2.1 Cg_endo -61.59 -173.35 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.549 1.499 . . . . 0.0 110.815 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.9 -13.69 8.48 Favored Glycine 0 N--CA 1.483 1.788 0 C-N-CA 119.195 -1.479 . . . . 0.0 110.474 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.597 HG11 ' HB3' ' A' ' 2' ' ' ALA . 2.6 m -151.72 129.42 2.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 118.919 -1.112 . . . . 0.0 112.105 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.495 ' O ' HG13 ' A' ' 84' ' ' VAL . 15.8 ttpt -98.74 149.54 22.74 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.847 ' C ' HD12 ' A' ' 51' ' ' ILE . . . -134.17 149.62 51.04 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.365 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 1.066 HD13 HH22 ' A' ' 83' ' ' ARG . 1.9 mp -137.66 116.2 14.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.383 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.479 HD12 ' H ' ' A' ' 52' ' ' LEU . 4.3 mp -88.2 156.94 18.96 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.669 -1.212 . . . . 0.0 111.655 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -133.47 110.66 10.12 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.122 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -49.42 -79.38 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.48 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -62.4 153.88 29.94 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.987 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 21.7 p-10 -64.66 178.46 0.77 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.756 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.0 32.23 66.35 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.248 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 52.73 68.08 0.89 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.748 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.41 -170.92 3.62 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.121 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.38 175.01 6.17 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.287 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -44.27 111.66 0.32 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.623 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.605 ' CD ' ' H ' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -95.62 128.32 42.39 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.146 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.573 HD11 HD11 ' A' ' 75' ' ' LEU . 2.5 mt -96.8 163.78 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.553 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -136.99 130.52 31.59 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.706 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 50' ' ' ALA . 11.0 m -150.3 163.72 3.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 118.813 -1.155 . . . . 0.0 112.178 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 t -147.42 -3.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.389 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.22 -146.13 0.32 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.273 -1.331 . . . . 0.0 109.122 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -96.94 124.39 40.9 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.546 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.433 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.16 108.73 19.77 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.054 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -65.05 -85.58 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.709 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 73' ' ' GLY . 9.8 mm-40 -80.35 5.86 13.7 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.354 -0.939 . . . . 0.0 111.539 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.408 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 3.0 tp 60.49 -79.63 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.045 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 71' ' ' GLU . . . 170.56 174.72 38.77 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.397 -1.383 . . . . 0.0 110.477 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.26 -27.72 64.03 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.086 1.857 . . . . 0.0 111.982 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.573 HD11 HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -83.4 18.81 1.69 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.549 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -68.89 7.59 0.66 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -83.86 -10.48 57.99 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.519 -0.872 . . . . 0.0 111.269 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -165.75 122.94 1.44 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.381 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.589 ' HB ' HD12 ' A' ' 39' ' ' ILE . 3.5 t -149.49 142.79 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.657 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.7 m -158.35 -35.36 0.07 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.196 -1.001 . . . . 0.0 111.855 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.5 m -94.58 143.14 26.67 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.164 -1.014 . . . . 0.0 111.468 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.98 143.74 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.234 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 1.066 HH22 HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -125.0 135.07 52.44 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.81 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.748 ' CA ' ' NH1' ' A' ' 83' ' ' ARG . 13.2 t -141.22 142.92 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.391 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 68.6 mt -140.32 138.62 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.593 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.0 m -55.24 146.23 19.53 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.191 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.428 HG22 ' HD2' ' A' ' 88' ' ' PRO . 1.1 t -140.91 149.33 55.79 Favored Pre-proline 0 N--CA 1.483 1.225 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.626 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.428 ' HD2' HG22 ' A' ' 87' ' ' VAL . 3.1 Cg_exo -56.79 157.76 18.75 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.491 1.461 . . . . 0.0 111.58 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 89' ' ' VAL . 10.4 m -71.52 136.7 25.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.333 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -145.71 130.89 9.16 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.438 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -60.81 -154.34 0.02 OUTLIER 'Trans proline' 0 C--O 1.21 -0.877 0 C-N-CA 121.276 1.317 . . . . 0.0 111.09 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 178.28 -161.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.017 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.483 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.71 173.25 11.71 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.36 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.422 ' C ' ' CD1' ' A' ' 95' ' ' PHE . 10.7 mtm180 -134.79 148.47 50.21 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.002 -1.079 . . . . 0.0 112.148 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 10.9 m-85 -133.79 133.34 41.56 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.764 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.492 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 27.2 m-85 -94.62 179.09 5.38 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.342 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.546 ' CE1' HG21 ' A' ' 127' ' ' THR . 0.2 OUTLIER -100.36 -64.7 1.02 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.431 -0.907 . . . . 0.0 112.973 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.503 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 46.4 tttm -81.02 158.19 25.21 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.94 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.575 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 42.2 mt-10 -64.65 108.31 1.66 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.567 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 1.145 ' NE2' ' HD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 106.04 57.14 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.208 0 O-C-N 125.109 1.505 . . . . 0.0 110.327 179.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 1.145 ' HD1' ' NE2' ' A' ' 100' ' ' GLN . 13.9 p90 26.41 40.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.672 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 100' ' ' GLN . 65.4 m-20 -100.72 -9.42 21.82 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.014 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.503 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -105.92 150.73 16.97 Favored Glycine 0 N--CA 1.499 2.9 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.395 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 103' ' ' GLY . 94.8 mttt -35.04 145.53 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.498 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.33 160.81 14.1 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.961 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.8 HG21 ' O ' ' A' ' 122' ' ' GLY . 1.5 t -143.6 165.38 14.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.232 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.513 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 5.7 p-10 -145.37 153.78 41.59 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 118.571 -1.252 . . . . 0.0 112.311 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.472 HD22 ' CD2' ' A' ' 121' ' ' TYR . 60.6 mt -139.39 146.38 48.23 Favored Pre-proline 0 N--CA 1.491 1.595 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.371 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -73.15 165.75 31.84 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 121.676 1.584 . . . . 0.0 112.645 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.12 146.87 95.21 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 122.394 2.063 . . . . 0.0 111.491 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.11 -166.21 23.78 Favored Glycine 0 N--CA 1.501 2.973 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.154 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.587 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 55.3 mt-30 -113.37 159.22 19.66 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.737 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.587 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 44.9 m-85 -144.97 148.53 33.89 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.072 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.3 p -87.91 -165.68 1.38 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.879 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.91 57.0 0.73 Allowed 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.901 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.08 -68.16 0.13 Allowed 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.426 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 121' ' ' TYR . 9.7 pt-20 -69.8 -42.61 73.51 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.431 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.575 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -37.16 -74.49 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.529 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.722 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -52.08 -51.57 56.84 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.727 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 2.4 mpt_? -76.88 18.66 0.34 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.754 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 117' ' ' GLU . 16.7 t80 -127.71 -10.11 5.57 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.23 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.8 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -141.69 -49.77 0.05 OUTLIER Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.114 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.6 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -146.1 -102.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.627 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.6 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 20.1 m-20 -161.02 162.56 31.8 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.629 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.457 ' N ' ' HB3' ' A' ' 119' ' ' GLU . 17.3 p30 -60.47 -22.83 63.94 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.507 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.769 ' O ' HG22 ' A' ' 127' ' ' THR . 9.8 t30 -97.63 -175.3 3.15 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.184 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 126' ' ' ASN . 10.1 t 55.04 -152.39 0.35 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.091 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.573 ' N ' HG23 ' A' ' 127' ' ' THR . 2.6 mt 76.43 127.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.295 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.426 ' HB3' ' CA ' ' A' ' 161' ' ' GLY . 47.6 m -160.58 -54.77 0.05 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.895 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.732 ' CB ' ' H ' ' A' ' 101' ' ' PHE . 1.7 m -84.08 117.18 23.27 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.789 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 t -119.46 143.58 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.885 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -139.7 106.6 6.98 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.257 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.55 122.37 9.35 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.103 1.202 . . . . 0.0 111.07 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.483 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 1.0 OUTLIER -90.15 -2.13 58.03 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.964 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -175.92 -36.24 0.05 OUTLIER Glycine 0 N--CA 1.493 2.448 0 C-N-CA 118.469 -1.824 . . . . 0.0 111.805 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.3 164.34 16.45 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.852 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 173' ' ' SER . . . -78.03 155.78 30.48 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.374 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.5 t -119.43 140.12 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.427 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.451 ' C ' HD12 ' A' ' 140' ' ' LEU . 92.2 t -130.98 124.52 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.845 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 140' ' ' LEU . 11.2 mp -103.01 141.23 36.15 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.43 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.426 ' CB ' ' HA ' ' A' ' 146' ' ' PHE . 48.3 m-85 -120.13 125.78 49.09 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.14 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -65.78 -64.69 0.8 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.947 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.54 165.63 23.5 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.4 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 146' ' ' PHE . 31.4 m-20 -63.18 -158.72 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.723 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.655 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 4.0 m120 42.89 22.89 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.753 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.655 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.9 p90 40.6 59.17 2.2 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.114 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 t -143.25 -150.8 0.33 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.334 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 54.4 -153.79 9.55 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.42 -1.371 . . . . 0.0 109.974 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.51 143.13 50.96 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.068 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.2 p -143.99 167.67 21.8 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.47 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.3 mt -138.03 83.41 23.05 Favored Pre-proline 0 N--CA 1.485 1.31 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.922 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -64.88 104.41 0.56 Allowed 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 121.615 1.543 . . . . 0.0 111.933 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.6 t -86.0 81.83 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.959 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -71.84 12.55 0.38 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.326 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 13.4 t -169.83 -151.71 0.09 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.378 -1.329 . . . . 0.0 111.618 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.3 m-20 -85.22 155.02 21.59 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.628 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.519 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -171.9 62.64 0.34 Allowed Pre-proline 0 C--N 1.302 -1.469 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.404 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 10.2 Cg_endo -69.87 69.8 1.68 Allowed 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.954 1.769 . . . . 0.0 111.197 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.714 HG23 ' H ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER 173.97 -94.45 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.379 -0.928 . . . . 0.0 111.064 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.714 ' H ' HG23 ' A' ' 159' ' ' THR . 49.7 mt 53.26 -90.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.842 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 159' ' ' THR . . . 46.23 13.63 0.08 OUTLIER Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.764 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -95.0 46.83 1.13 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.801 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.453 ' O ' ' N ' ' A' ' 165' ' ' ASN . 2.0 ptt? -161.64 57.71 0.27 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.746 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -53.51 91.67 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.71 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 163' ' ' MET . 6.3 t-20 -154.13 -125.3 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.648 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.421 ' CG ' ' C ' ' A' ' 165' ' ' ASN . 3.4 m120 -158.28 102.85 1.78 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.959 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -55.74 122.28 11.07 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.222 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 73.0 m -91.23 -72.1 0.6 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.242 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.61 160.72 19.64 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.244 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.407 HG12 ' CD1' ' A' ' 118' ' ' LEU . 29.2 pt -142.37 169.87 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 119.506 -0.877 . . . . 0.0 110.633 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -154.1 107.0 2.86 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.052 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.5 mt -82.99 99.34 5.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.716 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 137' ' ' ALA . 11.0 t . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 116.328 -1.796 . . . . 0.0 110.966 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.3 tpp . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.538 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -161.37 158.02 26.22 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.212 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -179.97 115.33 0.05 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.18 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.4 pt -70.1 162.46 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.82 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 m -143.88 119.03 10.1 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.544 -0.863 . . . . 0.0 110.705 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 m -101.8 162.58 3.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.069 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.515 ' CZ ' ' CZ ' ' A' ' 12' ' ' PHE . 31.3 m-85 -120.62 152.7 37.81 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.934 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.98 -47.94 60.24 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.642 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 9.6 m120 -101.17 177.42 4.94 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.969 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 11' ' ' ASP . 5.5 tp10 -82.19 177.06 9.0 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.861 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.457 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 4.1 t70 61.58 36.26 16.9 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.15 -1.02 . . . . 0.0 110.756 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.515 ' CZ ' ' CZ ' ' A' ' 7' ' ' PHE . 1.3 t80 60.95 2.34 0.54 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.701 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -88.24 167.98 13.11 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.724 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.642 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 93.74 133.98 6.99 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 119.974 -1.107 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 14' ' ' GLY . 25.4 mtmm -30.15 139.47 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.095 0.474 . . . . 0.0 112.193 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.38 162.07 13.65 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.935 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 t -147.82 122.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.629 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 1.6 m-20 -90.25 138.78 31.25 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.798 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 mt -132.24 133.26 23.59 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.639 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -68.65 164.56 32.63 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 120.962 1.108 . . . . 0.0 111.494 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.02 -167.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.756 1.637 . . . . 0.0 110.533 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.474 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 89.56 178.8 45.19 Favored Glycine 0 N--CA 1.486 1.989 0 C-N-CA 118.79 -1.671 . . . . 0.0 110.88 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.889 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -110.52 141.84 43.13 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.359 -0.537 . . . . 0.0 112.2 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.455 ' OH ' HD12 ' A' ' 82' ' ' ILE . 17.2 p90 -155.77 178.87 9.77 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.879 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.6 p -142.47 -168.65 2.79 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.616 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -57.97 -24.31 57.52 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.381 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -64.87 -63.4 1.12 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.003 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 8.9 tp-100 -56.73 -39.61 74.25 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.437 -1.305 . . . . 0.0 109.326 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.645 HD13 HD11 ' A' ' 34' ' ' ILE . 46.1 mt -62.04 -40.1 94.6 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.324 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -48.76 -33.78 10.98 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 118.864 -1.135 . . . . 0.0 107.972 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -71.53 -38.68 71.05 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.575 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.509 HD12 HD23 ' A' ' 29' ' ' LEU . 15.2 mt -71.89 -80.93 0.06 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.927 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.14 -21.87 0.1 OUTLIER Glycine 0 N--CA 1.491 2.324 0 C-N-CA 118.802 -1.666 . . . . 0.0 111.422 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.645 HD11 HD13 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -81.27 155.21 4.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.984 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.765 ' H ' HG21 ' A' ' 38' ' ' THR . 5.0 pt-20 174.32 117.88 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.468 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.641 ' CG ' ' N ' ' A' ' 37' ' ' ASN . 1.5 p-10 92.43 -150.67 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.966 0 O-C-N 124.299 0.999 . . . . 0.0 113.032 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.809 HD22 ' H ' ' A' ' 37' ' ' ASN . 1.9 m-80 -51.49 4.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.496 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.765 HG21 ' H ' ' A' ' 35' ' ' GLU . 43.4 p -56.78 -54.26 48.36 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 117.801 -1.559 . . . . 0.0 110.944 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.505 ' N ' ' OG1' ' A' ' 38' ' ' THR . 3.6 mt -58.75 77.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.112 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 38' ' ' THR . 35.6 t -81.38 -58.53 3.0 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.101 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.76 169.49 8.79 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -149.68 148.79 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 118.137 -1.425 . . . . 0.0 112.919 -179.907 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -137.01 114.65 11.15 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.616 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.3 t -133.93 110.09 11.96 Favored Pre-proline 0 N--CA 1.498 1.955 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.063 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.414 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.0 OUTLIER -68.46 171.47 12.93 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 121.219 1.28 . . . . 0.0 111.223 179.879 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.5 Cg_endo -63.71 -171.92 0.15 Allowed 'Trans proline' 0 C--N 1.317 -1.079 0 C-N-CA 121.922 1.748 . . . . 0.0 111.131 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.418 ' C ' HG13 ' A' ' 48' ' ' VAL . . . 78.38 -17.13 6.7 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.538 HG11 ' CB ' ' A' ' 2' ' ' ALA . 26.6 m -150.58 143.63 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.232 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -108.78 138.42 45.14 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.972 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -117.49 140.24 49.87 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.369 -0.932 . . . . 0.0 112.436 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -129.09 118.99 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.33 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.47 ' HA ' HG23 ' A' ' 82' ' ' ILE . 3.8 mp -94.58 163.79 13.24 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.975 -1.09 . . . . 0.0 112.81 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -143.61 121.01 11.65 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.069 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -54.96 -85.87 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.665 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -59.88 154.07 19.45 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.28 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -62.45 -176.67 0.11 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.525 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.22 21.32 59.43 Favored Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.052 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 57.07 48.64 15.15 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.798 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -128.71 -177.83 4.35 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.591 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.41 171.68 36.44 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.076 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.5 m-20 -46.99 123.69 5.54 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.021 -1.071 . . . . 0.0 110.407 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.728 ' CD ' ' H ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -102.85 176.06 5.28 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.854 -0.739 . . . . 0.0 111.112 179.951 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.626 HD11 HD11 ' A' ' 75' ' ' LEU . 6.1 mt -143.65 164.31 15.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.625 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.567 ' N ' ' CD ' ' A' ' 64' ' ' GLU . 3.0 mp0 -142.94 132.16 23.26 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.191 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.3 m -149.95 162.95 3.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.645 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 t -145.46 -1.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.664 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -124.47 -125.07 0.25 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.877 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.565 ' C ' HD22 ' A' ' 68' ' ' ASN . 0.2 OUTLIER -121.64 115.83 23.47 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.201 179.915 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.57 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -90.1 83.47 6.06 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.575 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -54.33 -51.16 65.59 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.444 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 72' ' ' LEU . 8.5 tp10 -111.93 81.46 1.46 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.87 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.441 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 4.5 tp -31.17 -87.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.233 -0.894 . . . . 0.0 113.167 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.441 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 179.5 -168.17 38.56 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.007 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.64 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.1 Cg_endo -69.37 -50.38 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.402 2.068 . . . . 0.0 112.611 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.798 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.3 pt? -57.97 10.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.873 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.64 ' H ' ' C ' ' A' ' 74' ' ' PRO . 30.2 p30 -62.56 -0.58 0.63 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.861 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.509 ' H ' ' C ' ' A' ' 75' ' ' LEU . 55.0 t30 -71.22 -10.53 59.91 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.394 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -172.94 124.85 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.302 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.85 141.67 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.031 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.0 m -160.17 -41.77 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.748 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 m -94.6 139.03 31.73 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.244 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.47 HG23 ' HA ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -146.25 162.59 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 118.919 -1.112 . . . . 0.0 111.728 -179.952 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.892 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.24 114.42 5.85 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.116 -179.881 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.892 ' H ' HH22 ' A' ' 83' ' ' ARG . 10.9 t -110.11 130.31 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.613 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.438 HG13 ' NH1' ' A' ' 83' ' ' ARG . 4.9 mt -132.43 127.4 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.088 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.8 m -39.98 153.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.904 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.586 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -158.11 141.86 11.25 Favored Pre-proline 0 N--CA 1.488 1.437 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.98 179.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.586 ' HD2' HG22 ' A' ' 87' ' ' VAL . 7.6 Cg_exo -50.46 153.79 7.04 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.346 1.364 . . . . 0.0 111.64 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.531 HG22 ' N ' ' A' ' 90' ' ' GLN . 3.1 p -90.51 158.59 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.96 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.531 ' N ' HG22 ' A' ' 89' ' ' VAL . 52.5 mt-30 -142.25 150.46 55.31 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.432 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.567 ' C ' ' HE ' ' A' ' 92' ' ' ARG . 3.3 Cg_exo -59.71 -36.76 90.86 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.496 1.464 . . . . 0.0 111.299 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.567 ' HE ' ' C ' ' A' ' 91' ' ' PRO . 2.5 mtm180 57.21 -165.72 0.15 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.048 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.544 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -140.07 179.77 6.43 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.967 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -140.42 149.84 43.11 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.711 -1.195 . . . . 0.0 111.966 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -134.64 131.34 37.65 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.011 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.564 ' CZ ' ' CD ' ' A' ' 105' ' ' GLU . 5.4 m-85 -92.58 173.34 7.83 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.027 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.44 -68.89 0.75 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 118.893 -1.123 . . . . 0.0 112.117 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -75.46 166.7 23.19 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.319 -0.953 . . . . 0.0 111.844 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.725 ' C ' ' HG2' ' A' ' 100' ' ' GLN . 5.2 pt-20 -89.68 52.75 2.39 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.674 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.725 ' HG2' ' C ' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -159.32 33.24 0.2 Allowed 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.903 -179.995 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.7 t80 58.4 38.11 25.76 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.447 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -137.97 173.81 11.23 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 81.78 134.02 1.72 Allowed Glycine 0 N--CA 1.487 2.033 0 C-N-CA 119.38 -1.391 . . . . 0.0 109.893 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 103' ' ' GLY . 13.6 ptpt -32.69 148.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.066 0.509 . . . . 0.0 112.008 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.564 ' CD ' ' CZ ' ' A' ' 96' ' ' PHE . 20.9 mt-10 -108.52 167.54 9.97 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.737 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 122' ' ' GLY . 2.6 t -137.19 130.0 43.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.768 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -102.1 155.87 17.92 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.338 -0.945 . . . . 0.0 113.103 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 108' ' ' LEU . 89.1 mt -145.45 125.36 7.05 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.266 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.18 166.38 16.98 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 121.108 1.205 . . . . 0.0 111.756 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.97 150.24 84.96 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 121.78 1.653 . . . . 0.0 111.07 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 139.32 -140.62 11.03 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.188 -1.482 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.528 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 19.2 tt0 -147.55 159.46 43.72 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.791 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 53.5 m-85 -141.71 155.41 45.65 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.842 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.2 p -100.61 175.42 5.67 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.66 -0.816 . . . . 0.0 112.29 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.71 41.01 0.15 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.667 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.415 ' N ' ' OE2' ' A' ' 119' ' ' GLU . . . -154.32 -52.93 0.1 Allowed 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.273 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 118' ' ' LEU . 5.1 tp10 -71.83 -52.11 19.1 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.043 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.571 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -36.17 -72.09 0.06 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.435 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.695 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 1.2 pm0 -52.99 -54.93 27.82 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.728 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.419 ' H ' ' HG2' ' A' ' 119' ' ' GLU . 3.4 mpt_? -74.31 15.56 0.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.173 -1.011 . . . . 0.0 112.516 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.401 ' O ' ' CG ' ' A' ' 121' ' ' TYR . 41.0 t80 -121.1 -17.85 7.64 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.536 -0.865 . . . . 0.0 111.476 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.537 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -142.94 -40.61 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 C-N-CA 118.632 -1.747 . . . . 0.0 111.44 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.623 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -139.01 -105.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.54 -179.867 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.538 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 19.1 t70 -162.61 -172.96 3.32 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.609 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.538 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 15.9 t-20 -59.09 -2.32 0.25 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.218 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 127' ' ' THR . 28.2 p30 -172.25 -134.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.754 -1.178 . . . . 0.0 111.948 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.55 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 9.1 t 41.0 33.98 0.25 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.877 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.484 ' C ' ' OG ' ' A' ' 129' ' ' SER . 3.0 mt -88.06 -75.75 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.122 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.484 ' OG ' ' C ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 77.22 -142.39 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 179.784 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.6 m -37.09 128.42 0.92 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.277 -1.329 . . . . 0.0 113.646 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.8 t -122.18 147.43 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.156 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -145.72 98.99 4.45 Favored Pre-proline 0 C--N 1.3 -1.549 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.125 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.02 110.13 1.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.044 1.163 . . . . 0.0 111.519 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.544 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 61.1 tp60 -57.95 -21.32 43.57 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.423 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.57 -36.32 0.03 OUTLIER Glycine 0 N--CA 1.495 2.602 0 C-N-CA 118.516 -1.802 . . . . 0.0 112.103 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.415 HD21 ' HG2' ' A' ' 91' ' ' PRO . 1.8 mt -92.11 -171.46 2.84 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.704 -1.198 . . . . 0.0 110.968 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.1 146.31 35.65 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.1 t -111.86 141.76 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 119.409 -0.916 . . . . 0.0 112.86 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.465 HG12 ' CE1' ' A' ' 141' ' ' PHE . 91.1 t -133.14 123.57 47.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.1 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 140' ' ' LEU . 5.2 mp -105.23 144.6 31.79 Favored 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 118.838 -1.145 . . . . 0.0 113.598 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.465 ' CE1' HG12 ' A' ' 139' ' ' VAL . 14.9 m-85 -120.14 132.51 55.43 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.047 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -73.91 -55.26 6.4 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.57 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -74.58 -158.52 0.07 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.872 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 145' ' ' ASN . 17.8 t70 -64.49 -147.03 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.2 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.559 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 6.0 m-80 -51.59 88.57 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.559 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 8.1 p90 38.44 68.34 0.34 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.946 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 81.1 p -132.95 43.37 2.97 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.971 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -178.8 -155.53 14.88 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -65.73 152.88 43.26 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.234 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 22.5 p -149.83 163.1 38.91 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.806 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.25 97.91 14.46 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.275 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -70.55 109.93 2.59 Favored 'Trans proline' 0 C--N 1.325 -0.664 0 C-N-CA 121.536 1.491 . . . . 0.0 112.087 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' A' ' 155' ' ' SER . 3.3 t -89.02 74.73 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.504 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.73 31.07 0.08 Allowed 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.055 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 153' ' ' VAL . 10.5 t -170.31 -153.42 0.1 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.595 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -90.47 164.04 14.41 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.739 -0.785 . . . . 0.0 111.481 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.532 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -167.65 73.13 0.95 Allowed Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.784 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.8 23.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.07 1.846 . . . . 0.0 112.891 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -178.48 79.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.731 179.89 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.456 ' C ' ' H ' ' A' ' 162' ' ' ALA . 17.2 tp -70.71 -45.18 65.4 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.193 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.63 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 73.52 -10.09 7.08 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.151 -1.5 . . . . 0.0 109.64 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 161' ' ' GLY . . . 70.16 110.27 0.06 Allowed 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.047 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.418 ' N ' ' SD ' ' A' ' 163' ' ' MET . 0.0 OUTLIER -74.6 -58.6 3.18 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.604 179.951 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.574 HD22 ' C ' ' A' ' 164' ' ' ASN . 0.4 OUTLIER -86.8 -156.19 0.31 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.503 -179.977 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.408 ' ND2' ' OD1' ' A' ' 166' ' ' ASN . 19.2 p-10 -73.27 -37.25 66.35 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.339 -0.945 . . . . 0.0 111.006 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.494 ' N ' HD22 ' A' ' 164' ' ' ASN . 41.8 p-10 -171.25 169.73 6.27 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.18 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.21 126.21 42.26 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.422 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.0 m -99.09 -73.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.635 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 4.0 p -112.01 158.69 19.24 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.203 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.429 HG12 ' CD1' ' A' ' 118' ' ' LEU . 16.3 pt -139.81 170.56 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.748 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -147.95 109.0 4.25 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.97 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.2 mt -88.88 94.73 4.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.957 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 116.356 -1.783 . . . . 0.0 111.069 -179.966 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.0 mtm . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.885 0.374 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.623 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -82.95 166.74 18.6 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.849 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -178.57 127.39 0.11 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.61 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.449 HD11 HD12 ' A' ' 19' ' ' LEU . 2.0 pp -81.24 147.65 6.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.331 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 1.085 HG21 ' NE2' ' A' ' 16' ' ' GLN . 22.6 m -128.64 139.15 52.4 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.515 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.13 173.69 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.821 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.47 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 52.7 m-85 -132.63 154.74 49.78 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.385 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -79.4 -19.17 50.72 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.023 1.119 . . . . 0.0 114.023 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.493 ' C ' ' OG ' ' A' ' 40' ' ' SER . 5.7 m120 -136.26 170.89 15.3 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.587 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.36 175.64 4.55 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.22 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 13' ' ' GLN . 6.9 t0 52.63 49.12 21.06 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.122 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.516 ' CE2' ' HG2' ' A' ' 70' ' ' GLU . 16.4 m-85 53.52 -4.25 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.745 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.554 ' H ' ' C ' ' A' ' 11' ' ' ASP . 29.4 mt-30 -75.58 169.05 18.86 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.613 -1.235 . . . . 0.0 111.24 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.6 134.13 5.73 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.495 -1.336 . . . . 0.0 110.498 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.604 ' NZ ' ' CB ' ' A' ' 15' ' ' LYS . 7.1 mtmp? -43.59 157.01 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.027 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 1.085 ' NE2' HG21 ' A' ' 5' ' ' THR . 0.0 OUTLIER -122.38 167.76 12.9 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.447 -0.901 . . . . 0.0 112.821 -179.79 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -145.06 130.35 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.675 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.37 118.09 30.88 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.38 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.449 HD12 HD11 ' A' ' 4' ' ' ILE . 5.9 mt -112.67 139.78 23.15 Favored Pre-proline 0 N--CA 1.49 1.562 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.218 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -70.42 164.43 35.21 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 120.892 1.061 . . . . 0.0 111.075 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -163.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.037 0 C-N-CA 121.715 1.61 . . . . 0.0 110.723 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.24 176.12 50.59 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.779 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.804 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.4 OUTLIER -108.57 145.11 35.33 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.655 -179.885 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.603 ' CE2' HD12 ' A' ' 82' ' ' ILE . 2.6 p90 -159.03 -173.54 4.29 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.152 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 p -146.53 -162.46 1.53 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.067 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.432 ' HG2' ' H ' ' A' ' 26' ' ' ARG . 7.3 ptp180 -62.67 -17.82 61.25 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.577 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -66.06 -62.86 1.26 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.258 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.549 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 36.1 tt0 -56.06 -42.41 76.59 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.114 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.576 HD23 HD12 ' A' ' 32' ' ' LEU . 68.9 mt -60.26 -39.86 88.27 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.454 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -49.56 -33.0 13.79 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 118.586 -1.246 . . . . 0.0 107.887 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -68.72 -39.43 80.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.151 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.576 HD12 HD23 ' A' ' 29' ' ' LEU . 17.7 mt -74.88 -75.59 0.16 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.771 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.53 -24.87 0.66 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 118.801 -1.666 . . . . 0.0 111.471 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.533 HD13 ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -85.04 149.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.405 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.567 ' O ' HG23 ' A' ' 38' ' ' THR . 6.0 pt-20 176.95 151.87 0.18 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.473 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.496 ' CG ' ' C ' ' A' ' 35' ' ' GLU . 0.6 OUTLIER 80.37 -144.5 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 179.754 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -67.5 29.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.249 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 35' ' ' GLU . 80.6 p -87.01 -43.87 12.01 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.44 -1.304 . . . . 0.0 110.626 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.404 HD12 ' CG1' ' A' ' 79' ' ' VAL . 9.2 mt -60.05 78.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.779 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.558 ' N ' ' O ' ' A' ' 38' ' ' THR . 19.0 t -77.5 -69.65 0.52 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.967 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.47 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -104.49 170.2 8.03 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.486 179.862 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.2 t -147.49 146.92 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 118.498 -1.281 . . . . 0.0 112.895 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -132.62 117.69 18.24 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.168 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.689 ' H ' HD22 ' A' ' 68' ' ' ASN . 72.3 t -140.5 109.14 6.71 Favored Pre-proline 0 N--CA 1.495 1.801 0 C-N-CA 119.318 -0.953 . . . . 0.0 112.083 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.413 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 1.0 OUTLIER -69.67 170.94 15.3 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.404 1.403 . . . . 0.0 111.711 179.977 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.8 Cg_endo -62.69 -176.84 0.27 Allowed 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 122.263 1.975 . . . . 0.0 111.214 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.93 -12.25 18.2 Favored Glycine 0 N--CA 1.482 1.729 0 C-N-CA 119.189 -1.481 . . . . 0.0 110.563 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.623 HG11 ' CB ' ' A' ' 2' ' ' ALA . 18.1 m -149.27 131.72 6.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.799 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -105.85 136.78 44.87 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.125 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -117.87 151.98 36.3 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.351 -0.94 . . . . 0.0 112.627 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.527 ' C ' HD12 ' A' ' 52' ' ' LEU . 97.1 mt -138.49 119.38 16.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 114.57 -1.196 . . . . 0.0 108.523 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.893 HD12 ' N ' ' A' ' 52' ' ' LEU . 2.7 mp -91.97 161.85 14.63 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.535 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -142.75 108.95 5.24 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.785 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -48.17 -85.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.38 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.514 HD22 ' H ' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -59.47 150.2 27.41 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.421 -0.911 . . . . 0.0 111.225 -179.97 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.514 ' H ' HD22 ' A' ' 55' ' ' ASN . 20.6 p-10 -62.1 178.78 0.34 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.465 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.4 24.8 71.0 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.113 -1.518 . . . . 0.0 110.106 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 54.65 63.89 2.0 Allowed 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.72 -161.19 1.27 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.015 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.58 169.46 1.4 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.087 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -43.68 119.1 1.57 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.476 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -97.86 172.18 7.82 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.279 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.525 HD12 HD22 ' A' ' 52' ' ' LEU . 3.4 mt -142.31 164.31 17.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.601 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -141.86 130.7 22.97 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.796 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -147.66 159.18 8.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 118.758 -1.177 . . . . 0.0 112.43 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.31 -5.05 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.179 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -124.64 -147.58 0.37 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.534 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.689 HD22 ' H ' ' A' ' 44' ' ' VAL . 8.4 m120 -101.63 113.6 26.89 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.02 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.556 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -92.01 100.6 13.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.139 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.516 ' HG2' ' CE2' ' A' ' 12' ' ' PHE . 17.5 mt-10 -66.58 -86.34 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.773 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.437 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 28.3 tp10 -57.9 -16.11 10.9 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.533 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 71' ' ' GLU . 4.6 tp 73.39 -83.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.528 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.58 -169.76 42.87 Favored Glycine 0 N--CA 1.5 2.901 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.552 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.8 Cg_endo -66.41 -47.78 2.88 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.385 2.056 . . . . 0.0 112.308 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.964 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.1 pt? -71.54 29.45 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.951 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.562 HD22 ' C ' ' A' ' 76' ' ' ASN . 0.5 OUTLIER -82.64 55.63 3.05 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.902 179.951 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -145.92 1.48 0.88 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -171.76 115.55 0.37 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.249 -0.981 . . . . 0.0 111.012 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.404 ' CG1' HD12 ' A' ' 39' ' ' ILE . 2.2 t -139.14 156.12 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.463 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.5 t -166.41 -41.14 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 118.952 -1.099 . . . . 0.0 112.152 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 m -99.77 144.29 29.0 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.304 -0.959 . . . . 0.0 111.349 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.603 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -149.23 163.47 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.779 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.86 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -146.89 113.99 6.2 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.834 -179.972 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.86 ' H ' HH22 ' A' ' 83' ' ' ARG . 45.0 t -121.33 138.46 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.701 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.66 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 2.3 mt -143.43 132.43 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.269 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.6 m -40.17 153.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.917 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -149.24 149.88 30.43 Favored Pre-proline 0 N--CA 1.482 1.155 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.805 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.18 153.12 28.03 Favored 'Trans proline' 0 C--N 1.324 -0.732 0 C-N-CA 121.251 1.3 . . . . 0.0 111.354 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.14 134.73 27.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.776 -0.77 . . . . 0.0 111.236 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -145.25 126.12 7.47 Favored Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.366 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.62 -177.35 0.08 OUTLIER 'Trans proline' 0 C--O 1.212 -0.812 0 C-N-CA 120.851 1.034 . . . . 0.0 111.119 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.75 -160.33 0.69 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.713 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.49 161.23 27.58 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.157 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -119.42 147.94 43.8 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.981 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -134.75 136.63 42.78 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.564 -1.198 . . . . 0.0 107.889 179.813 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.498 ' CE2' ' OE2' ' A' ' 105' ' ' GLU . 18.3 m-85 -100.89 164.67 11.72 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 118.991 -1.084 . . . . 0.0 112.463 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.62 -56.88 3.59 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.421 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -93.34 167.0 12.02 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.043 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -87.98 68.33 9.19 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.563 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.656 ' C ' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -175.59 49.56 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.555 -179.946 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.656 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 26.2 p90 39.58 40.31 0.61 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.644 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 20.9 p-10 -142.63 174.76 10.35 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.259 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 85.71 141.24 5.83 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.163 -1.494 . . . . 0.0 110.002 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 103' ' ' GLY . 11.9 tptt -28.49 123.15 0.12 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 124.016 0.48 . . . . 0.0 111.76 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.498 ' OE2' ' CE2' ' A' ' 96' ' ' PHE . 43.8 mt-10 -94.41 115.18 27.33 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.11 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.705 HG21 ' O ' ' A' ' 122' ' ' GLY . 3.6 t -96.17 143.76 11.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.592 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -123.92 156.58 36.07 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.88 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.2 mt -143.4 137.96 15.08 Favored Pre-proline 0 N--CA 1.488 1.469 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.896 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -67.77 165.56 27.32 Favored 'Trans proline' 0 C--O 1.213 -0.762 0 C-N-CA 121.732 1.621 . . . . 0.0 112.018 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.69 153.11 51.57 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 C-N-CA 122.171 1.914 . . . . 0.0 111.599 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.97 -159.3 21.14 Favored Glycine 0 N--CA 1.503 3.107 0 C-N-CA 119.35 -1.405 . . . . 0.0 111.42 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.538 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 24.8 mt-30 -123.65 157.18 34.41 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.196 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 27.8 m-85 -138.43 143.92 39.91 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.156 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.2 p -91.37 176.25 6.63 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.838 -0.745 . . . . 0.0 112.604 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.408 ' C ' ' OE2' ' A' ' 119' ' ' GLU . 39.0 tt0 -77.72 46.01 0.53 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.543 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -146.76 -64.17 0.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.073 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 121' ' ' TYR . 6.6 pt-20 -71.16 -49.1 47.42 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.927 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.553 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -31.9 -70.33 0.07 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.424 -179.999 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.697 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -58.18 -55.98 28.0 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.63 179.956 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.499 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.8 OUTLIER -75.1 21.27 0.12 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.526 -0.869 . . . . 0.0 111.806 -179.876 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' A' ' 117' ' ' GLU . 30.0 t80 -128.75 -15.95 4.3 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.206 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.705 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -143.87 -39.36 0.06 OUTLIER Glycine 0 N--CA 1.491 2.331 0 C-N-CA 118.742 -1.694 . . . . 0.0 111.09 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.557 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -144.57 -104.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.5 -179.968 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.557 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 0.3 OUTLIER -162.51 -169.81 2.23 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.013 179.931 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -88.8 36.37 0.8 Allowed 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.008 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.53 ' O ' ' N ' ' A' ' 128' ' ' ILE . 63.2 t30 -172.33 -74.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 118.702 -1.199 . . . . 0.0 112.418 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -40.62 85.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' A' ' 126' ' ' ASN . 42.3 mt -158.43 143.33 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.657 179.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.9 m -159.51 -119.84 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.267 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.3 m -38.5 128.11 1.45 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.014 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -122.22 154.48 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.714 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -147.59 100.68 3.76 Favored Pre-proline 0 C--N 1.302 -1.467 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.369 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -54.4 94.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 120.976 1.118 . . . . 0.0 110.461 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -57.65 -15.87 8.93 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.307 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.34 -25.6 0.05 OUTLIER Glycine 0 N--CA 1.488 2.131 0 C-N-CA 118.747 -1.692 . . . . 0.0 111.461 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 mt -120.87 148.28 44.26 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.539 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -66.38 161.96 21.42 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.496 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 40.4 t -131.39 147.83 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.482 -0.887 . . . . 0.0 112.259 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.592 HG12 ' CE1' ' A' ' 141' ' ' PHE . 76.2 t -138.82 124.02 22.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.442 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.9 mp -104.34 142.17 35.03 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 119.642 -0.823 . . . . 0.0 112.755 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.592 ' CE1' HG12 ' A' ' 139' ' ' VAL . 18.6 m-85 -120.68 135.06 55.23 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.621 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -72.63 -47.2 49.62 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.527 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.556 ' CG ' ' H ' ' A' ' 144' ' ' ASP . 5.1 t-20 -83.22 -157.33 0.23 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.703 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.556 ' H ' ' CG ' ' A' ' 143' ' ' ASN . 1.0 OUTLIER -69.25 -140.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.927 -179.924 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.604 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 6.0 m120 -52.67 86.09 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.053 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.604 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 6.2 p90 38.73 68.96 0.3 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.953 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 p -136.24 60.05 1.69 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.733 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 160.04 -151.68 22.38 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.134 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -59.41 156.81 12.22 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.336 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.5 p -149.01 170.14 19.03 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.754 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.507 ' C ' HD23 ' A' ' 151' ' ' LEU . 3.2 tt -144.24 83.04 10.32 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.449 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.85 105.92 0.71 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 121.999 1.799 . . . . 0.0 113.207 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 38.5 t -82.32 89.97 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.136 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.61 HD22 ' N ' ' A' ' 154' ' ' ASN . 0.0 OUTLIER -68.66 -7.48 33.6 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -179.831 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.555 ' N ' HD22 ' A' ' 154' ' ' ASN . 21.0 t -169.62 -135.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 117.666 -1.614 . . . . 0.0 113.293 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.462 ' N ' ' OG ' ' A' ' 155' ' ' SER . 23.7 m-20 -77.18 152.72 34.68 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.987 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -167.86 67.14 0.79 Allowed Pre-proline 0 C--N 1.307 -1.247 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.035 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.4 Cg_endo -62.72 20.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.231 1.954 . . . . 0.0 112.847 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.551 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -175.32 83.62 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.755 -1.178 . . . . 0.0 110.953 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 30.2 tp -98.78 -47.66 5.23 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.297 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 56.03 -165.15 4.5 Favored Glycine 0 N--CA 1.484 1.875 0 C-N-CA 119.212 -1.471 . . . . 0.0 110.043 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.49 105.13 12.42 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.214 -0.995 . . . . 0.0 110.861 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 3.4 mmt -90.27 -77.47 0.4 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.186 -1.005 . . . . 0.0 109.491 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -91.71 -43.8 9.37 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.264 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -177.07 -161.81 0.07 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.328 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -77.13 172.05 13.86 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.374 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.5 m -103.26 150.82 23.36 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.745 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.9 p -124.44 -68.04 0.88 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.157 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.408 ' OG ' ' HB2' ' A' ' 141' ' ' PHE . 77.3 p -116.33 153.19 32.43 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.611 -0.835 . . . . 0.0 108.819 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 19.2 pt -137.04 175.52 9.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.717 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -155.65 103.97 2.32 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.227 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.3 mt -78.23 103.38 5.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.791 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.0 t . . . . . 0 C--N 1.305 -1.349 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.777 -179.898 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.896 0.379 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.555 ' C ' HD22 ' A' ' 3' ' ' ASN . . . -95.21 175.21 6.69 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.822 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.555 HD22 ' C ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER -175.04 118.32 0.18 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.365 -179.97 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 4' ' ' ILE . 24.5 pt -69.27 145.8 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.684 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.427 HG23 ' NE2' ' A' ' 16' ' ' GLN . 3.5 m -121.56 112.87 19.01 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.003 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 m -91.12 175.47 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.238 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.544 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 23.9 m-85 -132.24 151.18 51.94 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.449 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.17 -6.77 59.27 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 118.824 -1.15 . . . . 0.0 113.289 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.52 ' C ' ' OG ' ' A' ' 40' ' ' SER . 34.1 m120 -147.13 161.85 40.04 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.646 -1.222 . . . . 0.0 111.536 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.449 ' N ' ' OG ' ' A' ' 40' ' ' SER . 26.2 mt-10 -70.85 179.02 2.84 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.394 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.9 t70 59.37 39.33 22.32 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.402 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.6 t80 57.48 5.45 0.3 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.272 -0.971 . . . . 0.0 111.792 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.465 ' HG2' ' H ' ' A' ' 14' ' ' GLY . 6.7 tt0 -92.45 176.66 6.39 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.291 -0.963 . . . . 0.0 111.217 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.465 ' H ' ' HG2' ' A' ' 13' ' ' GLN . . . 88.47 131.43 3.84 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.993 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -42.78 157.64 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.572 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.438 HE21 ' N ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -121.23 166.96 13.24 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.461 -0.895 . . . . 0.0 112.545 -179.758 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.438 ' N ' HE21 ' A' ' 16' ' ' GLN . 58.6 t -143.86 135.41 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.929 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -94.1 113.28 25.21 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.419 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.8 mt -107.35 137.68 19.69 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.572 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -71.15 155.76 60.64 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 121.072 1.181 . . . . 0.0 110.972 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.44 -161.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 121.576 1.517 . . . . 0.0 110.533 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.54 178.45 49.43 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 119.175 -1.488 . . . . 0.0 111.038 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.788 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.5 OUTLIER -103.11 134.3 46.77 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.671 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 7.4 p90 -153.71 174.77 14.08 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.143 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.5 p -145.67 -154.21 0.53 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.98 -179.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.837 HH11 ' HB2' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -62.72 -30.92 71.77 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.973 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -59.98 -61.77 2.36 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.95 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.506 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.9 tp60 -56.47 -47.4 79.28 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.502 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.679 HD23 HD12 ' A' ' 32' ' ' LEU . 20.2 mt -54.98 -39.48 69.03 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.528 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.837 ' HB2' HH11 ' A' ' 26' ' ' ARG . . . -51.68 -34.2 37.34 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 118.948 -1.101 . . . . 0.0 108.359 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -66.77 -39.49 87.87 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.696 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.679 HD12 HD23 ' A' ' 29' ' ' LEU . 10.3 mt -74.8 -75.07 0.17 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.617 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.59 -34.91 0.54 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.094 -1.526 . . . . 0.0 110.909 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.444 HG21 HD13 ' A' ' 34' ' ' ILE . 8.5 tt -79.89 150.76 4.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.735 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 179.92 150.74 0.38 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.605 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.69 -146.8 0.14 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.913 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -55.33 92.62 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.998 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 40' ' ' SER . 73.1 p -153.18 -46.97 0.1 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.106 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.406 HD12 HG11 ' A' ' 79' ' ' VAL . 7.3 mt -61.86 75.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 C-N-CA 119.661 -0.815 . . . . 0.0 109.764 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.549 ' O ' HD22 ' A' ' 72' ' ' LEU . 8.6 t -74.21 -59.74 2.59 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.429 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.544 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -116.81 177.29 4.76 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.709 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -156.43 152.64 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 117.549 -1.66 . . . . 0.0 113.486 -179.896 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -140.17 106.97 5.38 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.595 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -126.08 108.21 24.71 Favored Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.598 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.419 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -69.81 171.04 15.25 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.042 1.162 . . . . 0.0 110.549 179.86 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 1.9 Cg_endo -62.39 -170.87 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.841 1.694 . . . . 0.0 110.91 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.9 -14.61 12.97 Favored Glycine 0 N--CA 1.478 1.468 0 C-N-CA 119.024 -1.56 . . . . 0.0 111.005 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.543 HG11 ' HB3' ' A' ' 2' ' ' ALA . 0.5 OUTLIER -151.66 131.72 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 118.716 -1.194 . . . . 0.0 112.588 -179.832 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.445 ' HA ' HG13 ' A' ' 66' ' ' VAL . 57.7 tttt -101.73 130.8 48.21 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.35 158.09 20.22 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.025 -1.07 . . . . 0.0 113.519 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.545 HD12 ' NH1' ' A' ' 83' ' ' ARG . 33.6 mt -144.71 116.24 2.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.242 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.546 ' HA ' HG23 ' A' ' 82' ' ' ILE . 2.7 mp -94.42 159.46 15.1 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.167 -1.013 . . . . 0.0 113.368 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.488 ' CE1' HG22 ' A' ' 51' ' ' ILE . 83.2 m-85 -139.33 114.77 9.82 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.111 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -44.61 -87.05 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.459 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -59.45 151.02 24.98 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.338 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -58.99 -178.99 0.06 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.169 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.666 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 55.61 37.31 67.31 Favored Glycine 0 N--CA 1.484 1.853 0 C-N-CA 118.906 -1.616 . . . . 0.0 109.437 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.771 ' H ' ' CB ' ' A' ' 81' ' ' SER . 0.3 OUTLIER 41.1 69.08 0.37 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.838 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.02 174.39 10.63 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.767 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.71 173.61 40.64 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.236 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -48.46 122.28 5.29 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 118.999 -1.081 . . . . 0.0 110.352 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.401 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 1.9 pt20 -99.05 173.32 6.88 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.93 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.878 HD11 HD11 ' A' ' 75' ' ' LEU . 7.3 mt -138.66 169.93 17.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.711 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.517 ' H ' HG22 ' A' ' 63' ' ' ILE . 22.0 mt-10 -147.21 130.88 16.9 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.394 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.64 164.74 2.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 118.661 -1.216 . . . . 0.0 112.441 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.622 HG12 ' NH2' ' A' ' 92' ' ' ARG . 0.5 OUTLIER -146.67 -9.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.658 179.856 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -118.01 -153.21 0.52 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.837 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -95.48 120.7 36.18 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.637 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.573 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.73 108.37 19.65 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.174 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 8.2 tp10 -73.62 -76.78 0.12 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.95 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.464 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 23.1 tp10 -76.86 2.02 15.8 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.038 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.549 HD22 ' O ' ' A' ' 40' ' ' SER . 10.1 tp 51.83 -97.55 0.06 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.111 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.465 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -174.5 -173.83 40.77 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 118.937 -1.601 . . . . 0.0 110.979 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.629 ' C ' ' H ' ' A' ' 76' ' ' ASN . 3.8 Cg_endo -71.86 -53.8 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.649 2.233 . . . . 0.0 112.306 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.878 HD11 HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -60.82 14.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.775 -179.853 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.629 ' H ' ' C ' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -67.51 0.81 2.74 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.453 179.943 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 75' ' ' LEU . 25.8 t-20 -80.82 -8.77 59.79 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.091 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -164.75 122.54 1.66 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.596 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.406 HG11 HD12 ' A' ' 39' ' ' ILE . 2.8 t -148.33 137.47 15.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.72 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.5 p -145.11 -47.4 0.23 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.65 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.771 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 7.4 m -93.61 142.76 26.98 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.334 -179.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.546 HG23 ' HA ' ' A' ' 52' ' ' LEU . 0.8 OUTLIER -147.98 160.38 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.01 -179.923 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.78 HH22 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.92 137.4 21.09 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.151 180.0 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.78 ' CA ' HH22 ' A' ' 83' ' ' ARG . 5.4 t -140.74 143.87 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.7 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.494 HG12 ' NH2' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -135.71 135.13 51.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.125 -179.928 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.1 t -42.87 154.41 0.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.108 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.7 143.72 13.59 Favored Pre-proline 0 C--N 1.307 -1.27 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.118 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.54 130.12 28.83 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.091 1.194 . . . . 0.0 110.73 179.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.3 p -59.48 140.24 17.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -117.33 152.44 49.25 Favored Pre-proline 0 N--CA 1.49 1.57 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.25 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.442 ' HG2' HD21 ' A' ' 136' ' ' LEU . 2.5 Cg_endo -59.33 -34.27 97.74 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.287 1.324 . . . . 0.0 111.207 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.622 ' NH2' HG12 ' A' ' 66' ' ' VAL . 22.3 mtt180 52.15 -161.96 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.359 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.572 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.1 175.86 9.42 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.867 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.51 ' NH2' HE22 ' A' ' 134' ' ' GLN . 28.3 ttm180 -143.68 120.15 11.01 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.45 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.42 ' CD1' HG13 ' A' ' 131' ' ' VAL . 6.7 m-30 -95.77 164.54 12.71 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.028 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.638 ' CD1' ' CE1' ' A' ' 101' ' ' PHE . 2.8 m-85 -143.41 149.06 37.12 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.468 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.576 ' N ' ' CD1' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -93.68 160.43 14.77 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.597 -179.895 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.423 ' C ' ' OG ' ' A' ' 129' ' ' SER . 10.3 tttm 67.19 136.52 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.004 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.532 ' N ' ' OG ' ' A' ' 129' ' ' SER . 5.1 pt-20 -77.27 70.99 3.73 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.626 -1.23 . . . . 0.0 111.003 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.642 ' NE2' ' OD2' ' A' ' 102' ' ' ASP . 6.3 tt0 -173.67 19.02 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.515 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.638 ' CE1' ' CD1' ' A' ' 96' ' ' PHE . 33.8 t80 49.34 40.35 18.27 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.424 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.642 ' OD2' ' NE2' ' A' ' 100' ' ' GLN . 90.3 m-20 -104.09 -87.22 0.44 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.543 -0.863 . . . . 0.0 112.556 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 102' ' ' ASP . . . -30.68 145.88 0.01 OUTLIER Glycine 0 N--CA 1.507 3.402 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.917 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -34.72 155.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 114.587 -0.807 . . . . 0.0 112.998 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.492 ' HB3' ' CE1' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -116.4 164.74 14.1 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.411 -179.849 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.65 141.16 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -102.53 157.69 16.75 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.965 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 108' ' ' LEU . 88.8 mt -144.27 140.01 16.37 Favored Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.964 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -72.86 164.39 35.71 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 121.756 1.637 . . . . 0.0 111.825 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.5 143.79 70.52 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.603 1.535 . . . . 0.0 110.72 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.9 -160.78 27.52 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 118.795 -1.669 . . . . 0.0 111.573 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.561 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 29.3 tt0 -117.63 158.13 25.19 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.216 -0.492 . . . . 0.0 111.038 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.561 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 56.0 m-85 -145.52 151.47 38.22 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.765 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.4 p -103.02 -168.24 1.49 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.322 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.47 ' CG ' ' OG ' ' A' ' 168' ' ' SER . 6.6 tt0 -92.23 49.64 1.54 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.146 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -151.19 -63.51 0.19 Allowed 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.744 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -70.2 -54.07 14.39 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.326 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.558 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -30.82 -69.34 0.07 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.012 -179.99 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.713 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 21.2 mp0 -54.92 -59.29 4.94 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.173 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.42 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 12.3 mpt_? -74.73 19.54 0.14 Allowed 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.71 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.543 ' N ' ' O ' ' A' ' 117' ' ' GLU . 16.1 t80 -121.22 -15.4 8.17 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.881 -0.727 . . . . 0.0 110.773 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.07 -37.19 0.05 OUTLIER Glycine 0 N--CA 1.483 1.817 0 C-N-CA 118.928 -1.606 . . . . 0.0 110.337 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.473 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -146.01 -112.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.527 -179.843 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -151.98 -147.3 0.22 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.275 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.738 HD22 ' N ' ' A' ' 126' ' ' ASN . 0.2 OUTLIER -73.81 -108.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.52 179.935 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.738 ' N ' HD22 ' A' ' 125' ' ' ASN . 23.7 t-20 -80.2 55.17 2.13 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.074 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.601 ' O ' HG22 ' A' ' 127' ' ' THR . 18.7 m -100.58 4.58 43.53 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.482 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.42 HG12 ' H ' ' A' ' 128' ' ' ILE . 2.3 mm -76.73 161.81 4.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.665 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 99' ' ' GLU . 2.4 t -161.91 -47.98 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.1 m -137.34 134.98 36.63 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.149 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.42 HG13 ' CD1' ' A' ' 95' ' ' PHE . 3.0 t -120.7 145.31 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.572 0.701 . . . . 0.0 111.855 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -146.18 93.56 5.06 Favored Pre-proline 0 C--N 1.296 -1.753 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.986 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -59.15 105.71 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.164 1.243 . . . . 0.0 111.877 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.572 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 8.2 tt0 -56.52 -9.52 0.75 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.568 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.44 -41.93 0.08 OUTLIER Glycine 0 N--CA 1.494 2.536 0 C-N-CA 118.49 -1.814 . . . . 0.0 111.933 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.442 HD21 ' HG2' ' A' ' 91' ' ' PRO . 4.9 mt -88.05 -167.12 1.78 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.105 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -115.79 142.64 46.5 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 153' ' ' VAL . 53.6 t -107.75 144.91 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.696 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 88.1 t -132.62 120.61 42.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.033 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.8 mp -97.84 139.33 33.85 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.343 -179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.427 ' CD2' ' HB3' ' A' ' 146' ' ' PHE . 29.4 m-85 -115.48 129.23 56.48 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.689 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.455 ' HE3' ' H ' ' A' ' 149' ' ' ASP . 19.5 ttpp -61.44 -75.02 0.07 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.653 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -76.22 167.98 20.88 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.259 -0.977 . . . . 0.0 110.513 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 146' ' ' PHE . 1.4 p30 -63.48 -158.43 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.59 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.643 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 0.4 OUTLIER 39.33 26.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.248 179.953 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.643 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 41.87 57.89 3.02 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.343 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.0 t -136.45 -172.93 3.27 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.028 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.48 -161.94 53.49 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.169 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.455 ' H ' ' HE3' ' A' ' 142' ' ' LYS . 5.9 t70 -59.77 156.31 14.27 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.104 179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.5 p -148.16 170.39 17.95 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.476 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.7 mt -137.93 82.56 25.32 Favored Pre-proline 0 C--N 1.303 -1.419 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.463 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -62.13 103.93 0.32 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.848 1.699 . . . . 0.0 112.231 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 138' ' ' VAL . 3.1 t -89.34 74.1 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.883 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -79.22 36.29 0.29 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.001 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.6 t -170.97 -155.85 0.11 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.328 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.2 155.89 19.91 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.136 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.97 69.51 1.38 Allowed Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.526 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.4 Cg_endo -66.44 23.84 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.075 1.85 . . . . 0.0 111.313 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.597 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.3 t -168.76 134.34 1.7 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.412 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 129' ' ' SER . 0.2 OUTLIER -141.74 -55.57 0.46 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.949 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 79.06 -94.01 1.33 Allowed Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.106 -1.521 . . . . 0.0 110.154 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -171.47 96.15 0.18 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.254 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 32.6 mmt -90.04 -69.24 0.73 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.285 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.522 ' C ' ' CG ' ' A' ' 165' ' ' ASN . 24.2 m120 -87.23 38.73 0.83 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.23 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.566 ' O ' ' ND2' ' A' ' 166' ' ' ASN . 0.1 OUTLIER 42.98 88.79 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.347 -179.997 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.566 ' ND2' ' O ' ' A' ' 165' ' ' ASN . 0.1 OUTLIER 69.12 153.57 0.11 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.961 179.813 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.45 125.61 51.22 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.838 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.47 ' OG ' ' CG ' ' A' ' 115' ' ' GLN . 36.8 t -91.15 -62.03 1.53 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.223 -0.991 . . . . 0.0 112.09 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.49 161.0 19.78 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.819 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.406 HG12 ' CD1' ' A' ' 118' ' ' LEU . 45.7 pt -143.16 174.64 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.729 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.5 ttt85 -160.66 114.25 2.08 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.492 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 11.7 mt -86.87 101.41 11.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.466 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.5 t . . . . . 0 C--N 1.306 -1.307 0 CA-C-O 116.284 -1.817 . . . . 0.0 110.874 179.949 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttm . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 120.761 0.315 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.423 ' C ' ' ND2' ' A' ' 3' ' ' ASN . . . -86.74 123.67 32.15 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.028 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.423 ' ND2' ' C ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER 179.83 125.89 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.683 179.969 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 pt -82.04 128.02 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.06 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -105.69 112.25 25.25 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.2 m -90.11 169.5 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 119.591 -0.844 . . . . 0.0 113.206 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -129.14 141.61 51.13 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.407 -1.27 . . . . 0.0 108.196 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.17 -21.72 58.55 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -123.95 169.73 11.32 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.028 -1.069 . . . . 0.0 112.477 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 11' ' ' ASP . 25.4 tt0 -67.21 173.77 3.64 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.888 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.558 ' O ' ' CD1' ' A' ' 12' ' ' PHE . 14.5 m-20 52.01 58.2 5.69 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.774 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.563 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 7.3 p90 33.59 28.69 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.506 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 11' ' ' ASP . 8.7 tp-100 -106.55 168.44 9.17 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.92 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.52 ' H ' ' CD ' ' A' ' 13' ' ' GLN . . . 93.94 136.81 8.26 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.995 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -30.54 140.82 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 O-C-N 123.922 0.425 . . . . 0.0 111.712 -179.931 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 1.203 ' CD ' ' OE1' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -100.52 151.71 21.26 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.498 -0.881 . . . . 0.0 113.17 -179.802 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -135.9 142.99 37.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.822 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -107.79 133.71 51.79 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.659 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 mt -129.3 126.81 23.08 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.982 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -67.91 163.59 35.0 Favored 'Trans proline' 0 C--N 1.327 -0.599 0 C-N-CA 120.629 0.886 . . . . 0.0 110.961 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.05 -162.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.493 1.462 . . . . 0.0 111.06 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.23 172.94 37.11 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.073 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.633 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.9 OUTLIER -106.12 133.9 50.09 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.564 -179.947 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -155.24 177.12 11.71 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.394 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 p -137.88 -159.78 0.99 Allowed 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.85 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.86 -20.78 66.07 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.614 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -62.97 -58.9 5.78 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.216 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.489 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 28.6 tp60 -56.67 -45.2 81.84 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.007 -1.077 . . . . 0.0 109.738 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.64 HD23 HD12 ' A' ' 32' ' ' LEU . 13.7 mt -58.73 -39.09 79.88 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.567 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -53.15 -32.66 48.8 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.853 -1.139 . . . . 0.0 108.589 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -69.1 -42.31 76.3 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.095 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.64 HD12 HD23 ' A' ' 29' ' ' LEU . 10.3 mt -69.93 -71.39 0.24 Allowed 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.666 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.64 -34.67 0.81 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.117 -1.516 . . . . 0.0 110.923 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 34' ' ' ILE . 12.5 tt -83.32 141.62 14.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.27 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 175.82 154.96 0.19 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.031 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.1 t30 60.76 104.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.643 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.471 ' H ' HG22 ' A' ' 79' ' ' VAL . 66.5 t30 51.23 69.99 0.59 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.586 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 40' ' ' SER . 77.9 p -146.57 -32.23 0.33 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.339 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 40' ' ' SER . 8.9 mt -78.09 42.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.516 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 38' ' ' THR . 32.6 t -38.78 -53.73 1.65 Allowed 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.026 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.59 163.98 29.88 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.211 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.964 HG22 ' HB3' ' A' ' 69' ' ' ALA . 20.1 m -143.89 171.66 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 118.502 -1.279 . . . . 0.0 113.444 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -142.23 95.06 2.74 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.559 -1.655 . . . . 0.0 107.461 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 51.8 t -115.63 110.25 44.82 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -70.28 169.64 19.1 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.065 1.177 . . . . 0.0 110.311 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.85 -170.28 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.715 1.61 . . . . 0.0 111.207 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.86 -15.34 15.6 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.392 -1.385 . . . . 0.0 111.016 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -152.97 148.48 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.414 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -123.8 128.67 49.87 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.137 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.77 165.06 11.84 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.83 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.675 HG23 ' O ' ' A' ' 63' ' ' ILE . 66.7 mt -138.73 125.09 24.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.661 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.17 122.65 42.66 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.647 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -109.78 119.55 39.72 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.318 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -54.76 -77.01 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.144 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -62.28 156.16 22.94 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.0 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 19.2 p-10 -68.1 174.53 3.78 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.623 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.422 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 62.13 31.31 78.43 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.236 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.48 ' H ' ' CB ' ' A' ' 81' ' ' SER . 0.2 OUTLIER 54.2 67.18 1.05 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.619 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.42 -170.53 3.47 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.332 -0.947 . . . . 0.0 111.195 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 61' ' ' ASP . . . 67.43 174.52 7.28 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.377 -1.392 . . . . 0.0 109.858 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 60' ' ' GLY . 13.4 m-20 -42.98 118.67 1.32 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.136 -1.026 . . . . 0.0 110.33 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.412 ' CD ' ' H ' ' A' ' 62' ' ' GLN . 0.1 OUTLIER -91.36 160.8 15.3 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.259 -0.977 . . . . 0.0 111.33 -179.887 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.675 ' O ' HG23 ' A' ' 51' ' ' ILE . 7.2 mm -137.53 168.63 20.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.353 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.67 ' N ' HG22 ' A' ' 63' ' ' ILE . 20.2 mp0 -147.96 134.19 19.45 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.306 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.7 m -149.76 147.5 16.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 118.676 -1.21 . . . . 0.0 112.252 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 48' ' ' VAL . 2.0 t -140.77 -0.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.49 -153.85 0.59 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.686 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -93.49 144.05 25.72 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.437 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.964 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -111.17 108.98 18.83 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.732 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -78.29 -63.34 1.42 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.401 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -100.45 4.43 43.73 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.259 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.0 tp 46.18 -98.93 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.097 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -168.95 -177.24 39.63 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 118.778 -1.677 . . . . 0.0 110.842 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.583 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.0 OUTLIER -67.16 -46.02 3.4 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.169 1.913 . . . . 0.0 112.055 -179.983 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.728 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.4 pt? -56.72 3.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.403 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.643 HD22 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -65.04 5.79 0.31 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.403 179.945 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.643 ' N ' HD22 ' A' ' 76' ' ' ASN . 26.3 t30 -86.92 -11.01 51.93 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.725 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -166.15 98.94 0.63 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.665 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.471 HG22 ' H ' ' A' ' 37' ' ' ASN . 18.9 m -97.09 171.0 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.582 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.1 t -171.31 -69.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 118.348 -1.341 . . . . 0.0 112.901 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.48 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 4.4 m -96.99 148.64 22.77 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.72 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.68 153.05 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.311 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.809 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -145.91 140.42 26.96 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.753 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.809 ' CA ' HH12 ' A' ' 83' ' ' ARG . 10.1 t -138.82 140.45 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.99 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.549 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 2.8 mt -136.99 125.61 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.57 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -50.12 126.85 15.52 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.579 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.696 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -114.97 145.32 33.79 Favored Pre-proline 0 N--CA 1.49 1.545 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.302 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.696 ' HD2' HG22 ' A' ' 87' ' ' VAL . 5.8 Cg_exo -52.61 120.29 7.26 Favored 'Trans proline' 0 C--N 1.326 -0.618 0 C-N-CA 121.356 1.37 . . . . 0.0 111.354 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 89' ' ' VAL . 7.1 p -45.47 130.59 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.841 -179.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -139.35 150.21 63.28 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.394 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.438 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 1.7 Cg_endo -59.13 -166.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.106 1.204 . . . . 0.0 111.102 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.89 -157.56 0.1 Allowed 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.049 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.68 162.08 36.24 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.156 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -129.99 117.43 20.05 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.043 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 10.5 m-85 -102.85 131.11 49.97 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.116 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -99.42 159.99 14.61 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.848 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.524 ' CZ ' HG21 ' A' ' 127' ' ' THR . 1.0 OUTLIER -97.43 158.68 15.35 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.629 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt 62.47 138.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.815 0.816 . . . . 0.0 111.514 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.588 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 10.6 tp10 -71.12 102.44 2.49 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.605 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.854 ' NE2' ' HB2' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 129.67 39.25 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.467 0 O-C-N 125.286 1.616 . . . . 0.0 109.654 179.766 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.65 ' CD1' ' C ' ' A' ' 100' ' ' GLN . 28.5 p90 33.96 48.33 0.23 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.124 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.854 ' HB2' ' NE2' ' A' ' 100' ' ' GLN . 53.5 t0 -124.36 57.58 1.23 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.472 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -177.01 156.42 20.39 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.902 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.487 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -28.81 139.9 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.827 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -94.67 154.5 17.3 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.902 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.636 HG21 ' O ' ' A' ' 122' ' ' GLY . 2.5 t -140.31 165.67 20.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.888 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.553 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 17.7 p-10 -149.24 159.37 44.32 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.759 -1.176 . . . . 0.0 111.651 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.4 mt -142.07 149.08 51.07 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 119.639 -0.825 . . . . 0.0 111.23 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.41 165.93 24.79 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.044 1.829 . . . . 0.0 111.661 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.36 142.9 67.96 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.566 1.511 . . . . 0.0 110.687 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.422 ' C ' ' NE2' ' A' ' 112' ' ' GLN . . . 144.75 -158.72 27.66 Favored Glycine 0 N--CA 1.502 3.063 0 C-N-CA 118.787 -1.673 . . . . 0.0 111.711 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.541 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 11.2 mp0 -116.77 153.4 32.49 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.759 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 50.8 m-85 -145.84 146.68 31.22 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.633 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.9 p -89.47 -147.93 0.18 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.435 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.779 ' CD ' ' H ' ' A' ' 115' ' ' GLN . 0.3 OUTLIER -116.06 27.35 9.32 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.783 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.47 ' HB2' HE21 ' A' ' 115' ' ' GLN . . . -129.54 -64.56 0.88 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.762 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.495 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 8.1 pt-20 -68.67 -42.64 77.61 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.42 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.569 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -38.04 -72.65 0.06 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.77 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.438 ' HB3' ' C ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -52.55 -54.41 33.16 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.168 -179.969 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -72.93 16.66 0.14 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.432 -179.791 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 117' ' ' GLU . 13.9 t80 -124.49 -17.9 5.88 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.912 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.636 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -133.91 -49.75 0.08 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.114 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.533 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -144.99 -99.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.628 -179.934 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.533 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 13.3 t70 -168.73 177.69 4.99 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.172 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.638 HD22 ' N ' ' A' ' 126' ' ' ASN . 0.5 OUTLIER -59.15 135.14 57.54 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.701 -179.84 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.638 ' N ' HD22 ' A' ' 125' ' ' ASN . 5.7 p-10 35.85 81.28 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.812 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.524 HG21 ' CZ ' ' A' ' 97' ' ' TYR . 97.9 m -161.56 -11.0 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.394 -0.923 . . . . 0.0 111.012 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.477 ' CG2' HG22 ' A' ' 131' ' ' VAL . 1.5 mp -53.84 -56.32 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.256 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.9 m 55.35 -113.63 0.8 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.682 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.2 m -63.06 122.42 16.03 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.93 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.477 HG22 ' CG2' ' A' ' 128' ' ' ILE . 1.8 t -120.76 159.76 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.427 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -153.15 85.46 4.24 Favored Pre-proline 0 C--N 1.301 -1.518 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.135 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -62.42 97.06 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.416 1.41 . . . . 0.0 110.723 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -81.83 22.4 0.76 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.35 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.8 -54.44 0.04 OUTLIER Glycine 0 N--CA 1.498 2.778 0 C-N-CA 118.042 -2.027 . . . . 0.0 112.38 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.438 ' CD1' ' HB2' ' A' ' 91' ' ' PRO . 1.3 mp -115.87 -172.07 2.09 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.002 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.75 143.11 31.31 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.652 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.6 t -110.0 139.09 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.765 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.587 ' C ' HD12 ' A' ' 140' ' ' LEU . 59.6 t -125.97 138.02 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.036 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.587 HD12 ' C ' ' A' ' 139' ' ' VAL . 9.3 mp -112.26 134.5 53.76 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.926 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 141' ' ' PHE . 7.2 m-85 -115.0 131.92 56.77 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.78 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -64.21 -79.16 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.028 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -60.35 160.66 8.3 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.357 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 146' ' ' PHE . 10.0 m-20 -63.9 -156.19 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.554 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.686 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 6.3 t-20 41.13 24.44 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.017 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.686 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.1 OUTLIER 44.08 59.82 3.03 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.822 -179.946 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.6 t -141.83 -174.49 4.09 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.358 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.91 -163.22 54.2 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.591 -1.29 . . . . 0.0 110.025 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -59.81 160.47 7.52 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.952 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.0 p -150.34 174.73 12.54 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.809 -179.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 26.5 tp -141.78 89.45 9.04 Favored Pre-proline 0 C--N 1.307 -1.258 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.53 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.21 106.27 0.8 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 121.699 1.599 . . . . 0.0 113.23 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.98 92.42 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.285 -0.966 . . . . 0.0 109.537 179.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -55.79 -34.57 65.41 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.8 t -164.15 -149.82 0.14 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 117.907 -1.517 . . . . 0.0 112.665 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -43.72 146.51 0.54 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.31 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -172.45 69.15 0.41 Allowed Pre-proline 0 C--N 1.307 -1.244 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.343 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.442 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.2 Cg_endo -64.9 23.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.197 1.931 . . . . 0.0 112.481 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.569 ' O ' HG23 ' A' ' 159' ' ' THR . 0.8 OUTLIER -177.72 102.3 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.139 179.967 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.498 ' CD2' ' N ' ' A' ' 160' ' ' LEU . 3.7 mm? -99.37 -56.42 2.41 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.705 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 68.69 -171.66 37.42 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.375 -1.393 . . . . 0.0 110.53 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.39 137.93 57.81 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.994 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.607 ' CG ' ' H ' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -138.69 -80.55 0.33 Allowed 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.301 179.894 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.607 ' H ' ' CG ' ' A' ' 163' ' ' MET . 49.9 m-80 -90.75 -54.36 4.01 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.736 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -174.14 -67.23 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.847 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -163.13 141.55 8.2 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.812 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.528 ' OG1' HD23 ' A' ' 140' ' ' LEU . 1.5 m -86.31 107.84 18.15 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.826 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 27.5 m -95.33 -53.16 3.87 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.172 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.54 160.91 21.51 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.032 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.414 HG12 ' CD1' ' A' ' 118' ' ' LEU . 31.4 pt -138.96 166.51 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -148.75 103.36 3.37 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.591 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.0 mt -81.17 97.55 3.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 118.978 -1.089 . . . . 0.0 109.347 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 C--N 1.305 -1.343 0 CA-C-O 116.324 -1.798 . . . . 0.0 111.026 -179.993 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.594 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.8 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . 68.7 168.13 0.28 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.696 -0.801 . . . . 0.0 111.088 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.42 ' ND2' ' C ' ' A' ' 2' ' ' ALA . 31.3 m-80 -159.28 125.62 4.48 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.156 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.501 HG22 HG22 ' A' ' 44' ' ' VAL . 7.0 pt -72.01 155.17 7.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.513 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -134.0 156.5 48.08 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.067 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 m -147.26 171.41 3.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 119.086 -1.045 . . . . 0.0 111.062 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -131.97 156.15 46.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.744 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -72.17 -51.6 20.52 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -179.525 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.713 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 73.2 m-80 -87.22 179.23 6.67 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.842 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -80.31 166.05 21.71 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.189 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.471 ' C ' ' H ' ' A' ' 13' ' ' GLN . 3.7 t0 66.15 45.35 2.36 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.782 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER 56.71 0.7 0.07 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.128 -1.029 . . . . 0.0 112.075 179.893 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 11' ' ' ASP . 6.9 tt0 -87.97 162.96 16.57 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.199 -1.0 . . . . 0.0 112.287 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.713 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 98.06 147.67 22.62 Favored Glycine 0 N--CA 1.503 3.107 0 C-N-CA 120.259 -0.972 . . . . 0.0 110.926 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 14' ' ' GLY . 3.7 mptp? -29.26 139.0 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 O-C-N 123.956 0.445 . . . . 0.0 112.137 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 1.026 ' H ' ' NE2' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -103.92 160.19 15.02 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.459 -179.775 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.613 ' CG1' ' N ' ' A' ' 18' ' ' ASP . 6.9 t -147.53 165.69 5.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.62 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.613 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 14.9 t70 -135.49 124.6 24.41 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.268 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mt -122.85 129.92 24.82 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.017 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -67.35 165.31 27.38 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.123 1.216 . . . . 0.0 111.317 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.99 -165.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 121.542 1.494 . . . . 0.0 110.289 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.53 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 94.95 -175.22 33.57 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 118.836 -1.649 . . . . 0.0 111.176 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.809 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.2 OUTLIER -113.2 134.02 54.78 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.153 -179.795 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.565 ' CE2' HD12 ' A' ' 82' ' ' ILE . 3.4 p90 -154.54 175.89 13.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.673 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.475 HG22 ' OG ' ' A' ' 81' ' ' SER . 7.0 p -146.82 -155.43 0.62 Allowed 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.984 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -60.33 -20.92 61.22 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.692 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.96 -63.11 1.16 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.474 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.508 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 15.7 tt0 -56.02 -46.73 78.71 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.486 -1.286 . . . . 0.0 109.805 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.586 HD23 HD12 ' A' ' 32' ' ' LEU . 22.9 mt -59.4 -38.95 81.89 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.539 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.57 -26.92 56.57 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 118.328 -1.349 . . . . 0.0 108.419 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -75.41 -37.95 60.16 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.739 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.586 HD12 HD23 ' A' ' 29' ' ' LEU . 14.4 mt -73.34 -74.97 0.16 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.525 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.29 -32.82 0.65 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.248 -1.454 . . . . 0.0 110.692 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 34' ' ' ILE . 7.8 tt -85.26 139.42 17.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.909 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.59 ' H ' HG21 ' A' ' 38' ' ' THR . 3.4 pt-20 174.24 142.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.195 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.596 ' ND2' ' ND2' ' A' ' 78' ' ' ASN . 1.7 t-20 75.57 116.31 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 47.14 9.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.735 179.74 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.59 HG21 ' H ' ' A' ' 35' ' ' GLU . 71.4 p -83.35 -57.67 3.16 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 117.941 -1.503 . . . . 0.0 111.206 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.417 ' N ' ' OG1' ' A' ' 38' ' ' THR . 30.2 mt -57.92 78.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.23 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 38' ' ' THR . 13.7 t -77.79 -48.3 16.89 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.562 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.409 ' CB ' ' H ' ' A' ' 12' ' ' PHE . 42.7 t -126.87 132.02 51.04 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.58 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -105.54 158.8 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 C-N-CA 119.492 -0.883 . . . . 0.0 113.052 -179.742 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.411 ' N ' HG13 ' A' ' 42' ' ' VAL . 33.4 tttp -143.38 98.43 3.25 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.788 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.501 HG22 HG22 ' A' ' 4' ' ' ILE . 93.1 t -121.78 109.37 34.19 Favored Pre-proline 0 N--CA 1.496 1.842 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.318 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -69.07 168.43 20.69 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 120.989 1.126 . . . . 0.0 110.898 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.42 -175.7 0.15 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 121.818 1.678 . . . . 0.0 111.097 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.69 -14.54 17.98 Favored Glycine 0 N--CA 1.481 1.688 0 C-N-CA 119.178 -1.487 . . . . 0.0 110.295 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.8 HG11 ' HB3' ' A' ' 2' ' ' ALA . 15.5 m -149.28 135.42 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.685 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.414 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 37.4 tttm -110.32 156.2 21.06 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.249 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -149.7 158.62 44.34 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 118.139 -1.424 . . . . 0.0 112.916 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.687 HG23 ' O ' ' A' ' 63' ' ' ILE . 78.4 mt -133.19 123.05 46.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 114.317 -1.311 . . . . 0.0 108.846 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.542 HD12 ' H ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -100.37 138.97 36.71 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.725 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.45 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 49.2 m-85 -113.73 114.05 25.82 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.712 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -46.72 -83.1 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.721 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -59.23 141.96 53.01 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.272 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -53.65 178.0 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.271 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.671 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 59.08 37.74 92.07 Favored Glycine 0 N--CA 1.487 2.049 0 C-N-CA 118.95 -1.595 . . . . 0.0 109.69 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.671 ' CG ' ' C ' ' A' ' 57' ' ' GLY . 0.3 OUTLIER 41.08 70.52 0.25 Allowed 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.987 -179.943 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.05 -162.67 1.61 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.11 -178.03 5.14 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.325 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -49.46 123.79 8.23 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.45 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 62' ' ' GLN . 16.7 pt20 -95.54 158.3 15.51 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.101 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.687 ' O ' HG23 ' A' ' 51' ' ' ILE . 7.7 mm -133.42 168.38 24.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.766 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.679 ' N ' HG22 ' A' ' 63' ' ' ILE . 20.2 mt-10 -146.4 135.02 22.17 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.986 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.5 m -150.09 161.12 4.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.687 -1.205 . . . . 0.0 112.103 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 t -147.55 -3.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 114.402 -1.272 . . . . 0.0 107.799 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -131.31 -152.13 0.49 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.024 -1.443 . . . . 0.0 109.188 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -90.94 121.0 32.4 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.544 179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.58 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.01 81.22 6.87 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.51 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -45.56 -69.48 0.13 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.594 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.67 -3.47 56.27 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.606 -0.837 . . . . 0.0 111.868 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tp 60.74 -93.61 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.164 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.76 -174.61 44.25 Favored Glycine 0 N--CA 1.491 2.367 0 C-N-CA 118.915 -1.612 . . . . 0.0 110.628 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.543 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.9 Cg_endo -65.27 -29.81 54.73 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.18 1.92 . . . . 0.0 112.092 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.631 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -65.41 13.25 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.219 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.543 ' H ' ' C ' ' A' ' 74' ' ' PRO . 3.6 t-20 -60.25 -2.12 0.42 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.071 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.518 ' H ' ' C ' ' A' ' 75' ' ' LEU . 9.6 t-20 -77.35 -24.17 50.76 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.852 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.66 HD22 ' N ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -171.45 133.3 0.81 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.303 -179.99 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.66 ' N ' HD22 ' A' ' 78' ' ' ASN . 5.9 t -127.86 157.47 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.332 179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.6 m -165.68 -61.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 117.915 -1.514 . . . . 0.0 114.136 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.62 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 11.7 m -93.92 148.24 22.34 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.027 -1.069 . . . . 0.0 112.88 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.565 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -148.57 158.64 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.858 179.971 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.802 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -139.29 120.18 14.42 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.519 -179.887 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.802 ' H ' HH12 ' A' ' 83' ' ' ARG . 3.1 t -119.4 133.79 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.706 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.783 HD11 HH21 ' A' ' 83' ' ' ARG . 3.2 mp -135.88 121.32 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.886 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.6 m -40.63 151.82 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.623 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -147.76 149.33 33.18 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.681 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -52.81 160.53 3.91 Favored 'Trans proline' 0 C--N 1.326 -0.643 0 C-N-CA 121.296 1.331 . . . . 0.0 111.672 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.0 137.81 21.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.701 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -146.11 131.67 9.3 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.657 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -59.84 -156.42 0.02 OUTLIER 'Trans proline' 0 C--O 1.211 -0.85 0 C-N-CA 121.245 1.297 . . . . 0.0 110.715 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.491 ' HE ' ' HB2' ' A' ' 107' ' ' ASP . 5.7 ptm180 -174.36 -157.96 0.08 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 118.626 -1.23 . . . . 0.0 112.044 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.549 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.5 168.06 20.74 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.854 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.49 ' HE ' ' CB ' ' A' ' 105' ' ' GLU . 38.5 ttt180 -129.13 128.6 43.79 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.954 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.518 ' CD2' HG13 ' A' ' 131' ' ' VAL . 71.8 m-85 -120.44 134.12 55.32 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.2 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.555 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 66.9 m-85 -89.43 175.21 7.4 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.969 -1.092 . . . . 0.0 111.237 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.72 -28.87 51.0 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 118.772 -1.171 . . . . 0.0 113.032 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -156.79 -178.82 7.64 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 117.363 -1.735 . . . . 0.0 113.585 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.613 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -62.61 108.1 1.08 Allowed 'General case' 0 C--O 1.202 -1.425 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.857 -179.83 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 1.321 ' NE2' ' CD1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER 121.97 41.33 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.434 0 O-C-N 125.081 1.488 . . . . 0.0 109.881 179.802 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 1.321 ' CD1' ' NE2' ' A' ' 100' ' ' GLN . 37.2 p90 30.32 34.51 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.878 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 100' ' ' GLN . 21.3 t70 -106.54 169.61 8.42 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.338 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 77.2 136.68 0.82 Allowed Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.203 -1.475 . . . . 0.0 109.727 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.47 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.7 OUTLIER -29.1 136.94 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.236 0.541 . . . . 0.0 112.097 -179.778 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.597 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 1.4 pm0 -93.31 164.28 13.28 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.619 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 107' ' ' ASP . 3.9 t -140.04 167.83 18.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.691 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.557 ' N ' ' CG1' ' A' ' 106' ' ' VAL . 2.8 p30 -148.16 159.28 44.11 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.346 -1.342 . . . . 0.0 111.81 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.8 mt -141.49 149.55 54.66 Favored Pre-proline 0 N--CA 1.495 1.776 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -76.99 166.34 26.93 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 121.763 1.642 . . . . 0.0 111.422 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.33 140.8 78.83 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 121.7 1.6 . . . . 0.0 110.928 179.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 145.52 -164.08 28.12 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 118.927 -1.606 . . . . 0.0 111.36 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.586 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 33.4 tt0 -115.99 157.25 24.88 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.211 -0.494 . . . . 0.0 110.783 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.586 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 53.8 m-85 -146.08 153.85 41.18 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.9 p -98.71 -159.62 0.75 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.412 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.91 54.3 0.68 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.211 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.55 -67.43 0.13 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.346 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 121' ' ' TYR . 4.8 pt-20 -67.33 -50.05 61.6 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.359 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.498 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -36.23 -57.41 0.72 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.859 179.784 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 51.9 mt-10 -53.15 -66.52 0.37 Allowed 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.171 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.453 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 14.8 mmm-85 -73.66 7.23 2.56 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.641 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.547 ' N ' ' O ' ' A' ' 117' ' ' GLU . 15.0 t80 -99.95 -17.65 17.46 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.203 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.646 ' C ' HD13 ' A' ' 123' ' ' ILE . . . -163.62 -28.32 0.02 OUTLIER Glycine 0 N--CA 1.484 1.841 0 C-N-CA 117.771 -2.156 . . . . 0.0 112.107 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.646 HD13 ' C ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -135.83 -101.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.362 -179.848 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.597 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 25.2 t70 -173.28 -163.97 0.21 Allowed 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.663 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.597 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 1.5 t30 -72.17 -22.36 61.31 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.125 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -170.21 89.95 0.17 Allowed 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.8 t -168.05 14.05 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.968 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 128' ' ' ILE . 4.6 mt -68.98 -70.66 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.508 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 69.9 -135.01 0.06 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.819 -0.752 . . . . 0.0 112.338 179.881 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.421 ' CB ' ' H ' ' A' ' 101' ' ' PHE . 16.2 m -45.29 128.36 7.65 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.7 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.518 HG13 ' CD2' ' A' ' 95' ' ' PHE . 5.5 t -121.67 160.35 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.183 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.413 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -154.91 89.55 3.12 Favored Pre-proline 0 C--N 1.29 -1.981 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.784 179.913 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.22 121.54 10.09 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.091 1.194 . . . . 0.0 110.608 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.549 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 29.0 tt0 -90.96 -8.67 48.6 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.183 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.8 -32.68 0.02 OUTLIER Glycine 0 N--CA 1.494 2.502 0 C-N-CA 118.026 -2.035 . . . . 0.0 112.476 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.28 156.93 28.0 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.904 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.98 145.36 42.6 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.007 -1.077 . . . . 0.0 109.214 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.4 t -112.42 148.61 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.021 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.2 t -137.36 118.53 17.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.02 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 140' ' ' LEU . 11.2 mp -98.94 142.42 30.46 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.883 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.489 ' CB ' ' HA ' ' A' ' 146' ' ' PHE . 63.9 m-85 -120.02 134.46 55.24 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.402 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -65.88 -68.53 0.36 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.08 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -78.34 169.3 18.48 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.392 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 146' ' ' PHE . 11.1 p-10 -64.34 -160.99 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.014 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.645 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 5.8 m120 42.66 21.03 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.938 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.645 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.4 OUTLIER 40.77 58.65 2.38 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.677 -179.91 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.6 t -148.09 149.32 31.83 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.335 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 108.43 -146.67 16.5 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -65.36 105.02 1.05 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.171 -1.011 . . . . 0.0 110.204 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.0 p -103.18 168.93 8.86 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.781 -0.767 . . . . 0.0 111.826 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 tt -139.37 81.14 21.09 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.139 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.24 108.37 0.58 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.961 1.774 . . . . 0.0 112.968 -179.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.7 87.25 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.294 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -58.33 -21.97 51.53 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.886 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 12.9 t -168.9 -141.59 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 117.979 -1.489 . . . . 0.0 112.895 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.8 OUTLIER -57.66 141.19 49.18 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.159 -179.811 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.55 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -162.24 61.12 1.17 Allowed Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.294 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.5 Cg_endo -65.31 19.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 122.222 1.948 . . . . 0.0 112.856 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.685 ' O ' HG23 ' A' ' 159' ' ' THR . 4.7 t -169.12 101.92 0.37 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.385 -1.326 . . . . 0.0 111.867 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 160' ' ' LEU . 94.5 mt -128.03 -48.9 1.34 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.646 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 51.06 -135.43 31.12 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.316 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.09 126.9 29.19 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.66 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 10.8 mmt -153.43 -80.71 0.09 Allowed 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.354 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 165' ' ' ASN . 30.2 p-10 -92.11 20.15 6.18 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.168 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 164' ' ' ASN . 0.3 OUTLIER 77.71 -47.24 0.48 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.787 -179.922 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -175.07 137.81 0.42 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.141 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.451 ' OG1' HD23 ' A' ' 140' ' ' LEU . 1.8 m -82.39 114.96 21.19 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.446 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 36.1 t -86.86 -47.51 8.97 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.104 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.19 165.96 23.89 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.152 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 38.1 pt -145.93 167.07 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 118.652 -1.219 . . . . 0.0 111.463 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -149.42 109.74 4.18 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.02 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mt -88.18 96.81 6.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.095 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 116.304 -1.808 . . . . 0.0 110.931 -179.973 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.581 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpp? . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.611 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -150.45 153.73 36.44 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.882 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.8 120.76 0.06 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.496 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.6 pt -67.72 146.73 12.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 118.723 -1.191 . . . . 0.0 110.263 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.9 m -123.96 117.57 25.09 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.186 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.492 ' O ' ' CB ' ' A' ' 16' ' ' GLN . 1.2 m -92.1 174.18 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.434 -0.906 . . . . 0.0 111.167 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' A' ' 12' ' ' PHE . 61.1 m-85 -135.98 146.67 47.48 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.231 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -75.02 -28.1 60.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.63 -0.828 . . . . 0.0 112.764 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.499 ' C ' ' OG ' ' A' ' 40' ' ' SER . 33.6 m120 -126.76 163.0 24.5 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.451 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.592 ' N ' ' OG ' ' A' ' 40' ' ' SER . 18.9 mm-40 -63.56 -163.57 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.928 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.613 ' C ' ' H ' ' A' ' 13' ' ' GLN . 8.7 m-20 40.5 39.59 0.75 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.852 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER 56.22 -5.86 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.327 179.991 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.613 ' H ' ' C ' ' A' ' 11' ' ' ASP . 21.9 mt-30 -73.84 174.33 8.63 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.296 -0.961 . . . . 0.0 110.745 179.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 86.21 129.87 2.54 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.339 -1.41 . . . . 0.0 111.027 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.9 OUTLIER -37.79 147.93 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.964 179.907 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.911 ' C ' HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -119.91 162.1 19.73 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.724 -0.79 . . . . 0.0 112.286 -179.868 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.07 139.35 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.882 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -94.41 134.47 36.89 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.421 -179.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.9 mt -129.86 126.47 22.53 Favored Pre-proline 0 N--CA 1.496 1.851 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.202 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.21 164.37 28.22 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 121.053 1.169 . . . . 0.0 111.157 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.24 -172.25 0.14 Allowed 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 121.648 1.565 . . . . 0.0 111.14 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.492 ' N ' ' HB ' ' A' ' 84' ' ' VAL . . . 103.65 -166.38 15.88 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.356 179.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.487 ' N ' HD22 ' A' ' 23' ' ' ASN . 0.4 OUTLIER -130.93 132.41 45.07 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.069 -179.978 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -148.12 -177.05 5.53 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.037 -179.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.577 ' CG2' ' CE2' ' A' ' 58' ' ' PHE . 20.3 p -141.26 -159.28 0.94 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.87 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -63.78 -24.23 67.68 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.061 -1.055 . . . . 0.0 110.361 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -61.03 -61.84 2.29 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.555 179.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -55.59 -44.14 76.66 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.543 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.686 HD23 HD12 ' A' ' 32' ' ' LEU . 23.1 mt -61.95 -32.84 73.31 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.789 -1.164 . . . . 0.0 109.633 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -55.8 -31.7 62.88 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 118.601 -1.24 . . . . 0.0 108.231 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.28 -37.28 69.06 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.38 179.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.686 HD12 HD23 ' A' ' 29' ' ' LEU . 15.3 mt -74.98 -77.07 0.13 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.471 179.887 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.09 -28.17 0.72 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.296 -1.43 . . . . 0.0 111.058 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.847 HD13 ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -87.69 133.3 30.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.748 -179.988 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 169.72 174.51 0.05 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.492 -179.905 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 1.5 t-20 70.91 -28.84 0.18 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.117 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.547 ' H ' ' C ' ' A' ' 35' ' ' GLU . 16.1 m120 -160.17 -108.61 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.767 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.658 HG21 HG12 ' A' ' 34' ' ' ILE . 2.6 p 42.71 -134.98 0.4 Allowed 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.572 179.943 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.921 HD12 HG11 ' A' ' 79' ' ' VAL . 1.9 mt 30.26 49.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.291 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.592 ' OG ' ' N ' ' A' ' 10' ' ' GLU . 44.1 t -61.11 -44.3 97.56 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.598 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.47 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -129.82 170.22 14.16 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.116 179.774 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -148.94 146.73 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 118.596 -1.242 . . . . 0.0 112.255 -179.838 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -136.67 102.59 4.96 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.897 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.4 t -120.98 106.16 39.37 Favored Pre-proline 0 N--CA 1.497 1.898 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.876 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -67.59 169.28 16.16 Favored 'Trans proline' 0 C--N 1.326 -0.633 0 C-N-CA 121.091 1.194 . . . . 0.0 110.458 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.03 -173.7 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.766 1.644 . . . . 0.0 110.683 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.25 -20.62 10.01 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 118.878 -1.629 . . . . 0.0 109.944 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.611 HG11 ' CB ' ' A' ' 2' ' ' ALA . 24.2 m -149.22 145.15 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 119.232 -0.987 . . . . 0.0 111.892 -179.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.4 tttt -120.97 152.46 38.51 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.604 179.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.92 147.81 30.12 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.896 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 63' ' ' ILE . 84.9 mt -122.88 120.46 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.021 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.007 HD23 HG23 ' A' ' 82' ' ' ILE . 6.5 mt -89.07 154.46 20.17 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.752 -179.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -130.51 111.77 12.58 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.887 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.28 -79.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.032 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.573 ' HB3' ' HB3' ' A' ' 59' ' ' ALA . 18.0 t-20 -59.16 139.06 57.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.089 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.99 170.65 0.17 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.917 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.24 33.16 86.49 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.425 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CE2' ' CG2' ' A' ' 25' ' ' THR . 19.4 m-85 53.74 65.11 1.61 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.931 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.573 ' HB3' ' HB3' ' A' ' 55' ' ' ASN . . . -144.65 -162.63 1.53 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.689 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.4 ' HA3' ' H ' ' A' ' 55' ' ' ASN . . . 56.04 178.72 0.35 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.274 -1.441 . . . . 0.0 110.002 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -44.77 153.19 0.18 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.897 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -130.17 151.96 50.13 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.014 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.798 HG22 ' N ' ' A' ' 64' ' ' GLU . 51.1 mt -123.65 173.16 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.876 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.798 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -150.09 130.3 13.64 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.03 179.988 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.3 m -148.36 156.59 8.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 118.806 -1.158 . . . . 0.0 112.565 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 t -140.49 -5.7 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.536 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -128.7 -148.33 0.37 Allowed 'General case' 0 C--O 1.209 -1.07 0 CA-C-N 113.822 -1.536 . . . . 0.0 109.228 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.653 HD21 HG13 ' A' ' 106' ' ' VAL . 14.2 p-10 -99.57 120.44 39.66 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.038 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.53 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -90.84 96.44 10.64 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.218 179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -56.01 -86.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.973 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 13.8 mm-40 -67.61 -11.46 58.18 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.915 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 39' ' ' ILE . 4.0 tp 75.54 -84.57 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.724 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.461 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 171.12 -169.48 42.51 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.202 -1.475 . . . . 0.0 110.629 -179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.499 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.0 Cg_endo -66.02 -50.45 1.59 Allowed 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.208 1.938 . . . . 0.0 112.299 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.995 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.9 pt? -72.53 33.45 0.06 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.026 -1.069 . . . . 0.0 111.503 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.499 ' H ' ' C ' ' A' ' 74' ' ' PRO . 1.8 t30 -76.63 -6.01 50.23 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.388 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.511 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 20.7 m120 -95.49 6.46 48.91 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.028 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -158.45 119.51 3.41 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.204 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.921 HG11 HD12 ' A' ' 39' ' ' ILE . 4.1 t -150.17 154.34 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 119.254 -0.979 . . . . 0.0 110.668 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.8 p -174.04 -41.92 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 118.981 -1.088 . . . . 0.0 111.549 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.3 t -99.0 141.49 31.69 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.556 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 1.007 HG23 HD23 ' A' ' 52' ' ' LEU . 13.4 mt -148.6 158.0 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.004 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.762 ' NH1' ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -135.61 135.15 40.01 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.3 -179.876 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.762 ' CA ' ' NH1' ' A' ' 83' ' ' ARG . 11.2 t -139.96 135.8 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.956 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.9 mt -140.08 129.48 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.665 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 53.1 m -43.1 151.94 0.13 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.487 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.409 HG22 ' HD2' ' A' ' 88' ' ' PRO . 1.1 t -151.44 150.22 26.26 Favored Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.647 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD2' HG22 ' A' ' 87' ' ' VAL . 3.4 Cg_exo -58.55 166.24 6.6 Favored 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.166 1.244 . . . . 0.0 111.263 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 89' ' ' VAL . 2.0 p -102.23 145.75 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.845 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -130.53 150.63 76.85 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.458 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.34 -22.18 70.05 Favored 'Trans proline' 0 C--O 1.209 -0.928 0 C-N-CA 121.347 1.365 . . . . 0.0 111.302 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.685 HH11 ' CB ' ' A' ' 107' ' ' ASP . 31.4 ptt180 38.29 -158.77 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.995 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.501 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.46 176.66 9.01 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.848 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -150.29 121.65 7.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.912 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 18.2 m-85 -96.58 170.09 9.45 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.952 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.87 155.92 47.0 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.709 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -88.34 154.84 20.07 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.86 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt 60.08 158.59 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.438 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -90.44 69.82 6.93 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.03 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 1.434 ' NE2' ' CE1' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -174.26 34.88 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.417 179.999 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 1.434 ' CE1' ' NE2' ' A' ' 100' ' ' GLN . 42.1 p90 39.82 27.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.188 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 100' ' ' GLN . 32.0 t70 -127.53 117.55 22.29 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.947 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 137.57 140.98 4.14 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 103' ' ' GLY . 0.0 OUTLIER -32.73 124.44 0.35 Allowed 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.273 179.987 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.624 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -100.75 158.79 15.7 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.771 -179.875 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.796 HG21 ' O ' ' A' ' 122' ' ' GLY . 18.1 t -118.99 168.32 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.497 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.685 ' CB ' HH11 ' A' ' 92' ' ' ARG . 5.8 p-10 -145.24 143.68 30.38 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.13 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.467 HD22 ' CD2' ' A' ' 121' ' ' TYR . 11.2 mt -140.45 137.34 17.54 Favored Pre-proline 0 N--CA 1.499 1.994 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.944 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.536 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 2.4 Cg_endo -65.68 169.82 12.29 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 C-N-CA 121.522 1.481 . . . . 0.0 111.902 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 109' ' ' PRO . 1.8 Cg_endo -61.12 142.8 98.05 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.106 1.871 . . . . 0.0 111.468 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.02 -146.6 16.88 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.013 -1.565 . . . . 0.0 111.163 179.881 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.649 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 64.6 mt-30 -137.95 156.36 47.94 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.649 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 10.0 m-85 -145.0 142.97 30.25 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.91 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 114' ' ' THR . 0.7 OUTLIER -94.24 174.03 7.35 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.378 -179.789 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -61.26 -24.05 66.11 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.941 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.3 -45.68 8.89 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.209 -0.996 . . . . 0.0 112.026 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.463 ' O ' ' C ' ' A' ' 118' ' ' LEU . 8.6 tp10 -73.55 -65.21 0.85 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.707 -179.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.563 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -33.9 -68.62 0.11 Allowed 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.015 0.822 . . . . 0.0 110.547 179.961 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.507 ' N ' ' CD ' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -44.7 -68.37 0.2 Allowed 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.798 -179.95 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.524 ' HD3' ' H ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -75.07 20.89 0.13 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.159 -1.016 . . . . 0.0 113.249 -179.426 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.467 ' CD2' HD22 ' A' ' 108' ' ' LEU . 15.8 t80 -114.01 -21.0 10.79 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.952 179.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.796 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -166.46 -6.01 0.03 OUTLIER Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.318 -1.896 . . . . 0.0 110.764 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.475 ' C ' ' CG ' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -149.93 -134.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.605 -179.959 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.475 ' CG ' ' C ' ' A' ' 123' ' ' ILE . 0.7 OUTLIER -159.64 -173.36 4.09 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.615 179.909 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -58.49 109.51 0.8 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.442 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 128' ' ' ILE . 5.1 t-20 63.2 -125.64 0.58 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.905 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 126' ' ' ASN . 10.0 t 39.78 24.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.868 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.491 ' N ' ' O ' ' A' ' 126' ' ' ASN . 3.5 mt -82.21 -71.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.611 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.428 ' OG ' ' C ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 69.91 -147.57 0.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.88 179.819 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 129' ' ' SER . 5.6 m -27.73 127.36 0.07 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.622 -179.862 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.3 t -121.87 136.89 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.843 179.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.28 86.69 29.88 Favored Pre-proline 0 C--N 1.302 -1.483 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.307 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.456 ' C ' ' H ' ' A' ' 135' ' ' GLY . 5.6 Cg_exo -59.0 101.49 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 121.105 1.204 . . . . 0.0 111.093 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.501 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 30.6 tp60 -56.63 -0.16 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.208 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 133' ' ' PRO . . . 172.3 -42.98 0.17 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 118.048 -2.025 . . . . 0.0 112.532 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.42 HD12 ' CA ' ' A' ' 92' ' ' ARG . 2.0 mt -92.2 -173.79 3.54 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.771 -1.171 . . . . 0.0 111.38 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -110.6 126.8 54.84 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 9.3 t -95.1 145.08 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.191 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.466 HG12 ' CZ ' ' A' ' 141' ' ' PHE . 96.2 t -129.77 110.29 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.13 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 140' ' ' LEU . 7.9 mp -89.29 138.26 31.59 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.376 -0.93 . . . . 0.0 113.03 -179.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' A' ' 146' ' ' PHE . 53.1 m-85 -120.8 136.23 54.95 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.7 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -73.97 0.12 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.278 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -64.42 -174.96 0.14 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.201 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 146' ' ' PHE . 2.0 m-20 -84.77 -168.28 2.14 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.769 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.677 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 44.1 m-80 35.9 31.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.021 179.882 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.677 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 0.0 OUTLIER 58.47 52.93 6.61 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.46 179.981 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 10.3 t -119.59 171.7 8.19 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.333 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.498 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 73.91 -165.63 54.77 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.214 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.411 ' C ' ' CG2' ' A' ' 150' ' ' THR . 1.0 OUTLIER -59.8 170.54 1.11 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.395 179.947 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.411 ' CG2' ' C ' ' A' ' 149' ' ' ASP . 2.2 p -150.19 158.08 43.78 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.593 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 151' ' ' LEU . 2.1 tt -132.24 83.59 54.91 Favored Pre-proline 0 N--CA 1.483 1.214 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.346 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -63.18 104.42 0.41 Allowed 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 121.717 1.611 . . . . 0.0 112.761 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.33 78.77 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.986 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 154' ' ' ASN . 1.8 p-10 -83.64 27.98 0.59 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.394 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.427 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 19.0 t -170.28 -164.15 0.38 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.972 -1.091 . . . . 0.0 111.199 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.427 ' N ' ' OG ' ' A' ' 155' ' ' SER . 1.3 m-20 -79.94 154.89 27.99 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.15 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -165.1 69.98 1.37 Allowed Pre-proline 0 C--N 1.304 -1.391 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.904 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.8 Cg_endo -64.18 23.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.062 1.841 . . . . 0.0 112.579 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.562 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.3 OUTLIER -170.34 143.82 2.41 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.753 179.98 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.9 tp -163.92 -48.15 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.836 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 50.58 -163.59 0.88 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.541 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -58.9 105.19 0.29 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.678 -179.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -97.63 -79.01 0.47 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.56 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.478 HD22 ' C ' ' A' ' 164' ' ' ASN . 0.5 OUTLIER -91.1 -68.53 0.79 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.829 -179.955 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.448 ' OD1' ' ND2' ' A' ' 166' ' ' ASN . 6.3 t-20 -154.06 -53.36 0.1 Allowed 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.637 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.448 ' ND2' ' OD1' ' A' ' 165' ' ' ASN . 0.8 OUTLIER 175.4 113.66 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.449 -0.901 . . . . 0.0 110.874 -179.973 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.496 ' OG1' HD23 ' A' ' 140' ' ' LEU . 1.2 m -61.63 155.01 23.49 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.891 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.583 ' OG ' ' N ' ' A' ' 169' ' ' SER . 24.8 p -136.38 -53.73 0.73 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.164 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.583 ' N ' ' OG ' ' A' ' 168' ' ' SER . 20.7 p -127.58 149.98 49.92 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.213 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.516 HD12 ' CD1' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -140.72 -172.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.658 179.95 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.468 ' N ' HG12 ' A' ' 170' ' ' ILE . 43.7 ttt85 -155.05 106.7 2.65 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.062 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -75.38 94.16 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.008 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.305 -1.345 0 CA-C-O 116.326 -1.797 . . . . 0.0 110.754 -179.974 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.811 0.338 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.629 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -57.39 165.2 1.56 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.791 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.478 ' N ' ' OD1' ' A' ' 3' ' ' ASN . 4.8 p30 -177.99 130.82 0.14 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.493 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.752 HG22 HG22 ' A' ' 44' ' ' VAL . 18.6 pt -78.49 160.01 4.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.909 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.3 m -134.99 119.41 17.93 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.476 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -103.36 172.03 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.975 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -133.4 148.81 51.83 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.726 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -37.07 84.59 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.5 -0.88 . . . . 0.0 112.991 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.454 ' C ' ' OG ' ' A' ' 40' ' ' SER . 2.3 m-20 -121.48 173.73 7.21 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.979 -179.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.446 ' N ' ' OG ' ' A' ' 40' ' ' SER . 15.6 pt-20 -70.35 -173.87 0.76 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.742 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.557 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 4.8 t70 49.64 48.0 22.05 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.655 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.557 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 54.4 p90 40.65 20.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.424 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 11' ' ' ASP . 3.7 tt0 -97.76 166.14 11.62 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.582 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 15' ' ' LYS . . . 92.54 141.56 10.53 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.363 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' GLY . 1.1 tptp -33.97 144.66 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.769 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.03 156.42 20.54 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.556 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.2 t -145.04 127.2 9.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.264 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -93.07 125.89 37.89 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.059 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.4 mt -119.21 125.09 27.8 Favored Pre-proline 0 N--CA 1.491 1.58 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.455 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.73 167.24 19.82 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 120.932 1.088 . . . . 0.0 111.098 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.8 170.4 10.14 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 121.636 1.558 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.474 ' H ' ' HB ' ' A' ' 84' ' ' VAL . . . 116.65 170.91 15.71 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 119.728 -1.225 . . . . 0.0 111.054 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.875 ' CB ' ' HE ' ' A' ' 83' ' ' ARG . 1.1 p30 -97.78 128.87 44.72 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.862 ' N ' HH21 ' A' ' 83' ' ' ARG . 27.6 p90 -153.04 178.98 9.11 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.096 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.51 HG22 ' OG ' ' A' ' 81' ' ' SER . 1.5 p -151.1 -159.37 1.02 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.101 -179.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.425 ' H ' ' HB ' ' A' ' 25' ' ' THR . 72.0 ttt180 -57.99 -21.73 46.08 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.675 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.19 -69.48 0.29 Allowed 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.828 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 7.5 tt0 -56.83 -45.31 82.43 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.461 -1.296 . . . . 0.0 109.696 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.579 HD23 HD12 ' A' ' 32' ' ' LEU . 20.0 mt -55.92 -41.62 74.84 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.615 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.47 -31.68 56.24 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 118.128 -1.429 . . . . 0.0 108.49 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -72.27 -30.74 65.12 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.611 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.579 HD12 HD23 ' A' ' 29' ' ' LEU . 15.6 mt -79.54 -77.8 0.17 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.718 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.97 -28.21 0.08 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.127 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.469 ' HB ' HD22 ' A' ' 29' ' ' LEU . 6.9 mm -75.54 152.84 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 119.544 -0.863 . . . . 0.0 110.241 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 36' ' ' ASN . 4.4 pt-20 -178.93 116.69 0.07 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 118.761 -1.175 . . . . 0.0 112.196 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.849 HD22 HD22 ' A' ' 37' ' ' ASN . 3.0 t30 68.2 -145.94 0.12 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.76 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.849 HD22 HD22 ' A' ' 36' ' ' ASN . 0.7 OUTLIER -49.22 95.55 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.394 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.584 ' O ' ' N ' ' A' ' 40' ' ' SER . 2.2 p -157.78 -61.55 0.09 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.653 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 39' ' ' ILE . 72.5 mt -56.72 79.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.979 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 38' ' ' THR . 43.6 t -81.47 -52.62 7.06 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.661 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.61 168.56 9.9 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.58 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -151.33 159.86 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 118.305 -1.358 . . . . 0.0 112.919 -179.89 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.449 ' N ' HG13 ' A' ' 42' ' ' VAL . 43.2 tttm -150.46 113.16 4.74 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.387 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.752 HG22 HG22 ' A' ' 4' ' ' ILE . 76.1 t -134.03 111.88 12.2 Favored Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 119.525 -0.87 . . . . 0.0 112.619 -179.689 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -69.57 169.97 17.44 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 121.145 1.23 . . . . 0.0 110.696 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.96 -175.12 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 121.989 1.793 . . . . 0.0 111.464 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.86 -14.27 10.93 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.569 -1.301 . . . . 0.0 110.622 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.629 HG11 ' CB ' ' A' ' 2' ' ' ALA . 23.2 m -147.46 139.46 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.156 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.457 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -116.76 155.37 29.03 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.639 179.999 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.457 ' N ' ' HG2' ' A' ' 49' ' ' LYS . . . -144.88 154.8 43.01 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.652 -1.219 . . . . 0.0 112.413 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 63' ' ' ILE . 4.1 mp -132.39 121.35 45.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.84 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.53 ' HA ' HG23 ' A' ' 82' ' ' ILE . 3.5 mp -93.95 154.72 17.53 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 118.936 -1.106 . . . . 0.0 112.536 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.426 ' CB ' ' HA ' ' A' ' 58' ' ' PHE . 54.0 m-85 -140.24 116.65 10.69 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -46.61 -88.87 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.904 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -59.59 144.0 48.83 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.178 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -54.21 175.64 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.631 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.435 ' C ' ' CG ' ' A' ' 58' ' ' PHE . . . 63.96 32.62 84.78 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 119.22 -1.467 . . . . 0.0 109.959 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.573 ' H ' ' CB ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 48.64 35.95 6.96 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.678 -179.938 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.78 -163.29 0.97 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.423 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 56.06 -174.0 1.34 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.027 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 62' ' ' GLN . 18.1 t70 -54.47 174.42 0.06 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.697 -1.201 . . . . 0.0 109.949 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.436 ' N ' ' OD1' ' A' ' 61' ' ' ASP . 20.6 pt20 -147.96 161.86 40.49 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.052 -1.059 . . . . 0.0 111.282 -179.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.558 ' CG1' HD11 ' A' ' 75' ' ' LEU . 3.9 mt -137.05 160.87 36.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.905 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 64' ' ' GLU . 2.6 mp0 -135.53 127.55 29.68 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.281 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.509 HG12 ' CE1' ' A' ' 121' ' ' TYR . 22.9 m -144.83 162.94 13.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 118.737 -1.185 . . . . 0.0 112.787 -179.796 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.437 ' H ' ' H ' ' A' ' 67' ' ' ALA . 2.1 t -150.04 -7.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.011 -1.449 . . . . 0.0 107.642 179.819 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.437 ' H ' ' H ' ' A' ' 66' ' ' VAL . . . -121.29 -146.35 0.37 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.944 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.409 HD22 ' HG3' ' A' ' 43' ' ' LYS . 36.2 t-20 -101.03 134.55 43.86 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.109 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.466 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -114.89 101.82 9.4 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.046 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -65.27 -77.68 0.06 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.792 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -74.56 -9.77 58.9 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.529 -179.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.408 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 6.3 tp 64.98 -79.8 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.065 -179.925 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 172.0 -177.0 44.95 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.111 -1.519 . . . . 0.0 110.626 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.538 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.0 Cg_endo -64.08 -42.44 18.62 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.247 1.965 . . . . 0.0 111.884 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.843 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.0 pt? -70.99 21.51 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.181 -1.007 . . . . 0.0 111.113 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.619 HD22 ' N ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -75.79 5.02 6.86 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.652 179.953 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.619 ' N ' HD22 ' A' ' 76' ' ' ASN . 29.9 m-80 -88.85 -2.29 58.52 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.031 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.412 ' C ' ' ND2' ' A' ' 78' ' ' ASN . 0.5 OUTLIER -169.29 128.67 1.03 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.035 -179.998 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.2 t -149.17 143.24 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.35 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.0 m -155.78 -40.93 0.08 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.22 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.573 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 3.4 m -96.16 136.31 36.8 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.132 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.53 HG23 ' HA ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -150.73 134.1 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 118.79 -1.164 . . . . 0.0 112.185 -179.94 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.875 ' HE ' ' CB ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -110.02 120.08 41.32 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.025 179.877 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.474 ' HB ' ' H ' ' A' ' 22' ' ' GLY . 6.7 t -122.17 130.65 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.514 179.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.4 HD13 ' O ' ' A' ' 84' ' ' VAL . 4.6 mm -141.01 130.22 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.665 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 p -48.65 142.1 6.44 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.084 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.597 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -134.47 142.43 42.77 Favored Pre-proline 0 N--CA 1.492 1.638 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.513 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.597 ' HD2' HG22 ' A' ' 87' ' ' VAL . 2.8 Cg_exo -53.62 129.81 35.76 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.133 1.222 . . . . 0.0 110.977 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 p -53.21 134.03 15.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.98 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -140.76 148.45 52.8 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.207 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.422 ' C ' HD11 ' A' ' 136' ' ' LEU . 1.6 Cg_endo -59.92 -167.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.104 1.203 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.412 ' CA ' HD12 ' A' ' 136' ' ' LEU . 24.8 ptt180 -172.88 -155.45 0.08 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.754 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.496 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -143.15 161.19 38.88 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.232 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -136.2 115.67 12.76 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.149 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 20.0 m-85 -100.29 150.54 22.45 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.897 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.454 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 39.4 m-85 -105.18 170.62 7.77 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.654 -0.819 . . . . 0.0 111.064 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.3 -57.55 2.57 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.919 -1.113 . . . . 0.0 111.988 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -83.06 154.2 24.52 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.377 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.604 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 30.3 tt0 -68.55 104.58 1.98 Allowed 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.03 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.604 ' CB ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 119.18 68.55 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.441 0 O-C-N 125.323 1.64 . . . . 0.0 110.918 179.755 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.556 ' O ' ' CD2' ' A' ' 101' ' ' PHE . 33.2 p90 29.63 55.61 0.14 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.318 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.523 ' CG ' ' N ' ' A' ' 103' ' ' GLY . 4.5 t70 -144.57 170.52 15.91 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.706 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.523 ' N ' ' CG ' ' A' ' 102' ' ' ASP . . . 78.93 145.15 2.94 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 118.886 -1.626 . . . . 0.0 109.881 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 103' ' ' GLY . 5.0 tmtt? -28.76 131.24 0.06 Allowed 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 121.195 0.522 . . . . 0.0 112.106 -179.816 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -95.7 157.34 15.94 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.311 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.765 HG21 ' O ' ' A' ' 122' ' ' GLY . 1.7 t -142.65 150.68 18.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.533 179.875 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 22.3 p-10 -130.9 159.28 37.86 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.806 -179.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.414 HD22 ' CD2' ' A' ' 121' ' ' TYR . 86.2 mt -141.77 151.18 59.22 Favored Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.144 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -78.96 167.37 22.14 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.976 1.784 . . . . 0.0 111.05 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.18 142.97 69.44 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 C-N-CA 121.4 1.4 . . . . 0.0 110.757 179.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.39 -157.23 26.06 Favored Glycine 0 N--CA 1.504 3.202 0 C-N-CA 119.021 -1.561 . . . . 0.0 111.572 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.504 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 11.2 mt-30 -116.12 158.79 22.67 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.141 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.504 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 79.2 m-85 -145.82 143.23 29.52 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.629 179.839 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.1 p -95.91 164.71 12.61 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.807 -179.718 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -58.97 -8.07 1.28 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.719 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.94 -48.68 3.56 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.347 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 118' ' ' LEU . 4.5 tp10 -70.34 -50.27 40.8 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.834 -179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.565 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -40.62 -72.83 0.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.368 -179.916 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -55.95 10.03 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.041 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.443 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.5 OUTLIER -73.81 15.11 0.31 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.54 -179.716 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.509 ' CE1' HG12 ' A' ' 65' ' ' VAL . 16.8 t80 -126.77 -10.36 6.11 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.355 179.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -140.78 -48.49 0.05 OUTLIER Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.208 -1.472 . . . . 0.0 110.218 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.566 ' CG1' ' H ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -144.58 -97.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.664 -179.937 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.566 ' H ' ' CG1' ' A' ' 123' ' ' ILE . 3.0 t70 -171.78 175.72 3.86 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -66.28 134.88 53.56 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.31 -179.871 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.75 HD22 ' H ' ' A' ' 166' ' ' ASN . 4.0 t-20 52.24 94.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.602 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.7 t -174.01 -12.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.457 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 129' ' ' SER . 4.2 mm -73.53 163.27 4.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.17 -179.886 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.436 ' N ' HG22 ' A' ' 128' ' ' ILE . 29.9 t -169.83 -48.24 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.45 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.474 ' CB ' ' H ' ' A' ' 101' ' ' PHE . 49.7 m -122.93 127.61 49.15 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.044 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.443 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.5 t -120.54 159.63 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.569 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.58 79.31 8.05 Favored Pre-proline 0 C--N 1.296 -1.731 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.746 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -53.21 96.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.215 1.277 . . . . 0.0 110.703 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.496 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 58.2 tp60 -45.91 -23.74 0.32 Allowed 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.54 -1.209 . . . . 0.0 113.064 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.91 -31.88 0.02 OUTLIER Glycine 0 N--CA 1.494 2.515 0 C-N-CA 117.738 -2.172 . . . . 0.0 112.942 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.422 HD11 ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -98.66 179.4 4.69 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.659 -1.216 . . . . 0.0 111.161 -179.895 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -94.93 144.26 25.82 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.042 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 153' ' ' VAL . 7.5 t -115.54 147.97 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.849 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.485 ' C ' HD12 ' A' ' 140' ' ' LEU . 98.3 t -136.53 129.3 45.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.897 179.842 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.485 HD12 ' C ' ' A' ' 139' ' ' VAL . 10.8 mp -105.64 138.7 41.4 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.369 -0.932 . . . . 0.0 113.174 -179.766 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 146' ' ' PHE . 18.0 m-85 -117.39 121.59 41.49 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.778 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -63.44 -68.29 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.165 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -73.2 165.55 24.84 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.376 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 146' ' ' PHE . 16.7 m-20 -64.37 -157.82 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.796 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.643 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 10.9 p-10 32.0 35.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.216 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.643 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 2.0 p90 41.04 61.61 1.69 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.787 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 148' ' ' GLY . 35.9 t -143.59 -176.22 4.87 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.121 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.531 ' N ' ' OG ' ' A' ' 147' ' ' SER . . . 75.87 -163.43 53.4 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.064 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 149' ' ' ASP . 1.4 m-20 -60.08 144.88 48.52 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.314 179.878 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.4 p -141.29 175.42 9.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.159 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.51 ' CD2' HD21 ' A' ' 160' ' ' LEU . 24.8 tp -152.78 95.05 3.08 Favored Pre-proline 0 C--N 1.305 -1.364 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.044 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.87 107.48 1.11 Allowed 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 121.385 1.39 . . . . 0.0 112.075 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 138' ' ' VAL . 47.0 t -79.08 91.28 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.145 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -44.33 -49.2 9.6 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.565 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.5 m -160.15 -133.9 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 118.728 -1.189 . . . . 0.0 111.923 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -48.05 137.61 10.17 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.119 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.536 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -164.36 63.96 1.13 Allowed Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.238 179.814 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.9 Cg_endo -67.08 24.83 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.126 1.884 . . . . 0.0 111.837 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.536 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.6 t -175.1 132.82 0.31 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.785 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.51 HD21 ' CD2' ' A' ' 151' ' ' LEU . 1.6 tp -165.23 -59.23 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.34 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 163' ' ' MET . . . 45.11 -152.31 0.72 Allowed Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.164 -1.493 . . . . 0.0 110.317 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . 51.29 -91.09 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.647 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.669 ' C ' ' H ' ' A' ' 165' ' ' ASN . 32.8 tpp -59.43 -35.25 73.65 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.15 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 164' ' ' ASN . 1.6 m120 -58.41 7.87 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.817 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.669 ' H ' ' C ' ' A' ' 163' ' ' MET . 2.0 t-20 -68.21 113.01 5.47 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.477 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.75 ' H ' HD22 ' A' ' 126' ' ' ASN . 31.5 t30 64.14 60.69 0.97 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.633 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -70.32 119.22 14.17 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.743 -1.183 . . . . 0.0 109.269 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 72.4 m -89.08 -80.02 0.31 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.96 -179.819 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 p -108.87 160.75 15.74 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.225 -179.803 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 27.8 pt -139.67 173.18 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.729 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -152.47 110.16 3.61 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.2 mt -87.47 93.29 4.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.236 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 69.4 m . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 116.363 -1.78 . . . . 0.0 110.963 -179.971 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 tpt . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.868 0.366 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.91 123.46 28.87 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.149 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -159.98 123.99 3.72 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.429 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.403 HG22 HG22 ' A' ' 44' ' ' VAL . 40.3 pt -76.72 149.24 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.594 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.4 m -136.98 118.28 14.6 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.733 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.485 ' HB ' HG23 ' A' ' 39' ' ' ILE . 1.6 m -109.63 160.59 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.672 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.407 ' CE2' ' CD2' ' A' ' 12' ' ' PHE . 56.0 m-85 -115.98 162.06 17.94 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.304 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -87.44 3.8 45.74 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.483 ' N ' ' HB3' ' A' ' 40' ' ' SER . 15.2 m120 -147.27 168.25 22.22 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.502 -1.279 . . . . 0.0 111.809 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.74 177.14 1.72 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.224 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 13' ' ' GLN . 6.6 t70 56.2 39.56 30.25 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.893 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.574 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER 56.17 -3.43 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.137 179.957 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.596 ' H ' ' C ' ' A' ' 11' ' ' ASP . 7.4 tt0 -80.73 172.66 13.47 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.269 -0.973 . . . . 0.0 111.241 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.583 ' N ' ' CG ' ' A' ' 13' ' ' GLN . . . 100.55 141.93 12.51 Favored Glycine 0 N--CA 1.5 2.94 0 C-N-CA 119.877 -1.154 . . . . 0.0 110.548 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -33.41 140.56 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 120.191 -0.603 . . . . 0.0 111.432 179.96 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.5 157.9 15.93 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.392 -179.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.5 t -148.75 118.5 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.731 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -92.54 132.75 36.57 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.734 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -132.46 137.46 29.96 Favored Pre-proline 0 N--CA 1.49 1.56 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.909 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -72.1 166.27 30.15 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 120.843 1.029 . . . . 0.0 110.789 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.23 -163.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 121.628 1.552 . . . . 0.0 110.63 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.71 176.19 39.87 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.129 -1.51 . . . . 0.0 111.366 179.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.641 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.9 OUTLIER -107.75 132.66 53.13 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.496 -179.921 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.705 ' OH ' HD12 ' A' ' 82' ' ' ILE . 35.7 p90 -154.7 -177.96 6.86 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.502 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.964 HG23 ' H ' ' A' ' 27' ' ' ALA . 8.3 t -151.95 -161.23 1.27 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.337 -179.721 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.533 ' N ' ' OG1' ' A' ' 25' ' ' THR . 0.1 OUTLIER -54.96 -15.5 2.06 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.065 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.964 ' H ' HG23 ' A' ' 25' ' ' THR . . . -69.23 -64.59 0.84 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.563 179.849 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.551 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 19.9 tt0 -57.83 -42.12 83.68 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 117.964 -1.495 . . . . 0.0 109.567 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.6 mt -63.68 -37.57 87.83 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.301 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 26' ' ' ARG . . . -56.26 -27.29 54.68 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 118.112 -1.435 . . . . 0.0 107.785 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -73.84 -36.21 64.88 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.95 179.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.6 mt -75.97 -70.51 0.43 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.512 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.21 -24.9 0.6 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.055 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.6 tt -80.44 156.61 4.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.546 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -147.82 -179.62 7.03 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.068 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 5.1 p30 -47.95 169.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.795 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.642 ' H ' ' H ' ' A' ' 79' ' ' VAL . 8.8 t30 78.25 -23.85 0.23 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.939 179.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 80.6 p -85.66 -139.66 0.08 Allowed 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.861 -1.135 . . . . 0.0 110.789 179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.485 HG23 ' HB ' ' A' ' 6' ' ' VAL . 43.5 mt 41.81 62.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.93 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.483 ' HB3' ' N ' ' A' ' 9' ' ' ASN . 32.4 t -62.32 -44.43 96.52 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.868 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.7 m -129.09 176.95 7.49 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.11 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -144.29 146.74 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 119.025 -1.07 . . . . 0.0 112.197 -179.966 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -132.79 118.65 19.28 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.753 179.829 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.403 HG22 HG22 ' A' ' 4' ' ' ILE . 69.7 t -146.55 107.82 4.1 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.049 -1.06 . . . . 0.0 112.293 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.418 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . 2.0 Cg_endo -66.79 170.89 11.84 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 121.245 1.296 . . . . 0.0 110.719 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.418 ' HD2' ' CB ' ' A' ' 45' ' ' PRO . 2.9 Cg_endo -59.54 -167.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.851 1.7 . . . . 0.0 110.922 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.93 -9.71 23.14 Favored Glycine 0 N--CA 1.48 1.609 0 C-N-CA 118.905 -1.617 . . . . 0.0 110.915 179.798 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.67 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -155.72 151.87 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 118.279 -1.368 . . . . 0.0 112.407 179.972 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -117.92 125.28 50.17 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.883 179.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.53 158.26 17.72 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.807 -179.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.585 ' C ' HD12 ' A' ' 52' ' ' LEU . 51.9 mt -145.43 123.25 4.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.482 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.904 HD12 ' N ' ' A' ' 52' ' ' LEU . 2.4 mp -95.37 165.79 12.2 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.712 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -142.33 105.14 4.54 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.882 179.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -43.57 -84.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.775 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -58.9 133.57 56.15 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.502 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -54.47 171.82 0.11 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.423 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.25 29.93 71.83 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.205 -1.474 . . . . 0.0 110.06 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 53.66 63.22 2.28 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.031 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.13 -177.77 6.01 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.21 168.16 13.37 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.439 -1.363 . . . . 0.0 110.22 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -47.26 144.27 2.88 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.94 -1.104 . . . . 0.0 110.145 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -121.48 163.26 19.1 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.175 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.798 HD11 HD21 ' A' ' 75' ' ' LEU . 9.6 mm -125.26 174.46 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.5 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.709 ' N ' HG22 ' A' ' 63' ' ' ILE . 20.1 mt-10 -146.44 130.6 17.43 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.751 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.4 m -149.18 163.24 4.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.816 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.67 HG13 ' O ' ' A' ' 48' ' ' VAL . 3.3 t -146.76 -8.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.826 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.74 -147.2 0.39 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.103 179.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.514 HD21 HG13 ' A' ' 106' ' ' VAL . 4.4 p-10 -103.03 113.39 26.83 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.943 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.487 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.52 94.68 9.96 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.125 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -54.29 -63.08 1.27 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.141 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' A' ' 73' ' ' GLY . 6.5 tp10 -103.96 99.48 9.24 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.906 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 tp -52.34 -5.86 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.979 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 71' ' ' GLU . . . 78.34 -149.09 33.39 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 118.94 -1.6 . . . . 0.0 110.464 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 76' ' ' ASN . 3.4 Cg_exo -63.53 -151.68 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 121.505 1.47 . . . . 0.0 111.658 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.798 HD21 HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER 30.34 35.04 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 123.964 0.79 . . . . 0.0 112.06 -179.942 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 74' ' ' PRO . 13.5 t-20 -89.31 -3.93 58.31 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.286 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -93.03 3.92 54.9 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.964 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.451 ' HA ' ' H ' ' A' ' 37' ' ' ASN . 17.1 t-20 -162.53 109.67 1.28 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.743 -1.183 . . . . 0.0 111.444 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.642 ' H ' ' H ' ' A' ' 37' ' ' ASN . 7.1 t -147.96 92.82 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.149 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.8 t -121.07 -33.24 3.76 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.547 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.0 m -92.31 136.29 33.32 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.739 -1.185 . . . . 0.0 110.9 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.705 HD12 ' OH ' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -150.98 158.8 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 118.262 -1.375 . . . . 0.0 111.656 -179.857 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.794 HH12 ' CA ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -148.45 140.11 23.65 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.637 -179.922 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.794 ' CA ' HH12 ' A' ' 83' ' ' ARG . 16.1 t -144.99 146.38 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.684 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.552 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 1.5 mt -144.58 135.47 20.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.492 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.4 m -44.74 161.5 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.899 -0.721 . . . . 0.0 111.544 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.533 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -162.01 140.58 7.03 Favored Pre-proline 0 N--CA 1.483 1.18 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.209 -179.986 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.533 ' HD2' HG22 ' A' ' 87' ' ' VAL . 12.5 Cg_exo -47.38 139.53 16.71 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.116 1.211 . . . . 0.0 110.775 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.574 HG22 ' N ' ' A' ' 90' ' ' GLN . 3.8 p -74.99 160.79 5.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.661 -0.816 . . . . 0.0 112.353 -179.839 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.574 ' N ' HG22 ' A' ' 89' ' ' VAL . 23.1 mp0 -141.06 154.87 68.6 Favored Pre-proline 0 N--CA 1.49 1.534 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.405 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.428 ' HG2' HD21 ' A' ' 136' ' ' LEU . 1.9 Cg_endo -64.3 -45.37 9.75 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 121.47 1.447 . . . . 0.0 111.739 179.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.493 ' H ' HD11 ' A' ' 136' ' ' LEU . 9.9 mtm180 64.7 -160.73 0.29 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.265 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.527 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -142.96 172.77 12.25 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.65 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -142.49 121.38 12.77 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.544 -1.262 . . . . 0.0 112.547 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -103.57 162.77 12.77 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -124.59 163.73 21.32 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.528 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.57 -77.41 0.22 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.149 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.483 ' C ' ' OG ' ' A' ' 129' ' ' SER . 34.3 mmtt -66.09 154.41 39.67 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.737 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.627 ' C ' ' HG2' ' A' ' 100' ' ' GLN . 29.0 tt0 -81.71 86.69 6.38 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.118 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.627 ' HG2' ' C ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 163.56 35.68 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.297 -179.946 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.7 t80 56.13 42.38 28.33 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 119.634 -0.827 . . . . 0.0 110.488 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 103' ' ' GLY . 25.1 t0 -143.14 178.36 7.76 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.565 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . 81.58 139.24 2.73 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.157 -1.496 . . . . 0.0 109.724 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 103' ' ' GLY . 1.1 mppt? -28.63 132.91 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.729 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -97.8 159.33 14.99 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.106 -179.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.514 HG13 HD21 ' A' ' 68' ' ' ASN . 53.4 t -144.3 116.05 2.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.115 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -104.72 154.73 19.62 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.413 -179.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.9 mt -139.64 138.13 19.67 Favored Pre-proline 0 N--CA 1.492 1.675 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.436 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.72 168.77 12.66 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 121.237 1.291 . . . . 0.0 110.998 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.08 150.31 87.04 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.655 1.57 . . . . 0.0 111.06 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.04 -155.04 24.24 Favored Glycine 0 N--CA 1.498 2.817 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.969 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.601 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 35.7 tt0 -133.48 158.35 43.31 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.699 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.601 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 30.2 m-85 -142.51 155.1 45.0 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.185 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.2 p -102.91 -175.38 2.79 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.017 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.446 ' N ' ' OE1' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -88.1 53.89 2.9 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.686 179.977 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -152.12 -65.88 0.17 Allowed 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.593 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -72.61 -50.18 27.08 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.343 -0.943 . . . . 0.0 109.467 179.963 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.564 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -33.81 -71.73 0.06 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.897 179.962 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.535 ' OE2' ' CZ ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -52.27 -57.63 9.14 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.103 179.923 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' CZ ' ' OE2' ' A' ' 119' ' ' GLU . 3.3 mpt_? -76.36 23.07 0.15 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.92 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.564 ' N ' ' O ' ' A' ' 117' ' ' GLU . 24.7 t80 -127.11 -17.06 4.9 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.659 179.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.06 -42.6 0.03 OUTLIER Glycine 0 N--CA 1.482 1.705 0 C-N-CA 118.74 -1.695 . . . . 0.0 111.118 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.574 HG13 HD11 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -135.8 -105.7 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.225 -179.93 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 125' ' ' ASN . 18.6 t70 -171.72 -168.45 0.59 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.77 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.528 ' C ' HD22 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -86.03 35.14 0.63 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.45 -179.9 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.405 ' C ' HG22 ' A' ' 127' ' ' THR . 6.0 p-10 -166.48 -155.0 0.19 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.532 -1.267 . . . . 0.0 112.133 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.571 ' OG1' ' N ' ' A' ' 128' ' ' ILE . 2.6 t 40.31 -125.96 0.44 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.267 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.574 HD11 HG13 ' A' ' 123' ' ' ILE . 98.2 mt 60.67 118.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.568 0 CA-C-O 121.041 0.448 . . . . 0.0 111.209 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.483 ' OG ' ' C ' ' A' ' 98' ' ' LYS . 59.2 p -160.99 140.85 10.84 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.419 -0.913 . . . . 0.0 111.124 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 67.92 113.16 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.965 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.0 t -120.27 149.85 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.732 -179.795 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.547 ' NZ ' ' OD2' ' A' ' 156' ' ' ASP . 13.1 tptp -142.4 93.66 7.03 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.793 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 135' ' ' GLY . 4.1 Cg_exo -59.37 99.75 0.12 Allowed 'Trans proline' 0 C--N 1.32 -0.942 0 C-N-CA 120.959 1.106 . . . . 0.0 111.474 -179.799 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.527 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 5.6 tt0 -47.43 -14.23 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.074 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 133' ' ' PRO . . . 175.56 -34.02 0.09 OUTLIER Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.467 -1.825 . . . . 0.0 111.936 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.493 HD11 ' H ' ' A' ' 92' ' ' ARG . 2.2 mt -93.13 -173.82 3.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.664 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.22 144.15 36.06 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.746 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.5 t -112.8 143.56 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.962 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.4 ' C ' HD12 ' A' ' 140' ' ' LEU . 91.3 t -135.39 122.3 34.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.91 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 140' ' ' LEU . 10.1 mp -99.75 144.79 28.41 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.761 -179.802 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.492 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 21.9 m-85 -120.47 129.47 53.87 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.101 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -73.72 -63.15 1.27 Allowed 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.144 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -71.32 170.95 12.05 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.608 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 146' ' ' PHE . 47.7 m-20 -67.73 -161.41 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.254 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.641 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 7.6 p-10 28.96 38.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.371 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.641 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.4 p90 41.69 61.51 1.85 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.982 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.524 ' CB ' HD21 ' A' ' 145' ' ' ASN . 0.5 OUTLIER -139.52 -167.7 2.32 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.353 -179.865 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 65.02 -160.4 42.44 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.706 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.404 ' OD2' ' ND2' ' A' ' 164' ' ' ASN . 21.5 t70 -59.55 158.72 9.37 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.301 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.4 p -148.55 170.69 17.51 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.979 -1.088 . . . . 0.0 111.818 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 151' ' ' LEU . 23.4 tp -138.9 85.0 16.79 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.315 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -61.74 105.77 0.39 Allowed 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.922 1.748 . . . . 0.0 113.049 -179.85 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.467 ' C ' ' H ' ' A' ' 155' ' ' SER . 2.0 t -95.09 57.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.758 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.405 ' ND2' ' H ' ' A' ' 154' ' ' ASN . 5.8 p30 -70.54 32.85 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.819 -179.862 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 153' ' ' VAL . 21.0 p -170.65 -169.06 0.75 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.705 -1.198 . . . . 0.0 111.605 180.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.547 ' OD2' ' NZ ' ' A' ' 132' ' ' LYS . 1.3 m-20 -75.86 153.23 36.93 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.556 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.532 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -168.65 72.17 0.79 Allowed Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.935 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.93 24.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.057 1.838 . . . . 0.0 112.385 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.9 OUTLIER -170.61 68.23 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.633 179.925 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.8 tp -80.76 -64.19 1.24 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 77.59 -176.75 53.45 Favored Glycine 0 N--CA 1.485 1.905 0 C-N-CA 119.136 -1.507 . . . . 0.0 109.863 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -83.1 120.67 26.06 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.791 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.445 ' HG2' ' H ' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -89.03 -76.68 0.4 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.371 -0.932 . . . . 0.0 109.858 -179.98 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.445 ' H ' ' HG2' ' A' ' 163' ' ' MET . 74.9 m-20 -91.48 -64.12 1.16 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.318 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -172.17 96.99 0.16 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.545 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.1 m120 52.14 -165.06 0.06 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.731 -0.787 . . . . 0.0 111.274 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.7 124.31 20.96 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.949 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 169' ' ' SER . 57.3 p -86.18 -68.58 0.73 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.697 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.426 ' N ' ' OG ' ' A' ' 168' ' ' SER . 2.0 p -119.44 161.93 19.7 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.416 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 29.0 pt -141.01 171.59 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.199 -1.001 . . . . 0.0 111.649 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -153.21 110.92 3.56 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.76 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.6 mt -89.17 92.92 4.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.107 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 116.313 -1.803 . . . . 0.0 111.088 -179.904 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.56 178.63 3.1 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.792 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.629 ' N ' ' ND2' ' A' ' 3' ' ' ASN . 0.1 OUTLIER 179.77 130.8 0.09 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.489 -179.906 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.665 HG22 HG22 ' A' ' 44' ' ' VAL . 2.9 pt -82.53 128.75 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.585 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.7 m -100.22 113.32 25.91 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.561 -0.856 . . . . 0.0 108.74 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.518 HG11 HD11 ' A' ' 19' ' ' LEU . 1.5 m -96.83 160.06 2.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.196 -1.002 . . . . 0.0 113.436 -179.688 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.455 ' CD1' ' O ' ' A' ' 12' ' ' PHE . 87.9 m-85 -118.46 144.86 45.69 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.754 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -58.05 3.59 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.634 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 87.8 m-20 -85.52 -176.41 6.07 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.614 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -75.99 176.73 7.64 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.343 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.582 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 1.5 m-20 48.68 56.61 7.37 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.695 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 55.8 p90 40.19 20.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.23 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 11' ' ' ASP . 2.5 tp-100 -98.31 164.37 12.33 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.874 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.634 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 94.18 148.27 23.61 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.802 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.567 ' H ' ' HE3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -29.09 137.74 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.882 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.434 ' H ' ' HG3' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -104.63 152.26 22.67 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.424 -179.889 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.1 t -149.42 138.79 15.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.884 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 1.1 m-20 -99.78 134.86 42.07 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.245 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.518 HD11 HG11 ' A' ' 6' ' ' VAL . 6.4 mt -123.89 122.57 26.3 Favored Pre-proline 0 N--CA 1.496 1.851 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.263 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.33 161.76 39.24 Favored 'Trans proline' 0 C--O 1.217 -0.533 0 C-N-CA 121.022 1.148 . . . . 0.0 111.247 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.54 -166.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.889 0 C-N-CA 121.602 1.534 . . . . 0.0 110.738 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.465 ' O ' ' NH1' ' A' ' 83' ' ' ARG . . . 92.77 -163.59 27.18 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.989 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.75 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.1 OUTLIER -117.96 133.22 56.13 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.432 -179.947 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.614 ' CE2' HD12 ' A' ' 82' ' ' ILE . 6.1 p90 -154.78 177.65 11.02 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.404 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.422 HG22 ' OG ' ' A' ' 81' ' ' SER . 14.3 p -149.51 -150.12 0.33 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.415 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.5 mtm-85 -62.82 -36.66 83.91 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.301 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -56.79 -61.51 2.38 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.44 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.449 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.7 tp60 -56.02 -47.67 77.37 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.325 -1.35 . . . . 0.0 109.367 -179.902 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 29' ' ' LEU . 90.1 mt -57.87 -33.49 68.74 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.39 179.839 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -54.0 -33.02 55.99 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.86 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -70.4 -36.09 73.85 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.18 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.401 HD12 HD23 ' A' ' 29' ' ' LEU . 11.9 mt -78.48 -75.26 0.23 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.727 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 163.7 -29.47 0.24 Allowed Glycine 0 N--CA 1.493 2.464 0 C-N-CA 118.898 -1.62 . . . . 0.0 111.244 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -73.99 166.12 2.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.761 179.971 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.898 ' H ' HG21 ' A' ' 38' ' ' THR . 0.2 OUTLIER 174.66 103.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.403 179.946 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.804 ' O ' HG23 ' A' ' 38' ' ' THR . 2.1 t-20 69.23 140.61 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.7 p30 37.39 21.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.39 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.898 HG21 ' H ' ' A' ' 35' ' ' GLU . 40.9 p -93.95 -48.06 6.43 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.542 -1.263 . . . . 0.0 110.963 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 mt -62.6 74.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.148 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' THR . 26.8 t -72.06 -49.82 33.44 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.122 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.34 163.98 28.79 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.246 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.137 HG22 ' HB3' ' A' ' 69' ' ' ALA . 25.1 m -148.94 167.82 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 C-N-CA 118.194 -1.402 . . . . 0.0 113.295 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -139.76 97.96 3.37 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 113.671 -1.604 . . . . 0.0 107.981 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.665 HG22 HG22 ' A' ' 4' ' ' ILE . 44.5 t -116.46 109.54 43.83 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.797 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.83 169.11 16.9 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 121.227 1.284 . . . . 0.0 110.507 179.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.02 -172.44 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.708 1.605 . . . . 0.0 110.368 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.36 -15.37 35.02 Favored Glycine 0 C--N 1.3 -1.428 0 C-N-CA 118.654 -1.736 . . . . 0.0 110.486 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.722 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -148.53 151.76 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.951 179.938 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -127.17 126.23 42.5 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.869 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.16 160.34 17.02 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.873 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.524 ' C ' HD12 ' A' ' 52' ' ' LEU . 62.4 mt -139.92 121.48 15.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.726 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.826 HD12 ' N ' ' A' ' 52' ' ' LEU . 1.8 mp -90.17 159.8 16.57 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.927 -1.109 . . . . 0.0 112.584 -179.697 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -144.73 106.33 4.26 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.863 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -44.47 -81.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.298 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -58.87 138.2 57.43 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.544 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -54.92 173.39 0.09 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.439 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.31 27.69 72.72 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.184 -1.484 . . . . 0.0 110.156 -179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 55.13 67.91 0.94 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.8 -165.52 2.28 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.235 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.72 -170.01 14.35 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.021 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -51.34 167.89 0.08 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.818 -1.153 . . . . 0.0 109.805 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -147.03 162.71 38.24 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.477 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.93 HD11 HD21 ' A' ' 75' ' ' LEU . 32.1 mt -142.23 173.61 7.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.944 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.736 ' H ' HG22 ' A' ' 63' ' ' ILE . 2.0 tm-20 -146.44 129.71 16.66 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.778 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.536 ' N ' ' OE2' ' A' ' 64' ' ' GLU . 32.2 m -145.64 158.02 12.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 118.629 -1.229 . . . . 0.0 112.465 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' ' 48' ' ' VAL . 3.8 t -146.61 -7.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-N 114.312 -1.313 . . . . 0.0 107.783 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.418 ' H ' ' H ' ' A' ' 66' ' ' VAL . . . -117.13 -151.15 0.47 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.557 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -97.09 122.81 40.51 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.455 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.137 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -89.81 113.46 25.03 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.1 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.465 ' C ' ' CD ' ' A' ' 70' ' ' GLU . 4.1 tp10 -72.33 -70.84 0.32 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.582 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.441 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 12.1 tt0 -96.69 -0.2 48.72 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.223 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.4 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 2.5 tp 69.74 -88.26 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.042 -0.663 . . . . 0.0 112.17 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.4 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 179.33 -162.08 28.61 Favored Glycine 0 N--CA 1.499 2.885 0 C-N-CA 118.99 -1.576 . . . . 0.0 111.086 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.46 ' C ' ' H ' ' A' ' 76' ' ' ASN . 2.2 Cg_endo -66.88 -49.84 1.34 Allowed 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.168 1.912 . . . . 0.0 112.159 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.043 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.7 pt? -74.65 33.52 0.09 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.419 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.46 ' H ' ' C ' ' A' ' 74' ' ' PRO . 21.8 p30 -70.28 -23.89 62.95 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.276 -0.97 . . . . 0.0 110.548 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.514 HD22 ' C ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -80.84 14.43 2.19 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.902 -179.99 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.563 HD22 ' C ' ' A' ' 78' ' ' ASN . 0.5 OUTLIER -168.51 108.48 0.51 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.364 -179.975 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.562 ' N ' HD22 ' A' ' 78' ' ' ASN . 16.5 t -146.44 106.07 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.132 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.7 t -124.73 -44.66 1.94 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.679 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.422 ' OG ' HG22 ' A' ' 25' ' ' THR . 3.4 m -94.5 138.86 31.9 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.597 -179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.614 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -146.94 152.03 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 119.069 -1.053 . . . . 0.0 111.873 -179.971 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.854 HH12 ' H ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -130.09 123.24 29.97 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.272 -179.908 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.854 ' H ' HH12 ' A' ' 83' ' ' ARG . 13.3 t -136.01 137.75 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.59 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.54 ' CG1' ' NH2' ' A' ' 83' ' ' ARG . 1.4 mt -145.52 142.96 22.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.784 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.4 p -43.99 160.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.809 -0.756 . . . . 0.0 111.746 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.2 t -159.09 148.74 14.89 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.128 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -57.64 157.71 22.35 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.045 1.163 . . . . 0.0 110.067 179.735 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.567 HG12 ' N ' ' A' ' 90' ' ' GLN . 86.8 t -78.85 159.73 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.722 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.567 ' N ' HG12 ' A' ' 89' ' ' VAL . 30.0 mt-30 -143.41 145.63 32.71 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.607 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.4 ' HG2' HD21 ' A' ' 136' ' ' LEU . 3.6 Cg_exo -65.3 -48.94 2.92 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 121.377 1.385 . . . . 0.0 111.854 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.515 ' H ' HD11 ' A' ' 136' ' ' LEU . 0.0 OUTLIER 64.81 -156.02 0.29 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.939 179.984 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.525 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -141.73 178.13 7.69 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.717 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -142.08 113.31 7.6 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.931 -1.107 . . . . 0.0 111.412 -179.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.682 ' CD2' HG13 ' A' ' 131' ' ' VAL . 96.8 m-85 -106.53 146.63 30.38 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.471 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -95.69 171.87 8.4 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.386 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.48 -66.86 0.87 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.889 -179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -86.47 147.28 26.05 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.488 -0.885 . . . . 0.0 112.442 -179.778 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.585 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 5.8 tm-20 -71.51 101.43 2.45 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.262 -179.907 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.916 ' CA ' HE21 ' A' ' 100' ' ' GLN . 0.0 OUTLIER 135.7 53.09 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.059 0 O-C-N 125.099 1.499 . . . . 0.0 109.94 179.891 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.504 ' CG ' ' O ' ' A' ' 101' ' ' PHE . 58.8 t80 43.12 52.54 5.43 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.689 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 103' ' ' GLY . 3.2 t70 -145.38 158.35 43.85 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.062 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.524 ' N ' ' OD1' ' A' ' 102' ' ' ASP . . . 85.16 133.29 2.85 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.87 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 103' ' ' GLY . 8.6 mtpm? -35.17 146.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.178 0.513 . . . . 0.0 111.813 -179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -90.96 164.28 14.05 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.215 -179.885 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.0 t -145.79 112.49 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.941 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -89.99 159.64 16.78 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.264 -0.975 . . . . 0.0 112.576 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.9 mt -143.93 131.39 10.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.986 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -66.82 168.66 16.38 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 121.36 1.374 . . . . 0.0 111.441 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.2 145.19 88.58 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 121.557 1.505 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.4 -171.87 24.1 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.137 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.596 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 16.7 tm0? -109.18 159.89 16.55 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.596 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 52.9 m-85 -146.18 148.66 32.77 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.441 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.6 p -102.25 170.99 7.74 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.423 -179.849 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -60.29 -8.92 2.88 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.604 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.38 -52.17 3.07 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 119.314 -0.954 . . . . 0.0 113.437 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 121' ' ' TYR . 23.9 mt-10 -72.79 -53.07 12.53 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.3 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.569 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -36.61 -67.48 0.17 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.807 0.813 . . . . 0.0 110.593 179.906 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 28.2 mp0 -52.35 -60.86 2.72 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.13 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.475 ' HD3' ' H ' ' A' ' 120' ' ' ARG . 4.9 mpt_? -72.13 4.89 3.13 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.792 -179.634 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 117' ' ' GLU . 14.3 t80 -105.34 -16.28 14.8 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.973 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -151.36 -36.36 0.03 OUTLIER Glycine 0 N--CA 1.487 2.063 0 C-N-CA 117.684 -2.198 . . . . 0.0 112.141 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.99 -102.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.979 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 176.42 -173.91 0.1 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.975 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.505 ' C ' ' CG ' ' A' ' 126' ' ' ASN . 59.1 t30 -58.55 125.87 25.22 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.594 -1.243 . . . . 0.0 110.281 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.599 ' C ' HG23 ' A' ' 127' ' ' THR . 0.4 OUTLIER 74.34 -139.02 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.967 -179.893 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.635 ' OG1' ' N ' ' A' ' 128' ' ' ILE . 1.4 p 59.28 -137.95 0.76 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.586 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.635 ' N ' ' OG1' ' A' ' 127' ' ' THR . 39.4 mt 59.37 -74.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.763 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 130' ' ' SER . 60.3 p 47.71 -123.41 1.55 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 120.239 -0.585 . . . . 0.0 112.335 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.552 ' N ' ' OG ' ' A' ' 129' ' ' SER . 0.8 OUTLIER -41.88 126.68 3.19 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.004 -179.847 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.682 HG13 ' CD2' ' A' ' 95' ' ' PHE . 6.8 t -122.42 156.71 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.262 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.404 ' N ' HG12 ' A' ' 131' ' ' VAL . 1.5 ttmp? -150.39 84.46 5.65 Favored Pre-proline 0 C--N 1.296 -1.749 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.998 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.47 103.8 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.985 1.79 . . . . 0.0 111.706 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.525 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 52.1 tp60 -49.25 -30.6 7.41 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.215 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -169.91 -26.31 0.02 OUTLIER Glycine 0 N--CA 1.494 2.503 0 C-N-CA 118.407 -1.854 . . . . 0.0 112.322 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.515 HD11 ' H ' ' A' ' 92' ' ' ARG . 1.4 mt -96.57 165.02 12.36 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.492 -1.283 . . . . 0.0 110.425 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.86 143.72 26.44 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.464 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.3 t -110.05 148.49 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.654 -0.819 . . . . 0.0 112.616 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.497 ' C ' HD12 ' A' ' 140' ' ' LEU . 46.8 t -137.37 125.54 32.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.926 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 139' ' ' VAL . 8.8 mp -102.32 144.84 30.31 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.707 -179.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -117.75 131.38 56.61 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.544 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.693 ' NZ ' ' ND2' ' A' ' 143' ' ' ASN . 26.3 ttpp -67.85 -79.24 0.05 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.554 -179.739 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.693 ' ND2' ' NZ ' ' A' ' 142' ' ' LYS . 0.8 OUTLIER -51.92 166.03 0.17 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.19 -179.884 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -46.82 -100.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.893 -1.048 . . . . 0.0 113.264 -179.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.606 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 5.8 m120 -73.18 75.65 1.28 Allowed 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.578 -179.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.606 ' CD1' ' C ' ' A' ' 145' ' ' ASN . 1.2 p90 34.22 72.47 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.358 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.0 m -141.5 64.67 1.4 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.719 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 171.77 -148.59 11.06 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.294 -1.432 . . . . 0.0 110.35 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -75.53 168.49 19.91 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.293 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.3 p -146.98 155.39 42.22 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.616 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.427 ' HA ' HD12 ' A' ' 151' ' ' LEU . 35.4 tp -123.79 90.93 50.21 Favored Pre-proline 0 N--CA 1.488 1.468 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.59 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.11 108.02 0.89 Allowed 'Trans proline' 0 C--N 1.321 -0.875 0 C-N-CA 121.738 1.625 . . . . 0.0 112.855 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 45.5 t -84.88 88.16 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.452 179.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.494 ' C ' ' OG ' ' A' ' 155' ' ' SER . 18.8 p-10 -52.28 -33.82 43.77 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.494 ' OG ' ' C ' ' A' ' 154' ' ' ASN . 0.8 OUTLIER -163.82 -130.93 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 117.867 -1.533 . . . . 0.0 113.232 -179.699 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -59.73 153.4 20.45 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.299 -179.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.603 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -176.06 69.91 0.25 Allowed Pre-proline 0 N--CA 1.48 1.061 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.657 179.874 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.76 20.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.039 1.826 . . . . 0.0 112.184 -179.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.603 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -176.38 117.42 0.13 Allowed 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.285 179.935 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.1 tp -148.96 -63.97 0.23 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.214 -179.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 74.41 -173.81 50.89 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.2 -1.476 . . . . 0.0 109.606 -179.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.28 108.08 10.15 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.094 -1.042 . . . . 0.0 110.718 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 28.5 mmm -77.8 -56.18 4.71 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.788 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -81.72 -63.24 1.43 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.456 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -157.76 -59.57 0.08 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.685 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -161.93 127.83 3.61 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.412 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 m -68.48 105.93 2.37 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.754 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 28.6 m -87.74 -64.26 1.18 Allowed 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.218 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 p -115.63 163.62 15.53 Favored 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.011 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.418 HG12 ' CD1' ' A' ' 118' ' ' LEU . 30.1 pt -142.74 177.19 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.934 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -156.56 111.08 2.78 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.325 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.3 mt -90.19 98.03 7.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.314 -0.955 . . . . 0.0 110.385 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 C--N 1.306 -1.31 0 CA-C-O 116.393 -1.765 . . . . 0.0 110.957 -179.99 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 mmm . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.605 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -75.06 146.13 41.77 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.369 -0.933 . . . . 0.0 111.171 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 2' ' ' ALA . 45.6 m-80 -163.34 117.69 1.63 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.348 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.8 pt -70.31 149.79 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.532 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.2 m -128.86 116.04 18.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.581 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 m -93.6 171.04 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 C-N-CA 119.526 -0.869 . . . . 0.0 110.78 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.788 ' CE2' ' NE2' ' A' ' 16' ' ' GLN . 31.5 m-85 -133.83 154.21 51.18 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.73 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -83.77 -45.08 13.73 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.278 -0.969 . . . . 0.0 113.152 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.534 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 7.5 m120 -97.66 -175.69 3.26 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.54 -179.864 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.86 -178.14 7.0 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.54 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.614 ' C ' ' CD1' ' A' ' 12' ' ' PHE . 0.9 OUTLIER 47.43 57.29 5.99 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.623 -179.946 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.614 ' CD1' ' C ' ' A' ' 11' ' ' ASP . 48.3 p90 39.14 25.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.66 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 11' ' ' ASP . 7.6 tt0 -104.18 170.01 8.16 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.247 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.534 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 88.36 136.21 5.36 Favored Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.633 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 14' ' ' GLY . 25.8 mmtm -32.01 139.5 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.439 180.0 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.788 ' NE2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -115.27 170.07 8.66 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.805 -179.883 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 76.7 t -141.63 133.93 28.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.334 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -93.91 119.26 32.59 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.192 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.9 mt -116.6 138.25 24.34 Favored Pre-proline 0 N--CA 1.491 1.587 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.376 179.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -72.11 164.94 34.11 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 120.973 1.116 . . . . 0.0 111.027 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.19 -162.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 121.691 1.594 . . . . 0.0 110.761 179.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.525 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 88.54 -178.95 46.02 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.098 -1.525 . . . . 0.0 111.164 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.651 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -109.99 137.47 47.71 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.818 -179.995 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.638 ' CE2' HD12 ' A' ' 82' ' ' ILE . 4.8 p90 -156.12 178.05 10.73 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.36 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.481 ' HB ' ' H ' ' A' ' 26' ' ' ARG . 1.3 p -151.25 -153.09 0.47 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.801 -179.801 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.481 ' H ' ' HB ' ' A' ' 25' ' ' THR . 35.0 ptt85 -58.61 -20.86 51.03 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.931 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.67 -64.11 0.92 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.244 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.513 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 31.1 tt0 -58.38 -45.36 88.44 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.244 -1.383 . . . . 0.0 109.695 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 29' ' ' LEU . 27.8 mt -61.93 -35.25 77.84 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.576 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 26' ' ' ARG . . . -59.5 -25.41 64.43 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 118.098 -1.441 . . . . 0.0 107.879 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -76.85 -36.35 56.87 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.69 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.5 mt -76.23 -76.72 0.15 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.741 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.42 -26.94 0.87 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.684 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.883 HD13 ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -88.14 139.01 18.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.842 180.0 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.721 ' N ' HD13 ' A' ' 34' ' ' ILE . 2.9 pt-20 174.02 168.73 0.21 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.515 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' C ' ' H ' ' A' ' 38' ' ' THR . 1.7 t-20 80.91 -145.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 120.147 -0.621 . . . . 0.0 112.654 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -53.24 6.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.988 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 35' ' ' GLU . 71.4 p -72.6 -149.05 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.358 -1.337 . . . . 0.0 110.75 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 38' ' ' THR . 2.8 mt 42.12 58.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.899 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t -72.92 -50.04 25.94 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.917 -179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.434 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -119.27 176.62 5.24 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.763 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -154.43 148.22 13.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 C-N-CA 117.856 -1.538 . . . . 0.0 112.813 -179.95 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -136.6 109.88 7.85 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.513 -1.222 . . . . 0.0 108.607 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.2 t -132.54 110.86 13.66 Favored Pre-proline 0 N--CA 1.495 1.803 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.322 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.13 167.96 20.43 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.007 1.138 . . . . 0.0 110.726 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.483 ' CG ' HH21 ' A' ' 92' ' ' ARG . 1.6 Cg_endo -62.18 -168.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.781 1.654 . . . . 0.0 111.326 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.89 -17.47 9.13 Favored Glycine 0 N--CA 1.482 1.73 0 C-N-CA 119.365 -1.397 . . . . 0.0 110.854 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.605 HG11 ' CB ' ' A' ' 2' ' ' ALA . 27.3 m -148.59 140.35 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.825 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -104.82 127.14 52.52 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.49 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.57 149.19 28.32 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.539 -0.864 . . . . 0.0 112.283 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.8 mt -139.87 114.58 7.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.569 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.502 ' HA ' HG23 ' A' ' 82' ' ' ILE . 3.6 mp -94.11 164.95 12.86 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.942 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -140.46 116.37 10.37 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.006 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -49.22 -84.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.363 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 59' ' ' ALA . 14.9 t-20 -59.01 141.26 54.42 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.521 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -60.92 -169.87 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.318 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 51.81 31.97 32.34 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.137 -1.506 . . . . 0.0 110.005 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.429 ' CE1' ' HG3' ' A' ' 83' ' ' ARG . 25.3 m-85 51.29 65.59 1.44 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.087 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 55' ' ' ASN . . . -144.06 -174.14 4.19 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.171 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.67 177.9 15.39 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.037 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -50.89 170.72 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.212 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -143.58 133.03 23.41 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.058 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.549 HG22 ' N ' ' A' ' 64' ' ' GLU . 6.5 mm -98.91 167.64 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.097 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.549 ' N ' HG22 ' A' ' 63' ' ' ILE . 51.5 mt-10 -145.29 129.16 17.35 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.163 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -149.24 164.52 4.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 118.598 -1.241 . . . . 0.0 112.609 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.33 -11.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 114.372 -1.285 . . . . 0.0 107.69 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -119.69 -152.19 0.5 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.144 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.662 HD21 ' H ' ' A' ' 107' ' ' ASP . 1.3 p30 -101.51 122.57 44.05 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.886 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.531 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.53 121.85 32.13 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.723 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -74.33 -83.67 0.05 Allowed 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.328 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -77.32 -0.25 24.84 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.962 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.4 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 5.8 tp 59.24 -97.47 0.07 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.717 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.4 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . -173.43 -174.83 40.73 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 118.893 -1.622 . . . . 0.0 111.117 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.595 ' C ' ' H ' ' A' ' 76' ' ' ASN . 1.4 Cg_endo -66.9 -34.04 31.25 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.688 2.259 . . . . 0.0 112.587 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.752 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.0 pt? -67.91 24.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.457 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.595 ' H ' ' C ' ' A' ' 74' ' ' PRO . 4.3 t30 -74.73 -6.35 48.35 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.201 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' ND2' ' A' ' 78' ' ' ASN . 4.6 t-20 -74.54 -25.11 59.11 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.992 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 31.9 m120 -158.14 132.03 7.9 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.384 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 t -147.81 138.52 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.843 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.9 m -162.53 -34.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.44 -1.304 . . . . 0.0 112.831 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.5 m -95.7 138.81 32.83 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.023 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.638 HD12 ' CE2' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -150.02 159.86 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 118.581 -1.248 . . . . 0.0 112.497 -179.869 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.846 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -149.94 116.84 5.92 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.417 -179.977 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.846 ' H ' HH22 ' A' ' 83' ' ' ARG . 14.1 t -120.63 139.54 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.438 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.77 HD11 HH11 ' A' ' 83' ' ' ARG . 1.4 mp -138.72 129.25 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.562 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 p -40.5 152.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.989 -0.685 . . . . 0.0 111.609 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.565 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -154.47 141.25 13.26 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.266 179.989 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.565 ' HD2' HG22 ' A' ' 87' ' ' VAL . 4.8 Cg_exo -52.37 132.55 45.05 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 121.168 1.246 . . . . 0.0 111.28 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.589 HG22 ' N ' ' A' ' 90' ' ' GLN . 4.0 p -59.13 163.96 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.639 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.589 ' N ' HG22 ' A' ' 89' ' ' VAL . 82.5 mm-40 -145.21 148.08 36.63 Favored Pre-proline 0 N--CA 1.487 1.387 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.045 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.64 -20.12 67.63 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 121.503 1.469 . . . . 0.0 111.846 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.483 HH21 ' CG ' ' A' ' 46' ' ' PRO . 20.3 ptt180 38.07 -158.31 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.463 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -147.87 172.76 13.65 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.61 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -141.21 115.48 9.37 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.865 -1.134 . . . . 0.0 112.087 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.42 ' CD2' HG13 ' A' ' 131' ' ' VAL . 66.7 m-85 -99.97 159.17 15.29 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.634 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 101' ' ' PHE . 26.0 m-85 -109.83 179.66 4.06 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.267 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.29 -66.97 0.91 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.438 -0.905 . . . . 0.0 112.755 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.513 ' CG ' ' N ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -87.49 163.05 16.91 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.918 0.866 . . . . 0.0 113.083 -179.735 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 13.6 tp10 -62.25 108.86 1.16 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.703 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 96.66 61.54 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.934 0 O-C-N 124.725 1.265 . . . . 0.0 111.113 179.895 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.542 ' O ' ' CD2' ' A' ' 101' ' ' PHE . 9.1 p90 29.4 33.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.422 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 100' ' ' GLN . 23.8 t70 -96.93 32.85 2.01 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.754 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -161.2 144.48 9.88 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 103' ' ' GLY . 15.7 tptm -34.5 144.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.929 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.468 ' C ' ' OE1' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -99.14 164.99 11.93 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.712 -0.795 . . . . 0.0 112.806 -179.803 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.417 HG11 ' CA ' ' A' ' 122' ' ' GLY . 7.0 t -140.28 118.57 10.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.495 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.662 ' H ' HD21 ' A' ' 68' ' ' ASN . 2.2 p-10 -93.83 163.08 13.66 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.535 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 108' ' ' LEU . 94.2 mt -144.08 144.44 26.27 Favored Pre-proline 0 N--CA 1.486 1.339 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.632 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.21 163.48 32.6 Favored 'Trans proline' 0 C--O 1.213 -0.771 0 C-N-CA 121.708 1.605 . . . . 0.0 111.095 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.68 142.73 95.24 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 121.452 1.435 . . . . 0.0 110.892 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.87 -157.13 26.97 Favored Glycine 0 N--CA 1.501 3.026 0 C-N-CA 118.758 -1.687 . . . . 0.0 111.522 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.66 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 46.1 tt0 -128.26 157.27 41.37 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.518 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.66 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 13.4 m-85 -142.43 155.99 45.15 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.799 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.4 p -99.61 176.47 5.47 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -179.674 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.531 ' NE2' ' OD2' ' A' ' 144' ' ' ASP . 20.9 pt20 -73.42 37.63 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.866 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.32 -56.3 0.08 Allowed 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.615 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.11 -42.61 75.86 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.163 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.617 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -45.25 -74.1 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.159 179.912 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.69 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 0.1 OUTLIER -50.69 -55.45 16.48 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.011 -1.076 . . . . 0.0 112.796 -179.63 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -10.59 6.45 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.915 -1.114 . . . . 0.0 111.319 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -100.04 -8.08 24.25 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.471 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.58 ' C ' HD13 ' A' ' 123' ' ' ILE . . . -152.0 -62.08 0.01 OUTLIER Glycine 0 N--CA 1.484 1.887 0 C-N-CA 118.498 -1.81 . . . . 0.0 111.989 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 1.062 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -140.63 127.82 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.968 -179.746 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 126' ' ' ASN . 36.9 t70 -39.48 161.41 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.84 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -58.29 13.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.105 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.637 ' O ' HG23 ' A' ' 127' ' ' THR . 1.6 p-10 -167.7 77.99 0.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.552 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 126' ' ' ASN . 1.1 p -163.66 -15.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.37 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -64.68 160.4 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.143 -179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.4 t -170.38 -87.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.55 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 m -81.93 138.02 35.07 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.487 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.42 HG13 ' CD2' ' A' ' 95' ' ' PHE . 2.1 t -121.14 156.84 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.509 0.671 . . . . 0.0 111.703 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -154.02 79.06 5.23 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.963 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.78 102.42 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.533 1.489 . . . . 0.0 110.834 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.463 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 3.5 mm-40 -51.55 -12.92 0.19 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.089 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 178.76 -34.86 0.08 OUTLIER Glycine 0 N--CA 1.49 2.278 0 C-N-CA 117.93 -2.081 . . . . 0.0 112.579 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.452 HD12 ' CA ' ' A' ' 92' ' ' ARG . 6.4 mt -87.35 171.87 10.27 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.185 -1.406 . . . . 0.0 111.824 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -95.16 123.21 38.53 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.41 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 153' ' ' VAL . 8.8 t -94.44 133.05 36.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.627 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.488 ' C ' HD12 ' A' ' 140' ' ' LEU . 62.0 t -124.2 132.13 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.48 179.805 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 139' ' ' VAL . 9.9 mp -107.31 134.13 50.83 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.435 -179.783 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.431 ' CD2' ' CB ' ' A' ' 146' ' ' PHE . 25.8 m-85 -110.59 122.06 46.83 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.105 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -55.4 -84.19 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.988 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.447 HD21 ' HB3' ' A' ' 147' ' ' SER . 26.2 p-10 -71.91 173.58 8.13 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.193 179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.531 ' OD2' ' NE2' ' A' ' 115' ' ' GLN . 2.3 m-20 -65.29 -153.35 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.175 -179.893 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.635 ' C ' ' CG ' ' A' ' 146' ' ' PHE . 71.7 m-20 41.91 22.61 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.288 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.635 ' CG ' ' C ' ' A' ' 145' ' ' ASN . 1.5 p90 40.08 57.12 2.44 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.154 -179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.447 ' HB3' HD21 ' A' ' 143' ' ' ASN . 8.4 t -138.66 -151.05 0.36 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.605 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 54.88 -166.02 2.87 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.377 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.5 157.14 11.87 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.88 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 p -148.12 174.68 11.71 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.568 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.3 mt -138.32 85.09 18.76 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.444 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -64.1 97.53 0.24 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 121.766 1.644 . . . . 0.0 112.387 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 138' ' ' VAL . 2.1 t -77.78 92.99 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.857 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -62.41 -21.49 65.42 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.808 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 52.3 p -169.84 -150.19 0.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 117.852 -1.539 . . . . 0.0 112.862 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -43.78 150.26 0.26 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.779 -179.818 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.554 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -171.8 65.07 0.39 Allowed Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.902 179.841 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 2.3 Cg_endo -61.95 19.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.267 1.978 . . . . 0.0 113.14 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.554 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER 178.67 111.76 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.053 179.873 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 13.5 mt -141.35 -42.97 0.37 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.467 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 74.37 -174.39 50.15 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.318 -1.42 . . . . 0.0 110.16 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.79 145.22 40.88 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.674 -179.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 2.4 tpt -88.62 -76.52 0.4 Allowed 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.483 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -91.6 -41.86 10.53 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.79 179.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.65 -32.85 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.152 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 176.24 134.23 0.05 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.802 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.37 131.12 45.08 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.504 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 169' ' ' SER . 97.0 p -93.69 -67.31 0.86 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.945 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.52 ' N ' ' OG ' ' A' ' 168' ' ' SER . 1.8 p -113.99 162.55 16.28 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.982 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.43 HG12 ' CD1' ' A' ' 118' ' ' LEU . 23.9 pt -143.01 175.73 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 118.735 -1.186 . . . . 0.0 112.037 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.403 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 3.2 ttp85 -154.51 109.18 3.04 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.477 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 172' ' ' ILE . 9.4 mt -89.6 92.8 4.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.574 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 116.325 -1.798 . . . . 0.0 110.944 179.996 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_